PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Barman, RK; Saha, S; Das, S				Barman, Ranjan Kumar; Saha, Sudipto; Das, Santasabuj			Prediction of Interactions between Viral and Host Proteins Using Supervised Machine Learning Methods	PLOS ONE			English	Article							HEPATITIS-E VIRUS; INFORMATION; SEQUENCES; NETWORK; SWINE; MODEL; INDIA	Background: Viral-host protein-protein interaction plays a vital role in pathogenesis, since it defines viral infection of the host and regulation of the host proteins. Identification of key viral-host protein-protein interactions (PPIs) has great implication for therapeutics. Methods: In this study, a systematic attempt has been made to predict viral-host PPIs by integrating different features, including domain-domain association, network topology and sequence information using viral-host PPIs from VirusMINT. The three well-known supervised machine learning methods, such as SVM, Naive Bayes and Random Forest, which are commonly used in the prediction of PPIs, were employed to evaluate the performance measure based on five-fold cross validation techniques. Results: Out of 44 descriptors, best features were found to be domain-domain association and methionine, serine and valine amino acid composition of viral proteins. In this study, SVM-based method achieved better sensitivity of 67% over Naive Bayes (37.49%) and Random Forest (55.66%). However the specificity of Naive Bayes was the highest (99.52%) as compared with SVM (74%) and Random Forest (89.08%). Overall, the SVM and Random Forest achieved accuracy of 71% and 72.41%, respectively. The proposed SVM-based method was evaluated on blind dataset and attained a sensitivity of 64%, specificity of 83%, and accuracy of 74%. In addition, unknown potential targets of hepatitis B virus-human and hepatitis E virus-human PPIs have been predicted through proposed SVM model and validated by gene ontology enrichment analysis. Our proposed model shows that, hepatitis B virus "C protein'' binds to membrane docking protein, while "X protein'' and "P protein'' interacts with cell-killing and metabolic process proteins, respectively. Conclusion: The proposed method can predict large scale interspecies viral-human PPIs. The nature and function of unknown viral proteins (HBV and HEV), interacting partners of host protein were identified using optimised SVM model.	[Barman, Ranjan Kumar; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India; [Das, Santasabuj] Natl Inst Cholera & Enter Dis, Div Clin Med, Kolkata, W Bengal, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute	Saha, S (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	ssaha4@jcbose.ac.in; dasss@icmr.org.in	Saha, Sudipto/AAF-1034-2020; Barman, Ranjan Kumar/GXZ-8073-2022	Barman, Ranjan Kumar/0000-0001-9901-3108; Saha, Sudipto/0000-0001-9433-8894	Council of Medical Research [2013-1551G]; Department of Biotechnology [BT/RLF/Re-entry/11/2011]	Council of Medical Research; Department of Biotechnology	This project was supported by the Indian Council of Medical Research [extramural project (IRIS ID: 2013-1551G)]. SS thanks the Department of Biotechnology for a Ramalingaswami fellowship (BT/RLF/Re-entry/11/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arnold R, 2012, METHODS, V57, P508, DOI 10.1016/j.ymeth.2012.06.011; Begum N, 2010, INDIAN J MED RES, V132, P504; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Caron M, 2006, J CLIN MICROBIOL, V44, P3440, DOI 10.1128/JCM.00939-06; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Cui G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S5; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; Davis FP, 2007, PROTEIN SCI, V16, P2585, DOI 10.1110/ps.073228407; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954; Dyer MD, 2011, INFECT GENET EVOL, V11, P917, DOI 10.1016/j.meegid.2011.02.022; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Hayashida M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S8; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Joachims T., 2002, THESIS KLUWER; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Memisevic V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-154; Priya SB, 2013, J THEOR BIOL, V326, P36, DOI 10.1016/j.jtbi.2013.02.016; Qi YJ, 2010, BIOINFORMATICS, V26, pi645, DOI 10.1093/bioinformatics/btq394; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; WILSON DW, 1994, J VIROL, V68, P6985, DOI 10.1128/JVI.68.11.6985-6993.1994; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Zhou HF, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720012300018	34	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112034	10.1371/journal.pone.0112034	http://dx.doi.org/10.1371/journal.pone.0112034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375323	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600092
J	Bassiony, H; Sabet, S; El-Din, TAS; Mohamed, MM; El-Ghor, AA				Bassiony, Heba; Sabet, Salwa; El-Din, Taher A. Salah; Mohamed, Mona M.; El-Ghor, Akmal A.			Magnetite Nanoparticles Inhibit Tumor Growth and Upregulate the Expression of P53/P16 in Ehrlich Solid Carcinoma Bearing Mice	PLOS ONE			English	Article							P53; CANCER; GENE; CELLS	Background: Magnetite nanoparticles (MNPs) have been widely used as contrast agents and have promising approaches in cancer treatment. In the present study we used Ehrlich solid carcinoma (ESC) bearing mice as a model to investigate MNPs antitumor activity, their effect on expression of p53 and p16 genes as an indicator for apoptotic induction in tumor tissues. Method: MNPs coated with ascorbic acid (size: 25.0 +/- 5.0 nm) were synthesized by co-precipitation method and characterized. Ehrlich mice model were treated with MNPs using 60 mg/Kg day by day for 14 injections; intratumorally (IT) or intraperitoneally (IP). Tumor size, pathological changes and iron content in tumor and normal muscle tissues were assessed. We also assessed changes in expression levels of p53 and p16 genes in addition to p53 protein level by immunohistochemistry. Results: Our results revealed that tumor growth was significantly reduced by IT and IP MNPs injection compared to untreated tumor. A significant increase in p53 and p16 mRNA expression was detected in Ehrlich solid tumors of IT and IP treated groups compared to untreated Ehrlich solid tumor. This increase was accompanied with increase in p53 protein expression. It is worth mentioning that no significant difference in expression of p53 and p16 could be detected between IT ESC and control group. Conclusion: MNPs might be more effective in breast cancer treatment if injected intratumorally to be directed to the tumor tissues.	[Bassiony, Heba; Sabet, Salwa; Mohamed, Mona M.; El-Ghor, Akmal A.] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt; [El-Din, Taher A. Salah] Agr Res Ctr, Nanotechnol & Adv Mat Cent Lab, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	El-Ghor, AA (corresponding author), Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt.	akmalelghor@gmail.com		Sabet, Salwa/0000-0002-4097-7866				Al-Raawi D, 2011, INT J CLIN EXP MED, V4, P265; Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0; Fouad DM, 2011, J NANOTECHNOL, V2011, DOI 10.1155/2011/416060; Gasco M, 2002, BREAST CANC RES, V4; Hartman KB, 2008, MOL DIAGN THER, V12, P1; Hartmann A, 1997, TRENDS GENET, V13, P27, DOI 10.1016/S0168-9525(96)10043-3; Heath JR, 2008, ANNU REV MED, V59, P251, DOI 10.1146/annurev.med.59.061506.185523; Huang JZ, 2003, WORLD J GASTROENTERO, V9, P84, DOI 10.3748/wjg.v9.i1.84; Jaganathan SK, 2010, J BIOMEDICINE BIOTEC, V2010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin C, 2008, CANCER BIOL THER, V7, P911, DOI 10.4161/cbt.7.6.5912; Johannsen M, 2007, INT J HYPERTHER, V23, P315, DOI 10.1080/02656730601175479; Kabel AM, 2014, AM J MED, V2, P12; Klien K, 2012, ARH HIG RADA TOKSIKO, V63, P133, DOI 10.2478/10004-1254-63-2012-2213; Laurent S, 2011, INT J MOL EPIDEMIOL, V2, P367; Levison DA, 1997, J PATHOL, V183, P243, DOI DOI 10.1002/(SICI)1096-9896(199710)183:2<243::AID-PATH770>3; Lozano G, 2010, COLD SPRING HARBOR P, V2; MAEDA H, 1989, CRIT REV THER DRUG, V6, P193; Markides H, 2012, J NANOMATER, V2012, DOI 10.1155/2012/614094; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; McGill G, 1999, J CLIN INVEST, V104, P223, DOI 10.1172/JCI7861; Mondal N, 2010, INT J PHARMACEUT, V397, P194, DOI 10.1016/j.ijpharm.2010.06.049; Peng X-H, 2008, INT J NANOMEDICINE, V3; Ruiz A, 2013, NANOSCALE, V5, P11400, DOI 10.1039/c3nr01412f; Salah El-Din TA, 2010, MAGNETITE NANOPARTIC; Sharpless NE, 2002, CANCER RES, V62, P2761; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; STOKINGER HE, 1984, AM IND HYG ASSOC J, V45, P127, DOI 10.1080/15298668491399497; Stone V, 2007, IEEE T NANOBIOSCIENC, V6; Szalay B, 2012, IRON OXIDE NANOPARTI; Vieira J, 2010, BRAZ ARCH BIOL TECHN, V53, P609, DOI 10.1590/S1516-89132010000300014; Wahajuddin SA, 2012, INT J NANOMEDICINE, V7; WILLIAMS JF, 1989, BIOTECHNIQUES, V7, P762; Wu J, 2010, INEC: 2010 3RD INTERNATIONAL NANOELECTRONICS CONFERENCE, VOLS 1 AND 2, P842; Wu WW, 2010, INT J NANOMED, V5, P1079, DOI 10.2147/IJN.S15660; Ye WP, 2011, INT J MOL SCI, V12, P1519, DOI 10.3390/ijms12031519; Zaklina K, 2012, VITAMINS TRACE ELEME; Zhao Q, 2012, THERANOSTICS, V2, P113, DOI 10.7150/thno.3854	40	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111960	10.1371/journal.pone.0111960	http://dx.doi.org/10.1371/journal.pone.0111960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375144	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600080
J	Butler, CA; Dashper, SG; Zhang, LY; Seers, CA; Mitchell, HL; Catmull, DV; Glew, MD; Heath, JE; Tan, Y; Khan, HSG; Reynolds, EC				Butler, Catherine A.; Dashper, Stuart G.; Zhang, Lianyi; Seers, Christine A.; Mitchell, Helen L.; Catmull, Deanne V.; Glew, Michelle D.; Heath, Jacqueline E.; Tan, Yan; Khan, Hasnah S. G.; Reynolds, Eric C.			The Porphyromonas gingivalis Ferric Uptake Regulator Orthologue Binds Hemin and Regulates Hemin-Responsive Biofilm Development	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; STRAIN ATCC 33277; ESCHERICHIA-COLI; IRON-METABOLISM; GENE-EXPRESSION; FUR REPRESSOR; METAL UPTAKE; BACTEROIDES; DEGRADATION; TRANSPORT	Porphyromonas gingivalis is a Gram-negative pathogen associated with the biofilm-mediated disease chronic periodontitis. P. gingivalis biofilm formation is dependent on environmental heme for which P. gingivalis has an obligate requirement as it is unable to synthesize protoporphyrin IX de novo, hence P. gingivalis transports iron and heme liberated from the human host. Homeostasis of a variety of transition metal ions is often mediated in Gram-negative bacteria at the transcriptional level by members of the Ferric Uptake Regulator (Fur) superfamily. P. gingivalis has a single predicted Fur superfamily orthologue which we have designated Har (heme associated regulator). Recombinant Har formed dimers in the presence of Zn2+ and bound one hemin molecule per monomer with high affinity (K-d of 0.23 mu M). The binding of hemin resulted in conformational changes of Zn(II) Har and residue (97)Cys was involved in hemin binding as part of a predicted -C-97-P-98-L-99-hemin binding motif. The expression of 35 genes was down-regulated and 9 up-regulated in a Har mutant (ECR455) relative to wild-type. Twenty six of the down-regulated genes were previously found to be up-regulated in P. gingivalis grown as a biofilm and 11 were up-regulated under hemin limitation. A truncated Zn(II) Har bound the promoter region of dnaA (PGN_0001), one of the up-regulated genes in the ECR455 mutant. This binding decreased as hemin concentration increased which was consistent with gene expression being regulated by hemin availability. ECR455 formed significantly less biofilm than the wild-type and unlike wild-type biofilm formation was independent of hemin availability. P. gingivalis possesses a hemin-binding Fur orthologue that regulates hemin-dependent biofilm formation.	[Butler, Catherine A.; Dashper, Stuart G.; Zhang, Lianyi; Seers, Christine A.; Mitchell, Helen L.; Catmull, Deanne V.; Glew, Michelle D.; Heath, Jacqueline E.; Tan, Yan; Khan, Hasnah S. G.; Reynolds, Eric C.] Univ Melbourne, Inst Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Inst Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia.	e.reynolds@unimelb.edu.au	Glew, Michelle/AAW-9955-2020; Zhang, Lianyi/H-7491-2014	Glew, Michelle/0000-0002-0690-6079; Butler, Catherine/0000-0001-6371-3954; Khan, Hasnah/0000-0001-9807-438X; Reynolds, Eric/0000-0002-6618-4856; Dashper, Stuart/0000-0003-0106-8691; Mitchell, Helen/0000-0002-8359-9279; Seers, Christine/0000-0002-7777-443X	Australian National Health and Medical Research Council [1008055]; Australian Dental Research Foundation [22/2002]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Dental Research Foundation	Financial assistance was received from The Australian National Health and Medical Research Council (https://www.nhmc.gov.au/) project grant 1008055 and Australian Dental Research Foundation (http://www.ada.org.au/about/adrfgrants.aspx) grant 22/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Ahmad R, 2009, PROTEINS, V75, P373, DOI 10.1002/prot.22247; Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x; Althaus EW, 1999, BIOCHEMISTRY-US, V38, P6559, DOI 10.1021/bi982788s; Anaya-Bergman C, 2015, MOL ORAL MICROBIOL, V30, P39, DOI 10.1111/omi.12066; Ang CS, 2008, PROTEOMICS, V8, P1645, DOI 10.1002/pmic.200700557; Berlutti F, 2004, BIOMETALS, V17, P271; Bsat N, 1999, J BACTERIOL, V181, P4299, DOI 10.1128/JB.181.14.4299-4307.1999; CALDERWOOD SB, 1987, J BACTERIOL, V169, P4759, DOI 10.1128/jb.169.10.4759-4764.1987; Carpenter BM, 2013, J BACTERIOL, V195, P5526, DOI 10.1128/JB.01026-13; Dashper SG, 2005, J BIOL CHEM, V280, P28095, DOI 10.1074/jbc.M503896200; Dashper SG, 2012, ANTIMICROB AGENTS CH, V56, P1548, DOI 10.1128/AAC.05100-11; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fleischhacker AS, 2011, CURR OPIN CHEM BIOL, V15, P335, DOI 10.1016/j.cbpa.2011.01.006; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HANTKE K, 1987, FEMS MICROBIOL LETT, V44, P53, DOI 10.1111/j.1574-6968.1987.tb02241.x; He J, 2006, INFECT IMMUN, V74, P4214, DOI 10.1128/IAI.00014-06; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; KARJALAINEN TK, 1991, MICROB PATHOGENESIS, V11, P317, DOI 10.1016/0882-4010(91)90017-5; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LEBEK G, 1985, INFECT IMMUN, V50, P682, DOI 10.1128/IAI.50.3.682-686.1985; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Lo AW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-18; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOESCHE WJ, 1981, J CLIN PERIODONTOL, V8, P29, DOI 10.1111/j.1600-051X.1981.tb02022.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; OSTROY F, 1978, BIOCHIM BIOPHYS ACTA, V527, P56, DOI 10.1016/0005-2744(78)90255-3; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pidot SJ, 2010, MOL MICROBIOL, V78, P1216, DOI 10.1111/j.1365-2958.2010.07401.x; Robertson KP, 2006, INFECT IMMUN, V74, P2304, DOI 10.1128/IAI.74.4.2304-2316.2006; Roper JM, 2000, J BIOL CHEM, V275, P40316, DOI 10.1074/jbc.M007146200; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; SHIZUKUISHI S, 1995, FEMS MICROBIOL LETT, V131, P313; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; SLOTS J, 1977, SCAND J DENT RES, V85, P247; SPIEGEL CA, 1979, J PERIODONTAL RES, V14, P376, DOI 10.1111/j.1600-0765.1979.tb00234.x; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Toney JH, 2006, JALA, V11, P30; Vajrala N, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-37; VANDYKE TE, 1988, J PERIODONTOL, V59, P184, DOI 10.1902/jop.1988.59.3.184; Vitale S, 2009, BIOCHEMISTRY-US, V48, P5582, DOI 10.1021/bi9004396; WHITE D, 1981, J PERIODONTAL RES, V16, P259, DOI 10.1111/j.1600-0765.1981.tb00974.x; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yamamoto R, 2011, APPL ENVIRON MICROB, V77, P6733, DOI 10.1128/AEM.00746-11; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	77	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111168	10.1371/journal.pone.0111168	http://dx.doi.org/10.1371/journal.pone.0111168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375181	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600027
J	Kosmidis, EK; Moschou, V; Ziogas, G; Boukovinas, I; Albani, M; Laskaris, NA				Kosmidis, Efstratios K.; Moschou, Vasiliki; Ziogas, Georgios; Boukovinas, Ioannis; Albani, Maria; Laskaris, Nikolaos A.			Functional Aspects of the EGF-Induced MAP Kinase Cascade: A Complex Self-Organizing System Approach	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ERBB SIGNALING NETWORK; MATHEMATICAL-MODEL; ACTIVATION; DYNAMICS; RESPONSES; INFORMATION; CANCER; TRANSDUCTION; MECHANISMS	The EGF-induced MAP kinase cascade is one of the most important and best characterized networks in intracellular signalling. It has a vital role in the development and maturation of living organisms. However, when deregulated, it is involved in the onset of a number of diseases. Based on a computational model describing a "surface" and an "internalized" parallel route, we use systems biology techniques to characterize aspects of the network's functional organization. We examine the re-organization of protein groups from low to high external stimulation, define functional groups of proteins within the network, determine the parameter best encoding for input intensity and predict the effect of protein removal to the system's output response. Extensive functional re-organization of proteins is observed in the lower end of stimulus concentrations. As we move to higher concentrations the variability is less pronounced. 6 functional groups have emerged from a consensus clustering approach, reflecting different dynamical aspects of the network. Mutual information investigation revealed that the maximum activation rate of the two output proteins best encodes for stimulus intensity. Removal of each protein of the network resulted in a range of graded effects, from complete silencing to intense activation. Our results provide a new "vista" of the EGF-induced MAP kinase cascade, from the perspective of complex self-organizing systems. Functional grouping of the proteins reveals an organizational scheme contrasting the current understanding of modular topology. The six identified groups may provide the means to experimentally follow the dynamics of this complex network. Also, the vulnerability analysis approach may be used for the development of novel therapeutic targets in the context of personalized medicine.	[Kosmidis, Efstratios K.; Moschou, Vasiliki; Albani, Maria] Aristotle Univ Thessaloniki, Dept Med, Physiol Lab, GR-54006 Thessaloniki, Greece; [Ziogas, Georgios; Laskaris, Nikolaos A.] Aristotle Univ Thessaloniki, Dept Informat, AIIA Lab, GR-54006 Thessaloniki, Greece; [Boukovinas, Ioannis] Bioclin Oncol Unit, Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Kosmidis, EK (corresponding author), Aristotle Univ Thessaloniki, Dept Med, Physiol Lab, Univ Campus, GR-54006 Thessaloniki, Greece.	kosmidef@med.auth.gr		Laskaris, Nikos/0000-0002-1960-394X	AUTH research committee [89347]; Amgen Hellas [89547]	AUTH research committee; Amgen Hellas	This research was partially funded by AUTH research committee (grant 89347, www.rc.auth.gr) and Amgen Hellas (grant 89547, www.amgen.gr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamos DA, 2010, J NEUROSCI METH, V190, P129, DOI 10.1016/j.jneumeth.2010.04.018; Araujo RP, 2005, BIOSYSTEMS, V80, P57, DOI 10.1016/j.biosystems.2004.10.002; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Castagnino N, 2010, LECT N BIOINFORMAT, V6160, P151; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cooper GM, 2000, CELL MOL APPROACH; El-Masri HA, 1999, B MATH BIOL, V61, P379, DOI 10.1006/bulm.1998.0077; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Hubbard SR, 2005, CANCER CELL, V7, P287, DOI 10.1016/j.ccr.2005.04.004; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iyengar R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003563; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Laskaris NA, 2004, IEEE SIGNAL PROC MAG, V21, P66, DOI 10.1109/MSP.2004.1296544; Laskaris NA, 2002, CLIN NEUROPHYSIOL, V113, P1209, DOI 10.1016/S1388-2457(02)00124-4; Laskaris NA, 2008, IEEE ENG MED BIOL, V27, P69, DOI 10.1109/EMB.2007.913555; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030140; Liu G, 2005, BIOINFORMATICS, V21, P1194, DOI 10.1093/bioinformatics/bti118; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nielsen UB, 2005, IDRUGS, V8, P822; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Pavan M, 2007, IEEE T PATTERN ANAL, V29, P167, DOI 10.1109/TPAMI.2007.250608; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schoeberl Birgit, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P53; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Shankaran H, 2012, MOL BIOSYST, V8, P2868, DOI 10.1039/c2mb25190f; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; STARBUCK C, 1992, BIOTECHNOL PROGR, V8, P132, DOI 10.1021/bp00014a007; Sun XQ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-218; Tasaki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013926; Wang DYQ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-118; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111612	10.1371/journal.pone.0111612	http://dx.doi.org/10.1371/journal.pone.0111612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372488	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900056
J	Skala, V; Cernikova, A; Jindrova, Z; Kasny, M; Vostry, M; Walker, AJ; Horak, P				Skala, Vladimir; Cernikova, Alena; Jindrova, Zuzana; Kasny, Martin; Vostry, Martin; Walker, Anthony J.; Horak, Petr			Influence of Trichobilharzia regenti (Digenea: Schistosomatidae) on the Defence Activity of Radix lagotis (Lymnaeidae) Haemocytes	PLOS ONE			English	Article							RESISTANT BIOMPHALARIA-GLABRATA; PROTEIN-KINASE; AVIAN SCHISTOSOME; IMMUNE-RESPONSES; MANSONI; STAGNALIS; SNAIL; PHAGOCYTOSIS; SPOROCYSTS; CELLS	Radix lagotis is an intermediate snail host of the nasal bird schistosome Trichobilharzia regenti. Changes in defence responses in infected snails that might be related to host-parasite compatibility are not known. This study therefore aimed to characterize R. lagotis haemocyte defence mechanisms and determine the extent to which they are modulated by T. regenti. Histological observations of R. lagotis infected with T. regenti revealed that early phases of infection were accompanied by haemocyte accumulation around the developing larvae 2-36 h post exposure (p. e.) to the parasite. At later time points, 44-92 h p. e., no haemocytes were observed around T. regenti. Additionally, microtubular aggregates likely corresponding to phagocytosed ciliary plates of T. regenti miracidia were observed within haemocytes by use of transmission electron microscopy. When the infection was in the patent phase, haemocyte phagocytic activity and hydrogen peroxide production were significantly reduced in infected R. lagotis when compared to uninfected counterparts, whereas haemocyte abundance increased in infected snails. At a molecular level, protein kinase C (PKC) and extracellular-signal regulated kinase (ERK) were found to play an important role in regulating these defence reactions in R. lagotis. Moreover, haemocytes from snails with patent infection displayed lower PKC and ERK activity in cell adhesion assays when compared to those from uninfected snails, which may therefore be related to the reduced defence activities of these cells. These data provide the first integrated insight into the immunobiology of R. lagotis and demonstrate modulation of haemocyte-mediated responses in patent T. regenti infected snails. Given that immunomodulation occurs during patency, interference of snail-host defence by T. regenti might be important for the sustained production and/or release of infective cercariae.	[Skala, Vladimir; Jindrova, Zuzana; Kasny, Martin; Vostry, Martin; Horak, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Cernikova, Alena] Charles Univ Prague, Fac Sci, Inst Appl Math & Informat Technol, Prague, Czech Republic; [Jindrova, Zuzana] Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague, Czech Republic; [Kasny, Martin] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Vostry, Martin] Inst Hematol & Blood Transfus, Prague, Czech Republic; [Walker, Anthony J.] Univ Kingston, Sch Life Sci, Mol Parasitol Lab, Kingston Upon Thames KT1 2EE, Surrey, England	Charles University Prague; Charles University Prague; Charles University Prague; Masaryk University Brno; Institute of Hematology Prague; Kingston University	Skala, V (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	mich007@email.cz	Cernikova, Alena/V-4090-2017; Fremuntova, Zuzana/G-3859-2017; Skála, Vladimír/J-7405-2017; Horák, Petr/AGF-2029-2022; Horák, Petr/C-6482-2009; Skala, Vladimir/J-7405-2017	Cernikova, Alena/0000-0001-6954-9075; Fremuntova, Zuzana/0000-0002-7910-5344; Skála, Vladimír/0000-0003-0898-5708; Horák, Petr/0000-0001-9820-5044; Horák, Petr/0000-0001-9820-5044; Vostry, Martin/0000-0002-7557-2543; Skala, Vladimir/0000-0001-9113-3658	Charles University in Prague [435911, PRVOUK - P41/PrF, UNCE 204017, SVV 260074/2014]	Charles University in Prague	The study was financially supported by the Charles University in Prague (Grant GAUK no. 435911, research programmes PRVOUK - P41/PrF, UNCE 204017 and SVV 260074/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-El-Naga IF, 2012, REV BIOL TROP, V60, P1195; ADEMA CM, 1991, DEV COMP IMMUNOL, V15, P17, DOI 10.1016/0145-305X(91)90043-X; Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; ADEMA CM, 1994, J PARASITOL, V80, P719, DOI 10.2307/3283251; AMEN RI, 1992, PARASITOLOGY, V104, P33, DOI 10.1017/S0031182000060777; Arumugam M, 2000, EUR J CELL BIOL, V79, P513, DOI 10.1078/0171-9335-00068; BAYNE CJ, 1980, J PARASITOL, V66, P413, DOI 10.2307/3280740; BAYNE CJ, 1980, EXP PARASITOL, V50, P409, DOI 10.1016/0014-4894(80)90043-0; Bender RC, 2005, J PARASITOL, V91, P275, DOI 10.1645/GE-415R; Chen QM, 1996, J BIOL CHEM, V271, P18122, DOI 10.1074/jbc.271.30.18122; CONNORS VA, 1990, J PARASITOL, V76, P895, DOI 10.2307/3282811; de Jong-Brink M, 2001, PARASITOLOGY, V123, pS129, DOI 10.1017/S0031182001008149; DIKKEBOOM R, 1988, DEV COMP IMMUNOL, V12, P509, DOI 10.1016/0145-305X(88)90068-7; Flye-Sainte-Marie J, 2009, J EXP MAR BIOL ECOL, V377, P1, DOI 10.1016/j.jembe.2009.06.003; Garcia-Garcia E, 2008, DEV COMP IMMUNOL, V32, P637, DOI 10.1016/j.dci.2007.10.004; Gorbushin AM, 2008, FISH SHELLFISH IMMUN, V24, P745, DOI 10.1016/j.fsi.2008.01.018; Hahn UK, 2001, J PARASITOL, V87, P292, DOI 10.1645/0022-3395(2001)087[0292:KOSMSB]2.0.CO;2; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Horak P, 1998, PARASITE, V5, P349, DOI 10.1051/parasite/1998054349; Horak P, 2002, ADV PARASIT, V52, P155, DOI 10.1016/S0065-308X(02)52012-1; Humphries JE, 2003, INTEGR COMP BIOL, V43, P305, DOI 10.1093/icb/43.2.305; Humphries JE, 2008, DEV COMP IMMUNOL, V32, P554, DOI 10.1016/j.dci.2007.09.001; Hunova K, 2012, ACTA PARASITOL, V57, P273, DOI 10.2478/s11686-012-0040-7; Iakovleva NV, 2006, EXP PARASITOL, V113, P24, DOI 10.1016/j.exppara.2005.12.002; ITO T, 1992, DEV COMP IMMUNOL, V16, P287, DOI 10.1016/0145-305X(92)90003-U; Kolarova L, 2013, CLIN REV ALLERG IMMU, V45, P63, DOI 10.1007/s12016-012-8334-y; Lacchini AH, 2006, J EXP BIOL, V209, P4829, DOI 10.1242/jeb.02561; Lehmacher W, 1999, BIOMETRICS, V55, P1286, DOI 10.1111/j.0006-341X.1999.01286.x; LIE KJ, 1981, J PARASITOL, V67, P790, DOI 10.2307/3280701; LOKER ES, 1987, J PARASITOL, V73, P1090, DOI 10.2307/3282286; LOKER ES, 1982, J PARASITOL, V68, P84, DOI 10.2307/3281328; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mohamed AH, 2011, EXP PARASITOL, V127, P789, DOI 10.1016/j.exppara.2011.01.020; MOUNKASSA JB, 1990, J INVERTEBR PATHOL, V55, P306, DOI 10.1016/0022-2011(90)90071-D; Nacif-Pimenta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045637; NODA S, 1989, J PARASITOL, V75, P261, DOI 10.2307/3282775; NUNEZ PE, 1994, PARASITOLOGY, V109, P299, DOI 10.1017/S0031182000078331; Plows LD, 2006, J INVERTEBR PATHOL, V91, P74, DOI 10.1016/j.jip.2005.10.011; Plows LD, 2005, INT J PARASITOL, V35, P293, DOI 10.1016/j.ijpara.2004.11.012; Plows LD, 2004, BBA-MOL CELL RES, V1692, P25, DOI 10.1016/j.bbamer.2004.03.002; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RILEY EM, 1992, J INVERTEBR PATHOL, V59, P190, DOI 10.1016/0022-2011(92)90032-Y; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V130, P497, DOI 10.1007/BF00307004; SURESH PG, 1994, COMP HAEMATOL INT, V4, P17, DOI 10.1007/BF00368261; Theron A, 1997, EXP PARASITOL, V85, P1, DOI 10.1006/expr.1996.4106; VANDERKNAAP WPW, 1993, COMP HAEMATOL INT, V3, P20, DOI 10.1007/BF00394923; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Walker AJ, 2003, BIOL CELL, V95, P527, DOI 10.1016/j.biolcel.2003.09.001; Zahoor Z, 2008, DEV COMP IMMUNOL, V32, P1561, DOI 10.1016/j.dci.2008.05.014; Zelck UE, 2007, DEV COMP IMMUNOL, V31, P321, DOI 10.1016/j.dci.2006.06.006	51	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111696	10.1371/journal.pone.0111696	http://dx.doi.org/10.1371/journal.pone.0111696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372492	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000344556900065
J	Tsen, SWD; Kingsley, DH; Kibler, K; Jacobs, B; Sizemore, S; Vaiana, SM; Anderson, J; Tsen, KT; Achilefu, S				Tsen, Shaw-Wei D.; Kingsley, David H.; Kibler, Karen; Jacobs, Bert; Sizemore, Sara; Vaiana, Sara M.; Anderson, Jeanne; Tsen, Kong-Thon; Achilefu, Samuel			Pathogen Reduction in Human Plasma Using an Ultrashort Pulsed Laser	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; HEPATITIS-A VIRUS; INACTIVATION; FIBRINOGEN	Pathogen reduction is a viable approach to ensure the continued safety of the blood supply against emerging pathogens. However, the currently licensed pathogen reduction techniques are ineffective against non-enveloped viruses such as hepatitis A virus, and they introduce chemicals with concerns of side effects which prevent their widespread use. In this report, we demonstrate the inactivation of both enveloped and non-enveloped viruses in human plasma using a novel chemical-free method, a visible ultrashort pulsed laser. We found that laser treatment resulted in 2-log, 1-log, and 3-log reductions in human immunodeficiency virus, hepatitis A virus, and murine cytomegalovirus in human plasma, respectively. Laser-treated plasma showed >= 70% retention for most coagulation factors tested. Furthermore, laser treatment did not alter the structure of a model coagulation factor, fibrinogen. Ultrashort pulsed lasers are a promising new method for chemical-free, broad-spectrum pathogen reduction in human plasma.	[Tsen, Shaw-Wei D.; Achilefu, Samuel] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Kingsley, David H.] Delaware State Univ, James WW Baker Ctr, Food Safety & Intervent Technol Res Unit, USDA ARS, Delaware, OH USA; [Kibler, Karen; Jacobs, Bert] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Sizemore, Sara; Vaiana, Sara M.; Tsen, Kong-Thon] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Anderson, Jeanne] Barnes Jewish Hosp, Dept Hematol, St Louis, MO 63110 USA; [Sizemore, Sara; Vaiana, Sara M.; Tsen, Kong-Thon] Arizona State Univ, Ctr Biophys, Tempe, AZ USA; [Achilefu, Samuel] Washington Univ, Sch Med, St Louis, MO USA	Washington University (WUSTL); United States Department of Agriculture (USDA); Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Barnes-Jewish Hospital; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; Washington University (WUSTL)	Achilefu, S (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	achilefus@mir.wustl.edu	Achilefu, Samuel/AAC-2401-2019	Achilefu, Samuel/0000-0002-3133-6717	National Heart, Lung, and Blood Institute Ruth L. Kirschstein NRSA F30 [HL116183-01]; Mallinckrodt Institute of Radiology Development Fund; National Institutes of Health [R01 EB008111, R33 CA123537, S10 OD016237]; NATIONAL CANCER INSTITUTE [R33CA123537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL116183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008111] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016237] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Ruth L. Kirschstein NRSA F30; Mallinckrodt Institute of Radiology Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Heart, Lung, and Blood Institute Ruth L. Kirschstein NRSA F30 grant HL116183-01 (SDT), by the Mallinckrodt Institute of Radiology Development Fund, and resources from National Institutes of Health grants R01 EB008111, R33 CA123537, and S10 OD016237 (SA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005; AuBuchon J, 2011, ISBT SCI SERIES, V6, P181; Bhadri PR, 2008, ANALOG INTEGR CIRC S, V56, P127, DOI 10.1007/s10470-007-9076-2; Bryant BJ, 2007, ARCH PATHOL LAB MED, V131, P719; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Feng L, 1995, ACS SYM SER, V602, P66; Garwood M, 2003, TRANSFUSION, V43, P1238, DOI 10.1046/j.1537-2995.2003.00485.x; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hellstern P, 2004, CURR OPIN HEMATOL, V11, P346, DOI 10.1097/01.moh.0000137915.88478.23; Hellstern P, 2011, TRANSFUS MED HEMOTH, V38, P65, DOI 10.1159/000323552; Kingsley DH, 2009, INT J FOOD MICROBIOL, V130, P61, DOI 10.1016/j.ijfoodmicro.2009.01.004; LEMON SM, 1991, J VIROL, V65, P2056, DOI 10.1128/JVI.65.4.2056-2065.1991; Musso D, 2014, TRANSFUSION; Qian ZK, 2012, J VIROL, V86, P6712, DOI 10.1128/JVI.00200-12; Rock G, 2011, VOX SANG, V100, P169, DOI 10.1111/j.1423-0410.2010.01374.x; ROSSI E, 1988, THROMB RES, V52, P453, DOI 10.1016/0049-3848(88)90029-1; Schmaier AH, 2012, HEMATOLOGY BASIC PRI; Singh Y, 2006, TRANSFUSION, V46, P1168, DOI 10.1111/j.1537-2995.2006.00867.x; Tsen KT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/47/472201; Tsen KT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/322102; Tsen KT, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/25/252205; Tsen KT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600771; Tsen KT, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275477; Tsen KT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821713; Tsen SWD, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-20; Tsen SWD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.128002; Tsen SWD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-62; ZEILER T, 1994, TRANSFUSION, V34, P685, DOI 10.1046/j.1537-2995.1994.34894353464.x	28	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111673	10.1371/journal.pone.0111673	http://dx.doi.org/10.1371/journal.pone.0111673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372037	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900061
J	Bellefeuille, SD; Dorion, S; Rivoal, J; Morse, D				Bellefeuille, Steve Dagenais; Dorion, Sonia; Rivoal, Jean; Morse, David			The Dinoflagellate Lingulodinium polyedrum Responds to N Depletion by a Polarized Deposition of Starch and Lipid Bodies	PLOS ONE			English	Article							RED TIDE DINOFLAGELLATE; HARMFUL ALGAL BLOOMS; NITROGEN LIMITATION; KARENIA-BREVIS; CARBON; PHOTOSYNTHESIS; PHOSPHORUS; NITRATE; GROWTH; AVAILABILITY	Dinoflagellates are important contributors to the marine phytoplankton and global carbon fixation, but are also infamous for their ability to form the spectacular harmful algal blooms called red tides. While blooms are often associated with high available nitrogen, there are instances where they are observed in oligotrophic environments. In order to maintain their massive population in conditions of nitrogen limitation, dinoflagellates must have evolved efficient adaptive mechanisms. Here we report the physiological responses to nitrogen deprivation in Lingulodinium polyedrum. We find that this species reacts to nitrogen stress, as do most plants and microalgae, by stopping cell growth and diminishing levels of internal nitrogen, in particular in the form of protein and chlorophyll. Photosynthesis is maintained at high levels for roughly a week following nitrate depletion, resulting in accumulated photosynthetic products in the form of starch. During the second week, photosynthesis rates decrease due to a reduction in the number of chloroplasts and the accumulation of neutral lipid droplets. Surprisingly, the starch granules and lipid droplets are seen to accumulate at opposite poles of the cell. Lastly, we observe that cells acclimated to nitrogen-depleted conditions resume normal growth after addition of inorganic nitrogen, but are able to maintain high cell densities far longer than cells grown continuously in nitrogen-replete conditions.	[Bellefeuille, Steve Dagenais; Dorion, Sonia; Rivoal, Jean; Morse, David] Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada	Universite de Montreal	Morse, D (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada.	david.morse@umontreal.ca	Rivoal, Jean/J-6544-2014	Rivoal, Jean/0000-0002-8991-0566; Dagenais Bellefeuille, Steve/0000-0001-5281-5971; Morse, David/0000-0003-4131-4367	Natural Sciences and Engineering Research Council of Canada (NSERC); Fond de Recherche du Quebec- Nature et Technologies (FQRNT)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fond de Recherche du Quebec- Nature et Technologies (FQRNT)(FQRNT)	Financial support by the Natural Sciences and Engineering Research Council of Canada (NSERC) for discovery grants to DM and JR and by the Fond de Recherche du Quebec- Nature et Technologies (FQRNT) for a studentship (SD-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; Atkinson M, 1994, J AQUARI AQUA SCI, V8, P39; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Dagenais-Bellefeuille S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00369; Dauvillee D, 2009, P NATL ACAD SCI USA, V106, P21126, DOI 10.1073/pnas.0907424106; Davey MP, 2014, EUKARYOT CELL, V13, P392, DOI 10.1128/EC.00178-13; Deschamps P, 2008, EUKARYOT CELL, V7, P872, DOI 10.1128/EC.00461-07; Deschamps P, 2006, EUKARYOT CELL, V5, P954, DOI 10.1128/EC.00380-05; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Perez-Perez ME, 2010, PLANT PHYSIOL, V152, P1874, DOI 10.1104/pp.109.152520; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Foyer CH, 2003, J EXP BOT, V54, P585, DOI 10.1093/jxb/erg053; Graf A, 2011, TRENDS PLANT SCI, V16, P169, DOI 10.1016/j.tplants.2010.12.003; Hastings JW, 2007, COLD SPRING HARB SYM, V72, P141, DOI 10.1101/sqb.2007.72.026; Heldt H-W, 2011, PLANT BIOCH, P241, DOI DOI 10.1016/B978-0-12-384986-1.00009-0; Hicks GR, 2001, PLANT PHYSIOL, V127, P1334; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; HOLMES RW, 1967, LIMNOL OCEANOGR, V12, P503, DOI 10.4319/lo.1967.12.3.0503; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jiang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087416; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kopp C, 2013, MBIO, V4, DOI 10.1128/mBio.00052-13; Kudela RM, 2000, AQUAT MICROB ECOL, V21, P31, DOI 10.3354/ame021031; Lei QY, 2011, MAR POLLUT BULL, V62, P2692, DOI 10.1016/j.marpolbul.2011.09.021; Lin SJ, 2004, J PHYCOL, V40, P1062, DOI 10.1111/j.1529-8817.2004.03217.x; Liu BL, 2012, PROTIST, V163, P746, DOI 10.1016/j.protis.2011.11.001; MacKenzie TDB, 2011, PLANT CELL ENVIRON, V34, P669, DOI 10.1111/j.1365-3040.2010.02271.x; Moorthi SD, 2006, MICROB ECOL, V52, P136, DOI 10.1007/s00248-006-9030-3; Morey JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-346; Nassoury N, 2001, PLANT CELL, V13, P923; OLSON RJ, 1986, J PLANKTON RES, V8, P785, DOI 10.1093/plankt/8.4.785; Plancke C, 2008, EUKARYOT CELL, V7, P247, DOI 10.1128/EC.00373-07; Pleissner D, 2012, BIOTECHNOL BIOENG, V109, P2005, DOI 10.1002/bit.24470; PREZELIN BB, 1986, MAR BIOL, V93, P1, DOI 10.1007/BF00428648; RIVOAL J, 1993, PLANT PHYSIOL, V101, P553, DOI 10.1104/pp.101.2.553; Roenneberg T, 1996, FASEB J, V10, P1443, DOI 10.1096/fasebj.10.12.8903515; SCHMITTER RE, 1971, J CELL SCI, V9, P147; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Trethewey RN, 1998, PLANT J, V15, P109, DOI 10.1046/j.1365-313X.1998.00190.x; TURPIN DH, 1991, J PHYCOL, V27, P14, DOI 10.1111/j.0022-3646.1991.00014.x; Vanucci S, 2012, HARMFUL ALGAE, V15, P78, DOI 10.1016/j.hal.2011.12.003; Vargo GA, 2008, CONT SHELF RES, V28, P73, DOI 10.1016/j.csr.2007.04.008; Viola R, 2001, P ROY SOC B-BIOL SCI, V268, P1417, DOI 10.1098/rspb.2001.1644; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Walsh JJ, 2009, PROG OCEANOGR, V80, P51, DOI 10.1016/j.pocean.2008.12.005; ZHOU J, 1994, J PHYCOL, V30, P39, DOI 10.1111/j.0022-3646.1994.00039.x	54	17	17	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111067	10.1371/journal.pone.0111067	http://dx.doi.org/10.1371/journal.pone.0111067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368991	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402000034
J	Day, CP; Carter, J; Ohler, ZW; Bonomi, C; El Meskini, R; Martin, P; Graff-Cherry, C; Feigenbaum, L; Tuting, T; Van Dyke, T; Hollingshead, M; Merlino, G				Day, Chi-Ping; Carter, John; Ohler, Zoe Weaver; Bonomi, Carrie; El Meskini, Rajaa; Martin, Philip; Graff-Cherry, Cari; Feigenbaum, Lionel; Tueting, Thomas; Van Dyke, Terry; Hollingshead, Melinda; Merlino, Glenn			"Glowing Head'' Mice: A Genetic Tool Enabling Reliable Preclinical Image-Based Evaluation of Cancers in Immunocompetent Allografts	PLOS ONE			English	Article							IN-VIVO; TRANSGENE EXPRESSION; IMMUNE-RESPONSES; TUMOR-SUPPRESSOR; DRUG DEVELOPMENT; PITUITARY-GLAND; LUNG METASTASIS; BONE-MARROW; CELLS; MOUSE	Preclinical therapeutic assessment currently relies on the growth response of established human cell lines xenografted into immunocompromised mice, a strategy that is generally not predictive of clinical outcomes. Immunocompetent genetically engineered mouse (GEM)-derived tumor allograft models offer highly tractable preclinical alternatives and facilitate analysis of clinically promising immunomodulatory agents. Imageable reporters are essential for accurately tracking tumor growth and response, particularly for metastases. Unfortunately, reporters such as luciferase and GFP are foreign antigens in immunocompetent mice, potentially hindering tumor growth and confounding therapeutic responses. Here we assessed the value of reporter-tolerized GEMs as allograft recipients by targeting minimal expression of a luciferase-GFP fusion reporter to the anterior pituitary gland (dubbed the "Glowing Head'' or GH mouse). The luciferase-GFP reporter expressed in tumor cells induced adverse immune responses in wildtype mouse, but not in GH mouse, as transplantation hosts. The antigenicity of optical reporters resulted in a decrease in both the growth and metastatic potential of the labeled tumor in wildtype mice as compared to the GH mice. Moreover, reporter expression can also alter the tumor response to chemotherapy or targeted therapy in a context-dependent manner. Thus the GH mice and experimental approaches vetted herein provide concept validation and a strategy for effective, reproducible preclinical evaluation of growth and response kinetics for traceable tumors.	[Day, Chi-Ping; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Carter, John; Bonomi, Carrie] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, In Vivo Evaluat, Frederick, MD USA; [Van Dyke, Terry] NCI, Ctr Adv Preclin Res, Ctr Canc Res, Frederick, MD 21701 USA; [Ohler, Zoe Weaver; El Meskini, Rajaa; Martin, Philip] Leidos Biomed Res Inc, Ctr Adv Preclin Res, Natl Lab Canc Res, Frederick, MD USA; [Graff-Cherry, Cari; Feigenbaum, Lionel] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Lab Anim Sci Program, Frederick, MD USA; [Tueting, Thomas] Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Hollingshead, Melinda] NCI, Biol Testing Branch, Dev Therapeut Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bonn; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	gmerlino@helix.nih.gov	Tüting, Thomas/AAJ-3610-2021	Tüting, Thomas/0000-0001-7146-0934; Weaver Ohler, Zoe/0000-0002-6287-2504	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis; Center for Cancer Research, NCI, NIH; Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE [ZIABC011462] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis; Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. This work was supported in part by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis and Intramural Research Program of the Center for Cancer Research, NCI, NIH. Leidos Biomedical Research Inc. provided support in the form of salaries for authors John Carter, Zoe Weaver-Ohler, Carrie Bonomi, Rajaa El Meskini, Philip Martin, Cari Graff-Cherry, and Lionel Feigenbaum, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	*ADM USFAD, 2004, INN STAGN CHALL OPP; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Andersson G, 2003, MOL THER, V8, P385, DOI 10.1016/S1525-0016(03)00210-7; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Day CP, 2012, INT J CANCER, V130, P190, DOI 10.1002/ijc.25978; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; Day CP, 2011, FED REGISTER, V76, P40382; de Jersey J, 2002, J IMMUNOL, V169, P6753, DOI 10.4049/jimmunol.169.12.6753; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Herper M, 2012, FORBES; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Holzel M, 2013, NAT REV CANCER, V13, P365, DOI 10.1038/nrc3498; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Luque RM, 2007, ENDOCRINOLOGY, V148, P1946, DOI 10.1210/en.2006-1542; MELIEF CJM, 1993, CURR OPIN IMMUNOL, V5, P709, DOI 10.1016/0952-7915(93)90125-C; Merlino G, 2013, PIGMENT CELL MELANOM; Michou AI, 1997, GENE THER, V4, P473, DOI 10.1038/sj.gt.3300412; Mishra PJ, 2010, ONCOGENE, V29, P2449, DOI 10.1038/onc.2009.521; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Recio JA, 2002, CANCER RES, V62, P6724; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Sparreboom A, 1996, CANCER RES, V56, P2112; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Yang Y, 1996, GENE THER, V3, P137; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	38	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109956	10.1371/journal.pone.0109956	http://dx.doi.org/10.1371/journal.pone.0109956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369133	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000013
J	Ko, MC; Lee, MC; Amstislavskaya, TG; Tikhonova, MA; Yang, YL; Lu, KT				Ko, Meng Chang; Lee, Min Chong; Amstislavskaya, Tamara G.; Tikhonova, Maria A.; Yang, Yi-Ling; Lu, Kwok-Tung			Inhibition of NKCC1 Attenuated Hippocampal LTP Formation and Inhibitory Avoidance in Rat	PLOS ONE			English	Article							CATION-CHLORIDE-COTRANSPORTERS; K+-CL-COTRANSPORTER; INDUCED BRAIN EDEMA; PROTEIN-KINASE-C; AREA CA1; BUMETANIDE; INJURY; STIMULATION; HOMEOSTASIS; ACTIVATION	The loop diuretic bumetanide (Bumex) is thought to have antiepileptic properties via modulate GABA(A) mediated signaling through their antagonism of cation-chloride cotransporters. Given that loop diuretics may act as antiepileptic drugs that modulate GABAergic signaling, we sought to investigate whether they also affect hippocampal function. The current study was performed to evaluate the possible role of NKCC1 on the hippocampal function. Brain slice extracellular recording, inhibitory avoidance, and western blot were applied in this study. Results showed that hippocampal Long-term potentiation was attenuated by suprafusion of NKCC1 inhibitor bumetanide, in a dose dependent manner. Sequent experiment result showed that Intravenous injection of bumetanide (15.2 mg/kg) 30 min prior to the training session blocked inhibitory avoidance learning significantly. Subsequent control experiment's results excluded the possible non-specific effect of bumetanide on avoidance learning. We also found the phosphorylation of hippocampal MAPK was attenuated after bumetanide administration. These results suggested that hippocampal NKCC1 may via MAPK signaling cascade to possess its function.	[Ko, Meng Chang; Lee, Min Chong; Lu, Kwok-Tung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Amstislavskaya, Tamara G.; Tikhonova, Maria A.] State Res Inst Physiol & Fundamental Med, Lab Biol Psychiat, SB RAMS, Novosibirsk, Russia; [Yang, Yi-Ling] Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan	National Taiwan Normal University; Research Institute for Neurosciences & Medicine; Russian Academy of Medical Sciences; National Chiayi University	Yang, YL (corresponding author), Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw; ktlu@ntnu.edu.tw	Tikhonova, Maria A/K-3455-2018; Amstislavskaya, Tamara G/K-4149-2018	Tikhonova, Maria A/0000-0002-4265-8981; 	National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding provided by National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Beck J, 2003, J NEUROSCI, V23, P5061; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Busse S, 2005, BRAIN RES, V1046, P116, DOI 10.1016/j.brainres.2005.03.055; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; Deisz RA, 2011, J PHYSIOL-LONDON, V589, P1317, DOI 10.1113/jphysiol.2010.201830; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; HUGHES IW, 1990, CURR MED RES OPIN, V12, P151, DOI 10.1185/03007999009111496; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E22; Kahle KT, 2012, JASPERS BASIC MECH E; Kilb W, 2007, NEUROPHARMACOLOGY, V53, P524, DOI 10.1016/j.neuropharm.2007.06.015; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Krystal AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035417; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Lu KT, 1999, CHINESE J PHYSIOL, V42, P249; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; O'Donnell ME, 2006, J CEREBR BLOOD F MET, V26, P1234, DOI 10.1038/sj.jcbfm.9600278; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; ODONNELL ME, 1995, AM J PHYSIOL-CELL PH, V268, pC747, DOI 10.1152/ajpcell.1995.268.3.C747; Panet R, 2006, J CELL PHYSIOL, V206, P578, DOI 10.1002/jcp.20506; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schomberg SL, 2001, J NEUROPHYSIOL, V85, P2563, DOI 10.1152/jn.2001.85.6.2563; SCHWARTZ MA, 1981, J CLIN PHARMACOL, V21, P555, DOI 10.1002/j.1552-4604.1981.tb05664.x; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1147, DOI 10.1152/ajpcell.00538.2001; Sun DD, 1998, AM J PHYSIOL-CELL PH, V275, pC772, DOI 10.1152/ajpcell.1998.275.3.C772; WARD A, 1984, DRUGS, V28, P426, DOI 10.2165/00003495-198428050-00003; Yang YL, 2005, NEUROSCIENCE, V134, P247, DOI 10.1016/j.neuroscience.2005.04.003	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e106692	10.1371/journal.pone.0106692	http://dx.doi.org/10.1371/journal.pone.0106692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369049	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000003
J	Kumar, J; Gurav, R; Kale, V; Limaye, L				Kumar, Jeetendra; Gurav, Rupali; Kale, Vaijayanti; Limaye, Lalita			Exogenous Addition of Arachidonic Acid to the Culture Media Enhances the Functionality of Dendritic Cells for Their Possible Use in Cancer Immunotherapy	PLOS ONE			English	Article							CORD BLOOD; CD34(+) PROGENITORS; PROSTAGLANDIN E-2; GENERATION; MIGRATION; MATURATION; MATURE; PRECURSORS; IMMUNITY; SPEED	The development of dendritic cell based vaccines is a promising approach in cancer immunotherapy. For their successful use in the clinics, the propagation and functionality of DCs is crucial. We earlier established a two-step method for the large scale generation of DCs from umbilical cord blood derived MNCs/CD34+ cells. This work aims at improving their functionality based on the following observations: in vitro generated DCs can be less efficient in migration and other functional activities due to lower eicosanoid levels. The production of eicosanoids from Arachidonic Acid (AA) can be hampered due to suppression of the enzyme phospholipase A2 by IL-4, an essential cytokine required for the differentiation of DCs. We hypothesized that exogenous addition of AA to the culture media during DC generation may result in DCs with improved functionality. DCs were generated with and without AA. The two DC sets were compared by phenotypic analysis, morphology and functional assays like antigen uptake, MLR, CTL assay and in vitro and in vivo migration. Though there were no differences between the two types of DCs in terms of morphology, phenotype and antigen uptake, AA(+) DCs exhibited an enhanced in vitro and in vivo migration, T cell stimulatory capacity, CTL activity and significantly higher transcript levels of COX-2. AA(+) DCs also show a favorable Th1 cytokine profile than AA(-) DCs. Thus addition of AA to the culture media is skewing the DCs towards the secretion of more IL-12 and less of IL-10 along with the restoration of eicosanoids levels in a COX-2 mediated pathway thereby enhancing the functionality of these cells to be used as a potent cellular vaccine. Taken together, these findings will be helpful in the better contriving of DC based vaccines for cancer immunotherapy.	[Kumar, Jeetendra; Gurav, Rupali; Kale, Vaijayanti; Limaye, Lalita] Natl Ctr Cell Sci, Stem Cell Lab, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Limaye, L (corresponding author), Natl Ctr Cell Sci, Stem Cell Lab, Pune, Maharashtra, India.	lslimaye@nccs.res.in	Kale, Vaijayanti/R-9342-2019	Kale, Vaijayanti/0000-0001-7498-7563	Department of Biotechnology (DBT), Government of India [BT/PR13565/MED/31/89/2010]; Council of Scientific and Industrial Research (CSIR) India; DBT [PR-4930/31]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India)	The project received funds from Department of Biotechnology (DBT), Government of India via grant no. BT/PR13565/MED/31/89/2010. JK received his fellowship from Council of Scientific and Industrial Research (CSIR) India and from DBT (PR-4930/31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Arrighi JF, 1999, BLOOD, V93, P2244, DOI 10.1182/blood.V93.7.2244.407a29_2244_2252; Balan S, 2010, TRANSFUSION, V50, P2413, DOI 10.1111/j.1537-2995.2010.02706.x; Balan S, 2009, TRANSFUSION, V49, P2109, DOI 10.1111/j.1537-2995.2009.02231.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Bontkes HJ, 2002, J LEUKOCYTE BIOL, V72, P321; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Encabo A, 2004, STEM CELLS, V22, P725, DOI 10.1634/stemcells.22-5-725; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P1111, DOI 10.4161/onci.21494; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Harizi H, 2013, CELL MOL IMMUNOL, V10, P213, DOI 10.1038/cmi.2013.1; Hsu AKW, 2006, BIOL BLOOD MARROW TR, V12, P855, DOI 10.1016/j.bbmt.2006.05.004; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kalinski P, 2011, IMMUNOL RES, V50, P235, DOI 10.1007/s12026-011-8224-z; Lee H, 2008, CANCER IMMUNOL IMMUN, V57, P1; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Morse MA, 1999, CANCER RES, V59, P56; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Perroud Jr MW, 2011, J EXP CLIN CANC RES, V17, P30; Ridgway D, 2003, CANCER INVEST, V21, P873, DOI 10.1081/CNV-120025091; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Ryan EP, 2006, J IMMUNOL, V177, P7811, DOI 10.4049/jimmunol.177.11.7811; Ryu KH, 2004, INT J HEMATOL, V80, P281, DOI 10.1532/IJH97.A10406; SANTIAGOSCHWARZ F, 1995, STEM CELLS, V13, P186, DOI 10.1002/stem.5530130210; Saraya K, 1996, BRIT J HAEMATOL, V93, P258, DOI 10.1046/j.1365-2141.1996.5131053.x; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Soruri A, 2005, INT J BIOCHEM CELL B, V37, P241, DOI 10.1016/j.biocel.2004.07.003; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Thurnher M, 2001, FASEB J, V15, P1054, DOI 10.1096/fj.00-0508hyp; Usharauli D, 2006, NAT PROTOC, V1, P673, DOI 10.1038/nprot.2006.107; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Verdijk P, 2009, CLIN CANCER RES, V15, P2531, DOI 10.1158/1078-0432.CCR-08-2729	38	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111759	10.1371/journal.pone.0111759	http://dx.doi.org/10.1371/journal.pone.0111759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369453	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000097
J	Leem, YE; Ha, HL; Bae, JH; Baek, KH; Kang, JS				Leem, Young-Eun; Ha, Hye-Lim; Bae, Ju-Hyeon; Baek, Kwan-Hyuck; Kang, Jong-Sun			CDO, an Hh-Coreceptor, Mediates Lung Cancer Cell Proliferation and Tumorigenicity through Hedgehog Signaling	PLOS ONE			English	Article							SONIC-HEDGEHOG; PROSTATE-CANCER; IN-VIVO; PATHWAY; MUTATIONS; ACTIVATION; GAS1; REQUIREMENT; RECEPTOR; DROSOPHILA	Hedgehog (Hh) signaling plays essential roles in various developmental processes, and its aberrant regulation results in genetic disorders or malignancies in various tissues. Hyperactivation of Hh signaling is associated with lung cancer development, and there have been extensive efforts to investigate how to control Hh signaling pathway and regulate cancer cell proliferation. In this study we investigated a role of CDO, an Hh co-receptor, in non-small cell lung cancer (NSCLC). Inhibition of Hh signaling by SANT-1 or siCDO in lung cancer cells reduced proliferation and tumorigenicity, along with the decrease in the expression of the Hh components. Histological analysis with NSCLC mouse tissue demonstrated that CDO was expressed in advanced grade of the cancer, and precisely co-localized with GLI1. These data suggest that CDO is required for proliferation and survival of lung cancer cells via Hh signaling.	[Leem, Young-Eun; Ha, Hye-Lim; Bae, Ju-Hyeon; Baek, Kwan-Hyuck; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea	Sungkyunkwan University (SKKU)	Kang, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	kangj01@skku.edu			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2012R1A1A2005448, NRF-2011-0017315]	National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was funded by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2012R1A1A2005448 to YEL) and (NRF-2011-0017315 to JSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Camp D, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-28; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Delloye-Bourgeois C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001623; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gialmanidis IP, 2009, LUNG CANCER, V66, P64, DOI 10.1016/j.lungcan.2009.01.007; Gonnissen A, 2013, INT J MOL SCI, V14, P13979, DOI 10.3390/ijms140713979; Hahn H, 2004, GENOMICS, V84, P853, DOI 10.1016/j.ygeno.2004.07.002; Hayashi T, 2011, PATHOBIOLOGY, V78, P277, DOI 10.1159/000329588; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hwang JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079634; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 1997, J CELL BIOL, V138, P203, DOI 10.1083/jcb.138.1.203; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Oh JE, 2009, FASEB J, V23, P2088, DOI 10.1096/fj.08-119255; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Raffel C, 1997, CANCER RES, V57, P842; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seppala M, 2007, J CLIN INVEST, V117, P1575, DOI 10.1172/JCI32032; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Shi S, 2012, J BIOL CHEM, V287, P7845, DOI 10.1074/jbc.M111.315416; Shin J, 2014, CANCER LETT, V342, P70, DOI 10.1016/j.canlet.2013.08.047; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Unden AB, 1996, CANCER RES, V56, P4562; Vestergaard J, 2006, LUNG CANCER, V52, P281, DOI 10.1016/j.lungcan.2005.12.014; Watkins DN, 2003, CELL CYCLE, V2, P196, DOI 10.4161/cc.2.3.378; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	52	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111701	10.1371/journal.pone.0111701	http://dx.doi.org/10.1371/journal.pone.0111701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369201	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402000086
J	Morioka, H; Itani, O; Kaneita, Y; Iwasa, H; Ikeda, M; Yamamoto, R; Osaki, Y; Kanda, H; Nakagome, S; Ohida, T				Morioka, Hisayoshi; Itani, Osamu; Kaneita, Yoshitaka; Iwasa, Hajime; Ikeda, Maki; Yamamoto, Ryuichiro; Osaki, Yoneatsu; Kanda, Hideyuki; Nakagome, Sachi; Ohida, Takashi			Factors Affecting Unhappiness at School among Japanese Adolescents: An Epidemiological Study	PLOS ONE			English	Article							MENTAL-HEALTH; BEHAVIOR; TRUANCY; POPULATION; DRINKING; REFUSAL; YOUTH; LIFE	Background: Unhappiness at school is one of the main reasons for truancy among adolescents. In order to assess this problem more thoroughly in the context of Japanese adolescents, the present study examined the associations between feelings of unhappiness at school and lifestyle habits, school life realities, and mental health status. Method: This study was designed as a cross-sectional survey. A self-administered questionnaire was provided to students enrolled in randomly selected junior and senior high schools throughout Japan. We calculated the percentages of both junior and senior high school students who felt unhappy at school based on factors related to school life, lifestyle habits, and mental health status. Multiple logistic regression analyses were performed in order to examine the associations between those factors and students' feelings of unhappiness at school. Results: A total of 98,867 valid responses were analysed, 7.9% (Boys: 8.4%, Girls: 7.4%) of which came from students who responded that they felt unhappy at school. For both junior and senior high school students, the percentages of those who felt unhappy at school were significantly higher among those who had not yet decided on their future life course, who did not participate in extracurricular activities, did not eat breakfast every day, went to bed late, had used tobacco or alcohol in the previous 30 days, and had poor mental health compared with others. The results of multiple logistic regression analyses indicated that the adjusted odds ratios for feeling unhappy at school with regard to the above-mentioned factors were significantly high for both junior and senior high school students. Conclusions: The present results suggest that school employees and administrators must provide health guidance to students, considering that irregular lifestyle habits, lower school engagement, smoking, drinking alcohol, and poor mental health status are all associated with maladaptation to school among adolescents.	[Morioka, Hisayoshi; Itani, Osamu; Ikeda, Maki; Nakagome, Sachi; Ohida, Takashi] Nihon Univ, Sch Med, Dept Social Med, Div Publ Hlth, Tokyo, Japan; [Kaneita, Yoshitaka] Oita Univ, Fac Med, Dept Publ Hlth & Epidemiol, Oita 87011, Japan; [Iwasa, Hajime] Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan; [Yamamoto, Ryuichiro] Joetsu Univ Educ, Grad Sch Educ, Div Clin Psychol Hlth Care & Special Support, Niigata, Japan; [Osaki, Yoneatsu] Tottori Univ, Fac Med, Dept Social Med, Div Environm & Prevent Med, Tottori 680, Japan; [Kanda, Hideyuki] Shimane Univ, Fac Med, Dept Publ Hlth, Matsue, Shimane, Japan	Nihon University; Oita University; Fukushima Medical University; Joetsu University Education; Tottori University; Shimane University	Itani, O (corresponding author), Nihon Univ, Sch Med, Dept Social Med, Div Publ Hlth, Tokyo, Japan.	itani.osamu@nihon-u.ac.jp	Yamamoto, Ryuichiro/AAF-8615-2019; Itani, Osamu/GRJ-6767-2022; Itani, Osamu/AAT-7056-2021; Iwasa, Hajime/AFQ-6399-2022	Itani, Osamu/0000-0002-8526-785X; Itani, Osamu/0000-0002-8526-785X; 	Ministry of Health Labor and Welfare of the Japanese Government	Ministry of Health Labor and Welfare of the Japanese Government(Ministry of Health, Labour and Welfare, Japan)	Financial support for this study was provided by a health science Research Grant from the Ministry of Health Labor and Welfare of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTWOOD G, 2006, RES PAPERS ED, V0021; Best D, 2006, ADDICT BEHAV, V31, P1424, DOI 10.1016/j.addbeh.2005.12.002; Cabinet Office Government of Japan, 2007, SURV LIF STYL ATT JA; Chou LC, 2006, ADDICT BEHAV, V31, P149, DOI 10.1016/j.addbeh.2005.04.011; DARCY C, 1984, PSYCHOL MED, V14, P615, DOI 10.1017/S0033291700015221; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; Egger HL, 2003, J AM ACAD CHILD PSY, V42, P797, DOI 10.1097/01.CHI.0000046865.56865.79; Henry KL, 2007, J SCHOOL HEALTH, V77, P67, DOI 10.1111/j.1746-1561.2007.00169.x; Henry KL, 2007, J SCHOOL HEALTH, V77, P29, DOI 10.1111/j.1746-1561.2007.00159.x; Henry KL, 2010, J STUD ALCOHOL DRUGS, V71, P115, DOI 10.15288/jsad.2010.71.115; Henry KL, 2007, J ADOLESCENT HEALTH, V40; Hirschfield PJ, 2011, J YOUTH ADOLESCENCE, V40, P3, DOI 10.1007/s10964-010-9579-5; Kaneita Y, 2006, SLEEP, V29, P1543, DOI 10.1093/sleep/29.12.1543; Kaneita Y, 2009, SLEEP MED, V10, P780, DOI 10.1016/j.sleep.2008.06.014; Kearney CA, 2008, CLIN PSYCHOL REV, V28, P451, DOI 10.1016/j.cpr.2007.07.012; Kuramoto H, 1995, Nihon Koshu Eisei Zasshi, V42, P930; Maynard BR, 2012, J YOUTH ADOLESCENCE, V41, P1671, DOI 10.1007/s10964-012-9788-1; Ministry of Education Culture Sports Science and Technology (MEXT), 2012, SCH BAS SURV; Ministry of Education Culture Sports Science and Technology (MEXT), 2011, RES ISS TEACH GUID S; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Ohida T, 2004, SLEEP, V27, P978, DOI 10.1093/sleep/27.5.978; Ohida T, 2001, SLEEP, V24, P333, DOI 10.1093/sleep/24.3.333; Penfold Suzanne C, 2009, BMC Res Notes, V2, P42, DOI 10.1186/1756-0500-2-42; Petrides KV, 2005, BRIT J EDUC PSYCHOL, V75, P239, DOI 10.1348/000709904X24735; Shimbo M, 2005, PUBLIC HEALTH NUTR, V8, P1300, DOI 10.1079/PHN2005752; Suzuki H, 2011, PSYCHIAT RES, V188, P138, DOI 10.1016/j.psychres.2010.10.025; Suzuki K, 2000, ALCOHOL CLIN EXP RES, V24, P377, DOI 10.1097/00000374-200003000-00022; U.S. Department of Education, 2006, CONDITION ED 2006 NC; Vaughn MG, 2013, J ADOLESCENCE, V36, P767, DOI 10.1016/j.adolescence.2013.03.015; Vaughn MG, 2011, PSYCHIAT QUART, V82, P191, DOI 10.1007/s11126-010-9160-0; White HR, 2007, NICOTINE TOB RES, V9, P153, DOI 10.1080/14622200601078350	31	11	11	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111844	10.1371/journal.pone.0111844	http://dx.doi.org/10.1371/journal.pone.0111844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369261	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000111
J	Muller, B; Nienaber, CA; Reis, O; Kropp, P; Meyer, W				Mueller, Britta; Nienaber, Christoph A.; Reis, Olaf; Kropp, Peter; Meyer, Wolfgang			Sexuality and Affection among Elderly German Men and Women in Long-Term Relationships: Results of a Prospective Population-Based Study	PLOS ONE			English	Article							LATER LIFE; MARITAL SATISFACTION; OLDER WOMEN; HEALTH; ATTITUDES; SYMPTOMS; ASSOCIATION; DYSFUNCTION; BEHAVIOR; SEEKING	Satisfaction with sexual activity i.e. sexual satisfaction and the importance of sexuality and affection were analysed using data from the German "Interdisciplinary Longitudinal Study of Adult Development'' (ILSE). At three measurement points, 1993-1995, 1997-1998, and 2004-2006 i.e. subjects' ages of 63, 67, and 74 years, participants' reports about their affection and sexual activity were collected. The sample of completed records used for this study consisted of 194 urban non-institutionalised participants, 68% male, all living with partners. Median levels of sexual satisfaction were reported, fluctuating between the measurement points of ages 63 to 74. Between baseline, first and second follow-up no differences were found in levels of sexual satisfaction, though at measurement points age 63 and 67 women were more satisfied than men. When measured at age 74, affection was given a higher priority than sexual activity. Although men and women reported similar priorities, sexual activity and affection were more important for men than for women. Satisfaction within the relationship can be predicted by the importance of affection, but not by that of sexual activity. Our results confirm the thesis of the 'second language of sexuality': for humans in their later years affection seems to be more important than for younger individuals.	[Mueller, Britta; Kropp, Peter] Univ Rostock, Fac Med, Inst Med Psychol & Med Sociol, D-18055 Rostock, Germany; [Nienaber, Christoph A.] Univ Rostock, Rostock Univ Hosp, Med Ctr Rostock, Dept Cardiol & Angiol, D-18055 Rostock, Germany; [Reis, Olaf] Univ Rostock, Rostock Univ Hosp, Clin Child & Adolescent Psychiat, D-18055 Rostock, Germany; [Meyer, Wolfgang] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of Rostock; University of Rostock; University of Rostock; University of London; Queen Mary University London	Muller, B (corresponding author), Univ Rostock, Fac Med, Inst Med Psychol & Med Sociol, D-18055 Rostock, Germany.	britta.mueller@med.uni-rostock.de	Kropp, Peter/B-8132-2012		German Federal Ministry for Families, Senior Citizens, Women and Youth [AZ 314-1722-102/16, AZ 301-1720-295/2]; Ministry for Science, Research and Art Baden-Wurttemberg; University of Rostock [FORUN 989020, 889048]	German Federal Ministry for Families, Senior Citizens, Women and Youth; Ministry for Science, Research and Art Baden-Wurttemberg; University of Rostock	The study was funded by the German Federal Ministry for Families, Senior Citizens, Women and Youth (AZ 314-1722-102/16; AZ 301-1720-295/2), the Ministry for Science, Research and Art Baden-Wurttemberg, and the University of Rostock (FORUN 989020; 889048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SEX ROMANCE RELATION; Avis NE, 2005, MENOPAUSE, V12, P385, DOI 10.1097/01.GME.0000151656.92317.A9; Baltes PB, 2003, PSYCHOL HUMAN STRENG, P23; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; Bomsdorf E, 1993, GENERATIONENSTERBETA; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Bundesamt S, 2011, FOCUS ELDERLY GERMAN; Burgess EO, 2004, HANDBOOK OF SEXUALITY IN CLOSE RELATIONSHIPS, P437; Butler RN, 1996, ALTE LIEBE ROSTET NI; CALL V, 1995, J MARRIAGE FAM, V57, P639, DOI 10.2307/353919; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; CARSTENSEN LL, 1995, PSYCHOL AGING, V10, P140, DOI 10.1037/0882-7974.10.1.140; Clarke LH, 2006, CAN J AGING, V25, P129, DOI 10.1353/cja.2006.0034; DeLamater J, 2007, J AGING HEALTH, V19, P921, DOI 10.1177/0898264307308342; DeLamater J, 2012, J SEX RES, V49, P125, DOI 10.1080/00224499.2011.603168; Dillaway HE, SEX LIFE VIRGINITY V; EDWARDS JN, 1994, SEXUALITY LIFE COURS, P233; Fooken I, 2006, GERONTOLOGIE MEDIZIN, P328; Gades NM, 2009, J SEX MED, V6, P2455, DOI 10.1111/j.1743-6109.2009.01374.x; Gallicchio L, 2007, J PSYCHOSOM RES, V63, P263, DOI 10.1016/j.jpsychores.2007.02.003; Harper JM, 2009, AGING MENT HEALTH, V13, P546, DOI 10.1080/13607860902774485; Heiman JR, 2011, ARCH SEX BEHAV, V40, P741, DOI 10.1007/s10508-010-9703-3; Henry NJM, 2007, PSYCHOL AGING, V22, P428, DOI 10.1037/0882-7974.22.3.428; Hinchliff S, 2011, J SEX RES, V48, P106, DOI 10.1080/00224499.2010.548610; Hopflinger F, 1987, WANDEL FAMILIENBILDU; Howard JR, 2006, CLIMACTERIC, V9, P355, DOI 10.1080/13697130600961870; Hyde Z, 2010, ANN INTERN MED, V153, P693, DOI 10.7326/0003-4819-153-11-201012070-00002; Koch PB, 2005, J SEX RES, V42, P215, DOI 10.1080/00224490509552276; Kruse A, 2008, INTERDISZIPLINARE LA; Laumann EO, 2006, ARCH SEX BEHAV, V35, P145, DOI 10.1007/s10508-005-9005-3; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Leiblum SR, 2006, MENOPAUSE, V13, P46, DOI 10.1097/01.gme.0000172596.76272.06; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Moreira ED, 2008, SEX HEALTH, V5, P227, DOI 10.1071/SH07055; Muller B, 2012, KONSTRUKTE GELINGEND, P207; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Rothermund K, 2003, PSYCHOL AGING, V18, P896, DOI 10.1037/0882-7974.18.4.896; Thompson WK, 2011, J AM GERIATR SOC, V59, P1503, DOI 10.1111/j.1532-5415.2011.03495.x; Waite L, 2010, DEMOGRAPHY, V47, pS87; Waite LJ, 2009, J GERONTOL B-PSYCHOL, V64, pI56, DOI 10.1093/geronb/gbp038; Walker R, 2013, INT J AGING HUM DEV, V76, P123, DOI 10.2190/AG.76.2.b; Woloski-Wruble AC, 2010, J SEX MED, V7, P2401, DOI 10.1111/j.1743-6109.2010.01747.x	43	24	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111404	10.1371/journal.pone.0111404	http://dx.doi.org/10.1371/journal.pone.0111404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369193	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000054
J	Ulrichsen, SP; Mor, A; Svensson, E; Larsen, FB; Thomsen, RW				Ulrichsen, Sinna P.; Mor, Anil; Svensson, Elisabeth; Larsen, Finn B.; Thomsen, Reimar W.			Lifestyle Factors Associated with Type 2 Diabetes and Use of Different Glucose-Lowering Drugs: Cross-Sectional Study	PLOS ONE			English	Article							DIETARY QUALITY; HEALTH SURVEY; MORTALITY; METFORMIN; COHORT; RISK; VALIDATION; REGISTER; MELLITUS; INDEX	Aims: To examine the lifestyle profile among persons with and without Type 2 diabetes mellitus (DM) and among users of different glucose-lowering drugs. Methods: We used questionnaire data from a Danish health survey and identified presence of Type 2 DM and use of medications through medical databases. We calculated age-and gender-standardized prevalence ratios (PRs) of lifestyle factors according to Type 2 DM and different glucose-lowering drugs. Results: Of 21,637 survey participants aged 25-79 years, 680 (3%) had Type 2 DM (median age 63 years) with a median diabetes duration of 5 years. Participants with Type 2 DM had a substantially higher prevalence of obesity (36% vs. 13%, PR: 3.1, 95% confidence interval (CI): 2.8-3.6), yet more reported to eat a very healthy diet (25% vs. 21%, PR: 1.2, 95% CI: 1.0-1.4) and to exercise regularly (67% vs. 53%, PR: 1.3, 95% CI: 1.2-1.4). Also, fewer were current smokers or had high alcohol intake. When compared with metformin users, obesity was substantially less prevalent in users of sulfonylurea (PR: 0.5, 95% CI: 0.40-8), and insulin and analogues (PR: 0.4, 95% CI: 0.3-0.7). Tobacco smoking was more prevalent in sulfonylurea users (PR: 1.4, 95% CI: 0.9-2.1) compared with metformin users. We found no material differences in physical exercise, diet or alcohol intake according to type of glucose-lowering drug. Conclusions: Type 2 DM patients are substantially more obese than other individuals, but otherwise report to have a healthier lifestyle. Metformin use is strongly associated with obesity, whereas sulfonylurea use tends to be associated with tobacco smoking.	[Ulrichsen, Sinna P.; Mor, Anil; Svensson, Elisabeth; Thomsen, Reimar W.] Aarhus Univ Hosp, Fac Hlth, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Larsen, Finn B.] Cent Denmark Reg, Ctr Publ Hlth & Qual Improvement, Aarhus, Denmark	Aarhus University	Mor, A (corresponding author), Aarhus Univ Hosp, Fac Hlth, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	anil.mor@clin.au.dk	Mor, Anil/ABH-9147-2020; Svensson, Elisabeth/L-2493-2013	Mor, Anil/0000-0002-4002-0618; Thomsen, Reimar/0000-0001-9135-3474; Svensson, Elisabeth/0000-0001-6706-6336	Clinical Epidemiology Research Foundation, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital	Clinical Epidemiology Research Foundation, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital	This research was supported by the Clinical Epidemiology Research Foundation, Aarhus University Hospital, Aarhus, Denmark. The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bo S, 2012, DIABETES OBES METAB, V14, P23, DOI 10.1111/j.1463-1326.2011.01480.x; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen AI, 2012, SCAND J PUBLIC HEALT, V40, P391, DOI 10.1177/1403494812451412; Christiansen CF, 2013, CRIT CARE, V17, DOI 10.1186/cc12886; Cichosz SL, 2013, DIABETIC MED, V30, P1063, DOI 10.1111/dme.12199; de Leeuw E. D., 2008, INT HDB SURVEY METHO; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; Garg SK, 2014, DIABETES OBES METAB, V16, P97, DOI 10.1111/dom.12124; Horsdal HT, 2012, J STROKE CEREBROVASC, V21, P717, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.007; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Larsen F, 2008, HVORDAN HAR SUNDHEDS; Laugesen K, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen,2013-003024, DOI 10.1136/BMJOPEN,2013-003024]; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Magas S, 2009, COLLEGIUM ANTROPOL, V33, P115; Mor A, 2014, DIABETOLOGIA, V57, pS139; Murray AE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-110; Nichols M., 2012, EUROPEAN CARDIOVASCU; Nwaneri C, 2013, BR J DIABETES VASC D, V13, P192; Samuel-Hodge CD, 2004, DIABETES CARE, V27, P663, DOI 10.2337/diacare.27.3.663; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tabak AG, 2014, LANCET DIABETES ENDO, V2, P236, DOI 10.1016/S2213-8587(13)70139-6; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Thomsen RW, 2006, DIABETES CARE, V29, P805, DOI 10.2337/diacare.29.04.06.dc05-1748; Thomsen RW, 2012, OPEN INFECT DIS J S1, V6, P27, DOI DOI 10.2174/1874279301206010027; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Yannakoulia Mary, 2006, Review of Diabetic Studies, V3, P11, DOI 10.1900/RDS.2006.3.11	37	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111849	10.1371/journal.pone.0111849	http://dx.doi.org/10.1371/journal.pone.0111849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369331	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000112
J	Xiang, L; Wei, ZL; Cao, YX				Xiang, Lan; Wei, Zhaolian; Cao, Yunxia			Symptoms of an Intrauterine Hematoma Associated with Pregnancy Complications: A Systematic Review	PLOS ONE			English	Article							DIFFUSE CHORIOAMNIOTIC HEMOSIDEROSIS; MASSIVE SUBCHORIONIC THROMBOHEMATOMA; THREATENED-ABORTION; CLINICAL-SIGNIFICANCE; PLACENTAL ABRUPTION; 1ST TRIMESTER; RETROPLACENTAL HEMORRHAGE; SONOGRAPHIC SPECTRUM; PRENATAL-DIAGNOSIS; MISCARRIAGE	Objective: To evaluate the predictive value of the symptoms of an intrauterine hematoma (IUH) for adverse pregnancy outcomes. Methods: A literature review was performed with the search terms, including intrauterine/subchorionic/retroplacental/subplacental hematoma/hemorrhage/bleeding/collection/fluid, covering the period from January, 1981 to January, 2014. We just focused on the pregnancy outcomes associated with different symptoms of an IUH. Results: It is generally agreed that a retroplacental, posterior or subchorionic in the fundus of uterus, and/or persistent IUH is associated with adverse outcomes in the ongoing pregnancy. However, the prognosis value of both volume and gestational age at diagnosis of IUH still remains controversial. Some researchers argue that a large IUH is associated with an increased risk of adverse events during pregnancy while others refuted. It is believed by some that the earlier an IUH was detected, the higher the risk for adverse outcomes would be, while no or weak association were reported by other studies. The prognostic value of the simultaneous presence of vaginal bleeding on pregnancy outcome is also controversial. Conclusions: Both the position relative to the placenta or uterus and duration of IUH have strong predictive value on the prognosis in the ongoing pregnancy. However, the prognostic values of the IUH volume, gestational age at diagnosis and the simultaneous presence of vaginal bleeding remain controversial up to now. Moreover, most of previous reports are small, uncontrolled studies with incomplete information. Prospective, large sample, cohorts studies which take all detailed symptoms of an IUH into consideration are needed when we evaluate its clinical significance in the prognosis of pregnancy.	[Xiang, Lan; Wei, Zhaolian; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Hefei, Peoples R China	Anhui Medical University	Wei, ZL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Hefei, Peoples R China.	weizhaolian_1@126.com			National Science and Technology [2012BAI32B01]	National Science and Technology	The study was supported by Planning Project Supported by "Twelve-Five'' National Science and Technology (2012BAI32B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUYOUSEF MM, 1987, AM J ROENTGENOL, V149, P737, DOI 10.2214/ajr.149.4.737; Alanjari A, 2013, PRENATAL DIAG, V33, P973, DOI 10.1002/pd.4176; Aoki S, 2014, ARCH GYNECOL OBSTET, V289, P307, DOI 10.1007/s00404-013-2972-z; Ball RH, 1996, AM J OBSTET GYNECOL, V174, P996, DOI 10.1016/S0002-9378(96)70339-3; Ben-Haroush A, 2003, ISRAEL MED ASSOC J, V5, P422; Bennett GL, 1996, RADIOLOGY, V200, P803, DOI 10.1148/radiology.200.3.8756935; BLOCH C, 1989, MT SINAI J MED, V56, P290; BORLUM KG, 1989, OBSTET GYNECOL, V74, P231; Deans A, 1998, ULTRASOUND OBST GYN, V11, P319, DOI 10.1046/j.1469-0705.1998.11050319.x; DICKEY RP, 1992, OBSTET GYNECOL, V80, P415; Dongol A, 2011, Kathmandu Univ Med J (KUMJ), V9, P41; Fung TY, 2010, ACTA OBSTET GYN SCAN, V89, P1357, DOI 10.3109/00016349.2010.512656; GLAVIND K, 1991, EUR J OBSTET GYN R B, V40, P7, DOI 10.1016/0028-2243(91)90037-L; GOLDSTEIN SR, 1983, AM J ROENTGENOL, V141, P975; Johns J, 2003, OBSTET GYNECOL, V102, P483, DOI 10.1016/S0029-7844(03)00580-5; JOUPPILA P, 1980, ACTA OBSTET GYN SCAN, V59, P405, DOI 10.3109/00016348009155418; JOUPPILA P, 1985, J CLIN ULTRASOUND, V13, P107, DOI 10.1002/jcu.1870130205; Kurjak A, 1996, J Matern Fetal Med, V5, P41; Leite J, 2006, J ULTRAS MED, V25, P1441, DOI 10.7863/jum.2006.25.11.1441; MANDRUZZATO GP, 1989, J CLIN ULTRASOUND, V17, P503, DOI 10.1002/jcu.1870170708; MANTONI M, 1985, OBSTET GYNECOL, V65, P471; MANTONI M, 1981, BRIT J OBSTET GYNAEC, V88, P47, DOI 10.1111/j.1471-0528.1981.tb00936.x; Maso G, 2005, OBSTET GYNECOL, V105, P339, DOI 10.1097/01.AOG.0000152000.71369.bd; MCGAHAN JP, 1982, RADIOLOGY, V142, P481, DOI 10.1148/radiology.142.2.7054842; MOONEY EE, 1994, BRIT J OBSTET GYNAEC, V101, P965, DOI 10.1111/j.1471-0528.1994.tb13041.x; Morita A, 2014, J OBSTET GYNAECOL RE, V40, P1118, DOI 10.1111/jog.12289; NAEYE RL, 1980, OBSTET GYNECOL, V55, P701; Nagy S, 2003, OBSTET GYNECOL, V102, P94, DOI 10.1016/S0029-7844(03)00403-4; Norman SM, 2010, OBSTET GYNECOL, V116, P311, DOI 10.1097/AOG.0b013e3181e90170; NYBERG DA, 1987, AM J ROENTGENOL, V148, P161, DOI 10.2214/ajr.148.1.161; NYBERG DA, 1987, RADIOLOGY, V164, P357, DOI 10.1148/radiology.164.2.3299486; Ohyama M, 2004, PEDIATRICS, V113, P800, DOI 10.1542/peds.113.4.800; Ozkaya E, 2011, J OBSTET GYNAECOL, V31, P210, DOI 10.3109/01443615.2010.545899; Pearlstone M, 1993, Obstet Gynecol Surv, V48, P65; PEDERSEN JF, 1990, BRIT J OBSTET GYNAEC, V97, P75, DOI 10.1111/j.1471-0528.1990.tb01720.x; PEDERSEN JF, 1990, AM J ROENTGENOL, V154, P535, DOI 10.2214/ajr.154.3.2106217; Poulose T, 2006, J Obstet Gynaecol, V26, P782; Redline RW, 1999, AM J CLIN PATHOL, V111, P804; RIZZO G, 1995, J CLIN ULTRASOUND, V23, P525, DOI 10.1002/jcu.1870230904; SAUERBREI EE, 1986, RADIOLOGY, V160, P109, DOI 10.1148/radiology.160.1.3520643; Seki H, 1998, INT J GYNECOL OBSTET, V63, P123, DOI 10.1016/S0020-7292(98)00153-2; Sharma G, 2003, AM J OBSTET GYNECOL, V189, P994, DOI 10.1067/S0002-9378(03)00823-8; Signore CC, 1998, AM J OBSTET GYNECOL, V178, P336, DOI 10.1016/S0002-9378(98)80022-7; STABILE I, 1987, LANCET, V2, P1237; Tower CL, 2001, HUM REPROD, V16, P2005, DOI 10.1093/humrep/16.9.2005; Tuuli MG, 2011, OBSTET GYNECOL, V117, P1205, DOI 10.1097/AOG.0b013e31821568de; van Oppenraaij RHF, 2009, HUM REPROD UPDATE, V15, P409, DOI 10.1093/humupd/dmp009; Wijesiriwardana A, 2006, OBSTET GYNECOL, V107, P557, DOI 10.1097/01.AOG.0000199952.82151.de; Yamada S, 2012, PATHOL INT, V62, P543, DOI 10.1111/j.1440-1827.2012.02834.x; YLOSTALO P, 1984, BRIT J OBSTET GYNAEC, V91, P353, DOI 10.1111/j.1471-0528.1984.tb05922.x; Yoshida S, 2007, J OBSTET GYNAECOL RE, V33, P788, DOI 10.1111/j.1447-0756.2007.00657.x	51	33	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111676	10.1371/journal.pone.0111676	http://dx.doi.org/10.1371/journal.pone.0111676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369062	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000084
J	Forsberg, L; Naver, L; Gustafsson, LL; Wide, K				Forsberg, Lisa; Naver, Lars; Gustafsson, Lars L.; Wide, Katarina			Neonatal Adaptation in Infants Prenatally Exposed to Antidepressants-Clinical Monitoring Using Neonatal Abstinence Score	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; IN-UTERO EXPOSURE; TERM INFANTS; MATERNAL USE; PREGNANCY; SYMPTOMS; HYPOGLYCEMIA; PRETERM; RISK	Background: Intrauterine exposure to antidepressants may lead to neonatal symptoms from the central nervous system, respiratory system and gastrointestinal system. Finnegan score (Neonatal Abstinence Score, NAS) has routinely been used to assess infants exposed to antidepressants in utero. Aim: The purpose was to study neonatal maladaptation syndrome in infants exposed to selective serotonin reuptake inhibitors (SSRI) or serotonin-norepinephrine reuptake inhibitors (SNRI) in utero. Method: Retrospective cohort study of women using antidepressants during pregnancy and their infants. Patients were identified from the electronic health record system at Karolinska University Hospital Huddinge containing pre-, peri-and postnatal information. Information was collected on maternal and infant health, social factors and pregnancy. NAS sheets were scrutinized. Results: 220 women with reported 3 rd trimester exposure to SSRIs or SNRIs and who gave birth between January 2007 and June 2009 were included. Seventy seven women (35%) used citalopram, 76 used (35%) sertraline, 34 (15%) fluoxetine and 33 (15%) other SSRI/SNRI. Twenty-nine infants (13%) were admitted to the neonatal ward, 19 were born prematurely. NAS was analyzed in 205 patients. Severe abstinence was defined as eight points or higher on at least two occasions (on a scale with maximum 40 points), mild abstinence as 4 points or higher on at least two occasions. Seven infants expressed signs of severe abstinence and 46 (22%) had mild abstinence symptoms. Hypoglycemia (plasma glucose,2.6 mmol/L) was found in 42 infants (19%). Conclusion: Severe abstinence in infants prenatally exposed to antidepressants was found to be rare (3%) in this study population, a slightly lower prevalence than reported in previous studies. Neonatal hypoglycemia in infants prenatally exposed to antidepressant may however be more common than previously described.	[Forsberg, Lisa; Naver, Lars; Wide, Katarina] Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden; [Forsberg, Lisa; Naver, Lars; Wide, Katarina] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Gustafsson, Lars L.] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Forsberg, L (corresponding author), Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden.	lisa.forsberg.1@ki.se	Navér, Lars/E-5085-2013	Wide, Katarina/0000-0003-3024-0657; Naver, Lars/0000-0001-6027-0211; Gustafsson, Lars Lennart/0000-0002-0063-552X	Swedish Research Council [2011-3440, 2012-3466]; Mayflower Foundation; Samariten Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Mayflower Foundation; Samariten Foundation	Funding provided by Swedish Research Council, grant number 2011-3440 www.vr.se to LLG, Swedish Research Council, grant number 2012-3466, www.vr.se to KW, The Mayflower Foundation, www.majblomman.se to KW LF and The Samariten Foundation, www.stiftelsensamariten.se to LF KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Boardman JP, 2013, ARCH DIS CHILDHOOD-E, V98, P2, DOI 10.1136/archdischild-2012-302569; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X; FINNEGAN LP, 1975, ADDICT DIS, V2, P141; HAWDON JM, 1992, ARCH DIS CHILD-FETAL, V67, P357, DOI 10.1136/adc.67.4_Spec_No.357; Hilli J, 2009, EUR NEUROPSYCHOPHARM, V19, P363, DOI 10.1016/j.euroneuro.2009.01.006; Jimenez-Solem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063034; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Leibovitch L, 2013, NEONATOLOGY, V104, P65, DOI 10.1159/000350506; Lennestal R, 2007, J CLIN PSYCHOPHARM, V27, P607, DOI 10.1097/jcp.0b013e31815ac4d2; Levison-Castiel R, 2006, ARCH PEDIAT ADOL MED, V160, P173, DOI 10.1001/archpedi.160.2.173; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Oberlander TF, 2008, MOL PSYCHIATR, V13, P65, DOI 10.1038/sj.mp.4002007; Oberlander TF, 2004, J CLIN PSYCHIAT, V65, P230; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; ter Horst PGJ, 2008, OBSTET GYNECOL SURV, V63, P267, DOI 10.1097/OGX.0b013e3181676be8; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Warburton W, 2010, ACTA PSYCHIAT SCAND, V121, P471, DOI 10.1111/j.1600-0447.2009.01490.x; Winklbaur B, 2009, EUR ADDICT RES, V15, P150, DOI 10.1159/000216466	24	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111327	10.1371/journal.pone.0111327	http://dx.doi.org/10.1371/journal.pone.0111327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365553	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100060
J	Hold, GL; Berry, S; Saunders, KA; Drew, J; Mayer, C; Brookes, H; Gay, NJ; El-Omar, EM; Bryant, CE				Hold, Georgina L.; Berry, Susan; Saunders, Karin A.; Drew, Janice; Mayer, Claus; Brookes, Heather; Gay, Nick J.; El-Omar, Emad M.; Bryant, Clare E.			The TLR4 D299G and T399I SNPs Are Constitutively Active to Up-Regulate Expression of Trif-Dependent Genes	PLOS ONE			English	Article							RECEPTOR-4 POLYMORPHISMS; ASP299GLY POLYMORPHISM; CYTOKINE RELEASE; WHOLE-BLOOD; LIPID-A; TOLL; LIPOPOLYSACCHARIDE; ENDOTOXIN; DISEASE; HUMANS	Dysregulated Toll-Like Receptor (TLR) signalling and genetic polymorphisms in these proteins are linked to many human diseases. We investigated TLR4 functional variants D299G and T399I to assess the impact on LPS-induced responsiveness in comparison to wild-type TLR4. The mechanism by which this occurs in unclear as these SNPs do not lie within the lipid A binding domain or dimerisation sites of the LPS-TLR4/MD2 receptor complexes. Transfection of TLR4D299G, TLR4T399I or TLR4D299G. T399I into HEK cells resulted in constitutive activation of an NF-kappa B reporter gene and a blunting of the LPS-induced reporter activation compared to WT-TLR4. Unstimulated human monocyte/macrophages, from patients with the D299G and T399I SNPs demonstrated a downregulation of many genes, particularly Tram/Trif signalling pathway constitutents compared to the TLR4 wild-type subjects supporting the concept of basal receptor activity. Monocyte/macrophages from carriers of the TLR4 D299G and T399I polymorphisms stimulated with LPS showed >6 fold lower levels of NF-kappa B and similar to 12 fold higher IFN-beta gene expression levels compared to wild-type subjects (P < 0.05; MWU test) and dramatically altered resultant cytokine profiles. We conclude that these TLR4 SNPs affect constitutive receptor activity which impacts on the hosts ability to respond to LPS challenge leading to a dysregulated sub-optimal immune response to infection.	[Hold, Georgina L.; Berry, Susan; Saunders, Karin A.; El-Omar, Emad M.] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Drew, Janice] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Mayer, Claus] Biomath & Stat Scotland, Aberdeen, Scotland; [Brookes, Heather; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Gay, Nick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Aberdeen; University of Aberdeen; James Hutton Institute; University of Cambridge; University of Cambridge	Hold, GL (corresponding author), Univ Aberdeen, Div Appl Med, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Mayer, Claus-Dieter/L-9353-2013; El-Omar, Emad/AAT-7780-2021; Hold, Georgina Louise/AAG-9923-2020	Hold, Georgina Louise/0000-0001-7573-3397; El-Omar, Emad/0000-0002-0011-3924; Mayer, Claus-Dieter/0000-0001-8788-3149	Cancer Research UK; EEO, Tenovus Scotland; Wellcome program; BBSRC [BB/K006436/1] Funding Source: UKRI; MRC [G1000133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K006436/1] Funding Source: researchfish; Medical Research Council [G1000133] Funding Source: researchfish; Wellcome Trust [100321/Z/12/Z] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EEO, Tenovus Scotland; Wellcome program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Cancer Research UK to GLH and EEO, Tenovus Scotland grant funding to GLH, JD and MRC, and Wellcome program grants to CEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Haag AF, 2011, J BIOL CHEM, V286, P17455, DOI 10.1074/jbc.M111.236356; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Heesen M, 2003, EUR CYTOKINE NETW, V14, P234; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kumpf O, 2006, SHOCK, V25, P123, DOI 10.1097/01.shk.0000190823.44030.e6; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Marsik C, 2005, CLIN CHEM, V51, P2178, DOI 10.1373/clinchem.2005.051649; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McAleer JP, 2009, J IMMUNOL, V182, P5322, DOI 10.4049/jimmunol.0803616; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Ohto U, 2012, J BIOL CHEM, V287, P40611, DOI 10.1074/jbc.M112.404608; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Schwartz DA, 2001, J ENDOTOXIN RES, V7, P389, DOI 10.1179/096805101101532972; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; von Aulock S, 2003, J INFECT DIS, V188, P938, DOI 10.1086/378095; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	32	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111460	10.1371/journal.pone.0111460	http://dx.doi.org/10.1371/journal.pone.0111460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365308	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100067
J	Oishi, T; Imai, H; Go, Y; Imamura, M; Hirai, H; Takada, M				Oishi, Takao; Imai, Hiroo; Go, Yasuhiro; Imamura, Masanori; Hirai, Hirohisa; Takada, Masahiko			Sporadic Premature Aging in a Japanese Monkey: A Primate Model for Progeria	PLOS ONE			English	Article							WERNERS-SYNDROME; EXPOSURE; CULTURE; NERVE	In our institute, we have recently found a child Japanese monkey who is characterized by deep wrinkles of the skin and cataract of bilateral eyes. Numbers of analyses were performed to identify symptoms representing different aspects of aging. In this monkey, the cell cycle of fibroblasts at early passage was significantly extended as compared to a normal control. Moreover, both the appearance of senescent cells and the deficiency in DNA repair were observed. Also, pathological examination showed that this monkey has poikiloderma with superficial telangiectasia, and biochemical assay confirmed that levels of HbA1c and urinary hyaluronan were higher than those of other ( child, adult, and aged) monkey groups. Of particular interest was that our MRI analysis revealed expansion of the cerebral sulci and lateral ventricles probably due to shrinkage of the cerebral cortex and the hippocampus. In addition, the conduction velocity of a peripheral sensory but not motor nerve was lower than in adult and child monkeys, and as low as in aged monkeys. However, we could not detect any individual-unique mutations of known genes responsible for major progeroid syndromes. The present results indicate that the monkey suffers from a kind of progeria that is not necessarily typical to human progeroid syndromes.	[Oishi, Takao; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan; [Imai, Hiroo; Imamura, Masanori; Hirai, Hirohisa] Kyoto Univ, Primate Res Inst, Mol Biol Sect, Inuyama, Aichi 484, Japan; [Go, Yasuhiro] Natl Inst Nat Sci, Dept Brain Sci, Ctr Novel Sci Initiat, Tokyo, Japan; [Go, Yasuhiro] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Kyoto University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Novel Science Initiatives (CNSI); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Oishi, T (corresponding author), Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan.	oishi.takao.5e@kyoto-u.ac.jp	Imamura, Masanori/AAV-5743-2021; Go, Yasuhiro/AAD-3313-2020	Imamura, Masanori/0000-0001-7609-2026; Go, Yasuhiro/0000-0003-4581-0325; Oishi, Takao/0000-0003-1067-3746; Imai, Hiroo/0000-0003-0729-0322	Grants-in-Aid for Scientific Research [25250003, 25860222] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arora H, 2014, INT J DERMATOL, V53, P798, DOI 10.1111/ijd.12408; DANES BS, 1971, J CLIN INVEST, V50, P2000, DOI 10.1172/JCI106692; de Magalhaes JP, 2004, ANN NY ACAD SCI, V1019, P375, DOI 10.1196/annals.1297.066; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Epstein C J, 1965, Trans Assoc Am Physicians, V78, P73; EPSTEIN J, 1973, P NATL ACAD SCI USA, V70, P977, DOI 10.1073/pnas.70.4.977; Gordon LB, 2012, J CELL BIOL, V199, P9, DOI 10.1083/jcb.201207072; Goto M, 2004, MED INTELL UNIT, P1; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Hirai H, 2002, CHROMOSOME RES, V10, P313, DOI 10.1023/A:1016523909096; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; HOPKINS AP, 1971, J NEUROL NEUROSUR PS, V34, P415, DOI 10.1136/jnnp.34.4.415; Lu H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.168; Marigliano M, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/965605; MCDONALD WI, 1963, BRAIN, V86, P501, DOI 10.1093/brain/86.3.501; McTighe MS, 2011, J AM ASSOC LAB ANIM, V50, P165; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Mohaghegh P, 2002, INT J BIOCHEM CELL B, V34, P1496, DOI 10.1016/S1357-2725(02)00039-0; Nishimura T, 2008, AM J PHYS ANTHROPOL, V135, P182, DOI 10.1002/ajpa.20719; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Peters A, 2003, J COMP NEUROL, V462, P139, DOI 10.1002/cne.10715; Pollex RL, 2004, CLIN GENET, V66, P375, DOI 10.1111/j.1399-0004.2004.00315.x; PURSER DA, 1983, BRIT J IND MED, V40, P402; Ramsden CA, 2000, J PEDIATR-US, V136, P62, DOI 10.1016/S0022-3476(00)90051-9; Takemoto M, 2013, GERIATR GERONTOL INT, V13, P475, DOI 10.1111/j.1447-0594.2012.00913.x; Tanabe M, 2001, GERONTOLOGY, V47, P77, DOI 10.1159/000052777; Weimer MB, 2005, MUSCLE NERVE, V32, P185, DOI 10.1002/mus.20350	27	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111867	10.1371/journal.pone.0111867	http://dx.doi.org/10.1371/journal.pone.0111867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365557	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100131
J	Woo, HD; Shin, A; Kim, J				Woo, Hae Dong; Shin, Aesun; Kim, Jeongseon			Dietary Patterns of Korean Adults and the Prevalence of Metabolic Syndrome: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; RISK-FACTORS; ATHEROSCLEROSIS RISK; NATIONAL-HEALTH; SEX DIFFERENCE; SERUM FERRITIN; FOOD PATTERNS	The prevalence of metabolic syndrome has been increasing in Korea and has been associated with dietary habits. The aim of our study was to identify the relationship between dietary patterns and the prevalence of metabolic syndrome. Using a validated food frequency questionnaire, we employed a cross-sectional design to assess the dietary intake of 1257 Korean adults aged 31 to 70 years. To determine the participants' dietary patterns, we considered 37 predefined food groups in principal components analysis. Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III. The abdominal obesity criterion was modified using Asian guidelines. Prevalence ratios and 95% confidence intervals for the metabolic syndrome were calculated across the quartiles of dietary pattern scores using log binomial regression models. The covariates used in the model were age, sex, total energy intake, tobacco intake, alcohol consumption, and physical activity. The prevalence of metabolic syndrome was 19.8% in men and 14.1% in women. The PCA identified three distinct dietary patterns: the 'traditional' pattern, the 'meat' pattern, and the 'snack' pattern. There was an association of increasing waist circumference and body mass index with increasing score in the meat dietary pattern. The multivariate-adjusted prevalence ratio of metabolic syndrome for the highest quartile of the meat pattern in comparison with the lowest quartile was 1.47 (95% CI: 1.00-2.15, p for trend = 0.016). A positive association between the prevalence of metabolic syndrome and the dietary pattern score was found only for men with the meat dietary pattern (2.15, 95% CI: 1.10-4.21, p for trend = 0.005). The traditional pattern and the snack pattern were not associated with an increased prevalence of metabolic syndrome. The meat dietary pattern was associated with a higher prevalence of metabolic syndrome in Korean male adults.	[Woo, Hae Dong; Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea; [Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU)	Kim, J (corresponding author), Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea.	jskim@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022; Stefanadis, Christodoulos/ABH-2232-2020; Shin, Aesun/E-9145-2014	Stefanadis, Christodoulos/0000-0001-5974-6454; Shin, Aesun/0000-0002-6426-1969	National Cancer Center, Korea [1210141]	National Cancer Center, Korea	This study was supported by a grant from the National Cancer Center, Korea (no. 1210141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Amini M, 2010, NUTRITION, V26, P986, DOI 10.1016/j.nut.2010.03.006; [Anonymous], 2005, GUIDELINES DATA PROC; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Azadbakht L, 2009, J NUTR, V139, P335, DOI 10.3945/jn.108.096297; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Bozzini C, 2005, DIABETES CARE, V28, P2061, DOI 10.2337/diacare.28.8.2061; Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018; Damiao R, 2006, BRIT J NUTR, V96, P532, DOI 10.1079/BJN20061876; de Valk B, 1999, ARCH INTERN MED, V159, P1542, DOI 10.1001/archinte.159.14.1542; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261; DiBello JR, 2009, J NUTR, V139, P1933, DOI 10.3945/jn.109.107888; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Ferreira Sandra R G, 2002, J Epidemiol, V12, P431; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Gimeno SGA, 2002, DIABETOLOGIA, V45, P1635, DOI 10.1007/s00125-002-0963-x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040919; Hong S, 2012, METABOLISM, V61, P883, DOI 10.1016/j.metabol.2011.10.018; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kim HJ, 2014, INT J CARDIOL, V174, P64, DOI 10.1016/j.ijcard.2014.03.163; Kim S H, 1996, World Rev Nutr Diet, V79, P109; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Mascitelli L, 2011, J CARDIOVASC MED, V12, P64, DOI 10.2459/JCM.0b013e3283403942; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Merchant AT, 2007, AM J CLIN NUTR, V85, P225; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Panagiotakos DB, 2007, J AM DIET ASSOC, V107, P979, DOI 10.1016/j.jada.2007.03.006; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Song Y, 2012, NUTR METAB CARDIOVAS, V22, P456, DOI 10.1016/j.numecd.2010.09.002; SULLIVAN JL, 1981, LANCET, V1, P1293; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Tappel A, 2007, MED HYPOTHESES, V68, P562, DOI 10.1016/j.mehy.2006.08.025; TREVISAN M, 1990, JAMA-J AM MED ASSOC, V263, P688, DOI 10.1001/jama.263.5.688; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; Wirfalt E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150; World Health Organization Western Pacific Region, 2000, INT ASS STUD OB TASK, P15	53	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111593	10.1371/journal.pone.0111593	http://dx.doi.org/10.1371/journal.pone.0111593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365577	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558100085
J	Chowanadisai, W				Chowanadisai, Winyoo			Comparative Genomic Analysis of slc39a12/ZIP12: Insight into a Zinc Transporter Required for Vertebrate Nervous System Development	PLOS ONE			English	Article							ACRODERMATITIS-ENTEROPATHICA; FUNCTIONAL EXPRESSION; METAL TRANSPORTER; MESSENGER-RNA; EVOLUTION; IDENTIFICATION; PROTEINS; ZEBRAFISH; XENOPUS; GENES	The zinc transporter ZIP12, which is encoded by the gene slc39a12, has previously been shown to be important for neuronal differentiation in mouse Neuro-2a neuroblastoma cells and primary mouse neurons and necessary for neurulation during Xenopus tropicalis embryogenesis. However, relatively little is known about the biochemical properties, cellular regulation, or the physiological role of this gene. The hypothesis that ZIP12 is a zinc transporter important for nervous system function and development guided a comparative genetics approach to uncover the presence of ZIP12 in various genomes and identify conserved sequences and expression patterns associated with ZIP12. Ortholog detection of slc39a12 was conducted with reciprocal BLAST hits with the amino acid sequence of human ZIP12 in comparison to the human paralog ZIP4 and conserved local synteny between genomes. ZIP12 is present in the genomes of almost all vertebrates examined, from humans and other mammals to most teleost fish. However, ZIP12 appears to be absent from the zebrafish genome. The discrimination of ZIP12 compared to ZIP4 was unsuccessful or inconclusive in other invertebrate chordates and deuterostomes. Splice variation, due to the inclusion or exclusion of a conserved exon, is present in humans, rats, and cows and likely has biological significance. ZIP12 also possesses many putative di-leucine and tyrosine motifs often associated with intracellular trafficking, which may control cellular zinc uptake activity through the localization of ZIP12 within the cell. These findings highlight multiple aspects of ZIP12 at the biochemical, cellular, and physiological levels with likely biological significance. ZIP12 appears to have conserved function as a zinc uptake transporter in vertebrate nervous system development. Consequently, the role of ZIP12 may be an important link to reported congenital malformations in numerous animal models and humans that are caused by zinc deficiency.	Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis	Chowanadisai, W (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	wchowanadisai@ucdavis.edu			University of California, Davis Center for Health and Nutrition Research	University of California, Davis Center for Health and Nutrition Research	Funding for this research was provided by a grant from the University of California, Davis Center for Health and Nutrition Research (to Robert B. Rucker). No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Benito-Gutierrez E, 2006, INT J BIOL SCI, V2, P149; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Chalfie M, 1998, TRENDS GENET, V14, P506, DOI 10.1016/S0168-9525(98)01623-0; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Christiaen L., 2009, COLD SPRING HARB PRO, V2009; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; Costello LC, 1999, J BIOL CHEM, V274, P17499, DOI 10.1074/jbc.274.25.17499; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Ehsani S, 2012, J MOL BIOL, V422, P556, DOI 10.1016/j.jmb.2012.06.003; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; FORBES RM, 1984, FED PROC, V43, P2835; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gabaldon Toni, 2008, V439, P387, DOI 10.1007/978-1-59745-188-8_26; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gilchrist MJ, 2012, GENESIS, V50, P143, DOI 10.1002/dvg.22008; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; HIDIROGLOU M, 1979, J DAIRY SCI, V62, P1195, DOI 10.3168/jds.S0022-0302(79)83400-1; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Hofmann T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010519; Hogstrand C, 2013, BIOCHEM J, V455, P229, DOI 10.1042/BJ20130483; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang LP, 2007, FEBS J, V274, P3986, DOI 10.1111/j.1742-4658.2007.05933.x; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jun J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-630; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kao HT, 1996, MOL BRAIN RES, V43, P174, DOI 10.1016/S0169-328X(96)00173-8; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lichten LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021526; Long YS, 2011, J GENET GENOMICS, V38, P157, DOI 10.1016/j.jgg.2011.03.003; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; LUECKE RW, 1984, FED PROC, V43, P2823; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Mathews WR, 2006, DEVELOPMENT, V133, P1143, DOI 10.1242/dev.02256; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Mimoto MS, 2011, METHODS MOL BIOL, V770, P55, DOI 10.1007/978-1-61779-210-6_3; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PRASAD AS, 1988, J AM COLL NUTR, V7, P377, DOI 10.1080/07315724.1988.10720255; Richardson MK, 2003, J MORPHOL, V257, P348, DOI 10.1002/jmor.10119; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Sauka-Spengler T., 2009, COLD SPRING HARB PRO, V2009, pt5122; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Siepel A, 2007, GENOME RES, V17, P1763, DOI 10.1101/gr.7128207; Sive H. L., 2007, CSH PROTOC, V2007; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; SWENERTON H, 1969, SCIENCE, V166, P1014, DOI 10.1126/science.166.3908.1014; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Velthuis AJWT, 2008, CURR GENOMICS, V9, P88, DOI 10.2174/138920208784139537; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Yuzbasiyan-Gurkan V, 2006, GENOMICS, V88, P521, DOI 10.1016/j.ygeno.2006.03.018; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Zhao H, 2009, GENOME RES, V19, P934, DOI 10.1101/gr.086009.108; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	91	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111535	10.1371/journal.pone.0111535	http://dx.doi.org/10.1371/journal.pone.0111535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375179	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600046
J	Lancaster, GI; Kraakman, MJ; Kammoun, HL; Langley, KG; Estevez, E; Banerjee, A; Grumont, RJ; Febbraio, MA; Gerondakis, S				Lancaster, Graeme I.; Kraakman, Michael J.; Kammoun, Helene L.; Langley, Katherine G.; Estevez, Emma; Banerjee, Ashish; Grumont, Raelene J.; Febbraio, Mark A.; Gerondakis, Steve			The Dual-Specificity Phosphatase 2 (DUSP2) Does Not Regulate Obesity-Associated Inflammation or Insulin Resistance in Mice	PLOS ONE			English	Article							MAP KINASE PHOSPHATASE-1; T-CELLS; IMMUNE-RESPONSES; SENSITIVITY; ACTIVATION; LACKING; INNATE; PAC-1; PTP1B	Alterations in the immune cell profile and the induction of inflammation within adipose tissue are a hallmark of obesity in mice and humans. Dual-specificity phosphatase 2 (DUSP2) is widely expressed within the immune system and plays a key role promoting immune and inflammatory responses dependent on mitogen-activated protein kinase (MAPK) activity. We hypothesised that the absence of DUSP2 would protect mice against obesity-associated inflammation and insulin resistance. Accordingly, male and female littermate mice that are either wild-type (wt) or homozygous for a germ-line null mutation of the dusp2 gene (dusp2 2/2) were fed either a standard chow diet (SCD) or high fat diet (HFD) for 12 weeks prior to metabolic phenotyping. Compared with mice fed the SCD, all mice consuming the HFD became obese, developed glucose intolerance and insulin resistance, and displayed increased macrophage recruitment and markers of inflammation in epididymal white adipose tissue. The absence of DUSP2, however, had no effect on the development of obesity or adipose tissue inflammation. Whole body insulin sensitivity in male mice was unaffected by an absence of DUSP2 in response to either the SCD or HFD; however, HFD-induced insulin resistance was slightly, but significantly, reduced in female dusp2 2/2 mice. In conclusion, DUSP2 plays no role in regulating obesity-associated inflammation and only a minor role in controlling insulin sensitivity following HFD in female, but not male, mice. These data indicate that rather than DUSP2 being a pan regulator of MAPK dependent immune cell mediated inflammation, it appears to differentially regulate inflammatory responses that have a MAPK component.	[Lancaster, Graeme I.; Kraakman, Michael J.; Kammoun, Helene L.; Langley, Katherine G.; Estevez, Emma; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Grumont, Raelene J.; Gerondakis, Steve] Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Grumont, Raelene J.; Gerondakis, Steve] Monash Univ, Cent Clin Sch, Dept Clin Hematol, Melbourne, Vic 3004, Australia; [Banerjee, Ashish] Monash Univ, MIMR PHI Inst Med Res, Ctr Canc Res, Clayton, Vic 3800, Australia	Baker Heart and Diabetes Institute; Monash University; Monash University; Monash University; Prince Henry's Institute of Medical Research	Lancaster, GI (corresponding author), Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia.	Graeme.lancaster@bakeridi.edu.au	Febbraio, Mark/AAE-9632-2019	Kraakman, Michael/0000-0002-5755-0447; Febbraio, Mark/0000-0002-9296-4418; Estevez, Emma/0000-0002-5125-2190	Victorian Government; Baker IDI Bright Sparks Stipend; Monash University Faculty of Medicine, Nursing and Health Sciences Postgraduate Research Scholarship; Australian Postgraduate Award	Victorian Government; Baker IDI Bright Sparks Stipend; Monash University Faculty of Medicine, Nursing and Health Sciences Postgraduate Research Scholarship; Australian Postgraduate Award(Australian Government)	This study was supported by the Victorian Government Operational Infrastructure Support Program. M.A.F. and S.G. are Research Fellows of the National Health & Medical Research Council of Australia. K.G.L. is supported by a Baker IDI Bright Sparks Stipend and a Monash University Faculty of Medicine, Nursing and Health Sciences Postgraduate Research Scholarship. M.J.K. is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger-Messier M, 2013, CIRC RES, V112, P48, DOI 10.1161/CIRCRESAHA.112.272963; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fukushima A, 2010, DIABETES, V59, P1906, DOI 10.2337/db09-1365; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Lancaster GI, 2012, BIOCHEM J, V442, P723, DOI 10.1042/BJ20112037; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Xu E, 2014, REV ENDOCR METAB DIS, V15, P79, DOI 10.1007/s11154-013-9282-4; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111524	10.1371/journal.pone.0111524	http://dx.doi.org/10.1371/journal.pone.0111524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375135	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600044
J	Simental-Rodriguez, SL; Quinones-Perez, CZ; Moya, D; Hernandez-Tecles, E; Lopez-Sanchez, CA; Wehenkel, C				Leonel Simental-Rodriguez, Sergio; Zulema Quinones-Perez, Carmen; Moya, Daniel; Hernandez-Tecles, Enrique; Lopez-Sanchez, Carlos Antonio; Wehenkel, Christian			The Relationship between Species Diversity and Genetic Structure in the Rare Picea chihuahuana Tree Species Community, Mexico	PLOS ONE			English	Article							POPULUS-TREMULOIDES; POPULATION-STRUCTURE; DIFFERENTIATION; CLIMATE; AFLP; POLYMORPHISM; RESPONSES; GENOTYPES; RICHNESS; ECOLOGY	Species diversity and genetic diversity, the most basic elements of biodiversity, have long been treated as separate topics, although populations evolve within a community context. Recent studies on community genetics and ecology have suggested that genetic diversity is not completely independent of species diversity. The Mexican Picea chihuahuana Martinez is an endemic species listed as "Endangered'' on the Red List. Forty populations of Chihuahua spruce have been identified. This species is often associated with tree species of eight genera in gallery forests. This rare Picea chihuahuana tree community covers an area no more than 300 ha and has been subject of several studies involving different topics such as ecology, genetic structure and climate change. The overall aim of these studies was to obtain a dataset for developing management tools to help decision makers implement preservation and conservation strategies. However, this unique forest tree community may also represent an excellent subject for helping us to understand the interplay between ecological and evolutionary processes in determining community structure and dynamics. The AFLP technique and species composition data were used together to test the hypothesis that species diversity is related to the adaptive genetic structure of some dominant tree species (Picea chihuahuana, Pinus strobiformis, Pseudotsuga menziesii and Populus tremuloides) of the Picea chihuahuana tree community at fourteen locations. The Hill numbers were used as a diversity measure. The results revealed a significant correlation between tree species diversity and genetic structure in Populus tremuloides. Because the relationship between the two levels of diversity was found to be positive for the putative adaptive AFLP detected, genetic and species structures of the tree community were possibly simultaneously adapted to a combination of ecological or environmental factors. The present findings indicate that interactions between genetic variants and species diversity may be crucial in shaping tree communities.	[Leonel Simental-Rodriguez, Sergio; Zulema Quinones-Perez, Carmen; Lopez-Sanchez, Carlos Antonio; Wehenkel, Christian] Univ Juarez Estado Durango, Forestry & Wood Ind Inst, Durango, Mexico; [Moya, Daniel; Hernandez-Tecles, Enrique] Univ Castilla La Mancha, Higher Tech Sch Agr & Forestry Engn, Albacete, Spain	Universidad Juarez del Estado de Durango; Universidad de Castilla-La Mancha	Wehenkel, C (corresponding author), Univ Juarez Estado Durango, Forestry & Wood Ind Inst, Durango, Mexico.	wehenkel@ujed.mx	Moya, Daniel/N-1616-2019; Moya, Daniel/B-5979-2015; López-Sánchez, Carlos A./K-6486-2016	Moya, Daniel/0000-0002-1909-1200; Moya, Daniel/0000-0002-1909-1200; López-Sánchez, Carlos A./0000-0002-5135-5739	Mexican Council of Science and Technology (CONACyT); Ministry of Education (SEP) [CB-2010-01 158054]	Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministry of Education (SEP)	This study was supported by joint funding from the Mexican Council of Science and Technology (CONACyT:http://www.conacyt.gob.mx/) and the Ministry of Education (SEP: http://www.sep.gob.mx/; Project CB-2010-01 158054). CW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P605, DOI 10.2307/2260497; Achere V, 2005, MOL ECOL, V14, P3191, DOI 10.1111/j.1365-294X.2005.02646.x; [Anonymous], 2014, SILVAE GENE IN PRESS; [Anonymous], 2010, DIARIO OFICIAL FEDER; Antonovics J, 2003, ECOLOGY, V84, P598, DOI 10.1890/0012-9658(2003)084[0598:TCG]2.0.CO;2; ANTONOVICS J, 1992, PLANT RESISTANCE HER, P429; Bergmann F, 2013, SILVAE GENET, V62, P25, DOI 10.1515/sg-2013-0004; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; CHAN FJ, 1989, US FOR SERV T R PSW, V110, P428; Dupre C, 2002, J VEG SCI, V13, P505, DOI 10.1111/j.1654-1103.2002.tb02077.x; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; GORDON AG, 1968, ECOLOGY, V49, P880, DOI 10.2307/1936540; Gregorius HR, 2007, SILVAE GENET, V56, P190, DOI 10.1515/sg-2007-0029; Gregorius Hans-Rolf, 2010, Diversity, V2, P370; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; IUCN Red List of Threatened Species, 2013, IUCN RED LIST THREAT; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; JELINSKI DE, 1992, AM J BOT, V79, P728, DOI 10.2307/2444937; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; KARLIN AA, 1984, COPEIA, P343, DOI 10.2307/1445190; Kelly CK, 2003, ECOL LETT, V6, P87, DOI 10.1046/j.1461-0248.2003.00402.x; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Kuchma O, 2011, MUTAT RES-GEN TOX EN, V725, P29, DOI 10.1016/j.mrgentox.2011.07.003; Ledig F. Thomas, 2000, Madrono, V47, P71; Ledig FT, 2010, AM J BOT, V97, P970, DOI 10.3732/ajb.0900329; Ledig FT, 1997, EVOLUTION, V51, P1815, DOI [10.2307/2411004, 10.1111/j.1558-5646.1997.tb05105.x]; Lindroth RL, 2013, FOREST ECOL MANAG, V299, P14, DOI 10.1016/j.foreco.2012.11.018; LUMARET R, 1984, HEREDITY, V52, P153, DOI 10.1038/hdy.1984.18; Manly BJF, 1997, RANDOMIZATION BOOTST, P399; Martinez-Antunez P, 2013, POL J ECOL, V61, P283; Mendoza-Maya E, 2014, PROPUESTA C IN PRESS; Narvaez FR, 1984, THESIS U AUTONOMA NU; PINERO D, 2008, DIVERSIDAD GENETICA, V1, P437; Quinones-Perez CZ, 2012, KASTAMONU UNIV J FOR, V12, P180; Richardson BA, 2009, INT J PLANT SCI, V170, P1120, DOI 10.1086/605870; Saenz-Romero C, 2010, CLIMATIC CHANGE, V102, P595, DOI 10.1007/s10584-009-9753-5; Sanchez CJ, 1984, CIENC FOREST, V9, P51; Scotti-Saintagne C, 2004, GENETICS, V168, P1615, DOI 10.1534/genetics.104.026849; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Silva-Flores R, 2014, PLOS ONE IN PRESS; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Vavrek MC, 1998, AM J BOT, V85, P947, DOI 10.2307/2446361; Vellend M, 2005, AM NAT, V166, P199, DOI 10.1086/431318; Vellend M, 2004, ECOLOGY, V85, P3043, DOI 10.1890/04-0435; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang XZ, 2001, NEW PHYTOL, V150, P675, DOI 10.1046/j.1469-8137.2001.00138.x; Wehenkel C., 2012, Forstarchiv, V83, P48; Wehenkel C, 2014, GENETIC ERO IN PRESS; Wehenkel C, 2007, SILVAE GENET, V56, P101, DOI 10.1515/sg-2007-0016; Wehenkel C, 2006, PLANT ECOL, V185, P151, DOI 10.1007/s11258-005-9091-2; Wehenkel C, 2012, TREE GENET GENOMES, V8, P1085, DOI 10.1007/s11295-012-0488-5; Wehenkel C, 2010, PLANT ECOL, V208, P47, DOI 10.1007/s11258-009-9685-1; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Wullschleger SD, 2002, PLANT CELL, V14, P2651, DOI 10.1105/tpc.141120; ZANGERL AR, 1984, ECOLOGY, V65, P218, DOI 10.2307/1939473; Quinones-Perez CZ, 2014, POL J ECOL, V62, P55, DOI 10.3161/104.062.0106; Zyczkowski K, 2003, OPEN SYST INF DYN, V10, P297, DOI 10.1023/A:1025128024427	70	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111623	10.1371/journal.pone.0111623	http://dx.doi.org/10.1371/journal.pone.0111623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375134	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600054
J	Naganuma, T; Hoshino, W; Shikanai, Y; Sato, R; Liu, KY; Sato, S; Muramoto, K; Osada, M; Yoshimi, K; Ogawa, T				Naganuma, Takako; Hoshino, Wataru; Shikanai, Yukihiro; Sato, Rie; Liu, Kaiyue; Sato, Saho; Muramoto, Koji; Osada, Makoto; Yoshimi, Kyosuke; Ogawa, Tomohisa			Novel Matrix Proteins of Pteria penguin Pearl Oyster Shell Nacre Homologous to the Jacalin-Related beta-Prism Fold Lectins	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; ORGANIC MATRIX; CALCIUM-CARBONATE; MOLECULAR-CLONING; KEY MACROMOLECULE; CRYSTAL-STRUCTURE; LAYER FORMATION; BIOMINERALIZATION; TREHALOSE; PHYLOGENIES	Nacreous layers of pearl oyster are one of the major functional biominerals. By participating in organic compound-crystal interactions, they assemble into consecutive mineral lamellae-like photonic crystals. Their biomineralization mechanisms are controlled by macromolecules; however, they are largely unknown. Here, we report two novel lectins termed PPL2A and PPL2B, which were isolated from the mantle and the secreted fluid of Pteria penguin oyster. PPL2A is a hetero-dimer composed of alpha and gamma subunits, and PPL2B is a homo-dimer of beta subunit, all of which surprisingly shared sequence homology with the jacalin-related plant lectin. On the basis of knockdown experiments at the larval stage, the identification of PPLs in the shell matrix, and in vitro CaCO3 crystallization analysis, we conclude that two novel jacalin-related lectins participate in the biomineralization of P. penguin nacre as matrix proteins. Furthermore, it was found that trehalose, which is specific recognizing carbohydrates for PPL2A and is abundant in the secreted fluid of P. penguin mantle, functions as a regulatory factor for biomineralization via PPL2A. These observations highlight the unique functions, diversity and molecular evolution of this lectin family involved in the mollusk shell formation.	[Naganuma, Takako; Hoshino, Wataru; Shikanai, Yukihiro; Sato, Rie; Liu, Kaiyue; Sato, Saho; Muramoto, Koji; Ogawa, Tomohisa] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808577, Japan; [Naganuma, Takako; Osada, Makoto; Yoshimi, Kyosuke; Ogawa, Tomohisa] Tohoku Univ, Ctr Interdisciplinary Res, Sendai, Miyagi 9808578, Japan; [Osada, Makoto] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Yoshimi, Kyosuke] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808578, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Ogawa, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808577, Japan.	ogawa@biochem.tohoku.ac.jp	Osada, Makoto/AAI-9967-2020	Osada, Makoto/0000-0001-6247-5106; Ogawa, Tomohisa/0000-0001-8700-6330	Ministry of Education, Culture, Sports, Science and Technology, Japan [23107505, 20350073]; "Program Research'' in the Center for Interdisciplinary Research, Tohoku University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Program Research'' in the Center for Interdisciplinary Research, Tohoku University	This work was supported by Grant-in-Aid for Scientific Research (B) (No. 20350073) and Scientific Research on the Innovative Area "Fusion Materials'' (No. 23107505) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and "Program Research'' in the Center for Interdisciplinary Research, Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Astoul CH, 2002, BIOCHEM J, V367, P817, DOI 10.1042/BJ20020856; BADMAN DG, 1967, COMP BIOCHEM PHYSIOL, V23, P621, DOI 10.1016/0010-406X(67)90413-6; Baeuerlein Edmund, 2007, P1; Behrens P., 2007, HDB BIOMINERALIZATIO; Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200; BROOKS R, 1950, PHILOS T R SOC S-A, V243, P145, DOI 10.1098/rsta.1950.0016; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; CRONSHAGEN U, 1994, EUR J CELL BIOL, V65, P366; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Howard EW, 2001, DEVELOPMENT, V128, P365; Jakob W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000694; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kanagawa M, 2011, BIOCHEM BIOPH RES CO, V404, P201, DOI 10.1016/j.bbrc.2010.11.093; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Liener I.E., 1986, LECTINS PROPERTIES F; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Mann K, 2001, EUR J BIOCHEM, V268, P4414, DOI 10.1046/j.1432-1327.2001.02368.x; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marsh ME, 2003, COMP BIOCHEM PHYS B, V136, P743, DOI 10.1016/S1096-4959(03)00180-5; Marshall RD, 1972, GLYCOPROTEINS A, P251; MATSUMOTO I, 1979, J BIOCHEM-TOKYO, V85, P1091, DOI 10.1093/oxfordjournals.jbchem.a132417; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; McGinty EL, 2012, MAR GENOM, V5, P27, DOI 10.1016/j.margen.2011.08.006; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Nomura K, 2000, BIOCHEM BIOPH RES CO, V276, P23, DOI 10.1006/bbrc.2000.3420; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Ogawa Tomohisa, 2011, J Amino Acids, V2011, P838914, DOI 10.4061/2011/838914; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Shirai T, 2009, J MOL BIOL, V391, P390, DOI 10.1016/j.jmb.2009.06.027; Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403; Smith-Keune C, 2009, AQUAC RES, V40, P1054, DOI 10.1111/j.1365-2109.2009.02199.x; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Van Damme EJM, 1999, EUR J BIOCHEM, V259, P135, DOI 10.1046/j.1432-1327.1999.00013.x; Wang N, 2012, MAR BIOTECHNOL, V14, P177, DOI 10.1007/s10126-011-9400-9; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; WORMS D, 1986, J EXP ZOOL, V237, P11, DOI 10.1002/jez.1402370104; Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098; Zhang WL, 2000, PLANTA, V210, P970, DOI 10.1007/s004250050705	69	16	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112326	10.1371/journal.pone.0112326	http://dx.doi.org/10.1371/journal.pone.0112326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375177	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600128
J	Ray, P; Knowlton, KF; Shang, C; Xia, K				Ray, Partha; Knowlton, Katharine F.; Shang, Chao; Xia, Kang			Development and Validation of a UPLC-MS/MS Method to Monitor Cephapirin Excretion in Dairy Cows following Intramammary Infusion	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; ANTIBIOTIC-RESISTANCE; TISSUE DISTRIBUTION; VETERINARY ANTIBIOTICS; STAPHYLOCOCCUS-AUREUS; CEFTIOFUR SODIUM; DRUG RESIDUES; BOVINE-MILK; PHARMACOKINETICS; ABSORPTION	Cephapirin, a cephalosporin antibiotic, is used by the majority of dairy farms in the US. Fecal and urinary excretion of cephapirin could introduce this compound into the environment when manure is land applied as fertilizer, and may cause development of bacterial resistance to antibiotics critical for human health. The environmental loading of cephapirin by the livestock industry remains un-assessed, largely due to a lack of appropriate analytical methods. Therefore, this study aimed to develop and validate a cephapirin quantification method to capture the temporal pattern of cephapirin excretion in dairy cows following intramammary infusion. The method includes an extraction with phosphate buffer and methanol, solid-phase extraction (SPE) clean-up, and quantification using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). The LOQ values of the developed method were 4.02 mu g kg(-1) and 0.96 mu g L-1 for feces and urine, respectively. This robust method recovered >60% and >80% cephapirin from spiked blank fecal and urine samples, respectively, with acceptable intra-and inter-day variation (<10%). Using this method, we detected trace amounts (mu g kg(-1)) of cephapirin in dairy cow feces, and cephapirin in urine was detected at very high concentrations (133 to 480 mu g L-1). Cephapirin was primarily excreted via urine and its urinary excretion was influenced by day (P = 0.03). Peak excretion (2.69 mg) was on day 1 following intramammary infusion and decreased sharply thereafter (0.19, 0.19, 0.08, and 0.17 mg on day 2, 3, 4, and 5, respectively) reflecting a quadratic pattern of excretion (Quadratic: P = 0.03). The described method for quantification of cephapirin in bovine feces and urine is sensitive, accurate, and robust and allowed to monitor the pattern of cephapirin excretion in dairy cows. This data will help develop manure segregation and treatment methods to minimize the risk of antibiotic loading to the environment from dairy farms.	[Ray, Partha; Knowlton, Katharine F.] Virginia Polytech Inst & State Univ, Dept Dairy Sci, Blacksburg, VA 24061 USA; [Shang, Chao; Xia, Kang] Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Ray, P (corresponding author), Virginia Polytech Inst & State Univ, Dept Dairy Sci, Blacksburg, VA 24061 USA.	drray@vt.edu			Virginia Agricultural Experiment Station, Virginia Cooperative Extension; College of Agriculture and Life Sciences at Virginia Tech	Virginia Agricultural Experiment Station, Virginia Cooperative Extension; College of Agriculture and Life Sciences at Virginia Tech	This activity was funded, in part, with an integrated, internal competitive grant from Virginia Agricultural Experiment Station, Virginia Cooperative Extension, and the College of Agriculture and Life Sciences at Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; AXELROD J, 1971, APPL MICROBIOL, V22, P904, DOI 10.1128/AEM.22.5.904-908.1971; BeconiBarker MG, 1996, J VET PHARMACOL THER, V19, P192, DOI 10.1111/j.1365-2885.1996.tb00038.x; BECONIBARKER MG, 1995, J AGR FOOD CHEM, V43, P1589, DOI 10.1021/jf00054a033; CABANA BE, 1975, J PHARMACOKINET BIOP, V3, P419, DOI 10.1007/BF01059474; CABANA BE, 1976, ANTIMICROB AGENTS CH, V10, P307, DOI 10.1128/AAC.10.2.307; Cortinhas CS, 2013, AM J VET RES, V74, P683, DOI 10.2460/ajvr.74.5.683; Dasenbrock CO, 1998, ANAL CHEM, V70, P2415, DOI 10.1021/ac971375e; du Preez JH, 2000, J S AFR VET ASSOC, V71, P201; Ehinger AM, 2000, J VET MED A, V47, P157, DOI 10.1046/j.1439-0442.2000.00272.x; FASCHING CE, 1982, ANTIMICROB AGENTS CH, V21, P628, DOI 10.1128/AAC.21.4.628; Feng SX, 2012, J CHROMATOGR B, V898, P62, DOI 10.1016/j.jchromb.2012.04.020; Gehring R, 2006, J VET PHARMACOL THER, V29, P237, DOI 10.1111/j.1365-2885.2006.00750.x; GILBERTSON TJ, 1990, J AGR FOOD CHEM, V38, P890, DOI 10.1021/jf00093a064; GOLDSTEIN A, 1949, PHARMACOL REV, V1, P102; Gorden PJ, 2013, J DAIRY SCI, V96, P4455, DOI 10.3168/jds.2012-6487; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heller DN, 2006, J AGR FOOD CHEM, V54, P5267, DOI 10.1021/jf0605502; Heller DN, 2000, J AGR FOOD CHEM, V48, P6030, DOI 10.1021/jf000046b; Hleba L, 2012, J MICROB BIOTEC FOOD, V2, P253; HORNISH RE, 1992, ACS SYM SER, V503, P132; Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679; Junza A, 2011, J CHROMATOGR B, V879, P2601, DOI 10.1016/j.jchromb.2011.07.018; Junza R, 2010, OVIDIUS U ANAL CHEM, V21, P109; Kaufmann A, 2007, ANAL CHIM ACTA, V586, P13, DOI 10.1016/j.aca.2006.10.026; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kuchta SL, 2009, ARCH ENVIRON CON TOX, V57, P1, DOI 10.1007/s00244-008-9229-z; Kwon JW, 2009, J AOAC INT, V92, P359; Kwon SI, 2011, WASTE MANAGE, V31, P39, DOI 10.1016/j.wasman.2010.08.018; Lamshoft M, 2010, SCI TOTAL ENVIRON, V408, P1563, DOI 10.1016/j.scitotenv.2009.12.010; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; LEWIS JE, 1972, NATURE-NEW BIOL, V239, P214, DOI 10.1038/newbio239214a0; MAHON WA, 1973, ANTIMICROB AGENTS CH, V3, P585, DOI 10.1128/AAC.3.5.585; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; McDougall S, 2014, NEW ZEAL VET J, V62, P68, DOI 10.1080/00480169.2013.843135; Moats WA, 1998, J CHROMATOGR A, V812, P237, DOI 10.1016/S0021-9673(98)00387-2; Moats WA, 2000, J AGR FOOD CHEM, V48, P498, DOI 10.1021/jf990638y; OWENS WE, 1987, J DAIRY SCI, V70, P1946, DOI 10.3168/jds.S0022-0302(87)80236-9; Pikkemaat MG, 2009, ANAL BIOANAL CHEM, V395, P893, DOI 10.1007/s00216-009-2841-6; PRADES M, 1988, AM J VET RES, V49, P1888; SABATH LD, 1976, HUM PATHOL, V7, P287, DOI 10.1016/S0046-8177(76)80039-1; Sandegren L, 2014, UPSALA J MED SCI, V119, P103, DOI 10.3109/03009734.2014.904457; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; SOBACK S, 1990, J DAIRY SCI, V73, P661, DOI 10.3168/jds.S0022-0302(90)78717-6; Stockler RM, 2009, J DAIRY SCI, V92, P4262, DOI 10.3168/jds.2008-1916; Tello A, 2012, ENVIRON HEALTH PERSP, V120, P1100, DOI 10.1289/ehp.1104650; Turnipseed SB, 2008, RAPID COMMUN MASS SP, V22, P1467, DOI 10.1002/rcm.3532; TYCZKOWSKA KL, 1991, J VET PHARMACOL THER, V14, P51, DOI 10.1111/j.1365-2885.1991.tb00804.x; USDA/APHIS/VS/CEAH, ANT US US DAIR OP 20; USDA/APHIS/VS/CEAH, 2007, FAC CHAR COW COMF IU; Wagner RD, 2011, ANTIMICROB AGENTS CH, V55, P4990, DOI 10.1128/AAC.00008-11; WELIKY I, 1974, ANTIMICROB AGENTS CH, V5, P49, DOI 10.1128/AAC.5.1.49; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; WIESNER P, 1972, ANTIMICROB AGENTS CH, V1, P303, DOI 10.1128/AAC.1.4.303; Zhou LJ, 2012, J CHROMATOGR A, V1244, P123, DOI 10.1016/j.chroma.2012.04.076; ZIV G, 1976, BRIT VET J, V132, P318, DOI 10.1016/S0007-1935(17)34692-4; ZIV G, 1973, ANTIMICROB AGENTS CH, V3, P607, DOI 10.1128/AAC.3.5.607; ZIV G, 1986, ACS SYM SER, V320, P8, DOI 10.1021/bk-1986-0320.ch002; ZIV G, 1975, J DAIRY SCI, V58, P1637, DOI 10.3168/jds.S0022-0302(75)84762-X; Zonca A, 2011, J DAIRY SCI, V94, P3455, DOI 10.3168/jds.2010-4109	62	24	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112343	10.1371/journal.pone.0112343	http://dx.doi.org/10.1371/journal.pone.0112343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375097	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000344402600133
J	Zheng, X; Zhang, XY; Ding, LL; Lee, JR; Weinberger, PM; Dynan, WS				Zheng, Xuan; Zhang, Xinyan; Ding, Lingling; Lee, Jeffrey R.; Weinberger, Paul M.; Dynan, William S.			Synergistic Effect of High Charge and Energy Particle Radiation and Chronological Age on Biomarkers of Oxidative Stress and Tissue Degeneration: A Ground-Based Study Using the Vertebrate Laboratory Model Organism Oryzias latipes	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MEDAKA; DAMAGE; EXPOSURE; IRRADIATION; EXPRESSION; MEMORY; CELLS; FISH; RATS	High charge and energy (HZE) particles are a main hazard of the space radiation environment. Uncertainty regarding their health effects is a limiting factor in the design of human exploration-class space missions, that is, missions beyond low earth orbit. Previous work has shown that HZE exposure increases cancer risk and elicits other aging-like phenomena in animal models. Here, we investigate how a single exposure to HZE particle radiation, early in life, influences the subsequent age-dependent evolution of oxidative stress and appearance of degenerative tissue changes. Embryos of the laboratory model organism, Oryzias latipes (Japanese medaka fish), were exposed to HZE particle radiation at doses overlapping the range of anticipated human exposure. A separate cohort was exposed to reference gamma-radiation. Survival was monitored for 750 days, well beyond the median lifespan. The population was also sampled at intervals and liver tissue was subjected to histological and molecular analysis. HZE particle radiation dose and aging contributed synergistically to accumulation of lipid peroxidation products, which are a marker of chronic oxidative stress. This was mirrored by a decline in PPARGC1A mRNA, which encodes a transcriptional co-activator required for expression of oxidative stress defense genes and for mitochondrial maintenance. Consistent with chronic oxidative stress, mitochondria had an elongated and enlarged ultrastructure. Livers also had distinctive, cystic lesions. Depending on the endpoint, effects of gamma-rays in the same dose range were either lesser or not detected. Results provide a quantitative and qualitative framework for understanding relative contributions of HZE particle radiation exposure and aging to chronic oxidative stress and tissue degeneration.	[Zheng, Xuan; Dynan, William S.] Georgia Regents Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30901 USA; [Zheng, Xuan] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China; [Zhang, Xinyan] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Ding, Lingling] Wuhan Univ, Sch Med, Dept Anat & Embryol, Wuhan 430072, Peoples R China; [Lee, Jeffrey R.] Georgia Regents Univ, Dept Pathol, Augusta, GA USA; [Weinberger, Paul M.] Georgia Regents Univ, Dept Otolaryngol, Augusta, GA USA; [Weinberger, Paul M.] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Dynan, William S.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Dynan, William S.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA	University System of Georgia; Augusta University; Wuhan University; University of Alabama System; University of Alabama Birmingham; Wuhan University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University; Emory University	Dynan, WS (corresponding author), Georgia Regents Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30901 USA.	wdynan@emory.edu	Weinberger, Paul/B-7007-2008; Zhang, Xinyan/AAC-4406-2019	Weinberger, Paul/0000-0002-5885-2631; Zhang, Xinyan/0000-0002-8274-8711; Dynan, William/0000-0002-4045-5662	US Department of Energy Low Dose Radiation Research Program [DE-SC0002343]; National Aeronautics and Space Administration [NNX11AC30G]	US Department of Energy Low Dose Radiation Research Program(United States Department of Energy (DOE)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by the US Department of Energy Low Dose Radiation Research Program, award number DE-SC0002343 to WSD and the National Aeronautics and Space Administration, award number NNX11AC30G to WSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwood JS, 2010, BONE, V47, P248, DOI 10.1016/j.bone.2010.05.004; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Autsavapromporn N, 2011, J RADIAT RES, V52, P408, DOI 10.1269/jrr.10114; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Bielefeldt-Ohmann H, 2012, HEALTH PHYS, V103, P568, DOI 10.1097/HP.0b013e318265a257; Bladen CL, 2005, NUCLEIC ACIDS RES, V33, P3002, DOI 10.1093/nar/gki613; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Ding LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013287; EGAMI N, 1973, EXP GERONTOL, V8, P219, DOI 10.1016/0531-5565(73)90029-6; EGAMI N, 1966, RADIAT RES, V27, P630, DOI 10.2307/3571846; EGAMI NOBUO, 1962, ANNOT ZOOL JAPAN, V35, P188; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Gonon G, 2013, RADIAT RES, V179, P444, DOI 10.1667/RR3017.1; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Kuhne WW, 2009, RADIAT RES, V172, P473, DOI 10.1667/RR1556.1; Li M, 2013, ANTIOXID REDOX SIGNA; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Limoli CL, 2003, CANCER RES, V63, P3107; Lonart G, 2012, RADIAT RES, V178, P289, DOI 10.1667/RR2862.1; National Research Council, 2008, MAN SPAC RAD RISK NE; Okihiro MS, 1999, CARCINOGENESIS, V20, P933, DOI 10.1093/carcin/20.6.933; Poulose SM, 2011, RADIAT RES, V176, P761, DOI 10.1667/RR2605.1; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun C, 2014, J CELL PHYSIOL, V229, P100, DOI 10.1002/jcp.24424; Takeda H, 2010, ANNU REV GENET, V44, P217, DOI 10.1146/annurev-genet-051710-151001; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Tseng BP, 2013, ANTIOXID REDOX SIGNA; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villasana L, 2010, HIPPOCAMPUS, V20, P19, DOI 10.1002/hipo.20659; Villasana LE, 2013, PHARMACOL BIOCHEM BE, V103, P487, DOI 10.1016/j.pbb.2012.09.021; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yu T, 2011, RADIAT RES, V175, P766, DOI 10.1667/RR2482.1; Yumoto K, 2010, RADIAT RES, V173, P494, DOI 10.1667/RR1754.1; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989; Zhang ZB, 2007, TOXICOL SCI, V95, P356, DOI 10.1093/toxsci/kfl161	49	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111362	10.1371/journal.pone.0111362	http://dx.doi.org/10.1371/journal.pone.0111362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375139	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600035
J	Rao, RPN; Stocco, A; Bryan, M; Sarma, D; Youngquist, TM; Wu, J; Prat, CS				Rao, Rajesh P. N.; Stocco, Andrea; Bryan, Matthew; Sarma, Devapratim; Youngquist, Tiffany M.; Wu, Joseph; Prat, Chantel S.			A Direct Brain-to-Brain Interface in Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COMPUTER INTERFACE; MOTOR; BCI	We describe the first direct brain-to-brain interface in humans and present results from experiments involving six different subjects. Our non-invasive interface, demonstrated originally in August 2013, combines electroencephalography (EEG) for recording brain signals with transcranial magnetic stimulation (TMS) for delivering information to the brain. We illustrate our method using a visuomotor task in which two humans must cooperate through direct brain-to-brain communication to achieve a desired goal in a computer game. The brain-to-brain interface detects motor imagery in EEG signals recorded from one subject (the "sender") and transmits this information over the internet to the motor cortex region of a second subject (the "receiver"). This allows the sender to cause a desired motor response in the receiver (a press on a touchpad) via TMS. We quantify the performance of the brain-to-brain interface in terms of the amount of information transmitted as well as the accuracies attained in (1) decoding the sender's signals, (2) generating a motor response from the receiver upon stimulation, and (3) achieving the overall goal in the cooperative visuomotor task. Our results provide evidence for a rudimentary form of direct information transmission from one human brain to another using non-invasive means.	[Rao, Rajesh P. N.; Bryan, Matthew; Wu, Joseph] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Stocco, Andrea; Prat, Chantel S.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Stocco, Andrea; Prat, Chantel S.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Sarma, Devapratim; Youngquist, Tiffany M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rao, RPN (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	rao@cs.washington.edu; stocco@u.washington.edu	Stocco, Andrea/A-2159-2013	Stocco, Andrea/0000-0001-8919-3934; Rao, Rajesh P. N./0000-0003-0682-8952	Army Research Office [W911NF-11-1-0307]	Army Research Office	This study was funded by a grant from the Army Research Office (grant no. W911NF-11-1-0307) to RPNR and by a grant from the W.M. Keck foundation to AS, CSP, and RPNR (http:// www.arl.army.mil/www/default.cfm?page = 181, http://www.wmkeck.org/grant-programs/research/medical-research-grant-abstracts/science-and-engineering-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Blakely T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0977; BORKO H, 1992, J RES MATH EDUC, V23, P194, DOI 10.2307/749118; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Cover T. M., 1991, ELEMENTS INFORM THEO; Damasio A., 1994, LARGE SCALE NEURONAL, P61; Fabiani GE, 2004, IEEE T NEUR SYS REH, V12, P331, DOI 10.1109/TNSRE.2004.834627; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HOUSE WF, 1976, ANN OTO RHINOL LARYN, V85, P3, DOI 10.1177/00034894760850S303; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Min BK, 2010, TRENDS BIOTECHNOL, V28, P552, DOI 10.1016/j.tibtech.2010.08.002; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Pais-Vieira M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01319; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Rao R., 2013, BRAIN COMPUTER INTER; Rao R. P. N., 2013, DIRECT BRAIN TO BRAI; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe	26	63	68	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111332	10.1371/journal.pone.0111332	http://dx.doi.org/10.1371/journal.pone.0111332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372285	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900045
J	Shao, YC; Lei, Y; Wang, LB; Zhai, TY; Jin, X; Ni, W; Yang, Y; Tan, SW; Wen, B; Ye, EM; Yang, Z				Shao, Yongcong; Lei, Yu; Wang, Lubin; Zhai, Tianye; Jin, Xiao; Ni, Wei; Yang, Yue; Tan, Shuwen; Wen, Bo; Ye, Enmao; Yang, Zheng			Altered Resting-State Amygdala Functional Connectivity after 36 Hours of Total Sleep Deprivation	PLOS ONE			English	Article							EMOTION REGULATION; PREFRONTAL CORTEX; CINGULATE CORTEX; ACTIVATION; BRAIN; NETWORK; METAANALYSIS; INHIBITION; REACTIVITY; PHOBIA	Objectives: Recent neuroimaging studies have identified a potentially critical role of the amygdala in disrupted emotion neurocircuitry in individuals after total sleep deprivation (TSD). However, connectivity between the amygdala and cerebral cortex due to TSD remains to be elucidated. In this study, we used resting-state functional MRI (fMRI) to investigate the functional connectivity changes of the basolateral amygdala (BLA) and centromedial amygdala (CMA) in the brain after 36 h of TSD. Materials and Methods: Fourteen healthy adult men aged 25.9 +/- 62.3 years (range, 18-28 years) were enrolled in a within-subject crossover study. Using the BLA and CMA as separate seed regions, we examined resting-state functional connectivity with fMRI during rested wakefulness (RW)and after 36 h of TSD. Results: TSD resulted in a significant decrease in the functional connectivity between the BLA and several executive control regions (left dorsolateral prefrontal cortex [DLPFC], right dorsal anterior cingulate cortex [ACC], right inferior frontal gyrus [IFG]). Increased functional connectivity was found between the BLA and areas including the left posterior cingulate cortex/precuneus (PCC/PrCu) and right parahippocampal gyrus. With regard to CMA, increased functional connectivity was observed with the rostral anterior cingulate cortex (rACC) and right precentral gyrus. Conclusion: These findings demonstrate that disturbance in amygdala related circuits may contribute to TSD psychophysiology and suggest that functional connectivity studies of the amygdala during the resting state may be used to discern aberrant patterns of coupling within these circuits after TSD.	[Shao, Yongcong; Lei, Yu; Wang, Lubin; Zhai, Tianye; Jin, Xiao; Ni, Wei; Yang, Yue; Tan, Shuwen; Wen, Bo; Ye, Enmao; Yang, Zheng] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Shao, Yongcong; Lei, Yu; Wang, Lubin; Zhai, Tianye; Jin, Xiao; Ni, Wei; Yang, Yue; Tan, Shuwen; Ye, Enmao; Yang, Zheng] Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Ye, EM (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yem008@163.com; yangzhengchina@aliyun.com			National Military Science Foundation of China [BWS11J045, 06z066, AWS11Z005-2, AWS12J003, 2013BAHD2806]	National Military Science Foundation of China	The research reported in this article was supported by grants from the National Military Science Foundation of China, Grant No. BWS11J045, No. 06z066, No. AWS11Z005-2, No. AWS12J003, and No. 2013BAHD2806. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anderson C, 2011, BEHAV BRAIN RES, V217, P463, DOI 10.1016/j.bbr.2010.09.020; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; CARLSON J S, 1979, Intelligence, V3, P323, DOI 10.1016/0160-2896(79)90002-3; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Demenescu LR, 2013, J PSYCHIATR RES, V47, P1024, DOI 10.1016/j.jpsychires.2013.03.020; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Duerden EG, 2013, BRAIN RES, V1533, P80, DOI 10.1016/j.brainres.2013.08.021; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fang Z, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00704; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gee DG, 2013, J NEUROSCI, V33, P4584, DOI 10.1523/JNEUROSCI.3446-12.2013; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hermann A, 2009, SOC COGN AFFECT NEUR, V4, P257, DOI 10.1093/scan/nsp013; Killgore WDS, 2013, SLEEP, V36, P1597, DOI 10.5665/sleep.3106; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Motomura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056578; Mu QW, 2005, SLEEP, V28, P55, DOI 10.1093/sleep/28.1.55; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2007, HDB EMOTION REGULATI, P135; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Qin SZ, 2012, P NATL ACAD SCI USA, V109, P7941, DOI 10.1073/pnas.1120408109; Robinson JL, 2010, HUM BRAIN MAPP, V31, P173, DOI 10.1002/hbm.20854; Rosales-Lagarde A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00025; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Scott JPR, 2006, PHYSIOL BEHAV, V87, P396, DOI 10.1016/j.physbeh.2005.11.009; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; Talbot LS, 2010, EMOTION, V10, P831, DOI 10.1037/a0020138; Townsend JD, 2013, BIOL PSYCHIAT, V73, P127, DOI 10.1016/j.biopsych.2012.06.030; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van der Helm E, 2010, SLEEP, V33, P335, DOI 10.1093/sleep/33.3.335; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Wright P, 2008, NEUROIMAGE, V39, P894, DOI 10.1016/j.neuroimage.2007.09.014; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	48	41	47	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112222	10.1371/journal.pone.0112222	http://dx.doi.org/10.1371/journal.pone.0112222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372882	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900123
J	Stover, J; Hallett, TB; Wu, Z; Warren, M; Gopalappa, C; Pretorius, C; Ghys, PD; Montaner, J; Schwartlander, B				Stover, John; Hallett, Timothy B.; Wu, Zunyou; Warren, Mitchell; Gopalappa, Chaitra; Pretorius, Carel; Ghys, Peter D.; Montaner, Julio; Schwartlander, Bernhard		New Prevention Technology Study Gr	How Can We Get Close to Zero? The Potential Contribution of Biomedical Prevention and the Investment Framework towards an Effective Response to HIV	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; TRANSMISSION; INFECTION	Background: In 2011 an Investment Framework was proposed that described how the scale-up of key HIV interventions could dramatically reduce new HIV infections and deaths in low and middle income countries by 2015. This framework included ambitious coverage goals for prevention and treatment services resulting in a reduction of new HIV infections by more than half. However, it also estimated a leveling in the number of new infections at about 1 million annually after 2015. Methods: We modeled how the response to AIDS can be further expanded by scaling up antiretroviral treatment (ART) within the framework provided by the 2013 WHO treatment guidelines. We further explored the potential contributions of new prevention technologies: 'Test and Treat', pre-exposure prophylaxis and an HIV vaccine. Findings: Immediate aggressive scale up of existing approaches including the 2013 WHO guidelines could reduce new infections by 80%. A 'Test and Treat' approach could further reduce new infections. This could be further enhanced by a future highly effective pre-exposure prophylaxis and an HIV vaccine, so that a combination of all four approaches could reduce new infections to as low as 80,000 per year by 2050 and annual AIDS deaths to 260,000. Interpretation: In a set of ambitious scenarios, we find that immediate implementation of the 2013 WHO antiretroviral therapy guidelines could reduce new HIV infections by 80%. Further reductions may be achieved by moving to a ' Test and Treat' approach, and eventually by adding a highly effective pre-exposure prophylaxis and an HIV vaccine, if they become available.	[Stover, John; Gopalappa, Chaitra; Pretorius, Carel] Futures Inst, Glastonbury, CT 06033 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, London, England; [Wu, Zunyou] China Ctr Dis Control, Beijing, Peoples R China; [Warren, Mitchell] AIDS Vaccine Advocacy AVAC, New York, NY USA; [Montaner, Julio] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Ghys, Peter D.] UNAIDS, United Nations Joint Programme HIV AIDS, Geneva, Switzerland; [Schwartlander, Bernhard] WHO, Beijing, Peoples R China	Imperial College London; Chinese Center for Disease Control & Prevention; B.C. Centre for Excellence in HIV/AIDS; UNAIDS; World Health Organization	Stover, J (corresponding author), Futures Inst, Glastonbury, CT 06033 USA.	JStover@FuturesInstitute.org	Gopalappa, Chaitra/Y-4031-2018	Gopalappa, Chaitra/0000-0001-8384-6041; Hallett, Timothy/0000-0002-9681-0424; Terris-Prestholt, Fern/0000-0003-1693-5196; Grant, Robert/0000-0002-0851-7085; Cremin, Ide/0000-0003-2560-6247	Bill and Melinda Gates Foundation; UNAIDS; American people through the United States Agency for International Development (USAID); Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNAIDS; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was sponsored by the Bill and Melinda Gates Foundation, UNAIDS, and the International AIDS Vaccine Initiative (IAVI) by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Staff from UNAIDS, the Bill and Melinda Gates Foundation and IAVI participated in the New Prevention Technology Study Group which contributed to the study design and review of the manuscript.	[Anonymous], 19 C RETR OPP INF SE; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Eaton JW, 2013, LANCET GLOBAL HLTH; Futures Institute, 2011, GOALS MAN MOD EST EF; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2014, AIDS, V28, pS1, DOI 10.1097/QAD.0000000000000115; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; Nosyk B, 2013, AIDS, V27, P1159, DOI 10.1097/QAD.0b013e32835f1d68; Nosyk B, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001174; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Vaccine, 2011, VACCINE, V29, P36	25	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111956	10.1371/journal.pone.0111956	http://dx.doi.org/10.1371/journal.pone.0111956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372770	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000344556900095
J	Harden, JL; Lewis, SM; Pierson, KC; Suarez-Farinas, M; Lentini, T; Ortenzio, FS; Zaba, LC; Goldbach-Mansky, R; Bowcock, AM; Lowes, MA				Harden, Jamie L.; Lewis, Steven M.; Pierson, Katherine C.; Suarez-Farinas, Mayte; Lentini, Tim; Ortenzio, Francesca S.; Zaba, Lisa C.; Goldbach-Mansky, Raphaela; Bowcock, Anne M.; Lowes, Michelle A.			CARD14 Expression in Dermal Endothelial Cells in Psoriasis	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNITY; INFLAMMATION; PATHOGENESIS; SIGNALOSOME; ACTIVATION; MICROARRAY; MUTATIONS; PATHWAYS; THERAPY	Mutations in the caspase recruitment domain, family member 14 (CARD14) gene have recently been described in psoriasis patients, and explain the psoriasis susceptibility locus 2 (PSORS2). CARD14 is a scaffolding protein that regulates NF-kappa B activation, and psoriasis-associated CARD14 mutations lead to enhanced NF-kappa B signaling. CARD14 is expressed mainly in epidermal keratinocytes, but also in unidentified dermal cells. In this manuscript, the identity of the dermal cell types expressing CARD14, as well the potential functional consequence of overactive CARD14 in these dermal cell types, was determined. Using two-color immunofluorescence, dermal CARD14 did not co-localize with T-cells, dendritic cells, or macrophages. However, dermal CARD14 did highly co-localize with CD31(+) endothelial cells (ECs). CARD14 was also expressed non-dermal endothelial cells, such as aortic endothelial cells, which may indicate a role of CARD14(+) ECs in the systemic inflammation and cardiovascular comorbidities associated with psoriasis. Additionally, phosphorylated NF-kappa B was found in psoriatic CARD14(+) CD31(+) ECs, demonstrating this pathway is active in dermal ECs in psoriasis. Transfection of dermal ECs with psoriasis-associated CARD14 mutations resulted in increased expression of several chemokines, including CXCL10, IL-8, and CCL2. These results provide preliminary evidence that CARD14 expression in ECs may contribute to psoriasis through increased expression of chemokines and facilitating recruitment of immune cells into skin.	[Harden, Jamie L.; Lewis, Steven M.; Pierson, Katherine C.; Suarez-Farinas, Mayte; Lentini, Tim; Ortenzio, Francesca S.; Zaba, Lisa C.; Lowes, Michelle A.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Goldbach-Mansky, Raphaela] NIAMS, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD USA; [Bowcock, Anne M.] Univ London Imperial Coll Sci Technol & Med, London, England	Rockefeller University; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Imperial College London	Lowes, MA (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	lowesm@rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012; Zaba, Lisa/Q-9681-2019; Goldbach-Mansky, Raphaela/N-5917-2017; Lowes, Michelle A/G-9585-2016	Suarez-Farinas, Mayte/0000-0001-8712-3553; Lowes, Michelle A/0000-0003-4256-478X; Lewis, Steven/0000-0002-1979-0554; Zaba, Lisa/0000-0001-9036-5465; Bowcock, Anne/0000-0001-8691-9090	National Center for Research Resources [8 UL1 TR000043]; National Center for Advancing Translational Sciences (NCATS); National Institutes of Health [AR050266]; National Psoriasis Foundation; NIH [1R01AR060222]; National Institutes of Health Medical Scientist Training Program (MSTP) [GM07739]; Rockefeller University Center for Clinical and Translational Science (RUCCTS) Pilot Project award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060222, ZIAAR041138] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Psoriasis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Medical Scientist Training Program (MSTP); Rockefeller University Center for Clinical and Translational Science (RUCCTS) Pilot Project award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported in part by grant # 8 UL1 TR000043 from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS), and AR050266 (AMB) from the National Institutes of Health. The CARD14 research project was supported by a National Psoriasis Foundation Discovery grant to MAL. NIH 1R01AR060222 fully or partially supported MAL, JLH, and MSF. At the time of the research, LCZ was supported by National Institutes of Health Medical Scientist Training Program (MSTP) grant GM07739, and the study of aortic specimens was supported by a 2009 Rockefeller University Center for Clinical and Translational Science (RUCCTS) Pilot Project award. FSO is an RUCCTS-supported medical student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin DA, 2013, JAMA DERMATOL, V149, P178, DOI 10.1001/jamadermatol.2013.1609; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Fuchs-Telem D, 2012, AM J HUM GENET, V91, P163, DOI 10.1016/j.ajhg.2012.05.010; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Heidenreich R, 2009, INT J EXP PATHOL, V90, P232, DOI 10.1111/j.1365-2613.2009.00669.x; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Johnson-Huang LM, 2010, J INVEST DERMATOL, V130, P2654, DOI 10.1038/jid.2010.166; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Madonna S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.69; McAllister-Lucas LM, 2010, J BIOL CHEM, V285, P25880, DOI 10.1074/jbc.C110.109421; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Suarez-Farinas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084634; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	35	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111255	10.1371/journal.pone.0111255	http://dx.doi.org/10.1371/journal.pone.0111255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369198	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000046
J	Miotto, JM; Altmann, EG				Miotto, Jose M.; Altmann, Eduardo G.			Predictability of Extreme Events in Social Media	PLOS ONE			English	Article							AREA	It is part of our daily social-media experience that seemingly ordinary items (videos, news, publications, etc.) unexpectedly gain an enormous amount of attention. Here we investigate how unexpected these extreme events are. We propose a method that, given some information on the items, quantifies the predictability of events, i.e., the potential of identifying in advance the most successful items. Applying this method to different data, ranging from views in YouTube videos to posts in Usenet discussion groups, we invariantly find that the predictability increases for the most extreme events. This indicates that, despite the inherently stochastic collective dynamics of users, efficient prediction is possible for the most successful items.	[Miotto, Jose M.; Altmann, Eduardo G.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany	Max Planck Society	Miotto, JM (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	jmiotto@pks.mpg.de	Altmann, Eduardo G./ABD-2012-2020; Altmann, Eduardo/A-3320-2009	Altmann, Eduardo G./0000-0002-1932-3710; Altmann, Eduardo/0000-0002-1932-3710; Miotto, Jose Maria/0000-0002-5850-3394				Albeverio S, 2006, EXTREME EVENTS NATUR; Altmann EG, 2011, PLOS ONE, P6; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Bandari R, 2012, P 6 ICWSM; Bogachev MI, 2011, PHYSICA A, V390, P2240, DOI 10.1016/j.physa.2011.02.024; Brocker J, 2009, Q J ROY METEOR SOC, V135, P1512, DOI 10.1002/qj.456; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Coles S., 2001, INTRO STAT MODELING; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Fang Wu, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P409, DOI 10.1109/CSE.2009.430; Fenner M, 2013, CUMULATIVE USAGE STA; Ghil M, 2011, NONLINEAR PROC GEOPH, V18, P295, DOI 10.5194/npg-18-295-2011; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Hallerberg S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011108; Hallerberg S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016706; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kantz H, 2006, EXTREME EVENTS NATUR; Marsili M, 2013, J STAT MECH-THEORY E, V2013, DOI DOI 10.1088/1742-5468/2013/09/P09003; Miotto JM, 2014, TIME SERIES SOCIAL M; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pareto V, 1896, COURBE REPARTITION R; Penner O, 2013, SCI REP-UK, V3, DOI 10.1038/srep03052; Perc M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0378; Peterson J, 2013, P NATL ACAD SCI USA, V110, P20380, DOI 10.1073/pnas.1320578110; Preis T, 2013, SCI REPORTS, P3; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Provost F., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P445; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Simon H.A., 1971, COMPUTERS COMMUNICAT, P37; Sornette D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228701; Sornette D, 2002, P NATL ACAD SCI USA, V99, P2522, DOI 10.1073/pnas.022581999; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; SUKHATME S, 1994, BIOMETRICS, V50, P149, DOI 10.2307/2533205; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Yasseri T, 2013, MODELING RI IN PRESS	39	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111506	10.1371/journal.pone.0111506	http://dx.doi.org/10.1371/journal.pone.0111506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369138	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000061
J	Poon, VTW; Kuk, JL; Ardern, CI				Poon, Vivian T. W.; Kuk, Jennifer L.; Ardern, Chris I.			Trajectories of Metabolic Syndrome Development in Young Adults	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; 3RD NATIONAL-HEALTH; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; MIXTURE-MODELS; PREVALENCE; CHILDREN; FITNESS; CARDIA	Background: Metabolic syndrome (MetS) is a constellation of metabolic aberrations that collectively increase the risk for cardiovascular disease and type 2 diabetes. Greater understanding of MetS developments may provide insight into targeted prevention strategies for individuals at greatest risk. The purpose of this study was to i) identify distinct patterns of longitudinal MetS development and; ii) develop a character profile that differentiates groups by level of MetS risk. Methods and Results: Data from the Coronary Artery Risk Development in Young Adults (CARDIA) study (n = 3 804; 18-30 y) was obtained by limited access application from the National Heart, Lung, and Blood Institute and used for this analysis. MetS, as defined by the Harmonized criteria, was assessed over a 20 year follow-up period. Group-level trajectory analysis identified 4 distinct groups with varying rates of component development [No (23.8% of sample); Low (33.5%); Moderate (35.3%); and High MetS (7.4%)]. After adjusting for covariates, individuals in the At-Risk groups (Low, Moderate and High MetS) were more likely to be of black ethnicity (1.37, 1.14-1.66), have a family history of cardiovascular disease (1.61, 1.31-1.97) and history of dieting (1.69, 1.20-2.39) when compared to the No Risk trajectory group (No MetS). Conversely, increasing baseline education (0.76, 0.65-0.89) and aerobic fitness (0.55, 0.47-0.64) was inversely associated with At-Risk group membership. Conclusions: Results suggest distinct profiles of MetS development that can be identified by baseline risk factors. Further research is necessary to understand the clinical implication of intermediate MetS development groups with respect to overall cardiometabolic risk.	[Poon, Vivian T. W.; Kuk, Jennifer L.; Ardern, Chris I.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	York University - Canada	Ardern, CI (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	cardern@yorku.ca			Canadian Institutes of Health Research [131594]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JLK and CIA received funding for this work through the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) (Grant #131594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Arrandale V.H, 2006, THESIS U BRIT COLUMB; Bauer DJ, 2007, MULTIVAR BEHAV RES, V42, P757, DOI 10.1080/00273170701710338; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Carnethon MR, 2004, DIABETES CARE, V27, P2707, DOI 10.2337/diacare.27.11.2707; Chen W, 2007, AM J EPIDEMIOL, V166, P527, DOI 10.1093/aje/kwm105; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DONAHUE RP, 1989, ARTERIOSCLEROSIS, V9, P656, DOI 10.1161/01.ATV.9.5.656; Ekelund U, 2005, DIABETES CARE, V28, P1195, DOI 10.2337/diacare.28.5.1195; Field AE, 2007, OBESITY, V15, P456, DOI 10.1038/oby.2007.560; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Haffner SM, 1996, DIABETES, V45, P742, DOI 10.2337/diabetes.45.6.742; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; MAHONEY LT, 1991, ANN NY ACAD SCI, V623, P120, DOI 10.1111/j.1749-6632.1991.tb43723.x; Nagin DS, 2005, ANN AM ACAD POLIT SS, V602, P82, DOI 10.1177/0002716205280565; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Schmitz KH, 2000, INT J OBESITY, V24, P1475, DOI 10.1038/sj.ijo.0801415; SIDNEY S, 1991, AM J EPIDEMIOL, V133, P1231, DOI 10.1093/oxfordjournals.aje.a115835; Sumner AE, 2009, J PEDIAT, V155; U.S. Department of Health and Human Services National Heart Lung and Blood Institute, 2007, NIH PUBLICATION; WATTIGNEY WA, 1995, PREV MED, V24, P617, DOI 10.1006/pmed.1995.1097; White HR, 2002, DRUG ALCOHOL DEPEN, V65, P167, DOI 10.1016/S0376-8716(01)00159-4	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111647	10.1371/journal.pone.0111647	http://dx.doi.org/10.1371/journal.pone.0111647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368999	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000082
J	Zhan, GM; Tian, Y; Wang, FP; Chen, XM; Guo, J; Jiao, M; Huang, LL; Kang, ZS				Zhan, Gangming; Tian, Yuan; Wang, Fuping; Chen, Xianming; Guo, Jun; Jiao, Min; Huang, Lili; Kang, Zhensheng			A Novel Fungal Hyperparasite of Puccinia striiformis f. sp tritici, the Causal Agent of Wheat Stripe Rust	PLOS ONE			English	Article							GENETIC DIVERSITY	Puccinia striiformis f. sp. tritici (Pst), the causal fungus of wheat stripe rust, was previously reported to be infected by Lecanicillium lecanii, Microdochium nivale and Typhula idahoensis. Here, we report a novel hyperparasite on Pst. This hyperparasitic fungus was identified as Cladosporium cladosporioides (Fresen.) GA de Vries based on morphological characteristics observed by light and scanning electron microscopy together with molecular data. The hyperparasite reduced the production and viability of urediniospores and, therefore, could potentially be used for biological control of wheat stripe rust.	[Zhan, Gangming; Tian, Yuan; Wang, Fuping; Guo, Jun; Jiao, Min; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Zhan, Gangming; Tian, Yuan; Wang, Fuping; Guo, Jun; Jiao, Min; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China; [Chen, Xianming] Washington State Univ, USDA ARS, Wheat Genet Physiol Qual & Dis Res Unit, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Northwest A&F University - China; Northwest A&F University - China; United States Department of Agriculture (USDA); Washington State University; Washington State University	Kang, ZS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.	kangzs@nwsuaf.edu.cn		Kang, Zhensheng/0000-0001-5575-0122	National Key Basic Research Program of China [2013CB127700]; Special Fund for Agro-scientific Research in the Public Interest [201303023]; Nature Science Foundation of China [31371882]; 111 Project from the Ministry of Education of China [B07049]	National Key Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from the Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was supported by the National Key Basic Research Program of China (2013CB127700), Special Fund for Agro-scientific Research in the Public Interest (No. 201303023), the Nature Science Foundation of China (31371882), and the 111 Project from the Ministry of Education of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bensch K, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.67.01; Braun Uwe, 2003, Mycological Progress, V2, P3, DOI 10.1007/s11557-006-0039-2; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Crous PW, 2006, STUD MYCOL, P235, DOI 10.3114/sim.55.1.235; Crous PW, 2007, STUD MYCOL, V58, P3; Dugan FM, 2008, PERSOONIA, V21, P9, DOI 10.3767/003158508X334389; Dugan Frank M., 2004, Schlechtendalia, V11, P1; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gams W, 2007, CBS COURSE MYCOLOGY; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAWKSWORTH DL, 1995, AINSWORTH BISBYS DIC; Heather W. A., 1977, Australian Forestry, V40, P28; HIJWEGEN T, 1984, NETH J PLANT PATHOL, V90, P79, DOI 10.1007/BF01999956; Inderbitzin P, 2010, MYCOLOGIA, V102, P1350, DOI 10.3852/10-006; KEENER PAUL D., 1954, PLANT DIS REPORTER, V38, P690; Kiss L, 1997, MYCOL RES, V101, P1073, DOI 10.1017/S0953756297003705; Kohl JJ, 2009, EUR J PLANT PATHOL, V123, P401, DOI 10.1007/s10658-008-9377-z; Littlefield LJ., 1981, BIOL PLANT RUSTS INT; Lu NH, 2011, EUR J PLANT PATHOL, V131, P685, DOI 10.1007/s10658-011-9842-y; OMAR M, 1979, T BRIT MYCOL SOC, V72, P225, DOI 10.1016/S0007-1536(79)80036-4; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARMA JK, 1980, EUR J FOREST PATHOL, V10, P360; SRIVASTAVA AK, 1985, PHYTOPATHOL Z, V114, P73; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandermeer J, 2009, PLANT PATHOL, V58, P636, DOI 10.1111/j.1365-3059.2009.02067.x; Wang XN, 2013, J AGR FOOD CHEM, V61, P4551, DOI 10.1021/jf400212y; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhang ZY, 2003, FLORA FUNGORUM SINIC, V14, P11	33	19	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111484	10.1371/journal.pone.0111484	http://dx.doi.org/10.1371/journal.pone.0111484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369036	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000059
J	Tatineni, S; Riethoven, JJM; Graybosch, RA; French, R; Mitra, A				Tatineni, Satyanarayana; Riethoven, Jean-Jack M.; Graybosch, Robert A.; French, Roy; Mitra, Amitava			Dynamics of Small RNA Profiles of Virus and Host Origin in Wheat Cultivars Synergistically Infected by Wheat Streak Mosaic Virus and Triticum Mosaic Virus: Virus Infection Caused a Drastic Shift in the Endogenous Small RNA Profile	PLOS ONE			English	Article							SMALL INTERFERING RNAS; HELPER COMPONENT-PROTEINASE; DOUBLE-STRANDED-RNA; DICER-LIKE PROTEINS; FAMILY POTYVIRIDAE; ANTIVIRAL DEFENSE; DISEASE SYNERGISM; POLYMERASE GENE; PLANT-VIRUSES; CURL MITE	Co-infection of wheat (Triticum aestivum L.) by Wheat streak mosaic virus (WSMV, a Tritimovirus) and Triticum mosaic virus (TriMV, a Poacevirus) of the family Potyviridae causes synergistic interaction. In this study, the effects of the synergistic interaction between WSMV and TriMV on endogenous and virus-derived small interfering RNAs (vsiRNAs) were examined in susceptible ('Arapahoe') and temperature-sensitive resistant ('Mace') wheat cultivars at 18 degrees C and 27 degrees C. Single and double infections in wheat caused a shift in the profile of endogenous small RNAs from 24 nt being the most predominant in healthy plants to 21 nt in infected wheat. Massive amounts of 21 and 22 nt vsiRNAs accumulated in singly and doubly infected Arapahoe at both temperatures and in Mace at 27 degrees C but not 18 degrees C. The plus-and minus-sense vsiRNAs were distributed throughout the genomic RNAs in Arapahoe at both temperature regimens and in Mace at 27 degrees C, although some regions served as hot-spots, spawning an excessive number of vsiRNAs. The vsiRNA peaks were conserved among cultivars, suggesting that the Dicer-like enzymes in susceptible and resistant cultivars similarly accessed the genomic RNAs of WSMV or TriMV. Accumulation of large amounts of vsiRNAs in doubly infected plants suggests that the silencing suppressor proteins encoded by TriMV and WSMV do not prevent the formation of vsiRNAs; thus, the synergistic effect observed is independent from RNA-silencing mediated vsiRNA biogenesis. The high-resolution map of endogenous and vsiRNAs from WSMV-and/or TriMV-infected wheat cultivars may form a foundation for understanding the virus-host interactions, the effect of synergistic interactions on host defense, and virus resistance mechanisms in wheat.	[Tatineni, Satyanarayana; Graybosch, Robert A.; French, Roy] Univ Nebraska, USDA ARS, Lincoln, NE 68583 USA; [Tatineni, Satyanarayana; Mitra, Amitava] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Riethoven, Jean-Jack M.] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Graybosch, Robert A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tatineni, S (corresponding author), Univ Nebraska, USDA ARS, Lincoln, NE 68583 USA.	satya.tatineni@ars.usda.gov		Tatineni, Satyanatayana/0000-0003-0395-6000; Riethoven, Jean-Jack/0000-0002-2709-7880	Nebraska Research Initiative; ARS [ARS-0424225] Funding Source: Federal RePORTER	Nebraska Research Initiative; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Partial support was provided by the Nebraska Research Initiative to J. -J. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brakke MK, 1987, VIRUS DIS WHAET; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Burrows M, 2009, PLANT HLTH PROG, DOI 10.1094/PHP-2009-0706-01-RS; Byamukama E, 2013, PLANT DIS, V97, P21, DOI 10.1094/PDIS-06-12-0535-RE; Byamukama E, 2012, PLANT DIS, V96, P859, DOI 10.1094/PDIS-11-11-0957-RE; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Choi IR, 1999, PHYTOPATHOLOGY, V89, P1182, DOI 10.1094/PHYTO.1999.89.12.1182; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Folimonova SY, 2010, J VIROL, V84, P1314, DOI 10.1128/JVI.02075-09; French R, 2004, VIRUSES VIRUS DIS PO, P602; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Gonzalez-Jara P, 2005, PHYTOPATHOLOGY, V95, P894, DOI 10.1094/PHYTO-95-0894; Gonzalez-Jara P, 2004, MOL PLANT PATHOL, V5, P29, DOI 10.1111/j.1364-3703.2004.00202.x; Graybosch RA, 2009, J PLANT REGIST, V3, P51, DOI 10.3198/jpr2008.06.0345crc; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hull R., 2002, MATTHEWS PLANT VIROL; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAY CL, 1971, CROP SCI, V11, P431, DOI 10.2135/cropsci1971.0011183X001100030037x; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McMechan AJ, 2014, PLANT DIS, V98, P806, DOI 10.1094/PDIS-06-13-0582-RE; Mendez-Lozano J, 2003, PHYTOPATHOLOGY, V93, P270, DOI 10.1094/PHYTO.2003.93.3.270; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Ruiz-Ruiz S, 2011, PLANT MOL BIOL, V75, P607, DOI 10.1007/s11103-011-9754-4; Seifers DL, 2008, PLANT DIS, V92, P808, DOI 10.1094/PDIS-92-5-0808; Seifers DL, 2009, PLANT DIS, V93, P25, DOI 10.1094/PDIS-93-1-0025; Silva TF, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-40; SLYKHUIS JT, 1955, PHYTOPATHOLOGY, V45, P116; Stenger DC, 1998, PHYTOPATHOLOGY, V88, P782, DOI 10.1094/PHYTO.1998.88.8.782; Stenger DC, 2007, PHYTOPATHOLOGY, V97, P1213, DOI 10.1094/PHYTO-97-10-1213; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tatineni S, 2012, VIROLOGY, V433, P104, DOI 10.1016/j.virol.2012.07.016; Tatineni S, 2010, PHYTOPATHOLOGY, V100, P230, DOI 10.1094/PHYTO-100-3-0230; Tatineni S, 2009, PHYTOPATHOLOGY, V99, P943, DOI 10.1094/PHYTO-99-8-0943; VANCE VB, 1991, VIROLOGY, V182, P486, DOI 10.1016/0042-6822(91)90589-4; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang JB, 2009, VIRUS RES, V144, P163, DOI 10.1016/j.virusres.2009.04.017; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wintermantel WM, 2008, PHYTOPATHOLOGY, V98, P1340, DOI 10.1094/PHYTO-98-12-1340; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046238; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016928; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Young BA, 2012, VIRUS RES, V163, P672, DOI 10.1016/j.virusres.2011.12.019; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Ziebell H, 2010, ADV VIRUS RES, V76, P211, DOI 10.1016/S0065-3527(10)76006-1	74	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111577	10.1371/journal.pone.0111577	http://dx.doi.org/10.1371/journal.pone.0111577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365307	Green Published, gold			2022-12-27	WOS:000345558100080
J	Liu, D; Cai, WW; Xia, JZ; Dong, WJ; Zhou, GS; Chen, Y; Zhang, HC; Yuan, WP				Liu, Dan; Cai, Wenwen; Xia, Jiangzhou; Dong, Wenjie; Zhou, Guangsheng; Chen, Yang; Zhang, Haicheng; Yuan, Wenping			Global Validation of a Process-Based Model on Vegetation Gross Primary Production Using Eddy Covariance Observations	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; PARAMETER-ESTIMATION; TERRESTRIAL GROSS; SEASONAL DROUGHT; CARBON-DIOXIDE; WATER; FOREST; PHOTOSYNTHESIS; UNCERTAINTY; PATTERNS	Gross Primary Production (GPP) is the largest flux in the global carbon cycle. However, large uncertainties in current global estimations persist. In this study, we examined the performance of a process-based model (Integrated BIosphere Simulator, IBIS) at 62 eddy covariance sites around the world. Our results indicated that the IBIS model explained 60% of the observed variation in daily GPP at all validation sites. Comparison with a satellite-based vegetation model (Eddy Covariance-Light Use Efficiency, EC-LUE) revealed that the IBIS simulations yielded comparable GPP results as the EC-LUE model. Global mean GPP estimated by the IBIS model was 107.50 +/- 1.37 Pg C year (-1) (mean value +/- standard deviation) across the vegetated area for the period 2000-2006, consistent with the results of the EC-LUE model (109.39 +/- 1.48 Pg C year (-1)). To evaluate the uncertainty introduced by the parameter V-cmax, which represents the maximum photosynthetic capacity, we inversed V-cmax using Markov Chain-Monte Carlo (MCMC) procedures. Using the inversed V-cmax values, the simulated global GPP increased by 16.5 Pg C year (-1), indicating that IBIS model is sensitive to V-cmax, and large uncertainty exists in model parameterization.	[Liu, Dan; Cai, Wenwen; Xia, Jiangzhou; Dong, Wenjie; Chen, Yang; Zhang, Haicheng; Yuan, Wenping] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Zhou, Guangsheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Yuan, WP (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	wenpingyuancn@yahoo.com		Zhang, Haicheng/0000-0002-9313-5953	National Science Foundation for Excellent Young Scholars of China [41322005]; National High Technology Research and Development Program of China (863 Program) [2013AA122003]; National Natural Science Foundation of China [41201078]; Program for New Century Excellent Talents in University [NCET-32212-0060]; Fundamental Research Funds for the Central Universities	National Science Foundation for Excellent Young Scholars of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Science Foundation for Excellent Young Scholars of China (41322005), the National High Technology Research and Development Program of China (863 Program) (2013AA122003), National Natural Science Foundation of China (41201078), Program for New Century Excellent Talents in University (NCET-32212-0060) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi DD, 2004, AGR FOREST METEOROL, V123, P13, DOI 10.1016/j.agrformet.2003.11.006; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bonan GB, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001593; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Botta A, 2000, GLOBAL CHANGE BIOL, V6, P709, DOI 10.1046/j.1365-2486.2000.00362.x; CHILDES SL, 1989, VEGETATIO, V79, P151; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; David TS, 2004, AGR FOREST METEOROL, V122, P193, DOI 10.1016/j.agrformet.2003.09.014; Eamus D, 2001, ADV ECOL RES, V32, P113, DOI 10.1016/S0065-2504(01)32012-3; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friend AD, 2007, GLOBAL CHANGE BIOL, V13, P610, DOI 10.1111/j.1365-2486.2006.01223.x; Friend AD, 2010, J EXP BOT, V61, P1293, DOI 10.1093/jxb/erq019; Groenendijk M, 2011, AGR FOREST METEOROL, V151, P22, DOI 10.1016/j.agrformet.2010.08.013; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Huntingford C, 2009, TELLUS B, V61, P355, DOI 10.1111/j.1600-0889.2009.00414.x; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Kleidon A, 2007, BIOGEOSCIENCES, V4, P707, DOI 10.5194/bg-4-707-2007; Knorr W, 2001, GLOBAL BIOGEOCHEM CY, V15, P207, DOI 10.1029/1998GB001059; Kucharik CJ, 2006, ECOL MODEL, V196, P1, DOI 10.1016/j.ecolmodel.2005.11.031; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; Leuning R, 2005, AGR FOREST METEOROL, V129, P151, DOI 10.1016/j.agrformet.2004.12.004; Li XL, 2013, ECOL MODEL, V261, P80, DOI 10.1016/j.ecolmodel.2013.03.024; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Monasterio M., 1976, J BIOGEOGR, V3, P325; Nobre P, 2013, J CLIMATE, V26, P6716, DOI 10.1175/JCLI-D-12-00580.1; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Raupach MR, 2008, BIOGEOSCIENCES, V5, P1601, DOI 10.5194/bg-5-1601-2008; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003430; Rogers A, 2014, PHOTOSYNTH RES, V119, P15, DOI 10.1007/s11120-013-9818-1; Rojstaczer S, 2001, SCIENCE, V294, P2549, DOI 10.1126/science.1064375; Schaefer K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000603; Schwalm CR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001229; Solomon S., 2007, PHYS SCI BASIS WORKI; Wolf A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005927; Xu T, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002468; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Yuan WP, 2012, ECOL MODEL, V240, P29, DOI 10.1016/j.ecolmodel.2012.04.027; Yuan WP, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2011GB004150; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Yuan WP, 2009, GLOBAL CHANGE BIOL, V15, P2905, DOI 10.1111/j.1365-2486.2009.01870.x; Zhang FM, 2012, REMOTE SENS ENVIRON, V124, P717, DOI 10.1016/j.rse.2012.06.023; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	47	5	5	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110407	10.1371/journal.pone.0110407	http://dx.doi.org/10.1371/journal.pone.0110407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375227	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600011
J	Sun, HW; Li, G; Zhang, WJ; Zhou, Q; Yu, YN; Shi, Y; Offermanns, S; Lu, JX; Zhou, NM				Sun, Huawang; Li, Guo; Zhang, Wenjuan; Zhou, Qi; Yu, Yena; Shi, Ying; Offermanns, Stefan; Lu, Jianxin; Zhou, Naiming			Niacin Activates the PI3K/Akt Cascade via PKC- and EGFR-Transactivation-Dependent Pathways through Hydroxyl-Carboxylic Acid Receptor 2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; EPIDERMAL-GROWTH-FACTOR; CORONARY-ARTERY-DISEASE; NICOTINIC-ACID; KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-IDENTIFICATION; CELL-PROLIFERATION; SIGNALING PATHWAYS; PI 3-KINASE	Niacin has been demonstrated to activate a PI3K/Akt signaling cascade to prevent brain damage after stroke and UV-induced skin damage; however, the underlying molecular mechanisms for HCA(2)-induced Akt activation remain to be elucidated. Using CHO-K1 cells stably expressing HCA(2) and A431 cells, a human epidermoid cell line with high levels of endogenous expression of functional HCA(2) receptors, we first demonstrated that niacin induced a robust Akt phosphorylation at both Thr(308) and Ser(473) in a time-dependent fashion, with a maximal activation at 5 min and a subsequent reduction to baseline by 30 min through HCA(2), and that the activation was significantly blocked by pertussis toxin. The HCA(2)-mediated activation of Akt was also significantly inhibited by the PKC inhibitors GF109203x and Go6983 in both cell lines, by the PDGFR-selective inhibitor tyrphostin A9 in CHO-HCA(2) cells and by the MMP inhibitor GM6001 and EGFR-specific inhibitor AG1478 in A431 cells. These results suggest that the PKC pathway and PDGFR/EGFR transactivation pathway play important roles in HCA(2)-mediated Akt activation. Further investigation indicated that PI3K and the G(beta gamma) subunit were likely to play an essential role in HCA(2)-induced Akt activation. Moreover, Immunobloting analyses using an antibody that recognizes p70S6K1 phosphorylated at Thr(389) showed that niacin evoked p70S6K1 activation via the PI3K/Akt pathway. The results of our study provide new insight into the signaling pathways involved in HCA(2) activation.	[Sun, Huawang; Zhang, Wenjuan; Zhou, Qi; Yu, Yena; Lu, Jianxin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China; [Li, Guo; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Guo] Hangzhou Normal Univ, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany	Wenzhou Medical University; Zhejiang University; Hangzhou Normal University; Max Planck Society	Lu, JX (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; znm2000@yahoo.com	Lu, Jianxin/E-4485-2015; Zhou, Naiming/AHC-1121-2022; Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805	Ministry of Science and Technology of China [2012CB910402, 2012AA020303]; National Natural Science Foundation of China [81173106]; Zhejiang Natural Science Foundation [Z2080207]; German Research Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the Ministry of Science and Technology of China (2012CB910402 and 2012AA020303), the National Natural Science Foundation of China (81173106) and the Zhejiang Natural Science Foundation (Z2080207). Dr. S. Offermanns was supported by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Antonelli V, 2000, MOL BIOL CELL, V11, P1129, DOI 10.1091/mbc.11.4.1129; Assefa Z, 1999, BIOCHEM BIOPH RES CO, V261, P641, DOI 10.1006/bbrc.1999.1090; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brown BG, 2008, AM J CARDIOL, V101, p58B, DOI 10.1016/j.amjcard.2008.02.039; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; CASHINHEMPHILL L, 1990, JAMA-J AM MED ASSOC, V264, P3013, DOI 10.1001/jama.264.23.3013; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Digby JE, 2009, CURR OPIN LIPIDOL, V20, P321, DOI 10.1097/MOL.0b013e32832d3b9d; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; KATHER H, 1983, FEBS LETT, V161, P149, DOI 10.1016/0014-5793(83)80749-2; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Lauring B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003877; Li G, 2011, J BIOL CHEM, V286, P31199, DOI 10.1074/jbc.M111.241372; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Lin FQ, 2012, INT J MOL MED, V29, P593, DOI 10.3892/ijmm.2012.886; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lukasova M, 2011, TRENDS PHARMACOL SCI, V32, P700, DOI 10.1016/j.tips.2011.08.002; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Riese DJ, 1998, J BIOL CHEM, V273, P11288, DOI 10.1074/jbc.273.18.11288; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shehadah A, 2010, NEUROBIOL DIS, V40, P277, DOI 10.1016/j.nbd.2010.05.034; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wu EH, 2006, CELL SIGNAL, V18, P285, DOI 10.1016/j.cellsig.2005.04.009; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141; Zhou LB, 2007, MOL CELL BIOCHEM, V294, P243, DOI 10.1007/s11010-006-9150-6	62	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112310	10.1371/journal.pone.0112310	http://dx.doi.org/10.1371/journal.pone.0112310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375133	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600125
J	Wails, CN; Oswald, SA; Arnold, JM				Wails, Christy N.; Oswald, Stephen A.; Arnold, Jennifer M.			Are Morphometrics Sufficient for Estimating Age of Pre-Fledging Birds in the Field? A Test Using Common Terns (Sterna hirundo)	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; WING LENGTH; GROWTH; PATTERNS; PRODUCTIVITY; ALLOCATION; SURVIVAL; ECOLOGY; CHICKS; DATE	Age is a key component of fitness, affecting survival and reproductive capacities. Where it is not possible to study known individuals from birth, morphometrics (predominantly patterns of plumage development for birds) are most often used to estimate age. Although criteria for age estimations exist for many species, the degree to which these criteria improve the precision of estimates remains to be tested, restricting their widespread acceptance. We develop a photographic tool for estimating ages of Common Tern (Sterna hirundo) chicks and test it using 100 human observers of varying prior experience across four breeding colonies (three North American sites and one European site) and under controlled laboratory conditions. We followed the design approach of other morphometric tools, expanding it to create a user-friendly guide (divided into six age groupings). The majority (86%) of observers improved in chick-aging accuracy when using the tool by an average of 20.1% (+/- 1.4 SE) and correctly estimated 60.3% (+/- 1.4) of chick ages. This was similar to the intrinsic aging ability of our best field observer (63.3%). Observers with limited experience showed the greatest increases in chick-aging accuracy over experienced observers who likely had established a method for estimating chick ages prior to using the tool. Even the best observers only correctly estimated ages of chicks 62.9% (+/- 2.8) of the time in the field and 84.0% (+/- 2.9) of the time in the lab when using the tool and typically underestimated ages. This indicates that developmental variation between individual chicks can prevent completely reliable age estimates and corroborates the few existing data that suggest that morphometric criteria fail to achieve robust levels of accuracy and may introduce error into studies that rely on them. We conclude that novel approaches for estimating age, not only morphometric criteria, must be pursued.	[Wails, Christy N.; Oswald, Stephen A.; Arnold, Jennifer M.] Penn State Univ, Div Sci, Reading, PA 19610 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Wails, CN (corresponding author), Penn State Univ, Div Sci, Berks Campus, Reading, PA 19610 USA.	c.wails@unb.ca	Wails, Christy N./L-9450-2014	Wails, Christy N./0000-0003-2084-5003	Pennsylvania State University Berks Campus; Ned Smith Center for Nature and Art; Friends of Presqu'ile Provincial Park; Baird Ornithological Club; Pennsylvania State University Summer Discovery Grant	Pennsylvania State University Berks Campus; Ned Smith Center for Nature and Art; Friends of Presqu'ile Provincial Park; Baird Ornithological Club; Pennsylvania State University Summer Discovery Grant	Funding for this study was provided by the Pennsylvania State University Berks Campus, Pennsylvania State University Summer Discovery Grant (2013), Ned Smith Center for Nature and Art, Friends of Presqu'ile Provincial Park and Baird Ornithological Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; ANDERSON DW, 1980, BIOL CONSERV, V18, P65, DOI 10.1016/0006-3207(80)90067-1; Arnold JM, 2006, IBIS, V148, P98, DOI 10.1111/j.1474-919X.2006.00487.x; Arnold JM, 2004, J AVIAN BIOL, V35, P33, DOI 10.1111/j.0908-8857.2004.03059.x; Barton K, 2020, MUMIN MULTIMODEL INF; BECHARD MJ, 1985, J WILDLIFE MANAGE, V49, P226, DOI 10.2307/3801875; Becker PH, 2003, BEHAV ECOL SOCIOBIOL, V54, P136, DOI 10.1007/s00265-003-0605-4; Benowitz-Fredericks ZM, 2006, AUK, V123, P722, DOI 10.1642/0004-8038(2006)123[722:GAAICC]2.0.CO;2; Blas J, 2006, GEN COMP ENDOCR, V148, P172, DOI 10.1016/j.ygcen.2006.02.011; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARLSSON BG, 1994, CONDOR, V96, P555, DOI 10.2307/1369336; Carney KM, 1999, WATERBIRDS, V22, P68, DOI 10.2307/1521995; Dahdul WM, 2003, AUK, V120, P1069, DOI 10.1642/0004-8038(2003)120[1069:EAAPGI]2.0.CO;2; DESANTE DF, 1987, CONDOR, V89, P636, DOI 10.2307/1368653; ELIAS P K, 1976, Experimental Aging Research, V2, P165, DOI 10.1080/03610737608257985; ELOWE K D, 1979, Bird-Banding, V50, P49; Erickson Wallace P., 2005, U S Forest Service General Technical Report PSW, V191, P1029; Erwin R.M., 1982, Colonial Waterbirds, V5, P49, DOI 10.2307/1521032; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; HORWICH RH, 1966, BIRD BANDING, V37, P257, DOI 10.2307/4511310; Hunter Janet M., 1995, Wildfowl, V46, P55; MARTIN K, 1995, AM ZOOL, V35, P340; Mayfield H.F., 1961, WILSON B, V73, P225; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Morales Fernaz Judith, 2012, Ringing & Migration, V27, P65; Morris RD, 2010, J GREAT LAKES RES, V36, P44, DOI 10.1016/j.jglr.2009.09.008; NISBET ICT, 1990, COLON WATERBIRD, V13, P85, DOI 10.2307/1521572; PARR R, 1975, J WILDLIFE MANAGE, V39, P188, DOI 10.2307/3800485; PETERSEN LR, 1977, J WILDLIFE MANAGE, V41, P587, DOI 10.2307/3800538; PRATT HM, 1985, AUK, V102, P49, DOI 10.2307/4086822; Reed LM, 1998, COLON WATERBIRD, V21, P414, DOI 10.2307/1521653; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RICKLEFS RE, 1977, AUK, V94, P86; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Rodway MS, 1997, J FIELD ORNITHOL, V68, P338; SHANAWANY MM, 1984, BRIT POULTRY SCI, V25, P449, DOI 10.1080/00071668408454886; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Steinkamp M., 2003, BREEDING SEASON SURV; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Wendeln H, 2000, BEHAV ECOL SOCIOBIOL, V47, P382, DOI 10.1007/s002650050681	42	7	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111987	10.1371/journal.pone.0111987	http://dx.doi.org/10.1371/journal.pone.0111987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375105	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600088
J	Eggers, F; Slotte, A; Libungan, LA; Johannessen, A; Kvamme, C; Moland, E; Olsen, EM; Nash, RDM				Eggers, Florian; Slotte, Aril; Libungan, Lisa Anne; Johannessen, Arne; Kvamme, Cecilie; Moland, Even; Olsen, Esben M.; Nash, Richard D. M.			Seasonal Dynamics of Atlantic Herring (Clupea harengus L.) Populations Spawning in the Vicinity of Marginal Habitats	PLOS ONE			English	Article							OTOLITH SHAPE-ANALYSIS; NORTH-SEA; MARINE FISH; STOCK IDENTIFICATION; GENETIC-STRUCTURE; DISCRETENESS; RECOVERY; METAPOPULATIONS; DISCRIMINATE; MECHANISMS	Gillnet sampling and analyses of otolith shape, vertebral count and growth indicated the presence of three putative Atlantic herring (Clupea harengus L.) populations mixing together over the spawning season February-June inside and outside an inland brackish water lake (Landvikvannet) in southern Norway. Peak spawning of oceanic Norwegian spring spawners and coastal Skagerrak spring spawners occurred in March-April with small proportions of spawners entering the lake. In comparison, spawning of Landvik herring peaked in May-June with high proportions found inside the lake, which could be explained by local adaptations to the environmental conditions and seasonal changes of this marginal habitat. The 1.85 km 2 lake was characterized by oxygen depletion occurring between 2.5 and 5 m depth between March and June. This was followed by changes in salinity from 1-7% in the 0-1 m surface layer to levels of 20-25% deeper than 10 m. In comparison, outside the 3 km long narrow channel connecting the lake with the neighboring fjord, no anoxic conditions were found. Here salinity in the surface layer increased over the season from 10 to 25%, whereas deeper than 5 m it was stable at around 35%. Temperature at 0-5 m depth increased significantly over the season in both habitats, from 7 to 14 degrees C outside and 5 to 17 degrees C inside the lake. Despite differences in peak spawning and utilization of the lake habitat between the three putative populations, there was an apparent temporal and spatial overlap in spawning stages suggesting potential interbreeding in accordance with the metapopulation concept.	[Eggers, Florian; Slotte, Aril; Kvamme, Cecilie; Nash, Richard D. M.] Inst Marine Res, N-5024 Bergen, Norway; [Eggers, Florian; Johannessen, Arne] Univ Bergen, Dept Biol, Bergen, Norway; [Libungan, Lisa Anne] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland; [Moland, Even] Inst Marine Res, Flodevigen, Norway; [Olsen, Esben M.] Univ Oslo, CEES, Dept Biosci, Oslo, Norway; [Olsen, Esben M.] Univ Agder, Fac Sci & Engn, Dept Nat Sci, Kristiansand, Norway	Institute of Marine Research - Norway; University of Bergen; University of Iceland; Institute of Marine Research - Norway; University of Oslo; University of Agder	Eggers, F (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	eggersf@t-online.de	Berg, Florian/M-9678-2014; Olsen, Esben Moland/B-1894-2012; Moland, Even/A-7788-2013	Berg, Florian/0000-0003-1543-8112; Olsen, Esben Moland/0000-0003-3807-7524; Nash, Richard/0000-0003-0958-149X				Aasen O, 1952, FISKDIR SKR SER HAVU, V10; Aguera A, 2011, FISH RES, V110, P465, DOI 10.1016/j.fishres.2011.06.003; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Begg GA, 2001, FISH B-NOAA, V99, P1; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bekkevold D, 2007, MAR ECOL PROG SER, V337, P187, DOI 10.3354/meps337187; Bekkevold D, 2011, MAR ECOL PROG SER, V442, P187, DOI 10.3354/meps09352; Bivand R, 2011, PIXMAP BITMAP IMAGES; BLAXTER J. H. S., 1965, J CONS CONS PERMA INT EXPLOR MER, V30, P40; Blaxter JHS, 1957, MAR RES, V1, P1; Broch H, 1908, BERGEN MUSEUMS ARBOK, V1; Brophy D, 2006, CAN J FISH AQUAT SCI, V63, P607, DOI 10.1139/f05-235; Claude J, 2008, MORPHOMETRICS R; Clausen LAW, 2007, ICES J MAR SCI, V64, P377, DOI 10.1093/icesjms/fsl036; Cochrane KL, 2009, FISHERY MANAGERS GUIDEBOOK, 2ND EDITION, P1, DOI 10.1002/9781444316315.ch1; CORTEN A, 1986, J CONSEIL, V42, P281; Corten A, 2002, REV FISH BIOL FISHER, V11, P339; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Directorate of Fisheries, 2013, LAND SAL DOC LAND SL; Dragesund O., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P43; Eggers F, 2013, METAPOPULATION DYNAM; Eggers F, 2014, MAR ECOL PROG UNPUB; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Geffen AJ, 2011, ICES J MAR SCI, V68, P1447, DOI 10.1093/icesjms/fsr051; HAEGELE CW, 1985, CAN J FISH AQUAT SCI, V42, P39, DOI 10.1139/f85-261; HAMLEY JM, 1975, J FISH RES BOARD CAN, V32, P1943, DOI 10.1139/f75-233; Heincke F, 1898, NATURGESCHICHTE HERI; HEMPEL G, 1953, NATURWISSENSCHAFTEN, V40, P467, DOI 10.1007/BF00628850; Hempel G, 1961, RAPP P VERB REUN CON, V26, P336; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hintzen NT, 2014, ICES J MAR IN PRESS; HOGNESTAD PT, 1994, ICES J MAR SCI, V51, P281, DOI 10.1006/jmsc.1994.1029; HORRALL RM, 1981, CAN J FISH AQUAT SCI, V38, P1481, DOI 10.1139/f81-201; HOURSTON AS, 1959, J FISH RES BOARD CAN, V16, P309, DOI 10.1139/f59-024; HULME TJ, 1995, ICES J MAR SCI, V52, P775, DOI 10.1006/jmsc.1995.0074; Huse G, 2010, MAR ECOL PROG SER, V409, P189, DOI 10.3354/meps08620; Husebo A, 2005, MAR FRESHWATER RES, V56, P763, DOI 10.1071/MF04170; ICES, 2012, REP ICES ADV COMM 20; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johannessen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102462; Johannessen A, 2009, ICES J MAR SCI, V66, P1740, DOI 10.1093/icesjms/fsp183; Johnston IA, 1997, J EXP BIOL, V200, P849; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Jorstad KE, 1986, 1986H63 ICES CM; Kell LT, 2009, ICES J MAR SCI, V66, P1776, DOI 10.1093/icesjms/fsp181; LIE U, 1978, Fiskeridirektoratets Skrifter Serie Havundersokelser, V16, P369; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Longmore C, 2010, ENVIRON BIOL FISH, V89, P591, DOI 10.1007/s10641-010-9674-1; MACLEAN JA, 1981, CAN J FISH AQUAT SCI, V38, P1889, DOI 10.1139/f81-235; McPherson AA, 2001, J FISH BIOL, V59, P356, DOI 10.1006/jfbi.2001.1769; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Meyer HA, 1878, WISS MEER, V2, P227; Mjanger H, 2012, HDB PROVETAKING FISK; Nason G., 2012, WAVETHRESH WAVELETS; NEB KE, 1970, BER DEUT WISS KOMM, V21, P265; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pampoulie C, 2014, MAR ECOL PROG UNPUB; PAVLOV DA, 1998, J ICHTHYOL+, V38, P251; Petitgas P, 2010, ICES J MAR SCI, V67, P1841, DOI 10.1093/icesjms/fsq082; PITCHER TJ, 1985, MAR BIOL, V86, P319, DOI 10.1007/BF00397518; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen J., 1942, FISKDIR SKR SER HAVU, VVII, P63; Runnstrom S, 1941, FISKDIR SKR SER HAVU, V6; Russell F. S., 1976, EGGS PLANKTONIC STAG; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Silva FFG, 2013, FISH RES, V138, P71, DOI 10.1016/j.fishres.2012.07.013; Sinclair M, 1988, AQUAT LIVING RESOUR, V1, P71, DOI 10.1051/alr:1988009; Skirnisdottir S, 2012, NORDIC NETWORK STOCK; Slotte A, 1999, SARSIA, V84, P111, DOI 10.1080/00364827.1999.10420439; Slotte A, 2000, J FISH BIOL, V56, P138; Slotte A, 2009, NOTE NSS HERRING FIS; Slotte A, 2001, HERRING EXPECTATIONS, P255; SMITH PJ, 1986, FISH RES, V4, P223, DOI 10.1016/0165-7836(86)90004-4; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Soleim PA, 1942, FISKDIR SKR SER HAVU, V7; Stephenson RL, 2009, ICES J MAR SCI, V66, P1733, DOI 10.1093/icesjms/fsp189; von Bertalanffy L, 1934, ROUX ARCH DEV BIOL, V131, P613, DOI 10.1007/BF00650112; Wallace RK, 1997, UNDERSTANDING FISHER; Winkler, 1888, BER DTSCH CHEM GES, V21, P2843, DOI [10.1002/cber.188802102122, DOI 10.1002/CBER.188802102122]; WOODHEAD PMJ, 1955, NATURE, V176, P349, DOI 10.1038/176349c0	83	19	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111985	10.1371/journal.pone.0111985	http://dx.doi.org/10.1371/journal.pone.0111985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372461	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000344556900101
J	Oguz, T; Macias, D; Garcia-Lafuente, J; Pascual, A; Tintore, J				Oguz, Temel; Macias, Diego; Garcia-Lafuente, Jesus; Pascual, Ananda; Tintore, Joaquin			Fueling Plankton Production by a Meandering Frontal Jet: A Case Study for the Alboran Sea (Western Mediterranean)	PLOS ONE			English	Article							ALMERIA-ORAN FRONT; VERTICAL CIRCULATION; MESOSCALE SUBDUCTION; GEOSTROPHIC FRONT; SIZE-STRUCTURE; ATLANTIC JET; PHYTOPLANKTON; DYNAMICS; VARIABILITY; FRONTOGENESIS	A three dimensional biophysical model was employed to illustrate the biological impacts of a meandering frontal jet, in terms of efficiency and persistency of the autotrophic frontal production, in marginal and semi-enclosed seas. We used the Alboran Sea of the Western Mediterranean as a case study. Here, a frontal jet with a width of 15-20 km, characterized by the relatively low density Atlantic water mass, flows eastward within the upper 100 m as a marked meandering current around the western and the eastern anticyclonic gyres prior to its attachment to the North African shelf/slope topography of the Algerian basin. Its inherent nonlinearity leads to the development of a strong ageostrophic cross-frontal circulation that supplies nutrients into the nutrient-starved euphotic layer and stimulates phytoplankton growth along the jet. Biological production is larger in the western part of the basin and decreases eastwards with the gradual weakening of the jet. The higher production at the subsurface levels suggests that the Alboran Sea is likely more productive than predicted by the satellite chlorophyll data. The Mediterranean water mass away from the jet and the interiors of the western and eastern anticyclonic gyres remain unproductive.	[Oguz, Temel; Tintore, Joaquin] Balearic Isl Coastal Ocean Observing & Forecastin, SOCIB, Palma de Mallorca, Spain; [Oguz, Temel] Middle E Tech Univ, Inst Marine Sci, Mersin, Turkey; [Macias, Diego] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; [Garcia-Lafuente, Jesus] Univ Malaga, Dept Fis Aplicada 2, E-29071 Malaga, Spain; [Pascual, Ananda; Tintore, Joaquin] UIB, CSIC, IMEDEA, Palma de Mallorca, Spain	Middle East Technical University; European Commission Joint Research Centre; EC JRC ISPRA Site; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Macias, D (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy.	diego.macias-moy@jrc.ec.europa.eu	oguz, temel/J-4252-2017; Macías, Diego/G-1972-2010	Macías, Diego/0000-0002-7772-255X; Garcia Lafuente, Jesus/0000-0001-7816-576X; Pascual, Ananda/0000-0001-9476-9272; Tintore, Joaquin/0000-0002-6311-0093	Perseus EU; Spanish-funded project [CTM2010-21229-C01]	Perseus EU; Spanish-funded project	This study is part of the Ocean Forecasting Facility from SOCIB and is also partially supported by Perseus EU funded Project whose support is gratefully acknowledged. JGL acknowledges partial support from the Spanish-funded project CTM2010-21229-C01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JT, 2001, J MARINE SYST, V30, P263, DOI 10.1016/S0924-7963(01)00062-8; Batteen ML, 1997, J GEOPHYS RES-OCEANS, V102, P985, DOI 10.1029/96JC02803; Berntsen J, 2010, OCEAN DYNAM, V60, P317, DOI 10.1007/s10236-009-0245-y; Capet X, 2008, J PHYS OCEANOGR, V38, P44, DOI 10.1175/2007JPO3672.1; CLAUSTRE H, 1994, J MAR RES, V52, P711, DOI 10.1357/0022240943077000; Delgado J, 2012, SCI MAR, V76, P95, DOI 10.3989/scimar.03609.18E; Fielding S, 2001, J MARINE SYST, V30, P287, DOI 10.1016/S0924-7963(01)00063-X; Garcia-Gorriz E, 2001, J GEOPHYS RES-OCEANS, V106, P16795, DOI 10.1029/1999JC000029; Garcia-Lafuente J., 2004, J PHYS OCEANOGR, V34, P685; Gomis D, 2001, DEEP-SEA RES PT I, V48, P269, DOI 10.1016/S0967-0637(00)00060-1; HAIDVOGEL DB, 1991, J GEOPHYS RES-OCEANS, V96, P15017, DOI 10.1029/91JC00943; Herbaut C, 1996, J PHYS OCEANOGR, V26, P65, DOI 10.1175/1520-0485(1996)026<0065:ASSOTG>2.0.CO;2; L'Helguen S, 2002, DEEP-SEA RES PT I, V49, P83, DOI 10.1016/S0967-0637(01)00044-9; Lafuente JG, 2002, DEEP-SEA RES PT II, V49, P4051, DOI 10.1016/S0967-0645(02)00142-X; Lapeyre G, 2006, J PHYS OCEANOGR, V36, P1577, DOI 10.1175/JPO2923.1; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Leblanc K, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001878; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Macias D, 2008, ESTUAR COAST SHELF S, V78, P250, DOI 10.1016/j.ecss.2007.12.008; Macias D, 2014, ECOL MODEL, V281, P26, DOI 10.1016/j.ecolmodel.2014.03.002; Mahadevan A, 2012, SCIENCE, V337, P54, DOI 10.1126/science.1218740; Martin AP, 2001, J MARINE SYST, V28, P65, DOI 10.1016/S0924-7963(00)00084-1; MCCALPIN JD, 1994, INT J NUMER METH FL, V18, P361, DOI 10.1002/fld.1650180404; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Mellor GL, 1998, J ATMOS OCEAN TECH, V15, P1122, DOI 10.1175/1520-0426(1998)015<1122:SCPGEA>2.0.CO;2; Mellor GL, 2003, PROG ATMOS OCEAN SCI, P53; Mercado JM, 2007, PROG OCEANOGR, V74, P273, DOI 10.1016/j.pocean.2007.04.013; Moran XAG, 2001, MAR ECOL PROG SER, V212, P53, DOI 10.3354/meps212053; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Naranjo C, 2012, DEEP-SEA RES PT I, V63, P157, DOI 10.1016/j.dsr.2011.10.003; Oguz T, 2013, PROG OCEANOGR, V112, P1, DOI 10.1016/j.pocean.2013.03.001; PEINERT R, 1994, J MARINE SYST, V5, P377, DOI 10.1016/0924-7963(94)90057-4; Peliz A, 2013, OCEAN MODEL, V72, P32, DOI 10.1016/j.ocemod.2013.07.002; POLLARD RT, 1992, J PHYS OCEANOGR, V22, P609, DOI 10.1175/1520-0485(1992)022<0609:VAVCAA>2.0.CO;2; PRIEUR L, 1994, J MARINE SYST, V5, P187, DOI 10.1016/0924-7963(94)90046-9; Ramirez T, 2005, ESTUAR COAST SHELF S, V65, P654, DOI 10.1016/j.ecss.2005.07.012; Renault L, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007659; Reul A, 2005, CONT SHELF RES, V25, P589, DOI 10.1016/j.csr.2004.09.016; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Ruiz J, 2001, J MARINE SYST, V29, P277, DOI 10.1016/S0924-7963(01)00020-3; Sanchez-Garrido JC, 2013, PROG OCEANOGR, V116, P142, DOI 10.1016/j.pocean.2013.07.002; Sarhan T, 2000, J MARINE SYST, V23, P317, DOI 10.1016/S0924-7963(99)00068-8; Sheng JY, 2001, J PHYS OCEANOGR, V31, P3146, DOI 10.1175/1520-0485(2001)031<3146:DOABDC>2.0.CO;2; Skliris N, 2009, OCEAN DYNAM, V59, P489, DOI 10.1007/s10236-009-0185-6; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Soto-Navarro J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006302; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860; Speich S, 1996, J PHYS OCEANOGR, V26, P320, DOI 10.1175/1520-0485(1996)026<0320:ASOCPS>2.0.CO;2; Stips A.K., 2006, GEOPH RES ABSTR, V8; Taupier-Letage I, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/1999JC000117; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; TINTORE J, 1988, J PHYS OCEANOGR, V18, P1384, DOI 10.1175/1520-0485(1988)018<1384:ASOAID>2.0.CO;2; Tintore J, 2013, MAR TECHNOL SOC J, V47, P101, DOI 10.4031/MTSJ.47.1.10; Uitz J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004055; Vargas-Yanez M, 2002, J MARINE SYST, V35, P229, DOI 10.1016/S0924-7963(02)00128-8; VIDEAU C, 1994, J MARINE SYST, V5, P235, DOI 10.1016/0924-7963(94)90049-3; Viudez A, 1996, J PHYS OCEANOGR, V26, P684, DOI 10.1175/1520-0485(1996)026<0684:CITASA>2.0.CO;2; Viudez A, 1997, J PHYS OCEANOGR, V27, P175, DOI 10.1175/1520-0485(1997)027<0175:OTRVOT>2.0.CO;2; Viudez A, 1998, J GEOPHYS RES-OCEANS, V103, P21653, DOI 10.1029/98JC01082; Volpe G, 2012, REMOTE SENS ENVIRON, V117, P223, DOI 10.1016/j.rse.2011.09.020; Wang DP, 2011, OCEAN MODEL, V38, P161, DOI 10.1016/j.ocemod.2011.02.012; WANG DP, 1993, J MAR RES, V51, P497, DOI 10.1357/0022240933224034; Yoshikawa Y, 2012, J PHYS OCEANOGR, V42, P991, DOI 10.1175/JPO-D-11-0154.1	63	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111482	10.1371/journal.pone.0111482	http://dx.doi.org/10.1371/journal.pone.0111482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372789	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900050
J	Selchenkova, T; Francois, C; Schon, D; Corneyllie, A; Perrin, F; Tillmann, B				Selchenkova, Tatiana; Francois, Clement; Schoen, Daniele; Corneyllie, Alexandra; Perrin, Fabien; Tillmann, Barbara			Metrical Presentation Boosts Implicit Learning of Artificial Grammar	PLOS ONE			English	Article							EVENT SEQUENCES; MUSIC; TIME; PERCEPTION; EXPLICIT; LANGUAGE; ERP; EXPECTATIONS; ENTRAINMENT; POTENTIALS	The present study investigated whether a temporal hierarchical structure favors implicit learning. An artificial pitch grammar implemented with a set of tones was presented in two different temporal contexts, notably with either a strongly metrical structure or an isochronous structure. According to the Dynamic Attending Theory, external temporal regularities can entrain internal oscillators that guide attention over time, allowing for temporal expectations that influence perception of future events. Based on this framework, it was hypothesized that the metrical structure provides a benefit for artificial grammar learning in comparison to an isochronous presentation. Our study combined behavioral and event-related potential measurements. Behavioral results demonstrated similar learning in both participant groups. By contrast, analyses of event-related potentials showed a larger P300 component and an earlier N2 component for the strongly metrical group during the exposure phase and the test phase, respectively. These findings suggests that the temporal expectations in the strongly metrical condition helped listeners to better process the pitch dimension, leading to improved learning of the artificial grammar.	[Selchenkova, Tatiana; Corneyllie, Alexandra; Perrin, Fabien; Tillmann, Barbara] Univ Lyon 1, CNRS, INSERM,Unite Mixte Rech 5292,Unite 1028, Lyon Neurosci Res Ctr,Auditory Cognit & Psychoaco, Lyon, France; [Francois, Clement] Bellvitge Biomed Res Inst, Cognit & Brain Plast Grp, Barcelona, Spain; [Francois, Clement] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Francois, Clement] Hosp St Joan Deu, Attent Percept & Acquisit Language Lab, Barcelona, Spain; [Schoen, Daniele] Aix Marseille Univ, Inst Neurosci Syst, Marseille, France; [Schoen, Daniele] INSERM, Unite 1106, Marseille, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Selchenkova, T (corresponding author), Univ Lyon 1, CNRS, INSERM,Unite Mixte Rech 5292,Unite 1028, Lyon Neurosci Res Ctr,Auditory Cognit & Psychoaco, Lyon, France.	tatiana.selchenkova@gmail.com	Schön, Daniele/B-2484-2013; François, Clément/F-7133-2013	Schön, Daniele/0000-0003-4472-4150; François, Clément/0000-0003-2271-6942; , Fabien/0000-0002-1444-3414	EBRAMUS ITN (Europe BRAin and MUSic) [238157]	EBRAMUS ITN (Europe BRAin and MUSic)	This research was supported by a grant from EBRAMUS ITN (Europe BRAin and MUSic) (Grant Agreement number 238157). The team "Auditory cognition and psychoacoustics" is part of the LabEx CeLyA ("Centre Lyonnais d'Acoustique", ANR-10-LABX-60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN GTM, 1995, J EXP PSYCHOL LEARN, V21, P899, DOI 10.1037/0278-7393.21.4.899; Baldwin KB, 1997, PSYCHOPHYSIOLOGY, V34, P74, DOI 10.1111/j.1469-8986.1997.tb02418.x; Brochard R, 2003, PSYCHOL SCI, V14, P362, DOI 10.1111/1467-9280.24441; Carrion RE, 2007, NEUROREPORT, V18, P191, DOI 10.1097/WNR.0b013e328011b8ae; Christiansen MH, 2010, COGNITION, V116, P382, DOI 10.1016/j.cognition.2010.05.015; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eimer M, 1996, J EXP PSYCHOL LEARN, V22, P970, DOI 10.1037/0278-7393.22.4.970; Ferdinand NK, 2008, J COGNITIVE NEUROSCI, V20, P629, DOI 10.1162/jocn.2008.20046; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Francois C, 2010, NEUROREPORT, V21, P928, DOI 10.1097/WNR.0b013e32833ddd5e; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; Fu QF, 2013, CONSCIOUS COGN, V22, P22, DOI 10.1016/j.concog.2012.10.008; Geiser E, 2012, J NEUROSCI, V32, P6177, DOI 10.1523/JNEUROSCI.5153-11.2012; Goschke T, 2001, J COGNITIVE NEUROSCI, V13, P370, DOI 10.1162/08989290151137412; Hoch L, 2013, PSYCHON B REV, V20, P142, DOI 10.3758/s13423-012-0309-8; Jones M., 2009, OXFORD HDB MUSIC PSY, P81, DOI DOI 10.1093/OXFORDHB/9780199298457.013.0008; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Lange K, 2009, BRAIN COGNITION, V69, P127, DOI 10.1016/j.bandc.2008.06.004; Marmel F, 2011, J COGNITIVE NEUROSCI, V23, P3095, DOI 10.1162/jocn.2011.21632; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Perruchet P., 2008, LEARNING MEMORY COMP, V2, P597, DOI DOI 10.1016/B978-012370509-9.00149-2; Petersson KM, 2012, PHILOS T R SOC B, V367, P1971, DOI 10.1098/rstb.2012.0101; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Russeler J, 2000, ACTA PSYCHOL, V104, P45, DOI 10.1016/S0001-6918(99)00053-0; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; SAMS M, 1983, BIOL PSYCHOL, V17, P41, DOI 10.1016/0301-0511(83)90065-0; Schankin A, 2011, NEUROREPORT, V22, P642, DOI 10.1097/WNR.0b013e328349d146; Schmidt-Kassow M, 2008, BRAIN RES, V1226, P144, DOI 10.1016/j.brainres.2008.06.017; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P31, DOI 10.1097/WNR.0b013e32831b4287; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Selchenkova T, 2014, Q J EXP PSY IN PRESS; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Udden J, 2008, BRAIN RES, V1224, P69, DOI 10.1016/j.brainres.2008.05.070	44	16	16	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112233	10.1371/journal.pone.0112233	http://dx.doi.org/10.1371/journal.pone.0112233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372147	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900125
J	Severino, V; Farina, A; Fleischmann, F; Dalio, RJD; Di Maro, A; Scognamiglio, M; Fiorentino, A; Parente, A; Osswald, W; Chambery, A				Severino, Valeria; Farina, Annarita; Fleischmann, Frank; Dalio, Ronaldo J. D.; Di Maro, Antimo; Scognamiglio, Monica; Fiorentino, Antonio; Parente, Augusto; Osswald, Wolfgang; Chambery, Angela			Molecular Profiling of the Phytophthora plurivora Secretome: A Step towards Understanding the Cross-Talk between Plant Pathogenic Oomycetes and Their Hosts	PLOS ONE			English	Article							EFFECTOR AVR3A; RXLR EFFECTORS; EXPRESSION; ZOOSPORES; DEFENSE; ELICITINS; VIRULENCE; PROTEINS; FAMILY; SOJAE	The understanding of molecular mechanisms underlying host-pathogen interactions in plant diseases is of crucial importance to gain insights on different virulence strategies of pathogens and unravel their role in plant immunity. Among plant pathogens, Phytophthora species are eliciting a growing interest for their considerable economical and environmental impact. Plant infection by Phytophthora phytopathogens is a complex process coordinated by a plethora of extracellular signals secreted by both host plants and pathogens. The characterization of the repertoire of effectors secreted by oomycetes has become an active area of research for deciphering molecular mechanisms responsible for host plants colonization and infection. Putative secreted proteins by Phytophthora species have been catalogued by applying high-throughput genome-based strategies and bioinformatic approaches. However, a comprehensive analysis of the effective secretome profile of Phytophthora is still lacking. Here, we report the first large-scale profiling of P. plurivora secretome using a shotgun LC-MS/MS strategy. To gain insight on the molecular signals underlying the cross-talk between plant pathogenic oomycetes and their host plants, we also investigate the quantitative changes of secreted protein following interaction of P. plurivora with the root exudate of Fagus sylvatica which is highly susceptible to the root pathogen. We show that besides known effectors, the expression and/or secretion levels of cell-wall-degrading enzymes were altered following the interaction with the host plant root exudate. In addition, a characterization of the F. sylvatica root exudate was performed by NMR and amino acid analysis, allowing the identification of the main released low-molecular weight components, including organic acids and free amino acids. This study provides important insights for deciphering the extracellular network involved in the highly susceptible P. plurivora-F. sylvatica interaction.	[Severino, Valeria; Di Maro, Antimo; Scognamiglio, Monica; Fiorentino, Antonio; Parente, Augusto; Chambery, Angela] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Farina, Annarita] Univ Geneva, Dept Human Prot Sci, Geneva, Switzerland; [Fleischmann, Frank; Dalio, Ronaldo J. D.; Osswald, Wolfgang] Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany; [Chambery, Angela] IRCCS Multimed, Milan, Italy	Universita della Campania Vanvitelli; University of Geneva; Technical University of Munich; IRCCS Multimedica	Osswald, W (corresponding author), Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany.	osswald@wzw.tum.de; angela.chambery@unina2.it	Scognamiglio, Monica/AAJ-6957-2020; Scognamiglio, Monica/U-1116-2017; Farina, Annarita/Y-7835-2019; Fiorentino, Antonio/W-3531-2018; Dalio, Ronaldo J. D./E-8151-2015	Scognamiglio, Monica/0000-0001-9614-0929; Farina, Annarita/0000-0002-0099-4557; Fiorentino, Antonio/0000-0002-9439-7074; Chambery, Angela/0000-0002-5136-0941; Dalio, Ronaldo J. D./0000-0002-1457-4828	German Research Foundation (DFG); Technische Universitat Munchen within the funding programme Open Access Publishing; European project COST Action [FP0801]	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing; European project COST Action	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The authors acknowledge the European project COST Action FP0801 for supporting researchers cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2009, J EXP BOT, V60, P1133, DOI 10.1093/jxb/ern353; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bircher U, 1997, MYCOL RES, V101, P395, DOI 10.1017/S0953756296002730; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Brummer M, 2002, PHYSIOL MOL PLANT P, V61, P109, DOI [10.1016/S0885-5765(02)90419-4, 10.1006/pmpp.2002.0419]; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLARKE DD, 1966, NATURE, V211, P649, DOI 10.1038/211649a0; Dalio RJD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087860; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong SM, 2014, SCIENCE, V343, P552, DOI 10.1126/science.1246300; Erwin D. C., 1996, Phytophthora diseases worldwide.; Farina A, 2011, PROTEOMICS, V11, P3972, DOI 10.1002/pmic.201100063; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Fleischmann F, 2005, PLANT BIOLOGY, V7, P650, DOI 10.1055/s-2005-872891; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Gluck F, 2013, J PROTEOMICS, V79, P146, DOI 10.1016/j.jprot.2012.12.012; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Heiser I, 1999, PLANT PHYSIOL BIOCH, V37, P73, DOI 10.1016/S0981-9428(99)80069-2; Henniger H, 1963, Z ALLG MIKROBIOL, V3, P126, DOI DOI 10.1002/JOBM.3630030204; HICKMAN CJ, 1966, ANNU REV PHYTOPATHOL, V14, P195; HUET JC, 1989, FEBS LETT, V257, P302, DOI 10.1016/0014-5793(89)81557-1; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iriti M, 2009, J AGR FOOD CHEM, V57, P201, DOI 10.1021/jf802819m; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Jung T, 2009, FOREST PATHOL, V39, P73, DOI 10.1111/j.1439-0329.2008.00566.x; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; Jung Thomas, 2005, Mycologist, V19, P159, DOI 10.1017/S0269915X05004052; KAMOUN S, 1994, APPL ENVIRON MICROB, V60, P1593, DOI 10.1128/AEM.60.5.1593-1598.1994; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P1028, DOI 10.1094/MPMI.1997.10.8.1028; Kamoun S, 2009, MYCOTA, P173; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Lackie J, 1981, BIOL CHEMOTACTIC RES; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2006, MOL PLANT MICROBE IN, V19, P1368, DOI 10.1094/MPMI-19-1368; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; Meijer HJG, 2014, MOL CELL PROTEOMICS, V13, P2101, DOI 10.1074/mcp.M113.035873; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; MORRIS PF, 1992, PHYSIOL MOL PLANT P, V40, P17, DOI 10.1016/0885-5765(92)90067-6; Osswald W, 2014, FOREST PATHOL, V44, P169, DOI 10.1111/efp.12096; Pemberton CL, 2004, MOL PLANT PATHOL, V5, P353, DOI 10.1111/j.1364-3703.2004.00235.x; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rocco M, 2011, J PROTEOME RES, V10, P4703, DOI 10.1021/pr200511f; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Severino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.445; Severino V, 2013, BBA-PROTEINS PROTEOM, V1834, P2385, DOI 10.1016/j.bbapap.2012.12.005; Severino Valeria, 2013, Methods Mol Biol, V1002, P37, DOI 10.1007/978-1-62703-360-2_4; Shah P, 2009, PROTEOMICS, V9, P3126, DOI 10.1002/pmic.200800933; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tousson T, 1970, ROOT DIS SOIL BORNE; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 1996, APPL ENVIRON MICROB, V62, P2811, DOI 10.1128/AEM.62.8.2811-2817.1996; Valcu CM, 2009, J PROTEOME RES, V8, P4077, DOI 10.1021/pr900456c; YU LM, 1995, P NATL ACAD SCI USA, V92, P4088, DOI 10.1073/pnas.92.10.4088; ZENTMYER GA, 1961, SCIENCE, V133, P1595, DOI 10.1126/science.133.3464.1595	73	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112317	10.1371/journal.pone.0112317	http://dx.doi.org/10.1371/journal.pone.0112317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372870	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900132
J	Christiansen, KM; Mossner, BK; Hansen, JF; Jarnbjer, EF; Pedersen, C; Christensen, PB				Christiansen, Karen M.; Mossner, Belinda K.; Hansen, Janne F.; Jarnbjer, Erik F.; Pedersen, Court; Christensen, Peer B.			Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; DISEASE PROGRESSION; NONINVASIVE TESTS; FIBROSIS; DIAGNOSIS; CIRRHOSIS; PERFORMANCE; ACCURACY; OUTCOMES; VIRUS	Liver stiffness measurement (LSM) is widely used to evaluate liver fibrosis, but longitudinal studies are rare. The current study was aimed to monitor LSM during follow-up, and to evaluate the association of LSM data with mortality and liverrelated outcomes. We included all patients with chronic viral hepatitis and valid LSM using Fibroscan. Information about liver biopsy, antiviral treatment, and clinical outcome was obtained from medical records and national registers. The study included 845 patients: 597 (71%) with hepatitis C virus (HCV), 235 (28%) with hepatitis B virus (HBV) and 13 (2%) with dual infection. The initial LSM distribution (<7/7-9.9/10-16.9/>= 17 kPa) was 58%/16%/14%/12%. Among patients with initial LSM values of 7-9.9 kPa, 60% of HCV patients and 83% of HBV patients showed LSM values of <7 kPa at the latest follow-up. Progression rates (defined as >20% and >2 kPa increase, with one measure >7 kPa) were 3.4/100 person years (PY) for HCV and 1.5/100 PY for HBV infected patients. Patients with LSM values of >= 17 kPa had the same liver-related complication incidence as patients with biopsy-proven cirrhosis (11.1 versus 12.1/100 PY). Thirteen liver-related deaths occurred among HCV patients (0.6/100 PY), but none among HBV patients. Among patients who died of liver-related causes, all but one had baseline LSM values of >= 17 kPa. Overall, patients with LSM values <17 kPa were not associated with adverse outcomes. In contrast, LSM values >= 17 kPa were associated with significant risk of liver-related problems. The results of the current study suggest that clinical decisions should not be taken based on a single LSM measurement.	[Christiansen, Karen M.; Mossner, Belinda K.; Hansen, Janne F.; Jarnbjer, Erik F.; Pedersen, Court; Christensen, Peer B.] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital	Christensen, PB (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	peer.christensen@dadlnet.dk	Christensen, Peer B./B-8042-2015	Christensen, Peer Brehm/0000-0003-1394-058X				Arena U, 2013, HEPATOLOGY, V58, P65, DOI 10.1002/hep.26343; Asrani Sumeet K, 2013, Curr Gastroenterol Rep, V15, P308, DOI 10.1007/s11894-012-0308-y; Berzigotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058742; Cardoso AC, 2012, LIVER INT, V32, P612, DOI 10.1111/j.1478-3231.2011.02660.x; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Castera L, 2012, J HEPATOL, V56, P696, DOI 10.1016/j.jhep.2011.07.005; Christensen PB, 2012, DAN MED J, V59; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Colombo S, 2011, DIGEST LIVER DIS, V43, P231, DOI 10.1016/j.dld.2010.07.008; de Ledinghen V, 2013, ALIMENT PHARM THER, V37, P979, DOI 10.1111/apt.12307; de Ledinghen V, 2012, J HEPATOL, V56, P833, DOI 10.1016/j.jhep.2011.10.017; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Fialla AD, 2012, SCAND J GASTROENTERO, V47, P702, DOI 10.3109/00365521.2012.661759; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2011, J VIRAL HEPATITIS, V18, pE200, DOI 10.1111/j.1365-2893.2010.01428.x; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036676; Klibansky DA, 2012, J VIRAL HEPATITIS, V19, pE184, DOI 10.1111/j.1365-2893.2011.01493.x; Lannerstedt H, 2013, SCAND J GASTROENTERO, V48, P93, DOI 10.3109/00365521.2012.746389; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Marcellin P, 2002, HEPATOLOGY, V36, pS47, DOI 10.1053/jhep.2002.36993; McHutchison J, 2010, GASTROENTEROLOGY, V138, P1365, DOI 10.1053/j.gastro.2009.12.003; Mehta SH, 2012, ANTIVIR THER, V17, P813, DOI 10.3851/IMP2085; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Moessner BK, 2011, ADDICTION, V106, P970, DOI 10.1111/j.1360-0443.2010.03246.x; Poynard T, 2014, J HEPATOL, V60, P706, DOI 10.1016/j.jhep.2013.11.016; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; van de Putte DEF, 2011, HAEMOPHILIA, V17, pE975, DOI 10.1111/j.1365-2516.2011.02542.x; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Ydreborg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093601	40	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111912	10.1371/journal.pone.0111912	http://dx.doi.org/10.1371/journal.pone.0111912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369038	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000123
J	Ciccacci, C; Perricone, C; Ceccarelli, F; Rufini, S; Di Fusco, D; Alessandri, C; Spinelli, FR; Cipriano, E; Novelli, G; Valesini, G; Borgiani, P; Conti, F				Ciccacci, Cinzia; Perricone, Carlo; Ceccarelli, Fulvia; Rufini, Sara; Di Fusco, Davide; Alessandri, Cristiano; Spinelli, Francesca Romana; Cipriano, Enrica; Novelli, Giuseppe; Valesini, Guido; Borgiani, Paola; Conti, Fabrizio			A Multilocus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; CONGENITAL HEART-BLOCK; INFLAMMATORY-BOWEL-DISEASE; AUTOIMMUNE-DISEASES; RHEUMATOID-ARTHRITIS; EPIDERMAL NECROLYSIS; NEONATAL LUPUS; TRAF3IP2 GENE; SUSCEPTIBILITY	Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with complex pathogenesis in which genes and environmental factors are involved. We aimed at analyzing previously identified loci associated with SLE or with other autoimmune and/or inflammatory disorders (STAT4, IL10, IL23R, IRAK1, PSORS1C1, HCP5, MIR146a, PTPN2, ERAP1, ATG16L1, IRGM) in a sample of Italian SLE patients in order to verify or confirm their possible involvement and relative contribution in the disease. Materials and methods: Two hundred thirty-nine consecutive SLE patients and 278 matched healthy controls were enrolled. Study protocol included complete physical examination, and clinical and laboratory data collection. Nineteen polymorphisms were genotyped by allelic discrimination assays. A case-control association study and a genotype-phenotype correlation were performed. Results: STAT4 was the most associated gene [P = 3x10(-7), OR = 2.13 (95% CI: 1.59-2.85)]. IL10 confirmed its association with SLE [rs3024505: P = 0.02, OR = 1.52 (95% CI: 1.07-2.16)]. We describe a novel significant association between HCP5 locus and SLE susceptibility [rs3099844: P = 0.01, OR = 2.06 (95% CI: 1.18-3.6)]. The genotype/phenotype correlation analysis showed several associations including a higher risk to develop pericarditis with STAT4, and an association between HCP5 rs3099844 and anti-Ro/SSA antibodies. Conclusions: STAT4 and IL10 confirm their association with SLE. We found that some SNPs in PSORS1C1, ATG16L1, IL23R, PTPN2 and MIR146a genes can determine particular disease phenotypes. HCP5 rs3099844 is associated with SLE and with anti-Ro/SSA. This polymorphism has been previously found associated with cardiac manifestations of SLE, a condition related with anti-Ro/SSA antibodies. Thus, our results may provide new insights into SLE pathogenesis.	[Ciccacci, Cinzia; Rufini, Sara; Di Fusco, Davide; Novelli, Giuseppe; Borgiani, Paola] Univ Roma Tor Vergata, Sch Med, Dept Biomed & Prevent, Genet Sect, Rome, Italy; [Perricone, Carlo; Ceccarelli, Fulvia; Alessandri, Cristiano; Spinelli, Francesca Romana; Cipriano, Enrica; Valesini, Guido; Conti, Fabrizio] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Lupus Clin, I-00185 Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome	Borgiani, P (corresponding author), Univ Roma Tor Vergata, Sch Med, Dept Biomed & Prevent, Genet Sect, Rome, Italy.	borgiani@med.uniroma2.it	Spinelli, Francesca Romana/F-1475-2013; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Ciccacci, Cinzia/Z-6114-2019; Spinelli, Francesca Romana/AAM-7061-2020; Novelli, Giuseppe/A-5195-2013	Novelli, Giuseppe/0000-0002-7781-602X; Spinelli, Francesca Romana/0000-0003-1969-2097; Novelli, Giuseppe/0000-0002-7781-602X; Valesini, Guido/0000-0002-7757-8092; BORGIANI, PAOLA/0000-0003-0859-4328; Di Fusco, Davide/0000-0002-8908-9237; Alessandri, Cristiano/0000-0003-4149-5321; Perricone, Carlo/0000-0003-4771-6981; Ciccacci, Cinzia/0000-0002-3995-7032				Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; ARGOV S, 1991, IMMUNOL LETT, V30, P31, DOI 10.1016/0165-2478(91)90086-P; Billaut-Mulot O, 2001, J CLIN INVEST, V108, P861, DOI 10.1172/JCI13469; Borgiani P, 2014, EUR J CLIN PHARMACOL, V70, P275, DOI 10.1007/s00228-013-1622-5; CHANG YN, 1995, J VIROL, V69, P618, DOI 10.1128/JVI.69.1.618-619.1995; Chang YT, 2005, BRIT J DERMATOL, V153, P90, DOI 10.1111/j.1365-2133.2005.06570.x; Ciccacci C, 2013, J CROHNS COLITIS, V7, P44, DOI 10.1016/j.crohns.2012.02.020; Clancy RM, 2010, ARTHRITIS RHEUM-US, V62, P3415, DOI 10.1002/art.27658; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Deas JE, 1998, CLIN DIAGN LAB IMMUN, V5, P181, DOI 10.1128/CDLI.5.2.181-185.1998; Delgado-Vega A, 2010, CURR OPIN IMMUNOL, V22, P698, DOI 10.1016/j.coi.2010.09.002; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Eronen M, 2004, ACTA PAEDIATR, V93, P803, DOI 10.1111/j.1651-2227.2004.tb03022.x; Espino-Paisan L, 2011, IMMUNOGENETICS, V63, P255, DOI 10.1007/s00251-010-0500-x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fritsch C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1848; Genin E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-52; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033682; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Guerini FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029931; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; Jarvinen TM, 2012, RHEUMATOLOGY, V51, P87, DOI 10.1093/rheumatology/ker263; JULKUNEN H, 1993, ARTHRITIS RHEUM-US, V36, P1588, DOI 10.1002/art.1780361114; Kariuki SN, 2010, TRANSL RES, V155, P109, DOI 10.1016/j.trsl.2009.08.012; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kaufman KM, 2013, ANN RHEUM DIS, V72, P437, DOI 10.1136/annrheumdis-2012-201851; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069547; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; MULLER S, 1992, AIDS, V6, P933, DOI 10.1097/00002030-199209000-00004; Perricone C, 2013, IMMUNOGENETICS, V65, P703, DOI 10.1007/s00251-013-0717-6; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Perricone R, 2011, AUTOIMMUN REV, V10, P575, DOI 10.1016/j.autrev.2011.05.003; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Salomonsson S, 2011, SCAND J IMMUNOL, V74, P511, DOI 10.1111/j.1365-3083.2011.02610.x; Salomonsson S, 2002, ARTHRITIS RHEUM-US, V46, P1233, DOI 10.1002/art.10232; Schotte H, 2014, LUPUS, V23, P378, DOI 10.1177/0961203314522334; Song GG, 2012, MOL BIOL REP, V39, P10655, DOI 10.1007/s11033-012-1955-7; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun HJ, 2013, IMMUNOL LETT, V153, P9, DOI 10.1016/j.imlet.2013.06.001; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; Wang C, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-201364; Zhai Y, 2012, MOL BIOL REP, V39, P8987, DOI 10.1007/s11033-012-1768-8; Zheng JF, 2013, HUM IMMUNOL, V74, P986, DOI 10.1016/j.humimm.2013.04.034; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	55	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111991	10.1371/journal.pone.0111991	http://dx.doi.org/10.1371/journal.pone.0111991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369137	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000133
J	Fu, YF; Lu, ZJ; Li, PH; Cao, YM; Sun, P; Tian, MN; Wang, N; Bao, HF; Bai, XW; Li, D; Chen, YL; Liu, ZX				Fu, Yuanfang; Lu, Zengjun; Li, Pinghua; Cao, Yimei; Sun, Pu; Tian, Meina; Wang, Na; Bao, Huifang; Bai, Xingwen; Li, Dong; Chen, Yingli; Liu, Zaixin			Development of a Blocking ELISA Based on a Monoclonal Antibody against a Predominant Epitope in Non-Structural Protein 3B2 of Foot-and-Mouth Disease Virus for Differentiating Infected from Vaccinated Animals	PLOS ONE			English	Article							CATTLE; IDENTIFICATION; ASSAY	A monoclonal antibody (McAb) against non-structural protein (NSP) 3B of foot-mouth-disease virus (FMDV) (3B4B1) was generated and shown to recognize a conserved epitope spanning amino acids 24-32 of 3B (GPYAGPMER) by peptide screening ELISA. This epitope was further shown to be a unique and predominant B cell epitope in 3B2, as sera from animals infected with different serotypes of FMDV blocked the ability of McAb 3B4B1 to bind to NSP 2C3AB. Also, a polyclonal antibody against NSP 2C was produced in a rabbit vaccinated with 2C epitope regions expressed in E. coli. Using McAb 3B4B1 and the 2C polyclonal antibody, a solid-phase blocking ELISA (SPB-ELISA) was developed for the detection of antibodies against NSP 2C3AB to distinguish FMDV-infected from vaccinated animals (DIVA test). The parameters for this SPB-ELISA were established by screening panels of sera of different origins. Serum samples with a percent inhibition (PI) greater than or equal to 46% were considered to be from infected animals, and a PI lower than 46% was considered to indicate a non-infected animal. This test showed a similar performance as the commercially available PrioCHECK NS ELISA. This is the first description of the conserved and predominant GPYAGPMER epitope of 3B and also the first report of a DIVA test for FMDV NSP 3B based on a McAb against this epitope.	[Fu, Yuanfang; Lu, Zengjun; Li, Pinghua; Cao, Yimei; Sun, Pu; Tian, Meina; Wang, Na; Bao, Huifang; Bai, Xingwen; Li, Dong; Chen, Yingli; Liu, Zaixin] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Lu, ZJ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	luzengjun@caas.cn; liuzaixin@caas.cn	Li, Ping/GYV-4914-2022		national "863'' research project [2012AA101304]; General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China [201410061]	national "863'' research project; General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China	This study was supported by a national "863'' research project (grant no. 2012AA101304) and a research grant for public welfare from the General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China (grant no. 201410061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010735; Bergmann IE, 2000, ARCH VIROL, V145, P473, DOI 10.1007/s007050050040; Brocchi E, 2006, VACCINE, V24, P6966, DOI 10.1016/j.vaccine.2006.04.050; Clavijo A, 2004, VET J, V167, P9, DOI 10.1016/S1090-0233(03)00087-X; Earley EM, 1985, J TISSUE CULT METHOD, V9, P129; Fu YF, 2011, J VIROL METHODS, V171, P234, DOI 10.1016/j.jviromet.2010.11.006; Gao MC, 2012, APPL MICROBIOL BIOT, V93, P1271, DOI 10.1007/s00253-011-3815-0; Hohlich BJ, 2003, J VIROL, V77, P8633, DOI 10.1128/JVI.77.16.8633-8639.2003; Lu ZJ, 2007, VET MICROBIOL, V125, P157, DOI 10.1016/j.vetmic.2007.05.017; Lu ZJ, 2010, J VIROL METHODS, V170, P128, DOI 10.1016/j.jviromet.2010.09.016; Oem Jae Ku, 2005, J Vet Sci, V6, P317; Oem JK, 2007, J VIROL METHODS, V142, P174, DOI 10.1016/j.jviromet.2007.01.025; Office International des Epizooties OIE, 2012, MAN STAND DIAGN TEST; Paton DJ, 2006, VACCINE, V24, P6503, DOI 10.1016/j.vaccine.2006.06.032; Sorensen KJ, 2005, ARCH VIROL, V150, P805, DOI 10.1007/s00705-004-0455-z; Uddowla S, 2012, J VIROL, V86, P11675, DOI 10.1128/JVI.01254-12; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016	17	6	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111737	10.1371/journal.pone.0111737	http://dx.doi.org/10.1371/journal.pone.0111737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369323	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000096
J	Xu, GL; Zhang, ZZ; Lv, QS; Li, Y; Ye, RD; Xiong, YY; Jiang, YJ; Liu, XF				Xu, Gelin; Zhang, Zhizhong; Lv, Qiushi; Li, Yun; Ye, Ruidong; Xiong, Yunyun; Jiang, Yongjun; Liu, Xinfeng			NSFC Health Research Funding and Burden of Disease in China	PLOS ONE			English	Article							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; INJURIES	Background: Allocation of health research funds among diseases has never been evaluated in China. This study aimed to examine the relationship between disease-specific funding levels of National Nature Science Foundation of China (NSFC), the main governmental resource for health research in China, and burden of disease. Methods: Funding magnitudes for 53 diseases or conditions were obtained from the website of NSFC. Measures of disease burden, mortality, years of life lost (YLLs) and disability-adjusted life years (DALYs), were derived from the Global Burden of Disease Study 2010. The relationship between NSFC funding and disease burden was analyzed with univariate linear regression. For each measure associated with funding, regression-derived estimates were used to calculate the expected funds for each disease. The actual and expected funds were then compared. We also evaluated the impacts of changes of disease burden metrics since 1990, and differences from the world averages on NSFC funding. Results: NSFC health research funding was associated with disease burden measured in mortality (R = 0.33, P = 0.02), YLLs (R = 0.39, P = 0.004), and DALYs (R = 0.40, P = 0.003). But none of the changes of mortality (R = 0.22, P = 0.12), YLLs (R = -0.04, P = 0.79) and DALYs (R = -0.003, P = 0.98) since 1990 was associated with the funding magnitudes. None of the differences of mortality (R = -0.11, P = 0.45), YLLs (R = -0.11, P = 0.43) and DALYs (R = -0.12, P = 0.38) from that of the concurrent world averages were associated with the funding magnitudes. Measured by DALY, stroke and COPD received the least funding compared to expected; while leukemia and diabetes received the most funding compared to expected. Conclusion: Although NSFC funding were roughly associated with disease burden as measured in mortality, YLLs and DALYs. Some major diseases such as stroke were underfunded; while others such as leukaemia were overfunded. Change of disease burden during the last 20 years and country-specialized disease burden were not reflected in current allocation of NSFC funds.	[Xu, Gelin; Zhang, Zhizhong; Lv, Qiushi; Li, Yun; Ye, Ruidong; Xiong, Yunyun; Jiang, Yongjun; Liu, Xinfeng] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Liu, XF (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China.	xfliu2@vip.163.com		Liu, Zhi-Hong/0000-0001-6093-0726; Xu, Gelin/0000-0002-6194-0341	Nature Science Foundation of Jiangsu [BE2013713]	Nature Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province)	This study was sponsored by Nature Science Foundation of Jiangsu (BE2013713) to GX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao C, 2013, SCIENCE, V341, P460, DOI 10.1126/science.1234206; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McCarthy Mark, 2009, Health Res Policy Syst, V7, P17, DOI 10.1186/1478-4505-7-17; Morello L, 2014, NATURE, V507, P147, DOI 10.1038/507147a; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; National Bureau of Statistics Ministry of Science and Technology, 2013, CHIN STAT YB SCI TEC; Qiu JE, 2014, NATURE, V507, P148, DOI 10.1038/507148a; Rao Y, 2013, SCI CHINA LIFE SCI, V56, P495, DOI 10.1007/s11427-013-4487-z; Sampat BN, 2013, MILBANK Q, V91, P163, DOI 10.1111/milq.12005; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916; Van Noorden R, 2014, NATURE, V505, P144, DOI 10.1038/505144a; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	20	12	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111458	10.1371/journal.pone.0111458	http://dx.doi.org/10.1371/journal.pone.0111458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369330	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000056
J	Dukowska, M; Grzybkowska, M				Dukowska, Malgorzata; Grzybkowska, Maria			Coexistence of Fish Species in a Large Lowland River: Food Niche Partitioning between Small-Sized Percids, Cyprinids and Sticklebacks in Submersed Macrophytes	PLOS ONE			English	Article							RUFFE GYMNOCEPHALUS-CERNUUS; ROACH RUTILUS-RUTILUS; SELF-ORGANIZING MAP; IMPOUNDMENT IMPACT; LONG-TERM; CHIRONOMIDAE DIPTERA; FEEDING EFFICIENCY; JUVENILE FISHES; LITTORAL-ZONE; WARTA RIVER	In the spring and summer of each year, large patches of submersed aquatic macrophytes overgrow the bottom of the alluvial Warta River downstream of a large dam reservoir owing to water management practices. Environmental variables, macroinvertebrates (zoobenthos and epiphytic fauna, zooplankton) and fish abundance and biomass were assessed at this biologically productive habitat to learn intraseasonal dynamics of food types, and their occurrence in the gut contents of small-sized roach, dace, perch, ruffe and three-spined stickleback. Gut fullness coefficient, niche breadth and niche overlap indicated how the fishes coexist in the macrophytes. Chironomidae dominated in the diet of the percids. However, ruffe consumed mostly benthic chironomids, while perch epiphytic chironomids and zooplankton. The diet of dace resembled that in fast flowing water although this rheophilic species occurred at unusual density there. The generalist roach displayed the lowest gut fullness coefficient values and widest niche breadth; consequently, intraspecific rather than interspecific competition decided the fate of roach. Three-spined stickleback differed from the other fishes by consuming epiphytic simuliids and fish eggs. The diet overlap between fishes reaching higher gut fullness coefficient values was rather low when the food associated with the submersed aquatic macrophytes was most abundant; this is congruent with the niche overlap hypothesis that maximal tolerable niche overlap can be higher in less intensely competitive conditions.	[Dukowska, Malgorzata; Grzybkowska, Maria] Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, PL-90131 Lodz, Poland	University of Lodz	Dukowska, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, PL-90131 Lodz, Poland.	mdukow@biol.uni.lodz.pl		Grzybkowska, Maria/0000-0002-0581-3321; Dukowska, Malgorzata/0000-0003-1767-0759	University of Lodz [505/424]	University of Lodz	This work was supported by a grant of the University of Lodz No 505/424. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banbura J, 2000, FRESHWATER FISHES PO, P439; Barili E, 2011, ENVIRON BIOL FISH, V92, P41, DOI 10.1007/s10641-011-9814-2; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; BERGMAN E, 1988, J ANIM ECOL, V57, P443, DOI 10.2307/4916; Borcherding J, 2008, ECOL FRESHW FISH, V17, P207, DOI 10.1111/j.1600-0633.2007.00272.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chick JH, 1997, ECOL FRESHW FISH, V6, P27, DOI 10.1111/j.1600-0633.1997.tb00139.x; Clough S, 1997, J FISH BIOL, V50, P1117, DOI 10.1111/j.1095-8649.1997.tb01635.x; Danchin E., 2008, BEHAV ECOLOGY; de Nie H. W., 1987, 19 EIFACCECPI; Dieterich A, 2004, ECOL FRESHW FISH, V13, P236, DOI 10.1111/j.1600-0633.2004.00059.x; Dukowska M, 2013, ECOL MODEL, V265, P221, DOI 10.1016/j.ecolmodel.2013.06.022; Dukowska Malgorzata, 1999, Acta Hydrobiologica, V41, P219; Dukowska Malgorzata, 2005, Teka Komisji Ochrony i Ksztaltowania Srodowiska Przyrodniczego, V2, P48; Dukowska M, 2009, OCEANOL HYDROBIOL ST, V38, P39, DOI 10.2478/v10009-009-0020-x; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Feld CK, 2011, ADV ECOL RES, V44, P119, DOI 10.1016/B978-0-12-374794-5.00003-1; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; Fullerton AH, 2006, ECOL FRESHW FISH, V15, P1, DOI 10.1111/j.1600-0633.2005.00114.x; Glowacki L, 2011, RIVER RES APPL, V27, P612, DOI 10.1002/rra.1380; Grenouillet G, 2001, J FISH BIOL, V59, P939; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; GRZYBKOWSKA M, 1990, ARCH HYDROBIOL, V119, P439; GRZYBKOWSKA M, 1991, Regulated Rivers Research and Management, V6, P257, DOI 10.1002/rrr.3450060404; Grzybkowska M, 2002, ANN ZOOL, V52, P235; Grzybkowska M., 1983, P C POL HYDR SOC LUB, P71; Grzybkowska Maria, 2003, Ecohydrology & Hydrobiology, V3, P399; Grzybkowska Maria, 1996, Acta Universitatis Lodziensis Folia Limnologica, V6, P47; Grzybkowska Maria, 1988, Acta Universitatis Lodziensis Folia Limnologica, V3, P85; Gunderson JL, 1998, J GREAT LAKES RES, V24, P165, DOI 10.1016/S0380-1330(98)70810-X; Horppila J, 2009, J FISH BIOL, V75, P1230, DOI 10.1111/j.1095-8649.2009.02359.x; Ibanez C, 2012, SCI TOTAL ENVIRON, V440, P132, DOI 10.1016/j.scitotenv.2012.07.073; KENNEDY M, 1993, OIKOS, V68, P158, DOI 10.2307/3545322; Kleeberg A, 2010, FRESHWATER BIOL, V55, P326, DOI 10.1111/j.1365-2427.2009.02277.x; Kohler J, 2010, AQUAT BOT, V92, P129, DOI 10.1016/j.aquabot.2009.10.018; Kornijow R, 2005, FRESHWATER BIOL, V50, P262, DOI 10.1111/j.1365-2427.2004.01318.x; Kornijow R, 1997, HYDROBIOLOGIA, V342, P207, DOI 10.1023/A:1017067621668; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kruk A, 2007, J APPL ICHTHYOL, V23, P9, DOI 10.1111/j.1439-0426.2006.00784.x; Kruk A, 2003, ANN LIMNOL-INT J LIM, V39, P197, DOI 10.1051/limn/2003016; Kucharczyk D, 2008, DACE LEUCISCUS LEUCI; Li JM, 2010, ECOL MODEL, V221, P2076, DOI 10.1016/j.ecolmodel.2010.05.005; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Makino W, 2001, HYDROBIOLOGIA, V442, P309, DOI 10.1023/A:1017532717135; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; Marszal Lidia, 1996, Polskie Archiwum Hydrobiologii, V43, P185; Nunn AD, 2007, J FISH BIOL, V70, P726, DOI 10.1111/j.1095-8649.2007.01334.x; Nurminen L, 2010, J FISH BIOL, V76, P1848, DOI 10.1111/j.1095-8649.2010.02600.x; OGLE DH, 1995, T AM FISH SOC, V124, P356, DOI 10.1577/1548-8659(1995)124<0356:DAFPOR>2.3.CO;2; Opuszynski K., 1983, BASICS FISH BIOL; Penczak T, 2005, J APPL ICHTHYOL, V21, P169, DOI 10.1111/j.1439-0426.2005.00649.x; Penczak T, 2000, ECOL FRESHW FISH, V9, P109, DOI 10.1034/j.1600-0633.2000.90113.x; Penczak T, 2012, ECOL MODEL, V227, P64, DOI 10.1016/j.ecolmodel.2011.12.006; Penczak T, 1998, HYDROBIOLOGIA, V368, P157, DOI 10.1023/A:1003246115666; PERSSON L, 1987, OECOLOGIA, V73, P170, DOI 10.1007/BF00377504; PETERSEN RC, 1989, ECOL MONOGR, V59, P21, DOI 10.2307/2937290; Petts G.E., 1984, IMPOUNDED RIVERS PER, DOI [10.1177/030913338601000116., DOI 10.1016/0006-3207(85)90110-7]; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PINDER LCV, 1992, HYDROBIOLOGIA, V248, P39, DOI 10.1007/BF00008884; Raat AJP, 2001, REGUL RIVER, V17, P131, DOI 10.1002/rrr.608; Rezsu E, 2006, ECOL FRESHW FISH, V15, P339, DOI 10.1111/j.1600-0633.2006.00172.x; Rosh R, 1996, ACTA ZOOL LITU, V19, P18; ROZAS LP, 1988, OECOLOGIA, V77, P101, DOI 10.1007/BF00380932; Satora M, 2013, FOOD NICHE OVERLAP 5; Schleuter D, 2008, ECOL FRESHW FISH, V17, P86, DOI 10.1111/j.1600-0633.2007.00262.x; Schleuter D, 2006, FRESHWATER BIOL, V51, P287, DOI 10.1111/j.1365-2427.2005.01495.x; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Schulze T, 2012, LIMNOLOGICA, V42, P56, DOI 10.1016/j.limno.2011.08.001; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Tadajewska M., 2000, FRESHWATER FISHES PO, P311; Tarvainen M, 2005, FRESHWATER BIOL, V50, P447, DOI 10.1111/j.1365-2427.2005.01331.x; TOKESHI M, 1985, HOLARCTIC ECOL, V8, P313; Vanderstukken M, 2011, FRESHWATER BIOL, V56, P1837, DOI 10.1111/j.1365-2427.2011.02624.x; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Ward JS, 1980, P S SURF WAT IMP ASC; Zar JH., 1999, BIOSTAT ANAL	76	13	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109927	10.1371/journal.pone.0109927	http://dx.doi.org/10.1371/journal.pone.0109927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365420	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100011
J	Nevo, I; Woolard, K; Cam, M; Li, A; Webster, JD; Kotliarov, Y; Kim, HS; Ahn, S; Walling, J; Kotliarova, S; Belova, G; Song, H; Bailey, R; Zhang, W; Fine, HA				Nevo, Ido; Woolard, Kevin; Cam, Maggie; Li, Aiguo; Webster, Joshua D.; Kotliarov, Yuri; Kim, Hong Sug; Ahn, Susie; Walling, Jennifer; Kotliarova, Svetlana; Belova, Galina; Song, Hua; Bailey, Rolanda; Zhang, Wei; Fine, Howard A.			Identification of Molecular Pathways Facilitating Glioma Cell Invasion In Situ	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEURAL STEM-CELLS; GROWTH-FACTOR; GLIOBLASTOMA-MULTIFORME; EXPRESSION; ADHESION; PROGRESSION; MIGRATION; TUMORIGENICITY; PROLIFERATION	Gliomas are mostly incurable secondary to their diffuse infiltrative nature. Thus, specific therapeutic targeting of invasive glioma cells is an attractive concept. As cells exit the tumor mass and infiltrate brain parenchyma, they closely interact with a changing micro-environmental landscape that sustains tumor cell invasion. In this study, we used a unique microarray profiling approach on a human glioma stem cell (GSC) xenograft model to explore gene expression changes in situ in Invading Glioma Cells (IGCs) compared to tumor core, as well as changes in host cells residing within the infiltrated microenvironment relative to the unaffected cortex. IGCs were found to have reduced expression of genes within the extracellular matrix compartment, and genes involved in cell adhesion, cell polarity and epithelial to mesenchymal transition (EMT) processes. The infiltrated microenvironment showed activation of wound repair and tissue remodeling networks. We confirmed by protein analysis the downregulation of EMT and polarity related genes such as CD44 and PARD3 in IGCs, and EFNB3, a tissue-remodeling agent enriched at the infiltrated microenvironment. OLIG2, a proliferation regulator and glioma progenitor cell marker upregulated in IGCs was found to function in enhancing migration and stemness of GSCs. Overall, our results unveiled a more comprehensive picture of the complex and dynamic cell autonomous and tumor-host interactive pathways of glioma invasion than has been previously demonstrated. This suggests targeting of multiple pathways at the junction of invading tumor and microenvironment as a viable option for glioma therapy.	[Nevo, Ido; Woolard, Kevin; Cam, Maggie; Li, Aiguo; Kotliarov, Yuri; Kim, Hong Sug; Ahn, Susie; Walling, Jennifer; Kotliarova, Svetlana; Belova, Galina; Song, Hua; Bailey, Rolanda; Zhang, Wei; Fine, Howard A.] NINDS, Neurooncol Branch, NCI, NIH, Bethesda, MD 20892 USA; [Webster, Joshua D.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fine, HA (corresponding author), NINDS, Neurooncol Branch, NCI, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	Howard.Fine@nyumc.org	Kotliarov, Yuri/B-6938-2017	Kotliarov, Yuri/0000-0002-6558-8883	NIH Intramural Program (IRP); NATIONAL CANCER INSTITUTE [ZICBC011532] Funding Source: NIH RePORTER	NIH Intramural Program (IRP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by the NIH Intramural Program (IRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Fu J, 2013, CANCER RES, V73, P3062, DOI 10.1158/0008-5472.CAN-12-2033; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Janes PW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000215; Juncker-Jensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016954; Kim S, 2011, SEMIN CELL DEV BIOL, V22, P551, DOI 10.1016/j.semcdb.2011.03.008; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li X, 2012, ONCOGENE, V31, P595, DOI 10.1038/onc.2011.256; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Matise LA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3217; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Moshe Y, 2011, J BIOL CHEM, V286, P16647, DOI 10.1074/jbc.M111.223339; Nevo I, 2010, INT J CANCER, V126, P1570, DOI 10.1002/ijc.24889; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Shah GD, 2010, CANCER-AM CANCER SOC, V116, P1018, DOI 10.1002/cncr.24788; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Siebzehnrubl FA, 2013, EMBO MOL MED, V5, P1196, DOI 10.1002/emmm.201302827; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124; Thomas PD, 2007, CURR OPIN CHEM BIOL, V11, P4, DOI 10.1016/j.cbpa.2006.11.039; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Villena J, 2003, CELL BIOL INT, V27, P1005, DOI 10.1016/j.cellbi.2003.09.004; Waimey KE, 2008, DEV BIOL, V315, P448, DOI 10.1016/j.ydbio.2008.01.002; Wang SH, 2013, CURR NEUROVASC RES, V10, P54, DOI 10.2174/156720213804805945; Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0; Watanabe A, 2006, J NEURO-ONCOL, V77, P25, DOI 10.1007/s11060-005-9010-3; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Zecchini S, 2011, EMBO MOL MED, V3, P480, DOI 10.1002/emmm.201100152; Zimmer G, 2011, J NEUROSCI, V31, P18364, DOI 10.1523/JNEUROSCI.4690-11.2011	50	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111783	10.1371/journal.pone.0111783	http://dx.doi.org/10.1371/journal.pone.0111783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365423	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100120
J	Chadha, A; Cook, B				Chadha, Abhishek; Cook, Boaz			The Effect of Stress on Motor Function in Drosophila	PLOS ONE			English	Article							PITUITARY-ADRENAL RESPONSES; INTER-LEG COORDINATION; ELEVATED PLUS-MAZE; RESTRAINT STRESS; STICK INSECT; CARAUSIUS-MOROSUS; BEHAVIOR; WALKING; MICE; CORTICOSTERONE	Exposure to unpredictable and uncontrollable conditions causes animals to perceive stress and change their behavior. It is unclear how the perception of stress modifies the motor components of behavior and which molecular pathways affect the behavioral change. In order to understand how stress affects motor function, we developed an experimental platform that quantifies walking motions in Drosophila. We found that stress induction using electrical shock results in backwards motions of the forelegs at the end of walking strides. These leg retrogressions persisted during repeated stimulation, although they habituated substantially. The motions also continued for several strides after the end of the shock, indicating that stress induces a behavioral aftereffect. Such aftereffect could also be induced by restricting the motion of the flies via wing suspension. Further, the long-term effects could be amplified by combining either immobilization or electric shock with additional stressors. Thus, retrogression is a lingering form of response to a broad range of stressful conditions, which cause the fly to search for a foothold when it faces extreme and unexpected challenges. Mutants in the cAMP signaling pathway enhanced the stress response, indicating that this pathway regulates the behavioral response to stress. Our findings identify the effect of stress on a specific motor component of behavior and define the role of cAMP signaling in this stress response.	[Chadha, Abhishek; Cook, Boaz] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Cook, B (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	bcook@scripps.edu						Adamo SA, 2012, HORM BEHAV, V62, P324, DOI 10.1016/j.yhbeh.2012.02.012; Barreto RE, 2014, HORM BEHAV, V65, P394, DOI 10.1016/j.yhbeh.2014.03.007; Berg E, 2013, J EXP BIOL, V216, P1064, DOI 10.1242/jeb.076406; Bhatnagar S, 2003, HORM BEHAV, V43, P158, DOI 10.1016/S0018-506X(02)00011-9; Brewer JA, 2003, STRESS, V6, P121, DOI 10.1080/1025389031000116460; BYRNE JH, 1991, ANN NY ACAD SCI, V627, P124, DOI DOI 10.1111/J.1749-6632.1991.TB25918.X; Carpenter MG, 2004, J NEUROPHYSIOL, V92, P3255, DOI 10.1152/jn.01139.2003; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Clark AJ, 2011, J EXP BIOL, V214, P1369, DOI 10.1242/jeb.051136; CRUSE H, 1976, J COMP PHYSIOL, V112, P235, DOI 10.1007/BF00606541; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; Diegelmann S, 2013, J EXP BIOL, V216, P939, DOI 10.1242/jeb.076208; Durr V, 2001, J EXP BIOL, V204, P1589; Elenkov IJ, 2006, NEUROIMMUNOMODULAT, V13, P257, DOI 10.1159/000104853; Garcia A, 2000, NEUROENDOCRINOLOGY, V72, P114, DOI 10.1159/000054578; Gonzalo-Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036477; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1972, J COMP PHYSIOL, V81, P23, DOI 10.1007/BF00693548; Grissom N, 2007, HORM BEHAV, V51, P95, DOI 10.1016/j.yhbeh.2006.08.011; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Hashiguchi H, 1997, PHYSIOL BEHAV, V61, P731, DOI 10.1016/S0031-9384(96)00527-6; HAUGER RL, 1990, BRAIN RES, V532, P34, DOI 10.1016/0006-8993(90)91738-3; Iwamoto T, 2003, J BIOL CHEM, V278, P16936, DOI 10.1074/jbc.C300075200; Keller BR, 2007, J COMP PHYSIOL A, V193, P881, DOI 10.1007/s00359-007-0241-y; Kim KS, 2009, J NEUROSCI RES, V87, P2983, DOI 10.1002/jnr.22119; Klenerova V, 2007, J PHYSIOL PHARMACOL, V58, P83; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; MacNeil G, 1997, PHARMACOL BIOCHEM BE, V58, P737, DOI 10.1016/S0091-3057(97)00037-3; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; McVea DA, 2007, J NEUROPHYSIOL, V97, P659, DOI 10.1152/jn.00921.2006; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; Mercier S, 2003, BEHAV BRAIN RES, V139, P167, DOI 10.1016/S0166-4328(02)00265-6; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Michels B, 2011, LEARN MEMORY, V18, P332, DOI 10.1101/lm.2101411; Min VA, 2005, J NEUROSCI METH, V145, P63, DOI 10.1016/j.jneumeth.2004.11.022; Padovan CM, 2000, BRAZ J MED BIOL RES, V33, P79, DOI 10.1590/S0100-879X2000000100011; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; PEARSON KG, 1984, INT J ROBOT RES, V3, P101, DOI 10.1177/027836498400300209; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Pomerantz O, 2012, BEHAV BRAIN RES, V230, P274, DOI 10.1016/j.bbr.2012.02.019; Preat T, 1998, J NEUROSCI, V18, P8534; Razzoli M, 2010, NEUROSCIENCE, V170, P429, DOI 10.1016/j.neuroscience.2010.07.022; Sarenac O, 2011, EXP PHYSIOL, V96, P574, DOI 10.1113/expphysiol.2010.055970; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shakiryanova D, 2011, P NATL ACAD SCI USA, V108, P4477, DOI 10.1073/pnas.1017837108; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Trompeter WP, 2011, HORM BEHAV, V60, P152, DOI 10.1016/j.yhbeh.2011.04.001; Vittone MaP, 2006, SCENE J US COAST GUA; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139; Wust S, 2005, PSYCHONEUROENDOCRINO, V30, P591, DOI 10.1016/j.psyneuen.2005.01.008	54	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112076	10.1371/journal.pone.0112076	http://dx.doi.org/10.1371/journal.pone.0112076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375106	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600097
J	Hotta, G; Matsumura, Y; Kato, K; Nakano, S; Yunoki, T; Yamamoto, M; Nagao, M; Ito, Y; Takakura, S; Ichiyama, S				Hotta, Go; Matsumura, Yasufumi; Kato, Karin; Nakano, Satoshi; Yunoki, Tomoyuki; Yamamoto, Masaki; Nagao, Miki; Ito, Yutaka; Takakura, Shunji; Ichiyama, Satoshi			Risk Factors and Outcomes of Stenotrophomonas maltophilia Bacteraemia: A Comparison with Bacteraemia Caused by Pseudomonas aeruginosa and Acinetobacter Species	PLOS ONE			English	Article							XANTHOMONAS-MALTOPHILIA; TRIMETHOPRIM-SULFAMETHOXAZOLE; ANTIMICROBIAL THERAPY; SURVEILLANCE; MULTICENTER; MORTALITY	Stenotrophomonas maltophilia (SM) is an important nosocomial pathogen that exhibits intrinsic resistance to various antimicrobial agents. However, the risk factors for SM bacteraemia have not been sufficiently evaluated. From January 2005 to September 2012, we retrospectively compared the clinical backgrounds and outcomes of SM bacteraemic patients (SM group) with those of bacteraemic patients due to Pseudomonas aeruginosa (PA group) or Acinetobacter species (AC group). DNA genotyping of the SM isolates using the Diversilab system was performed to investigate the genetic relationships among the isolates. The SM, PA, and AC groups included 54, 167, and 69 patients, respectively. Nine of 17 patients in the SM group receiving trimethoprim-sulfamethoxazole prophylaxis developed SM bacteraemia. Independent risk factors for SM bacteraemia were the use of carbapenems and antipseudomonal cephalosporins and SM isolation within 30 days prior to the onset of bacteraemia. Earlier SM isolation was observed in 32 of 48 patients (66.7%) with SM bacteraemia who underwent clinical microbiological examinations. Of these 32 patients, 15 patients (46.9%) had the same focus of bacteraemia as was found in the previous isolation site. The 30-day all-cause mortality rate among the SM group (33.3%) was higher than that of the PA group (21.5%, p = 0.080) and the AC group (17.3%, p = 0.041). The independent factor that was associated with 30-day mortality was the SOFA score. DNA genotyping of SM isolates and epidemiological data suggested that no outbreak had occurred. SM bacteraemia was associated with high mortality and should be considered in patients with recent use of broad-spectrum antibiotics or in patients with recent isolation of the organism.	[Hotta, Go; Matsumura, Yasufumi; Kato, Karin; Nakano, Satoshi; Yunoki, Tomoyuki; Yamamoto, Masaki; Nagao, Miki; Takakura, Shunji; Ichiyama, Satoshi] Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Sakyo Ku, Kyoto, Japan; [Ito, Yutaka] Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Matsumura, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto, Japan.	yazblood@kuhp.kyoto-u.ac.jp	Nagao, Miki/ABG-8561-2021; Nakano, Satoshi/AAO-2188-2020	Nagao, Miki/0000-0002-8886-6145; Matsumura, Yasufumi/0000-0001-8595-8944; Nakano, Satoshi/0000-0002-8987-0250				Apisarnthanarak A, 2003, INFECT CONT HOSP EP, V24, P269, DOI 10.1086/502197; Araoka H, 2010, EUR J CLIN MICROBIOL, V29, P605, DOI 10.1007/s10096-010-0882-6; Baba H, 2011, EUR J CLIN MICROBIOL, V30, P739, DOI 10.1007/s10096-010-1146-1; Boktour M, 2006, CANCER-AM CANCER SOC, V106, P1967, DOI 10.1002/cncr.21846; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cho SY, 2014, ANTIMICROB AGENTS CH, V58, P581, DOI 10.1128/AAC.01682-13; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; de Oliveira-Garcia D, 2002, EMERG INFECT DIS, V8, P918, DOI 10.3201/eid0809.010535; Denton M, 1996, EUR J CLIN MICROBIOL, V15, P402, DOI 10.1007/BF01690098; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fihman V, 2012, J INFECTION, V64, P391, DOI 10.1016/j.jinf.2012.01.001; Friedman ND, 2002, J INFECTION, V45, P47, DOI 10.1053/jinf.2002.0978; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Garazi M, 2012, J HOSP INFECT, V81, P114, DOI 10.1016/j.jhin.2012.02.008; Hanes SD, 2002, CLIN INFECT DIS, V35, P228, DOI 10.1086/341022; Horcajada JP, 2013, CLIN MICROBIOL INFEC, V19, P962, DOI 10.1111/1469-0691.12089; Jang TN, 2009, J HOSP INFECT, V73, P143, DOI 10.1016/j.jhin.2009.06.007; Lai Chung-Hsu, 2004, Journal of Microbiology Immunology and Infection, V37, P350; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; MARSHALL WF, 1989, MAYO CLIN PROC, V64, P1097, DOI 10.1016/S0025-6196(12)64979-9; Metan G, 2005, ANTIMICROB AGENTS CH, V49, P3980, DOI 10.1128/AAC.49.9.3980-3981.2005; Metan G, 2006, SCAND J INFECT DIS, V38, P527, DOI 10.1080/00365540500452481; Micozzi A, 2000, CLIN INFECT DIS, V31, P705, DOI 10.1086/314043; Muder RR, 1996, CLIN INFECT DIS, V22, P508, DOI 10.1093/clinids/22.3.508; Nicodemo AC, 2007, EUR J CLIN MICROBIOL, V26, P229, DOI 10.1007/s10096-007-0279-3; Nseir S, 2006, CRIT CARE, V10, DOI 10.1186/cc5063; Samonis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037375; Senol E, 2002, CLIN INFECT DIS, V34, P1653, DOI 10.1086/340707; Stuart JC, 2010, ANTIMICROB AGENTS CH, V54, P2746, DOI 10.1128/AAC.01726-09; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Tunger O, 2007, J CHEMOTHERAPY, V19, P658, DOI 10.1179/joc.2007.19.6.658; Vartivarian SE, 1996, ARCH INTERN MED, V156, P433, DOI 10.1001/archinte.156.4.433; VICTOR MA, 1994, SCAND J INFECT DIS, V26, P163, DOI 10.3109/00365549409011780; Wang YL, 2014, ANTIMICROB AGENTS CH, V58, P176, DOI 10.1128/AAC.01324-13; Wu H, 2012, J MICROBIOL IMMUNOL, V45, P120, DOI 10.1016/j.jmii.2011.09.028; Wu ZB, 2011, J HOSP INFECT, V79, P180, DOI 10.1016/j.jhin.2011.06.006	39	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112208	10.1371/journal.pone.0112208	http://dx.doi.org/10.1371/journal.pone.0112208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375244	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600119
J	Leighton, GO; Konnova, TA; Idiyatullin, B; Hurr, SH; Zuev, YF; Nesmelova, IV				Leighton, Gage O.; Konnova, Tatiana A.; Idiyatullin, Bulat; Hurr, Sophia H.; Zuev, Yuriy F.; Nesmelova, Irina V.			The Folding of the Specific DNA Recognition Subdomain of the Sleeping Beauty Transposase Is Temperature-Dependent and Is Required for Its Binding to the Transposon DNA	PLOS ONE			English	Article							INDUCED-FIT; CONFORMATIONAL SELECTION; SELF-DIFFUSION; GENE-THERAPY; PROTEIN; SYSTEM; VIEW; SPECTROSCOPY; ENSEMBLES; MOS1	The reaction of DNA transposition begins when the transposase enzyme binds to the transposon DNA. Sleeping Beauty is a member of the mariner family of DNA transposons. Although it is an important tool in genetic applications and has been adapted for human gene therapy, its molecular mechanism remains obscure. Here, we show that only the folded conformation of the specific DNA recognition subdomain of the Sleeping Beauty transposase, the PAI subdomain, binds to the transposon DNA. Furthermore, we show that the PAI subdomain is well folded at low temperatures, but the presence of unfolded conformation gradually increases at temperatures above 15 degrees C, suggesting that the choice of temperature may be important for the optimal transposase activity. Overall, the results provide a molecular-level insight into the DNA recognition by the Sleeping Beauty transposase.	[Leighton, Gage O.; Konnova, Tatiana A.; Hurr, Sophia H.; Nesmelova, Irina V.] Univ N Carolina, Dept Phys & Opt Sci, Charlotte, NC 28223 USA; [Konnova, Tatiana A.; Idiyatullin, Bulat; Zuev, Yuriy F.] Kazan Inst Biochem & Biophys, Kazan, Russia; [Nesmelova, Irina V.] Univ N Carolina, Ctr Biomed Engn & Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; University of North Carolina; University of North Carolina Charlotte	Nesmelova, IV (corresponding author), Univ N Carolina, Dept Phys & Opt Sci, Charlotte, NC 28223 USA.	Irina.Nesmelova@uncc.edu	Leighton, Gage/AAG-6122-2020; Zuev, Yuriy/A-7761-2016; Zuev, Yuriy/O-6307-2019; Konnova, Tatiana/AAQ-9183-2021; Nesmelova, Irina/D-6033-2015	Leighton, Gage/0000-0003-4636-0370; Zuev, Yuriy/0000-0002-6715-2530; Zuev, Yuriy/0000-0002-6715-2530; Nesmelova, Irina/0000-0002-1835-1533; Konnova, Tatiana/0000-0002-9173-7854	North Carolina Biotechnology Center [2012-BRG-1206]; National Institute of General Medical Sciences of the National Institutes of Health [R15GM112076]; Charlotte Research Scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM112076] Funding Source: NIH RePORTER	North Carolina Biotechnology Center; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Charlotte Research Scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by North Carolina Biotechnology Center (2012-BRG-1206, http://www.ncbiotech.org/research-grants/research-funding/biotechnology-research) and National Institute of General Medical Sciences of the National Institutes of Health (R15GM112076, http://www.nigms.nih.gov/Pages/default.aspx) to IVN, and Charlotte Research Scholar award (http://graduateschool.uncc.edu/current-students/charlotte-research-scholars) to GOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bire S, 2013, GENE, V530, P165, DOI 10.1016/j.gene.2013.08.039; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouuaert CC, 2010, GENETICA, V138, P473, DOI 10.1007/s10709-009-9391-x; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; BUSHUEVA TL, 1978, BIOCHIM BIOPHYS ACTA, V534, P141, DOI 10.1016/0005-2795(78)90484-1; Carpentier CE, 2014, PROTEIN SCI, V23, P23, DOI 10.1002/pro.2386; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Dehner A, 2005, CHEMBIOCHEM, V6, P1550, DOI 10.1002/cbic.200500093; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farber PJ, 2011, J MOL BIOL, V405, P819, DOI 10.1016/j.jmb.2010.11.016; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Gueguen E, 2006, MOL MICROBIOL, V62, P1102, DOI 10.1111/j.1365-2958.2006.05424.x; Hackett PB, 2013, TRANSL RES, V161, P265, DOI 10.1016/j.trsl.2012.12.005; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Haren L, 1997, MOL MICROBIOL, V25, P531, DOI 10.1046/j.1365-2958.1997.4951854.x; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Ilyina E, 1997, BIOCHEMISTRY-US, V36, P3383, DOI 10.1021/bi9622229; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Izsvak Z, 2002, J BIOL CHEM, V277, P34581, DOI 10.1074/jbc.M204001200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Keller R., 2004, COMPUTER AIDED RESON, V1; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KRETSCHMER PJ, 1979, J BACTERIOL, V139, P515, DOI 10.1128/JB.139.2.515-519.1979; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lawler JF, 2002, J VIROL, V76, P4233, DOI 10.1128/JVI.76.9.4233-4240.2002; MCCALL DW, 1959, J CHEM PHYS, V31, P1555, DOI 10.1063/1.1730651; Menter JM, 2006, PHOTOCH PHOTOBIO SCI, V5, P403, DOI 10.1039/b516429j; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Nesmelova IV, 2002, BIOPOLYMERS, V63, P132, DOI 10.1002/bip.10023; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; PAQUIN CE, 1984, SCIENCE, V226, P53, DOI 10.1126/science.226.4670.53; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Sinzelle L, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-106; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; TSAI MM, 1987, J BACTERIOL, V169, P5556, DOI 10.1128/jb.169.12.5556-5562.1987; TURNER AK, 1990, J GEN MICROBIOL, V136, P65, DOI 10.1099/00221287-136-1-65; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Williams DA, 2008, MOL THER, V16, P1515, DOI 10.1038/mt.2008.169; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089	49	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112114	10.1371/journal.pone.0112114	http://dx.doi.org/10.1371/journal.pone.0112114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375127	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600106
J	Lu, J; Hu, SJ; Ma, XY; Chen, JM; Li, QQ; Ye, H				Lu, Jun; Hu, Shao-ji; Ma, Xue-yu; Chen, Jin-min; Li, Qing-qing; Ye, Hui			Origin and Expansion of the Yunnan Shoot Borer, Tomicus yunnanensis (Coleoptera: Scolytinae): A Mixture of Historical Natural Expansion and Contemporary Human-Mediated Relocation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; EVOLUTIONARY GENETICS; MAXIMUM-LIKELIHOOD; POPULATION-GROWTH; GLACIATION; WOLBACHIA; SEQUENCES; SOFTWARE; DISTANCE; TESTS	The Yunnan shoot borer, Tomicus yunnanensis, is a recently-discovered, aggressive pest of the Yunnan pine stands in southwestern China. Despite many bionomics studies and massive controlling efforts, research on its population genetics is extremely limited. The present study, aimed at investigating the origin and dispersal of this important forestry pest, analyzed the population genetic structure and demographic history using a mitochondrial cox1 gene fragment. Our results showed that T. yunnanensis most likely originated from the Central-Yunnan Altiplano, and the divergence time analysis placed the origin approximately 0.72 million-years ago. Host separation and specialization might have caused the speciation of T. yunnanensis. Genetic structure analyses identified two population groups, with six populations near the origin area forming one group and the remaining six populations from western and eastern Yunnan and southwestern Sichuan comprising the other. Divergence time analysis placed the split of the two groups at approximately 0.60 million-years ago, and haplotype phylogenetic tree, network, as well as migration rate suggested that populations of the latter group were established via a small number of individuals from the former one. Migration analysis also showed a certain degree of recent expansion from southwestern Sichuan to eastern Yunnan. Our findings implied that T. yunnanensis underwent both historical expansion and recent dispersal. The historical expansion may relate to the oscillation of regional climate due to glacial and interglacial periods in the Pleistocene, while human-mediated transportation of pine-wood material might have assisted the relocation and establishment of this pest in novel habitats.	[Lu, Jun; Hu, Shao-ji; Ma, Xue-yu; Ye, Hui] Yunnan Univ, Lab Biol Invas & Ecosecur, Kunming 650091, Peoples R China; [Lu, Jun; Hu, Shao-ji; Ye, Hui] Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Ecosecu, Kunming 650091, Peoples R China; [Ma, Xue-yu] Yunnan Univ Nationalities, Sch Math & Comp Sci, Kunming 650031, Peoples R China; [Chen, Jin-min] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Li, Qing-qing] Yunnan Normal Univ, Life Sci Coll, Kunming 650092, Peoples R China	Yunnan University; Yunnan University; Yunnan Minzu University; Yunnan University; Yunnan Normal University	Ye, H (corresponding author), Yunnan Univ, Lab Biol Invas & Ecosecur, Kunming 650091, Peoples R China.	yehui@ynu.edu.cn	Hu, Shao-Ji/AAO-6247-2021; Chen, Jinmin/GXN-4326-2022	Hu, Shao-Ji/0000-0002-1615-9601; 	National Natural Science Foundation of China [31360183]; Applied Basic Research Foundation of Yunnan Province [2013FA055]; Applied Basic Research Foundation for Young Scientists of Yunnan Province [2014FD025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Foundation of Yunnan Province; Applied Basic Research Foundation for Young Scientists of Yunnan Province	The present study was supported by the National Natural Science Foundation of China (31360183), the Applied Basic Research Foundation of Yunnan Province (2013FA055), and the Applied Basic Research Foundation for Young Scientists of Yunnan Province (2014FD025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 1999, GENETICS, V152, P763; Bertheau C, 2011, MOL ECOL RESOUR, V11, P1056, DOI 10.1111/j.1755-0998.2011.03050.x; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Dai XX, 2006, FOR PEST DIS, V25, P31; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duan W., 1980, GEOJOURNAL, V4, P515, DOI [10.1007/BF00214217, DOI 10.1007/BF00214217]; Duan Y, 2004, HEREDITY, V93, P416, DOI 10.1038/sj.hdy.6800518; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He DM, 2005, ADV EARTH SCI, V20, P932; He YH, 2009, FOR INVENTORY PLANN, V34, P98; Hu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057568; HUI Y, 1991, J APPL ENTOMOL, V112, P366, DOI 10.1111/j.1439-0418.1991.tb01069.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin ZZ, 2004, YUNNAN PINE; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirkendall LR, 2008, ZOOTAXA, P25, DOI 10.11646/zootaxa.1819.1.2; Langstrom B., 1983, Studia Forestalia Suecica; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Li X, 2010, ZOOTAXA, P57; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu H, 2010, J ECON ENTOMOL, V103, P95, DOI 10.1603/EC09080; Liu ZZ, 2007, GUIZHOU FOR SCI TECH, V35, P57; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, FIGTREE TREE FIGURE; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2011, MRBAYES VER IN PRESS; Rui RJ, 2007, J SW FOR COLL, V27, P56; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1991, GENETICS, V129, P555; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; [童国榜 Tong Guobang], 2002, [第四纪研究, Quaternary Sciences], V22, P332; Wang XD, 2005, CHINESE AGR SCI B, V21, P276; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P835; Yang JQ, 2007, SCI CHINA SER D, V50, P1685, DOI 10.1007/s11430-007-01149; Yang JQ, 2006, QUATERN INT, V154, P52, DOI 10.1016/j.quaint.2006.02.003; Ye H, 2012, YUNNAN SHOOT BORER; Ye H, 1992, J YUNNAN U, V14, P211; Ye H., 1986, J YUNNAN U, V8, P218; [赵希涛 Zhao Xitao], 2007, [第四纪研究, Quaternary Sciences], V27, P35; ZUCKERKANDL EMILE, 1965, P97	56	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111940	10.1371/journal.pone.0111940	http://dx.doi.org/10.1371/journal.pone.0111940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372458	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900092
J	Pastorino, L; Dellacasa, E; Noor, MR; Soulimane, T; Bianchini, P; D'Autilia, F; Antipov, A; Diaspro, A; Tofail, SAM; Ruggiero, C				Pastorino, Laura; Dellacasa, Elena; Noor, Mohamed R.; Soulimane, Tewfik; Bianchini, Paolo; D'Autilia, Francesca; Antipov, Alexei; Diaspro, Alberto; Tofail, Syed A. M.; Ruggiero, Carmelina			Multilayered Polyelectrolyte Microcapsules: Interaction with the Enzyme Cytochrome C Oxidase	PLOS ONE			English	Article							THERMUS-THERMOPHILUS; POLYMERIC CAPSULES; FILMS; ENCAPSULATION; STABILITY; NEUTRON; DENSITY	Cell-sized polyelectrolyte capsules functionalized with a redox-driven proton pump protein were assembled for the first time. The interaction of polyelectrolyte microcapsules, fabricated by electrostatic layer-by-layer assembly, with cytochrome c oxidase molecules was investigated. We found that the cytochrome c oxidase retained its functionality, that the functionalized microcapsules interacting with cytochrome c oxidase were permeable and that the permeability characteristics of the microcapsule shell depend on the shell components. This work provides a significant input towards the fabrication of an integrated device made of biological components and based on specific biomolecular functions and properties.	[Pastorino, Laura; Dellacasa, Elena; Ruggiero, Carmelina] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy; [Noor, Mohamed R.; Soulimane, Tewfik] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Bianchini, Paolo; D'Autilia, Francesca; Diaspro, Alberto] Ist Italiano Tecnol, Genoa, Italy; [Antipov, Alexei] PlasmaChem GmbH, Berlin, Germany; [Noor, Mohamed R.; Soulimane, Tewfik; Tofail, Syed A. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	University of Genoa; University of Limerick; Istituto Italiano di Tecnologia - IIT; University of Limerick	Pastorino, L (corresponding author), Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy.	laura.pastorino@unige.it	Bianchini, Paolo/A-9500-2008; D'Autilia, Francesca/AAA-8957-2019; Diaspro, Alberto/E-7833-2010; Ruggiero, Carmelina/B-6038-2015; Pastorino, Laura/M-1770-2015	Bianchini, Paolo/0000-0001-6457-751X; D'Autilia, Francesca/0000-0002-3675-9196; Diaspro, Alberto/0000-0002-4916-5928; Ruggiero, Carmelina/0000-0002-5275-2074; Pastorino, Laura/0000-0002-5928-3856; Syed, Tofail/0000-0003-4212-3351; DELLACASA, ELENA/0000-0001-6260-2216	European Community's Seventh Framework Programme: LANIR (FP7) [280804]	European Community's Seventh Framework Programme: LANIR (FP7)	The research leading to these results has received funding from the European Community's Seventh Framework Programme: LANIR (FP7/20012-2015) under grant agreement no. 280804. This article reflects the views of the authors only, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandhakumar S, 2010, COLLOID SURFACE B, V78, P266, DOI 10.1016/j.colsurfb.2010.03.016; Antipov AA, 2002, COLLOID SURFACE A, V198, P535, DOI 10.1016/S0927-7757(01)00956-6; Antipov AA, 2004, ADV COLLOID INTERFAC, V111, P49, DOI 10.1016/j.cis.2004.07.006; Balabushevitch NG, 2001, BIOTECHNOL BIOENG, V76, P207, DOI 10.1002/bit.1184; Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h; Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h; De Geest BG, 2009, SOFT MATTER, V5, P282, DOI 10.1039/b808262f; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Erokhina S, 2009, J AM CHEM SOC, V131, P9800, DOI 10.1021/ja903066s; FACCI P, 1993, THIN SOLID FILMS, V230, P86, DOI 10.1016/0040-6090(93)90496-C; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; Ho D, 2004, NANOTECHNOLOGY, V15, P1084, DOI 10.1088/0957-4484/15/8/038; Kannisto K, 2011, COLLOID SURFACE B, V86, P298, DOI 10.1016/j.colsurfb.2011.04.012; Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087; Losche M, 1998, MACROMOLECULES, V31, P8893, DOI 10.1021/ma980910p; LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026; Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015; Lvov Y., 2002, ENCY SURFACE COLLOID, P321; Muhonen J, 2008, ANAL BIOCHEM, V374, P133, DOI 10.1016/j.ab.2007.10.014; NOSSOL B, 1993, BIOELECTROMAGNETICS, V14, P361, DOI 10.1002/bem.2250140408; Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3; Pastorino L, 2013, CURR ORG CHEM, V17, P58, DOI 10.2174/138527213805289088; Pastorino L, 2011, J COLLOID INTERF SCI, V357, P56, DOI 10.1016/j.jcis.2011.02.010; Pastorino L, 2009, J NANOSCI NANOTECHNO, V9, P6753, DOI 10.1166/jnn.2009.1580; Robin S, 2011, J BACTERIOL, V193, P3988, DOI 10.1128/JB.05186-11; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schoeler B, 2002, MACROMOLECULES, V35, P889, DOI 10.1021/ma011349p; Skirtach AG, 2004, LANGMUIR, V20, P6988, DOI 10.1021/la048873k; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Soulimane T, 1997, BIOCHEM BIOPH RES CO, V237, P572, DOI 10.1006/bbrc.1997.7041; Soulimane T, 2000, PROTEIN SCI, V9, P2068, DOI 10.1110/ps.9.11.2068; Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1; Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q; Sukhorukov GB, 2007, TRENDS BIOTECHNOL, V25, P93, DOI 10.1016/j.tibtech.2006.12.007; Tarabia M, 1998, J APPL PHYS, V83, P725, DOI 10.1063/1.366744; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; Volodkin DV, 2004, BIOMACROMOLECULES, V5, P1962, DOI 10.1021/bm049669e; Volodkin DV, 2004, LANGMUIR, V20, P3398, DOI 10.1021/la036177z	39	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112192	10.1371/journal.pone.0112192	http://dx.doi.org/10.1371/journal.pone.0112192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372607	gold, Green Published			2022-12-27	WOS:000344556900120
J	Tang, Y; Hu, CJ; Yang, HP; Cao, LP; Li, YY; Deng, PB; Huang, L				Tang, Yongjun; Hu, Chengping; Yang, Huaping; Cao, Liming; Li, Yuanyuan; Deng, Pengbo; Huang, Li			Rnd3 Regulates Lung Cancer Cell Proliferation through Notch Signaling	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; DOWN-REGULATION; ROCK-I; PATHWAY; GROWTH; SUPPRESSION; PROGRESSION; EXPRESSION	Rnd3/RhoE is a small Rho GTPase involved in the regulation of different cell behaviors. Dysregulation of Rnd3 has been linked to tumorigenesis and metastasis. Lung cancers are the leading cause of cancer-related death in the West and around the world. The expression of Rnd3 and its ectopic role in non-small cell lung cancer (NSCLC) remain to be explored. Here, we reported that Rnd3 was down-regulated in three NSCLC cell lines: H358, H520 and A549. The down-regulation of Rnd3 led to hyper-activation of Rho Kinase and Notch signaling. The reintroduction of Rnd3 or selective inhibition of Notch signaling, but not Rho Kinase signaling, blocked the proliferation of H358 and H520 cells. Mechanistically, Notch intracellular domain (NICD) protein abundance in H358 cells was regulated by Rnd3-mediated NICD proteasome degradation. Rnd3 regulated H358 and H520 cell proliferation through a Notch1/NICD/Hes1 signaling axis independent of Rho Kinase.	[Tang, Yongjun; Hu, Chengping; Yang, Huaping; Cao, Liming; Li, Yuanyuan; Deng, Pengbo; Huang, Li] Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China	Central South University	Hu, CJ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China.	tyj7736@163.com	XIANG, HAOYUE/AAY-8862-2021; li, yuanyuan/GZA-4435-2022		Key cite of National Clincial Research Center for Respiratory Disease, National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]	Key cite of National Clincial Research Center for Respiratory Disease, National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer	This work was supported by the Key cite of National Clincial Research Center for Respiratory Disease, National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer, No. 2013BAI09B09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2000, INT J CANCER, V88, P873, DOI 10.1002/1097-0215(20001215)88:6<873::AID-IJC6>3.0.CO;2-B; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Dai Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.137; Gress TM, 1996, ONCOGENE, V13, P1819; Grimwood S, 2005, NEUROPHARMACOLOGY, V48, P1002, DOI 10.1016/j.neuropharm.2005.01.016; Grise F, 2012, HEPATOLOGY, V55, P1766, DOI 10.1002/hep.25568; Jiang Xin, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P1031; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Li JJ, 2011, DEV CELL, V20, P409, DOI 10.1016/j.devcel.2011.04.001; Lin X, 2013, P NATL ACAD SCI US; Lin X, 2013, P NATL ACAD SCI USA, V110, P8236, DOI 10.1073/pnas.1219995110; Liu JT, 2014, BIOCHEM BIOPH RES CO, V444, P670, DOI 10.1016/j.bbrc.2014.01.164; Luo HS, 2012, J SURG ONCOL, V105, P699, DOI 10.1002/jso.23019; Ma W, 2013, HEPATOLOGY, V57, P152, DOI 10.1002/hep.25987; Marcelo KL, 2013, DEV CELL, V27, P504, DOI 10.1016/j.devcel.2013.11.004; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; vanGroningen JJM, 1996, BIOCHEM BIOPH RES CO, V225, P808, DOI 10.1006/bbrc.1996.1255; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Xia HW, 2013, INT J MOL MED, V31, P1081, DOI 10.3892/ijmm.2013.1321; Zhang CY, 2007, ANN SURG ONCOL, V14, P2628, DOI 10.1245/s10434-007-9457-x; Zhang CY, 2007, CANCER BIOL THER, V6, P335, DOI 10.4161/cbt.6.3.3663; Zhao H, 2012, TUMOR BIOL, V33, P1363, DOI 10.1007/s13277-012-0384-5; Zheng QJ, 2007, ONCOL REP, V17, P847; Zhou JF, 2013, ANN SURG ONCOL, V20, P175, DOI 10.1245/s10434-012-2472-6; Zhu ZH, 2014, CANCER RES, V74, P2082, DOI 10.1158/0008-5472.CAN-12-0452	36	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111897	10.1371/journal.pone.0111897	http://dx.doi.org/10.1371/journal.pone.0111897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372032	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900088
J	Ceravolo, GS; Montezano, AC; Jordao, MT; Akamine, EH; Costa, TJ; Takano, AP; Fernandes, DC; Barreto-Chaves, ML; Laurindo, FR; Tostes, RC; Fortes, ZB; Chopard, RP; Touyz, RM; Carvalho, MHC				Ceravolo, Graziela S.; Montezano, Augusto C.; Jordao, Maria T.; Akamine, Eliana H.; Costa, Tiago J.; Takano, Ana P.; Fernandes, Denise C.; Barreto-Chaves, Maria L.; Laurindo, Francisco R.; Tostes, Rita C.; Fortes, Zuleica B.; Chopard, Renato P.; Touyz, Rhian M.; Carvalho, Maria Helena C.			An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro Studies	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; B1 RECEPTOR EXPRESSION; EXPERIMENTAL RAT MODEL; B-1 RECEPTOR; CELLULAR MECHANISMS; INSULIN-RESISTANCE; ENZYME-INHIBITORS; CONVERTING ENZYME; BLOOD-PRESSURE; NADPH OXIDASE	The kallikrein-kinin and renin-angiotensin systems interact at multiple levels. In the present study, we tested the hypothesis that the B1 kinin receptor (B1R) contributes to vascular hypertrophy in angiotensin II (ANG II)-induced hypertension, through a mechanism involving reactive oxygen species (ROS) generation and extracellular signal-regulated kinase (ERK1/2) activation. Male Wistar rats were infused with vehicle (control rats), 400 ng/Kg/min ANG II (ANG II rats) or 400 ng/Kg/min ANG II plus B1 receptor antagonist, 350 ng/Kg/min des-Arg(9)-Leu(8)-bradykinin (ANGII+DAL rats), via osmotic mini-pumps (14 days) or received ANG II plus losartan (10 mg/Kg, 14 days, gavage - ANG II+LOS rats). After 14 days, ANG II rats exhibited increased systolic arterial pressure [(mmHg) 184 +/- 5.9 vs 115 +/- 2.3], aortic hypertrophy; increased ROS generation [2-hydroxyethidium/dihydroethidium (EOH/DHE): 21.8 +/- 2.7 vs 6.0 +/- 1.8] and ERK1/2 phosphorylation (% of control: 218.3 +/- 29.4 vs 100 +/- 0.25]. B1R expression was increased in aortas from ANG II and ANG II+DAL rats than in aortas from the ANG II+LOS and control groups. B1R antagonism reduced aorta hypertrophy, prevented ROS generation (EOH/DHE: 9.17 +/- 3.1) and ERK1/2 phosphorylation (137 +/- 20.7%) in ANG II rats. Cultured aortic vascular smooth muscle cells (VSMC) stimulated with low concentrations (0.1 nM) of ANG II plus B1R agonist exhibited increased ROS generation, ERK1/2 phosphorylation, proliferating-cell nuclear antigen expression and [H3]leucine incorporation. At this concentration, neither ANG II nor the B1R agonist produced any effects when tested individually. The ANG II/B1R agonist synergism was inhibited by losartan (AT1 blocker, 10 mu M), B1R antagonist (10 mM) and Tiron (superoxide anion scavenger, 10 mM). These data suggest that B1R activation contributes to ANG II-induced aortic hypertrophy. This is associated with activation of redox-regulated ERK1/2 pathway that controls aortic smooth muscle cells growth. Our findings highlight an important cross-talk between the DABK and ANG II in the vascular system and contribute to a better understanding of the mechanisms involved in vascular remodeling in hypertension.	[Ceravolo, Graziela S.; Akamine, Eliana H.; Costa, Tiago J.; Fortes, Zuleica B.; Carvalho, Maria Helena C.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Ceravolo, Graziela S.] Univ Estadual Londrina, Ctr Biol Sci, Dept Physiol Sci, Londrina, Brazil; [Montezano, Augusto C.; Touyz, Rhian M.] Univ Ottawa, Kidney Res Ctr, Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Montezano, Augusto C.; Touyz, Rhian M.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Jordao, Maria T.; Takano, Ana P.; Barreto-Chaves, Maria L.; Chopard, Renato P.] Univ Sao Paulo, Inst Biomed Sci 3, Dept Anat, Sao Paulo, Brazil; [Tostes, Rita C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil; [Fernandes, Denise C.; Laurindo, Francisco R.] Univ Sao Paulo, Inst Heart, Vasc Biol Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina; University of Ottawa; Ottawa Hospital Research Institute; University of Glasgow; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Carvalho, MHC (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.	mhcarval@icb.usp.br	Carvalho, Maria Helena C/C-8539-2013; Barreto-Chaves, Maria Luiza/C-4459-2012; Akamine, Eliana Hiromi/C-5231-2012; Ceravolo, Graziela Scalianti/AAQ-8452-2020; Takano, Ana Paula C/P-6657-2016; Tostes, Rita C/C-1025-2012; Costa, Tiago/O-8302-2014; Takano, Ana Paula Cremasco/AAG-6514-2021; Costa, Tiago J/AAZ-2193-2020; Touyz, Rhian/AAM-3564-2020; Laurindo, Francisco R/J-6575-2015; Barreto-Chaves, Maria Luiza/Y-9264-2019	Barreto-Chaves, Maria Luiza/0000-0001-5514-7921; Akamine, Eliana Hiromi/0000-0003-2715-7158; Ceravolo, Graziela Scalianti/0000-0001-7558-6294; Tostes, Rita C/0000-0002-9446-0707; Costa, Tiago/0000-0003-0780-4290; Takano, Ana Paula Cremasco/0000-0002-5057-1560; Costa, Tiago J/0000-0003-0780-4290; Touyz, Rhian/0000-0003-0670-0887; Barreto-Chaves, Maria Luiza/0000-0001-5514-7921; de Castro Fernandes, Denise/0000-0003-0213-4291	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 200759278-7]; Canadian Institute of Health Research [44018]; Conselho Nacional de Amparo a Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Conselho Nacional de Amparo a Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was support by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 200759278-7), Canadian Institute of Health Research (grant 44018), Conselho Nacional de Amparo a Pesquisa (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; ALVAREZ AL, 1992, CLIN SCI, V82, P513, DOI 10.1042/cs0820513; Basei FL, 2012, PEPTIDES, V37, P216, DOI 10.1016/j.peptides.2012.07.020; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Ceravolo GS, 2007, HYPERTENSION, V50, P756, DOI 10.1161/HYPERTENSIONAHA.107.094706; Christopher J, 2001, HYPERTENSION, V38, P602, DOI 10.1161/01.HYP.38.3.602; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; Takano APC, 2013, MOL CELL ENDOCRINOL, V376, P43, DOI 10.1016/j.mce.2013.05.024; Dias JP, 2007, BRIT J PHARMACOL, V152, P280, DOI 10.1038/sj.bjp.0707388; Duchene J, 2009, ARTERIOSCL THROM VAS, V29, P1757, DOI 10.1161/ATVBAHA.109.191775; Emanueli C, 1999, BRIT J PHARMACOL, V126, P1769, DOI 10.1038/sj.bjp.0702527; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fernandes L, 2006, REGUL PEPTIDES, V136, P92, DOI 10.1016/j.regpep.2006.04.018; Jiang BB, 2002, ARTERIOSCL THROM VAS, V22, P1811, DOI 10.1161/01.ATV.0000037679.60584.3F; Kim S, 2000, PHARMACOL REV, V52, P11; Lagneux C, 2002, INT IMMUNOPHARMACOL, V2, P815, DOI 10.1016/S1567-5769(02)00022-X; Laplante MA, 2003, J HYPERTENS, V21, P927, DOI 10.1097/00004872-200305000-00017; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lungu C, 2007, NEUROPEPTIDES, V41, P375, DOI 10.1016/j.npep.2007.09.005; Marceau F, 1998, PHARMACOL REV, V50, P357; MARTINS DTO, 1991, BRIT J PHARMACOL, V103, P1851, DOI 10.1111/j.1476-5381.1991.tb12341.x; McLean PG, 1999, BRIT J PHARMACOL, V128, P275, DOI 10.1038/sj.bjp.0702743; Moniwa N, 2006, BIOL CHEM, V387, P203, DOI 10.1515/BC.2006.027; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Morand-Contant M, 2010, AM J PHYSIOL-HEART C, V299, pH1625, DOI 10.1152/ajpheart.00735.2009; Ohashi N, 2000, ARTERIOSCL THROM VAS, V20, P2521, DOI 10.1161/01.ATV.20.12.2521; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Raidoo DM, 1997, IMMUNOPHARMACOLOGY, V36, P153, DOI 10.1016/S0162-3109(97)00015-5; Rodrigues ES, 2009, BIOL CHEM, V390, P907, DOI 10.1515/BC.2009.081; Shen B, 2006, BIOL CHEM, V387, P145, DOI 10.1515/BC.2006.019; Skatchkov MP, 1999, BIOCHEM BIOPH RES CO, V254, P319, DOI 10.1006/bbrc.1998.9942; Su EJ, 1998, HYPERTENSION, V31, P1331, DOI 10.1161/01.HYP.31.6.1331; Touyz RM, 2000, PHARMACOL REV, V52, P639; Xu J, 2009, EXP PHYSIOL, V94, P322, DOI 10.1113/expphysiol.2008.045583; Yin H, 2007, PEPTIDES, V28, P1383, DOI 10.1016/j.peptides.2007.05.010; Zhuo JL, 1998, J HYPERTENS, V16, P2027, DOI 10.1097/00004872-199816121-00026	38	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111117	10.1371/journal.pone.0111117	http://dx.doi.org/10.1371/journal.pone.0111117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369284	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000344402000039
J	Li, J; Yuan, HH; Wu, MS; Dong, LA; Zhang, L; Shi, HL; Luo, SQ				Li, Jun; Yuan, Huihui; Wu, Mingshu; Dong, Linan; Zhang, Lu; Shi, Hongli; Luo, Shuqian			Quantitative Assessment of Murine Articular Cartilage and Bone Using X-Ray Phase-Contrast Imaging	PLOS ONE			English	Article							SUBCHONDRAL BONE; COLLAGEN; OSTEOARTHRITIS; TOMOGRAPHY; TISSUE; MRI; CT	Murine models for rheumatoid arthritis (RA) research can provide important insights for understanding RA pathogenesis and evaluating the efficacy of novel treatments. However, simultaneously imaging both murine articular cartilage and subchondral bone using conventional techniques is challenging because of low spatial resolution and poor soft tissue contrast. X-ray phase-contrast imaging (XPCI) is a new technique that offers high spatial resolution for the visualisation of cartilage and skeletal tissues. The purpose of this study was to utilise XPCI to observe articular cartilage and subchondral bone in a collagen-induced arthritis (CIA) murine model and quantitatively assess changes in the joint microstructure. XPCI was performed on the two treatment groups (the control group and CIA group, n = 9 per group) to monitor the progression of damage to the femur from the knee joint in a longitudinal study (at 0, 4 and 8 weeks after primary injection). For quantitative assessment, morphologic parameters were measured in three-dimensional (3D) images using appropriate image analysis software. Our results showed that the average femoral cartilage volume, surface area and thickness were significantly decreased (P<0.05) in the CIA group compared to the control group. Meanwhile, these decreases were accompanied by obvious destruction of the surface of subchondral bone and a loss of trabecular bone in the CIA group. This study confirms that XPCI technology has the ability to qualitatively and quantitatively evaluate microstructural changes in mouse joints. This technique has the potential to become a routine analysis method for accurately monitoring joint damage and comprehensively assessing treatment efficacy.	[Li, Jun; Wu, Mingshu; Dong, Linan; Zhang, Lu; Shi, Hongli; Luo, Shuqian] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Yuan, Huihui] Capital Med Univ, Dept Rheumatol & Immunol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Luo, SQ (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	shuqian_luo@aliyun.com			National Natural Science Foundation of China [61227802]; 7th Framework Program of the European Community [PIRSES-GA-2009-269124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 7th Framework Program of the European Community	This work was supported by the National Natural Science Foundation of China (grant No. 61227802) and by the 7th Framework Program of the European Community (grant No. PIRSES-GA-2009-269124). SL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanos Y, 2008, J RHEUMATOL, V35, P1354; Bech M, 2009, PHYS MED BIOL, V54, P2747, DOI 10.1088/0031-9155/54/9/010; Blair-Levy JM, 2008, ARTHRITIS RHEUM, V58, P1096, DOI 10.1002/art.23277; Bolbos R, 2008, NMR BIOMED, V21, P366, DOI 10.1002/nbm.1198; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Carmona L, 2010, BEST PRACT RES CL RH, V24, P733, DOI 10.1016/j.berh.2010.10.001; Dai CL, 2011, BIOMATERIALS, V32, P8506, DOI 10.1016/j.biomaterials.2011.07.090; Dusad A, 2014, IMMUNOL RES, V58, P51, DOI 10.1007/s12026-013-8479-7; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goebel JC, 2010, BIO-MED MATER ENG, V20, P189, DOI 10.3233/BME-2010-0631; Grandl S, 2013, Z MED PHYS, V23, P212, DOI 10.1016/j.zemedi.2013.02.005; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Imhof H, 2000, INVEST RADIOL, V35, P581, DOI 10.1097/00004424-200010000-00004; Kotwal N, 2012, OSTEOARTHR CARTILAGE, V20, P887, DOI 10.1016/j.joca.2012.04.012; Lee YS, 2010, ACAD RADIOL, V17, P244, DOI 10.1016/j.acra.2009.09.015; LeRoux MA, 2000, J ORTHOP RES, V18, P383, DOI 10.1002/jor.1100180309; Ley-Zaporozhan J, 2010, EUR J RADIOL, V73, P43, DOI 10.1016/j.ejrad.2008.09.029; Li J, 2009, OSTEOARTHR CARTILAGE, V17, P1193, DOI 10.1016/j.joca.2009.03.005; Marenzana M, 2012, PHYS MED BIOL, V24, P8171; Mrosek EH, 2006, OSTEOARTHR CARTILAGE, V14, P171, DOI 10.1016/j.joca.2005.08.004; Perry D, 2005, J RHEUMATOL, V32, P256; Peterfy CG, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4202; Pinzer BR, 2012, NEUROIMAGE, V61, P1336, DOI 10.1016/j.neuroimage.2012.03.029; Piscaer TM, 2008, BIORHEOLOGY, V45, P355, DOI 10.3233/BIR-2008-0482; Rengle A, 2009, IEEE T BIO-MED ENG, V56, P2891, DOI 10.1109/TBME.2008.2006015; Rieppo J, 2003, CELLS TISSUES ORGANS, V175, P121, DOI 10.1159/000074628; Roemer FW, 2011, RADIOLOGY, V260, P332, DOI 10.1148/radiol.11101359; Roemer FW, 2005, ARTHRIT RHEUM-ARTHR, V53, P491, DOI 10.1002/art.21318; Roemhildt ML, 2006, J BIOMECH, V39, P2331, DOI 10.1016/j.jbiomech.2005.07.017; Ruan MZC, 2013, ARTHRITIS RHEUM-US, V65, P388, DOI 10.1002/art.37766; SMITH JW, 2009, ARCH AM ART J, V48, P1; Smolen JS, 2012, NAT REV RHEUMATOL, V8, P235, DOI 10.1038/nrrheum.2012.23; Stutman D, 2011, PHYS MED BIOL, V56, P5697, DOI 10.1088/0031-9155/56/17/015; Yang F, 2013, BIOMATERIALS, V34, P1514, DOI 10.1016/j.biomaterials.2012.10.058	34	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111939	10.1371/journal.pone.0111939	http://dx.doi.org/10.1371/journal.pone.0111939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369528	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402000129
J	Raman, S; Srinivasan, K; Kurpad, A; Razee, H; Ritchie, J				Raman, Shanti; Srinivasan, Krishnamachari; Kurpad, Anura; Razee, Husna; Ritchie, Jan			"Nothing Special, Everything Is Maamuli'': Socio-Cultural and Family Practices Influencing the Perinatal Period in Urban India	PLOS ONE			English	Article							NEWBORN-CARE PRACTICES; DEVELOPING-COUNTRIES; CHILDBIRTH PRACTICES; SYSTEMATIC ANALYSIS; NEONATAL HEALTH; BIRTH-WEIGHT; SOUTH-INDIA; INFERTILITY; SURVIVAL; BANGLADESH	Background: Globally, India contributes the largest share in sheer numbers to the burden of maternal and infant under-nutrition, morbidity and mortality. A major gap in our knowledge is how socio-cultural practices and beliefs influence the perinatal period and thus perinatal outcomes, particularly in the rapidly growing urban setting. Methods and Findings: Using data from a qualitative study in urban south India, including in-depth interviews with 36 women who had recently been through childbirth as well as observations of family life and clinic encounters, we explored the territory of familial, cultural and traditional practices and beliefs influencing women and their families through pregnancy, childbirth and infancy. We found that while there were some similarities in cultural practices to those described before in studies from low resource village settings, there are changing practices and ideas. Fertility concerns dominate women's experience of married life; notions of gender preference and ideal family size are changing rapidly in response to the urban context; however inter-generational family pressures are still considerable. While a rich repertoire of cultural practices persists throughout the perinatal continuum, their existence is normalised and even underplayed. In terms of diet and nutrition, traditional messages including notions of 'hot' and 'cold' foods, are stronger than health messages; however breastfeeding is the cultural norm and the practice of delayed breastfeeding appears to be disappearing in this urban setting. Marriage, pregnancy and childbirth are so much part of the norm for women, that there is little expectation of individual choice in any of these major life events. Conclusions: A greater understanding is needed of the dynamic factors shaping the perinatal period in urban India, including an acknowledgment of the health promoting as well as potentially harmful cultural practices and the critical role of the family. This will help plan culturally appropriate integrated perinatal health care.	[Raman, Shanti] Liverpool Hosp, South Western Sydney Local Hlth Dist, Dept Community Paediat, Liverpool, NSW, England; [Srinivasan, Krishnamachari] St Johns Med Coll, Dept Psychiat, Bangalore, Karnataka, India; [Kurpad, Anura] St Johns Med Coll, Dept Physiol, Bangalore, Karnataka, India; [Razee, Husna; Ritchie, Jan] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Medical College; University of New South Wales Sydney	Raman, S (corresponding author), Liverpool Hosp, South Western Sydney Local Hlth Dist, Dept Community Paediat, Liverpool, NSW, England.	shanti.raman@sswahs.nsw.gov.au		Razee, Husna/0000-0002-6845-8136				Aborigo RA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-76; Bandyopadhyay Mridula, 2003, Health Care Women Int, V24, P910, DOI 10.1080/07399330390244220; Barnett S, 2006, J HEALTH POPUL NUTR, V24, P394; Bharadwaj A, 2003, SOC SCI MED, V56, P1867, DOI 10.1016/S0277-9536(02)00210-1; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Blanchet T., 1984, WOMEN POLLUTION MARG; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Callaghan-Koru JA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-198; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chatterjee N, 2013, THIS IS NORMAL PREGN; Chi Z, 2013, INDIAN J GEND STUD, V20, P51, DOI 10.1177/0971521512465936; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Dwarkanath P, 2007, ASIA PAC J CLIN NUTR, V16, P704; FELDMANSAVELSBERG P, 1994, SOC SCI MED, V39, P463, DOI 10.1016/0277-9536(94)90090-6; Fikree FF, 2005, SOC SCI MED, V60, P911, DOI 10.1016/j.socscimed.2004.06.034; FITZGERALD MH, 1997, QUALITATIVE RES DISC, P48; Forsey MG, 2010, ETHNOGRAPHY, V11, P558, DOI 10.1177/1466138110372587; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; GIDEON H, 1962, AM ANTHROPOL, V64, P1220, DOI 10.1525/aa.1962.64.6.02a00060; Gragnolati M, 2005, INDIAS UNDERNOURISHE; Grbich C., 2003, QUALITATIVE RES HLTH; Green J, 2009, QUALITATIVE METHODS; Holder Kelly, 2011, East Afr J Public Health, V8, P38; Hollos M, 2008, CULT HEALTH SEX, V10, P159, DOI 10.1080/13691050701656789; Inhorn MC, 2009, INT J GYNECOL OBSTET, V106, P172, DOI 10.1016/j.ijgo.2009.03.034; INHORN MC, 1994, SOC SCI MED, V39, P459, DOI 10.1016/0277-9536(94)90089-2; Iyengar SD, 2008, J PERINATOL, V28, pS23, DOI 10.1038/jp.2008.174; Kassebaum N.J, 2014, LANCET; Kesterton AJ, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-20; Kimani-Murage EW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-396; Kodzi IA, 2012, SOC SCI MED, V74, P966, DOI 10.1016/j.socscimed.2011.12.035; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee HMH, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-223; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maimbolwa MC, 2003, J ADV NURS, V43, P263, DOI 10.1046/j.1365-2648.2003.02709.x; Ministry of Health and Family Welfare, 2008, 2005 2006 NAT FAM HL; Moran AC, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-54; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Muthayya S, 2006, ASIA PAC J CLIN NUTR, V15, P538; Nachtigall RD, 2006, FERTIL STERIL, V85, P871, DOI 10.1016/j.fertnstert.2005.08.066; NEFF DL, 1994, SOC SCI MED, V39, P475, DOI 10.1016/0277-9536(94)90091-4; NICHTER M, 1983, HUM ORGAN, V42, P235, DOI 10.17730/humo.42.3.43081445235366lk; NICHTER M, 1985, SOC SCI MED, V21, P667, DOI 10.1016/0277-9536(85)90206-0; NICHTER M, 1987, SOC SCI MED, V25, P377, DOI 10.1016/0277-9536(87)90276-0; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Papreen N, 2000, REPROD HEALTH MATTER, V8, P33, DOI 10.1016/S0968-8080(00)90004-1; Puri S, 2011, SOC SCI MED, V72, P1169, DOI 10.1016/j.socscimed.2011.01.027; Ram K., 1994, Reproductive Health Matters, P20, DOI 10.1016/0968-8080(94)90004-3; Raman S., 2014, Health, Culture and Society, V6, P73; Raman S, 2014, MIDWIFERY, V30, P130, DOI 10.1016/j.midw.2013.03.003; Rodrigues M, 2003, SOC SCI MED, V57, P1797, DOI 10.1016/S0277-9536(03)00062-5; ROWE PJ, 1987, FERTIL STERIL, V47, P964; Rozario S., 1998, MATERNITIES MODERNIT, P144; Sahni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002224; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; Thomas T., 2009, RAISING MINIMUM ED G; UNFPA, 1994, PROGR ACT AD INT C P, DOI UNFPA; Veena SR, 2010, ARCH DIS CHILD, V95, P347, DOI 10.1136/adc.2009.165159	62	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111900	10.1371/journal.pone.0111900	http://dx.doi.org/10.1371/journal.pone.0111900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369447	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000120
J	Chinestra, P; Olichon, A; Medale-Giamarchi, C; Lajoie-Mazenc, I; Gence, R; Inard, C; Ligat, L; Faye, JC; Favre, G				Chinestra, Patrick; Olichon, Aurelien; Medale-Giamarchi, Claire; Lajoie-Mazenc, Isabelle; Gence, Remi; Inard, Cyril; Ligat, Laetitia; Faye, Jean-Charles; Favre, Gilles			Generation of a Single Chain Antibody Variable Fragment (scFv) to Sense Selectively RhoB Activation	PLOS ONE			English	Article							UVB-INDUCED APOPTOSIS; PHAGE-DISPLAY; HIGH-AFFINITY; CRYSTAL-STRUCTURE; EFFECTOR RECOGNITION; EXCHANGE-FACTOR; IN-VIVO; BINDING; GTPASES; CONFORMATION	Determining the cellular level of activated form of RhoGTPases is of key importance to understand their regulatory functions in cell physiopathology. We previously reported scFvC1, that selectively bind to the GTP-bound form of RhoA, RhoB and RhoC. In this present study we generate, by molecular evolution, a new phage library to isolate scFvs displaying high affinity and selectivity to RhoA and RhoB. Using phage display affinity maturation against the GTP-locked mutant RhoAL63, we isolated scFvs against RhoA active conformation that display K-d values at the nanomolar range, which corresponded to an increase of affinity of three orders of magnitude compared to scFvC1. Although a majority of these evolved scFvs remained selective towards the active conformation of RhoA, RhoB and RhoC, we identified some scFvs that bind to RhoA and RhoC but not to RhoB activated form. Alternatively, we performed a substractive panning towards RhoB, and isolated the scFvE3 exhibiting a 10 times higher affinity for RhoB than RhoA activated forms. We showed the peculiar ability of scFvE3 to detect RhoB but not RhoA GTP-bound form in cell extracts overexpressing Guanine nucleotide Exchange Factor XPLN as well as in EGF stimulated HeLa cells. Our results demonstrated the ability of scFvs to distinguish RhoB from RhoA GTP-bound form and provide new selective tools to analyze the cell biology of RhoB GTPase regulation.	[Chinestra, Patrick; Olichon, Aurelien; Medale-Giamarchi, Claire; Lajoie-Mazenc, Isabelle; Gence, Remi; Inard, Cyril; Faye, Jean-Charles; Favre, Gilles] Fac Med Toulouse, INSERM, UMR CRCT 1037, F-31073 Toulouse, France; [Olichon, Aurelien; Medale-Giamarchi, Claire; Lajoie-Mazenc, Isabelle; Gence, Remi; Favre, Gilles] Univ Toulouse 3, Fac Pharmaceut Sci, F-31062 Toulouse, France; [Favre, Gilles] Inst Claudius Regaud, Toulouse, France; [Ligat, Laetitia] CRCT, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Favre, G (corresponding author), Fac Med Toulouse, INSERM, UMR CRCT 1037, U317, F-31073 Toulouse, France.	favre.gilles@iuct-oncopole.fr	Lajoie-Mazenc, Isabelle/M-4636-2014; Olichon, Aurelien/Q-5425-2019; Medale Giamarchi, Claire/M-3263-2014; Gence, Rémi/O-8961-2014; FAVRE, Gilles/K-9189-2014; Olichon, Aurelien/M-3115-2014; CHINESTRA, C/M-3266-2014	Gence, Rémi/0000-0003-0747-3540; FAVRE, Gilles/0000-0002-2344-1883; Olichon, Aurelien/0000-0002-0821-3612; 	Institut National de la Sante et de la Recherche Medicale (INSERM), Centre de Recherche de l'Institut Claudius Regaud	Institut National de la Sante et de la Recherche Medicale (INSERM), Centre de Recherche de l'Institut Claudius Regaud	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre de Recherche de l'Institut Claudius Regaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Baron R, 2000, P NATL ACAD SCI USA, V97, P11626, DOI 10.1073/pnas.97.21.11626; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chinestra P, 2012, METHODS MOL BIOL, V827, P283, DOI 10.1007/978-1-61779-442-1_19; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gerald D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3824; Goffinet M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-34; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hoogenboom HR, 1997, TRENDS BIOTECHNOL, V15, P62, DOI 10.1016/S0167-7799(97)84205-9; Horn IR, 1999, FEBS LETT, V463, P115, DOI 10.1016/S0014-5793(99)01617-8; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; Lajoie-Mazenc I, 2008, J BIOL CHEM, V283, P4155, DOI 10.1074/jbc.M709639200; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Mamouni K, 2014, MOL CELL BIOL, V34, P3144, DOI 10.1128/MCB.01525-13; Martineau P, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P657, DOI 10.1007/978-3-642-01144-3_41; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Meyer N, 2014, J INVEST DERMATOL, V134, P203, DOI 10.1038/jid.2013.278; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Persson H, 2008, PROTEIN ENG DES SEL, V21, P485, DOI 10.1093/protein/gzn024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Soundararajan M, 2008, PROTEINS, V72, P498, DOI 10.1002/prot.22017; Suzuki Y, 2005, BIOSCI BIOTECH BIOCH, V69, P610, DOI 10.1271/bbb.69.610; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Thie Holger, 2009, V525, P309, DOI 10.1007/978-1-59745-554-1_16; Tillement V, 2008, EXP CELL RES, V314, P2811, DOI 10.1016/j.yexcr.2008.06.011; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wright MJ, 2007, MOL IMMUNOL, V44, P2860, DOI 10.1016/j.molimm.2007.01.026	52	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111034	10.1371/journal.pone.0111034	http://dx.doi.org/10.1371/journal.pone.0111034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365345	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100045
J	Luo, QY; Liu, XK; Li, ZH; Huang, CB; Zhang, W; Meng, J; Chang, ZH; Hua, ZZ				Luo, Qiyi; Liu, Xiangkun; Li, Zhonghua; Huang, Chubo; Zhang, Wen; Meng, Juan; Chang, Zhaohua; Hua, Zezhao			Degradation Model of Bioabsorbable Cardiovascular Stents	PLOS ONE			English	Article							IN-VITRO DEGRADATION; HYDROLYTIC DEGRADATION; PART 1; SCAFFOLD; POLYMER	This study established a numerical model to investigate the degradation mechanism and behavior of bioabsorbable cardiovascular stents. In order to generate the constitutive degradation material model, the degradation characteristics were characterized with user-defined field variables. The radial strength bench test and analysis were used to verify the material model. In order to validate the numerical degradation model, in vitro bench test and in vivo implantation studies were conducted under physiological and normal conditions. The results showed that six months of degradation had not influenced the thermodynamic properties and mechanical integrity of the stent while the molecular weight of the stents implanted in the in vivo and in vitro models had decreased to 61.8% and 68.5% respectively after six month's implantation. It was also found that the degradation rate, critical locations and changes in diameter of the stents in the numerical model were in good consistency in both in vivo and in vitro studies. It implies that the numerical degradation model could provide useful physical insights and prediction of the stent degradation behavior and evaluate, to some extent, the in-vivo performance of the stent. This model could eventually be used for design and optimization of bioabsorbable stent.	[Luo, Qiyi; Li, Zhonghua; Chang, Zhaohua; Hua, Zezhao] Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai, Peoples R China; [Luo, Qiyi; Liu, Xiangkun; Li, Zhonghua; Huang, Chubo; Zhang, Wen; Meng, Juan; Chang, Zhaohua; Hua, Zezhao] Shanghai MicroPort Med Grp Co Ltd, Shanghai, Peoples R China	University of Shanghai for Science & Technology	Luo, QY (corresponding author), Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai, Peoples R China.	xkliu@microport.com	li, zh/HII-5698-2022		Shanghai MicroPort Medical (Group) Co., Ltd.	Shanghai MicroPort Medical (Group) Co., Ltd.	All authors are employed by Shanghai MicroPort Medical (Group) Co., Ltd. Shanghai MicroPort Medical (Group) Co., Ltd. provided support in the form of author salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	da Silva Soares J.F, 2008, CONSTITUTIVE MODELIN; Domingos M, 2010, VIRTUAL PHYS PROTOTY, V5, P65, DOI 10.1080/17452751003769440; Gaona LA, 2012, POLYM DEGRAD STABIL, V97, P1621, DOI 10.1016/j.polymdegradstab.2012.06.031; Gong XY, 2009, J ASTM INT, V6, P1; Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008; ISO BE, 2009, J BIOMECHANICS; Jabara R, 2008, CATHETER CARDIO INTE, V72, P186, DOI 10.1002/ccd.21607; Lally C, 2005, J BIOMECH, V38, P1574, DOI 10.1016/j.jbiomech.2004.07.022; Liu H, 2010, FIBER POLYM, V11, P1024, DOI 10.1007/s12221-010-1024-6; Liu YS, 2014, MAT SCI ENG C-MATER, V38, P227, DOI 10.1016/j.msec.2014.02.007; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Marrey RV, 2006, BIOMATERIALS, V27, P1988, DOI 10.1016/j.biomaterials.2005.10.012; Onuma Y, 2011, CIRCULATION, V123, P779, DOI 10.1161/CIRCULATIONAHA.110.971606; Patrick S, 2013, J AM COLL CARDIOL, V61; Rajagopal KR, 2007, INT J PLASTICITY, V23, P1618, DOI 10.1016/j.ijplas.2007.02.007; Shi XD, 2011, COLLOID SURFACE B, V85, P73, DOI 10.1016/j.colsurfb.2010.11.016; Soares JS, 2008, ASAIO J, V54, P295, DOI 10.1097/MAT.0b013e31816ba55a; Soares JS, 2010, J MED DEVICES, V4, DOI 10.1115/1.4002759; Soares JS, 2007, THEORETICAL MODELING, P125; Tsuji H, 2010, POLYMER, V51, P2215, DOI 10.1016/j.polymer.2010.03.017; Verheye S, 2013, J AM COLL CARDIOL, V6, pS2; Weir NA, 2004, P I MECH ENG H, V218, P307, DOI 10.1243/0954411041932782; Zhao YY, 2008, J PHYS CHEM B, V112, P16461, DOI 10.1021/jp805230e	23	21	23	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110278	10.1371/journal.pone.0110278	http://dx.doi.org/10.1371/journal.pone.0110278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365310	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100019
J	Hellhammer, K; Zeus, T; Balzer, J; van Hall, S; Rammos, C; Wagstaff, R; Kelm, M; Rassaf, T				Hellhammer, Katharina; Zeus, Tobias; Balzer, Jan; van Hall, Silke; Rammos, Christos; Wagstaff, Rabea; Kelm, Malte; Rassaf, Tienush			Safety and Efficacy of Percutaneous Mitral Valve Repair Using the MitraClip (R) System in Patients with Diabetes Mellitus	PLOS ONE			English	Article							CORONARY-ARTERY-BYPASS; VALVULAR HEART-DISEASE; LONG-TERM OUTCOMES; RISK-FACTORS; CLINICAL-OUTCOMES; SURGERY; REGURGITATION; IMPLANTATION; MORTALITY; SURVIVAL	Background: Patients with diabetes mellitus show a negative outcome in percutaneous coronary intervention, aortic valve replacement and cardiac surgery. The impact of diabetes on patients undergoing treatment of severe mitral regurgitation (MR) using the MitraClip system is not known. We therefore sought to assess whether percutaneous mitral valve repair with the MitraClip system is safe and effective in patients with diabetes mellitus. Methods and Results: We included 58 patients with severe and moderate-to-severe MR in an open-label observational single-center study. Ninteen patients were under oral medication or insulin therapy for type II diabetes mellitus. MitraClip devices were successfully implanted in all patients with diabetes and in 97.4% (n = 38) of patients without diabetes (p = 0.672). Periprocedural major cardiac adverse and cerebrovascular events (MACCE) occurred in 5.1% (n = 2) of patients without diabetes whereas patients with diabetes did not show any MACCE (p = 0.448). 30-day mortality was 1.7% (n = 1) with no case of death in the diabetes group. Short-term follow up of three months showed a significant improvement of NYHA class and quality of life evaluated by the Minnesota Living with Heart Failure Questionnaire in both groups, with no changes in the 6-minute walk test. Conclusions: Mitral valve repair with the MitraClip system is safe and effective in patients with type II diabetes mellitus.	[Hellhammer, Katharina; Zeus, Tobias; Balzer, Jan; van Hall, Silke; Rammos, Christos; Wagstaff, Rabea; Kelm, Malte; Rassaf, Tienush] Univ Hosp Dusseldorf, Fac Med, Dept Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Rassaf, T (corresponding author), Univ Hosp Dusseldorf, Fac Med, Dept Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.	Tienush.Rassaf@med.uni-duesseldorf.de		Kelm, Malte/0000-0003-0060-1052	German Research Foundation [DFG RA969/7-2]; federal state government of North Rhine-Westphalia; European Union (EFRE-Program "Med in.NRW") [005-GW01-235A]	German Research Foundation(German Research Foundation (DFG)); federal state government of North Rhine-Westphalia; European Union (EFRE-Program "Med in.NRW")	TR is a Heisenbergprofessor funded by the German Research Foundation (DFG RA969/7-2). This study was supported in part with a restricted grant from the federal state government of North Rhine-Westphalia and the European Union (EFRE-Program "Med in.NRW", support code 005-GW01-235A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyaratnam P, 2010, INTERACT CARDIOV TH, V11, P543, DOI 10.1510/icvts.2010.237883; Bakker ALM, 2013, HERZ, V38, P484, DOI 10.1007/s00059-013-3860-9; Barsness GW, 1997, CIRCULATION, V96, P2551, DOI 10.1161/01.CIR.96.8.2551; Bitkover CY, 1998, ANN THORAC SURG, V65, P36, DOI 10.1016/S0003-4975(97)01003-5; Brown JR, 2006, SEMIN THORAC CARDIOV, V18, P281, DOI 10.1053/j.semtcvs.2006.04.004; Conrotto F, 2014, AM J CARDIOL, V113, P529, DOI 10.1016/j.amjcard.2013.10.025; Crabtree TD, 2008, ANN THORAC SURG, V85, P1537, DOI 10.1016/j.athoracsur.2008.01.079; CRAVER JM, 1990, ANN THORAC SURG, V49, P964, DOI 10.1016/0003-4975(90)90877-9; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Feldman T, 2009, J AM COLL CARDIOL, V54, P686, DOI 10.1016/j.jacc.2009.03.077; FREMES SE, 1989, CIRCULATION, V80, P77; Halkos ME, 2010, ANN THORAC SURG, V90, P124, DOI 10.1016/j.athoracsur.2010.03.111; Hillegass WB, 2012, J AM COLL CARDIOL, V60, P2280, DOI 10.1016/j.jacc.2012.08.993; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; JAIN SK, 1993, DIABETIC MED, V10, P27, DOI 10.1111/j.1464-5491.1993.tb01992.x; Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002; Koch CG, 2003, J CARDIOTHOR VASC AN, V17, P585, DOI 10.1016/S1053-0770(03)00201-5; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Nowicki ER, 2004, ANN THORAC SURG, V77, P1966, DOI 10.1016/j.athoracsur.2003.12.035; Olsen MA, 2002, J THORAC CARDIOV SUR, V124, P136, DOI 10.1067/mtc.2002.122306; Parolari A, 2012, ANN THORAC SURG, V93, P584, DOI 10.1016/j.athoracsur.2011.09.073; Patel JB, 2004, J CARD FAIL, V10, P285, DOI 10.1016/j.cardfail.2003.12.006; Pilgrim T, 2013, J THROMB THROMBOLYS, V35, P456, DOI 10.1007/s11239-012-0842-3; Reichenspurner H, 2013, EUR J CARDIO-THORAC, V44, pE280, DOI 10.1093/ejcts/ezt321; Rossi A, 2011, HEART, V97, P1675, DOI 10.1136/hrt.2011.225789; SALOMON NW, 1983, J THORAC CARDIOV SUR, V85, P264; Taramasso M, 2014, J THORAC CARDIOV SUR, V148, P2743, DOI 10.1016/j.jtcvs.2014.03.036; Trichon BH, 2003, AM J CARDIOL, V91, P538, DOI 10.1016/S0002-9149(02)03301-5; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Whitlow PL, 2012, J AM COLL CARDIOL, V59, P130, DOI 10.1016/j.jacc.2011.08.067; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111178	10.1371/journal.pone.0111178	http://dx.doi.org/10.1371/journal.pone.0111178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375257	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600028
J	Hou, XJ; Li, SB; Liu, SR; Hu, CG; Zhang, JZ				Hou, Xiao-Jin; Li, Si-Bei; Liu, Sheng-Rui; Hu, Chun-Gen; Zhang, Jin-Zhi			Genome-Wide Classification and Evolutionary and Expression Analyses of Citrus MYB Transcription Factor Families in Sweet Orange	PLOS ONE			English	Article							GENE DUPLICATION; MOLECULAR CHARACTERIZATION; ARABIDOPSIS; RICE; CELL; IDENTIFICATION; DIVERGENCE; REGULATOR; REVEALS; ENCODES	MYB family genes are widely distributed in plants and comprise one of the largest transcription factors involved in various developmental processes and defense responses of plants. To date, few MYB genes and little expression profiling have been reported for citrus. Here, we describe and classify 177 members of the sweet orange MYB gene (CsMYB) family in terms of their genomic gene structures and similarity to their putative Arabidopsis orthologs. According to these analyses, these CsMYBs were categorized into four groups (4R-MYB, 3R-MYB, 2R-MYB and 1R-MYB). Gene structure analysis revealed that 1R-MYB genes possess relatively more introns as compared with 2R-MYB genes. Investigation of their chromosomal localizations revealed that these CsMYBs are distributed across nine chromosomes. Sweet orange includes a relatively small number of MYB genes compared with the 198 members in Arabidopsis, presumably due to a paralog reduction related to repetitive sequence insertion into promoter and non-coding transcribed region of the genes. Comparative studies of CsMYBs and Arabidopsis showed that CsMYBs had fewer gene duplication events. Expression analysis revealed that the MYB gene family has a wide expression profile in sweet orange development and plays important roles in development and stress responses. In addition, 337 new putative microsatellites with flanking sequences sufficient for primer design were also identified from the 177 CsMYBs. These results provide a useful reference for the selection of candidate MYB genes for cloning and further functional analysis forcitrus.	[Hou, Xiao-Jin; Li, Si-Bei; Liu, Sheng-Rui; Hu, Chun-Gen; Zhang, Jin-Zhi] Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Hu, CG (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China.	chungen@mail.hzau.edu.cn; jinzhizhang@mail.hzau.edu.cn		Zhang, Jin-Zhi/0000-0002-3820-889X	National Natural Science Foundation of China [31130046, 31372046, 31221062, 31471863, 31360469]; Fundamental Research Funds for the Central Universities [2013PY083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported financially by the National Natural Science Foundation of China (grant nos. 31130046, 31372046, 31221062, 31471863 and 31360469) and the Fundamental Research Funds for the Central Universities (2013PY083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bedell JA, 2000, BIOINFORMATICS, V16, P1040, DOI 10.1093/bioinformatics/16.11.1040; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cultrone A, 2010, TREE GENET GENOMES, V6, P101, DOI 10.1007/s11295-009-0232-y; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Du H, 2013, DNA RES, V20, P437, DOI 10.1093/dnares/dst021; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Haga N, 2007, DEVELOPMENT, V134, P1101, DOI 10.1242/dev.02801; Hong SH, 2008, PLANT J, V55, P361, DOI 10.1111/j.1365-313X.2008.03508.x; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jia L, 2004, PLANT PHYSIOL, V134, P575, DOI 10.1104/pp.103.027201; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Karpinska B, 2004, PLANT MOL BIOL, V56, P255, DOI 10.1007/s11103-004-3354-5; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Li ZJT, 2012, TREE GENET GENOMES, V8, P675, DOI 10.1007/s11295-011-0455-6; Lipsick JS, 1996, ONCOGENE, V13, P223; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Liu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075149; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mondragon-Palomino M, 2002, GENOME RES, V12, P1305, DOI 10.1101/gr.159402; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Naz AA, 2013, P NATL ACAD SCI USA, V110, P2401, DOI 10.1073/pnas.1214300110; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Seo PJ, 2010, NEW PHYTOL, V186, P471, DOI 10.1111/j.1469-8137.2010.03183.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang RK, 2014, PHYSIOL PLANTARUM, V150, P76, DOI 10.1111/ppl.12069; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yang Yi, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-330; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2008, TREE PHYSIOL, V28, P1449, DOI 10.1093/treephys/28.10.1449; Zhang JZ, 2011, PLANT MOL BIOL, V76, P187, DOI 10.1007/s11103-011-9780-2; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhang PF, 2000, PLANT CELL, V12, P2311, DOI 10.1105/tpc.12.12.2311; Zhang ZG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r120	77	38	46	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112375	10.1371/journal.pone.0112375	http://dx.doi.org/10.1371/journal.pone.0112375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375352	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600138
J	Zhang, DD; Hua, YP; Wang, XH; Zhao, H; Shi, L; Xu, FS				Zhang, Didi; Hua, Yingpeng; Wang, Xiaohua; Zhao, Hua; Shi, Lei; Xu, Fangsen			A High-Density Genetic Map Identifies a Novel Major QTL for Boron Efficiency in Oilseed Rape (Brassica napus L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RHAMNOGALACTURONAN-II; MICROSATELLITE MARKERS; TRANSPORT MECHANISMS; PLANT-CELL; BORIC-ACID; GENOME; DEFICIENCY; EXPRESSION; BARLEY	Low boron (B) seriously limits the growth of oilseed rape (Brassica napus L.), a high B demand species that is sensitive to low B conditions. Significant genotypic variations in response to B deficiency have been observed among B. napus cultivars. To reveal the genetic basis for B efficiency in B. napus, quantitative trait loci (QTLs) for the plant growth traits, B uptake traits and the B efficiency coefficient (BEC) were analyzed using a doubled haploid (DH) population derived from a cross between a B-efficient parent, Qingyou 10, and a B-inefficient parent, Westar 10. A high-density genetic map was constructed based on single nucleotide polymorphisms (SNPs) assayed using Brassica 60 K Infinium BeadChip Array, simple sequence repeats (SSRs) and amplified fragment length polymorphisms (AFLPs). The linkage map covered a total length of 2139.5 cM, with 19 linkage groups (LGs) and an average distance of 1.6 cM between adjacent markers. Based on hydroponic evaluation of six B efficiency traits measured in three separate repeated trials, a total of 52 QTLs were identified, accounting for 6.14-46.27% of the phenotypic variation. A major QTL for BEC, qBEC-A3a, was co-located on A3 with other QTLs for plant growth and B uptake traits under low B stress. Using a subset of substitution lines, qBEC-A3a was validated and narrowed down to the interval between CNU384 and BnGMS436. The results of this study provide a novel major locus located on A3 for B efficiency in B. napus that will be suitable for fine mapping and marker-assisted selection breeding for B efficiency in B. napus.	[Zhang, Didi; Hua, Yingpeng; Wang, Xiaohua; Zhao, Hua; Shi, Lei; Xu, Fangsen] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhang, Didi; Hua, Yingpeng; Wang, Xiaohua; Zhao, Hua; Shi, Lei; Xu, Fangsen] Huazhong Agr Univ, Microelement Res Ctr, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Xu, FS (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	fangsenxu@mail.hzau.edu.cn	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	Natural Science Foundation of China [31372129, 31172018]; Fundamental Research Funds for the Central Universities, China [2011PY150]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China (31372129, 31172018) and the Fundamental Research Funds for the Central Universities (2011PY150), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; CHURCHILL GA, 1994, GENETICS, V138, P963; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Graham R. D., 1984, Advances in Plant Nutrition, V1, P57; GRANER A, 1991, THEOR APPL GENET, V83, P250, DOI 10.1007/BF00226259; Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Leaungthitikanchana S, 2013, PLANT CELL PHYSIOL, V54, P1056, DOI 10.1093/pcp/pct059; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Meyer M, 2009, AGRARFORSCHUNG, V16, P262; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Snowdon RJ, 2012, PLANT BREEDING, V131, P351, DOI 10.1111/j.1439-0523.2012.01976.x; Stange M, 2013, THEOR APPL GENET, V126, P2563, DOI 10.1007/s00122-013-2155-0; Stangoulis JCR, 2000, PLANT SOIL, V225, P253, DOI 10.1023/A:1026595012326; Stangoulis JCR, 2000, PLANT SOIL, V225, P243, DOI 10.1023/A:1026593528256; Sun JH, 2012, MOL BIOL REP, V39, P1963, DOI 10.1007/s11033-011-0930-z; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Suwabe K, 2002, THEOR APPL GENET, V104, P1092, DOI 10.1007/s00122-002-0875-7; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang S, 2012, WINDOWS QTL CARTOGRA; WANG YH, 1995, J HUAZHONG AGR U, V21, P71; Wang YH, 2007, ADVANCES IN PLANT AND ANIMAL BORON NUTRITION, P93, DOI 10.1007/978-1-4020-5382-5_8; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; Xu FS, 2002, BORON IN PLANT AND ANIMAL NUTRITION, P127; Xu FS, 2002, J PLANT NUTR, V25, P901, DOI 10.1081/PLN-120002968; Xu FS, 2001, PLANT BREEDING, V120, P319, DOI 10.1046/j.1439-0523.2001.00583.x; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Xue JM, 1998, PLANT SOIL, V204, P155, DOI 10.1023/A:1004326217479; Yang L, 2013, PLANT SOIL, V371, P95, DOI 10.1007/s11104-013-1669-1; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang DD, 2014, SOIL SCI PLANT NUTR, V60, P304, DOI 10.1080/00380768.2014.893537; Zhao H, 2008, MOL BREEDING, V22, P495, DOI 10.1007/s11032-008-9193-3; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215	53	27	31	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112089	10.1371/journal.pone.0112089	http://dx.doi.org/10.1371/journal.pone.0112089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375356	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600101
J	Angell, BJ; Muhunthan, J; Irving, M; Eades, S; Jan, S				Angell, Blake J.; Muhunthan, Janani; Irving, Michelle; Eades, Sandra; Jan, Stephen			Global Systematic Review of the Cost-Effectiveness of Indigenous Health Interventions	PLOS ONE			English	Article							ECONOMIC-EVALUATION; AUSTRALIA; DISEASE; PEOPLE; BURDEN; USERS; CARE	Background: Indigenous populations around the world have consistently been shown to bear a greater burden of disease, death and disability than their non-Indigenous counterparts. Despite this, little is known about what constitutes cost-effective interventions in these groups. The objective of this paper was to assess the global cost-effectiveness literature in Indigenous health to identify characteristics of successful and unsuccessful interventions and highlight areas for further research. Methods and Findings: A systematic review of the published literature was carried out. MEDLINE, PSYCINFO, ECONLIT, EMBASE and CINAHL were searched with terms to identify cost-effectiveness evaluations of interventions in Indigenous populations around the world. The WHO definition was followed in identifying Indigenous populations. 19 studies reporting on 27 interventions were included in the review. The majority of studies came from high-income nations with only two studies of interventions in low and middle-income nations. 22 of the 27 interventions included in the analysis were found to be cost-effective or cost-saving by the respective studies. There were only two studies that focused on Indigenous communities in urban areas, neither of which was found to be cost-effective. There was little attention paid to Indigenous conceptions of health in included studies. Of the 27 included studies, 23 were interventions that specifically targeted Indigenous populations. Outreach programs were shown to be consistently cost-effective. Conclusion: The comprehensive review found only a small number of studies examining the cost-effectiveness of interventions into Indigenous communities around the world. Given the persistent disparities in health outcomes faced by these populations and commitments from governments around the world to improving these outcomes, it is an area where the health economics and public health fields can play an important role in improving the health of millions of people.	[Angell, Blake J.; Irving, Michelle] Univ Sydney, Poche Ctr Indigenous Hlth, Sydney, NSW 2006, Australia; [Angell, Blake J.; Muhunthan, Janani; Jan, Stephen] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Eades, Sandra] Baker IDI, Sydney, NSW, Australia	University of Sydney; George Institute for Global Health; University of Sydney	Angell, BJ (corresponding author), Univ Sydney, Poche Ctr Indigenous Hlth, Sydney, NSW 2006, Australia.	bangell@georgeinstitute.org.au	Jan, Stephen/AAG-3333-2021; Eades, Sandra/C-1286-2014	Irving, Michelle/0000-0001-7526-6258; Jan, Stephen/0000-0003-2839-1405; SHANTHOSH, JANANI/0000-0002-1297-2400; Angell, Blake/0000-0002-7188-7740; Eades, Sandra/0000-0001-8629-3390	POCHE Centre for Indigenous Health; George Institute for Global Health	POCHE Centre for Indigenous Health; George Institute for Global Health	The authors received no specific funding for this work. The work forms part of a PhD being funded through a scholarship from the POCHE Centre for Indigenous Health and The George Institute for Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Arnold M, 2014, GUT, V63, P64, DOI 10.1136/gutjnl-2013-305033; Baker PR, 2005, ADV CHRONIC KIDNEY D, V12, P22, DOI 10.1053/j.ackd.2004.10.001; Brazier JE, 2004, BMJ-BRIT MED J, V329, P1233; Carvalho CH, 2011, SEX TRANSM INFECT, V87, pA333, DOI 10.1136/sextrans-2011-050108.574; Drummond MF, 1997, JAMA-J AM MED ASSOC, V277, P1552, DOI 10.1001/jama.277.19.1552; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dyson K, 2012, AUST J RURAL HEALTH, V20, P334, DOI 10.1111/j.1440-1584.2012.01318.x; Eades SJ, 2010, MED J AUSTRALIA, V193, P521, DOI 10.5694/j.1326-5377.2010.tb04036.x; Ferguson KL, 2011, ANN EMERG MED, V58, pS214, DOI 10.1016/j.annemergmed.2011.06.135; Gao Y, 2014, MIDWIFERY, V30, P447, DOI 10.1016/j.midw.2013.04.004; Goddard M, 2006, HEALTH ECON POLICY L, V1, P79, DOI 10.1017/S1744133105001040; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Jan S, 1998, SOC SCI MED, V47, P1565, DOI 10.1016/S0277-9536(98)00228-7; Jan S, 2008, SOC SCI MED, V66, P922, DOI 10.1016/j.socscimed.2007.11.010; Jan Stephen, 2004, J Health Serv Res Policy, V9, P14, DOI 10.1258/135581904322716067; Jin Andrew J, 2004, Int J Circumpolar Health, V63 Suppl 2, P124; Maberley D, 2003, CAN MED ASSOC J, V168, P160; Magnus A, 2013, OBES RES CLIN PRACT, V7, pe46; Martin J D, 1998, Int J Circumpolar Health, V57 Suppl 1, P379; McDermott R, 2006, AUST J PRIM HEALTH, V12, P124, DOI DOI 10.1071/PY06031; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Moonis G, 2009, CURR CLIN PATHOL, P1, DOI 10.1007/978-1-60327-396-1_1; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; Ong KS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-307; Ong KS, 2013, HEART LUNG CIRCULATI; Panattoni L, 2012, PHARMACOECONOMICS, V30, P1067, DOI 10.2165/11595080-000000000-00000; Reeve CA, 2006, J PAEDIATR CHILD H, V42, P253, DOI 10.1111/j.1440-1754.2006.00850.x; Rush E, 2013, OBESITY RES CLIN PRA; Sanson-Fisher RW, 2006, MED J AUSTRALIA, V184, P502, DOI 10.5694/j.1326-5377.2006.tb00343.x; Sheerin IG, 2004, DRUG ALCOHOL REV, V23, P261, DOI 10.1080/09595230412331289419; Shore JH, 2007, PSYCHIAT SERV, V58, P830, DOI 10.1176/appi.ps.58.6.830; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Tam Derrick Y, 2009, J Med Econ, V12, P361, DOI 10.3111/13696990903442155; Taylor CB, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2009.09.030; United Nations, 2011, HUMAN RIGHTS Q, V33, P909, DOI [DOI 10.1353/HRQ.2011.0040, 10.1353/hrq.2011.0040]; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wilson C, 2010, J CLIN LIPIDOL, V4, P165, DOI 10.1016/j.jacl.2010.01.008; World Health Organization, 2014, IND POP; Zaloshnja E, 2003, ACCIDENT ANAL PREV, V35, P631, DOI 10.1016/S0001-4575(02)00041-6; Ziolkowski NI, 2013, PLAST RECONSTR SURG, V132, P191, DOI 10.1097/PRS.0b013e318290f8f8	41	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111249	10.1371/journal.pone.0111249	http://dx.doi.org/10.1371/journal.pone.0111249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372606	gold, Green Published			2022-12-27	WOS:000344556900039
J	Beaven, CM; Willis, SJ; Cook, CJ; Holmberg, HC				Beaven, C. Martyn; Willis, Sarah J.; Cook, Christian J.; Holmberg, Hans-Christer			Physiological Comparison of Concentric and Eccentric Arm Cycling in Males and Females	PLOS ONE			English	Article							MECHANICAL EFFICIENCY; CARDIAC-OUTPUT; MUSCLE STRENGTH; NEGATIVE WORK; OXYGEN-UPTAKE; EXERCISE; POWER; RESPONSES; GENDER; LEG	Lower body eccentric exercise is well known to elicit high levels of muscular force with relatively low cardiovascular and metabolic strain. As a result, eccentric exercise has been successfully utilised as an adaptive stressor to improve lower body muscle function in populations ranging from the frail and debilitated, to highly-trained individuals. Here we investigate the metabolic, cardiorespiratory, and energy costs of upper body eccentric exercise in a healthy population. Seven men and seven women performed 4-min efforts of eccentric (ECC) or concentric (CON) arm cycling on a novel arm ergometer at workloads corresponding to 40, 60, and 80% of their peak workload as assessed in an incremental concentric trial. The heart rate, ventilation, cardiac output, respiratory exchange ratio, and blood lactate concentrations were all clearly greater in CON condition at all of the relative workloads (all p<0.003). Effect size calculations demonstrated that the magnitude of the differences in VO2 and work economy between the ECC and CON exercise ranged from very large to extremely large; however, in no case did mechanical efficiency (eta(MECH)) differ between the conditions (all p>0.05). In contrast, delta efficiency (eta(Delta)), as previously defined by Coyle and colleagues in 1992, demonstrated a sex difference (men>women; p<0.05). Sex differences were also apparent in arteriovenous oxygen difference and heart rate during CON. Here, we reinforce the high-force, low cost attributes of eccentric exercise which can be generalised to the muscles of the upper body. Upper body eccentric exercise is likely to form a useful adjunct in debilitative, rehabilitative, and adaptive clinical exercise programs; however, reports of a shift towards an oxidative phenotype should be taken into consideration by power athletes. We suggest delta efficiency as a sensitive measure of efficiency that allowed the identification of sex differences.	[Beaven, C. Martyn; Willis, Sarah J.; Holmberg, Hans-Christer] Mid Sweden Univ, Swedish Winter Sports Res Ctr, Dept Hlth Sci, Ostersund, Sweden; [Cook, Christian J.] Bangor Univ, Sch Sport Hlth & Exercise Sci, Bangor, Gwynedd, Wales	Mid-Sweden University; Bangor University	Beaven, CM (corresponding author), Mid Sweden Univ, Swedish Winter Sports Res Ctr, Dept Hlth Sci, Ostersund, Sweden.	Martyn.Beaven@miun.se	; Beaven, Christopher/Q-3109-2016	Willis, Sarah/0000-0002-0150-3182; Cook, Christian/0000-0001-9677-0306; Holmberg, Hans-Christer/0000-0002-3814-6246; Beaven, Christopher/0000-0003-2900-7460				Abbiss CR, 2009, INT J SPORTS MED, V30, P107, DOI 10.1055/s-0028-1103285; ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P380, DOI 10.1113/jphysiol.1952.sp004755; ASMUSSEN E, 1953, ACTA PHYSIOL SCAND, V28, P364, DOI 10.1111/j.1748-1716.1953.tb00988.x; AURA O, 1986, INT J SPORTS MED, V7, P44, DOI 10.1055/s-2008-1025734; AURA O, 1986, EUR J APPL PHYSIOL, V55, P37, DOI 10.1007/BF00422890; BIGLANDRITCHIE B, 1976, J PHYSIOL-LONDON, V260, P267, DOI 10.1113/jphysiol.1976.sp011515; Billat VL, 2012, SCI WORLD J, DOI 10.1100/2012/810859; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Calbet JAL, 2005, AM J PHYSIOL-REG I, V289, pR1448, DOI 10.1152/ajpregu.00824.2004; Calbet JAL, 2007, J APPL PHYSIOL, V103, P969, DOI 10.1152/japplphysiol.01281.2006; Chapman D, 2006, INT J SPORTS MED, V27, P591, DOI 10.1055/s-2005-865920; Chauveau MA, 1896, CR HEBD ACAD SCI, V122, P58; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Christensen TB, 2000, CLIN PHYSIOL, V20, P101; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook CJ, 2013, J STRENGTH COND RES, V27, P1280, DOI 10.1519/JSC.0b013e3182679278; Coyle EF, 2008, J APPL PHYSIOL, V105, P1021, DOI 10.1152/japplphysiol.90635.2008; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; Dufour SP, 2004, MED SCI SPORT EXER, V36, P1900, DOI 10.1249/01.MSS.0000145441.80209.66; Dufour SP, 2007, AM J PHYSIOL-REG I, V292, pR1641, DOI 10.1152/ajpregu.00567.2006; Elmer SJ, 2013, MED SCI SPORT EXER, V45, P206, DOI 10.1249/MSS.0b013e318269c79c; Farthing JP, 2003, EUR J APPL PHYSIOL, V89, P578, DOI 10.1007/s00421-003-0842-2; Fick A., 1892, PFL GERS ARCH, V51, P541, DOI [10.1007/BF01663505, DOI 10.1007/BF01663505]; Gross M, 2010, INT J SPORTS MED, V31, P572, DOI 10.1055/s-0030-1254082; Hansen EA, 2007, SCAND J MED SCI SPOR, V17, P408, DOI 10.1111/j.1600-0838.2006.00580.x; HENRIKSSON J, 1972, ERGONOMICS, V15, P537, DOI 10.1080/00140137208924455; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hody S, 2013, MED SCI SPORT EXER, V45, P1460, DOI 10.1249/MSS.0b013e3182894a33; Hody S, 2011, MED SCI SPORT EXER, V43, P2281, DOI 10.1249/MSS.0b013e318222edf3; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hopman MTE, 1995, EUR J APPL PHYSIOL O, V72, P111, DOI 10.1007/BF00964124; Isner-Horobeti ME, 2013, SPORTS MED, V43, P483, DOI 10.1007/s40279-013-0052-y; Jacquier-Bret J, 2013, J APPL BIOMECHANICS; JENSENURSTAD M, 1992, CLIN PHYSIOL, V12, P487, DOI 10.1111/j.1475-097X.1992.tb00352.x; KOMI PV, 1987, INT J SPORTS MED, V8, P22; LaStayo PC, 2003, J GERONTOL A-BIOL, V58, P419, DOI 10.1093/gerona/58.5.M419; LaStayo PC, 2000, AM J PHYSIOL-REG I, V278, pR1282, DOI 10.1152/ajpregu.2000.278.5.R1282; Laurent CM, 2011, J STRENGTH COND RES, V25, P620, DOI 10.1519/JSC.0b013e3181c69ec6; Lindstedt SL, 2001, NEWS PHYSIOL SCI, V16, P256, DOI 10.1152/physiologyonline.2001.16.6.256; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; MENARD MR, 1991, ARCH PHYS MED REHAB, V72, P976; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Mueller M, 2009, EUR J APPL PHYSIOL, V107, P145, DOI 10.1007/s00421-009-1108-4; Ochi E, 2010, J APPL PHYSIOL, V108, P306, DOI 10.1152/japplphysiol.00278.2009; Penailillo L, 2013, MED SCI SPORTS EXERC; Perrey S, 2001, J APPL PHYSIOL, V91, P2135, DOI 10.1152/jappl.2001.91.5.2135; PIMENTAL NA, 1982, ERGONOMICS, V25, P373, DOI 10.1080/00140138208925003; Richard R, 2004, EUR J APPL PHYSIOL, V93, P9, DOI 10.1007/s00421-004-1149-7; Richard R, 2001, EUR J APPL PHYSIOL, V85, P202, DOI 10.1007/s004210100458; Richardson RS, 2006, MED SCI SPORT EXER, V38, P1792, DOI 10.1249/01.mss.0000229568.17284.ab; Vieira DSR, 2011, COPD, V8, P270, DOI 10.3109/15412555.2011.579926; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Vallejo AF, 2006, AGE AGEING, V35, P291, DOI 10.1093/ageing/afj082; Wooles AL, 2005, SPORTS ENG, V8, P137, DOI 10.1007/BF02844014; Yasuda N, 2008, SCAND J MED SCI SPOR, V18, P205, DOI 10.1111/j.1600-0838.2007.00637.x	56	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112079	10.1371/journal.pone.0112079	http://dx.doi.org/10.1371/journal.pone.0112079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372404	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900109
J	George, J; Blanford, S; Thomas, MB; Baker, TC				George, Justin; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.			Malaria Mosquitoes Host-Locate and Feed upon Caterpillars	PLOS ONE			English	Article							CARBON-DIOXIDE; 1-OCTEN-3-OL; REDUVIIDAE; BEHAVIOR	Adult female mosquitoes need blood to develop their eggs and both sexes use nectar and honeydew as carbohydrate resources for flight, survival and to enhance reproduction. However, there are also a few reports in the literature of mosquitoes feeding on haemolymph of soft-bodied insects such as caterpillars. The frequency and significance of this entomophagous behavior is not well understood, but is thought to be a vestige of ancestral feeding behavior or an opportunistic behavior that has evolved over time. In our current paper we investigated the extent to which the malaria mosquito, Anopheles stephensi, is attracted to, and can successfully feed on, larvae of two common moth species, Manduca sexta and Heliothis subflexa. Using y-tube olfactometer assays we found that female An. stephensi readily flew upwind to and landed on the caterpillars of both moth species. The nature of the volatile cues used in host location remains unclear but respirometer studies suggest a possible role of CO2. Laboratory cage assays further showed that the female mosquitoes were able to actively feed on moth larvae and gain sufficient nutritional benefit to influence survival. The extent to which such an opportunistic behavior occurs in the field has yet to be explored but our results suggest that this haemolymph feeding behavior could play a role in malaria mosquito life history and could provide a novel mechanism for horizontal transmission of pathogens and other micro-organisms between hosts.	[George, Justin; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Blanford, Simon; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Baker, TC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	tcb10@psu.edu						Baker T.C., 1984, Springer Series in Experimental Entomology, V1984, P45; Beklemishev V.N., 1957, MEDITSINSKAYA PARAZI, V5, P562; Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x; DOWNES JA, 1958, ANNU REV ENTOMOL, V3, P249, DOI 10.1146/annurev.en.03.010158.001341; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; George J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062632; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Hagen H, 1883, ENTOMOL MON MAG, V19, P254; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; HARRIS P, 1969, NATURE, V222, P1264, DOI 10.1038/2221264a0; Hill SR, 2010, ARTHROPOD STRUCT DEV, V39, P322, DOI 10.1016/j.asd.2010.05.005; Howard LO, 1912, MOSQUITOES N CENTRAL, P520; KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x; KLOWDEN MJ, 1995, BIOSCIENCE, V45, P326, DOI 10.2307/1312493; Lorosa Elias Seixas, 2000, Entomologia y Vectores, V7, P287; Martel V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025658; Mattingly PF, 1965, NEW SCIENTIST, V25, P22; Nyasembe VO, 2014, CURR BIOL, V24, P217, DOI 10.1016/j.cub.2013.12.022; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Pontes GB, 2011, NEOTROP ENTOMOL, V40, P708, DOI 10.1590/S1519-566X2011000600013; Sandoval CM, 2010, MED VET ENTOMOL, V24, P124, DOI 10.1111/j.1365-2915.2010.00868.x; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; WAAGE JK, 1979, BIOL J LINN SOC, V12, P187, DOI 10.1111/j.1095-8312.1979.tb00055.x	25	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108894	10.1371/journal.pone.0108894	http://dx.doi.org/10.1371/journal.pone.0108894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372720	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900005
J	Shiozaki, A; Yoneda, S; Yoneda, N; Yonezawa, R; Matsubayashi, T; Seo, G; Saito, S				Shiozaki, Arihiro; Yoneda, Satoshi; Yoneda, Noriko; Yonezawa, Rika; Matsubayashi, Takamichi; Seo, Genichiro; Saito, Shigeru			Intestinal Microbiota is Different in Women with Preterm Birth: Results from Terminal Restriction Fragment Length Polymorphism Analysis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTERIAL VAGINOSIS; FECAL MICROBIOTA; PROBIOTIC FOOD; GUT MICROBIOTA; T-RFLP; PREGNANCY; CELLS; RISK; COMMUNITIES	Preterm birth is a leading cause of perinatal morbidity and mortality. Studies using a cultivation method or molecular identification have shown that bacterial vaginosis is one of the risk factors for preterm birth. However, an association between preterm birth and intestinal microbiota has not been reported using molecular techniques, although the vaginal microbiota changes during pregnancy. Our aim here was to clarify the difference in intestinal and vaginal microbiota between women with preterm birth and women without preterm labor. 16S ribosomal ribonucleic acid genes were amplified from fecal and vaginal DNA by polymerase chain reaction. Using terminal restriction fragment length polymorphism (T-RFLP), we compared the levels of operational taxonomic units of both intestinal and vaginal flora among three groups: pregnant women who delivered term babies without preterm labor (non-PTL group) (n = 20), those who had preterm labor but delivered term babies (PTL group) (n = 11), and those who had preterm birth (PTB group) (n = 10). Significantly low levels of Clostridium subcluster XVIII, Clostridium cluster IV, Clostridium subcluster XIVa, and Bacteroides, and a significantly high level of Lactobacillales were observed in the intestinal microbiota in the PTB group compared with those in the non-PTL group. The levels of Clostridium subcluster XVIII and Clostridium subcluster XIVa in the PTB group were significantly lower than those in the PTL group, and these levels in the PTL group were significantly lower than those in non-PTL group. However, there were no significant differences in vaginal microbiota among the three groups. Intestinal microbiota in the PTB group was found to differ from that in the non-PTL group using the T-RFLP method.	[Shiozaki, Arihiro; Yoneda, Satoshi; Yoneda, Noriko; Yonezawa, Rika; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan; [Matsubayashi, Takamichi] Toa Pharmaceut Co Ltd, Tokyo, Japan; [Seo, Genichiro] Toa Pharmaceut Co Ltd, Gunma, Japan	University of Toyama	Saito, S (corresponding author), Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan.	s30saito@med.u-toyama.ac.jp			Toa Pharmaceutical Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan [26670717, 23390386, 24592462]; Grants-in-Aid for Scientific Research [26670717] Funding Source: KAKEN	Toa Pharmaceutical Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The author(s) received no specific funding for this work from Toa Pharmaceutical Co., Ltd. Toa Pharmaceutical Co., Ltd., provided support in the form of salaries for authors TM and GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [a Grant-in-Aid for Exploratory Research 26670717, a Grant-in-Aid for Scientific Research (B) 23390386, a Grant-in-Aid for Scientific Research (C) 24592462]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bizargity P, 2009, BIOL REPROD, V80, P874, DOI 10.1095/biolreprod.108.074294; Brantsaeter AL, 2011, AM J EPIDEMIOL, V174, P807, DOI 10.1093/aje/kwr168; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Foxman B, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.003; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2012, IMMUNOL CELL BIOL, V90, P919, DOI 10.1038/icb.2012.48; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kisielewicz A, 2010, CLIN IMMUNOL, V137, P209, DOI 10.1016/j.clim.2010.07.008; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Madianos PN, 2013, J CLIN PERIODONTOL, V40, pS170, DOI [10.1902/jop.2013.1340015, 10.1111/jcpe.12082]; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Myhre R, 2011, AM J CLIN NUTR, V93, P151, DOI 10.3945/ajcn.110.004085; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Reiff C, 2010, INT J MED MICROBIOL, V300, P25, DOI 10.1016/j.ijmm.2009.08.004; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Schober L, 2012, IMMUNOL CELL BIOL, V90, P935, DOI 10.1038/icb.2012.33; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shiozaki A, 2014, J OBSTET GYNAECOL RE, V40, P53, DOI 10.1111/jog.12120; Steinborn A, 2012, CLIN EXP IMMUNOL, V167, P84, DOI 10.1111/j.1365-2249.2011.04493.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500	36	44	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111374	10.1371/journal.pone.0111374	http://dx.doi.org/10.1371/journal.pone.0111374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372390	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900046
J	Sohl, TL				Sohl, Terry L.			The Relative Impacts of Climate and Land-Use Change on Conterminous United States Bird Species from 2001 to 2075	PLOS ONE			English	Article							DISTRIBUTION MODELS; SELECTING THRESHOLDS; BREEDING BIRDS; SAMPLING BIAS; COVER DATA; DISTRIBUTIONS; PERFORMANCE; PREDICTION; MAXENT; EBIRD	Species distribution models often use climate data to assess contemporary and/or future ranges for animal or plant species. Land use and land cover (LULC) data are important predictor variables for determining species range, yet are rarely used when modeling future distributions. In this study, maximum entropy modeling was used to construct species distribution maps for 50 North American bird species to determine relative contributions of climate and LULC for contemporary (2001) and future (2075) time periods. Species presence data were used as a dependent variable, while climate, LULC, and topographic data were used as predictor variables. Results varied by species, but in general, measures of model fit for 2001 indicated significantly poorer fit when either climate or LULC data were excluded from model simulations. Climate covariates provided a higher contribution to 2001 model results than did LULC variables, although both categories of variables strongly contributed. The area deemed to be "suitable'' for 2001 species presence was strongly affected by the choice of model covariates, with significantly larger ranges predicted when LULC was excluded as a covariate. Changes in species ranges for 2075 indicate much larger overall range changes due to projected climate change than due to projected LULC change. However, the choice of study area impacted results for both current and projected model applications, with truncation of actual species ranges resulting in lower model fit scores and increased difficulty in interpreting covariate impacts on species range. Results indicate species-specific response to climate and LULC variables; however, both climate and LULC variables clearly are important for modeling both contemporary and potential future species ranges.	US Geol Survey, EROS Ctr, Sioux Falls, SD 57104 USA	United States Department of the Interior; United States Geological Survey	Sohl, TL (corresponding author), US Geol Survey, EROS Ctr, Sioux Falls, SD 57104 USA.	sohl@ugs.gov	Sohl, Terry/W-5486-2019	Sohl, Terry/0000-0002-9771-4231	U.S. Geological Survey's Climate and Land Use (CLU) Mission Area	U.S. Geological Survey's Climate and Land Use (CLU) Mission Area	TLS was supported by the U.S. Geological Survey's Climate and Land Use (CLU) Mission Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Bakker KK, 2002, CONSERV BIOL, V16, P1638, DOI 10.1046/j.1523-1739.2002.01328.x; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bradley BA, 2012, ECOL MODEL, V244, P57, DOI 10.1016/j.ecolmodel.2012.06.019; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; Bucklin DN, 2015, DIVERS DISTRIB, V21, P23, DOI 10.1111/ddi.12247; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dudik M, 2005, ADV NEURAL INFORM PR, V18, P320; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fearer TM, 2007, FOREST ECOL MANAG, V243, P128, DOI 10.1016/j.foreco.2007.02.016; Fink D, 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1; Hay LE, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI370.1; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hochachka W, 2012, FRONT BIOGEOGR, V4, P150, DOI DOI 10.21425/F54415350; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Jimenez-Valverde A, 2011, GLOBAL ECOL BIOGEOGR, V20, P114, DOI 10.1111/j.1466-8238.2010.00574.x; Johnston KM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00077.1; Jongsomjit D, 2013, LANDSCAPE ECOL, V28, P187, DOI 10.1007/s10980-012-9825-1; Jun Yu, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P1157, DOI 10.1109/ICDM.2010.103; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lerman SB, 2014, LANDSCAPE URBAN PLAN, V122, P29, DOI 10.1016/j.landurbplan.2013.10.006; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; Melles SJ, 2011, GLOBAL CHANGE BIOL, V17, P17, DOI 10.1111/j.1365-2486.2010.02214.x; Moreno R, 2011, ECOL INFORM, V6, P364, DOI 10.1016/j.ecoinf.2011.07.003; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; Naujokaitis-Lewis IR, 2013, DIVERS DISTRIB, V19, P541, DOI 10.1111/ddi.12063; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Prince K, 2013, ENVIRON SCI POLICY, V33, P120, DOI 10.1016/j.envsci.2013.04.009; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Ridgeby RS, 2003, DIGITAL DISTRIBUTION; Riordan EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086487; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Sohl TL, 2014, ECOL APPL, V24, P1015, DOI 10.1890/13-1245.1; Sohl TL, 2012, APPL GEOGR, V34, P111, DOI 10.1016/j.apgeog.2011.10.019; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thogmartin WE, 2006, CONDOR, V108, P25, DOI 10.1650/0010-5422(2006)108[0025:PRAORG]2.0.CO;2; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; U.S. Geological Survey, 1999, USGS 30 MET RES 6 DE; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watling JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063600; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wu YP, 2012, SCI TOTAL ENVIRON, V430, P150, DOI 10.1016/j.scitotenv.2012.04.058; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	63	61	63	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112251	10.1371/journal.pone.0112251	http://dx.doi.org/10.1371/journal.pone.0112251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372571	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900129
J	Zhang, MQ; Guo, Y; Powell, CA; Doud, MS; Yang, CY; Duan, YP				Zhang, Muqing; Guo, Ying; Powell, Charles A.; Doud, Melissa S.; Yang, Chuanyu; Duan, Yongping			Effective Antibiotics against 'Candidatus Liberibacter asiaticus' in HLB-Affected Citrus Plants Identified via the Graft-Based Evaluation	PLOS ONE			English	Article							SAO-PAULO-STATE; DISEASE; PHARMACODYNAMICS; PHYTOPHTHORA; MANAGEMENT; RESISTANCE; MOLECULES; PATHOGEN; MEDIA; ACID	Citrus huanglongbing (HLB), caused by three species of fastidious, phloem-limited 'Candidatus Liberibacter', is one of the most destructive diseases of citrus worldwide. To date, there is no established cure for this century-old and yet, newly emerging disease. As a potential control strategy for citrus HLB, 31 antibiotics were screened for effectiveness and phytotoxicity using the optimized graft-based screening system with 'Candidatus Liberibacter asiaticus' (Las)-infected citrus scions. Actidione and Oxytetracycline were the most phytotoxic to citrus with less than 10% of scions surviving and growing; therefore, this data was not used in additional analyses. Results of principal component (PCA) and hierarchical clustering analyses (HCA) demonstrated that 29 antibiotics were clustered into 3 groups: highly effective, partly effective, and not effective. In spite of different modes of actions, a number of antibiotics such as, Ampicillin, Carbenicillin, Penicillin, Cefalexin, Rifampicin and Sulfadimethoxine were all highly effective in eliminating or suppressing Candidatus Liberibacter asiaticus indicated by both the lowest Las infection rate and titers of the treated scions and inoculated rootstock. The non-effective group, including 11 antibiotics alone with three controls, such as Amikacin, Cinoxacin, Gentamicin, Kasugamycin, Lincomycin, Neomycin, Polymixin B and Tobramycin, did not eliminate or suppress Las in the tested concentrations, resulting in plants with increased titers of Las. The other 12 antibiotics partly eliminated or suppressed Las in the treated and graft-inoculated plants. The effective and non-phytotoxic antibiotics could be potential candidates for control of citrus HLB, either for the rescue of infected citrus germplasm or for restricted field application.	[Zhang, Muqing; Yang, Chuanyu] Guangxi Univ, Nanning 530004, Peoples R China; [Zhang, Muqing; Guo, Ying; Powell, Charles A.; Yang, Chuanyu] Univ Florida, Indian River Res & Educ Ctr, Inst Food & Agr Sci, Ft Pierce, FL 34945 USA; [Doud, Melissa S.; Duan, Yongping] USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA	Guangxi University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Duan, YP (corresponding author), USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA.	Yongping.Duan@ars.usda.gov		zhang, muqing/0000-0003-3138-3422; yang, chuanyu/0000-0003-1194-208X	Citrus Research and Development Foundation, Inc.; Specialty Crop Block Grant, FDACS; ARS [ARS-0423073] Funding Source: Federal RePORTER	Citrus Research and Development Foundation, Inc.; Specialty Crop Block Grant, FDACS; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by grants from the Citrus Research and Development Foundation, Inc. and the Specialty Crop Block Grant, FDACS to Y.P. Duan and C.A. Powell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenderfer MS, 1984, CLUSTER ANAL QUANTIT; Aubert B, 1980, 8TH P C INT ORG CITR, P103; Belasque J, 2010, J PLANT PATHOL, V92, P285; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brain RA, 2008, ENVIRON SCI TECHNOL, V42, P8965, DOI 10.1021/es801611a; Buitendag CH, 2003, 12 C INT ORG CITR VI, P269; Carryn S, 2003, INFECT DIS CLIN N AM, V17, P615, DOI 10.1016/S0891-5520(03)00066-7; Cheema S. S., 1986, Indian Journal of Virology, V2, P104; Chen XueFeng, 2012, Journal of South China Agricultural University, V33, P460; CHIOU CS, 1995, PHYTOPATHOLOGY, V85, P324, DOI 10.1094/Phyto-85-324; Chiu R. J., 1979, P ROC US COOP SCI SE, V1, P43; Christiano RSC, 2010, PLANT DIS, V94, P1213, DOI 10.1094/PDIS-04-10-0282; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Davis B, 1987, MICROBIOL REV, V51; Ding F, 2008, PLANT CELL REP, V27, P241, DOI 10.1007/s00299-007-0467-8; Doud MS, 2012, PHYTOPATHOLOGY, V102, P31; Garnier M, 2000, W CAPE PROVINCE S AF; GEORGE SW, 1986, PLANT DIS, V70, P1100, DOI 10.1094/PD-70-1100; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Ishikawa R, 2005, PHYTOPATHOLOGY, V95, P1209, DOI 10.1094/PHYTO-95-1209; Iwasa T., 1970, J ANTIBIOT, V23, P595, DOI DOI 10.7164/ANTIBIOTICS.23.595; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; JEFFERS SN, 1986, PLANT DIS, V70, P1038, DOI 10.1094/PD-70-1038; Ji GH, 2008, BIOL CONTROL, V45, P288, DOI 10.1016/j.biocontrol.2008.01.004; Jiang YH, 1987, ACTA PHYTOPATHOL SIN, V3, P007; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; LIN K. -H., 1956, Acta Phytopathologica Sinica, V2, P1; Lo X. H., 1983, Journal of the South China Agricultural College, V4, P97; MCCOY RE, 1982, PLANT DIS, V66, P539, DOI 10.1094/PD-66-539; McManus PS, 2001, PLANT HLTH PROG, V2, P14, DOI DOI 10.1094/PHP-2001-0327-01-RV; Michelini L, 2013, PLANT PHYSIOL BIOCH, V67, P55, DOI 10.1016/j.plaphy.2013.02.027; Moll J. N., 1977, P INT SOC CITRICULTU, V3, P903; Sachin BS, 2007, PHYTOTHER RES, V21, P157, DOI 10.1002/ptr.2046; SCHWARZ RE, 1971, PLANT DIS REP, V55, P747; SPRATT BG, 1988, REV INFECT DIS, V10, P699; Spreen TH, 2013, ANN M SO AGR EC ASS; STOKSTAD ELR, 1987, J NUTR, V117, P1335, DOI 10.1093/jn/117.7.1335; Su H. J., 1986, Plant virus diseases of horticultural crops in the tropics and subtropics., P142; Supriyanto A, 1991, P 11 C INT ORG CITR, P409; Tang W., 1981, ACTA PHYTOPATHOL SIN, V8, P47; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; Van Bambeke F, 2006, CURR OPIN DRUG DISC, V9, P218; VANVUUREN SP, 1977, PLANT DIS REP, V61, P358; YEE Y, 1986, J INFECT DIS, V154, P531, DOI 10.1093/infdis/154.3.531; Zhang MQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-112; Zhang MQ, 2012, PHYTOPATHOLOGY, V102, P567, DOI 10.1094/PHYTO-09-11-0265; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhao XY, 1981, CITRUS YELLOW SHOOT, P466; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	53	44	53	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111032	10.1371/journal.pone.0111032	http://dx.doi.org/10.1371/journal.pone.0111032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372135	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900035
J	Braun, N; Thorne, JD; Hildebrandt, H; Debener, S				Braun, Niclas; Thorne, Jeremy D.; Hildebrandt, Helmut; Debener, Stefan			Interplay of Agency and Ownership: The Intentional Binding and Rubber Hand Illusion Paradigm Combined	PLOS ONE			English	Article							SELF-ATTRIBUTION; PREMOTOR CORTEX; SENSE; BODY; MODEL; CONTRIBUTE; MOVEMENT; BRAIN; THATS; TIME	The sense of agency (SoA) refers to the phenomenal experience of initiating and controlling an action, whereas the sense of ownership (SoO) describes the feeling of myness an agent experiences towards his or her own body parts. SoA has been investigated with intentional binding paradigms, and the sense of ownership (SoO) with the rubber-hand illusion (RHI). We investigated the relationship between SoA and SoO by incorporating intentional binding into the RHI. Explicit and implicit measures of agency (SoA-questionnaire, intentional binding) and ownership (SoO-questionnaire, proprioceptive drift) were used. Artificial hand position (congruent/incongruent) and mode of agent (self-agent/other-agent) were systematically varied. Reported SoO varied mainly with position (higher in congruent conditions), but also with agent (higher in self-agent conditions). Reported SoA was modulated by agent (higher in self-agent conditions), and moderately by position (higher in congruent conditions). Implicit and explicit agency measures were not significantly correlated. Finally, intentional binding tended to be stronger in self-generated than observed voluntary actions. Results provide further evidence for a partial double dissociation between SoA and SoO, empirically distinct agency levels, and moderate intentional binding differences between self-generated and observed voluntary actions.	[Braun, Niclas; Thorne, Jeremy D.; Hildebrandt, Helmut] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Neuropsychol Lab, D-26111 Oldenburg, Germany; [Hildebrandt, Helmut] Klinikum Bremen Ost, Dept Neurol, Bremen, Germany; [Debener, Stefan] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Debener, Stefan] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Klinikum Bremen-Ost; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Braun, N (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Psychol, Neuropsychol Lab, D-26111 Oldenburg, Germany.	niclas.braun@uni-oldenburg.de						Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Buehner MJ, 2012, PSYCHOL SCI, V23, P1490, DOI 10.1177/0956797612444612; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Carruthers G, 2013, J CONSCIOUSNESS STUD, V20, P33; Chambon V, 2013, CEREB CORTEX, V23, P1031, DOI 10.1093/cercor/bhs059; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Engbert K, 2007, J EXP PSYCHOL HUMAN, V33, P1261, DOI 10.1037/0096-1523.33.6.1261; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; Ferri F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1140; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gallagher S, 2007, PHILOS COMPASS, V2, P347, DOI 10.1111/j.1747-9991.2007.00067.x; Guterstam A, 2011, PLOS ONE, V6; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Merleau-Ponty M, 2009, PHENOMENOLOGIE PERCE; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moore JW, 2012, CONSCIOUS COGN, V21, P1748, DOI 10.1016/j.concog.2012.10.005; Moore JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00023; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Noe A., 2006, ACTION PERCEPTION; Perez-Marcos D, 2012, COGN NEURODYNAMICS, V6, P295, DOI 10.1007/s11571-011-9178-5; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Poonian SK, 2013, EXP BRAIN RES, V229, P419, DOI 10.1007/s00221-013-3505-5; Riemer M, 2013, EXP BRAIN RES, V229, P383, DOI 10.1007/s00221-012-3374-3; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schutz-Bosbach S, 2009, J COGNITIVE NEUROSCI, V21, P1215, DOI 10.1162/jocn.2009.21068; Serino A, 2013, CONSCIOUS COGN, V22, P1239, DOI 10.1016/j.concog.2013.08.013; Siewert C., 2005, PHENOMENOLOGY PHILOS; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Thompson E., 2005, PHENOMENOL COGN SCI, V4/, P407, DOI [10.1007/s11097-005--9003-x, DOI 10.1007/S11097-005-9003-X]; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; Wohlschlager A, 2003, CONSCIOUS COGN, V12, P708, DOI 10.1016/S1053-8100(03)00083-7; Wohlschlager A, 2003, PSYCHOL SCI, V14, P586, DOI 10.1046/j.0956-7976.2003.psci_1469.x; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wong Hong Yu, 2010, COMPANION PHILOS ACT, P227, DOI DOI 10.1002/9781444323528.CH29; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011; [No title captured]	55	49	49	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111967	10.1371/journal.pone.0111967	http://dx.doi.org/10.1371/journal.pone.0111967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369067	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000132
J	Li, YG; He, MX				Li, Yaoguo; He, Maoxian			Genetic Mapping and QTL Analysis of Growth-Related Traits in Pinctada fucata Using Restriction-Site Associated DNA Sequencing	PLOS ONE			English	Article							JAPANESE PEARL OYSTER; LINKAGE MAP; AGRONOMIC TRAITS; SSR MARKERS; MICROSATELLITE; AFLP; IDENTIFICATION; SELECTION; GENOME; LOCI	The pearl oyster, Pinctada fucata (P. fucata), is one of the marine bivalves that is predominantly cultured for pearl production. To obtain more genetic information for breeding purposes, we constructed a high-density linkage map of P. fucata and identified quantitative trait loci (QTL) for growth-related traits. One F1 family, which included the two parents, 48 largest progeny and 50 smallest progeny, was sampled to construct a linkage map using restriction site-associated DNA sequencing (RAD-Seq). With low coverage data, 1956.53 million clean reads and 86,342 candidate RAD loci were generated. A total of 1373 segregating SNPs were used to construct a sex-average linkage map. This spanned 1091.81 centimorgans (cM), with 14 linkage groups and an average marker interval of 1.41 cM. The genetic linkage map coverage, Coa, was 97.24%. Thirty-nine QTL-peak loci, for seven growth-related traits, were identified using the single-marker analysis, nonparametric mapping Kruskal-Wallis (KW) test. Parameters included three for shell height, six for shell length, five for shell width, four for hinge length, 11 for total weight, eight for soft tissue weight and two for shell weight. The QTL peak loci for shell height, shell length and shell weight were all located in linkage group 6. The genotype frequencies of most QTL peak loci showed significant differences between the large subpopulation and the small subpopulation (P<0.05). These results highlight the effectiveness of RAD-Seq as a tool for generation of QTL-targeted and genome-wide marker data in the non-model animal, P. fucata, and its possible utility in marker-assisted selection (MAS).	[Li, Yaoguo; He, Maoxian] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Li, Yaoguo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, MX (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	hmx@scsio.ac.cn			National Science and Technology Program of China [2012AA10A410]; Chinese Academy of Sciences [ZCX2-EW-Q21]; Marine Fishery Science and Technology Promotion Program of Guangdong Province, China [A201201A05, A201301A03]	National Science and Technology Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Marine Fishery Science and Technology Promotion Program of Guangdong Province, China	This work was supported by grants from the National Science and Technology Program of China (2012AA10A410), the Funds of Knowledge Innovation program of Chinese Academy of Sciences (ZCX2-EW-Q21), and the Marine Fishery Science and Technology Promotion Program of Guangdong Province, China (A201201A05, A201301A03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco Carlos, 2006, V323, P79; Atienza SG, 2003, THEOR APPL GENET, V107, P123, DOI 10.1007/s00122-003-1220-5; Baga M, 2007, FUNCT INTEGR GENOMIC, V7, P53, DOI 10.1007/s10142-006-0030-7; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Cervera MT, 2001, GENETICS, V158, P787; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Dirlewanger E, 1999, THEOR APPL GENET, V98, P18, DOI 10.1007/s001220051035; Fishman L, 2001, GENETICS, V159, P1701; Gao HJ, 2006, CHINESE SCI BULL, V51, P1857, DOI 10.1007/s11434-006-2050-z; Guo X, 2012, MAR BIOTECHNOL, V14, P218, DOI 10.1007/s10126-011-9405-4; Gut IG, 2004, NAT GENET, V36, P789, DOI 10.1038/ng0804-789; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; He MX, 2008, AQUAC RES, V39, P801, DOI 10.1111/j.1365-2109.2008.01889.x; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Huang XD, 2013, J GENET, V93, pe1; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Hulata G, 2001, GENETICA, V111, P155, DOI 10.1023/A:1013776931796; Jiao WQ, 2014, DNA RES, V21, P85, DOI 10.1093/dnares/dst043; Jones DB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-810; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Klimenko I, 2010, THEOR APPL GENET, V120, P1253, DOI 10.1007/s00122-009-1253-5; Knox MR, 2002, GENETICS, V162, P861; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lallias D, 2007, ANIM GENET, V38, P560, DOI 10.1111/j.1365-2052.2007.01647.x; LANDE R, 1990, GENETICS, V124, P743; LANDER ES, 1989, GENETICS, V121, P185; Launey S, 2001, GENETICS, V159, P255; Lebowitz M., 1987, Machine Learning, V2, P103, DOI 10.1023/A:1022800624210; Li HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046926; Liao M, 2007, ANIM GENET, V38, P364, DOI 10.1111/j.1365-2052.2007.01617.x; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Lu X, 2013, MAR BIOTECHNOL, V15, P16, DOI 10.1007/s10126-012-9453-4; Magwene PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002255; Martinez-Navarro B, 2008, J HUM EVOL, V54, P157, DOI 10.1016/j.jhevol.2007.09.011; Massault C, 2008, AQUACULTURE, V285, P23, DOI 10.1016/j.aquaculture.2008.06.040; Miyazaki T, 1999, DIS AQUAT ORGAN, V37, P1, DOI 10.3354/dao037001; Naciri Y., 1995, Molecular Marine Biology and Biotechnology, V4, P83; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Petersen JL, 2012, AQUACULTURE, V350, P200, DOI 10.1016/j.aquaculture.2012.03.039; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Qin YJ, 2007, AQUACULTURE, V272, P281, DOI 10.1016/j.aquaculture.2007.07.214; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Sauvage C, 2010, ANIM GENET, V41, P390, DOI 10.1111/j.1365-2052.2009.02018.x; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Shi YH, 2013, MAR BIOTECHNOL, V15, P175, DOI 10.1007/s10126-012-9476-x; Shi YH, 2009, AQUAC RES, V41, P35, DOI 10.1111/j.1365-2109.2009.02299.x; STUBER CW, 1980, GENETICS, V95, P225; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Ulloa M, 2013, THEOR APPL GENET, V126, P1405, DOI 10.1007/s00122-013-2061-5; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; WADA H, 1995, MOL MAR BIOL BIOTECH, V4, P269; Wada K.T., 1976, JAP J MALAC, V35, P9; WADA KT, 1994, AQUACULTURE, V125, P59, DOI 10.1016/0044-8486(94)90282-8; Wada KT, 1996, AQUACULTURE, V142, P25, DOI 10.1016/0044-8486(95)01242-7; Wang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034874; Wang LL, 2005, AQUAC RES, V36, P643, DOI 10.1111/j.1365-2109.2005.01268.x; WELCH S, 1990, J CLIN ENDOCR METAB, V71, P1508, DOI 10.1210/jcem-71-6-1508; Woodhead M, 2013, MOL BREEDING, V31, P111, DOI 10.1007/s11032-012-9775-y; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Yu ZN, 2003, BIOL BULL-US, V204, P327, DOI 10.2307/1543603; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	67	553	569	4	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111707	10.1371/journal.pone.0111707	http://dx.doi.org/10.1371/journal.pone.0111707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369421	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000088
J	Pahr, S; Selb, R; Weber, M; Focke-Tejkl, M; Hofer, G; Dordic, A; Keller, W; Papadopoulos, NG; Giavi, S; Makela, M; Pelkonen, A; Niederberger, V; Vrtala, S; Valenta, R				Pahr, Sandra; Selb, Regina; Weber, Milena; Focke-Tejkl, Margarete; Hofer, Gerhard; Dordic, Andela; Keller, Walter; Papadopoulos, Nikolaos G.; Giavi, Stavroula; Makela, Mika; Pelkonen, Anna; Niederberger, Verena; Vrtala, Susanne; Valenta, Rudolf			Biochemical, Biophysical and IgE-Epitope Characterization of the Wheat Food Allergen, Tri a 37	PLOS ONE			English	Article							EXERCISE-INDUCED ANAPHYLAXIS; MOLECULAR-WEIGHT GLUTENIN; PEPTIDES; PROTEINS; ALPHA-1-PUROTHIONIN; IDENTIFICATION; IMMUNOTHERAPY; DIGESTIBILITY; GLIADIN	Wheat is an important staple food and potent allergen source. Recently, we isolated a cDNA coding for wheat alpha-purothionin which is recognized by wheat food allergic patients at risk for severe wheat-induced allergy. The purpose of the present study was the biochemical, biophysical and IgE epitope characterization of recombinant alpha-purothionin. Synthetic genes coding for alpha-purothionin were expressed in a prokaryotic system using Escherichia coli and in a eukaryotic expression system based on baculovirus-infected Sf9-insect cells. Recombinant proteins were purified and characterized by SDS-PAGE, mass spectrometry, circular dichroism, chemical cross-linking and size exclusion chromatography. Five overlapping peptid were synthesized for epitope mapping. Alpha-purothionin-specific rabbit antibodies were raised to perform IgE-inhibition experiments and to study the resistance to digestion. The IgE reactivity of the proteins and peptides from ten wheat food allergic patients was studied in non-denaturing RAST-based binding assays. Alpha-purothionin was expressed in the prokaryotic (EcTri a 37) and in the eukaryotic system (BvTri a 37) as a soluble and monomeric protein. However, circular dichroism analysis revealed that EcTri a 37 was unfolded whereas BvTri a 37 was a folded protein. Both proteins showed comparable IgE-reactivity and the epitope mapping revealed the presence of sequential IgE epitopes in the N-terminal basic thionin domain (peptide1:KSCCRSTLGRNCYNLCRARGAQKLCAGVCR) and in the C-terminal acidic extension domain (peptide3:KGFPKLALESNSDEPDTIEYCNLGCRSSVC, peptide4:CNLGCRSSVCDYMV-NAAADDEEMKLYVEN). Natural Tri a 37 was digested under gastric conditions but resistant to duodenal digestion. Immunization with EcTri a 37 induced IgG antibodies which recognized similar epitopes as IgE antibodies from allergic patients and inhibited allergic patients' IgE binding. Reactivity to Tri a 37 does not require a folded protein and the presence of sequential IgE epitopes indicates that sensitization to alpha-purothionin occurs via the gut. Both allergens can be used for in-vitro diagnosis of wheat food allergy. The induction of blocking IgG antibodies suggests the usefulness for immunotherapy.	[Pahr, Sandra; Weber, Milena; Focke-Tejkl, Margarete; Vrtala, Susanne; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Pahr, Sandra; Vrtala, Susanne] Med Univ Vienna, Christian Doppler Lab Dev Allergen Chips, Vienna, Austria; [Selb, Regina; Niederberger, Verena] Med Univ Vienna, Dept ENT, Vienna, Austria; [Hofer, Gerhard; Dordic, Andela; Keller, Walter] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Papadopoulos, Nikolaos G.; Giavi, Stavroula] Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece; [Makela, Mika; Pelkonen, Anna] Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Graz; National & Kapodistrian University of Athens; University of Helsinki; Helsinki University Central Hospital	Valenta, R (corresponding author), Med Univ Vienna, Ctr Pathophysiol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria.	rudolf.valenta@meduniwien.ac.at	Pelkonen, Anna/D-3153-2018; Papadopoulos, Nikolaos/ABE-1774-2021; Keller, Walter/AAW-1501-2021; N.G., Papadopoulos/L-8670-2013	Pelkonen, Anna/0000-0002-1482-8947; Papadopoulos, Nikolaos/0000-0002-4448-3468; Keller, Walter/0000-0002-2261-958X; N.G., Papadopoulos/0000-0002-4448-3468; Valenta, Rudolf/0000-0001-5944-3365; Hofer, Gerhard/0000-0002-9248-6989; Selb, Regina/0000-0001-5531-5198; Vrtala, Susanne/0000-0003-4250-8243	Phadia-Thermo Fisher, Uppsala, Sweden; Christian Doppler Research Association, Austria; Austrian Science Fund (FWF) [F4605]; European Commission [261357]	Phadia-Thermo Fisher, Uppsala, Sweden; Christian Doppler Research Association, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by research grants from Phadia-Thermo Fisher, Uppsala, Sweden, the Christian Doppler Research Association, Austria, project F4605 of the Austrian Science Fund (FWF) and in part by the European Commission's Seventh Framework program under grant agreement no. 261357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asero R, 2009, INT ARCH ALLERGY IMM, V150, P271, DOI 10.1159/000222679; Baar A, 2014, J ALLERGY CLIN IMMUN, V133, P585, DOI 10.1016/j.jaci.2013.10.044; Baar A, 2012, J IMMUNOL, V189, P3018, DOI 10.4049/jimmunol.1200438; Battais F, 2005, ALLERGY, V60, P815, DOI 10.1111/j.1398-9995.2005.00795.x; Campana R, 2011, MOL IMMUNOL, V48, P431, DOI 10.1016/j.molimm.2010.09.016; Chen KW, 2012, J ALLERGY CLIN IMMUN, V130, P435, DOI 10.1016/j.jaci.2012.05.035; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; Cordain L, 1999, World Rev Nutr Diet, V84, P19; Focke M, 2001, FASEB J, V15, P2042, DOI 10.1096/fj.01-0016fje; Helm Ricki M, 2008, Clin Allergy Immunol, V21, P219; Hofmann SC, 2012, ALLERGY, V67, P1457, DOI 10.1111/all.12020; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jones SM, 2014, J ALLERGY CLIN IMMUN, V133, P318, DOI 10.1016/j.jaci.2013.12.1040; Marlovits TC, 1998, J MOL RECOGNIT, V11, P49, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<49::AID-JMR388>3.0.CO;2-3; Matsuo H, 2005, J IMMUNOL, V175, P8116, DOI 10.4049/jimmunol.175.12.8116; Matsuo H, 2005, FEBS J, V272, P4431, DOI 10.1111/j.1742-4658.2005.04858.x; Nowak-Wegrzyn A, 2007, NESTLE NUTR WORKS SE, V59, P17, DOI 10.1159/000098510; Pahr S, 2012, CLIN EXP ALLERGY, V42, P597, DOI 10.1111/j.1365-2222.2012.03961.x; Pahr S, 2013, J ALLERGY CLIN IMMUN, V132, P1000, DOI 10.1016/j.jaci.2013.05.016; Palacin A, 2010, INT ARCH ALLERGY IMM, V152, P178, DOI 10.1159/000265539; Pourpak Z, 2004, INT ARCH ALLERGY IMM, V133, P168, DOI 10.1159/000076623; Reese G, 2001, J CHROMATOGR B, V756, P157, DOI 10.1016/S0378-4347(01)00104-9; Roth-Walter F, 2013, MOL NUTR FOOD RES, V57, P536, DOI 10.1002/mnfr.201200612; Sampson HA, 2006, ANN EMERG MED, V47, P373, DOI 10.1016/j.annemergmed.2006.01.018; TEETER MM, 1990, PROTEINS, V8, P118, DOI 10.1002/prot.340080203; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]; Untersmayr E, 2008, J ALLERGY CLIN IMMUN, V121, P1301, DOI 10.1016/j.jaci.2008.04.025; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; Vieths S, 1999, EUR FOOD RES TECHNOL, V209, P379, DOI 10.1007/s002170050513; Vila L, 2001, CLIN EXP ALLERGY, V31, P1599, DOI 10.1046/j.1365-2222.2001.01218.x; Zuidmeer-Jongejan Laurian, 2012, Clin Transl Allergy, V2, P5, DOI 10.1186/2045-7022-2-5	31	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111483	10.1371/journal.pone.0111483	http://dx.doi.org/10.1371/journal.pone.0111483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368998	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402000058
J	Ramalho, FS; Pachu, JKS; Lira, ACS; Malaquias, JB; Zanuncio, JC; Fernandes, FS				Ramalho, Francisco S.; Pachu, Jessica K. S.; Lira, Aline C. S.; Malaquias, Jose B.; Zanuncio, Jose C.; Fernandes, Francisco S.			Feeding and Dispersal Behavior of the Cotton Leafworm, Alabama argillacea (Hubner) (Lepidoptera: Noctuidae), on Bt and Non-Bt Cotton: Implications for Evolution and Resistance Management	PLOS ONE			English	Article							CORN-BORER LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; TRANSGENIC CORN; SEED MIXTURES; CRAMBIDAE; TEMPERATURE; SURVIVAL; CRY1AC; CROPS; ADAPTATION	The host acceptance of neonate Alabama argillacea (Hubner) (Lepidoptera: Noctuidae) larvae to Bt cotton plants exerts a strong influence on the potential risk that this pest will develop resistance to Bt cotton. This will also determine the efficiency of management strategies to prevent its resistance such as the "refuge-in-the-bag'' strategy. In this study, we assessed the acceptance of neonate A. argillacea larvae to Bt and non-Bt cotton plants at different temperatures during the first 24 h after hatching. Two cotton cultivars were used in the study, one a Bt DP 404 BG (Bollgard) cultivar, and the other, an untransformed isoline, DP 4049 cultivar. There was a greater acceptance by live neonate A. argillacea larvae for the non-Bt cotton plants compared with the Bt cotton plants, especially in the time interval between 18 and 24 h. The percentages of neonate A. argillacea larvae found on Bt or non-Bt plants were lower when exposed to temperatures of 31 and 34 degrees C. The low acceptance of A. argillacea larvae for Bt cotton plants at high temperatures stimulated the dispersion of A. argillacea larvae. Our results support the hypothesis that the dispersion and/or feeding behavior of neonate A. argillacea larvae is different between Bt and non-Bt cotton. The presence of the Cry1Ac toxin in Bt cotton plants, and its probable detection by the A. argillacea larvae tasting or eating it, increases the probability of dispersion from the plant where the larvae began. These findings may help to understand how the A. argillacea larvae detect the Cry1Ac toxin in Bt cotton and how the toxin affects the dispersion behavior of the larvae over time. Therefore, our results are extremely important for the management of resistance in populations of A. argillacea on Bt cotton.	[Ramalho, Francisco S.; Pachu, Jessica K. S.; Lira, Aline C. S.; Malaquias, Jose B.; Fernandes, Francisco S.] Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil; [Zanuncio, Jose C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa	Ramalho, FS (corresponding author), Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil.	ramalhohvv@globo.com	Lira, Aline/C-2354-2017; Pachú, Jéssica KS/F-3326-2016; FS, Ramalho/AAC-8058-2019; Pachú, Jéssica/T-2365-2019; Malaquias, José Bruno B/I-1945-2015; Fernandes, Francisco/E-4608-2016	Lira, Aline/0000-0002-8592-2068; Pachú, Jéssica KS/0000-0001-5224-4814; Malaquias, José Bruno B/0000-0003-3937-9575; Fernandes, Francisco/0000-0002-0592-2536	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Financiadora de Estudos e Projetos - FINEP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos - FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq and Financiadora de Estudos e Projetos - FINEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2011, MOL ECOL RESOUR, V11, P219, DOI 10.1111/j.1755-0998.2010.02944.x; Agi A. L., 2001, Journal of Cotton Science, V5, P74; Albernaz KC, 2013, J ECON ENTOMOL, V106, P1819, DOI 10.1603/EC12222; Andow DA., 2008, COLLECT BIOSAF REV, V4, P142; Andrade CFS, 1984, REV BRAS ZOOL, V2, P55; Askew R.R., 1986, P225; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bleicher E, 1981, 2 EMBRAPACNPA; Carvalho SM, 1981, THESIS ESALQ USP PIR; Chen DH, 2005, ENVIRON EXP BOT, V53, P333, DOI 10.1016/j.envexpbot.2004.04.004; Chen Y, 2013, SPAN J AGRIC RES, V11, P438, DOI 10.5424/sjar/2013112-2854; Chen Y, 2012, FIELD CROP RES, V137, P141, DOI 10.1016/j.fcr.2012.08.015; Davis PM, 1997, J KANSAS ENTOMOL SOC, V70, P31; Davis PM, 2000, J ECON ENTOMOL, V93, P937, DOI 10.1603/0022-0493-93.3.937; Lima MS, 2011, PESQUI AGROPECU BRAS, V46, P451, DOI 10.1590/S0100-204X2011000500001; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Domingues FA, 2012, J ECON ENTOMOL, V105, P2136, DOI 10.1603/EC12123; Fernandes Marcos G., 1999, Anais da Sociedade Entomologica do Brasil, V28, P695, DOI 10.1590/S0301-80591999000400012; Goldstein JA, 2010, J ECON ENTOMOL, V103, P331, DOI 10.1603/EC09304; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; Gravena S, 1991, B TECNICO; Hardee DD, 2000, USDAARS154; Huang FN, 2002, J ECON ENTOMOL, V95, P614, DOI 10.1603/0022-0493-95.3.614; JOHANSEN DONALD ALEXANDER, 1940; Jongsma MA, 2010, EVOL ECOL, V24, P1017, DOI 10.1007/s10682-010-9368-3; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Lopez C, 2013, ENTOMOL EXP APPL, V149, P256, DOI 10.1111/eea.12131; MALLET J, 1992, P ROY SOC B-BIOL SCI, V250, P165, DOI 10.1098/rspb.1992.0145; Medeiros R. S., 2003, Braz. J. Biol., V63, P589, DOI 10.1590/S1519-69842003000400006; Nascimento ARB, 2011, ANN ENTOMOL SOC AM, V104, P613, DOI 10.1603/AN10195; Oliveira J. E. de M., 2008, Cientifica (Jaboticabal), V36, P1; Olsen KM, 2005, J ECON ENTOMOL, V98, P1382, DOI 10.1603/0022-0493-98.4.1382; Onstad DW, 2011, J ECON ENTOMOL, V104, P343, DOI 10.1603/EC10388; Papaj D.R., 1983, P77; RAMALHO FS, 1994, ANNU REV ENTOMOL, V39, P563, DOI 10.1146/annurev.en.39.010194.003023; Razze JM, 2011, J ECON ENTOMOL, V104, P806, DOI 10.1603/EC10287; Santos R. L., 2010, Revista Brasileira de Ciencias Agrarias (Agraria), V5, P509, DOI 10.5039/agraria.v5i4a942; SAS Institute, 2006, SAS STAT US GUID; Schnepf EN, 1999, BIOCONTROL N INFORM, V20, P47; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Silva TBM, 2011, CROP PROT, V30, P1156, DOI 10.1016/j.cropro.2011.05.022; Sousa MEC, 2010, J INSECT PHYSIOL, V56, P1913, DOI 10.1016/j.jinsphys.2010.08.014; Tang JD, 2001, J ECON ENTOMOL, V94, P240, DOI 10.1603/0022-0493-94.1.240; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Walker KA, 2000, J ECON ENTOMOL, V93, P1276, DOI 10.1603/0022-0493-93.4.1276; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220	46	21	21	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111588	10.1371/journal.pone.0111588	http://dx.doi.org/10.1371/journal.pone.0111588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369211	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000070
J	Bennett, AB; Meehan, TD; Gratton, C; Isaacs, R				Bennett, Ashley B.; Meehan, Timothy D.; Gratton, Claudio; Isaacs, Rufus			Modeling Pollinator Community Response to Contrasting Bioenergy Scenarios	PLOS ONE			English	Article							FRUIT-SET; SERVICES; BIOFUELS; DIVERSITY; CROPS; ARTHROPODS; LANDSCAPES; INCREASES; BIOMASS; ENERGY	In the United States, policy initiatives aimed at increasing sources of renewable energy are advancing bioenergy production, especially in the Midwest region, where agricultural landscapes dominate. While policy directives are focused on renewable fuel production, biodiversity and ecosystem services will be impacted by the land-use changes required to meet production targets. Using data from field observations, we developed empirical models for predicting abundance, diversity, and community composition of flower-visiting bees based on land cover. We used these models to explore how bees might respond under two contrasting bioenergy scenarios: annual bioenergy crop production and perennial grassland bioenergy production. In the two scenarios, 600,000 ha of marginal annual crop land or marginal grassland were converted to perennial grassland or annual row crop bioenergy production, respectively. Model projections indicate that expansion of annual bioenergy crop production at this scale will reduce bee abundance by 0 to 71%, and bee diversity by 0 to 28%, depending on location. In contrast, converting annual crops on marginal soil to perennial grasslands could increase bee abundance from 0 to 600% and increase bee diversity between 0 and 53%. Our analysis of bee community composition suggested a similar pattern, with bee communities becoming less diverse under annual bioenergy crop production, whereas bee composition transitioned towards a more diverse community dominated by wild bees under perennial bioenergy crop production. Models, like those employed here, suggest that bioenergy policies have important consequences for pollinator conservation.	[Bennett, Ashley B.; Isaacs, Rufus] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Bennett, Ashley B.; Isaacs, Rufus] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Isaacs, R (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	isaacsr@msu.edu	Isaacs, Rufus/AAF-4646-2019	Isaacs, Rufus/0000-0001-7523-4643; Gratton, Claudio/0000-0001-6262-9670	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE OBP Office of Energy and Renewable Energy [DE-AC05-76RL01830]; USDA-NIFA grant [2012-67009-20146]	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE OBP Office of Energy and Renewable Energy(United States Department of Energy (DOE)); USDA-NIFA grant	This work was funded by the Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494), DOE OBP Office of Energy and Renewable Energy (DE-AC05-76RL01830), and by a USDA-NIFA grant to CG and RI(2012-67009-20146). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2012, P ROY SOC B-BIOL SCI, V279, P4845, DOI 10.1098/rspb.2012.1621; Bartomeus I, 2013, ECOL LETT, V16, P1331, DOI 10.1111/ele.12170; Barton K, 2013, MUMIN MULIT MODEL IN; BJORNSTAD ON, 2013, NCF SPATIAL NONPARAM; Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Clarke K. R., 2001, CHANGES MARINE COMMU; Ebeling A, 2008, OIKOS, V117, P1808, DOI 10.1111/j.1600-0706.2008.16819.x; Fabian Y, 2013, J ANIM ECOL, V82, P1203, DOI 10.1111/1365-2656.12103; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gibbs J, 2011, ZOOTAXA, P1; GINSBERG HS, 1983, ECOLOGY, V64, P165, DOI 10.2307/1937338; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Holzschuh A, 2012, BIOL CONSERV, V153, P101, DOI 10.1016/j.biocon.2012.04.032; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Jarchow ME, 2012, CROP SCI, V52, P1330, DOI 10.2135/cropsci2011.09.0481; Johnston CA, 2014, LANDSCAPE ECOL, V29, P81, DOI 10.1007/s10980-013-9947-0; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Landis DA, 2010, INSECT SCI, V17, P220, DOI 10.1111/j.1744-7917.2009.01310.x; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; MACIOR LW, 1968, ECOLOGY, V49, P20, DOI 10.2307/1933556; McCune B, 2002, ANAL ECOLOGICAL COMM; Meehan TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080093; Meehan TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041728; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rehan SM, 2011, ZOOTAXA, P35; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ricketts TH, 2013, ECOL APPL, V23, P1113, DOI 10.1890/12-1600.1; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Schubert C, 2006, NAT BIOTECHNOL, V24, P777, DOI 10.1038/nbt0706-777; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tyner WE, 2008, BIOSCIENCE, V58, P646, DOI 10.1641/B580718; Werling BP, 2011, BIOL CONTROL, V59, P304, DOI 10.1016/j.biocontrol.2011.06.014; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Wiens J, 2011, ECOL APPL, V21, P1085, DOI 10.1890/09-0673.1; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Wu F, 2013, J ECON DYN CONTROL, V37, P1755, DOI 10.1016/j.jedc.2013.03.013	56	21	21	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110676	10.1371/journal.pone.0110676	http://dx.doi.org/10.1371/journal.pone.0110676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365559	Green Published, gold			2022-12-27	WOS:000345558100025
J	Bratcher, PE; Gaggar, A				Bratcher, Preston E.; Gaggar, Amit			Factors Influencing the Measurement of Plasma/Serum Surfactant Protein D Levels by ELISA	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL-SIGNIFICANCE; SYSTEMIC-SCLEROSIS; SERUM-LEVELS; RADIATION PNEUMONITIS; RHEUMATOID-ARTHRITIS; BIOMARKER PROFILES; CIRCULATING LEVELS	Background: Extensive variations in human surfactant protein D (SP-D) levels in circulation as measured by ELISA exist in the published literature. In order to determine the source of these variations, factors influencing the measurement by ELISA were explored. Materials and Methods: Peripheral blood from healthy individuals was collected into various vacutainers during the same blood draw. Recombinant SP-D was diluted into different matrices and used for a standard curve. Samples were analyzed by capture ELISA using one of two distinct detection antibodies. Results: The type of matrix had some effects on detection of recombinant SP-D. The type of anticoagulant used and dilution factor had very little effect, except for in plasma collected in EDTA vacutainers. The extent of variation in published values seemed to be due to the ELISA configuration employed, and, in agreement with this, we found that by switching the detection antibody, there was a 50% decrease in the extrapolated SP-D value of serum and plasma samples. Storage of samples resulted in slight changes in measured SP-D levels. Conclusions: The ELISA configuration employed to measure circulating levels of SP-D has a significant effect on the extrapolated values. In both configurations tested, the use of EDTA as a coagulant resulted in inconsistent values, and we, therefore, suggest the avoidance of this anticoagulant when assaying for SP-D by ELISA. While the demonstrated effects of several factors on measurement of SP-D may not account for all the disparities amongst the previous studies, they stress that variations in methodologies for measuring the same protein can result in very inconsistent results.	[Bratcher, Preston E.; Gaggar, Amit] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bratcher, Preston E.; Gaggar, Amit] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Gaggar, Amit] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] US Dept Vet Affairs, Med Serv, Med Ctr, Birmingham, AL USA; [Bratcher, Preston E.; Gaggar, Amit] Univ Alabama Birmingham, Program Protease & Matrix Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; University of Alabama System; University of Alabama Birmingham	Bratcher, PE (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bratcher@uab.edu			National Institutes of Health [HL102371, 5T32HL105346-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102371, T32HL105346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Institutes of Health (HL102371 to AG and 5T32HL105346-02 to PEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2011, RESP MED, V105, P939, DOI 10.1016/j.rmed.2011.02.016; Al-Salmi QA, 2005, CHEST, V127, P403, DOI 10.1378/chest.127.1.403; Ando M, 2010, LUNG, V188, P247, DOI 10.1007/s00408-009-9223-x; Arai Y, 2001, EUR J PEDIATR, V160, P425, DOI 10.1007/s004310100763; Asano Y, 2001, ARTHRITIS RHEUM-US, V44, P1363, DOI 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5; Atkinson JJ, 2011, AM J RESP CRIT CARE, V183, P876, DOI 10.1164/rccm.201005-0718OC; Aul R, 2012, BRIT J CLIN PHARMACO, V74, P1023, DOI 10.1111/j.1365-2125.2012.04287.x; Bejvl I, 2013, TRANSPL INFECT DIS, V15, P645, DOI 10.1111/tid.12132; Bratcher PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073467; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Christensen AF, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2948; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Determann RM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-6; Determann Rogier M, 2009, BMC Pulm Med, V9, P49, DOI 10.1186/1471-2466-9-49; Duda I, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-24; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; El-Deek SE, 2013, MED PRIN PRACT, V22, P469, DOI 10.1159/000349934; Elhaj M, 2013, J RHEUMATOL, V40, P1114, DOI 10.3899/jrheum.120997; Engels GE, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-4; Engstrom G, 2012, RESP MED, V106, P1250, DOI 10.1016/j.rmed.2012.05.004; Fernandez-Luna A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068447; Gil HW, 2007, CLIN TOXICOL, V45, P463, DOI 10.1080/15563650701338138; Glas J, 2008, TISSUE ANTIGENS, V72, P21, DOI 10.1111/j.1399-0039.2008.01056.x; Gravholt CH, 2004, EUR J ENDOCRINOL, V150, P355, DOI 10.1530/eje.0.1500355; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Greene KE, 2002, EUR RESPIR J, V19, P439, DOI 10.1183/09031936.02.00081102; Haddam N, 2009, BIOMARKERS, V14, P292, DOI 10.1080/13547500902989088; Hant FN, 2009, J RHEUMATOL, V36, P773, DOI 10.3899/jrheum.080633; Heidinger K, 2005, IMMUNOGENETICS, V57, P1, DOI 10.1007/s00251-005-0775-5; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Higashi A, 2005, EUR RESPIR J, V26, P1069, DOI 10.1183/09031936.05.00106104; Hill J, 2011, EUR HEART J, V32, P1918, DOI 10.1093/eurheartj/ehr124; Hoegh SV, 2008, SCAND J IMMUNOL, V67, P71, DOI 10.1111/j.1365-3083.2007.02039.x; Hoegh SV, 2010, IMMUNOBIOLOGY, V215, P314, DOI 10.1016/j.imbio.2009.05.001; Hoegh SV, 2009, J RHEUMATOL, V36, P2449, DOI 10.3899/jrheum.090069; Hoffmann HJ, 2003, ANN AGR ENV MED, V10, P53; Hohwy T, 2006, EXP DERMATOL, V15, P168, DOI 10.1111/j.1600-0625.2006.00406.x; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Ichiyasu H, 2012, RESPIRATION, V83, P190, DOI 10.1159/000326924; Ihn H, 2002, RHEUMATOLOGY, V41, P1268, DOI 10.1093/rheumatology/41.11.1268; Ilumets H, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-19; Janssen R, 2003, CHEST, V124, P2119, DOI 10.1378/chest.124.6.2119; Ju CR, 2012, DIS MARKERS, V32, P281, DOI [10.1155/2012/509063, 10.3233/DMA-2011-0887]; Kamada S, 2000, FORENSIC SCI INT, V109, P51, DOI 10.1016/S0379-0738(99)00214-5; Kawasaki Y, 2011, PEDIATR PULM, V46, P18, DOI 10.1002/ppul.21270; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kobayashi H, 2008, BIOMARKERS, V13, P385, DOI [10.1080/13547500801903651, 10.1080/13547500801903651 ]; Koopmans JG, 2004, CLIN EXP ALLERGY, V34, P1827, DOI 10.1111/j.1365-2222.2004.02083.x; Kotecha S, 2013, THORAX, V68, P460, DOI 10.1136/thoraxjnl-2012-202729; Krane M, 2003, EUR RESPIR J, V22, P592, DOI 10.1183/09031936.03.00060603; Kuwano K, 2002, RESPIROLOGY, V7, P15, DOI 10.1046/j.1440-1843.2002.00369.x; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; Lin FC, 2008, MAYO CLIN PROC, V83, P1344, DOI 10.1016/S0025-6196(11)60782-9; Lomas DA, 2009, EUR RESPIR J, V34, P95, DOI 10.1183/09031936.00156508; Maeda M, 2001, J DERMATOL, V28, P467, DOI 10.1111/j.1346-8138.2001.tb00013.x; Fernandez-Real JM, 2010, DIABETES CARE, V33, P847, DOI 10.2337/dc09-0542; Mutti A, 2006, CHEST, V129, P1288, DOI 10.1378/chest.129.5.1288; Nadesalingam J, 2005, FEBS LETT, V579, P4449, DOI 10.1016/j.febslet.2005.07.012; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nishida S, 2011, PEDIATR INT, V53, P910, DOI 10.1111/j.1442-200X.2011.03398.x; Nybo M, 2007, CLIN IMMUNOL, V123, P333, DOI 10.1016/j.clim.2007.03.001; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378, DOI 10.1164/ajrccm.165.3.2107134; Olesen HV, 2010, J CYST FIBROS, V9, P257, DOI 10.1016/j.jcf.2010.03.011; Ozyurek BA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-36; Sasaki R, 2001, INT J RADIAT ONCOL, V50, P301, DOI 10.1016/S0360-3016(00)01591-1; Shah RJ, 2012, J HEART LUNG TRANSPL, V31, P942, DOI 10.1016/j.healun.2012.05.001; Shakoori TA, 2009, DIS MARKERS, V27, P287, DOI [10.3233/DMA-2009-0674, 10.1155/2009/759304]; Shiels MS, 2011, CANCER EPIDEM BIOMAR, V20, P2262, DOI 10.1158/1055-9965.EPI-11-0326; Sims MW, 2011, CHEST, V140, P489, DOI 10.1378/chest.10-2065; Sin Don D, 2007, BMC Pulm Med, V7, P13, DOI 10.1186/1471-2466-7-13; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Sorensen GL, 2006, SCAND J IMMUNOL, V64, P633, DOI 10.1111/j.1365-3083.2006.01853.x; Stapleton RD, 2010, CHEST, V138, P568, DOI 10.1378/chest.10-0014; Takahashi H, 2006, RESPIROLOGY, V11, pS51, DOI 10.1111/j.1440-1843.2006.00809.x; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P258, DOI 10.1164/ajrccm.162.1.9903014; Takahashi H, 2001, EUR RESPIR J, V17, P481, DOI 10.1183/09031936.01.17304810; Tkacova R, 2010, MED SCI MONITOR, V16, pCR540; Todd DA, 2010, PEDIATR CRIT CARE ME, V11, P82, DOI 10.1097/PCC.0b013e3181ae5a4c; Um SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083881; Van Miert E, 2011, EUR RESPIR J, V38, P1287, DOI 10.1183/09031936.00000911; Van Miert E, 2012, PEDIATR PULM, V47, P358, DOI 10.1002/ppul.21554; Vizcaya D, 2013, RESP MED, V107, P673, DOI 10.1016/j.rmed.2013.01.011; Wang SX, 2007, J OCCUP ENVIRON MED, V49, P834, DOI 10.1097/JOM.0b013e318124a927; Ware LB, 2013, CRIT CARE, V17, DOI 10.1186/cc13080; Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484; Watkins TR, 2008, CRIT CARE MED, V36, P1493, DOI 10.1097/CCM.0b013e318170a9ce; Winkler C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-29; Wu YP, 2009, SCAND J IMMUNOL, V69, P508, DOI 10.1111/j.1365-3083.2009.02245.x; Wutzler S, 2011, J TRAUMA, V71, pE31, DOI 10.1097/TA.0b013e3181f6f0b4; Yanaba K, 2004, J RHEUMATOL, V31, P1112; Zhao XM, 2007, SCAND J IMMUNOL, V66, P71, DOI 10.1111/j.1365-3083.2007.01943.x	92	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111466	10.1371/journal.pone.0111466	http://dx.doi.org/10.1371/journal.pone.0111466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365324	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100068
J	Dang, YN; Reinhardt, JD; Zhou, XY; Zhang, GX				Dang, Yini; Reinhardt, Jan D.; Zhou, Xiaoying; Zhang, Guoxin			The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; BIFIDOBACTERIUM-CONTAINING YOGURT; LACTOBACILLUS GG SUPPLEMENTATION; RANDOMIZED-CONTROLLED-TRIALS; TRIPLE THERAPY; DOUBLE-BLIND; SACCHAROMYCES-BOULARDII; PLUS LACTOFERRIN; SEQUENTIAL THERAPY; PEDIATRIC-PATIENTS	Background: Previous meta-analyses reported that probiotics improve the effectiveness of Helicobacter pylori (H. pylori) eradication during antibiotic therapy, while results regarding a possible reduction of side effects remained inconclusive. Moreover, the effectiveness of different strains of probiotics has not been studied so far. It is further conceivable that probiotics will produce additional effects only if antibiotics are relatively ineffective. Methods: This meta-analysis includes eligible randomized controlled trials examining effects of probiotics supplementation on eradication rates (ER) and side effects, published up to May 2014. Sub-group analysis was performed to compare different probiotic strains and antibiotic therapies with different effectiveness in controls (ER<80% vs.>80%). Publication bias was assessed with funnel plots and Harbord's test. The quality of the trials was assessed with the Cochrane risk of bias tool. Results: Thirty-three RCTs involving a total of 4459 patients met the inclusion criteria in case of eradication rates of which 20 assessed total side effects in addition. Overall, the pooled eradication rate in probiotics supplementation groups was significantly higher than in controls (ITT analysis: RR 1.122, 95% CI 1.086-1.159, PP analysis: RR 1.114, 95% CI 1.070-1.159). Sub group-analysis could, however, confirm this finding only for four individual strains (Lactobacillus acidophilus, Lactobacillus casei DN-114001, Lactobacillus gasseri, and Bifidobacterium infantis 2036) and for relatively ineffective antibiotic therapies. There was a significant difference between groups in the overall incidence of side effects (RR 0.735, 95% CI 0.598-0.902). This result was, however, only confirmed for non-blinded trials. Conclusions: The pooled data suggest that supplementation with specific strains of probiotics compared with eradication therapy may be considered an option for increasing eradication rates, particularly when antibiotic therapies are relatively ineffective. The impact on side effects remains unclear and more high quality trials on specific probiotic strains and side effects are thus needed.	[Dang, Yini; Zhou, Xiaoying; Zhang, Guoxin] Nanjing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Dang, Yini; Zhou, Xiaoying; Zhang, Guoxin] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Reinhardt, Jan D.] Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu 610064, Peoples R China; [Reinhardt, Jan D.] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci, Luzern, Switzerland; [Reinhardt, Jan D.] Swiss Parapleg Res, Nottwil, Switzerland	Nanjing Medical University; Nanjing Medical University; Sichuan University; Hong Kong Polytechnic University; University of Lucerne; Swiss Paraplegic Research	Zhang, GX (corresponding author), Nanjing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	guoxinz@njmu.edu.cn	Zhou, Xiaoying/I-5400-2016		National Natural Science Foundation of China [81072032, 81270476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81072032 and No. 81270476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armuzzi A, 2001, DIGESTION, V63, P1, DOI 10.1159/000051865; Armuzzi A, 2001, ALIMENT PHARM THER, V15, P163, DOI 10.1046/j.1365-2036.2001.00923.x; Bekar O, 2011, J MED FOOD, V14, P344, DOI 10.1089/jmf.2010.0099; Boonyaritichaikij S, 2009, HELICOBACTER, V14, P202, DOI 10.1111/j.1523-5378.2009.00675.x; Canducci F, 2000, ALIMENT PHARM THER, V14, P1625, DOI 10.1046/j.1365-2036.2000.00885.x; Cindoruk M, 2007, HELICOBACTER, V12, P309, DOI 10.1111/j.1523-5378.2007.00516.x; Cremonini F, 2002, AM J GASTROENTEROL, V97, P2744, DOI 10.1111/j.1572-0241.2002.07063.x; Medeiros JAD, 2011, EUR J CLIN MICROBIOL, V30, P555, DOI 10.1007/s10096-010-1119-4; Dajani AI, 2013, SAUDI J GASTROENTERO, V19, P113, DOI 10.4103/1319-3767.111953; de Bortoli N, 2007, AM J GASTROENTEROL, V102, P951, DOI 10.1111/j.1572-0241.2007.01085.x; Deguchi R, 2012, J GASTROEN HEPATOL, V27, P888, DOI 10.1111/j.1440-1746.2011.06985.x; Delgado S, 2013, MICROB ECOL, V65, P763, DOI 10.1007/s00248-013-0192-5; Dore MP, 2014, INTERN EMERG MED, V9, P649, DOI 10.1007/s11739-013-1013-z; Du YQ, 2012, WORLD J GASTROENTERO, V18, P6302, DOI 10.3748/wjg.v18.i43.6302; Fao/Who, 2001, HUM VIT MIN REQ; Francavilla R, 2008, HELICOBACTER, V13, P127, DOI 10.1111/j.1523-5378.2008.00593.x; Francavilla R, 2014, J CLIN GASTROENTEROL, V48, P407, DOI 10.1097/MCG.0000000000000007; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Goldman CG, 2006, NUTRITION, V22, P984, DOI 10.1016/j.nut.2006.06.008; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hurduc V, 2009, ACTA PAEDIATR, V98, P127, DOI 10.1111/j.1651-2227.2008.00977.x; Khodadad A, 2013, IRAN J PEDIATR, V23, P79; Kim MN, 2008, HELICOBACTER, V13, P261, DOI 10.1111/j.1523-5378.2008.00601.x; Li S, 2014, EUR J PEDIATR, V173, P153, DOI 10.1007/s00431-013-2220-3; Lionetti E, 2006, ALIMENT PHARM THER, V24, P1461, DOI 10.1111/j.1365-2036.2006.03145.x; Lionetti E, 2010, HELICOBACTER, V15, P79, DOI 10.1111/j.1523-5378.2009.00743.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Manfredi M, 2012, HELICOBACTER, V17, P254, DOI 10.1111/j.1523-5378.2012.00944.x; MARSHALL BJ, 1984, LANCET, V1, P1311; Megraud F, 2004, DRUGS, V64, P1893, DOI 10.2165/00003495-200464170-00003; Mehling H, 2013, NUTRIENTS, V5, P3062, DOI 10.3390/nu5083062; Mirzaee V, 2012, IRAN RED CRESCENT ME, V14, P657; Myllyluoma E, 2005, ALIMENT PHARM THER, V21, P1263, DOI 10.1111/j.1365-2036.2005.02448.x; Navarro-Rodriguez T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-56; Nista EC, 2004, ALIMENT PHARM THER, V20, P1181, DOI 10.1111/j.1365-2036.2004.02274.x; Ozdil K, 2011, HEPATO-GASTROENTEROL, V58, P1148, DOI 10.5754/hge11075; Patel A, 2014, J MICROBIOL IMMUNOL, V47, P429, DOI 10.1016/j.jmii.2013.03.010; Sachdeva A, 2009, EUR J GASTROEN HEPAT, V21, P45, DOI 10.1097/MEG.0b013e32830d0eff; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Scaccianoce G, 2008, EUR REV MED PHARMACO, V12, P251; Selinger CP, 2013, J HOSP INFECT, V84, P159, DOI 10.1016/j.jhin.2013.02.019; Shavakhi A, 2013, HELICOBACTER, V18, P280, DOI 10.1111/hel.12047; Sheu BS, 2006, AM J CLIN NUTR, V83, P864, DOI 10.1093/ajcn/83.4.864; Sheu BS, 2002, ALIMENT PHARM THER, V16, P1669, DOI 10.1046/j.1365-2036.2002.01335.x; Song MJ, 2010, HELICOBACTER, V15, P206, DOI 10.1111/j.1523-5378.2010.00751.x; Sykora J, 2005, J CLIN GASTROENTEROL, V39, P692, DOI 10.1097/01.mcg.0000173855.77191.44; Szajewska H, 2010, ALIMENT PHARM THER, V32, P1069, DOI 10.1111/j.1365-2036.2010.04457.x; Szajewska H, 2009, J PEDIATR GASTR NUTR, V48, P431, DOI 10.1097/MPG.0b013e318182e716; Tolone S, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-63; Tong JL, 2007, ALIMENT PHARM THER, V25, P155, DOI 10.1111/j.1365-2036.2006.03179.x; Walker MM, 2014, ALIMENT PHARM THER, V39, P767, DOI 10.1111/apt.12666; Wang YH, 2014, WORLD J MICROB BIOT, V30, P847, DOI 10.1007/s11274-013-1490-2; Wang ZH, 2013, J CLIN GASTROENTEROL, V47, P25, DOI 10.1097/MCG.0b013e318266f6cf; Yasar B, 2010, TURK J GASTROENTEROL, V21, P212, DOI 10.4318/tjg.2010.0090; Yogeswaran K, 2011, CAN J GASTROENTEROL, V25, P543, DOI 10.1155/2011/647904; Yoon H, 2011, J GASTROEN HEPATOL, V26, P44, DOI 10.1111/j.1440-1746.2010.06477.x; Zheng X, 2013, REV ESP ENFERM DIG, V105, P445, DOI 10.4321/s1130-01082013000800002; Ziemniak W, 2006, J PHYSIOL PHARMACOL, V57, P123; Zou J, 2009, HELICOBACTER, V14, P97, DOI 10.1111/j.1523-5378.2009.00716.x	60	46	72	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111030	10.1371/journal.pone.0111030	http://dx.doi.org/10.1371/journal.pone.0111030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365320	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100044
J	Gillen, JB; Percival, ME; Skelly, LE; Martin, BJ; Tan, RB; Tarnopolsky, MA; Gibala, MJ				Gillen, Jenna B.; Percival, Michael E.; Skelly, Lauren E.; Martin, Brian J.; Tan, Rachel B.; Tarnopolsky, Mark A.; Gibala, Martin J.			Three Minutes of All-Out Intermittent Exercise per Week Increases Skeletal Muscle Oxidative Capacity and Improves Cardiometabolic Health	PLOS ONE			English	Article							VOLUME SPRINT INTERVAL; MITOCHONDRIAL BIOGENESIS; METABOLIC ADAPTATIONS; INSULIN SENSITIVITY; ENDURANCE; ADULTS; FEMALES; MALES	We investigated whether a training protocol that involved 3 min of intense intermittent exercise per week - within a total training time commitment of 30 min including warm up and cool down - could increase skeletal muscle oxidative capacity and markers of health status. Overweight/obese but otherwise healthy men and women (n = 7 each; age = 29 +/- 9 y; BMI = 29.8 +/- 2.7 kg/m(2)) performed 18 training sessions over 6 wk on a cycle ergometer. Each session began with a 2 min warm-up at 50 W, followed by 3x20 s "all-out" sprints against 5.0% body mass (mean power output: similar to 450-500 W) interspersed with 2 min of recovery at 50 W, followed by a 3 min cool-down at 50 W. Peak oxygen uptake increased by 12% after training (32.6 +/- 4.5 vs. 29.1 +/- 4.2 ml/kg/min) and resting mean arterial pressure decreased by 7% (78610 vs. 83610 mmHg), with no difference between groups (both p < 0.01, main effects for time). Skeletal muscle biopsy samples obtained before and 72 h after training revealed increased maximal activity of citrate synthase and protein content of cytochrome oxidase 4 (p < 0.01, main effect), while the maximal activity of beta-hydroxy acyl CoA dehydrogenase increased in men only (p < 0.05). Continuous glucose monitoring measured under standard dietary conditions before and 48-72 h following training revealed lower 24 h average blood glucose concentration in men following training (5.4 +/- 0.6 vs. 5.9 +/- 0.5 mmol/L, p < 0.05), but not women (5.5 +/- 0.4 vs. 5.5 +/- 0.6 mmol/L). This was associated with a greater increase in GLUT4 protein content in men compared to women (138% vs. 23%, p < 0.05). Short-term interval training using a 10 min protocol that involved only 1 min of hard exercise, 3x/wk, stimulated physiological changes linked to improved health in overweight adults. Despite the small sample size, potential sex-specific adaptations were apparent that warrant further investigation.	[Gillen, Jenna B.; Percival, Michael E.; Skelly, Lauren E.; Martin, Brian J.; Tan, Rachel B.; Tarnopolsky, Mark A.; Gibala, Martin J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada	McMaster University; McMaster University	Gibala, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	gibalam@mcmaster.ca		Tan, Rachel/0000-0001-8669-168X	Natural Sciences and Engineering Research Council (NSERC); McMaster University; NSERC Vanier Canada; NSERC Canada	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University; NSERC Vanier Canada; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by a Natural Sciences and Engineering Research Council (NSERC) operating grant and McMaster University Internally Sponsored Research Grant to MJG. JBG held a NSERC Vanier Canada Graduate Scholarship. MEP was supported by a NSERC Canada Graduate Scholarship (Masters). LES held a NSERC undergraduate student research award and NSERC Canada Graduate Scholarship (Masters). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Brook RD, 2013, HYPERTENSION, V61, P1360, DOI 10.1161/HYP.0b013e318293645f; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gillen JB, 2014, APPL PHYSIOL NUTR ME, V39, P409, DOI 10.1139/apnm-2013-0187; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Skleryk JR, 2013, DIABETES OBES METAB, V15, P1146, DOI 10.1111/dom.12150; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Tarnopolsky MA, 2008, MED SCI SPORT EXER, V40, P648, DOI 10.1249/MSS.0b013e31816212ff; Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002	35	110	110	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111489	10.1371/journal.pone.0111489	http://dx.doi.org/10.1371/journal.pone.0111489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365337	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100069
J	Sytykiewicz, H; Chrzanowski, G; Czerniewicz, P; Sprawka, I; Lukasik, I; Golawska, S; Sempruch, C				Sytykiewicz, Hubert; Chrzanowski, Grzegorz; Czerniewicz, Pawel; Sprawka, Iwona; Lukasik, Iwona; Golawska, Sylwia; Sempruch, Cezary			Expression Profiling of Selected Glutathione Transferase Genes in Zea mays (L.) Seedlings Infested with Cereal Aphids	PLOS ONE			English	Article							PLANT DEFENSE RESPONSES; S-TRANSFERASE; ARABIDOPSIS-THALIANA; NICOTIANA-BENTHAMIANA; RHOPALOSIPHUM-PADI; ENZYME-ACTIVITIES; OXIDATIVE STRESS; RESISTANCE; ANTHOCYANIN; MECHANISMS	The purpose of this report was to evaluate the expression patterns of selected glutathione transferase genes (gst1, gst18, gst23 and gst24) in the tissues of two maize (Zea mays L.) varieties (relatively resistant Ambrozja and susceptible Tasty Sweet) that were colonized with oligophagous bird cherry-oat aphid (Rhopalosiphum padi L.) or monophagous grain aphid (Sitobion avenae L.). Simultaneously, insect-triggered generation of superoxide anion radicals (O-2(.-)) in infested Z. mays plants was monitored. Quantified parameters were measured at 1, 2, 4, 8, 24, 48 and 72 h post-initial aphid infestation (hpi) in relation to the non-infested control seedlings. Significant increases in gst transcript amounts were recorded in aphid-stressed plants in comparison to the control seedlings. Maximal enhancement in the expression of the gst genes in aphid-attacked maize plants was found at 8 hpi (gst23) or 24 hpi (gst1, gst18 and gst24) compared to the control. Investigated Z. mays cultivars formed excessive superoxide anion radicals in response to insect treatments, and the highest overproduction of O-2(.-) was noted 4 or 8 h after infestation, depending on the aphid treatment and maize genotype. Importantly, the Ambrozja variety could be characterized as having more profound increments in the levels of gst transcript abundance and O-2(.-) generation in comparison with the Tasty Sweet genotype.	[Sytykiewicz, Hubert; Chrzanowski, Grzegorz; Czerniewicz, Pawel; Sprawka, Iwona; Lukasik, Iwona; Golawska, Sylwia; Sempruch, Cezary] Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland		Sytykiewicz, H (corresponding author), Siedlce Univ Nat Sci & Humanities, Dept Biochem & Mol Biol, Siedlce, Poland.	huberts@uph.edu.pl	Czerniewicz, Pawel/V-4916-2017; Sytykiewicz, Hubert/AAC-1431-2020; Chrzanowski, Grzegorz/AAU-7061-2020	Czerniewicz, Pawel/0000-0003-0271-2290; Sytykiewicz, Hubert/0000-0002-6540-0561; Chrzanowski, Grzegorz/0000-0001-9836-1514; Lukasik, Iwona/0000-0002-1585-1866; Sprawka, Iwona/0000-0001-9511-1042; Golawska, Sylwia/0000-0001-9192-6738; Sempruch, Cezary/0000-0002-6389-1766	National Science Centre (NCS, Poland) [N N310 733940]	National Science Centre (NCS, Poland)	This research was financially supported by the National Science Centre (NCS, Poland) under the grant no. N N310 733940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo Timothy O., 2009, Journal of Plant Protection Research, V49, P399, DOI 10.2478/v10045-009-0063-8; Bandopadhyay L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073632; Basantani M, 2011, PESTIC BIOCHEM PHYS, V99, P111, DOI 10.1016/j.pestbp.2010.11.007; Bender RR, 2013, AGRON J, V105, P161, DOI 10.2134/agronj2012.0352; Beres P. K., 2008, Acta Scientiarum Polonorum - Agricultura, V7, P19; Bosak EJ, 2013, ENVIRON ENTOMOL, V42, P1309, DOI 10.1603/EN13079; CHAITANYA KSK, 1994, NEW PHYTOL, V126, P623, DOI 10.1111/j.1469-8137.1994.tb02957.x; Chronopoulou Evangelia G, 2009, Recent Pat Biotechnol, V3, P211; Cummins I, 2013, P NATL ACAD SCI USA, V110, P5812, DOI 10.1073/pnas.1221179110; Czapla A., 2011, Progress in Plant Protection, V51, P787; Czerniewicz P, 2011, ALLELOPATHY J, V27, P309; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2000, ARCH BIOCHEM BIOPHYS, V384, P407, DOI 10.1006/abbi.2000.2125; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Dukowic-Schulze S, 2014, J GENET GENOMICS, V41, P139, DOI 10.1016/j.jgg.2013.11.007; Gong HB, 2005, PLANT MOL BIOL, V57, P53, DOI 10.1007/s11103-004-4516-1; Halarewicz A, 2012, ARTHROPOD-PLANT INTE, V6, P497, DOI 10.1007/s11829-012-9228-x; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; Kitamura S, 2012, J PLANT PHYSIOL, V169, P636, DOI 10.1016/j.jplph.2011.12.011; Krawczyk Agnieszka, 2006, Progress in Plant Protection, V46, P378; Kumar M, 2009, MICROBIOL-SGM, V155, P780, DOI 10.1099/mic.0.019869-0; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Piero AR, 2010, FEBS J, V277, P255, DOI 10.1111/j.1742-4658.2009.07481.x; LUKASIK I, 2006, PESTYCYDY, V3, P67; Lukasik I, 2012, POL J ENVIRON STUD, V21, P1937; Luo M, 2011, TOXINS, V3, P766, DOI 10.3390/toxins3070766; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Morkunas I, 2011, ACTA PHYSIOL PLANT, V33, P2057, DOI 10.1007/s11738-011-0751-7; Morkunas I, 2013, PROTOPLASMA, V250, P63, DOI 10.1007/s00709-012-0374-x; Pienkosz Aneta, 2005, Progress in Plant Protection, V45, P989; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Prince DC, 2014, PLANT PHYSIOL, V164, P2207, DOI 10.1104/pp.114.235598; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Rao SAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057413; Rezaei MK, 2013, J PLANT PHYSIOL, V170, P1277, DOI 10.1016/j.jplph.2013.04.005; Rodriguez PA, 2014, MOL PLANT MICROBE IN, V27, P30, DOI 10.1094/MPMI-05-13-0156-R; Rossi GB, 2013, 4 S BRAS GEN MOL PLA, P26; Santamaria ME, 2013, TRANSGENIC RES, V22, P697, DOI 10.1007/s11248-013-9725-4; Seidl-Adams I, 2015, PLANT CELL ENVIRON, V38, P23, DOI 10.1111/pce.12347; Sempruch C, 2012, BIOCHEM SYST ECOL, V40, P162, DOI 10.1016/j.bse.2011.10.004; Sprawka I, 2011, PESTIC BIOCHEM PHYS, V100, P64, DOI 10.1016/j.pestbp.2011.02.006; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; Strazynski P, 2008, APHIDS OTHER HOMOPTE, V14, P123; Sytykiewicz H, 2008, 23 INT C ENT DURB RE; Sytykiewicz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094847; Sytykiewicz H, 2011, INT J MOL SCI, V12, P7982, DOI 10.3390/ijms12117982; Urbanska A., 2010, Electronic Journal of Polish Agricultural Universities, V13, P26; Urbanska A, 1990, ZESZ PROBL POST NAUK, V392, P201; Urbanska Anna, 2002, Electronic Journal of Polish Agricultural Universities, V5, pUnpaginated; Mai VC, 2013, PHYTOCHEMISTRY, V93, P49, DOI 10.1016/j.phytochem.2013.02.011; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wang Y, 2012, GENET MOL RES, V11, P4711, DOI 10.4238/2012.September.25.4; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Will T, 2008, PLANT SIGNAL BEHAV, V3, P427, DOI 10.4161/psb.3.6.5473; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; Zhao YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094126; Zielinska L, 2012, ACTA BIOL CRACOV BOT, V54, P97, DOI 10.2478/v10182-012-0010-2	67	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111863	10.1371/journal.pone.0111863	http://dx.doi.org/10.1371/journal.pone.0111863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365518	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100130
J	Ramos, ACS; Shah, A; Augusto, TM; Barbosa, GO; Leiria, LO; de Carvalho, HF; Antunes, E; Grant, AD				Saragossa Ramos-Filho, Antonio Celso; Shah, Ajay; Augusto, Taize Machado; Barbosa, Guilherme Oliveira; Leiria, Luiz Osorio; de Carvalho, Hernandes Faustino; Antunes, Edson; Grant, Andrew Douglas			Menthol Inhibits Detrusor Contractility Independently of TRPM8 Activation	PLOS ONE			English	Article							CALCIUM-CHANNEL; BLADDER; ACETYLCHOLINE; PIG; ATP	Agonists such as icilin and menthol can activate the cool temperature-sensitive ion channel TRPM8. However, biological responses to menthol may occur independently of TRPM8 activation. In the rodent urinary bladder, menthol facilitates the micturition reflex but inhibits muscarinic contractions of the detrusor smooth muscle. The site(s) of TRPM8 expression in the bladder are controversial. In this study we investigated the regulation of bladder contractility in vitro by menthol. Bladder strips from wild type and TRPM8 knockout male mice (25-30 g) were dissected free and mounted in organ baths. Isometric contractions to carbachol (1 nM-30 mu M), CaCl2 (1 mu M to 100 mM) and electrical field stimulation (EFS; 8, 16, 32 Hz) were measured. Strips from both groups contracted similarly in response to both carbachol and EFS. Menthol (300 mu M) or nifedipine (1 mu M) inhibited carbachol and EFS-induced contractions in both wild type and TRPM8 knockout bladder strips. Incubation with the sodium channel blocker tetrodotoxin (1 mu M), replacement of extracellular sodium with the impermeant cation N-Methyl-D-Glucamine, incubation with a cocktail of potassium channel inhibitors (100 nM charybdotoxin, 1 mu M apamin, 10 mu M glibenclamide and 1 mu M tetraethylammonium) or removal of the urothelium did not affect the inhibitory actions of menthol. Contraction to CaCl2 was markedly inhibited by either menthol or nifedipine. In cultured bladder smooth muscle cells, menthol or nifedipine abrogated the carbachol or KCl-induced increases in [Ca2+](i). Intravesical administration of menthol increased voiding frequency while decreasing peak voiding pressure. We conclude that menthol inhibits muscarinic bladder contractions through blockade of L-type calcium channels, independently of TRPM8 activation.	[Saragossa Ramos-Filho, Antonio Celso; Leiria, Luiz Osorio; Antunes, Edson] Univ Estadual Campinas, Dept Pharmacol, Campinas, Brazil; [Shah, Ajay; Grant, Andrew Douglas] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Augusto, Taize Machado; Barbosa, Guilherme Oliveira; de Carvalho, Hernandes Faustino] Univ Estadual Campinas, Inst Biol, Dept Anat Cellular Biol Physiol & Biophys, Campinas, Brazil	Universidade Estadual de Campinas; University of London; King's College London; Universidade de Sao Paulo; Universidade Estadual de Campinas	Grant, AD (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.	andrew.2.grant@kcl.ac.uk	ANTUNES, EDSON/F-6731-2012; Barbosa, Guilherme Oliveira/AAB-6855-2019; Grant, Andrew/A-8819-2008; Augusto, Taize/I-8458-2017	ANTUNES, EDSON/0000-0003-2201-8247; Barbosa, Guilherme Oliveira/0000-0002-5881-0896; Grant, Andrew/0000-0002-7032-3716; Augusto, Taize/0000-0001-7824-5102; Shah, Ajay/0000-0002-6547-0631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [08/57906-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [573913/2008-0]; Capacity Building Award in Integrative Mammalian Biology - (Biotechnology and Biological Sciences Research Council); Capacity Building Award in Integrative Mammalian Biology - (British Pharmacological Society); Capacity Building Award in Integrative Mammalian Biology - (Higher Education Funding Council for England); Capacity Building Award in Integrative Mammalian Biology - (Medical Research Council, UK)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capacity Building Award in Integrative Mammalian Biology - (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Capacity Building Award in Integrative Mammalian Biology - (British Pharmacological Society); Capacity Building Award in Integrative Mammalian Biology - (Higher Education Funding Council for England); Capacity Building Award in Integrative Mammalian Biology - (Medical Research Council, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (08/57906-3), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (573913/2008-0) and by a Capacity Building Award in Integrative Mammalian Biology (funded by the Biotechnology and Biological Sciences Research Council, British Pharmacological Society, Higher Education Funding Council for England and Medical Research Council, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylie RL, 2010, J PHYSIOL PHARMACOL, V61, P543; Birder L, 2013, PHYSIOL REV, V93, P653, DOI 10.1152/physrev.00030.2012; Calixto JB, 2005, PHARMACOL THERAPEUT, V106, P179, DOI 10.1016/j.pharmthera.2004.11.008; Chapple C, 2005, EUR UROL, V48, P5, DOI 10.1016/j.eururo.2005.02.024; Everaerts W, 2010, AM J PHYSIOL-RENAL, V298, pF692, DOI 10.1152/ajprenal.00599.2009; Fry CH, 2010, AUTON NEUROSCI-BASIC, V154, P3, DOI 10.1016/j.autneu.2009.10.006; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Gopalakrishnan M, 2002, J PHARMACOL EXP THER, V303, P379, DOI 10.1124/jpet.102.034538; Hans M, 2012, CHEM SENSES, V37, P463, DOI 10.1093/chemse/bjr128; Jiang CH, 2002, J PHYSIOL-LONDON, V543, P211, DOI 10.1113/jphysiol.2002.019042; Kullmann FA, 2009, AM J PHYSIOL-RENAL, V296, pF892, DOI 10.1152/ajprenal.90718.2008; Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V0939, P803; Lei Z, 2013, NEUROUROL URODYNAM, V32, P500, DOI 10.1002/nau.22325; Leiria LOS, 2011, BRIT J PHARMACOL, V163, P1276, DOI 10.1111/j.1476-5381.2011.01311.x; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mendes-Silverio CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047223; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Nomoto Y, 2008, UROLOGY, V72, P701, DOI 10.1016/j.urology.2007.11.137; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Ramos ACS, 2011, NEUROUROL URODYNAM, V30, P1392, DOI 10.1002/nau.21074; Rivera L, 2006, BJU INT, V98, P868, DOI 10.1111/j.1464-410X.2006.06431.x; Soder RP, 2013, AM J PHYSIOL-REG I, V304, pR155, DOI 10.1152/ajpregu.00363.2012; Stein RJ, 2004, J UROLOGY, V172, P1175, DOI 10.1097/01.ju.0000134880.55119.cf; Tong YC, 1997, J AUTON PHARMACOL, V17, P21, DOI 10.1046/j.1365-2680.1997.00436.x; Tsukimi Y, 2005, UROLOGY, V65, P406, DOI 10.1016/j.urology.2004.10.006; Vahabi B, 2013, CAN J PHYSIOL PHARM, V91, P503, DOI 10.1139/cjpp-2012-0406; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Zimmermann H, 2008, NEUROCHEM INT, V52, P634, DOI 10.1016/j.neuint.2007.09.004	30	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111616	10.1371/journal.pone.0111616	http://dx.doi.org/10.1371/journal.pone.0111616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375115	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600053
J	Taricani, L; Shanahan, F; Malinao, MC; Beaumont, M; Parry, D				Taricani, Lorena; Shanahan, Frances; Malinao, Maria-Christina; Beaumont, Maribel; Parry, David			A Functional Approach Reveals a Genetic and Physical Interaction between Ribonucleotide Reductase and CHK1 in Mammalian Cells	PLOS ONE			English	Article							S-PHASE CHECKPOINT; STALLED REPLICATION FORKS; HUMAN-LEUKEMIA-CELLS; DNA-DAMAGE; H2AX PHOSPHORYLATION; STRESS; GEMCITABINE; INHIBITION; ACTIVATION; CANCER	Ribonucleotide reductase (RNR) enzyme is composed of the homodimeric RRM1 and RRM2 subunits, which together form a heterotetramic active enzyme that catalyzes the de novo reduction of ribonucleotides to generate deoxyribonucleotides (dNTPs), which are required for DNA replication and DNA repair processes. In this study, we show that ablation of RRM1 and RRM2 by siRNA induces G1/S phase arrest, phosphorylation of Chk1 on Ser345 and phosphorylation of gamma-H2AX on S139. Combinatorial ablation of RRM1 or RRM2 and Chk1 causes a dramatic accumulation of gamma-H2AX, a marker of double-strand DNA breaks, suggesting that activation of Chk1 in this context is essential for suppression of DNA damage. Significantly, we demonstrate for the first time that Chk1 and RNR subunits co-immunoprecipitate from native cell extracts. These functional genomic studies suggest that RNR is a critical mediator of replication checkpoint activation.	[Taricani, Lorena; Shanahan, Frances; Malinao, Maria-Christina; Beaumont, Maribel; Parry, David] Merck Res Labs, Palo Alto, CA 94304 USA	Merck & Company	Beaumont, M (corresponding author), Merck Res Labs, Palo Alto, CA 94304 USA.	maribel.beaumont@merck.com	Shanahan, Fergus/ABF-2390-2020	Shanahan, Fergus/0000-0003-0467-0936	Merck Research Laboratories; Merck Research Labs	Merck Research Laboratories(Merck & Company); Merck Research Labs	Funding for this work was provided entirely by Merck Research Laboratories. The funder (Merck Research Labs) provided support in the form of salaries for authors [LT, FS, MCM, MB and DP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chiappori AA, 2010, J THORAC ONCOL, V5, P484, DOI 10.1097/JTO.0b013e3181ccb27b; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Cooper T, 2005, CANCER CHEMOTH PHARM, V55, P361, DOI 10.1007/s00280-004-0906-y; CORY JG, 1983, MOL CELL BIOCHEM, V53-4, P257; Cory JG, 1988, ADV ENZYME REGUL, V53-54, P257; Decosterd LA, 1999, ANAL BIOCHEM, V270, P59, DOI 10.1006/abio.1999.4066; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; GANDHI V, 1995, SEMIN ONCOL, V22, P61; GANDHI V, 1989, BIOCHEM PHARMACOL, V38, P3551, DOI 10.1016/0006-2952(89)90127-5; Goudelock DM, 2003, J BIOL CHEM, V278, P29940, DOI 10.1074/jbc.M301765200; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Guzi TJ, 2011, MOL CANCER THER, V10, P591, DOI 10.1158/1535-7163.MCT-10-0928; Han X, 2014, J BIOL CHEM, V114; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; Labroli MA, 2014, BIOORGAN MED CHEM, V22, P2303, DOI 10.1016/j.bmc.2014.02.007; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Lien E J, 1987, Prog Drug Res, V31, P101; Lin YF, 2014, NUCLEIC ACIDS RES, V42, P4463, DOI 10.1093/nar/gku116; Liu QH, 2000, GENE DEV, V14, P1448; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Nazarov OB, 2003, RADIAT RES, V160, P309, DOI 10.1667/RR3043; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nocentini G, 1996, CRIT REV ONCOL HEMAT, V22, P89, DOI 10.1016/1040-8428(95)00187-5; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shao JM, 2013, EXPERT OPIN THER TAR, V17, P1423, DOI 10.1517/14728222.2013.840293; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Szekeres T, 1997, CRIT REV CL LAB SCI, V34, P503, DOI 10.3109/10408369709006424; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Taricani L, 2009, CELL CYCLE, V8, P482, DOI 10.4161/cc.8.3.7661; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; THELANDER M, 1985, J BIOL CHEM, V260, P2737; Xie KC, 1996, CANCER RES, V56, P3030; Zachos G, 2005, MOL CELL BIOL, V25, P563, DOI 10.1128/MCB.25.2.563-574.2005; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058091	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111714	10.1371/journal.pone.0111714	http://dx.doi.org/10.1371/journal.pone.0111714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375241	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600057
J	Yang, YL; Luo, XP; Yang, N; Feng, RH; Xian, L				Yang, Yanlong; Luo, Xiuping; Yang, Nuo; Feng, Ronghao; Xian, Lei			The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; THYMIDYLATE SYNTHASE; PHASE-III; RESISTANCE; MANAGEMENT; ETOPOSIDE; SURVIVAL; THERAPY; PROTEIN	Recently, the correlation between the efficacy of platinum-based chemotherapy and ERCC1 expression in patients with SCLC has attracted wide-spread attention, and a lot of investigations have been conducted, whereas conflicting results were presented. Therefore, we performed the present meta-analysis of eligible studies to derive a more precise evaluation of the association between ERCC1 expression and the clinical outcome in SCLC patients receiving platinum-based chemotherapy. A literature search for relevant studies was conducted in the electronic databases of PubMed, EMBASE and Web of Science. The inclusive criteria were SCLC patients treated by platinum-based chemotherapy, and evaluated the relationship between ERCC1 expression and the clinical outcomes [including overall response rate (ORR), overall survival (OS) or progression-free survival (PFS)]. Odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI) was calculated to assess the risk. A total of nine studies including 1129 patients were included in final analysis. Our analysis indicated that positive/high ERCC1 expression was associated with unfavorable OS (HR = 1.18, 95%CI = 1.02-1.37) and PFS (HR = 1.46, 95%CI = 1.14-1.88). Subgroup analysis according to disease stage suggested the significant relationship was found in limited stage (LS-SCLC), but not in extensive stage (ES-SCLC). However, no significant association was found between ERCC1 expression and ORR. Our analysis suggested ERCC1 expression may be a prognostic factor in SCLC patients receiving platinum-based chemotherapy, especially for LS-SCLC.	[Yang, Yanlong; Yang, Nuo; Xian, Lei] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi Zhuang, Peoples R China; [Luo, Xiuping; Feng, Ronghao] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Chemotherapy, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University	Xian, L (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning, Guangxi Zhuang, Peoples R China.	xianlei59@163.com						Baba H, 2012, BRIT J CANCER, V107, P1950, DOI 10.1038/bjc.2012.502; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellmunt J, 2007, ANN ONCOL, V18, P522, DOI 10.1093/annonc/mdl435; Ceppi P, 2008, J THORAC ONCOL, V3, P583, DOI 10.1097/JTO.0b013e3181734f24; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI 10.1056/NEJMoa1214271; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Guldhammer B, 2010, J THORAC ONCOL, V5, P453, DOI 10.1097/JTO.0b013e3181ca063b; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hubner RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025164; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kang CH, 2009, J THORAC ONCOL, V4, P1307, DOI 10.1097/JTO.0b013e3181b9f236; Karachaliou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074611; Kawashima A, 2011, CLIN CANCER RES, V17, P2561, DOI 10.1158/1078-0432.CCR-10-1963; Kim MK, 2008, EUR J CANCER, V44, P54, DOI 10.1016/j.ejca.2007.09.006; Kim SH, 2009, AM J CLIN ONCOL-CANC, V32, P38, DOI 10.1097/COC.0b013e31817be58e; Kim YH, 2009, LUNG CANCER, V65, P105, DOI 10.1016/j.lungcan.2008.10.008; Knez L, 2011, LUNG CANCER, V72, P271, DOI 10.1016/j.lungcan.2011.02.014; Kwon HC, 2007, ANN ONCOL, V18, P504, DOI 10.1093/annonc/mdl430; Lee GW, 2012, J THORAC ONCOL, V7, P528, DOI 10.1097/JTO.0b013e3182417830; Lee HW, 2008, LUNG CANCER, V59, P95, DOI 10.1016/j.lungcan.2007.07.023; MANTEL N, 1959, J NATL CANCER I, V22, P719; Murray D, 1996, MUTAT RES-DNA REPAIR, V364, P217, DOI 10.1016/S0921-8777(96)00036-5; Murray D, 2002, ANTICANCER RES, V22, P21; Normanno N, 2014, LUNG CANCER, V85, P314, DOI 10.1016/j.lungcan.2014.05.002; Sandler AB, 2003, SEMIN ONCOL, V30, P9, DOI 10.1053/sonc.2003.50012; Scheil-Bertram S, 2010, GYNECOL ONCOL, V119, P325, DOI 10.1016/j.ygyno.2010.07.018; Sereno M, 2012, INT J ONCOL, V40, P2104, DOI 10.3892/ijo.2012.1378; Shin Hai-Rim, 2004, Cancer Res Treat, V36, P103, DOI 10.4143/crt.2004.36.2.103; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Smit EF, 2012, ANN ONCOL, V23, P1723, DOI 10.1093/annonc/mdr563; Sodja E, 2012, EUR J CANCER, V48, P3378, DOI 10.1016/j.ejca.2012.06.011; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Thatcher N, 2005, ANN ONCOL, V16, P235, DOI 10.1093/annonc/mdi700; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wang XY, 2014, CELL BIOCHEM BIOPHYS, V69, P633, DOI 10.1007/s12013-014-9845-3; Wells GA., 2003, NEWCASTLE OTTAWA SCA; Xia Ying, 2007, Zhongguo Fei Ai Za Zhi, V10, P362, DOI 10.3779/j.issn.1009-3419.2007.05.03	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111651	10.1371/journal.pone.0111651	http://dx.doi.org/10.1371/journal.pone.0111651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375151	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600055
J	Freisinger, CM; Huttenlocher, A				Freisinger, Christina M.; Huttenlocher, Anna			Live Imaging and Gene Expression Analysis in Zebrafish Identifies a Link between Neutrophils and Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							TRANSGENIC ZEBRAFISH; PANCREATIC-CANCER; RECEPTOR CXCR2; INTERLEUKIN-8; INFLAMMATION; PROGRESSION; TARGET; GROWTH; CELLS; MODEL	Chronic inflammation is associated with epithelial to mesenchymal transition (EMT) and cancer progression however the relationship between inflammation and EMT remains unclear. Here, we have exploited zebrafish to visualize and quantify the earliest events during epithelial cell transformation induced by oncogenic HRas(V12). Live imaging revealed that expression of HRas(V12) in the epidermis results in EMT and chronic neutrophil and macrophage infiltration. We have developed an in vivo system to probe and quantify gene expression changes specifically in transformed cells from chimeric zebrafish expressing oncogenic HRas(V12) using translating ribosomal affinity purification (TRAP). We found that the expression of genes associated with EMT, including slug, vimentin and mmp9, are enriched in HRas(V12) transformed epithelial cells and that this enrichment requires the presence of neutrophils. An early signal induced by HRas(V12) in epithelial cells is the expression of il-8 (cxcl8) and we found that the chemokine receptor, Cxcr2, mediates neutrophil but not macrophage recruitment to the transformed cells. Surprisingly, we also found a cell autonomous role for Cxcr2 signaling in transformed cells for both neutrophil recruitment and EMT related gene expression associated with Ras transformation. Taken together, these findings implicate both autocrine and paracrine signaling through Cxcr2 in the regulation of inflammation and gene expression in transformed epithelial cells.	[Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Microbiol, Madison, WI USA; Univ Wisconsin, Dept Immunol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.	huttenlocher@wisc.edu			National Institutes of Health (NIH) [R01 GM074827]; NCI [NIH R01 GM102924-01]; National Institute of Environmental Health Sciences [ES007015]; National Cancer Institute [CA157322]; NATIONAL CANCER INSTITUTE [T32CA157322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074827, R01GM102924] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Grant R01 GM074827 (A. Huttenlocher), NCI Grant NIH R01 GM102924-01 (A. Huttenlocher), National Institute of Environmental Health Sciences grant ES007015 (to C. M. Freisinger) and National Cancer Institute grant CA157322 (to C. M. Freisinger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrile BB, 2008, MOL INTERV, V8, P22, DOI 10.1124/mi.8.1.6; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Becker M, 2013, HISTOL HISTOPATHOL; Blackburn JS, 2014, DIS MODEL MECH, V7, P755, DOI 10.1242/dmm.015842; Boppana NB, 2014, EXP BIOL MED, V239, P509, DOI 10.1177/1535370213520110; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Burke RM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086003; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cataisson C, 2009, CANCER RES, V69, P319, DOI 10.1158/0008-5472.CAN-08-2490; Chan AT, 2011, LANCET, V378, P2051, DOI 10.1016/S0140-6736(11)61216-6; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Cieslewicz M, 2013, P NATL ACAD SCI US; Cossack M, 2013, J GENET COUNS; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Deng Q, 2013, J LEUKOCYTE BIOL, V93, P761, DOI 10.1189/jlb.1012534; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Dong YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083789; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Downward J, 1996, CANCER SURV, V27, P87; Dumitru CA, 2011, INT J CANC; Eisenhoffer GT, 2011, JOVE-J VIS EXP, DOI 10.3791/2689; Feng Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000562; Gong L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-154; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Grosse-Steffen T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/720768; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Hertzer KM, 2013, EXPERT OPIN THER TAR, V17, P667, DOI 10.1517/14728222.2013.772137; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kennedy BC, 2013, J ONCOL, V2013, DOI 10.1155/2013/486912; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kline M, 2007, LEUKEMIA RES, V31, P591, DOI 10.1016/j.leukres.2006.06.012; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lam PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084436; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Long S, 2002, BIOTECHNIQUES, V32, P494, DOI 10.2144/02323bm04; Mariani F, 2014, WORLD J GASTROENTERO, V20, P9716, DOI 10.3748/wjg.v20.i29.9716; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; MCKENNA WG, 1990, INT J RADIAT ONCOL, V18, P849, DOI 10.1016/0360-3016(90)90407-B; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rodriguez D, 2013, CELL IMMUNOL, V283, P51, DOI 10.1016/j.cellimm.2013.06.008; Rogers TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-177; SATO H, 1992, ONCOGENE, V7, P77; Shen X, 2013, CURR MED CHEM; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tazzyman S, 2011, INT J CANCER, V129, P847, DOI 10.1002/ijc.25987; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Varney ML, 2003, CLIN EXP METASTAS, V20, P723, DOI 10.1023/B:CLIN.0000006814.48627.bd; Wang DZ, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28581; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; WITTINGHOFER A, 1993, CIBA F SYMP, V176, P6; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yen J, 2014, CURR OPIN GENET DEV, V24, P38, DOI 10.1016/j.gde.2013.11.003; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Zachos G, 1996, J Exp Ther Oncol, V1, P335	77	43	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112183	10.1371/journal.pone.0112183	http://dx.doi.org/10.1371/journal.pone.0112183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372289	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900117
J	Zhang, XL; Li, YX; Liu, B; Wang, J; Feng, CH; Gao, M; Wang, LN				Zhang, Xuelian; Li, Yanxia; Liu, Bei; Wang, Jing; Feng, Chenghong; Gao, Min; Wang, Lina			Prevalence of Veterinary Antibiotics and Antibiotic-Resistant Escherichia coli in the Surface Water of a Livestock Production Region in Northern China	PLOS ONE			English	Article							TREATMENT PLANTS; FEEDING OPERATIONS; CLAY-MINERALS; SOUTH CHINA; RIVER; WASTE; MANURE; GENES; ENVIRONMENT; SOIL	This study investigated the occurrence of 12 veterinary antibiotics (VAs) and the susceptibility of Escherichia coli (E. coli) in a rural water system that was affected by livestock production in northern China. Each of the surveyed sites was determined with at least eight antibiotics with maximum concentration of up to 450 ng L-1. The use of VAs in livestock farming probably was a primary source of antibiotics in the rivers. Increasing total antibiotics were measured from up- to mid- and downstream in the two tributaries. Eighty-eight percent of the 218 E. coli isolates that were derived from the study area exhibited, in total, 48 resistance profiles against the eight examined drugs. Significant correlations were found among the resistance rates of sulfamethoxazole-trimethoprim, chloromycetin and ampicillin as well as between tetracycline and chlortetracycline, suggesting a possible cross-selection for resistance among these drugs. The E. coli resistance frequency also increased from up- to midstream in the three rivers. E. coli isolates from different water systems showed varying drug numbers of resistance. No clear relationship was observed in the antibiotic resistance frequency with corresponding antibiotic concentration, indicating that the antibiotic resistance for E. coli in the aquatic environment might be affected by factors besides antibiotics. High numbers of resistant E. coli were also isolated from the conserved reservoir. These results suggest that rural surface water may become a large pool of VAs and resistant bacteria. This study contributes to current information on VAs and resistant bacteria contamination in aquatic environments particularly in areas under intensive agriculture. Moreover, this study indicates an urgent need to monitor the use of VAs in animal production, and to control the release of animal-originated antibiotics into the environment.	[Zhang, Xuelian; Li, Yanxia; Liu, Bei; Wang, Jing; Feng, Chenghong; Gao, Min; Wang, Lina] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China	Beijing Normal University	Li, YX (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	liyxbnu@bnu.edu.cn		Feng, Chenghong/0000-0002-2130-8851	Natural Science Foundation of China [21277013, 20977010]; Special Fund for Environmental Protection Research in the Public Interest [200909042]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Environmental Protection Research in the Public Interest	The research was funded by the Natural Science Foundation of China (No. 21277013, 20977010) and the Special Fund for Environmental Protection Research in the Public Interest (200909042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi F, 2013, SCI TOTAL ENVIRON, V444, P508, DOI 10.1016/j.scitotenv.2012.11.077; Akiyama T, 2010, SCI TOTAL ENVIRON, V408, P6192, DOI 10.1016/j.scitotenv.2010.08.055; Ali M, 2013, CHEMOSPHERE, V91, P1583, DOI 10.1016/j.chemosphere.2012.12.050; [Anonymous], 2012, CHINA AGR STAT YB; Bao YY, 2009, WASTE MANAGE, V29, P1416, DOI 10.1016/j.wasman.2008.08.022; Batt AL, 2007, CHEMOSPHERE, V68, P428, DOI 10.1016/j.chemosphere.2007.01.008; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Blanco G, 2009, ENVIRON RES, V109, P405, DOI 10.1016/j.envres.2009.01.007; Campagnolo ER, 2002, SCI TOTAL ENVIRON, V299, P89, DOI 10.1016/S0048-9697(02)00233-4; China MOA (Ministry of Agriculture of the People Republic of China), 2010, CHIN VET PHARM; CLSI, 2012, M100S16 CLSI NAT COM; CLSI, 2009, M100S16 CLSI NAT COM; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; DANMAP, DANM 2011 US ANT AG; Dolliver H, 2008, J ENVIRON QUAL, V37, P1245, DOI 10.2134/jeq2007.0399; Gao JA, 2005, ENVIRON SCI TECHNOL, V39, P9509, DOI 10.1021/es050644c; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gutierrez IR, 2010, J SOIL SEDIMENT, V10, P537, DOI 10.1007/s11368-009-0168-8; Hagedorn C, 1999, APPL ENVIRON MICROB, V65, P5522; Ham YS, 2012, ENVIRON POLLUT, V162, P98, DOI 10.1016/j.envpol.2011.11.002; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hong PY, 2013, ANTIBIOTICS-BASEL, V2, P367, DOI 10.3390/antibiotics2030367; Hu JY, 2008, ENVIRON SCI TECHNOL, V42, P3415, DOI 10.1021/es7026746; Garcia-Galan MJ, 2011, ENVIRON INT, V37, P462, DOI 10.1016/j.envint.2010.11.011; Ji XL, 2012, J HAZARD MATER, V235, P178, DOI 10.1016/j.jhazmat.2012.07.040; Jiang L, 2013, SCI TOTAL ENVIRON, V458, P267, DOI 10.1016/j.scitotenv.2013.04.038; Jiang L, 2011, CHEMOSPHERE, V82, P822, DOI 10.1016/j.chemosphere.2010.11.028; Kahle M, 2007, CHEMOSPHERE, V68, P1224, DOI 10.1016/j.chemosphere.2007.01.061; Kay P, 2005, CHEMOSPHERE, V59, P951, DOI 10.1016/j.chemosphere.2004.11.055; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kumar K, 2005, ADV AGRON, V87, P1, DOI 10.1016/S0065-2113(05)87001-4; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Li YX, 2013, ENVIRON MONIT ASSESS, V185, P2211, DOI 10.1007/s10661-012-2702-1; Luo Y, 2011, ENVIRON SCI TECHNOL, V45, P1827, DOI 10.1021/es104009s; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106; Marti R, 2013, APPL ENVIRON MICROB, V79, P5701, DOI 10.1128/AEM.01682-13; Martinez-Carballo E, 2007, ENVIRON POLLUT, V148, P570, DOI 10.1016/j.envpol.2006.11.035; Meays CL, 2006, ENVIRON SCI TECHNOL, V40, P5289, DOI 10.1021/es060659q; Motoyama M, 2011, CHEMOSPHERE, V84, P432, DOI 10.1016/j.chemosphere.2011.03.048; Pan X, 2011, CHEMOSPHERE, V84, P695, DOI 10.1016/j.chemosphere.2011.03.022; Parveen S, 1997, APPL ENVIRON MICROB, V63, P2607, DOI 10.1128/AEM.63.7.2607-2612.1997; Pezzotti G, 2003, INT J FOOD MICROBIOL, V82, P281, DOI 10.1016/S0168-1605(02)00314-8; Pils JRV, 2007, ENVIRON SCI TECHNOL, V41, P1928, DOI 10.1021/es062316y; Rahube TO, 2010, AFR J BIOTECHNOL, V9, P9183; Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9; Rooklidge SJ, 2004, SCI TOTAL ENVIRON, V325, P1, DOI 10.1016/j.scitotenv.2003.11.007; Rysz M, 2004, WATER RES, V38, P3705, DOI 10.1016/j.watres.2004.06.015; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Su HC, 2012, ENVIRON POLLUT, V169, P42, DOI 10.1016/j.envpol.2012.05.007; Sun PZ, 2013, J CHROMATOGR A, V1312, P10, DOI 10.1016/j.chroma.2013.08.044; Tamtam F, 2008, SCI TOTAL ENVIRON, V393, P84, DOI 10.1016/j.scitotenv.2007.12.009; Walczak JJ, 2011, WATER AIR SOIL POLL, V219, P579, DOI 10.1007/s11270-010-0729-x; Wei RC, 2011, CHEMOSPHERE, V82, P1408, DOI 10.1016/j.chemosphere.2010.11.067; Whitlock JE, 2002, WATER RES, V36, P4273, DOI 10.1016/S0043-1354(02)00139-2; Wiegel S, 2004, CHEMOSPHERE, V57, P107, DOI 10.1016/j.chemosphere.2004.05.017; Wu CX, 2010, ENVIRON SCI TECHNOL, V44, P6157, DOI 10.1021/es1011115; Xu WH, 2007, ENVIRON POLLUT, V145, P672, DOI 10.1016/j.envpol.2006.05.038; Xu XR, 2010, CHEMOSPHERE, V78, P430, DOI 10.1016/j.chemosphere.2009.10.045; Yan CX, 2013, ENVIRON POLLUT, V175, P22, DOI 10.1016/j.envpol.2012.12.008; Zhao L, 2010, SCI TOTAL ENVIRON, V408, P1069, DOI 10.1016/j.scitotenv.2009.11.014; Zhou LJ, 2011, ENVIRON POLLUT, V159, P1877, DOI 10.1016/j.envpol.2011.03.034; Zou SC, 2011, ENVIRON POLLUT, V159, P2913, DOI 10.1016/j.envpol.2011.04.037	66	35	37	3	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111026	10.1371/journal.pone.0111026	http://dx.doi.org/10.1371/journal.pone.0111026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372873	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900033
J	Eberhard, JM; Hartjen, P; Kummer, S; Schmidt, RE; Bockhorn, M; Lehmann, C; Balagopal, A; Hauber, J; van Lunzen, J; zur Wiesch, JS				Eberhard, Johanna Maria; Hartjen, Philip; Kummer, Silke; Schmidt, Reinhold E.; Bockhorn, Maximilian; Lehmann, Clara; Balagopal, Ashwin; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze			CD161(+) MAIT Cells Are Severely Reduced in Peripheral Blood and Lymph Nodes of HIV-Infected Individuals Independently of Disease Progression	PLOS ONE			English	Article							INVARIANT T-CELLS; IMMUNE ACTIVATION; SOLUBLE CD163; HETEROGENEITY; EXPRESSION; RESPONSES; THERAPY; PATHWAY; ABSENCE; SUBSET	Mucosal-associated invariant T (MAIT) cells are characterized by the combined expression of the semi-invariant T cell receptor (TCR) V alpha 7.2, the lectin receptor CD161, as well as IL-18R, and play an important role in antibacterial host defense of the gut. The current study characterized CD161(+) MAIT and CD161(-)TCRVa7.2(+) T cell subsets within a large cohort of HIV patients with emphasis on patients with slow disease progression and elite controllers. Mononuclear cells from blood and lymph node samples as well as plasma from 63 patients and 26 healthy donors were analyzed by multicolor flow cytometry and ELISA for IL-18, sCD14 and sCD163. Additionally, MAIT cells were analyzed after in vitro stimulation with different cytokines and/or fixed E. coli. Reduced numbers of CD161(+) MAIT cells during HIV infection were detectable in the blood and lymph nodes of all patient groups, including elite controllers. CD161(+) MAIT cell numbers did not recover even after successful antiretroviral treatment. The loss of CD161(+) MAIT cells was correlated with higher levels of MAIT cell activation; an increased frequency of the CD161(-)TCRV alpha 7.2(+)T cell subset in HIV infection was observed. In vitro stimulation of MAIT cells with IL-18 and IL-12, IL-7 and fixed E. coli also resulted in a rapid and additive reduction of the MAIT cell frequency defined by CD161, IL-18R and CCR6. In summary, the irreversible reduction of the CD161(+) MAIT cell subset seems to be an early event in HIV infection that is independent of later stages of the disease. This loss appears to be at least partially due to the distinctive vulnerability of MAIT cells to the pronounced stimulation by microbial products and cytokines during HIV-infection.	[Eberhard, Johanna Maria; Hartjen, Philip; Kummer, Silke; van Lunzen, Jan; zur Wiesch, Julian Schulze] Univ Med Ctr Hamburg Eppendorf, Dept Med, Infect Dis Unit, Hamburg, Germany; [Hartjen, Philip] Univ Med Ctr Hamburg Eppendorf, Dept Oral & Maxillofacial Surg, Hamburg, Germany; [Bockhorn, Maximilian] Univ Med Ctr Hamburg Eppendorf, Dept Gen Surg, Hamburg, Germany; [Eberhard, Johanna Maria; Hartjen, Philip; Kummer, Silke; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Schmidt, Reinhold E.] Hannover Med Sch, Dept Immunol & Rheumatol, Hannover, Germany; [Lehmann, Clara] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Balagopal, Ashwin] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Schmidt, Reinhold E.; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze] Partner Site Hamburg & Hannover, German Ctr Infect Res DZIF, Hamburg, Germany; [Schmidt, Reinhold E.; Hauber, Joachim; van Lunzen, Jan; zur Wiesch, Julian Schulze] Partner Site Hamburg & Hannover, German Ctr Infect Res DZIF, Hannover, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; Hannover Medical School; University of Cologne; Johns Hopkins University; German Center for Infection Research; German Center for Infection Research	van Lunzen, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med, Infect Dis Unit, Hamburg, Germany.	v.lunzen@uke.de	Wiesch, Julian Schulze zur/AAT-8452-2021; Lehmann, Clara/F-9671-2016	Lehmann, Clara/0000-0002-7042-1578; Eberhard, Johanna Maria/0000-0002-8367-3870	Werner Otto Stiftung, the German Research Agency [SFB841]; DZIF (German Center for Infection Research); ECHAM (European Cohort HIV Ageing and Metabolic liver disease); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078] Funding Source: NIH RePORTER	Werner Otto Stiftung, the German Research Agency; DZIF (German Center for Infection Research); ECHAM (European Cohort HIV Ageing and Metabolic liver disease); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Werner Otto Stiftung, the German Research Agency (SFB841 project A6; JSzW), the DZIF (German Center for Infection Research; RES, JH, JvL, JSzW) and the ECHAM (European Cohort HIV Ageing and Metabolic liver disease; JvL, JME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082461; Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Gordon SM, 2011, J IMMUNOL, V186, P4573, DOI 10.4049/jimmunol.1100037; Grimaldi D, 2014, INTENS CARE MED, V40, P192, DOI 10.1007/s00134-013-3163-x; Hartjen P, 2013, J INFECT DIS, V208, P180, DOI 10.1093/infdis/jit141; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee OJ, 2014, EXP GERONTOL, V49, P47, DOI 10.1016/j.exger.2013.11.003; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Northfield JW, 2008, HEPATOLOGY, V47, P396, DOI 10.1002/hep.22040; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Sandberg JK, 2013, AIDS, V27, P2501, DOI 10.1097/QAD.0b013e3283620726; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Wakao H, 2013, CELL CYCLE, V12, P2341, DOI 10.4161/cc.25706; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Walker Bruce D, 2007, Top HIV Med, V15, P134; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wilson NL, 2013, J ASSOC NURSE AIDS C, V24, P98, DOI 10.1016/j.jana.2012.04.004; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	48	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111323	10.1371/journal.pone.0111323	http://dx.doi.org/10.1371/journal.pone.0111323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369333	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000048
J	Fransen, HP; May, AM; Beulens, JWJ; Struijk, EA; de Wit, GA; Boer, JMA; Onland-Moret, NC; Hoekstra, J; van der Schouw, YT; Bueno-De-Mesquita, HB; Peeters, PHM				Fransen, Heidi P.; May, Anne M.; Beulens, Joline W. J.; Struijk, Ellen A.; de Wit, G. Ardine; Boer, Jolanda M. A.; Onland-Moret, N. Charlotte; Hoekstra, Jeljer; van der Schouw, Yvonne T.; Bueno-de-Mesquita, H. Bas; Peeters, Petra H. M.			Association between Lifestyle Factors and Quality-Adjusted Life Years in the EPIC-NL Cohort	PLOS ONE			English	Article							MEDITERRANEAN DIET; RISK-FACTORS; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; 21 REGIONS; MORTALITY; HEALTH; BEHAVIORS; ALCOHOL; WOMEN	The aim of our study was to relate four modifiable lifestyle factors (smoking status, body mass index, physical activity and diet) to health expectancy, using quality-adjusted life years (QALYs) in a prospective cohort study. Data of the prospective EPIC-NL study were used, including 33,066 healthy men and women aged 20-70 years at baseline (1993-7), followed until 31-12-2007 for occurrence of disease and death. Smoking status, body mass index, physical activity and adherence to a Mediterranean-style diet (excluding alcohol) were investigated separately and combined into a healthy lifestyle score, ranging from 0 to 4. QALYs were used as summary measure of healthy life expectancy, combining a person's life expectancy with a weight for quality of life when having a chronic disease. For lifestyle factors analyzed separately the number of years living longer in good health varied from 0.12 year to 0.84 year, after adjusting for covariates. A combination of the four lifestyle factors was positively associated with higher QALYs (P-trend <0.0001). A healthy lifestyle score of 4 compared to a score of 0 was associated with almost a 2 years longer life in good health (1.75 QALYs [95% CI 1.37, 2.14]).	[Fransen, Heidi P.; May, Anne M.; Beulens, Joline W. J.; Struijk, Ellen A.; de Wit, G. Ardine; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Fransen, Heidi P.; Struijk, Ellen A.; de Wit, G. Ardine; Boer, Jolanda M. A.; Hoekstra, Jeljer; Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. Bas; Peeters, Petra H. M.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Bueno-de-Mesquita, H. Bas] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Imperial College London; Universiti Malaya	May, AM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	A.M.May@umcutrecht.nl	May, Anne M/G-9183-2011; van der Schouw, Yvonne T./F-8327-2014; Onland-Moret, N. Charlotte/G-9185-2011	van der Schouw, Yvonne T./0000-0002-4605-435X; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Beulens, Joline/0000-0002-4181-0937; , jeljer/0000-0001-8252-8906; Struijk, Ellen/0000-0002-9302-9616; de Wit, G. Ardine/0000-0002-1375-7657	"Europe against Cancer'' Program of the European Commission (SANCO); Dutch Ministry of Health; Dutch Cancer Society; Netherlands Organisation for Health research and Development (ZonMW) [40-00812-98-10040]; World Cancer Research Fund (WCRF)	"Europe against Cancer'' Program of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Health research and Development (ZonMW)(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	The EPIC-NL study was funded by the "Europe against Cancer'' Program of the European Commission (SANCO), the Dutch Ministry of Health, the Dutch Cancer Society, the Netherlands Organisation for Health research and Development (ZonMW, grant no 40-00812-98-10040), and the World Cancer Research Fund (WCRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Bronnum-Hansen H, 2007, SCAND J PUBLIC HEALT, V35, P510, DOI 10.1080/14034940701271908; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; May AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050712; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myint PK, 2011, AGE AGEING, V40, P589, DOI 10.1093/ageing/afr058; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Sluijs I, 2010, NETH J MED, V68, P333; Statistics Netherlands, 2012, LEV GESL LEEFT VAN 1; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116	24	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111480	10.1371/journal.pone.0111480	http://dx.doi.org/10.1371/journal.pone.0111480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369457	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000057
J	Jensen, DH; Hedback, N; Specht, L; Hogdall, E; Andersen, E; Therkildsen, MH; Friis-Hansen, L; Norrild, B; von Buchwald, C				Jensen, David Hebbelstrup; Hedback, Nora; Specht, Lena; Hogdall, Estrid; Andersen, Elo; Therkildsen, Marianne Hamilton; Friis-Hansen, Lennart; Norrild, Bodil; von Buchwald, Christian			Human Papillomavirus in Head and Neck Squamous Cell Carcinoma of Unknown Primary Is a Common Event and a Strong Predictor of Survival	PLOS ONE			English	Article							LYMPH-NODE METASTASES; CONTEMPORARY MANAGEMENT; ROBOTIC SURGERY; PRIMARY TUMORS; PRIMARY SITE; CANCER; HPV; DNA; PREVALENCE; ORIGIN	Background: The purpose of this study was to examine the prevalence of human papillomavirus (HPV) in patients with head and neck squamous cell carcinoma of unknown primary (CUP). Methods: All patients diagnosed with and treated for CUP between January 1, 2000, and June 1, 2011, at two Danish medical centers were included. All patients received a thorough diagnostic work-up, including FDG-PET, before being diagnosed as CUP. We determined the HPV status in all patients using a combination of HPV DNA PCR and p16 stain. In addition, clinical information on the study patients was retrieved from clinical records. Results: Of the identified 60 patients with CUP, 13 were shown to be positive for HPV DNA, amounting to 22% of the study population. In addition, we were able to show a clear disease-free and overall-survival benefit in the HPV-positive group, with a hazard ratio of 0.16 (95% CI: 0.038-0.67) for over-all survival. This survival benefit was also apparent when adjusted for advanced age in a multivariate Cox regression analysis. Conclusion: A fairly large percentage of CUP cases are HPV-related, and because this is related to both the location and prognosis, we recommend HPV testing as part of the diagnostic work-up.	[Jensen, David Hebbelstrup; Hedback, Nora; von Buchwald, Christian] Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Specht, Lena] Univ Copenhagen, Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Andersen, Elo] Univ Copenhagen, Herlev Hosp, Dept Oncol, DK-2730 Herlev, Denmark; [Therkildsen, Marianne Hamilton] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Friis-Hansen, Lennart] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Norrild, Bodil] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Jensen, DH (corresponding author), Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark.	david.hebbelstrup.jensen@regionh.dk	von Buchwald, Christian/D-5336-2016; Specht, Lena/J-6422-2019; Andersen, Elo/A-1639-2016	von Buchwald, Christian/0000-0001-6753-8129; Specht, Lena/0000-0002-6902-2190; Andersen, Elo/0000-0002-2476-1037; Friis-Hansen, Lennart/0000-0002-7222-0163; Hogdall, Estrid/0000-0003-4689-5658	Candys Foundation	Candys Foundation	David H. Jensen is supported by a grant from the non-profit foundation Candys Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armas GL, 2008, EUR ARCH OTO-RHINO-L, V265, P1379, DOI 10.1007/s00405-008-0670-4; Barnes L, 2005, PATHOLOGY GENETICS H; Barwad A, 2012, DIAGN CYTOPATHOL, V40, P893, DOI 10.1002/dc.21667; Begum S, 2003, CLIN CANCER RES, V9, P6469; Califano J, 1999, J NATL CANCER I, V91, P599, DOI 10.1093/jnci/91.7.599; Chernock RD, 2009, HEAD NECK PATHOL, V3, P186, DOI 10.1007/s12105-009-0126-1; Compton AM, 2011, OTOLARYNG HEAD NECK, V145, P51, DOI 10.1177/0194599811400385; Desai PC, 2009, EXP MOL PATHOL, V87, P94, DOI 10.1016/j.yexmp.2009.04.003; El-Mofty SK, 2008, HEAD NECK PATHOL, V2, P163, DOI 10.1007/s12105-008-0066-1; El-Mofty SK, 2003, AM J SURG PATHOL, V27, P1463, DOI 10.1097/00000478-200311000-00010; Goldenberg D, 2008, HEAD NECK-J SCI SPEC, V30, P898, DOI 10.1002/hed.20796; Grau C, 2000, RADIOTHER ONCOL, V55, P121, DOI 10.1016/S0167-8140(00)00172-9; Gronhoj Larsen C, 2014, BR J CANC; Groppo ER, 2011, LARYNGOSCOPE, V121, pS118; Hafkamp HC, 2008, INT J CANCER, V122, P2656, DOI 10.1002/ijc.23458; Hoffmann M, 2005, ACTA OTO-LARYNGOL, V125, P415, DOI 10.1080/00016480510028528; Hoffmann M, 2006, ANTICANCER RES, V26, P663; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Johansen J, 2002, LARYNGOSCOPE, V112, P2009, DOI 10.1097/00005537-200211000-00018; Keller LM, 2013, HEAD NECK; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mehta V, 2013, LARYNGOSCOPE, V123, P146, DOI 10.1002/lary.23562; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Patel SA, 2013, JAMA OTOLARYNGOL, V139, P1203, DOI 10.1001/jamaoto.2013.5189; Perkins SM, 2012, ARCH OTOLARYNGOL, V138, P656, DOI 10.1001/archoto.2012.1110; Sivars L, 2014, CANCER MED-US, V3, P376, DOI 10.1002/cam4.199; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Straetmans JMJAA, 2012, HEAD NECK-J SCI SPEC, V34, P1819, DOI 10.1002/hed.23166; Strojan P, 2013, HEAD NECK-J SCI SPEC, V35, P286, DOI 10.1002/hed.21899; Strojan P, 2013, HEAD NECK-J SCI SPEC, V35, P123, DOI 10.1002/hed.21898; Tribius S, 2012, ORAL ONCOL, V48, P1178, DOI 10.1016/j.oraloncology.2012.05.022; Weiss D, 2011, HEAD NECK-J SCI SPEC, V33, P856, DOI 10.1002/hed.21548; Westra WH, 2012, HEAD NECK PATHOL, V6, pS48, DOI 10.1007/s12105-012-0371-6; White HN, 2010, ARCH OTOLARYNGOL, V136, P1248, DOI 10.1001/archoto.2010.216; Zengel P, 2012, VIRCHOWS ARCH, V461, P283, DOI 10.1007/s00428-012-1290-3	35	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110456	10.1371/journal.pone.0110456	http://dx.doi.org/10.1371/journal.pone.0110456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369118	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000021
J	Mutwa, PR; Boer, KR; Asiimwe-Kateera, B; Tuyishimire, D; Muganga, N; Lange, JMA; van de Wijgert, J; Asiimwe, A; Reiss, P; Geelen, SPM				Mutwa, Philippe R.; Boer, Kimberly R.; Asiimwe-Kateera, Brenda; Tuyishimire, Diane; Muganga, Narcisse; Lange, Joep M. A.; van de Wijgert, Janneke; Asiimwe, Anita; Reiss, Peter; Geelen, Sibyl P. M.			Safety and Effectiveness of Combination Antiretroviral Therapy during the First Year of Treatment in HIV-1 Infected Rwandan Children: A Prospective Study	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CONTROLLED-TRIAL; VIRAL SUPPRESSION; UGANDAN CHILDREN; AFRICAN CHILDREN; DRUG-RESISTANCE; SOUTHERN AFRICA; WEST-AFRICA; NEVIRAPINE	Background: With increased availability of paediatric combination antiretroviral therapy (cART) in resource limited settings, cART outcomes and factors associated with outcomes should be assessed. Methods: HIV-infected children <15 years of age, initiating cART in Kigali, Rwanda, were followed for 18 months. Prospective clinical and laboratory assessments included weight-for-age (WAZ) and height-for-age (HAZ) z-scores, complete blood cell count, liver transaminases, creatinine and lipid profiles, CD4 T-cell count/percent, and plasma HIV-1 RNA concentration. Clinical success was defined as WAZ and WAZ >-22, immunological success as CD4 cells >= 500/mm(3) and >= 25% for respectively children over 5 years and under 5 years, and virological success as a plasma HIV-1 RNA concentration <40 copies/mL. Results: Between March 2008 and December 2009, 123 HIV-infected children were included. The median (interquartile (IQR) age at cART initiation was 7.4 (3.2, 11.5) years; 40% were <5 years and 54% were female. Mean (95% confidence interval (95% CI)) HAZ and WAZ at baseline were -2.01 (-2.23, -1.80) and -1.73 (-1.95, -1.50) respectively and rose to -1.75 (-1.98, -1.51) and -1.17 (-1.38, -0.96) after 12 months of cART. The median (IQR) CD4 T-cell values for children <5 and >= 5 years of age were 20% (13, 28) and 337 (236, 484) cells/mm(3) respectively, and increased to 36% (28, 41) and 620 (375, 880) cells/mm(3). After 12 months of cART, 24% of children had a detectable viral load, including 16% with virological failure (HIV-RNA>1000 c/mL). Older age at cART initiation, poor adherence, and exposure to antiretrovirals around birth were associated with virological failure. A third (33%) of children had side effects (by self-report or clinical assessment), but only 9% experienced a severe side effect requiring a cART regimen change. Conclusions: cART in Rwandan HIV-infected children was successful but success might be improved further by initiating cART as early as possible, optimizing adherence and optimizing management of side effects.	[Mutwa, Philippe R.; Muganga, Narcisse] Kigali Univ, Teaching Hosp, Dept Pediat, Kigali, Rwanda; [Mutwa, Philippe R.; Boer, Kimberly R.; Asiimwe-Kateera, Brenda; Lange, Joep M. A.; van de Wijgert, Janneke; Reiss, Peter; Geelen, Sibyl P. M.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Mutwa, Philippe R.; Boer, Kimberly R.; Asiimwe-Kateera, Brenda; Lange, Joep M. A.; van de Wijgert, Janneke; Reiss, Peter; Geelen, Sibyl P. M.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [van de Wijgert, Janneke] Rinda Ubuzima, Kigali, Rwanda; [Geelen, Sibyl P. M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Boer, Kimberly R.] Royal Trop Inst, Epidemiol Unit, NL-1105 AZ Amsterdam, Netherlands; [Tuyishimire, Diane] Treatment & Res HIV AIDS Ctr, Outpatients Clin, Kigali, Rwanda; [Asiimwe, Anita] Minist Hlth Rwanda, Kigali, Rwanda	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Mutwa, PR (corresponding author), Kigali Univ, Teaching Hosp, Dept Pediat, Kigali, Rwanda.	mutwaph@gmail.com	Asiimwe-Kateera, Brenda/H-3378-2019	Asiimwe Kateera, Brenda/0000-0001-6134-1042; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Infectious Diseases Network for Treatment and Research in Africa; Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP)	Infectious Diseases Network for Treatment and Research in Africa; Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP)	This work was funded by Infectious Diseases Network for Treatment and Research in Africa. An African-Dutch partnership programme, funded by The Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, DIVISION AIDS TABLE; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Azmeraw Daniel, 2012, Ethiop Med J, V50, P115; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; de Padua CAM, 2006, BRAZ J MED BIOL RES, V39, P495, DOI 10.1590/S0100-879X2006000400010; Essajee SM, 1999, AIDS, V13, P2523, DOI 10.1097/00002030-199912240-00005; Franco JM, 2000, CLIN EXP IMMUNOL, V119, P493, DOI 10.1046/j.1365-2249.2000.01152.x; Gusdal AK, 2011, AIDS CARE, V23, P657, DOI 10.1080/09540121.2010.532531; HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children-A Working Group of the Office of AIDS Research Advisory Council (OARAC), 2012, GUID US ANT AG PED H; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; King JR, 2002, CLIN PHARMACOKINET, V41, P1115, DOI 10.2165/00003088-200241140-00001; Lapphra K, 2008, INT J INFECT DIS, V12, pE33, DOI 10.1016/j.ijid.2007.10.008; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Mghamba FW, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-95; Mofenson LM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18650; Mofenson Lynne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Musiime V, 2013, AIDS RES HUM RETROV, V29, P449, DOI 10.1089/aid.2012.0283; Musoke PM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-56; Mutwa PR, 2014, PEDIATR INFECT DIS J, V33, P63, DOI 10.1097/INF.0b013e31829e6b9f; Mutwa PR, 2012, JAIDS-J ACQ IMM DEF, V60, P400, DOI 10.1097/QAI.0b013e3182569f57; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nachman SA, 2000, JAMA-J AM MED ASSOC, V283, P492, DOI 10.1001/jama.283.4.492; National Institute of Statistics of Rwanda/Ministry of Finance and Economic Planning R, 2012, COMPR FOOD SEC VULN; National Institute of Statistics Rwanda, 2010, RWAND DEM HLTH SURV; Ndumbi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094018; Okomo U, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-95; Oumar Aboubacar A, 2012, J Pediatr Pharmacol Ther, V17, P382, DOI 10.5863/1551-6776-17.4.382; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; PALUMBO PE, 1995, J PEDIATR-US, V126, P592, DOI 10.1016/S0022-3476(95)70357-8; Pelton SI, 1999, PEDIATR INFECT DIS J, V18, P650, DOI 10.1097/00006454-199907000-00019; Penazzato M, 2012, JAIDS-J ACQ IMM DEF, V61, P522, DOI 10.1097/QAI.0b013e31826f369d; Persaud D, 2011, AIDS RES HUM RETROV, V27, P823, DOI [10.1089/aid.2010.0346, 10.1089/AID.2010.0346]; Phan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030647; Pryce C, 2008, W INDIAN MED J, V57, P238; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Rwdanda Ministry of Health, 2009, GUID PROV COMPR CAR; Rwdanda Ministry of Health, 2012, NAT GUID COMPR CAR P; Rwdanda Ministry of Health, 2007, GUID PRIS CHARG PERS; Rwdanda Ministry of Health, 2012, NAT ANN REP HIV AIDS; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Shah I, 2006, J TROP PEDIATRICS, V52, P244, DOI 10.1093/tropej/fmi086; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Soh CH, 2003, LANCET, V362, P2045, DOI 10.1016/S0140-6736(03)15098-2; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Sutcliffe CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029294; Sutcliffe CG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-54; Sutcliffe CG, 2010, LANCET INFECT DIS, V10, P630, DOI 10.1016/S1473-3099(10)70116-X; Teasdale CA, 2013, PEDIATR INFECT DIS J, V32, P489, DOI 10.1097/INF.0b013e31827e84ba; Tukei VJ, 2012, JAIDS-J ACQ IMM DEF, V59, P274, DOI 10.1097/QAI.0b013e3182423668; van Rossum AMC, 2002, CLIN INFECT DIS, V34, P1008, DOI 10.1086/339443; Vreeman RC, 2008, JAIDS-J ACQ IMM DEF, V49, P163, DOI 10.1097/QAI.0b013e318183a996; Vyankandondera J, 2013, AIDS CARE, V25, P1504, DOI 10.1080/09540121.2013.779626; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007; Wamalwa DC, 2007, JAIDS-J ACQ IMM DEF, V45, P311; Wittkop L, 2013, 7 C HIV PATH TREATM; World Health Organisation, 2006, ANT THER HIV INF INF; Yotebieng M, 2010, AIDS, V24, P139, DOI 10.1097/QAD.0b013e328332d5ca	65	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111948	10.1371/journal.pone.0111948	http://dx.doi.org/10.1371/journal.pone.0111948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365302	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100139
J	Pitta, DW; Parmar, N; Patel, AK; Indugu, N; Kumar, S; Prajapathi, KB; Patel, AB; Reddy, B; Joshi, C				Pitta, Dipti W.; Parmar, Nidhi; Patel, Amrut K.; Indugu, Nagaraju; Kumar, Sanjay; Prajapathi, Karsanbhai B.; Patel, Anand B.; Reddy, Bhaskar; Joshi, Chaitanya			Bacterial Diversity Dynamics Associated with Different Diets and Different Primer Pairs in the Rumen of Kankrej Cattle	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; REAL-TIME PCR; GRADIENT GEL-ELECTROPHORESIS; INTERGENIC SPACER ANALYSIS; POLYMERASE-CHAIN-REACTION; MICROBIAL COMMUNITIES; GASTROINTESTINAL-TRACT; CELLULOLYTIC BACTERIA; PHYLOGENETIC ANALYSIS; RUMINAL ACIDOSIS	The ruminal microbiome in herbivores plays a dominant role in the digestion of lignocellulose and has potential to improve animal productivity. Kankrej cattle, a popular native breed of the Indian subcontinent, were used to investigate the effect of different dietary treatments on the bacterial diversity in ruminal fractions using different primer pairs. Two groups of four cows were assigned to two primary diets of either dry or green forages. Each group was fed one of three dietary treatments for six weeks each. Dietary treatments were; K1 (50% dry/green roughage: 50% concentrate), K2 (75% dry/green roughage: 25% concentrate) and K3 (100% dry/green roughage). Rumen samples were collected using stomach tube at the end of each dietary period and separated into solid and liquid fractions. The DNA was extracted and amplified for V1-V3, V4-V5 and V6-V8 hypervariable regions using P1, P2 and P3 primer pairs, sequenced on a 454 Roche platform and analyzed using QIIME. Community compositions and the abundance of most bacterial lineages were driven by interactions between primer pair, dietary treatment and fraction. The most abundant bacterial phyla identified were Bacteroidetes and Firmicutes however, the abundance of these phyla varied between different primer pairs; in each primer pair the abundance was dependent on the dietary treatment and fraction. The abundance of Bacteroidetes in cattle receiving K1 treatment indicate their diverse functional capabilities in the digestion of both carbohydrate and protein while the predominance of Firmicutes in the K2 and K3 treatments signifies their metabolic role in fibre digestion. It is apparent that both liquid and solid fractions had distinct bacterial community patterns (P<0.001) congruent to changes in the dietary treatments. It can be concluded that the P1 primer pair flanking the V1-V3 hyper-variable region provided greater species richness and diversity of bacterial populations in the rumen of Kankrej cattle.	[Pitta, Dipti W.; Indugu, Nagaraju; Kumar, Sanjay] Univ Penn, Sch Vet Med, Ctr Anim Hlth & Prod, Philadelphia, PA 19104 USA; [Parmar, Nidhi; Patel, Amrut K.; Patel, Anand B.; Reddy, Bhaskar; Joshi, Chaitanya] Anand Agr Univ, Dept Anim Biotechnol, Ome Res Facil, Anand, Gujarat, India; [Prajapathi, Karsanbhai B.] Sardar Krushi Nagar Dantiwada Agr Univ, Coll Vet Sci & Anim Husb, Livestock Prod & Management Dept, Sardar Krushi Nagar, Gujarat, India	University of Pennsylvania; Anand Agricultural University	Pitta, DW (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Hlth & Prod, Philadelphia, PA 19104 USA.	dpitta@vet.upenn.edu	Joshi, Chaitanya G/A-2591-2013; Indugu, Nagaraju/AAT-7497-2021; Gohil, Nidhi Nidhi R Parmar/AAU-9206-2020; Joshi, Chaitanya G/AAK-1842-2020	Joshi, Chaitanya G/0000-0003-4680-2861; Indugu, Nagaraju/0000-0001-9424-2155; Gohil, Nidhi Nidhi R Parmar/0000-0002-3814-0629; Joshi, Chaitanya G/0000-0003-4680-2861; Patel, Amrutlal/0000-0003-1021-4013; Kumar, Sanjay/0000-0002-0937-918X; Reddy, Bhaskar/0000-0002-8177-9305	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	Funding was received from the Indian Council of Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baker GC, 2004, BIOCHEM SOC T, V32, P218, DOI 10.1042/BST0320218; Bates D., 2013, LME4 LINEAR MIXED EF; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Chaucheyras-Durand F., 2014, Professional Animal Scientist, V30, P1; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089682; Hernandez-Sanabria E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058461; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; HUNGATE RE, 1966, RUMEN ITS MICROBES; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Jumpponen A, 2007, MICROB ECOL, V53, P233, DOI 10.1007/s00248-004-0006-x; Kale DS, 2010, INDIAN J BIOTECHNOL, V9, P126; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Li ZP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-151; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Michalet-Doreau B, 2002, J ANIM SCI, V80, P790; Michalet-Doreau B, 2001, REPROD NUTR DEV, V41, P187, DOI 10.1051/rnd:2001122; Mona Upreti, 2012, African Journal of Biotechnology, V11, P16313; Morgavi DP, 2013, ANIMAL, V7, P184, DOI 10.1017/S1751731112000419; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Mukesh M, 2009, LIVEST SCI, V121, P72, DOI 10.1016/j.livsci.2008.05.019; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Oksanen J., **DATA OBJECT**; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinloche E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067824; Pitta DW, 2014, J ANIM SCI, V92, P4014, DOI 10.2527/jas.2014-7621; Pitta DW, 2014, ANAEROBE, V25, P31, DOI 10.1016/j.anaerobe.2013.11.008; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RCore Team, 2020, R LANG ENV STAT COMP; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Saro C, 2012, J ANIM SCI, V90, P4487, DOI 10.2527/jas.2012-5265; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Thomas F., 2011, FRONT MICROBIOL, P2, DOI DOI 10.3049/FMICB.2011.00093; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2; Wallace RJ, 1996, J NUTR, V126, pS1326, DOI 10.1093/jn/126.suppl_4.1326S; WALLACE RJ, 1979, NATURE, V279, P424, DOI 10.1038/279424a0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	74	48	68	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111710	10.1371/journal.pone.0111710	http://dx.doi.org/10.1371/journal.pone.0111710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365522	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100109
J	Stidham, TA; Krishan, K; Singh, B; Ghosh, A; Patnaik, R				Stidham, Thomas A.; Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik; Patnaik, Rajeev			A Pelican Tarsometatarsus (Aves: Pelecanidae) from the Latest Pliocene Siwaliks of India	PLOS ONE			English	Article								We report a new fossil specimen of a pelican from the Tatrot Formation of the Siwalik Hills, India. It likely represents Pelecanus sivalensis Davies, 1880, the smaller of the two previously published species from the Siwalik Group stratigraphic sequence. This complete tarsometatarsus is the first fossil bone of a pelican collected in India for over 100 years. It is from the latest Pliocene (similar to 2.6 Ma), and is the youngest pelican fossil from the region. The new specimen exhibits a derived distoplantar 'slant' to the plantar margin of the medial crest of the hypotarsus, and a combination of features related to the morphology of the hypotarsus, the distal foramen, trochleae, and overall size that allow further differentiation from known tarsometatarsi of fossil and extant pelicans, including the three species of extant pelicans that occur in India ( Pelecanus crispus, P. onocrotalus, and P. philippensis). It is of appropriate size for Pelecanus sivalensis, which to date has been known only by fragments of other skeletal elements of the wing, leg, and shoulder girdle. Thus, the observation that this tarsometatarsus is morphologically distinct from those of known pelicans provides further support for the distinctiveness of at least one extinct species of pelican from the Siwalik Group sediments. While the morphology of the tarsometatarsus allows for separation from other taxa known from tarsometatarsi, we found no clear shared derived states to place this taxon with any confidence in a phylogenetic context relative to any other pelican species, or even determine if it is part of the crown group of Pelecanidae. However, published molecular data are consistent with an origin of the crown clade prior to the Pleistocene, suggesting (along with one morphological character) the possibility that this species belongs to the Old World clade of pelican species.	[Stidham, Thomas A.] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Systemat, Beijing, Peoples R China; [Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik] Panjab Univ, Dept Anthropol, Chandigarh 160014, India; [Patnaik, Rajeev] Panjab Univ, Dept Geol, Chandigarh 160014, India	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Panjab University; Panjab University	Stidham, TA (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Systemat, Beijing, Peoples R China.	presbyornis@gmail.com	Singh, Bahadur/H-5783-2019; Ghosh, Abhik/AAH-1277-2020; Krishan, Kewal/I-3285-2014	Singh, Bahadur/0000-0002-5370-6029; Ghosh, Abhik/0000-0003-1161-6364; Krishan, Kewal/0000-0001-5321-0958	Chinese Academy of Sciences Professorship for Visiting Senior International Scientists Grant [2011Y2ZA01]; Strategic Priority Research Program of Chinese Academy of Sciences (CAS) [XDB03020501]; DST PURSE Grant	Chinese Academy of Sciences Professorship for Visiting Senior International Scientists Grant; Strategic Priority Research Program of Chinese Academy of Sciences (CAS); DST PURSE Grant	TAS is supported by a Chinese Academy of Sciences Professorship for Visiting Senior International Scientists Grant (2011Y2ZA01) and Strategic Priority Research Program of Chinese Academy of Sciences (CAS, XDB03020501). RP acknowledges funding from the DST PURSE Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry John C., 2013, P373; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Cheneval J., 1984, Palaeovertebrata (Montpellier), V14, P33; Davies W., 1880, GEOL MAG, V7, P18, DOI [10.1017/S0016756800146904, DOI 10.1017/S0016756800146904]; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Harrison C.J.O., 1976, Bulletin Br Mus nat Hist (Geol), V27, P315; Harrison C.J.O., 1982, Tertiary Research, V4, P53; Kennedy M, 2013, MOL PHYLOGENET EVOL, V66, P215, DOI 10.1016/j.ympev.2012.09.034; KUMAR R, 1985, SEDIMENT GEOL, V105, P1; Kumaravel V, 2005, CURR SCI INDIA, V88, P1453; Louchart A, 2008, J HUM EVOL, V55, P513, DOI 10.1016/j.jhevol.2008.06.002; Louchart A, 2011, J ORNITHOL, V152, P15, DOI 10.1007/s10336-010-0537-5; Lydekker R., 1891, CATALOGUE FOSSIL BIR; Miller A. H., 1966, Memoirs of the Queensland Museum, V14, P181; Nanda A.C., 1979, Himalayan Geology, V8, P149; Olson S.L., 1985, Avian Biology, V8, P79; Olson SL, 1999, P BIOL SOC WASH, V112, P503; Patnaik Rajeev, 2013, P423; PILBEAM D, 1979, POSTILLA, V179, P1; RICH P V, 1981, Records of the South Australian Museum (Adelaide), V18, P235; SAHNI A, 1980, PALAEOGEOGR PALAEOCL, V31, P39, DOI 10.1016/0031-0182(80)90003-6; Smith ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013354; Tandon SK, 1984, J GEOL SOC INDIA, V46, P429; Tripathi C., 1986, J PALAEONTOL SOC IND, V31, P1; [No title captured]	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111210	10.1371/journal.pone.0111210	http://dx.doi.org/10.1371/journal.pone.0111210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365300	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100055
J	Zhang, J; Ketola, T; Ormala-Odegrip, AM; Mappes, J; Laakso, J				Zhang, Ji; Ketola, Tarmo; Ormala-Odegrip, Anni-Maria; Mappes, Johanna; Laakso, Jouni			Coincidental Loss of Bacterial Virulence in Multi-Enemy Microbial Communities	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; AMEBA ACANTHAMOEBA-CASTELLANII; MEDIA COMPOSITION INFLUENCES; LEGIONELLA-PNEUMOPHILA; DICTYOSTELIUM-DISCOIDEUM; ANTAGONISTIC COEVOLUTION; TETRAHYMENA-THERMOPHILA; LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; SERRATIA-MARCESCENS	The coincidental virulence evolution hypothesis suggests that outside-host selection, such as predation, parasitism and resource competition can indirectly affect the virulence of environmentally-growing bacterial pathogens. While there are some examples of coincidental environmental selection for virulence, it is also possible that the resource acquisition and enemy defence is selecting against it. To test these ideas we conducted an evolutionary experiment by exposing the opportunistic pathogen bacterium Serratia marcescens to the particle-feeding ciliate Tetrahymena thermophila, the surface-feeding amoeba Acanthamoeba castellanii, and the lytic bacteriophage Semad11, in all possible combinations in a simulated pond water environment. After 8 weeks the virulence of the 384 evolved clones were quantified with fruit fly Drosophila melanogaster oral infection model, and several other life-history traits were measured. We found that in comparison to ancestor bacteria, evolutionary treatments reduced the virulence in most of the treatments, but this reduction was not clearly related to any changes in other life-history traits. This suggests that virulence traits do not evolve in close relation with these life-history traits, or that different traits might link to virulence in different selective environments, for example via resource allocation trade-offs.	[Zhang, Ji; Ketola, Tarmo; Mappes, Johanna; Laakso, Jouni] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla, Finland; [Zhang, Ji; Ormala-Odegrip, Anni-Maria; Laakso, Jouni] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland	University of Jyvaskyla; University of Helsinki	Zhang, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla, Finland.	Ji.Zhang@Helsinki.Fi	Mappes, Johanna/AAZ-3627-2021; Ketola, Tarmo/AAD-2609-2019; Laakso, Jouni/I-7794-2013	Ketola, Tarmo/0000-0001-5151-7980; Zhang, Ji/0000-0003-2582-2978; Laakso, Jouni/0000-0001-8245-9912; Mappes, Johanna/0000-0002-1117-5629	Finnish Academy [1130724, 1255572]; CoE in Biological Interactions [252411]; Finnish Cultural Foundation; Ellen and Artturi Nyyssonen Foundation	Finnish Academy(Academy of Finland); CoE in Biological Interactions; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ellen and Artturi Nyyssonen Foundation	This work was supported by the Finnish Academy to JL, 1130724 and 1255572 (URL: www.aka.fi), which had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This work was also supported by the CoE in Biological Interactions to JM, 252411 (URL: https://www.jyu.fi/bioenv/en/divisions/coe-interactions), which had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This work was also supported by the Finnish Cultural Foundation to JZ (URL: www.skr.fi), which had a role in data collection and analysis, decision to publish and preparation of the manuscript. This work was also supported by the Ellen and Artturi Nyyssonen Foundation to JZ (URL: www.eans.fi), which had a role in study design, data collection and analysis.	Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127; Adiba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011882; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Ali S, 2009, ENTOMOL EXP APPL, V131, P30, DOI 10.1111/j.1570-7458.2009.00833.x; [Anonymous], 1988, NEW KEY FRESHWATER S; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bonifait L, 2011, APPL ENVIRON MICROB, V77, P6271, DOI 10.1128/AEM.00659-11; Boyd EF, 2012, ADV VIRUS RES, V82, P91, DOI 10.1016/B978-0-12-394621-8.00014-5; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Casas V, 2011, FUTURE MICROBIOL, V6, P1461, DOI [10.2217/fmb.11.124, 10.2217/FMB.11.124]; CHESBRO WR, 1969, CAN J MICROBIOL, V15, P723, DOI 10.1139/m69-127; Coombes BK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00090; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Ensminger AW, 2012, PLOS PATHOG, V8; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLYG C, 1980, J GEN MICROBIOL, V120, P173; FRIEDMAN ME, 1962, J BACTERIOL, V83, P456, DOI 10.1128/JB.83.3.456-462.1962; Friman VP, 2011, J EVOLUTION BIOL, V24, P2563, DOI 10.1111/j.1420-9101.2011.02379.x; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Friman VP, 2011, AM NAT, V177, P334, DOI 10.1086/658364; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2004, EMERG INFECT DIS, V10, P470, DOI 10.3201/eid1003.020792; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Hall AR, 2008, J EVOLUTION BIOL, V21, P610, DOI 10.1111/j.1420-9101.2007.01473.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hasselbring BM, 2011, INFECT IMMUN, V79, P2079, DOI 10.1128/IAI.01233-10; HECKLY RJ, 1980, APPL ENVIRON MICROB, V39, P541, DOI 10.1128/AEM.39.3.541-543.1980; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kennedy GM, 2012, APPL ENVIRON MICROB, V78, P2049, DOI 10.1128/AEM.06965-11; Ketola T, 2013, EVOLUTION, V67, P2936, DOI 10.1111/evo.12148; KIY T, 1992, APPL MICROBIOL BIOT, V37, P576; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Laakso J, 2003, OIKOS, V102, P663, DOI 10.1034/j.1600-0706.2003.12319.x; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LEVIN BR, 1990, PARASITOLOGY, V100, pS103, DOI 10.1017/S0031182000073054; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Midelet-Bourdin G, 2006, J APPL MICROBIOL, V101, P300, DOI 10.1111/j.1365-2672.2006.02925.x; Mikonranta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043801; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ohno A, 2008, APPL ENVIRON MICROB, V74, P4585, DOI 10.1128/AEM.00083-08; Page F. C, 1976, ILLUSTRATED KEY FRES; Potvin C, 2001, DESIGN ANAL ECOLOGIC, P69; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Safavi SA, 2007, FEMS MICROBIOL LETT, V270, P116, DOI 10.1111/j.1574-6968.2007.00666.x; Sahly H, 2008, INFECT IMMUN, V76, P1322, DOI 10.1128/IAI.00910-07; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Wu JH, 2010, PAK J ZOOL, V42, P451; Zhang J, 2012, ECOL EVOL, V2, P2347, DOI 10.1002/ece3.356	82	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111871	10.1371/journal.pone.0111871	http://dx.doi.org/10.1371/journal.pone.0111871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365586	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000345558100133
J	Pel, MJC; Wintermans, PCA; Cabral, A; Robroek, BJM; Seidl, MF; Bautor, J; Parker, JE; Van den Ackerveken, G; Pieterse, CMJ				Pel, Michiel J. C.; Wintermans, Paul C. A.; Cabral, Adriana; Robroek, Bjorn J. M.; Seidl, Michael F.; Bautor, Jaqueline; Parker, Jane E.; Van den Ackerveken, Guido; Pieterse, Corne M. J.			Functional Analysis of Hyaloperonospora arabidopsidis RXLR Effectors	PLOS ONE			English	Article							POTATO FAMINE PATHOGEN; HOST-TARGETING SIGNAL; PHYTOPHTHORA-INFESTANS; DOWNY MILDEW; SALICYLIC-ACID; PLANT IMMUNITY; BACTERIAL FLAGELLIN; SYSTEMIC RESISTANCE; DISEASE RESISTANCE; OOMYCETE EFFECTORS	The biotrophic plant pathogen Hyaloperonospora arabidopsidis produces a set of putative effector proteins that contain the conserved RXLR motif. For most of these RXLR proteins the role during infection is unknown. Thirteen RXLR proteins from H. arabidopsidis strain Waco9 were analyzed for sequence similarities and tested for a role in virulence. The thirteen RXLR proteins displayed conserved N-termini and this N-terminal conservation was also found in the 134 predicted RXLR genes from the genome of H. arabidopsidis strain Emoy2. To investigate the effects of single RXLR effector proteins on plant defense responses, thirteen H. arabidopsidis Waco9 RXLR genes were expressed in Arabidopsis thaliana. Subsequently, these plants were screened for altered susceptibility to the oomycetes H. arabidopsidis and Phytophthora capsici, and the bacterial pathogen Pseudomonas syringae. Additionally, the effect of the RXLR proteins on flg22-triggered basal immune responses was assessed. Multifactorial analysis of results collated from all experiments revealed that, except for RXLR20, all RXLR effector proteins tested affected plant immunity. For RXLR9 this was confirmed using a P. syringae DCEL-mediated effector delivery system. Together, the results show that many H. arabidopsidis RXLR effectors have small effects on the plant immune response, suggesting that suppression of host immunity by this biotrophic pathogen is likely to be caused by the combined actions of effectors.	[Pel, Michiel J. C.; Wintermans, Paul C. A.; Cabral, Adriana; Robroek, Bjorn J. M.; Seidl, Michael F.; Van den Ackerveken, Guido; Pieterse, Corne M. J.] Univ Utrecht, Fac Sci, Dept Biol, Plant Microbe Interact, Utrecht, Netherlands; [Pel, Michiel J. C.; Seidl, Michael F.; Van den Ackerveken, Guido; Pieterse, Corne M. J.] Ctr BioSyst Genom, Wageningen, Netherlands; [Bautor, Jaqueline; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Cologne, Germany	Utrecht University; Centre for BioSystems Genomics; Max Planck Society	Pieterse, CMJ (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Plant Microbe Interact, Utrecht, Netherlands.	C.M.J.Pieterse@uu.nl	Seidl, Michael F./ABD-6042-2021; Robroek, Bjorn/P-7929-2016; Pel, Michiel/A-3638-2014; Van den Ackerveken, Guido/B-8568-2011; Pieterse, Corné/A-9326-2011; Cabral, Adriana/AAX-3284-2021	Robroek, Bjorn/0000-0002-6714-0652; Van den Ackerveken, Guido/0000-0002-0183-8978; Pieterse, Corné/0000-0002-5473-4646; Seidl, Michael F/0000-0002-5218-2083	Centre for BioSystems Genomics [CBSG-PG7, CBSG-PG8, CBSG-BB16]; European Research Council (ERC) [269072]	Centre for BioSystems Genomics; European Research Council (ERC)(European Research Council (ERC))	This work was supported by the Centre for BioSystems Genomics [projects CBSG-PG7, CBSG-PG8 and CBSG-BB16] and the European Research Council (ERC) [ERC Advanced Grant agreement number 269072 - PLANTIMMUSYS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARIZTIA EV, 1991, J PHYCOL, V27, P428, DOI 10.1111/j.0022-3646.1991.00428.x; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Cabral A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019328; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fabro G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002348; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FINCHAM JRS, 1989, MICROBIOL REV, V53, P148, DOI 10.1128/MMBR.53.1.148-170.1989; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Goritschnig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002502; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoagland DR, 1938, Calif Agric Exp Stn Bull, V347, P36; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Jassey VEJ, 2011, GLOBAL CHANGE BIOL, V17, P2945, DOI 10.1111/j.1365-2486.2011.02437.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JUDELSON HS, 1993, GENE, V133, P63, DOI 10.1016/0378-1119(93)90225-R; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pel MJC, 2013, J EXP BOT, V64, P1237, DOI 10.1093/jxb/ers262; Perumal R, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-77; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; PIETERSE CMJ, 1991, PLANT MOL BIOL, V17, P799, DOI 10.1007/BF00037062; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; PIETERSE CMJ, 1994, MOL GEN GENET, V244, P269, DOI 10.1007/BF00285454; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; R Core Team, 2012, R LANG ENV STAT COMP; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Suzuki R, 2011, PVCLUST HIERARCHICAL; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2009, PLANT CELL, V21, P2179, DOI 10.1105/tpc.109.066811; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; van Wees SCM, 1999, PLANT MOL BIOL, V41, P537, DOI 10.1023/A:1006319216982; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang Y, 2013, PLANT CELL ENVIRON, V36, P1192, DOI 10.1111/pce.12052; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108	68	10	11	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110624	10.1371/journal.pone.0110624	http://dx.doi.org/10.1371/journal.pone.0110624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375163	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600018
J	Zhang, MQ; Wan, Y; Jin, Y; Xin, JB; Zhang, JC; Xiong, XZ; Chen, L; Chen, G				Zhang, Ming-Qiang; Wan, Yong; Jin, Yang; Xin, Jian-Bao; Zhang, Jian-Chu; Xiong, Xian-Zhi; Chen, Long; Chen, Gang			Cigarette Smoking Promotes Inflammation in Patients with COPD by Affecting the Polarization and Survival of Th/Tregs through Up-Regulation of Muscarinic Receptor 3 and 5 Expression	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NONNEURONAL CHOLINERGIC SYSTEM; T-CELL-ACTIVATION; AIRWAY-OBSTRUCTION; EPITHELIAL-CELLS; IMMUNE FUNCTION; TH17 CELLS; APOPTOSIS; ACETYLCHOLINE; MECHANISMS	Background: CD4(+) T cells in the lung are involved in the pathogenesis of chronic obstructive pulmonary disease (COPD), although CD4(+) T cell subsets and the direct effect of smoking on these cells, especially the expression of MRs, have not been comprehensively examined. Methods: First, circulating CD4(+) T cell subsets in healthy nonsmokers, patients with SCOPD and patients with AECOPD were evaluated by flow cytometry. Then, differentiation experiments were carried out using RT-PCR, and Ki-67/Annexin V antibodies were used to measure proliferation and apoptosis. We also explored the impact of CSE on the differentiation and survival of CD4(+) Th/Tregs and examined the expression of MRs in healthy nonsmokers and patients with SCOPD. Results: We found the percentages of circulating Th1 and Th17 cells were increased in patients with AECOPD, while the percentage of Th2 cells was decreased in patients with SCOPD. The percentages of Th10 cells were decreased in both patients with SCOPD and patients with AECOPD, while the percentages of Tregs were increased. In addition, the percentages of CD4(+) alpha-7(+) T cells were decreased in patients with SCOPD and patients with AECOPD. However, only the decrease observed in patients with AECOPD was significant. In vitro studies also revealed MR expression affected the polarization of T cells, with different CD4(+) T cell subtypes acquiring different MR expression profiles. The addition of CSE facilitated CD4(+) T cell polarization towards pro-inflammatory subsets (Th1 and Th17) and affected the survival of CD4(+) T cells and Treg cells by up-regulating the expression of MR3 and 5, resulting in an imbalance of CD4(+) T cell subsets. Conclusions: Our findings suggest an imbalance of circulating CD4(+) T cell subsets is involved in COPD pathogenesis in smokers. Cigarette smoking may contribute to this imbalance by affecting the polarization and survival of Th/Tregs through the up-regulation of MR3 and MR5.	[Zhang, Ming-Qiang; Jin, Yang; Xin, Jian-Bao; Zhang, Jian-Chu; Xiong, Xian-Zhi; Chen, Long; Chen, Gang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Resp & Crit Care Med,Key Lab Pulm Dis Hlth M, Wuhan 430074, Peoples R China; [Wan, Yong] WUHAN 1 HOSP, Dept Resp & Crit Care Med, Wuhan, Peoples R China	Huazhong University of Science & Technology	Xiong, XZ (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Resp & Crit Care Med,Key Lab Pulm Dis Hlth M, Wuhan 430074, Peoples R China.	xxz0508@hust.edu.cn	Jin, Yang/AAX-2586-2021		Science and Technology Program of Wuhan, China [201052399660]; Natural Science Fund of Hubei Province, China [2010CDB07805]; National Natural Science Foundation of China [81370146]	Science and Technology Program of Wuhan, China; Natural Science Fund of Hubei Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant from the Science and Technology Program of Wuhan, China (No. 201052399660), and in part by a grant from the Natural Science Fund of Hubei Province, China (No. 2010CDB07805); and in part by a grant from the National Natural Science Foundation of China (No. 81370146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J ALLERGY; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BLUE ML, 1978, AM REV RESPIR DIS, V117, P317; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Fujii T, 2008, J PHARMACOL SCI, V106, P186, DOI 10.1254/jphs.FM0070109; Glader P, 2006, RESP MED, V100, P818, DOI 10.1016/j.rmed.2005.09.008; Glader P, 2006, RESP MED, V100, P1088, DOI 10.1016/j.rmed.2005.09.025; Grando SA, 2012, LIFE SCI, V91, P969, DOI 10.1016/j.lfs.2012.10.004; GROSS NJ, 1984, NEW ENGL J MED, V311, P421, DOI 10.1056/NEJM198408163110701; HellstromLindahl E, 1996, J NEUROIMMUNOL, V68, P139, DOI 10.1016/0165-5728(96)00079-3; Hodge G, 2007, CLIN EXP IMMUNOL, V150, P22, DOI 10.1111/j.1365-2249.2007.03451.x; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hou J, 2013, THORAX; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Isajevs S, 2009, EUR RESPIR J, V33, P61, DOI 10.1183/09031936.00145307; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; Lane N, 2010, CLIN SCI, V119, P75, DOI 10.1042/CS20100033; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Noakes PS, 2003, ALLERGY, V58, P1053, DOI 10.1034/j.1398-9995.2003.00290.x; Pace E, 2004, J ALLERGY CLIN IMMUN, V114, P1216, DOI 10.1016/j.jaci.2004.07.052; Profita M, 2014, IMMUNOBIOLOGY, V219, P392, DOI 10.1016/j.imbio.2014.01.004; Profita M, 2012, IMMUNOBIOLOGY, V217, P345, DOI 10.1016/j.imbio.2011.07.013; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAETTA M, 1993, AM REV RESPIR DIS, V147, P301, DOI 10.1164/ajrccm/147.2.301; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tan DB, 2014, IMMUNOBIOLOGY; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Wang H., 2014, CLIN RESP J; Wessler I, 2001, JPN J PHARMACOL, V85, P2, DOI 10.1254/jjp.85.2; Wouters Emiel F M, 2005, Proc Am Thorac Soc, V2, P26, DOI 10.1513/pats.200408-039MS; Zhang JC, 2011, J HUAZHONG U SCI-MED, V31, P463, DOI 10.1007/s11596-011-0474-4; Zhong CY, 2008, TOXICOL APPL PHARM, V230, P150, DOI 10.1016/j.taap.2008.02.005; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	46	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112350	10.1371/journal.pone.0112350	http://dx.doi.org/10.1371/journal.pone.0112350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375131	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600134
J	Ekwaru, JP; Zwicker, JD; Holick, MF; Giovannucci, E; Veugelers, PJ				Ekwaru, John Paul; Zwicker, Jennifer D.; Holick, Michael F.; Giovannucci, Edward; Veugelers, Paul J.			The Importance of Body Weight for the Dose Response Relationship of Oral Vitamin D Supplementation and Serum 25-Hydroxyvitamin D in Healthy Volunteers	PLOS ONE			English	Article							D DEFICIENCY; WOMEN	Unlike vitamin D recommendations by the Institute of Medicine, the Clinical Practice Guidelines by the Endocrine Society acknowledge body weight differentials and recommend obese subjects be given two to three times more vitamin D to satisfy their body's vitamin D requirement. However, the Endocrine Society also acknowledges that there are no good studies that clearly justify this. In this study we examined the combined effect of vitamin D supplementation and body weight on serum 25-hydroxyvitamin (25(OH)D) and serum calcium in healthy volunteers. We analyzed 22,214 recordings of vitamin D supplement use and serum 25(OH)D from 17,614 healthy adult volunteers participating in a preventive health program. This program encourages the use of vitamin D supplementation and monitors its use and serum 25(OH)D and serum calcium levels. Participants reported vitamin D supplementation ranging from 0 to 55,000 IU per day and had serum 25(OH) D levels ranging from 10.1 to 394 nmol/L. The dose response relationship between vitamin D supplementation and serum 25(OH)D followed an exponential curve. On average, serum 25(OH)D increased by 12.0 nmol/L per 1,000 IU in the supplementation interval of 0 to 1,000 IU per day and by 1.1 nmol/L per 1,000 IU in the supplementation interval of 15,000 to 20,000 IU per day. BMI, relative to absolute body weight, was found to be the better determinant of 25(OH)D. Relative to normal weight subjects, obese and overweight participants had serum 25(OH)D that were on average 19.8 nmol/L and 8.0 nmol/L lower, respectively (P<0.001). We did not observe any increase in the risk for hypercalcemia with increasing vitamin D supplementation. We recommend vitamin D supplementation be 2 to 3 times higher for obese subjects and 1.5 times higher for overweight subjects relative to normal weight subjects. This observational study provides body weight specific recommendations to achieve 25(OH)D targets.	[Ekwaru, John Paul; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Zwicker, Jennifer D.] Univ Calgary, Sch Publ Policy, Calgary, AB, Canada; [Holick, Michael F.] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Nutr & Diabet, Boston, MA 02118 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Alberta; University of Calgary; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	paul.veugelers@ualberta.ca		Veugelers, Paul/0000-0001-8996-0822	Alberta Innovates Health Scholarship; Canada Research Chair through the Canadian Institutes for Health Research; School of Public Health at the University of Alberta through a thematic research; Alberta provincial government through Alberta Innovates Health Solutions	Alberta Innovates Health Scholarship; Canada Research Chair through the Canadian Institutes for Health Research; School of Public Health at the University of Alberta through a thematic research; Alberta provincial government through Alberta Innovates Health Solutions	This is an analysis of secondary data. The data had been collected for the purpose of lifestyle counseling of participants of a preventive health program. None of the authors are involved in the execution of this program neither do they provide financial support for the data collection. PJV holds a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention, and an Alberta Innovates Health Scholarship. The funding for the Canada Research Chair is provided through the Canadian Institutes for Health Research to the University of Alberta. The Alberta Research Chair is awarded by the School of Public Health at the University of Alberta through a thematic research contract with the Pure North S'Energy Foundation. The Health Scholarship is funded by the Alberta provincial government through Alberta Innovates Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Blum M, 2008, J AM COLL NUTR, V27, P274, DOI 10.1080/07315724.2008.10719700; Chao YS, 2013, OCCUP MED-OXFORD, V63, P485, DOI 10.1093/occmed/kqt106; Chao YS, 2013, NUTRIENTS, V5, P4067, DOI 10.3390/nu5104067; Cianferotti L, 2012, BEST PRACT RES CL EN, V26, P523, DOI 10.1016/j.beem.2011.12.007; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; DiVasta AD, 2011, J CLIN ENDOCR METAB, V96, P2575, DOI 10.1210/jc.2011-0243; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Ebeling Peter R, 2014, Bonekey Rep, V3, P511, DOI 10.1038/bonekey.2014.6; Gallagher JC, 2012, ANN INTERN MED, V156, P425, DOI 10.7326/0003-4819-156-6-201203200-00005; Gallagher JC, 2013, J BONE MINER RES; Garland CF, 2011, ANTICANCER RES, V31, P607; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; Health Canada, VIT D CALC UPD DIET; Heaney RP, 2013, ADV NUTR, V4, P303, DOI 10.3945/an.113.003731; Heaney RP, 2011, AM J CLIN NUTR, V94, P619, DOI 10.3945/ajcn.111.019539; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Holick MF, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60327-303-9; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Institute of Medicine, 2011, DIETARY REFERENCE IN; Langlois Kellie, 2010, Health Rep, V21, P47; Lee P, 2009, AM J MED, V122, P1056, DOI 10.1016/j.amjmed.2009.06.008; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; Nelson ML, 2009, J NUTR, V139, P540, DOI 10.3945/jn.108.096180; Sanabria Álvaro, 2011, Rev. salud pública, V13, P804; Shab-Bidar S, 2013, EUR J ENDOCRINOL, V169, P597, DOI 10.1530/EJE-13-0068; Tepper S, 2013, J STEROID BIOCH MOL; Vieth R, 2006, J NUTR, V136, P1117, DOI 10.1093/jn/136.4.1117; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vieth R, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P995; Winzenberg T, 2013, CALCIFIED TISSUE INT, V92, P140, DOI 10.1007/s00223-012-9615-4; World Health Organization, 2006, BMI CLASS INT CLASS; Zittermann A, 2013, EUR J NUTR	37	132	138	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111265	10.1371/journal.pone.0111265	http://dx.doi.org/10.1371/journal.pone.0111265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372709	Green Published, gold			2022-12-27	WOS:000344556900040
J	Pontieri, L; Vojvodic, S; Graham, R; Pedersen, JS; Linksvayer, TA				Pontieri, Luigi; Vojvodic, Svjetlana; Graham, Riley; Pedersen, Jes Soe; Linksvayer, Timothy A.			Ant Colonies Prefer Infected over Uninfected Nest Sites	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; REPELLENCY; AVOIDANCE; VIRULENCE; IMMUNITY	During colony relocation, the selection of a new nest involves exploration and assessment of potential sites followed by colony movement on the basis of a collective decision making process. Hygiene and pathogen load of the potential nest sites are factors worker scouts might evaluate, given the high risk of epidemics in group-living animals. Choosing nest sites free of pathogens is hypothesized to be highly efficient in invasive ants as each of their introduced populations is often an open network of nests exchanging individuals (unicolonial) with frequent relocation into new nest sites and low genetic diversity, likely making these species particularly vulnerable to parasites and diseases. We investigated the nest site preference of the invasive pharaoh ant, Monomorium pharaonis, through binary choice tests between three nest types: nests containing dead nestmates overgrown with sporulating mycelium of the entomopathogenic fungus Metarhizium brunneum (infected nests), nests containing nestmates killed by freezing (uninfected nests), and empty nests. In contrast to the expectation pharaoh ant colonies preferentially (84%) moved into the infected nest when presented with the choice of an infected and an uninfected nest. The ants had an intermediate preference for empty nests. Pharaoh ants display an overall preference for infected nests during colony relocation. While we cannot rule out that the ants are actually manipulated by the pathogen, we propose that this preference might be an adaptive strategy by the host to "immunize'' the colony against future exposure to the same pathogenic fungus.	[Pontieri, Luigi; Pedersen, Jes Soe] Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark; [Vojvodic, Svjetlana] Univ Arizona, Ctr Insect Sci, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Vojvodic, Svjetlana] Rowan Univ, Dept Biol Sci, Glassboro, NJ USA; [Graham, Riley; Linksvayer, Timothy A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Copenhagen; University of Arizona; Rowan University; University of Pennsylvania	Pontieri, L (corresponding author), Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark.	lpontieri@bio.ku.dk	Pedersen, Jes Søe/J-6337-2014	Pedersen, Jes Søe/0000-0002-4439-2638; Linksvayer, Timothy/0000-0001-7034-1546; Pontieri, Luigi/0000-0002-1506-3827; Vojvodic Kruse, Svjetlana/0000-0003-0660-6540	Danish National Research Foundation [DNRF57]; NIH-PERT fellowship [K12GM000708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); NIH-PERT fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LP and JSP were funded by the Danish National Research Foundation (grant DNRF57) to the Centre for Social Evolution. SV was funded by NIH-PERT fellowship K12GM000708. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Boucias DG, 2012, BIOCOMMUNICATION FUN, P305, DOI DOI 10.1007/978-94-007-4264-2_20; Brutsch T, 2014, MYRMECOL NEWS, V20, P71; Buczkowski G, 2009, ETHOLOGY, V115, P1091, DOI 10.1111/j.1439-0310.2009.01698.x; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Dussutour A, 2008, INSECT SOC, V55, P329, DOI 10.1007/s00040-008-1008-3; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Franks NR, 2005, BIOL LETTERS, V1, P190, DOI 10.1098/rsbl.2005.0302; George J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062632; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Jaccoud DB, 1999, ENTOMOL EXP APPL, V93, P51, DOI 10.1023/A:1003830625680; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Lacey Lawrence A., 1997, P1, DOI 10.1016/B978-012432555-5/50004-X; Lam K, 2010, J CHEM ECOL, V36, P141, DOI 10.1007/s10886-010-9741-2; Mburu DM, 2009, J INSECT PHYSIOL, V55, P774, DOI 10.1016/j.jinsphys.2009.04.015; Mburu DM, 2011, J EXP BIOL, V214, P956, DOI 10.1242/jeb.050419; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Meyling NV, 2006, ECOL ENTOMOL, V31, P162, DOI 10.1111/j.0307-6946.2006.00781.x; Moore J., 2002, PARASITES BEHAV ANIM; Naug D, 2002, J THEOR BIOL, V215, P427, DOI 10.1006/jtbi.2001.2524; Ormond EL, 2011, FEMS MICROBIOL ECOL, V77, P229, DOI 10.1111/j.1574-6941.2011.01100.x; PASSERA L, 1994, WESTV STUD, P23; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rosengaus RB, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0563; Schmid-Hempel P., 1998, Parasites in social insects.; Schmidt AM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-20; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; Ugelvig LV, 2012, FUNCT ECOL, V26, P1300, DOI 10.1111/1365-2435.12013; Wetterer JK, 2010, MYRMECOL NEWS, V13, P115	34	24	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111961	10.1371/journal.pone.0111961	http://dx.doi.org/10.1371/journal.pone.0111961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372856	gold, Green Published			2022-12-27	WOS:000344556900096
J	Wehr, A; Baeck, C; Ulmer, F; Gassler, N; Hittatiya, K; Luedde, T; Neumann, UP; Trautwein, C; Tacke, F				Wehr, Alexander; Baeck, Christer; Ulmer, Florian; Gassler, Nikolaus; Hittatiya, Kanishka; Luedde, Tom; Neumann, Ulf Peter; Trautwein, Christian; Tacke, Frank			Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury	PLOS ONE			English	Article							KILLER T-CELLS; FATTY LIVER; NKT CELLS; NONALCOHOLIC STEATOHEPATITIS; MONOCLONAL-ANTIBODIES; FIBROSIS; DISEASE; INFLAMMATION; RECEPTOR; INTRAPERITONEAL	Non-alcoholic fatty liver disease (NAFLD) is a major cause of morbidity and mortality in developed countries, resulting in steatohepatitis (NASH), fibrosis and eventually cirrhosis. Modulating inflammatory mediators such as chemokines may represent a novel therapeutic strategy for NAFLD. We recently demonstrated that the chemokine receptor CXCR6 promotes hepatic NKT cell accumulation, thereby controlling inflammation in experimental NAFLD. In this study, we first investigated human biopsies (n = 20), confirming that accumulation of inflammatory cells such as macrophages is a hallmark of progressive NAFLD. Moreover, CXCR6 gene expression correlated with the inflammatory activity (ALT levels) in human NAFLD. We then tested the hypothesis that pharmacological inhibition of CXCL16 might hold therapeutic potential in NAFLD, using mouse models of acute carbon tetrachloride (CCl4)- and chronic methionine-choline-deficient (MCD) diet-induced hepatic injury. Neutralizing CXCL16 by i.p. injection of anti-CXCL16 antibody inhibited the early intrahepatic NKT cell accumulation upon acute toxic injury in vivo. Weekly therapeutic anti-CXCL16 administrations during the last 3 weeks of 6 weeks MCD diet significantly decreased the infiltration of inflammatory macrophages into the liver and intrahepatic levels of inflammatory cytokines like TNF or MCP-1. Importantly, anti-CXCL16 treatment significantly reduced fatty liver degeneration upon MCD diet, as assessed by hepatic triglyceride levels, histological steatosis scoring and quantification of lipid droplets. Moreover, injured hepatocytes up-regulated CXCL16 expression, indicating that scavenging functions of CXCL16 might be additionally involved in the pathogenesis of NAFLD. Targeting CXCL16 might therefore represent a promising novel therapeutic approach for liver inflammation and steatohepatitis.	[Wehr, Alexander; Baeck, Christer; Luedde, Tom; Trautwein, Christian; Tacke, Frank] RWTH Univ Hosp, Dept Med 3, Aachen, Germany; [Ulmer, Florian; Neumann, Ulf Peter] RWTH Univ Hosp, Dept Gen Visceral & Transplant Surg, Aachen, Germany; [Gassler, Nikolaus] RWTH Univ Hosp, Inst Pathol, Aachen, Germany; [Hittatiya, Kanishka] Univ Bonn, Dept Pathol, Bonn, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn	Tacke, F (corresponding author), RWTH Univ Hosp, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Luedde, Tom/AAE-9135-2022; Tacke, Frank/ABF-2212-2020	Luedde, Tom/0000-0002-6288-8821; 	German Research Foundation [DFG Ta434/2-1, DFG SFB/TRR 57]; Interdisciplinary Center for Clinical Research (IZKF) Aachen	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Aachen	This work was supported by the German Research Foundation (DFG Ta434/2-1 to F.T., DFG SFB/TRR 57) and by the Interdisciplinary Center for Clinical Research (IZKF) Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; BARRETT JS, 1991, CANCER RES, V51, P3434; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Boisvert J, 2003, J HEPATOL, V38, P67, DOI 10.1016/S0168-8278(02)00328-8; Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gutwein P, 2009, J CELL MOL MED, V13, P3809, DOI 10.1111/j.1582-4934.2009.00761.x; Gutwein P, 2009, AM J PATHOL, V174, P2061, DOI 10.2353/ajpath.2009.080960; Hammerich L, 2014, HEPATOLOGY, V59, P630, DOI 10.1002/hep.26697; Ishikawa S, 2011, J HEPATOL, V54, P1195, DOI 10.1016/j.jhep.2010.08.022; Jepsen P, 2003, HEPATO-GASTROENTEROL, V50, P2101; Jin ZX, 2011, HEPATOLOGY, V53, P219, DOI 10.1002/hep.23983; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Marra F, 2013, CURR PHARM DESIGN, V19, P5250, DOI 10.2174/13816128113199990344; MATTES MJ, 1987, J NATL CANCER I, V79, P855; Mederacke I, 2013, Z GASTROENTEROL, V51, P55, DOI 10.1055/s-0032-1330422; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Postea O, 2008, J CELL MOL MED, V12, P1700, DOI 10.1111/j.1582-4934.2008.00223.x; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Shimaoka T, 2007, J IMMUNOL, V179, P8172, DOI 10.4049/jimmunol.179.12.8172; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Tacke F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S27; Tannapfel A, 2011, VIRCHOWS ARCH, V458, P511, DOI 10.1007/s00428-011-1066-1; Tuncer C, 2013, LIVER INT, V33, P852, DOI 10.1111/liv.12182; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; WAHL RL, 1988, CANCER IMMUNOL IMMUN, V26, P187; Wang H, 2013, HEPATOLOGY; Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909; Xu HB, 2005, WORLD J GASTROENTERO, V11, P4979, DOI 10.3748/wjg.v11.i32.4979; YOSHIDA K, 1992, SURG TODAY, V22, P155, DOI 10.1007/BF00311341; Zimmermann Henning W., 2011, Inflammation & Allergy Drug Targets, V10, P509; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	44	50	54	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112327	10.1371/journal.pone.0112327	http://dx.doi.org/10.1371/journal.pone.0112327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372401	gold, Green Published			2022-12-27	WOS:000344556900136
J	Ye, Z; Gorman, AA; Uittenbogaard, AM; Myers-Morales, T; Kaplan, AM; Cohen, DA; Straley, SC				Ye, Zhan; Gorman, Amanda A.; Uittenbogaard, Annette M.; Myers-Morales, Tanya; Kaplan, Alan M.; Cohen, Donald A.; Straley, Susan C.			Caspase-3 Mediates the Pathogenic Effect of Yersinia pestis YopM in Liver of C57BL/6 Mice and Contributes to YopM's Function in Spleen	PLOS ONE			English	Article							INNATE IMMUNE DEFENSE; CELL-DEATH; PROTEIN; PLAGUE; INTERLEUKIN-8; MACROPHAGES; INHIBITION; APOPTOSIS; GROWTH	The virulence protein YopM of the plague bacterium Yersinia pestis has different dominant effects in liver and spleen. Previous studies focused on spleen, where YopM inhibits accumulation of inflammatory dendritic cells. In the present study we focused on liver, where PMN function may be directly undermined by YopM without changes in inflammatory cell numbers in the initial days of infection, and foci of inflammation are easily identified. Mice were infected with parent and Delta yopM-1 Y. pestis KIM5, and effects of YopM were assessed by immunohistochemistry and determinations of bacterial viable numbers in organs. The bacteria were found associated with myeloid cells in foci of inflammation and in liver sinusoids. A new in-vivo phenotype of YopM was revealed: death of inflammatory cells, evidenced by TUNEL staining beginning at d 1 of infection. Based on distributions of Ly6G(+), F4/80(+), and iNOS(+) cells within foci, the cells that were killed could have included both PMNs and macrophages. By 2 d post-infection, YopM had no effect on distribution of these cells, but by 3 d cellular decomposition had outstripped acute inflammation in foci due to parent Y. pestis, while foci due to the Delta yopM-1 strain still contained many inflammatory cells. The destruction depended on the presence of both PMNs in the mice and YopM in the bacteria. In mice that lacked the apoptosis mediator caspase-3 the infection dynamics were novel: the parent Y. pestis was limited in growth comparably to the Delta yopM-1 strain in liver, and in spleen a partial growth limitation for parent Y. pestis was seen. This result identified caspase-3 as a co-factor or effector in YopM's action and supports the hypothesis that in liver YopM's main pathogenic effect is mediated by caspase-3 to cause apoptosis of PMNs.	[Ye, Zhan; Gorman, Amanda A.; Uittenbogaard, Annette M.; Myers-Morales, Tanya; Kaplan, Alan M.; Cohen, Donald A.; Straley, Susan C.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA	University of Kentucky	Straley, SC (corresponding author), Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA.	scstra01@uky.edu			United States Public Health Service (NIAID) [R01 AI67869]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026827] Funding Source: NIH RePORTER	United States Public Health Service (NIAID); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant R01 AI67869 from the United States Public Health Service (NIAID; www.niaid.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Chung LK, 2014, MBIO, V5, DOI 10.1128/mBio.01402-14; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Felek S, 2010, INFECT IMMUN, V78, P4134, DOI 10.1128/IAI.00167-10; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Geering B, 2013, TRENDS IMMUNOL, V34, P398, DOI 10.1016/j.it.2013.04.002; Glynn PC, 2002, PULM PHARMACOL THER, V15, P103, DOI 10.1006/pupt.2001.0323; Gregory SH, 2002, J LEUKOCYTE BIOL, V72, P239; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; Heusipp G, 2006, MICROBIOL-SGM, V152, P1327, DOI 10.1099/mic.0.28697-0; Hines J, 2001, MICROB PATHOGENESIS, V30, P193, DOI 10.1006/mpat.2000.0424; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Kettritz R, 1998, KIDNEY INT, V53, P84, DOI 10.1046/j.1523-1755.1998.00741.x; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Neel NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023813; Nemeth J, 1997, INFECT IMMUN, V65, P924, DOI 10.1128/IAI.65.3.924-930.1997; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Raczynski AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033099; Ruter C, 2010, J CELL SCI, V123, P2190, DOI 10.1242/jcs.063016; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shannon JG, 2013, MBIO, V4, DOI 10.1128/mBio.00170-13; Skrzypek E, 1998, TARGETING YERSINIA P; Spinner JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009279; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Viboud G. H., 2011, ANNU REV MICROBIOL, V59, P69; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Yasuda M, 2000, J HISTOCHEM CYTOCHEM, V48, P1331, DOI 10.1177/002215540004801004; Ye Z, 2011, INFECT IMMUN, V79, P674, DOI 10.1128/IAI.00808-10; Ye Z, 2009, INFECT IMMUN, V77, P3791, DOI 10.1128/IAI.00284-09	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110956	10.1371/journal.pone.0110956	http://dx.doi.org/10.1371/journal.pone.0110956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372388	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900028
J	Eikemo, TA; Hoffmann, R; Kulik, MC; Kulhanova, I; Toch-Marquardt, M; Menvielle, G; Looman, C; Jasilionis, D; Martikainen, P; Lundberg, O; Mackenbach, JP				Eikemo, Terje A.; Hoffmann, Rasmus; Kulik, Margarete C.; Kulhanova, Ivana; Toch-Marquardt, Marlen; Menvielle, Gwenn; Looman, Caspar; Jasilionis, Domantas; Martikainen, Pekka; Lundberg, Olle; Mackenbach, Johan P.		EURO-GBD-SE Consortium	How Can Inequalities in Mortality Be Reduced? A Quantitative Analysis of 6 Risk Factors in 21 European Populations	PLOS ONE			English	Article							WELFARE-STATE REGIMES; ALL-CAUSE MORTALITY; HEALTH INEQUALITIES; SOCIOECONOMIC INEQUALITIES; EDUCATIONAL INEQUALITIES; SOCIAL INEQUALITIES; LABOR-MARKET; ALCOHOL-USE; FOLLOW-UP; SMOKING	Background: Socioeconomic inequalities in mortality are one of the greatest challenges for health policy in all European countries, but the potential for reducing these inequalities is unclear. We therefore quantified the impact of equalizing the distribution of six risk factors for mortality: smoking, overweight, lack of physical exercise, lack of social participation, low income, and economic inactivity. Methods: We collected and harmonized data on mortality and risk factors by educational level for 21 European populations in the early 2000s. The impact of the risk factors on mortality in each educational group was determined using Population Attributable Fractions. We estimated the impact on inequalities in mortality of two scenarios: a theoretical upward levelling scenario in which inequalities in the risk factor were completely eliminated, and a more realistic best practice scenario, in which inequalities in the risk factor were reduced to those seen in the country with the smallest inequalities for that risk factor. Findings: In general, upward levelling of inequalities in smoking, low income and economic inactivity hold the greatest potential for reducing inequalities in mortality. While the importance of low income is similar across Europe, smoking is more important in the North and East, and overweight in the South. On the basis of best practice scenarios the potential for reducing inequalities in mortality is often smaller, but still substantial in many countries for smoking and physical inactivity. Interpretation: Theoretically, there is a great potential for reducing inequalities in mortality in most European countries, for example by equity-oriented tobacco control policies, income redistribution and employment policies. Although it is necessary to achieve substantial degrees of upward levelling to make a notable difference for inequalities in mortality, the existence of best practice countries with more favourable distributions for some of these risk factors suggests that this is feasible.	[Eikemo, Terje A.; Hoffmann, Rasmus; Kulik, Margarete C.; Kulhanova, Ivana; Toch-Marquardt, Marlen; Looman, Caspar; Mackenbach, Johan P.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Eikemo, Terje A.; Toch-Marquardt, Marlen] Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, N-7034 Trondheim, Norway; [Menvielle, Gwenn] INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France; [Menvielle, Gwenn] Univ Paris 04, Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France; [Jasilionis, Domantas] Max Planck Inst Demog Res, Rostock, Germany; [Martikainen, Pekka] Univ Helsinki, Dept Sociol, Helsinki, Finland; [Lundberg, Olle] Stockholm Univ, Karolinska Inst, CHESS, S-10691 Stockholm, Sweden	Erasmus University Rotterdam; Erasmus MC; Norwegian University of Science & Technology (NTNU); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; University of Helsinki; Karolinska Institutet; Stockholm University	Eikemo, TA (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	terje.andreas.eikemo@svt.ntnu.no	Toch-Marquardt, Marlen/I-7252-2019; Kulhánová, Ivana/B-9253-2019; Menvielle, Gwenn/E-7201-2017; Rychtarikova, Jitka/R-1828-2017; Leinsalu, Mall/I-3768-2018	Kulhánová, Ivana/0000-0002-9688-1548; Rychtarikova, Jitka/0000-0002-6417-1920; Leinsalu, Mall/0000-0003-4453-4760; Martikainen, Pekka/0000-0001-9374-1438; Dibben, Chris/0000-0003-1769-3774; Helakorpi, Satu/0000-0002-5619-1219; Jasilionis, Domantas/0000-0001-9959-9292; Strand, Bjorn Heine/0000-0003-4385-8886; Hoffmann, Rasmus/0000-0002-9007-3144; Deboosere, Patrick/0000-0002-8148-3694	European Commission, through the Public Health Programme [20081309]; Netherlands Organisation for Health Research and Development (ZonMw) [121020026]; NATIONAL CANCER INSTITUTE [R25CA113710] Funding Source: NIH RePORTER	European Commission, through the Public Health Programme; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project was funded by the European Commission, through the Public Health Programme, grant agreement 20081309, and the Netherlands Organisation for Health Research and Development (ZonMw), project number 121020026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Akinwale B, 2011, J EPIDEMIOL COMMUN H, V65, P786, DOI 10.1136/jech.2009.099325; [Anonymous], 2009, GBD STUD OP MAN; [Anonymous], POTENTIAL REDUCING H; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P92, DOI 10.1136/jech.2008.077354; Bartley M, 2002, INT J EPIDEMIOL, V31, P336, DOI 10.1093/ije/31.2.336; Bartley M, 1996, BRIT MED J, V313, P445; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Brennenstuhl S, 2012, J EPIDEMIOL COMMUN H, V66, P397, DOI 10.1136/jech-2011-200277; Cavelaars A E, 1997, J Health Psychol, V2, P353, DOI 10.1177/135910539700200306; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Demarest S, 2007, TACKLING HLTH INEQUA; Department of Health, 2003, TACKL HLTH IN PROGR; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151; Eikemo TA, 2008, EUR J PUBLIC HEALTH, V18, P593, DOI 10.1093/eurpub/ckn092; Eikemo TA, 2008, SOC SCI MED, V66, P2281, DOI 10.1016/j.socscimed.2008.01.022; Elstad JI, 1998, SOCIOL HEALTH ILL, V20, P598, DOI 10.1111/1467-9566.00121; Elstad JI, 2003, SOC SCI MED, V57, P1475, DOI 10.1016/S0277-9536(02)00514-2; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gesthuizen M, 2008, EUR SOCIOL REV, V24, P617, DOI 10.1093/esr/jcn021; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Hoffmann R, 2013, J EPIDEMIOL COMMUN H, V67, P56, DOI 10.1136/jech-2011-200886; Hoffmann R, 2011, SOC SCI MED, V72, P1986, DOI 10.1016/j.socscimed.2011.04.019; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Huisman M, 2005, TOB CONTROL, V14, P106, DOI 10.1136/tc.2004.008573; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; Katikireddi SV, 2013, J EPIDEMIOLOGY COMMU; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kulik MC, EUROPEAN J IN PRESS; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Lhachimi SK, 2011, DYNAMIC POPULATION H; Lindahl M, 2005, J HUM RESOUR, V40, P144, DOI 10.3368/jhr.XL.1.144; Lindholm C, 2001, SCAND J PUBLIC HEALT, V29, P63, DOI 10.1177/14034948010290011201; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lissau I, 2001, SCAND J PUBLIC HEALT, P19; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lundberg O, 2008, LANCET, V372, P1633, DOI 10.1016/S0140-6736(08)61686-4; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2004, EUR J CANCER, V40, P126, DOI 10.1016/j.ejca.2003.10.018; Mackenbach JP, 2002, BRIT MED J, V325, P1029, DOI 10.1136/bmj.325.7371.1029; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Makela P, 1997, BRIT MED J, V315, P211, DOI 10.1136/bmj.315.7102.211; Marinacci C, 2011, EPIDEMIOL PREV, V35, P2; Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056; MARMOT MG, 1986, LANCET, V2, P274; Martikainen P, 1999, INT J EPIDEMIOL, V28, P899, DOI 10.1093/ije/28.5.899; Martikainen PT, 1996, LANCET, V348, P909, DOI 10.1016/S0140-6736(96)03291-6; Ministry of Social Affairs and Health, 2008, NAT ACT PLAN RED HLT; Minton JW, 2012, HLTH EMPLOYMENT EC C; Moller H, 2013, J PUBLIC HEALTH-UK, V35, P313, DOI 10.1093/pubmed/fds085; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Navarro V, 2001, SOC SCI MED, V52, P481, DOI 10.1016/S0277-9536(00)00197-0; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Norwegian Ministry of Health and Care Services, 2007, 2020062007 NORW MIN; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Proctor Robert N, 2004, Clin Lung Cancer, V5, P371, DOI 10.3816/CLC.2004.n.016; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reques L, 2014, J EPIDEMIOL COMMUNIT; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Schrijvers CTM, 1999, AM J PUBLIC HEALTH, V89, P535, DOI 10.2105/AJPH.89.4.535; Shkolnikov VM, 2007, SOC SCI MED, V64, P1392, DOI 10.1016/j.socscimed.2006.11.014; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stronks K, 1998, SOC SCI MED, V46, P611, DOI 10.1016/S0277-9536(97)00206-2; Swedish National Institute of Public Health, 2005, 2005 PUBL HLTH POL R; Thun MJ., 1997, CHANGES CIGARETTE RE, V8, P305; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; Wilkinson R., 2009, SPIRIT LEVEL	71	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110952	10.1371/journal.pone.0110952	http://dx.doi.org/10.1371/journal.pone.0110952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369287	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000031
J	Morley, KI; Wallace, J; Denaxas, SC; Hunter, RJ; Patel, RS; Perel, P; Shah, AD; Timmis, AD; Schilling, RJ; Hemingway, H				Morley, Katherine I.; Wallace, Joshua; Denaxas, Spiros C.; Hunter, Ross J.; Patel, Riyaz S.; Perel, Pablo; Shah, Anoop D.; Timmis, Adam D.; Schilling, Richard J.; Hemingway, Harry			Defining Disease Phenotypes Using National Linked Electronic Health Records: A Case Study of Atrial Fibrillation	PLOS ONE			English	Article							MEDICAL-RECORDS; GENERAL-PRACTICE; EMERGE NETWORK; RISK-FACTORS; POPULATION; STROKE; PREDICTORS; WHITES; PREVALENCE; VALIDATION	Background: National electronic health records (EHR) are increasingly used for research but identifying disease cases is challenging due to differences in information captured between sources (e. g. primary and secondary care). Our objective was to provide a transparent, reproducible model for integrating these data using atrial fibrillation (AF), a chronic condition diagnosed and managed in multiple ways in different healthcare settings, as a case study. Methods: Potentially relevant codes for AF screening, diagnosis, and management were identified in four coding systems: Read (primary care diagnoses and procedures), British National Formulary (BNF; primary care prescriptions), ICD-10 (secondary care diagnoses) and OPCS-4 (secondary care procedures). From these we developed a phenotype algorithm via expert review and analysis of linked EHR data from 1998 to 2010 for a cohort of 2.14 million UK patients aged >= 30 years. The cohort was also used to evaluate the phenotype by examining associations between incident AF and known risk factors. Results: The phenotype algorithm incorporated 286 codes: 201 Read, 63 BNF, 18 ICD-10, and four OPCS-4. Incident AF diagnoses were recorded for 72,793 patients, but only 39.6% (N = 28,795) were recorded in primary care and secondary care. An additional 7,468 potential cases were inferred from data on treatment and pre-existing conditions. The proportion of cases identified from each source differed by diagnosis age; inferred diagnoses contributed a greater proportion of younger cases (<= 60 years), while older patients (>= 80 years) were mainly diagnosed in SC. Associations of risk factors (hypertension, myocardial infarction, heart failure) with incident AF defined using different EHR sources were comparable in magnitude to those from traditional consented cohorts. Conclusions: A single EHR source is not sufficient to identify all patients, nor will it provide a representative sample. Combining multiple data sources and integrating information on treatment and comorbid conditions can substantially improve case identification.	[Morley, Katherine I.; Wallace, Joshua; Denaxas, Spiros C.; Patel, Riyaz S.; Perel, Pablo; Shah, Anoop D.; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London, England; [Morley, Katherine I.; Wallace, Joshua; Denaxas, Spiros C.; Patel, Riyaz S.; Perel, Pablo; Shah, Anoop D.; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, London, England; [Morley, Katherine I.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Morley, Katherine I.] Univ Melbourne, Melbourne Sch Global & Populat Hlth, Melbourne, Vic, Australia; [Hunter, Ross J.; Timmis, Adam D.; Schilling, Richard J.] Queen Mary Univ London, Barts NIHR Biomed Res Unit, London, England; [Patel, Riyaz S.] Univ Coll London NHS Trust, Heart Hosp, London, England; [Perel, Pablo] London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; University of London; University College London; University of London; King's College London; University of Melbourne; University of London; Queen Mary University London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Morley, KI (corresponding author), UCL, Farr Inst Hlth Informat Res, London, England.	katherine.morley@ucl.ac.uk	Shah, Anoop Dinesh/D-4396-2014; Morley, Katherine I/A-2986-2011; Hemingway, Harry/C-1219-2009	Shah, Anoop Dinesh/0000-0002-8907-5724; Morley, Katherine I/0000-0002-2725-5535; Denaxas, Spiros/0000-0001-9612-7791; /0000-0002-2342-301X; Hemingway, Harry/0000-0003-2279-0624	National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z, MR/K006584/1, 0938/30/Z/10/Z]; Medical Research Council Prognosis Research Strategy (PROGRESS) [G0902393/99558]; Farr Institute of Health Informatics Research at UCL Partners; Medical Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; PROGRESS Partnership; UCL Provost's Strategic Development Fund Fellowship; Barts and The London NIHR Cardiovascular Biomedical Research Unit - National Institute for Health Research; Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish; Medical Research Council [G0902393, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [CL-2011-11-003] Funding Source: researchfish; ESRC [ES/L007517/1] Funding Source: UKRI; MRC [G0902393] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council Prognosis Research Strategy (PROGRESS)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Farr Institute of Health Informatics Research at UCL Partners; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; PROGRESS Partnership; UCL Provost's Strategic Development Fund Fellowship; Barts and The London NIHR Cardiovascular Biomedical Research Unit - National Institute for Health Research; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was carried out on behalf of the ClinicAL research using LInked bespoke studies and Electronic health Records (CALIBER) programme. This study was supported by National Institute for Health Research (ADT, HH, RP-PG-0407-10314), Wellcome Trust (ADT, HH, 086091/Z/08/Z), and the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (PP, ADT, HH, G0902393/99558; www. progress-partnership. org), and by awards to establish the Farr Institute of Health Informatics Research at UCL Partners (HH, SCD, ADT), from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (ADT, HH, grant MR/K006584/1). KIM and JW were supported by the PROGRESS Partnership while undertaking this research. SCD was supported by a UCL Provost's Strategic Development Fund Fellowship. ADS was supported by a clinical research training fellowship from the Wellcome Trust (0938/30/Z/10/Z). ADT was supported by Barts and The London NIHR Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; Albers DJ, 2010, PHYS LETT A, V374, P1159, DOI 10.1016/j.physleta.2009.12.067; Albers DJ, 2012, CHAOS WOODBURY NY, V22; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Andersen PK, 2002, STAT MED, V26, P2389; Camm AJ, 2012, EUR HEART J, V33; Chiang CH, 2013, INT J CARDIOL, V164, P201, DOI 10.1016/j.ijcard.2011.06.126; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; COX DR, 1972, J R STAT SOC B, V34, P187; Davis RC, 2012, EUROPACE, V14, P1553, DOI 10.1093/europace/eus087; De Caterina R, 2010, ARCH INTERN MED, V170, P1450, DOI 10.1001/archinternmed.2010.305; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Emilsson L, 2011, EUR HEART J, V32, P2430, DOI 10.1093/eurheartj/ehr167; Fedorowski A, 2010, J INTERN MED, V268, P383, DOI 10.1111/j.1365-2796.2010.02261.x; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Friberg J, 2003, EPIDEMIOLOGY, V14, P666, DOI 10.1097/01.ede.0000091649.26364.c0; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Gillam S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f659; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Grosso A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004720; Grundvold I, 2012, AM J CARDIOL, V110, P425, DOI 10.1016/j.amjcard.2012.03.043; Heeringa J, 2008, AM HEART J, V156, P1163, DOI 10.1016/j.ahj.2008.08.003; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Hodgkinson JA, 2011, INT J CLIN PRACT, P44; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, pE311, DOI 10.1136/amiajnl-2013-001922; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Hripcsak G, 2011, J AM MED INFORM ASSN, V18, pI109, DOI 10.1136/amiajnl-2011-000463; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kirchhof P, 2013, EUR HEART J, V34, P1471, DOI 10.1093/eurheartj/ehs446; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lipworth L, 2012, AM J CARDIOL, V110, P1637, DOI 10.1016/j.amjcard.2012.07.032; Maddox TM, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-11; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; National Institute for Health and Care Excellence, 2006, ATR FIBR MAN ATR FIB; National Resource Management Ministerial Council, 2007, AN CURR SIT CAUS SUI, P1; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Nicholson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054878; Nyrnes A, 2012, EUROPEAN J PREVENTIV; Overby CL, 2013, J AM MED INFORM ASSN, P1; Pakhomov SSV, 2007, AM HEART J, V153, P666, DOI 10.1016/j.ahj.2006.12.022; Pascoe SW, 2008, FAM PRACT, V25, P215, DOI 10.1093/fampra/cmn023; Peissig PL, 2012, J AM MED INFORM ASSN, V19, P225, DOI 10.1136/amiajnl-2011-000456; Perez MV, 2009, AM HEART J, V158, P622, DOI 10.1016/j.ahj.2009.08.002; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Perotte A, 2013, IEEE J BIOMED HEALTH, V17, P477, DOI 10.1109/JBHI.2013.2244610; Pivovarov R, 2014, J AM MED INFORM ASSN, P1; Psaty BM, 1997, CIRCULATION, V96, P2455; R Core Team, 2021, R LANGUAGE ENV STAT; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rea S, 2012, J BIOMED INFORM, V45, P763, DOI 10.1016/j.jbi.2012.01.009; Richesson RL, 2013, J AM MED INFORM ASSN, P1; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; Schnabel RB, 2010, ARCH INTERN MED, V170, P1909, DOI 10.1001/archinternmed.2010.434; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Scowcroft ACE, 2014, INT J CARDIOL, V171, P169, DOI 10.1016/j.ijcard.2013.11.086; Selmer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7895; Shah AD, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-88; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Wang ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030412; Watanabe H, 2006, AM HEART J, V152, P731, DOI 10.1016/j.ahj.2006.05.032; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	69	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110900	10.1371/journal.pone.0110900	http://dx.doi.org/10.1371/journal.pone.0110900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369203	Green Accepted, Green Published, gold			2022-12-27	WOS:000344402000030
J	Pathak, PK; Tripathi, N; Subramanian, SV				Pathak, Praveen Kumar; Tripathi, Niharika; Subramanian, S. V.			Secular Trends in Menarcheal Age in India-Evidence from the Indian Human Development Survey	PLOS ONE			English	Article							PUBERTY; URBAN; HEALTH; GIRLS; DETERMINANTS; NUTRITION; PATTERNS; EARLIER; OSLO	Background: Evidence from a number of countries in Europe and North America point towards the secular declining trend in menarcheal age with considerable spatial variations over the past two centuries. Similar trends were reported in several developing countries from Asia, Africa and Latin America. However, data corroborating any secular trend in the menarcheal age of the Indian population remained sparse and inadequately verified. Methods: We examined secular trends, regional heterogeneity and association of socioeconomic, anthropometric and contextual factors with menarcheal age among ever-married women (15-49 years) in India. Using the pseudo cohort data approach, we fit multiple linear regression models to estimate secular trends in menarcheal age of 91394 ever-married women using the Indian Human Development Survey. Results: The mean age at menarche among Indian women was 13.76 years (95 % CI: 13.75, 13.77) in 2005. It declined by three months from 13.83 years (95% CI: 13.81, 13.85) among women born prior to 1955-1964, to nearly 13.62 years (95% CI: 13.58, 13.67) among women born during late 1985-1989. However, these aggregate national figures mask extensive spatial heterogeneity as mean age at menarche varied from 15.0 years in Himachal Pradesh during 1955-1964 (95% CI: 14.89-15.11) to about 12.1 years in Assam (95% CI: 11.63-12.56) during 1985-1989. Conclusion: The regression analysis established a reduction of nearly one month per decade, suggesting a secular decline in age at menarche among Indian women. Notably, the menarcheal age was significantly associated with the area of residence, geographic region, linguistic groups, educational attainment, wealth status, caste and religious affiliations among Indian women.	[Pathak, Praveen Kumar] Univ Delhi, Delhi Sch Econ, Dept Geog, Delhi 110007, India; [Pathak, Praveen Kumar; Tripathi, Niharika] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Delhi School of Economics; University of Delhi; International Institute for Population Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Pathak, PK (corresponding author), Univ Delhi, Delhi Sch Econ, Dept Geog, Delhi 110007, India.	pkp_pathak@rediffmail.com	Pathak, Praveen Kumar/M-6010-2014; Pathak, Praveen Kumar/GPG-1695-2022	Pathak, Praveen Kumar/0000-0003-1571-7859; Tripathi, Niharika/0000-0002-7502-132X				Adali T, 2011, ANN HUM BIOL, V38, P345, DOI 10.3109/03014460.2011.552891; Adanu R M K, 2006, J Obstet Gynaecol, V26, P550, DOI 10.1080/01443610600811425; [Anonymous], 2011, J INDIAN ACAD FORENS; [Anonymous], 2008, ANAL HLTH EQUITY USI; Bagga Amrita, 2000, Acta Biologica Szegediensis, V44, P53; BAI KI, 1978, J TROP PED ENV CH H, V24, P171, DOI 10.1093/tropej/24.4.171; Bakshi A, 2008, NOTE HOUSEHOLD INCOM; Baldridge J., 1996, RECONCILING LINGUIST; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bellis MA, 2006, J EPIDEMIOL COMMUN H, V60, P910, DOI 10.1136/jech.2006.049379; Bhalla S R, 1983, Z Morphol Anthropol, V73, P323; Bhaskaran Mythili, 2003, Indian J Physiol Pharmacol, V47, P361; Cameron N, 1996, ANN HUM BIOL, V23, P113, DOI 10.1080/03014469600004332; CAMERON N, 1991, AM J HUM BIOL, V3, P251, DOI 10.1002/ajhb.1310030304; Chakravarty K, 1994, J Assam Science Society, V36, P49; Chavarro J, 2004, ANN HUM BIOL, V31, P245, DOI 10.1080/03014460310001652239; Chitnis S., 1997, POLITICS BACKWARDNES, P88; Cho GJ, 2010, EUR J PEDIATR, V169, P89, DOI 10.1007/s00431-009-0993-1; DAMON A, 1974, HUM BIOL, V46, P381; DANN TC, 1973, BRIT MED J, V3, P265, DOI 10.1136/bmj.3.5874.265; Deb R, 2009, ANTHROPOLOGIST, V11, P259, DOI 10.1080/09720073.2009.11891113; Deb R, 2011, INDIAN PEDIATR, V48, P69; Desai S, 2007, 1 U MAR NAT COUNC AP; Desai S, 2010, MARGIN, V4, P293, DOI 10.1177/097380101000400303; do Lago MJ, 2003, ANN HUM BIOL, V30, P347, DOI 10.1080/0301446031000091783; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Facchini F, 2008, ANN HUM BIOL, V35, P50, DOI 10.1080/03014460701784567; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garg S, 2001, REPROD HEALTH MATTER, V9, P16, DOI 10.1016/S0968-8080(01)90004-7; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Harris MA, 2008, J ADOLESCENT HEALTH, V43, P548, DOI 10.1016/j.jadohealth.2008.07.017; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Huen KF, 1997, ACTA PAEDIATR, V86, P1121, DOI 10.1111/j.1651-2227.1997.tb14820.x; INDIAN COUNCIL OF MEDICAL RESEARCH, 1972, IND COUNC MED RES TE; Jones LL, 2009, AM J HUM BIOL, V21, P130, DOI 10.1002/ajhb.20836; Keizer-Schrama SMPFD, 2001, HUM REPROD UPDATE, V7, P287; Laslett P, 1971, J Interdiscip Hist, V2, P221, DOI 10.2307/202843; LIESTOL K, 1995, ANN HUM BIOL, V22, P199, DOI 10.1080/03014469500003862; LIESTOL K, 1982, ANN HUM BIOL, V9, P521, DOI 10.1080/03014468200006051; Matton L, 2007, AM J HUM BIOL, V19, P345, DOI 10.1002/ajhb.20592; McDowell MA, 2007, J ADOLESCENT HEALTH, V40, P227, DOI 10.1016/j.jadohealth.2006.10.002; Mishra GD, 2009, WOMENS HEALTH, V5, P175, DOI 10.2217/17455057.5.2.175; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Pasquet P, 1999, ANN HUM BIOL, V26, P89, DOI 10.1080/030144699283001; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Planning Commission Government of India, 2011, IND HUM DEV REP 2011; Po JYT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016844; Rah JH, 2009, J HEALTH POPUL NUTR, V27, P802; REES M, 1993, LANCET, V342, P1375, DOI 10.1016/0140-6736(93)92746-G; Rigon F, 2010, J ADOLESCENT HEALTH, V46, P238, DOI 10.1016/j.jadohealth.2009.07.009; Rokade S.A., 2009, INTERNET J BIOL ANTH, V3, P1, DOI [10.5580/115b, DOI 10.5580/115B, https://doi.org/10.5580/115b]; Sanchez-Andres A, 1997, Anthropol Anz, V55, P69; SATYANARAYANA K, 1979, ANN HUM BIOL, V6, P163, DOI 10.1080/03014467900003501; SHARMA K, 1990, ANN HUM BIOL, V17, P159, DOI 10.1080/03014469000000912; Sharma N, 2005, ANTHROPOLOGIST, V8, P55; Silva HP, 2006, AM J HUM BIOL, V18, P83, DOI 10.1002/ajhb.20458; Singh L, 1983, Anthropol Anz, V41, P259; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Talma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060056; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; Tanner JM, 1955, GROWTH ADOLESCENCE; Thomas F, 2001, HUM BIOL, V73, P271, DOI 10.1353/hub.2001.0029; Tripathi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071584; Tyagi D, 1983, J Indian Med Assoc, V80, P133; United Nations Children's Fund, 2011, STAT WORLDS CHILDR 2; Viner R, 2002, ARCH DIS CHILD, V86, P8, DOI 10.1136/adc.86.1.8; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walvoord EC, 2010, J ADOLESCENT HEALTH, V47, P433, DOI 10.1016/j.jadohealth.2010.05.018; Wang DL, 2002, J BIOSOC SCI, V34, P349, DOI 10.1017/S0021932002003498; Whincup PH, 2001, BRIT MED J, V322, P1095, DOI 10.1136/bmj.322.7294.1095; World Health Organization, 2007, AD SEX REPR HLTH HIV; Wronka I, 2005, ANN HUM BIOL, V32, P630, DOI 10.1080/03014460500204478; WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707; ZACHARIAS L, 1969, NEW ENGL J MED, V280, P868, DOI 10.1056/NEJM196904172801606	75	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111027	10.1371/journal.pone.0111027	http://dx.doi.org/10.1371/journal.pone.0111027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369507	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000033
J	Rahman, SU; Lee, MS; Baek, JH; Ryoo, HM; Woo, KM				Rahman, Saeed Ur; Lee, Min-Sun; Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi			The Prolyl Hydroxylase Inhibitor Dimethyloxalylglycine Enhances Dentin Sialophoshoprotein Expression through VEGF-Induced Runx2 Stabilization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; IN-VIVO; CLEIDOCRANIAL DYSPLASIA; SIGNALING PATHWAYS; BONE-DEVELOPMENT; DIABETIC MICE; HIF-ALPHA; CELLS	Prolyl hydroxylase (PHD) inhibitors are suggested as therapeutic agents for tissue regeneration based on their ability to induce pro-angiogenic responses. In this study, we examined the effect of the PHD inhibitor dimethyloxalylglycine (DMOG) on odontoblast maturation and sought to determine the underlying mechanism using MDPC-23 odontoblast-like cells. DMOG significantly enhanced matrix mineralization, confirmed by alizarin red staining and by measurement of the calcium content. DMOG dose-dependently increased alkaline phosphatase activity and the expressions of dentin sialophosphoprotein (Dspp) and osteocalcin. To determine the underlying events leading to DMOG-induced Dspp expression, we analyzed the effect of DMOG on Runx2. Knockdown of Runx2 using siRNAs decreased Dspp expression and prevented DMOG-induced Dspp expression. DMOG enhanced the transcriptional activity and level of Runx2 protein but not Runx2 transcript, and this enhancement was linked to the inhibitory effects of DMOG on the degradation of Runx2 protein. The vascular endothelial growth factor (VEGF) siRNAs profoundly decreased the Runx2 protein levels and inhibited the DMOG-increased Runx2 protein. Recombinant VEGF protein treatment significantly and dose-dependently increased the transcriptional activity and level of the Runx2 protein but not Runx2 transcript. Dspp expression was also enhanced by VEGF. Last, we examined the involvement of the Erk mitogen-activated protein kinase and Pin1 pathway in VEGF-enhanced Runx2 because this pathway can regulate the stability and activity of the Runx2 protein. VEGF stimulated Erk activation, and the inhibitors of Erk and Pin1 hampered VEGF-enhanced Runx2 protein. Taken together, the results of this study provide evidence that DMOG can enhance Dspp expression through VEGF-induced stabilization of Runx2 protein, and thus, suggest that DMOG can be used as a therapeutic tool for enhancing odontoblast maturation in dental procedures.	[Rahman, Saeed Ur; Lee, Min-Sun; Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Mol Genet, Seoul, South Korea; [Rahman, Saeed Ur; Lee, Min-Sun; Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi] Seoul Natl Univ, Sch Dent, Plus Program BK21, Seoul, South Korea; [Baek, Jeong-Hwa; Ryoo, Hyun-Mo; Woo, Kyung Mi] Seoul Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Woo, KM (corresponding author), Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Mol Genet, Seoul, South Korea.	kmwoo@snu.ac.kr	Rahman, Saeed Ur/H-1957-2018; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009	Rahman, Saeed Ur/0000-0003-2234-2274; Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189	Korea Healthcare technology R&D Project from the Ministry for Health, Welfare and Family Affairs [A120815]	Korea Healthcare technology R&D Project from the Ministry for Health, Welfare and Family Affairs	This research was supported by the Korea Healthcare technology R&D Project (A120815; KMW) from the Ministry for Health, Welfare and Family Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Gaikwad J S, 2001, Adv Dent Res, V15, P19; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Han NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088890; Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442; Hara K, 2011, J ENDODONT, V37, P1647, DOI 10.1016/j.joen.2011.08.023; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Hiltunen MO, 2003, FASEB J, V17, P1147, DOI 10.1096/fj.02-0514fje; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061960; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu LX, 2008, J CELL PHYSIOL, V217, P319, DOI 10.1002/jcp.21503; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240; Miyazaki T, 2008, ARCH HISTOL CYTOL, V71, P131, DOI 10.1679/aohc.71.131; Muller HD, 2012, J ENDODONT, V38, P1498, DOI 10.1016/j.joen.2012.08.003; Mullane EM, 2008, J DENT RES, V87, P1144, DOI 10.1177/154405910808701204; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Oh JH, 2011, BIOMATERIALS, V32, P5826, DOI 10.1016/j.biomaterials.2011.04.074; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Pashley David H, 2002, Dent Clin North Am, V46, P211, DOI 10.1016/S0011-8532(01)00009-X; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Segar CE, 2013, CURR PHARM DESIGN, V19, P3403, DOI 10.2174/1381612811319190007; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yoon WJ, 2014, J BIOL CHEM, V289, P8828, DOI 10.1074/jbc.M113.516237; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhao C, 2007, ARCH ORAL BIOL, V52, P945, DOI 10.1016/j.archoralbio.2007.04.015	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112078	10.1371/journal.pone.0112078	http://dx.doi.org/10.1371/journal.pone.0112078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369078	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000140
J	Pettinato, G; Vanden Berg-Foels, WS; Zhang, N; Wen, XJ				Pettinato, Giuseppe; Vanden Berg-Foels, Wendy S.; Zhang, Ning; Wen, Xuejun			ROCK Inhibitor Is Not Required for Embryoid Body Formation from Singularized Human Embryonic Stem Cells	PLOS ONE			English	Article							TBX5 TRANSCRIPTION FACTOR; BETA-CELLS; CARDIAC DIFFERENTIATION; MOLECULAR-MECHANISMS; CULTURE; GENERATION; BODIES; LINES; AGGREGATION; SYSTEM	We report a technology to form human embryoid bodies (hEBs) from singularized human embryonic stem cells (hESCs) without the use of the p160 rho-associated coiled-coil kinase inhibitor (ROCKi) or centrifugation (spin). hEB formation was tested under four conditions: +ROCKi/+spin, +ROCKi/-spin, -ROCKi/+spin, and -ROCKi/-spin. Cell suspensions of BG01V/hOG and H9 hESC lines were pipetted into non-adherent hydrogel substrates containing defined microwell arrays. hEBs of consistent size and spherical geometry can be formed in each of the four conditions, including the -ROCKi/-spin condition. The hEBs formed under the -ROCKi/-spin condition differentiated to develop the three embryonic germ layers and tissues derived from each of the germ layers. This simplified hEB production technique offers homogeneity in hEB size and shape to support synchronous differentiation, elimination of the ROCKi xeno-factor and rate-limiting centrifugation treatment, and low-cost scalability, which will directly support automated, large-scale production of hEBs and hESC-derived cells needed for clinical, research, or therapeutic applications.	[Pettinato, Giuseppe; Vanden Berg-Foels, Wendy S.; Wen, Xuejun] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA USA; [Pettinato, Giuseppe; Zhang, Ning] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA; [Pettinato, Giuseppe; Vanden Berg-Foels, Wendy S.; Zhang, Ning; Wen, Xuejun] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Vanden Berg-Foels, Wendy S.; Wen, Xuejun] Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Wen, Xuejun] Tongji Univ, Tongji Med Sch, Shanghai East Hosp, Inst Biomed Engn & Nano Sci iNANO, Shanghai 200092, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Clemson University; Medical University of South Carolina; Tongji University	Zhang, N (corresponding author), Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.	nzhang2@vcu.edu; xwen@vcu.edu		Pettinato, Giuseppe/0000-0001-6785-6370; Vanden Berg-Foels, Wendy/0000-0002-1557-3317	Ministry of Science and Technology [2012CB966300, 2014CB964600]; NSFC [81271369]; NSF [0748129, 1055922]; William H. Goodwin Endowment; Div Of Chem, Bioeng, Env, & Transp Sys [1346387] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE023123, R00DE023123] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSFC(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); William H. Goodwin Endowment; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This publication was supported by the Ministry of Science and Technology (2012CB966300, 2014CB964600), NSFC (81271369), NSF (0748129, 1055922), and William H. Goodwin Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Azarin SM, 2012, BIOMATERIALS, V33, P2041, DOI 10.1016/j.biomaterials.2011.11.070; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Bataille D, 2002, DIABETES METAB, V28, pS7; Bernard AB, 2012, TISSUE ENG PART C-ME, V18, P583, DOI [10.1089/ten.tec.2011.0504, 10.1089/ten.TEC.2011.0504]; Bose B, 2012, CELL BIOL INT, V36, P1013, DOI 10.1042/CBI20120210; BUNN PA, 1993, J NATL CANCER I, V85, P1168, DOI 10.1093/jnci/85.14.1168; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Cai J, 2008, PROTOCOL DIRECTED DI; Chaddah R, 2012, J NEUROSCI, V32, P7771, DOI 10.1523/JNEUROSCI.3286-11.2012; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fathi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022856; Ferraro GA, 2011, AESTHET PLAST SURG, V35, P341, DOI 10.1007/s00266-010-9613-8; Fung WT, 2009, LAB CHIP, V9, P2591, DOI [10.1039/b903753e, 10.1039/b903753c]; Hatcher CJ, 2000, DEV DYNAM, V219, P90, DOI 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L; Hatcher CJ, 2001, DEV BIOL, V230, P177, DOI 10.1006/dbio.2000.0134; Ho PJ, 2012, CELL TRANSPLANT, V21, P801, DOI 10.3727/096368911X627507; Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Irion S, 2008, COLD SH Q B, V73, P101, DOI 10.1101/sqb.2008.73.065; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Kim J, 2013, EXP HEMATOL, V41, P749, DOI 10.1016/j.exphem.2013.04.003; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; KRAMER PL, 1992, GENOMICS, V13, P904, DOI 10.1016/0888-7543(92)90185-U; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Marzban L, 2004, DIABETES, V53, P141, DOI 10.2337/diabetes.53.1.141; McDevitt TC, 2008, CURR OPIN BIOTECH, V19, P527, DOI 10.1016/j.copbio.2008.08.005; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagatsu T, 1995, ESSAYS BIOCHEM, V30, P15; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; Parsons XH, 2012, J REGEN MED TISSUE E, V1; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Russell MW, 1998, BBA-GENE STRUCT EXPR, V1443, P393, DOI 10.1016/S0167-4781(98)00237-1; Skeberdis Vytenis Arvydas, 2004, Medicina (Kaunas), V40, P407; Son MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019134; Spelke DP, 2011, METHODS MOL BIOL, V690, P151, DOI 10.1007/978-1-60761-962-8_10; Stolarczyk E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001288; Stover AE, 2011, METHODS MOL BIOL, V767, P391, DOI 10.1007/978-1-61779-201-4_28; Sugiyama T, 2008, DIABETES OBES METAB, V10, P179, DOI 10.1111/j.1463-1326.2008.00954.x; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Walcher T, 2013, DEVELOPMENT, V140, P1123, DOI 10.1242/dev.082875; Walker AS, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/894374; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Watanabe M, 2002, INT REV CYTOL, V213, P1; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292	64	11	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e100742	10.1371/journal.pone.0100742	http://dx.doi.org/10.1371/journal.pone.0100742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365581	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100001
J	Zhang, L; Feng, X; Wang, X; Liu, CY				Zhang, Lei; Feng, Xiao; Wang, Xin; Liu, Changyong			On the Constitutive Model of Nitrogen-Containing Austenitic Stainless Steel 316LN at Elevated Temperature	PLOS ONE			English	Article							STRESS-CORROSION CRACKING; BEHAVIOR; DEFORMATION; FLOW	The nitrogen-containing austenitic stainless steel 316LN has been chosen as the material for nuclear main-pipe, which is one of the key parts in 3rd generation nuclear power plants. In this research, a constitutive model of nitrogen-containing austenitic stainless steel is developed. The true stress-true strain curves obtained from isothermal hot compression tests over a wide range of temperatures (900-1250 degrees C) and strain rates (10(-3) - 10 s(-1)), were employed to study the dynamic deformational behavior of and recrystallization in 316LN steels. The constitutive model is developed through multiple linear regressions performed on the experimental data and based on an Arrhenius-type equation and Zener-Hollomon theory. The influence of strain was incorporated in the developed constitutive equation by considering the effect of strain on the various material constants. The reliability and accuracy of the model is verified through the comparison of predicted flow stress curves and experimental curves. Possible reasons for deviation are also discussed based on the characteristics of modeling process.	[Zhang, Lei; Feng, Xiao; Wang, Xin; Liu, Changyong] Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University	Zhang, L (corresponding author), Tsinghua Univ, Key Lab Adv Mat Proc Technol, Minist Educ, Beijing 100084, Peoples R China.	stoneszhang@tsinghua.edu.cn	Liu, Changyong/AAN-8402-2021	Liu, Changyong/0000-0003-3919-0713	National Science and Technology Major Project of China [2012ZX0401008]; National High-tech R&D Program of China (863 Program) [2012AA040202]	National Science and Technology Major Project of China; National High-tech R&D Program of China (863 Program)	This research is supported by the National Science and Technology Major Project of China (Grant No. 2012ZX0401008) and the National High-tech R&D Program of China (863 Program, Grant No. 2012AA040202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YQ, 2009, J TAIYUAN U SCI TECH, V30, P424; Begum Z, 2011, CORROS SCI, V53, P1424, DOI 10.1016/j.corsci.2011.01.003; Chen Mingming, 2010, CHINA METALFONNING E, V45, P83; Gavriljuk V.G., 1999, HIGH NITROGEN STEELS, P323, DOI [10.1007/978-3-662-03760-7_6, DOI 10.1007/978-3-662-03760-7_6]; Japan Stainless Steel Association, 1995, STAINLESS STEEL HDB, P1427; Johnson G.R., 1983, P 7 INT S BALLISTICS, P541; Jones RL, 1996, MATER PERFORMANCE, V35, P63; Kim DW, 2008, INT J PRES VES PIP, V85, P378, DOI 10.1016/j.ijpvp.2007.11.013; Kim DW, 2012, J NUCL MATER, V420, P473, DOI 10.1016/j.jnucmat.2011.11.001; Lin C.G., 2008, ADV PASSIVE PLANT AP; Lorenzetto P, 1996, J NUCL MATER, V233, P1387, DOI 10.1016/S0022-3115(96)00140-7; Momeni A, 2012, APPL MATH MODEL, V36, P5624, DOI 10.1016/j.apm.2012.01.008; Pan Pinli, 2012, China Mechanical Engineering, V23, P1354, DOI 10.3969/j.issn.1004-132X.2012.11.020; [潘品李 Pan Pinli], 2011, [塑性工程学报, Journal of Plasticity Engineering], V18, P13; Shaikh H, 2007, CORROS SCI, V49, P740, DOI 10.1016/j.corsci.2006.06.007; Shaikh H, 2010, CORROS SCI, V52, P1146, DOI 10.1016/j.corsci.2009.12.031; VOCE E, 1948, J I MET, V74, P537; Zener C, 1944, J APPL PHYS, V15, P22, DOI 10.1063/1.1707363; ZERILLI FJ, 1987, J APPL PHYS, V61, P1816, DOI 10.1063/1.338024; Zhou M, 1998, MECH MATER, V27, P63, DOI 10.1016/S0167-6636(97)00035-5	20	17	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e102687	10.1371/journal.pone.0102687	http://dx.doi.org/10.1371/journal.pone.0102687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375345	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402600001
J	Akkerman, S; Prickaerts, J; Bruder, AK; Wolfs, KHM; De Vry, J; Vanmierlo, T; Blokland, A				Akkerman, Sven; Prickaerts, Jos; Bruder, Ann K.; Wolfs, Kevin H. M.; De Vry, Jochen; Vanmierlo, Tim; Blokland, Arjan			PDE5 Inhibition Improves Object Memory in Standard Housed Rats but Not in Rats Housed in an Enriched Environment: Implications for Memory Models?	PLOS ONE			English	Article							INDUCED BEHAVIORAL-RESPONSES; RECOGNITION MEMORY; NEUROTROPHIC FACTOR; SPATIAL MEMORY; BASE-LINE; PHOSPHODIESTERASE INHIBITORS; COGNITIVE DEFICITS; LOCOMOTOR-ACTIVITY; PHYSICAL-EXERCISE; DENTATE GYRUS	Drug effects are usually evaluated in animals housed under maximally standardized conditions. However, it is assumed that an enriched environment (EE) more closely resembles human conditions as compared to maximally standardized laboratory conditions. In the present study, we examined the acute cognition enhancing effects of vardenafil, a PDE5 inhibitor, which stimulates protein kinase G/CREB signaling in cells, in three different groups of male Wistar rats tested in an object recognition task (ORT). Rats were either housed solitarily (SOL) or socially (SOC) under standard conditions, or socially in an EE. Although EE animals remembered object information longer in the vehicle condition, vardenafil only improved object memory in SOL and SOC animals. While EE animals had a heavier dorsal hippocampus, we found no differences between experimental groups in total cell numbers in the dentate gyrus, CA2-3 or CA1. Neither were there any differences in markers for pre-and postsynaptic density. No changes in PDE5 mRNA-and protein expression levels were observed. Basal pCREB levels were increased in EE rats only, whereas beta-catenin was not affected, suggesting specific activation of the MAP kinase signaling pathway and not the AKT pathway. A possible explanation for the inefficacy of vardenafil could be that CREB signaling is already optimally stimulated in the hippocampus of EE rats. Since previous data has shown that acute PDE5 inhibition does not improve memory performance in humans, the use of EE animals could be considered as a more valid model for testing cognition enhancing drugs.	[Akkerman, Sven; Prickaerts, Jos; Wolfs, Kevin H. M.; De Vry, Jochen] Maastricht Univ, European Sch Neurosci EURON, Fac Hlth Med & Life Sci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Blokland, Arjan] Maastricht Univ, European Sch Neurosci EURON, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Vanmierlo, Tim] Hasselt Univ, Biomed Res Inst, Dept Immunol & Biochem, Hasselt, Belgium; [Bruder, Ann K.] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	Maastricht University; Maastricht University; Hasselt University; University of Bonn	Blokland, A (corresponding author), Maastricht Univ, European Sch Neurosci EURON, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.	blokland@maastrichtuniversity.nl	Vanmierlo, Tim/C-7773-2013	Vanmierlo, Tim/0000-0003-2912-0578				Akar F, 2014, DRUG RES ST IN PRESS; Akar F, 2014, MED SCI MONIT BASIC, V20, P105, DOI 10.12659/MSMBR.891149; Akkerman S, 2014, NEUROBIOL LEARN MEM, V109, P139, DOI 10.1016/j.nlm.2014.01.006; Akkerman S, 2012, BEHAV BRAIN RES, V232, P317, DOI 10.1016/j.bbr.2012.03.024; Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Andin J, 2007, BRAIN RES, V1174, P18, DOI 10.1016/j.brainres.2007.06.101; Arndt DL, 2014, EXP CLIN PSYCHOPHARM, V22, P257, DOI 10.1037/a0035273; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bechara RG, 2013, BEHAV BRAIN RES, V245, P96, DOI 10.1016/j.bbr.2013.02.018; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Boccia MM, 2011, BEHAV BRAIN RES, V220, P319, DOI 10.1016/j.bbr.2011.02.016; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cao W, 2014, BEHAV BRAIN RES; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Del Arco A, 2007, J NEURAL TRANSM, V114, P43, DOI 10.1007/s00702-006-0565-8; Devan BD, 2004, PHARMACOL BIOCHEM BE, V79, P691, DOI 10.1016/j.pbb.2004.09.019; Diniz DG, 2010, EUR J NEUROSCI, V32, P509, DOI 10.1111/j.1460-9568.2010.07296.x; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; ESCORIHUELA RM, 1995, NEUROBIOL LEARN MEM, V64, P49, DOI 10.1006/nlme.1995.1043; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Galani R, 2007, NEUROBIOL LEARN MEM, V88, P1, DOI 10.1016/j.nlm.2007.03.009; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; Grass H., 2001, International Urology and Nephrology, V32, P409, DOI 10.1023/A:1017573722074; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gurwitz D, 2001, DRUG DISCOV TODAY, V6, P342, DOI 10.1016/S1359-6446(01)01747-0; Harati H, 2013, AGE, V35, P1027, DOI 10.1007/s11357-012-9424-8; Harati H, 2011, NEUROBIOL AGING, V32, P718, DOI 10.1016/j.neurobiolaging.2009.03.012; Hebb D.O., 1947, AM PSYCHOL, V2, P306; Hellemans KGC, 2005, BEHAV BRAIN RES, V159, P207, DOI 10.1016/j.bbr.2004.10.018; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hosseini-Sharifabad A, 2012, PHARMACOL BIOCHEM BE, V101, P311, DOI 10.1016/j.pbb.2012.01.017; Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jin F, 2014, INT J NEUROPSYCHOPH, V17, P871, DOI 10.1017/S1461145713001533; Kazlauckas V, 2011, PHYSIOL BEHAV, V102, P475, DOI 10.1016/j.physbeh.2010.12.025; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Kobilo T, 2011, LEARN MEMORY, V18, P103, DOI 10.1101/lm.2001611; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; Leger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048043; Lynch G, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00143; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pamplona FA, 2009, PROG NEURO-PSYCHOPH, V33, P1153, DOI 10.1016/j.pnpbp.2009.06.012; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prickaerts J, 2004, NEUROCHEM INT, V45, P915, DOI 10.1016/j.neuint.2004.03.022; Prickaerts J, 2002, EUR J PHARMACOL, V436, P83, DOI 10.1016/S0014-2999(01)01614-4; Prickaerts J, 2002, NEUROSCIENCE, V113, P351, DOI 10.1016/S0306-4522(02)00199-9; Ramirez-Rodriguez G, 2014, NEUROSCIENCE, V260, P158, DOI 10.1016/j.neuroscience.2013.12.026; Reneerkens OAH, 2013, J PSYCHOPHARMACOL, V27, P600, DOI 10.1177/0269881113477747; Reneerkens OAH, 2012, NEUROBIOL LEARN MEM, V97, P370, DOI 10.1016/j.nlm.2012.02.008; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; ROSENZWEIG MR, 1972, J COMP PHYSIOL PSYCH, V80, P304, DOI 10.1037/h0032978; Rutten K, 2007, EUR J PHARMACOL, V558, P107, DOI 10.1016/j.ejphar.2006.11.041; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; Sarter M, 2006, TRENDS PHARMACOL SCI, V27, P602, DOI 10.1016/j.tips.2006.09.004; Schmitz C, 2004, AM J PATHOL, V164, P1495, DOI 10.1016/S0002-9440(10)63235-X; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schultheiss D, 2001, WORLD J UROL, V19, P46, DOI 10.1007/PL00007092; Sierksma ASR, 2012, NEUROCHEM INT, V61, P697, DOI 10.1016/j.neuint.2012.06.022; Simpson J, 2012, BEHAV BRAIN RES, V234, P175, DOI 10.1016/j.bbr.2012.06.015; Simpson J, 2012, PROG NEURO-PSYCHOPH, V37, P252, DOI 10.1016/j.pnpbp.2012.02.008; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Thouvarecq R, 2007, PHYSIOL BEHAV, V90, P155, DOI 10.1016/j.physbeh.2006.09.024; Turner CA, 2003, PHYSIOL BEHAV, V80, P259, DOI 10.1016/j.physbeh.2003.07.008; Uthayathas S, 2013, SYNAPSE, V67, P741, DOI 10.1002/syn.21676; van Donkelaar EL, 2008, EUR J PHARMACOL, V600, P98, DOI 10.1016/j.ejphar.2008.10.027; van Praag H, 2001, DRUG DISCOV TODAY, V6, P615, DOI 10.1016/S1359-6446(01)01844-X; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Vedovelli K, 2011, NEUROSCIENCE, V199, P284, DOI 10.1016/j.neuroscience.2011.08.012; Viola GG, 2014, BRAIN STRUCT FUNCT, V219, P1509, DOI 10.1007/s00429-013-0563-1; Viola GG, 2010, PHYSIOL BEHAV, V99, P17, DOI 10.1016/j.physbeh.2009.10.003; Vivar Carmen, 2013, Curr Top Behav Neurosci, V15, P189, DOI 10.1007/7854_2012_220; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Yildirim E, 2012, PHARMACOL BIOCHEM BE, V101, P278, DOI 10.1016/j.pbb.2011.12.017; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zeeb FD, 2013, PSYCHOPHARMACOLOGY, V225, P381, DOI 10.1007/s00213-012-2822-x	83	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111692	10.1371/journal.pone.0111692	http://dx.doi.org/10.1371/journal.pone.0111692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372140	Green Published, gold			2022-12-27	WOS:000344556900062
J	Ambelu, A; Mekonen, S; Koch, M; Addis, T; Boets, P; Everaert, G; Goethals, P				Ambelu, Argaw; Mekonen, Seblework; Koch, Magaly; Addis, Taffere; Boets, Pieter; Everaert, Gert; Goethals, Peter			The Application of Predictive Modelling for Determining Bio-Environmental Factors Affecting the Distribution of Blackflies (Diptera: Simuliidae) in the Gilgel Gibe Watershed in Southwest Ethiopia	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; AZOLLA-FILICULOIDES LAM.; ANZALI WETLAND; HABITAT; DIVERSITY; ABUNDANCE; TREES	Blackflies are important macroinvertebrate groups from a public health as well as ecological point of view. Determining the biological and environmental factors favouring or inhibiting the existence of blackflies could facilitate biomonitoring of rivers as well as control of disease vectors. The combined use of different predictive modelling techniques is known to improve identification of presence/absence and abundance of taxa in a given habitat. This approach enables better identification of the suitable habitat conditions or environmental constraints of a given taxon. Simuliidae larvae are important biological indicators as they are abundant in tropical aquatic ecosystems. Some of the blackfly groups are also important disease vectors in poor tropical countries. Our investigations aim to establish a combination of models able to identify the environmental factors and macroinvertebrate organisms that are favourable or inhibiting blackfly larvae existence in aquatic ecosystems. The models developed using macroinvertebrate predictors showed better performance than those based on environmental predictors. The identified environmental and macroinvertebrate parameters can be used to determine the distribution of blackflies, which in turn can help control river blindness in endemic tropical places. Through a combination of modelling techniques, a reliable method has been developed that explains environmental and biological relationships with the target organism, and, thus, can serve as a decision support tool for ecological management strategies.	[Ambelu, Argaw; Mekonen, Seblework] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Koch, Magaly] Boston Univ, Ctr Remote Sensing, Boston, MA 02215 USA; [Addis, Taffere] Univ Addis Ababa, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Boets, Pieter; Everaert, Gert; Goethals, Peter] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium	Jimma University; Boston University; Addis Ababa University; Ghent University	Ambelu, A (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, POB 378, Jimma, Ethiopia.	aambelu@yahoo.com	Everaert, Gert/B-7707-2017; Ambelu, Argaw/GQA-6114-2022; Addis, Taffere/AAC-3460-2019; Goethals, Peter LM/A-1116-2008; Ambelu, Argaw/V-8317-2018; Koch, Magaly/B-3467-2017	Everaert, Gert/0000-0003-4305-0617; Ambelu, Argaw/0000-0003-1898-4100; Addis, Taffere/0000-0003-1647-4131; Ambelu, Argaw/0000-0003-1898-4100; Mekonen, Seblework/0000-0002-4255-6264; Koch, Magaly/0000-0002-6186-1619	Jimma University, Ethiopia; VLIR-UOS, Belgium	Jimma University, Ethiopia; VLIR-UOS, Belgium	This research was supported by Jimma University, Ethiopia and VLIR-UOS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambelu A, 2009, BIOL MONITORING BASE; Ambelu A, 2010, ECOL INFORM, V5, P147, DOI 10.1016/j.ecoinf.2009.12.004; Andrewartha H.G., 1986, ECOLOGICAL WEB MORE; [Anonymous], 2005, STANDARD METHODS EXA; Austin MP, 2009, J ECOL, V97, P496, DOI 10.1111/j.1365-2745.2009.01494.x; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Bouchard J. R. W, 2004, GUIDE AQUATIC INVERT; Breiman L, 1993, CLASSIFICATION REGRE; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; D'heyere T, 2006, ECOL MODEL, V195, P20, DOI 10.1016/j.ecolmodel.2005.11.005; Dakou E, 2007, AQUAT ECOL, V41, P399, DOI 10.1007/s10452-006-9058-y; Figueiro Ronaldo, 2010, Oecologia Australis, V14, P745; Figueiro R, 2012, MEM I OSWALDO CRUZ, V107, P362, DOI 10.1590/S0074-02762012000300011; Giannoulaki M, 2008, HYDROBIOLOGIA, V612, P225, DOI 10.1007/s10750-008-9498-6; Giannoulaki M, 2011, FISH OCEANOGR, V20, P367, DOI 10.1111/j.1365-2419.2011.00590.x; Gibbins EG, 2009, T ROYAL ENTOMOLOGICA, V82, P51, DOI [10.1111/j.1365-2311.1934.tb00028.x, DOI 10.1111/J.1365-2311.1934.TB00028.X]; Goethals PLM, 2007, AQUAT ECOL, V41, P491, DOI 10.1007/s10452-007-9093-3; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283; Hastie T., 1986, STAT SCI, V1, P297; Hastie T., 1999, GEN ADDITIVE MODELS; Hilborn Ray, 1997, V28; Hoang TH, 2010, ECOL INFORM, V5, P140, DOI 10.1016/j.ecoinf.2009.12.001; Holland J. H., 1992, ADAPTATION NATURAL A; IBN, 1984, T92402 IBN; Jowett IG, 2007, T AM FISH SOC, V136, P428, DOI 10.1577/T06-104.1; Katsanevakis S, 2009, FISH OCEANOGR, V18, P439, DOI 10.1111/j.1365-2419.2009.00523.x; Kazanci Nilgun, 2010, Review of Hydrobiology, V3, P27; Kazanci Nilgun, 2006, Acta Entomologica Serbica, V11, P69; KEELE L, 2008, SEMIPARAMETRIC REGRE; Lechthaler Wolfgang, 2004, Acta Zoologica Universitatis Comenianae, V46, P39; Lock K, 2014, LIMNOLOGICA, V44, P58, DOI 10.1016/j.limno.2013.08.001; Mereta ST, 2012, ECOL INFORM, V7, P52, DOI 10.1016/j.ecoinf.2011.11.005; Palialexis A, 2011, HYDROBIOLOGIA, V670, P241, DOI 10.1007/s10750-011-0673-9; Planque B, 2007, FISH OCEANOGR, V16, P16, DOI 10.1111/j.1365-2419.2006.00411.x; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; R Core Team, 2012, R LANG ENV STAT COMP; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Sadeghi R, 2013, ECOL MODEL, V251, P44, DOI 10.1016/j.ecolmodel.2012.12.010; Sadeghi R, 2012, ECOL MODEL, V243, P8, DOI 10.1016/j.ecolmodel.2012.06.011; Taylor MJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-7; Vose M.D., 1999, COM ADAP SY; Voshell J.R., 2002, GUIDE COMMON FRESHWA; Witten IH, 2011, MOR KAUF D, P1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Wooley JC, 2005, CATALYZING INQUIRY B; Zarkami R., 2010, Caspian Journal of Environmental Sciences, V8, P55; Zarkami R, 2012, ECOL MODEL, V230, P44, DOI 10.1016/j.ecolmodel.2012.01.011	52	16	16	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112221	10.1371/journal.pone.0112221	http://dx.doi.org/10.1371/journal.pone.0112221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372843	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900122
J	Barreiro, A; Dominguez, JM; Crespo, AJC; Gonzalez-Jorge, H; Roca, D; Gomez-Gesteira, M				Barreiro, Anxo; Dominguez, Jose M.; Crespo, Alejandro J. C.; Gonzalez-Jorge, Higinio; Roca, David; Gomez-Gesteira, Moncho			Integration of UAV Photogrammetry and SPH Modelling of Fluids to Study Runoff on Real Terrains	PLOS ONE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; FREE-SURFACE FLOWS; BREAKWATER; SPHYSICS; SOLVER	Roads can experience runoff problems due to the intense rain discharge associated to severe storms. Two advanced tools are combined to analyse the interaction of complex water flows with real terrains. UAV (Unmanned Aerial Vehicle) photogrammetry is employed to obtain accurate topographic information on small areas, typically on the order of a few hectares. The Smoothed Particle Hydrodynamics (SPH) technique is applied by means of the DualSPHysics model to compute the trajectory of the water flow during extreme rain events. The use of engineering solutions to palliate flood events is also analysed. The study case simulates how the collected water can flow into a close road and how precautionary measures can be effective to drain water under extreme conditions. The amount of water arriving at the road is calculated under different protection scenarios and the efficiency of a ditch is observed to decrease when sedimentation reduces its depth.	[Barreiro, Anxo; Dominguez, Jose M.; Crespo, Alejandro J. C.; Gomez-Gesteira, Moncho] Univ Vigo, EPHYSLAB Environm Phys Lab, Orense, Spain; [Gonzalez-Jorge, Higinio; Roca, David] Univ Vigo, Dept Nat Resources & Environm Engn, Appl Geotechnol Grp, Vigo 36310, Spain	Universidade de Vigo; Universidade de Vigo	Crespo, AJC (corresponding author), Univ Vigo, EPHYSLAB Environm Phys Lab, Orense, Spain.	alexbexe@uvigo.es	Gesteira, Moncho Gomez/R-9431-2019; C. Crespo, Alejandro J./G-9948-2015; Domínguez, José M./N-2219-2014	Gesteira, Moncho Gomez/0000-0002-0661-9731; C. Crespo, Alejandro J./0000-0003-3384-5061; Domínguez, José M./0000-0002-2586-5081; Gonzalez-Jorge, Higinio/0000-0002-0195-8849; Barreiro, Anxo/0000-0002-8563-9334	Xunta de Galicia under project Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referencia Competitiva), Parga Pondal [IPP055]; European Regional Development Fund (FEDER); Spanish Centre for Technological and Industrial Development [IDI-20101770]; Ministerio de Economia y Competitividad [BIA2012-38676C03-03]; Barcelona Supercomputing Centre [FI-2013-2-0013, FI-2013-3-0008.]	Xunta de Galicia under project Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referencia Competitiva), Parga Pondal; European Regional Development Fund (FEDER)(European Commission); Spanish Centre for Technological and Industrial Development; Ministerio de Economia y Competitividad(Spanish Government); Barcelona Supercomputing Centre	This work was partially financed by Xunta de Galicia under project Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referencia Competitiva), Parga Pondal grant IPP055, both co-funded by European Regional Development Fund (FEDER), by the Spanish Centre for Technological and Industrial Development under Project IDI-20101770 and by Ministerio de Economia y Competitividad under Project BIA2012-38676C03-03. The authors also thank Barcelona Supercomputing Centre for providing computational time at the Minotauro under the activity FI-2013-2-0013 & FI-2013-3-0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 2014, COMPUT STRUCT, V130, P34, DOI 10.1016/j.compstruc.2013.10.011; Barreiro A, 2013, COMPUT STRUCT, V120, P96, DOI 10.1016/j.compstruc.2013.02.010; Batchelor G.K., 1974, INTRO FLUID DYNAMICS; Gomez-Collado MC, 2010, J INEQUAL APPL, DOI [10.1155/2010/253690, 10.1080/00221686.2010.9641242]; Crespo AJC, 2007, CMC-COMPUT MATER CON, V5, P173; Crespo A.J.C., 2008, THESIS U VIGO; Crespo AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020685; Dalrymple RA, 2006, COAST ENG, V53, P141, DOI 10.1016/j.coastaleng.2005.10.004; Dominguez JM, 2013, COMPUT PHYS COMMUN, V184, P1848, DOI 10.1016/j.cpc.2013.03.008; Dominguez JM, 2011, INT J NUMER METH FL, V67, P2026, DOI 10.1002/fld.2481; Dominguez JM, 2011, 6 INT SPHERIC WORKSH, P117; Dominguez JM, 2013, COMPUT PHYS COMMUN, V184, P617, DOI 10.1016/j.cpc.2012.10.015; Everaerts J., 2008, INT ARCH PHOTOGRAM R, VXXXVII, P1187; Gomez-Gesteira M, 2012, COMPUT GEOSCI-UK, V48, P289, DOI 10.1016/j.cageo.2012.02.029; Gomez-Gesteira M, 2012, COMPUT GEOSCI-UK, V48, P300, DOI 10.1016/j.cageo.2012.02.028; Gonzalez-Jorge H, 2011, OPT ENG, V50, DOI 10.1117/1.3598868; Luhmann T., 2011, CLOSE RANGE PHOTOGRA; Medeiros SC, 2013, INT J NUMER METH FL, V71, P473, DOI 10.1002/fld.3668; MONAGHAN JJ, 1992, ANNU REV ASTRON ASTR, V30, P543, DOI 10.1146/annurev.aa.30.090192.002551; MONAGHAN JJ, 1994, J COMPUT PHYS, V110, P399, DOI 10.1006/jcph.1994.1034; Pilgrim DH, 1993, HDB HYDROLOGY; Remondino F., 2011, INT ARCH PHOTOGRAMME; Rogers BD, 2010, J HYDRAUL RES, V48, P135, DOI 10.1080/00221686.2010.9641254; Violeau D, 2007, INT J NUMER METH FL, V53, P277, DOI 10.1002/fld.1292; Wendland H., 1995, Advances in Computational Mathematics, V4, P389, DOI 10.1007/BF02123482	25	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111031	10.1371/journal.pone.0111031	http://dx.doi.org/10.1371/journal.pone.0111031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372035	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900034
J	De Buck, J; Shaykhutdinov, R; Barkema, HW; Vogel, HJ				De Buck, Jeroen; Shaykhutdinov, Rustem; Barkema, Herman W.; Vogel, Hans J.			Metabolomic Profiling in Cattle Experimentally Infected with Mycobacterium avium subsp paratuberculosis	PLOS ONE			English	Article							CLINICAL JOHNES-DISEASE; INTERFERON-GAMMA ASSAY; FECAL CULTURE; DAIRY CALVES; H-1-NMR SPECTROSCOPY; BIOMARKER DISCOVERY; PLASMA; TISSUE; SERUM; SUSCEPTIBILITY	The sensitivity of current diagnostics for Johne's disease, a slow, progressing enteritis in ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP), is too low to reliably detect all infected animals in the subclinical stage. The objective was to identify individual metabolites or metabolite profiles that could be used as biomarkers of early MAP infection in ruminants. In a monthly follow-up for 17 months, calves infected at 2 weeks of age were compared with aged-matched controls. Sera from all animals were analyzed by H-1 nuclear magnetic resonance spectrometry. Spectra were acquired, processed, and quantified for analysis. The concentration of many metabolites changed over time in all calves, but some metabolites only changed over time in either infected or non-infected groups and the change in others was impacted by the infection. Hierarchical multivariate statistical analysis achieved best separation between groups between 300 and 400 days after infection. Therefore, a cross-sectional comparison between 1-year-old calves experimentally infected at various ages with either a high-or a low-dose and age-matched non-infected controls was performed. Orthogonal Projection to Latent Structures Discriminant Analysis (OPLS DA) yielded distinct separation of non-infected from infected cattle, regardless of dose and time (3, 6, 9 or 12 months) after infection. Receiver Operating Curves demonstrated that constructed models were high quality. Increased isobutyrate in the infected cattle was the most important agreement between the longitudinal and cross-sectional analysis. In general, high-and low-dose cattle responded similarly to infection. Differences in acetone, citrate, glycerol and iso-butyrate concentrations indicated energy shortages and increased fat metabolism in infected cattle, whereas changes in urea and several amino acids (AA), including the branched chain AA, indicated increased protein turnover. In conclusion, metabolomics was a sensitive method for detecting MAP infection much sooner than with current diagnostic methods, with individual metabolites significantly distinguishing infected from non-infected cattle.	[De Buck, Jeroen; Barkema, Herman W.] Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, Calgary, AB, Canada; [Shaykhutdinov, Rustem; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Fac Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	De Buck, J (corresponding author), Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, Calgary, AB, Canada.	jdebuck@ucalgary.ca	De Buck, Jeroen/H-5509-2018; Barkema, Herman/B-9583-2008	De Buck, Jeroen/0000-0002-4824-9580; Barkema, Herman/0000-0002-9678-8378	Alberta Innovates Technology Futures; Alberta Innovates Biosolutions; Alberta Livestock and Meat Agency; Alberta Milk; Dairy Farmers of Canada; Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation	Alberta Innovates Technology Futures; Alberta Innovates Biosolutions; Alberta Livestock and Meat Agency; Alberta Milk; Dairy Farmers of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Cancer Foundation	The study was funded by the Alberta Innovates Technology Futures, Alberta Innovates Biosolutions, Alberta Livestock and Meat Agency, Alberta Milk, the Dairy Farmers of Canada, the Natural Sciences and Engineering Research Council of Canada and the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001303; Borges DC, 2013, IMMUNOLOGY, V138, P145, DOI 10.1111/imm.12022; Casey JL, 2011, PROTEIN ENG DES SEL, V24, P589, DOI 10.1093/protein/gzr026; Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011; Davis VW, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-271; Denholm JT, 2010, CLIN EXP IMMUNOL, V162, P84, DOI 10.1111/j.1365-2249.2010.04221.x; Durudas A, 2011, CURR HIV RES, V9, P276, DOI 10.2174/157016211797635928; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; Hoerr V, 2012, J PROTEOME IN PRESS; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jungersen G, 2012, VET IMMUNOL IMMUNOP, V148, P48, DOI 10.1016/j.vetimm.2011.05.010; Li JV, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-179; Lin ZY, 2009, NMR BIOMED, V22, P601, DOI 10.1002/nbm.1373; Maertzdorf J, 2012, INT J TUBERC LUNG D, V16, P1140, DOI 10.5588/ijtld.12.0246; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; McKenna SLB, 2005, VET MICROBIOL, V110, P105, DOI 10.1016/j.vetmic.2005.07.010; McKenna SLB, 2005, J VET DIAGN INVEST, V17, P463, DOI 10.1177/104063870501700510; Mortier RAR, 2014, VET IMMUNOL IMMUNOP, V161, P205, DOI 10.1016/j.vetimm.2014.08.007; Mortier RAR, 2014, VET RES, V45, DOI 10.1186/s13567-014-0071-1; Mortier RAR, 2014, J DAIRY SCI, V97, P5558, DOI 10.3168/jds.2014-8139; Mortier RAR, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-94; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Ooi M, 2011, INFLAMM RES, V60, P831, DOI 10.1007/s00011-011-0340-7; PATTERS.DSP, 1966, VET REC, V78, P364, DOI 10.1136/vr.78.11.364; PATTERSON DS, 1967, VET REC, V81, P435, DOI 10.1136/vr.81.17.435; PATTERSON DS, 1969, J MED MICROBIOL, V2, P327, DOI 10.1099/00222615-2-3-327; Plattner BL, 2011, VET PATHOL, V48, P584, DOI 10.1177/0300985810383874; Pushie MJ, 2011, J TOXICOL ENV HEAL A, V74, P1476, DOI 10.1080/15287394.2011.618977; Raizman EA, 2007, PREV VET MED, V78, P179, DOI 10.1016/j.prevetmed.2006.10.006; Reimer RA, 2012, J PROTEOME RES, V11, P4065, DOI 10.1021/pr300487s; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; Schicho R, 2012, J PROTEOME RES; Schicho R, 2010, J PROTEOME RES, V9, P6265, DOI 10.1021/pr100547y; Schmerler D, 2012, J LIPID RES, V53, P1369, DOI 10.1194/jlr.P023309; Seth M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005478; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Skovgaard K, 2006, VET IMMUNOL IMMUNOP, V112, P210, DOI 10.1016/j.vetimm.2006.02.006; Sweeney RW, 2011, VET CLIN N AM-FOOD A, V27, P537, DOI 10.1016/j.cvfa.2011.07.001; Sweeney RW, 2006, RES VET SCI, V80, P253, DOI 10.1016/j.rvsc.2005.07.007; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wolfe R R, 1983, Prog Clin Biol Res, V111, P89; You QM, 2012, VET IMMUNOL IMMUNOP, V148, P243, DOI 10.1016/j.vetimm.2012.05.002; Zhong L, 2011, COMP IMMUNOL MICROB, V34, P315, DOI 10.1016/j.cimid.2011.03.001	54	35	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111872	10.1371/journal.pone.0111872	http://dx.doi.org/10.1371/journal.pone.0111872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372282	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900081
J	Ni, XJ; Zhang, XL; Ou-Yang, QW; Qian, GW; Wang, L; Chen, S; Jiang, YZ; Zuo, WJ; Wu, J; Hu, X; Shao, ZM				Ni, Xiao-Jian; Zhang, Xiao-Lan; Ou-Yang, Qian-Wen; Qian, Guo-Wei; Wang, Lei; Chen, Sheng; Jiang, Yi-Zhou; Zuo, Wen-Jia; Wu, Jiong; Hu, Xin; Shao, Zhi-Ming			An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy	PLOS ONE			English	Article							ABSOLUTE MONOCYTE; POOR SURVIVAL; COUNT; NEUTROPHIL; SUBTYPES; ADULTS; CELLS; RISK	Purpose: Neoadjuvant chemotherapy (NCT) is a standard treatment option for locally advanced breast cancer. However, the lack of an efficient method to predict treatment response and patient prognosis hampers the clinical evaluation of patient eligibility for NCT. An elevated lymphocyte-to-monocyte ratio (LMR) has been reported to be associated with a favorable prognosis for certain hematologic malignancies and for nasopharyngeal carcinoma; however, this association has not been investigated in breast cancer. The purpose of this study was to evaluate whether pre-NCT LMR analysis could predict the prognosis of patients with locally advanced breast cancer. Methods: A retrospective cohort of 542 locally advanced breast cancer patients (T3/T4 and/or N2/N3 disease) receiving NCT followed by radical surgery was recruited between May 2002 and August 2011 at the Fudan University Shanghai Cancer Center. Counts for pre-NCT peripheral absolute lymphocytes and monocytes were obtained and used to calculate the LMR. Results: Univariate and multivariate analysis revealed that higher LMR levels (>= 4.25) were significantly associated with favorable DFS (P = 0.009 and P = 0.011, respectively). Additionally, univariate analysis revealed that a higher lymphocyte count (>= 1.5x10(9)/L) showed borderline significance for improved DFS (P = 0.054), while a lower monocyte count (,0.4x10(9)/L) was associated with a significantly better DFS (P = 0.010). Conclusions: An elevated pre-NCT peripheral LMR level was a significantly favorable factor for locally advanced breast cancer patient prognosis. This easily obtained variable may serve as a valuable marker to predict the outcomes of locally advanced breast cancer.	[Ni, Xiao-Jian; Qian, Guo-Wei; Wang, Lei; Chen, Sheng; Jiang, Yi-Zhou; Zuo, Wen-Jia; Wu, Jiong; Hu, Xin; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200433, Peoples R China; [Ni, Xiao-Jian; Qian, Guo-Wei; Wang, Lei; Chen, Sheng; Jiang, Yi-Zhou; Zuo, Wen-Jia; Wu, Jiong; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shao, Zhi-Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Xiao-Lan] Nanjing Med Univ, Changzhou Peoples Hosp Affiliated 2, Nanjing, Jiangsu, Peoples R China; [Ou-Yang, Qian-Wen] Third Hosp Nanchang, Dept Breast Surg, Nanchang, Jiangxi, Peoples R China	Fudan University; Fudan University; Fudan University; Nanjing Medical University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200433, Peoples R China.	zhi_ming_shao@163.com			National Natural Science Foundation of China [81201531]; Shanghai Committee of Science and Technology Funds [12ZR1406200, 12DZ2260100, 12140901502]; Shanghai Committee of Science and Technology Fund [11QA1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee); Shanghai Committee of Science and Technology Fund(Shanghai Science & Technology Committee)	The study was supported by grants from the National Natural Science Foundation of China (81201531), the 2012 Shanghai Committee of Science and Technology Funds (12ZR1406200, 12DZ2260100 and 12140901502) and the Shanghai Committee of Science and Technology Fund for 2013 Qimingxing Project (11QA1401400 to XH). The authors also greatly appreciate the assistance of American Journal Experts (AJE) editors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bejon P, 2013, PLOS ONE, V8; Bishara S, 2008, EUR J OBSTET GYN R B, V138, P71, DOI 10.1016/j.ejogrb.2007.05.012; BRUCKNER HW, 1982, JAMA-J AM MED ASSOC, V247, P1004, DOI 10.1001/jama.247.7.1004; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Dworacki G, 2001, CLIN CANCER RES, V7, p947S; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Hornychova H, 2008, CANCER INVEST, V26, P1024, DOI 10.1080/07357900802098165; HUSSAIN SP, 1994, ONCOGENE, V9, P2277; Iyengar Neil M, 2013, Am Soc Clin Oncol Educ Book, P46, DOI 10.1200/EdBook_AM.2013.33.46; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; NAKAMURA Y, 1988, CARCINOGENESIS, V9, P203, DOI 10.1093/carcin/9.2.203; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Porrata LF, 2013, BONE MARROW RES, DOI 10.1155/2013/658371; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; RABINOWICH H, 1987, CANCER RES, V47, P173; SALIM AS, 1993, INT J CANCER, V53, P1031; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Shen GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036515; Sun D, 2012, AM J HEMATOL, V87, P957, DOI 10.1002/ajh.23279; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177	33	81	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111886	10.1371/journal.pone.0111886	http://dx.doi.org/10.1371/journal.pone.0111886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372468	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900083
J	Oliveira-Pinto, AV; Santos, RM; Coutinho, RA; Oliveira, LM; Santos, GB; Alho, ATL; Leite, REP; Farfel, JM; Suemoto, CK; Grinberg, LT; Pasqualucci, CA; Jacob, W; Lent, R				Oliveira-Pinto, Ana V.; Santos, Raquel M.; Coutinho, Renan A.; Oliveira, Lays M.; Santos, Glaucia B.; Alho, Ana T. L.; Leite, Renata E. P.; Farfel, Jose M.; Suemoto, Claudia K.; Grinberg, Lea T.; Pasqualucci, Carlos A.; Jacob-Filho, Wilson; Lent, Roberto			Sexual Dimorphism in the Human Olfactory Bulb: Females Have More Neurons and Glial Cells than Males	PLOS ONE			English	Article							CELLULAR SCALING RULES; ISOTROPIC FRACTIONATOR; PERCEIVED INTENSITY; BRAIN ACTIVATION; MITRAL CELLS; NEUROGENESIS; GENDER; ODOR; COMMUNICATION; PERCEPTION	Sex differences in the human olfactory function reportedly exist for olfactory sensitivity, odorant identification and memory, and tasks in which odors are rated based on psychological features such as familiarity, intensity, pleasantness, and others. Which might be the neural bases for these behavioral differences? The number of cells in olfactory regions, and especially the number of neurons, may represent a more accurate indicator of the neural machinery than volume or weight, but besides gross volume measures of the human olfactory bulb, no systematic study of sex differences in the absolute number of cells has yet been undertaken. In this work, we investigate a possible sexual dimorphism in the olfactory bulb, by quantifying postmortem material from 7 men and 11 women (ages 55-94 years) with the isotropic fractionator, an unbiased and accurate method to estimate absolute cell numbers in brain regions. Female bulbs weighed 0.132 g in average, while male bulbs weighed 0.137 g, a non-significant difference; however, the total number of cells was 16.2 million in females, and 9.2 million in males, a significant difference of 43.2%. The number of neurons in females reached 6.9 million, being no more than 3.5 million in males, a difference of 49.3%. The number of non-neuronal cells also proved higher in women than in men: 9.3 million and 5.7 million, respectively, a significant difference of 38.7%. The same differences remained when corrected for mass. Results demonstrate a sex-related difference in the absolute number of total, neuronal and non-euronal cells, favoring women by 40-50%. It is conceivable that these differences in quantitative cellularity may have functional impact, albeit difficult to infer how exactly this would be, without knowing the specific circuits cells make. However, the reported advantage of women as compared to men may stimulate future work on sex dimorphism of synaptic microcircuitry in the olfactory bulb.	[Oliveira-Pinto, Ana V.; Santos, Raquel M.; Coutinho, Renan A.; Oliveira, Lays M.; Lent, Roberto] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Santos, Glaucia B.; Alho, Ana T. L.; Leite, Renata E. P.; Farfel, Jose M.; Suemoto, Claudia K.; Grinberg, Lea T.; Pasqualucci, Carlos A.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Aging Brain Study Grp, Sao Paulo, Brazil; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol & Pathol, San Francisco, CA 94143 USA; [Lent, Roberto] Natl Inst Translat Neurosci, Minist Sci & Technol, Sao Paulo, Brazil; [Farfel, Jose M.; Suemoto, Claudia K.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Discipline Geriatr, Sao Paulo, Brazil; [Santos, Glaucia B.; Alho, Ana T. L.] Hosp Israelita Albert Einstein, Inst Brain, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; University of California System; University of California San Francisco; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Lent, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	rlent@icb.ufrj.br	Alho, Ana Tereza D L/C-3317-2014; Suemoto, Claudia K/C-7218-2012; Farfel, Jose/C-8936-2012; Suemoto, Claudia Kimie/AAC-7238-2019	Suemoto, Claudia K/0000-0002-5942-4778; Farfel, Jose/0000-0003-2057-3669; grinberg, lea/0000-0002-6809-0618	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Ciencia e Tecnologia em Neurociencia Translacional; Fundacao Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Neurociencia Translacional; Fundacao Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The following Brazilian institutions contributed with research grants of different types, as well as fellowships of different categories to students who participated on the work. The grants are not unified as in the American system, so the total number of formal "grants'' totalize something like 30 or so. This is why they cannot be listed by their protocol numbers in each agency. (1) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (R. Lent) (www.cnpq.br). (2) Instituto Nacional de Ciencia e Tecnologia em Neurociencia Translacional (R. Lent). (3) Fundacao Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (R. Lent, A.V. Oliveira-Pinto) (www.capes.gov.br). (4) Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (R. Lent) (www.faperj.br). (5) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Lea T. Grinberg, C. Pasqualucci, W. Jacob-Filho) (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Moraes CH, 2013, BRAIN, V136, P3738, DOI 10.1093/brain/awt273; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bahney J, 2014, J NEUROSCI METH, V222, P165, DOI 10.1016/j.jneumeth.2013.11.002; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Bengtsson S, 2001, NEUROREPORT, V12, P2027, DOI 10.1097/00001756-200107030-00048; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Brus M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00135; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Crespo C, 2013, ANAT REC, V296, P1401, DOI 10.1002/ar.22732; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; de Groot JHB, 2014, J EXP PSYCHOL GEN, V143, P1515, DOI 10.1037/a0035950; de Sousa AA, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00051; Diamond J, 2005, CHEM SENSES, V30, pI224, DOI 10.1093/chemse/bjh195; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; DOTY RL, 1978, BEHAV BIOL, V23, P373, DOI 10.1016/S0091-6773(78)91393-7; DOTY RL, 1982, HORM BEHAV, V16, P13, DOI 10.1016/0018-506X(82)90002-2; DOTY RL, 1975, SCIENCE, V190, P1316, DOI 10.1126/science.1239080; DOTY RL, 1986, CLIN MEASUREMENT TAS, P377; Doty RL, 2014, FRONT PSYCHOL, V5, P20, DOI [DOI 10.3389/FPSYG.2014.00020, DOI 10.3389/fpsyg.2014.00020]; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; EVANS WJ, 1995, ELECTROEN CLIN NEURO, V95, P293, DOI 10.1016/0013-4694(95)00055-4; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Garcia-Falgueras A, 2006, BRAIN RES, V1116, P103, DOI 10.1016/j.brainres.2006.07.115; Gardener EKT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073475; Giessel AJ, 2014, CURR OPIN NEUROBIOL, V24, P120, DOI 10.1016/j.conb.2013.09.010; Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z; Gur RC, 1999, J NEUROSCI, V19, P4065; Hahn CG, 2005, J COMP NEUROL, V483, P154, DOI 10.1002/cne.20424; Harasty J, 1997, ARCH NEUROL-CHICAGO, V54, P171, DOI 10.1001/archneur.1997.00550140045011; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00046; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Huart C, 2013, MOLECULES, V18, P11586, DOI 10.3390/molecules180911586; Hummel T, 2011, EXP BRAIN RES, V214, P285, DOI 10.1007/s00221-011-2832-7; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jacobs LF, 2012, P NATL ACAD SCI USA, V109, P10693, DOI 10.1073/pnas.1201880109; Jafari FH, 2008, ANN PARK I MED SCI, V4, P136; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Knaapila A, 2012, ARCH SEX BEHAV, V41, P1403, DOI 10.1007/s10508-011-9804-7; KOELEGA HS, 1994, PERCEPT MOTOR SKILL, V78, P203, DOI 10.2466/pms.1994.78.1.203; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lent R, 2012, EUR J NEUROSCI, V35, P1, DOI 10.1111/j.1460-9568.2011.07923.x; LISS L, 1958, ARCHIV OTOLARYNGOL, V67, P167; Lledo PM, 2004, NEUROSCIENTIST, V10, P292, DOI 10.1177/1073858404263460; Lotsch J, 2013, BRAIN STRUCT FUNCT, DOI [10.1007/s00429-013-0618-2, DOI 10.1007/S00429-013-0618-2]; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Meisami E, 1998, ANN NY ACAD SCI, V855, P708, DOI 10.1111/j.1749-6632.1998.tb10649.x; Migliore M, 2013, FUNCT NEUROL, V28, P241, DOI 10.11138/FNeur/2013.28.3.241; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Ohla K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00607; Olofsson JK, 2004, CHEM SENSES, V29, P629, DOI 10.1093/chemse/bjh066; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Radulescu AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068485; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; Sama-ul-Haq, 2008, JCPSP-J COLL PHYSICI, V18, P669, DOI 11.2008/JCPSP.669973; Sama-ul-haq, 2008, BIOMEDICA, V24, P12; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; SCHNEIDER RA, 1958, J CLIN ENDOCR METAB, V18, P379, DOI 10.1210/jcem-18-4-379; Segovia S, 1996, HORM BEHAV, V30, P618, DOI 10.1006/hbeh.1996.0065; Segovia S, 1996, NEUROREPORT, V7, P2553, DOI 10.1097/00001756-199611040-00030; Seo HS, 2011, CHEM SENSES, V36, P177, DOI 10.1093/chemse/bjq112; Ship JA, 1996, J GERONTOL A-BIOL, V51, pM86, DOI 10.1093/gerona/51A.2.M86; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P3, DOI 10.1016/j.physbeh.2004.07.018; Thilers PP, 2006, PSYCHONEUROENDOCRINO, V31, P565, DOI 10.1016/j.psyneuen.2005.12.005; Tovar-Moll F, 2014, P NATL ACAD SCI USA, V111, P7843, DOI 10.1073/pnas.1400806111; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Yousem DM, 1999, BRAIN RES, V818, P480, DOI 10.1016/S0006-8993(98)01276-1	81	67	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111733	10.1371/journal.pone.0111733	http://dx.doi.org/10.1371/journal.pone.0111733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372872	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900069
J	Shin, SW; Park, BL; Chang, H; Park, JS; Bae, DJ; Song, HJ; Choi, IS; Kim, MK; Park, HS; Kim, LH; Namgoong, S; Kim, JO; Shin, HD; Park, CS				Shin, Seung-Woo; Park, Byung Lae; Chang, HunSoo; Park, Jong Sook; Bae, Da-Jeong; Song, Hyun-Ji; Choi, Inseon S.; Kim, Mi-Kyeong; Park, Hea-Sim; Kim, Lyoung Hyo; Namgoong, Suhg; Kim, Ji On; Shin, Hyoung Doo; Park, Choon-Sik			Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTOLERANT ASTHMA; GENE POLYMORPHISMS; PROMOTER POLYMORPHISM; NATURAL-HISTORY; SUSCEPTIBILITY; EXPRESSION; MARKER; HYPERSENSITIVITY; THROMBOXANE	Aspirin-exacerbated respiratory disease (AERD) is one phenotype of asthma, often occurring in the form of a severe and sudden attack. Due to the time-consuming nature and difficulty of oral aspirin challenge (OAC) for AERD diagnosis, non-invasive biomarkers have been sought. The aim of this study was to identify AERD-associated exonic SNPs and examine the diagnostic potential of a combination of these candidate SNPs to predict AERD. DNA from 165 AERD patients, 397 subjects with aspirin-tolerant asthma (ATA), and 398 normal controls were subjected to an Exome BeadChip assay containing 240K SNPs. 1,023 models (2(10)-1) were generated from combinations of the top 10 SNPs, selected by the p-values in association with AERD. The area under the curve (AUC) of the receiver operating characteristic (ROC) curves was calculated for each model. SNP Function Portal and PolyPhen-2 were used to validate the functional significance of candidate SNPs. An exonic SNP, exm537513 in HLA-DPB1, showed the lowest p-value (p = 3.40x10(-8)) in its association with AERD risk. From the top 10 SNPs, a combination model of 7 SNPs (exm537513, exm83523, exm1884673, exm538564, exm2264237, exm396794, and exm791954) showed the best AUC of 0.75 (asymptotic p-value of 7.94x10(-21)), with 34% sensitivity and 93% specificity to discriminate AERD from ATA. Amino acid changes due to exm83523 in CHIA were predicted to be "probably damaging" to the structure and function of the protein, with a high score of '1'. A combination model of seven SNPs may provide a useful, non-invasive genetic marker combination for predicting AERD.	[Shin, Seung-Woo; Chang, HunSoo; Park, Jong Sook; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Div Allergy & Resp Med, Puchon, South Korea; [Park, Byung Lae; Kim, Lyoung Hyo; Namgoong, Suhg; Kim, Ji On; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Chang, HunSoo; Bae, Da-Jeong; Song, Hyun-Ji] Soonchunhyang Univ, Major Grad Sch, Dept Interdisciplinary Program Biomed Sci, Asan, South Korea; [Choi, Inseon S.] Chonnam Natl Univ, Sch Med, Dept Allergy, Kwangju, South Korea; [Choi, Inseon S.] Chonnam Natl Univ, Res Inst Med Sci, Kwangju, South Korea; [Kim, Mi-Kyeong] Chungbuk Natl Univ, Dept Internal Med, Div Allergy, Cheongju, South Korea; [Park, Hea-Sim] Ajou Univ Hosp, Dept Allergy & Clin Immunol, Suwoon, South Korea; [Kim, Lyoung Hyo; Namgoong, Suhg; Kim, Ji On; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea	Soonchunhyang University; SNP Genetics; Soonchunhyang University; Chonnam National University; Chonnam National University; Chungbuk National University; Ajou University; Ajou University Hospital; Sogang University	Park, CS (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Div Allergy & Resp Med, Puchon, South Korea.	hdshin@sogang.ac.kr; mdcspark@unitel.co.kr			Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, and Republic of Korea [HI13C0319]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, and Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, and Republic of Korea (HI13C0319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akahoshi M, 2005, HUM GENET, V117, P16, DOI 10.1007/s00439-005-1285-0; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Berges-Gimeno MP, 2002, ANN ALLERG ASTHMA IM, V89, P474, DOI 10.1016/S1081-1206(10)62084-4; Birben E, 2011, RESP MED, V105, P1160, DOI 10.1016/j.rmed.2011.03.017; Chang HS, 2011, ALLERGY ASTHMA IMMUN, V3, P256, DOI 10.4168/aair.2011.3.4.256; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Dekker JW, 1997, CLIN EXP ALLERGY, V27, P574, DOI 10.1046/j.1365-2222.1997.540848.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisner MD, 2007, NICOTINE TOB RES, V9, P53, DOI 10.1080/14622200601078293; Hedman J, 1999, INT J EPIDEMIOL, V28, P717, DOI 10.1093/ije/28.4.717; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kim BS, 2010, PHARMACOGENET GENOM, V20, P748, DOI 10.1097/FPC.0b013e3283402155; Kim JH, 2011, J CLIN IMMUNOL, V31, P112, DOI 10.1007/s10875-010-9462-x; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Kim SH, 2006, CLIN EXP ALLERGY, V36, P877, DOI 10.1111/j.1365-2222.2006.02443.x; Kim SH, 2007, PHARMACOGENET GENOM, V17, P295, DOI 10.1097/01.fpc.0000239977.61841.fe; Kim SH, 2009, RESP MED, V103, P356, DOI 10.1016/j.rmed.2008.10.008; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kim SH, 2005, CLIN EXP ALLERGY, V35, P339, DOI 10.1111/j.1365-2222.2004.02197.x; Kim TH, 2008, CLIN EXP ALLERGY, V38, P1727, DOI 10.1111/j.1365-2222.2008.03082.x; Lee JS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-138; Lee RU, 2011, ALLERGY ASTHMA IMMUN, V3, P3, DOI 10.4168/aair.2011.3.1.3; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Oh SH, 2011, PHARMACOGENOMICS, V12, P351, DOI [10.2217/pgs.10.181, 10.2217/PGS.10.181]; Oh SH, 2009, ALLERGY ASTHMA IMMUN, V1, P30, DOI 10.4168/aair.2009.1.1.30; Palikhe NS, 2010, ALLERGY, V65, P338, DOI 10.1111/j.1398-9995.2009.02158.x; Palikhe NS, 2008, RESP MED, V102, P1132, DOI 10.1016/j.rmed.2008.03.017; Palikhe NS, 2011, ALLERGY ASTHMA IMMUN, V3, P123, DOI 10.4168/aair.2011.3.2.123; Park BL, 2013, HUM GENET, V132, P313, DOI 10.1007/s00439-012-1247-2; Park BL, 2010, BMB REP, V43, P445, DOI 10.5483/BMBRep.2010.43.6.445; Park HS, 2004, J ALLERGY CLIN IMMUN, V114, P688, DOI 10.1016/j.jaci.2004.05.051; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Park SM, 2013, ALLERGY ASTHMA IMMUN, V5, P258, DOI 10.4168/aair.2013.5.5.258; Park TJ, 2011, INT ARCH ALLERGY IMM, V155, P395, DOI 10.1159/000321267; Pasaje CFA, 2010, ANN HUM GENET, V74, P326, DOI 10.1111/j.1469-1809.2010.00584.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sakagami T, 2007, J HUM GENET, V52, P66, DOI 10.1007/s10038-006-0081-6; Sanak M, 2000, AM J RESP CELL MOL, V23, P290, DOI 10.1165/ajrcmb.23.3.4051; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Shin SW, 2012, DNA CELL BIOL, V31, P1604, DOI 10.1089/dna.2012.1688; SPURR NK, 1984, EMBO J, V3, P159, DOI 10.1002/j.1460-2075.1984.tb01777.x; Stevenson DD, 2006, J ALLERGY CLIN IMMUN, V118, P773, DOI 10.1016/j.jaci.2006.07.024; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241	52	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111887	10.1371/journal.pone.0111887	http://dx.doi.org/10.1371/journal.pone.0111887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372592	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900084
J	Tennant, JP; MacLeod, N				Tennant, Jonathan P.; MacLeod, Norman			Snout Shape in Extant Ruminants	PLOS ONE			English	Article							BODY-SIZE; MAMMALIAN HERBIVORES; NUTRITIONAL ECOLOGY; AFRICAN RUMINANTS; GRAZING RUMINANTS; EXTINCT RUMINANTS; MORPHOMETRIC DATA; RUMEN PHYSIOLOGY; ORAL MORPHOLOGY; LIFE-HISTORIES	Snout shape is a prominent aspect of herbivore feeding ecology, interacting with both forage selectivity and intake rate. Previous investigations have suggested ruminant feeding styles can be discriminated via snout shape, with grazing and browsing species characterised by 'blunt' and 'pointed' snouts respectively, often with specification of an 'intermediate' sub-grouping to represent ambiguous feeding styles and/or morphologies. Snout shape morphology is analysed here using a geometric morphometric approach to compare the two-dimensional profiles of the premaxilla in ventral aspect for a large sample of modern ruminant species, for which feeding modes are known from secondary criteria. Results suggest that, when browsing and grazing ruminants are classified ecologically based on a range of feeding style indicators, they cannot be discriminated unambiguously on the basis of snout profile shape alone. Profile shapes in our sample form a continuum with substantial overlap between groupings and a diverse range of morphologies. Nevertheless, we obtained an 83.8 percent ratio of correct post hoc feeding style categorisations based on the proximity of projected profile shapes to group centroids in the discriminant space. Accordingly, this procedure for identifying species whose feeding strategy is 'unknown' can be used with a reasonable degree of confidence, especially if backed-up by additional information. Based on these results we also refine the definitions of snout shape varieties, taking advantage of the descriptive power that geometric morphometrics offers to characterize the morphological disparities observed. The shape variance exhibited by both browsing and grazing ruminants corresponds strongly to body mass, providing further evidence for an interaction between snout shape, feeding style, and body size evolution. Finally, by exploring the role of phylogenetic similarity in snout shape, we find a slight increase in successful categorisation when repeating the analysis with phylogenetic control on the geometric	[Tennant, Jonathan P.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England; [MacLeod, Norman] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Imperial College London; Natural History Museum London	Tennant, JP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England.	jonathan.tennant10@imperial.ac.uk	Tennant, Jonathan P./H-2762-2019	Tennant, Jon/0000-0001-7794-0218				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BODMER RE, 1990, OIKOS, V57, P319, DOI 10.2307/3565960; HADLEY M., 1970, Annual review of ecology and systematics., V1, P125, DOI 10.1146/annurev.es.01.110170.001013; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1549, DOI 10.1098/rspb.2008.0262; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; Clauss M, 2010, ANIMAL, V4, P979, DOI 10.1017/S1751731110000388; Clauss M, 2008, OECOLOGIA, V157, P377, DOI 10.1007/s00442-008-1093-z; Clauss Marcus, 2008, V195, P47, DOI 10.1007/978-3-540-72422-3_3; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; Clauss M, 2009, J MORPHOL, V270, P929, DOI 10.1002/jmor.10729; Clauss M, 2009, COMP BIOCHEM PHYS A, V152, P398, DOI 10.1016/j.cbpa.2008.11.009; Codron D, 2008, OIKOS, V117, P344, DOI 10.1111/j.2007.0030-1299.16387.x; Codron D, 2007, EUR J WILDLIFE RES, V53, P100, DOI 10.1007/s10344-006-0071-1; Codron D, 2010, CAN J ZOOL, V88, P1129, DOI 10.1139/Z10-077; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; du Toit Johan T., 2003, P292; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Figueirido B, 2010, J EVOLUTION BIOL, V23, P2579, DOI 10.1111/j.1420-9101.2010.02117.x; Fletcher TM, 2010, PALAEONTOL ELECTRON, V13, P1; Fraser D, 2011, J VERTEBR PALEONTOL, V31, P1366, DOI 10.1080/02724634.2011.605404; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1994, OECOLOGIA, V98, P167, DOI 10.1007/BF00341469; Gordon IJ, 1996, J ANIM ECOL, V65, P18, DOI 10.2307/5696; Gordon IJ, 2003, FOREST ECOL MANAG, V181, P13, DOI 10.1016/S0378-1127(03)00124-5; Gordon IJ, 1996, FUNCT ECOL, V10, P219, DOI 10.2307/2389846; GWYNNE MD, 1968, NATURE, V220, P390, DOI 10.1038/220390a0; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; Hofmann R. R., 1988, Aspects of digestive physiology in ruminants. Proceedings of a Satellite Symposium of the 30th International Congress of the International Union of Physiological Sciences, July 21-23, 1986. Ithaca, New York, P1; Hofmann R. R, 1999, RANGIFER, V20, P71; Hofmann RR, 2008, J MORPHOL, V269, P240, DOI 10.1002/jmor.10580; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HOFMANN RR, 1991, RECENT ADV NUTR HERB, P27; Hofmann RR., 1973, RUMINANT STOMACH STO; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Isaac NJB, 2005, AM NAT, V165, P600, DOI 10.1086/429148; JANIS C M, 1990, Memoirs of the Queensland Museum, V28, P349; Janis CM, 2010, J ANIM PHYSIOL AN N, V94, pE402, DOI 10.1111/j.1439-0396.2010.01030.x; JANIS CM, 1988, ZOOL J LINN SOC-LOND, V92, P267, DOI 10.1111/j.1096-3642.1988.tb01513.x; JANIS CM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P76; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; MacFadden BJ, 2000, ANNU REV ECOL SYST, V31, P33, DOI 10.1146/annurev.ecolsys.31.1.33; MACLEOD N, 2007, PALAEONTOLOGICAL ASS, V65, P36; MACLEOD N, 2007, PALAEONTOLOGICAL ASS, V64, P35; MacLeod N., 2009, PALAEONTOLOGICAL ASS, V72, P14; MACLEOD N, 2013, PALAEONTOL NEWSL, V82, P32; MacLeod N., 2005, PALAEONTOL NEWSL, V59, P44; MacLeod Norman, 2013, Palaeontology Newsletter, V84, P20; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Mendoza M, 2002, J ZOOL, V258, P223, DOI 10.1017/S0952836902001346; MILLAR JS, 1983, ECOLOGY, V64, P631, DOI 10.2307/1937181; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MURRAY MG, 1993, J ANIM ECOL, V62, P380, DOI 10.2307/5369; Owen-Smith N, 1997, Z SAUGETIERKD, V62, P176; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perez-Barberia FJ, 2001, OECOLOGIA, V129, P498, DOI 10.1007/s004420100768; Perez-Barberia FJ, 1999, OECOLOGIA, V118, P157, DOI 10.1007/s004420050714; Perez-Barberia FJ, 2001, EVOL ECOL RES, V3, P221; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Perez-Barberia FJ, 1998, J ZOOL, V245, P307, DOI 10.1111/j.1469-7998.1998.tb00106.x; Perez-Barberia FJ, 2001, P ROY SOC B-BIOL SCI, V268, P1023, DOI 10.1098/rspb.2001.1619; Perez-Barberia FJ, 2000, EVOL ECOL RES, V2, P667; Polly DP, 2011, HYSTRIX ITALIAN J MA, V24, P33; R Core Team, 2018, R LANG ENV STAT COMP; Raia P, 2011, P ROY SOC B-BIOL SCI, V278, P3474, DOI 10.1098/rspb.2011.0273; Raia P, 2010, EVOLUTION, V64, P1489, DOI 10.1111/j.1558-5646.2009.00921.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; ROBBINS CT, 1995, OECOLOGIA, V103, P208, DOI 10.1007/BF00329082; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; SAND H, 1995, OECOLOGIA, V102, P433, DOI 10.1007/BF00341355; Sanson G, 2006, AM J BOT, V93, P1531, DOI 10.3732/ajb.93.10.1531; SATORRA A, 1985, PSYCHOMETRIKA, V50, P83, DOI 10.1007/BF02294150; SHIPLEY LA, 1994, AM NAT, V143, P1055, DOI 10.1086/285648; Shipley LA., 1999, P GRAZING BEHAV LIVE, P20; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; SOLOUNIAS N, 1988, PALAEOGEOGR PALAEOCL, V65, P149, DOI 10.1016/0031-0182(88)90021-1; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; Sponheimer M, 2003, J MAMMAL, V84, P471, DOI 10.1644/1545-1542(2003)084&lt;0471:DOSABS&gt;2.0.CO;2; Steuer P, 2011, COMP BIOCHEM PHYS A, V160, P355, DOI 10.1016/j.cbpa.2011.07.005; VAN ZYL J. H. M., 1965, ZOOL AFRICANA, V1, P55; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; Walker A., 1984, P119; Zhang WQ, 2012, GENET MOL RES, V11, P628, DOI 10.4238/2012.March.14.6	102	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112035	10.1371/journal.pone.0112035	http://dx.doi.org/10.1371/journal.pone.0112035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372878	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900105
J	Dernedde, J; Weise, C; Muller, EC; Hagiwara, A; Bachmann, S; Suzuki, M; Reutter, W; Tauber, R; Scherer, H				Dernedde, Jens; Weise, Christoph; Mueller, Eva-Christina; Hagiwara, Akira; Bachmann, Sebastian; Suzuki, Mamoru; Reutter, Werner; Tauber, Rudolf; Scherer, Hans			Cupulin Is a Zona Pellucida-Like Domain Protein and Major Component of the Cupula from the Inner Ear	PLOS ONE			English	Article							RECEPTOR; MODEL; ZP3	The extracellular membranes of the inner ear are essential constituents to maintain sensory functions, the cupula for sensing torsional movements of the head, the otoconial membrane for sensing linear movements and accelerations like gravity, and the tectorial membrane in the cochlea for hearing. So far a number of structural proteins have been described, but for the gelatinous cupula precise data are missing. Here, we describe for the first time a major proteinogenic component of the cupula structure with an apparent molecular mass of 45 kDa from salmon. Analyses of respective peptides revealed highly conserved amino-acid sequences with identity to zona pellucida-like domain proteins. Immunohistochemistry studies localized the protein in the ampulla of the inner ear from salmon and according to its anatomical appearance we identified this glycoprotein as Cupulin. Future research on structure and function of zona pellucida-like domain proteins will enhance our knowledge of inner ear diseases, like sudden loss of vestibular function and other disturbances.	[Dernedde, Jens; Reutter, Werner; Tauber, Rudolf] Charite, Klin Chem & Pathobiochem, Inst Lab Med, D-13353 Berlin, Germany; [Weise, Christoph] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Mueller, Eva-Christina] Max Delbruck Ctr Mol Med, Berlin, Germany; [Hagiwara, Akira; Suzuki, Mamoru] Tokyo Med Univ, Dept Otolaryngol, Shinjuku Ku, Tokyo 1608402, Japan; [Bachmann, Sebastian] Charite, Inst Vegetat Anat, D-13353 Berlin, Germany; [Scherer, Hans] Charite, Klin Otorhinolaryngol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Tokyo Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dernedde, J (corresponding author), Charite, Klin Chem & Pathobiochem, Inst Lab Med, D-13353 Berlin, Germany.	jens.dernedde@charite.de	Dernedde, Jens/H-4097-2017	Dernedde, Jens/0000-0001-5319-7677	Charite	Charite	The work was supported by internal funding of Charite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Dohlman G F, 1969, J Laryngol Otol, V83, P43, DOI 10.1017/S0022215100070031; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Helling K, 2000, HNO, V48, P822, DOI 10.1007/s001060050668; Helling K, 2002, ACTA OTO-LARYNGOL, V122, P386, DOI 10.1080/00016480260000067; Iimura Y, 2010, ACTA OTO-LARYNGOL, V130, P1092, DOI 10.3109/00016481003677456; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; KILLICK R, 1995, J CELL BIOL, V129, P535, DOI 10.1083/jcb.129.2.535; Konomi U, 2010, ACTA OTO-LARYNGOL, V130, P652, DOI 10.3109/00016480903370779; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; MARCUS DC, 1983, HEARING RES, V12, P17, DOI 10.1016/0378-5955(83)90116-8; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Quint E, 1998, HEARING RES, V118, P157, DOI 10.1016/S0378-5955(98)00026-4; Scherer H, 2001, Biol Sci Space, V15, P350, DOI 10.2187/bss.15.350; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Takumida M, 2001, Biol Sci Space, V15, P356, DOI 10.2187/bss.15.356	25	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111917	10.1371/journal.pone.0111917	http://dx.doi.org/10.1371/journal.pone.0111917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369234	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000126
J	Lee, JM; Park, J; Jeon, KH; Jung, JH; Lee, SE; Han, JK; Kim, HL; Yang, HM; Park, KW; Kang, HJ; Koo, BK; Jo, SH; Kim, HS				Lee, Joo Myung; Park, Jonghanne; Jeon, Ki-Hyun; Jung, Ji-hyun; Lee, Sang Eun; Han, Jung-Kyu; Kim, Hack-Lyoung; Yang, Han-Mo; Park, Kyung Woo; Kang, Hyun-Jae; Koo, Bon-Kwon; Jo, Sang-Ho; Kim, Hyo-Soo			Efficacy of Short-Term High-Dose Statin Pretreatment in Prevention of Contrast-Induced Acute Kidney Injury: Updated Study-Level Meta-Analysis of 13 Randomized Controlled Trials	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; INDUCED NEPHROPATHY; ATORVASTATIN PRETREATMENT; RENAL-FUNCTION; TASK-FORCE; THERAPY; ASSOCIATION; ANGIOGRAPHY; SOCIETY	Background: There have been conflicting results across the trials that evaluated prophylactic efficacy of short-term high-dose statin pre-treatment for prevention of contrast-induced acute kidney injury (CIAKI) in patients undergoing coronary angiography (CAG). The aim of the study was to perform an up-to-date meta-analysis regarding the efficacy of high-dose statin pre-treatment in preventing CIAKI. Methods and Results: Randomized-controlled trials comparing high-dose statin versus low-dose statin or placebo pretreatment for prevention of CIAKI in patients undergoing CAG were included. The primary endpoint was the incidence of CIAKI within 2-5days after CAG. The relative risk (RR) with 95% CI was the effect measure. This analysis included 13 RCTs with 5,825 total patients; about half of them (n = 2,889) were pre-treated with high-dose statin (at least 40 mg of atorvastatin) before CAG, and the remainders (n = 2,936) pretreated with low-dose statin or placebo. In random-effects model, high-dose statin pre-treatment significantly reduced the incidence of CIAKI (RR 0.45, 95% CI 0.35-0.57, p < 0.001, I-2 = 8.2%, NNT 16), compared with low-dose statin or placebo. The benefit of high-dose statin was consistent in both comparisons with low-dose statin (RR 0.47, 95% CI 0.34-0.65, p < 0.001, I-2 = 28.4%, NNT 19) or placebo (RR 0.34, 95% CI 0.21-0.58, p < 0.001, I-2 = 0.0%, NNT 16). In addition, high-dose statin showed significant reduction of CIAKI across various subgroups of chronic kidney disease, acute coronary syndrome, and old age (>= 60years), regardless of osmolality of contrast or administration of N-acetylcystein. Conclusions: High-dose statin pre-treatment significantly reduced overall incidence of CIAKI in patients undergoing CAG, and emerges as an effective prophylactic measure to prevent CIAKI.	[Lee, Joo Myung; Park, Jonghanne; Jeon, Ki-Hyun; Jung, Ji-hyun; Lee, Sang Eun; Han, Jung-Kyu; Yang, Han-Mo; Park, Kyung Woo; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Lee, Joo Myung; Park, Jonghanne; Jeon, Ki-Hyun; Jung, Ji-hyun; Lee, Sang Eun; Han, Jung-Kyu; Yang, Han-Mo; Park, Kyung Woo; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea; [Kim, Hack-Lyoung] Seoul Natl Univ, Boramae Med Ctr, Ctr Cardiovasc, Seoul, South Korea; [Jo, Sang-Ho] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, Anyang Si, Gyeonggi Do, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU)	Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	hyosoo@snu.ac.kr	Park, Kyung Woo/AAX-3046-2020; Lee, Jeong Min/V-3429-2019; Kim, Hack-Lyoung/AAL-5038-2020; Kang, Hyun-Jae/D-6121-2012	Lee, Jeong Min/0000-0003-0561-8777; Kim, Hack-Lyoung/0000-0002-6703-1472; Kang, Hyun-Jae/0000-0002-3500-1746; Lee, Joo Myung/0000-0002-2178-4014	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government [2010-0020258]; IRICT, Seoul National University Hospital - Ministry of Health and Welfare, Republic of Korea [A062260]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government; IRICT, Seoul National University Hospital - Ministry of Health and Welfare, Republic of Korea	This study was supported by grants from the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (2010-0020258) and from the IRICT, Seoul National University Hospital (A062260), sponsored by the Ministry of Health and Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikel S, 2010, BLOOD COAGUL FIBRIN, V21, P750, DOI 10.1097/MBC.0b013e32834014a4; Attallah N, 2004, CLIN NEPHROL, V62, P273; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Cao Shiping, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1600; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Han YL, 2014, J AM COLL CARDIOL, V63, P62, DOI 10.1016/j.jacc.2013.09.017; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ichiki T, 2001, ARTERIOSCL THROM VAS, V21, P1896, DOI 10.1161/hq1201.099430; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jia XW, 2009, AM J CARDIOL, V104, P519, DOI 10.1016/j.amjcard.2009.04.014; Jo SH, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.042; John Stefan, 2005, Am Heart J, V149, P473; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Khanal S, 2005, AM J MED, V118, P843, DOI 10.1016/j.amjmed.2005.03.031; Kitzler TM, 2012, WIEN KLIN WOCHENSCHR, V124, P312, DOI 10.1007/s00508-012-0169-2; Klein LW, 2009, CATHETER CARDIO INTE, V74, P728, DOI 10.1002/ccd.22113; Lee JM, 2014, CRIT CARE MED, V42, P1252, DOI 10.1097/CCM.0000000000000122; Leoncini M, 2014, J AM COLL CARDIOL, V63, P71, DOI 10.1016/j.jacc.2013.04.105; Li W, 2012, CARDIOLOGY, V122, P195, DOI 10.1159/000339472; Li YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034450; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McCullough PA, 2006, AM J CARDIOL, V98, p5K, DOI 10.1016/j.amjcard.2006.01.019; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Ozhan H, 2010, ANGIOLOGY, V61, P711, DOI 10.1177/0003319710364216; Pappy R, 2011, INT J CARDIOL, V151, P348, DOI 10.1016/j.ijcard.2011.05.045; Patti G, 2011, AM J CARDIOL, V108, P1, DOI 10.1016/j.amjcard.2011.03.001; Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Takagi H, 2011, INT J CARDIOL, V153, P323, DOI 10.1016/j.ijcard.2011.08.047; Toso A, 2010, AM J CARDIOL, V105, P288, DOI 10.1016/j.amjcard.2009.09.026; WIJNS W, 2010, EUR HEART J, V31, P2501, DOI DOI 10.1093/EURHEARTJ/EHQ277; X-p H, 2010, MILIT MED J S CHINA, V24, P448; Zhang BC, 2011, CAN J CARDIOL, V27, P851, DOI 10.1016/j.cjca.2011.05.005; Zhang L, 2011, INT J CLIN PRACT, V65, P624, DOI 10.1111/j.1742-1241.2010.02588.x; Zhang T, 2011, AM J NEPHROL, V33, P344, DOI 10.1159/000326269; Zhou Xia, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P394, DOI 10.3760/cma.j.issn.0253-3758.2009.05.003	38	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111397	10.1371/journal.pone.0111397	http://dx.doi.org/10.1371/journal.pone.0111397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369120	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000053
J	Ren, SX; Lu, G; Ota, A; Zhou, ZH; Vondriska, TM; Lane, TF; Wang, YB				Ren, Shuxun; Lu, Gang; Ota, Asuka; Zhou, Z. Hong; Vondriska, Thomas M.; Lane, Timothy F.; Wang, Yibin			IRE1 Phosphatase PP2Ce Regulates Adaptive ER Stress Response in the Postpartum Mammary Gland	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; MESSENGER-RNA; CARDIOVASCULAR-DISEASE; TRANSLATIONAL CONTROL; ACTIVATION; CASPASE-12; ATF6; XBP1	We recently reported that the PPM1l gene encodes an endoplasmic reticulum (ER) membrane targeted protein phosphatase (named PP2Ce) with highly specific activity towards Inositol-requiring protein-1 (IRE1) and regulates the functional outcome of ER stress. In the present report, we found that the PP2Ce protein is highly expressed in lactating epithelium of the mammary gland. Loss of PP2Ce in vivo impairs physiological unfolded protein response (UPR) and induces stress kinase activation, resulting in loss of milk production and induction of epithelial apoptosis in the lactating mammary gland. This study provides the first in vivo evidence that PP2Ce is an essential regulator of normal lactation, possibly involving IRE1 signaling and ER stress regulation in mammary epithelium.	[Ren, Shuxun; Lu, Gang; Ota, Asuka; Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; [Lane, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Lane, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu	Zhou, Z Hong/HDN-0747-2022	Lane, Timothy F./0000-0002-0210-970X; Wang, Yibin/0000-0003-0852-0767	NIH [HL070079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108186, R01HL070079] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by NIH (HL070079 for YW), an NIH Ruth L. Kirschstein National Research Service Award (AO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bergmann RL, 2013, J PERINAT MED, P1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Invernizzi G, 2012, J DAIRY SCI, V95, P2562, DOI 10.3168/jds.2011-4806; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lu G, 2013, MOL METABOLISM; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thomas SE, 2010, DIABETES-METAB RES, V26, P611, DOI 10.1002/dmrr.1132; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vidal R, 2011, CURR MOL MED, V11, P1, DOI 10.2174/156652411794474419; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	32	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111606	10.1371/journal.pone.0111606	http://dx.doi.org/10.1371/journal.pone.0111606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369058	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000076
J	Tan, YS; Kim, M; Kingsbury, TJ; Civin, CI; Cheng, WC				Tan, Yee Sun; Kim, MinJung; Kingsbury, Tami J.; Civin, Curt I.; Cheng, Wen-Chih			Regulation of RAB5C Is Important for the Growth Inhibitory Effects of MiR-509 in Human Precursor-B Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RENAL-CELL CARCINOMA; LARGE GENE LISTS; SMALL GTPASE; MICRORNA SIGNATURES; MESSENGER-RNA; CANCER; EXPRESSION; TARGET; PROLIFERATION	MicroRNAs (miRs) regulate essentially all cellular processes, but few miRs are known to inhibit growth of precursor-B acute lymphoblastic leukemias (B-ALLs). We identified miR-509 via a human genome-wide gain-of-function screen for miRs that inhibit growth of the NALM6 human B-ALL cell line. MiR-509-mediated inhibition of NALM6 growth was confirmed by 3 independent assays. Enforced miR-509 expression inhibited 2 of 2 additional B-ALL cell lines tested, but not 3 non-B-ALL leukemia cell lines. MiR-509-transduced NALM6 cells had reduced numbers of actively proliferating cells and increased numbers of cells undergoing apoptosis. Using miR target prediction algorithms and a filtering strategy, RAB5C was predicted as a potentially relevant target of miR-509. Enforced miR-509 expression in NALM6 cells reduced RAB5C mRNA and protein levels, and RAB5C was demonstrated to be a direct target of miR-509. Knockdown of RAB5C in NALM6 cells recapitulated the growth inhibitory effects of miR-509. Co-expression of the RAB5C open reading frame without its 39 untranslated region (3'UTR) blocked the growth-inhibitory effect mediated by miR-509. These findings establish RAB5C as a target of miR-509 and an important regulator of B-ALL cell growth with potential as a therapeutic target.	[Tan, Yee Sun; Kim, MinJung; Kingsbury, Tami J.; Civin, Curt I.; Cheng, Wen-Chih] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Kingsbury, Tami J.; Civin, Curt I.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Kim, MinJung; Kingsbury, Tami J.; Civin, Curt I.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kim, MinJung; Civin, Curt I.; Cheng, Wen-Chih] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Cheng, WC (corresponding author), Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA.	WCheng@som.umaryland.edu			National Foundation for Cancer Research; National Institutes of Health [PO1CA70970]; Maryland Stem Cell Research Foundation/TEDCO [2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065-00]; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER	National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation/TEDCO; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants from National Foundation for Cancer Research (http://www.nfcr.org), the National Institutes of Health (http://www.nih.gov) (PO1CA70970) and Maryland Stem Cell Research Foundation/TEDCO (http://www.mscrf.org) (2007-MSCRFII-0114, 2008-MSCRF-303524 and 2010-MSCRFII-0065-00) to CIC, and Gabrielle's Angel Foundation (http://www.gabriellesangels.org) to WCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Amendola M, 2009, MOL THER, V17, P1039, DOI 10.1038/mt.2009.48; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Candia J, 2014, UNCOVERING IN PRESS; Capalbo L, 2011, P NATL ACAD SCI USA, V108, P17343, DOI 10.1073/pnas.1103720108; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090384; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Cheng WC, 2013, BIOTECHNIQUES, V54, P77, DOI 10.2144/000113991; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dou L, 2012, ONCOGENE, V31, P507, DOI 10.1038/onc.2011.248; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heiser D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094852; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hunger SP, 2011, PEDIATR BLOOD CANCER, V56, P984, DOI 10.1002/pbc.22996; Izumiya M, 2011, CANCER SCI, V102, P1615, DOI 10.1111/j.1349-7006.2011.02007.x; Izumiya M, 2010, CARCINOGENESIS, V31, P1354, DOI 10.1093/carcin/bgq112; Ju XL, 2009, PEDIATR HEMAT ONCOL, V26, P1, DOI 10.1080/08880010802378338; Kaplan IM, 2011, J IMMUNOL, V186, P2826, DOI 10.4049/jimmunol.1002806; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Maia S, 2005, CANCER RES, V65, P10050, DOI 10.1158/0008-5472.CAN-05-1574; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; MAY WS, 1985, J MEMBRANE BIOL, V88, P205, DOI 10.1007/BF01871086; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Poell JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043569; Raetz EA, 2012, HEMATOL-AM SOC HEMAT, P129, DOI 10.1182/asheducation-2012.1.129; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schotte D, 2012, LEUKEMIA, V26, P1, DOI 10.1038/leu.2011.151; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Serio G, 2011, P NATL ACAD SCI USA, V108, P17337, DOI 10.1073/pnas.1103516108; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhang WB, 2013, IRISH J MED SCI, V182, P621, DOI 10.1007/s11845-013-0941-y	72	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111777	10.1371/journal.pone.0111777	http://dx.doi.org/10.1371/journal.pone.0111777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368993	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000098
J	Wolkow, PP; Kosiniak-Kamysz, W; Osmenda, G; Wilk, G; Bujak-Gizycka, B; Ignacak, A; Kanitkar, M; Walus-Miarka, M; Harrison, DG; Korbut, R; Malecki, MT; Guzik, TJ				Wolkow, Pawel P.; Kosiniak-Kamysz, Wladyslaw; Osmenda, Grzegorz; Wilk, Grzegorz; Bujak-Gizycka, Beata; Ignacak, Adam; Kanitkar, Mihir; Walus-Miarka, Malgorzata; Harrison, David G.; Korbut, Ryszard; Malecki, Maciej T.; Guzik, Tomasz J.			GTP Cyclohydrolase I Gene Polymorphisms Are Associated with Endothelial Dysfunction and Oxidative Stress in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							VASCULAR SUPEROXIDE-PRODUCTION; PAIN SENSITIVITY; NAD(P)H OXIDASE; NITRIC-OXIDE; RISK-FACTORS; GCH1; MECHANISMS; ATHEROSCLEROSIS; PANCREAS; DISEASE	Background: The genetic background of atherosclerosis in type 2 diabetes mellitus (T2DM) is complex and poorly understood. Studying genetic components of intermediate phenotypes, such as endothelial dysfunction and oxidative stress, may aid in identifying novel genetic components for atherosclerosis in diabetic patients. Methods: Five polymorphisms forming two haplotype blocks within the GTP cyclohydrolase 1 gene, encoding a rate limiting enzyme in tetrahydrobiopterin synthesis, were studied in the context of flow and nitroglycerin mediated dilation (FMD and NMD), intima-media thickness (IMT), and plasma concentrations of von Willebrand factor (vWF) and malondialdehyde (MDA). Results: Rs841 was associated with FMD (p = 0.01), while polymorphisms Rs10483639, Rs841, Rs3783641 (which form a single haplotype) were associated with both MDA (p = 0.012, p = 0.0015 and p = 0.003, respectively) and vWF concentrations (p = 0.016, p = 0.03 and p = 0.045, respectively). In addition, polymorphism Rs8007267 was also associated with MDA (p = 0.006). Haplotype analysis confirmed the association of both haplotypes with studied variables. Conclusions: Genetic variation of the GCH1 gene is associated with endothelial dysfunction and oxidative stress in T2DM patients.	[Wolkow, Pawel P.; Bujak-Gizycka, Beata] Jagiellonian Univ, Coll Med, Ctr Med Genom OMICRON, Krakow, Poland; [Wolkow, Pawel P.; Bujak-Gizycka, Beata; Korbut, Ryszard] Jagiellonian Univ, Coll Med, Dept Pharmacol, Krakow, Poland; [Kosiniak-Kamysz, Wladyslaw; Osmenda, Grzegorz; Wilk, Grzegorz; Ignacak, Adam; Guzik, Tomasz J.] Jagiellonian Univ, Coll Med, Dept Internal & Agr Med, Krakow, Poland; [Kanitkar, Mihir; Harrison, David G.] Vanderbilt Univ, Dept Clin Pharmacol, Nashville, TN 37235 USA; [Walus-Miarka, Malgorzata; Malecki, Maciej T.] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland; [Malecki, Maciej T.] Univ Hosp, Krakow, Poland; [Guzik, Tomasz J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Vanderbilt University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Glasgow	Guzik, TJ (corresponding author), Jagiellonian Univ, Coll Med, Dept Internal & Agr Med, Krakow, Poland.	t.guzik@uj.edu.pl	Wolkow, Pawel/AAI-4222-2021; Guzik, Tomasz Jan/AAM-5007-2020	Wolkow, Pawel/0000-0002-9322-5545; Guzik, Tomasz/0000-0002-5039-7849	Foundation for Polish Science; Wellcome Trust; Polish National Center of Science (NCN) [N402 096 32/3258, N402 468937]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431] Funding Source: NIH RePORTER	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Polish National Center of Science (NCN); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Foundation for Polish Science Welcome/02/09 Grant and by the Wellcome Trust Senior International Research Fellowship. PW and TJG were supported by grants from the Polish National Center of Science (NCN) including No N402 096 32/3258 and No N402 468937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Antoniades C, 2008, J AM COLL CARDIOL, V52, P158, DOI 10.1016/j.jacc.2007.12.062; Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322; Channon KM, 2002, J PHYSIOL PHARMACOL, V53, P515; COLLINS R, 1995, LANCET, V345, P669; De Cobelli F, 2004, DIABETES CARE, V27, P947, DOI 10.2337/diacare.27.4.947; Doehring A, 2008, MUTAT RES-REV MUTAT, V659, P195, DOI 10.1016/j.mrrev.2008.04.007; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fiorina P, 2001, DIABETES, V50, P496, DOI 10.2337/diabetes.50.3.496; Flossmann E, 2005, CEREBROVASC DIS, V19, P1, DOI 10.1159/000081905; Folli F, 2011, CURR DIABETES REV, V7, P313, DOI 10.2174/157339911797415585; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gesierich A, 2003, BASIC RES CARDIOL, V98, P69, DOI 10.1007/s00395-003-0394-y; Gotschy A, 2013, CIRC-CARDIOVASC IMAG, V6, P916, DOI 10.1161/CIRCIMAGING.113.000611; Guzik B, 2013, INT J CARDIOL, V168, P2389, DOI 10.1016/j.ijcard.2013.01.278; Guzik TJ, 2004, ARTERIOSCL THROM VAS, V24, P1614, DOI 10.1161/01.ATV.0000139011.94634.9d; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; HANSSON GK, 1993, BRIT HEART J, V69, pS38; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Kim H, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-6; Kishi T, 2012, J AFFECT DISORDERS, V142, P315, DOI 10.1016/j.jad.2012.05.004; Liao YF, 2010, J DIABETES COMPLICAT, V24, P313, DOI 10.1016/j.jdiacomp.2009.04.003; Lotsch J, 2007, CLIN CHEM, V53, P1010, DOI 10.1373/clinchem.2006.082883; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malecki MT, 2008, EUR J CLIN INVEST, V38, P925, DOI 10.1111/j.1365-2362.2008.02051.x; Oertel BG, 2012, HUM MOL GENET, V21, P4751, DOI 10.1093/hmg/dds314; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petrelli A, 2012, EXP DIABETES RES, DOI 10.1155/2012/471823; Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X; SMITH PG, 1984, INT J EPIDEMIOL, V13, P356, DOI 10.1093/ije/13.3.356; Steinberger D, 1998, ANN NEUROL, V43, P634, DOI 10.1002/ana.410430512; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Thony B, 1997, HUM MUTAT, V10, P11; Tie L, 2014, AM J PHYSIOL-ENDOC M, V306, pE1120, DOI 10.1152/ajpendo.00696.2013; Tu YC, 2010, ACTA PHARMACOL SIN, V31, P874, DOI 10.1038/aps.2010.68; WATANABE T, 1985, LAB INVEST, V53, P80; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WERNS SW, 1989, CIRCULATION, V79, P287, DOI 10.1161/01.CIR.79.2.287; Wilk G, 2013, POL ARCH MED WEWN, V123, P443, DOI 10.20452/pamw.1879; Zhang L, 2007, J CLIN INVEST, V117, P2658, DOI 10.1172/JCI31093	41	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e108587	10.1371/journal.pone.0108587	http://dx.doi.org/10.1371/journal.pone.0108587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369080	Green Published, Green Accepted, gold			2022-12-27	WOS:000344402000004
J	Borovnik-Lesjak, V; Whitehouse, K; Baetiong, A; Miao, Y; Currie, BM; Velmurugan, S; Radhakrishnan, J; Gazmuri, RJ				Borovnik-Lesjak, Vesna; Whitehouse, Kasen; Baetiong, Alvin; Miao, Yang; Currie, Brian M.; Velmurugan, Sathya; Radhakrishnan, Jeejabai; Gazmuri, Raul J.			Effects of Intraosseous Erythropoietin during Hemorrhagic Shock in Swine	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; ISCHEMIA-REPERFUSION INJURY; COMBAT CASUALTY CARE; RAT MODEL; VENTRICULAR-FIBRILLATION; MYOCARDIAL-INFARCTION; CARDIAC RESUSCITATION; ARGININE-VASOPRESSIN; FLUID RESUSCITATION; ABDOMINAL-SURGERY	Objective: To determine whether erythropoietin given during hemorrhagic shock (HS) ameliorates organ injury while improving resuscitation and survival. Methods: Three series of 24 pigs each were studied. In an initial series, 50% of the blood volume (BV) was removed in 30 minutes and normal saline (threefold the blood removed) started at minute 90 infusing each third in 30, 60, and 150 minutes with shed blood reinfused at minute 330 (HS-50(BV)). In a second series, the same HS-50(BV) protocol was used but removing an additional 15% of BV from minute 30 to 60 (HS-65(BV)). In a final series, blood was removed as in HS-65(BV) and intraosseous vasopressin given from minute 30 (0.04 U/kg min(-1)) until start of shed blood reinfusion at minute 150 (HS-65(BV)+VP). Normal saline was reduced to half the blood removed and given from minute 90 to 120 in half of the animals. In each series, animals were randomized 1:1 to receive erythropoietin (1,200 U/kg) or control solution intraosseously after removing 10% of the BV. Results: In HS-50(BV), O-2 consumption remained near baseline yielding minimal lactate increases, 88% resuscitability, and 60% survival at 72 hours. In HS-65(BV), O-2 consumption was reduced and lactate increased yielding 25% resuscitability. In HS-65(BV)+VP, vasopressin promoted hemodynamic stability yielding 92% resuscitability and 83% survival at 72 hours. Erythropoietin did not affect resuscitability or subsequent survival in any of the series but increased interleukin-10, attenuated lactate increases, and ameliorated organ injury based on lesser troponin I, AST, and ALT increases and lesser neurological deficits in the HS-65(BV)+VP series. Conclusions: Erythropoietin given during HS in swine failed to alter resuscitability and 72 hour survival regardless of HS severity and concomitant treatment with fluids and vasopressin but attenuated acute organ injury. The studies also showed the efficacy of vasopressin and restrictive fluid resuscitation for hemodynamic stabilization and survival.	[Borovnik-Lesjak, Vesna; Whitehouse, Kasen; Baetiong, Alvin; Miao, Yang; Currie, Brian M.; Velmurugan, Sathya; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL USA; [Radhakrishnan, Jeejabai] Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL USA; [Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Dept Med, Dept Physiol & Biophys, N Chicago, IL USA; [Gazmuri, Raul J.] Captain James A Lovell Fed Hlth Care Ctr, N Chicago, IL USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Med, Dept Physiol & Biophys, N Chicago, IL 60064 USA.	raul.gazmuri@rosalindfranklin.edu	Velmurugan, Sathya/AAD-6646-2021	Gazmuri, Raul J./0000-0002-3848-7227; velmurugan, sathya/0000-0003-0769-8424	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD [W81XWH-11-2-0019]	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD	This research was supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD under contract number: W81XWH-11-2-0019. Funding was received by RJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2004, SHOCK, V22, P63, DOI 10.1097/01.shk.00001276869.21260.9d; Anand T, 2012, J SURG RES, V178, P321, DOI 10.1016/j.jss.2012.02.062; Beiser DG, 2010, AM J PHYSIOL-HEART C, V298, pH1761, DOI 10.1152/ajpheart.00187.2010; BERG RA, 1994, CRIT CARE MED, V22, P282, DOI 10.1097/00003246-199402000-00020; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Borovnik-Lesjak V, 2013, TRANSL RES, V162, P110, DOI 10.1016/j.trsl.2013.06.002; Bougle A, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-1; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bryl E, 1998, ARTIF ORGANS, V22, P177, DOI 10.1046/j.1525-1594.1998.06002.x; Buemi M, 2002, ACTA DERM-VENEREOL, V82, P411, DOI 10.1080/000155502762064520; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Faybik P, 2010, RESUSCITATION, V81, P1584, DOI 10.1016/j.resuscitation.2010.05.024; Grmec S, 2009, RESUSCITATION, V80, P631, DOI 10.1016/j.resuscitation.2009.03.010; GUDIPATI CV, 1990, J APPL PHYSIOL, V68, P1405, DOI 10.1152/jappl.1990.68.4.1405; Guzman JA, 2003, J APPL PHYSIOL, V95, P803, DOI 10.1152/japplphysiol.00017.2003; Huang HH, 2014, AM J CHINESE MED, V42, P79, DOI 10.1142/S0192415X14500050; Jia HB, 2009, CAN J ANAESTH, V56, P597, DOI 10.1007/s12630-009-9111-0; Jonasson R, 2004, J MED MICROBIOL, V53, P267, DOI 10.1099/jmm.0.05359-0; Kao RLC, 2011, J TRAUMA, V71, pS456, DOI 10.1097/TA.0b013e318232e782; Kao RLC, 2010, J TRAUMA, V68, P1342, DOI 10.1097/TA.0b013e3181d27dbe; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; KELLEY KW, 1973, J ANIM SCI, V36, P927; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; Liu XM, 2006, LIFE SCI, V78, P2255, DOI 10.1016/j.lfs.2005.09.053; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Nandra KK, 2013, DIS MODEL MECH, V6, P701, DOI 10.1242/dmm.011353; Nunez TC, 2010, J TRAUMA, V68, P1498, DOI 10.1097/TA.0b013e3181d3cc25; Ozawa T, 2010, CIRC J, V74, P1415, DOI 10.1253/circj.CJ-10-0109; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Radhakrishnan J, 2013, AM J TRANSL RES, V5, P316; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Russell JA, 2013, AM J RESP CRIT CARE, V188, P356, DOI 10.1164/rccm.201302-0355OC; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Shimoda M, 2009, HEPATO-GASTROENTEROL, V56, P470; Simon F, 2011, INTENS CARE MED, V37, P1525, DOI 10.1007/s00134-011-2303-4; Singh Dinesh, 2007, Am J Ther, V14, P361, DOI 10.1097/01.pap.0000249957.35673.f0; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Vilarinho KAS, 2013, EUR J CARDIO-THORAC, V43, P156, DOI 10.1093/ejcts/ezs254; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Voelckel WG, 2010, J TRAUMA, V69, pS69, DOI 10.1097/TA.0b013e3181e44937; Volta CA, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-29; Wu WT, 2010, INJURY, V41, P724, DOI 10.1016/j.injury.2009.12.006	50	5	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110908	10.1371/journal.pone.0110908	http://dx.doi.org/10.1371/journal.pone.0110908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365317	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100032
J	Hayashida, I; Tanimoto, Y; Takahashi, Y; Kusabiraki, T; Tamaki, J				Hayashida, Itsushi; Tanimoto, Yoshimi; Takahashi, Yuka; Kusabiraki, Toshiyuki; Tamaki, Junko			Correlation between Muscle Strength and Muscle Mass, and Their Association with Walking Speed, in Community-Dwelling Elderly Japanese Individuals	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; OLDER PERSONS; SARCOPENIA; MEN; AGE; WOMEN; FAT; PERFORMANCE; DISABILITY; PREDICTOR	Objectives: We aimed to assess the correlation between muscle strength and muscle mass based on sex and age, and their association with walking speed, which is a health predictor for independent living, in elderly Japanese individuals. Methods: The participants included 318 (111 men, 207 women) community-dwelling elderly Japanese individuals aged >= 65 years. Knee extension strength was assessed as an indicator of muscle strength, and bioelectrical impedance analysis was used to measure muscle mass. The maximum walking speed of participants was recorded. All measurements were categorized based on sex and age groups as follows: young-old (age, 65-74 years) and old-old (age >= 75 years). Results: Appendicular muscle mass and knee extension strength decreased with age in both men and women. In men, knee extension strength showed significant positive correlations with leg and appendicular muscle mass in both young-old and old-old age groups. However, in women, only the old-old age group showed significant positive correlations between knee extension strength and leg and appendicular muscle mass. Muscle strength was significantly positively correlated with maximum walking speed in all groups, whereas muscle mass was not significantly correlated with maximum walking speed in men and women. Conclusions: Muscle strength was significantly correlated with muscle mass in both age groups in men. However, in women, the correlation between muscle strength and muscle mass differed according to age. This finding suggests that the relationship between muscle strength and muscle mass differs according to sex and age. Muscle strength showed significant correlation with walking speed in both men and women in both age groups. These findings suggest that it is necessary to recognize that muscle strength is different from muscle mass, and that an individualized approach to prevent decline of muscle strength and muscle mass is necessary for health promotion in elderly.	[Hayashida, Itsushi; Tanimoto, Yoshimi; Takahashi, Yuka; Kusabiraki, Toshiyuki; Tamaki, Junko] Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka, Japan	Osaka Medical College	Tanimoto, Y (corresponding author), Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka, Japan.	hyg022@art.osaka-med.ac.jp			KAKENHI - Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24590823]	KAKENHI - Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a KAKENHI Grant-in-Aid for Scientific Research (C), (grant number, 24590823)(http://www.jsps.go.jp/j-grantsinaid/), funded by The Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The funding source played no role in the study design, in the collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to submit the manuscript for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSEY EJ, 1992, CLIN SCI, V82, P321, DOI 10.1042/cs0820321; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Buchner DM, 1996, AGE AGEING, V25, P386, DOI 10.1093/ageing/25.5.386; Cabinet Office of Japan, 2013, WHIT PAP AG SOC; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; FRIEDMAN PJ, 1988, AGE AGEING, V17, P227, DOI 10.1093/ageing/17.4.227; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gibson AL, 2004, INT J SPORT NUTR EXE, V14, P657, DOI 10.1123/ijsnem.14.6.657; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Incorporated Administrative Agency National Institute of Health and Nutrition, 2012, PRES COND NAT HLTH N; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2010, APPL PHYSIOL NUTR ME, V35, P707, DOI 10.1139/H10-067; Katoh M, 2010, J PHYS THER SCI, V22, P359, DOI 10.1589/jpts.22.359; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lauretani F, 2006, NEUROBIOL AGING, V27, P1145, DOI 10.1016/j.neurobiolaging.2005.06.009; Lima RM, 2009, J CLIN DENSITOM, V12, P35, DOI 10.1016/j.jocd.2008.10.003; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Nagasaki H, 1995, AGING-CLIN EXP RES, V7, P451, DOI 10.1007/BF03324360; Nakao H., 2006, J PHYS THER SCI, V18, P73, DOI [10.1589/jpts.18.73, DOI 10.1589/JPTS.18.73]; Nemoto M., 2012, INT J BODY COMPOS RE, V10, P55; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P433, DOI 10.1007/BF02982704; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Rush EC, 2006, INT J OBESITY, V30, P1125, DOI 10.1038/sj.ijo.0803230; Shinkai S., 2003, GERIATR GERONTOL INT, V3, pS31, DOI [10.1111/j.1444-0594.2003.00094.x, DOI 10.1111/J.1444-0594.2003.00094.X]; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Snih SA, 2004, AGING CLIN EXP RES, V16, P481, DOI 10.1007/BF03327406; Snyder AC, 1998, EXERCISE NUTR HLTH; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Tanimoto Yoshimi, 2008, Nihon Ronen Igakkai Zasshi, V45, P213, DOI 10.3143/geriatrics.45.213; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324	40	86	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111810	10.1371/journal.pone.0111810	http://dx.doi.org/10.1371/journal.pone.0111810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365291	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100127
J	Laidlaw, CT; Condon, JM; Belk, MC				Laidlaw, Clinton T.; Condon, Jacob M.; Belk, Mark C.			Viability Costs of Reproduction and Behavioral Compensation in Western Mosquitofish (Gambusia affinis)	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; LIVEBEARING FISH; SWIMMING PERFORMANCE; FEMALE MOSQUITOFISH; FRESH-WATER; GRAVID LIZARDS; SPRINT SPEED; PREDATOR; LOCOMOTOR; PREGNANCY	The cost of reproduction hypothesis suggests that current reproduction has inherent tradeoffs with future reproduction. These tradeoffs can be both in the form of energy allocated to current offspring as opposed to somatic maintenance and future reproduction (allocation costs), or as an increase in mortality as a result of morphological or physiological changes related to reproduction (viability costs). Individuals may be able to decrease viability costs by altering behavior. Female western mosquitofish, Gambusia affinis experience a reduction in swimming ability as a consequence of pregnancy. We test for a viability cost of reproduction, and for behavioral compensation in pregnant female G. affinis by measuring survival of females in early and later stages of pregnancy when exposed to predation. Late-stage pregnant females experience a 70% greater probability of mortality compared to early-stage pregnant females. The presence of a refuge roughly doubled the odds of survival of both early and late-stage pregnant females. However, there was no interaction between refuge availability and stage of pregnancy. These data do not provide evidence for behavioral compensation by female G. affinis for elevated viability costs incurred during later stages of pregnancy. Behavioral compensation may be constrained by other aspects of the cost of reproduction.	[Laidlaw, Clinton T.; Condon, Jacob M.; Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University	Laidlaw, CT (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	clintlaidlaw@gmail.com			Department of Biology; Honors Department at Brigham Young University	Department of Biology; Honors Department at Brigham Young University	Funding was provided by The Department of Biology and the Honors Department at Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almbro M, 2012, J INSECT BEHAV, V25, P441, DOI 10.1007/s10905-011-9309-1; Altwegg R, 2002, ECOLOGY, V83, P2542, DOI 10.2307/3071813; Belk Mark C., 1995, Bulletin of the Ecological Society of America, V76, P18; Belk MC, 2010, OIKOS, V119, P163, DOI 10.1111/j.1600-0706.2009.17742.x; BELK MC, 1994, COPEIA, P296; BRANA F, 1993, OIKOS, V66, P216, DOI 10.2307/3544807; BRODIE ED, 1989, AM NAT, V134, P225, DOI 10.1086/284977; BROWNPETERSON N, 1990, ENVIRON BIOL FISH, V27, P33, DOI 10.1007/BF00004902; COSTA DP, 1991, AM ZOOL, V31, P111; Courtenay W.R. Jr, 1989, P319; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Cuthill IC, 1997, MANAGING TIME ENERGY, P97; DeWitt TJ, 1998, J EVOLUTION BIOL, V11, P465, DOI 10.1007/s000360050100; Downes SJ, 2002, BEHAV ECOL SOCIOBIOL, V52, P444, DOI 10.1007/s00265-002-0538-3; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Hassell EMA, 2012, ECOL EVOL, V2, P1738, DOI 10.1002/ece3.278; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; HOY JB, 1970, MOSQ NEWS, V30, P222; Husak JF, 2006, OECOLOGIA, V150, P339, DOI 10.1007/s00442-006-0513-1; Johnson JB, 2001, OECOLOGIA, V126, P142, DOI 10.1007/s004420000504; Johnson MA, 2010, ETHOLOGY, V116, P1217, DOI 10.1111/j.1439-0310.2010.01840.x; Koya Y, 1998, ICHTHYOL RES, V45, P241, DOI 10.1007/BF02673922; KRUMHOLZ LA, 1948, ECOL MONOGR, V18, P1, DOI 10.2307/1948627; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Leinonen T, 2011, EVOLUTION, V65, P2916, DOI 10.1111/j.1558-5646.2011.01349.x; Lloyd L.N., 1986, P6; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marsh-Matthews E, 2005, OECOLOGIA, V144, P12, DOI 10.1007/s00442-005-0030-7; Miles DB, 2000, EVOLUTION, V54, P1386; Miller AM, 2009, J ANIM ECOL, V78, P1134, DOI 10.1111/j.1365-2656.2009.01589.x; Noren SR, 2011, J EXP BIOL, V214, P4151, DOI 10.1242/jeb.059121; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Olsson M, 2000, J EVOLUTION BIOL, V13, P263; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Plaut I, 2002, FUNCT ECOL, V16, P290, DOI 10.1046/j.1365-2435.2002.00638.x; Rehage JS, 2005, BEHAV ECOL SOCIOBIOL, V57, P256, DOI 10.1007/s00265-004-0850-1; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Riesch R, 2013, AM NAT, V181, P78, DOI 10.1086/668597; Rodewald AD, 1998, J FISH BIOL, V52, P973, DOI 10.1006/jfbi.1998.0646; Roff Derek A., 1992; SCHWARZKOPF L, 1992, BEHAV ECOL SOCIOBIOL, V31, P17, DOI 10.1007/BF00167812; SEIGEL RA, 1987, OECOLOGIA, V73, P481, DOI 10.1007/BF00379404; Shine R, 2003, FUNCT ECOL, V17, P526, DOI 10.1046/j.1365-2435.2003.00756.x; SINERVO B, 1991, J EXP BIOL, V155, P323; Stearns S.C., 1992, pi; TOLLRIAN R, 1995, ECOLOGY, V76, P1691, DOI 10.2307/1940703; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Webb JK, 2004, COPEIA, P357, DOI 10.1643/CH-03-171R1; Weeks SC, 1996, OIKOS, V75, P345, DOI 10.2307/3546263; Wesner JS, 2011, BIOL J LINN SOC, V104, P386, DOI 10.1111/j.1095-8312.2011.01715.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson ADM, 2010, ETHOLOGY, V116, P96, DOI 10.1111/j.1439-0310.2009.01719.x	55	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110524	10.1371/journal.pone.0110524	http://dx.doi.org/10.1371/journal.pone.0110524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365426	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100023
J	McCarville, JL; Nisemblat, Y; Galipeau, HJ; Jury, J; Tabakman, R; Cohen, A; Naftali, E; Neiman, B; Halbfinger, E; Murray, JA; Anbazhagan, AN; Dudeja, PK; Varvak, A; Leroux, JC; Verdu, EF				McCarville, Justin L.; Nisemblat, Yotam; Galipeau, Heather J.; Jury, Jennifer; Tabakman, Rinat; Cohen, Ad; Naftali, Esmira; Neiman, Bela; Halbfinger, Efrat; Murray, Joseph A.; Anbazhagan, Arivarasu N.; Dudeja, Pradeep K.; Varvak, Alexander; Leroux, Jean-Christophe; Verdu, Elena F.			BL-7010 Demonstrates Specific Binding to Gliadin and Reduces Gluten-Associated Pathology in a Chronic Mouse Model of Gliadin Sensitivity	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; CELIAC-DISEASE; LARAZOTIDE ACETATE; VILLOUS EPITHELIUM; IMMUNE-RESPONSE; DOUBLE-BLIND; MICE; SPECTRUM; DIAGNOSIS; COMPLEX	Celiac disease (CD) is an autoimmune disorder in individuals that carry DQ2 or DQ8 MHC class II haplotypes, triggered by the ingestion of gluten. There is no current treatment other than a gluten-free diet (GFD). We have previously shown that the BL-7010 copolymer poly(hydroxyethyl methacrylate-co-styrene sulfonate) (P(HEMA-co-SS)) binds with higher efficiency to gliadin than to other proteins present in the small intestine, ameliorating gliadin-induced pathology in the HLA-HCD4/DQ8 model of gluten sensitivity. The aim of this study was to investigate the efficiency of two batches of BL-7010 to interact with gliadin, essential vitamins and digestive enzymes not previously tested, and to assess the ability of the copolymer to reduce gluten-associated pathology using the NOD-DQ8 mouse model, which exhibits more significant small intestinal damage when challenged with gluten than HCD4/DQ8 mice. In addition, the safety and systemic exposure of BL-7010 was evaluated in vivo (in rats) and in vitro (genetic toxicity studies). In vitro binding data showed that BL-7010 interacted with high affinity with gliadin and that BL-7010 had no interaction with the tested vitamins and digestive enzymes. BL-7010 was effective at preventing gluten-induced decreases in villus-to-crypt ratios, intraepithelial lymphocytosis and alterations in paracellular permeability and putative anion transporter-1 mRNA expression in the small intestine. In rats, BL-7010 was well-tolerated and safe following 14 days of daily repeated administration of 3000 mg/kg. BL-7010 did not exhibit any mutagenic effect in the genetic toxicity studies. Using complementary animal models and chronic gluten exposure the results demonstrate that administration of BL-7010 is effective and safe and that it is able to decrease pathology associated with gliadin sensitization warranting the progression to Phase I trials in humans.	[McCarville, Justin L.; Galipeau, Heather J.; Jury, Jennifer; Verdu, Elena F.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Nisemblat, Yotam; Tabakman, Rinat; Cohen, Ad; Naftali, Esmira; Neiman, Bela; Halbfinger, Efrat] BioLineRx Ltd, Jerusalem, Israel; [Murray, Joseph A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Anbazhagan, Arivarasu N.; Dudeja, Pradeep K.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA; [Anbazhagan, Arivarasu N.; Dudeja, Pradeep K.] Chicago & Jesse Brown VA Med Ctr, Chicago, IL USA; [Varvak, Alexander] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sci Equipment Ctr, Chromatog Unit, Ramat Gan, Israel; [Leroux, Jean-Christophe] ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, Zurich, Switzerland	McMaster University; Mayo Clinic; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Bar Ilan University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Verdu, EF (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	verdue@mcmaster.ca	Leroux, Jean-Christophe/N-4202-2015	Leroux, Jean-Christophe/0000-0001-5601-1292; McCarville, Justin/0000-0002-3311-5678; Galipeau, Heather/0000-0002-6413-0803	CIHR [MOP-123282]; Canadian Celiac Association; BioLineRx; NIH [DK54016, DK92441]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054016, R01DK081858, R01DK092441] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Celiac Association; BioLineRx; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a CIHR grant to EFV (MOP-123282) and by JA Campbell Young Investigator Awards from the Canadian Celiac Association to HJG and JLM, and a grant by BioLineRx. YN, RT, AC, EN, BN and EH (employees of BioLineRx) were involved in discussions about the dose ratios to be employed in the study and provided feedback to the manuscript's discussion. The funders had no role in data collection and analysis of results performed at McMaster University. EFV holds a Canada Research Chair. Studies in the laboratory of PKD were supported by NIH DK54016, DK92441 and Department of Veterans Affairs.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Barker Jennifer M, 2008, Adv Pediatr, V55, P349, DOI 10.1016/j.yapd.2008.07.001; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Correia JJ, 2008, BIOPHYSICAL TOOLS BI; Perez LC, 2012, EUR J INTERN MED, V23, P9, DOI 10.1016/j.ejim.2011.08.030; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Galipeau HJ, 2011, J IMMUNOL, V187, P4338, DOI 10.4049/jimmunol.1100854; Gopalakrishnan S, 2012, PEPTIDES, V35, P95, DOI 10.1016/j.peptides.2012.02.016; Gopalakrishnan S, 2012, PEPTIDES, V35, P86, DOI 10.1016/j.peptides.2012.02.015; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Leffler DA, 2012, AM J GASTROENTEROL, V107, P1554, DOI 10.1038/ajg.2012.211; Liang L, 2009, BIOPOLYMERS, V91, P169, DOI 10.1002/bip.21109; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Natividad JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006472; Pinier M, 2012, GASTROENTEROLOGY, V142, P316, DOI 10.1053/j.gastro.2011.10.038; Pinier M, 2010, AM J GASTROENTEROL, V105, P2551, DOI 10.1038/ajg.2010.372; Pinier M, 2009, GASTROENTEROLOGY, V136, P288, DOI 10.1053/j.gastro.2008.09.016; Rubio-Tapia A, 2012, AM J GASTROENTEROLOG; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Simpson JE, 2007, AM J PHYSIOL-GASTR L, V292, pG1079, DOI 10.1152/ajpgi.00354.2006; Simpson JE, 2010, AM J PHYSIOL-GASTR L, V298, pG683, DOI 10.1152/ajpgi.00293.2009; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Tack GJ, 2010, NAT REV GASTRO HEPAT, V7, P204, DOI 10.1038/nrgastro.2010.23; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Tye-Din JA, 2010, CLIN IMMUNOL, V134, P289, DOI 10.1016/j.clim.2009.11.001; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Walker NM, 2009, GASTROENTEROLOGY, V136, P893, DOI 10.1053/j.gastro.2008.11.016	36	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109972	10.1371/journal.pone.0109972	http://dx.doi.org/10.1371/journal.pone.0109972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365555	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100013
J	Moser, DA; Braga, L; Raso, A; Zacchigna, S; Giacca, M; Simon, P				Moser, Dirk A.; Braga, Luca; Raso, Andrea; Zacchigna, Serena; Giacca, Mauro; Simon, Perikles			Transgene Detection by Digital Droplet PCR	PLOS ONE			English	Article							GENE-TRANSFER; ATHLETIC PERFORMANCE; AUTOIMMUNE ANEMIA; ERYTHROPOIETIN; DNA; EXPRESSION; BLOOD; LEADS	Somatic gene therapy is a promising tool for the treatment of severe diseases. Because of its abuse potential for performance enhancement in sports, the World Anti-Doping Agency (WADA) included the term 'gene doping' in the official list of banned substances and methods in 2004. Several nested PCR or qPCR-based strategies have been proposed that aim at detecting long-term presence of transgene in blood, but these strategies are hampered by technical limitations. We developed a digital droplet PCR (ddPCR) protocol for Insulin-Like Growth Factor 1 (IGF1) detection and demonstrated its applicability monitoring 6 mice injected into skeletal muscle with AAV9-IGF1 elements and 2 controls over a 33-day period. A duplex ddPCR protocol for simultaneous detection of Insulin-Like Growth Factor 1 (IGF1) and Erythropoietin (EPO) transgenic elements was created. A new DNA extraction procedure with target-orientated usage of restriction enzymes including on-column DNA-digestion was established. In vivo data revealed that IGF1 transgenic elements could be reliably detected for a 33-day period in DNA extracted from whole blood. In vitro data indicated feasibility of IGF1 and EPO detection by duplex ddPCR with high reliability and sensitivity. On-column DNA-digestion allowed for significantly improved target detection in downstream PCR-based approaches. As ddPCR provides absolute quantification, it ensures excellent day-to-day reproducibility. Therefore, we expect this technique to be used in diagnosing and monitoring of viral and bacterial infection, in detecting mutated DNA sequences as well as profiling for the presence of foreign genetic material in elite athletes in the future.	[Moser, Dirk A.] Ruhr Univ Bochum, Fac Psychol Genet Psychol, Bochum, Germany; [Braga, Luca; Raso, Andrea; Zacchigna, Serena; Giacca, Mauro] ICGEB, Trieste, Italy; [Moser, Dirk A.; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, D-55122 Mainz, Germany	Ruhr University Bochum; International Center for Genetic Engineering & Biotechnology (ICGEB); Johannes Gutenberg University of Mainz	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, D-55122 Mainz, Germany.	simonpe@uni-mainz.de	Simon, Perikles D/B-2293-2013; Moser, Dirk/ABA-1018-2021; Giacca, Mauro/J-9287-2016; Moser, Dirk A/R-8003-2016; ZACCHIGNA, SERENA/E-9496-2017	Simon, Perikles D/0000-0002-7996-4034; Moser, Dirk/0000-0002-7021-1204; Giacca, Mauro/0000-0003-2927-7225; Moser, Dirk A/0000-0002-7021-1204; Braga, Luca/0000-0002-9827-6755; ZACCHIGNA, SERENA/0000-0001-6705-3076	World Anti-Doping Agency (WADA)	World Anti-Doping Agency (WADA)	Work of PS and MG is carried out with the support of the World Anti-Doping Agency (WADA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Baoutina A, 2010, GENE THER, V17, P1022, DOI 10.1038/gt.2010.49; Baoutina A, 2007, MOL THER, V15, P1751, DOI 10.1038/sj.mt.6300278; Baoutina A, 2013, HUM GENE THER METHOD, V24, P345, DOI 10.1089/hgtb.2013.128; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Beiter T, 2011, GENE THER, V18, P225, DOI 10.1038/gt.2010.122; Beiter T, 2008, EXERC IMMUNOL REV, V14, P73; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Chenuaud P, 2004, BLOOD, V103, P3303, DOI 10.1182/blood-2003-11-3845; Gao GP, 2004, BLOOD, V103, P3300, DOI 10.1182/blood-2003-11-3852; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029101; Lippi G, 2003, CLIN CHEM, V49, P2106, DOI 10.1373/clinchem.2003.025312; Little S, 2001, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0908s07; Macedo A, 2012, HUM GENE THER, V23, P146, DOI 10.1089/hum.2011.157; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Moser DA, 2012, DRUG TEST ANAL, V4, P870, DOI 10.1002/dta.1348; Ni W, 2011, GENE THER, V18, P709, DOI 10.1038/gt.2011.19; Ni WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036461; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Schneider AJ, 2006, ADV GENET, V51, P1, DOI 10.1016/S0065-2660(06)51001-6; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Zhou S, 1998, GENE THER, V5, P665, DOI 10.1038/sj.gt.3300648	29	19	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111781	10.1371/journal.pone.0111781	http://dx.doi.org/10.1371/journal.pone.0111781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375130	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600062
J	Shan, XY; Zhang, J; Zhou, HJ; Zhu, BQ; Xu, L; Shao, ZJ; Jiang, BF				Shan, Xiaoying; Zhang, Ji; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun; Jiang, Baofa			Genetic Diversity of Neisseria meningitidis Serogroup C ST-4821 in China Based on Multiple-Locus Variable Number Tandem Repeat Analysis	PLOS ONE			English	Article							W135 MENINGOCOCCAL DISEASE; CLONE; IDENTIFICATION; EPIDEMIOLOGY; EMERGENCE; OUTBREAK; SPREAD	Neisseria meningitidis sequence type (ST)-4821 was first reported in China in 2003, and a new hyper-virulent lineage has been designated as the ST-4821 complex. A large number of N. meningitidis ST-4821 strains have been identified in China since 2003; however, the microevolution characteristics of this complex are unclear. Different combinations of variable number of tandem repeats (VNTR) loci were used in multiple-locus VNTR analysis (MLVA) to analyze 118 N. meningitidis serogroup C ST-4821 strains isolated from seventeen provinces between 2003 and 2012. Additionally, MLVA with five VNTR loci was performed due to its high discriminatory power. One hundred and eighteen isolates were found to comprise 112 subtypes based on MLVA, and 16 outbreak-associated strains were clustered into one group. These data indicate a high level of diversity for N. meningitidis ST-4821 due to microevolution in the last decade. In addition, the results revealed high similarity between isolates from the same geographic origins, which is helpful when monitoring the spread of N. meningitidis serogroup C ST-4821 and will provide valuable information for the control and prevention of bacterial meningitis in China.	[Shan, Xiaoying; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Shan, Xiaoying; Zhang, Ji] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Shan, Xiaoying; Zhou, Haijian; Zhu, Bingqing; Xu, Li; Shao, Zhujun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Peoples R China	Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shao, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	shaozhujun@126.com; bjiang@sdu.edu.cn			National Key Program for Infectious Disease of China [2013ZX10004221]; National Basic Research Program of China (973 Program) [2011CB504900]	National Key Program for Infectious Disease of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Key Program for Infectious Disease of China (Contract No. 2013ZX10004221) and the National Basic Research Program of China (973 Program, 2011CB504900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Fazio C, 2009, EUROSURVEILLANCE, V14, P16; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kilic A, 2006, J CLIN MICROBIOL, V44, P222, DOI 10.1128/JCM.44.1.222-224.2006; Liao JC, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-44; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414; Moodley C, 2012, J CLIN MICROBIOL, V50, P3678, DOI 10.1128/JCM.01079-12; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Schouls LM, 2006, J CLIN MICROBIOL, V44, P1509, DOI 10.1128/JCM.44.4.1509-1518.2006; Shao ZJ, 2006, LANCET, V367, P419, DOI 10.1016/S0140-6736(06)68141-5; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; [田国忠 TIAN Guozhong], 2006, [中华流行病学杂志, Chinese Journal of Epidemiology], V27, P595; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Yakubu DE, 1999, J MED MICROBIOL, V48, P1055, DOI 10.1099/00222615-48-12-1055; Yazdankhah SP, 2005, J CLIN MICROBIOL, V43, P1699, DOI 10.1128/JCM.43.4.1699-1705.2005; Zhang J, 2013, BIOMED ENVIRON SCI, V26, P331, DOI 10.3967/0895-3988.2013.05.002; Zhou H, 2012, EPIDEMIOL INFECT, V140, P1296, DOI 10.1017/S0950268811001865	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111866	10.1371/journal.pone.0111866	http://dx.doi.org/10.1371/journal.pone.0111866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375168	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600072
J	Tang, L; Wang, F; Li, YX; Zhao, L; Xi, HJ; Guo, ZH; Li, XY; Gao, CJ; Wang, J; Zhou, LJ				Tang, Lu; Wang, Fei; Li, Yuxiang; Zhao, Liang; Xi, Huijun; Guo, Zhihong; Li, Xiuyun; Gao, Chengjie; Wang, Jian; Zhou, Lingjun			Ultrasound Guidance for Radial Artery Catheterization: An Updated Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CANNULATION; INFANTS; LONG	Background: Since a previous meta-analysis reported that ultrasound guidance was associated with a higher first-attempt success rate in catheterization of the radial artery, a number of randomized controlled trials (RCTs) have reported inconsistent results. The aim of the present study is to conduct an updated meta-analysis to clarify the role of ultrasound guidance for radial artery catheterization. Methods: A systematic literature search of PubMed, Embase, and Cochrane Central Register of Controlled Trials was conducted using specific search terms. Eligible studies were RCTs that compared ultrasound guidance with traditional palpation for radial artery catheterization. The Mantel-Haenszel method using the random effects model was adopted in this meta-analysis. Results: Seven RCTs with 482 patients were included. Compared with traditional palpation, ultrasound guidance significantly increased the first-attempt success rate of radial artery catheterization (RR 1.51, 95% CI 1.07-2.14, P = 0.02). Subgroup analyses suggested that the superiority of ultrasound guidance for radial artery catheterization was significant when the technique was operated by experienced users, performed in small children and infants, and on elective procedures in the operating room. In addition, ultrasound guidance significantly reduced mean-attempts to success (WMD -1.13, 95% CI -1.58 to -0.69, P<0.00001), mean-time to success (WMD -74.77s, 95% CI -137.89s to -11.64s, P = 0.02), and the occurrence of hematoma (RR 0.17, 95% CI 0.07-0.41, P = 0.0001). Conclusions: The present meta-analysis suggests a clear benefit from ultrasound guidance for radial artery catheterization compared with the traditional palpation. Preliminary training and familiarization with the ultrasound-guided technique is needed before applying it for radial artery catheterization, especially for inexperienced operators.	[Tang, Lu; Wang, Fei; Guo, Zhihong; Gao, Chengjie; Wang, Jian] Gen Hosp Jinan Mil Command, Dept Anesthesiol, Jinan 250031, Peoples R China; [Li, Yuxiang] Ningxia Med Univ, Sch Nursing, Yinchuan 750004, Peoples R China; [Zhao, Liang] Guangxi Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanning 530021, Peoples R China; [Xi, Huijun] Second Mil Med Univ, Changhai Hosp, Digest Endoscopy Ctr, Shanghai 200433, Peoples R China; [Li, Xiuyun] Gen Hosp Jinan Mil Command, Dept Nursing, Jinan 250031, Peoples R China; [Zhou, Lingjun] Second Mil Med Univ, Inst Translat Med, Shanghai 200433, Peoples R China	Ningxia Medical University; Guangxi Medical University; Naval Medical University; Naval Medical University	Wang, J (corresponding author), Gen Hosp Jinan Mil Command, Dept Anesthesiol, Jinan 250031, Peoples R China.	wenhaow2000@hotmail.com; zhoulingjun5771@163.com	Li, yu/HHZ-5236-2022					Amer Soc Anesthesiologists, 2012, ANESTHESIOLOGY, V116, P539, DOI 10.1097/ALN.0b013e31823c9569; Berk D, 2013, J CLIN MONIT COMPUT, V27, P319, DOI 10.1007/s10877-013-9437-6; Bobbia X, 2013, AM J EMERG MED, V31, P810, DOI 10.1016/j.ajem.2013.01.029; Chittoodan S, 2011, MED ULTRASON, V13, P21; Clemmesen L, 2012, ULTRASCHALL MED, V33, P1; Ganesh A, 2009, PEDIATR CRIT CARE ME, V10, P45, DOI 10.1097/PCC.0b013e31819368ca; Gu WJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13862; HACK WWM, 1990, INTENS CARE MED, V16, P50, DOI 10.1007/BF01706325; Hansen MA, 2014, ACTA ANAESTH SCAND, V58, P446, DOI 10.1111/aas.12299; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishii S, 2013, PEDIATR CRIT CARE ME, V14, P471, DOI 10.1097/PCC.0b013e31828a8657; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levin PD, 2003, CRIT CARE MED, V31, P481, DOI 10.1097/01.CCM.0000050452.17304.2F; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MCCORMACK LJ, 1953, SURG GYNECOL OBSTET, V96, P43; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; National Institute for Health and Clinical Excellence, NICE TECHN APPR 49 C; Scheer BV, 2002, CRIT CARE, V6, P198, DOI 10.1186/cc1489; Schwemmer U, 2006, EUR J ANAESTH, V23, P476, DOI 10.1017/S0265021506000275; Shiloh AL, 2011, CHEST, V139, P524, DOI 10.1378/chest.10-0919; Shiver S, 2006, ACAD EMERG MED, V13, P1275, DOI 10.1197/j.aem.2006.07.015; Shojania K G, 2001, Evid Rep Technol Assess (Summ), pi; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Troianos CA, 2012, ANESTH ANALG, V114, P46, DOI 10.1213/ANE.0b013e3182407cd8; Ueda K, 2013, BRIT J ANAESTH, V110, P281, DOI 10.1093/bja/aes383; Weiner MM, 2013, J CARDIOTHOR VASC AN, V27, P345, DOI 10.1053/j.jvca.2012.07.007	26	51	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111527	10.1371/journal.pone.0111527	http://dx.doi.org/10.1371/journal.pone.0111527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375152	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600045
J	Arico, A; Ferraresso, S; Bresolin, S; Marconato, L; Comazzi, S; Kronnie, GT; Aresu, L				Arico, Arianna; Ferraresso, Serena; Bresolin, Silvia; Marconato, Laura; Comazzi, Stefano; Kronnie, Geertruy Te; Aresu, Luca			Array-Based Comparative Genomic Hybridization Analysis Reveals Chromosomal Copy Number Aberrations Associated with Clinical Outcome in Canine Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							IMMUNOGLOBULIN HEAVY; CLONAL EVOLUTION; SUBTYPES; CANCER; GENE; MUTATIONS; MELANOMA; SURVIVAL; TUMORS; DOGS	Canine Diffuse Large B-cell Lymphoma (cDLBCL) is an aggressive cancer with variable clinical response. Despite recent attempts by gene expression profiling to identify the dog as a potential animal model for human DLBCL, this tumor remains biologically heterogeneous with no prognostic biomarkers to predict prognosis. The aim of this work was to identify copy number aberrations (CNAs) by high-resolution array comparative genomic hybridization (aCGH) in 12 dogs with newly diagnosed DLBCL. In a subset of these dogs, the genetic profiles at the end of therapy and at relapse were also assessed. In primary DLBCLs, 90 different genomic imbalances were counted, consisting of 46 gains and 44 losses. Two gains in chr13 were significantly correlated with clinical stage. In addition, specific regions of gains and losses were significantly associated to duration of remission. In primary DLBCLs, individual variability was found, however 14 recurrent CNAs (>30%) were identified. Losses involving IGK, IGL and IGH were always found, and gains along the length of chr13 and chr31 were often observed (>41%). In these segments, MYC, LDHB, HSF1, KIT and PDGFR alpha are annotated. At the end of therapy, dogs in remission showed four new CNAs, whereas three new CNAs were observed in dogs at relapse compared with the previous profiles. One ex novo CNA, involving TCR, was present in dogs in remission after therapy, possibly induced by the autologous vaccine. Overall, aCGH identified small CNAs associated with outcome, which, along with future expression studies, may reveal target genes relevant to cDLBCL.	[Arico, Arianna; Ferraresso, Serena; Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Bresolin, Silvia; Kronnie, Geertruy Te] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Marconato, Laura] Ctr Oncol Vet, Sasso Marconi, Italy; [Comazzi, Stefano] Univ Milan, Dept Anim Pathol Hyg & Publ Hlth, Milan, Italy	University of Padua; University of Padua; University of Milan	Aresu, L (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	luca.aresu@unipd.it	Kronnie, Geertruy te/L-1014-2016; Marconato, Laura/AAD-7263-2020; Bresolin, Silvia/K-6576-2016; Aresu, Luca/J-9788-2018; Comazzi, Stefano/K-8062-2017; Arico, Arianna/J-4873-2018	Marconato, Laura/0000-0002-7843-615X; Bresolin, Silvia/0000-0001-7677-7084; Aresu, Luca/0000-0002-7893-1740; Ferraresso, Serena/0000-0001-5928-9361; /0000-0001-5636-1006; Comazzi, Stefano/0000-0002-1567-8055; Arico, Arianna/0000-0002-2397-0064; te Kronnie, Geertruy/0000-0001-7143-4795	Ministry of Health; University of Padua	Ministry of Health; University of Padua	This work was supported by a grant from Ministry of Health (PRIN 2008) and by a grant from University of Padua (ex-60%). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Aresu L, 2015, VET COMP ONCOL, V13, P348, DOI 10.1111/vco.12048; Arico A, 2014, J COMP PATHOL, V151, P322, DOI 10.1016/j.jcpa.2014.07.001; BAUER TR, 1993, IMMUNOGENETICS, V38, P387, DOI 10.1007/BF00184519; Capello D, 2006, HEMATOL ONCOL, V24, P212, DOI 10.1002/hon.791; DEJONG D, 1989, J EXP MED, V169, P613, DOI 10.1084/jem.169.3.613; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grier DD, 2012, INT J CLIN EXP PATHO, V5, P110; Hashemi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-505; Kanamori Masahiko, 2012, J Exp Clin Cancer Res, V31, P100, DOI 10.1186/1756-9966-31-100; Kreisel F, 2011, CANCER GENET-NY, V204, P129, DOI 10.1016/j.cancergen.2010.12.010; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Maekawa M, 2003, CLIN CHEM, V49, P1518, DOI 10.1373/49.9.1518; Manne J, 2002, J IMMUNOL, V169, P3407, DOI 10.4049/jimmunol.169.6.3407; Marconato L, 2014, CLIN CANCER RES, V20, P668, DOI 10.1158/1078-0432.CCR-13-2283; Marconato L, 2011, VET J, V188, P34, DOI 10.1016/j.tvjl.2010.04.027; Marconato L, 2010, JAVMA-J AM VET MED A, V236, P969, DOI 10.2460/javma.236.9.969; Martinez-Climent JA, 2010, METHODS MOL BIOL, V576, P231, DOI 10.1007/978-1-59745-545-9_13; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Ristow M, 2006, CURR OPIN CLIN NUTR, V9, P339, DOI 10.1097/01.mco.0000232892.43921.98; Romania P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078481; Schmitt-Graeff AH, 2014, BLOOD, V123, P595, DOI 10.1182/blood-2013-10-530642; Shi ZZ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-52; Tagawa H, 2005, BLOOD, V106, P1770, DOI 10.1182/blood-2005-02-0542; Tagawa H, 2004, CANCER RES, V64, P5948, DOI 10.1158/0008-5472.CAN-03-4056; Takeuchi I, 2009, HAEMATOL-HEMATOL J, V94, P61, DOI 10.3324/haematol.12986; Thomas R, 2011, LEUKEMIA LYMPHOMA, V52, P1321, DOI 10.3109/10428194.2011.559802; Tirado CA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-54; Tzankov A, 2014, MODERN PATHOL, V27, P958, DOI 10.1038/modpathol.2013.214; Wang L, 2013, J MOL DIAGN, V15, P581, DOI 10.1016/j.jmoldx.2013.04.001; Wang X, 2012, CARCINOGENESIS, V33, P2228, DOI 10.1093/carcin/bgs245; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zong L, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-71	39	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111817	10.1371/journal.pone.0111817	http://dx.doi.org/10.1371/journal.pone.0111817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372838	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900077
J	Humphreys, GI; Ziegler, YS; Nardulli, AM				Humphreys, Gwendolyn I.; Ziegler, Yvonne S.; Nardulli, Ann M.			17 beta-Estradiol Modulates Gene Expression in the Female Mouse Cerebral Cortex	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BLOOD-BRAIN-BARRIER; ESTROGEN-RESPONSIVE GENES; DIFFERENTIAL EXPRESSION; NEURITE OUTGROWTH; CORTICAL-NEURONS; RECEPTOR-ALPHA; OPITZ-SYNDROME; ESTRADIOL; GROWTH	17 beta-estradiol (E2) plays critical roles in a number of target tissues including the mammary gland, reproductive tract, bone, and brain. Although it is clear that E2 reduces inflammation and ischemia-induced damage in the cerebral cortex, the molecular mechanisms mediating the effects of E2 in this brain region are lacking. Thus, we examined the cortical transcriptome using a mouse model system. Female adult mice were ovariectomized and implanted with silastic tubing containing oil or E2. After 7 days, the cerebral cortices were dissected and RNA was isolated and analyzed using RNA-sequencing. Analysis of the transcriptomes of control and E2-treated animals revealed that E2 treatment significantly altered the transcript levels of 88 genes. These genes were associated with long term synaptic potentiation, myelination, phosphoprotein phosphatase activity, mitogen activated protein kinase, and phosphatidylinositol 3-kinase signaling. E2 also altered the expression of genes linked to lipid synthesis and metabolism, vasoconstriction and vasodilation, cell-cell communication, and histone modification. These results demonstrate the far-reaching and diverse effects of E2 in the cerebral cortex and provide valuable insight to begin to understand cortical processes that may fluctuate in a dynamic hormonal environment.	[Humphreys, Gwendolyn I.; Ziegler, Yvonne S.; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Nardulli, AM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	anardull@illinois.edu			National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK053884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053884] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant (R01 DK053884) from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov) to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2001, IEEE COMMUN MAG, V39, P98, DOI 10.1109/35.925676; Aenlle KK, 2010, HIPPOCAMPUS, V20, P1047, DOI 10.1002/hipo.20703; Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Arevalo MA, 2012, J STEROID BIOCHEM, V131, P52, DOI 10.1016/j.jsbmb.2011.09.004; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Belcher SM, 2001, J PHARMACOL EXP THER, V299, P408; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berti C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-9; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Bryant DN, 2005, NEUROSCIENCE, V133, P343, DOI 10.1016/j.neuroscience.2005.02.024; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Chesik D, 2007, CYTOKINE GROWTH F R, V18, P267, DOI 10.1016/j.cytogfr.2007.04.001; Cipolla M.J., 2009, CEREBRAL CIRCULATION; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dahlin A, 2009, J PHARMACOL EXP THER, V329, P558, DOI 10.1124/jpet.108.149831; Deroo BJ, 2009, MOL REPROD DEV, V76, P733, DOI 10.1002/mrd.21041; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fink G, 1996, CELL MOL NEUROBIOL, V16, P325, DOI 10.1007/BF02088099; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonda Y, 2007, GENE EXPR PATTERNS, V7, P431, DOI 10.1016/j.modgep.2006.11.005; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Haneda M, 1999, EUR J PHARMACOL, V365, P1, DOI 10.1016/S0014-2999(98)00857-7; HARLAN RE, 1988, MOL NEUROBIOL, V2, P183, DOI 10.1007/BF02935345; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Keenan PA, 2001, PSYCHONEUROENDOCRINO, V26, P577, DOI 10.1016/S0306-4530(01)00013-0; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Law C, 2013, THESIS U MELBOURNE A; Liang KW, 2010, J BIOL CHEM, V285, P935, DOI 10.1074/jbc.M109.051664; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; Marin R, 2013, J NEUROENDOCRINOL; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; MCEWEN BS, 1994, EXP GERONTOL, V29, P431, DOI 10.1016/0531-5565(94)90022-1; Mendelsohn ME, 2000, J STEROID BIOCHEM, V74, P337, DOI 10.1016/S0960-0760(00)00110-2; Mhyre AJ, 2006, NEUROSCIENCE, V138, P851, DOI 10.1016/j.neuroscience.2005.10.019; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; NAKAI Y, 1978, ENDOCRINOLOGY, V102, P1008, DOI 10.1210/endo-102-4-1008; NELSON JF, 1992, ENDOCRINOLOGY, V130, P805, DOI 10.1210/en.130.2.805; Nieves JW, 1998, AM J CLIN NUTR, V67, P18, DOI 10.1093/ajcn/67.1.18; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Pechenino AS, 2009, NEUROBIOL LEARN MEM, V91, P313, DOI 10.1016/j.nlm.2008.09.017; Peng ZF, 2007, NEUROPHARMACOLOGY, V53, P687, DOI 10.1016/j.neuropharm.2007.07.016; R Core Team, 2021, R LANGUAGE ENV STAT; Raval AP, 2006, NEUROSCIENCE, V141, P1721, DOI 10.1016/j.neuroscience.2006.05.016; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; RICHELSON LS, 1984, NEW ENGL J MED, V311, P1273, DOI 10.1056/NEJM198411153112002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11; Rozovsky I, 2005, NEUROBIOL AGING, V26, P705, DOI 10.1016/j.neurobiolaging.2004.06.009; Rozovsky I, 2002, ENDOCRINOLOGY, V143, P636, DOI 10.1210/en.143.2.636; Rutkowsky JM, 2011, AM J PHYSIOL-CELL PH, V301, pC204, DOI 10.1152/ajpcell.00399.2010; Sarvari M, 2010, ENDOCRINOLOGY, V151, P3847, DOI 10.1210/en.2010-0375; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Smith P, 2007, CLIN CANCER RES, V13, P4061, DOI 10.1158/1078-0432.CCR-06-3052; Sortino MA, 2004, ENDOCRINOLOGY, V145, P5080, DOI 10.1210/en.2004-0973; Spittau B, 2013, GLIA, V61, P287, DOI 10.1002/glia.22435; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Takeo C, 2009, ENDOCR J, V56, P113, DOI 10.1507/endocrj.K08E-220; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tian XC, 2013, REPRODUCTION, V145, P577, DOI 10.1530/REP-13-0042; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; ToranAllerand CD, 1996, DEV NEUROSCI-BASEL, V18, P36, DOI 10.1159/000111393; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Ullrich M, 2011, J BIOL CHEM, V286, P9477, DOI 10.1074/jbc.M110.171306; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; Wang XF, 2006, MOL PHARMACOL, V70, P395, DOI 10.1124/mol.106.022384; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Willis CL, 2013, NEUROSCIENCE, V250, P773, DOI 10.1016/j.neuroscience.2013.06.061; WISE PM, 1981, BIOL REPROD, V24, P820, DOI 10.1095/biolreprod24.4.820; Wong T.P., 2002, MJM, V6, P104, DOI DOI 10.1073/PNAS.1016709108; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	105	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111975	10.1371/journal.pone.0111975	http://dx.doi.org/10.1371/journal.pone.0111975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372139	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900098
J	Spainhour, JCG; Janech, MG; Schwacke, JH; Velez, JCQ; Ramakrishnan, V				Spainhour, John Christian G.; Janech, Michael G.; Schwacke, John H.; Velez, Juan Carlos Q.; Ramakrishnan, Viswanathan			The Application of Gaussian Mixture Models for Signal Quantification in MALDI-ToF Mass Spectrometry of Peptides	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; COMPLEX PROTEIN MIXTURES; RENIN-ANGIOTENSIN SYSTEM; ABSOLUTE QUANTIFICATION; LC-MS; PROTEOMICS; ENZYME; CARBOXYPEPTIDASE; IDENTIFICATION; QUANTITATION	Matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) coupled with stable isotope standards (SIS) has been used to quantify native peptides. This peptide quantification by MALDI-TOF approach has difficulties quantifying samples containing peptides with ion currents in overlapping spectra. In these overlapping spectra the currents sum together, which modify the peak heights and make normal SIS estimation problematic. An approach using Gaussian mixtures based on known physical constants to model the isotopic cluster of a known compound is proposed here. The characteristics of this approach are examined for single and overlapping compounds. The approach is compared to two commonly used SIS quantification methods for single compound, namely Peak Intensity method and Riemann sum area under the curve (AUC) method. For studying the characteristics of the Gaussian mixture method, Angiotensin II, Angiotensin-2-10, and Angiotenisn-1-9 and their associated SIS peptides were used. The findings suggest, Gaussian mixture method has similar characteristics as the two methods compared for estimating the quantity of isolated isotopic clusters for single compounds. All three methods were tested using MALDI-TOF mass spectra collected for peptides of the renin-angiotensin system. The Gaussian mixture method accurately estimated the native to labeled ratio of several isolated angiotensin peptides (5.2% error in ratio estimation) with similar estimation errors to those calculated using peak intensity and Riemann sum AUC methods (5.9% and 7.7%, respectively). For overlapping angiotensin peptides, (where the other two methods are not applicable) the estimation error of the Gaussian mixture was 6.8%, which is within the acceptable range. In summary, for single compounds the Gaussian mixture method is equivalent or marginally superior compared to the existing methods of peptide quantification and is capable of quantifying overlapping (convolved) peptides within the acceptable margin of error.	[Spainhour, John Christian G.; Ramakrishnan, Viswanathan] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Janech, Michael G.; Velez, Juan Carlos Q.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Velez, Juan Carlos Q.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Schwacke, John H.] Sci Res Corp, N Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Spainhour, JCG (corresponding author), Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	jcs21@musc.edu	janech, michael/AAA-1011-2019; Velez, Juan Carlos/N-3782-2016	Janech, Michael/0000-0002-3202-4811	National Institute of General Medicine [5T32GM74934-8]; National Institutes of Health [5DK080944]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074934] Funding Source: NIH RePORTER	National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JCGS was supported under a training grant from the National Institute of General Medicine (5T32GM74934-8) http://www.nigms.nih.gov/Pages/default.aspx. JCQV was supported by a grant from the National Institutes of Health (5DK080944) http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091537; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Barkauskas DA, 2010, ANAL CHIM ACTA, V657, P191, DOI 10.1016/j.aca.2009.10.043; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Benton HP, 2010, BIOINFORMATICS, V26, P2488, DOI 10.1093/bioinformatics/btq441; Bouzegrhane F, 2002, CARDIOVASC RES, V53, P304, DOI 10.1016/S0008-6363(01)00448-5; Bronsema KJ, 2012, J CHROMATOGR B, V893, P1, DOI 10.1016/j.jchromb.2012.02.021; Camenzind AG, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-20; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cui L, 2007, ANAL BIOCHEM, V369, P27, DOI 10.1016/j.ab.2007.06.045; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deutsch EW, 2008, PHYSIOL GENOMICS, V33, P18, DOI 10.1152/physiolgenomics.00298.2007; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gonzalez-Galarza FF, 2012, OMICS, V16, P431, DOI 10.1089/omi.2012.0022; Grobe N, 2013, AM J PHYSIOL-CELL PH, V304, pC945, DOI 10.1152/ajpcell.00346.2012; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hoffmann E, 2007, MASS SPECTROMETRY PR; HOLLENBERG NK, 1984, J CARDIOVASC PHARM, V6, pS176, DOI 10.1097/00005344-198400061-00028; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P297, DOI 10.1161/01.ATV.0000253889.09765.5f; Karpievitch YV, 2007, BIOINFORMATICS, V23, P264, DOI 10.1093/bioinformatics/btl583; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; Lortie M, 2009, ANAL BIOCHEM, V394, P164, DOI 10.1016/j.ab.2009.07.021; Markus K, 2012, METHODS MOL BIOL QUA, P85, DOI [10.1007/978-1-61779-885-6_29, DOI 10.1007/978-1-61779-885-6_]; Melnykov V, 2013, J R STAT SOC C-APPL, V62, P573, DOI 10.1111/rssc.12010; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Parry RM, 2013, J AM SOC MASS SPECTR, V24, P646, DOI 10.1007/s13361-012-0572-y; Plechawska M, 2009, STUD HEALTH TECHNOL, V150, P804, DOI 10.3233/978-1-60750-044-5-804; Polanska J, 2012, EXPERT SYST, V29, P216, DOI 10.1111/j.1468-0394.2011.00582.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ranjbar MRN, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-S1-S13; Reid JD, 2010, J AM SOC MASS SPECTR, V21, P1680, DOI 10.1016/j.jasms.2010.01.024; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Russell DH, 1997, J MASS SPECTROM, V32, P263, DOI 10.1002/(SICI)1096-9888(199703)32:3<263::AID-JMS501>3.3.CO;2-T; Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362; Schwacke JH, 2013, HYPERTENSION, V61, P690, DOI 10.1161/HYPERTENSIONAHA.111.00318; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Velez JCQ, 2007, AM J PHYSIOL-RENAL, V293, pF398, DOI 10.1152/ajprenal.00050.2007; Velez JCQ, 2012, AM J PHYSIOL-RENAL, V302, pF1583, DOI 10.1152/ajprenal.00087.2012; Velez JCQ, 2009, HYPERTENSION, V53, P790, DOI 10.1161/HYPERTENSIONAHA.109.128819; Weir MR, 1999, AM J HYPERTENS, V12, p205S; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c	56	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111016	10.1371/journal.pone.0111016	http://dx.doi.org/10.1371/journal.pone.0111016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372836	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900032
J	Stanley, WT; Rogers, MA; Kihaule, PM; Munissi, MJ				Stanley, William T.; Rogers, Mary Anne; Kihaule, Philip M.; Munissi, Maiko J.			Elevational Distribution and Ecology of Small Mammals on Africa's Highest Mountain	PLOS ONE			English	Article							WEST USAMBARA MOUNTAINS; SPECIES RICHNESS; ABUNDANCE; EAST; INVENTORIES; DIVERSITY; MURIDAE; KILIMANJARO; GRADIENTS; TRANSECT	Mt Kilimanjaro is Africa's highest mountain, and an icon for a country famous for its mammalian fauna. The distribution and abundance of small mammals on the mountain are poorly known. Here we document the distribution of shrews and rodents along an elevational gradient on the southeastern versant of Kilimanjaro. Five sites were sampled with elevational center points of 2000, 2500, 3000, 3500 and 4000 m, using a systematic methodology of standard traps and pitfall lines, to inventory the shrews and rodents of the slope. Sixteen species of mammal were recorded, including 6 shrew and 10 rodent species, and the greatest diversity of both was found at 3000 m, the elevational midpoint of the transect. No species previously unrecorded on Kilimanjaro were observed. Two genera of rodents that occur in nearby mountains (Hylomyscus and Beamys) were not recorded. Myosorex zinki, the only mammal endemic to Mt. Kilimanjaro, which previously was known by only a few specimens collected in the ericaceous or moorland habitat, was found in all but one (the lowest) of the sites sampled, and was one of the most widespread species of small mammal along the gradient. Two shrews (Crocidura allex and Sylvisorex granti) and one rodent (Dendromus insignis) were found throughout the entire transect, with Dendromus being observed at our highest trap point (4240 m). As in similar faunal surveys on other mountains of Tanzania, rainfall influenced the sample success of shrews, but not rodents. Trap success for rodents at 3500 m was notably low. This study contributes further justification for the conservation of the forest habitat of Mt. Kilimanjaro.	[Stanley, William T.; Rogers, Mary Anne] Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA; [Kihaule, Philip M.] Univ Dar Es Salaam, Dept Zool, Dar Es Salaam, Tanzania; [Munissi, Maiko J.] Southern Highlands Conservat Programme, Mbeya, Tanzania	Field Museum of Natural History (Chicago); University of Dar es Salaam	Stanley, WT (corresponding author), Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA.	bstanley@fieldmuseum.org			Field Museum of Natural History; Marshall Field, Barbara Brown and Ellen Thorne Smith Funds of the Field Museum	Field Museum of Natural History; Marshall Field, Barbara Brown and Ellen Thorne Smith Funds of the Field Museum	Funding for this study came from the Field Museum of Natural History, including awards from the Marshall Field, Barbara Brown and Ellen Thorne Smith Funds of the Field Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP IR, 1979, MAMMALIA, V43, P519, DOI 10.1515/mamm.1979.43.4.519; Carleton MD, 2005, P BIOL SOC WASH, V118, P619, DOI 10.2988/0006-324X(2005)118[619:ROTHDC]2.0.CO;2; Carleton MD, 2006, P BIOL SOC WASH, V119, P477, DOI 10.2988/0006-324X(2006)119[477:TSOOOD]2.0.CO;2; Carleton MD, 2012, ZOOL J LINN SOC-LOND, V165, P420, DOI 10.1111/j.1096-3642.2012.00817.x; Child G. S., 1965, Tanganyika Notes and Records, V64, P77; DEMETER A, 1986, Cimbebasia Series A, V8, P199; Dieterlen F, 1979, STUTTGARTER BEITR A, V330, P1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goodman S.M., 2003, P1159; Goodman Steven M., 1995, Oryx, V29, P212; Grimshaw J.M., 1997, Journal of East African Natural History, V84, P105, DOI 10.2982/0012-8317(1995)84[105:TMOK]2.0.CO;2; Hanby J, 1987, KILIMANJARO NATL PAR; HEANEY LR, 1989, J TROP ECOL, V5, P259, DOI 10.1017/S0266467400003643; HEIDEMAN PD, 1987, J MAMMAL, V68, P884, DOI 10.2307/1381575; Holden ME, 2005, MAMMAL SPECIES WORLD, V2, P819; Hutterer R, 2005, MAMMAL SPECIES WORLD, P220; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mulungu LS, 2008, MAMMALIA, V72, P178, DOI 10.1515/MAMM.2008.021; Musser GG, 2005, MAMMAL SPECIES WORLD, P894; Mwasaga BC, 1991, CONSERVATION MOUNT K, P111; Newmark WD, 1991, CONSERVATION MOUNT K, P111; Nor SM, 2001, GLOBAL ECOL BIOGEOGR, V10, P41, DOI 10.1046/j.1466-822x.2001.00231.x; PATTERSON BD, 1989, J MAMMAL, V70, P67, DOI 10.2307/1381670; RICKART EA, 1991, J MAMMAL, V72, P458, DOI 10.2307/1382128; Sampson DN, 1965, TANGANYIKA NOTES REC, V64, P118; SHORE RF, 1991, MAMMALIA, V55, P601, DOI 10.1515/mamm.1991.55.4.601; Stanley WT, 2005, BELG J ZOOL, V135, P141; Stanley W.T., 2000, Journal of East African Natural History, V87, P91, DOI 10.2982/0012-8317(1998)87[91:SMOTEA]2.0.CO;2; Stanley WT, 2007, ACTA THERIOL, V52, P261, DOI 10.1007/BF03194222; Stanley William T., 2005, Journal of East African Natural History, V94, P203, DOI 10.2982/0012-8317(2005)94[203:SMCITU]2.0.CO;2; Stanley William T., 2002, Journal of East African Natural History, V89, P73, DOI 10.2982/0012-8317(2000)89[73:ASOTSM]2.0.CO;2; Stanley William T., 1998, Zoologische Abhandlungen (Dresden), V50, P145; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P18; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P53; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P1; Stanley William T., 1996, Zoologische Abhandlungen (Dresden), V49, P131; Stanley William T., 2005, Journal of East African Natural History, V94, P223, DOI 10.2982/0012-8317(2005)94[223:ROASOS]2.0.CO;2; Stanley William T., 2007, Journal of East African Natural History, V96, P215, DOI 10.2982/0012-8317(2007)96[215:SMOTFR]2.0.CO;2; Stanley WT, 2003, P 3 ANN SCI C AR DEC; Swynnerton G.H., 1951, Journal of the East Africa Natural History Society, V20, P274; THESIGER W, 1970, East African Wildlife Journal, V8, P202; Thomas O, 1909, ANN MAGAZINE NATUR 8, V8, P98; Thompson LG, 2009, P NATL ACAD SCI USA, V106, P19770, DOI 10.1073/pnas.0906029106; YU HT, 1994, J ZOOL, V234, P577, DOI 10.1111/j.1469-7998.1994.tb04866.x	46	19	19	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109904	10.1371/journal.pone.0109904	http://dx.doi.org/10.1371/journal.pone.0109904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372387	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900010
J	Zhao, JD; Yuan, YY; Huang, SS; Huang, BQ; Cheng, J; Kang, DY; Wang, GJ; Han, DY; Dai, P				Zhao, Jiandong; Yuan, Yongyi; Huang, Shasha; Huang, Bangqing; Cheng, Jing; Kang, Dongyang; Wang, Guojian; Han, Dongyi; Dai, Pu			KCNJ10 May Not Be a Contributor to Nonsyndromic Enlargement of Vestibular Aqueduct (NSEVA) in Chinese Subjects	PLOS ONE			English	Article							SLC26 GENE FAMILY; PENDRED-SYNDROME; HEARING-LOSS; PDS GENE; MUTATIONS; DEAFNESS; SPECTRUM; SECRETION; DISTINCT; FOXI1	Background: Nonsyndromic enlargement of vestibular aqueduct (NSEVA) is an autosomal recessive hearing loss disorder that is associated with mutations in SLC26A4. However, not all patients with NSEVA carry biallelic mutations in SLC26A4. A recent study proposed that single mutations in both SLC26A4 and KCNJ10 lead to digenic NSEVA. We examined whether KCNJ10 excert a role in the pathogenesis of NSEVA in Chinese patients. Methods: SLC26A4 was sequenced in 1056 Chinese patients with NSEVA. KCNJ10 was screened in 131 patients who lacked mutations in either one or both alleles of SLC26A4. Additionally, KCNJ10 was screened in 840 controls, including 563 patients diagnosed with NSEVA who carried biallelic SLC26A4 mutations, 48 patients with nonsyndromic hearing loss due to inner ear malformations that did not involve enlargement of the vestibular aqueduct (EVA), 96 patients with conductive hearing loss due to various causes, and 133 normal-hearing individuals with no family history of hereditary hearing loss. Results: 925 NSEVA patients were found carrying two- allele pathogenic SLC26A4 mutations. The most frequently detected KCNJ10 mutation was c.812G>A ( p. R271H). Compared with the normal-hearing control subjects, the occurrence rate of c.812>G. A in NSEVA patients with lacking mutations in one or both alleles of SLC26A4 had no significant difference(1.53% vs. 5.30%, x(2) = 2.798, p = 0.172), which suggested that it is probably a nonpathogenic benign variant. KCNJ10 c.1042C > T (p.R348C), the reported EVA-related mutation, was not found in patients with NSEVA who lacked mutations in either one or both alleles of SLC26A4. Furthermore, the normal-hearing parents of patients with NSEVA having two SLC26A4 mutations carried the KCNJ10 c.1042C > T or c.812G. A mutation and a SLC26A4 pathogenic mutation. Conclusion: SLC26A4 is the major genetic cause in Chinese NSEVA patients, accounting for 87.59%. KCNJ10 may not be a contributor to NSEVA in Chinese population. Other genetic or environmental factors are possibly play a role in the etiology of Chinese EVA patients with zero or monoallelic SLC26A4 mutation.	[Zhao, Jiandong; Yuan, Yongyi; Huang, Shasha; Cheng, Jing; Kang, Dongyang; Wang, Guojian; Han, Dongyi; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Yuan, Yongyi; Huang, Bangqing; Wang, Guojian; Dai, Pu] Hainan Branch PLA Gen Hosp, Dept Otolaryngol, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital	Han, DY (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China.	hdy301@263.net; daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	Minister of Science and Technology [2012BAI09B02]; 12th Five-Year National Key Technologies R D program [2012BAI12B01]; Chinese National Nature Science Foundation Research [30728030, 31071109, 81230020, 81070792, 81371098]; State 863 High Technology R & D Key Project of China [SQ2010AA0221634001]; PLA General Hospital Culturing Foundation [12KMM32]; Beijing Natural Science Foundation [7132177]; Beijing Nova programme [2009B34]	Minister of Science and Technology; 12th Five-Year National Key Technologies R D program; Chinese National Nature Science Foundation Research(National Natural Science Foundation of China (NSFC)); State 863 High Technology R & D Key Project of China(National High Technology Research and Development Program of China); PLA General Hospital Culturing Foundation; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova programme(Beijing Municipal Science & Technology Commission)	This work was supported by funding from a grant from the Minister of Science and Technology (2012BAI09B02) and the 12th Five-Year National Key Technologies R & D program (No. 2012BAI12B01), Chinese National Nature Science Foundation Research Grants (30728030, 31071109, 81230020), and the State 863 High Technology R & D Key Project of China (SQ2010AA0221634001) to Dr. Pu Dai; the PLA General Hospital Culturing Foundation to Dr. Jiandong Zhao (12KMM32); a Chinese National Nature Science Foundation Research Grant (81070792) to Dr. Dongyi Han; and the Beijing Natural Science Foundation (7132177), Beijing Nova programme (2009B34) and Chinese National Nature Science Foundation (81371098) to Dr. Yongyi Yuan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Blons H, 2004, CLIN GENET, V66, P333, DOI 10.1111/j.1399-0004.2004.00296.x; Chen KT, 2012, OTOLARYNG HEAD NECK, V146, P972, DOI 10.1177/0194599812439670; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Dai P, 2009, PHYSIOL GENOMICS, V38, P281, DOI 10.1152/physiolgenomics.00047.2009; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Jin Z, 2008, EUR J NEUROSCI, V27, P145, DOI 10.1111/j.1460-9568.2007.05994.x; Jonard L, 2010, INT J PEDIATR OTORHI, V74, P1049, DOI 10.1016/j.ijporl.2010.06.002; Landa P, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-85; Lu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064906; Lu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022150; Maciaszczyk K, 2008, NEUROENDOCRINOL LETT, V29, P29; MAFEE MF, 1992, AM J NEURORADIOL, V13, P805; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; Mercer S, 2011, GENET TEST MOL BIOMA, V15, P365, DOI 10.1089/gtmb.2010.0177; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yoshino T, 2004, HEARING RES, V195, P9, DOI 10.1016/j.heares.2004.05.005; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049984	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108134	10.1371/journal.pone.0108134	http://dx.doi.org/10.1371/journal.pone.0108134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372295	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900001
J	de Carvalho, MA; Freitas, FGR; Silva, HT; Bafi, AT; Machado, FR; Pestana, JOM				de Carvalho, Monica Andrade; Rezende Freitas, Flavio Geraldo; Silva Junior, Helio Tedesco; Bafi, Antonio Toneti; Machado, Flavia Ribeiro; Medina Pestana, Jose Osmar			Mortality Predictors in Renal Transplant Recipients with Severe Sepsis and Septic Shock	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE KIDNEY INJURY; INFECTIOUS COMPLICATIONS; ILL PATIENTS; SOFA SCORE; EPIDEMIOLOGY; OUTCOMES; GENDER; DEFINITIONS; SURVIVAL	Introduction: The growing number of renal transplant recipients in a sustained immunosuppressive state is a factor that can contribute to increased incidence of sepsis. However, relatively little is known about sepsis in this population. The aim of this single-center study was to evaluate the factors associated with hospital mortality in renal transplant patients admitted to the intensive care unit (ICU) with severe sepsis and septic shock. Methods: Patient demographics and transplant-related and ICU stay data were retrospectively collected. Multiple logistic regression was conducted to identify the independent risk factors associated with hospital mortality. Results: A total of 190 patients were enrolled, 64.2% of whom received kidneys from deceased donors. The mean patient age was 51 +/- 13 years (males, 115 [60.5%]), and the median APACHE II was 20 (16-23). The majority of patients developed sepsis late after the renal transplantation (2.1 [0.6-2.3] years). The lung was the most common infection site (59.5%). Upon ICU admission, 16.4% of the patients had <= 1 systemic inflammatory response syndrome criteria. Among the patients, 61.5% presented with >= 2 organ failures at admission, and 27.9% experienced septic shock within the first 24 hours of ICU admission. The overall hospital mortality rate was 38.4%. In the multivariate analysis, the independent determinants of hospital mortality were male gender (OR = 5.9; 95% CI, 1.7-19.6; p = 0.004), delta SOFA 24 h (OR = 1.7; 95% CI, 1.2-2.3; p = 0.001), mechanical ventilation (OR = 30; 95% CI, 8.8-102.2; p<0.0001), hematologic dysfunction (OR = 6.8; 95% CI, 2.0-22.6; p = 0.002), admission from the ward (OR = 3.4; 95% CI, 1.2-9.7; p = 0.02) and acute kidney injury stage 3 (OR = 5.7; 95% CI, 1.9-16.6; p = 0.002). Conclusions: Hospital mortality in renal transplant patients with severe sepsis and septic shock was associated with male gender, admission from the wards, worse SOFA scores on the first day and the presence of hematologic dysfunction, mechanical ventilation or advanced graft dysfunction.	[de Carvalho, Monica Andrade; Rezende Freitas, Flavio Geraldo; Silva Junior, Helio Tedesco; Bafi, Antonio Toneti; Medina Pestana, Jose Osmar] Univ Fed Sao Paulo, Unidade Transplante, Disciplina Nefrol, Sao Paulo, Brazil; [Rezende Freitas, Flavio Geraldo; Bafi, Antonio Toneti; Machado, Flavia Ribeiro] Univ Fed Sao Paulo, Disciplina Anestesiol Dor & Terapia Intens, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Carvalho, MA (corresponding author), Univ Fed Sao Paulo, Unidade Transplante, Disciplina Nefrol, Sao Paulo, Brazil.	mactulha@hotmail.com	Bafi, Antonio/H-2015-2012	Bafi, Antonio/0000-0003-2283-9109	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Hospital do Rim	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hospital do Rim	The project was supported by funding from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) programme and Hospital do Rim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2006, AM J KIDNEY DIS, V47, pS65, DOI 10.1053/j.ajkd.2005.12.043; Adrie C, 2007, CHEST, V132, P1786, DOI 10.1378/chest.07-0420; Ak O, 2013, TRANSPL P, V45, P944, DOI 10.1016/j.transproceed.2013.02.080; Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Aldawood A, 2007, SAUDI J KIDNEY DIS T, V18, P536; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; [Anonymous], CRIT CARE MED; Arulkumaran N, 2012, CLIN TRANSPLANT, V26, pE24, DOI 10.1111/j.1399-0012.2011.01520.x; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Candan S, 2006, TRANSPL P, V38, P1354, DOI 10.1016/j.transproceed.2006.02.083; Canet E, 2011, CRIT CARE, V15, DOI 10.1186/cc10091; Davis CL, 2004, AM J KIDNEY DIS, V43, P508, DOI 10.1053/j.ajkd.2003.10.044; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Gallon LG, 2002, SEMIN NEPHROL, V22, P515, DOI 10.1053/snep.2002.35966; Glyda Maciej, 2011, Pol Przegl Chir, V83, P188, DOI 10.2478/v10035-011-0029-1; Ingsathit A, 2010, TRANSPL P, V42, P4014, DOI 10.1016/j.transproceed.2010.09.061; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Klouche K, 2009, TRANSPLANTATION, V87, P889, DOI 10.1097/TP.0b013e31819a688a; KNAUS WA, 1992, CHEST, V101, P1656, DOI 10.1378/chest.101.6.1656; Knoll G, 2008, DRUGS, V68, P3, DOI 10.2165/00003495-200868001-00002; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Lopes JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11911; Medina-Pestana Jose O, 2010, Clin Transpl, P107; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Mouloudi E, 2012, TRANSPL P, V44, P2718, DOI 10.1016/j.transproceed.2012.09.097; Mouloudi E, 2012, TRANSPL P, V44, P2721, DOI 10.1016/j.transproceed.2012.09.023; Nakamura M, 2012, CLIN TRANSPLANT, V26, P520, DOI 10.1111/j.1399-0012.2011.01546.x; Noritomi DT, 2014, INTENS CARE MED, V40, P182, DOI 10.1007/s00134-013-3131-5; Pelletier SJ, 2000, CLIN TRANSPLANT, V14, P401, DOI 10.1034/j.1399-0012.2000.14040802.x; Conde KAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064790; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; Pietropaoli AP, 2010, GENDER MED, V7, P422, DOI 10.1016/j.genm.2010.09.005; Pourmand Gholamreza, 2006, Urol J, V3, P23; REIS MA, 1995, J ROY SOC MED, V88, P24; Sakr Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12570; Sam R, 2000, NEW ENGL J MED, V342, P1837; Sawyer RG, 1999, CLIN TRANSPLANT, V13, P260, DOI 10.1034/j.1399-0012.1999.130307.x; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Veroux M, 2008, TRANSPL P, V40, P1873, DOI 10.1016/j.transproceed.2008.05.065; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Walkey AJ, 2013, CRIT CARE MED, V41, P1450, DOI 10.1097/CCM.0b013e31827caa89; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; [No title captured]	52	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111610	10.1371/journal.pone.0111610	http://dx.doi.org/10.1371/journal.pone.0111610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369197	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000078
J	Dharia, AP; Obla, A; Gajdosik, MD; Simon, A; Nelson, CE				Dharia, Asav P.; Obla, Ajay; Gajdosik, Matthew D.; Simon, Amanda; Nelson, Craig E.			Tempo and Mode of Gene Duplication in Mammalian Ribosomal Protein Evolution	PLOS ONE			English	Article							WHOLE-GENOME; PSEUDOGENES; EXPRESSION; DIVERSITY; FATE	Gene duplication has been widely recognized as a major driver of evolutionary change and organismal complexity through the generation of multi-gene families. Therefore, understanding the forces that govern the evolution of gene families through the retention or loss of duplicated genes is fundamentally important in our efforts to study genome evolution. Previous work from our lab has shown that ribosomal protein (RP) genes constitute one of the largest classes of conserved duplicated genes in mammals. This result was surprising due to the fact that ribosomal protein genes evolve slowly and transcript levels are very tightly regulated. In our present study, we identified and characterized all RP duplicates in eight mammalian genomes in order to investigate the tempo and mode of ribosomal protein family evolution. We show that a sizable number of duplicates are transcriptionally active and are very highly conserved. Furthermore, we conclude that existing gene duplication models do not readily account for the preservation of a very large number of intact retroduplicated ribosomal protein (RT-RP) genes observed in mammalian genomes. We suggest that selection against dominant-negative mutations may underlie the unexpected retention and conservation of duplicated RP genes, and may shape the fate of newly duplicated genes, regardless of duplication mechanism.	[Dharia, Asav P.; Obla, Ajay; Gajdosik, Matthew D.; Simon, Amanda; Nelson, Craig E.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Nelson, CE (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	craig.nelson@uconn.edu	Obla, Ajay/GON-8118-2022		National Science Foundation (NSF) [1024803]; NSF	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) Grant Award Number: 1024803 (http://nsf.gov/awardsearch/showAward?AWD_ID = 1024803&HistoricalAwards = false). Author CEN was the principal investigator on the NSF grant who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2006, NATURE MED; Amoutzias GD, 2010, P NATL ACAD SCI USA, V107, P2967, DOI 10.1073/pnas.0911603107; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bailey J, 2002, SCIENCE NEW YORK NY; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bastian F, BGEE INTEGRATING COM, P124, DOI [10.1007/978-3-540-69828-9_12., DOI 10.1007/978-3-540-69828-9_12]; Blanc G, 2004, PLANT CELL ONLINE; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Carnemolla A, 2009, J BIOL; COLOMBO P, 1992, NUCLEIC ACIDS RES, V20, P3367, DOI 10.1093/nar/20.13.3367; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Cusack B, 2007, MOL BIOL EVOLUTION; De Smet R, 2013, P NATL ACAD SCI USA, V110, P2898, DOI 10.1073/pnas.1300127110; Dehal P, 2005, PLOS BIOL; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; DENNIS PP, 1974, P NATL ACAD SCI USA, V71, P3819, DOI 10.1073/pnas.71.10.3819; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Evangelisti AM, 2010, GENOME BIOL EVOL, V2, P826, DOI 10.1093/gbe/evq067; Farfan M, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-23; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Flygare J, 2007, HUMAN RPS19 GENE MUT, P1; Force A, 1999, GENETICS, V151, P1531; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gibson TJ, 1998, TRENDS GENET, V14, P46, DOI 10.1016/S0168-9525(97)01367-X; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Han MV, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P114; Hariharan N, 1989, GENES DEV; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Hori H, 1977, J MOL EVOLUTION; Huang X, 2010, HUMAN MOL; Hughes T, 2007, J MOL EVOLUTION; Hughes T, 2007, GENOME; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jiang Z, 2008, CLIN CANC; Jiang Z, 2008, CANCER; Jun J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-630; Jun J, 2009, J COMPUT BIOL, V16, P1429, DOI 10.1089/cmb.2009.0073; Jun J, 2009, J COMPUT BIOL, V16, P1253, DOI 10.1089/cmb.2009.0074; Kenmochi N, 1998, GENOME; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Kittler R, 2004, NATURE; Konrad A, 2011, GENOME BIOL EVOL, V3, P1197, DOI 10.1093/gbe/evr093; Liberles DA, 2013, GENOME BIOL EVOL, V5, P2008, DOI 10.1093/gbe/evt151; Liberles DA, 2011, P ROY SOC B-BIOL SCI, V278, P1930, DOI 10.1098/rspb.2010.2637; Maere S, 2005, MODELING GENE GENOME; Mager W, 2013, BIOCHIM BIOPHYS ACTA, V949, P1; Marais D, 2008, NATURE; Marygold S, 2007, GENOME; Marygold S, 2005, GENETICS; Meyer A, 1999, CURRENT OPINION CELL; Mikkelsen TS, 2007, NATURE; Nielsen R, 1998, GENETICS, V148, P929; OHNO S, EVOLUTION GENE DUPLI; Panopoulou G, 2003, GENOME; Parker H, 2009, SCIENCE NEW YORK NY; Parker HG, 2009, SCIENCE; Rodriguez V, 2007, GENE CHROMOSOME CANC, V46, P694, DOI 10.1002/gcc.20454; Roman T, 2005, MOLECULAR; Rosengren A, 2010, SCIENCE; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Tan J, 1996, AM J HUMAN; Thorrez L, 2008, POTENTIAL CAPACITY G, P1; Uechi T, 2002, NUCL ACIDS RES; Ureta-Vidal A, 2003, NATURE REV GENETICS; VanRaay TJ, 1996, GENOMICS, V37, P172, DOI 10.1006/geno.1996.0538; Veitia R, 2007, PLANT CELL ONLINE; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Wang P, 2004, TRENDS ENDOCRINOLOGY; Wapinski I, 2007, BIOINFORMATICS; WATANABE T, 2008, NATURE; Willig T, 1999, BLOOD; Wolfe K, 1997, NATURE; Wool IG, BIOCH CELL BIOL, V73, P933; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu H, 2006, HUMAN MOL; Yu Z, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-308; Zhang J, 2003, TRENDS ECOLOGY EVOLU; Zhang L, 2005, MOL BIOL EVOLUTION; Zhang Y, 2013, DEV CELL; Zhang Z, 2006, BIOINFORMATICS OXFOR; Zhang Z, 2002, GENOME RES; Zhao Y, 2006, FINE STRUCTURE ANAL; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072	90	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111721	10.1371/journal.pone.0111721	http://dx.doi.org/10.1371/journal.pone.0111721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369106	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000093
J	Garcia-Martin, A; Reyes-Garcia, R; Garcia-Fontana, B; Morales-Santana, S; Coto-Montes, A; Munoz-Garach, M; Rozas-Moreno, P; Munoz-Torres, M				Garcia-Martin, Antonia; Reyes-Garcia, Rebeca; Garcia-Fontana, Beatriz; Morales-Santana, Sonia; Coto-Montes, Ana; Munoz-Garach, Manuel; Rozas-Moreno, Pedro; Munoz-Torres, Manuel			Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CALCIFIED ATHEROSCLEROTIC PLAQUE; CORONARY-ARTERY CALCIFICATION; MINERAL DENSITY; AFRICAN-AMERICANS; SCLEROSTIN; OSTEOPOROSIS; POPULATION; EXPRESSION; RECEPTORS; PATHWAYS	Objectives: Dickkopf-1 (DKK1) is a potent inhibitor of Wnt signalling, which exerts anabolic effects on bone and also takes part in the regulation of vascular cells. Our aims were to evaluate serum DKK1 in type 2 diabetes (T2DM) patients and to analyze its relationships with cardiovascular disease (CVD). We also evaluated the relationship between DKK1 and bone metabolism. Design: We conducted a cross-sectional study in which we measured serum DKK1 (ELISA, Biomedica) in 126 subjects: 72 patients with T2DM and 54 non-diabetic subjects. We analysed its relationship with clinical CVD, preclinical CVD expressed as carotid intima media thickness (IMT), and bone metabolism. Results: T2DM patients with CVD (P = 0,026) and abnormal carotid IMT (P = 0,038) had higher DKK1 concentrations. DKK1 was related to the presence of CVD in T2DM, independently of the presence of risk factors for atherosclerosis. Therefore, for each increase of 28 pg/ml of serum DKK1 there was a 6,2% increase in the risk of CVD in T2DM patients. The ROC curve analysis to evaluate the usefulness of DKK1 as a marker for high risk of CVD showed an area under the curve of 0,667 (95% CI: 0,538-0,795; P = 0,016). In addition, there was a positive correlation between serum DKK1 and spine bone mineral density in the total sample (r = 0,183; P = 0,048). Conclusion: In summary, circulating DKK1 levels are higher in T2DM with CVD and are associated with an abnormal carotid IMT in this cross-sectional study. DKK1 may be involved in vascular disease of T2DM patients.	[Garcia-Martin, Antonia; Reyes-Garcia, Rebeca; Garcia-Fontana, Beatriz; Morales-Santana, Sonia; Munoz-Torres, Manuel] Hosp Univ San Cecilio, Inst Invest Biosanit Granada, Div Endocrinol, Bone Metab Unit RETICEF, Granada, Spain; [Garcia-Martin, Antonia] Hosp Comarcal Noroeste Caravaca Cruz, Murcia, Spain; [Reyes-Garcia, Rebeca] Univ Rafael Mendez, Gen Hosp, Endocrinol Unit, Murcia, Spain; [Morales-Santana, Sonia] FIBAO, Prote Res Serv, Granada, Spain; [Coto-Montes, Ana] Univ Oviedo, Fac Med, Dept Morphol & Cellular Biol RETICEF, Oviedo, Spain; [Munoz-Garach, Manuel] Hosp Univ San Cecilio, Crit Care & Emergencies Unit, Granada, Spain; [Rozas-Moreno, Pedro] Hosp Gen Ciudad Real, Div Endocrinol, Ciudad Real, Spain	Hospital Universitario San Cecilio; University of Oviedo; Hospital Universitario San Cecilio	Munoz-Torres, M (corresponding author), Hosp Univ San Cecilio, Inst Invest Biosanit Granada, Div Endocrinol, Bone Metab Unit RETICEF, Granada, Spain.	mmt@mamuto.es	Torres, Manuel Muñoz/O-2330-2016; Morales-Santana, Sonia/ABG-8889-2020; coto-montes, ana/D-2544-2016; Garcia-Fontana, Beatriz/AAB-4330-2021	Torres, Manuel Muñoz/0000-0002-9645-3260; Morales-Santana, Sonia/0000-0001-8403-2496; coto-montes, ana/0000-0002-6609-6258; Garcia Fontana, Beatriz/0000-0002-4134-5561; Reyes-Garcia, Rebeca/0000-0003-1729-4431	Consejeria de Salud y Bienestar Social, Junta de Andalucia [PI-0514-2012]; Red de Investigacion Colaborativa en Envejecimiento y Fragilidad (RETICEF) [RD06/0013/1014-RD12/0043/0014]	Consejeria de Salud y Bienestar Social, Junta de Andalucia(Junta de Andalucia); Red de Investigacion Colaborativa en Envejecimiento y Fragilidad (RETICEF)	This work was supported in part by Consejeria de Salud y Bienestar Social, Junta de Andalucia (PI-0514-2012) and Red de Investigacion Colaborativa en Envejecimiento y Fragilidad (RETICEF) (RD06/0013/1014-RD12/0043/0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia JF, 1996, CALCIFIED TISSUE INT, V59, P415, DOI 10.1007/BF00369203; Bell NH, 2001, OSTEOPOROSIS INT, V12, P43, DOI 10.1007/s001980170156; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Butler JS, 2011, J ORTHOP RES, V29, P414, DOI 10.1002/jor.21260; Cannata-Andia JB, 2011, NEPHROL DIAL TRANSPL, V26, P3429, DOI 10.1093/ndt/gfr591; Carr JJ, 2008, BONE, V42, P43, DOI 10.1016/j.bone.2007.08.023; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Cheng SL, 2013, ARTERIOSCL THROM VAS, V33, P1679, DOI 10.1161/ATVBAHA.113.300647; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Divers J, 2013, CIRC-CARDIOVASC GENE, V6, P97, DOI 10.1161/CIRCGENETICS.112.964114; Divers J, 2011, J BONE MINER RES, V26, P1554, DOI 10.1002/jbmr.389; Epstein S, 2008, BONE, V43, P3, DOI 10.1016/j.bone.2008.03.017; Fang YF, 2014, J AM SOC NEPHROL, V25, P1760, DOI 10.1681/ASN.2013080818; Freedman BI, 2012, NAT REV NEPHROL, V8, P459, DOI 10.1038/nrneph.2012.112; Freedman BI, 2005, DIABETOLOGIA, V48, P2511, DOI 10.1007/s00125-005-0017-2; Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Junyent M, 2005, MED CLIN-BARCELONA, V125, P770, DOI 10.1016/S0025-7753(05)72186-2; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim KI, 2011, J KOREAN MED SCI, V26, P1178, DOI 10.3346/jkms.2011.26.9.1178; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Lee TC, 2003, J AM COLL CARDIOL, V41, P39, DOI 10.1016/S0735-1097(02)02618-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Magnus JH, 2005, OSTEOPOROSIS INT, V16, P2053, DOI 10.1007/s00198-005-1999-9; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Polyzos SA, 2012, OSTEOPOROSIS INT, V23, P1171, DOI 10.1007/s00198-010-1525-6; Register TC, 2013, J CLIN ENDOCR METAB, V98, pE60, DOI 10.1210/jc.2012-3038; Scott EL, 2013, BRAIN RES, V1514, P63, DOI 10.1016/j.brainres.2012.12.015; Seifert-Held T, 2011, ATHEROSCLEROSIS, V218, P233, DOI 10.1016/j.atherosclerosis.2011.05.015; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Thambiah S, 2012, CALCIFIED TISSUE INT, V90, P473, DOI 10.1007/s00223-012-9595-4; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Wade AN, 2011, DIABETES RES CLIN PR, V91, P101, DOI 10.1016/j.diabres.2010.07.004; Wang YY, 2009, CLIN CANCER RES, V15, P5784, DOI 10.1158/1078-0432.CCR-09-0814; Wylie-Sears J, 2011, ARTERIOSCL THROM VAS, V31, P598, DOI 10.1161/ATVBAHA.110.216184; Young BA, 2003, DIABETES CARE, V26, P2392, DOI 10.2337/diacare.26.8.2392	43	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111703	10.1371/journal.pone.0111703	http://dx.doi.org/10.1371/journal.pone.0111703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369286	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000087
J	Martinu, K; Nagano-Saito, A; Fogel, S; Monchi, O				Martinu, Kristina; Nagano-Saito, Atsuko; Fogel, Stuart; Monchi, Oury			Asymmetrical Effect of Levodopa on the Neural Activity of Motor Regions in PD	PLOS ONE			English	Article							PRIMATE BASAL GANGLIA; PARKINSONS-DISEASE; INTERNAL GENERATION; ANTERIOR STRIATUM; FINGER MOVEMENTS; FRONTAL-CORTEX; FUNCTIONAL MRI; FMRI; APOMORPHINE; ACTIVATION	Parkinson's disease (PD) is a neurodegenerative illness often characterized by asymmetrical symptoms. However, the reason for this asymmetry and the cerebral correlates underlying symptom asymmetry are still not well understood. Furthermore, the effects of levodopa on the cerebral correlates of disease asymmetry have not been investigated. In this study, right-handed PD patients performed self-initiated, externally triggered and repetitive control finger movements with both their right and left hands during functional magnetic resonance imaging (fMRI) to investigate asymmetrical effects of levodopa on the hemodynamic correlates of finger movements. Patients completed two experimental sessions OFF and ON medication after a minimum of 12 hours medication withdrawal. We compared the effect of levodopa on the neural activation patterns underlying the execution of both the more affected and less affected hand for self-initiated and externally triggered movements. Our results show that levodopa led to larger differences in cerebral activity for movements of the more affected, left side: there were significant differences in activity after levodopa administration in regions of the motor cortico-striatal network when patients performed self-initiated and externally triggered movements with their left hand. By contrast, when patients used their right hand, levodopa led to differences in cerebellar activity only. As our patients were affected more severely on their left side, we propose that levodopa may help provide additional dopaminergic input, improving movements for the more severely affected side. These results suggest that the impact of reduced dopamine in the cortico-striatal system and the action of levodopa is not symmetrical.	[Martinu, Kristina; Nagano-Saito, Atsuko; Fogel, Stuart; Monchi, Oury] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Fogel, Stuart] Western Univ, Brain & Mind Inst, Dept Psychol, London, ON, Canada; [Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada	Universite de Montreal; Western University (University of Western Ontario); Universite de Montreal	Monchi, O (corresponding author), Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada.	oury.monchi@umontreal.ca	Fogel, Stuart/F-7179-2017; Monchi, Oury/N-8417-2019	Fogel, Stuart/0000-0002-3227-5370; 	Canadian Institutes of Health Research [MOP-81114]; Parkinson Society Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Society Canada	This study was supported by an operating grant (MOP-81114) from the Canadian Institutes of Health Research to OM. KM received a PhD fellowship from the Parkinson Society Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; DUVOISIN RC, 1989, NEUROLOGY, V39, P4; Feigin A, 2002, NEUROLOGY, V59, P220, DOI 10.1212/WNL.59.2.220; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Francois-Brosseau FE, 2009, EUR J NEUROSCI, V29, P1277, DOI 10.1111/j.1460-9568.2009.06671.x; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; KEMPSTER PA, 1989, J NEUROL NEUROSUR PS, V52, P72, DOI 10.1136/jnnp.52.1.72; Kraft E, 2009, PARKINSONISM RELAT D, V15, P558, DOI 10.1016/j.parkreldis.2009.02.005; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; Lewis MM, 2009, EUR J NEUROL, V16, P475, DOI 10.1111/j.1468-1331.2008.02430.x; Martinu K, 2012, EUR J NEUROSCI, V35, P572, DOI 10.1111/j.1460-9568.2011.07979.x; Mattay VS, 1998, PSYCHIAT RES-NEUROIM, V83, P7, DOI 10.1016/S0925-4927(98)00023-7; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ng B, 2010, HUM BRAIN MAPP, V31, P88, DOI 10.1002/hbm.20847; RODRIGUEZ M, 1994, J NEUROL NEUROSUR PS, V57, P562, DOI 10.1136/jnnp.57.5.562; ROMO R, 1992, EXP BRAIN RES, V91, P385, DOI 10.1007/BF00227835; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; van der Hoorn A, 2011, PARKINSONISM RELAT D, V17, P58, DOI 10.1016/j.parkreldis.2010.10.002; Verreyt N, 2011, NEUROPSYCHOL REV, V21, P405, DOI 10.1007/s11065-011-9182-x; Winterer G, 2006, PHARMACOPSYCHIATRY, V39, pS68, DOI 10.1055/s-2006-931498; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2005, NEUROIMAGE, V28, P1056, DOI 10.1016/j.neuroimage.2005.06.053; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; Yust-Katz S, 2008, PARKINSONISM RELAT D, V14, P633, DOI 10.1016/j.parkreldis.2008.01.017; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111600	10.1371/journal.pone.0111600	http://dx.doi.org/10.1371/journal.pone.0111600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369523	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402000073
J	Oshi, DC; Oshi, SN; Alobu, I; Ukwaja, KN				Oshi, Daniel C.; Oshi, Sarah N.; Alobu, Isaac; Ukwaja, Kingsley N.			Profile and Treatment Outcomes of Tuberculosis in the Elderly in Southeastern Nigeria, 2011-2012	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; HIV-INFECTION; OLDER-ADULTS; AGE; EPIDEMIOLOGY; PREVALENCE; MORTALITY; AFRICA; PEOPLE; IMPACT	Background: The demographic transition and increasing life expectancy in Africa has lead to a rising elderly population. In Nigeria, little is known about the profile of and treatment outcomes of tuberculosis (TB) in the elderly. Methods: Retrospective cohort study of adult TB patients treated between January 2011 and December 2012 in two large health facilities in Nigeria. The demographic, clinical and treatment outcomes of patients aged 60 and older were compared with those aged 15 to 59 years. Results: Elderly (>= 60 years) TB patients accounted for 12.7% of all (1668) adult TB enrolled. Elderly patients had a higher proportion of men compared to non-elderly (64.2% vs 56.8%; p = 0.043); but a lower proportion of smear-positive TB at baseline (40.7% vs 65.8%; p<0.001). A higher proportion of elderly patients failed to smear convert after the intensive phase of treatment (23.7% vs 19.8%; p = 0.06), and overall elderly patients had lower treatment success rates (68.9% vs 77.1%; p = 0.009). Unsuccessful outcomes were mainly due to higher default and deaths in the elderly. The risk factors for unsuccessful outcomes in the elderly were: extrapulmonary TB case (adjusted odds ratio (aOR) 10.9; 95% confidence interval (CI) 1.1-108), and HIV co-infection (aOR 3.6; CI 1.1-11.7). Conclusions: Treatment outcomes of elderly TB patients were inferior to non-elderly adults with higher death and default rates being implicated. With the rising elderly population, specific strategies are needed to quickly address TB management in the elderly in resource-limited settings.	[Oshi, Daniel C.; Oshi, Sarah N.] Ctr Dev & Reprod Hlth, Enugu, Enugu State, Nigeria; [Alobu, Isaac] Minist Hlth, Natl TB & Leprosy Control Programme, Abakaliki, Ebonyi State, Nigeria; [Ukwaja, Kingsley N.] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria		Ukwaja, KN (corresponding author), Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria.	ukwajakingsley@yahoo.co.uk	Ukwaja, Kingsley N./A-7794-2013	Ukwaja, Kingsley N./0000-0002-1974-8735				Ananthakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067288; [Anonymous], 2010, NAT GUID EST PRIV WI; [Anonymous], 2013, UNAIDS REP GLOB AIDS, P122; Arora V K, 2003, Indian J Chest Dis Allied Sci, V45, P231; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Balakrishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046502; Cantalice Filho João Paulo, 2007, J. bras. pneumol., V33, P691, DOI 10.1590/S1806-37132007000600013; Chan-Yeung M, 2006, J AM GERIATR SOC, V54, P1334, DOI 10.1111/j.1532-5415.2006.00850.x; Davies PDO, 1996, DRUG AGING, V8, P436, DOI 10.2165/00002512-199608060-00005; Gavazzi G, 2004, CLIN INFECT DIS, V39, P83, DOI 10.1086/421559; Hauer B, 2011, EUR RESPIR J, V38, P467, DOI 10.1183/09031936.00199910; Ijaz K, 2002, J AM GERIATR SOC, V50, P1213, DOI 10.1046/j.1532-5415.2002.50307.x; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Leung CC, 2002, J AM GERIATR SOC, V50, P1219, DOI 10.1046/j.1532-5415.2002.50308.x; Leung KK, 1999, AGE AGEING, V28, P199, DOI 10.1093/ageing/28.2.199; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Office S.I.N.S, 2009, REPORT 2009 POPULATI; Cruz-Hervert LP, 2012, AGE AGEING, V41, P488, DOI 10.1093/ageing/afs028; Patra S, 2013, T ROY SOC TROP MED H, V107, P763, DOI 10.1093/trstmh/trt094; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; Pillay NK, 2013, AGING HLTH AFRICA, P11, DOI DOI 10.1089/jwh.2008.1090; Pratt RH, 2011, J AM GERIATR SOC, V59, P851, DOI 10.1111/j.1532-5415.2011.03369.x; Salvado M, 2010, J AM GERIATR SOC, V58, P18, DOI 10.1111/j.1532-5415.2009.02619.x; Toure NO, 2010, REV MAL RESPIR, V27, P1062, DOI 10.1016/j.rmr.2010.04.017; Ukwaja K N, 2013, Niger Postgrad Med J, V20, P125; Ukwaja Kingsley, 2011, Pan Afr Med J, V9, P12; Ukwaja KN, 2014, T ROY SOC TROP MED H, V108, P431, DOI 10.1093/trstmh/tru070; Ukwaja KN, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-25; Velayutham BRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088045; Wang CS, 2008, INFECTION, V36, P335, DOI 10.1007/s15010-008-7199-8; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WOO J, 1992, ADVERSE DRUG REACT T, V11, P13	34	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111910	10.1371/journal.pone.0111910	http://dx.doi.org/10.1371/journal.pone.0111910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369001	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000122
J	Garaizar, P; Vadillo, MA				Garaizar, Pablo; Vadillo, Miguel A.			Accuracy and Precision of Visual Stimulus Timing in PsychoPy: No Timing Errors in Standard Usage	PLOS ONE			English	Article							SOFTWARE	In a recent report published in PLoS ONE, we found that the performance of PsychoPy degraded with very short timing intervals, suggesting that it might not be perfectly suitable for experiments requiring the presentation of very brief stimuli. The present study aims to provide an updated performance assessment for the most recent version of PsychoPy (v1.80) under different hardware/software conditions. Overall, the results show that PsychoPy can achieve high levels of precision and accuracy in the presentation of brief visual stimuli. Although occasional timing errors were found in very demanding benchmarking tests, there is no reason to think that they can pose any problem for standard experiments developed by researchers.	[Garaizar, Pablo] Univ Deusto, DeustoTech, Deusto Inst Technol, Bilbao, Spain; [Vadillo, Miguel A.] UCL, Dept Expt Psychol, London, England; [Vadillo, Miguel A.] Kings Coll London, London, England	University of Deusto; University of London; University College London; University of London; King's College London	Garaizar, P (corresponding author), Univ Deusto, DeustoTech, Deusto Inst Technol, Bilbao, Spain.	garaizar@deusto.es	Garaizar, Pablo/U-6469-2019; Vadillo, Miguel A./A-8702-2011; Garaizar, Pablo/A-9031-2011	Garaizar, Pablo/0000-0001-8160-9130; Vadillo, Miguel A./0000-0001-8421-816X; Garaizar, Pablo/0000-0001-8160-9130				Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brand A, 2012, SOC SCI COMPUT REV, V30, P350, DOI 10.1177/0894439311415604; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Damian MF, 2010, BEHAV RES METHODS, V42, P205, DOI 10.3758/BRM.42.1.205; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Donkin C, 2009, BEHAV RES METHODS, V41, P1095, DOI 10.3758/BRM.41.4.1095; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Garaizar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085108; Gray J, 2014, PSYCHOPY TIMING TEST; Hassin RR, 2007, P NATL ACAD SCI USA, V104, P19757, DOI 10.1073/pnas.0704679104; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2014, PSYCHOPY CAN PROVIDE; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Plant RR, 2013, COGN AFFECT BEHAV NE, V13, P598, DOI 10.3758/s13415-013-0166-6; Plant RR, 2004, BEHAV RES METH INS C, V36, P291, DOI 10.3758/BF03195575; Plant RR, 2014, DO THESE RESULTS GEN; RATCLIFF R, 1978, J VERB LEARN VERB BE, V17, P403, DOI 10.1016/S0022-5371(78)90238-4; Reimers S, BEHAV RES M IN PRESS; Reingold EM, 2014, VIS COGN, V22, P635, DOI 10.1080/13506285.2013.876481; Schmidt WC, 2001, BEHAV RES METH INS C, V33, P187, DOI 10.3758/BF03195365; Stewart N, 2006, BEHAV RES METHODS, V38, P142, DOI 10.3758/BF03192759; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067	23	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e112033	10.1371/journal.pone.0112033	http://dx.doi.org/10.1371/journal.pone.0112033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365382	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100143
J	Rebeiro, PF; Horberg, MA; Gange, SJ; Gebo, KA; Yehia, BR; Brooks, JT; Buchacz, K; Silverberg, MJ; Gill, J; Moore, RD; Althoff, KN				Rebeiro, Peter F.; Horberg, Michael A.; Gange, Stephen J.; Gebo, Kelly A.; Yehia, Baligh R.; Brooks, John T.; Buchacz, Kate; Silverberg, Michael J.; Gill, John; Moore, Richard D.; Althoff, Keri N.		North American AIDS Cohort Collabo	Strong Agreement of Nationally Recommended Retention Measures from the Institute of Medicine and Department of Health and Human Services	PLOS ONE			English	Article							HIV CARE; COHORT	Objective: We sought to quantify agreement between Institute of Medicine (IOM) and Department of Health and Human Services (DHHS) retention indicators, which have not been compared in the same population, and assess clinical retention within the largest HIV cohort collaboration in the U.S. Design: Observational study from 2008-2010, using clinical cohort data in the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Methods: Retention definitions used HIV primary care visits. The IOM retention indicator was: >= 2 visits, >= 90 days apart, each calendar year. This was extended to a 2-year period; retention required meeting the definition in both years. The DHHS retention indicator was: >= 1 visit each semester over 2 years, each >= 60 days apart. Kappa statistics detected agreement between indicators and C statistics (areas under Receiver-Operating Characteristic curves) from logistic regression analyses summarized discrimination of the IOM indicator by the DHHS indicator. Results: Among 36,769 patients in 2008-2009 and 34,017 in 2009-2010, there were higher percentages of participants retained in care under the IOM indicator than the DHHS indicator (80% vs. 75% in 2008-2009; 78% vs. 72% in 2009-2010, respectively) (p<0.01), persisting across all demographic and clinical characteristics (p<0.01). There was high agreement between indicators overall (kappa = 0.83 in 2008-2009; kappa = 0.79 in 2009-2010, p<0.001), and C statistics revealed a very strong ability to predict retention according to the IOM indicator based on DHHS indicator status, even within characteristic strata. Conclusions: Although the IOM indicator consistently reported higher retention in care compared with the DHHS indicator, there was strong agreement between IOM and DHHS retention indicators in a cohort demographically similar to persons living with HIV/AIDS in the U.S. Persons with poorer retention represent subgroups of interest for retention improvement programs nationally, particularly in light of the White House Executive Order on the HIV Care Continuum.	[Rebeiro, Peter F.; Gange, Stephen J.; Gebo, Kelly A.; Moore, Richard D.; Althoff, Keri N.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Horberg, Michael A.] Kaiser Permanente Mid Atlant States, Rockville, MD USA; [Yehia, Baligh R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Brooks, John T.; Buchacz, Kate] Ctr Dis Control & Prevent, Atlanta, GA USA; [Silverberg, Michael J.] Kaiser Permanente No Calif, Oakland, CA USA; [Gill, John] Univ Calgary, Calgary, AB, Canada	Johns Hopkins University; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; Centers for Disease Control & Prevention - USA; Kaiser Permanente; University of Calgary	Rebeiro, PF (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	prebeiro@jhu.edu; kalthoff@jhu.edu	Althoff, Keri N/HGC-5595-2022; Gebo, Kelly/AHA-7533-2022; Dodsley, Maria/G-7083-2016; Gange, Stephen/AGY-5004-2022	Gebo, Kelly/0000-0003-4010-398X; Dodsley, Maria/0000-0001-7587-558X; Gange, Stephen/0000-0001-7842-512X; Justice, Amy/0000-0003-0139-5502; Rebeiro, Peter/0000-0003-1951-9104; Althoff, Keri/0000-0002-5068-6595	National Institutes of Health, USA [U01-AI069918, U01-AA013566, U24-AA020794, U01-AA020790, U01-AI31834]; Center's for Disease Control and Prevention, USA [CDC200-2006-18797]; Agency for Healthcare Research and Quality, USA [90047713]; Health Resources and Services Administration, USA [90051652]; Canadian Institutes of Health Research, Canada [TGF-96118, HCP-97105, CBR-86906, CBR-94036]; Ontario Ministry of Health and Long Term Care; Government of Alberta, Canada;  [UL1-RR024131];  [UL1-TR000083];  [U54-MD007587];  [G12-MD007583];  [K01-AI071754];  [K01-AI093197];  [K23 EY013707];  [K24-AI065298];  [K24-00432];  [MO1-RR-00052];  [N02-CP55504];  [P30-AI027763];  [P30-AI094189];  [U01-AI35041];  [U01-AI35042];  [U01-AI35043];  [U01-AI37613];  [U01-AI37984];  [R01-DA11602];  [R01-DA04334];  [R01-DA12568];  [U01-AI38855];  [U01-AI38858];  [U01-AI42590];  [U01-AI68634];  [U01-AI68636];  [U01-AI69432];  [U01-AI69434];  [U01-HD32632];  [U10-EY08057];  [U10-EY08052];  [U10-EY08067];  [P30-AI27757];  [P30-AI27767];  [P30-AI50410];  [P30-AI54999];  [P30-AI036219];  [P30-MH62246];  [R01-CA165937];  [R01-AA16893];  [R24-AI067039];  [R56-AI102622];  [Z01-CP010214];  [Z01-CP010176];  [U01-AI34989];  [U01-AI34993];  [U01-AI34994];  [U01-AI35004];  [U01-AI35039];  [U01-AI35040]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP010176, R01CA165937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083, UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, U54RR026139, M01RR000052] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY013707, U10EY008067, U10EY008057, U10EY008052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, U01AI035004, P30AI094189, R56AI102622, R24AI067039, U01AI037984, P30AI036219, U01AI068634, P30AI050410, U01AI035042, P30AI027757, K01AI093197, P30AI054999, P30AI027767, U01AI068636, U01AI035039, U01AI038855, U01AI035043, U01AI069432, U01AI069918, U01AI034989, U01AI031834, U01AI034994, U01AI038858, U01AI035041, U01AI069434, P30AI027763, U01AI042590, K24AI065298, K01AI071754, U01AI034993, U01AI037613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U01AA020790, U01AA013566, R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA011602, U01DA036935, R01DA012568] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583, U54MD007587] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center's for Disease Control and Prevention, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality, USA(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Health Resources and Services Administration, USA; Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Government of Alberta, Canada; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants U01-AI069918, U01-AA013566, U24-AA020794, U01-AA020790, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01-AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-AI69432, U01-AI69434, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-TR000083, U54-MD007587, G12-MD007583, K01-AI071754, K01-AI093197, K23 EY013707, K24-AI065298, K24-00432, MO1-RR-00052, N02-CP55504, P30-AI027763, P30-AI094189, P30-AI27757, P30-AI27767, P30-AI50410, P30-AI54999, P30-AI036219, P30-MH62246, R01-CA165937, R01-AA16893, R01-DA11602, R01-DA04334, R01-DA12568, R24-AI067039, R56-AI102622, Z01-CP010214, and Z01-CP010176 from the National Institutes of Health, USA; contract CDC200-2006-18797 from the Center's for Disease Control and Prevention, USA; contract 90047713 from the Agency for Healthcare Research and Quality, USA; contract 90051652 from the Health Resources and Services Administration, USA; grants TGF-96118, HCP-97105, CBR-86906, CBR-94036 from the Canadian Institutes of Health Research, Canada; Ontario Ministry of Health and Long Term Care; and the Government of Alberta, Canada. PFR: F31-DA035713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; [Anonymous], 2012, MON HIV CAR US IND D; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Forsyth A, 2012, COMMON INDICATORS HH; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Harrell FE, 2001, REGRESSION MODELING; Lau B, 2007, AIDS RES HUM RETROV, V23, P769, DOI 10.1089/aid.2006.0171; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2008, GUIDELINES USE ANTIR, P1; The White House Office of National AIDS Policy, 2010, NAT HIV AIDS STRAT; Valdiserri Ronald O, 2013, Public Health Rep, V128, P354; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	13	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111772	10.1371/journal.pone.0111772	http://dx.doi.org/10.1371/journal.pone.0111772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375099	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600061
J	Kormos, R; Kormos, CF; Humle, T; Lanjouw, A; Rainer, H; Victurine, R; Mittermeier, RA; Diallo, MS; Rylands, AB; Williamson, EA				Kormos, Rebecca; Kormos, Cyril F.; Humle, Tatyana; Lanjouw, Annette; Rainer, Helga; Victurine, Ray; Mittermeier, Russell A.; Diallo, Mamadou S.; Rylands, Anthony B.; Williamson, Elizabeth A.			Great Apes and Biodiversity Offset Projects in Africa: The Case for National Offset Strategies	PLOS ONE			English	Article							NO NET LOSS; FEMALE CHIMPANZEES; LOWLAND GORILLAS; WILD CHIMPANZEES; SEED DISPERSAL; LOPE RESERVE; LOSS POLICY; CONSERVATION; RESTORATION; ENVIRONMENT	The development and private sectors are increasingly considering "biodiversity offsets" as a strategy to compensate for their negative impacts on biodiversity, including impacts on great apes and their habitats in Africa. In the absence of national offset policies in sub-Saharan Africa, offset design and implementation are guided by company internal standards, lending bank standards or international best practice principles. We examine four projects in Africa that are seeking to compensate for their negative impacts on great ape populations. Our assessment of these projects reveals that not all apply or implement best practices, and that there is little standardization in the methods used to measure losses and gains in species numbers. Even if they were to follow currently accepted best-practice principles, we find that these actions may still fail to contribute to conservation objectives over the long term. We advocate for an alternative approach in which biodiversity offset and compensation projects are designed and implemented as part of a National Offset Strategy that (1) takes into account the cumulative impacts of development in individual countries, (2) identifies priority offset sites, (3) promotes aggregated offsets, and (4) integrates biodiversity offset and compensation projects with national biodiversity conservation objectives. We also propose supplementary principles necessary for biodiversity offsets to contribute to great ape conservation in Africa. Caution should still be exercised, however, with regard to offsets until further field-based evidence of their effectiveness is available.	[Kormos, Rebecca] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kormos, Cyril F.] WILD Fdn, Berkeley, CA USA; [Humle, Tatyana] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Lanjouw, Annette] Arcus Fdn, Strateg Initiat & Great Apes Program, Cambridge, England; [Rainer, Helga] Arcus Fdn, Conservat Program, Cambridge, England; [Victurine, Ray] Wildlife Conservat Soc, Business Conservat Initiat & Conservat Finance, Bronx, NY USA; [Mittermeier, Russell A.] Conservat Int, Arlington, VA USA; [Rylands, Anthony B.] Conservat Int, Arlington, VA USA; [Williamson, Elizabeth A.] Univ Stirling, Sch Nat Sci, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland	University of California System; University of California Berkeley; University of Kent; Wildlife Conservation Society; Conservation International; Conservation International; University of Stirling	Kormos, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rebeccakormos@yahoo.com	Williamson, Elizabeth/B-9090-2011; Williamson, Elizabeth/N-8958-2019; Williamson, Elizabeth/E-4727-2016	Williamson, Elizabeth/0000-0001-6848-9154; Williamson, Elizabeth/0000-0001-6848-9154	Arcus Foundation [1104-38]	Arcus Foundation	Funding for part of this study was provided by the Arcus Foundation grant no. 1104-38 (http://www.arcusfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish. They did contribute to discussions of these ideas and preparation of the manuscript.	African Development Bank, 2009, OIL GAS AFR; Ancrenaz M., 2006, J TROP BIOL CONSERV, V2, P65; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; Anderson JR, 2011, AM J PRIMATOL, V73, P410, DOI 10.1002/ajp.20922; [Anonymous], 2013, EQUATOR PRINCIPLES; Arcus Foundation, 2014, STAT AP EXTR IND AP; Bean M., 2008, DESIGN US HABITAT BA; Bekessy SA, 2010, CONSERV LETT, V3, P151, DOI 10.1111/j.1755-263X.2010.00110.x; Bendor T, 2009, LANDSCAPE URBAN PLAN, V89, P17, DOI 10.1016/j.landurbplan.2008.09.003; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Brncic TM., 2010, SIERRA LEONE NATL CH; Brownlie S., 2009, IMPACT ASSESS PROJ A, V27, P227, DOI DOI 10.3152/146155109X465968; Bull JW, 2013, ORYX, V47, P369, DOI 10.1017/S003060531200172X; Business and and Biodiversity Offsets Programme (BBOP), 2013, NO NET LOSS OV BUS B; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler RA, 2008, TRENDS ECOL EVOL, V23, P469, DOI 10.1016/j.tree.2008.05.006; Carroll N., 2008, CONSERVATION BIODIVE; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Dinerstein E., 2010, WILDLIFE PREMIUM MAR; Edwards DP, 2014, CONSERV LETT, V7, P302, DOI 10.1111/conl.12076; Endangered Species Act (ESA), 1973, 108 C DEP INT US WAS; Fox J, 2005, CONSERV BIOL, V19, P996, DOI 10.1111/j.1523-1739.2005.00231.x; Gardner A, 1980, SPEAKING APES CRITIC, P287; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; Goossens B, 2005, BIOL CONSERV, V123, P461, DOI 10.1016/j.biocon.2005.01.008; Haider SW, 2013, SIERRA LEONE SL BUMB; Ham R, 1998, NATIONWIDE CHIMPANZE; Hockings K., 2009, BEST PRACTICE GUIDEL; Humle T, 2011, INT J PRIMATOL, V32, P456, DOI 10.1007/s10764-010-9482-7; ICMM IUCN, 2012, IND REP BIOD OFFS; IFC, 2012, GUID NOT 6 BIOD CONS; IFC, 2013, GOOD PRACT HDB; International Finance Corporation (IFC), 2012, 6 IFC; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; K?hl H., 2008, BEST PRACTICE GUIDEL; Kahlenberg SM, 2008, ANIM BEHAV, V76, P1497, DOI 10.1016/j.anbehav.2008.05.029; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kormos C., 2011, STRATEGIC NATL PLAN; Kormos R., 2003, W AFRICAN CHIMPANZEE; Kormos R, 2008, CRIT HAB ASS REP GUI; LEADERWILLIAMS N, 2000, PRIORITIES CONSERVAT, P53; Macfie EJ, 2010, BEST PRACTICE GUIDEL; Madsen B., 2010, STATE BIODIVERSITY M; Maisels F, 2011, GORILLA J, V4, P18; Maisels F, 2013, DENG DENG NATL PARK; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; MCGREW WC, 1992, J ZOOL, V228, P689, DOI 10.1111/j.1469-7998.1992.tb04469.x; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Mittermeier R., 2013, HDB MAMMALS WORLD, V3; Morgan D., 2007, BEST PRACTICE GUIDEL; Pilgrim JD, 2013, CONSERV LETT, V6, P376, DOI 10.1111/conl.12002; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; PLUMPTRE AJ, 1994, AFR J ECOL, V32, P115, DOI 10.1111/j.1365-2028.1994.tb00563.x; Poulsen JR, 2009, CONSERV BIOL, V23, P1597, DOI 10.1111/j.1523-1739.2009.01251.x; Quetier F, 2014, ENVIRON SCI POLICY, V38, P120, DOI 10.1016/j.envsci.2013.11.009; Reuters, 2014, CORRECTED EM GLOB AL; Rijksen HD, 1999, OUR VANISHING RELATI; Rio Tinto, 2008, RIO TINT BIOD BIOD O; Rogers ME, 1998, AM J PRIMATOL, V45, P45, DOI 10.1002/(SICI)1098-2345(1998)45:1<45::AID-AJP5>3.0.CO;2-W; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Stratus Consulting Inc, 2003, NAT SURV CONS BANKS; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; ten Kate K., 2004, BIODIVERSITY OFFSETS; The Biodiversity Consultancy, 2013, GOV POL BIOD OFFS; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Thompson-Handler N., 1995, ACTION PLAN PAN PANI; TUTIN CEG, 1991, J TROP ECOL, V7, P181, DOI 10.1017/S0266467400005320; U.S. Environmental Protection Agency, 1995, FEDERAL GUIDANCE EST; UN Development Programme (UNDP), 2013, 2013 HUM DEV REP RIS; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Voysey BC, 1999, J TROP ECOL, V15, P39, DOI 10.1017/S0266467499000668; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warren Y, 2004, ZOO BIOL, V23, P375, DOI 10.1002/zoo.20001; WCF, 2012, ET FAUN MEN AIR PROT; WCF, 2012, OFFS STRAT GUIN ALUM; WCF, 2011, BIOD MAN PLAN GUIN A; Weber A., 1987, RUHENGERI ITS RESOUR; Weng LF, 2013, GLOB FOOD SECUR-AGR, V2, P195, DOI 10.1016/j.gfs.2013.07.003; White A, 2014, STATE APES 2013 EXTR, P197; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wich SA, 2014, CURR BIOL, V24, P1659, DOI 10.1016/j.cub.2014.05.077; Williamson E.A., 2013, P792; World Bank, 2005, SIERR LEON COMPL BUM; ZSL, 2006, BAS PRIM SURV MON PR	94	27	27	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111671	10.1371/journal.pone.0111671	http://dx.doi.org/10.1371/journal.pone.0111671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372894	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000344556900060
J	Ogusu, N; Saruwatari, J; Nakashima, H; Noai, M; Nishimura, M; Deguchi, M; Oniki, K; Yasui-Furukori, N; Kaneko, S; Ishitsu, T; Nakagaswa, K				Ogusu, Naoki; Saruwatari, Junji; Nakashima, Hiroo; Noai, Madoka; Nishimura, Miki; Deguchi, Mariko; Oniki, Kentaro; Yasui-Furukori, Norio; Kaneko, Sunao; Ishitsu, Takateru; Nakagaswa, Kazuko			Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of gamma-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MANGANESE SUPEROXIDE-DISMUTASE; ANTIEPILEPTIC DRUGS; ILAE-COMMISSION; RISK-FACTORS; CHILDREN; ADOLESCENTS; OVERWEIGHT; GENOTYPES; CLOBAZAM	Background: There has been accumulating evidence that there are associations among c-glutamyltransferase (gamma-GT) elevation and all-cause mortality, cardiovascular diseases and metabolic diseases, including nonalcoholic fatty liver disease. The primary objective of this study was to evaluate the impact of the most common and potentially functional polymorphisms of antioxidant enzyme genes, i.e. superoxide dismutase 2 (SOD2), glutathione S-transferase M1 and glutathione S-transferase T1, on the gamma-GT elevation during valproic acid (VPA) therapy. Methods and Findings: This retrospective study included 237 and 169 VPA-treated Japanese patients with epilepsy for population pharmacokinetic and pharmacokinetic-pharmacodynamic analyses, respectively. A nonlinear mixed-effect model represented the pharmacokinetics of VPA and the relationships between VPA exposure and gamma-GT elevation. A one-compartment model of the pharmacokinetic parameters of VPA adequately described the data; while the model for the probability of the gamma-GT elevation was fitted using a logistic regression model, in which the logit function of the probability was a linear function of VPA exposure. The SOD2 Val16Ala polymorphism and complication with intellectual disability were found to be significant covariates influencing the intercept of the logit function for the probability of an elevated gamma-GT level. The predicted mean percentages of the subjects with gamma-GT elevation were about 2- to 3-fold, 3- to 4-fold and 4- to 8-fold greater in patients with the SOD2 Val/Val genotype but without any intellectual disability, those with the SOD2 Val/Ala or Ala/Ala genotype and intellectual disability and those with the SOD2 Val/Val genotype and intellectual disability, respectively, compared to those with the SOD2 Val/Ala or Ala/Ala genotype without intellectual disability. Conclusion: Our results showed that the SOD2 Val16Ala polymorphism has an impact on the relationship between VPA exposure and gamma-GT elevation in patients with epilepsy. These results suggest that determining the SOD2 genotype could be helpful for preventing the VPA-induced gamma-GT elevation.	[Ogusu, Naoki; Saruwatari, Junji; Nakashima, Hiroo; Noai, Madoka; Nishimura, Miki; Deguchi, Mariko; Oniki, Kentaro; Nakagaswa, Kazuko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan; [Yasui-Furukori, Norio; Kaneko, Sunao] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Ishitsu, Takateru] Kumamoto Saishunso Natl Hosp, Kumamoto, Japan; [Ishitsu, Takateru] Kumamoto Ezuko Ryoiku Iryo Ctr, Kumamoto, Japan; [Nakagaswa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Hirosaki University; Kumamoto University	Saruwatari, J (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan.	junsaru@gpo.kumamoto-u.ac.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347	Japan Research Foundation for Clinical Pharmacology and KAKENHI [24590652, 25860117, 26360049]; Smoking Research Foundation; Asteras; Dainippon; Eli Lilly; GlaxoSmithKline; Janssen-Pharma; Meiji; Mochida; Merck Sharp Dohme; Otsuka; Pfizer; Takada; Yoshitomi; Grants-in-Aid for Scientific Research [26360049] Funding Source: KAKEN	Japan Research Foundation for Clinical Pharmacology and KAKENHI; Smoking Research Foundation; Asteras; Dainippon; Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Pharma; Meiji; Mochida; Merck Sharp Dohme(Merck & Company); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Takada; Yoshitomi(Mitsubishi Tanabe Pharma Corporation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Research Foundation for Clinical Pharmacology and KAKENHI (Nos. 24590652, 25860117, 26360049), and in part by a grant from the Smoking Research Foundation. Norio Yasui-Furukori has received grant/research support or honoraria from and spoken for Asteras, Dainippon, Eli Lilly, GlaxoSmithKline, Janssen-Pharma, Meiji, Mochida, Merck Sharp & Dohme, Otsuka, Pfizer, Takada, and Yoshitomi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Shirazi N, 2010, TOXICOL MECH METHOD, V20, P452, DOI 10.3109/15376516.2010.497977; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Birnbaum AK, 2007, THER DRUG MONIT, V29, P571, DOI 10.1097/FTD.0b013e31811f3296; BRAIDE SA, 1987, ANN CLIN BIOCHEM, V24, P391, DOI 10.1177/000456328702400408; Castellano I, 2012, CELL MOL LIFE SCI, V69, P3381, DOI 10.1007/s00018-012-0988-3; Chang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059999; Cronin-Fenton DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087450; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Fukushima Y, 2008, CLIN CHIM ACTA, V389, P98, DOI 10.1016/j.cca.2007.11.035; Ghodke-Puranik Y, 2013, PHARMACOGENET GENOM, V23, P236, DOI 10.1097/FPC.0b013e32835ea0b2; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Irie M, 2012, J INT MED RES, V40, P924, DOI 10.1177/147323001204000311; Jagarinec N, 1998, CLIN CHEM LAB MED, V36, P327, DOI 10.1515/CCLM.1998.055; Jankovic SM, 2010, INT J CLIN PHARM TH, V48, P767; Jiang DC, 2009, EUR J CLIN PHARMACOL, V65, P1187, DOI 10.1007/s00228-009-0712-x; Jiang SY, 2013, EXP CLIN CARDIOL, V18, P53; JIMENEZRODRIGUEZVILA M, 1986, INT J CLIN PHARM RES, V6, P217; Kariz S, 2012, DIABETES RES CLIN PR, V98, P144, DOI 10.1016/j.diabres.2012.07.003; Keizer RJ, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.24; Lioudaki E, 2011, CURR PHARM DESIGN, V17, P3632, DOI 10.2174/138161211798220945; Luef G, 2009, EPILEPSY RES, V86, P42, DOI 10.1016/j.eplepsyres.2009.04.004; Maiano C, 2011, OBES REV, V12, P189, DOI 10.1111/j.1467-789X.2010.00744.x; Nanau RM, 2013, CLIN BIOCHEM, V46, P1323, DOI 10.1016/j.clinbiochem.2013.06.012; Oniki K, 2013, TOXICOL LETT, V220, P143, DOI 10.1016/j.toxlet.2013.04.019; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Petta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051165; Saruwatari J, 2014, THER DRUG MONIT, V36, P302, DOI 10.1097/FTD.0000000000000015; Saruwatari J, 2013, NEUROPSYCH DIS TREAT, V9, P1683, DOI 10.2147/NDT.S52585; Saruwataria J, 2012, EPILEPSY RES, V99, P183, DOI 10.1016/j.eplepsyres.2011.10.033; Suarez-Kurtz G, 2012, PHARMACOGENOMICS J, V12, P267, DOI 10.1038/tpj.2010.89; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Tan L, 2010, CLIN NEUROL NEUROSUR, V112, P320, DOI 10.1016/j.clineuro.2010.01.002; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; Theis JGW, 1997, J CHILD NEUROL, V12, P208, DOI 10.1177/088307389701200311; Verrijken A, 2010, INT J OBESITY, V34, P899, DOI 10.1038/ijo.2010.4; Verrotti A, 2011, EPILEPSY BEHAV, V20, P382, DOI 10.1016/j.yebeh.2010.12.012; Wallach J.B., 1996, INTERPRETATION DIAGN, Vsixth; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	41	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111066	10.1371/journal.pone.0111066	http://dx.doi.org/10.1371/journal.pone.0111066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372290	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900036
J	Socarras, TO; Vasconcelos, AC; Campos, PP; Pereira, NB; Souza, JPC; Andrade, SP				Oviedo Socarras, Teresa; Vasconcelos, Anilton C.; Campos, Paula P.; Pereira, Nubia B.; Souza, Jessica P. C.; Andrade, Silvia P.			Foreign Body Response to Subcutaneous Implants in Diabetic Rats	PLOS ONE			English	Article							INFLAMMATORY ANGIOGENESIS; GROWTH-FACTOR; MICE; MODEL; MECHANISMS; APOPTOSIS; MOUSE	Implantation of synthetic matrices and biomedical devices in diabetic individuals has become a common procedure to repair and/or replace biological tissues. However, an adverse foreign body reaction that invariably occurs adjacent to implant devices impairing their function is poorly characterized in the diabetic environment. We investigated the influence of this condition on the abnormal tissue healing response in implants placed subcutaneously in normoglycemic and streptozotocin-induced diabetes in rats. In polyether-polyurethane sponge discs removed 10 days after implantation, the components of the fibrovascular tissue (angiogenesis, inflammation, fibrogenesis, and apoptosis) were assessed. Intra-implant levels of hemoglobin and vascular endothelial growth factor were not different after diabetes when compared with normoglycemic counterparts. However, there were a lower number of vessels in the fibrovascular tissue from diabetic rats when compared with vessel numbers in implants from non-diabetic animals. Overall, the inflammatory parameters (neutrophil accumulation - myeloperoxidase activity, tumor necrosis factor alpha, and monocyte chemotactic protein-1 levels and mast cell counting) increased in subcutaneous implants after diabetes induction. However, macrophage activation (N-acetyl-beta-D-glucosaminidase activity) was lower in implants from diabetic rats when compared with those from normoglycemic animals. All fibrogenic markers (transforming growth factor beta 1 levels, collagen deposition, fibrous capsule thickness, and foreign body giant cells) decreased after diabetes, whereas apoptosis (TUNEL) increased. Our results showing that hyperglycemia down regulates the main features of the foreign body reaction induced by subcutaneous implants in rats may be relevant in understanding biomaterial integration and performance in diabetes.	[Oviedo Socarras, Teresa; Vasconcelos, Anilton C.; Campos, Paula P.; Pereira, Nubia B.; Souza, Jessica P. C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil; [Oviedo Socarras, Teresa] Univ Cordoba, Dept Livestock Sci, Monteria, Cordoba, Colombia; [Andrade, Silvia P.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Campos, PP (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.	paulapc@icb.ufmg.br	CAMPOS, PAULA PEIXOTO/N-9004-2019; Vasconcelos, Anilton ACV/L-9861-2014; Pereira, Nubia Braga/N-9381-2017	CAMPOS, PAULA PEIXOTO/0000-0003-2016-2210; Vasconcelos, Anilton ACV/0000-0001-6202-580X; Pereira, Nubia Braga/0000-0002-6714-3124	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq-processo [481659/2012-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq-processo	The work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq-processo no481659/2012-9 http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1; Araujo FA, 2011, CLIN EXP PHARMACOL P, V38, P262, DOI 10.1111/j.1440-1681.2011.05496.x; Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4; BAILEY PJ, 1988, METHOD ENZYMOL, V162, P327; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Campos PP, 2006, HISTOL HISTOPATHOL, V21, P1263, DOI 10.14670/HH-21.1263; Campos PP, 2008, WOUND REPAIR REGEN, V16, P416, DOI 10.1111/j.1524-475X.2008.00381.x; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Ferreira MAND, 2004, BRIT J PHARMACOL, V141, P1185, DOI 10.1038/sj.bjp.0705731; Gerritsen R, 2000, J MATER SCI-MATER M, V11, P499, DOI 10.1023/A:1008970108339; KAHN AM, 1993, HYPERTENSION, V22, P735, DOI 10.1161/01.HYP.22.5.735; KILZER P, 1985, DIABETES, V34, P333, DOI 10.2337/diabetes.34.4.333; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Le Nga N, 2011, J Diabetes Sci Technol, V5, P605; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Mendes JB, 2007, J BIOMED MATER RES B, V83B, P408, DOI 10.1002/jbm.b.30810; Mendes JB, 2009, MICROVASC RES, V78, P265, DOI 10.1016/j.mvr.2009.08.008; Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3; Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003; Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011; Rai N K, 2005, J Wound Care, V14, P277; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Thomson SE, 2010, DIABETOLOGIA, V53, P572, DOI 10.1007/s00125-009-1610-6; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	30	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110945	10.1371/journal.pone.0110945	http://dx.doi.org/10.1371/journal.pone.0110945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372281	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900027
J	Vossen, T; Towns, A; Ruysschaert, S; Quiroz, D; van Andel, T				Vossen, Tessa; Towns, Alexandra; Ruysschaert, Sofie; Quiroz, Diana; van Andel, Tinde			Consequences of the Trans-Atlantic Slave Trade on Medicinal Plant Selection: Plant Use for Cultural Bound Syndromes Affecting Children in Suriname and Western Africa	PLOS ONE			English	Article							SEXUAL ABSTINENCE; BULGING FONTANEL; HEALTH; CARE; DEFICIENCY; DIARRHEA; ILLNESS; SYMPTOM; BABY	Folk perceptions of health and illness include cultural bound syndromes (CBS), ailments generally confined to certain cultural groups or geographic regions and often treated with medicinal plants. Our aim was to compare definitions and plant use for CBS regarding child health in the context of the largest migration in recent human history: the trans-Atlantic slave trade. We compared definitions of four CBS (walk early, evil eye, atita and fontanels) and associated plant use among three Afro-Surinamese populations and their African ancestor groups in Ghana, Benin and Gabon. We expected plant use to be similar on species level, and assumed the majority to be weedy or domesticated species, as these occur on both continents and were probably recognized by enslaved Africans. Data were obtained by identifying plants mentioned during interviews with local women from the six different populations. To analyse differences and similarities in plant use we used Detrended Component Analysis (DCA) and a Wald Chi-square test. Definitions of the four cultural bound syndromes were roughly the same on both continents. In total, 324 plant species were used. There was little overlap between Suriname and Africa: 15 species were used on two continents, of which seven species were used for the same CBS. Correspondence on family level was much higher. Surinamese populations used significantly more weedy species than Africans, but equal percentages of domesticated plants. Our data indicate that Afro-Surinamers have searched for similar plants to treat their CBS as they remembered from Africa. In some cases, they have found the same species, but they had to reinvent the largest part of their herbal pharmacopeia to treat their CBS using known plant families or trying out new species. Ideas on health and illness appear to be more resilient than the use of plants to treat them.	[Vossen, Tessa] Leiden Univ, Leiden, Netherlands; [Towns, Alexandra; Quiroz, Diana; van Andel, Tinde] Leiden Univ, Nat Biodivers Ctr, Leiden, Netherlands; [Ruysschaert, Sofie] WWF Guianas, Paramaribo, Suriname; [Quiroz, Diana] Wageningen Univ, Biosystemat Grp, NL-6700 AP Wageningen, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Wageningen University & Research	van Andel, T (corresponding author), Leiden Univ, Nat Biodivers Ctr, Leiden, Netherlands.	tinde.vanandel@naturalis.nl		Towns, Alexandra/0000-0002-1886-9447	Netherlands Organization for Scientific Research (NWO): ALW-Vidi [864.09.007]; Alberta Mennega Foundation; van Eeden Fund	Netherlands Organization for Scientific Research (NWO): ALW-Vidi(Netherlands Organization for Scientific Research (NWO)); Alberta Mennega Foundation; van Eeden Fund	This research was financed by the Netherlands Organization for Scientific Research (NWO): ALW-Vidi grant #864.09.007, the Alberta Mennega Foundation and the van Eeden Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOKUN LA, 1982, AFRICA, V52, P1, DOI 10.2307/1160091; Akoegninou A, 2006, FLORE ANAL BENIN, DOI DOI 10.1007/s11056-010-9214-z; Algemeen Bureau voor de Statistiek, 2005, ZEV ALG VOLKS WON SU, VI; [Anonymous], 1990, USEFUL PLANTS GHANA; Apostolides A, 2008, HTS TEOL STUD-THEOL, V64, P1021; BASS MH, 1961, NEUROLOGY, V11, P1091, DOI 10.1212/WNL.11.12.1091; Baxerres C, 2012, RIM, V4, P14; Bazzano AN, 2008, TROP MED INT HEALTH, V13, P123, DOI 10.1111/j.1365-3156.2007.01981.x; BLEEK W, 1976, SOC SCI MED, V10, P225, DOI 10.1016/0037-7856(76)90003-2; BOWER BD, 1964, BRIT MED J, V2, P1577, DOI 10.1136/bmj.2.5424.1577; Brav A, 1981, EVIL EYE CASEBOOK, P44; Burkill H, 1985, USEFUL PLANTS W TROP, V1; Dahlberg CG, 1771, CATALOGUS VLESSEN VA; de Medeiros PM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/807452; Desgrees-du-Lou A, 2005, REPROD HEALTH MATTER, V13, P155, DOI 10.1016/S0968-8080(05)25167-4; Donaldson Bess Allen, 1938, WILD RUE STUDY MUHAM; Dundes Alan, 1981, EVIL EYE CASEBOOK; Elliott John H., 1992, BIBLICAL THEOLOGY B, V22, P52, DOI DOI 10.1177/014610799202200203; Eltis D., 2010, ATLAS TRANSATLANTIC; FIELDS JP, 1961, J PEDIATR-US, V58, P74, DOI 10.1016/S0022-3476(61)80061-9; Foster G.M., 1953, J AM FOLKLORE, V66, P2101, DOI [DOI 10.2307/537230, 10.2307/537230]; Funk V., 2007, CHECKLIST PLANTS GUI; Gottlieb Alma, 2004, AFTERLIFE IS WE COME; Guarnaschelli J, 1972, JAMA-J AM MED ASSOC, V222, P1546; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Helman CG, 2007, CULTURE HLTH ILLNESS; HUDELSON PM, 1993, SOC SCI MED, V37, P97, DOI 10.1016/0277-9536(93)90322-U; Idehen CO, 2007, J PAN AFRICAN STUDIE, V1, P114; International Society of Ethnobiology (ISE), ISE COD ETH; Irvine FR, 1961, WOODY PLANTS GHANA S; Jelliffe D B, 1972, J Trop Pediatr Environ Child Health, V18, P25; KRAJEWSKIJAIME ER, 1991, CHILD WELFARE, V70, P157; Lanjouw J, 1935, W INDISCHE GIDS, V17, P173; LOCKWOOD M, 1995, POPUL DEV REV, V21, P1, DOI 10.2307/2137411; LONGE AC, 1984, ACTA PAEDIATR SCAND, V73, P477, DOI 10.1111/j.1651-2227.1984.tb09958.x; Martinez GJ, 2008, MIDWIFERY, V24, P490, DOI 10.1016/j.midw.2006.12.011; MCCLURE SA, 1982, ECON BOT, V36, P291, DOI 10.1007/BF02858552; Moret E. S., 2012, AFRICAN ETHNOBOTANY, P217, DOI DOI 10.1007/978-1-4614-0836-9_9; Mshana N.R., 2000, TRADITIONAL MED PHAR; NEALE G, 1965, BRIT MED J, V2, P1223, DOI 10.1136/bmj.2.5472.1223; Price R, 1976, GUIANA MAROONS HIST; Quiroz D, 2014, J ETHNOPHARMACOL, V151, P1100, DOI 10.1016/j.jep.2013.12.019; REHM S, 1991, CULTIVATED PLANTS TR; RISSER AL, 1995, ARCH PEDIAT ADOL MED, V149, P978, DOI 10.1001/archpedi.1995.02170220044006; De Moraes PLR, 2012, PHYTOTAXA, V41, P1; RUBEL AJ, 1964, ETHNOLOGY, V3, P268, DOI 10.2307/3772883; Ruysschaert S, 2009, J ETHNOPHARMACOL, V121, P148, DOI 10.1016/j.jep.2008.10.020; Sosef MSM, 2006, SCRIPTA BOT BELGICA, V35; Stephen H. J., 1998, WINTI CULTURE MYSTER; Thorne R.F., 1973, TROPICAL FOREST ECOS, P27; Ticktin T, 2005, J ETHNOPHARMACOL, V96, P233, DOI 10.1016/j.jep.2004.09.015; Towns AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105972; Towns AM, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-42; VAN ANDEL T.R., 2011, MEDICINALE RITUELE P; van Andel T, 2012, J ETHNOPHARMACOL, V143, P840, DOI 10.1016/j.jep.2012.08.008; van Andel T, 2012, TAXON, V61, P852, DOI 10.1002/tax.614010; van Andel T, 2012, J ETHNOPHARMACOL, V140, P368, DOI 10.1016/j.jep.2012.01.028; Van der Pijl Y, 2007, BRONNEN STUDIE SURIN, V27; Voeks, 2013, AFRICAN ETHNOBOTANY, DOI 10.1007/978-1-4614-0836-9; Voeks R., 2009, MOBILITY MIGRATION I, P275; Voeks RA, 2004, ANN ASSOC AM GEOGR, V94, P868; Vossen TE, 2013, THESIS LEIDEN U; WEISS MG, 1988, SOC SCI MED, V27, P5, DOI 10.1016/0277-9536(88)90159-1; Wooding CJ, 1979, ISSUE J OPINION, V9, P35; YAP PM, 1967, AUST NZ J PSYCHIAT, V1, P172, DOI 10.3109/00048676709159191; Zulu EM, 2001, DEMOGRAPHY, V38, P467, DOI 10.1353/dem.2001.0042	66	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112345	10.1371/journal.pone.0112345	http://dx.doi.org/10.1371/journal.pone.0112345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372485	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900137
J	Wang, XH; Cai, L; Yu, RJ; Huang, WZ; Zong, ZY				Wang, Xiaohui; Cai, Lin; Yu, Rujia; Huang, Wenzhi; Zong, Zhiyong			ICU-Onset Clostridium difficile Infection in a University Hospital in China: A Prospective Cohort Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; EPIDEMIOLOGY; COLONIZATION; MORTALITY	A prospective study was conducted to investigate the incidence, clinical profiles and outcome of ICU-onset CDI in a 50-bed medical ICU at a university hospital in China. Stools were collected from patients who developed ICU-onset diarrhea and was screened for tcdA (toxin A gene) and tcdB (toxin B gene) by PCR. CDI cases were compared with the ICU-onset non-CDI diarrhea cases for demographics, comorbidities, potential risk factors, major laboratory findings and outcomes. Stool samples from CDI cases were subjected to C. difficile culture and C. difficile isolates were screened for tcdA, tcdB and the binary toxin genes (cdtA and cdtB) using multiplex PCR. Strain typing of toxigenic C. difficile isolates was performed using multilocus sequence typing. There were 1,277 patients in the ICU during the study period and 124 (9.7%) developed ICU-onset diarrhea, of which 31 patients had CDI. The incidence of ICU-onset CDI was 25.2 cases per 10,000 ICU days. ICU-onset CDI cases had similar features with ICU-onset non-CDI diarrhea cases including the use of proton pump inhibitors and antibacterial agents. The crude mortality rate of ICU-onset CDI was 22.6%, but the attributable mortality rate of ICU-onset CDI was only 3.2% here. Toxigenic C. difficile isolates were recovered from 28 out of the 31 patients with CDI. cdtA and cdtB were found in two strains. Seventeen STs including 11 new STs were identified. All of the 11 new STs were single-locus variants of known STs and the 17 STs identified here could be clustered into 3 clades. The incidence of ICU-onset CDI here is similar to those in Europe and North America, suggesting that CDI is likely to be a common problem in China. Toxigenic C. difficile here belonged to a variety of STs, which may represent a significant clonal expansion rather than the true clonal diversity.	[Wang, Xiaohui; Yu, Rujia; Zong, Zhiyong] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China; [Wang, Xiaohui; Yu, Rujia; Zong, Zhiyong] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Peoples R China; [Cai, Lin] Sichuan Univ, West China Hosp, Dept Intens Care Unit, Chengdu 610064, Peoples R China; [Huang, Wenzhi; Zong, Zhiyong] Sichuan Univ, West China Hosp, Dept Infect Control, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China.	zongzhiy@scu.edu.cn	Wang, Xiaohui/X-3814-2019	, Xiaohui/0000-0003-2780-2823; ZONG, ZHIYONG/0000-0002-7675-260X	Technology support program of Sichuan provincial Science and Technology Agency, China [2011FZ0111]	Technology support program of Sichuan provincial Science and Technology Agency, China	The work was supported by the Technology support program of Sichuan provincial Science and Technology Agency, China (project no. 2011FZ0111). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2008, J INFECTION, V57, P435, DOI 10.1016/j.jinf.2008.10.002; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bobo LD, 2011, CHEST, V140, P1643, DOI 10.1378/chest.11-0556; Chen YB, 2013, J MED MICROBIOL; Dodek PM, 2013, J CRIT CARE, V28, P335, DOI 10.1016/j.jcrc.2012.11.008; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Huang H, 2011, CHIN J INFECT CHEMOT, V11, P1; Jin K, 2010, J BIOMED RES, V24, P411, DOI 10.1016/S1674-8301(10)60055-3; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Micek ST, 2013, CRIT CARE MED, V41, P1968, DOI 10.1097/CCM.0b013e31828a40d5; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Morrison RH, 2011, CLIN INFECT DIS, V53, P1173, DOI 10.1093/cid/cir668; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Wang P, 2014, INFECT CONT HOSP EP, V35, P95, DOI 10.1086/674405; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453; Zahar JR, 2012, CRIT CARE, V16, DOI 10.1186/cc11852	21	23	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111735	10.1371/journal.pone.0111735	http://dx.doi.org/10.1371/journal.pone.0111735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372033	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900070
J	Yang, HK; Choi, JY; Kim, DH; Hwang, JM				Yang, Hee Kyung; Choi, Jung Yeon; Kim, Dae Hyun; Hwang, Jeong-Min			Changes in Refractive Errors Related to Spectacle Correction of Hyperopia	PLOS ONE			English	Article							CHILDREN; EMMETROPIZATION; CHILDHOOD; INFANTS; MYOPIA	Background: Hyperopic undercorrection is a common clinical practice. However, less is known of its effect on the change in refractive errors and emmetropization throughout the later years of childhood. Objectives: To evaluate the effect of spectacle correction on the change in refractive errors in hyperopic children less than 12 years of age with or without strabismus. Data Extraction: A retrospective cohort study was performed by a computer based search of the hospital database of patients with hyperopia, accommodative esotropia or exotropia. A total of 150 hyperopic children under 12 years of age were included. Patients were classified into four groups: 1) accommodative esotropia with full correction of hyperopia, 2) exotropia with undercorrection of hyperopia, 3) orthotropia with full correction of hyperopia, 4) orthotropia with undercorrection of hyperopia. The 4 groups were matched by initial age on examination and spherical equivalent refractive errors (SER). The main outcome measure was the change in SER (Diopter/year) in both eyes after two years of follow-up. Results: An overall negative shift in SER was noted during the follow-up period in all groups, except for the group with esotropia and full correction. The mean negative shift of hyperopia was more rapid in groups receiving undercorrection of hyperopia with or without strabismus. The amount of undercorrection of hyperopia was positively correlated to the magnitude of decrease in hyperopia in all patients (r = 0.289, P<0.001) and in the subgroup of patients with orthotropia (r = 0.304, P = 0.011). The amount of undercorrection of hyperopia was the only factor associated with a more negative shift in SER (OR, 2.414; 95% CI, 1.202-4.849; P = 0.013). Conclusions: The amount of undercorrection is significantly correlated to the change in hyperopic refractive errors. Full correction of hyperopia may inhibit emmetropization during early and late childhood.	[Yang, Hee Kyung; Choi, Jung Yeon; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Kim, Dae Hyun] Chosun Univ, Chosun Univ Hosp, Coll Med, Dept Ophthalmol, Kwangju, South Korea	Seoul National University (SNU); Chosun University	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	hjm@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2010606]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2010606). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J, 2000, INVEST OPHTH VIS SCI, V41, P3726; Black Bradley Charles, 2006, Trans Am Ophthalmol Soc, V104, P303; Chung SA, 2011, J PEDIAT OPHTH STRAB, V48, P278, DOI 10.3928/01913913-20101217-01; Cotter SA, 2007, OPTOMETRY VISION SCI, V84, P103, DOI 10.1097/OPX.0b013e318031b08a; de Paula JS, 2009, ARQ BRAS OFTALMOL, V72, P751, DOI 10.1590/S0004-27492009000600002; Dirani M, 2006, INVEST OPHTH VIS SCI, V47, P4756, DOI 10.1167/iovs.06-0270; Donahue SP, 2007, OPTOMETRY VISION SCI, V84, P110, DOI 10.1097/OPX.0b013e318031b09b; Ekdawi NS, 2010, AM J OPHTHALMOL, V149, P503, DOI 10.1016/j.ajo.2009.10.009; Ingram RM, 2000, BRIT J OPHTHALMOL, V84, P324, DOI 10.1136/bjo.84.3.324; Khan Arif O, 2009, Binocul Vis Strabismus Q, V24, P151; Kulp MT, 2012, AM J OPHTHALMOL, V154, P297, DOI 10.1016/j.ajo.2012.02.035; Kushner BJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P638; Lambert SR, 2006, BRIT J OPHTHALMOL, V90, P357, DOI 10.1136/bjo.2005.078105; Leat SJ, 2011, OPTOMETRY VISION SCI, V88, P1333, DOI 10.1097/OPX.0b013e31822f4b9c; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; Mutti DO, 2007, OPTOMETRY VISION SCI, V84, P97, DOI 10.1097/OPX.0b013e318031b079; Park KA, 2010, OPHTHALMOLOGY, V117, P2196, DOI 10.1016/j.ophtha.2010.02.019; Rah SH, 1997, J KOREAN OPHTHALMOL, V38, P2195; Robaei D, 2005, OPHTHALMOLOGY, V112, P1275, DOI 10.1016/j.ophtha.2005.01.052; Smith EL, 1999, OPHTHAL PHYSL OPT, V19, P90, DOI 10.1046/j.1475-1313.1999.00429.x; TROILO D, 1991, VISION RES, V31, P1237, DOI 10.1016/0042-6989(91)90048-A; Wildsoet CF, 1997, OPHTHAL PHYSL OPT, V17, P279, DOI 10.1111/j.1475-1313.1997.tb00059.x	22	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110663	10.1371/journal.pone.0110663	http://dx.doi.org/10.1371/journal.pone.0110663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372594	Green Submitted, gold, Green Published			2022-12-27	WOS:000344556900021
J	Zhang, T; Chen, HM; Liang, SS; Chen, DC; Zheng, CX; Zeng, CH; Zhang, HT; Liu, ZH				Zhang, Tao; Chen, Huimei; Liang, Shaoshan; Chen, Dacheng; Zheng, Chunxia; Zeng, Caihong; Zhang, Haitao; Liu, Zhihong			A Non-Invasive Laboratory Panel as a Diagnostic and Prognostic Biomarker for Thrombotic Microangiopathy: Development and Application in a Chinese Cohort Study	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; VON-WILLEBRAND-FACTOR; THROMBOCYTOPENIC PURPURA; ADAMTS13 ACTIVITY; KIDNEY-TRANSPLANTATION; PLATELET COUNT; FEATURES; OUTCOMES; DISEASE	Background: Thrombotic microangiopathy (TMA) in the kidney is a histopathologic lesion that occurs in a number of clinical settings and is often associated with poor renal prognosis. The standard test for the diagnosis of TMA is the renal biopsy; noninvasive parameters such as potential biomarkers have not been developed. Methods: We analyzed routine parameters in a cohort of 220 patients with suspected TMA and developed a diagnostic laboratory panel by logistic regression. The levels of candidate markers were validated using an independent cohort (n = 46), a cohort of systemic lupus erythematosus (SLE) (n = 157) and an expanded cohort (n = 113), as well as 9 patients with repeat biopsies. Results: Of the 220 patients in the derivation cohort, 51 patients with biopsy-proven TMA presented with a worse renal prognosis than those with no TMA (P = 0.002). Platelet and L-lactate dehydrogenase (LDH) levels showed an acceptable diagnostic value of TMA (AUC = 0.739 and 0.756, respectively). A panel of 4 variables - creatinine, platelets, ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats 13) activity and LDH - can effectively discriminate patients with TMA (AUC = 0.800). In the validation cohort, the platelet and LDH levels and the 4-variable panel signature robustly distinguished patients with TMA. The discrimination effects of these three markers were confirmed in patients with SLE. Moreover, LDH levels and the 4-variable panel signature also showed discrimination values in an expanded set. Among patients undergoing repeat biopsy, increased LDH levels and panel signatures were associated with TMA status when paired evaluations were performed. Importantly, only the 4-variable panel was an independent prognostic marker for renal outcome (hazard ratio = 3.549; P, 0.001). Conclusions: The noninvasive laboratory diagnostic panel is better for the early detection and prognosis of TMA compared with a single parameter, and may provide a promising biomarker for clinical application.	[Zhang, Tao; Chen, Huimei; Liang, Shaoshan; Chen, Dacheng; Zheng, Chunxia; Zeng, Caihong; Zhang, Haitao; Liu, Zhihong] Nanjing Univ, Jinling Hosp, Sch Med, Natl Clin Res Ctr Kidney Dis, Nanjing 210002, Jiangsu, Peoples R China; [Chen, Huimei] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Chen, HM (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Natl Clin Res Ctr Kidney Dis, Nanjing 210002, Jiangsu, Peoples R China.	chenhuimei@nju.edu.cn; liuzhihong@nju.edu.cn		Liu, Zhi-Hong/0000-0001-6093-0726; Chen, Huimei/0000-0001-7788-1334	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517606]; National Natural Science Foundation (NSF) [81370788]; National Key Technology R D Program [2011BAI10B04]; Six Talent Peaks Project of Jiangsu Province [2012- SN-071]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation (NSF)(National Natural Science Foundation of China (NSFC)); National Key Technology R D Program(National Key Technology R&D Program); Six Talent Peaks Project of Jiangsu Province	This work was supported in part by National Basic Research Program of China 973 Program No.2012CB517600 (No.2012CB517606) (to Z.L.)(http://www. 973.gov.cn/AreaMana.aspx), National Natural Science Foundation (NSF) Grant 81370788 (to H.C.) (http://www.nsfc.gov.cn/),The National Key Technology R& D Program (2011BAI10B04) (to Z.L.) (http://kjzc.jhgl.org/) and Six Talent Peaks Project of Jiangsu Province (2012- SN-071) (to H.C.) (http://archives.nuist.edu.cn/rcgf/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Baliga RS, 2003, AM J MED SCI, V326, P378, DOI 10.1097/00000441-200312000-00015; Cataland SR, 2012, BRIT J HAEMATOL, V157, P501, DOI 10.1111/j.1365-2141.2012.09032.x; Cataland SR, 2009, EUR J HAEMATOL, V83, P559, DOI 10.1111/j.1600-0609.2009.01331.x; Clark WF, 2012, SEMIN DIALYSIS, V25, P214, DOI 10.1111/j.1525-139X.2011.01035.x; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Droz D, 2000, Adv Nephrol Necker Hosp, V30, P235; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Galbusera M, 1999, BLOOD, V94, P610, DOI 10.1182/blood.V94.2.610.414k22_610_620; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; George JN, 2007, SOUTH MED J, V100, P512, DOI 10.1097/SMJ.0b013e318046583f; George JN, 2006, NEW ENGL J MED, V354, P1927, DOI 10.1056/NEJMcp053024; Goldberg RJ, 2010, AM J KIDNEY DIS, V56, P1168, DOI 10.1053/j.ajkd.2010.06.006; Hastings MC, 2007, PEDIATR NEPHROL, V22, P742, DOI 10.1007/s00467-006-0392-z; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu WX, 2010, LUPUS, V19, P1591, DOI 10.1177/0961203310376523; HUGHSON MD, 1992, AM J KIDNEY DIS, V20, P150, DOI 10.1016/S0272-6386(12)80543-9; Kaplan B, 2002, AM J TRANSPLANT, V2, P970, DOI 10.1034/j.1600-6143.2002.21015.x; Laurence J, 2000, LANCET, V355, P497, DOI 10.1016/S0140-6736(00)82052-8; Michael M, 2009, AM J KIDNEY DIS, V53, P259, DOI 10.1053/j.ajkd.2008.07.038; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Noris M, 2010, AM J TRANSPLANT, V10, P1517, DOI 10.1111/j.1600-6143.2010.03156.x; Park YA, 2010, AM J CLIN PATHOL, V133, P460, DOI 10.1309/AJCPPNF63FLIORCI; Peng JH, 2011, MOLECULES, V16, P10709, DOI 10.3390/molecules161210709; Reynolds JC, 2003, AM J KIDNEY DIS, V42, P1058, DOI 10.1016/j.ajkd.2003.07.008; Stiles KP, 2000, AM J KIDNEY DIS, V36, P419, DOI 10.1053/ajkd.2000.8998; SYMMERS WS, 1952, BRIT MED J, V2, P897, DOI 10.1136/bmj.2.4790.897; van den Born BJH, 2008, HYPERTENSION, V51, P862, DOI 10.1161/HYPERTENSIONAHA.107.103127; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; White LE, 2012, SHOCK, V38, P320, DOI 10.1097/SHK.0b013e31826359d0	33	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111992	10.1371/journal.pone.0111992	http://dx.doi.org/10.1371/journal.pone.0111992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372665	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900103
J	Geng, P; Zhao, XX; Xiang, LS; Liao, YM; Wang, N; Ou, JJ; Xie, GF; Liu, C; Li, JJ; Li, HT; Zeng, R; Liang, HJ				Geng, Peiliang; Zhao, Xiaoxin; Xiang, Lisha; Liao, Yunmei; Wang, Ning; Ou, Juanjuan; Xie, Ganfeng; Liu, Chen; Li, Jianjun; Li, Hongtao; Zeng, Rui; Liang, Houjie			Distinct Role of CD86 Polymorphisms (rs1129055, rs17281995) in Risk of Cancer: Evidence from a Meta-Analysis	PLOS ONE			English	Article							CD86+1057G/A POLYMORPHISM; SUSCEPTIBILITY; MOLECULES	Background and Purpose: Previous studies concerning the role of CD86 polymorphisms (rs1129055 and rs17281995) in cancer fail to provide compelling evidence. The aim of this study was to investigate the role of common polymorphisms in the risk of cancer by meta-analysis. Methods: By using the search terms Cluster of Differentiation 86/CD86/B7-2/polymorphism/polymorphisms/cancer, we searched PubMed, Embase, CNKI, and Wanfang and identified four studies for rs1129055 (2137 subjects) and rs17281995 (2856 subjects) respectively. Cancer risk was estimated by odds ratio (OR) and 95% confidence interval (95% CI). Major Findings: Overall, we observed significant reduced risk of cancer in relation to rs1129055. Compared with the individuals with AA genotype, the individuals with GG genotype appeared to have 62% decreased risk to develop cancer (GG versus AA: OR, 0.62; 95% CI, 0.49-0.79; P-het., 0.996). Similar effects were indicated in the G versus A allele model and the GG versus GA+AA genetic model (OR, 0.83; 95% CI, 0.74-0.93; P-het., 0.987; OR, 0.63; 95% CI, 0.50-0.79; P-het., 0.973). In addition, we found genotypes of rs17281995 had a major effect on overall cancer risk (CC versus GG: OR, 2.38; 95% CI, 1.43-3.95; P-het., 0.433; C versus G: OR, 1.23; 95% CI, 1.06-1.43; P-het., 0.521; CC versus GC+GG: OR, 2.38; 95% CI, 1.45-3.93; P-het., 0.443). The association was also observed in Caucasians and colorectal cancer. No obvious publication bias was detected in this meta-analysis. Conclusions: These data reveal that rs1129055 may have protective effects on cancer risk in Asians and that rs17281995 is likely to contribute to risk of cancer, particularly colorectal cancer in Caucasians.	[Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com	Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198	National Natural Science Foundation of China [81172115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grant number 81172115 from the National Natural Science Foundation of China (to H.J.L.) (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh Pedram, 2013, Gastroenterol Hepatol Bed Bench, V6, P86; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Corydon TJ, 2007, J MED GENET, V44, P509, DOI 10.1136/jmg.2007.049536; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Landi D, 2011, MUTAT RES-FUND MOL M, V717, P109, DOI 10.1016/j.mrfmmm.2010.10.002; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liu Y, 2010, HUM IMMUNOL, V71, P1141, DOI 10.1016/j.humimm.2010.08.007; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marin LA, 2005, TRANSPL IMMUNOL, V15, P69, DOI 10.1016/j.trim.2005.04.003; Mokart D, 2011, MINERVA ANESTESIOL, V77, P522; Palermo MD, 2012, MEM I OSWALDO CRUZ, V107, P167, DOI 10.1590/S0074-02762012000900024; Pan XM, 2010, DNA CELL BIOL, V29, P381, DOI 10.1089/dna.2009.1003; Rakoff-Nahoum Seth, 2006, Yale J Biol Med, V79, P123; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Seliger B, 2008, TRENDS MOL MED, V14, P550, DOI 10.1016/j.molmed.2008.09.010; Slavik JM, 1999, J BIOL CHEM, V274, P3116, DOI 10.1074/jbc.274.5.3116; Teng Guang-shuai, 2012, Zhonghua Xue Ye Xue Za Zhi, V33, P865; Wang J, 2012, DNA CELL BIOL, V31, P537, DOI 10.1089/dna.2011.1370; Wang W, 2011, DNA CELL BIOL, V30, P925, DOI 10.1089/dna.2011.1211; Xiang HG, 2012, J CANCER RES CLIN, V138, P2061, DOI 10.1007/s00432-012-1289-9	27	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109131	10.1371/journal.pone.0109131	http://dx.doi.org/10.1371/journal.pone.0109131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369324	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000007
J	Mota, S; Vieira, N; Barbosa, S; Delaveau, T; Torchet, C; Le Saux, A; Garcia, M; Pereira, A; Lemoine, S; Coulpier, F; Darzacq, X; Benard, L; Casal, M; Devaux, F; Paiva, S				Mota, Sandra; Vieira, Neide; Barbosa, Sonia; Delaveau, Thierry; Torchet, Claire; Le Saux, Agnes; Garcia, Mathilde; Pereira, Ana; Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier; Benard, Lionel; Casal, Margarida; Devaux, Frederic; Paiva, Sandra			Role of the DHH1 Gene in the Regulation of Monocarboxylic Acids Transporters Expression in Saccharomyces cerevisiae	PLOS ONE			English	Article							PUTATIVE RNA HELICASE; LACTATE-PROTON SYMPORT; DEAD-BOX HELICASE; MESSENGER-RNA; P-BODIES; TRANSLATIONAL REPRESSION; DNA-DAMAGE; YEAST; PROTEIN; TRANSCRIPTION	Previous experiments revealed that DHH1, a RNA helicase involved in the regulation of mRNA stability and translation, complemented the phenotype of a Saccharomyces cerevisiae mutant affected in the expression of genes coding for monocarboxylic-acids transporters, JEN1 and ADY2 (Paiva S, Althoff S, Casal M, Leao C. FEMS Microbiol Lett, 1999, 170:301-306). In wild type cells, JEN1 expression had been shown to be undetectable in the presence of glucose or formic acid, and induced in the presence of lactate. In this work, we show that JEN1 mRNA accumulates in a dhh1 mutant, when formic acid was used as sole carbon source. Dhh1 interacts with the decapping activator Dcp1 and with the deadenylase complex. This led to the hypothesis that JEN1 expression is post-transcriptionally regulated by Dhh1 in formic acid. Analyses of JEN1 mRNAs decay in wild-type and dhh1 mutant strains confirmed this hypothesis. In these conditions, the stabilized JEN1 mRNA was associated to polysomes but no Jen1 protein could be detected, either by measurable lactate carrier activity, Jen1-GFP fluorescence detection or western blots. These results revealed the complexity of the expression regulation of JEN1 in S. cerevisiae and evidenced the importance of DHH1 in this process. Additionally, microarray analyses of dhh1 mutant indicated that Dhh1 plays a large role in metabolic adaptation, suggesting that carbon source changes triggers a complex interplay between transcriptional and post-transcriptional effects.	[Mota, Sandra; Vieira, Neide; Barbosa, Sonia; Pereira, Ana; Casal, Margarida; Paiva, Sandra] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, P-4700 Braga, Portugal; [Mota, Sandra] Polytech Inst Porto, Sch Allied Hlth Sci, Ctr Hlth & Environm Res CISA, Vila Nova De Gaia, Portugal; [Delaveau, Thierry; Garcia, Mathilde; Devaux, Frederic] Univ Paris 06, Sorbonne Univ, UMR7238, Lab Biol Computat & Quantitat, Paris, France; [Delaveau, Thierry; Garcia, Mathilde; Devaux, Frederic] CNRS, Lab Biol Computat & Quantitat, UMR7238, Paris, France; [Torchet, Claire; Benard, Lionel] CNRS, Lab Biol Mol & Cellulaire Eucaryotes, UMR8226, Inst Biol Phys Chim, Paris, France; [Torchet, Claire; Benard, Lionel] Univ Paris 06, Sorbonne Univ, UMR8226, Inst Biol Phys Chim,Lab Biol Mol & Cellulaire Euc, Paris, France; [Le Saux, Agnes] CNRS, Inst Biol Phys Chim, Lab Express Genet Microbienne, FRE3630, Paris, France; [Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier] Ecole Normale Super, Inst Biol, ENS, IBENS, F-75231 Paris, France; [Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier] INSERM, U1024, Paris, France; [Lemoine, Sophie; Coulpier, Fanny; Darzacq, Xavier] CNRS, UMR 8197, Paris, France	Universidade do Minho; Polytechnic Institute of Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Devaux, F (corresponding author), Univ Paris 06, Sorbonne Univ, UMR7238, Lab Biol Computat & Quantitat, Paris, France.	frederic.devaux@upmc.fr; spaiva@bio.uminho.pt	BENARD, LIONEL/E-4057-2019; DEVAUX, Frédéric/N-2288-2019; CASAL, MARGARIDA/B-6386-2009; Paiva, Sandra Cristina Almeida/H-8864-2013; Vieira, Neide/K-7702-2015	BENARD, LIONEL/0000-0003-1745-1361; DEVAUX, Frédéric/0000-0002-0039-9096; CASAL, MARGARIDA/0000-0002-0143-9758; Paiva, Sandra Cristina Almeida/0000-0003-2270-4546; Vieira, Neide/0000-0002-7166-4336; De Oliveira Barbosa, Sonia/0000-0002-7027-1530; Darzacq, Xavier/0000-0003-2537-8395; TORCHET, Claire/0000-0002-6583-823X; Santos Pereira, Ana/0000-0001-6410-7972; Mota, Sandra/0000-0002-2803-7230	Portuguese grant (Eixo 2, Medida 2.3, QCAIII - FEDER) [POCI/BIA-BCM/57812/2004]; FCT PhD fellowship [SFRH/BD/23503/2005, SFRH/BD/74790/2010]; Agence pour la Recherche contre le Cancer (ARC); FEDER through POFC-COMPETE; Portuguese funds from FCT [PEst-OE/BIA/UI4050/2014]; Fundação para a Ciência e a Tecnologia [POCI/BIA-BCM/57812/2004] Funding Source: FCT	Portuguese grant (Eixo 2, Medida 2.3, QCAIII - FEDER); FCT PhD fellowship(Portuguese Foundation for Science and Technology); Agence pour la Recherche contre le Cancer (ARC); FEDER through POFC-COMPETE; Portuguese funds from FCT(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This study was supported by the Portuguese grant POCI/BIA-BCM/57812/2004 (Eixo 2, Medida 2.3, QCAIII - FEDER). N.V. received a FCT PhD fellowship (SFRH/BD/23503/2005). S.M. received a FCT PhD fellowship (SFRH/BD/74790/2010). F.D.'s work is supported by a grant from the Agence pour la Recherche contre le Cancer (ARC). Support to C.B.M.A. by FEDER through POFC-COMPETE and by Portuguese funds from FCT through the project PEst-OE/BIA/UI4050/2014 is also acknowledged. The authors thank Josette Banroques and Kyle Tanner for their advice regarding polysome gradients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO Y, 1995, CANCER RES, V55, P3444; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Andrade RP, 2001, FUNGAL GENET BIOL, V32, P105, DOI 10.1006/fgbi.2001.1254; Ausubel F., 1998, CURRENT PROTOCOLS MO, P211; Balagopal V, 2012, BBA-GENE REGUL MECH, V1819, P593, DOI 10.1016/j.bbagrm.2012.01.001; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; Beliakova-Bethell N, 2006, RNA, V12, P94, DOI 10.1261/rna.2264806; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Blewett NH, 2012, MOL CELL BIOL, V32, P4181, DOI 10.1128/MCB.00483-12; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Carroll JS, 2011, J CELL BIOL, V194, P527, DOI 10.1083/jcb.201007151; CASAL M, 1995, FEMS MICROBIOL LETT, V128, P279, DOI 10.1016/0378-1097(95)00117-N; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Casal M, 1999, J BACTERIOL, V181, P2620, DOI 10.1128/JB.181.8.2620-2623.1999; Casal M, 2008, FEMS MICROBIOL REV, V32, P974, DOI 10.1111/j.1574-6976.2008.00128.x; CASSIO F, 1987, APPL ENVIRON MICROB, V53, P509; Checkley MA, 2010, MOL CELL BIOL, V30, P382, DOI 10.1128/MCB.00251-09; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; DEVALOIR T, 1991, P NATL ACAD SCI USA, V88, P2113, DOI 10.1073/pnas.88.6.2113; Erez O, 2002, BIOCHEM BIOPH RES CO, V295, P1142, DOI 10.1016/S0006-291X(02)00823-9; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fujita K, 2006, FEMS YEAST RES, V6, P744, DOI 10.1111/j.1567-1364.2006.00040.x; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gregori C, 2008, J BIOL CHEM, V283, P25752, DOI 10.1074/jbc.M803095200; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Hata H, 1998, GENETICS, V148, P571; Holetz FB, 2010, FEBS J, V277, P3415, DOI 10.1111/j.1742-4658.2010.07747.x; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Hurto RL, 2011, RNA, V17, P912, DOI 10.1261/rna.2558511; Ka M, 2008, BIOCHEM BIOPH RES CO, V367, P680, DOI 10.1016/j.bbrc.2007.12.169; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kramer S, 2010, J CELL SCI, V123, P699, DOI 10.1242/jcs.058511; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Kushner N, 2003, P NATL ACAD SCI USA, V100, P6652, DOI 10.1073/pnas.1131930100; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Liu HD, 2005, MOL CELL BIOL, V25, P9764, DOI 10.1128/MCB.25.22.9764-9772.2005; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; MAEKAWA H, 1994, MOL GEN GENET, V244, P456, DOI 10.1007/BF00583896; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Makuc J, 2001, YEAST, V18, P1131, DOI 10.1002/yea.763; Mazzoni C, 2003, MOL BIOL CELL, V14, P721, DOI 10.1091/mbc.E02-05-0258; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Olszewska M, 2012, CELL BIOCHEM FUNCT, V30, P177, DOI 10.1002/cbf.2804; Pagani MA, 2007, MOL MICROBIOL, V65, P521, DOI 10.1111/j.1365-2958.2007.05807.x; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Paiva S, 2002, BIOCHEM J, V363, P737, DOI 10.1042/0264-6021:3630737; Paiva S, 1999, FEMS MICROBIOL LETT, V170, P301, DOI 10.1111/j.1574-6968.1999.tb13387.x; Park YU, 2006, EUKARYOT CELL, V5, P2120, DOI 10.1128/EC.00121-06; PARKER R, 1991, P415; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seto M, 1995, GENE, V166, P293, DOI 10.1016/0378-1119(95)00559-5; SHARIF H, 2013, NUCL ACIDS RES; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STRAHLBOLSINGER S, 1993, YEAST, V9, P429, DOI 10.1002/yea.320090414; Stribinskis V, 2007, NUCLEIC ACIDS RES, V35, P1301, DOI 10.1093/nar/gkm023; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Taylor R, 2005, EUKARYOT CELL, V4, P2066, DOI 10.1128/EC.4.12.2066-2077.2005; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tseng-Rogenski SSI, 2003, NUCLEIC ACIDS RES, V31, P4995, DOI 10.1093/nar/gkg712; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Wickens M, 2003, SCIENCE, V300, P753, DOI 10.1126/science.1084512; Wyers F, 2000, MOL CELL BIOL, V20, P3538, DOI 10.1128/MCB.20.10.3538-3549.2000; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	90	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111589	10.1371/journal.pone.0111589	http://dx.doi.org/10.1371/journal.pone.0111589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365506	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100083
J	Nourrisson, C; Scanzi, J; Pereira, B; NkoudMongo, C; Wawrzyniak, I; Cian, A; Viscogliosi, E; Livrelli, V; Delbac, F; Dapoigny, M; Poirier, P				Nourrisson, Celine; Scanzi, Julien; Pereira, Bruno; NkoudMongo, Christina; Wawrzyniak, Ivan; Cian, Amandine; Viscogliosi, Eric; Livrelli, Valerie; Delbac, Frederic; Dapoigny, Michel; Poirier, Philippe			Blastocystis Is Associated with Decrease of Fecal Microbiota Protective Bacteria: Comparative Analysis between Patients with Irritable Bowel Syndrome and Control Subjects	PLOS ONE			English	Article							REAL-TIME PCR; DIENTAMOEBA-FRAGILIS; QUANTITATIVE PCR; GUT MICROBIOTA; HOMINIS; DISEASE; BIFIDOBACTERIA; IDENTIFICATION; PREVALENCE; DIVERSITY	Blastocystis is a protistan parasite living in the digestive tract of many animals, including humans. This highly prevalent intestinal parasite is suspected to be linked to Irritable Bowel Syndrome (IBS), a chronic functional bowel disorder. Here, we first compared the prevalence of Blastocystis among 56 IBS patients (40 IBS with constipation (IBS-C), 9 IBS with diarrhea (IBS-D), 4 mixed IBS (IBS-M) and 3 unsubtyped IBS (IBS-U) according to the Rome III criteria) and 56 control (i.e. without any diagnosed chronic or acute gastrointestinal disorder) subjects. The highest prevalence of Blastocystis spp. was observed in the IBS group, but was only statistically significant in men (36.8% in the IBS group versus 4.8% in the control group). We then conducted a meta-analysis including epidemiological studies attempting to determine whether Blastocystis carriage could be linked to IBS, and highlighted that IBS patients had a relative risk of 2.34 to be infected by Blastocystis when compared to non-IBS subjects. We also looked for Dientamoeba fragilis, which is often associated with IBS, and identified this parasite only in some IBS patients (n = 6/56). Several studies provided evidence for a major role of the gut microbiota in the pathophysiology of IBS. Thus, we investigated the possible impact of Blastocystis carriage on the enteric bacterial community through quantification of 8 major bacterial groups from the enteric flora. Our data indicated that men with IB-SC had a significant decrease in Bifidobacterium sp. when infected by Blastocystis. Interestingly, in control subjects (i.e. without any gastrointestinal disorder) positive for Blastocystis, Faecalibacterium prausnitzii, which is known for its anti-inflammatory properties, was significantly decreased in men. Our results support the hypothesis that Blastocystis might be linked to the pathophysiology of IBS-C and intestinal flora imbalance.	[Nourrisson, Celine; NkoudMongo, Christina; Livrelli, Valerie; Poirier, Philippe] CHU Clermont Ferrand, Ctr Biol, Lab Parasitol Mycol, Hop G Montpied, Clermont Ferrand, France; [Nourrisson, Celine; Wawrzyniak, Ivan; Delbac, Frederic; Poirier, Philippe] Univ Clermont Ferrand 2, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Nourrisson, Celine; Wawrzyniak, Ivan; Delbac, Frederic; Poirier, Philippe] CNRS, UMR 6023, LMGE, Aubiere, France; [Scanzi, Julien; Dapoigny, Michel] CHU Clermont Ferrand, Serv Med Digest & Hepatobiliaire, Hop Estaing, Clermont Ferrand, France; [Scanzi, Julien; Dapoigny, Michel] Univ Clermont Ferrand 2, Univ Auvergne, UMR 1107, INSERM, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, DRCI, Clermont Ferrand, France; [Cian, Amandine; Viscogliosi, Eric] Univ Lille Nord France, INSERM U1019, CNRS UMR 8204, Ctr Infect & Immunite Lille,Inst Pasteur, Lille, France; [Livrelli, Valerie] Univ Clermont Ferrand 2, Univ Auvergne,USC INRA U1071 2018, Ctr Rech Nutr Humaine Auvergne,M2iSH, Microbes Intestin Inflammat & Susceptibilite Hote, Clermont Ferrand, France	CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; INRAE; Universite Clermont Auvergne (UCA)	Poirier, P (corresponding author), CHU Clermont Ferrand, Ctr Biol, Lab Parasitol Mycol, Hop G Montpied, Clermont Ferrand, France.	ppoirier@chu-clermontferrand.fr	DAPOIGNY, Michel/M-1285-2015; Nourrisson, Céline/AAC-1527-2019; scanzi, julien/Y-2346-2019	Nourrisson, Céline/0000-0002-4003-805X; Pereira, Bruno/0000-0003-3778-7161; Viscogliosi, Eric/0000-0002-5805-7179; wawrzyniak, ivan/0000-0002-5362-6117; Poirier, Philippe/0000-0001-9173-2634				Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barratt JLN, 2011, GUT MICROBES, V2, P3, DOI 10.4161/gmic.2.1.14755; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Borenstein M., 2005, COMPREHENSIVE META A; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Cekin AH, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-122; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Chassard C, 2012, ALIMENT PHARM THER, V35, P828, DOI 10.1111/j.1365-2036.2012.05007.x; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Cremon C, 2010, EXPERT REV MOL DIAGN, V10, P389, DOI 10.1586/ERM.10.33; Crouzet L, 2013, NEUROGASTROENT MOTIL, V25, pe272, DOI 10.1111/nmo.12103; Dapoigny M, 2009, GASTROEN CLIN BIOL, V33, pS3, DOI 10.1016/S0399-8320(09)71519-2; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Dogruman-Al F, 2009, MEM I OSWALDO CRUZ, V104, P724, DOI 10.1590/S0074-02762009000500011; El Safadi D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-164; Jimenez-Gonzalez DE, 2012, PARASITOL RES, V110, P1269, DOI 10.1007/s00436-011-2626-7; Engsbro AL, 2012, AM J TROP MED HYG, V87, P1046, DOI 10.4269/ajtmh.2012.11-0761; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P436, DOI 10.1007/s100960050314; Gueimonde M, 2004, APPL ENVIRON MICROB, V70, P4165, DOI 10.1128/AEM.70.7.4165-4169.2004; Heitkemper M, 2008, J PSYCHOSOM RES, V64, P583, DOI 10.1016/j.jpsychores.2008.02.020; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lopez-Siles M, 2014, INT J MED MICROBIOL, V304, P464, DOI 10.1016/j.ijmm.2014.02.009; Lovell RM, 2012, AM J GASTROENTEROL, V107, P991, DOI 10.1038/ajg.2012.131; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Galvan-Moroyoqui JM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000266; Matsunami M, 2009, GUT, V58, P751, DOI 10.1136/gut.2007.144543; Miquel S, 2014, GUT MICROBES, V5, P146, DOI 10.4161/gmic.27651; Park SR, 2010, APPL MICROBIOL BIOT, V85, P1227, DOI 10.1007/s00253-009-2326-8; Perez PF, 2001, APPL ENVIRON MICROB, V67, P5037, DOI 10.1128/AEM.67.11.5037-5042.2001; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Poirier P, 2014, PARASITOLOGY, V141, P670, DOI 10.1017/S0031182013001996; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Ramirez-Miranda M E, 2011, Rev Gastroenterol Mex, V76, P309; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; Scanlan PD, 2013, TRENDS PARASITOL, V29, P523, DOI 10.1016/j.pt.2013.08.006; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Stark D, 2006, J CLIN MICROBIOL, V44, P232, DOI 10.1128/JCM.44.1.232-235.2006; Stark DJ, 2006, TRENDS PARASITOL, V22, P92, DOI 10.1016/j.pt.2005.12.001; Surangsrirat Surapon, 2010, J Med Assoc Thai, V93 Suppl 6, pS119; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Thamrongwittawatpong L, 2006, THAI J GASTROENTEROL; Tungtrongchitr Anchalee, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P705; Verma AK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-183; Dominguez-Marquez MV, 2009, PARASITOL RES, V105, P949, DOI 10.1007/s00436-009-1485-y; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Yakoob J, 2010, PARASITOL RES, V107, P679, DOI 10.1007/s00436-010-1918-7; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x	57	102	108	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111868	10.1371/journal.pone.0111868	http://dx.doi.org/10.1371/journal.pone.0111868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365580	Green Published, gold			2022-12-27	WOS:000345558100132
J	Rangel-Negrin, A; Coyohua-Fuentes, A; Chavira, R; Canales-Espinosa, D; Dias, PAD				Rangel-Negrin, Ariadna; Coyohua-Fuentes, Alejandro; Chavira, Roberto; Canales-Espinosa, Domingo; Dias, Pedro Americo D.			Primates Living Outside Protected Habitats Are More Stressed: The Case of Black Howler Monkeys in the Yucatan Peninsula	PLOS ONE			English	Article							TROPICAL FOREST; ALOUATTA-PIGRA; FECAL GLUCOCORTICOIDS; ADRENAL ACTIVITY; WILD; FRAGMENTATION; RESPONSES; CORTISOL; CONSEQUENCES; POPULATIONS	The non-invasive monitoring of glucocorticoid hormones allows for the assessment of the physiological effects of anthropogenic disturbances on wildlife. Variation in glucocorticoid levels of the same species between protected and unprotect areas seldom has been measured, and the available evidence suggests that this relationship may depend on species-specific habitat requirements and biology. In the present study we focused on black howler monkeys (Alouatta pigra), a canopy-dwelling primate species, as a case study to evaluate the physiological consequences of living in unprotected areas, and relate them with intragroup competition and competition with extragroup individuals. From February 2006 to September 2007 we collected 371 fecal samples from 21 adults belonging to five groups (two from protected and three from unprotected areas) in Campeche, Mexico. We recorded agonistic interactions within groups and encounters with other groups (1,200 h of behavioral observations), and determined fecal glucocorticoid metabolite (FGM) concentrations with radioimmunoassays. We used linear mixed models and Akaike's information criterion to choose the best model explaining variation in FGM concentrations between protected and unprotected areas calculated from five categorical variables: habitat type (protected vs. unprotected), participation in agonistic interactions, intergroup encounters, sex and female reproductive state, and season. The best model included habitat type, the interaction between habitat type and agonism, and the interaction between habitat type and season. FGM concentrations were higher in unprotected habitats, particularly when individuals were involved in agonistic interactions; seasonal variation in FGM concentrations was only detected in protected habitats. High FGM concentrations in black howler monkeys living in unprotected habitats are associated with increased within-group food competition and probably associated with exposure to anthropogenic stressors and overall food scarcity. Because persistent high GC levels can be detrimental to health and fitness, populations living in disturbed unprotected areas may not be viable in the long-term.	[Rangel-Negrin, Ariadna; Coyohua-Fuentes, Alejandro; Canales-Espinosa, Domingo; Dias, Pedro Americo D.] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Chavira, Roberto] Inst Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico	Universidad Veracruzana	Dias, PAD (corresponding author), Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico.	paddias@hotmail.com	Rangel_Negrín, Ariadna/AGR-6540-2022; Dias, Pedro Américo D./C-2035-2009	Dias, Pedro Américo D./0000-0002-2919-6479; Rangel-Negrin, Ariadna/0000-0003-3539-3652	CFE [RGCPTTPUV-001/04]; CONACyT [235839, i010/152/2014, C-133/2014]; Idea Wild; Universidad Veracruzana	CFE; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Idea Wild; Universidad Veracruzana	This work was supported by CFE (RGCPTTPUV-001/04), Universidad Veracruzana, CONACyT (Grant Number: 235839; i010/152/2014 & C-133/2014) and Idea Wild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2013, CONSERV BIOL, V27, P569, DOI 10.1111/cobi.12061; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; Behie AM, 2009, AM J PRIMATOL, V71, P100; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burnham K.P., 2010, MODEL SELECTION MULT; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Canales-Espinosa D., 2011, CONSERVACI N PRIMATE, P81, DOI 10.13140/2.1.2389.9204; Candelero-Rueda R, 2011, PERSPECTIVAS PRIMATO, P289; Cowlishaw G, 1999, CONSERV BIOL, V13, P1183, DOI 10.1046/j.1523-1739.1999.98433.x; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot021; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; Dias PAD, 2014, PRIMATES, V55, P1, DOI 10.1007/s10329-013-0383-1; Dias PAD, 2011, AM J PHYS ANTHROPOL, V145, P137, DOI 10.1002/ajpa.21481; Dunn JC, 2013, INT J PRIMATOL, V34, P246, DOI 10.1007/s10764-013-9657-0; Edwards KL, 2013, GEN COMP ENDOCR, V186, P72, DOI 10.1016/j.ygcen.2013.02.023; Edwards MS, 1999, ZOO BIOL, V18, P537, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;537::AID-ZOO8&gt;3.0.CO;2-F; Escamilla A, 2000, CONSERV BIOL, V14, P1592, DOI 10.1046/j.1523-1739.2000.99069.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foerster S, 2010, HORM BEHAV, V58, P685, DOI 10.1016/j.yhbeh.2010.06.002; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Fowler GS, 1995, AUK, V112, P382, DOI 10.2307/4088725; Girard I, 2002, J APPL PHYSIOL, V92, P1553, DOI 10.1152/japplphysiol.00465.2001; Gobierno del Estado de Campeche, 2012, SIST EST AR NAT PROT; Gomez-Espinosa E, 2014, AM J PRIMATOL, V76, P362, DOI 10.1002/ajp.22240; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Harcourt AH, 2005, J APPL ECOL, V42, P630, DOI 10.1111/j.1365-2664.2005.01037.x; Hinsley SA, 1999, J AVIAN BIOL, V30, P271, DOI 10.2307/3677353; HORWICH RH, 1986, PRIMATES, V27, P53, DOI 10.1007/BF02382522; Jones Clara B., 2004, Journal of Applied Animal Welfare Science, V7, P127, DOI 10.1207/s15327604jaws0702_4; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Marsh LK, 2008, IUCN 2014 RED LIST T; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Miller WL., 2001, ENDOCRINOLOGY METABO, P387; Muehlenbein MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033357; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Pimbert M. P., 1997, SOCIAL CHANGE CONSER; Pope ML, 2004, WILDLIFE RES, V31, P559, DOI 10.1071/WR02110; Putz F.E., 1990, GARDEN, V14, P18; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Rangel-Negrin A., 2011, PERSPECTIVAS PRIMATO, P271; Rangel-Negrin A, 2011, HORM BEHAV, V59, P159, DOI 10.1016/j.yhbeh.2010.11.005; Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schaffner CM, 2012, INT J PRIMATOL, V33, P922, DOI 10.1007/s10764-012-9621-4; Spercoski KM, 2012, GEN COMP ENDOCR, V179, P232, DOI 10.1016/j.ygcen.2012.08.002; Thompson ME, 2012, BEHAV ECOL, V23, P1234, DOI 10.1093/beheco/ars107; Van Belle S, 2006, DEV PRIMATOL-PROG PR, P121; Van Belle S, 2009, AM J PRIMATOL, V71, P153, DOI 10.1002/ajp.20635; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Watts ES, 1986, PRIMATE CONSERV, V7, P17; Wieczkowski J, 2005, AM J PHYS ANTHROPOL, V128, P381, DOI 10.1002/ajpa.20123; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Zwijacz-Kozica T, 2013, ACTA THERIOL, V58, P215, DOI 10.1007/s13364-012-0108-7	63	20	21	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112329	10.1371/journal.pone.0112329	http://dx.doi.org/10.1371/journal.pone.0112329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375243	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600129
J	Yamaguchi, S; Maida, Y; Yasukawa, M; Kato, T; Yoshida, M; Masutomi, K				Yamaguchi, Satoko; Maida, Yoshiko; Yasukawa, Mami; Kato, Tomoyasu; Yoshida, Masayuki; Masutomi, Kenkichi			Eribulin Mesylate Targets Human Telomerase Reverse Transcriptase in Ovarian Cancer Cells	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; TUMOR-INITIATING CELLS; STEM-CELLS; CARCINOMA; HETEROCHROMATIN; PROLIFERATION; ASSOCIATION; EXPRESSION; RESISTANCE; PROTEIN	Treatment of advanced ovarian cancer involves platinum-based chemotherapy. However, chemoresistance is a major obstacle. Cancer stem cells (CSCs) are thought to be one of the causes of chemoresistance, but the underlying mechanism remains elusive. Recently, human telomerase reverse transcriptase (hTERT) has been reported to promote CSC-like traits. In this study, we found that a mitotic inhibitor, eribulin mesylate (eribulin), effectively inhibited growth of platinum-resistant ovarian cancer cell lines. Eribulin-sensitive cells showed a higher efficiency for sphere formation, suggesting that these cells possess an enhanced CSC-like phenotype. Moreover, these cells expressed a higher level of hTERT, and suppression of hTERT expression by siRNA resulted in decreased sensitivity to eribulin, suggesting that hTERT may be a target for eribulin. Indeed, we found that eribulin directly inhibited RNA-dependent RNA polymerase (RdRP) activity, but not telomerase activity of hTERT in vitro. We propose that eribulin targets the RdRP activity of hTERT and may be an effective therapeutic option for CSCs. Furthermore, hTERT may be a useful biomarker to predict clinical responses to eribulin.	[Yamaguchi, Satoko; Maida, Yoshiko; Yasukawa, Mami; Masutomi, Kenkichi] Natl Canc Ctr, Res Inst, Div Canc Stem Cell, Tokyo 104, Japan; [Kato, Tomoyasu] Natl Canc Ctr, Dept Gynecol, Tokyo, Japan; [Yoshida, Masayuki] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Yoshida, Masayuki] Natl Canc Ctr, Clin Labs, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Masutomi, K (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Stem Cell, Tokyo 104, Japan.	kmasutom@ncc.go.jp	Kato, Tomoyasu/C-6900-2013		Japan Society for the Promotion of Science [26462544]; Funding program for the Next Generation World-Leading Researchers (NEXT program) from Japan Society for the Promotion of Science; Mitsubishi Foundation; Uehara Memorial Foundation; National Cancer Center Research and Development Funds [26-A-5]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding program for the Next Generation World-Leading Researchers (NEXT program) from Japan Society for the Promotion of Science; Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); National Cancer Center Research and Development Funds	This work was supported by Grant in Aid for Scientific Research (26462544) (to SY) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/), Funding program for the Next Generation World-Leading Researchers (NEXT program) (to KM) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/elisedai/), the Mitsubishi Foundation (to KM) (http://www.mitsubishi-zaidan.jp/en/), the Uehara Memorial Foundation (to KM) (http://www.ueharazaidan.or.jp/), and National Cancer Center Research and Development Funds (26-A-5) (to KM) (http://www.ncc.go.jp/jp/about/rinri/kaihatsu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Chung SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083971; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; GORAI I, 1995, GYNECOL ONCOL, V57, P33, DOI 10.1006/gyno.1995.1097; HAMILTON TC, 1984, SEMIN ONCOL, V11, P285; HAMILTON TC, 1983, CANCER RES, V43, P5379; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kobayashi T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-215; LANGDON SP, 1988, CANCER RES, V48, P6166; LAU DHM, 1991, CANCER RES, V51, P5181; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Maida Y, 2014, MOL CELL BIOL, V34, P1576, DOI 10.1128/MCB.00093-14; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Nozawa S, 1988, Hum Cell, V1, P426; Ohta I, 2001, CANCER LETT, V162, P39, DOI 10.1016/S0304-3835(00)00605-4; Okamoto N, 2011, P NATL ACAD SCI USA, V108, P20388, DOI 10.1073/pnas.1015171108; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Smith JA, 2010, BIOCHEMISTRY-US, V49, P1331, DOI 10.1021/bi901810u; Takano M, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-53; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Towle MJ, 2001, CANCER RES, V61, P1013; Towle MJ, 2011, CANCER RES, V71, P496, DOI 10.1158/0008-5472.CAN-10-1874; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Yanagibashi T, 1997, BRIT J CANCER, V76, P829, DOI 10.1038/bjc.1997.471; Yoshida T, 2014, BRIT J CANCER, V110, P1497, DOI 10.1038/bjc.2014.80	39	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112438	10.1371/journal.pone.0112438	http://dx.doi.org/10.1371/journal.pone.0112438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375122	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600143
J	Harper, NS; Scott, BH; Semple, MN; McAlpine, D				Harper, Nicol S.; Scott, Brian H.; Semple, Malcolm N.; McAlpine, David			The Neural Code for Auditory Space Depends on Sound Frequency and Head Size in an Optimal Manner	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; CENTRAL SPECTRUM THEORY; INFERIOR COLLICULUS; BINAURAL INTERACTION; UNANESTHETIZED RABBIT; DELAY SENSITIVITY; DORSAL NUCLEUS; NERVE DATA; NEURONS; REPRESENTATION	A major cue to the location of a sound source is the interaural time difference (ITD)-the difference in sound arrival time at the two ears. The neural representation of this auditory cue is unresolved. The classic model of ITD coding, dominant for a half-century, posits that the distribution of best ITDs (the ITD evoking a neuron's maximal response) is unimodal and largely within the range of ITDs permitted by head-size. This is often interpreted as a place code for source location. An alternative model, based on neurophysiology in small mammals, posits a bimodal distribution of best ITDs with exquisite sensitivity to ITDs generated by means of relative firing rates between the distributions. Recently, an optimal-coding model was proposed, unifying the disparate features of these two models under the framework of efficient coding by neural populations. The optimal-coding model predicts that distributions of best ITDs depend on head size and sound frequency: for high frequencies and large heads it resembles the classic model, for low frequencies and small head sizes it resembles the bimodal model. The optimal-coding model makes key, yet unobserved, predictions: for many species, including humans, both forms of neural representation are employed, depending on sound frequency. Furthermore, novel representations are predicted for intermediate frequencies. Here, we examine these predictions in neurophysiological data from five mammalian species: macaque, guinea pig, cat, gerbil and kangaroo rat. We present the first evidence supporting these untested predictions, and demonstrate that different representations appear to be employed at different sound frequencies in the same species.	[Harper, Nicol S.; McAlpine, David] UCL, Ear Inst, London, England; [Harper, Nicol S.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Scott, Brian H.] NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; [Scott, Brian H.; Semple, Malcolm N.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of London; University College London; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); New York University	Harper, NS (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg, Oxford, England.	nicol.harper@eng.ox.ac.uk	Scott, Brian H/G-7932-2012	McAlpine, David/0000-0001-5467-6725; Harper, Nicol/0000-0002-7851-4840	Wellcome Trust [040044, WT076508AIA]; Sir Henry Wellcome Postdoctoral Fellowship; Department of Physiology, Anatomy and Genetics, University of Oxford; Action on Hearing Loss [PA07]; National Institute on Deafness and Other Communication Disorders [DC-05287-01]; New York University; W. M. Keck Foundation; MRC Programme [G0300417]; MRC [G0300417, G1002267] Funding Source: UKRI; Medical Research Council [G0300417, G1002267] Funding Source: researchfish; RNID [PA07] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005287] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Sir Henry Wellcome Postdoctoral Fellowship; Department of Physiology, Anatomy and Genetics, University of Oxford; Action on Hearing Loss; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); New York University; W. M. Keck Foundation(W.M. Keck Foundation); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Nicol S. Harper was supported by the Wellcome Trust (040044), (WT076508AIA), including a Sir Henry Wellcome Postdoctoral Fellowship, by the Department of Physiology, Anatomy and Genetics, University of Oxford and by Action on Hearing Loss (PA07). Brian H. Scott was supported by the National Institute on Deafness and Other Communication Disorders (DC-05287-01) and by a James Arthur Fellowship from New York University. Malcolm N. Semple was supported by the W. M. Keck Foundation. David McAlpine was supported by an MRC Programme Grant (G0300417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapiou JP, 2007, THESIS U COLL LONDON; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BILSEN FA, 1977, J ACOUST SOC AM, V61, P150, DOI 10.1121/1.381276; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brette R, 2010, J ACOUST SOC AM, V128, P2965, DOI 10.1121/1.3488311; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; Colburn HS, 1996, AUDITORY COMPUTATION, P332; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; CROW G, 1978, J ACOUST SOC AM, V64, P493, DOI 10.1121/1.381999; FRIJNS JHM, 1986, J ACOUST SOC AM, V80, P442, DOI 10.1121/1.394040; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; Joris PX, 2006, P NATL ACAD SCI USA, V103, P12917, DOI 10.1073/pnas.0601396103; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; KUWADA S, 1987, J NEUROPHYSIOL, V57, P1338, DOI 10.1152/jn.1987.57.5.1338; Kuwada S, 2006, J NEUROPHYSIOL, V95, P1309, DOI 10.1152/jn.00901.2005; Rayleigh,, 1907, PHILOS MAG, V13, P214, DOI 10.1080/14786440709463595; Maki K, 2005, J ACOUST SOC AM, V118, P872, DOI 10.1121/1.1944647; Marquardt T, 2007, HEARING - FROM SENSORY PROCESSING TO PERCEPTION, P407, DOI 10.1007/978-3-540-73009-5_44; McAlpine D, 1998, J NEUROSCI, V18, P6026; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Moore B., 2003, INTRO PSYCHOL HEARIN; PALMER AR, 1990, HEARING RES, V50, P71, DOI 10.1016/0378-5955(90)90034-M; PALMER AR, 1992, PHILOS T R SOC B, V336, P415, DOI 10.1098/rstb.1992.0077; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; RAATGEVER J, 1986, J ACOUST SOC AM, V80, P429, DOI 10.1121/1.394039; Raatgever J, 1977, PSYCHOPHYSICS PHYSL, P443; ROTH GL, 1980, J ACOUST SOC AM, V68, P1643, DOI 10.1121/1.385196; SAYERS BM, 1957, J ACOUST SOC AM, V29, P973, DOI 10.1121/1.1914990; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; Scott BH, 2009, J NEUROPHYSIOL, V101, P1781, DOI 10.1152/jn.00678.2007; Siveke I, 2006, J NEUROPHYSIOL, V96, P1425, DOI 10.1152/jn.00713.2005; Spezio ML, 2000, HEARING RES, V144, P73, DOI 10.1016/S0378-5955(00)00050-2; Sterbing SJ, 2003, J NEUROPHYSIOL, V90, P2648, DOI 10.1152/jn.00348.2003; STERN RM, 1978, J ACOUST SOC AM, V64, P127, DOI 10.1121/1.381978; STERN RM, 1988, J ACOUST SOC AM, V84, P156, DOI 10.1121/1.396982; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; WAGNER H, 1987, J NEUROSCI, V7, P3105; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1984, J ACOUST SOC AM, V76, P1401, DOI 10.1121/1.391457; YIN TCT, 1983, J NEUROPHYSIOL, V50, P1000, DOI 10.1152/jn.1983.50.4.1000	46	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108154	10.1371/journal.pone.0108154	http://dx.doi.org/10.1371/journal.pone.0108154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372405	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900002
J	Sartagul, W; Zhou, X; Yamada, Y; Ma, N; Tanaka, K; Furuyashiki, T; Ma, Y				Sartagul, Wugangerile; Zhou, Xin; Yamada, Yuki; Ma, Ning; Tanaka, Katsunori; Furuyashiki, Tomoyuki; Ma, Yan			The MluI Cell Cycle Box (MCB) Motifs, but Not Damage-Responsive Elements (DREs), Are Responsible for the Transcriptional Induction of the rhp51(+) Gene in Response to DNA Replication Stress	PLOS ONE			English	Article							FISSION YEAST; G1-SPECIFIC TRANSCRIPTION; SCHIZOSACCHAROMYCES-POMBE; ACTIVATED KINASE; S PHASE; CHECKPOINT; PHOSPHORYLATION; ASSOCIATION; INHIBITOR; PATHWAYS	DNA replication stress induces the transcriptional activation of rhp51(+), a fission yeast recA homolog required for repair of DNA double strand breaks. However, the mechanism by which DNA replication stress activates rhp51(+) transcription is not understood. The promoter region of rhp51(+) contains two damage-responsive elements (DREs) and two MluI cell cycle box (MCB) motifs. Using luciferase reporter assays, we examined the role of these elements in rhp51(+) transcription. The fulllength rhp51(+) promoter and a promoter fragment containing MCB motifs only, but not a fragment containing DREs, mediated transcriptional activation upon DNA replication stress. Removal of the MCB motifs from the rhp51(+) promoter abolished the induction of rhp51(+) transcription by DNA replication stress. Consistent with a role for MCB motifs in rhp51(+) transcription activation, deletion of the MBF (MCB-binding factor) co-repressors Nrm1 and Yox1 precluded rhp51(+) transcriptional induction in response to DNA replication stress. Using cells deficient in checkpoint signaling molecules, we found that the Rad3-Cds1/Chk1 pathway partially mediated rhp51(+) transcription in response to DNA replication stress, suggesting the involvement of unidentified checkpoint signaling pathways. Because MBF is critical for G1/S transcription, we examined how the cell cycle affected rhp51(+) transcription. The transcription of rhp51(+) and cdc18(+), an MBF-dependent G1/S gene, peaked simultaneously in synchronized cdc25-22 cells. Furthermore, DNA replication stress maintained transcription of rhp51(+) similarly to cdc18(+). Collectively, these results suggest that MBF and its regulators mediate rhp51(+) transcription in response to DNA replication stress, and underlie rhp51(+) transcription at the G1/S transition.	[Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China; [Sartagul, Wugangerile; Zhou, Xin; Yamada, Yuki; Ma, Ning; Furuyashiki, Tomoyuki; Ma, Yan] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan; [Tanaka, Katsunori] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Japan	Jinzhou Medical University; Kobe University; Kwansei Gakuin University	Zhou, X (corresponding author), Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China.	xinzhoulmu@gmail.com; mayan@med.kobe-u.ac.jp	Furuyashiki, Tomoyuki/B-8760-2014; Furuyashiki, Tomoyuki/AAG-5283-2019; Tanaka, Katsunori/F-8086-2010; Yamada, Yuki/B-2671-2008	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Tanaka, Katsunori/0000-0001-9692-0968; Yamada, Yuki/0000-0003-1431-568X	National Natural Science Foundation of China [31301158]; Ministry of Education, Culture, Sports, Science and Technology in Japan; Grants-in-Aid for Scientific Research [24689015] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the National Natural Science Foundation of China (grant no. 31301158) (A) (X.Z.) and Grant-in-Aid for Young Scientists (B) (Y.M.) and Grant-in-Aid for Scientific Research (C) (Y.M.) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Caetano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017211; Cooper K, 2006, ONCOGENE, V25, P5228, DOI 10.1038/sj.onc.1209630; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gomez-Escoda B, 2011, EMBO REP, V12, P84, DOI 10.1038/embor.2010.187; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Ivanova T, 2013, MOL BIOL CELL, V24, P3350, DOI 10.1091/mbc.E13-05-0257; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Ma Y, 2006, GENETICS, V174, P1259, DOI 10.1534/genetics.106.064709; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Purtill FS, 2011, CELL CYCLE, V10, P664, DOI 10.4161/cc.10.4.14824; Rhind N, 2000, J CELL SCI, V113, P3889; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; SAKA Y, 1994, EMBO J, V13, P5319, DOI 10.1002/j.1460-2075.1994.tb06866.x; Shim YS, 2000, MOL CELL BIOL, V20, P8958, DOI 10.1128/MCB.20.23.8958-8968.2000; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111936	10.1371/journal.pone.0111936	http://dx.doi.org/10.1371/journal.pone.0111936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372384	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900091
J	Sun, PZ; Wang, YL; Liu, H; Wang, KL; Wu, DH; Xu, ZP; Zhu, HW				Sun, Pengzhan; Wang, Yanlei; Liu, He; Wang, Kunlin; Wu, Dehai; Xu, Zhiping; Zhu, Hongwei			Structure Evolution of Graphene Oxide during Thermally Driven Phase Transformation: Is the Oxygen Content Really Preserved?	PLOS ONE			English	Article							GRAPHITE OXIDE; MECHANICAL-PROPERTIES; REDUCTION; MEMBRANES; FILMS; WATER; TRANSPARENT; ELECTRONICS; SERIES	A mild annealing procedure was recently proposed for the scalable enhancement of graphene oxide (GO) properties with the oxygen content preserved, which was demonstrated to be attributed to the thermally driven phase separation. In this work, the structure evolution of GO with mild annealing is closely investigated. It reveals that in addition to phase separation, the transformation of oxygen functionalities also occurs, which leads to the slight reduction of GO membranes and furthers the enhancement of GO properties. These results are further supported by the density functional theory based calculations. The results also show that the amount of chemically bonded oxygen atoms on graphene decreases gradually and we propose that the strongly physisorbed oxygen species constrained in the holes and vacancies on GO lattice might be responsible for the preserved oxygen content during the mild annealing procedure. The present experimental results and calculations indicate that both the diffusion and transformation of oxygen functional groups might play important roles in the scalable enhancement of GO properties.	[Sun, Pengzhan; Wang, Kunlin; Zhu, Hongwei] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Key Lab Mat Proc Technol MOE, Beijing 100084, Peoples R China; [Wang, Yanlei; Xu, Zhiping; Zhu, Hongwei] Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China; [Wang, Yanlei; Liu, He; Wu, Dehai; Xu, Zhiping] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Zhu, HW (corresponding author), Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Key Lab Mat Proc Technol MOE, Beijing 100084, Peoples R China.	hongweizhu@tsinghua.edu.cn	Wang, Yanlei/F-3253-2019; Zhu, Hongwei/C-4655-2008; Xu, Zhiping/A-1520-2010; Wang, Yanlei/E-8286-2016	Wang, Yanlei/0000-0002-2214-8781; Zhu, Hongwei/0000-0001-6484-3371; Wang, Yanlei/0000-0002-2214-8781	Beijing Natural Science Foundation [2122027]; National Science Foundation of China [51372133]; National Program on Key Basic Research Project [2011CB013000]; Tsinghua University Initiative Scientific Research Program [2012Z02102]; Training Program of Innovation and Entrepreneurship for Undergraduates [201410003B046]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project(National Basic Research Program of China); Tsinghua University Initiative Scientific Research Program; Training Program of Innovation and Entrepreneurship for Undergraduates	This work was supported by Beijing Natural Science Foundation (2122027), National Science Foundation of China (51372133), National Program on Key Basic Research Project (2011CB013000), Tsinghua University Initiative Scientific Research Program (2012Z02102) and the Training Program of Innovation and Entrepreneurship for Undergraduates (201410003B046). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Acik M, 2010, ACS NANO, V4, P5861, DOI 10.1021/nn101844t; Bagri A, 2010, NAT CHEM, V2, P581, DOI [10.1038/NCHEM.686, 10.1038/nchem.686]; Buchsteiner A, 2006, J PHYS CHEM B, V110, P22328, DOI 10.1021/jp0641132; Cabrera-Sanfelix P, 2007, J PHYS CHEM C, V111, P18258, DOI 10.1021/jp076241b; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83; Eda G, 2010, ADV MATER, V22, P2392, DOI 10.1002/adma.200903689; Gao W, 2011, NAT NANOTECHNOL, V6, P496, DOI [10.1038/NNANO.2011.110, 10.1038/nnano.2011.110]; Gao W, 2009, NAT CHEM, V1, P403, DOI [10.1038/NCHEM.281, 10.1038/nchem.281]; HONTORIALUCAS C, 1995, CARBON, V33, P1585, DOI 10.1016/0008-6223(95)00120-3; Hunt A, 2012, ADV FUNCT MATER, V22, P3950, DOI 10.1002/adfm.201200529; Johns JE, 2013, ACCOUNTS CHEM RES, V46, P77, DOI 10.1021/ar300143e; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Kim S, 2012, NAT MATER, V11, P544, DOI [10.1038/NMAT3316, 10.1038/nmat3316]; Kumar PV, 2014, NAT CHEM, V6, P151, DOI [10.1038/nchem.1820, 10.1038/NCHEM.1820]; Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907; Mao S, 2012, RSC ADV, V2, P2643, DOI 10.1039/c2ra00663d; Mattevi C, 2009, ADV FUNCT MATER, V19, P2577, DOI 10.1002/adfm.200900166; Medhekar NV, 2010, ACS NANO, V4, P2300, DOI 10.1021/nn901934u; Ortiz-Young D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3482; Park S, 2008, ACS NANO, V2, P572, DOI 10.1021/nn700349a; Park S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1643; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rourke JP, 2011, ANGEW CHEM INT EDIT, V50, P3173, DOI 10.1002/anie.201007520; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Sun PZ, 2014, ACS NANO, V8, P850, DOI 10.1021/nn4055682; Sun PZ, 2013, ACS APPL MATER INTER, V5, P9563, DOI 10.1021/am403186r; Sun PZ, 2013, ACS NANO, V7, P428, DOI 10.1021/nn304471w; Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258+; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Wei ZQ, 2010, SCIENCE, V328, P1373, DOI 10.1126/science.1188119; Zhou S, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300106; Zhou S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02484	34	24	24	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111908	10.1371/journal.pone.0111908	http://dx.doi.org/10.1371/journal.pone.0111908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372142	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900089
J	Bogomolnaya, LM; Aldrich, L; Ragoza, Y; Talamantes, M; Andrews, KD; McClelland, M; Andrews-Polymenis, HL				Bogomolnaya, Lydia M.; Aldrich, Lindsay; Ragoza, Yuri; Talamantes, Marissa; Andrews, Katharine D.; McClelland, Michael; Andrews-Polymenis, Helene L.			Identification of Novel Factors Involved in Modulating Motility of Salmonella enterica Serotype Typhimurium	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; SEROVAR TYPHIMURIUM; SWARMING MOTILITY; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; GENE-EXPRESSION; TYPE-1 FIMBRIAE; VIRULENCE; HOST	Salmonella enterica serotype Typhimurium can move through liquid using swimming motility, and across a surface by swarming motility. We generated a library of targeted deletion mutants in Salmonella Typhimurium strain ATCC14028, primarily in genes specific to Salmonella, that we have previously described. In the work presented here, we screened each individual mutant from this library for the ability to move away from the site of inoculation on swimming and swarming motility agar. Mutants in genes previously described as important for motility, such as flgF, motA, cheY are do not move away from the site of inoculation on plates in our screens, validating our approach. Mutants in 130 genes, not previously known to be involved in motility, had altered movement of at least one type, 9 mutants were severely impaired for both types of motility, while 33 mutants appeared defective on swimming motility plates but not swarming motility plates, and 49 mutants had reduced ability to move on swarming agar but not swimming agar. Finally, 39 mutants were determined to be hypermotile in at least one of the types of motility tested. Both mutants that appeared non-motile and hypermotile on plates were assayed for expression levels of FliC and FljB on the bacterial surface and many of them had altered levels of these proteins. The phenotypes we report are the first phenotypes ever assigned to 74 of these open reading frames, as they are annotated as 'hypothetical genes' in the Typhimurium genome.	[Bogomolnaya, Lydia M.; Aldrich, Lindsay; Ragoza, Yuri; Talamantes, Marissa; Andrews, Katharine D.; Andrews-Polymenis, Helene L.] Texas A&M Univ, Coll Med, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA; [Bogomolnaya, Lydia M.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [McClelland, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	Texas A&M University System; Texas A&M University College Station; Kazan Federal University; University of California System; University of California Irvine	Andrews-Polymenis, HL (corresponding author), Texas A&M Univ, Coll Med, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA.	handrews@medicine.tamhsc.edu		McClelland, Michael/0000-0003-1788-9347	NIH/NIAID [R01AI083646, R56AI077645, R01 AI075093]; Kazan Federal University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075093, R56AI077645, R01AI083646] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kazan Federal University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH/NIAID grants R01AI083646, R56AI077645 awarded to HAP, R01 AI075093 awarded to MM. LMB was supported in part by a subsidy to support the Program of competitive growth of Kazan Federal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Ahmad I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028351; Alteri CJ, 2011, MOL MICROBIOL, V82, P145, DOI 10.1111/j.1365-2958.2011.07804.x; Belas R, 1998, J BACTERIOL, V180, P6126; Berg HC, 2005, CURR BIOL, V15, pR599, DOI 10.1016/j.cub.2005.07.042; BLAIR DF, 1991, J BACTERIOL, V173, P4049, DOI 10.1128/jb.173.13.4049-4055.1991; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Brinkman FSL, 2001, INFECT IMMUN, V69, P5207, DOI 10.1128/IAI.69.8.5207-5211.2001; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Chandra H, 2008, ENVIRON MICROBIOL, V10, P1285, DOI 10.1111/j.1462-2920.2007.01542.x; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Chen BG, 2007, J BACTERIOL, V189, P8750, DOI 10.1128/JB.01109-07; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Clegg S, 2002, J BACTERIOL, V184, P1209, DOI 10.1128/jb.184.4.1209-1213.2002; Clernmer KM, 2008, J MED MICROBIOL, V57, P931, DOI 10.1099/jmm.0.47778-0; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Gomez-Gomez JM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-14; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; GuardPetter J, 1997, FEMS MICROBIOL LETT, V149, P173, DOI 10.1016/S0378-1097(97)00071-2; Haneda T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-324; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kato Y, 2007, BIOSCI BIOTECH BIOCH, V71, P77, DOI 10.1271/bbb.60375; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Ledeboer NA, 2006, INFECT IMMUN, V74, P3156, DOI 10.1128/IAI.01428-05; Lee J, 2012, MOL MICROBIOL, V84, P550, DOI 10.1111/j.1365-2958.2012.08043.x; Li BQ, 2012, NUCLEIC ACIDS RES, V40, P11073, DOI 10.1093/nar/gks869; Liaw SJ, 2001, J MED MICROBIOL, V50, P1039, DOI 10.1099/0022-1317-50-12-1039; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; NEVOLA JJ, 1985, INFECT IMMUN, V50, P152, DOI 10.1128/IAI.50.1.152-159.1985; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; Reynolds MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015800; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Shah DH, 2005, MICROBIOL-SGM, V151, P3957, DOI 10.1099/mic.0.28126-0; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Stafford GP, 2007, MICROBIOL-SGM, V153, P541, DOI 10.1099/mic.0.2006/002576-0; Stewart MW, 2011, EYE REP, V1, P12, DOI [10.4081/eye.2011.e5, 10.1007/978-94-007-0934-8_1]; STOCKER BA, 1961, NATURE, V189, P556, DOI 10.1038/189556a0; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Takaya A, 2012, MOL MICROBIOL, V83, P1268, DOI 10.1111/j.1365-2958.2012.08007.x; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Wada T, 2011, J BACTERIOL, V193, P1600, DOI 10.1128/JB.01494-10; Waite RD, 2012, J BACTERIOL, V194, P4521, DOI 10.1128/JB.06678-11; Wang KC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-111; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wang QF, 2006, J BACTERIOL, V188, P7981, DOI 10.1128/JB.00852-06; Wang WB, 2008, INFECT IMMUN, V76, P2051, DOI 10.1128/IAI.01557-07; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07; YEH KS, 1995, J BACTERIOL, V177, P6861, DOI 10.1128/jb.177.23.6861-6865.1995; Yeh KS, 2002, MICROBIOL IMMUNOL, V46, P1, DOI 10.1111/j.1348-0421.2002.tb02670.x; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Zhao RB, 1996, J BACTERIOL, V178, P258, DOI 10.1128/jb.178.1.258-265.1996	84	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111513	10.1371/journal.pone.0111513	http://dx.doi.org/10.1371/journal.pone.0111513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369209	Green Published, gold			2022-12-27	WOS:000344402000062
J	Brock, WA; Bentley, RA; O'Brien, MJ; Caiado, CCS				Brock, William A.; Bentley, R. Alexander; O'Brien, Michael J.; Caiado, Camilia C. S.			Estimating a Path through a Map of Decision Making	PLOS ONE			English	Article							INDIVIDUALS; MODELS; TRANSMISSION; TEMPERATURE; SIMULATION; DEMOGRAPHY; EVOLUTION; PEER	Studies of the evolution of collective behavior consider the payoffs of individual versus social learning. We have previously proposed that the relative magnitude of social versus individual learning could be compared against the transparency of payoff, also known as the "transparency'' of the decision, through a heuristic, two-dimensional map. Moving from west to east, the estimated strength of social influence increases. As the decision maker proceeds from south to north, transparency of choice increases, and it becomes easier to identify the best choice itself and/or the best social role model from whom to learn (depending on position on east-west axis). Here we show how to parameterize the functions that underlie the map, how to estimate these functions, and thus how to describe estimated paths through the map. We develop estimation methods on artificial data sets and discuss real-world applications such as modeling changes in health decisions.	[Brock, William A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Bentley, R. Alexander] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [O'Brien, Michael J.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Caiado, Camilia C. S.] Univ Durham, Dept Math Sci, Durham, England	University of Wisconsin System; University of Wisconsin Madison; University of Bristol; University of Missouri System; University of Missouri Columbia; Durham University	Bentley, RA (corresponding author), Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England.	r.a.bentley@bristol.ac.uk	Bentley, R Alexander/GWZ-8982-2022	Bentley, R. Alexander/0000-0001-9086-2197; Caiado, Camila/0000-0002-8136-1531	Leverhulme Trust "Tipping Points'' program	Leverhulme Trust "Tipping Points'' program	This research was partially supported by the Leverhulme Trust "Tipping Points'' program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEMIYA T, 1981, J ECON LIT, V19, P1483; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Arcidiacono P, 2013, ADV ECONOMETRICS, V31, P45, DOI 10.1108/S0731-9053(2013)0000032002; Baronchelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052742; Bentley RA, 2014, BEHAV BRAIN SCI, V37, P63, DOI 10.1017/S0140525X13000289; Bentley RA, 2012, CURR ZOOL, V58, P298, DOI 10.1093/czoolo/58.2.298; Boyd R., 1985, CULTURE EVOLUTIONARY; Brock W.A., 2001, HDB ECONOMETRICS, V5, P3297, DOI DOI 10.1016/S1573-4412(01)05007-3; Colleran H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2732; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Dean D, 2011, MCKINSEY Q       JAN, P1; Gibson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048708; Gintis H, 2007, BEHAV BRAIN SCI, V30, P1, DOI 10.1017/S0140525X07000581; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Greene W.H., 2012, ECONOMETRIC ANAL; Hausmann R, 2011, J ECON GROWTH, V16, P309, DOI 10.1007/s10887-011-9071-4; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J., 2010, INNOVATION CULTURAL, P99, DOI DOI 10.1038/nature00823; Henrich J, 2011, PHILOS T R SOC B, V366, P1139, DOI 10.1098/rstb.2010.0323; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Kempe M, 2014, EVOLUTION HUMAN BEHA, V35; Krauth BV, 2007, J BUS ECON STAT, V25, P288, DOI 10.1198/073500106000000396; Krauth BV, 2006, J ECONOMETRICS, V133, P243, DOI 10.1016/j.jeconom.2005.03.015; Laland KN, 2004, LEARN BEHAV, V32, P4; Malakoff D, 2011, SCIENCE, V333, P544, DOI 10.1126/science.333.6042.544; Mann RP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002961; Mavrodiev P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01360; McElreath R., 2007, MATH MODELS SOCIAL E; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mesoudi A., 2011, CULTURAL EVOLUTION D; Mesoudi A, 2008, EVOL HUM BEHAV, V29, P350, DOI 10.1016/j.evolhumbehav.2008.04.005; Mesoudi Alex, 2008, Biological Theory, V3, P63, DOI 10.1162/biot.2008.3.1.63; Nettle D, 2009, TRENDS ECOL EVOL, V24, P618, DOI 10.1016/j.tree.2009.05.013; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; O'Brien MJ, 2011, J ARCHAEOL METHOD TH, V9, P1; PALFREY TR, 1987, AM J POLIT SCI, V31, P511, DOI 10.2307/2111281; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Shenk MK, 2013, P NATL ACAD SCI USA, V110, P8045, DOI 10.1073/pnas.1217029110; Snijders TA, 2013, SOCIOLOGICAL METHODS, V4; Sridhar S, 2012, J MARKETING, V76, P70, DOI 10.1509/jm.10.0377; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Traulsen A, 2007, J THEOR BIOL, V244, P349, DOI 10.1016/j.jtbi.2006.08.008; Turchin P, 2013, P NATL ACAD SCI US	49	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111022	10.1371/journal.pone.0111022	http://dx.doi.org/10.1371/journal.pone.0111022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369369	Green Published, Green Accepted, gold			2022-12-27	WOS:000344402000032
J	Ding, SJ; Niu, GY; Xu, XH; Li, JP; Zhang, XM; Yin, HY; Zhang, NJ; Jiang, XL; Wang, SW; Liang, MF; Wang, XJ; Yu, XJ				Ding, Shujun; Niu, Guoyu; Xu, Xuehua; Li, Jinping; Zhang, Xiaomei; Yin, Haiying; Zhang, Naijie; Jiang, Xiaolin; Wang, Shiwen; Liang, Mifang; Wang, Xianjun; Yu, Xue-jie			Age Is a Critical Risk Factor for Severe Fever with Thrombocytopenia Syndrome	PLOS ONE			English	Article							SYNDROME VIRUS; SHANDONG PROVINCE; BUNYAVIRUS; CHINA	Background: Severe Fever with Thrombocytopenia Syndrome (SFTS) is an emerging infectious disease in East Asia. SFTS is a tick borne hemorrhagic fever caused by SFTSV, a new bunyavirus named after the syndrome. We investigated the epidemiology of SFTS in Laizhou County, Shandong Province, China. Methods: We collected serum specimens of all patients who were clinically diagnosed as suspected SFTS cases in 2010 and 2011 in Laizhou County. The patients' serum specimens were tested for SFTSV by real time fluorescence quantitative PCR (RT-qPCR). We collected 1,060 serum specimens from healthy human volunteers by random sampling in Laizhou County in 2011. Healthy persons' serum specimens were tested for specific SFTSV IgG antibody by ELISA. Results: 71 SFTS cases were diagnosed in Laizhou County in 2010 and 2011, which resulted in the incidence rate of 4.1/100,000 annually. The patients ranged from 15 years old to 87 years old and the median age of the patients were 59 years old. The incidence rate of SFTS was significantly higher in patients over 40 years old and fatal cases only occurred in patients over 50 years old. 3.3% (35/1,060) of healthy people were positive to SFTSV IgG antibody. The SFTSV antibody positive rate was not significantly different among people at different age groups. Conclusion: Our results revealed that seroprevalence of SFTSV in healthy people in Laizhou County was not significantly different among age groups, but SFTS patients were mainly elderly people, suggesting that age is the critical risk factor or determinant for SFTS morbidity and mortality.	[Ding, Shujun; Yu, Xue-jie] Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China; [Ding, Shujun; Zhang, Xiaomei; Jiang, Xiaolin; Wang, Xianjun] Shandong Ctr Dis Control & Prevent, Dept Viral Infect Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Jinan, Shandong, Peoples R China; [Niu, Guoyu; Wang, Shiwen; Liang, Mifang] China CDC, Natl Inst Viral Dis Control & Prevent, MOH, Key Lab Med Virol, Beijing, Peoples R China; [Niu, Guoyu] Tianjin Int Travel Hlth Care Ctr, Tianjin, Peoples R China; [Xu, Xuehua; Li, Jinping; Yin, Haiying; Zhang, Naijie] Laizhou City Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Laizhou, Shandong, Peoples R China; [Yu, Xue-jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Texas System; University of Texas Medical Branch Galveston	Wang, XJ (corresponding author), Shandong Ctr Dis Control & Prevent, Dept Viral Infect Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Jinan, Shandong, Peoples R China.	xjwang62@163.com; yuxuejie@sdu.edu.cn	Yu, Xuejie/AAP-9246-2021		National Natural Science Foundation of China [81102171]; Shandong Medical Science and Technology Development Program [2011HZ055]; Shandong Province Science and Technology Development Plan [2012GHZ30031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Medical Science and Technology Development Program; Shandong Province Science and Technology Development Plan	This work was supported by the National Natural Science Foundation of China (Grant No. 81102171), (http://www.nsfc.gov.cn) to SJD, Shandong Medical Science and Technology Development Program (Grant No. 2011HZ055), (http://www.sdws.gov.cn) to SJD, and Shandong Province Science and Technology Development Plan (Grant No. 2012GHZ30031), (http://www.sdstc.gov.cn) to XMZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Chen K, 2014, LETT BIOTECHNOLOGY, V25, P100; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Liu Y, 2011, VECTOR-BORNE ZOONOT, V12, P160; Liu Y, 2014, J VIROL, V88, P1781, DOI 10.1128/JVI.02277-13; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Wen HL, 2014, EMERG INFECT DIS, V20, P1, DOI 10.3201/eid2001.120532; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	20	51	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111736	10.1371/journal.pone.0111736	http://dx.doi.org/10.1371/journal.pone.0111736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369237	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000095
J	Fuchs, H; Theuser, M; Wruck, W; Adjaye, J				Fuchs, Heiko; Theuser, Matthias; Wruck, Wasco; Adjaye, James			miR-27 Negatively Regulates Pluripotency-Associated Genes in Human Embryonal Carcinoma Cells	PLOS ONE			English	Article							LIVER RECEPTOR HOMOLOG-1; STEM-CELLS; TGF-BETA; NEURONAL DIFFERENTIATION; OCT4 EXPRESSION; E-CADHERIN; MICRORNAS; MOUSE; ANGIOGENESIS; REPRESSION	Human embryonic stem cells and human embryonal carcinoma cells have been studied extensively with respect to the transcription factors (OCT4, SOX2 and NANOG), epigenetic modulators and associated signalling pathways that either promote self-renewal or induce differentiation in these cells. The ACTIVIN/NODAL axis (SMAD2/3) of the TGF beta signalling pathway coupled with FGF signalling maintains self-renewal in these cells, whilst the BMP (SMAD1,5,8) axis promotes differentiation. Here we show that miR-27, a somatic-enriched miRNA, is activated upon RNAi-mediated suppression of OCT4 function in human embryonic stem cells. We further demonstrate that miR-27 negatively regulates the expression of the pluripotency-associated ACTIVIN/NODAL axis (SMAD2/3) of the TGF beta signalling pathway by targeting ACVR2A, TGF beta R1 and SMAD2. Additionally, we have identified a number of pluripotency-associated genes such as NANOG, LIN28, POLR3G and NR5A2 as novel miR-27 targets. Transcriptome analysis revealed that miR-27 over-expression in human embryonal carcinoma cells leads indeed to a significant up-regulation of genes involved in developmental pathways such as TGF beta- and WNT-signalling.	[Fuchs, Heiko; Wruck, Wasco; Adjaye, James] Univ Dusseldorf, Fac Med, Inst Stem Cell Res & Regenerat Med, Dusseldorf, Germany; [Theuser, Matthias; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, D-14195 Berlin, Germany	Heinrich Heine University Dusseldorf; Max Planck Society	Adjaye, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Stem Cell Res & Regenerat Med, Dusseldorf, Germany.	james.adjaye@med.uni-duesseldorf.de		Fuchs, Heiko/0000-0001-9142-4084	BMBF Initiative "MedizinischenSystembiologie-MedSys'' [DRUG-iPS/0315398G]; Medical Faculty of Heinrich Heine University, Duesseldorf	BMBF Initiative "MedizinischenSystembiologie-MedSys''; Medical Faculty of Heinrich Heine University, Duesseldorf	This work was funded by the BMBF Initiative "MedizinischenSystembiologie-MedSys'' (DRUG-iPS/0315398G) and partly by the Medical Faculty of Heinrich Heine University, Duesseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jiang JM, 2008, CELL STEM CELL, V3, P127, DOI 10.1016/j.stem.2008.07.011; Jozefczuk J, 2011, STEM CELLS DEV, V20, P1259, DOI 10.1089/scd.2010.0361; Kang H, 2012, J BIOL CHEM, V287, P38656, DOI 10.1074/jbc.M112.390898; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Lozano-Velasco E, 2011, DEV BIOL, V357, P165, DOI 10.1016/j.ydbio.2011.06.039; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Mazda M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028688; Miyazaki S, 2012, JPN J CLIN ONCOL, V42, P773, DOI 10.1093/jjco/hys108; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sung B, 2012, BIOCHEM BIOPH RES CO, V427, P315, DOI 10.1016/j.bbrc.2012.09.049; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang W, 2012, PLOS ONE, V7; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Wong RCB, 2011, STEM CELLS, V29, P1517, DOI 10.1002/stem.714; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zheng YB, 2010, J BIOL CHEM, V285, P35654, DOI 10.1074/jbc.M110.128959; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	64	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111637	10.1371/journal.pone.0111637	http://dx.doi.org/10.1371/journal.pone.0111637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369332	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000080
J	Medimegh, I; Omrane, I; Privat, M; Uhrhummer, N; Ayari, H; Belaiba, F; Benayed, F; Benromdhan, K; Mader, S; Bignon, IJ; Elgaaied, AB				Medimegh, Imen; Omrane, Ines; Privat, Maud; Uhrhummer, Nancy; Ayari, Hajer; Belaiba, Fadoua; Benayed, Farhat; Benromdhan, Khaled; Mader, Sylvie; Bignon, Ives-Jean; Elgaaied, Amel Benammar			MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; SIGNATURE; RISK; METASTASIS; INVASION; MIR-146A; TARGETS; MIR-21; ASSOCIATION; CARCINOMAS	Introduction: MicroRNAs are small, non coding regulatory molecules containing approximately 21 to 25 nucleotides. They function as controllers of expression at post transcriptional levels of most human protein-coding genes and play an essential role in cell signaling pathways. The objective of the present study is to evaluate the expression profile of the following micro-RNAs: miR-10b, miR-17, miR-21, miR-34a, miR-146a, miR-148a and miR-182, and to determine their possible interaction in triple-negative and non triple-negative primary breast cancers based on clinical outcome. Methods: 60 triple-negative and non triple-negative breast cancer cases, along with their corresponding normal samples were investigated in relation to the expression of the seven studied miRNAs using qPCR Syber Green. Results: We observed that miR-21, miR-146a and miR-182 were significantly over expressed in triple negative breast cancer. Moreover, miR-10b, miR-21 and miR-182 were significantly associated to lymph node metastases occurrence in triple negative breast carcinoma while only miR-10b was associated with grade III in non triple negative breast cancer cases. Almost all the analyzed microRNAs were strongly associated with patients' genico-obstetric history in non triple negative breast cancer cases except for miR-34a. All the studied microRNAs were strongly correlated with the use of the contraceptive pills in non triple negative breast cancer groups. The additive effect of hormonal factors in triple negative breast cancer cases showed an association with all the studied miRs except for miR-34 and miR-146a. Conclusion: The studied microRNAs are strongly influenced by environmental factors especially with hormonal patients' history. Moreover, miR-10b, miR-21 and miR-182 could be defined as biomarkers in breast cancer to predict both lymph node metastases and grade III occurrence.	[Medimegh, Imen; Omrane, Ines; Ayari, Hajer; Belaiba, Fadoua; Elgaaied, Amel Benammar] Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Immunol & Human Pathol, Tunis, Tunisia; [Benayed, Farhat; Benromdhan, Khaled] Salah Azaiez Inst Carcinol, Tunis, Tunisia; [Privat, Maud; Uhrhummer, Nancy; Bignon, Ives-Jean] Ctr Jean Perrin, Lab Genet & Mol Diagnost, Clermont Ferrand, France; [Mader, Sylvie] Univ Montreal, Immunol & Canc Res Inst, Lab Mol Screening Treatment Breast Canc, Montreal, PQ, Canada	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); UNICANCER; Centre Jean Perrin; Universite de Montreal	Medimegh, I (corresponding author), Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Immunol & Human Pathol, Tunis, Tunisia.	imen.medimegh@gmail.com	, Maud/ABB-9090-2021; Elgaaied, Amel Ben Ammar/AAL-1183-2020	, Maud/0000-0002-9373-3902; 				Andres R, 2014, CLIN TRANSL ONCOL, V16, P280, DOI 10.1007/s12094-013-1070-9; Bagaria SP, 2014, JAMA SURG, V149, P125, DOI 10.1001/jamasurg.2013.3181; Beaber EF, 2014, CANCER EPIDEM BIOMAR, V23, P755, DOI 10.1158/1055-9965.EPI-13-0944; Calvano Filho CM, 2014, TUMOUR BIOL; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Chou WW, 2013, CELL PHYSIOL BIOCHEM, V32, P127, DOI 10.1159/000350131; Christodoulatos GS, 2014, WORLD J CLIN ONCOL, V5, P71, DOI 10.5306/wjco.v5.i2.71; Elebro K, 2014, CANC CAUSES CONTROL; Fritz HK, 2014, EUR J CANC; Gao JJ, 2013, CHINESE J CANCER RES, V25, P743, DOI 10.3978/j.issn.1000-9604.2013.12.04; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Hardell E, 2010, SCI TOTAL ENVIRON, V408, P4412, DOI 10.1016/j.scitotenv.2010.06.029; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Iorfida M, 2012, BREAST CANCER RES TR, V133, P713, DOI 10.1007/s10549-012-2002-z; Jaitak V, 2014, ANTICANCER AGENTS ME; Jiang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096698; Knoop AS, 2014, EUR J CANCER, V50, P1412, DOI 10.1016/j.ejca.2014.02.022; Korlimarla A, 2014, ANN ONCOL         S1, V25, pi9; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kumar S, 2013, INDIAN J BIOCHEM BIO, V50, P210; Leidy J, 2014, ARCH PATHOL LAB MED, V138, P37, DOI 10.5858/arpa.2012-0439-RA; Leite KRM, 2013, UROL ONCOL-SEMIN ORI, V31, P796, DOI 10.1016/j.urolonc.2011.07.002; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maly JJ, 2014, BREAST CANCER-BASIC, V8, P81, DOI 10.4137/BCBCR.S9032; McMillen BD, 2012, MODERN PATHOL, V25, P1644, DOI 10.1038/modpathol.2012.118; Montero JC, 2014, ONCOGENE, V33, P148, DOI 10.1038/onc.2012.572; Niemiec JA, 2014, APPL IMMUNOHISTO M M, V22, P10, DOI 10.1097/PAI.0b013e318286030d; Nugent M, 2014, CANCER MANAG RES, V6, P15, DOI 10.2147/CMAR.S53928; Park HS, 2014, MOD PATHOL; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petrovic N, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0977-5; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Puppin C, 2014, ENDOCRINE; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Shah MY, 2014, WIRES RNA, V5, P537, DOI 10.1002/wrna.1229; Subtil FSB, 2014, FASEB J, V28, P1412, DOI 10.1096/fj.13-242230; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Varendi K, 2014, CELL MOL LIFE SCI; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; VORHERR H, 1979, SEMIN PERINATOL, V3, P299; Vormoor B, 2014, CURR OPIN ONCOL; Wang JB, 2012, MUTAGENESIS, V27, P779, DOI 10.1093/mutage/ges052; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Williams CKO, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.396; Zhu K, 2013, CARCINOGENESIS, V34, P2071, DOI 10.1093/carcin/bgt160	48	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111877	10.1371/journal.pone.0111877	http://dx.doi.org/10.1371/journal.pone.0111877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369070	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000116
J	Cui, ZY; Pan, XL; Wang, QR				Cui, Zhaoyang; Pan, Xinliang; Wang, Qirong			LOH Detected by Microsatellite Markers Reveals the Clonal Origin of Recurrent Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							NECK-CANCER; INTRAHEPATIC METASTASIS; FIELD CANCERIZATION; ADVANCED HEAD; HETEROZYGOSITY; PROGRESSION; DIAGNOSIS; MICROMETASTASIS; CHEMOTHERAPY; MUTATIONS	Background: The question of whether "recurrent'' laryngeal carcinoma is truly a new tumour with a clonal origin that differs from that of the primary tumour has remained unanswered. The objective of this study was to determine whether recurrent tumours have the same genetic basis as primary tumours, as the answer to this question is important for the development of treatment strategies. Materials and Methods: Matched samples consisting of primary tumour, recurrent tumour and normal tissue were obtained from the same patient. A total of 37 patients with laryngeal cancer were examined for loss of heterozygosity (LOH) on the 3p, 5p, 7q, 8p, 9p, 13p, 17p and 18q chromosomal arms using PCR to amplify microsatellite markers. All patients were routinely followed up and 5-year survival rates were calculated using directly calculating method and Kaplan-Meier's method. Results: A total of 28 out of 37 (75.6%) patients showed LOH at a minimum of one locus, and 19 out of 37 (51.3%) patients showed LOH at two loci. Primary and recurrent tumours in each patient showed identical allelic loss patterns and incidence rates. Patients without LOH had a longer average time to recurrence than patients with LOH (P<0.05). Additionally, patients with LOH had a longer average smoking duration prior to surgery than patients without LOH (P<0.05). The 5-year survival rates were 32.14% in patients with LOH versus 44.4% in patients without LOH. Conclusions: The data indicate that primary and recurrent tumours have the same clonal origin. This result implies that we failed to radically resect the primary tumours and/or micrometastases in these patients. Consequently, some form of adjunctive therapy may be necessary. Additionally, the data indicate that the recurrence of laryngeal squamous cell carcinoma is closely related to chromosomal aberrations (specifically LOH).	[Cui, Zhaoyang; Wang, Qirong] Shandong Univ, Dept Otorhinolaryngol, Clin Med Coll, Shandong Prov Qianfoshan Hosp, Jinan 250100, Peoples R China; [Pan, Xinliang] Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Cui, ZY (corresponding author), Shandong Univ, Dept Otorhinolaryngol, Clin Med Coll, Shandong Prov Qianfoshan Hosp, Jinan 250100, Peoples R China.	ty0261_cn@sina.com			Natural Science Foundation of Shandong [2010HL004]	Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This study was supported by the Natural Science Foundation of Shandong (2010HL004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizel DM, 1998, NEW ENGL J MED, V338, P1798, DOI 10.1056/NEJM199806183382503; Calais G, 1999, J NATL CANCER I, V91, P2081, DOI 10.1093/jnci/91.24.2081; Califano J, 1996, CANCER RES, V56, P2488; Collaud S, 2010, J BIOMOL TECH, V1, P25; dos RPP, 2002, MED SCI MONITOR, V3, pBR89; Goodwin WJ, 2000, LARYNGOSCOPE, V110, P1, DOI 10.1097/00005537-200003001-00001; Graveland AP, 2011, INT J CANCER, V128, P1852, DOI 10.1002/ijc.25523; Hamakawa H, 1999, CLIN EXP METASTAS, V17, P593, DOI 10.1023/A:1006732911057; Harrison D, 1990, LARYNGOSCOPE, V11, P1191; Jamieson TA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-4; Jia I, 2012, MED RECAPITULATE, V15, P2410; Kamat N, 2013, ONCOL LETT, V6, P1413, DOI 10.3892/ol.2013.1573; Marioni G, 2006, CANCER TREAT REV, V32, P504, DOI 10.1016/j.ctrv.2006.07.002; Marshak G, 1999, INT J RADIAT ONCOL, V43, P1009, DOI 10.1016/S0360-3016(98)00547-1; Martin-Guerrero I, 2013, HAEMATOLOGICA, V98, P1237, DOI 10.3324/haematol.2012.073916; NAWROZ H, 1994, CANCER RES, V54, P1152; Ng IOL, 2003, J PATHOL, V199, P345, DOI 10.1002/path.1287; Okada S, 2012, ANN SURG ONCOL, V19, P1499, DOI 10.1245/s10434-011-2166-5; Pack SD, 1999, GENE CHROMOSOME CANC, V25, P160, DOI 10.1002/(SICI)1098-2264(199906)25:2<160::AID-GCC12>3.0.CO;2-U; Pepinski W, 2009, FOLIA HISTOCHEM CYTO, V47, P105, DOI 10.2478/v10042-009-0019-x; Rawnaq T, 2011, J SURG RES, V169, P31, DOI 10.1016/j.jss.2009.12.032; Robinson WP, 2000, BIOESSAYS, V22, P452; Rube C, 1997, Strahlenther Onkol, V173, P83; Sang-Hyuk LSH, 2011, OTOLARYNGOL HEAD NEC, V1, P64; Sharma A, 2008, ANN OTO RHINOL LARYN, V117, P591, DOI 10.1177/000348940811700807; Shiga K, 2004, TOHOKU J EXP MED, V204, P163, DOI 10.1620/tjem.204.163; Shiga K, 2003, ANTICANCER RES, V23, P3911; SIMONEAU AR, 1994, WORLD J UROL, V12, P89; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Sow FB, 2009, INT J BIOMED SCI, V2, P105; Spurlock G, 2010, J CANCER RES CLIN, V136, P1869, DOI 10.1007/s00432-010-0846-3; Takai N, 2011, ARCH GYNECOL OBSTET, V284, P951, DOI 10.1007/s00404-010-1725-5; Tian YQ, 2002, OTORHINOLARYNGOLOGY; van Oijen MGCT, 2000, CANCER EPIDEM BIOMAR, V9, P249; Wendt TG, 1998, J CLIN ONCOL, V16, P1318, DOI 10.1200/JCO.1998.16.4.1318; Yoo WJ, 2004, J KOREAN MED SCI, V19, P345, DOI 10.3346/jkms.2004.19.3.345; Yoshioka S, 2002, SURGERY, V132, P34, DOI 10.1067/msy.2002.125306; YUEN APW, 1995, J LARYNGOL OTOL, V109, P1063; Zhao J, 2008, LIN CHUNG ER BI YAN, V18, P837; Zhu Z, 2013, CHINESE MED J-PEKING, V126, P3187, DOI 10.3760/cma.j.issn.0366-6999.20130656	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111857	10.1371/journal.pone.0111857	http://dx.doi.org/10.1371/journal.pone.0111857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365429	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100129
J	Sun, X; Zhong, Y; Huang, Z; Yang, YF				Sun, Xian; Zhong, Yu; Huang, Zhi; Yang, Yufeng			Selenium Accumulation in Unicellular Green Alga Chlorella vulgaris and Its Effects on Antioxidant Enzymes and Content of Photosynthetic Pigments	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE STRESS; CHLOROPHYLL-A; GROWTH; DAMAGE; PHYTOPLANKTON; REQUIREMENTS; SPECIATION; NUTRITION; TOXICITY	The aim of the present study was to investigate selenite effects in the unicellular green algae Chlorella vulgaris as a primary producer and the relationship with intracellular bioaccumulation. The effects of selenite were evaluated by measuring the effect of different selenite concentrations on algal growth during a 144 h exposure period. It was found that lower Se concentrations (<75 mg L-1) positively promoted C. vulgaris growth and acted as antioxidant by inhibiting lipid peroxidation (LPO) and intracellular reactive oxygen species (ROS). The antioxidative effect was associated with an increase in guaiacol peroxidase (GPX), catalase (CAT), superoxide dismutase (SOD) and photosynthetic pigments. Meanwhile, significant increase in the cell growth rate and organic Se content was also detected in the algae. In contrast, these changes were opposite in C. vulgaris exposed to Se higher than 100 mg L-1. The antioxidation and toxicity appeared to be correlated to Se bioaccumulation, which suggests the appropriate concentration of Se in the media accumulation of C. vulgaris should be 75 mg L-1. Taken together, C. vulgaris possesses tolerance to Se, and Se-Chlorella could be developed as antioxidative food for aquaculture and human health.	[Sun, Xian; Zhong, Yu; Yang, Yufeng] Jinan Univ, Inst Hydrobiol, Guangzhou 510632, Guangdong, Peoples R China; [Sun, Xian; Zhong, Yu; Yang, Yufeng] Guangdong Higher Educ Inst, Key Lab Aquat Eutrophicat & Control Harmful Algal, Guangzhou 510632, Guangdong, Peoples R China; [Huang, Zhi] Jinan Univ, Dept Biotechnol, Guangzhou 510632, Guangdong, Peoples R China	Chinese Academy of Sciences; Jinan University; Jinan University	Yang, YF (corresponding author), Jinan Univ, Inst Hydrobiol, Guangzhou 510632, Guangdong, Peoples R China.	tyyf@jnu.edu.cn			Nature Science Foundation of China [U1301235, 41173079]; Support Project of the Science and Technology, China [2012BAC07B05, 2012BAD18B01]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Support Project of the Science and Technology, China	This work was supported by Nature Science Foundation of China (U1301235, 41173079) and the Support Project of the Science and Technology, China (2012BAC07B05, 2012BAD18B01). (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuner E, 2004, PROCESS BIOCHEM, V39, P623, DOI 10.1016/S0032-9592(03)00138-9; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; Baines SB, 2004, LIMNOL OCEANOGR, V49, P566, DOI 10.4319/lo.2004.49.2.0566; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEER S, 1985, AUST J MAR FRESH RES, V36, P785; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; Candan N, 2003, PLANT PHYSIOL BIOCH, V41, P35, DOI 10.1016/S0981-9428(02)00006-2; Chang WP, 2005, DEV COMP IMMUNOL, V29, P265, DOI 10.1016/j.dci.2004.07.004; Chassaigne H, 2002, J CHROMATOGR A, V976, P409, DOI 10.1016/S0021-9673(02)00945-7; Chen TF, 2008, J INTEGR PLANT BIOL, V50, P40, DOI 10.1111/j.1744-7909.2007.00600.x; Conde JE, 1997, CHEM REV, V97, P1979, DOI 10.1021/cr960100g; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762, DOI 10.1093/oxfordjournals.pcp.a029603; de Alcantara S., 1998, Indian Journal of Experimental Biology, V36, P1286; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DEVOS CHR, 1989, J PLANT PHYSIOL, V135, P164, DOI 10.1016/S0176-1617(89)80171-3; Doblin MA, 1999, J PLANKTON RES, V21, P1153, DOI 10.1093/plankt/21.6.1153; Donahue JL, 1997, PLANT PHYSIOL, V113, P249, DOI 10.1104/pp.113.1.249; Doucha J, 2009, APPL MICROBIOL BIOT, V83, P1001, DOI 10.1007/s00253-009-2058-9; Douskova I., 2007, SEFS 5 S EUR FRESHW, P197; Ebert R, 2006, STEM CELLS, V24, P1226, DOI 10.1634/stemcells.2005-0117; Ekelund NGA, 2001, AQUAT SCI, V63, P457, DOI 10.1007/s00027-001-8044-7; Fan TWM, 2002, AQUAT TOXICOL, V57, P65, DOI 10.1016/S0166-445X(01)00261-2; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Furness RW, 1990, HEAVY METALS MARINE; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HARRISON PJ, 1988, MAR ECOL PROG SER, V47, P89, DOI 10.3354/meps047089; Hartikainen H, 2000, PLANT SOIL, V225, P193, DOI 10.1023/A:1026512921026; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HEMEDA HM, 1990, J FOOD SCI, V55, P184, DOI 10.1111/j.1365-2621.1990.tb06048.x; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Jeong DW, 2002, FEBS LETT, V517, P225, DOI 10.1016/S0014-5793(02)02628-5; KIFFNEY P, 1990, ARCH ENVIRON CON TOX, V19, P488, DOI 10.1007/BF01059066; Kong LA, 2005, PLANT GROWTH REGUL, V45, P155, DOI 10.1007/s10725-005-1893-7; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lavu RVS, 2013, J PLANT NUTR SOIL SC, V176, P634, DOI 10.1002/jpln.201200339; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Levy JL, 2005, ENVIRON TOXICOL CHEM, V24, P2630, DOI 10.1897/04-580R.1; Li ZY, 2003, BIORESOURCE TECHNOL, V89, P171, DOI 10.1016/S0960-8524(03)00041-5; Lin YH, 2007, AQUACULTURE, V267, P38, DOI 10.1016/j.aquaculture.2006.12.015; Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Neumann PM, 2003, PLANT CELL ENVIRON, V26, P897, DOI 10.1046/j.1365-3040.2003.01022.x; Patrick Lyn, 2004, Altern Med Rev, V9, P239; Pedrero Z, 2008, J AGR FOOD CHEM, V56, P266, DOI 10.1021/jf072266w; Pelah D, 2005, PLANT GROWTH REGUL, V45, P225, DOI 10.1007/s10725-005-3230-6; Phang SM, 2001, PHOTOSYNTHETIC MICROORGANISMS IN ENVIRONMENTAL BIOTECHNOLOGY, P51; Polatajko A, 2006, J ANAL ATOM SPECTROM, V21, P639, DOI 10.1039/b605654g; Pronina NA, 2002, RUSS J PLANT PHYSL+, V49, P235, DOI 10.1023/A:1014809825140; Rana SVS, 1997, B ENVIRON CONTAM TOX, V59, P152, DOI 10.1007/s001289900458; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sager M, 2006, PURE APPL CHEM, V78, P111, DOI 10.1351/pac200678010111; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Srivastava M, 2009, BIORESOURCE TECHNOL, V100, P1115, DOI 10.1016/j.biortech.2008.08.026; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Thomas H, 2001, ADV BOT RES, V35, P1, DOI 10.1016/S0065-2296(01)35003-6; THOMPSON JE, 1987, NEW PHYTOL, V105, P317, DOI 10.1111/j.1469-8137.1987.tb00871.x; Wada O, 1993, JPN J NUTR ASSESS, V10, P199; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; Wu QY, 1992, PROG NAT SCI, V3, P435; YAMAOKA Y, 1994, APPL ORGANOMET CHEM, V8, P229, DOI 10.1002/aoc.590080312	68	33	37	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112270	10.1371/journal.pone.0112270	http://dx.doi.org/10.1371/journal.pone.0112270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375113	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600124
J	Yamanaka, Y; Oshima, T; Ishihama, A; Yamamoto, K				Yamanaka, Yuki; Oshima, Taku; Ishihama, Akira; Yamamoto, Kaneyoshi			Characterization of the YdeO Regulon in Escherichia coli	PLOS ONE			English	Article							DEPENDENT ACID RESISTANCE; CYX-APPA OPERON; TRANSCRIPTIONAL ACTIVATOR; BINDING PROFILES; GADE YHIE; GENE; REGULATOR; NETWORK; PROTEIN; SYSTEM	Enterobacteria are able to survive under stressful conditions within animals, such as acidic conditions in the stomach, bile salts during transfer to the intestine and anaerobic conditions within the intestine. The glutamate-dependent ( GAD) system plays a major role in acid resistance in Escherichia coli, and expression of the GAD system is controlled by the regulatory cascade consisting of EvgAS > YdeO > GadE. To understand the YdeO regulon in vivo, we used ChIP-chip to interrogate the E. coli genome for candidate YdeO binding sites. All of the seven operons identified by ChIP-chip as being potentially regulated by YdeO were confirmed as being under the direct control of YdeO using RT-qPCR, EMSA, DNaseI-footprinting and reporter assays. Within this YdeO regulon, we identified four stress-response transcription factors, DctR, NhaR, GadE, and GadW and enzymes for anaerobic respiration. Both GadE and GadW are involved in regulation of the GAD system and NhaR is an activator for the sodium/proton antiporter gene. In conjunction with co-transcribed Slp, DctR is involved in protection against metabolic endoproducts under acidic conditions. Taken all together, we suggest that YdeO is a key regulator of E. coli survival in both acidic and anaerobic conditions.	[Yamanaka, Yuki; Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Micronano Technol Res Ctr, Koganei, Tokyo 184, Japan; [Oshima, Taku] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan	Hosei University; Hosei University; Nara Institute of Science & Technology	Yamamoto, K (corresponding author), Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan.	kanyamam@hosei.ac.jp	Yamanaka, Yuki/AAV-3504-2020	Yamanaka, Yuki/0000-0003-3479-9896	MEXT; Special Coordination Funds for Promoting Science and Technology and JSPS-DST International Collaborations; Grants-in-Aid for Scientific Research [25430173] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology and JSPS-DST International Collaborations; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities and Special Coordination Funds for Promoting Science and Technology and JSPS-DST International Collaborations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATLUNG T, 1994, J BACTERIOL, V176, P5414, DOI 10.1128/JB.176.17.5414-5422.1994; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brondsted L, 1996, J BACTERIOL, V178, P1556, DOI 10.1128/jb.178.6.1556-1564.1996; Burton NA, 2010, J MOL BIOL, V401, P726, DOI 10.1016/j.jmb.2010.06.054; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chumsakul O, 2011, NUCLEIC ACIDS RES, V39, P414, DOI 10.1093/nar/gkq780; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fried L, 2013, J BACTERIOL, V195, P807, DOI 10.1128/JB.02051-12; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Itou J, 2009, BIOSCI BIOTECH BIOCH, V73, P870, DOI 10.1271/bbb.80795; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kraxenberger T, 2012, 1 INSIGHTS UNEXPLORE; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Ma Z, 2004, J BACTERIOL, V186, P7378, DOI 10.1128/JB.186.21.7378-7389.2004; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Nguyen TM, 2012, ARCH MICROBIOL, V194, P637, DOI 10.1007/s00203-012-0798-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Uyar E, 2009, J BACTERIOL, V191, P2388, DOI 10.1128/JB.01594-08; Uzzau S, 2001, P NATL ACAD SCI USA, V94, P13997; Vanaja SK, 2009, J BACTERIOL, V191, P1868, DOI 10.1128/JB.01481-08; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wadington MC, 2009, BIOCHEMISTRY-US, V48, P6559, DOI 10.1021/bi9008825; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; Yamamoto K, 2014, BIOSCI BIOTECH BIOCH, V78, P737, DOI 10.1080/09168451.2014.915731; Yamanaka Y, 2012, BIOSCI BIOTECH BIOCH, V76, P1236, DOI 10.1271/bbb.120041	39	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111962	10.1371/journal.pone.0111962	http://dx.doi.org/10.1371/journal.pone.0111962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375160	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600081
J	Adnadevic, T; Jovanovic, VM; Blagojevic, J; Budinski, I; Cabrilo, B; Bijelic-Cabrilo, O; Vujosevic, M				Adnadevic, Tanja; Jovanovic, Vladimir M.; Blagojevic, Jelena; Budinski, Ivana; Cabrilo, Borislav; Bijelic-Cabrilo, Olivera; Vujosevic, Mladen			Possible Influence of B Chromosomes on Genes Included in Immune Response and Parasite Burden in Apodemus flavicollis	PLOS ONE			English	Article							YELLOW-NECKED MOUSE; CLASS-II EXPRESSION; REGULATORY T-CELLS; HELIGMOSOMOIDES-POLYGYRUS; SPECIES RICHNESS; BODY CONDITION; FIELD MICE; WOOD MICE; TGF-BETA; RESISTANCE	Genetic background underlying wild populations immune response to different parasites is still not well understood. We studied immune response to multiple infections and to competition between different parasite species at different developmental stages in population of yellow-necked mouse, Apodemus flavicollis. Quantitative real-time PCR was used to investigate associations of MHC II-DRB, IL-10 and Tgf-beta genes expressions with presence of intestinal parasites at different developmental stages. Furthermore, we were interested whether the host related characteristics (sex, age, body condition, presence of B chromosomes or expression of other genes) or characteristics of present parasites (number of adult parasites of each identified species, egg count of each parasite genus, total number of nematode individuals) affect differential expression of the studied genes. A significant invert association between the expression of MHC II-DRB and Tgf-beta gene was found, which together with absence of IL-10 association confirmed modified Th2 as the main type of immune response to nematode infections. Effect of recorded parasites and parasite life-cycle stage on expression levels of MHC II-DRB gene was detected only through interactions with host-related characteristics such as sex, age, and the presence of B chromosomes. The presence of B chromosomes is associated with lower expression level of Tgf-beta gene. Although the influence of host genetic background on parasite infection has already been well documented, this is the first study in mammals that gave presence of B chromosomes on immune response full consideration.	[Adnadevic, Tanja; Jovanovic, Vladimir M.; Blagojevic, Jelena; Budinski, Ivana; Vujosevic, Mladen] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Genet Res, Belgrade, Serbia; [Cabrilo, Borislav; Bijelic-Cabrilo, Olivera] Univ Novi Sad, Fac Sci, Dept Biol & Ecol, Novi Sad, Serbia	University of Belgrade; University of Novi Sad	Adnadevic, T (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Genet Res, Belgrade, Serbia.	tanja.adnadjevic@ibiss.bg.ac.rs	Budinski, Ivana/L-5470-2019; Blagojević, Jelena/B-4593-2008; Vujosevic, Mladen/C-3707-2016	Budinski, Ivana/0000-0001-8834-4200; Blagojević, Jelena/0000-0001-7102-5510; Vujosevic, Mladen/0000-0002-5577-4455; Cabrilo, Borislav/0000-0002-6085-3289; Adnadevic, Tanja/0000-0002-6665-861X; Jovanovic, Vladimir/0000-0002-8056-5065	Ministry of Education and Science of Serbia [173003]	Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of Serbia (http://www.mpn.gov.rs/nauka), Contract No. 173003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Axtner J, 2011, INFECT GENET EVOL, V11, P2063, DOI 10.1016/j.meegid.2011.09.020; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; Behnke JM, 2009, PARASITOLOGY, V136, P793, DOI 10.1017/S0031182009006039; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; Behnke JM, 1999, J HELMINTHOL, V73, P31, DOI 10.1017/S0022149X99000049; Blagojevic J, 2004, HEREDITY, V93, P249, DOI 10.1038/sj.hdy.6800460; Bordes F, 2009, OIKOS, V118, P801, DOI 10.1111/j.1600-0706.2008.17169.x; Bordes F, 2009, PARASITOL RES, V106, P33, DOI 10.1007/s00436-009-1623-6; Borisavljevic L, 1955, ZBORNIK RADOVA I EKO, V6, P1; Bradley JE, 2008, PARASITOLOGY, V135, P807, DOI 10.1017/S0031182008000322; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Cheng YM, 2003, GENETICS, V164, P299; Danilowicz-Luebert E, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/821578; Degen AA, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P371, DOI 10.1007/978-4-431-36025-4_19; DHERAWAT.A, 1973, CROP SCI, V13, P591, DOI 10.2135/cropsci1973.0011183X001300060002x; Eira C, 2006, ACTA PARASITOL, V51, P300, DOI 10.2478/s11686-006-0046-0; Ferrari N, 2004, ECOL LETT, V7, P88, DOI 10.1046/j.1461-0248.2003.00552.x; Ferrari N, 2009, PARASITOLOGY, V136, P305, DOI 10.1017/S0031182008005404; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Genov T, 1984, HELMINTI NASEKOMOYAD; Gorlov PI, 2000, HEREDITY EDINB, V84, P209; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hawrylowicz CM, 2005, J EXP MED, V202, P1459, DOI 10.1084/jem.20052211; Hayward AD, 2013, PARASITE IMMUNOL, V35, P362, DOI 10.1111/pim.12054; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hsu TC, 1969, COMP MAMMALIAN CYTOG, P454; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jackson JA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-16; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jojic V, 2007, J MAMMAL, V88, P689, DOI 10.1644/06-MAMM-A-019R1.1; Jojic V, 2011, J MAMMAL, V92, P396, DOI 10.1644/10-MAMM-A-158.1; Klein SL, 1998, AM NAT, V151, P59, DOI 10.1086/286102; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Klimpel S, 2007, PARASITOL RES, V100, P867, DOI 10.1007/s00436-006-0368-8; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; MCGIRR SC, 1978, GENETICS, V90, P331; Metwali A, 2006, AM J PHYSIOL-GASTR L, V291, pG253, DOI 10.1152/ajpgi.00409.2005; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Meyer-Lucht Y, 2009, EVOL ECOL RES, V11, P1085; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; MIAO VPW, 1991, MOL GEN GENET, V226, P214, DOI 10.1007/BF00273606; Muller-Graf CDM, 1999, PARASITOLOGY, V118, P425, DOI 10.1017/S003118209800393X; Musolf K, 2004, IMMUNOGENETICS, V56, P420, DOI 10.1007/s00251-004-0715-9; NABAGLO L, 1979, ACTA THERIOL, V24, P118, DOI 10.4098/AT.arch.79-15; Ohta T, 1998, J MOL EVOL, V46, P633, DOI 10.1007/PL00006343; Page BT, 2001, GENETICS, V159, P291; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pernthaner A, 2005, INFECT IMMUN, V73, P2175, DOI 10.1128/IAI.73.4.2175-2183.2005; Pinheiro J, 2020, R PACKAGE VERSION 31; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; R Core Team, 2012, R LANG ENV STAT COMP; Reiczigel J., 2005, QUANTITATIVE PARASIT; Roepstorff A, 1998, 3 FAO, V3; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Ryikov K., 1979, KEY RODENT HELMINTH; Ryikov K., 1978, KEY RODENT HELMINTH; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwensow N, 2011, INFECT GENET EVOL, V11, P23, DOI 10.1016/j.meegid.2010.10.017; StatSoft Inc, 1997, STAT WIND COMP PROGR; Tanic N, 2005, CHROMOSOMA, V113, P418, DOI 10.1007/s00412-004-0327-z; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vallance BA, 1999, INFECT IMMUN, V67, P6090, DOI 10.1128/IAI.67.11.6090-6097.1999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vujosevic M, 2007, ITAL J ZOOL, V74, P313, DOI 10.1080/11250000701508578; Vujosevic M, 2004, CYTOGENET GENOME RES, V106, P247, DOI 10.1159/000079295; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Zima J, 2003, CAN J ZOOL, V81, P1312, DOI 10.1139/Z03-128	72	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112260	10.1371/journal.pone.0112260	http://dx.doi.org/10.1371/journal.pone.0112260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372668	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900130
J	Evans, TA; Perdue, B; Beran, MJ				Evans, Theodore A.; Perdue, Bonnie; Beran, Michael J.			The Relationship between Event-Based Prospective Memory and Ongoing Task Performance in Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							SPONTANEOUS RETRIEVAL; LANGUAGE-SKILLS; INTENTION; COST; INTERFERENCE; DEMANDS; RAT	Prospective memory is remembering to do something at a future time. A growing body of research supports that prospective memory may exist in nonhuman animals, but the methods used to test nonhuman prospective memory differ from those used with humans. The current work tests prospective memory in chimpanzees using a method that closely approximates a typical human paradigm. In these experiments, the prospective memory cue was embedded within an ongoing task. Tokens representing food items could be used in one of two ways: in a matching task with pictures of items (the ongoing task) or to request a food item hidden in a different location at the beginning of the trial. Chimpanzees had to disengage from the ongoing task in order to use the appropriate token to obtain a higher preference food item. In Experiment 1, chimpanzees effectively matched tokens to pictures, when appropriate, and disengaged from the ongoing task when the token matched the hidden item. In Experiment 2, performance did not differ when the target item was either hidden or visible. This suggested no effect of cognitive load on either the prospective memory task or the ongoing task, but performance was near ceiling, which may have contributed to this outcome. In Experiment 3, we created a more challenging version of the task. More errors on the matching task occurred before the prospective memory had been carried out, and this difference seemed to be limited to the hidden condition. This finding parallels results from human studies and suggests that working memory load and prospective memory may have a similar relationship in nonhuman primates.	[Evans, Theodore A.; Beran, Michael J.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [Perdue, Bonnie] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA	University System of Georgia; Georgia State University	Evans, TA (corresponding author), Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA.	theodore.evans@gmail.com	Beran, Michael J./ABY-1786-2022; Beran, Michael J./M-8743-2016	Beran, Michael J./0000-0002-2504-0338; Beran, Michael J./0000-0002-2504-0338	National Science Foundation [BCS-0924811]; National Institute of Child Health and Human Development [P01HD060563]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD060563] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant BCS-0924811 from the National Science Foundation and by grant P01HD060563 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beran MJ, 2013, PSYCHOL SCI, V24, P660, DOI 10.1177/0956797612458936; Beran MJ, 2012, LEARN MOTIV, V43, P192, DOI 10.1016/j.lmot.2012.05.002; Beran MJ, 2012, AM J PRIMATOL, V74, P864, DOI 10.1002/ajp.22042; Beran MJ, 1998, EVOLUTION COMMUNICAT, V2, P171; Brakke KE, 1996, LANG COMMUN, V16, P361, DOI 10.1016/S0271-5309(96)00018-3; BRAKKE KE, 1995, LANG COMMUN, V15, P121, DOI 10.1016/0271-5309(95)00001-7; Brewer GA, 2011, APPL COGNITIVE PSYCH, V25, P632, DOI 10.1002/acp.1733; Brosnan SF, 2009, J COMP PSYCHOL, V123, P181, DOI 10.1037/a0015092; Crystal JD, 2013, BEHAV PROCESS, V93, P39, DOI 10.1016/j.beproc.2012.11.014; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1990, J EXPT PSYCHOL LEARN, V16, P716; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Evans TA, 2012, COGNITION, V125, P131, DOI 10.1016/j.cognition.2012.07.012; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Hicks JL, 2005, J MEM LANG, V53, P430, DOI 10.1016/j.jml.2005.04.001; Honig WK, 1982, PSYCHOL LEARN MOTIV, V16, P239, DOI DOI 10.1016/S0079-7421(08)60551-4; Kliegel M, 2001, MEMORY, V9, P1, DOI 10.1080/09658210042000003; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Kumar D, 2008, CLIN NEUROPSYCHOL, V22, P497, DOI 10.1080/13854040701396687; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Marsh RL, 2007, AGING NEUROPSYCHOL C, V14, P168, DOI 10.1080/138255891007074; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; Marsh RL, 2002, PSYCHON B REV, V9, P604, DOI 10.3758/BF03196319; McDaniel M. A., 2007, PROSPECTIVE MEMORY; McDaniel MA, 2004, APPL COGNITIVE PSYCH, V18, P533, DOI 10.1002/acp.1002; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Menzel CR, 1999, J COMP PSYCHOL, V113, P426, DOI 10.1037/0735-7036.113.4.426; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; Perdue BM, 2014, ANIM COGN, V17, P287, DOI 10.1007/s10071-013-0661-8; Rumbaugh D. M., 2003, INTELLIGENCE APES OT; Rumbaugh DM., 1977, LANGUAGE LEARNING CH; Savage-Rumbaugh E.S., 1986, APE LANGUAGE CONDITI, DOI DOI 10.7312/SAVA90374; Scullin MK, 2010, PSYCHOL SCI, V21, P1028, DOI 10.1177/0956797610373373; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; Scullin MK, 2009, MEM COGNITION, V37, P425, DOI 10.3758/MC.37.4.425; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; Wilson AG, 2013, CURR BIOL, V23, P1089, DOI 10.1016/j.cub.2013.04.067; Wilson AG, 2012, ANIM COGN, V15, P349, DOI 10.1007/s10071-011-0459-5	45	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112015	10.1371/journal.pone.0112015	http://dx.doi.org/10.1371/journal.pone.0112015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372809	Green Published, gold			2022-12-27	WOS:000344556900104
J	Matthies, IE; Malosetti, M; Roder, MS; van Eeuwijk, F				Matthies, Inge E.; Malosetti, Marcos; Roeder, Marion S.; van Eeuwijk, Fred			Genome-Wide Association Mapping for Kernel and Malting Quality Traits Using Historical European Barley Records	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; GRAIN PROTEIN-CONTENT; DOUBLED-HAPLOID POPULATION; BACKCROSS-QTL ANALYSIS; LINKAGE DISEQUILIBRIUM; SPRING BARLEY; YIELD COMPONENTS; GENETIC DIVERSITY; AGRONOMIC TRAITS; LOCI	Malting quality is an important trait in breeding barley (Hordeum vulgare L.). It requires elaborate, expensive phenotyping, which involves micro-malting experiments. Although there is abundant historical information available for different cultivars in different years and trials, that historical information is not often used in genetic analyses. This study aimed to exploit historical records to assist in identifying genomic regions that affect malting and kernel quality traits in barley. This genome-wide association study utilized information on grain yield and 18 quality traits accumulated over 25 years on 174 European spring and winter barley cultivars combined with diversity array technology markers. Marker-trait associations were tested with a mixed linear model. This model took into account the genetic relatedness between cultivars based on principal components scores obtained from marker information. We detected 140 marker-trait associations. Some of these associations confirmed previously known quantitative trait loci for malting quality (on chromosomes 1H, 2H, and 5H). Other associations were reported for the first time in this study. The genetic correlations between traits are discussed in relation to the chromosomal regions associated with the different traits. This approach is expected to be particularly useful when designing strategies for multiple trait improvements.	[Matthies, Inge E.; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Gene & Genome Mapping, Gatersleben, Sachsen Anhalt, Germany; [Malosetti, Marcos; van Eeuwijk, Fred] Wageningen Univ & Res Ctr, Wageningen, Gelderland, Netherlands	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Wageningen University & Research	Matthies, IE (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Gene & Genome Mapping, Gatersleben, Sachsen Anhalt, Germany.	matthies@ipk-gatersleben.de; marcos.malosetti@wur.nl	Malosetti, Marcos/J-7685-2013	Malosetti, Marcos/0000-0002-8150-1397; Roder, Marion/0000-0002-9313-0650	Federal Ministry of Education and Research (BMBF) within the GABI program (GENOBAR) [0315066C]; Generation Challenge Program (GCP) [221]	Federal Ministry of Education and Research (BMBF) within the GABI program (GENOBAR)(Federal Ministry of Education & Research (BMBF)); Generation Challenge Program (GCP)	This study was supported by a grant from the Federal Ministry of Education and Research (BMBF) within the GABI program (GENOBAR, project No. 0315066C). The work of Marcos Malosetti and Fred van Eeuwijk was supported by the Generation Challenge Program (GCP), project No. 221. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Adetunji I, 2014, THEOR APPL GENET, V127, P559, DOI 10.1007/s00122-013-2239-x; Alsop BP, 2011, MOL BREEDING, V27, P77, DOI 10.1007/s11032-010-9415-3; [Anonymous], 2013, GENSTAT WINDOWS; Barr AR, 2003, AUST J AGR RES, V54, P1117, DOI 10.1071/AR02190; Bauer AM, 2009, THEOR APPL GENET, V119, P105, DOI 10.1007/s00122-009-1021-6; Beattie AD, 2010, CROP SCI, V50, P1649, DOI 10.2135/cropsci2009.06.0334; Bezant J, 1997, MOL BREEDING, V3, P29, DOI 10.1023/A:1009648220852; Blake VC, 2012, PLANT GENOME-US, V5, P81, DOI 10.3835/plantgenome2012.03.0002; Bradbury P, 2011, CROP SCI, V51, P52, DOI 10.2135/cropsci2010.02.0064; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cai SG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-35; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Dreher K, 2003, MOL BREEDING, V11, P221, DOI 10.1023/A:1022820520673; Edney MJ, 2004, J CEREAL SCI, V39, P283, DOI 10.1016/j.jcs.2003.10.008; Emebiri LC, 2005, J CEREAL SCI, V41, P107, DOI 10.1016/j.jcs.2004.08.012; Fischbeck G, 1992, BARLEY GENET, P887; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fox GP, 2003, AUST J AGR RES, V54, P1081, DOI 10.1071/AR02237; Grewal TS, 2008, THEOR APPL GENET, V116, P529, DOI 10.1007/s00122-007-0688-9; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Han F, 1997, MOL BREEDING, V3, P427, DOI 10.1023/A:1009608312385; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Haseneyer G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-5; HAYES PM, 1993, THEOR APPL GENET, V87, P392, DOI 10.1007/BF01184929; Heuberger AL, 2013, PLANT BIOTECHNOL J, P1; Igartua E, 2000, CROP SCI, V40, P1426, DOI 10.2135/cropsci2000.4051426x; Iwata H, 2011, CROP SCI, V51, P1915, DOI 10.2135/cropsci2010.12.0732; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kalladan R, 2013, MOL BREEDING, V32, P71, DOI 10.1007/s11032-013-9853-9; Kjaer B, 1996, EUPHYTICA, V90, P39; KOENKER RW, 1987, J R STAT SOC C-APPL, V36, P383; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kraakman ATW, 2006, MOL BREEDING, V17, P41, DOI 10.1007/s11032-005-1119-8; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Krumnacker K, 2009, THESIS TUM; Lapitan NLV, 2009, THEOR APPL GENET, V118, P937, DOI 10.1007/s00122-008-0951-8; Larson SR, 1996, THEOR APPL GENET, V93, P618, DOI 10.1007/BF00417957; Li J, 2005, THEOR APPL GENET, V110, P356, DOI 10.1007/s00122-004-1847-x; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Marquez-Cedillo LA, 2000, THEOR APPL GENET, V101, P173, DOI 10.1007/s001220051466; Marquez-Cedillo LA, 2001, THEOR APPL GENET, V103, P625, DOI 10.1007/PL00002919; Mather DE, 1997, CROP SCI, V37, P544, DOI 10.2135/cropsci1997.0011183X003700020039x; Matthies IE, 2009, MOL BREEDING, V23, P139, DOI 10.1007/s11032-008-9221-3; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; Matthies IE, 2012, EUPHYTICA, V184, P73, DOI 10.1007/s10681-011-0563-2; Matthies IE, 2009, EUPHYTICA, V170, P109, DOI 10.1007/s10681-009-9915-6; Molina-Cano JL, 2007, MOL BREEDING, V19, P275, DOI 10.1007/s11032-006-9075-5; Moralejo M, 2004, THEOR APPL GENET, V110, P116, DOI 10.1007/s00122-004-1805-7; Morris M, 2003, MONEY MATTERS 2 COST; Oliphant A., 2002, BIOTECHNIQUES, V32, pS56, DOI DOI 10.2144/JUN0207; Oziel A, 1996, PLANT BREEDING, V115, P43, DOI 10.1111/j.1439-0523.1996.tb00869.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pswarayi A, 2008, EUPHYTICA, V163, P435, DOI 10.1007/s10681-008-9726-1; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rode J, 2012, MOL BREEDING, V30, P831, DOI 10.1007/s11032-011-9667-6; Romagosa I, 1996, THEOR APPL GENET, V93, P30, DOI 10.1007/BF00225723; Romagosa I, 1999, MOL BREEDING, V5, P143, DOI 10.1023/A:1009684108922; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Schmalenbach I, 2009, THEOR APPL GENET, V118, P1411, DOI 10.1007/s00122-009-0991-8; Schmierer DA, 2004, MOL BREEDING, V14, P463, DOI 10.1007/s11032-004-0903-1; Schnaithmann F, 2013, EUPHYTICA, V189, P67, DOI 10.1007/s10681-012-0711-3; See D, 2002, CROP SCI, V42, P680, DOI 10.2135/cropsci2002.0680; Stich B, 2010, THEOR APPL GENET, V120, P553, DOI 10.1007/s00122-009-1175-2; SWANSTON JS, 2002, BARLEY SCI RECENT AD, P85; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Ullrich E, 2000, THEOR APPL GENET, V101, P173; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Varshney RK, 2010, TRENDS BIOTECHNOL, V28, P452, DOI 10.1016/j.tibtech.2010.06.007; von Korff M, 2008, MOL BREEDING, V21, P81, DOI 10.1007/s11032-007-9110-1; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Weise S., 2009, Barley Genetics Newsletter, V39, P1; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xu YB, 2012, MOL BREEDING, V29, P833, DOI 10.1007/s11032-012-9699-6; Xue DW, 2010, J ZHEJIANG UNIV-SC B, V11, P169, DOI 10.1631/jzus.B0900332; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang LY, 2009, THEOR APPL GENET, V119, P43, DOI 10.1007/s00122-009-1015-4; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zhu H, 1999, THEOR APPL GENET, V99, P1221, DOI 10.1007/s001220051328	100	38	38	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110046	10.1371/journal.pone.0110046	http://dx.doi.org/10.1371/journal.pone.0110046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372869	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900015
J	Mtatiro, SN; Singh, T; Rooks, H; Mgaya, J; Mariki, H; Soka, D; Mmbando, B; Msaki, E; Kolder, I; Thein, SL; Menzel, S; Cox, SE; Makani, J; Barrett, JC				Mtatiro, Siana Nkya; Singh, Tarjinder; Rooks, Helen; Mgaya, Josephine; Mariki, Harvest; Soka, Deogratius; Mmbando, Bruno; Msaki, Evarist; Kolder, Iris; Thein, Swee Lay; Menzel, Stephan; Cox, Sharon E.; Makani, Julie; Barrett, Jeffrey C.			Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania	PLOS ONE			English	Article							GENETIC-VARIATION; BCL11A; PAIN; EPIDEMIOLOGY; DISEASE	Background: Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously been shown to be affected by variants at three loci on chromosomes 2, 6 and 11, but it is likely that additional loci remain to be discovered. Methods and Findings: We conducted a genome-wide association study (GWAS) in 1,213 SCA (HbSS/HbS beta(0)) patients in Tanzania. Genotyping was done with Illumina Omni2.5 array and imputation using 1000 Genomes Phase I release data. Association with HbF was analysed using a linear mixed model to control for complex population structure within our study. We successfully replicated known associations for HbF near BCL11A and the HBS1L-MYB intergenic polymorphisms (HMIP), including multiple independent effects near BCL11A, consistent with previous reports. We observed eight additional associations with P < 10(-6). These associations could not be replicated in a SCA population in the UK. Conclusions: This is the largest GWAS study in SCA in Africa. We have confirmed known associations and identified new genetic associations with HbF that require further replication in SCA populations in Africa.	[Mtatiro, Siana Nkya; Mgaya, Josephine; Mariki, Harvest; Soka, Deogratius; Mmbando, Bruno; Msaki, Evarist; Cox, Sharon E.; Makani, Julie] Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Muhimbili Wellcome Programme, Dar es salaam, Tanzania; [Mtatiro, Siana Nkya] Dar Es Salaam Univ, Coll Educ, Dept Biol Sci, Dar es salaam, Tanzania; [Singh, Tarjinder; Kolder, Iris; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Rooks, Helen; Thein, Swee Lay; Menzel, Stephan] Kings Coll London, Dept Mol Haematol, Div Canc Studies, London, England; [Mmbando, Bruno] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [Thein, Swee Lay] Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England; [Cox, Sharon E.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MRC Int Nutr Grp, London WC1, England; [Makani, Julie] Univ Oxford, Nuffield Dept Med, Oxford, England	Muhimbili University of Health & Allied Sciences; University of Dar es Salaam; Wellcome Trust Sanger Institute; University of London; King's College London; National Institute of Medical Research; King's College Hospital NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Mtatiro, SN (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Muhimbili Wellcome Programme, Dar es salaam, Tanzania.	siana.nkya@muhimbili-wellcome.org	Menzel, Stephan/U-6906-2019; Cox, Sharon E/ABA-7986-2020; Makani, Julie/E-8525-2017	Cox, Sharon E/0000-0002-9908-2936; Makani, Julie/0000-0002-4801-6250; Nkya, Siana/0000-0001-7576-6279; Kolder, Iris/0000-0001-5219-3439; Singh, Tarjinder/0000-0003-0601-6815; Mmbando, Bruno/0000-0001-7232-8708; Barrett, Jeffrey/0000-0002-1152-370X; Menzel, Stephan/0000-0002-1590-9108	Wellcome Trust, UK [098051, 084538]; Commonwealth split-side fellowship, UK [TZCN-2012-361]	Wellcome Trust, UK(Wellcome Trust); Commonwealth split-side fellowship, UK	The work was supported by the following: Wellcome Trust, UK (JCB 098051, J.Makani, SEC; strategic award 084538); and Commonwealth split-side fellowship, UK (SNM; TZCN-2012-361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Borg J, 2011, HAEMATOL-HEMATOL J, V96, P635, DOI 10.3324/haematol.2011.043265; Creary LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004218; Dampier C, 2004, PEDIATR BLOOD CANCER, V43, P674, DOI 10.1002/pbc.20162; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Makani J, 2011, BLOOD, V117, P1390, DOI 10.1182/blood-2010-08-302703; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; NAGEL RL, 1992, BAILLIERE CLIN HAEM, V5, P331, DOI 10.1016/S0950-3536(11)80023-5; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sedgewick AE, 2008, BLOOD CELLS MOL DIS; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wonkam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092506	24	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111464	10.1371/journal.pone.0111464	http://dx.doi.org/10.1371/journal.pone.0111464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372704	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900049
J	Wu, SY; Pan, SL; Xiao, ZY; Hsu, JL; Chen, MC; Lee, KH; Teng, CM				Wu, Szu-Ying; Pan, Shiow-Lin; Xiao, Zhi-Yan; Hsu, Jui-Ling; Chen, Mei-Chuan; Lee, Kuo-Hsiung; Teng, Che-Ming			NPRL-Z-1, as a New Topoisomerase II Poison, Induces Cell Apoptosis and ROS Generation in Human Renal Carcinoma Cells	PLOS ONE			English	Article							MEDIATED DNA-DAMAGE; CANCER-CHEMOTHERAPY; ANTITUMOR AGENTS; CYCLE REGULATION; PROTEIN-KINASE; HISTONE H2AX; CEM CELLS; ETOPOSIDE; ATM; ACTIVATION	NPRL-Z-1 is a 4 beta-[( 4 ''-benzamido)-amino]-4'-O-demethyl-epipodophyllotoxin derivative. Previous reports have shown that NPRL-Z-1 possesses anticancer activity. Here NPRL-Z-1 displayed cytotoxic effects against four human cancer cell lines (HCT 116, A549, ACHN, and A498) and exhibited potent activity in A498 human renal carcinoma cells, with an IC50 value of 2.38 mu M via the MTT assay. We also found that NPRL-Z-1 induced cell cycle arrest in G1-phase and detected DNA double-strand breaks in A498 cells. NPRL-Z-1 induced ataxia telangiectasia-mutated(ATM) protein kinase phosphorylation at serine 1981, leading to the activation of DNA damage signaling pathways, including Chk2, histone H2AX, and p53/p21. By ICE assay, the data suggested that NPRL-Z-1 acted on and stabilized the topoisomerase II(TOP2)-DNA complex, leading to TOP2cc formation. NPRL-Z-1-induced DNA damage signaling and apoptotic death was also reversed by TOP2 alpha or TOP2 beta knockdown. In addition, NPRL-Z-1-inhibited the Akt signaling pathway and induced reactive oxygen species(ROS) generation. These results demonstrated that NPRL-Z-1 appeared to be a novel TOP2 poison and ROS generator. Thus, NPRLZ-1 may present a significant potential anticancer candidate against renal carcinoma.	[Wu, Szu-Ying; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Pan, Shiow-Lin] Taipei Med Univ, Coll Med Sci & Technol, Ph D Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Xiao, Zhi-Yan] Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Substance Discovery & Drug, Beijing 100050, Peoples R China; [Xiao, Zhi-Yan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hsu, Jui-Ling] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Chen, Mei-Chuan] Taipei Med Univ, Coll Pharm, Ph D Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan; [Chen, Mei-Chuan] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	National Taiwan University; Taipei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Taiwan University; Taipei Medical University; Taipei Medical University; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan	Teng, CM (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	cmteng@ntu.edu.tw		TENG, CHE-MING/0000-0002-9719-7334	National Science Council of the Republic of China [NSC 98-2320-B-002-009-MY3]; NATIONAL CANCER INSTITUTE [R01CA177584] Funding Source: NIH RePORTER	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Research Grant from the National Science Council of the Republic of China (NSC 98-2320-B-002-009-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Banath JP, 2003, CANCER RES, V63, P4347; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chikamori K, 2010, CURR CANCER DRUG TAR, V10, P758, DOI 10.2174/156800910793605785; Costanzi-Strauss E, 1998, EXP CELL RES, V238, P51, DOI 10.1006/excr.1997.3810; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Delia D, 2003, ONCOGENE, V22, P7866, DOI 10.1038/sj.onc.1207086; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Gantchev TG, 1997, ANTI-CANCER DRUG, V8, P164, DOI 10.1097/00001813-199702000-00007; Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393; GOTO T, 1982, J BIOL CHEM, V257, P5866; Guo A, 2002, DRUG METAB DISPOS, V30, P457, DOI 10.1124/dmd.30.4.457; Haglof K.J., 2006, UPDATE CANC THERAP, V1, P117; Hande KR, 1998, BBA-GENE STRUCT EXPR, V1400, P173, DOI 10.1016/S0167-4781(98)00134-1; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hande KR, 2008, UPDATE CANC THERAPEU, V3, P13, DOI DOI 10.1016/J.UCT.2008.02.001; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hawtin RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010186; Hong Y, 2012, NEUROSCI LETT, V518, P138, DOI 10.1016/j.neulet.2012.04.071; Horiguchi A, 2003, J UROLOGY, V169, P710, DOI 10.1016/S0022-5347(05)63998-5; Hug H, 1997, J BIOL CHEM, V272, P28191, DOI 10.1074/jbc.272.45.28191; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Jin ZY, 2002, CELL CYCLE, V1, P82, DOI 10.4161/cc.1.1.104; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Morgan SE, 2000, MOL PHARMACOL, V57, P296; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Parker AS, 2013, EUROPEAN UROLOGY; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Piret B, 1996, NUCLEIC ACIDS RES, V24, P4242, DOI 10.1093/nar/24.21.4242; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Rashad AE, 2011, EUR J MED CHEM, V46, P1019, DOI 10.1016/j.ejmech.2011.01.013; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Son YS, 1998, CANCER CHEMOTH PHARM, V41, P353, DOI 10.1007/s002800050751; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; van der Veldt AAM, 2010, DISCOV MED, V10, P394; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang HK, 1997, MED RES REV, V17, P367, DOI 10.1002/(SICI)1098-1128(199707)17:4<367::AID-MED3>3.0.CO;2-U; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WINICK NJ, 1993, J CLIN ONCOL, V11, P209, DOI 10.1200/JCO.1993.11.2.209; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727; Xiao ZY, 2004, J MED CHEM, V47, P5140, DOI 10.1021/jm030609l; Ye RQ, 2001, J BIOL CHEM, V276, P4828, DOI 10.1074/jbc.M004894200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	63	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112220	10.1371/journal.pone.0112220	http://dx.doi.org/10.1371/journal.pone.0112220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372714	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900121
J	Djordjevic, D; Yang, A; Zadoorian, A; Rungrugeecharoen, K; Ho, JWK				Djordjevic, Djordje; Yang, Andrian; Zadoorian, Armella; Rungrugeecharoen, Kevin; Ho, Joshua W. K.			How Difficult Is Inference of Mammalian Causal Gene Regulatory Networks?	PLOS ONE			English	Article							PACKAGE	Gene regulatory networks (GRNs) play a central role in systems biology, especially in the study of mammalian organ development. One key question remains largely unanswered: Is it possible to infer mammalian causal GRNs using observable gene co-expression patterns alone? We assembled two mouse GRN datasets (embryonic tooth and heart) and matching microarray gene expression profiles to systematically investigate the difficulties of mammalian causal GRN inference. The GRNs were assembled based on >2,000 pieces of experimental genetic perturbation evidence from manually reading > 150 primary research articles. Each piece of perturbation evidence records the qualitative change of the expression of one gene following knock-down or over-expression of another gene. Our data have thorough annotation of tissue types and embryonic stages, as well as the type of regulation (activation, inhibition and no effect), which uniquely allows us to estimate both sensitivity and specificity of the inference of tissue specific causal GRN edges. Using these unprecedented datasets, we found that gene co-expression does not reliably distinguish true positive from false positive interactions, making inference of GRN in mammalian development very difficult. Nonetheless, if we have expression profiling data from genetic or molecular perturbation experiments, such as gene knock-out or signalling stimulation, it is possible to use the set of differentially expressed genes to recover causal regulatory relationships with good sensitivity and specificity. Our result supports the importance of using perturbation experimental data in causal network reconstruction. Furthermore, we showed that causal gene regulatory relationship can be highly cell type or developmental stage specific, suggesting the importance of employing expression profiles from homogeneous cell populations. This study provides essential datasets and empirical evidence to guide the development of new GRN inference methods for mammalian organ development.	[Djordjevic, Djordje; Yang, Andrian; Zadoorian, Armella; Rungrugeecharoen, Kevin; Ho, Joshua W. K.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Djordjevic, Djordje; Zadoorian, Armella; Rungrugeecharoen, Kevin; Ho, Joshua W. K.] Univ New S Wales, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Ho, JWK (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW, Australia.	j.ho@victorchang.edu.au	Ho, Joshua W. K./AAK-7759-2020	Ho, Joshua W. K./0000-0003-2331-7011; Djordjevic, Djordje/0000-0003-3669-6292	Victor Chang Cardiac Research Institute	Victor Chang Cardiac Research Institute	This project is supported by the Victor Chang Cardiac Research Institute. The funder provided financial support for the research staff and students involved in this project. It had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barzel B, 2013, NAT BIOTECHNOL, V31; Buckingham M, 2005, NATURE REV GENETICS, V6; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Edgar R., 2002, NUCLEIC ACIDS RES, V30; Frhlich H, 2009, BIOMETRICAL J, V51; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Frohlich H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-322; Glass K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064832; Ho Joshua W K, 2012, Biophys Rev, V4, P245, DOI 10.1007/s12551-012-0092-9; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Maathuis MH, 2010, NATURE METHODS, V7; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mora A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-455; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olsen C, 2014, GENOMICS, V103, P329, DOI 10.1016/j.ygeno.2014.03.004; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sing T, 2005, BIOINFORMATICS, V21; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Wang Y, 2014, BIOINFORMATICS	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111661	10.1371/journal.pone.0111661	http://dx.doi.org/10.1371/journal.pone.0111661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369032	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000083
J	Quinones-Valles, C; Sanchez-Osorio, I; Martinez-Antonio, A				Quinones-Valles, Cesar; Sanchez-Osorio, Ismael; Martinez-Antonio, Agustino			Dynamical Modeling of the Cell Cycle and Cell Fate Emergence in Caulobacter crescentus	PLOS ONE			English	Article							REGULATORY NETWORKS; GENE-EXPRESSION; DNA-REPLICATION; MASTER REGULATOR; LOGICAL ANALYSIS; DIVISION; PROTEIN; DIFFERENTIATION; LOCALIZATION; ROBUSTNESS	The division of Caulobacter crescentus, a model organism for studying cell cycle and differentiation in bacteria, generates two cell types: swarmer and stalked. To complete its cycle, C. crescentus must first differentiate from the swarmer to the stalked phenotype. An important regulator involved in this process is CtrA, which operates in a gene regulatory network and coordinates many of the interactions associated to the generation of cellular asymmetry. Gaining insight into how such a differentiation phenomenon arises and how network components interact to bring about cellular behavior and function demands mathematical models and simulations. In this work, we present a dynamical model based on a generalization of the Boolean abstraction of gene expression for a minimal network controlling the cell cycle and asymmetric cell division in C. crescentus. This network was constructed from data obtained from an exhaustive search in the literature. The results of the simulations based on our model show a cyclic attractor whose configurations can be made to correspond with the current knowledge of the activity of the regulators participating in the gene network during the cell cycle. Additionally, we found two point attractors that can be interpreted in terms of the network configurations directing the two cell types. The entire network is shown to be operating close to the critical regime, which means that it is robust enough to perturbations on dynamics of the network, but adaptable to environmental changes.	[Quinones-Valles, Cesar] Natl Polytech Inst Monterrey, Ctr Res & Adv Studies, Engn & Biomed Phys Dept, Apodaca, Nuevo Leon, Mexico; [Quinones-Valles, Cesar; Sanchez-Osorio, Ismael; Martinez-Antonio, Agustino] Natl Polytech Inst Irapuato, Ctr Res & Adv Studies, Genet Engn Dept, Guanajuato, Mexico		Martinez-Antonio, A (corresponding author), Natl Polytech Inst Irapuato, Ctr Res & Adv Studies, Genet Engn Dept, Guanajuato, Mexico.	amartinez@ira.cinvestav.mx	Martínez-Antonio, Agustino/GQQ-2363-2022; Antonio, Agustino Martínez/AAG-4309-2021	Martínez-Antonio, Agustino/0000-0003-2231-5014; Antonio, Agustino Martínez/0000-0003-2231-5014	Consejo Nacional de Ciencia y Tecnologia from Mexico [103686, 206011]	Consejo Nacional de Ciencia y Tecnologia from Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by grant 103686 to AM-A and fellowship 206011 to CQ-V, both from the Consejo Nacional de Ciencia y Tecnologia from Mexico (http://www.conacyt.gob.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Aldana-Gonzalez M, 2003, SPRINGER APPL MATH S, P23; Balleza E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002456; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Blinov ML, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-92; Brazhnik P, 2006, CELL CYCLE, V5, P522, DOI 10.4161/cc.5.5.2493; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; DERRIDA B, 1986, EUROPHYS LETT, V1, P45, DOI 10.1209/0295-5075/1/2/001; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Furusawa C, 2002, ANAT RECORD, V268, P327, DOI 10.1002/ar.10164; GOBER JW, 1995, MICROBIOL REV, V59, P31, DOI 10.1128/MMBR.59.1.31-47.1995; Gora KG, 2010, MOL CELL, V39, P455, DOI 10.1016/j.molcel.2010.06.024; Holtzendorff J, 2006, BIOESSAYS, V28, P355, DOI 10.1002/bies.20384; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jensen RB, 2006, J BACTERIOL, V188, P2244, DOI 10.1128/JB.188.6.2244-2253.2006; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li S, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040009, 10.1371/journal.pcbi.0040009.eor]; Li SH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000463; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McAdams HH, 2011, J MOL BIOL, V409, P28, DOI 10.1016/j.jmb.2011.02.041; McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Naldi A, 2009, LECT N BIOINFORMAT, V5688, P266, DOI 10.1007/978-3-642-03845-7_18; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; Reisenauer A, 1999, J BACTERIOL, V181, P2430, DOI 10.1128/JB.181.8.2430-2439.1999; Reisinger SJ, 2007, J BACTERIOL, V189, P8308, DOI 10.1128/JB.00868-07; Ryan KR, 2003, ANNU REV BIOCHEM, V72, P367, DOI 10.1146/annurev.biochem.72.121801.161824; SHAPIRO L, 1971, SCIENCE, V173, P884, DOI 10.1126/science.173.4000.884; Shen XL, 2008, P NATL ACAD SCI USA, V105, P11340, DOI 10.1073/pnas.0805258105; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003221; Tan MH, 2010, P NATL ACAD SCI USA, V107, P18985, DOI 10.1073/pnas.1014395107; TERRANA B, 1975, DEV BIOL, V44, P380, DOI 10.1016/0012-1606(75)90409-1; THIEFFRY D, 1995, B MATH BIOL, V57, P277, DOI 10.1016/0092-8240(94)00037-D; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Tsokos CG, 2012, CURR OPIN MICROBIOL, V15, P744, DOI 10.1016/j.mib.2012.10.011; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Wagner JK, 2005, J BACTERIOL, V187, P544, DOI 10.1128/JB.187.2.544-553.2005; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Winzeler E, 1996, J MOL BIOL, V264, P412, DOI 10.1006/jmbi.1996.0650; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	57	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111116	10.1371/journal.pone.0111116	http://dx.doi.org/10.1371/journal.pone.0111116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369202	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000038
J	Solomon, A; Tennakoon, S; Leeansyah, E; Arribas, J; Hill, A; Van Delft, Y; Moecklinghoff, C; Lewin, SR				Solomon, Ajantha; Tennakoon, Surekha; Leeansyah, Edwin; Arribas, Jose; Hill, Andrew; Van Delft, Yvon; Moecklinghoff, Christiane; Lewin, Sharon R.			No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; LIFE-SPAN; CD4(+); RISK	Objective: To determine whether nucleos(t) ide reverse transcriptase inhibitors (NRTI) contribute to an accelerated loss in telomere length (TL) in HIV-infected patients on antiretroviral therapy (ART). Design: Substudy of randomised controlled trial. Methods: Patients with HIV RNA <50 copies/mL on combination ART (n = 256) were randomised to darunavir/ritonavir (DRV/r) 800/100 mg once daily, either as monotherapy (n = 127) or with 2 NRTIs (n = 129) for up to 144 weeks. TL and telomerase activity was quantified on stored peripheral blood mononuclear cells (PBMC; n = 124) using quantitative real time PCR. Results: Patients in the sub-study had a mean age of 44 years and had received NRTI for a mean of 6.4 years (range 1-20 years). As expected, older patients have significantly shorter TL (p = 0.006), while women had significantly longer TL (p = 0.026). There was no significant association between TL and either the duration of prior NRTI treatment (p = 0.894) or the use of a PI versus NNRTI (p = 0.107). There was no significant difference between patients who continued or ceased NRTI in the mean change/year of TL or telomerase (p = 0.580 and 0.280 respectively). Conclusion: Continuation versus cessation of NRTI treatment was not associated with an accelerated loss in TL or telomerase activity.	[Solomon, Ajantha; Tennakoon, Surekha; Lewin, Sharon R.] Monash Univ & Alfred Hlth, Ctr Biomed Res, Burnet Inst, Dept Infect Dis, Melbourne, Vic, Australia; [Leeansyah, Edwin] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden; [Arribas, Jose] Hosp La Paz, IdiPAZ, Madrid, Spain; [Hill, Andrew] Janssen, High Wycombe, Bucks, England; [Van Delft, Yvon] Janssen, Tilburg, Netherlands; [Moecklinghoff, Christiane] Janssen, Neuss, Germany	Burnet Institute; Monash University; Karolinska Institutet; Karolinska University Hospital; Hospital Universitario La Paz; Johnson & Johnson; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Lewin, SR (corresponding author), Monash Univ & Alfred Hlth, Ctr Biomed Res, Burnet Inst, Dept Infect Dis, Melbourne, Vic, Australia.	lewins@unimelb.edu.au	Leeansyah, Edwin/J-1017-2019; Lewin, Sharon/Z-3297-2019; Arribas, Jose/A-1595-2015	Leeansyah, Edwin/0000-0003-0505-4967; Lewin, Sharon Ruth/0000-0002-0330-8241; Arribas, Jose/0000-0002-7410-9450	National Health and Medical Research Council (NHMRC) of Australia [APP1042654]; National Institutes for Health (NIH) [1R56AI095073-01A1, U19 AI096109]; Janssen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109, R56AI095073] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes for Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors AH, YVD, and CM received salary from Janssen to fund part of this study. SRL is supported by the National Health and Medical Research Council (NHMRC) of Australia Practitioner Fellowship [APP1042654] and the National Institutes for Health (NIH) [grant number 1R56AI095073-01A1 and U19 AI096109]. The funders contributed to the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Arribas JR, 2012, HIV MED, V13, P398, DOI 10.1111/j.1468-1293.2012.00989.x; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Franzese O, 2007, J MED VIROL, V79, P639, DOI 10.1002/jmv.20855; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hukezalie KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047505; Justice Amy C, 2012, AIDS, V26 Suppl 1, pS11; Leeansyah E, 2013, J INFECT DIS, V207, P1157, DOI 10.1093/infdis/jit006; Liu Xiaohong, 2007, Nucleic Acids Symp Ser (Oxf), P253; Palmer LD, 1997, J EXP MED, V185, P1381, DOI 10.1084/jem.185.7.1381; Pathai S, 2013, ACCELERATED BIOL AGI; Rickabaugh TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016459; Wolthers KC, 1999, BLOOD, V93, P1011	17	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109718	10.1371/journal.pone.0109718	http://dx.doi.org/10.1371/journal.pone.0109718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368992	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000010
J	Upadhyay, M; Sharma, N; Vivekanandan, P				Upadhyay, Mohita; Sharma, Neha; Vivekanandan, Perumal			Systematic CpT (ApG) Depletion and CpG Excess Are Unique Genomic Signatures of Large DNA Viruses Infecting Invertebrates	PLOS ONE			English	Article							CODON USAGE BIAS; BACKGROUND NUCLEOTIDE COMPOSITION; CYTOSINE METHYLATION; PATTERNS; OLIGODEOXYNUCLEOTIDES; HOST; INTERLEUKIN-8; EXPRESSION; EVOLUTION; SEQUENCES	Differences in the relative abundance of dinucleotides, if any may provide important clues on host-driven evolution of viruses. We studied dinucleotide frequencies of large DNA viruses infecting vertebrates (n = 105; viruses infecting mammals = 99; viruses infecting aves = 6; viruses infecting reptiles = 1) and invertebrates (n = 88; viruses infecting insects = 84; viruses infecting crustaceans = 4). We have identified systematic depletion of CpT(ApG) dinucleotides and over-representation of CpG dinucleotides as the unique genomic signature of large DNA viruses infecting invertebrates. Detailed investigation of this unique genomic signature suggests the existence of invertebrate host-induced pressures specifically targeting CpT(ApG) and CpG dinucleotides. The depletion of CpT dinucleotides among large DNA viruses infecting invertebrates is at least in part, explained by non-canonical DNA methylation by the infected host. Our findings highlight the role of invertebrate host-related factors in shaping virus evolution and they also provide the necessary framework for future studies on evolution, epigenetics and molecular biology of viruses infecting this group of hosts.	[Upadhyay, Mohita; Sharma, Neha; Vivekanandan, Perumal] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Vivekanandan, P (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India.	vperumal@bioschool.iitd.ac.in			Department of Biotechnology (DBT), India [BT/PR15062/GBD/27/295/2011]; Kusuma Trust	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Kusuma Trust	Funding provided by Department of Biotechnology (DBT), India (BT/PR15062/GBD/27/295/2011) Kusuma Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Borsatti F, 2004, CARYOLOGIA, V57, P305, DOI 10.1080/00087114.2004.10589410; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Chinnery HR, 2012, AM J PATHOL, V180, P209, DOI 10.1016/j.ajpath.2011.09.041; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; Feliciello I, 2013, EPIGENETICS-US, V8, P534, DOI 10.4161/epi.24507; Fuglsang A, 2006, MOL BIOL EVOL, V23, P1345, DOI 10.1093/molbev/msl009; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Jabbari K, 1998, GENE, V224, P123, DOI 10.1016/S0378-1119(98)00474-0; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; Kim D, 2011, MOL IMMUNOL, V48, P1494, DOI 10.1016/j.molimm.2011.04.009; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Ottaviani E, 2000, CELL MOL LIFE SCI, V57, P506, DOI 10.1007/PL00000711; Parilla NW, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-84; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Ren LC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r35; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Simmonds P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-610; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takayama S, 2014, GENOME RES; Tidona CA, 1996, VIRUS GENES, V12, P219, DOI 10.1007/BF00284642; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Upadhyay M, 2013, J VIROL, V87, P13816, DOI 10.1128/JVI.02515-13; Vollmer J, 2004, IMMUNOLOGY, V113, P212, DOI 10.1111/j.1365-2567.2004.01962.x; Wiebauer K, 1993, EXS, V64, P510; WILLIS DB, 1980, VIROLOGY, V107, P250, DOI 10.1016/0042-6822(80)90290-1; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	46	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111793	10.1371/journal.pone.0111793	http://dx.doi.org/10.1371/journal.pone.0111793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369195	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402000102
J	Yang, J; Yang, J; Gao, Y; Zhao, LY; Liu, LY; Qin, YN; Wang, XF; Song, TS; Huang, C				Yang, Juan; Yang, Jin; Gao, Yan; Zhao, Lingyu; Liu, Liying; Qin, Yannan; Wang, Xiaofei; Song, Tusheng; Huang, Chen			Identification of Potential Serum Proteomic Biomarkers for Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; CANCER; EXPRESSION; TISSUE; PATHOGENESIS; STABILITY; CANDIDATE; PROGNOSIS; DIAGNOSIS; MARKERS	Objective: To investigate discriminating protein patterns and serum biomarkers between clear cell renal cell carcinoma (ccRCC) patients and healthy controls, as well as between paired pre- and post-operative ccRCC patients. Methods: We used magnetic bead-based separation followed by matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) to identify patients with ccRCC. A total of 162 serum samples were analyzed in this study, among which there were 58 serum samples from ccRCC patients, 40 from additional paired pre- and post-operative ccRCC patients (n = 20), and 64 from healthy volunteers as healthy controls. ClinProTools software identified several distinct markers between ccRCC patients and healthy controls, as well as between pre- and post-operative patients. Results: Patients with ccRCC could be identified with a mean sensitivity of 88.38% and a mean specificity of 91.67%. Of 67 m/z peaks that differed among the ccRCC, healthy controls, pre- and post-operative ccRCC patients, 24 were significantly different (P<0.05). Three candidate peaks, which were upregulated in ccRCC group and showed a tendency to return to healthy control values after surgery, were identified as peptide regions of RNA-binding protein 6 (RBP6), tubulin beta chain (TUBB), and zinc finger protein 3 (ZFP3) with the m/z values of 1466.98, 1618.22, and 5905.23, respectively. Conclusion: MB-MALDI-TOF-MS method could generate serum peptidome profiles of ccRCC, and provide a new approach to identify potential biomarkers for diagnosis as well as prognosis of this malignancy.	[Yang, Juan; Zhao, Lingyu; Liu, Liying; Qin, Yannan; Wang, Xiaofei; Song, Tusheng; Huang, Chen] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Key Lab Environm & Genes Related Dis,Educ Minist, Xian 710049, Peoples R China; [Yang, Jin; Gao, Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Huang, C (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Key Lab Environm & Genes Related Dis,Educ Minist, Xian 710049, Peoples R China.	hchen@mail.xjtu.edu.cn			National Natural Science Foundation of China [81200845]; Key Science and Technology Program of Shaanxi province [2012 K13-02-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Program of Shaanxi province	This work was supported by The National Natural Science Foundation of China (grant number: 81200845) and the Key Science and Technology Program of Shaanxi province (grant number: 2012 K13-02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kandari W, 2007, MOL IMMUNOL, V44, P311, DOI 10.1016/j.molimm.2006.02.029; Atrih A, 2014, BRIT J CANCER, V110, P1622, DOI 10.1038/bjc.2014.24; Banville N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105365; Berrieman HK, 2004, LANCET ONCOL, V5, P158, DOI 10.1016/S1470-2045(04)01411-1; Bhattacharya R, 2004, MOL BIOL CELL, V15, P3123, DOI 10.1091/mbc.E04-01-0060; Brannon A Rose, 2010, Genes Cancer, V1, P152; Cheng L, 2009, HUM PATHOL, V40, P10, DOI 10.1016/j.humpath.2008.09.009; Cho WCS, 2011, EXPERT REV PROTEOMIC, V8, P1, DOI [10.1586/EPR.10.108, 10.3779/j.issn.1009-3419.2011.08.12]; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Craven RA, 2013, CLIN BIOCHEM, V46, P456, DOI 10.1016/j.clinbiochem.2012.11.029; Cremona M, 2014, EXPERT REV PROTEOMIC, V11, P237, DOI 10.1586/14789450.2014.893193; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis VW, 2011, J SURG ONCOL, V103, P451, DOI 10.1002/jso.21831; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hosoya N, 2013, BBA-PROTEINS PROTEOM, V1834, P2630, DOI 10.1016/j.bbapap.2013.08.009; Issaq HJ, 2011, ELECTROPHORESIS, V32, P967, DOI 10.1002/elps.201000588; Jones EE, 2014, PROTEOMICS, V14, P924, DOI 10.1002/pmic.201300434; Khalfallah O, 2009, STEM CELLS, V27, P1643, DOI 10.1002/stem.88; Lam JS, 2006, WORLD J UROL, V24, P255, DOI 10.1007/s00345-006-0055-5; Linge A, 2012, INVEST OPHTH VIS SCI, V53, P4634, DOI 10.1167/iovs.11-9019; Liu AN, 2014, TUMOUR BIOL; Liu JY, 2014, J ETHNOPHARMACOL, V155, P1322, DOI 10.1016/j.jep.2014.07.025; Ljungberg B, 2007, CURR OPIN UROL, V17, P303, DOI 10.1097/MOU.0b013e328277f180; Ma Y, 2012, DIAGN MOL PATHOL, V21, P157, DOI 10.1097/PDM.0b013e31824d3435; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Mustafa A, 2011, J UROLOGY, V186, P1206, DOI 10.1016/j.juro.2011.05.085; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Ohishi Y, 2007, GYNECOL ONCOL, V105, P586, DOI 10.1016/j.ygyno.2007.01.044; Qi YJ, 2014, PROTEOMICS, V14, P186, DOI 10.1002/pmic.201300226; Raimondo F, 2012, MOL BIOSYST, V8, P1040, DOI 10.1039/c2mb05390j; Sanjmyatav J, 2011, J UROLOGY, V186, P289, DOI 10.1016/j.juro.2011.03.033; Saude EJ, 2007, METABOLOMICS, V3, P19, DOI 10.1007/s11306-006-0042-2; Schaub NP, 2009, J AM COLL SURGEONS, P1; Seliger B, 2007, PROTEOMICS, V7, P4601, DOI 10.1002/pmic.200700415; Steurer S, 2014, ANTICANCER RES, V34, P2255; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; White NMA, 2014, ONCOTARGET, V5, P506, DOI 10.18632/oncotarget.1529; Yang J, 2012, CLIN EXP MED, V12, P79, DOI 10.1007/s10238-011-0149-2; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Zigeuner R, 2010, EUR UROL, V57, P102, DOI 10.1016/j.eururo.2008.11.033	42	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111364	10.1371/journal.pone.0111364	http://dx.doi.org/10.1371/journal.pone.0111364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368985	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000050
J	Brenowitz, WD; Hubbard, RA; Crane, PK; Gray, SL; Zaslavsky, O; Larson, EB				Brenowitz, Willa D.; Hubbard, Rebecca A.; Crane, Paul K.; Gray, Shelly L.; Zaslavsky, Oleg; Larson, Eric B.			Longitudinal Associations between Self-Rated Health and Performance-Based Physical Function in a Population-Based Cohort of Older Adults	PLOS ONE			English	Article							FOLLOW-UP; WALKING SPEED; MORTALITY; COMMUNITY; LIFE; PREDICTORS; DISABILITY; PEOPLE; AGE; DETERMINANTS	Background: Although self-rated health (SRH) and performance-based physical function (PPF) are both strong predictors of mortality, little research has investigated the relationships between them. The objective of this study was to evaluate longitudinal, bi-directional associations between SRH and PPF. Methods: We evaluated longitudinal associations between SRH and PPF in 3,610 adults aged 65-89 followed for an average of 4.8 (standard deviation [SD]: 4.4) years between 1994 and July 2011 in the Adult Changes in Thought study, a population-based cohort in the Seattle area. SRH was assessed with a single-item question in the ACT study. Participants were asked at each evaluation to rate their health as "excellent'', "very good'', "good'', "fair'', or "poor'' in response to the question "In general, how would you rate your health at this time''. PPF scores (ranging from 0-16, with higher indicating better performance) included walking speed, chair rises, grip strength, and balance. Results: At the baseline visit, participants averaged 74.5 (SD: 5.8) years of age and 2,115 (58.6%) were female. In multivariable linear mixed models, PPF declined with age, with more rapid decreases associated with very good, good, and fair (vs. excellent) baseline SRH. Adjusted annual change in PPF was -0.17 points (95% confidence interval [CI]: -0.19, -0.15) for individuals with excellent baseline SRH and -0.21 points (95% CI: -0.22, -0.19) for participants with fair SRH. In multivariable generalized linear mixed models, lower baseline PPF quartiles were associated with lower odds of excellent/very good/good SRH at age 75, however, differences between baseline PPF quartiles diminished with age. Conclusions: These results suggest that less than excellent SRH predicts decline in physical functioning, however, poor physical functioning may not predict change in SRH in a reciprocal fashion. SRH provides a simple assessment tool for identifying individuals at increased risk for decline in physical function.	[Brenowitz, Willa D.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Hubbard, Rebecca A.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Hubbard, Rebecca A.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Crane, Paul K.; Larson, Eric B.] Univ Washington, Div Gen Internal Med, Dept Med, Seattle, WA 98195 USA; [Gray, Shelly L.] Univ Washington, Sch Pharm, Seattle, WA 98195 USA; [Zaslavsky, Oleg] Univ Haifa, IL-31999 Haifa, Israel	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Haifa	Brenowitz, WD (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.	wbrenow@u.washington.edu	Hubbard, Rebecca/Y-6500-2019	Hubbard, Rebecca/0000-0003-0879-0994; Zaslavsky, Oleg/0000-0002-6724-9252	National Institutes of Health [U01-AG-06781]; NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (grant number U01-AG-06781). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arnadottir SA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-670; Ashburner JM, 2011, AM J EPIDEMIOL, V173, P882, DOI 10.1093/aje/kwq445; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Benyamini Y, 2003, SOC SCI MED, V56, P1661, DOI 10.1016/S0277-9536(02)00175-2; Bopp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030795; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; CRESS ME, 1995, J AM GERIATR SOC, V43, P93, DOI 10.1111/j.1532-5415.1995.tb06372.x; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; Dening TR, 1998, AGE AGEING, V27, P23, DOI 10.1093/ageing/27.1.23; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; Ferraro KF, 2000, J GERONTOL B-PSYCHOL, V55, pS173, DOI 10.1093/geronb/55.3.S173; Ferraro KF, 2001, J GERONTOL B-PSYCHOL, V56, pS195, DOI 10.1093/geronb/56.4.S195; Freiberger E, 2012, AGE AGEING, V41, P712, DOI 10.1093/ageing/afs099; Galenkamp H, 2012, J CLIN EPIDEMIOL, V65, P978, DOI 10.1016/j.jclinepi.2012.03.010; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Halford C, 2010, UPSALA J MED SCI, V115, P266, DOI 10.3109/03009734.2010.496910; Hays JC, 1996, AM J GERIAT PSYCHIAT, V4, P188, DOI 10.1097/00019442-199622430-00002; Hoeymans N, 1997, SOC SCI MED, V45, P1527, DOI 10.1016/S0277-9536(97)00089-0; Hubbard RA, 2009, J AM STAT ASSOC, V104, P912, DOI 10.1198/jasa.2009.ap08423; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Ishizaki T, 2009, GERONTOLOGY, V55, P344, DOI 10.1159/000183749; Jurges H, 2008, EUR J EPIDEMIOL, V23, P773, DOI 10.1007/s10654-008-9287-6; Jylha M, 2001, J GERONTOL A-BIOL, V56, pM609, DOI 10.1093/gerona/56.10.M609; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Leibson CL, 1999, GERONTOLOGIST, V39, P291, DOI 10.1093/geront/39.3.291; Leinonen R, 2001, SOC SCI MED, V52, P1329, DOI 10.1016/S0277-9536(00)00249-5; Little R. J. A., 1987, STAT ANAL MISSING DA; Manor O, 2000, INT J EPIDEMIOL, V29, P149, DOI 10.1093/ije/29.1.149; Martinez DJ, 2010, J GERONTOL B-PSYCHOL, V65, P715, DOI 10.1093/geronb/gbp115; Miller TR, 2007, J GERONTOL B-PSYCHOL, V62, pS22, DOI 10.1093/geronb/62.1.S22; Pietilainen O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REUBEN DB, 1992, J GERONTOL, V47, pM106, DOI 10.1093/geronj/47.4.M106; REUBEN DB, 1990, J AM GERIATR SOC, V38, P1105, DOI 10.1111/j.1532-5415.1990.tb01373.x; REUBEN DB, 1995, J AM GERIATR SOC, V43, P17, DOI 10.1111/j.1532-5415.1995.tb06236.x; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Sargent-Cox KA, 2010, HEALTH PSYCHOL, V29, P143, DOI 10.1037/a0017652; Schuz B, 2011, QUAL LIFE RES, V20, P1573, DOI 10.1007/s11136-011-9909-4; Siskind V, 2002, LANCET, V360, P724, DOI 10.1016/S0140-6736(02)09861-6; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Wang C, 2007, J GERONTOL A-BIOL, V62, P1428, DOI 10.1093/gerona/62.12.1428; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Xu JP, 2010, HEALTH PSYCHOL, V29, P9, DOI 10.1037/a0016767; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204	52	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111761	10.1371/journal.pone.0111761	http://dx.doi.org/10.1371/journal.pone.0111761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365288	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100115
J	Higashikawa, K; Yagi, K; Watanabe, K; Kamino, S; Ueda, M; Hiromura, M; Enomoto, S				Higashikawa, Kei; Yagi, Katsuharu; Watanabe, Keiko; Kamino, Shinichiro; Ueda, Masashi; Hiromura, Makoto; Enomoto, Shuichi			Cu-64-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CANCER-IMMUNOTHERAPY; AUTOIMMUNE-DISEASE; ANTITUMOR-ACTIVITY; IMMUNE-SYSTEM; BIODISTRIBUTION; IPILIMUMAB; EXPRESSION; RESPONSES; SIGNALS	Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) targeted therapy by anti-CTLA-4 monoclonal antibody (mAb) is highly effective in cancer patients. However, it is extremely expensive and potentially produces autoimmune-related adverse effects. Therefore, the development of a method to evaluate CTLA-4 expression prior to CTLA-4-targeted therapy is expected to open doors to evidence-based and cost-efficient medical care and to avoid adverse effects brought about by ineffective therapy. In this study, we aimed to develop a molecular imaging probe for CTLA-4 visualization in tumor. First, we examined CTLA-4 expression in normal colon tissues, cultured CT26 cells, and CT26 tumor tissues from tumor-bearing BALB/c mice and BALB/c nude mice by reverse transcription polymerase chain reaction (RT-PCR) analysis and confirmed whether CTLA-4 is strongly expressed in CT26 tumor tissues. Second, we newly synthesized Cu-64-1,4,7,10-tetraazacyclododecane-N,N',N '',N'''-tetraacetic acid-anti-mouse CTLA-4 mAb (Cu-64-DOTA-anti-CTLA-4 mAb) and evaluated its usefulness in positron emission tomography (PET) and ex-vivo biodistribution analysis in CT26-bearing BALB/c mice. High CTLA-4 expression was confirmed in the CT26 tumor tissues of tumor-bearing BALB/c mice. However, CTLA-4 expression was extremely low in the cultured CT26 cells and the CT26 tumor tissues of tumor-bearing BALB/c nude mice. The results suggested that T cells were responsible for the high CTLA-4 expression. Furthermore, Cu-64-DOTA-anti-CTLA-4 mAb displayed significantly high accumulation in the CT26 tumor, thereby realizing non-invasive CTLA-4 visualization in the tumor. Together, the results indicate that Cu-64-DOTA-anti-CTLA-4 mAb would be useful for the evaluation of CTLA-4 expression in tumor.	[Higashikawa, Kei; Yagi, Katsuharu; Watanabe, Keiko; Ueda, Masashi; Enomoto, Shuichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Higashikawa, Kei] Japan Soc Promot Sci, Tokyo, Japan; [Kamino, Shinichiro; Hiromura, Makoto; Enomoto, Shuichi] RIKEN, Ctr Life Sci Technol, Next Generat Imaging Team, Kobe, Hyogo, Japan	Okayama University; Japan Society for the Promotion of Science; RIKEN	Enomoto, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	semo@riken.jp	Ueda, Masashi/K-4096-2013	Ueda, Masashi/0000-0001-7027-1568; Multhoff, Gabriele/0000-0002-2616-3137	MEXT, Japan; Japan Society for the Promotion of Science [12J06885]; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [12J06885, 23000005] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for COE projects by MEXT, Japan, titled "Center of excellence for molecular and gene targeting therapies with micro-doze molecular imaging modalities.", a grant from Japan Society for the Promotion of Science (grant number: 12J06885, URL: http://www.jsps.go.jp/english/index.html), and a grant form the Ministry of Education, Culture, Sports, Science and Technology ( URL: http://www.pref.okayama.jp/page/287673.html). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Araki M, 2009, J IMMUNOL, V183, P5146, DOI 10.4049/jimmunol.0802610; Bhattacharyya S, 2013, NUCL MED BIOL, V40, P451, DOI 10.1016/j.nucmedbio.2013.01.007; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P850, DOI 10.1007/s00259-006-0361-6; Contardi E, 2005, INT J CANCER, V117, P538, DOI 10.1002/ijc.21155; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Gerold KD, 2011, DIABETES, V60, P1955, DOI 10.2337/db11-0130; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Higashikawa K, 2011, BIOCHEM BIOPH RES CO, V410, P416, DOI 10.1016/j.bbrc.2011.05.146; Knowles SM, 2012, J CLIN ONCOL, V30, P3884, DOI 10.1200/JCO.2012.42.4887; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Liu SM, 2012, J IMMUNOL, V188, P155, DOI 10.4049/jimmunol.1102042; Lu SX, 2005, J PHARM SCI-US, V94, P788, DOI 10.1002/jps.20289; Mitsui J, 2010, CLIN CANCER RES, V16, P2781, DOI 10.1158/1078-0432.CCR-09-3243; Nagengast WB, 2010, J NUCL MED, V51, P761, DOI 10.2967/jnumed.109.071043; Niu G, 2009, J NUCL MED, V50, P1116, DOI 10.2967/jnumed.109.061820; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paudyal B, 2011, CANCER SCI, V102, P117, DOI 10.1111/j.1349-7006.2010.01763.x; Ribas A, 2007, ONCOLOGIST, V12, P873, DOI 10.1634/theoncologist.12-7-873; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; Sondak VK, 2011, NAT REV DRUG DISCOV, V10, P411, DOI 10.1038/nrd3463; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Torino F, 2012, ONCOLOGIST, V17, P525, DOI 10.1634/theoncologist.2011-0404; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Yaguchi T, 2011, INT J HEMATOL, V93, P294, DOI 10.1007/s12185-011-0799-6; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017	33	76	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109866	10.1371/journal.pone.0109866	http://dx.doi.org/10.1371/journal.pone.0109866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365349	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100010
J	Prakash, O; Ahmad, A; Tripathi, VK; Tandon, S; Pant, AB; Khan, F				Prakash, Om; Ahmad, Ateeque; Tripathi, Vinay Kumar; Tandon, Sudeep; Pant, Aditya Bhusan; Khan, Feroz			In Silico Assay Development for Screening of Tetracyclic Triterpenoids as Anticancer Agents against Human Breast Cancer Cell Line MCF7	PLOS ONE			English	Article							WILD-TYPE P53; OENOTHERA-BIENNIS; EXPRESSION; OENOTHERALANOSTEROL	Experimental activity of a compound on cancer cell line/target is mostly analyzed in the form of percentage inhibition at different concentration gradient and time of incubation. In this study a statistical model has been developed referred as in silico assay using support vector regression model, which can act with change in concentration gradient and time of incubation. This model is a function of concentration gradient, treatment hour and independent components; which calculate the percentage inhibition in combination of above three components. This model is designed to screen tetracyclic triterpenoids active against human breast cancer cell line MCF7. The model has been statistically validated, checked for applicability domain and predicted results were reconfirmed by MTT assay, for example Oenotheranstrol derivatives, OenA & B. Computational SAR, target and docking studies were performed to understand the cytotoxic mechanism of action of Oenotheranstrol compounds. The proposed in silico assay model will work for specific chemical family for which it will be optimized. This model can be used to analyze growth kinetics pattern on different human cancer cell lines for designed compounds.	[Prakash, Om; Khan, Feroz] CSIR, Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India; [Ahmad, Ateeque; Tandon, Sudeep] CSIR, Cent Inst Med & Aromat Plants, Proc Chem & Chem Engn Dept, Lucknow, Uttar Pradesh, India; [Tripathi, Vinay Kumar; Pant, Aditya Bhusan] CSIR, Indian Inst Toxicol Res, In Vitro Toxicol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Khan, F (corresponding author), CSIR, Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India.	f.khan@cimap.res.in	Khan, Feroz/AHC-3474-2022	Khan, Feroz/0000-0002-2704-5925; PRAKASH, OM/0000-0001-7893-8873	Council of Scientific and Industrial Research (CSIR), New Delhi through CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India [BSC0121, BSC0203]	Council of Scientific and Industrial Research (CSIR), New Delhi through CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India	The authors acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi, for financial support through CSIR networking project "GENESIS'' (BSC0121) and "CHEM-BIO'' (BSC0203) at the CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, CHINESE J CHEM, V28, P2474, DOI 10.1002/cjoc.201190024; Alkhalaf M, 2003, J ENDOCRINOL, V179, P55, DOI 10.1677/joe.0.1790055; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Ciolino H, 2003, INT J CANCER, V105, P321, DOI 10.1002/ijc.11075; Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141; FAN SJ, 1995, CANCER RES, V55, P1649; Gasi KMP, 2003, STEROIDS, V68, P667, DOI 10.1016/S0039-128X(03)00097-7; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kim E, 2009, BIOCHEM PHARMACOL, V77, P11, DOI 10.1016/j.bcp.2008.08.030; Leung T, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3574; Liao WY, 2012, J NAT PROD, V75, P630, DOI 10.1021/np200866z; Shibahara Y, 2012, J PATHOL, V227, P357, DOI 10.1002/path.4019; Singh R, 2012, J ETHNOPHARMACOL, V141, P357, DOI 10.1016/j.jep.2012.02.046; Teixeira AL, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-9; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V346, P161, DOI 10.1006/abbi.1997.0302; Zhang F, 2012, J NAT PROD, V75, P538, DOI 10.1021/np200579b; Zhang YX, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-153	19	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111049	10.1371/journal.pone.0111049	http://dx.doi.org/10.1371/journal.pone.0111049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365399	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100046
J	Sakao, Y; Kuroda, H; Mun, M; Uehara, H; Motoi, N; Ishikawa, Y; Nakagawa, K; Okumura, S				Sakao, Yukinori; Kuroda, Hiroaki; Mun, Mingyon; Uehara, Hirofumi; Motoi, Noriko; Ishikawa, Yuichi; Nakagawa, Ken; Okumura, Sakae			Prognostic Significance of Tumor Size of Small Lung Adenocarcinomas Evaluated with Mediastinal Window Settings on Computed Tomography	PLOS ONE			English	Article							IA PERIPHERAL ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; INDICATOR; SCAR	Background: We aimed to clarify that the size of the lung adenocarcinoma evaluated using mediastinal window on computed tomography is an important and useful modality for predicting invasiveness, lymph node metastasis and prognosis in small adenocarcinoma. Methods: We evaluated 176 patients with small lung adenocarcinomas (diameter, 1-3 cm) who underwent standard surgical resection. Tumours were examined using computed tomography with thin section conditions (1.25 mm thick on high-resolution computed tomography) with tumour dimensions evaluated under two settings: lung window and mediastinal window. We also determined the patient age, gender, preoperative nodal status, tumour size, tumour disappearance ratio, preoperative serum carcinoembryonic antigen levels and pathological status (lymphatic vessel, vascular vessel or pleural invasion). Recurrence-free survival was used for prognosis. Results: Lung window, mediastinal window, tumour disappearance ratio and preoperative nodal status were significant predictive factors for recurrence-free survival in univariate analyses. Areas under the receiver operator curves for recurrence were 0.76, 0.73 and 0.65 for mediastinal window, tumour disappearance ratio and lung window, respectively. Lung window, mediastinal window, tumour disappearance ratio, preoperative serum carcinoembryonic antigen levels and preoperative nodal status were significant predictive factors for lymph node metastasis in univariate analyses; areas under the receiver operator curves were 0.61, 0.76, 0.72 and 0.66, for lung window, mediastinal window, tumour disappearance ratio and preoperative serum carcinoembryonic antigen levels, respectively. Lung window, mediastinal window, tumour disappearance ratio, preoperative serum carcinoembryonic antigen levels and preoperative nodal status were significant factors for lymphatic vessel, vascular vessel or pleural invasion in univariate analyses; areas under the receiver operator curves were 0.60, 0.81, 0.81 and 0.65 for lung window, mediastinal window, tumour disappearance ratio and preoperative serum carcinoembryonic antigen levels, respectively. Conclusions: According to the univariate analyses including a logistic regression and ROCs performed for variables with p-values of <0.05 on univariate analyses, our results suggest that measuring tumour size using mediastinal window on high-resolution computed tomography is a simple and useful preoperative prognosis modality in small adenocarcinoma.	[Sakao, Yukinori; Kuroda, Hiroaki; Mun, Mingyon; Uehara, Hirofumi; Nakagawa, Ken; Okumura, Sakae] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan; [Sakao, Yukinori; Kuroda, Hiroaki] Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 464, Japan; [Motoi, Noriko; Ishikawa, Yuichi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Tokyo, Japan	Japanese Foundation for Cancer Research; Aichi Cancer Center; Japanese Foundation for Cancer Research	Sakao, Y (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan.	ysakao@aichi-cc.jp	Motoi, Noriko/A-9718-2009; Motoi, Noriko/AAO-5642-2020	Motoi, Noriko/0000-0001-7098-3311; Motoi, Noriko/0000-0001-7098-3311; Sakao, Yukinori/0000-0002-6826-2280				Bhure UN, 2010, BRIT J RADIOL, V83, P841, DOI 10.1259/bjr/13711326; Borezuk AC, 2009, AM J SURG PATHOL, V33, P462, DOI 10.1097/PAS.0b013e318190157c; Kulpa J, 2002, CLIN CHEM, V48, P1931; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Nakazono T, 2005, EUR RADIOL, V15, P1563, DOI 10.1007/s00330-004-2595-7; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Okada M, 2004, J THORAC CARDIOV SUR, V127, P857, DOI 10.1016/j.jtcvs.2003.08.048; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Sakao Y, 2004, EUR J CARDIO-THORAC, V26, P1211, DOI 10.1016/j.ejcts.2004.08.021; Sakao Y, 2004, ANN THORAC SURG, V77, P1157, DOI 10.1016/j.athoracsur.2003.09.055; Sakao Y, 2003, ANN THORAC SURG, V75, P1113, DOI 10.1016/S0003-4975(02)04718-5; Sakao Y, 2007, ANN THORAC SURG, V83, P209, DOI 10.1016/j.athoracsur.2006.07.051; Sawabata N, 2004, CANCER-AM CANCER SOC, V101, P803, DOI 10.1002/cncr.20421; SHIMOSATO Y, 1980, AM J SURG PATHOL, V4, P365, DOI 10.1097/00000478-198008000-00005; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Takashima S, 2002, LUNG CANCER-J IASLC, V36, P289, DOI 10.1016/S0169-5002(01)00489-5; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221	17	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110305	10.1371/journal.pone.0110305	http://dx.doi.org/10.1371/journal.pone.0110305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365326	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100020
J	Cugno, M; Marzano, AV; Lorini, M; Carbonelli, V; Tedeschi, A				Cugno, Massimo; Marzano, Angelo V.; Lorini, Maurizio; Carbonelli, Vincenzo; Tedeschi, Alberto			Enhanced Tissue Factor Expression by Blood Eosinophils from Patients with Hypereosinophilia: A Possible Link with Thrombosis	PLOS ONE			English	Article							CHURG-STRAUSS-SYNDROME; POTENTIAL MECHANISM; CHRONIC URTICARIA; GRANULE PROTEINS; DISEASE; ACTIVATION; LOCALIZATION; COAGULATION; DISORDERS; CLONES	Thrombotic risk is increased in eosinophil-mediated disorders, and several hypotheses have been proposed to link eosinophilia and thrombosis. In particular, eosinophils have been described as source of tissue factor (TF), the main initiator of blood coagulation; however, this aspect is still controversial. This study was aimed to evaluate whether TF expression varies in eosinophils isolated from normal subjects and patients with different hypereosinophilic conditions. Eosinophils were immunologically purified from peripheral blood samples of 9 patients with different hypereosinophilic conditions and 9 normal subjects. Western blot analysis and real-time polymerase chain reaction (RT-PCR) were performed to test eosinophil TF expression. For comparison, TF expression was evaluated in monocytes from blood donors and in human endothelial (ECV304) and fibroblast (IMR90) cell lines. Western blot analysis revealed a major band of 47,000 corresponding to native TF in homogenates of purified eosinophils with a higher intensity in the 9 patients than in the 9 controls (p<0.0001). According to RT-PCR cycle threshold (Ct), TF gene expression was higher in eosinophils from patients than in those from controls, median (range) 35.10 (19.45-36.50) vs 37.17 (35.33-37.87) (p = 0.002), and was particularly abundant in one patient with idiopathic hypereosinophilic syndrome and ischemic heart attacks (Ct: 19.45). TF gene expression was moderate in monocytes, Ct: 31.32 (29.82-33.49) and abundant in endothelial cells, Ct: 28.70 (27.79-29.57) and fibroblasts, Ct: 22.77 (19.22-25.05). Our results indicate that human blood eosinophils contain variable amounts of TF. The higher TF expression in patients with hypereosinophilic disorders may contribute to increase the thrombotic risk.	[Cugno, Massimo; Lorini, Maurizio; Carbonelli, Vincenzo] Univ Milan, Dipartimento Fisiopatol Medicochirurg & Trapianti, Milan, Italy; [Cugno, Massimo] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy; [Marzano, Angelo V.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Dermatol, Milan, Italy; [Tedeschi, Alberto] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Allergol & Immunol Clin, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Cugno, M (corresponding author), Univ Milan, Dipartimento Fisiopatol Medicochirurg & Trapianti, Milan, Italy.	massimo.cugno@unimi.it	Cugno, Massimo/K-8106-2016	Cugno, Massimo/0000-0002-9918-0763	"Ricerca corrente'', Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy	"Ricerca corrente'', Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy	This work was supported by "Ricerca corrente'', Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2007, IMMUNOL ALLERGY CLIN, V27, P357, DOI 10.1016/j.iac.2007.07.004; Ames PRJ, 2010, CLIN APPL THROMB-HEM, V16, P628, DOI 10.1177/1076029609348647; Asero R, 2007, J ALLERGY CLIN IMMUN, V119, P705, DOI 10.1016/j.jaci.2006.08.043; Basavaraj MG, 2012, THROMB RES, V130, P538, DOI 10.1016/j.thromres.2012.06.001; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Chen YYK, 2014, J ALLERGY CLIN IMMUN, V133, P1195, DOI 10.1016/j.jaci.2013.06.037; Cugno M, 2009, INT ARCH ALLERGY IMM, V148, P170, DOI 10.1159/000155748; Egorina EM, 2008, BLOOD, V111, P1208, DOI 10.1182/blood-2007-08-107698; GAUCHAT JF, 1995, EUR J IMMUNOL, V25, P863, DOI 10.1002/eji.1830250335; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Kita H, 2013, INT ARCH ALLERGY IMM, V161, P3, DOI 10.1159/000350662; Langan SM, 2009, BRIT J DERMATOL, V161, P1149, DOI 10.1111/j.1365-2133.2009.09350.x; Maino A, 2012, CURR VASC PHARMACOL, V10, P670, DOI 10.2174/157016112801784594; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Marzano AV, 2011, CLIN EXP IMMUNOL, V165, P44, DOI 10.1111/j.1365-2249.2011.04391.x; Marzano AV, 2010, J INVEST ALLERG CLIN, V20, P616; Marzano AV, 2009, BRIT J DERMATOL, V160, P266, DOI 10.1111/j.1365-2133.2008.08880.x; Moosbauer C, 2007, BLOOD, V109, P995, DOI 10.1182/blood-2006-02-004945; Ogbogu PU, 2007, IMMUNOL ALLERGY CLIN, V27, P457, DOI 10.1016/j.iac.2007.07.001; OJIMAUCHIYAMA A, 1991, LIPIDS, V26, P1200, DOI 10.1007/BF02536531; Pena E, 2012, J THROMB HAEMOST, V10, P2373, DOI 10.1111/j.1538-7836.2012.04910.x; ROHRBACH MS, 1990, J EXP MED, V172, P1271, DOI 10.1084/jem.172.4.1271; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Roufosse F, 2010, J ALLERGY CLIN IMMUN, V126, P39, DOI 10.1016/j.jaci.2010.04.011; Santilli F, 2007, INTERN EMERG MED, V2, P256, DOI 10.1007/s11739-007-0076-0; SLUNGAARD A, 1993, J CLIN INVEST, V91, P1721, DOI 10.1172/JCI116382; Sovershaev MA, 2008, J THROMB HAEMOST, V6, P1742, DOI 10.1111/j.1538-7836.2008.03105.x; Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Yang YW, 2011, STROKE, V42, P319, DOI 10.1161/STROKEAHA.110.596361; Zhu L, 2012, CLIN EXP DERMATOL, V37, P395, DOI 10.1111/j.1365-2230.2011.04254.x	32	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111862	10.1371/journal.pone.0111862	http://dx.doi.org/10.1371/journal.pone.0111862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375118	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600070
J	Hirai, H; Arai, K; Kariyazono, R; Yamamoto, M; Sato, M				Hirai, Hayato; Arai, Kunio; Kariyazono, Ryo; Yamamoto, Masayuki; Sato, Masamitsu			The Kinetochore Protein Kis1/Eic1/Mis19 Ensures the Integrity of Mitotic Spindles through Maintenance of Kinetochore Factors Mis6/CENP-I and CENP-A	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEX; YEAST SCHIZOSACCHAROMYCES-POMBE; MICROTUBULE-ORGANIZING CENTERS; SISTER-CHROMATID SEPARATION; FISSION YEAST; POLE BODY; CELL-CYCLE; BIPOLAR SPINDLE; NUCLEAR-ENVELOPE; KINASE 1	Microtubules play multiple roles in a wide range of cellular phenomena, including cell polarity establishment and chromosome segregation. A number of microtubule regulators have been identified, including microtubule-associated proteins and kinases, and knowledge of these factors has contributed to our molecular understanding of microtubule regulation of each relevant cellular process. The known regulators, however, are insufficient to explain how those processes are linked to one another, underscoring the need to identify additional regulators. To find such novel mechanisms and microtubule regulators, we performed a screen that combined genetics and microscopy for fission yeast mutants defective in microtubule organization. We isolated approximately 900 mutants showing defects in either microtubule organization or the nuclear envelope, and these mutants were classified into 12 categories. We particularly focused on one mutant, kis1, which displayed spindle defects in early mitosis. The kis1 mutant frequently failed to assemble a normal bipolar spindle. The responsible gene encoded a kinetochore protein, Mis19 (also known as Eic1), which localized to the interface of kinetochores and spindle poles. We also found that the inner kinetochore proteins Mis6/CENP-I and Cnp1/CENP-A were delocalized from kinetochores in the kis1 cells and that kinetochore-microtubule attachment was defective. Another mutant, mis6, also displayed similar spindle defects. We conclude that Kis1 is required for inner kinetochore organization, through which Kis1 ensures kinetochore-microtubule attachment and spindle integrity. Thus, we propose an unexpected relationship between inner kinetochore organization and spindle integrity.	[Hirai, Hayato; Arai, Kunio; Sato, Masamitsu] Waseda Univ, Grad Sch Adv Sci & Technol, Dept Life Sci & Med Biosci, Lab Cytoskeletal Logist, Tokyo, Japan; [Arai, Kunio; Kariyazono, Ryo; Yamamoto, Masayuki; Sato, Masamitsu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Yamamoto, Masayuki] Natl Inst Basic Biol, Lab Cell Responses, Okazaki, Aichi, Japan; [Sato, Masamitsu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Waseda University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST)	Sato, M (corresponding author), Waseda Univ, Grad Sch Adv Sci & Technol, Dept Life Sci & Med Biosci, Lab Cytoskeletal Logist, Tokyo, Japan.	masasato@waseda.jp		Hirai, Hayato/0000-0001-9811-429X	JSPS [21687015, 25291041, 21227007]; Naito Foundation; Senri Life Science Foundation; Sumitomo Foundation; Kato Life Science Foundation; Waseda University Grant for Special Research Projects [2013A-911, 2013B-178, 2013A-6313, 2013A-912, 2013B-181]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Senri Life Science Foundation; Sumitomo Foundation; Kato Life Science Foundation; Waseda University Grant for Special Research Projects	This work was supported by Grants-in-Aid for Young Scientists (A) (Grant Number 21687015) and for Scientific Research (B) (25291041) (to MS) and Grant-in-Aid for Scientific Research (S) (21227007) (to MY) from JSPS (http://www.jsps.go.jp/english/). This work was also supported by the Naito Foundation (https://www.naito-f.or.jp/en/), the Senri Life Science Foundation (http://www.senri-life.or.jp/), the Sumitomo Foundation (http://www.sumitomo.or.jp/e/) and Kato Life Science Foundation (https://www.katokinen.or.jp/) (to MS), and by Waseda University Grant for Special Research Projects (2013A-911, 2013B-178 and 2013A-6313 to MS.; 2013A-912 and 2013B-181 to KA). KA was a research fellow of JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akera T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1725; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Aoi Y, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140063; Aoki K, 2006, CURR BIOL, V16, P1627, DOI 10.1016/j.cub.2006.06.065; Asakawa K, 2006, MOL BIOL CELL, V17, P1421, DOI 10.1091/mbc.e05-08-0802; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; Balasubramanian MK, 1998, GENETICS, V149, P1265; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Chang L, 2000, P NATL ACAD SCI USA, V97, P5249, DOI 10.1073/pnas.97.10.5249; Chen XQ, 2004, YEAST, V21, P495, DOI 10.1002/yea.1115; DEMETER J, 1995, P NATL ACAD SCI USA, V92, P1436, DOI 10.1073/pnas.92.5.1436; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fong CS, 2010, EMBO J, V29, P120, DOI 10.1038/emboj.2009.331; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Fujita A, 2002, MOL BIOL CELL, V13, P2360, DOI 10.1091/mbc.02-01-0603; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Gascoigne KE, 2011, CURR OPIN CELL BIOL, V23, P102, DOI 10.1016/j.ceb.2010.07.007; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; HAGAN IM, 1988, J CELL SCI, V89, P343; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayashi T, 2014, GENES CELLS; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Heald R, 2000, TRENDS CELL BIOL, V10, P1, DOI 10.1016/S0962-8924(99)01691-8; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOFER F, 1979, CURR GENET, V1, P45, DOI 10.1007/BF00413306; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hsu KS, 2011, CURR BIOL, V21, P214, DOI 10.1016/j.cub.2010.12.048; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kakui Y, 2013, NAT CELL BIOL, V15, P786, DOI 10.1038/ncb2782; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lehmann A, 2004, FEBS LETT, V566, P77, DOI 10.1016/j.febslet.2004.04.022; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MATSUMOTO T, 1990, CURR GENET, V18, P323, DOI 10.1007/BF00318213; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; McKinley KL, 2014, CELL, V158, P397, DOI 10.1016/j.cell.2014.06.016; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mori R, 2013, MOL BIOL CELL, V24, P1713, DOI 10.1091/mbc.E12-11-0792; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Ohta M, 2012, MOL BIOL CELL, V23, P1799, DOI 10.1091/mbc.E11-11-0951; Okada Y, 2014, MOL BIOL CELL, V25; Okamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030622; Paoletti A, 2003, MOL BIOL CELL, V14, P2793, DOI 10.1091/mbc.E02-10-0661; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Radcliffe P, 1998, MOL BIOL CELL, V9, P1757, DOI 10.1091/mbc.9.7.1757; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Saitoh S, 2005, MOL BIOL CELL, V16, P3666, DOI 10.1091/mbc.E05-01-0014; Saitoh S, 2008, MOL BIOL CELL, V19, P3885, DOI 10.1091/mbc.E08-03-0298; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Sato M, 2009, METHODS MOL BIOL, V545, P185, DOI 10.1007/978-1-60327-993-2_11; Sato M, 2009, EMBO REP, V10, P1161, DOI 10.1038/embor.2009.158; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sawin KE, 2006, YEAST, V23, P1001, DOI 10.1002/yea.1404; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Simanis V, 2003, J CELL SCI, V116, P4261, DOI 10.1242/jcs.00777; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Subramanian L, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140043; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; TANAKA K, 1986, J CELL SCI, V80, P253; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; UMESONO K, 1983, J MOL BIOL, V168, P271, DOI 10.1016/S0022-2836(83)80018-7; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Venkatram S, 2005, MOL BIOL CELL, V16, P3052, DOI 10.1091/mbc.E04-12-1043; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; West RR, 2002, J CELL SCI, V115, P931; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Xu DZ, 2011, P NATL ACAD SCI USA, V108, P11301, DOI 10.1073/pnas.1107723108; Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664; Yamada H, 1997, J CELL SCI, V110, P1793; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamashita A, 1997, GENES CELLS, V2, P155, DOI 10.1046/j.1365-2443.1997.1100307.x; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676; Zimmerman S, 2004, DEV CELL, V6, P497, DOI 10.1016/S1534-5807(04)00096-6	109	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111905	10.1371/journal.pone.0111905	http://dx.doi.org/10.1371/journal.pone.0111905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375240	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600073
J	Yeap, LL; Lo, YL				Yeap, Li-Ling; Lo, Yoke-Lin			Rapid and Simultaneous Quantification of Levetiracetam and Its Carboxylic Metabolite in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry	PLOS ONE			English	Article							DRIED BLOOD SPOTS; ANTIEPILEPTIC DRUGS; PHARMACODYNAMIC INTERACTIONS; HPLC-UV; PERFORMANCE; EPILEPSY; SERUM; PHARMACOKINETICS; CHILDREN; ZONISAMIDE	A simple liquid chromatography tandem mass spectrometry method was developed and validated according to the guidelines of the US Food and Drug Administration and the European Medicines Agency for a simultaneous quantification of levetiracetam (LEV) and its metabolite, UCB L057 in the plasma of patients. A 0.050 mL plasma sample was prepared by a simple and direct protein precipitation with 0.450 mL acetonitrile (ACN) containing 1 mu g/mL of internal standard (IS, diphenhydramine), then vortex mixed and centrifuged. A 0.100 mL of the clear supernatant was diluted with 0.400 mL water and well mixed. A 0.010 mL of the resultant solution was injected into an Agilent Zorbax SB-C18 (2.1 mm x 100 mm, 3.5 mu m) column with an isocratic elution at 0.5 mL/min using a mixture of 0.1% formic acid in water and ACN (40: 60 v/v). Detection was performed using an AB Sciex API 3000 triple quadrupole mass spectrometer, equipped with a Turbo Ion Spray source, operating in a positive mode: LEV at transition 171.1>154.1, UCB L057 at 172.5>126.1, and IS at 256.3>167.3; with an assay run time of 2 minutes. The lower limit of quantification (LLOQ) for both LEV and UCB L057 was validated at 0.5 mu g/mL, while their lower limit of detection (LOD) was 0.25 mu g/mL. The calibration curves were linear between 0.5 and 100 mu g/mL for both analytes. The inaccuracy and imprecision of both intra-assay and inter-assay were less than 10%. Matrix effects were consistent between sources of plasma and the recoveries of all compounds were between 100% and 110%. Stability was established under various storage and processing conditions. The carryovers from both LEV and UCB L057 were less than 6% of the LLOQ and 0.13% of the IS. This assay method has been successfully applied to a population pharmacokinetic study of LEV in patients with epilepsy.	[Yeap, Li-Ling; Lo, Yoke-Lin] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya	Yeap, LL (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	lilingyeap@gmail.com	LO, YOKE LIN/B-8879-2010; Yeap, Li Ling/V-5036-2018; Lo, Lin/B-1477-2010; Yeap, Li Ling/GFX-9225-2022	LO, YOKE LIN/0000-0001-5521-2543; Yeap, Li Ling/0000-0001-7238-868X; Lo, Lin/0000-0001-5521-2543; Yeap, Li Ling/0000-0001-7238-868X	Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/H-20001-00-E000038]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This study is supported financially by the Ministry of Higher Education, Malaysia under High Impact Research grant. The grant number is UM.C/HIR/MOHE/H-20001-00-E000038. The grant was awarded to YLL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, GUID IND BIOAN METH; [Anonymous], 2011, KEPPR PRESCR INF PRO; Antonilli L, 2011, J PHARMACEUT BIOMED, V56, P763, DOI 10.1016/j.jpba.2011.07.018; Blonk MI, 2010, J CHROMATOGR B, V878, P675, DOI 10.1016/j.jchromb.2010.01.037; Brockmoller J, 2005, CLIN PHARMACOL THER, V77, P529, DOI 10.1016/j.clpt.2005.02.003; Can NO, 2010, J AOAC INT, V93, P1077; Collins Jennifer A, 2012, Methods Mol Biol, V902, P201, DOI 10.1007/978-1-61779-934-1_18; Contin M, 2008, J CHROMATOGR B, V873, P129, DOI 10.1016/j.jchromb.2008.08.007; Coupez R, 2003, EPILEPSIA, V44, P171, DOI 10.1046/j.1528-1157.2003.25302.x; European Medicines Agency, 2011, GUIDELINE BIOANALYTI; Fountain NB, 2007, EPILEPSY RES, V74, P60, DOI 10.1016/j.eplepsyres.2006.12.005; Glauser TA, 2007, EPILEPSIA, V48, P1117, DOI 10.1111/j.1528-1167.2007.01090.x; Grim SA, 2003, THER DRUG MONIT, V25, P61, DOI 10.1097/00007691-200302000-00009; Guo TD, 2007, CLIN CHIM ACTA, V375, P115, DOI 10.1016/j.cca.2006.06.022; Isoherranen N, 2000, J CHROMATOGR B, V745, P325, DOI 10.1016/S0378-4347(00)00293-0; Ivanova M, 2003, ELECTROPHORESIS, V24, P992, DOI 10.1002/elps.200390143; Jain DS, 2006, RAPID COMMUN MASS SP, V20, P2539, DOI 10.1002/rcm.2623; Juenke JM, 2006, J ANAL TOXICOL, V30, P27, DOI 10.1093/jat/30.1.27; Juenke JM, 2011, THER DRUG MONIT, V33, P209, DOI 10.1097/FTD.0b013e31820b1fce; Kaufman KR, 2013, EPILEPSY BEHAV CASE, V1, P110, DOI 10.1016/j.ebcr.2013.07.002; Kim KB, 2011, J PHARMACEUT BIOMED, V56, P771, DOI 10.1016/j.jpba.2011.07.019; Kuhn J, 2013, TALANTA, V110, P71, DOI 10.1016/j.talanta.2013.02.010; Lancelin F, 2007, THER DRUG MONIT, V29, P576, DOI 10.1097/FTD.0b013e318157032d; Luo WX, 2013, BIOANALYSIS, V5, P1843, DOI 10.4155/bio.13.143; Martens-Lobenhoffer J, 2005, J CHROMATOGR B, V819, P197, DOI 10.1016/j.jchromb.2005.01.040; Matar KM, 2008, J PHARMACEUT BIOMED, V48, P822, DOI 10.1016/j.jpba.2008.05.035; May TW, 2003, THER DRUG MONIT, V25, P690, DOI 10.1097/00007691-200312000-00007; Meearelli O, 2007, THER DRUG MONIT, V29, P313, DOI 10.1097/FTD.0b013e3180683d55; Mendu DR, 2010, CLIN BIOCHEM, V43, P485, DOI 10.1016/j.clinbiochem.2009.11.008; Olah E, 2012, J CHROMATOGR SCI, V50, P253, DOI 10.1093/chromsci/bmr053; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Patsalos PN, 2006, EPILEPSIA, V47, P1818, DOI 10.1111/j.1528-1167.2006.00819.x; Patsalos PN, 2013, CLIN PHARMACOKINET, V52, P1045, DOI 10.1007/s40262-013-0088-z; Patsalos PN, 2013, CLIN PHARMACOKINET, V52, P927, DOI 10.1007/s40262-013-0087-0; Patsalos PN, 2000, PHARMACOL THERAPEUT, V85, P77, DOI 10.1016/S0163-7258(99)00052-2; Patsalos PN, 2004, CLIN PHARMACOKINET, V43, P707, DOI 10.2165/00003088-200443110-00002; Patsalos PN, 2003, METHOD FIND EXP CLIN, V25, P123, DOI 10.1358/mf.2003.25.2.723686; Pellock JM, 2001, EPILEPSIA, V42, P1574, DOI 10.1046/j.1528-1157.2001.41300.x; Pucci V, 2004, BIOMED CHROMATOGR, V18, P37, DOI 10.1002/bmc.289; Ratnaraj N, 1996, THER DRUG MONIT, V18, P154, DOI 10.1097/00007691-199604000-00008; Reineks EZ, 2011, THER DRUG MONIT, V33, P124, DOI 10.1097/FTD.0b013e3182048e05; Shah NM, 2013, J CHROMATOGR B, V923, P65, DOI 10.1016/j.jchromb.2013.02.005; Shibata M, 2012, BIOMED CHROMATOGR, V26, P1519, DOI 10.1002/bmc.2726; VERMEIJ TAC, 1994, J CHROMATOGR B, V662, P134, DOI 10.1016/0378-4347(94)00393-9; Zufia L, 2010, CLIN BIOCHEM, V43, P473, DOI 10.1016/j.clinbiochem.2009.10.014	45	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111544	10.1371/journal.pone.0111544	http://dx.doi.org/10.1371/journal.pone.0111544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375249	Green Published, gold			2022-12-27	WOS:000344402600047
J	Durham, NM; Nirschl, CJ; Jackson, CM; Elias, J; Kochel, CM; Anders, RA; Drake, CG				Durham, Nicholas M.; Nirschl, Christopher J.; Jackson, Christopher M.; Elias, Jimmy; Kochel, Christina M.; Anders, Robert A.; Drake, Charles G.			Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T- cells to Be Suppressed In Vivo	PLOS ONE			English	Article							RECEPTOR-GAMMA CHAIN; SELF-TOLERANCE; HOMEOSTATIC MAINTENANCE; FAMILY CYTOKINES; DENDRITIC CELLS; LIFE-SPAN; INTERLEUKIN-2; MOLECULES; NAIVE; SURVIVAL	Lymphocyte Activation Gene - 3 (LAG-3) is an immune checkpoint molecule that regulates both T-cell activation and homeostasis. However, the molecular mechanisms underlying LAG-3's function are generally unknown. Using a model in which LAG-3 blockade or absence reliably augmented homeostatic proliferation in vivo, we found that IL-2 and STAT5 are critical for LAG-3 function. Similarly, LAG-3 blockade was ineffective in the absence of regulatory T-cells (Treg), suggesting an important role for LAG-3 in either the responsiveness of conventional T-cells (Tconv) to regulation, or a relative defect in the ability of LAG-3 KO regulatory T-cells (Treg) to suppress the proliferation of Tconv. In this model, LAG-3 KO Treg suppressed proliferation in a manner fairly similar to wild-type (WT) Treg, but LAG-3 KO Tconv were relatively resistant to suppression. Further studies also identified a role for LAG-3 in the induction/expansion of Treg. Finally, we found that LAG-3 blockade (or knockout) led to a relative skewing of naive CD4 T-cells toward a T(H)1 phenotype both in vitro and in in vivo. Together, these data suggest that LAG-3 expression on Tconv cells makes them more susceptible to Treg based suppression, and also regulates the development of a T(H)1 T-cell response.	[Durham, Nicholas M.; Nirschl, Christopher J.; Jackson, Christopher M.; Elias, Jimmy; Kochel, Christina M.; Anders, Robert A.; Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Anders, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Drake, CG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	cdrake@jhmi.edu			National Institutes of Health [R01 CA127153, 1P50CA58236-15]; Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA127153, P50CA058236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick C. Walsh Fund; OneInSix Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CGD is a Damon Runyon-Lilly Clinical Investigator and is supported by National Institutes of Health R01 CA127153, 1P50CA58236-15, the Patrick C. Walsh Fund, the OneInSix Foundation and the Prostate Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boyman O, 2012, CELL MOL LIFE SCI, V69, P1597, DOI 10.1007/s00018-012-0968-7; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Hannier S, 1998, J IMMUNOL, V161, P4058; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; He YW, 1997, J IMMUNOL, V158, P2592; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nirschl CJ, 2013, CLIN CANCER RES, V19, P4917, DOI 10.1158/1078-0432.CCR-12-1972; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sakaguchi S, 1996, J AUTOIMMUN, V9, P211, DOI 10.1006/jaut.1996.0026; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sega EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086551; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sprent J, 2008, IMMUNOL CELL BIOL, V86, P312, DOI 10.1038/icb.2008.12; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Workman CJ, 2011, METHODS MOL BIOL, V707, P119, DOI 10.1007/978-1-61737-979-6_9; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	53	90	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109080	10.1371/journal.pone.0109080	http://dx.doi.org/10.1371/journal.pone.0109080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372844	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900006
J	Gao, ZF; Guo, W; Liu, X; Huang, WH; Zhang, HY; Tan, N; Hau, WK; Zhang, YT; Liu, HF				Gao, Zhifan; Guo, Wei; Liu, Xin; Huang, Wenhua; Zhang, Heye; Tan, Ning; Hau, William Kongto; Zhang, Yuan-Ting; Liu, Huafeng			Automated Detection Framework of the Calcified Plaque with Acoustic Shadowing in IVUS Images	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; EXPERT CONSENSUS DOCUMENT; INTRAVASCULAR ULTRASOUND; COMPUTED-TOMOGRAPHY; AMERICAN-COLLEGE; PROGNOSTIC VALUE; SEGMENTATION; RISK	Intravascular Ultrasound (IVUS) is one ultrasonic imaging technology to acquire vascular cross-sectional images for the visualization of the inner vessel structure. This technique has been widely used for the diagnosis and treatment of coronary artery diseases. The detection of the calcified plaque with acoustic shadowing in IVUS images plays a vital role in the quantitative analysis of atheromatous plaques. The conventional method of the calcium detection is manual drawing by the doctors. However, it is very time-consuming, and with high inter-observer and intra-observer variability between different doctors. Therefore, the computer-aided detection of the calcified plaque is highly desired. In this paper, an automated method is proposed to detect the calcified plaque with acoustic shadowing in IVUS images by the Rayleigh mixture model, the Markov random field, the graph searching method and the prior knowledge about the calcified plaque. The performance of our method was evaluated over 996 in-vivo IVUS images acquired from eight patients, and the detected calcified plaques are compared with manually detected calcified plaques by one cardiology doctor. The experimental results are quantitatively analyzed separately by three evaluation methods, the test of the sensitivity and specificity, the linear regression and the Bland-Altman analysis. The first method is used to evaluate the ability to distinguish between IVUS images with and without the calcified plaque, and the latter two methods can respectively measure the correlation and the agreement between our results and manual drawing results for locating the calcified plaque in the IVUS image. High sensitivity (94.68%) and specificity (95.82%), good correlation and agreement (>96.82% results fall within the 95% confidence interval in the Student t-test) demonstrate the effectiveness of the proposed method in the detection of the calcified plaque with acoustic shadowing in IVUS images.	[Gao, Zhifan] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Peoples R China; [Gao, Zhifan; Liu, Xin; Zhang, Heye; Zhang, Yuan-Ting] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Gao, Zhifan; Liu, Xin; Zhang, Heye; Zhang, Yuan-Ting] Chinese Acad Sci, Key Lab Biomed Informat & Hlth Engn, Shenzhen, Peoples R China; [Guo, Wei; Tan, Ning] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Huang, Wenhua] Southern Med Univ, Inst Clin Anat, Guangzhou, Guangdong, Peoples R China; [Hau, William Kongto] Univ Hong Kong, LiKaShing Fac Med, Inst Cardiovasc Med & Res, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yuan-Ting] Chinese Univ Hong Kong, Dept Elect Engn, Joint Res Ctr Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Liu, Huafeng] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310027, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University of Hong Kong; Chinese University of Hong Kong; Zhejiang University	Zhang, HY (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	hy.zhang@siat.ac.cn; Tanning100@126.com	huang, wenhua/AAO-5990-2020; Gao, Zhifan/O-9082-2019	huang, wenhua/0000-0003-2382-9180; Gao, Zhifan/0000-0002-1576-4439; ZHANG, Yuanting/0000-0003-4150-5470	Research Team Fund for Low-cost Health-care Technologies in China; Enhancing Program of Key Laboratories of Shenzhen City [ZDSY20120617113021359]; National High-tech R & D Program (863 Program) [2012AA02A603]; National Natural Science Foundation of China [81101120]; Inovation funding in Shenzhen [SGLH20131010110119871, GJHZ20140415152115754]	Research Team Fund for Low-cost Health-care Technologies in China; Enhancing Program of Key Laboratories of Shenzhen City; National High-tech R & D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inovation funding in Shenzhen	ZFG, XL, HYZ, YTZ: Research Team Fund for Low-cost Health-care Technologies in China (http://cxtd.gdstc.gov.cn/) and the Enhancing Program of Key Laboratories of Shenzhen City (ZDSY20120617113021359, http://www.szsti.gov.cn/). WHH: the National High-tech R & D Program (863 Program) (No. 2012AA02A603, http://www.most.gov.cn/). HYZ: the National Natural Science Foundation of China (No. 81101120, www.nsfc.gov.cn). HFL: Inovation funding in Shenzhen (SGLH20131010110119871, GJHZ20140415152115754, http://www.szsti.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2012, IEEE T BIO-MED ENG, V59, P1022, DOI 10.1109/TBME.2011.2181372; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; ANTONIOU A, 2007, PRACTICAL OPTIMIZATI; Bishop C. M, 2006, PATTERN RECOGNITION; Brusseau E, 2004, IEEE T MED IMAGING, V23, P554, DOI 10.1109/TMI.2004.825602; Cardinal MHR, 2006, IEEE T MED IMAGING, V25, P590, DOI 10.1109/TMI.2006.872142; Cardinal MHR, 2003, LECT NOTES COMPUT SC, V2879, P432; Dey N., 2012, NAT C COMP COMM SYST, P1; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Filho ES, 2008, ULTRASOUND MED BIOL, V34, P160, DOI 10.1016/j.ultrasmedbio.2007.06.025; Forbes C., 2011, STAT DISTRIBUTIONS; Friedman A., 2011, PARTIAL DIFFERENTIAL; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Gao Z, 2014, IFMBE INT C HLTH INF, P197; Gil D, 2002, C AN SOC ESP ING BIO, P133; Goodman J. W., 2007, SPECKLE PHENOMENA OP; GOODMAN JW, 1976, J OPT SOC AM, V66, P1145, DOI 10.1364/JOSA.66.001145; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Herrington D. M., 1992, Proceedings of Computer in Cardiology 1992 (Cat. No.92CH3259-9), P103, DOI 10.1109/CIC.1992.269436; Kovalski G, 2000, ULTRASOUND MED BIOL, V26, P527, DOI 10.1016/S0301-5629(99)00167-2; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Lakemeyer G., 2003, EXPLORING ARTIFICIAL, P239; Li S. Z., 2009, MARKOV RANDOM FIELD; Meier DS, 1997, AM HEART J, V133, P681, DOI 10.1016/S0002-8703(97)70170-4; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Mojsilovic A, 1997, ANN BIOMED ENG, V25, P1059, DOI 10.1007/BF02684141; Nilsson N.J., 1982, PRINCIPLES ARTIFICIA; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papadogiorgaki Maria, 2007, Open Biomed Eng J, V1, P53, DOI 10.2174/1874120700701010053; Plissiti ME, 2004, IEEE T INF TECHNOL B, V8, P131, DOI 10.1109/TITB.2004.828889; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Ravindraiah R., 2014, INT J ADV RES COMPUT, V3; Roodaki A, 2009, ADV COMPUTER SCI ENG, P629; Schoenhagen P, 2005, IVUS MADE EASY; Seabra J, 2010, I S BIOMED IMAGING, P1, DOI 10.1109/ISBI.2010.5490428; Seabra JC, 2011, IEEE T BIO-MED ENG, V58, P1314, DOI 10.1109/TBME.2011.2106498; Shaw LJ, 2006, ATHEROSCLEROSIS, V188, P112, DOI 10.1016/j.atherosclerosis.2005.10.010; Shaw LJ, 2006, EUR HEART J, V27, P968, DOI 10.1093/eurheartj/ehi750; Nguyen TM, 2012, IEEE T SYST MAN CY B, V42, P193, DOI 10.1109/TSMCB.2011.2161284; Wayhs R, 2002, J AM COLL CARDIOL, V39, P225, DOI 10.1016/S0735-1097(01)01737-5; Xing D., 2013, WORLD C MED PHYS BIO, P931; Yedidia JS, 2001, BETHE FREE ENERGY KI; Zhang Q, 2010, ULTRASOUND MED BIOL, V36, P111, DOI 10.1016/j.ultrasmedbio.2009.06.1097	46	39	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109997	10.1371/journal.pone.0109997	http://dx.doi.org/10.1371/journal.pone.0109997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372784	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900014
J	Nelissen, BGL; van Herwaarden, JA; Moll, FL; van Diest, PJ; Pasterkamp, G				Nelissen, Bastiaan G. L.; van Herwaarden, Joost A.; Moll, Frans L.; van Diest, Paul J.; Pasterkamp, Gerard			SlideToolkit: An Assistive Toolset for the Histological Quantification of Whole Slide Images	PLOS ONE			English	Article								The demand for accurate and reproducible phenotyping of a disease trait increases with the rising number of biobanks and genome wide association studies. Detailed analysis of histology is a powerful way of phenotyping human tissues. Nonetheless, purely visual assessment of histological slides is time-consuming and liable to sampling variation and optical illusions and thereby observer variation, and external validation may be cumbersome. Therefore, within our own biobank, computerized quantification of digitized histological slides is often preferred as a more precise and reproducible, and sometimes more sensitive approach. Relatively few free toolkits are, however, available for fully digitized microscopic slides, usually known as whole slides images. In order to comply with this need, we developed the slideToolkit as a fast method to handle large quantities of low contrast whole slides images using advanced cell detecting algorithms. The slideToolkit has been developed for modern personal computers and high-performance clusters (HPCs) and is available as an open-source project on github.com. We here illustrate the power of slideToolkit by a repeated measurement of 303 digital slides containing CD3 stained (DAB) abdominal aortic aneurysm tissue from a tissue biobank. Our workflow consists of four consecutive steps. In the first step (acquisition), whole slide images are collected and converted to TIFF files. In the second step (preparation), files are organized. The third step (tiles), creates multiple manageable tiles to count. In the fourth step (analysis), tissue is analyzed and results are stored in a data set. Using this method, two consecutive measurements of 303 slides showed an intraclass correlation of 0.99. In conclusion, slideToolkit provides a free, powerful and versatile collection of tools for automated feature analysis of whole slide images to create reproducible and meaningful phenotypic data sets.	[Nelissen, Bastiaan G. L.; van Herwaarden, Joost A.; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Nelissen, BGL (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands.	b.g.l.nelissen@umcutrecht.nl		van Herwaarden, Joost/0000-0003-1165-5179				Belien JAM, 1999, J CLIN PATHOL, V52, P184, DOI 10.1136/jcp.52.3.184; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hurks R, 2010, EUR SURG RES, V45, P34, DOI 10.1159/000318160; Iyengar JN, 2009, INDIAN J PATHOL MICR, V52, P1, DOI 10.4103/0377-4929.44951; Kalinski T, 2011, AM J CLIN PATHOL, V136, P889, DOI 10.1309/AJCPYI1Z3TGGAIEP; Lopez XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082710; Lovett JK, 2004, CEREBROVASC DIS, V18, P117, DOI 10.1159/000079259; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Osborne JM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003506; Prlic A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002802; Ramos-Vara JA, 2014, VET PATHOL, V51, P42, DOI 10.1177/0300985813505879; Revelle W, 2012, CRAN PACKAGE PSYCH; Scholtes VPW, 2011, CURR CARDIOL REV, V7, P9, DOI 10.2174/157340311795677707; Tange O., 2018, USENIX MAGAZINE, V36, P42; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Vokes Martha S, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1417s82; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	18	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110289	10.1371/journal.pone.0110289	http://dx.doi.org/10.1371/journal.pone.0110289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372389	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900019
J	Spencer, WC; McWhirter, R; Miller, T; Strasbourger, P; Thompson, O; Hillier, LW; Waterston, RH; Miller, DM				Spencer, W. Clay; McWhirter, Rebecca; Miller, Tyne; Strasbourger, Pnina; Thompson, Owen; Hillier, LaDeana W.; Waterston, Robert H.; Miller, David M., III			Isolation of Specific Neurons from C. elegans Larvae for Gene Expression Profiling	PLOS ONE			English	Article							MOTOR-NEURONS; DIFFERENTIAL EXPRESSION; HOMEOBOX GENES; CAENORHABDITIS; CELL; IDENTIFICATION; NORMALIZATION; CHANNELS; IDENTITY; SYSTEM	Background: The simple and well-described structure of the C. elegans nervous system offers an unprecedented opportunity to identify the genetic programs that define the connectivity and function of individual neurons and their circuits. A correspondingly precise gene expression map of C. elegans neurons would facilitate the application of genetic methods toward this goal. Here we describe a powerful new approach, SeqCeL (RNA-Seq of C. elegans cells) for producing gene expression profiles of specific larval C. elegans neurons. Methods and Results: We have exploited available GFP reporter lines for FACS isolation of specific larval C. elegans neurons for RNA-Seq analysis. Our analysis showed that diverse classes of neurons are accessible to this approach. To demonstrate the applicability of this strategy to rare neuron types, we generated RNA-Seq profiles of the NSM serotonergic neurons that occur as a single bilateral pair of cells in the C. elegans pharynx. These data detected >1,000 NSM enriched transcripts, including the majority of previously known NSM-expressed genes. Significance: This work offers a simple and robust protocol for expression profiling studies of post-embryonic C. elegans neurons and thus provides an important new method for identifying candidate genes for key roles in neuron-specific development and function.	[Spencer, W. Clay; McWhirter, Rebecca; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Miller, Tyne] Vanderbilt Univ, Program Neurosci, Nashville, TN 37235 USA; [Strasbourger, Pnina; Thompson, Owen; Hillier, LaDeana W.; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle	Miller, DM (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	david.miller@vanderbilt.edu		Miller-Fleming, Tyne/0000-0002-0398-5162	US National Institutes of Health (NIH) National Center for Research Resources; Vanderbilt Silvio O. Conte Center grant [MH078028]; NIH [R01 NS26115, U01 HG004263]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026115] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vanderbilt Silvio O. Conte Center grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The C. elegans Genetics Center is supported by US National Institutes of Health (NIH) National Center for Research Resources. This work was supported by Vanderbilt Silvio O. Conte Center grant MH078028 to TM and NIH Grants R01 NS26115 to DMM and U01 HG004263 to RHW and DMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bonferroni E, 1935, CALCOLO ASSICURAZION; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gerstein MB, 2014, NATURE IN PRESS; Guillermin ML, 2011, GENETICS, V189, P1327, DOI 10.1534/genetics.111.133835; Haenni S, 2012, NUCLEIC ACIDS RES, V40, P6304, DOI 10.1093/nar/gks282; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Hillier LW, 2009, GENOME RES; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim K, 2010, DEVELOPMENT, V137, P963, DOI 10.1242/dev.044719; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Nelson JC, 2013, J NEUROSCI, V33, P1366, DOI 10.1523/JNEUROSCI.3471-12.2012; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; SCHACHAT F, 1978, CELL, V15, P405, DOI 10.1016/0092-8674(78)90009-0; Schwarz EM, 2012, P NATL ACAD SCI USA, V109, P16246, DOI 10.1073/pnas.1203045109; Shagina I, 2010, BIOTECHNIQUES, V48, P455, DOI 10.2144/000113422; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shipley FB, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00028; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Steiner FA, 2012, GENOME RES, V22, P766, DOI 10.1101/gr.131748.111; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sze JY, 2002, DEVELOPMENT, V129, P3901; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Zhang FF, 2014, DEVELOPMENT, V141, P422, DOI 10.1242/dev.099721; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhang Sihui, 2013, WormBook, P1, DOI 10.1895/wormbook.1.157.1; Zhang SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019505; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	54	50	50	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112102	10.1371/journal.pone.0112102	http://dx.doi.org/10.1371/journal.pone.0112102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372608	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900111
J	Virga, D; CurSeu, PL; Maricutoiu, L; Sava, FA; Macsinga, I; Magurean, S				Virga, Delia; CurSeu, Petru Lucian; Maricutoiu, Laurentiu; Sava, Florin A.; Macsinga, Irina; Magurean, Silvia			Personality, Relationship Conflict, and Teamwork-Related Mental Models	PLOS ONE			English	Article							INTRAGROUP CONFLICT; ENVIRONMENT FIT; PERFORMANCE; ORGANIZATIONS; TRAITS; TASK; SATISFACTION; TEAMS	This study seeks to explore whether neuroticism, agreeableness, and conscientiousness moderate the influence of relationship conflict experienced in groups on changes in group members' evaluative cognitions related to teamwork quality (teamwork-related mental models). Data from 216 students, nested in 48 groups were analyzed using a multilevel modeling approach. Our results show that the experience of relationship conflict leads to a negative shift from the pre-task to the post-task teamwork-related mental models. Moreover, the results indicate that conscientiousness buffered the negative association between relationship conflict and the change in teamwork-related mental models. Our results did not support the hypothesized moderating effect of agreeableness and show that the detrimental effect of relationship conflict on the shift in teamwork-related mental models is accentuated for group members scoring low rather than high on neuroticism. These findings open new research venues for exploring the association between personality, coping styles and change in teamwork-related mental models.	[Virga, Delia; Maricutoiu, Laurentiu; Sava, Florin A.; Macsinga, Irina; Magurean, Silvia] West Univ Timisoara, Dept Psychol, Timisoara, Romania; [CurSeu, Petru Lucian] Tilburg Univ, Dept Org Studies, NL-5000 LE Tilburg, Netherlands; [CurSeu, Petru Lucian] Univ Babes Bolyai, Dept Psychol, R-3400 Cluj Napoca, Romania	West University of Timisoara; Tilburg University; Babes Bolyai University from Cluj	CurSeu, PL (corresponding author), Tilburg Univ, Dept Org Studies, NL-5000 LE Tilburg, Netherlands.	P.L.Curseu@uvt.nl	Sava, Florin A./C-1427-2011; Magurean, Silvia/A-3732-2013; Maricutoiu, Laurentiu P./B-6875-2011; Virga, Delia/AAB-4022-2022; Curseu, Petru Lucian/AAD-5084-2019; Maricutoiu, Laurentiu/O-9568-2019; Curseu, Petru Lucian/H-7620-2012; Sava, Florin Alin/AAD-4065-2020	Sava, Florin A./0000-0001-8898-1306; Magurean, Silvia/0000-0001-9387-0379; Maricutoiu, Laurentiu P./0000-0001-8358-3130; Virga, Delia/0000-0002-9321-4520; Curseu, Petru Lucian/0000-0003-0067-6310; Maricutoiu, Laurentiu/0000-0001-8358-3130; Curseu, Petru Lucian/0000-0003-0067-6310; 	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PN-II-ID-PCE-2012-4-0621, PN-II-ID-PCE-2011-3-0482]	Romanian National Authority for Scientific Research, CNCS - UEFISCDI	This work was supported by two grants of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project numbers PN-II-ID-PCE-2012-4-0621 and PN-II-ID-PCE-2011-3-0482 (http://uefiscdi.gov.ro/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnulf JK, 2012, TEAM PERFORM MANAG, V18, P433, DOI 10.1108/13527591211281156; Barrick MR, 2001, INT J SELECT ASSESS, V9, P9, DOI 10.1111/1468-2389.00160; Bell ST, 2007, J APPL PSYCHOL, V82, P62; BOLGER N, 1995, J PERS SOC PSYCHOL, V69, P890, DOI 10.1037/0022-3514.69.5.890; Bono JE, 2002, J PERS, V70, P311, DOI 10.1111/1467-6494.05007; Brebner J, 2001, PERS INDIV DIFFER, V31, P317, DOI 10.1016/S0191-8869(00)00138-0; CAPLAN RD, 1987, J VOCAT BEHAV, V31, P248, DOI 10.1016/0001-8791(87)90042-X; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Chen G, 2011, J APPL PSYCHOL, V96, P541, DOI 10.1037/a0021886; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Costa PT, 2007, REVISED NEO PERSONAL; Curseu PL, 2012, INT J CONFL MANAGE, V23, P97, DOI 10.1108/10444061211199331; De Dreu CKW, 2003, J APPL PSYCHOL, V88, P741, DOI 10.1037/0021-9010.88.4.741; de Wit FRC, 2012, J APPL PSYCHOL, V97, P360, DOI 10.1037/a0024844; Driskell JE, 2006, GROUP DYN-THEOR RES, V10, P249, DOI 10.1037/1089-2699.10.4.249; Eby LT, 1999, ORGAN RES METHODS, V2, P366, DOI 10.1177/109442819924003; Edwards JR, 2008, ACAD MANAG ANN, V2, P167, DOI 10.1080/19416520802211503; Graziano WG, 1997, J PERS SOC PSYCHOL, V73, P1394, DOI 10.1037/0022-3514.73.6.1394; Ilies R, 2011, J ORGAN BEHAV, V32, P44, DOI 10.1002/job.677; Iliescu D, 2009, NEO PI R MANUAL TECH; JEHN KA, 1995, ADMIN SCI QUART, V40, P256, DOI 10.2307/2393638; Jensen-Campbell LA, 2002, J RES PERS, V36, P476, DOI 10.1016/S0092-6566(02)00004-1; Jensen-Campbell LA, 2007, J RES PERS, V41, P403, DOI 10.1016/j.jrp.2006.05.001; Judge TA, 2002, J APPL PSYCHOL, V87, P797, DOI 10.1037//0021-9010.87.4.797; Kozlowski SWJ, 2013, ORGAN RES METHODS, V16, P581, DOI 10.1177/1094428113493119; Kozlowski SWJ, 2012, ROUTL COMMUN SER, P260; Langelaan S, 2006, PERS INDIV DIFFER, V40, P521, DOI 10.1016/j.paid.2005.07.009; Le H, 2011, J APPL PSYCHOL, V96, P113, DOI 10.1037/a0021016; LePine JA, 2001, J APPL PSYCHOL, V86, P326, DOI 10.1037//0021-9010.86.2.326; Lord W., 2007, NEO PI R GUIDE INTER; Mathieu JE, 2000, J APPL PSYCHOL, V85, P273, DOI 10.1037//0021-9010.85.2.273; Mount MK, 1998, HUM PERFORM, V11, P145, DOI 10.1207/s15327043hup1102&3_3; Neuman GA, 1999, J APPL PSYCHOL, V84, P376, DOI 10.1037/0021-9010.84.3.376; Peeters MAG, 2006, EUR J PERSONALITY, V20, P377, DOI 10.1002/per.588; PERVIN LA, 1968, PSYCHOL BULL, V69, P56, DOI 10.1037/h0025271; Peterson RS, 2003, ORGAN BEHAV HUM DEC, V92, P102, DOI 10.1016/S0749-5978(03)00090-6; Pluut H, 2013, GROUP PROCESS INTERG, V16, P412, DOI 10.1177/1368430212453633; Porter COLH, 2003, J APPL PSYCHOL, V88, P391, DOI 10.1037/0021-9010.88.3.391; Prewett MS, 2009, HUM PERFORM, V22, P273, DOI 10.1080/08959280903120253; Raudenbush S., 2010, HLM 7 HIERARCHICAL L; Shaw JD, 2011, J APPL PSYCHOL, V96, P391, DOI 10.1037/a0021340; Spector PE, 2011, HUM RESOUR MANAGE R, V21, P342, DOI 10.1016/j.hrmr.2010.10.002; STEVENS MJ, 1994, J MANAGE, V20, P503, DOI 10.1177/014920639402000210; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656	44	6	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110223	10.1371/journal.pone.0110223	http://dx.doi.org/10.1371/journal.pone.0110223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372143	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900017
J	Mezger, A; Ohrmalm, C; Herthnek, D; Blomberg, J; Nilsson, M				Mezger, Anja; Ohrmalm, Christina; Herthnek, David; Blomberg, Jonas; Nilsson, Mats			Detection of Rotavirus Using Padlock Probes and Rolling Circle Amplification	PLOS ONE			English	Article							LATEX AGGLUTINATION; ASSAY	Rotavirus infections are one of the most common reasons for hospitalizations due to gastrointestinal diseases. Rotavirus is often diagnosed by latex agglutination assay, chromatography immunoassay, or by electron microscopy, which are all quite insensitive. Reverse transcription polymerase chain reaction, on the other hand, is very sensitive to variations at the genomic level. We developed a novel assay based on a set of 58 different padlock probes with a detection limit of 1,000 copies. Twenty-two patient samples were analyzed and the assay showed high concordance with a PCR-based assay. In summary, we present a new assay for sensitive and variation tolerant detection of rotavirus.	[Mezger, Anja; Herthnek, David; Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden; [Ohrmalm, Christina; Blomberg, Jonas] Univ Uppsala Hosp, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden	Stockholm University; Uppsala University; Uppsala University Hospital	Nilsson, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden.	Mats.Nilsson@scilifelab.se		Blomberg, Jonas/0000-0001-6492-2491; Mezger, Anja/0000-0002-7337-9547; Ohrmalm, Christina/0000-0002-3287-3549	Swedish Research Council; VINNOVA; Science for Life Laboratory, Stockholm	Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Science for Life Laboratory, Stockholm	This work was supported by the Swedish Research Council (www.vr.se), VINNOVA (www.vinnova.se), and the Science for Life Laboratory, Stockholm (www.scilifelab.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agocs Mary, 2011, Morbidity and Mortality Weekly Report, V60, P514; Baner J, 1998, NUCLEIC ACIDS RES, V26, P5073, DOI 10.1093/nar/26.22.5073; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Engstrom A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062015; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Ke RQ, 2011, J CLIN MICROBIOL, V49, P4279, DOI 10.1128/JCM.00713-11; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf065; Ohrmalm C, 2012, J CLIN MICROBIOL, V50, P3208, DOI 10.1128/JCM.06382-11; Ohrmalm C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq777; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Raboni SM, 2002, AM J CLIN PATHOL, V117, P392; SANDERS RC, 1986, J VIROL METHODS, V13, P285, DOI 10.1016/0166-0934(86)90053-4; Tate JE, 2013, PEDIATR INFECT DIS J, V32, P741, DOI 10.1097/INF.0b013e31828d639c	15	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111874	10.1371/journal.pone.0111874	http://dx.doi.org/10.1371/journal.pone.0111874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369034	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000115
J	An, FM; Zhan, Q; Xia, M; Jiang, LS; Lu, GM; Huang, MD; Guo, JZ; Liu, SD				An, Fangmei; Zhan, Qiang; Xia, Min; Jiang, Lisha; Lu, Guoming; Huang, Mindan; Guo, Jizhong; Liu, Side			From Moderately Severe to Severe Hypertriglyceridemia Induced Acute Pancreatitis: Circulating MiRNAs Play Role as Potential Biomarkers	PLOS ONE			English	Article							FREE FATTY-ACIDS; CANCER; MICRORNA; PROCALCITONIN; EXPRESSION; DIAGNOSIS; CALCIUM; CELLS; SERUM; TOOL	The incidence of hypertriglyceridemia induced acute pancreatitis (HTAP) continues to rise in China. It has systemic complications and high mortality, making the early assessment of the severity of this disease even more important. Circulating microRNAs (miRNAs) could be novel, non-invasive biomarkers for disease progression judgment. This study aimed to identify the potential role of serum miRNAs as novel biomarkers of HTAP progression. HTAP patients were divided into two groups: moderately severe (HTMSAP) and severe (HTSAP), healthy people were used as control group. The serum miRNA expression profiles of these three groups were determined by microarray and verified by qRT-PCR. The functions and pathways of the targeted genes of deregulated miRNAs were predicted, using bioinformatics analysis; miRNA-mRNA network was generated. Moreover, the correlation between miR-181a-5p and pancreatitis metabolism related substances were studied and the serum concentration of inflammatory cytokines and miRNAs at different time points during the MSAP and SAP were investigated, respectively. Finally, the receiver operating characteristic (ROC) curve of miRNAs was studied. Significant changes in the serum concentration of the following miRNAs of HTAP patients (P<0.05) were discovered: miR24-3p, 361-5p, 1246, and 222-3p (constantly upregulated), and 181a-5p (constantly downregulated) (P<0.05). Bioinformatics analysis predicted that 13 GOs and 36 pathways regulated by overlap miRNAs were involved in glucose, fat, calcium (Ca++), and insulin metabolism (P<0.001). miRNA-mRNA network revealed that the overlap miRNAs targeted genes participating in pancreas metabolism and miR-181a-5p, the only downregulated miRNA, had good negative correlation with triglyceride (TG), total cholesterol (TC), and fast blood glucose (FBG), but a positive correlation with Ca++. When compared with inflammatory cytokines, the changes of all five overlap miRNAs were more stable. It was found that when used for evaluating the progression of HTAP, miRNAs showed good AUC. These data suggested that serum miRNAs have the potential to be excellent HTAP biomarkers.	[An, Fangmei; Zhan, Qiang; Xia, Min; Jiang, Lisha; Lu, Guoming; Huang, Mindan; Guo, Jizhong] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China; [Zhan, Qiang; Liu, Side] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China	Jiangnan University; Nanjing Medical University; Southern Medical University - China	An, FM (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China.	wdf8025@163.com; liuside2011@163.com	An, Fangmei/AAV-6977-2021		Science and Technology grant of Jiangsu Province [BK20120098]; Wuxi Municipal Science and Technology Development Plan [CSZ00N1304]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	Science and Technology grant of Jiangsu Province; Wuxi Municipal Science and Technology Development Plan; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	This project was supported by the grant of Science and Technology grant of Jiangsu Province (BK20120098), by the grant of Wuxi Municipal Science and Technology Development Plan (CSZ00N1304), by the grant of Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FM, 2012, APOPTOSIS, V17, P702, DOI 10.1007/s10495-012-0704-7; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger F, 2013, THERANOSTICS, V3, P932, DOI 10.7150/thno.7445; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Cugnet-Anceau Christine, 2011, Rev Prat, V61, P1110; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; deBeaux AC, 1996, BRIT J SURG, V83, P1071, DOI 10.1002/bjs.1800830811; Devaraj Saranya, 2011, In Silico Biology, V11, P281, DOI 10.3233/ISB-2012-0444; DOMSCHKE S, 1993, INT J PANCREATOL, V13, P105; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du YQ, 2013, CANCER BIOTHER RADIO, V28, P361, DOI 10.1089/cbr.2012.1389; Farina NH, 2013, J CELL BIOCH; Frick TW, 2012, SURGERY, V152, pS157, DOI 10.1016/j.surg.2012.05.013; Gerasimenko JV, 2013, P NATL ACAD SCI USA, V110, P13186, DOI 10.1073/pnas.1300910110; Gerasimenko JV, 2013, J PHYSL; Gurda-Duda A, 2008, PANCREAS, V37, P449, DOI 10.1097/MPA.0b013e3181706d67; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Huang GJ, 2006, J CELL SCI, V119, P153, DOI 10.1242/jcs.02731; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karpavicius A, 2012, WORLD J GASTROENTERO, V18, P6620, DOI 10.3748/wjg.v18.i45.6620; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kusnierz-Cabala Beata, 2013, Przegl Lek, V70, P392; Linares CL, 2008, PANCREAS, V37, P13, DOI 10.1097/MPA.0b013e31816074a1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macha MA, 2014, CURR PHARM DES; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Modrau IS, 2005, AM J GASTROENTEROL, V100, P1593, DOI 10.1111/j.1572-0241.2005.41456.x; Nagayama Daiji, 2013, Nihon Rinsho, V71, P1602; Orabi AI, 2013, J BIOL CHEM, V288, P27128, DOI 10.1074/jbc.M113.494534; Rau BM, 2007, ANN SURG, V245, P745, DOI 10.1097/01.sla.0000252443.22360.46; Sarr MG, 2013, SURG CLIN N AM, V93, P549, DOI 10.1016/j.suc.2013.02.012; Shi CM, 2014, J INTERF CYTOK RES, V34, P342, DOI 10.1089/jir.2013.0078; Sztefko K, 2001, PANCREATOLOGY, V1, P230, DOI 10.1159/000055816; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Volante E, 2004, J Matern Fetal Neonatal Med, V16 Suppl 2, P13, DOI 10.1080/14767050410001727116; Wang Y, 2009, GUT, V58, P422, DOI 10.1136/gut.2007.146258; Yang F, 2009, ACTA PHYSIOL, V195, P13, DOI 10.1111/j.1748-1716.2008.01933.x; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30	42	19	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111058	10.1371/journal.pone.0111058	http://dx.doi.org/10.1371/journal.pone.0111058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365448	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100047
J	Halatchliyski, I; Cress, U				Halatchliyski, Iassen; Cress, Ulrike			How Structure Shapes Dynamics: Knowledge Development in Wikipedia - A Network Multilevel Modeling Approach	PLOS ONE			English	Article							COLLABORATION; EMERGENCE; WEB	Using a longitudinal network analysis approach, we investigate the structural development of the knowledge base of Wikipedia in order to explain the appearance of new knowledge. The data consists of the articles in two adjacent knowledge domains: psychology and education. We analyze the development of networks of knowledge consisting of interlinked articles at seven snapshots from 2006 to 2012 with an interval of one year between them. Longitudinal data on the topological position of each article in the networks is used to model the appearance of new knowledge over time. Thus, the structural dimension of knowledge is related to its dynamics. Using multilevel modeling as well as eigenvector and betweenness measures, we explain the significance of pivotal articles that are either central within one of the knowledge domains or boundary-crossing between the two domains at a given point in time for the future development of new knowledge in the knowledge base.	[Halatchliyski, Iassen; Cress, Ulrike] Knowledge Media Res Ctr, Knowledge Construct Lab, Tubingen, Germany; [Cress, Ulrike] Univ Tubingen, Dept Appl Cognit Psychol & Media Psychol, Tubingen, Germany	Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien; Eberhard Karls University of Tubingen	Halatchliyski, I (corresponding author), Knowledge Media Res Ctr, Knowledge Construct Lab, Tubingen, Germany.	i.halatchliyski@iwm-kmrc.de	Cress, Ulrike/AAB-4264-2020; Cress, Ulrike/A-5615-2013	Cress, Ulrike/0000-0002-8996-8303; Cress, Ulrike/0000-0002-8996-8303	Leibniz ScienceCampus Tubingen "Informational Environments''	Leibniz ScienceCampus Tubingen "Informational Environments''	This work was supported by Leibniz ScienceCampus Tubingen "Informational Environments'' (http://www.wissenschaftscampus-tuebingen.de/www/index.html) to UC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind TC, 1997, J DOC, V53, P404, DOI 10.1108/EUM0000000007205; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Bruckman A, 2006, CAMB HANDB PSYCHOL, P461; Buriol LS, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, (WI 2006 MAIN CONFERENCE PROCEEDINGS), P45, DOI 10.1109/WI.2006.164; Capocci A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036116; Cress U, 2008, INT J COMP-SUPP COLL, V3, P69, DOI 10.1007/s11412-007-9032-2; Cress U, 2013, HANDBOOK OF DESIGN IN EDUCATIONAL TECHNOLOGY, P416; Cress U, 2008, INT J COMP-SUPP COLL, V3, P105, DOI 10.1007/s11412-007-9035-z; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Forte A., 2006, P 7 INT C LEARN SCI, V1, P182; Forte A., 2008, P 41 ANN HAW INT C S, DOI [DOI 10.1109/HICSS.2008.383, 10.1109/HICSS.2008.383]; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gabrilovich E, 2006, AAAI, V6, P1301; Halatchliyski I, 2012, FUTURE LEARNING, VII, P162; Halatchliyski I., 2010, P 6 INT S WIK OP COL; Halatchliyski I, 2014, J LEARNING ANAL, V1, P72, DOI DOI 10.18608/JLA.2014.12.5; Halatchliyski I, 2014, INT J COMP-SUPP COLL, V9, P97, DOI 10.1007/s11412-013-9182-3; Halfaker A, 2013, AM BEHAV SCI, V57, P664, DOI 10.1177/0002764212469365; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Iriberri A, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459356; Janssen J, 2011, COMPUT-SUPP COLLAB L, P187, DOI 10.1007/978-1-4419-7710-6_9; Kimmerle J, 2010, INFORM COMMUN SOC, V13, P1099, DOI 10.1080/13691180903521547; Kitsak M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056115; Kittur A, 2007, ALT CHI 2007 SAN JOS; Kolbitsch J, 2006, J UNIVERS COMPUT SCI, V12, P187; Ling K, 2005, J COMPUT-MEDIAT COMM, V10; Lucio-Arias D, 2007, SCIENTOMETRICS, V70, P603, DOI 10.1007/s11192-007-0304-4; Lucio-Arias D, 2012, UNDERST COMPLEX SYST, P23, DOI 10.1007/978-3-642-23068-4_2; Lucio-Arias D, 2009, J INFORMETR, V3, P261, DOI 10.1016/j.joi.2009.03.003; Mali F, 2012, UNDERST COMPLEX SYST, P195, DOI 10.1007/978-3-642-23068-4_6; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; O'Reilly T., 2005, WHAT IS WEB 2 0 DESI; Oeberst A, 2014, J LEARN SCI, V23, P149, DOI 10.1080/10508406.2014.888352; Ortega F., 2009, THESIS U REY JUAN CA; Park H.W., 2003, J COMPUTER MEDIATED, V8, pJCMC843, DOI https://doi.org/10.1111/j.1083-6101.2003.tb00223.x; Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002; Pirolli P., 2009, P 5 INT S WIKIS OP C, V8, P1, DOI DOI 10.1145/1641309.1641322; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Radicchi F, 2012, UNDERST COMPLEX SYST, P233, DOI 10.1007/978-3-642-23068-4_7; RAUDENBUSH SW, 1993, J CONSULT CLIN PSYCH, V61, P941, DOI 10.1037/0022-006X.61.6.941; Ridings C, 2004, J COMPUT-MEDIAT COMM, V10, P00, DOI [10.1111/j.1083-6101.2004.tb00229.x, DOI 10.1111/J.1083-6101.2004.TB00229.X, 10.1111/j.1083-6101.2004.tb00229]; Scharnhorst A, 2012, UNDERST COMPLEX SYST, P1, DOI [10.1007/978-3-642-23068-4, 10.1007/978-3-642-23068-4_1]; Shaw A, 2014, J COMMUN, V64, P215, DOI 10.1111/jcom.12082; Swarts J, 2009, SIGDOC'09: PROCEEDINGS OF THE 27TH ACM INTERNATIONAL CONFERENCE ON DESIGN OF COMMUNICATION, P281; Theiner G, 2010, COGN SYST RES, V11, P378, DOI 10.1016/j.cogsys.2010.07.002; Wasko MM, 2005, MIS QUART, V29, P35, DOI 10.2307/25148667; Wellman B., 1999, COMMUNITIES CYBERSPA, DOI 10.4324/9780429498718; Wikipedia, LINKING; Wilkinson D. M., 2007, P 2007 INT S WIK, P157, DOI DOI 10.1145/1296951.1296968; Yasseri T, 2013, J STAT PHYS, V151, P414, DOI 10.1007/s10955-013-0728-6	55	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111958	10.1371/journal.pone.0111958	http://dx.doi.org/10.1371/journal.pone.0111958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365319	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100140
J	Ma, HT; Fang, CL; Pang, B; Li, GD				Ma, Haitao; Fang, Chuanglin; Pang, Bo; Li, Guangdong			The Effect of Geographical Proximity on Scientific Cooperation among Chinese Cities from 1990 to 2010	PLOS ONE			English	Article							BIBLIOMETRIC INDICATORS; KNOWLEDGE TRANSFER; COLLABORATION; NETWORKS; SCIENCE; END; INNOVATION; IMPACT; FIRMS	Background: The relations between geographical proximity and spatial distance constitute a popular topic of concern. Thus, how geographical proximity affects scientific cooperation, and whether geographically proximate scientific cooperation activities in fact exhibit geographic scale features should be investigated. Methodology: Selected statistics from the ISI database on cooperatively authored papers, the authors of which resided in 60 typical cites in China, and which were published in the years 1990, 1995, 2000, 2005, and 2010, were used to establish matrices of geographic distance and cooperation levels between cities. By constructing a distance-cooperation model, the degree of scientific cooperation based on spatial distance was calculated. The relationship between geographical proximity and scientific cooperation, as well as changes in that relationship, was explored using the fitting function. Result: (1) Instead of declining, the role of geographical proximity in inter-city scientific cooperation has increased gradually but significantly with the popularization of telecommunication technologies; (2) the relationship between geographical proximity and scientific cooperation has not followed a perfect declining curve, and at certain spatial scales, the distancedecay regularity does not work; (3) the Chinese scientific cooperation network gathers around different regional center cities, showing a trend towards a regional network; within this cooperation network the amount of inter-city cooperation occurring at close range increased greatly. Conclusion: The relationship between inter-city geographical distance and scientific cooperation has been enhanced and strengthened over time.	[Ma, Haitao; Fang, Chuanglin; Pang, Bo; Li, Guangdong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Ma, HT (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	maht@igsnrr.ac.cn		MA, Haitao/0000-0003-4828-050X	National Natural Science Foundation of China [41201128]; National Social Science Foundation of China [13ZD027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	The National Natural Science Foundation of China (grant no 41201128) (URLhttp://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) contributed to data collection and analysis. The major project of the National Social Science Foundation of China (grant no 13&ZD027) (URL http://www.npopss-cn.gov.cn/n/2013/1107/c371054-23467028.html) contributed to study design.	Abramovsky L, 2011, J ECON GEOGR, V11, P949, DOI 10.1093/jeg/lbq052; Acs JZ, 2010, HDB ENTREPRENEURSHIP; Agnes P, 2000, ECON GEOGR, V76, P347, DOI 10.2307/144391; Agrawal A, 2008, AM ECON REV, V98, P1578, DOI 10.1257/aer.98.4.1578; Asheim B. T., 2005, OXFORD HDB INNOVATIO, P291, DOI DOI 10.1093/OXFORDHB/9780199286805.003.0011; Ben Letaifa S, 2013, J BUS RES, V66, P2071, DOI 10.1016/j.jbusres.2013.02.033; Boekema F, 2007, REG STUD, V41, P868; Bornmann L, 2011, J INFORMETR, V5, P537, DOI 10.1016/j.joi.2011.05.005; Boschma R, 2010, HANDBOOK OF EVOLUTIONARY ECONOMIC GEOGRAPHY, P1; Brownell J, 2012, J HEALTH CARE POOR U, V23, P125, DOI 10.1353/hpu.2012.0130; Dymski GA, 2009, CAMB J REG ECON SOC, V2, P267, DOI 10.1093/cjres/rsp011; Friedman T.L., 2005, WORLD IS FLAT BRIEF; Gluckler J, 2007, J ECON GEOGR, V7, P619, DOI 10.1093/jeg/lbm023; Graham S, 1998, PROG HUM GEOG, V22, P165, DOI 10.1191/030913298671334137; Griffith R, 2009, J REGIONAL SCI, V49, P689, DOI 10.1111/j.1467-9787.2009.00630.x; HESSE BW, 1993, COMMUN ACM, V36, P90, DOI 10.1145/163381.163409; Hong W, 2008, RES POLICY, V37, P580, DOI 10.1016/j.respol.2007.12.008; Hou H, 2008, SCIENTOMETRICS, V75, P189, DOI 10.1007/s11192-007-1771-3; Jonkers K, 2009, SCIENTOMETRICS, V80, P775, DOI 10.1007/s11192-008-2115-7; Kamalski J, 2012, CITIES, V29, pS3, DOI 10.1016/j.cities.2012.06.012; KATZ JS, 1994, SCIENTOMETRICS, V31, P31, DOI 10.1007/BF02018100; Kolympiris C, 2013, SMALL BUS ECON, V40, P1059, DOI 10.1007/s11187-012-9441-0; Kroll H, 2010, TECHNOVATION, V30, P117, DOI 10.1016/j.technovation.2009.10.003; Lambooy JG, 2002, URBAN STUD, V39, P1019, DOI 10.1080/00420980220128435; Lei XP, 2013, SCIENTOMETRICS, V96, P427, DOI 10.1007/s11192-012-0944-x; Liang LM, 2002, SCIENTOMETRICS, V55, P287, DOI 10.1023/A:1019623925759; Liu C, 2011, SCIENTOMETRICS, V89, P89, DOI 10.1007/s11192-011-0450-6; Lublinski AE, 2003, REG STUD, V37, P453, DOI 10.1080/0034340032000089031; Matthiessen CW, 2010, URBAN STUD, V47, P1879, DOI 10.1177/0042098010372683; Matthiessen CW, 1999, URBAN STUD, V36, P453, DOI 10.1080/0042098993475; Ro A, 2013, CULT HEALTH SEX, V15, P836, DOI 10.1080/13691058.2013.785025; Singh J, 2013, MANAGE SCI, V59, P2056, DOI 10.1287/mnsc.1120.1700; Wallace R, 1999, ENVIRON PLANN A, V31, P113, DOI 10.1068/a310113; Xie N, 2012, GERONTOLOGIST, V52, P73; Yu Q, 2011, SCIENTOMETRICS, V89, P553, DOI 10.1007/s11192-011-0465-z; Zhou P, 2006, RES POLICY, V35, P83, DOI 10.1016/j.respol.2005.08.006	36	24	26	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111705	10.1371/journal.pone.0111705	http://dx.doi.org/10.1371/journal.pone.0111705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365449	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558100108
J	Santos, VC; Vale, VF; Silva, SM; Nascimento, AAS; Saab, NAA; Soares, RPP; Michalick, MSM; Araujo, RN; Pereira, MH; Fujiwara, RT; Gontijo, NF				Santos, Vania Cristina; Vale, Vladimir Fazito; Silva, Sydnei Magno; Sousa Nascimento, Alexandre Alves; Araujo Saab, Natalia Alvim; Pinto Soares, Rodrigo Pedro; Marques Michalick, Marilene Suzan; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Fujiwara, Ricardo Toshio; Gontijo, Nelder Figueiredo			Host Modulation by a Parasite: How Leishmania infantum Modifies the Intestinal Environment of Lutzomyia longipalpis to Favor Its Development	PLOS ONE			English	Article							PHLEBOTOMUS-PAPATASI DIPTERA; DIGESTIVE ENZYMES; SAND FLIES; MIDGUT; TRYPSIN; LIPOPHOSPHOGLYCAN; MOSQUITO; DONOVANI; PROTEIN; PH	Some reports have described the interference of Leishmania on sand flies physiology, and such behavior most likely evolved to favor the development and transmission of the parasite. Most of these studies showed that Leishmania could modulate the level of proteases in the midgut after an infective blood meal, and decreased proteolytic activity is indeed beneficial for the development of promastigotes in the gut of sand flies. In the present study, we performed a detailed investigation of the intestinal pH in Lutzomyia longipalpis females naturally infected with Leishmania infantum and investigated the production of trypsin by these insects using different approaches. Our results allowed us to propose a mechanism by which these parasites interfere with the physiology of L. longipalpis to decrease the production of proteolytic enzymes. According to our hypothesis L. infantum promastigotes indirectly interfere with the production of trypsin by modulating the mechanism that controls the intestinal pH via the action of a yet non- identified substance released by promastigote forms inside the midgut. This substance is not an acid, whose action would be restrict on to release H+ to the medium, but is a substance that is able to interfere with midgut physiology through a mechanism involving pH control. According to our hypothesis, as the pH decreases, the proteolytic enzymes efficiency is also reduced, leading to a decline in the supply of amino acids to the enterocytes: this decline reduces the stimulus for protease production because it is regulated by the supply of amino acids, thus leading to a delay in digestion.	[Santos, Vania Cristina; Vale, Vladimir Fazito; Sousa Nascimento, Alexandre Alves; Araujo Saab, Natalia Alvim; Marques Michalick, Marilene Suzan; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Fujiwara, Ricardo Toshio; Gontijo, Nelder Figueiredo] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Silva, Sydnei Magno] Univ Fed Uberlandia, Inst Biomed Sci, BR-38400 Uberlandia, MG, Brazil; [Pinto Soares, Rodrigo Pedro] Ctr Pesquisas Rene Rachou CPqRR, Lab Med Entomol, Belo Horizonte, MG, Brazil; [Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Gontijo, Nelder Figueiredo] Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Natl Inst Sci & Technol Mol Entomol, Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Uberlandia; Fundacao Oswaldo Cruz	Gontijo, NF (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	nelder@icb.ufmg.br	Soares, Rodrigo/S-5191-2019; Araujo, Ricardo N/O-1967-2017; Pereira, Marcos Horácio/AAE-7076-2021; Gontijo, Nelder F/D-2539-2013; Pereira, Marcos H/A-3774-2012; Fujiwara, Ricardo Toshio/J-7579-2012	Soares, Rodrigo/0000-0002-7966-3629; Araujo, Ricardo N/0000-0002-1272-4386; Pereira, Marcos Horácio/0000-0003-4843-0088; Gontijo, Nelder F/0000-0003-3357-2497; Pereira, Marcos H/0000-0003-4843-0088; Fujiwara, Ricardo Toshio/0000-0002-4713-575X	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, INCT Entomologia Molecular); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, INCT Entomologia Molecular)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, INCT Entomologia Molecular), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1938, HAREFUAH, V14, P1; BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; BEACH R, 1985, AM J TROP MED HYG, V34, P278, DOI 10.4269/ajtmh.1985.34.278; BOROVSKY D, 1987, MED VET ENTOMOL, V1, P235, DOI 10.1111/j.1365-2915.1987.tb00349.x; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Caroci AS, 2003, J INSECT PHYSIOL, V49, P839, DOI 10.1016/S0022-1910(03)00134-3; Coelho-Finamore JM, 2011, INT J PARASITOL, V41, P333, DOI 10.1016/j.ijpara.2010.10.004; da Costa-Val AP, 2007, VET J, V174, P636, DOI 10.1016/j.tvjl.2006.11.006; DILLON RJ, 1993, PARASITOL RES, V79, P492, DOI 10.1007/BF00931590; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; do Vale VF, 2007, J INSECT PHYSIOL, V53, P1151, DOI 10.1016/j.jinsphys.2007.06.005; Gontijo NF, 1998, EXP PARASITOL, V90, P212, DOI 10.1006/expr.1998.4336; GOODING RH, 1972, COMP BIOCHEM PHYSIOL, V43, P815, DOI 10.1016/0305-0491(72)90228-3; Gossage SA, 2003, INT J PARASITOL, V33, P1027, DOI 10.1016/S0020-7519(03)00142-5; Graf R, 1998, J INSECT PHYSIOL, V44, P451, DOI 10.1016/S0022-1910(98)00042-0; Hodgkinson VH, 1996, EXP PARASITOL, V83, P94, DOI 10.1006/expr.1996.0053; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; LEHANE MJ, 1995, COMP BIOCHEM PHYS B, V110, P285, DOI 10.1016/0305-0491(94)00157-P; MCCONVILLE MJ, 1995, BIOCHEM J, V310, P807, DOI 10.1042/bj3100807; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MODI GB, 1983, J MED ENTOMOL, V20, P568, DOI 10.1093/jmedent/20.5.568; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; Pimenta PFP, 1997, PARASITOLOGY, V115, P359, DOI 10.1017/S0031182097001510; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; SACKS DL, 1995, J EXP MED, V181, P685, DOI 10.1084/jem.181.2.685; Sant'Anna MRV, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-62; Santos VC, 2008, J EXP BIOL, V211, P2792, DOI 10.1242/jeb.019836; Santos VC, 2011, J EXP BIOL, V214, P1411, DOI 10.1242/jeb.051490; SCHLEIN Y, 1990, T ROY SOC TROP MED H, V84, P353, DOI 10.1016/0035-9203(90)90315-6; Schlein Y, 1998, PARASITOLOGY, V117, P467, DOI 10.1017/S0031182098003321; SCHLEIN Y, 1986, EXP PARASITOL, V62, P376, DOI 10.1016/0014-4894(86)90045-7; Secundino N, 2010, CELL MICROBIOL, V12, P906, DOI 10.1111/j.1462-5822.2010.01439.x; Soares R. P., 2010, Journal of Biomedicine & Biotechnology, V2010, P439174, DOI 10.1155/2010/439174; Soares RPP, 2002, MOL BIOCHEM PARASIT, V121, P213, DOI 10.1016/S0166-6851(02)00033-6; Telleria EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010697; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Vaidyanathan R, 2005, J MED ENTOMOL, V42, P142, DOI 10.1603/0022-2585(2005)042[0142:IOAMPF]2.0.CO;2; Vaidyanathan R, 2004, J INVERTEBR PATHOL, V87, P123, DOI 10.1016/j.jip.2004.09.001; Volf P, 2008, PARASITE, V15, P237, DOI 10.1051/parasite/2008153237	44	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111241	10.1371/journal.pone.0111241	http://dx.doi.org/10.1371/journal.pone.0111241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365351	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100057
J	Liu, G; Zhou, LZ; Li, B; Zhang, LL				Liu, Gang; Zhou, Lizhi; Li, Bo; Zhang, Lili			The Complete Mitochondrial Genome of Aix galericulata and Tadorna ferruginea: Bearings on Their Phylogenetic Position in the Anseriformes	PLOS ONE			English	Article							CONTROL REGION; MOLECULAR PHYLOGENY; EVOLUTION; ANATIDAE; GENE; CHARACTERS; DNA; MORPHOLOGY; SEQUENCE; PATTERNS	Aix galericulata and Tadorna ferruginea are two Anatidae species representing different taxonomic groups of Anseriformes. We used a PCR-based method to determine the complete mtDNAs of both species, and estimated phylogenetic trees based on the complete mtDNA alignment of these and 14 other Anseriforme species, to clarify Anseriform phylogenetics. Phylogenetic trees were also estimated using a multiple sequence alignment of three mitochondrial genes (Cyt b, ND2, and COI) from 68 typical species in GenBank, to further clarify the phylogenetic relationships of several groups among the Anseriformes. The new mtDNAs are circular molecules, 16,651 bp (Aix galericulata) and 16,639 bp (Tadorna ferruginea) in length, containing the 37 typical genes, with an identical gene order and arrangement as those of other Anseriformes. Comparing the protein-coding genes among the mtDNAs of 16 Anseriforme species, ATG is generally the start codon, TAA is the most frequent stop codon, one of three, TAA, TAG, and T-, commonly observed. All tRNAs could be folded into canonical cloverleaf secondary structures except for tRNASer (AGY) and tRNALeu (CUN), which are missing the "DHU" arm. Phylogenetic relationships demonstrate that Aix galericula and Tadorna ferruginea are in the same group, the Tadorninae lineage, based on our analyses of complete mtDNAs and combined gene data. Molecular phylogenetic analysis suggests the 68 species of Anseriform birds be divided into three families: Anhimidae, Anatidae, and Anseranatidae. The results suggest Anatidae birds be divided into five subfamilies: Anatinae, Tadorninae, Anserinae, Oxyurinae, and Dendrocygninae. Oxyurinae and Dendrocygninae should not belong to Anserinae, but rather represent independent subfamilies. The Anatinae includes species from the tribes Mergini, Somaterini, Anatini, and Aythyini. The Anserinae includes species from the tribes Anserini and Cygnini.	[Liu, Gang; Zhou, Lizhi; Li, Bo; Zhang, Lili] Anhui Univ, Sch Resources & Environm Engn, Inst Biodivers & Wetland Ecol, Hefei, Anhui, Peoples R China; [Liu, Gang; Zhou, Lizhi; Li, Bo; Zhang, Lili] Anhui Biodivers Informat Ctr, Hefei, Anhui, Peoples R China	Anhui University	Zhou, LZ (corresponding author), Anhui Univ, Sch Resources & Environm Engn, Inst Biodivers & Wetland Ecol, Hefei, Anhui, Peoples R China.	zhoulz@ahu.edu.cn	Zhou, Lizhi/AAF-4535-2021	Zhou, Lizhi/0000-0002-5702-4658	National Natural Science Foundation of China [31172117]; Graduate Student Innovation Research Projects of Anhui University [YQH100111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Research Projects of Anhui University	This research was supported by the National Natural Science Foundation of China (Grant no. 31172117) and the Graduate Student Innovation Research Projects of Anhui University (YQH100111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 1960, WILDFOWL, V11, P55; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Crochet PA, 2000, MOL BIOL EVOL, V17, P1797, DOI 10.1093/oxfordjournals.molbev.a026280; Delport W, 2002, J MOL EVOL, V54, P794, DOI 10.1007/s00239-001-0083-0; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Dickinson EC, 2003, HAWARD MOORE COMPLET; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; Guan X, 2009, ANIM GENET, V40, P134, DOI 10.1111/j.1365-2052.2008.01810.x; Hoyo Del, 1992, HDB BIRDS WORLD, V2; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061685; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Liu G, 2013, PLOS ONE, V8; Liu G, 2012, MOL BIOL REP, V39, P2139, DOI 10.1007/s11033-011-0961-5; LIVEZEY BC, 1991, AUK, V108, P471, DOI 10.2307/4088089; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Livezey BC, 1997, IBIS, V139, P51, DOI 10.1111/j.1474-919X.1997.tb04504.x; LIVEZEY BC, 1995, WILSON BULL, V107, P214; LIVEZEY BC, 1986, AUK, V103, P737, DOI 10.1093/auk/103.4.737; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; Sraml M, 1996, AUST J ZOOL, V44, P47, DOI 10.1071/ZO9960047; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3	31	15	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e109701	10.1371/journal.pone.0109701	http://dx.doi.org/10.1371/journal.pone.0109701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375111	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600007
J	Wang, RZ; Tan, Y; Wang, XY; Ma, LL; Wang, DM; Hu, YH; Qin, YH; Liu, K; Chang, C; Yu, JM				Wang, Ruozheng; Tan, Yao; Wang, Xiyan; Ma, Lingling; Wang, Duoming; Hu, Yunhui; Qin, Yonghui; Liu, Kai; Chang, Cheng; Yu, Jinming			Prognoses and Long-Term Outcomes of Nasopharyngeal Carcinoma in Han and Uyghur Patients Treated with Intensity-Modulated Radiotherapy in the Xinjiang Autonomous Region of China	PLOS ONE			English	Article							SURVIVAL; PATTERNS; FAILURE; AGE	Objectives: The objective of this study was to investigate the long-term outcomes and prognostic factors for nasopharyngeal carcinoma (NPC) in Han and Uyghur patients treated with intensity-modulated radiotherapy (IMRT) in the Xinjiang region of China. Materials and Methods: One hundred twenty-one Han and 60 Uyghur patients with newly diagnosed NPC without distant metastasis received IMRT at the Affiliated Tumor Hospital of Xinjiang Medical University between 2005 and 2008. The Kaplan-Meier method was used to estimate survival rates, and the log-rank test was used to evaluate differences in survival. Results: Comparing Han and Uyghur patients, the 5-year overall survival (OS), disease-free survival (DFS), local control (LC), regional control (RC), and distant metastasis-free survival (DMFS) rates were 81.9% vs 77.6% (P = 0.297), 72.1% vs 65.6% (P = 0.493), 88.3% vs 86.5% (P = 0.759), 95.0% vs 94.6% (P = 0.929), and 79.1% vs 75.2% (P = 0.613), respectively. Multivariate Cox proportional hazards regression identified the following independent prognostic factors in Han patients: N stage (P = 0.007) and age (P = 0.028) for OS, and age (P = 0.028) for DFS. OS differed significantly between Han and Uyghur patients >60 years old group (P = 0.036). Among Uyghur patients, the independent prognostic factors were age for OS (P = 0.033), as well as N stage (P = 0.037) and age (P = 0.021) for DFS. Additionally, Uyghur patients were less likely to experience mucositis and dermatitis than Han patients. Conclusion: Han and Uyghur patients with NPC had statistically significant differences in age, smoking history, and N staging. There was no significant difference in overall treatment outcomes with IMRT between these 2 ethnic populations in Xinjiang, China.	[Wang, Ruozheng] Tianjin Med Univ, Tianjin, Peoples R China; [Wang, Ruozheng; Tan, Yao; Wang, Xiyan; Ma, Lingling; Wang, Duoming; Hu, Yunhui; Qin, Yonghui; Liu, Kai; Chang, Cheng] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Radiat Oncol, Urumqi, Xinjiang, Peoples R China; [Yu, Jinming] Tumor Hosp Shandong, Dept Radiat Oncol, Jinnan, Shandong, Peoples R China	Tianjin Medical University; Xinjiang Medical University	Yu, JM (corresponding author), Tumor Hosp Shandong, Dept Radiat Oncol, Jinnan, Shandong, Peoples R China.	wrz8526@163.com			Department of International Cooperation Project [2012DFA31560]; Chinese Nature Science Foundation [81160327, 30960432]; Xinjiang International Collaboration Fund [101141038, 20126024]; Special Fund on Urumqi Talent Project [P08131002]; Youth Science Foundation of Xinjiang Uygur Autonomous Region [2011211B22]; Xinjiang Science and Technology Infrastructure Project [PT1401]	Department of International Cooperation Project; Chinese Nature Science Foundation; Xinjiang International Collaboration Fund; Special Fund on Urumqi Talent Project; Youth Science Foundation of Xinjiang Uygur Autonomous Region; Xinjiang Science and Technology Infrastructure Project	This study received funding from the Department of International Cooperation Project (2012DFA31560), the Chinese Nature Science Foundation (81160327, 30960432), the Xinjiang International Collaboration Fund (101141038, 20126024), the Special Fund on Urumqi Talent Project (P08131002), the Youth Science Foundation of Xinjiang Uygur Autonomous Region (2011211B22), and the Xinjiang Science and Technology Infrastructure Project (PT1401). The funders had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chen R, 1993, Yi Chuan Xue Bao, V20, P389; Han Lu, 2010, Chin J Cancer, V29, P145; Itzhaki O, 2004, BBA-MOL BASIS DIS, V1688, P145, DOI 10.1016/j.bbadis.2003.11.009; Ji XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056208; Jin J, 2010, XINJIANG STAT YB; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; MK Su, 2004, J MOD ONCOL, V12, P589; MK Su, 2001, J XINJIANG MED U, V24, P371; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Su Sheng-Fa, 2011, Chin J Cancer, V30, P565, DOI 10.5732/cjc.010.10547; Sze HCK, 2012, ORAL ONCOL, V48, P162, DOI 10.1016/j.oraloncology.2011.08.019; Wang DM, 2008, J XINJIANG MED U, V31, P1504; Wang JH, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-2; Xiao GL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-226; Xue WQ, 2013, AM J EPIDEMIOL, V178, P325, DOI 10.1093/aje/kws479; Yeh SA, 2005, INT J RADIAT ONCOL, V62, P672, DOI 10.1016/j.ijrobp.2004.11.002	20	2	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111145	10.1371/journal.pone.0111145	http://dx.doi.org/10.1371/journal.pone.0111145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375129	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600026
J	Albertine, JM; Manning, WJ; DaCosta, M; Stinson, KA; Muilenberg, ML; Rogers, CA				Albertine, Jennifer M.; Manning, William J.; DaCosta, Michelle; Stinson, Kristina A.; Muilenberg, Michael L.; Rogers, Christine A.			Projected Carbon Dioxide to Increase Grass Pollen and Allergen Exposure Despite Higher Ozone Levels	PLOS ONE			English	Article							RAGWEED AMBROSIA-ARTEMISIIFOLIA; EMERGENCY-DEPARTMENT VISITS; ELEVATED ATMOSPHERIC CO2; CLIMATE-CHANGE; ASTHMA; RESPONSES; NITROGEN; HEALTH; L.	One expected effect of climate change on human health is increasing allergic and asthmatic symptoms through changes in pollen biology. Allergic diseases have a large impact on human health globally, with 10-30% of the population affected by allergic rhinitis and more than 300 million affected by asthma. Pollen from grass species, which are highly allergenic and occur worldwide, elicits allergic responses in 20% of the general population and 40% of atopic individuals. Here we examine the effects of elevated levels of two greenhouse gases, carbon dioxide (CO2), a growth and reproductive stimulator of plants, and ozone (O-3), a repressor, on pollen and allergen production in Timothy grass (Phleum pratense L.). We conducted a fully factorial experiment in which plants were grown at ambient and/or elevated levels of O-3 and CO2, to simulate present and projected levels of both gases and their potential interactive effects. We captured and counted pollen from flowers in each treatment and assayed for concentrations of the allergen protein, Phl p 5. We found that elevated levels of CO2 increased the amount of grass pollen produced by similar to similar to 50% per flower, regardless of O-3 levels. Elevated O-3 significantly reduced the Phl p 5 content of the pollen but the net effect of rising pollen numbers with elevated CO2 indicate increased allergen exposure under elevated levels of both greenhouse gases. Using quantitative estimates of increased pollen production and number of flowering plants per treatment, we estimated that airborne grass pollen concentrations will increase in the future up to,200%. Due to the widespread existence of grasses and the particular importance of P. pratense in eliciting allergic responses, our findings provide evidence for significant impacts on human health worldwide as a result of future climate change.	[Albertine, Jennifer M.] Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; [Manning, William J.; DaCosta, Michelle] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Stinson, Kristina A.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Muilenberg, Michael L.; Rogers, Christine A.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA	Harvard University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Albertine, JM (corresponding author), Harvard Univ, Harvard Forest, Petersham, MA 01366 USA.	jalbertine@fas.harvard.edu; car@ehs.umass.edu	Rogers, Christine A/A-2189-2008; Rogers, Christine A/M-6007-2017	Rogers, Christine A/0000-0003-0887-9606; Rogers, Christine A/0000-0003-0887-9606				Ainsworth EA, 2012, ANNU REV PLANT BIOL, V63, P637, DOI 10.1146/annurev-arplant-042110-103829; Albertine JM, 2013, THESIS U MASSACHUSET; Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Cecchi L, 2010, ALLERGY, V65, P1073, DOI 10.1111/j.1398-9995.2010.02423.x; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; EPA NAAQS (Environmental Protection Agency National Ambient Air Quality Standards), 2014, NAAQS HOM; Frei T, 1998, GRANA, V37, P172, DOI 10.1080/00173139809362662; Gamble J. L., 2008, REV IMPACTS CLIMATE; Heguy L, 2008, ENVIRON RES, V106, P203, DOI 10.1016/j.envres.2007.10.005; Johnson BG, 1996, J ENVIRON QUAL, V25, P908, DOI 10.2134/jeq1996.00472425002500040036x; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Knox RB, 1996, SEX PLANT REPROD, V9, P318, DOI 10.1007/BF02441949; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Manning WJ, 1992, SURFACE LEVEL OZONE, P111; Masuch G, 1997, ALLERGY, V52, P874, DOI 10.1111/j.1398-9995.1997.tb02163.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Motta AC, 2006, INT ARCH ALLERGY IMM, V139, P294, DOI 10.1159/000091600; Pawankar R., 2011, WORLD ALLERGY ORG WA; PEDEN DB, 1995, AM J RESP CRIT CARE, V151, P1336, DOI 10.1164/ajrccm.151.5.7735583; Rogerieux F, 2007, INT ARCH ALLERGY IMM, V143, P127, DOI 10.1159/000099079; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Roshchina V. V., 2003, OZONE PLANT CELL, P55; Schoene K, 2004, ENVIRON POLLUT, V131, P347, DOI 10.1016/j.envpol.2004.03.014; Shea KM, 2008, J ALLERGY CLIN IMMUN, V122, P443, DOI 10.1016/j.jaci.2008.06.032; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Stinson KA, 2006, OECOLOGIA, V147, P155, DOI 10.1007/s00442-005-0250-x; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; White JF, 2003, ANN ALLERG ASTHMA IM, V91, P425, DOI 10.1016/S1081-1206(10)61509-8; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2008, MITIG ADAPT STRAT GL, V13, P607, DOI 10.1007/s11027-007-9134-1; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P893	37	62	63	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111712	10.1371/journal.pone.0111712	http://dx.doi.org/10.1371/journal.pone.0111712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372614	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900066
J	Berdyyeva, T; Otte, S; Aluisio, L; Ziv, Y; Burns, LD; Dugovic, C; Yun, SJ; Ghosh, KK; Schnitzer, MJ; Lovenberg, T; Bonaventure, P				Berdyyeva, Tamara; Otte, Stephani; Aluisio, Leah; Ziv, Yaniv; Burns, Laurie D.; Dugovic, Christine; Yun, Sujin; Ghosh, Kunal K.; Schnitzer, Mark J.; Lovenberg, Timothy; Bonaventure, Pascal			Zolpidem Reduces Hippocampal Neuronal Activity in Freely Behaving Mice: A Large Scale Calcium Imaging Study with Miniaturized Fluorescence Microscope	PLOS ONE			English	Article							GABA(A) RECEPTOR SUBUNITS; IMMUNOCYTOCHEMICAL DISTRIBUTION; HYPNOTIC ZOLPIDEM; EXTENDED-RELEASE; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; CA1 REGION; SLEEP EEG; REM-SLEEP; MEMORY	Therapeutic drugs for cognitive and psychiatric disorders are often characterized by their molecular mechanism of action. Here we demonstrate a new approach to elucidate drug action on large-scale neuronal activity by tracking somatic calcium dynamics in hundreds of CA1 hippocampal neurons of pharmacologically manipulated behaving mice. We used an adeno-associated viral vector to express the calcium sensor GCaMP3 in CA1 pyramidal cells under control of the CaMKII promoter and a miniaturized microscope to observe cellular dynamics. We visualized these dynamics with and without a systemic administration of Zolpidem, a GABAA agonist that is the most commonly prescribed drug for the treatment of insomnia in the United States. Despite growing concerns about the potential adverse effects of Zolpidem on memory and cognition, it remained unclear whether Zolpidem alters neuronal activity in the hippocampus, a brain area critical for cognition and memory. Zolpidem, when delivered at a dose known to induce and prolong sleep, strongly suppressed CA1 calcium signaling. The rate of calcium transients after Zolpidem administration was significantly lower compared to vehicle treatment. To factor out the contribution of changes in locomotor or physiological conditions following Zolpidem treatment, we compared the cellular activity across comparable epochs matched by locomotor and physiological assessments. This analysis revealed significantly depressive effects of Zolpidem regardless of the animal's state. Individual hippocampal CA1 pyramidal cells differed in their responses to Zolpidem with the majority (similar to 65%) significantly decreasing the rate of calcium transients, and a small subset (3%) showing an unexpected and significant increase. By linking molecular mechanisms with the dynamics of neural circuitry and behavioral states, this approach has the potential to contribute substantially to the development of new therapeutics for the treatment of CNS disorders.	[Berdyyeva, Tamara; Aluisio, Leah; Dugovic, Christine; Yun, Sujin; Lovenberg, Timothy; Bonaventure, Pascal] Janssen Res & Dev LLC, San Diego, CA 92121 USA; [Otte, Stephani; Ziv, Yaniv; Burns, Laurie D.; Ghosh, Kunal K.; Schnitzer, Mark J.] Inscopix, Palo Alto, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Berdyyeva, T (corresponding author), Janssen Res & Dev LLC, San Diego, CA 92121 USA.	tberdyy6@its.jnj.com	Bonaventure, Pascal/K-3052-2015	Bonaventure, Pascal/0000-0003-2971-6152	Inscopix	Inscopix	TB, LA, CD, SY, TL, and PB are paid employees at Janssen Pharmaceutical Research & Development, LLC; SO and KG are paid employees at Inscopix; YZ and LB are paid consultants at Inscopix; KG is a founder and CEO of Inscopix; and MS is a Chief Scientist at Inscopix. The funders provided support in the form of salaries for authors (TB, LA, CD, SY, TL, PB, SO, and KG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Kazuo, 2008, Recent Pat CNS Drug Discov, V3, P55, DOI 10.2174/157488908783421519; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Alexandre C, 2008, SLEEP, V31, P259, DOI 10.1093/sleep/31.2.259; Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Anaclet C, 2012, SLEEP, V35, P103, DOI 10.5665/sleep.1596; Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Behrendt RP, 2013, REV NEUROSCIENCE, V24, P239, DOI 10.1515/revneuro-2012-0088; BENOIT O, 1994, PSYCHOPHARMACOLOGY, V116, P297, DOI 10.1007/BF02245332; BERLIN I, 1993, J CLIN PSYCHOPHARM, V13, P100; Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Working Group, 2013, INT REP; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Buibas M, 2011, NEURAL COMPUT, V23, P183, DOI 10.1162/NECO_a_00065; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Cope DW, 2005, EUR J NEUROSCI, V21, P3002, DOI 10.1111/j.1460-9568.2005.04127.x; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Danjou P, 1999, BRIT J CLIN PHARMACO, V48, P367; Deisseroth K, 2013, NEURON, V80, P568, DOI 10.1016/j.neuron.2013.10.032; DEPOORTERE H, 1986, J PHARMACOL EXP THER, V237, P649; Di Lazzaro V, 2006, J PHYSIOL-LONDON, V575, P721, DOI 10.1113/jphysiol.2006.114694; Diezi Leonore, 2014, Rev Med Suisse, V10, P119; Ding JJ, 2014, SCI CHINA LIFE SCI, V57, P269, DOI 10.1007/s11427-013-4599-5; Doble A, 1999, J PSYCHOPHARMACOL, V13, pS11, DOI 10.1177/026988119901304S03; Drover DR, 2004, CLIN PHARMACOKINET, V43, P227, DOI 10.2165/00003088-200443040-00002; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; Dugovic C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00028; Dugovic C, 2009, J PHARMACOL EXP THER, V330, P142, DOI 10.1124/jpet.109.152009; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1993, MEMORY AMNESIA HIPPO; EVANS SM, 1990, J PHARMACOL EXP THER, V255, P1246; Farber RH, 2008, CURR MED RES OPIN, V24, P837, DOI 10.1185/030079908X273327; Fava M, 2009, J CLIN PSYCHOPHARM, V29, P222, DOI 10.1097/JCP.0b013e3181a390ba; FDA Drug Safety Communication, RISK NEXT MORN IMP U; Fernandez FR, 2010, J NEUROSCI, V30, P230, DOI 10.1523/JNEUROSCI.3995-09.2010; Fitzgerald AC, 2014, PSYCHOPHARMACOLOGY, V231, P1865, DOI 10.1007/s00213-014-3457-x; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goldstein PA, 2002, J NEUROPHYSIOL, V88, P3208, DOI 10.1152/jn.00885.2001; Graham D, 1996, EUR NEUROPSYCHOPHARM, V6, P119, DOI 10.1016/0924-977X(95)00072-W; Greenblatt DJ, 2012, EXPERT OPIN PHARMACO, V13, P879, DOI 10.1517/14656566.2012.667074; Groen MR, 2014, J NEUROPHYSIOL; Gunja N, 2013, J MED TOXICOL, V9, P163, DOI 10.1007/s13181-013-0294-y; Harrison NL, 2007, J CLIN PSYCHIAT, V68, P6; Heja L, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-26; Heldt SA, 2007, NEUROSCIENCE, V150, P370, DOI 10.1016/j.neuroscience.2007.09.008; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Henson RN, 2010, HIPPOCAMPUS, V20, P1315, DOI 10.1002/hipo.20857; Higashima M, 1998, NEUROSCI LETT, V245, P77, DOI 10.1016/S0304-3940(98)00178-5; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Huang MP, 2010, BEHAV BRAIN RES, V210, P54, DOI 10.1016/j.bbr.2010.02.018; Inagaki Takuji, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.09r00849bro; Inostroza M, 2013, ANNU REV NEUROSCI, V36, P79, DOI 10.1146/annurev-neuro-062012-170429; Isawa S, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, V20, P61; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jessen SB, 2014, CEREB CORTEX; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Kemere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073114; Kleykamp BA, 2012, EXP CLIN PSYCHOPHARM, V20, P28, DOI 10.1037/a0025237; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Kopp C, 2004, NEUROREPORT, V15, P2299, DOI 10.1097/00001756-200410050-00031; Kostowski Wojciech, 1995, Polish Journal of Pharmacology, V47, P237; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P645, DOI 10.1001/jama.2013.323; Lee V, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00003; Leufkens TRM, 2009, J SLEEP RES, V18, P387, DOI 10.1111/j.1365-2869.2009.00746.x; Liang J, 2004, J PHARMACOL EXP THER, V310, P1234, DOI 10.1124/jpet.104.067983; Lieberman Joseph A, 2007, Prim Care Companion J Clin Psychiatry, V9, P25; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Lucchesi LM, 2005, PROG NEURO-PSYCHOPH, V29, P557, DOI 10.1016/j.pnpbp.2005.01.013; Lundahl J, 2012, J PSYCHOPHARMACOL, V26, P1081, DOI 10.1177/0269881111424457; Machado C, 2013, CURR PHARM DES; Manuel NA, 1998, BRIT J PHARMACOL, V125, P1529, DOI 10.1038/sj.bjp.0702237; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Meskali M, 2009, PSYCHOPHARMACOLOGY, V207, P461, DOI 10.1007/s00213-009-1677-2; Mizumori SJY, 1995, BEHAV NEUROSCI, V109, P1081; Mohammadi B, 2006, MUSCLE NERVE, V33, P778, DOI 10.1002/mus.20531; Mokler DJ, 2001, NUTR NEUROSCI, V4, P109, DOI 10.1080/1028415X.2001.11747355; Monti JM, 2000, SLEEP, V23, P1075; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Mura E, 2013, CURR PHARM DES; Murphy HM, 2011, PHARMACOL BIOCHEM BE, V98, P81, DOI 10.1016/j.pbb.2010.12.012; Nazar M, 1999, J NEURAL TRANSM, V106, P369, DOI 10.1007/s007020050165; Otmani S, 2008, HUM PSYCHOPHARM CLIN, V23, P693, DOI 10.1002/hup.980; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Pericic D, 2008, J NEURAL TRANSM, V115, P795, DOI 10.1007/s00702-008-0020-0; Perouansky M, 2011, CAN J ANESTH, V58, P157, DOI 10.1007/s12630-010-9417-y; Perrais D, 1999, J NEUROSCI, V19, P578; Pick CG, 2005, PHARMACOL BIOCHEM BE, V81, P417, DOI 10.1016/j.pbb.2005.02.013; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pistoia F, 2013, CURR PHARM DES; Ramirez AD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00254; Richey SM, 2011, CURR PHARM DESIGN, V17, P1471; Rode F, 2005, EUR J PHARMACOL, V516, P131, DOI 10.1016/j.ejphar.2005.04.034; ROVIRA C, 1993, J NEUROPHYSIOL, V70, P1076, DOI 10.1152/jn.1993.70.3.1076; Rowlett JK, 2011, PSYCHOPHARMACOLOGY, V214, P855, DOI 10.1007/s00213-010-2093-3; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Saari TI, 2011, PHARMACOL REV, V63, P243, DOI 10.1124/pr.110.002717; Sanger DJ, 2004, CNS DRUGS, V18, P9, DOI 10.2165/00023210-200418001-00004; Sanger DJ, 1996, EUR J PHARMACOL, V313, P35, DOI 10.1016/0014-2999(96)00510-9; Schacter Daniel L, 2012, Dialogues Clin Neurosci, V14, P7; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Shelton J, 2009, NEUROPHARMACOLOGY, V56, P448, DOI 10.1016/j.neuropharm.2008.09.014; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Taketo M, 2000, NEUROSCIENCE, V96, P507, DOI 10.1016/S0306-4522(99)00574-6; Tashjian Robert Z, 2006, J Knee Surg, V19, P105; Thonnard M, 2014, FUNCT NEUROL, V11, P1; Tietz EI, 1999, J NEUROPHYSIOL, V81, P1575, DOI 10.1152/jn.1999.81.4.1575; Ujfalussy B, 2007, NEUROPHARMACOLOGY, V52, P733, DOI 10.1016/j.neuropharm.2006.09.022; Uslaner JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005213; Vargas-Caballero M, 2010, NEUROPHARMACOLOGY, V58, P668, DOI 10.1016/j.neuropharm.2009.11.005; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Vermeeren A, 2014, SLEEP, V37, P489, DOI 10.5665/sleep.3482; Verster JC, 2007, CURR DRUG SAF, V2, P220, DOI 10.2174/157488607781668882; Vlainic J, 2010, BRAIN RES, V1310, P181, DOI 10.1016/j.brainres.2009.11.018; Vlainic J, 2009, NEUROPHARMACOLOGY, V56, P1124, DOI 10.1016/j.neuropharm.2009.03.010; Vyazovskiy VV, 2013, NAT REV NEUROSCI, V14, P445, DOI 10.1038/nrn3494; Vyazovskiy VV, 2011, PROG BRAIN RES, V193, P17, DOI 10.1016/B978-0-444-53839-0.00002-8; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; WILKINSON CJ, 1995, J CLIN PSYCHIAT, V56, P309; Xu Q, 2014, PHARMACOL BIOCHEM BE, V116, P129, DOI 10.1016/j.pbb.2013.11.029; Yeung JYT, 2003, MOL PHARMACOL, V63, P2, DOI 10.1124/mol.63.1.2; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42; Zahreddine N., 2013, CURR CLIN PHARM; Zammit Gary K., 2001, Prim Care Companion J Clin Psychiatry, V3, P53; Zanin KA, 2013, PSYCHOPHARMACOLOGY, V226, P459, DOI 10.1007/s00213-012-2756-3; Zeng XJ, 1999, SYNAPSE, V31, P263, DOI 10.1002/(SICI)1098-2396(19990315)31:4<263::AID-SYN4>3.3.CO;2-A; Zheng F, 2001, NEUROSCIENCE, V103, P985, DOI 10.1016/S0306-4522(01)00006-9; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	141	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112068	10.1371/journal.pone.0112068	http://dx.doi.org/10.1371/journal.pone.0112068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372144	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900107
J	Dong, Y; Shen, XX; Guo, RZ; Liu, BC; Zhu, LY; Wang, J; Zhang, LX; Sun, J; Zhang, XY; Xu, JQ				Dong, Yuan; Shen, Xiaoxing; Guo, Ruizhang; Liu, Baochi; Zhu, Lingyan; Wang, Jing; Zhang, Linxia; Sun, Jun; Zhang, Xiaoyan; Xu, Jianqing			Willingness to Participate in HIV Therapeutic Vaccine Trials among HIV-Infected Patients on ART in China	PLOS ONE			English	Article							INJECTION-DRUG USERS; ANTIRETROVIRAL THERAPY; COGNITIVE-FACTORS; CLINICAL-TRIALS; IMMUNIZATION; AIDS; VIREMIA; ACCEPTABILITY; RESISTANCE; IMMUNOGEN	Background: More and more HIV therapeutic vaccines will enter clinical trials; however, little is known about the willingness to participate (WTP) in HIV therapeutic vaccine trials among HIV-positive individuals. Objective: To investigate the WTP in HIV therapeutic vaccine trials among Chinese HIV-infected patients. Methods: We conducted a cross-sectional survey on HIV-positive inpatients and outpatients at Shanghai Public Health Center. A total of 447 participants were recruited into this study. Following an introduction with general information on HIV therapeutic vaccine and its potential effectiveness and side effects, each participant completed a questionnaire in a self-administered form. The questionnaires covered demographics, high-risk behaviors, clinical characteristics and willingness to participate in HIV therapeutic vaccine trial. Results: The overall willingness to participate in HIV therapeutic vaccine trials was 91.5%. Interestingly, multivariate logistic regression analyses demonstrated that the willingness was higher for those sexually infected by HIV (odds ratio [OR]: 4.36; 95% confidence interval [CI]: 1.53-12.41), diagnosed as HIV-1 infection for greater than 5 years (OR: 7.12, 95% CI: 1.83-27.76), and with the presence of infectious complications (OR: 2.75; 95% CI: 1.02-7.45). The primary reason for participation was to delay or reduce antiretroviral treatment (ART) and to avoid ART side effects (76.6%), and then followed by delaying disease progression (74.9%), increasing immune response to suppress opportunistic infections (57.7%) and preventing the development of drug resistance (37.1%). Reasons for unwillingness to participate mainly included concern for safety (37.0%), lack of knowledge on therapeutic vaccine (33.3%), and satisfaction with ART effectiveness (22.2%). Conclusions: The WTP in HIV therapeutic vaccine trials was high among HIV-infected Chinese patients. HIV+ subjects who acquired infection through sexual contact and who were diagnosed for more than 5 years may represent a good candidate population for enrollment in therapeutic vaccine trials.	[Dong, Yuan; Guo, Ruizhang; Liu, Baochi; Zhu, Lingyan; Wang, Jing; Zhang, Linxia; Sun, Jun; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Dong, Yuan; Guo, Ruizhang; Liu, Baochi; Zhu, Lingyan; Wang, Jing; Zhang, Linxia; Sun, Jun; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol,Minist Educ Hlth, Shanghai 200433, Peoples R China; [Shen, Xiaoxing] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Zhang, Xiaoyan; Xu, Jianqing] China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chinese Center for Disease Control & Prevention	Zhang, XY (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhangxy066@gmail.com		Dong, Yuan/0000-0002-8587-2291	National Grand Program on Key Infectious Disease Control and Prevention of China [2013ZX10001-002]	National Grand Program on Key Infectious Disease Control and Prevention of China	This work was supported by National Grand Program on Key Infectious Disease Control and Prevention (2013ZX10001-002) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel JB, 2011, AIDS, V25, P731, DOI 10.1097/QAD.0b013e328344cea5; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Balfour L, 2010, AIDS CARE, V22, P1403, DOI 10.1080/09540121003693522; Bartholow BN, 1997, J ACQ IMMUN DEF SYND, V16, P108, DOI 10.1097/00042560-199710010-00006; Bishai D, 2004, B WORLD HEALTH ORGAN, V82, P652; Boberg A, 2008, EXPERT REV VACCINES, V7, P131, DOI 10.1586/14760584.7.1.131; Carcelain G, 2013, IMMUNOL REV, V254, P355, DOI 10.1111/imr.12083; Chantratita W, 2004, HIV MED, V5, P317, DOI 10.1111/j.1468-1293.2004.00230.x; Chu ZX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/493128; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dhalla S, 2007, AIDS CARE, V19, P1118, DOI 10.1080/09540120701352258; Dhalla S, 2012, PSYCHOL HEALTH MED, V17, P223, DOI 10.1080/13548506.2011.608803; Dhalla S, 2010, VACCINE, V28, P1663, DOI 10.1016/j.vaccine.2009.12.023; Evangeli M, 2013, AIDS CARE, V25, P910, DOI 10.1080/09540121.2012.748163; Fernandez-Cruz Eduardo, 2003, Expert Rev Vaccines, V2, P739, DOI 10.1586/14760584.2.6.739; Etcheverry MF, 2011, VACCINE, V29, P1991, DOI 10.1016/j.vaccine.2010.12.043; Etcheverry MF, 2010, AIDS BEHAV, V14, P607, DOI 10.1007/s10461-008-9486-x; Garcia F, 2012, HUM VACC IMMUNOTHER, V8, P569, DOI 10.4161/hv.19555; Golub ET, 2005, AIDS BEHAV, V9, P301, DOI 10.1007/s10461-005-9004-3; Harrer E, 2005, ANTIVIR THER, V10, P285; Joseph J, 2005, AIDS REV, V7, P131; Kahn JO, 2000, JAMA-J AM MED ASSOC, V284, P2193, DOI 10.1001/jama.284.17.2193; Kinloch-de Loes S, 2005, J INFECT DIS, V192, P607, DOI 10.1086/432002; Kiwanuka N, 2004, JAIDS-J ACQ IMM DEF, V36, P721, DOI 10.1097/00126334-200406010-00009; Koff WC, 2013, VACCINE, V31, pB204, DOI 10.1016/j.vaccine.2012.10.115; Kwong PD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17407; Lederman MM, 2000, JAMA-J AM MED ASSOC, V284, P223, DOI 10.1001/jama.284.2.223; Li QC, 2010, VACCINE, V28, P4638, DOI 10.1016/j.vaccine.2010.04.073; Liau A, 2001, AIDS CARE, V13, P643, DOI 10.1080/09540120120075275; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Metifiot M, 2013, ADV PHARMACOL, V67, P75, DOI 10.1016/B978-0-12-405880-4.00003-2; Newman PA, 2010, AIDS, V24, P1749, DOI 10.1097/QAD.0b013e32833adbe8; Puls RL, 2006, CLIN SCI, V110, P59, DOI 10.1042/CS20050157; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Schooley RT, 2010, J INFECT DIS, V202, P705, DOI 10.1086/655468; Shimada M, 2009, GENE THER, V16, P218, DOI 10.1038/gt.2008.152; Strauss RP, 2001, J ACQ IMMUN DEF SYND, V26, P63, DOI 10.1097/00126334-200101010-00010; Valentin A, 2010, VACCINE, V28, P1962, DOI 10.1016/j.vaccine.2009.10.099; Vanham G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-72; von Gegerfelt AS, 2007, J VIROL, V81, P1972, DOI 10.1128/JVI.01990-06; Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Yin L, 2008, VACCINE, V26, P762, DOI 10.1016/j.vaccine.2007.11.091; Zimet GD, 1997, J ADOLESCENT HEALTH, V20, P354, DOI 10.1016/S1054-139X(97)00031-1	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111321	10.1371/journal.pone.0111321	http://dx.doi.org/10.1371/journal.pone.0111321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372044	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900043
J	Matangila, R; Doua, JY; Linsuke, S; Madinga, J; da Luz, RI; Van Geertruyden, JP; Lutumba, P				Matangila, Junior R.; Doua, Joachim Yorokpa; Linsuke, Sylvie; Madinga, Joule; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre; Lutumba, Pascal			Malaria, Schistosomiasis and Soil Transmitted Helminth Burden and Their Correlation with Anemia in Children Attending Primary Schools in Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							ASYMPTOMATIC MALARIA; INFECTION; EPIDEMIOLOGY; COINFECTION; DURATION; MANSONI	Background: Anaemia reduces cognitive potential in school children, retards their growth and predisposes them to other diseases. As there is a paucity of data on the current burden of P. falciparum, S. mansoni and soil transmitted helminths (STH) infections and their correlation with schoolchildren's anemia in the Democratic Republic of Congo (DRC), we collect these data. Methods: This study reports baseline data collected from a randomized controlled trial investigating the impact of IPT with SP and SP-PQ on anemia and malaria morbidity in Congolese schoolchildren (Trial registration: NCT01722539; PACTR201211000449323). S. mansoni and STH infections were assessed using kato-katz technique. Malaria infection and hemoglobin concentration were assessed using Blood smear and Hemocontrol device, respectively. Results: A total of 616 primary schoolchildren from 4 to 13 years old were enrolled in the study. The prevalence of Plasmodium spp. infection was 18.5% (95%CI:15.6-21.9). Amongst those infected, 24 (21%), 40 (35.1%), 40 (35.1%), 10 (8.8%), had light, moderate, heavy, very high malaria parasite density, respectively. Above 9 years of age (p = 0.02),male and history of fever (p = 0.04) were both associated with malaria infection. The overall prevalence of S. mansoni infection was 6.4% (95%CI:4.4-9.1). Girls were associated with S. mansoni infection (p = 0.04). T. trichiura was the most prevalent STH infection (26.3%), followed by A. lumbricoides (20.1%). Co-infection with malaria-S. mansoni and malaria-STH was, respectively, 1.5% (CI95%:0.7-3.3) and 6.4% (CI95% 4.4-9.1). The prevalence of anemia was found to be 41.6% (95%CI:37.7-45.6) and anemia was strongly related with Plasmodium ssp infection (aOR:4.1; CI95%:2.6-6.5;p<0.001) and S. mansoni infection (aOR:3.3;CI95%:1.4-7.8;p<0.01). Conclusion: Malaria and S. mansoni infection were strongly associated with high prevalence of anemia in schoolchildren. Therefore, specific school-based interventions, such as intermittent preventive treatment or prophylaxis, LLITN distribution, anthelminthic mass treatment and micronutrient supplementation are needed to improve school children's health.	[Matangila, Junior R.; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Matangila, Junior R.; Doua, Joachim Yorokpa; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol, B-2020 Antwerp, Belgium; [Linsuke, Sylvie] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Madinga, Joule] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium	Universite de Kinshasa; University of Antwerp; Institute Nacional de Recherche Biomedical; Universite Catholique Louvain	Matangila, R (corresponding author), Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO.	matangilaj@yahoo.fr	Inocencio da Luz, Raquel/ABE-8206-2021; da Luz, Raquel A Inocencio/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014; Van geertruyden, Jean-Pierre/S-3254-2019	Inocencio da Luz, Raquel/0000-0002-2870-0311; da Luz, Raquel A Inocencio/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364	VLIR UOS project [ZRDC2012 70447]; University of Antwerp; Fonds Wetenschappelijk Onderzoek (FWO) [G.0978.11N]	VLIR UOS project; University of Antwerp; Fonds Wetenschappelijk Onderzoek (FWO)(FWO)	This study was financed by the VLIR UOS project (ZRDC2012 70447), University of Antwerp (JPV), and Fonds Wetenschappelijk Onderzoek (FWO) project G.0978.11N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaolu SO, 2003, ACTA TROP, V86, P283, DOI 10.1016/S0001-706X(03)00060-3; Brooker SJ, 2012, J INFECT DIS, V205, P841, DOI 10.1093/infdis/jir844; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Brutus L, 2007, AM J TROP MED HYG, V77, P1091, DOI 10.4269/ajtmh.2007.77.1091; BUCK AA, 1978, TROPENMED PARASITOL, V29, P61; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Doua JY, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-311; Ezeamama AE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000245; FAQUIN W C, 1992, Blood, V79, P1987; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Gbadegesin RA, 1997, ANN TROP PAEDIATR, V17, P89, DOI 10.1080/02724936.1997.11747869; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Hesran J, 2004, T R SOC TROP MED HYG, V98, P397, DOI DOI 10.1016/j.trstmh.2003.10.009; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; JANCLOES MF, 1980, REV EPIDEMIOL SANTE, V28, P89; JELKMANN W, 1992, LIFE SCI, V50, P301, DOI 10.1016/0024-3205(92)90338-P; Kabongo M, 2012, THESIS; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kazadi W, 2004, AM J TROP MED HYG, V71, P97, DOI 10.4269/ajtmh.2004.71.97; Lelo Nzuzi F, 2008, KINSHASA VILLE ENV; Lemaitre M, 2014, AM J TROP MED HYG, V90, P329, DOI 10.4269/ajtmh.12-0431; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Mazigoi Humphrey D, 2010, Tanzan J Health Res, V12, P299; Midzi N, 2010, ACTA TROP, V115, P103, DOI 10.1016/j.actatropica.2010.02.010; Okanla EO, 1991, NIG J PURE APPL SCI, V6, P154; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Roper C, 1996, AM J TROP MED HYG, V54, P325, DOI 10.4269/ajtmh.1996.54.325; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; Smith T, 1999, Trans R Soc Trop Med Hyg, V93 Suppl 1, P59, DOI 10.1016/S0035-9203(99)90329-2; Sturrock RF, 1996, T ROY SOC TROP MED H, V90, P48, DOI 10.1016/S0035-9203(96)90477-0; The World's Women, 2010, TREND STAT; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P26, DOI 10.1016/0035-9203(87)90474-3; Vandepitte J, 1988, HELMINTTHOLOGIE MED; Verhoef H, 2010, AM J CLIN NUTR, V92, P1285, DOI 10.3945/ajcn.110.006700; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wang B, 2014, J CLIN MICROBIOL, V52, P1838, DOI 10.1128/JCM.03615-13; WARREN KS, 1974, AM J TROP MED HYG, V23, P902, DOI 10.4269/ajtmh.1974.23.902; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; World Health Organization, 2008, WORLD MALARIA REPORT; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization, 2002, PREV CONTR SCHIST SO; World Health Organization, WORLDWIDE PREVALENCE	45	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110789	10.1371/journal.pone.0110789	http://dx.doi.org/10.1371/journal.pone.0110789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372029	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900025
J	Huang, LQ; Wong, CC; Cheng, KW; Rigas, B				Huang, Liqun; Wong, Chi C.; Cheng, Ka W.; Rigas, Basil			Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUGS; OXIDATIVE STRESS; PIK3CA MUTATION; COLORECTAL-CANCER; ASPIRIN INTAKE; P53; SURVIVAL; THERAPY; MDC-917	Phospho-aspirin (PA-2) is a novel aspirin derivative that exhibits promising anticancer properties and is considerably safer than conventional aspirin. In this study, we investigated the chemotherapeutic efficacy of PA-2 in preclinical models of estrogen receptor positive (ER+) breast cancer and elucidated its mechanism of action. PA-2 inhibited the growth of ER+ cells more potently than aspirin in vitro, and exerted a triple cytokinetic effect that includes induction of apoptosis and cell cycle arrest as well as the inhibition of cell proliferation. PA-2 is highly efficacious in vivo, as treatment of established MCF7 xenografts with PA-2 induced tumor stasis (98.2% inhibition, p<0.01). PA-2 triggered the activation of p53-dependent apoptosis via two distinct mechanisms: 1) acetylation of p53 (at K373), which disrupts its interaction with its transcription repressor MDM2, and 2) translocation of p53 to the mitochondria leading to the dissipation of mitochondrial transmembrane potential (Delta Psi(m)). Consistent with these observations, both the RNAi-mediated knockdown of p53 and forced deactylation via HDAC1 over-expression attenuated the anticancer effect of PA-2 in MCF7 cells. An upstream mediator of the signaling effects of PA-2 is RONS. PA-2 induced oxidative stress in vitro and in mice bearing MCF7 xenografts; its induction effect appears to be tumor-specific. Crucially, administration of N-acetylcysteine, a ROS scavenger, abrogated the effect of PA-2 on p53 acetylation and mitochondria translocation, thus identifying RONS as proximal molecules mediating the anticancer effect of PA-2. In summary, our findings demonstrate that PA-2 is a promising antineoplastic compound against ER+ breast cancer, warranting further evaluation as an anticancer agent.	[Huang, Liqun; Wong, Chi C.; Cheng, Ka W.; Rigas, Basil] SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA; [Rigas, Basil] Medicon Pharmaceut Inc, Setauket, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rigas, B (corresponding author), SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA.	basil.rigas@stonybrookmedicine.edu	Wong, Chi Chun/C-4636-2016; Cheng, Ka Wing/V-9433-2019		NIH [R01CA13945402, 1N01CN43302WA22]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NIH grants R01CA13945402 and 1N01CN43302WA22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2004, JNCI-J NATL CANCER I, V96, P4, DOI 10.1093/jnci/djh027; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bond S, 2010, J MIDWIFERY WOM HEAL, V55, P389, DOI 10.1016/j.jmwh.2010.04.002; Cheng KW, 2013, MOL CANCER THER, V12, P1417, DOI 10.1158/1535-7163.MCT-13-0006-T; Cheng KW, 2012, INT J ONCOL, V41, P1199, DOI 10.3892/ijo.2012.1577; Choi BH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.91; Coates AS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3348; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322; Fink M, 2011, STRAHLENTHER ONKOL, V187, P151; Fuchs CS, 2013, J CLIN ONCOL, V31, P4358, DOI 10.1200/JCO.2013.52.0080; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Huang L, 2011, BRIT J PHARMACOL, V162, P1521, DOI 10.1111/j.1476-5381.2010.01162.x; Huang LQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-141; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Nie T, 2012, BRIT J PHARMACOL, V166, P991, DOI 10.1111/j.1476-5381.2011.01799.x; Peuget S, 2014, CELL DEATH DIFFER; Rinsema TJ, 1999, MED HIST, V43, P502, DOI 10.1017/S0025727300065728; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stanley P, 2000, Biologist (London), V47, P269; Sun Y, 2011, J PHARMACOL EXP THER, V338, P775, DOI 10.1124/jpet.111.183533; Sun Y, 2009, CARCINOGENESIS, V30, P93, DOI 10.1093/carcin/bgn242; Tacconelli S, 2010, METHODS MOL BIOL, V644, P165, DOI 10.1007/978-1-59745-364-6_14; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Vaseva Angelina V, 2013, Methods Mol Biol, V962, P75, DOI 10.1007/978-1-62703-236-0_6; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wong CC, 2012, J PHARMACOL EXP THER, V340, P422, DOI 10.1124/jpet.111.188508; Zhao WP, 2009, CARCINOGENESIS, V30, P512, DOI 10.1093/carcin/bgp015; Zhu R, PHARM RES, V29, P3090	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111720	10.1371/journal.pone.0111720	http://dx.doi.org/10.1371/journal.pone.0111720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369051	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000092
J	Sutton, ME; op den Dries, S; Karimian, N; Weeder, PD; de Boer, MT; Wiersema-Buist, J; Gouw, ASH; Leuvenink, HGD; Lisman, T; Porte, RJ				Sutton, Michael E.; op den Dries, Sanna; Karimian, Negin; Weeder, Pepijn D.; de Boer, Marieke T.; Wiersema-Buist, Janneke; Gouw, Annette S. H.; Leuvenink, Henri G. D.; Lisman, Ton; Porte, Robert J.			Criteria for Viability Assessment of Discarded Human Donor Livers during Ex Vivo Normothermic Machine Perfusion	PLOS ONE			English	Article							BILE-SALT TOXICITY; BILIARY STRICTURES; COLD-STORAGE; TRANSPLANTATION; PRESERVATION; INJURY; DONATION; GRAFTS; DEATH; DUCTS	Although normothermic machine perfusion of donor livers may allow assessment of graft viability prior to transplantation, there are currently no data on what would be a good parameter of graft viability. To determine whether bile production is a suitable biomarker that can be used to discriminate viable from non-viable livers we have studied functional performance as well as biochemical and histological evidence of hepatobiliary injury during ex vivo normothermic machine perfusion of human donor livers. After a median duration of cold storage of 6.5 h, twelve extended criteria human donor livers that were declined for transplantation were ex vivo perfused for 6 h at 37 degrees C with an oxygenated solution based on red blood cells and plasma, using pressure controlled pulsatile perfusion of the hepatic artery and continuous portal perfusion. During perfusion, two patterns of bile flow were identified: (1) steadily increasing bile production, resulting in a cumulative output of >= 30 g after 6 h (high bile output group), and (2) a cumulative bile production <20 g in 6 h (low bile output group). Concentrations of transaminases and potassium in the perfusion fluid were significantly higher in the low bile output group, compared to the high bile output group. Biliary concentrations of bilirubin and bicarbonate were respectively 4 times and 2 times higher in the high bile output group. Livers in the low bile output group displayed more signs of hepatic necrosis and venous congestion, compared to the high bile output group. In conclusion, bile production could be an easily assessable biomarker of hepatic viability during ex vivo machine perfusion of human donor livers. It could potentially be used to identify extended criteria livers that are suitable for transplantation. These ex vivo findings need to be confirmed in a transplant experiment or a clinical trial.	[Sutton, Michael E.; op den Dries, Sanna; Karimian, Negin; Weeder, Pepijn D.; de Boer, Marieke T.; Lisman, Ton; Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [Sutton, Michael E.; op den Dries, Sanna; Karimian, Negin; Weeder, Pepijn D.; Wiersema-Buist, Janneke; Leuvenink, Henri G. D.; Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands; [Gouw, Annette S. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Porte, RJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands.	r.j.porte@umcg.nl		Lisman, Ton/0000-0002-3503-7140; Leuvenink, Henri/0000-0001-5036-2999	Innovatief Actieprogramma Groningen; Jan Kornelis de Cock Stichting; Tekke Huizingafonds	Innovatief Actieprogramma Groningen; Jan Kornelis de Cock Stichting; Tekke Huizingafonds	This work was supported by: 1. Innovatief Actieprogramma Groningen (author SODD), http://www.provinciegroningen.nl/servicelinks-provinciegroningen/english/; 2. Jan Kornelis de Cock Stichting, http://www.decockstichting.nl/subsidies.html (authors: SODD MES); 3. Tekke Huizingafonds, http://tekkehuizingafonds.nl/ (author SODD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae C, 2012, CURR OPIN ORGAN TRAN, V17, P137, DOI 10.1097/MOT.0b013e328351083d; Brockmann J, 2009, ANN SURG, V250, P1, DOI 10.1097/SLA.0b013e3181a63c10; Buis CL, 2009, J HEPATOL, V50, P69, DOI 10.1016/j.jhep.2008.07.032; Dutkowski P, 2008, AM J TRANSPLANT, V8, P917, DOI 10.1111/j.1600-6143.2008.02165.x; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Fondevila C, 2012, TRANSPLANTATION, V94, P22, DOI 10.1097/TP.0b013e31825774d7; Hessheimer AJ, 2012, CURR OPIN ORGAN TRAN, V17, P143, DOI 10.1097/MOT.0b013e328351082a; Hoekstra H, 2006, HEPATOLOGY, V43, P1022, DOI 10.1002/hep.21169; Imber CJ, 2002, AM J TRANSPLANT, V2, P593, DOI 10.1034/j.1600-6143.2002.20703.x; Imber CJ, 2002, TRANSPLANTATION, V73, P701, DOI 10.1097/00007890-200203150-00008; Impedovo Stefano Vittorio, 2012, Arch Ital Urol Androl, V84, P279; Karimian N, 2013, J HEPATOL, V58, P1065, DOI 10.1016/j.jhep.2013.02.023; Markmann JF, 2003, J AM COLL SURGEONS, V196, P566, DOI 10.1016/S1072-7515(02)01907-5; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Merion RM, 2006, J HEPATOL, V45, P484, DOI 10.1016/j.jhep.2006.07.016; Monbaliu D, 2010, CURR OPIN ORGAN TRAN, V15, P160, DOI 10.1097/MOT.0b013e328337342b; Moon JH, 2013, GASTROENTEROLOGY, V144, P276, DOI 10.1053/j.gastro.2012.10.045; Nyberg SL, 2005, TRANSPLANTATION, V80, P925, DOI 10.1097/01.TP.0000173798.04043.AF; Obara H, 2012, TRANSPL P, V44, P959, DOI 10.1016/j.transproceed.2012.01.104; op den Dries S, 2013, AM J TRANSPLANT, V13, P1327, DOI 10.1111/ajt.12187; op den Dries S, 2011, TRANSPLANTATION, V92, P373, DOI 10.1097/TP.0b013e318223a384; Orman ES, 2013, LIVER TRANSPLANT, V19, P59, DOI 10.1002/lt.23547; Pomfret EA, 2008, AM J TRANSPLANT, V8, P745, DOI 10.1111/j.1600-6143.2007.02146.x; Portincasa P, 2012, MOL ASPECTS MED, V33, P651, DOI 10.1016/j.mam.2012.03.010; Reddy SP, 2004, TRANSPLANTATION, V77, P1328, DOI 10.1097/01.TP.0000119206.63326.56; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Yska MJ, 2008, TRANSPLANTATION, V85, P1625, DOI 10.1097/TP.0b013e318170f5f7	27	127	132	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110642	10.1371/journal.pone.0110642	http://dx.doi.org/10.1371/journal.pone.0110642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369327	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000024
J	van Diggelen, JMH; Lamers, LPM; van Dijk, G; Schaafsma, MJ; Roelofs, JGM; Smolders, AJP				van Diggelen, Josepha M. H.; Lamers, Leon P. M.; van Dijk, Gijs; Schaafsma, Maarten J.; Roelofs, Jan G. M.; Smolders, Alfons J. P.			New Insights into Phosphorus Mobilisation from Sulphur-Rich Sediments: Time-Dependent Effects of Salinisation	PLOS ONE			English	Article							FRESH-WATER; INTERNAL EUTROPHICATION; PHOSPHATE; SULFATE; EXCHANGE; RELEASE; ACCUMULATION; ECOSYSTEMS; SALINITY; INLET	Internal phosphorus (P) mobilisation from aquatic sediments is an important process adding to eutrophication problems in wetlands. Salinisation, a fast growing global problem, is thought to affect P behaviour. Although several studies have addressed the effects of salinisation, interactions between salinity changes and nutrient cycling in freshwater systems are not fully understood. To tackle eutrophication, a clear understanding of the interacting effects of sediment characteristics and surface water quality is vital. In the present study, P release from two eutrophic sediments, both characterized by high pore water P and very low pore water iron (Fe2+) concentrations, was studied in a long-term aquarium experiment, using three salinity levels. Sediment P release was expected to be mainly driven by diffusion, due to the eutrophic conditions and low iron availability. Unexpectedly, this only seemed to be the driving mechanism in the short term (0-10 weeks). In the long term (>80 weeks), P mobilisation was absent in most treatments. This can most likely be explained by the oxidation of the sediment-water interface where Fe2+ immobilises P, even though it is commonly assumed that free Fe2+ concentrations need to be higher for this. Therefore, a controlling mechanism is suggested in which the partial oxidation of iron-sulphides in the sediment plays a key role, releasing extra Fe2+ at the sediment-water interface. Although salinisation was shown to lower short-term P mobilisation as a result of increased calcium concentrations, it may increase long-term P mobilisation by the interactions between sulphate reduction and oxygen availability. Our study showed time-dependent responses of sediment P mobilisation in relation to salinity, suggesting that sulphur plays an important role in the release of P from FeSx- rich sediments, its biogeochemical effect depending on the availability of Fe2+ and O-2.	[van Diggelen, Josepha M. H.; van Dijk, Gijs; Schaafsma, Maarten J.; Smolders, Alfons J. P.] Radboud Univ Nijmegen, B WARE Res Ctr, NL-6525 ED Nijmegen, Netherlands; [van Diggelen, Josepha M. H.; Lamers, Leon P. M.; van Dijk, Gijs; Roelofs, Jan G. M.; Smolders, Alfons J. P.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Diggelen, JMH (corresponding author), Radboud Univ Nijmegen, B WARE Res Ctr, Mercator 3, NL-6525 ED Nijmegen, Netherlands.	J.vanDiggelen@b-ware.eu	Smolders, Alfons J.P./H-2583-2012; Roelofs, Jan GM/C-1243-2011; Lamers, Leon P.M./A-8718-2012	Lamers, Leon P.M./0000-0003-3769-2154	Dutch Ministry of Agriculture, Nature and Food Quality (LNV)	Dutch Ministry of Agriculture, Nature and Food Quality (LNV)	This study was part of the National Research Programme "Wormer- en Jisperwater,'' funded by the Dutch Ministry of Agriculture, Nature and Food Quality (LNV), within the framework of "Nota Ruimte.'' The water management authority "Hoogheemraadschap Hollands Noorderkwartier'' facilitated this programme. The authors did not require further external funding source for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltman B, 2000, BIOGEOCHEMISTRY, V50, P183, DOI 10.1023/A:1006374018558; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; BOSTROM B, 1988, HYDROBIOLOGIA, V170, P229, DOI 10.1007/BF00024907; BOSTROM B, 1982, HYDROBIOLOGIA, V91-2, P415, DOI 10.1007/BF02391957; Boxman AW, 2008, ENVIRON POLLUT, V156, P1252, DOI 10.1016/j.envpol.2008.03.017; CARACO NF, 1993, HYDROBIOLOGIA, V253, P275, DOI 10.1007/BF00050748; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Carpenter PD, 1984, ENVIRON TECHNOL LETT, V6, P65; DEINEMA MH, 1980, FEMS MICROBIOL LETT, V9, P275; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Einsele W, 1936, ARCH HYDROBIOL, V29, P664; Geurts JJM, 2010, WATER RES, V44, P3487, DOI 10.1016/j.watres.2010.03.030; Geurts JJM, 2009, ENVIRON POLLUT, V157, P2072, DOI 10.1016/j.envpol.2009.02.024; Golterman HL, 1996, HYDROBIOLOGIA, V335, P87, DOI 10.1007/BF00013687; GRASSHOFF K, 1972, J CONSEIL, V34, P516; Gunnars A, 1997, BIOGEOCHEMISTRY, V37, P203, DOI 10.1023/A:1005744610602; Gunnars A, 2002, GEOCHIM COSMOCHIM AC, V66, P745, DOI 10.1016/S0016-7037(01)00818-3; HENRIKSEN A, 1965, ANALYST, V90, P29, DOI 10.1039/an9659000029; House WA, 1999, ENVIRON TECHNOL, V20, P727, DOI 10.1080/09593332008616867; HUPFER M, 1991, PROC INT ASSOC THE 5, V24, P2999; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; IMHOFF JF, 1995, HELGOLANDER MEERESUN, V49, P223, DOI 10.1007/BF02368352; Jordan TE, 2008, LIMNOL OCEANOGR, V53, P172, DOI 10.4319/lo.2008.53.1.0172; KAMPHAKE LJ, 1967, WATER RES, V1, P205, DOI 10.1016/0043-1354(67)90011-5; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Lamers LPM, 2002, LIMNOL OCEANOGR, V47, P585, DOI 10.4319/lo.2002.47.2.0585; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Reigersman CJA, 1946, ONTZILTING NOORD HOL; Roden EE, 2012, BIOCHEM SOC T, V40, P1249, DOI 10.1042/BST20120202; ROELOFS JGM, 1991, AQUAT BOT, V39, P267, DOI 10.1016/0304-3770(91)90004-O; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; SMOLDERS A, 1995, ARCH HYDROBIOL, V133, P349; Smolders AJP, 2006, CHEM ECOL, V22, P93, DOI 10.1080/02757540600579730; Smolders AJP, 2001, BIOGEOCHEMISTRY, V54, P219, DOI 10.1023/A:1010660401527; Suzumura M., 2000, J OCEANOGRAPHY, V56, P667, DOI [DOI 10.1023/A:1011125700301, 10.1023/a:1011125700301]; Van Dijk G, 2013, H2O, V46, P1; VANGEMERDEN H, 1984, ARCH MICROBIOL, V139, P289, DOI 10.1007/BF00408368; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wu YH, 2014, KSCE J CIV ENG, V18, P323, DOI 10.1007/s12205-014-0192-0; [No title captured]	41	20	20	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111106	10.1371/journal.pone.0111106	http://dx.doi.org/10.1371/journal.pone.0111106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369128	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000037
J	Young, NA; Bruss, MS; Gardner, M; Willis, WL; Mo, XK; Valiente, GR; Cao, Y; Liu, ZF; Jarjour, WN; Wu, LC				Young, Nicholas A.; Bruss, Michael S.; Gardner, Mark; Willis, William L.; Mo, Xiaokui; Valiente, Giancarlo R.; Cao, Yu; Liu, Zhongfa; Jarjour, Wael N.; Wu, Lai-Chu			Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NF kappa B Signaling and Macrophage Migration	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CLINICAL-TRIAL; IN-VITRO; CELLS; ACTIVATION; EXPRESSION; RECEPTOR; GENE; LIPOPOLYSACCHARIDE; BIOAVAILABILITY	Despite the widespread use of curcumin for centuries in Eastern medicine as an anti-inflammatory agent, its molecular actions and therapeutic viability have only recently been explored. While curcumin does have potential therapeutic efficacy, both solubility and bioavailability must be improved before it can be more successfully translated to clinical care. We have previously reported a novel formulation of nano-emulsion curcumin (NEC) that achieves significantly greater plasma concentrations in mice after oral administration. Here, we confirm the immunosuppressive effects of NEC in vivo and further examine its molecular mechanisms to better understand therapeutic potential. Using transgenic mice harboring an NF kappa B-luciferase reporter gene, we demonstrate a novel application of this in vivo inflammatory model to test the efficacy of NEC administration by bioluminescent imaging and show that LPS-induced NF kappa B activity was suppressed with NEC compared to an equivalent amount of curcumin in aqueous suspension. Administration of NEC by oral gavage resulted in a reduction of blood monocytes, decreased levels of both TLR4 and RAGE expression, and inhibited secretion of MCP-1. Mechanistically, curcumin blocked LPS-induced phosphorylation of the p65 subunit of NF kappa B and IkB alpha in murine macrophages. In a mouse model of peritonitis, NEC significantly reduced macrophage recruitment, but not T-cell or B-cell levels. In addition, curcumin treatment of monocyte derived cell lines and primary human macrophages in vitro significantly inhibited cell migration. These data demonstrate that curcumin can suppress inflammation by inhibiting macrophage migration via NF kappa B and MCP-1 inhibition and establish that NEC is an effective therapeutic formulation to increase the bioavailability of curcumin in order to facilitate this response.	[Young, Nicholas A.; Bruss, Michael S.; Gardner, Mark; Willis, William L.; Valiente, Giancarlo R.; Jarjour, Wael N.; Wu, Lai-Chu] Ohio State Univ, Wexner Med Ctr, Div Rheumatol & Immunol, Columbus, OH 43210 USA; [Young, Nicholas A.; Bruss, Michael S.; Gardner, Mark; Willis, William L.; Valiente, Giancarlo R.; Jarjour, Wael N.; Wu, Lai-Chu] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Cao, Yu; Liu, Zhongfa] Ohio State Univ, Wexner Med Ctr, Coll Pharm, Columbus, OH 43210 USA; [Liu, Zhongfa] Ohio State Univ, Wexner Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wu, LC (corresponding author), Ohio State Univ, Wexner Med Ctr, Div Rheumatol & Immunol, Columbus, OH 43210 USA.	LaiChu.Wu@osumc.edu	Wu, Lai-Chu/E-4328-2011	Wu, Lai-Chu/0000-0002-1348-269X; Young, Nicholas/0000-0002-9323-9437	Ohio State University's Wexner Medical Center; Comprehensive Cancer Center Support (CORE) Grant, NCI/NIH [P30 CA16058]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Ohio State University's Wexner Medical Center; Comprehensive Cancer Center Support (CORE) Grant, NCI/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided through The Ohio State University's Wexner Medical Center and Comprehensive Cancer Center Support (CORE) Grant, NCI/NIH, P30 CA16058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; CHANDRASEKARAN AN, 1995, BAILLIERE CLIN RHEUM, V9, P45, DOI 10.1016/S1521-6942(06)80019-7; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Dhanasekaran S, 2013, BIOCHIMIE, V95, P1567, DOI 10.1016/j.biochi.2013.04.004; Fu Y, 2014, INT IMMUNOPHARMACOL; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; Hoekstra M, 2004, J RHEUMATOL, V31, P645; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Hsu J., 1996, MULTIPLE COMP THEORY; Jacob A, 2013, IMMUNOLOGY, V139, P328, DOI 10.1111/imm.12079; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Kim DC, 2011, INFLAMM RES, V60, P1161, DOI 10.1007/s00011-011-0381-y; Kipari T, 2009, INFLAMM RES, V58, P553, DOI 10.1007/s00011-009-0019-5; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Kunwar A, 2006, BBA-GEN SUBJECTS, V1760, P1513, DOI 10.1016/j.bbagen.2006.06.012; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Li Xinjian, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P137; Liu ZF, 2012, CANCER CHEMOTH PHARM, V69, P679, DOI 10.1007/s00280-011-1749-y; Lubbad A, 2009, MOL CELL BIOCHEM, V322, P127, DOI 10.1007/s11010-008-9949-4; Luster AD, 1997, J LEUKOCYTE BIOL, V62, P620, DOI 10.1002/jlb.62.5.620; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Ngwuluka N, 2010, EXPERT OPIN DRUG DEL, V7, P203, DOI 10.1517/17425240903483166; Pae HO, 2008, MOL NUTR FOOD RES, V52, P1082, DOI 10.1002/mnfr.200700333; Pan MH, 2000, BIOCHEM PHARMACOL, V60, P1665, DOI 10.1016/S0006-2952(00)00489-5; Parodi FE, 2006, ANN VASC SURG, V20, P360, DOI 10.1007/s10016-006-9054-7; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Verbeke G, 2000, LINEAR MIXED MODELS; Verderio P, 2013, BIOMACROMOLECULES, V14, P672, DOI 10.1021/bm3017324; WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86; Wan H, 2009, J LEUKOCYTE BIOL, V86, P361, DOI 10.1189/jlb.0208126; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Young NA, 2013, MOL IMMUNOL, V54, P23, DOI 10.1016/j.molimm.2012.10.026; Zhong F, 2011, BIOL PHARM BULL, V34, P226, DOI 10.1248/bpb.34.226; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	40	44	45	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111559	10.1371/journal.pone.0111559	http://dx.doi.org/10.1371/journal.pone.0111559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369140	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000069
J	Zhou, Q; Ni, W; Dong, Y; Wang, N; Gan, SR; Wu, ZY				Zhou, Qi; Ni, Wang; Dong, Yi; Wang, Ning; Gan, Shi-Rui; Wu, Zhi-Ying			The Role of Apolipoprotein E as a Risk Factor for an Earlier Age at Onset for Machado-Joseph Disease Is Doubtful	PLOS ONE			English	Article							CAG REPEAT LENGTH; OF-ONSET; HUNTINGTONS-DISEASE; SPINOCEREBELLAR ATAXIA; ALZHEIMERS-DISEASE; GENOTYPES; GENE; EXPANSIONS; FEATURES; KINDREDS	Machado-Joseph disease (MJD) is an inherited neurodegenerative disease caused by an expanded CAG repeat in the ATXN3 gene. Although the principal genetic determinant of the age at onset (AAO) is the length of the expanded CAG repeat, the additional genetic contribution of MJD toward the AAO has mostly not yet been clarified. It was recently suggested in two independent studies that apolipoprotein E (APOE) might be associated with AAO variability in MJD patients. To identify the potential modifier effect of APOE polymorphisms on the AAO of MJD patients, 403 patients with MJD (confirmed by molecular tests) from eastern and southeastern China were enrolled in the present study. CAG repeats in the ATXN3 and APOE polymorphisms were genotyped. Data were analyzed using a statistical package. No contribution of APOE polymorphisms to the variance in disease onset was observed using ANCOVA (F = 0.183, P = 0.947). However, significant effects on the AAO of MJD were found for the normal ATXN3 allele and for the interaction of mutant and normal ATXN3 alleles in a multiple linear regression model (P = 0.043 and P = 0.035, respectively). Our study does not support a role for APOE as a genetic modifier of the AAO of MJD. Additionally, our study presents evidence that the normal ATXN3 allele and its interaction with mutant alleles contribute toward AAO variance in MJD patients.	[Zhou, Qi; Ni, Wang; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Qi; Ni, Wang; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Qi; Ni, Wang; Wang, Ning; Gan, Shi-Rui] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Fujian, Peoples R China; [Zhou, Qi; Ni, Wang; Wang, Ning; Gan, Shi-Rui] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Fujian, Peoples R China; [Dong, Yi; Wu, Zhi-Ying] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurol, Shanghai 200433, Peoples R China; [Dong, Yi; Wu, Zhi-Ying] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Inst Neurol, Shanghai 200433, Peoples R China	Zhejiang University; Zhejiang University; Fujian Medical University; Fujian Medical University; Fudan University; Fudan University	Wu, ZY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.	ganshirui1981@163.com; zhiyingwu67@yahoo.com			National Natural Science Foundation of China, Beijing [81125009, 81100851]	National Natural Science Foundation of China, Beijing(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Z-Y Wu (81125009, Beijing) and The National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to S-R Gan (81100851, Beijing). The funding agencies played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Aziz NA, 2009, NEUROLOGY, V73, P1280, DOI 10.1212/WNL.0b013e3181bd1121; Bettencourt C, 2011, ARCH NEUROL-CHICAGO, V68, P1580, DOI 10.1001/archneurol.2011.636; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeStefano AL, 1996, AM J HUM GENET, V59, P119; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Franca Marcondes C Jr, 2012, Front Neurol, V3, P164, DOI 10.3389/fneur.2012.00164; Gan SR, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-47; Ghaffar O, 2010, NEUROLOGY, V74, P1611, DOI 10.1212/WNL.0b013e3181e074a7; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kehoe P, 1999, J MED GENET, V36, P108; LINLEE YC, 1985, BIOCHEMISTRY-US, V24, P3751, DOI 10.1021/bi00335a050; MACIEL P, 1995, AM J HUM GENET, V57, P54; NAKAGAWA Y, 1995, LANCET, V345, P68, DOI 10.1016/S0140-6736(95)91196-0; Panas M, 1999, J NEUROL, V246, P574, DOI 10.1007/s004150050406; Peng H, 2014, NEUROBIOL AGING, V22; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; Saft C, 2004, J NEUROL NEUROSUR PS, V75, P1692, DOI 10.1136/jnnp.2003.022756; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Warrenburg BPCV, 2005, ANN NEUROL, V57, P505, DOI 10.1002/ana.20424; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077	26	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111356	10.1371/journal.pone.0111356	http://dx.doi.org/10.1371/journal.pone.0111356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369462	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000049
J	Durant, JM; Skern-Mauritzen, M; Krasnov, YV; Nikolaeva, NG; Lindstrom, U; Dolgov, A				Durant, Joel M.; Skern-Mauritzen, Mette; Krasnov, Yuri V.; Nikolaeva, Natalia G.; Lindstrom, Ulf; Dolgov, Andrey			Temporal Dynamics of Top Predators Interactions in the Barents Sea	PLOS ONE			English	Article							COD GADUS-MORHUA; WHALE BALAENOPTERA-ACUTOROSTRATA; CAPELIN MALLOTUS-VILLOSUS; URIA-AALGE; TROPHIC INTERACTIONS; SPAWNING STOCK; DIET-OVERLAP; FOOD WEBS; ECOSYSTEM; RECRUITMENT	The Barents Sea system is often depicted as a simple food web in terms of number of dominant feeding links. The most conspicuous feeding link is between the Northeast Arctic cod Gadus morhua, the world's largest cod stock which is presently at a historical high level, and capelin Mallotus villosus. The system also holds diverse seabird and marine mammal communities. Previous diet studies may suggest that these top predators (cod, bird and sea mammals) compete for food particularly with respect to pelagic fish such as capelin and juvenile herring (Clupea harengus), and krill. In this paper we explored the diet of some Barents Sea top predators (cod, Black-legged kittiwake Rissa tridactyla, Common guillemot Uria aalge, and Minke whale Balaenoptera acutorostrata). We developed a GAM modelling approach to analyse the temporal variation diet composition within and between predators, to explore intra-and inter-specific interactions. The GAM models demonstrated that the seabird diet is temperature dependent while the diet of Minke whale and cod is prey dependent; Minke whale and cod diets depend on the abundance of herring and capelin, respectively. There was significant diet overlap between cod and Minke whale, and between kittiwake and guillemot. In general, the diet overlap between predators increased with changes in herring and krill abundances. The diet overlap models developed in this study may help to identify inter-specific interactions and their dynamics that potentially affect the stocks targeted by fisheries.	[Durant, Joel M.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Skern-Mauritzen, Mette] Inst Marine Res, N-5024 Bergen, Norway; [Krasnov, Yuri V.] Murmansk Marine Biol Inst, Murmansk, Russia; [Nikolaeva, Natalia G.] Moscow MV Lomonosov State Univ, Dept Biol, White Sea Biol Stn, Moscow, Russia; [Lindstrom, Ulf] Inst Marine Res, Tromso, Norway; [Dolgov, Andrey] Knipovich Polar Res Inst Marine Fisheries & Ocean, Murmansk, Russia	University of Oslo; Institute of Marine Research - Norway; Russian Academy of Sciences; Lomonosov Moscow State University; Institute of Marine Research - Norway; Research lnstitute of Fisheries & Oceanography	Durant, JM (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	joel.durant@ibv.uio.no	Skern-Mauritzen, Mette/ABA-8173-2020; Dolgov, Andrey/D-3708-2012; Krasnov, Yuri V/H-1581-2016; Durant, Joël/D-3821-2013; Lindstrom, Ulf/AAU-1327-2020	Dolgov, Andrey/0000-0002-4806-3284; Durant, Joël/0000-0002-1129-525X; 	Research Council of Norway through the ADMAR project [200497/130).]	Research Council of Norway through the ADMAR project	This work was supported by the Research Council of Norway (http://www.forskningsradet.no/en/Home_ page/1177315753906) through the ADMAR project (grant no. 200497/130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker-Nilssen T., 2000, STATUS MARINE BIRDS; Barrett RT, 1996, ICES J MAR SCI, V53, P713, DOI 10.1006/jmsc.1996.0090; Barrett RT, 1997, POLAR RES, V16, P73, DOI 10.1111/j.1751-8369.1997.tb00249.x; Barrett RT, 2002, MAR ECOL PROG SER, V230, P275, DOI 10.3354/meps230275; Berenboim B.I., 2000, Journal of Northwest Atlantic Fishery Science, V27, P69, DOI 10.2960/J.v27.a6; Blanchard JL, 2002, EXPLORING MARINE MAM, V117; Bogstad B, 2000, NAMMCO SCI PUBL, V2, P98, DOI 10.7557/3.2975; Dalpadado P, 2001, ICES J MAR SCI, V58, P876, DOI 10.1006/jmsc.2001.1078; Dalpadado P, 2012, J CONSEIL; Dolgov A. V., 2008, LONG TERM BILATERAL, P44; Dolgov AV, 1999, BIOL REGULATION FISH, P5; Durant JM, 2012, OECOLOGIA, V169, P685, DOI 10.1007/s00442-011-2226-3; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Erikstad KE, 2013, MAR ECOL PROG SER, V475, P267, DOI 10.3354/meps10084; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Gjosaeter H, 1998, FISH RES, V38, P57, DOI 10.1016/S0165-7836(98)00114-3; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Haug T, 2002, SARSIA, V87, P409, DOI 10.1080/0036482021000155715; HAUG T, 1995, ICES J MAR SCI, V52, P77, DOI 10.1016/1054-3139(95)80017-4; Haug T, 2011, BARENTS SEA ECOSYSTE, P485; Haug T, 1994, INT S BIOL MAR MAMM, P545; Hilton GM, 2000, EVOL ECOL RES, V2, P207; Hjermann DO, 2007, P ROY SOC B-BIOL SCI, V274, P661, DOI 10.1098/rspb.2006.0069; Hjermann DO, 2010, CAN J FISH AQUAT SCI, V67, P1363, DOI 10.1139/F10-064; Hjermann DO, 2004, CAN J FISH AQUAT SCI, V61, P1747, DOI 10.1139/F04-115; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ICES, 2012, BOBLME2012ECOLOGY10; Jakobsen T., 2011, BARENTS SEA ECOSYSTE, P825; Johannesen E, 2012, MAR ECOL PROG SER, V458, P181, DOI 10.3354/meps09818; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Krasnov JV, 1995, ECOLOGY OF FJORDS AND COASTAL WATERS, P443; Krasnov Yu.V., 2007, Ornitologiya, V34, P65; Lindstrom U, 2009, DEEP-SEA RES PT II, V56, P2068, DOI 10.1016/j.dsr2.2008.11.017; Link JS, 2009, FISH FISH, V10, P58, DOI 10.1111/j.1467-2979.2008.00295.x; LINTON LR, 1981, J ANIM ECOL, V50, P283, DOI 10.2307/4045; Mehl S., 1991, INTERRELATIONS FISH, P5; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Nilssen KT, 2000, NAMMCO SCI PUBL, V2, P9, DOI 10.7557/3.2968; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Ottersen G, 2008, CAN J FISH AQUAT SCI, V65, P523, DOI 10.1139/F07-185; PAINE RT, 1980, J ANIM ECOL, V49, P667; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PIMM SL, 1982, FOOD WEBS; Prozorkevich DV, 2010, DEV RUSSIAN FISHERIE, P248; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RISSB, 2020, SPAD WORK GROUP; Sakshaug E., 2009, ECOSYSTEM BARENTS SE; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Sivertsen SP, 2006, MAR BIOL RES, V2, P89, DOI 10.1080/17451000600670952; Skern-Mauritzen M, 2011, MAR ECOL PROG SER, V426, P289, DOI 10.3354/meps09027; Spellerberg I.F, 2008, ENCY ECOLOGY, P3249, DOI DOI 10.1016/B978-008045405-4.00132-4; Stige LC, 2009, LIMNOL OCEANOGR, V54, P1025, DOI 10.4319/lo.2009.54.4.1025; Tereschenko VV, 1996, 1996C11 ICES CM; Vader W., 1990, Studies in Avian Biology, P175; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Yaragina NA, 2000, ICES J MAR SCI, V57, P42, DOI 10.1006/jmsc.1999.0493; Zatsepin VJ, 1939, T PINRO, P5; Zhukova NG, 2009, DEEP-SEA RES PT II, V56, P1959, DOI 10.1016/j.dsr2.2008.11.007	65	21	21	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110933	10.1371/journal.pone.0110933	http://dx.doi.org/10.1371/journal.pone.0110933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365430	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100036
J	Tang, KW; Norberg, P; Holmudden, M; Elias, P; Liljeqvist, JA				Tang, Ka-Wei; Norberg, Peter; Holmudden, Martin; Elias, Per; Liljeqvist, Jan-Ake			Rad51 and Rad52 Are Involved in Homologous Recombination of Replicating Herpes Simplex Virus DNA	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; TEMPERATURE-SENSITIVE MUTANTS; MISMATCH REPAIR PROTEINS; IN-VITRO; GENETIC-RECOMBINATION; REITERATED SEQUENCES; STRAND EXCHANGE; INFECTED CELLS; LIGASE-I; TYPE-1	Replication of herpes simplex virus 1 is coupled to recombination, but the molecular mechanisms underlying this process are poorly characterized. The role of Rad51 and Rad52 recombinases in viral recombination was examined in human fibroblast cells 1BR.3.N (wild type) and in GM16097 with replication defects caused by mutations in DNA ligase I. Intermolecular recombination between viruses, tsS and tsK, harboring genetic markers gave rise to similar to 17% recombinants in both cell lines. Knock-down of Rad51 and Rad52 by siRNA reduced production of recombinants to 11% and 5%, respectively, in wild type cells and to 3% and 5%, respectively, in GM16097 cells. The results indicate a specific role for Rad51 and Rad52 in recombination of replicating herpes simplex virus 1 DNA. Mixed infections using clinical isolates with restriction enzyme polymorphisms in the US4 and US7 genes revealed recombination frequencies of 0.7%/kbp in wild type cells and 4%/kbp in GM16097 cells. Finally, tandem repeats in the US7 gene remained stable upon serial passage, indicating a high fidelity of recombination in infected cells.	[Tang, Ka-Wei; Elias, Per] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Norberg, Peter; Holmudden, Martin; Liljeqvist, Jan-Ake] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis,Sect Virol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Tang, KW (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	kawei.tang@medkem.gu.se		Tang, Ka-Wei/0000-0003-1189-5092; Liljeqvist, Jan-Ake/0000-0002-1226-9870	ALF Foundation at Sahlgrenska University Hospital; Swedish Research Council; Magnus Bergvalls Foundation; Swedish Cancer Foundation; Goteborg Medical Society	ALF Foundation at Sahlgrenska University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Magnus Bergvalls Foundation; Swedish Cancer Foundation; Goteborg Medical Society	This work was supported by grants to JAL from the ALF Foundation at Sahlgrenska University Hospital, the Swedish Research Council, Magnus Bergvalls Foundation, to PE from the Swedish Cancer Foundation, the Swedish Research Council and from the ALF Foundation at Sahlgrenska University Hospital and to KWT from the Goteborg Medical Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; BLUMEL J, 1995, J GEN VIROL, V76, P3119, DOI 10.1099/0022-1317-76-12-3119; BONE DR, 1978, J VIROL, V28, P14, DOI 10.1128/JVI.28.1.14-19.1978; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; Bower JR, 1999, J VIROL, V73, P3843, DOI 10.1128/JVI.73.5.3843-3853.1999; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; DASGUPTA UB, 1980, MOL GEN GENET, V178, P617, DOI 10.1007/BF00337869; DAVISON MJ, 1984, J GEN VIROL, V65, P859, DOI 10.1099/0022-1317-65-5-859; DUTCH RE, 1994, J VIROL, V68, P3733, DOI 10.1128/JVI.68.6.3733-3741.1994; FRENKEL N, 1975, J VIROL, V16, P153, DOI 10.1128/JVI.16.1.153-167.1975; Fujita K, 1998, ARCH VIROL, V143, P25, DOI 10.1007/s007050050265; Hughes AL, 2007, VIRUS RES, V130, P28, DOI 10.1016/j.virusres.2007.05.008; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; LEWIS ME, 1984, J VIROL, V52, P300, DOI 10.1128/JVI.52.1.300-305.1984; Liljeqvist JA, 2009, J GEN VIROL, V90, P559, DOI 10.1099/vir.0.007070-0; Lingen M, 1997, MED MICROBIOL IMMUN, V185, P217, DOI 10.1007/s004300050033; Mackenney VJ, 1997, J BIOL CHEM, V272, P11550; Maertzdorf J, 1999, J CLIN MICROBIOL, V37, P3518, DOI 10.1128/JCM.37.11.3518-3523.1999; MARSDEN HS, 1976, J GEN VIROL, V31, P347, DOI 10.1099/0022-1317-31-3-347; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; McGeoch DJ, 2009, J GEN VIROL, V90, P963, DOI 10.1099/vir.0.007658-0; Meurens F, 2004, J VIROL, V78, P9828, DOI 10.1128/JVI.78.18.9828-9836.2004; Mohni KN, 2011, J VIROL, V85, P12241, DOI 10.1128/JVI.05487-11; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Muylaert I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R111.233981; Muylaert I, 2010, J BIOL CHEM, V285, P13761, DOI 10.1074/jbc.M110.107920; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Nimonkar AV, 2003, J BIOL CHEM, V278, P9678, DOI 10.1074/jbc.M212555200; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; Norberg P, 2007, J GEN VIROL, V88, P1683, DOI 10.1099/vir.0.82500-0; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Norberg P, 2006, J CLIN MICROBIOL, V44, P4511, DOI 10.1128/JCM.00421-06; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Reuven NB, 2003, J VIROL, V77, P7425, DOI 10.1128/JVI.77.13.7425-7433.2003; SARISKY RT, 1994, J VIROL, V68, P34, DOI 10.1128/JVI.68.1.34-47.1994; Schmidt-Chanasit J, 2011, INFECT GENET EVOL, V11, P1, DOI 10.1016/j.meegid.2010.08.014; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Umene K, 1999, REV MED VIROL, V9, P171, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;171::AID-RMV243&gt;3.0.CO;2-A; Umene K, 2003, J GEN VIROL, V84, P917, DOI 10.1099/vir.0.18809-0; Umene K, 2007, J CLIN VIROL, V39, P266, DOI 10.1016/j.jcv.2007.05.012; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238; Yao XD, 1997, J VIROL, V71, P6842, DOI 10.1128/JVI.71.9.6842-6849.1997; Yao XD, 2001, J BIOL CHEM, V276, P2905, DOI 10.1074/jbc.M005627200; Yao XD, 1999, REPLICATION RECOMBIN; Zell R, 2012, J VIROL, V86, P1608, DOI 10.1128/JVI.06233-11; Zhu YL, 2010, J VIROL, V84, P7459, DOI 10.1128/JVI.01875-09	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111584	10.1371/journal.pone.0111584	http://dx.doi.org/10.1371/journal.pone.0111584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365323	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100081
J	Gaskell, KM; Rothe, C; Gnanadurai, R; Goodson, P; Jassi, C; Heyderman, RS; Allain, TJ; Harrison, TS; Lalloo, DG; Sloan, DJ; Feasey, NA				Gaskell, Katherine M.; Rothe, Camilla; Gnanadurai, Roshina; Goodson, Patrick; Jassi, Chikondi; Heyderman, Robert S.; Allain, Theresa J.; Harrison, Thomas S.; Lalloo, David G.; Sloan, Derek J.; Feasey, Nicholas A.			A Prospective Study of Mortality from Cryptococcal Meningitis following Treatment Induction with 1200mg Oral Fluconazole in Blantyre, Malawi	PLOS ONE			English	Article							THERAPY; ANTIGEN; MANAGEMENT	Objective: We have previously reported high ten-week mortality from cryptococcal meningitis in Malawian adults following treatment-induction with 800mg oral fluconazole (57% [33/58]). National guidelines in Malawi and other African countries now advocate an increased induction dose of 1200mg. We assessed whether this has improved outcomes. Design: This was a prospective observational study of HIV-infected adults with cryptococcal meningitis confirmed by diagnostic lumbar puncture. Treatment was with fluconazole 1200mg/day for two weeks then 400mg/day for 8 weeks. Mortality within the first 10 weeks was the study end-point, and current results were compared with data from our prior patient cohort who started on fluconazole 800mg/day. Results: 47 participants received fluconazole monotherapy. Despite a treatment-induction dose of 1200mg, ten-week mortality remained 55% (26/47). This was no better than our previous study (Hazard Ratio [HR] of death on 1200mg vs. 800mg fluconazole: 1.29 (95% CI: 0.77-2.16, p = 0.332)). There was some evidence for improved survival in patients who had repeat lumbar punctures during early therapy to lower intracranial pressure (HR: 0.27 [95% CI: 0.07-1.03, p = 0.055]). Conclusion: There remains an urgent need to identify more effective, affordable and deliverable regimens for cryptococcal meningitis.	[Gaskell, Katherine M.; Goodson, Patrick; Jassi, Chikondi; Heyderman, Robert S.; Lalloo, David G.; Sloan, Derek J.; Feasey, Nicholas A.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Gaskell, Katherine M.; Heyderman, Robert S.; Lalloo, David G.; Sloan, Derek J.; Feasey, Nicholas A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Rothe, Camilla; Gnanadurai, Roshina; Goodson, Patrick; Allain, Theresa J.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Rothe, Camilla; Gnanadurai, Roshina; Goodson, Patrick; Allain, Theresa J.] Queen Elizabeth Cent Hosp, Minist Hlth, Blantyre, Malawi; [Harrison, Thomas S.] Univ London, Infect & Immun Res Ctr, St Georges Med Sch, London, England; [Sloan, Derek J.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Malawi; St Georges University London; University of London; Liverpool Heart & Chest Hospital	Gaskell, KM (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	kmgaskell@doctors.org.uk	Gnanadurai, Roshina/ABC-2771-2021	Sloan, Derek James/0000-0002-7888-5449; Harrison, Thomas/0000-0003-3619-4348; Feasey, Nicholas/0000-0003-4041-1405; Lalloo, David/0000-0001-7680-2200; Gaskell, Katherine M/0000-0003-4691-6359; Heyderman, Robert/0000-0003-4573-449X	Wellcome Trust Core Award [084679/Z/08/Z]; Medical Research Council [G1100814] Funding Source: researchfish; National Institute for Health Research [ACF-2014-20-001] Funding Source: researchfish; MRC [G1100814] Funding Source: UKRI	Wellcome Trust Core Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	There was no specific funding for this research. However MLW is supported by Wellcome Trust Core Award 084679/Z/08/Z. The Wellcome trust had no role in the development of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; de Vedia L, 2013, INFECTION, V41, P1073, DOI 10.1007/s15010-013-0538-4; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; MOH, 2011, CLIN MAN HIV CHILDR; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Rothe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067311; Rugemalila J, 2013, TROP MED INT HEALTH, V18, P1075, DOI 10.1111/tmi.12157; Sloan DJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-490; Sudan A, 2013, ANTIMICROB AGENTS CH, V57, P2793, DOI 10.1128/AAC.00216-13; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Wall EC ED, 2014, CID IN PRESS; Wijewardana I, 2011, J INFECTION, V63, P484, DOI 10.1016/j.jinf.2011.09.002	17	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110285	10.1371/journal.pone.0110285	http://dx.doi.org/10.1371/journal.pone.0110285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375145	Green Accepted, gold, Green Published			2022-12-27	WOS:000344402600009
J	Liberio, MS; Sadowski, MC; Soekmadji, C; Davis, RA; Nelson, CC				Liberio, Michelle S.; Sadowski, Martin C.; Soekmadji, Carolina; Davis, Rohan A.; Nelson, Colleen C.			Differential Effects of Tissue Culture Coating Substrates on Prostate Cancer Cell Adherence, Morphology and Behavior	PLOS ONE			English	Article							ADHESION; FIBRONECTIN; PROLIFERATION; EXPRESSION; FILOPODIA; GROWTH; LNCAP; APOPTOSIS; GENES; TUMOR	Weak cell-surface adhesion of cell lines to tissue culture surfaces is a common problem and presents technical limitations to the design of experiments. To overcome this problem, various surface coating protocols have been developed. However, a comparative and precise real-time measurement of their impact on cell behavior has not been conducted. The prostate cancer cell line LNCaP, derived from a patient lymph node metastasis, is a commonly used model system in prostate cancer research. However, the cells' characteristically weak attachment to the surface of tissue culture vessels and cover slips has impeded their manipulation and analysis and use in high throughput screening. To improve the adherence of LNCaP cells to the culture surface, we compared different coating reagents (poly-L-lysine, poly-L-ornithine, collagen type IV, fibronectin, and laminin) and culturing conditions and analyzed their impact on cell proliferation, adhesion, morphology, mobility and gene expression using real-time technologies. The results showed that fibronectin, poly-L-lysine and poly-L-ornithine improved LNCaP cells adherence and provoked cell morphology alterations, such as increase of nuclear and cellular area. These coating reagents also induced a higher expression of F-actin and reduced cell mobility. In contrast, laminin and collagen type IV did not improve adherence but promoted cell aggregation and affected cell morphology. Cells cultured in the presence of laminin displayed higher mobility than control cells. All the coating conditions significantly affected cell viability; however, they did not affect the expression of androgen receptor-regulated genes. Our comparative findings provide important insight for the selection of the ideal coating reagent and culture conditions for the cancer cell lines with respect to their effect on proliferation rate, attachment, morphology, migration, transcriptional response and cellular cytoskeleton arrangement.	[Liberio, Michelle S.; Davis, Rohan A.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Liberio, Michelle S.; Sadowski, Martin C.; Soekmadji, Carolina; Nelson, Colleen C.] Queensland Univ Technol, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Translat Res Inst,Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Griffith University; Queensland University of Technology (QUT)	Nelson, CC (corresponding author), Queensland Univ Technol, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Translat Res Inst,Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	colleen.nelson@qut.edu.au	Soekmadji, Carolina/M-2757-2016; Davis, Rohan A/B-1689-2008	Soekmadji, Carolina/0000-0002-6920-6627; Davis, Rohan A/0000-0003-4291-7573; Sadowski, Martin/0000-0002-5267-1442	Eskitis Institute Griffith University; Australian Prostate Cancer Research Centre-Queensland through the Australian Government Department of Health	Eskitis Institute Griffith University; Australian Prostate Cancer Research Centre-Queensland through the Australian Government Department of Health(Australian Government)	Funding for the study was provided by Eskitis Institute Griffith University and the Australian Prostate Cancer Research Centre-Queensland through funding from the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Atienzar FA, 2011, J BIOMOL SCREEN, V16, P575, DOI 10.1177/1087057111402825; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Collection ATC, 2012, NCIPBCFCRL1740 LNCAP, P24; Cordes N, 2003, INT J RADIAT BIOL, V79, P709, DOI 10.1080/09553000310001610240; Cross SS, 2008, DIAGN PATHOL, V14, P134; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Darrabie MD, 2005, BIOMATERIALS, V26, P6846, DOI 10.1016/j.biomaterials.2005.05.009; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; DIKE LE, 1988, P NATL ACAD SCI USA, V85, P6792, DOI 10.1073/pnas.85.18.6792; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021; Heng BC, 2010, BIOINTERPHASES, V5, pFA53, DOI 10.1116/1.3483218; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Jokhadar SZ, 2007, CELL BIOL INT, V31, P1097, DOI 10.1016/j.cellbi.2007.03.019; Kariya Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035546; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim IY, 2002, CANCER RES, V62, P3649; Knudsen BS, 2006, J CELL BIOCHEM, V99, P345, DOI 10.1002/jcb.20934; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; LABATROBERT J, 1990, FEBS LETT, V268, P386, DOI 10.1016/0014-5793(90)81291-U; Longhurst CM, 1998, CELL MOL LIFE SCI, V54, P514, DOI 10.1007/s000180050180; LYDON MJ, 1981, EXP CELL RES, V135, P347, DOI 10.1016/0014-4827(81)90170-1; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Morgan M, 2000, UROL ONCOL, V5, P155, DOI 10.1016/S1078-1439(99)00058-7; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Page K, 1997, J BIOL CHEM, V272, P19339, DOI 10.1074/jbc.272.31.19339; Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069; PARSONS TJ, 1983, ARTERIOSCLEROSIS, V3, P589, DOI 10.1161/01.ATV.3.6.589; Pegueroles M, 2011, J MATER SCI-MATER M, V22, P617, DOI 10.1007/s10856-011-4229-3; Ragetly G, 2010, ACTA BIOMATER, V6, P3988, DOI 10.1016/j.actbio.2010.05.016; Saltzman W.M., 2000, PRINCIPLES TISSUE EN, P995; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Science RA, 2010, XCELLIGENCE SYSTEM R; Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217; Sottile J, 1998, J CELL SCI, V111, P2933; Strauss S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053309; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Vergani L, 2004, INT J BIOCHEM CELL B, V36, P1447, DOI 10.1016/j.biocel.2003.11.015; Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	50	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112122	10.1371/journal.pone.0112122	http://dx.doi.org/10.1371/journal.pone.0112122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375165	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600108
J	Suwanpradid, J; Rojas, M; Behzadian, MA; Caldwell, RW; Caldwell, RB				Suwanpradid, Jutamas; Rojas, Modesto; Behzadian, M. Ali; Caldwell, R. William; Caldwell, Ruth B.			Arginase 2 Deficiency Prevents Oxidative Stress and Limits Hyperoxia-Induced Retinal Vascular Degeneration	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; NITRIC-OXIDE; HORIZONTAL CELLS; ENDOTHELIAL DYSFUNCTION; ISCHEMIC RETINOPATHY; MOUSE MODEL; PEROXYNITRITE; SUPEROXIDE; METABOLISM; MICE	Background: Hyperoxia exposure of premature infants causes obliteration of the immature retinal microvessels, leading to a condition of proliferative vitreoretinal neovascularization termed retinopathy of prematurity (ROP). Previous work has demonstrated that the hyperoxia-induced vascular injury is mediated by dysfunction of endothelial nitric oxide synthase resulting in peroxynitrite formation. This study was undertaken to determine the involvement of the ureahydrolase enzyme arginase in this pathology. Methods and Findings: Studies were performed using hyperoxia-treated bovine retinal endothelial cells (BRE) and mice with oxygen-induced retinopathy (OIR) as experimental models of ROP. Treatment with the specific arginase inhibitor 2(S)-amino- 6-boronohexanoic acid (ABH) prevented hyperoxia-induced apoptosis of BRE cells and reduced vaso-obliteration in the OIR model. Furthermore, deletion of the arginase 2 gene protected against hyperoxia-induced vaso-obliteration, enhanced physiological vascular repair, and reduced retinal neovascularization in the OIR model. Additional deletion of one copy of arginase 1 did not improve the vascular pathology. Analyses of peroxynitrite by quantitation of its biomarker nitrotyrosine, superoxide by dihydroethidium imaging and NO formation by diaminofluoroscein imaging showed that the protective actions of arginase 2 deletion were associated with blockade of superoxide and peroxynitrite formation and normalization of NOS activity. Conclusions: Our data demonstrate the involvement of arginase activity and arginase 2 expression in hyperoxia-induced vascular injury. Arginase 2 deletion prevents hyperoxia-induced retinal vascular injury by preventing NOS uncoupling resulting in decreased reactive oxygen species formation and increased nitric oxide bioavailability.	[Suwanpradid, Jutamas; Rojas, Modesto; Behzadian, M. Ali; Caldwell, Ruth B.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA; [Suwanpradid, Jutamas; Rojas, Modesto; Caldwell, R. William; Caldwell, Ruth B.] Georgia Regents Univ, Culver Vis Discovery Inst, Augusta, GA USA; [Rojas, Modesto; Caldwell, R. William] Georgia Regents Univ, Dept Cellular Biol & Anat, Dept Pharmacol & Toxicol, Augusta, GA USA; [Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caldwell, RB (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA.	rcaldwel@gru.edu	Suwanpradid, Jutamas/K-5799-2019	Rojas, Modesto/0000-0002-9441-3302; Caldwell, Ruth/0000-0003-0168-0354	National Institutes of Health (NIH) [R01-EY11766]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX001233]; Culver Vision Discovery Institute at Georgia Regents University; NATIONAL EYE INSTITUTE [R01EY011766] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001233] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); Culver Vision Discovery Institute at Georgia Regents University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported in part by grants from National Institutes of Health (NIH grant R01-EY11766), the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (BX001233), and the Culver Vision Discovery Institute at Georgia Regents University. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NKM, 2012, NEONATOLOGY, V101, P106, DOI 10.1159/000329540; [Anonymous], 2013, PREM BAB; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P397, DOI 10.1136/bjo.38.7.397; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Brooks SE, 1998, CURR EYE RES, V17, P875, DOI 10.1076/ceyr.17.9.875.5134; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; Christianson DW, 2005, ACCOUNTS CHEM RES, V38, P191, DOI 10.1021/ar040183k; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Deignan JL, 2006, MOL GENET METAB, V89, P87, DOI 10.1016/j.ymgme.2006.04.007; Durante W, 2001, CIRCULATION, V103, P1121, DOI 10.1161/01.CIR.103.8.1121; Edgar K, 2012, INVEST OPHTH VIS SCI, V53, P6833, DOI 10.1167/iovs.12-9797; Elms SC, 2013, DIABETOLOGIA, V56, P654, DOI 10.1007/s00125-012-2789-5; Feng YY, 1999, INVEST OPHTH VIS SCI, V40, P157; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Hardy P, 2000, CARDIOVASC RES, V47, P489, DOI 10.1016/S0008-6363(00)00084-5; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Knabe W, 1999, CELL TISSUE RES, V298, P33, DOI 10.1007/s004419900072; Krotova K, 2010, AM J PHYSIOL-CELL PH, V299, pC1541, DOI 10.1152/ajpcell.00068.2010; Mojumder DK, 2008, J ANAT SOC INDIA, V57, P34; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Narayanan SP, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.23; Narayanan SP, 2013, PROG RETIN EYE RES; Narayanan SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022460; Neu J, 2006, INVEST OPHTH VIS SCI, V47, P3151, DOI 10.1167/iovs.05-1473; Pandey D, 2014, ARTERIOSCL THROM VAS, V34, P1556, DOI 10.1161/ATVBAHA.114.303685; Patel C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00173; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Que LG, 1998, AM J PHYSIOL-LUNG C, V275, pL96, DOI 10.1152/ajplung.1998.275.1.L96; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Romero MJ, 2012, AM J PHYSIOL-HEART C, V302, pH159, DOI 10.1152/ajpheart.00774.2011; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Ryoo S, 2006, CIRC RES, V99, P951, DOI 10.1161/01.RES.0000247034.24662.b4; Sahin E, 2014, J IMMUNOL; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Shin W, 2012, EXP MOL MED, V44, P594, DOI 10.3858/emm.2012.44.10.068; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2008, INVEST OPHTH VIS SCI, V49, P5177, DOI 10.1167/iovs.08-2584; Stevenson L, 2010, INVEST OPHTH VIS SCI, V51, P3291, DOI 10.1167/iovs.09-4344; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	52	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110604	10.1371/journal.pone.0110604	http://dx.doi.org/10.1371/journal.pone.0110604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375125	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600017
J	Buhmann, MT; Poulsen, N; Klemm, J; Kennedy, MR; Sherrill, CD; Kroger, N				Buhmann, Matthias T.; Poulsen, Nicole; Klemm, Jennifer; Kennedy, Matthew R.; Sherrill, C. David; Kroeger, Nils			A Tyrosine-Rich Cell Surface Protein in the Diatom Amphora coffeaeformis Identified through Transcriptome Analysis and Genetic Transformation	PLOS ONE			English	Article							STABLE NUCLEAR TRANSFORMATION; SILICA; ADHESION; ESTABLISHMENT; PEPTIDES; PROMOTER; SYSTEM; DOPA	Diatoms are single-celled eukaryotic microalgae that are ubiquitously found in almost all aquatic ecosystems, and are characterized by their intricately structured SiO2 (silica)-based cell walls. Diatoms with a benthic life style are capable of attaching to any natural or man-made submerged surface, thus contributing substantially to both microbial biofilm communities and economic losses through biofouling. Surface attachment of diatoms is mediated by a carbohydrate-and protein-based glue, yet no protein involved in diatom underwater adhesion has been identified so far. In the present work, we have generated a normalized transcriptome database from the model adhesion diatom Amphora coffeaeformis. Using an unconventional bioinformatics analysis we have identified five proteins that exhibit unique amino acid sequences resembling the amino acid composition of the tyrosine-rich adhesion proteins from mussel footpads. Establishing the first method for the molecular genetic transformation of A. coffeaeformis has enabled investigations into the function of one of these proteins, AC3362, through expression as YFP fusion protein. Biochemical analysis and imaging by fluorescence microscopy revealed that AC3362 is not involved in adhesion, but rather plays a role in biosynthesis and/or structural stability of the cell wall. The methods established in the present study have paved the way for further molecular studies on the mechanisms of underwater adhesion and biological silica formation in the diatom A. coffeaeformis.	[Buhmann, Matthias T.; Poulsen, Nicole; Klemm, Jennifer; Kroeger, Nils] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01062 Dresden, Germany; [Kroeger, Nils] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany; [Kennedy, Matthew R.; Sherrill, C. David] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	Technische Universitat Dresden; Technische Universitat Dresden; University System of Georgia; Georgia Institute of Technology	Kroger, N (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01062 Dresden, Germany.	kroeger@bcube-dresden.de		Sherrill, David/0000-0002-5570-7666; Poulsen, Nicole/0000-0002-4533-8860	US Air Force Office of Scientific Research (AFOSR) [FA9550-12-1-0093]; Deutsche Forschungsgemeinschaft (DFG) [KR 1853/5-1]	US Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the US Air Force Office of Scientific Research (AFOSR grant number FA9550-12-1-0093) to NP and NK, and by the Deutsche Forschungsgemeinschaft (DFG grant number KR 1853/5-1) to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251; Cooper CL, 2005, CURR OPIN COLLOID IN, V10, P52, DOI 10.1016/j.cocis.2005.05.007; Davis AK, 2005, J PHYCOL, V41, P577, DOI 10.1111/j.1529-8817.2005.00076.x; de Jong H. G. B., 1932, PROTOPLASMA, V15, P110; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; DHIR SK, 1994, IMPROVEMENT OF CEREAL QUALITY BY GENETIC ENGINEERING, P71; DRUM RW, 1966, PROTOPLASMA, V62, P1, DOI 10.1007/BF01254629; EDGAR LA, 1983, PROC R SOC SER B-BIO, V218, P331, DOI 10.1098/rspb.1983.0042; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finlay JA, 2002, INTEGR COMP BIOL, V42, P1116, DOI 10.1093/icb/42.6.1116; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110; Hodson OM, 2012, BIOFOULING, V28, P381, DOI 10.1080/08927014.2012.680020; HUDON C, 1981, CAN J FISH AQUAT SCI, V38, P1371, DOI 10.1139/f81-184; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; JACOBS JD, 1992, MOL GEN GENET, V233, P302, DOI 10.1007/BF00587592; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Miyagawa A, 2009, PHYCOL RES, V57, P142, DOI 10.1111/j.1440-1835.2009.00531.x; Miyagawa-Yamaguchi A, 2011, PHYCOL RES, V59, P113, DOI 10.1111/j.1440-1835.2011.00607.x; Molino PJ, 2008, BIOFOULING, V24, P365, DOI 10.1080/08927010802254583; Muto M, 2013, MAR BIOTECHNOL, V15, P48, DOI 10.1007/s10126-012-9457-0; Nicklisch SCT, 2012, BIOFOULING, V28, P865, DOI 10.1080/08927014.2012.719023; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2013, J BIOL CHEM; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Poulsen N, 2014, BIOFOULING, V30, P513, DOI 10.1080/08927014.2014.895895; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sakaue K, 2008, PHYSIOL PLANTARUM, V133, P59, DOI 10.1111/j.1399-3054.2008.01089.x; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809; Silverman HG, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P273, DOI 10.1007/978-3-7091-0286-2_18; Smith A. M, 2006, BIOL ADHESIVES; Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330; Stief P, 2011, MARINE MICROBIAL EUK; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Tesson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061675; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Vournakis JN, 2012, NANOTECHNOLOGY NANOM, P345; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Wenzl S, 2008, ANGEW CHEM INT EDIT, V120, P1753; Wetherbee R, 1998, J PHYCOL, V34, P9, DOI 10.1046/j.1529-8817.1998.340009.x	49	21	21	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110369	10.1371/journal.pone.0110369	http://dx.doi.org/10.1371/journal.pone.0110369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372470	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900020
J	Fa, JE; Olivero, J; Farfan, MA; Marquez, AL; Vargas, JM; Real, R; Nasi, R				Fa, John E.; Olivero, Jesus; Farfan, Miguel Angel; Marquez, Ana Luz; Vargas, Juan Mario; Real, Raimundo; Nasi, Robert			Integrating Sustainable Hunting in Biodiversity Protection in Central Africa: Hot Spots, Weak Spots, and Strong Spots	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CONGO BASIN; POPULATION-DENSITY; TROPICAL FORESTS; EXTINCTION RISK; BODY-SIZE; BUSHMEAT; RESOLUTION; IMPACTS; MAMMALS	Wild animals are a primary source of protein (bushmeat) for people living in or near tropical forests. Ideally, the effect of bushmeat harvests should be monitored closely by making regular estimates of offtake rate and size of stock available for exploitation. However, in practice, this is possible in very few situations because it requires both of these aspects to be readily measurable, and even in the best case, entails very considerable time and effort. As alternative, in this study, we use high-resolution, environmental favorability models for terrestrial mammals (N = 165) in Central Africa to map areas of high species richness (hot spots) and hunting susceptibility. Favorability models distinguish localities with environmental conditions that favor the species' existence from those with detrimental characteristics for its presence. We develop an index for assessing Potential Hunting Sustainability (PHS) of each species based on their ecological characteristics (population density, habitat breadth, rarity and vulnerability), weighted according to restrictive and permissive assumptions of how species' characteristics are combined. Species are classified into five main hunting sustainability classes using fuzzy logic. Using the accumulated favorability values of all species, and their PHS values, we finally identify weak spots, defined as high diversity regions of especial hunting vulnerability for wildlife, as well as strong spots, defined as high diversity areas of high hunting sustainability potential. Our study uses relatively simple models that employ easily obtainable data of a species' ecological characteristics to assess the impacts of hunting in tropical regions. It provides information for management by charting the geography of where species are more or less likely to be at risk of extinction from hunting.	[Fa, John E.] Univ London Imperial Coll Sci Technol & Med, ICCS, Div Biol, Ascot, Berks, England; [Fa, John E.; Olivero, Jesus; Farfan, Miguel Angel; Marquez, Ana Luz; Vargas, Juan Mario; Real, Raimundo] Univ Malaga, Fac Ciencias, Dept Biol Anim, Grp Biogeog Diversidad & Conservac, E-29071 Malaga, Spain; [Nasi, Robert] CIFOR Headquarters, CGIAR, Bogor, Indonesia	Imperial College London; Universidad de Malaga; CGIAR; Center for International Forestry Research (CIFOR)	Fa, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, ICCS, Div Biol, Silwood Pk Campus, Ascot, Berks, England.	jfa949@gmail.com	Márquez, Ana Luz/K-8345-2014; Nasi, Robert/A-3549-2015; Real, Raimundo/E-6559-2010; Olivero, Jesús/K-8727-2014; Nasi, Robert/P-2382-2019; Farfan Aguilar, Miguel Angel/K-8783-2014	Márquez, Ana Luz/0000-0001-5586-9334; Nasi, Robert/0000-0001-9739-3135; Real, Raimundo/0000-0002-6642-1284; Olivero, Jesús/0000-0003-1714-0360; Nasi, Robert/0000-0001-9739-3135; FA, Julia Elizabeth/0000-0002-1572-9828; Farfan Aguilar, Miguel Angel/0000-0002-4617-6517	KnowFor (International Forestry Knowledge)	KnowFor (International Forestry Knowledge)	This work is supported by the KnowFor (International Forestry Knowledge) initiative of the UK Department for International Development (UKAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper is a contribution of the CIFOR Bushmeat Research Initiative.	Acevedo P, 2012, NATURWISSENSCHAFTEN, V99, P515, DOI 10.1007/s00114-012-0926-0; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Balmford A., 2008, EC BIODIVERSITY ECOS; Barbosa AM, 2010, CONSERV BIOL, V24, P1378, DOI 10.1111/j.1523-1739.2010.01517.x; Barbosa AM, 2003, BIOL CONSERV, V114, P377, DOI 10.1016/S0006-3207(03)00066-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierkens M., 2000, UPSCALING DOWNSCALIN; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Bombi P, 2012, J BIOGEOGR, V39, P640, DOI 10.1111/j.1365-2699.2011.02627.x; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brodie JF, 2009, ECOL APPL, V19, P854, DOI 10.1890/08-0955.1; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cowlishaw G, 2005, J APPL ECOL, V42, P460, DOI 10.1111/j.1365-2664.2005.01046.x; Cullen L, 2001, ORYX, V35, P137, DOI 10.1017/S0030605300031690; De Wasseige C., 2012, FORETS BASSIN CONGO; Delibes-Mateos M, 2012, ENVIRON CONSERV, V39, P337, DOI 10.1017/S0376892912000100; Estrada A, 2008, BIODIVERS CONSERV, V17, P857, DOI 10.1007/s10531-008-9328-1; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2003, ENVIRON CONSERV, V30, P71, DOI 10.1017/S0376892903000067; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Fielding AH, 1995, CONSERV BIOL, V9, P1466, DOI 10.1046/j.1523-1739.1995.09061466.x; Franklin J, 2009, MAPPING SPECIES DIST; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Keil P, 2013, METHODS ECOL EVOL, V4, P82, DOI 10.1111/j.2041-210x.2012.00264.x; KINGDON J, 2013, MAMMALS AFRICA; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; Barbosa AM, 2012, SCI WORLD J, DOI 10.1100/2012/428206; Margules C.R., 1986, P297; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Munoz AR, 2013, THESIS U MALAGA MALA; Olivero J, 2013, SYST BIOL, V62, P1, DOI 10.1093/sysbio/sys061; Olivero J, 2011, SYST BIOL, V60, P645, DOI 10.1093/sysbio/syr026; Peres CA, 2000, BIOL RESOURCE MANAGE, P31; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; Remis MJ, 2012, AM J PRIMATOL, V74, P602, DOI 10.1002/ajp.22012; Robinson J.G., 1991, P415; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; ROBINSON JG, 1986, AM NAT, V128, P665, DOI 10.1086/284596; ROBINSON JG, 1986, OECOLOGIA, V68, P516, DOI 10.1007/BF00378765; Romero D, 2013, ENVIRON CONSERV, V40, P48, DOI 10.1017/S0376892912000227; Rondinini C, 2006, BIOL CONSERV, V133, P358, DOI 10.1016/j.biocon.2006.06.013; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Taylor G, 2014, BIOL CONSER IN PRESS; TEEB, 2010, EC EC BIOD MAINSTR E; UNEP-WCMC, 2012, DAT STAND WORLD DAT; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; White F., 1983, VEGETATION AFRICA DE, P356; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	69	25	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112367	10.1371/journal.pone.0112367	http://dx.doi.org/10.1371/journal.pone.0112367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372705	Green Published, Green Accepted, gold			2022-12-27	WOS:000344556900139
J	McWethy, DB; Wilmshurst, JM; Whitlock, C; Wood, JR; McGlone, MS				McWethy, David B.; Wilmshurst, Janet M.; Whitlock, Cathy; Wood, Jamie R.; McGlone, Matt S.			A High-Resolution Chronology of Rapid Forest Transitions following Polynesian Arrival in New Zealand	PLOS ONE			English	Article							GREAT BARRIER-ISLAND; LANDSCAPE TRANSFORMATION; KAHAROA TEPHRA; CLIMATE-CHANGE; HAWKES BAY; FIRE; VEGETATION; SETTLEMENT; PATTERNS; IMPACTS	Human-caused forest transitions are documented worldwide, especially during periods when land use by dense agriculturally-based populations intensified. However, the rate at which prehistoric human activities led to permanent deforestation is poorly resolved. In the South Island, New Zealand, the arrival of Polynesians c. 750 years ago resulted in dramatic forest loss and conversion of nearly half of native forests to open vegetation. This transformation, termed the Initial Burning Period, is documented in pollen and charcoal records, but its speed has been poorly constrained. High-resolution chronologies developed with a series of AMS radiocarbon dates from two lake sediment cores suggest the shift from forest to shrubland occurred within decades rather than centuries at drier sites. We examine two sites representing extreme examples of the magnitude of human impacts: a drier site that was inherently more vulnerable to human-set fires and a wetter, less burnable site. The astonishing rate of deforestation at the hands of small transient populations resulted from the intrinsic vulnerability of the native flora to fire and from positive feedbacks in post-fire vegetation recovery that increased landscape flammability. Spatially targeting burning in highly-flammable seral vegetation in forests rarely experiencing fire was sufficient to create an alternate fire-prone stable state. The New Zealand example illustrates how seemingly stable forest ecosystems can experience rapid and permanent conversions. Forest loss in New Zealand is among the fastest ecological transitions documented in the Holocene; yet equally rapid transitions can be expected in present-day regions wherever positive feedbacks support alternate fire-inhibiting, fire-prone stable states.	[McWethy, David B.; Whitlock, Cathy] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Wilmshurst, Janet M.; Wood, Jamie R.; McGlone, Matt S.] Landcare Res, Lincoln, New Zealand; [Whitlock, Cathy] Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA; [Wilmshurst, Janet M.] Univ Auckland, Sch Environm, Auckland 1, New Zealand	Montana State University System; Montana State University Bozeman; Landcare Research - New Zealand; Montana State University System; Montana State University Bozeman; University of Auckland	McWethy, DB (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.	dmcwethy@montana.edu	Wood, Jamie/A-9393-2008; Wilmshurst, Janet M/C-2209-2009; Wood, Jamie/AAU-5530-2021; Wilmshurst, Janet/O-8611-2019	Wood, Jamie/0000-0001-8008-6083; Wilmshurst, Janet M/0000-0002-4474-8569; Wilmshurst, Janet/0000-0002-4474-8569	National Science Foundation [OISE-0966472, BCS-1024413]; New Zealand Foundation for Research Science and Technology; Royal Society of New Zealand Marsden; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported in part by National Science Foundation Grants OISE-0966472 (DBM, CW), and BCS-1024413 (DBM, CW), New Zealand Foundation for Research Science and Technology funding to JMW, JRW and MSM, and Royal Society of New Zealand Marsden funding to MSM, JMW, and CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Field RD, 2009, NAT GEOSCI, V2, P185, DOI 10.1038/NGEO443; Haslett J, 2008, J R STAT SOC C-APPL, V57, P399, DOI 10.1111/j.1467-9876.2008.00623.x; Higuera PE, 2007, QUATERNARY SCI REV, V26, P1790, DOI 10.1016/j.quascirev.2007.03.010; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Horrocks M, 2001, J ARCHAEOL SCI, V28, P153, DOI 10.1006/jasc.2000.0568; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Kitzberger T, 2011, ECOSYSTEMS, P1; Kitzberger T, 2007, P NATL ACAD SCI USA, V104, P543, DOI 10.1073/pnas.0606078104; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Mayer AL, 2011, SCIENCE, V334, P188, DOI 10.1126/science.1213908; McGlone MS, 1999, QUATERN INT, V59, P5, DOI 10.1016/S1040-6182(98)00067-6; McGlone MS, 2005, NEW ZEAL J ECOL, V29, P165; McGlone MS, 1995, QUATERNARY SCI REV, V14, P867, DOI 10.1016/0277-3791(95)00068-2; McWethy DB, 2013, GLOBAL ECOL BIOGEOGR, V22, P900, DOI 10.1111/geb.12038; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; McWethy DB, 2009, HOLOCENE, V19, P883, DOI 10.1177/0959683609336563; Moore P.D., 1991, BLACKWELL SCI PUBLI; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Newnham RM, 1998, J ARCHAEOL SCI, V25, P533, DOI 10.1006/jasc.1997.0217; Odion DC, 2004, CONSERV BIOL, V18, P927, DOI 10.1111/j.1523-1739.2004.00493.x; Odion DC, 2010, J ECOL, V98, P96, DOI 10.1111/j.1365-2745.2009.01597.x; Ogden J, 1998, ANN BOT-LONDON, V81, P687, DOI 10.1006/anbo.1998.0637; Parnell AC, 2011, QUATERNARY SCI REV, V30, P2948, DOI 10.1016/j.quascirev.2011.07.024; Perry G, 2014, NZ J ECOLOGY, V38; Perry GLW, 2012, GLOBAL CHANGE BIOL, V18, P1609, DOI 10.1111/j.1365-2486.2011.02631.x; Perry GLW, 2010, NEW ZEAL J ECOL, V34, P311; Perry GLW, 2012, GLOBAL ECOLOGY BIOGE; Pfeiffer M, 2013, GEOSCI MODEL DEV, V6, P643, DOI 10.5194/gmd-6-643-2013; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Sorensen T., 1948, BIOL SKAR, V5, P1; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Thompson JR, 2007, P NATL ACAD SCI USA, V104, P10743, DOI 10.1073/pnas.0700229104; Veblen TT, 2011, AUSTR ECOLOGY; Wardle P, 2001, NEW ZEAL J BOT, V39, P523; Whitlock C, 2001, TRACKING ENV CHANGE, P75, DOI DOI 10.1007/0-306-47668-1_5; Williams M, 2000, J HIST GEOGR, V26, P28, DOI 10.1006/jhge.1999.0189; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Wilmshurst JM, 2004, NEW ZEAL J ECOL, V28, P167; Wilmshurst JM, 1997, NEW ZEAL J BOT, V35, P79; Wilmshurst JM, 1997, NEW ZEAL J BOT, V35, P97	46	61	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111328	10.1371/journal.pone.0111328	http://dx.doi.org/10.1371/journal.pone.0111328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372150	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900044
J	Nazeer, W; Tipu, AL; Ahmad, S; Mahmood, K; Mahmood, A; Zhou, BL				Nazeer, Wajad; Tipu, Abdul Latif; Ahmad, Saghir; Mahmood, Khalid; Mahmood, Abid; Zhou, Baoliang			Evaluation of Cotton Leaf Curl Virus Resistance in BC1, BC2, and BC3 Progenies from an Interspecific Cross between Gossypium arboreum and Gossypium hirsutum	PLOS ONE			English	Article							NORTHWESTERN INDIA; FIELD CONDITIONS; SATELLITE DNAS; BUREWALA VIRUS; G. HIRSUTUM; IN-VITRO; DISEASE; HYBRIDIZATION; GENETICS; PAKISTAN	Cotton leaf curl virus disease (CLCuD) is an important constraint to cotton production. The resistance of G. arboreum to this devastating disease is well documented. In the present investigation, we explored the possibility of transferring genes for resistance to CLCuD from G. arboreum (2n = 26) cv 15-Mollisoni into G. hirsutum (2n = 52) cv CRSM-38 through conventional breeding. We investigated the cytology of the BC1 to BC3 progenies of direct and reciprocal crosses of G. arboreum and G. hirsutum and evaluated their resistance to CLCuD. The F-1 progenies were completely resistant to this disease, while a decrease in resistance was observed in all backcross generations. As backcrossing progressed, the disease incidence increased in BC1 (1.7-2.0%), BC2 (1.8-4.0%), and BC3 (4.2-7.0%). However, the disease incidence was much lower than that of the check variety CIM-496, with a CLCuD incidence of 96%. Additionally, the disease incidence percentage was lower in the direct cross 2(G. arboreum) x G. hirsutum than in that of G. hirsutum x G. arboreum. Phenotypic resemblance of BC1, BC3 progenies to G. arboreum confirmed the success of cross between the two species. Cytological studies of CLCuD-resistant plants revealed that the frequency of univalents and multivalents was high in BC1, with sterile or partially fertile plants, but low in BC2 (in both combinations), with shy bearing plants. In BC3, most of the plants exhibited normal bearing ability due to the high frequency of chromosome associations (bivalents). The assessment of CLCuD through grafting showed that the BC1 to BC3 progenies were highly resistant to this disease. Thus, this study successfully demonstrates the possibility of introgressing CLCuD resistance genes from G. arboreum to G. hirsutum.	[Nazeer, Wajad; Zhou, Baoliang] Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germpalsm Enhancement, Nanjing, Jiangsu, Peoples R China; [Nazeer, Wajad; Tipu, Abdul Latif; Ahmad, Saghir; Mahmood, Khalid] Ayub Agr Res Inst, Cotton Res Stn, Faisalabad, Punjab, Pakistan; [Mahmood, Abid] Ayub Agr Res Inst, Cotton Res Inst, Faisalabad, Punjab, Pakistan	Nanjing Agricultural University	Zhou, BL (corresponding author), Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germpalsm Enhancement, Nanjing, Jiangsu, Peoples R China.	baoliangzhou@njau.edu.cn	Nazeer, Wajad/P-7943-2014	Nazeer, Wajad/0000-0001-7479-6409	National Key Technology Support Program of China during the twelfth Five-year Plan Period [2013BAD01B03-04]; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [CX (14) 2065]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Punjab Agriculture Research Board (PARB) [27]	National Key Technology Support Program of China during the twelfth Five-year Plan Period; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Punjab Agriculture Research Board (PARB)	This work was supported by the following. Baoliang Zhou: Research was supported partially by National Key Technology Support Program of China during the twelfth Five-year Plan Period (2013BAD01B03-04), the Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [CX (14) 2065] and the Priority Academic Program Development of Jiangsu Higher Education Institutions. Saghir Ahmad: Punjab Agriculture Research Board (PARB) for providing financial support for these studies under PARB Project no. 27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, GENET MOL RES, V10, P2404, DOI 10.4238/2011.October.7.2; Ahmad S, 2011, 5 M AS COTT RES DEV; Ahmad S, 2011, PAK J BOT, V43, P725; Ahuja SL, 2007, J HERED, V98, P79, DOI 10.1093/jhered/esl049; Akhtar KP, 2010, ANN APPL BIOL, V157, P135, DOI 10.1111/j.1744-7348.2010.00416.x; Akhtar K.P., 2003, TROP AGR RES EXT, V5, P29; Akhtar KP, 2002, IMPROVED BOTTLE SHOO, P115; Akhtar KP, 2002, PLANT PATHOLOGY J, V18, P179; ALI MAHBUB, 1962, CROP SCI, V2, P20; ALTMAN DW, 1988, PLANT CELL REP, V7, P257, DOI 10.1007/BF00272537; AMIN K. C., 1940, INDIAN JOUR AGRIC SCI, V10, P404; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Azhar MT, 2013, J ANIM PLANT SCI, V23, P1436; Azhar MT, 2010, INT J AGRIC BIOL, V12, P744; Azhar MT, 2012, VIRUS GENES, V45, P402, DOI 10.1007/s11262-012-0766-1; Azhar MT, 2010, VIRUS GENES, V41, P417, DOI 10.1007/s11262-010-0521-4; BLANK LM, 1963, PHYTOPATHOLOGY, V53, P921; Borole V. K., 2000, Indian Journal of Genetics and Plant Breeding, V60, P105; Briddon RW, 2003, MOL PLANT PATHOL, V4, P427, DOI [10.1046/j.1364-3703.2003.00188.x, 10.1046/J.1364-3703.2003.00188.X]; Briddon RW, 2000, VIRUS RES, V71, P151, DOI 10.1016/S0168-1702(00)00195-7; Brubaker CL, 1999, EUPHYTICA, V108, P199, DOI 10.1023/A:1003641217653; Cai JH, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02266.x; Cao Z, 2013, THEOR APPL GENET, P1; Chen Y, 2014, THEOR APPL GENET, V127, P1105, DOI 10.1007/s00122-014-2283-1; Deshpande L. A., 1991, Indian Journal of Genetics and Plant Breeding, V51, P194; Farooq A, 2011, AUST J CROP SCI, V5, P1823; Gerstel D, 1956, EVOLUTION, P408; GILL MS, 1987, EUPHYTICA, V36, P625, DOI 10.1007/BF00041512; Gordillo LF, 2003, EUPHYTICA, V131, P15, DOI 10.1023/A:1023012703471; Guo WZ, 2006, THEOR APPL GENET, V112, P1573, DOI 10.1007/s00122-006-0261-y; Harland SC, 1929, J GENET, V20, P387, DOI 10.1007/BF02983156; Hussain T., 1975, Pakistan Cottons, V19, P71; Hussain T., 1988, Pakistan Cottons, V32, P248; Jafari Mofidabadi A, 2011, COTTON GENOMICS GENE, V2; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; Kalloo G, 1992, DISTANT HYBRIDIZATIO, P149; Kovaleva LV, 2005, RUSS J PLANT PHYSL+, V52, P521, DOI 10.1007/s11183-005-0077-7; LIANG C, 1978, SCI SINICA, V21, P545; Liang Z, 1982, ACTA GENET SIN, V9, P441; Mahmood T., 2003, ASIAN J PLANT SCI, V2, P968; Mann RS, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P69, DOI 10.1007/978-94-007-1524-04; Mansoor S, 2003, PLANT PATHOL, V52, P784, DOI 10.1111/j.1365-3059.2003.00893.x; Mansoor S, 2006, TRENDS PLANT SCI, V11, P209, DOI 10.1016/j.tplants.2006.03.003; Maqbool A, 2010, BIOTECHNOL PROGR, V26, P21, DOI 10.1002/btpr.306; Matthews REF., 2002, PLANT VIROLOGY; Mergeai G., 1997, BASE: Biotechnologie, Agronomie, Societe et Environnement, V1, P272; Mofidabadi A, 2009, ICAC RECORDER, V27, P10; Nazeer W, 2014, GENET MOL RES, V13, P1133, DOI 10.4238/2014.February.21.2; Nelson R.R., 1973, BREEDING PLANTS DIS; Pundir N, 1972, BOT GAZ, P7; Rahman M, 2005, PLANT PATHOL, V54, P764, DOI 10.1111/j.1365-3059.2005.01280.x; Rajagopalan PA, 2012, ARCH VIROL, V157, P855, DOI 10.1007/s00705-012-1225-y; Roy N. N., 1980, SABRAO Journal, V12, P43; Sacks EJ, 2009, FIELD CROP RES, V112, P1, DOI 10.1016/j.fcr.2009.01.006; Saghir Ahmad, 2012, African Journal of Biotechnology, V11, P4368, DOI 10.5897/AJB11.3075; Sattar MN, 2013, J GEN VIROL, V94, P695, DOI 10.1099/vir.0.049627-0; Sikka S, 1960, BREEDING, P137; Silow RA, 1941, J GENET, V42, P259, DOI 10.1007/BF02982878; Singh D, 2013, J ENVIRON BIOL, V34, P113; SITCH LA, 1987, EUPHYTICA, V36, P483, DOI 10.1007/BF00041492; STEPHENS SG, 1954, GENETICS, V39, P701; Tahir M., 2004, Plant Pathology Journal, V3, P61; Tahir MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020366; Thakur P. D., 2002, Diseases of field crops, P398; THENGANE S, 1986, PLANT CELL TISS ORG, V6, P209, DOI 10.1007/BF00040006; Tiendrebeogo F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-48; Ullah R, 2014, EUROPEAN J PLANT PAT, P1; Zafar Y, 2011, ICAC RECORDER, V29, P7; Zaffalon V, 2012, ARCH VIROL, V157, P483, DOI 10.1007/s00705-011-1201-y; Zahur M, 2009, MOL BIOL REP, V36, P1915, DOI 10.1007/s11033-008-9399-9; Zhang Ling, 2009, BMC Res Notes, V2, P120, DOI 10.1186/1756-0500-2-120	71	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111861	10.1371/journal.pone.0111861	http://dx.doi.org/10.1371/journal.pone.0111861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372141	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900080
J	Santiago, K; Bomfim, GF; Criado, PR; Almeida, SR				Santiago, Karla; Bomfim, Gisele Facholi; Criado, Paulo Ricardo; Almeida, Sandro Rogerio			Monocyte-Derived Dendritic Cells from Patients with Dermatophytosis Restrict the Growth of Trichophyton rubrum and Induce CD4-T Cell Activation	PLOS ONE			English	Article							LECTIN DC-SIGN; ANTIGEN; RECOGNITION; RECEPTOR; CONIDIA	Dermatophytes are the most common agents of superficial mycoses that are caused by mold fungi. Trichophyton rubrum is the most common pathogen causing dermatophytosis. The immunology of dermatophytosis is currently poorly understood. Recently, our group investigated the interaction of T. rubrum conidia with peritoneal mouse macrophages. We found that macrophages phagocytose T. rubrum conidia resulted in a down-modulation of class II major histocompatibility complex (MHC) antigens and in the expression of co-stimulatory molecules. Furthermore, it induced the production of IL-10, and T. rubrum conidia differentiated into hyphae that grew and killed the macrophages after 8 hrs of culture. This work demonstrated that dendritic cells (DCs) and macrophages, from patients or normal individuals, avidly interact with pathogenic fungus T. rubrum. The dermatophyte has two major receptors on human monocyte-derived DC: DC-SIGN and mannose receptor. In contrast macrophage has only mannose receptor that participates in the phagocytosis or bound process. Another striking aspect of this study is that unlike macrophages that permit rapid growth of T. rubrum, human DC inhibited the growth and induces Th activation. The ability of DC from patients to interact and kill T. rubrum and to present Ags to T cells suggests that DC may play an important role in the host response to T. rubrum infection by coordinating the development of cellular immune response.	[Santiago, Karla; Bomfim, Gisele Facholi; Almeida, Sandro Rogerio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Criado, Paulo Ricardo] Univ Sao Paulo, Fac Med, Dept Dermatol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Almeida, SR (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.	sandroal@usp.br	almeida, sandro r/F-5816-2012; Criado, Paulo/D-5369-2009	almeida, sandro r/0000-0002-0562-1610; Criado, Paulo/0000-0001-9785-6099; Facholi Bomfim, Gisele/0000-0001-5528-0028	Fundacao de Aparo a Pesquisa do Estado de Sao Paulo (FAPESP); Concelho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Aparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Concelho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by grants from the following: Fundacao de Aparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Concelho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Campos MRM, 2006, MICROBES INFECT, V8, P372, DOI 10.1016/j.micinf.2005.07.028; Claudia Montagnoli, 2002, Current Molecular Medicine (Hilversum), V2, P507, DOI 10.2174/1566524023362203; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; DAHL MV, 1994, J AM ACAD DERMATOL, V31, pS34, DOI 10.1016/S0190-9622(08)81265-0; Erbagci Z, 2002, MYCOPATHOLOGIA, V154, P163, DOI 10.1023/A:1016328001146; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; GRUSECK E, 1993, MYCOSES, V36, P275, DOI 10.1111/j.1439-0507.1993.tb00765.x; Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249; KORTING HC, 1993, MYCOSES, V36, P271, DOI 10.1111/j.1439-0507.1993.tb00764.x; Montagnoli C, 2001, IMMUNOBIOLOGY, V204, P582, DOI 10.1078/0171-2985-00095; Moulin V, 2012, CANCER GENE THER, V19, P303, DOI 10.1038/cgt.2012.2; Newman SL, 2011, MED MYCOL, V49, P356, DOI 10.3109/13693786.2010.531295; Romani L, 1997, CURR OPIN IMMUNOL, V9, P484, DOI 10.1016/S0952-7915(97)80099-4; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 1997, CLIN MICROBIOL REV, V10, P611, DOI 10.1128/CMR.10.4.611; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Schwingshackl P, 2012, ACTA DERM-VENEREOL, V92, P269, DOI 10.2340/00015555-1220; Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9; Stevens DA, 1998, MED MYCOL, V36, P174; Summerbell RC, 1997, DERMATOLOGY, V194, P32, DOI 10.1159/000246182; Svajger U, 2010, CELL SIGNAL, V22, P1397, DOI 10.1016/j.cellsig.2010.03.018; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240; Woodfolk JA, 1998, RES IMMUNOL, V149, P436, DOI 10.1016/S0923-2494(98)80767-0	25	15	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110879	10.1371/journal.pone.0110879	http://dx.doi.org/10.1371/journal.pone.0110879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372145	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900026
J	Sinn, DH; Gwak, GY; Cho, J; Paik, SW; Yoo, BC				Sinn, Dong Hyun; Gwak, Geum-Youn; Cho, Juhee; Paik, Seung Woon; Yoo, Byung Chul			Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort	PLOS ONE			English	Article							NONCIRRHOTIC LIVER; YOUNG-PATIENTS; ENDEMIC AREA; INFECTION; PROGNOSIS; SURVIVAL; ETIOLOGY; CIRRHOSIS; RESECTION; KOREA	Background: We analyzed whether difference exist in the clinical manifestations and outcomes of hepatocellular carcinoma (HCC) according to the two major etiologies of HCC from a nationwide, population-based, random HCC registry. Methods: Of the 31,521 new HCC cases registered at the Korea Central Cancer Registry between 2003 and 2005, 4,630 (14.7%) were randomly abstracted, and followed up until December 2011. Of those, 2,785 hepatitis B virus (HBV)-related and 447 hepatitis C virus (HCV)-related HCC patients were compared. Results: The mean annual incidence rates of HBV- and HCV-related HCC incidence per 100,000 persons were 20.8 and 4.9, respectively. The annual incidence rate of HBV-related HCC peaked at 50-59 age group (46.5 per 100,000 persons), while the annual incidence rate of HCV-related HCC increased gradually to the >= 70 year age group (13.2 per 100,000 persons). Large tumors (>= 5 cm) and portal vein invasion at initial diagnosis were more frequent in HBV-related HCC, while multiple tumors were more frequent in HCV-related HCC. In outcome analysis, HBV-related HCC showed poorer survival than HCV-related HCC [median survival: 1.34 vs. 2.17 years, adjusted hazard ratio (95% confidence interval): 0.88 (0.78-0.98), P = 0.03, adjusted for age, gender, Child-Pugh class, AJCC/mUICC stage, and initial treatment modality]. However, when divided according to the AJCC/mUICC stage, survival difference was observed only for those with AJCC/mUICC stage IV tumor, but not for AJCC/mUICC stage I, II or III tumors. The treatment outcome of each modality (resection, ablation, and transartherial chemoeombolization) was comparable between the two etiologies. Conclusion: HBV-related and HCV-related HCC have clear differences in clinical manifestation, requiring different screening strategy according to etiology to optimize HCC surveillance in HBV-endemic area. However, etiology did not affect treatment outcomes and long-term survival within the same stage except for far advanced tumors.	[Sinn, Dong Hyun; Gwak, Geum-Youn; Paik, Seung Woon; Yoo, Byung Chul] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc & Epidemiol, Baltimore, MD USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gwak, GY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea.	gy.gwak@samsung.com	Gwak, Geum Youn/F-4605-2014; Cho, Juhee/ABD-2280-2021; Sinn, Dong Hyun/L-3701-2019; Sinn, Dong Hyun/O-5941-2014	Sinn, Dong Hyun/0000-0002-7126-5554				Ahn Yoon-Ok, 2007, J Prev Med Public Health, V40, P265; Bae SH, 2005, J KOREAN MED SCI, V20, P816, DOI 10.3346/jkms.2005.20.5.816; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cantarini MC, 2006, AM J GASTROENTEROL, V101, P91, DOI 10.1111/j.1572-0241.2006.00364.x; Chae Hee Bok, 2009, Korean J Hepatol, V15 Suppl 6, pS13, DOI 10.3350/kjhep.2009.15.S6.S13; Chen PH, 2013, ANN HEPATOL, V12, P263, DOI 10.1016/S1665-2681(19)31365-1; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi MS, 2012, GUT LIVER, V6, P241, DOI 10.5009/gnl.2012.6.2.241; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ferlay J, 2014, INT J CANCER, V13, DOI [10.1022/ijc.29210, DOI 10.1022/IJC.29210]; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hai H, 2014, WORLD J GASTROENTERO, V20, P6236, DOI 10.3748/wjg.v20.i20.6236; Hiotis SP, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-64; Huang YH, 2005, LIVER INT, V25, P236, DOI 10.1111/j.1478-3231.2005.01081.x; KALAYCI C, 1991, J HEPATOL, V12, P54, DOI 10.1016/0168-8278(91)90909-U; Kao WY, 2011, WORLD J SURG, V35, P858, DOI 10.1007/s00268-010-0928-z; KASL, 2014, CLIN MOL HEPATOL, V20, P89, DOI 10.3350/cmh.2014.20.2.89; KASL, 2012, CLIN MOL HEPATOL, V18, P109, DOI 10.3350/cmh.2012.18.2.109; Kim JH, 2006, J GASTROEN HEPATOL, V21, P588, DOI 10.1111/j.1440-1746.2005.04127.x; Kim W, 2003, CLIN CANCER RES, V9, P5493; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Nishikawa H, 2013, J CANCER, V4, P502, DOI 10.7150/jca.6503; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403; Sinn DH, 2008, LIVER INT, V28, P1363, DOI 10.1111/j.1478-3231.2008.01860.x; Song Il Han, 2009, Korean J Hepatol, V15 Suppl 6, pS50, DOI 10.3350/kjhep.2009.15.S6.S50; Suh DJ, 2005, INTERVIROLOGY, V49, P70, DOI 10.1159/000087266; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Tanabe G, 1999, HEPATO-GASTROENTEROL, V46, P2442; Tandoi F, 2013, TRANSPL P, V45, P2711, DOI 10.1016/j.transproceed.2013.07.002; Wang Q, 2012, J DIGEST DIS, V13, P214, DOI 10.1111/j.1751-2980.2012.00577.x; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yeh MM, 2010, MODERN PATHOL, V23, P276, DOI 10.1038/modpathol.2009.174; Zhou YM, 2014, ANN SURG ONCOL, V21, P2406, DOI 10.1245/s10434-014-3505-0	35	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112184	10.1371/journal.pone.0112184	http://dx.doi.org/10.1371/journal.pone.0112184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372403	Green Submitted, gold, Green Published			2022-12-27	WOS:000344556900118
J	Sohn, SY; Kang, JI; Namkoong, K; Kim, SJ				Sohn, Sung Yun; Kang, Jee In; Namkoong, Kee; Kim, Se Joo			Multidimensional Measures of Impulsivity in Obsessive-Compulsive Disorder: Cannot Wait and Stop	PLOS ONE			English	Article							RISK-TAKING; RESPONSE-INHIBITION; NEUROCOGNITIVE ENDOPHENOTYPES; COGNITIVE FLEXIBILITY; MOTOR INHIBITION; ALCOHOL-USE; SIGNAL; AVERSION; TASK; SYMPTOMATOLOGY	Objective: Although the relationship between obsessive compulsive disorder (OCD) and impulsivity has long been debated, impulsivity has not been systematically examined in clinical samples of OCD. Meanwhile, recent findings suggest that impulsivity is multi-dimensional construct that can be examined through several constructs. Therefore, this study is aimed to evaluate multiple facets of impulsivity in OCD. Method: The recruitment includes 80 OCD and 76 healthy control participants. Participants completed a test battery comprising three behavioral tasks of stop signal task (SST), delay discounting task (DDT) and balloon analog risk test (BART), and one self-report measure of the Barratt Impulsiveness scale (BIS-11). Results: OCD subjects showed significantly lower stop signal reaction time of SST reflecting higher action impulsivity and higher delay discounting parameter of DDT suggesting increased choice impulsivity but significantly lower adjusted mean pump of BART implying lower risk taking propensity of BART than healthy control. Conclusion: Increased Action and choice impulsivity, and decreased risk taking propensities were found in OCD. These findings seem to be consistent with clinical characteristics of OCD such as greater preference for or avoid risky situations (avoidance), inability to wait tension relief may provoke safety behaviors (compulsion) and inability to stop already started behaviors (repetition).	[Kim, Se Joo] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	kimsejoo@yuhs.ac		KIM, SE JOO/0000-0002-5438-8210; kang, jee in/0000-0002-2818-7183; NAMKOONG, KEE/0000-0003-1400-8057	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0022363]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by grants (to S. J. Kim) from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0022363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch A, 2012, J NEUROPSYCHOL, V6, P161, DOI 10.1111/j.1748-6653.2011.02021.x; Admon R, 2012, PSYCHIAT RES-NEUROIM, V203, P207, DOI 10.1016/j.pscychresns.2012.02.002; Albrecht B, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-22; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ashenhurst JR, 2011, EXP CLIN PSYCHOPHARM, V19, P361, DOI 10.1037/a0024412; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Barkley-Levenson EE, 2013, DEV COGN NEUROS-NETH, V3, P72, DOI 10.1016/j.dcn.2012.09.007; Benatti B, 2014, INT J PSYCHIAT CLIN, V18, P156, DOI 10.3109/13651501.2013.855792; Boisseau CL, 2012, PSYCHIAT RES, V200, P1062, DOI 10.1016/j.psychres.2012.06.010; Chamberlain SR, 2007, NEUROPSYCHOLOGIA, V45, P654, DOI 10.1016/j.neuropsychologia.2006.07.016; Chamberlain SR, 2007, AM J PSYCHIAT, V164, P335, DOI 10.1176/appi.ajp.164.2.335; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Cicolini T, 2003, BEHAV COGN PSYCHOTH, V31, P247, DOI 10.1017/S1352465803003023; Congdon E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00173; Congdon E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00037; Courtney KE, 2012, ALCOHOL CLIN EXP RES, V36, P923, DOI 10.1111/j.1530-0277.2011.01635.x; Crosbie J, 2013, J ABNORM CHILD PSYCH, V41, P497, DOI 10.1007/s10802-012-9693-9; Dalley JW, 2012, NEUROSCIENCE, V215, P42, DOI 10.1016/j.neuroscience.2012.03.065; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Ettelt S, 2007, ACTA PSYCHIAT SCAND, V115, P41, DOI 10.1111/j.1600-0447.2006.00835.x; Fernie G, 2010, DRUG ALCOHOL DEPEN, V112, P54, DOI 10.1016/j.drugalcdep.2010.05.011; Fineberg NA, 2014, CNS SPECTRUMS, V19, P69, DOI 10.1017/S1092852913000801; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; First MB, 2002, USERS GUIDE STRUCTUR; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Fontenelle LE, 2005, PSYCHIAT CLIN NEUROS, V59, P30, DOI 10.1111/j.1440-1819.2005.01328.x; Frost, 1994, BEHAVIOURAL COGNITIV, V22, P287, DOI DOI 10.1017/S1352465800013175; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Grant JE, 2006, PSYCHIAT CLIN N AM, V29, P539, DOI 10.1016/j.psc.2006.02.002; HOEHNSARIC R, 1983, BRIT J PSYCHIAT, V143, P177, DOI 10.1192/bjp.143.2.177; Hurst RM, 2011, J ATTEN DISORD, V15, P412, DOI 10.1177/1087054710365993; Hwang JY, 2012, J GAMBL STUD, V28, P351, DOI 10.1007/s10899-011-9269-6; Kim B, 2012, PHILOS T R SOC B, V367, P650, DOI 10.1098/rstb.2011.0292; 노대영, 2009, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V48, P336; 원주영, 2008, [Korean Journal of Psychology: General, 한국심리학회지:일반], V27, P217; KIRBY KN, 1995, ORGAN BEHAV HUM DEC, V64, P22, DOI 10.1006/obhd.1995.1086; Lee HS, 1992, IMPULSIVENESS TEST G; Leigh BC, 1999, ADDICTION, V94, P371, DOI 10.1046/j.1360-0443.1999.9433717.x; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Leotti LA, 2010, J EXP PSYCHOL HUMAN, V36, P430, DOI 10.1037/a0016802; Linkovski O, 2013, J BEHAV THER EXP PSY, V44, P30, DOI 10.1016/j.jbtep.2012.07.002; Matsunaga H, 2005, COMPR PSYCHIAT, V46, P43, DOI 10.1016/j.comppsych.2004.07.001; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; 최부열, 2011, Korean Journal of Clinical Psychology, V30, P845; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morein-Zamir S, 2010, PSYCHOL MED, V40, P263, DOI 10.1017/S003329170999033X; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pinto A, 2013, BIOL PSYCHIAT; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Sella F, 2013, PSYCHOL RES-PSYCH FO, V77, P204, DOI 10.1007/s00426-012-0419-y; Sjoerds Z, 2013, PSYCHOL MED, P1; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; STEIN DJ, 1995, PSYCHOPATHOLOGY, V28, P208, DOI 10.1159/000284923; STEIN DJ, 1994, J NERV MENT DIS, V182, P240, DOI 10.1097/00005053-199404000-00009; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Weiss L.G., 2006, WISC 4 ADV CLIN INTE, DOI [10.1016/B978-0-12-088763-7.X5000-1, DOI 10.1016/B978-0-12-088763-7.X5000-1]; Xu SH, 2013, SOC BEHAV PERSONAL, V41, P477, DOI 10.2224/sbp.2013.41.3.477	69	45	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111739	10.1371/journal.pone.0111739	http://dx.doi.org/10.1371/journal.pone.0111739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372136	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900071
J	van Hooft, P; Greyling, BJ; Getz, WM; van Helden, PD; Zwaan, BJ; Bastos, ADS				van Hooft, Pim; Greyling, Ben J.; Getz, Wayne M.; van Helden, Paul D.; Zwaan, Bas J.; Bastos, Armanda D. S.			Positive Selection of Deleterious Alleles through Interaction with a Sex-Ratio Suppressor Gene in African Buffalo: A Plausible New Mechanism for a High Frequency Anomaly	PLOS ONE			English	Article							HETEROZYGOSITY-FITNESS CORRELATIONS; BOVINE TUBERCULOSIS; SYNCERUS-CAFFER; SOFTWARE; DISEASE; WILD	Although generally rare, deleterious alleles can become common through genetic drift, hitchhiking or reductions in selective constraints. Here we present a possible new mechanism that explains the attainment of high frequencies of deleterious alleles in the African buffalo (Syncerus caffer) population of Kruger National Park, through positive selection of these alleles that is ultimately driven by a sex-ratio suppressor. We have previously shown that one in four Kruger buffalo has a Y-chromosome profile that, despite being associated with low body condition, appears to impart a relative reproductive advantage, and which is stably maintained through a sex-ratio suppressor. Apparently, this sex-ratio suppressor prevents fertility reduction that generally accompanies sex-ratio distortion. We hypothesize that this body-condition-associated reproductive advantage increases the fitness of alleles that negatively affect male body condition, causing genome-wide positive selection of these alleles. To investigate this we genotyped 459 buffalo using 17 autosomal microsatellites. By correlating heterozygosity with body condition (heterozygosity-fitness correlations), we found that most microsatellites were associated with one of two gene types: one with elevated frequencies of deleterious alleles that have a negative effect on body condition, irrespective of sex; the other with elevated frequencies of sexually antagonistic alleles that are negative for male body condition but positive for female body condition. Positive selection and a direct association with a Y-chromosomal sex-ratio suppressor are indicated, respectively, by allele clines and by relatively high numbers of homozygous deleterious alleles among sex-ratio suppressor carriers. This study, which employs novel statistical techniques to analyse heterozygosity-fitness correlations, is the first to demonstrate the abundance of sexually-antagonistic genes in a natural mammal population. It also has important implications for our understanding not only of the evolutionary and ecological dynamics of sex-ratio distorters and suppressors, but also of the functioning of deleterious and sexually-antagonistic alleles, and their impact on population viability.	[van Hooft, Pim] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [van Hooft, Pim; Greyling, Ben J.; Bastos, Armanda D. S.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, South Africa; [Greyling, Ben J.] Agr Res Council, Irene, South Africa; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [van Helden, Paul D.] Univ Stellenbosch, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, US MRC Ctr TB Res,Div Mol Biol & Human Genet, ZA-7505 Tygerberg, South Africa; [Zwaan, Bas J.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; University of Pretoria; Agricultural Research Council of South Africa; University of California System; University of California Berkeley; University of Kwazulu Natal; National Research Foundation - South Africa; Stellenbosch University; Wageningen University & Research	van Hooft, P (corresponding author), Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands.	pim.vanhooft@wur.nl	Bastos, Armanda/B-6357-2009; Zwaan, Bas J/D-8721-2015; Getz, Wayne/I-4521-2013	Bastos, Armanda/0000-0002-9223-4204; Zwaan, Bas J/0000-0002-8221-4998; Getz, Wayne/0000-0001-8784-9354	US NIH/NSF Ecology of Infectious Disease Grant [GM83863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	US NIH/NSF Ecology of Infectious Disease Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Laboratory analyses were supported by US NIH/NSF Ecology of Infectious Disease Grant GM83863 awarded to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Barreto H., 2006, INTRO ECONOMETRICS U; Beldomenico Pablo M, 2010, Trends Ecol Evol, V25, P21, DOI 10.1016/j.tree.2009.06.015; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charlesworth B, 2010, MIGRATION MUTATION S, P143; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; de Garine-Wichatitsky M, 2010, EMERG INFECT DIS, V16, P884, DOI 10.3201/eid1605.090710; De Vos V, 1983, POPULATION CONTROL L; Dean R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002917; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greyling BJ, 2008, AFR J BIOTECHNOL, V7, P655; Hamilton M.B., 2009, POPULATION GENETICS; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Lynch M, 1999, GENETICS, V152, P1753; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; MAY RM, 1975, AM NAT, V109, P659, DOI 10.1086/283036; Miller JM, 2014, MOL ECOL, V23, P1899, DOI 10.1111/mec.12707; Mokkonen M, 2011, SCIENCE, V334, P972, DOI 10.1126/science.1208708; Orr HA, 2001, GENETICS, V157, P875; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pennell TM, 2013, ECOL EVOL, V3, P1819, DOI 10.1002/ece3.540; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; Price TAR, 2008, GENETICA, V132, P295, DOI 10.1007/s10709-007-9173-2; Rodwell TC, 2001, J WILDLIFE DIS, V37, P258, DOI 10.7589/0090-3558-37.2.258; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; SLATKIN M, 1973, GENETICS, V75, P733; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; van Hooft P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-106; van Hooft P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001086; van Hooft WF, 2000, MOL ECOL, V9, P2017, DOI 10.1046/j.1365-294X.2000.01101.x; Visscher DR, 2004, J ZOOL, V264, P111, DOI 10.1017/S0952836904005436; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	52	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111778	10.1371/journal.pone.0111778	http://dx.doi.org/10.1371/journal.pone.0111778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372610	gold, Green Published			2022-12-27	WOS:000344556900075
J	Di Giminiani, R; Fabiani, L; Baldini, G; Cardelli, G; Giovannelli, A; Tihanyi, J				Di Giminiani, Riccardo; Fabiani, Leila; Baldini, Giuliano; Cardelli, Giovanni; Giovannelli, Aldo; Tihanyi, Jozsef			Hormonal and Neuromuscular Responses to Mechanical Vibration Applied to Upper Extremity Muscles	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; SKELETAL-MUSCLE; RESISTANCE EXERCISE; GROWTH-HORMONE; EXTERNAL LOAD; STRENGTH; TESTOSTERONE; FORCE; CONTRACTION; INCREASES	Objective: To investigate the acute residual hormonal and neuromuscular responses exhibited following a single session of mechanical vibration applied to the upper extremities among different acceleration loads. Methods: Thirty male students were randomly assigned to a high vibration group (HVG), a low vibration group (LVG), or a control group (CG). A randomized double-blind, controlled-parallel study design was employed. The measurements and interventions were performed at the Laboratory of Biomechanics of the University of L'Aquila. The HVG and LVG participants were exposed to a series of 20 trials x 10 s of synchronous whole-body vibration (WBV) with a 10-s pause between each trial and a 4-min pause after the first 10 trials. The CG participants assumed an isometric push-up position without WBV. The outcome measures were growth hormone (GH), testosterone, maximal voluntary isometric contraction during bench-press, maximal voluntary isometric contraction during handgrip, and electromyography root-mean-square (EMG(rms)) muscle activity (pectoralis major [PM], triceps brachii [TB], anterior deltoid [DE], and flexor carpi radialis [FCR]). Results: The GH increased significantly over time only in the HVG (P = 0.003). Additionally, the testosterone levels changed significantly over time in the LVG (P = 0.011) and the HVG (P = 0.001). MVC during bench press decreased significantly in the LVG (P = 0.001) and the HVG (P = 0.002). In the HVG, the EMG(rms) decreased significantly in the TB (P = 0.006) muscle. In the LVG, the EMG(rms) decreased significantly in the DE (P = 0.009) and FCR (P = 0.006) muscles. Conclusion: Synchronous WBV acutely increased GH and testosterone serum concentrations and decreased the MVC and their respective maximal EMG(rms) activities, which indicated a possible central fatigue effect. Interestingly, only the GH response was dependent on the acceleration with respect to the subjects' responsiveness.	[Di Giminiani, Riccardo; Giovannelli, Aldo] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Fabiani, Leila] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Baldini, Giuliano; Cardelli, Giovanni] Giulianova Hosp, Lab Chem Clin & Microbiol Anal, Teramo, Italy; [Tihanyi, Jozsef] Semmelweis Univ, Fac Phys Educ & Sport Sci, Dept Biomech, H-1085 Budapest, Hungary	University of L'Aquila; University of L'Aquila; Semmelweis University; University of Physical Education	Di Giminiani, R (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	riccardo.digiminiani@univaq.it	Di Giminiani, Riccardo/AAB-1207-2020	Di Giminiani, Riccardo/0000-0003-3574-3114; giovannelli, aldo/0000-0003-1863-6202; FABIANI, Leila/0000-0002-0597-1450				Ahmadizad S, 2005, J SPORT SCI, V23, P243, DOI 10.1080/02640410410001730151; Biro A, 2007, EXP BRAIN RES, V177, P157, DOI 10.1007/s00221-006-0656-7; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Bosco C, 2000, MED SCI SPORT EXER, V32, P202; Cardinale M, 2010, BRIT J SPORT MED, V44, P284, DOI 10.1136/bjsm.2007.043232; Cochrane DJ, 2011, INT J SPORTS MED, V32, P75, DOI 10.1055/s-0030-1268010; Crewther B, 2006, SPORTS MED, V36, P215, DOI 10.2165/00007256-200636030-00004; Dent JR, 2012, J SPORT SCI MED, V11, P363; Di Giminiani R, 2010, J SPORT MED PHYS FIT, V50, P139; Di Giminiani R, 2013, J ELECTROMYOGR KINES, V23, P245, DOI 10.1016/j.jelekin.2012.08.018; Di Giminiani R, 2009, J SPORT SCI, V27, P169, DOI 10.1080/02640410802495344; Di Loreto C, 2004, J ENDOCRINOL INVEST, V27, P323, DOI 10.1007/BF03351056; Erskine J, 2007, CLIN PHYSIOL FUNCT I, V27, P242, DOI 10.1111/j.1475-097X.2007.00745.x; Falvo MJ, 2009, J ELECTROMYOGR KINES, V19, pE529, DOI 10.1016/j.jelekin.2008.10.010; Freeman S, 2006, MED SCI SPORT EXER, V38, P570, DOI 10.1249/01.mss.0000189317.08635.1b; Giunta M, 2013, HORM METAB RES, V45, P611, DOI 10.1055/s-0033-1341464; Giunta M, 2012, OBESITY FACTS, V5, P567, DOI 10.1159/000342066; Gyulai G, 2013, ACTA PHYSIOL HUNG, V100, P37, DOI 10.1556/APhysiol.99.2012.005; Hamdi MM, 2010, J PHYSIOL-LONDON, V588, P511, DOI 10.1113/jphysiol.2009.182162; Hayes LD, 2010, CHRONOBIOL INT, V27, P675, DOI 10.3109/07420521003778773; Hazell TJ, 2014, J STRENGTH COND RES, V28, P53, DOI 10.1519/JSC.0b013e318296484f; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Izquierdo M, 2009, EUR J APPL PHYSIOL, V107, P397, DOI 10.1007/s00421-009-1139-x; Janmahasatian S, 2005, CLIN PHARMACOKINET, V44, P1051, DOI 10.2165/00003088-200544100-00004; Jones DA, 2010, J PHYSIOL-LONDON, V588, P2977, DOI 10.1113/jphysiol.2010.190934; Kjaer M, 1992, Exerc Sport Sci Rev, V20, P161; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Maffiuletti NA, 2013, EUR J APPL PHYSIOL, V113, P1625, DOI 10.1007/s00421-013-2590-2; Marin PJ, 2011, INT J SPORTS MED, V32, P743, DOI 10.1055/s-0031-1273740; Mazzoccoli G, 2011, J BIOL REG HOMEOS AG, V25, P231; Mitchell CJ, 2013, PLOS ONE, V9; Mottram CJ, 2006, J NEUROPHYSIOL, V95, P1185, DOI 10.1152/jn.00807.2005; Nagashima K, 1999, J APPL PHYSIOL, V86, P867, DOI 10.1152/jappl.1999.86.3.867; Neumayr G, 2002, INT J SPORTS MED, V23, P158, DOI 10.1055/s-2002-23169; Pollock RD, 2012, J APPL PHYSIOL, V112, P388, DOI 10.1152/japplphysiol.01223.2010; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Ronnestad BR, 2011, EUR J APPL PHYSIOL, V111, P2249, DOI 10.1007/s00421-011-1860-0; Schroeder ET, 2013, MED SCI SPORT EXER, V45, P2044, DOI 10.1249/MSS.0000000000000147; Shinohara M, 2005, J APPL PHYSIOL, V99, P1835, DOI 10.1152/japplphysiol.00312.2005; Tanaka NI, 2007, J APPL PHYSIOL, V103, P1688, DOI 10.1152/japplphysiol.00255.2007; Ushiyama J, 2005, J APPL PHYSIOL, V98, P1427, DOI 10.1152/japplphysiol.00613.2004; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; Wilson GJ, 1996, SPORTS MED, V22, P19, DOI 10.2165/00007256-199622010-00003; Wirth B, 2011, J ELECTROMYOGR KINES, V21, P450, DOI 10.1016/j.jelekin.2010.12.007; Youdas JW, 2010, J STRENGTH COND RES, V24, P3352, DOI 10.1519/JSC.0b013e3181cc23b0	46	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111521	10.1371/journal.pone.0111521	http://dx.doi.org/10.1371/journal.pone.0111521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368995	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000066
J	Romero-Saavedra, F; Laverde, D; Wobser, D; Michaux, C; Budin-Verneuil, A; Bernay, B; Benachour, A; Hartke, A; Huebner, J				Romero-Saavedra, Felipe; Laverde, Diana; Wobser, Dominique; Michaux, Charlotte; Budin-Verneuil, Aurelie; Bernay, Benoit; Benachour, Abdellah; Hartke, Axel; Huebner, Johannes			Identification of Peptidoglycan-Associated Proteins as Vaccine Candidates for Enterococcal Infections	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; PREDICTING SUBCELLULAR-LOCALIZATION; PENICILLIN-BINDING PROTEINS; GROUP-A STREPTOCOCCUS; CELL-WALL ENVELOPE; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; RESISTANT ENTEROCOCCI; FAECIUM; FAECALIS	Infections by opportunistic bacteria have significant contributions to morbidity and mortality of hospitalized patients and also lead to high expenses in healthcare. In this setting, one of the major clinical problems is caused by Gram-positive bacteria such as enterococci and staphylococci. In this study we extract, purify, identify and characterize immunogenic surface-exposed proteins present in the vancomycin resistant enterococci (VRE) strain Enterococcus faecium E155 using three different extraction methods: trypsin shaving, biotinylation and elution at high pH. Proteomic profiling was carried out by gel-free and gel-nanoLC-MS/MS analyses. The total proteins found with each method were 390 by the trypsin shaving, 329 by the elution at high pH, and 45 using biotinylation. An exclusively extracytoplasmic localization was predicted in 39 (10%) by trypsin shaving, in 47 (15%) by elution at high pH, and 27 (63%) by biotinylation. Comparison between the three extraction methods by Venn diagram and subcellular localization predictors (CELLO v.2.5 and Gpos-mPLoc) allowed us to identify six proteins that are most likely surface-exposed: the SCP-like extracellular protein, a low affinity penicillin-binding protein 5 (PBP5), a basic membrane lipoprotein, a peptidoglycan-binding protein LysM (LysM), a D-alanyl-D-alanine carboxypeptidase (DdcP) and the peptidyl-prolyl cis-trans isomerase (PpiC). Due to their close relationship with the peptidoglycan, we chose PBP5, LysM, DdcP and PpiC to test their potential as vaccine candidates. These putative surface-exposed proteins were overexpressed in Escherichia coli and purified. Rabbit polyclonal antibodies raised against the purified proteins were able to induce specific opsonic antibodies that mediated killing of the homologous strain E. faecium E155 as well as clinical strains E. faecium E1162, Enterococcus faecalis 12030, type 2 and type 5. Passive immunization with rabbit antibodies raised against these proteins reduced significantly the colony counts of E. faecium E155 in mice, indicating the effectiveness of these surface-related proteins as promising vaccine candidates to target different enterococcal pathogens.	[Romero-Saavedra, Felipe; Laverde, Diana; Wobser, Dominique; Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany; [Romero-Saavedra, Felipe; Laverde, Diana; Michaux, Charlotte; Budin-Verneuil, Aurelie; Benachour, Abdellah; Hartke, Axel] Univ Caen Lower Normandy, EA4655 U2RM Stress Virulence, Caen, France; [Huebner, Johannes] Univ Munich, Dr Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany; [Bernay, Benoit] Univ Caen Lower Normandy, Proteogen Platform SFR ICORE 4206, Caen, France; [Huebner, Johannes] German Ctr Infect Res DZIF, Munich, Germany	University of Freiburg; Universite de Caen Normandie; University of Munich; Universite de Caen Normandie; German Center for Infection Research	Huebner, J (corresponding author), Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany.	johannes.huebner@med.uni-muenchen.de		Michaux, Charlotte/0000-0003-1089-7846; Huebner, Johannes/0000-0003-1232-4646; BUDIN-VERNEUIL, Aurelie/0000-0002-1173-251X				Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Assaad U, 2012, CLIN INTERV AGING, V7, P453, DOI 10.2147/CIA.S29675; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Burnie J, 2002, FEMS IMMUNOL MED MIC, V33, P179, DOI 10.1111/j.1574-695X.2002.tb00589.x; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; GILLIS TP, 1985, INFECT IMMUN, V49, P371, DOI 10.1128/IAI.49.2.371-377.1985; Giombini E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-39; Hempel K, 2011, J PROTEOME RES, V10, P1657, DOI 10.1021/pr1009838; Hempel K, 2010, J PROTEOME RES, V9, P1579, DOI 10.1021/pr901143a; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2003, INT J FOOD MICROBIOL, V88, P263, DOI 10.1016/S0168-1605(03)00189-2; Hyyrylainen HL, 2010, MOL MICROBIOL, V77, P108, DOI 10.1111/j.1365-2958.2010.07188.x; Janulczyk R, 2001, INFECT IMMUN, V69, P4019, DOI 10.1128/IAI.69.6.4019-4026.2001; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kropec A, 2011, MICROBIOL-SGM, V157, P3429, DOI 10.1099/mic.0.053207-0; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; McCormick JK, 2001, INFECT IMMUN, V69, P3305, DOI 10.1128/IAI.69.5.3305-3314.2001; Modun B, 1999, INFECT IMMUN, V67, P1086, DOI 10.1128/IAI.67.3.1086-1092.1999; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Morsczeck C, 2008, CLIN MICROBIOL INFEC, V14, P74, DOI 10.1111/j.1469-0691.2007.01878.x; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Olaya-Abril A, 2014, J PROTEOMICS, V97, P164, DOI 10.1016/j.jprot.2013.03.035; Olaya-Abril A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070365; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Reffuveille F, 2012, INFECT IMMUN, V80, P1728, DOI 10.1128/IAI.06251-11; Reffuveille F, 2012, MICROBIOL-SGM, V158, P816, DOI 10.1099/mic.0.055319-0; Repp C, 2012, ENTEROCOCCUS SAFETY, P305; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sava IG, 2010, J MED MICROBIOL, V59, P1001, DOI 10.1099/jmm.0.020578-0; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P39, DOI 10.1093/protein/gzl053; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Tjalsma H, 2008, PROTEOMICS, V8, P1415, DOI 10.1002/pmic.200700550; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Top J, 2008, J CLIN MICROBIOL, V46, P214, DOI 10.1128/JCM.01351-07; Treitman AN, 2005, J CLIN MICROBIOL, V43, P462, DOI 10.1128/JCM.43.1.462-463.2005; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P454, DOI 10.1093/jac/40.3.454; Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G; Werner G., 2008, EURO SURVEILL, V13, P19046; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zarb P, 2012, EURO SURVEILL, P17; Zervosen A, 2012, MOLECULES, V17, P12478, DOI 10.3390/molecules171112478; Zhang XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002804; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173; Zysk G, 2000, INFECT IMMUN, V68, P3740, DOI 10.1128/IAI.68.6.3740-3743.2000	73	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111880	10.1371/journal.pone.0111880	http://dx.doi.org/10.1371/journal.pone.0111880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369230	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000118
J	Rudra-Ganguly, N; Lowe, C; Mattie, M; Chang, MS; Satpayev, D; Verlinsky, A; An, ZL; Hu, LP; Yang, P; Challita-Eid, P; Stover, DR; Pereira, DS				Rudra-Ganguly, Nandini; Lowe, Christine; Mattie, Michael; Chang, Mi Sook; Satpayev, Daulet; Verlinsky, Alla; An, Zili; Hu, Liping; Yang, Peng; Challita-Eid, Pia; Stover, David R.; Pereira, Daniel S.			Discoidin Domain Receptor 1 Contributes to Tumorigenesis through Modulation of TGFBI Expression	PLOS ONE			English	Article							COLLAGEN TYPE-I; TYROSINE KINASE; CELL INVASION; BREAST-CANCER; LUNG-CANCER; DDR1; ACTIVATION; INTEGRIN; PATHWAY; BINDING	Discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family. The receptor is activated upon binding to its ligand, collagen, and plays a crucial role in many fundamental processes such as cell differentiation, adhesion, migration and invasion. Although DDR1 is expressed in many normal tissues, upregulated expression of DDR1 in a variety of human cancers such as lung, colon and brain cancers is known to be associated with poor prognosis. Using shRNA silencing, we assessed the oncogenic potential of DDR1. DDR1 knockdown impaired tumor cell proliferation and migration in vitro and tumor growth in vivo. Microarray analysis of tumor cells demonstrated upregulation of TGFBI expression upon DDR1 knockdown, which was subsequently confirmed at the protein level. TGFBI is a TGF beta-induced extracellular matrix protein secreted by the tumor cells and is known to act either as a tumor promoter or tumor suppressor, depending on the tumor environment. Here, we show that exogenous addition of recombinant TGFBI to BXPC3 tumor cells inhibited clonogenic growth and migration, thus recapitulating the phenotypic effect observed from DDR1 silencing. BXPC3 tumor xenografts demonstrated reduced growth with DDR1 knockdown, and the same xenograft tumors exhibited an increase in TGFBI expression level. Together, these data suggest that DDR1 expression level influences tumor growth in part via modulation of TGFBI expression. The reciprocal expression of DDR1 and TGFBI may help to elucidate the contribution of DDR1 in tumorigenesis and TGFBI may also be used as a biomarker for the therapeutic development of DDR1 specific inhibitors.	[Rudra-Ganguly, Nandini; Lowe, Christine; Mattie, Michael; Chang, Mi Sook; Verlinsky, Alla; An, Zili; Hu, Liping; Yang, Peng; Challita-Eid, Pia; Stover, David R.; Pereira, Daniel S.] Astellas Pharma Inc, Agensys Inc, Santa Monica, CA 90404 USA; [Satpayev, Daulet] ImaginAb Inc, Inglewood, CA USA	Astellas Pharmaceuticals	Rudra-Ganguly, N (corresponding author), Astellas Pharma Inc, Agensys Inc, Santa Monica, CA 90404 USA.	nganguly@agensys.com			Astellas	Astellas(Astellas Pharmaceuticals)	All authors are employees of Agensys, an affiliate of Astellas Pharma, Inc. Therefore, all of the funding and sources of support have been provided by Astellas including our decision to publish these studies. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Abdulhussein R, 2008, J BIOL CHEM, V283, P12026, DOI 10.1074/jbc.M704592200; Agarwal G, 2007, J MOL BIOL, V367, P443, DOI 10.1016/j.jmb.2006.12.073; Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Borzi RM, 2010, ARTHRITIS RHEUM-US, V62, P2370, DOI 10.1002/art.27512; Cader FZ, 2013, BLOOD, V122, P4237, DOI 10.1182/blood-2013-04-499004; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Castro-Sanchez L, 2011, CLIN EXP METASTAS, V28, P463, DOI 10.1007/s10585-011-9385-9; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Hu YC, 2001, CLIN CANCER RES, V7, P3519; Irigoyen M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-130; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Miao LY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0626-4; Ram R, 2006, J NEURO-ONCOL, V76, P239, DOI 10.1007/s11060-005-6874-1; Rilla K, 2002, J CELL SCI, V115, P3633, DOI 10.1242/jcs.00042; Rinehart-Kim J, 2000, INT J CANCER, V88, P180, DOI 10.1002/1097-0215(20001015)88:2<180::AID-IJC6>3.0.CO;2-H; Ruiz PA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-3; Shelton L, 2009, INVEST OPHTH VIS SCI, V50, P3542, DOI 10.1167/iovs.09-3460; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Slack BE, 2006, J CELL BIOCHEM, V98, P672, DOI 10.1002/jcb.20812; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wen GY, 2011, INT J ONCOL, V39, P1001, DOI 10.3892/ijo.2011.1097; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Yeh YC, 2011, MOL BIOL CELL, V22, P940, DOI 10.1091/mbc.E10-08-0678; Yeung D, 2013, J STRUCT BIOL, V183, P495, DOI 10.1016/j.jsb.2013.06.010; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	38	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111515	10.1371/journal.pone.0111515	http://dx.doi.org/10.1371/journal.pone.0111515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369402	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000064
J	Stewart, EH; Davis, B; Clemans-Taylor, BL; Littenberg, B; Estrada, CA; Centor, RM				Stewart, Emily H.; Davis, Brian; Clemans-Taylor, B. Lee; Littenberg, Benjamin; Estrada, Carlos A.; Centor, Robert M.			Rapid Antigen Group A Streptococcus Test to Diagnose Pharyngitis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							THROAT CULTURE; TEST ACCURACY; SENSITIVITY; MANAGEMENT; EMERGENCY; PERFORMANCE; PYOGENES; IMPACT; VALIDATION; SPECTRUM	Background: Pharyngitis management guidelines include estimates of the test characteristics of rapid antigen streptococcus tests (RAST) using a non-systematic approach. Objective: To examine the sensitivity and specificity, and sources of variability, of RAST for diagnosing group A streptococcal (GAS) pharyngitis. Data Sources: MEDLINE, Cochrane Reviews, Centre for Reviews and Dissemination, Scopus, SciELO, CINAHL, guidelines, 2000-2012. Study Selection: Culture as reference standard, all languages. Data Extraction and Synthesis: Study characteristics, quality. Main Outcome(s) and Measure(s): Sensitivity, specificity. Results: We included 59 studies encompassing 55,766 patients. Forty three studies (18,464 patients) fulfilled the higher quality definition (at least 50 patients, prospective data collection, and no significant biases) and 16 (35,634 patients) did not. For the higher quality immunochromatographic methods in children (10,325 patients), heterogeneity was high for sensitivity (inconsistency [I-2] 88%) and specificity (I-2 86%). For enzyme immunoassay in children (342 patients), the pooled sensitivity was 86% (95% CI, 79-92%) and the pooled specificity was 92% (95% CI, 88-95%). For the higher quality immunochromatographic methods in the adult population (1,216 patients), the pooled sensitivity was 91% (95% CI, 87 to 94%) and the pooled specificity was 93% (95% CI, 92 to 95%); however, heterogeneity was modest for sensitivity (I-2 61%) and specificity (I-2 72%). For enzyme immunoassay in the adult population (333 patients), the pooled sensitivity was 86% (95% CI, 81-91%) and the pooled specificity was 97% (95% CI, 96 to 99%); however, heterogeneity was high for sensitivity and specificity (both, I-2 88%). Conclusions: RAST immunochromatographic methods appear to be very sensitive and highly specific to diagnose group A streptococcal pharyngitis among adults but not in children. We could not identify sources of variability among higher quality studies. The present systematic review provides the best evidence for the wide range of sensitivity included in current guidelines.	[Stewart, Emily H.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Davis, Brian] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Clemans-Taylor, B. Lee; Centor, Robert M.] Univ Alabama, Huntsville, AL 35899 USA; [Littenberg, Benjamin] Univ Vermont, Burlington, VT USA; [Estrada, Carlos A.] Univ Alabama Birmingham, Birmingham, AL 35233 USA; [Estrada, Carlos A.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Estrada, Carlos A.] Vet Affairs Qual Scholar Program, Birmingham, AL USA	Walter Reed National Military Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Huntsville; University of Vermont; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Estrada, CA (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35233 USA.	cestrada@uab.edu		Littenberg, Benjamin/0000-0002-7647-1808	Justin Rogers Foundation	Justin Rogers Foundation	RMC received funding from Justin Rogers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Sabaah AH, 2006, BRIT J BIOMED SCI, V63, P155, DOI 10.1080/09674845.2006.11732740; Al-Najjar FYA, 2008, INT J INFECT DIS, V12, P308, DOI 10.1016/j.ijid.2007.07.006; Andersen Jesper Brandt, 2003, Ugeskr Laeger, V165, P2291; Araujo Filho Bernardo Cunha, 2005, Rev. Bras. Otorrinolaringol., V71, P168, DOI 10.1590/S0034-72992005000200009; Armengol CE, 2004, PEDIATRICS, V113, P924, DOI 10.1542/peds.113.4.924; Atlas SJ, 2005, J GEN INTERN MED, V20, P759, DOI 10.1111/j.1525-1497.2005.0143.x; Ayanruoh S, 2009, PEDIATR EMERG CARE, V25, P748, DOI 10.1097/PEC.0b013e3181bec88c; Bischoff Angelika, 2007, MMW Fortschr Med, V149, P17; Bossuyt P., 2013, COCHRANE HDB SYSTEMA, P3; Buchbinder N, 2007, ARCH PEDIATRIE, V14, P1057, DOI 10.1016/j.arcped.2007.06.027; Camurdan AD, 2008, INT J PEDIATR OTORHI, V72, P1203, DOI 10.1016/j.ijporl.2008.04.008; Centers for Disease Control and Prevention, 2010, NAT AMB MED CAR SURV; Chapin KC, 2002, J CLIN MICROBIOL, V40, P4207, DOI 10.1128/JCM.40.11.4207-4210.2002; Chiadmi F, 2004, ANN BIOL CLIN-PARIS, V62, P573; Cohen JF, 2013, EUR J CLIN MICROBIOL, V32, P787, DOI 10.1007/s10096-012-1809-1; Cohen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039085; Cohen R, 2004, EUR J PEDIATR, V163, P281, DOI 10.1007/s00431-004-1416-y; Contessotto Spadetto C, 2000, An Esp Pediatr, V52, P212; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DiMatteo LA, 2001, ANN EMERG MED, V38, P648, DOI 10.1067/mem.2001.119850; dos Santos Ana Gabriela P, 2005, J Pediatr (Rio J), V81, P23, DOI 10.2223/JPED.1278; Dwamena B., 2007, MIDAS STATA MODULE M; Edmonson MB, 2005, PEDIATRICS, V115, P280, DOI 10.1542/peds.2004-0907; Enright K, 2011, PEDIATR EMERG CARE, V27, P1148, DOI 10.1097/PEC.0b013e31823aff44; Ezike EN, 2005, ARCH PEDIAT ADOL MED, V159, P486, DOI 10.1001/archpedi.159.5.486; Faverge B, 2004, ARCH PEDIATRIE, V11, P862, DOI 10.1016/j.arcped.2004.02.024; Mateo GF, 2010, ATEN PRIM, V42, P356, DOI 10.1016/j.aprim.2010.01.011; Fontes MJF, 2007, J PEDIAT-BRAZIL, V83, P465, DOI [10.1590/S0021-75572007000600012, 10.2223/JPED.1695]; Forward Kevin R, 2006, Can J Infect Dis Med Microbiol, V17, P221; Fourati S, 2009, Bull Soc Pathol Exot, V102, P175; Fox JW, 2006, J CLIN MICROBIOL, V44, P3918, DOI 10.1128/JCM.01399-06; Fox JW, 2006, J CLIN MICROBIOL, V44, P2593, DOI 10.1128/JCM.00797-06; Gerber MA, 2004, CLIN MICROBIOL REV, V17, P571, DOI 10.1128/CMR.17.3.571-580.2004; Gieseker KE, 2003, PEDIATRICS, V111, pE666, DOI 10.1542/peds.111.6.e666; Gieseker KE, 2002, PEDIATR INFECT DIS J, V21, P922, DOI 10.1097/00006454-200210000-00007; Gurol Y, 2010, INT J PEDIATR OTORHI, V74, P591, DOI 10.1016/j.ijporl.2010.02.020; Hall MC, 2004, PEDIATRICS, V114, P182, DOI 10.1542/peds.114.1.182; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; HILLNER BE, 1987, J GEN INTERN MED, V2, P244, DOI 10.1007/BF02596449; Hinfey P, 2010, ANN EMERG MED, V56, pS132, DOI 10.1016/j.annemergmed.2010.06.532; Humair JP, 2006, ARCH INTERN MED, V166, P640, DOI 10.1001/archinte.166.6.640; Johansson L, 2003, FAM PRACT, V20, P108, DOI 10.1093/fampra/20.2.108; Kawakami Sayoko, 2003, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V14, P9; Keahey L, 2002, AM J EMERG MED, V20, P128, DOI 10.1053/ajem.2002.31141; Kim S, 2009, KOREAN J LAB MED, V29, P320, DOI 10.3343/kjlm.2009.29.4.320; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lindbaek M, 2004, SCAND J PRIM HEALTH, V22, P233, DOI 10.1080/02813430410006675; Llor C, 2009, INT J CLIN PRACT, V63, P1340, DOI 10.1111/j.1742-1241.2009.02048.x; Llor C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572436; Llor C, 2008, ATEN PRIM, V40, P489, DOI 10.1157/13127228; Maalej SM, 2010, MED MALADIES INFECT, V40, P226, DOI [10.1016/j.medma1.2009.10.016, 10.1016/j.medmal.2009.10.016]; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; Maltezou HC, 2008, J ANTIMICROB CHEMOTH, V62, P1407, DOI 10.1093/jac/dkn376; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; Mayes T, 2001, CLIN PEDIATR, V40, P191, DOI 10.1177/000992280104000402; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; Mirza A, 2007, CLIN PEDIATR, V46, P241, DOI 10.1177/0009922806290219; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nerbrand C, 2002, SCAND J INFECT DIS, V34, P797, DOI 10.1080/0036554021000026953; Neuner JM, 2003, ANN INTERN MED, V139, P113, DOI 10.7326/0003-4819-139-2-200307150-00011; Parviainen M, 2011, EUR INFECT DIS, V5, P143; Patel T, 2014, J INVEST MED, V62, P584; De Lorenzo GR, 2012, AN PEDIATR, V77, P193, DOI 10.1016/j.anpedi.2012.01.012; Rimoin AW, 2010, INT J INFECT DIS, V14, pE1048, DOI 10.1016/j.ijid.2010.02.2269; Rogo T, 2011, CLIN PEDIATR, V50, P294, DOI 10.1177/0009922810385675; Roosevelt GE, 2001, ANN EMERG MED, V37, P377, DOI 10.1067/mem.2001.114090; Rosenberg Paul, 2002, CJEM, V4, P178; Ruiz-Aragon J, 2010, AN PEDIATR, V72, P391, DOI 10.1016/j.anpedi.2009.12.012; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Santos Odimara, 2003, Braz J Infect Dis, V7, P297, DOI 10.1590/S1413-86702003000500003; Sarikaya S, 2010, ENT-EAR NOSE THROAT, V89, P180, DOI 10.1177/014556131008900410; Schmuziger N, 2003, HNO, V51, P806, DOI 10.1007/s00106-003-0816-z; Shaheen BH, 2006, QATAR MED J, V15, P37; Sheeler Robert D, 2002, J Am Board Fam Pract, V15, P261; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Tanz RR, 2009, PEDIATRICS, V123, P437, DOI 10.1542/peds.2008-0488; Toepfner N, 2013, EUR J CLIN MICROBIOL, V32, P609, DOI 10.1007/s10096-012-1783-7; Uhl JR, 2003, J CLIN MICROBIOL, V41, P242, DOI 10.1128/JCM.41.1.242-249.2003; Van Limbergen J, 2006, EMERG MED J, V23, P32, DOI 10.1136/emj.2004.022970; Wessels MR, 2011, NEW ENGL J MED, V364, P648, DOI 10.1056/NEJMcp1009126; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Wong M. C. K., 2002, Hong Kong Medical Journal, V8, P92	82	65	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111727	10.1371/journal.pone.0111727	http://dx.doi.org/10.1371/journal.pone.0111727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369170	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000094
J	Hui, FR; Nguyen, CTO; Bedggood, PA; He, Z; Fish, RL; Gurrell, R; Vingrys, AJ; Bui, BV				Hui, Flora; Nguyen, Christine T. O.; Bedggood, Phillip A.; He, Zheng; Fish, Rebecca L.; Gurrell, Rachel; Vingrys, Algis J.; Bui, Bang V.			Quantitative Spatial and Temporal Analysis of Fluorescein Angiography Dynamics in the Eye	PLOS ONE			English	Article							RETINAL BLOOD-FLOW; VEIN OCCLUSION; OCULAR FUNDUS; CIRCULATION; DISEASE; MICROANEURYSMS; QUANTIFICATION; PRESSURE; GLAUCOMA; RATS	Purpose: We describe a novel approach to analyze fluorescein angiography to investigate fluorescein flow dynamics in the rat posterior retina as well as identify abnormal areas following laser photocoagulation. Methods: Experiments were undertaken in adult Long Evans rats. Using a rodent retinal camera, videos were acquired at 30 frames per second for 30 seconds following intravenous introduction of sodium fluorescein in a group of control animals (n = 14). Videos were image registered and analyzed using principle components analysis across all pixels in the field. This returns fluorescence intensity profiles from which, the half-rise (time to 50% brightness), half-fall (time for 50% decay) back to an offset (plateau level of fluorescence). We applied this analysis to video fluorescein angiography data collected 30 minutes following laser photocoagulation in a separate group of rats (n = 7). Results: Pixel-by-pixel analysis of video angiography clearly delineates differences in the temporal profiles of arteries, veins and capillaries in the posterior retina. We find no difference in half-rise, half-fall or offset amongst the four quadrants (inferior, nasal, superior, temporal). We also found little difference with eccentricity. By expressing the parameters at each pixel as a function of the number of standard deviation from the average of the entire field, we could clearly identify the spatial extent of the laser injury. Conclusions: This simple registration and analysis provides a way to monitor the size of vascular injury, to highlight areas of subtle vascular leakage and to quantify vascular dynamics not possible using current fluorescein angiography approaches. This can be applied in both laboratory and clinical settings for in vivo dynamic fluorescent imaging of vasculature.	[Hui, Flora; Nguyen, Christine T. O.; Bedggood, Phillip A.; He, Zheng; Vingrys, Algis J.; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Fish, Rebecca L.; Gurrell, Rachel] Pfizer Res & Dev, Neusentis, Cambridge, England	University of Melbourne; Pfizer	Bui, BV (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	bvb@unimelb.edu.au	Hui, Flora/Z-5420-2019; Bui, Bang/AAD-2679-2021	Hui, Flora/0000-0003-2218-9951; Bui, Bang/0000-0001-7298-1352; Bedggood, Phillip/0000-0001-5144-3694; Nguyen, Christine/0000-0002-3298-3086; Vingrys, Algis/0000-0001-5920-4604; He, Zheng/0000-0001-6496-3971	Australia Research Council [LP100200129, FT130100388]	Australia Research Council(Australian Research Council)	RLF and RG are employees of Pfizer Neusentis and Pfizer Global Research and Development. CTN, PAB, AJV and BVB are employees of University of Melbourne, supported by Australia Research Council Linkage Project Grant (LP100200129). FH received an Australian postgraduate award. BVB received an Australia Research Council Future Fellowship (FT130100388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abelsdorff G, 1909, VOGEL ARCH AUGENHEIL, V64, P65; Arend O, 2004, BRAIN RES BULL, V62, P517, DOI 10.1016/j.brainresbull.2003.07.008; Arend O, 2002, BRIT J OPHTHALMOL, V86, P429, DOI 10.1136/bjo.86.4.429; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; Clermont AC, 2007, MICROCIRCULATION, V14, P49, DOI 10.1080/10739680601072164; Comander J, 2011, SEMIN OPHTHALMOL, V26, P329, DOI 10.3109/08820538.2011.588661; DAVID NJ, 1967, ARCH OPHTHALMOL-CHIC, V77, P619; FFYTCHE TJ, 1980, J ROY SOC MED, V73, P362, DOI 10.1177/014107688007300512; Guthrie MJ, 2014, MICROVASC RES, V91, P1, DOI 10.1016/j.mvr.2013.11.005; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; HICKAM JB, 1966, CIRCULATION, V33, P302, DOI 10.1161/01.CIR.33.2.302; HILL DW, 1970, BRIT MED BULL, V26, P161, DOI 10.1093/oxfordjournals.bmb.a070769; Hipwell JH, 1998, PHYSIOL MEAS, V19, P165, DOI 10.1088/0967-3334/19/2/004; Hong BK, 2013, CAN J OPHTHALMOL, V48, P489, DOI 10.1016/j.jcjo.2013.05.009; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Ieki Y, 2002, CURR EYE RES, V25, P317, DOI 10.1076/ceyr.25.5.317.13490; KOHNER EM, 1970, BRIT MED BULL, V26, P166, DOI 10.1093/oxfordjournals.bmb.a070770; Kong Mingui, 2012, Korean J Ophthalmol, V26, P428, DOI 10.3341/kjo.2012.26.6.428; Kowalczuk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017462; KOYAMA T, 1990, GRAEF ARCH CLIN EXP, V228, P442, DOI 10.1007/BF00927258; Lee J, 2014, INVEST OPHTH VIS SCI, V55, P2191, DOI 10.1167/iovs.14-13897; Leskova W, 2013, INVEST OPHTH VIS SCI, V54, P2992, DOI 10.1167/iovs.13-11915; Lim JKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098393; Nagai N, 2014, INVEST OPHTHALMOL VI; NH&MRC, 2013, AUSTR COD CAR US AN; Nichols JJ, 2012, INVEST OPHTH VIS SCI, V53, P5426, DOI 10.1167/iovs.12-10033; Patel M, 2014, CURR OPIN OPHTHALMOL, V25, P213, DOI 10.1097/ICU.0000000000000042; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Prager O, 2010, NEUROIMAGE, V49, P337, DOI 10.1016/j.neuroimage.2009.08.009; Richard G., 1990, FLUORESCEIN ANGIOGRA; SCOTT D J, 1963, Br J Ophthalmol, V47, P588, DOI 10.1136/bjo.47.10.588; Spencer T, 1996, COMPUT BIOMED RES, V29, P284, DOI 10.1006/cbmr.1996.0021; SPENCER T, 1992, GRAEF ARCH CLIN EXP, V230, P36, DOI 10.1007/BF00166760; Sun C, 2013, EXP EYE RES, V113, P105, DOI 10.1016/j.exer.2013.05.018; Canas RV, 2012, P I MECH ENG C-J MEC, V226, P2521, DOI 10.1177/0954406211435195; VIDT DG, 1959, CIRC RES, V7, P759, DOI 10.1161/01.RES.7.5.759; WOLF S, 1989, GRAEF ARCH CLIN EXP, V227, P145, DOI 10.1007/BF02169788; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	39	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111330	10.1371/journal.pone.0111330	http://dx.doi.org/10.1371/journal.pone.0111330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365578	Green Published, gold			2022-12-27	WOS:000345558100061
J	Li, E; Li, J; Song, Y; Xue, M; Zhou, CW				Li, Erni; Li, Jing; Song, Ying; Xue, Mei; Zhou, Chunwu			A Comparative Study of the Diagnostic Value of Contrast-Enhanced Breast MR Imaging and Mammography on Patients with BI-RADS 3-5 Microcalcifications	PLOS ONE			English	Article							CARCINOMA IN-SITU; CALCIFICATIONS	Objective: To retrospectively investigate the diagnostic value of breast MRI in patients with BI-RADS 3-5 microcalcifications in mammography. Methods: Eighty-four patients with BI-RADS 3-5 microcalcifications on mammography underwent breast MR exams before surgical biopsy with a hookwire position under mammographic guidance. Two radiologists reviewed each lesion with BIRADS by consensus. The diagnostic value of mammography and MRI was compared. Results: Histopathological examination revealed 49 benign lesions and 42 malignant lesions. In the assessments of mammography, 21 lesions (23.1%) were assigned to category 3, 51 lesions (56.0%) to category 4, and 19 lesions (20.9%) to category 5. The area under the receiver operating characteristic(ROC) curve for mammography and MR assessment was 0.844, and 0.945, respectively (p<0.05). In cases of category 3 microcalcifications, the specificity of mammography and MR was 100%, and 95.2% (p = 1.000), respectively. In cases of category 4 microcalcifications, the specificity, PPV and accuracy of mammography was 0%, 45.1% and 45.1%; whereas those for MR was 82.1% (p<0.05), 80.8% (P = 0.003) and 86.3% (p<0.05). All microcalcifications of category 5 were correctly diagnosed by mammography and MR. Conclusions: Breast MRI has the potential to significantly improve the diagnosis of category 4 microcalcifications on mammography. Among mammographic category 4 microcalcifications, about 82% of benign lesions can be degraded to BIRADS 1,3 by MRI. However for microcalcifications of category 3 and 5, MR exams do not show significant improvement over mammography.	[Li, Erni; Li, Jing; Song, Ying; Xue, Mei; Zhou, Chunwu] Chinese Acad Med Sci, Dept Diagnost Radiol, Canc Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhou, CW (corresponding author), Chinese Acad Med Sci, Dept Diagnost Radiol, Canc Hosp, Beijing 100730, Peoples R China.	cjr.zhouchunwu@vip.163.com						Akita A, 2009, EUR RADIOL, V19, P2089, DOI 10.1007/s00330-009-1396-4; BASSETT LW, 1992, RADIOL CLIN N AM, V30, P93; Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Cilotti A, 2007, RADIOL MED, V112, P272, DOI 10.1007/s11547-007-0141-9; Dorrius M D, 2010, Cancer Imaging, V10 Spec no A, pS54, DOI 10.1102/1470-7330.2010.9020; Fiaschetti Valeria, 2011, ISRN Oncol, V2011, P643890, DOI 10.5402/2011/643890; HEYWANGKOBRUNNER SH, 1994, INVEST RADIOL, V29, P94, DOI 10.1097/00004424-199401000-00019; Houserkova D, 2008, BIOMED PAP, V152, P107, DOI 10.5507/bp.2008.017; Jiang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099669; Kuhl CK, 2007, LANCET, V370, P485, DOI 10.1016/S0140-6736(07)61232-X; Kuhl CK, 2006, RADIOLOGY, V239, P666, DOI 10.1148/radiol.2392050509; Kuzmiak CM, 2006, ACAD RADIOL, V13, P621, DOI 10.1016/j.acra.2006.01.042; Linda A, 2013, RADIOL MED IN PRESS; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Rominger M, 2012, ROFO-FORTSCHR RONTG, V184, P1144, DOI 10.1055/s-0032-1313102; Santamaria G, 2013, BREAST J, V19, P402, DOI 10.1111/tbj.12135; Stehouwer BL, 2014, EUR RADIOL, V24, P603, DOI 10.1007/s00330-013-3029-1; STOMPER PC, 1994, AM J ROENTGENOL, V162, P585, DOI 10.2214/ajr.162.3.8109501; STOMPER PC, 1989, RADIOLOGY, V172, P235, DOI 10.1148/radiology.172.1.2544922; Uematsu T, 2007, BREAST CANCER RES TR, V103, P269, DOI 10.1007/s10549-006-9373-y; Uematsu T, 2012, AM J ROENTGENOL, V198, pW611, DOI 10.2214/AJR.11.7463; Westerhof JP, 1998, RADIOLOGY, V207, P675, DOI 10.1148/radiology.207.3.9609890; Yamada T, 2010, RADIOGRAPHICS, V30, P1183, DOI 10.1148/rg.305095073; Zhu J, 2007, J MAGN RESON IMAGING, V25, P96, DOI 10.1002/jmri.20809	24	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111217	10.1371/journal.pone.0111217	http://dx.doi.org/10.1371/journal.pone.0111217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365327	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100056
J	Venkata, C; Forster, MJ; Howe, PWA; Steinbeck, C				Venkata, Chandrasekhar; Forster, Mark J.; Howe, Peter W. A.; Steinbeck, Christoph			The Potential Utility of Predicted One Bond Carbon-Proton Coupling Constants in the Structure Elucidation of Small Organic Molecules by NMR Spectroscopy	PLOS ONE			English	Article								NMR spectroscopy is the most popular technique used for structure elucidation of small organic molecules in solution, but incorrect structures are regularly reported. One-bond proton-carbon J-couplings provide additional information about chemical structure because they are determined by different features of molecular structure than are proton and carbon chemical shifts. However, these couplings are not routinely used to validate proposed structures because few software tools exist to predict them. This study assesses the accuracy of Density Functional Theory for predicting them using 396 published experimental observations from a diverse range of small organic molecules. With the B3LYP functional and the TZVP basis set, Density Functional Theory calculations using the open-source software package NWChem can predict one-bond CH J-couplings with good accuracy for most classes of small organic molecule. The root-mean-square deviation after correction is 1.5 Hz for most sp(3) CH pairs and 1.9 Hz for sp(2) pairs; larger errors are observed for sp(3) pairs with multiple electronegative substituents and for sp pairs. These results suggest that prediction of one-bond CH J-couplings by Density Functional Theory is sufficiently accurate for structure validation. This will be of particular use in strained ring systems and heterocycles which have characteristic couplings and which pose challenges for structure elucidation.	[Venkata, Chandrasekhar; Steinbeck, Christoph] European Bioinformat Inst, Cambridge, England; [Forster, Mark J.] Syngenta, Jealotts Hill Res Ctr, Chem Res, Bracknell, Berks, England; [Howe, Peter W. A.] Syngenta, Jealotts Hill Res Ctr, Prod Safety, Bracknell, Berks, England	European Molecular Biology Laboratory (EMBL); Syngenta; Syngenta	Howe, PWA (corresponding author), Syngenta, Jealotts Hill Res Ctr, Prod Safety, Bracknell, Berks, England.	peter.howe@syngenta.com		Steinbeck, Christoph/0000-0001-6966-0814; Nainala, Venkata Chandrasekhar/0000-0002-2564-3243	Syngenta	Syngenta(Syngenta)	CV's internship at the EBI was funded by Syngenta. Syngenta approved the publication of this manuscript. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	BARFIELD M, 1973, CHEM REV, V73, P53, DOI 10.1021/cr60281a004; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Crews P., 2009, ORGANIC STRUCTURE AN; Dracinsky M, 2010, J CHEM THEORY COMPUT, V6, P288, DOI 10.1021/ct900498b; Elyashberg M, 2012, MAGN RESON CHEM, V50, P22, DOI 10.1002/mrc.2849; Elyashberg M, 2010, NAT PROD REP, V27, P1296, DOI 10.1039/c002332a; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; HANSEN PE, 1981, PROG NUCL MAG RES SP, V14, P175, DOI 10.1016/0079-6565(81)80001-5; Hanson RM, 2013, ISR J CHEM, V53, P207, DOI 10.1002/ijch.201300024; Harris R., 1986, NUCL MAGNETIC RESONA; Helgaker T, 2008, PROG NUCL MAG RES SP, V53, P249, DOI 10.1016/j.pnmrs.2008.02.002; Kalinowski H.O., 1988, CARBON 13 NMR SPECTR; LUNAZZI L, 1967, SPECTROCHIM ACTA A-M, VA 23, P841, DOI 10.1016/0584-8539(67)80011-4; Macias FA, 1998, PHYTOCHEMISTRY, V48, P631, DOI 10.1016/S0031-9422(97)00995-3; MACIEL GE, 1970, J AM CHEM SOC, V92, P11, DOI 10.1021/ja00704a002; MALINOWSKI E, 1961, J AM CHEM SOC, V83, P4479, DOI 10.1021/ja01482a050; MALINOWSKI ER, 1962, J AM CHEM SOC, V84, P2649, DOI 10.1021/ja00872a041; Maximoff SN, 2005, J CHEM THEORY COMPUT, V1, P541, DOI 10.1021/ct050083f; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1012, DOI 10.1002/anie.200460864; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Sahakyan AB, 2008, MAGN RESON CHEM, V46, P63, DOI 10.1002/mrc.2137; Sakuno E, 2000, J NAT PROD, V63, P1677, DOI 10.1021/np000194w; San Fabian J, 2013, MAGN RESON CHEM, V51, P775, DOI 10.1002/mrc.4014; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; SZALONTAI G, 1983, TETRAHEDRON, V39, P1783, DOI 10.1016/S0040-4020(01)88688-9; Takikawa H, 2003, TETRAHEDRON LETT, V44, P7023, DOI 10.1016/S0040-4039(03)01782-9; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wipf P, 2003, J NAT PROD, V66, P716, DOI 10.1021/np0300277; Yu BW, 2012, J MAGN RESON, V215, P10, DOI 10.1016/j.jmr.2011.09.037; Zhang Y, 2004, P UK E SCI ALL HANDS, P930	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e11157	10.1371/journal.pone.0111576	http://dx.doi.org/10.1371/journal.pone.0111576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365289	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100079
J	Gan, MY; Deng, JS; Zheng, XY; Hong, Y; Wang, K				Gan, Muye; Deng, Jinsong; Zheng, Xinyu; Hong, Yang; Wang, Ke			Monitoring Urban Greenness Dynamics Using Multiple Endmember Spectral Mixture Analysis	PLOS ONE			English	Article							LAND-COVER CHANGE; VEGETATION ABUNDANCE; SPACE COVERAGE; CHINA; AREA; URBANIZATION; MORPHOLOGY; SELECTION; DECADES; TREES	Urban greenness is increasingly recognized as an essential constituent of the urban environment and can provide a range of services and enhance residents' quality of life. Understanding the pattern of urban greenness and exploring its spatiotemporal dynamics would contribute valuable information for urban planning. In this paper, we investigated the pattern of urban greenness in Hangzhou, China, over the past two decades using time series Landsat-5 TM data obtained in 1990, 2002, and 2010. Multiple endmember spectral mixture analysis was used to derive vegetation cover fractions at the subpixel level. An RGB-vegetation fraction model, change intensity analysis and the concentric technique were integrated to reveal the detailed, spatial characteristics and the overall pattern of change in the vegetation cover fraction. Our results demonstrated the ability of multiple endmember spectral mixture analysis to accurately model the vegetation cover fraction in pixels despite the complex spectral confusion of different land cover types. The integration of multiple techniques revealed various changing patterns in urban greenness in this region. The overall vegetation cover has exhibited a drastic decrease over the past two decades, while no significant change occurred in the scenic spots that were studied. Meanwhile, a remarkable recovery of greenness was observed in the existing urban area. The increasing coverage of small green patches has played a vital role in the recovery of urban greenness. These changing patterns were more obvious during the period from 2002 to 2010 than from 1990 to 2002, and they revealed the combined effects of rapid urbanization and greening policies. This work demonstrates the usefulness of time series of vegetation cover fractions for conducting accurate and in-depth studies of the long-term trajectories of urban greenness to obtain meaningful information for sustainable urban development.	[Gan, Muye; Deng, Jinsong; Zheng, Xinyu; Wang, Ke] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Deng, Jinsong; Hong, Yang] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA; [Deng, Jinsong; Hong, Yang] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Hong, Yang] Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China	Zhejiang University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University	Deng, JS (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	jsong_deng@zju.edu.cn; kwang@zju.edu.cn	Hong, Yang/D-5132-2009	Hong, Yang/0000-0001-8720-242X	Chinese Ministry of Environmental Protection [STSN-05-11]	Chinese Ministry of Environmental Protection	This work was supported by the Survey and Evaluation of National Ecological Environment (2000-2010) using Remote Sensing Program of Chinese Ministry of Environmental Protection (No. STSN-05-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J.B., 1993, REMOTE GEOCHEMICAL A, P145; Akbari H, 2001, SOL ENERGY, V70, P295, DOI 10.1016/S0038-092X(00)00089-X; [Anonymous], 2012, HANGZHOU ALMANAC 201; Boardman JW, 1995, AVIRIS AIRB GEOSC WO; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; Davies Richard G., 2008, Urban Ecosystems, V11, P269, DOI 10.1007/s11252-008-0062-y; Deng JS, 2009, LANDSCAPE URBAN PLAN, V92, P187, DOI 10.1016/j.landurbplan.2009.05.001; Dennison PE, 2004, REMOTE SENS ENVIRON, V93, P359, DOI 10.1016/j.rse.2004.07.013; Dennison PE, 2003, REMOTE SENS ENVIRON, V87, P295, DOI 10.1016/j.rse.2003.07.001; Dennison PE, 2003, REMOTE SENS ENVIRON, V87, P123, DOI 10.1016/S0034-4257(03)00135-4; Donovan GH, 2013, AM J PREV MED, V44, P139, DOI 10.1016/j.amepre.2012.09.066; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Foody GM, 1999, INT J REMOTE SENS, V20, P2723, DOI 10.1080/014311699211769; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; He C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075920; Herold M., 2005, Computers, Environment and Urban Systems, V29, P369, DOI 10.1016/j.compenvurbsys.2003.12.001; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Li XM, 2013, LANDSCAPE URBAN PLAN, V114, P1, DOI 10.1016/j.landurbplan.2013.02.005; Liu T, 2013, REMOTE SENS ENVIRON, V133, P251, DOI 10.1016/j.rse.2013.02.020; Lu DS, 2011, ISPRS J PHOTOGRAMM, V66, P298, DOI 10.1016/j.isprsjprs.2010.10.010; Lu DS, 2004, PHOTOGRAMM ENG REM S, V70, P1053, DOI 10.14358/PERS.70.9.1053; Michishita R, 2012, INT J REMOTE SENS, V33, P3373, DOI 10.1080/01431161.2011.611185; Michishita R, 2012, REMOTE SENS ENVIRON, V117, P3, DOI 10.1016/j.rse.2011.06.021; Myint SW, 2006, INT J REMOTE SENS, V27, P2645, DOI 10.1080/01431160500534630; Nowak DJ, 2012, URBAN FOR URBAN GREE, V11, P21, DOI 10.1016/j.ufug.2011.11.005; Okin GS, 2001, REMOTE SENS ENVIRON, V77, P212, DOI 10.1016/S0034-4257(01)00207-3; Patino JE, 2013, COMPUT ENVIRON URBAN, V37, P1, DOI 10.1016/j.compenvurbsys.2012.06.003; Powell R. L., 2011, URBAN REMOTE SENSING, P111; Powell RL, 2007, REMOTE SENS ENVIRON, V106, P253, DOI 10.1016/j.rse.2006.09.005; Powell RL, 2010, J LAT AM GEOGR, V9, P183, DOI 10.1353/lag.2010.0028; Powell RL, 2008, EARTH INTERACT, V12, DOI 10.1175/2008EI246.1; Rashed T, 2005, INT J REMOTE SENS, V26, P699, DOI 10.1080/01431160512331316874; Rashed T, 2003, PHOTOGRAMM ENG REM S, V69, P1011, DOI 10.14358/PERS.69.9.1011; Roberts D.A., 2007, VIPER TOOLS USER MAN; Roberts DA, 2003, IEEE T GEOSCI REMOTE, V41, P1297, DOI 10.1109/TGRS.2003.812904; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Roberts DA, 1999, CHANGE IDENTIFICATIO, p318 16; Robinson SL, 2012, URBAN ECOSYST, V15, P545, DOI 10.1007/s11252-012-0225-8; Small C, 2006, REMOTE SENS ENVIRON, V100, P441, DOI 10.1016/j.rse.2005.10.023; Small C, 2001, INT J REMOTE SENS, V22, P1305, DOI 10.1080/01431160151144369; SMITH MO, 1990, REMOTE SENS ENVIRON, V31, P1, DOI 10.1016/0034-4257(90)90074-V; Somers B, 2011, REMOTE SENS ENVIRON, V115, P1603, DOI 10.1016/j.rse.2011.03.003; Song CH, 2005, REMOTE SENS ENVIRON, V95, P248, DOI 10.1016/j.rse.2005.01.002; Sun JY, 2011, ENVIRON MONIT ASSESS, V179, P1, DOI 10.1007/s10661-010-1715-x; Tan PY, 2013, CITIES, V32, P24, DOI 10.1016/j.cities.2013.02.001; Tang JM, 2012, LANDSCAPE URBAN PLAN, V105, P296, DOI 10.1016/j.landurbplan.2012.01.004; Tompkins S, 1997, REMOTE SENS ENVIRON, V59, P472, DOI 10.1016/S0034-4257(96)00122-8; Walsh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045814; Weng QH, 2009, INT J REMOTE SENS, V30, P2547, DOI 10.1080/01431160802552777; Wolch JR, 2014, LANDSCAPE URBAN PLAN; Wu CS, 2007, PHOTOGRAMM ENG REM S, V73, P1393, DOI 10.14358/PERS.73.12.1393; Wu CS, 2004, REMOTE SENS ENVIRON, V93, P480, DOI 10.1016/j.rse.2004.08.003; Wu KY, 2012, APPL GEOGR, V34, P137, DOI 10.1016/j.apgeog.2011.11.006; Yang J, 2013, URBAN FORESTRY URBAN; Zhao JJ, 2013, SCI TOTAL ENVIRON, V442, P455, DOI 10.1016/j.scitotenv.2012.10.014; Zhou XL, 2011, LANDSCAPE URBAN PLAN, V100, P268, DOI 10.1016/j.landurbplan.2010.12.013	57	34	34	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112202	10.1371/journal.pone.0112202	http://dx.doi.org/10.1371/journal.pone.0112202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375176	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600118
J	Illa, X; Vila, S; Yeste, J; Peralta, C; Gracia-Sancho, J; Villa, R				Illa, Xavi; Vila, Sergi; Yeste, Jose; Peralta, Carmen; Gracia-Sancho, Jordi; Villa, Rosa			A Novel Modular Bioreactor to In Vitro Study the Hepatic Sinusoid	PLOS ONE			English	Article							ORGANS-ON-CHIPS; SHEAR-STRESS; CELL-CULTURE; HEPATOCYTE CULTURE; ENDOTHELIAL-CELLS; DRUG DISCOVERY; BARRIER; STRATEGIES; CIRRHOSIS; RELEASE	We describe a unique, versatile bioreactor consisting of two plates and a modified commercial porous membrane suitable for in vitro analysis of the liver sinusoid. The modular bioreactor allows i) excellent control of the cell seeding process; ii) cell culture under controlled shear stress stimulus, and; iii) individual analysis of each cell type upon completion of the experiment. The advantages of the bioreactor detailed here are derived from the modification of a commercial porous membrane with an elastomeric wall specifically moulded in order to define the cell culture area, to act as a gasket that will fit into the bioreactor, and to provide improved mechanical robustness. The device presented herein has been designed to simulate the in vivo organization of a liver sinusoid and tested by co-culturing endothelial cells (EC) and hepatic stellate cells (HSC). The results show both an optimal morphology of the endothelial cells as well as an improvement in the phenotype of stellate cells, most probably due to paracrine factors released from endothelial cells. This device is proposed as a versatile, easy-to-use co-culture system that can be applied to biomedical research of vascular systems, including the liver.	[Illa, Xavi; Yeste, Jose; Villa, Rosa] CSIC, IMB CNM, Inst Microelect Barcelona, Bellaterra, Spain; [Illa, Xavi; Yeste, Jose; Villa, Rosa] CIBER BBN, Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Barcelona, Spain; [Vila, Sergi; Gracia-Sancho, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona Hepat Hemodynam Lab, Barcelona, Spain; [Peralta, Carmen] IDIBAPS, Barcelona, Spain; [Peralta, Carmen] CIBER EHD, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Illa, X (corresponding author), CSIC, IMB CNM, Inst Microelect Barcelona, Bellaterra, Spain.	xavier.illa@imb-cnm.csic.es; jgracia@clinic.ub.es	Villa, Rosa/AAC-1671-2020; Lozano, Jose Yeste/B-1194-2019; Peralta, Carmen/M-8170-2014; Villa, Rosa/A-6664-2015; Illa, Xavi/A-3523-2013; VILA, SERGI/G-5771-2015; Gracia-Sancho, Jordi/C-8920-2014	Villa, Rosa/0000-0003-2735-3204; Lozano, Jose Yeste/0000-0001-7540-7305; Peralta, Carmen/0000-0002-5767-0676; Villa, Rosa/0000-0003-2735-3204; Illa, Xavi/0000-0002-3212-1128; VILA, SERGI/0000-0003-1706-3916; Gracia-Sancho, Jordi/0000-0001-7736-4089	CSIC [PIE 201450E116]; Instituto de Salud Carlos III [FIS PI11/00235]; Ministerio de Economia y Competitividad [SAF2012-31238]; European Union (Fondos FEDER, "una manera de hacer Europa''); European Community's Seventh Framework Programme (EC FP7) [229673]; CIBER-EHD - Instituto de Salud Carlos III; CIBER-BBN - Instituto de Salud Carlos III	CSIC; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad(Spanish Government); European Union (Fondos FEDER, "una manera de hacer Europa''); European Community's Seventh Framework Programme (EC FP7); CIBER-EHD - Instituto de Salud Carlos III(Instituto de Salud Carlos III); CIBER-BBN - Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by: CSIC (PIE 201450E116) (RV); Instituto de Salud Carlos III (FIS PI11/00235) (JGS); Ministerio de Economia y Competitividad (SAF2012-31238) (CP); European Union (Fondos FEDER, "una manera de hacer Europa'') (JGS and CP); European Community's Seventh Framework Programme (EC FP7/2007-2013, grant agreement 229673) (JGS); CIBER-EHD (funded by Instituto de Salud Carlos III) (JGS and CP); and CIBER-BBN (funded by Instituto de Salud Carlos III) (RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Capulli AK, 2014, LAB CHIP, V14, P3181, DOI 10.1039/c4lc00276h; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Ebrahimkhani MR, 2014, ADV DRUG DELIVER REV, V69, P132, DOI 10.1016/j.addr.2014.02.011; Epshteyn AA, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3647824; Garcia-Pagan JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007; Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Goral VN, 2010, LAB CHIP, V10, P3380, DOI 10.1039/c01c00135j; Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166; Gracia-Sancho J, 2010, TRANSPLANTATION, V90, P142, DOI 10.1097/TP.0b013e3181e228db; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Hennenberg M, 2011, LAB INVEST, V91, P241, DOI 10.1038/labinvest.2010.148; Hide D, 2014, CLIN SCI, V127, P527, DOI 10.1042/CS20140125; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Kabirian F, 2015, J BIOMED MATER RES A, V103, P1231, DOI 10.1002/jbm.a.35233; Kang Y. B., 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P301, DOI 10.1109/Transducers.2013.6626762; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; LeCluyse EL, 1996, ADV DRUG DELIVER REV, V22, P133, DOI 10.1016/S0169-409X(96)00418-8; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Marrone G, 2013, J HEPATOL, V58, P98, DOI 10.1016/j.jhep.2012.08.026; Materne EM, 2013, LAB CHIP, V13, P3481, DOI 10.1039/c3lc50240f; Meissner R, 2011, LAB CHIP, V11, P2352, DOI 10.1039/c1lc20212j; Morimoto Y, 2013, BIOMATER SCI-UK, V1, P257, DOI 10.1039/c2bm00117a; Park J, 2005, BIOTECHNOL BIOENG, V90, P632, DOI 10.1002/bit.20463; Polini A, 2014, EXPERT OPIN DRUG DIS, V9, P335, DOI 10.1517/17460441.2014.886562; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Rosado E, 2012, J CELL MOL MED, V16, P2461, DOI 10.1111/j.1582-4934.2012.01563.x; Sung JH, 2009, LAB CHIP, V9, P1385, DOI 10.1039/b901377f; van de Stolpe A, 2013, LAB CHIP, V13, P3449, DOI 10.1039/c3lc50248a; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; van Midwoud PM, 2010, BIOTECHNOL BIOENG, V105, P184, DOI 10.1002/bit.22516; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Vozzi F, 2014, BIOTECHNOL J, V9, P146, DOI 10.1002/biot.201300016; Yum K, 2014, BIOTECHNOL J, V9, P16, DOI 10.1002/biot.201300187; Zhang MY, 2008, BIOMED MICRODEVICES, V10, P117, DOI 10.1007/s10544-007-9116-9	45	27	28	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111864	10.1371/journal.pone.0111864	http://dx.doi.org/10.1371/journal.pone.0111864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375141	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600071
J	Khatun, F; Hanifi, SMA; Iqbal, M; Rasheed, S; Rahman, MS; Ahmed, T; Hoque, S; Sharmin, T; Khan, NUZ; Mahmood, SS; Peters, DH; Bhuiya, A				Khatun, Fatema; Hanifi, S. M. A.; Iqbal, Mohammad; Rasheed, Sabrina; Rahman, M. Shafiqur; Ahmed, Tanvir; Hoque, Shahidul; Sharmin, Tamanna; Khan, Nazib Uz Zaman; Mahmood, Shehrin Shaila; Peters, David H.; Bhuiya, Abbas			Prospects of mHealth Services in Bangladesh: Recent Evidence from Chakaria	PLOS ONE			English	Article								Introduction: Bangladesh has a serious shortage of qualified health workforce. The limited numbers of trained service providers are based in urban areas, which limits access to quality healthcare for the rural population. mHealth provides a new opportunity to ensure access to quality services to the population. A recent review suggested that there are 19 mHealth initiatives in the country. This paper reports findings on people's knowledge, perception, use, cost and compliance with advice received from mHealth services from a study carried out during 2012-13 in Chakaria, a rural sub-district in Bangladesh. Methods: A total of 4,915 randomly-chosen respondents aged 18 years and above were interviewed. Results: Household ownership of mobile phones in the study area has increased from 2% in 2004 to 81% in 2012; 45% of the respondents reported that they had mobile phones. Thirty-one percent of the respondents were aware of the use of mobile phones for healthcare. Very few people were aware of the available mHealth services. Males, younger age group, better educated, and those from richer households were more knowledgeable about the existing mHealth services. Among the respondents who sought healthcare in the preceding two weeks of the survey, only 2% used mobile phones for healthcare. Adherence to the advice from the healthcare providers in terms of purchasing and taking the drugs was somewhat similar between the patients who used mobile phone for consultation versus making a physical visit. Conclusions: The high penetration of mobile phones into the society provides a unique opportunity to use the mHealth technology for consulting healthcare providers. Although knowledge of the existence of mHealth services was low, it was encouraging that the compliance with the prescriptions was almost similar for advice received through mobile phone and physical visits. The study revealed clear indications that society is looking forward to embracing the mHealth technology.	[Khatun, Fatema; Hanifi, S. M. A.; Iqbal, Mohammad; Rasheed, Sabrina; Rahman, M. Shafiqur; Ahmed, Tanvir; Hoque, Shahidul; Sharmin, Tamanna; Khan, Nazib Uz Zaman; Mahmood, Shehrin Shaila; Bhuiya, Abbas] Bangladesh icddr b, Int Ctr Diarrhoeal Dis Res, Dhaka 1212, Bangladesh; [Khatun, Fatema] Univ New S Wales, Sch Publ Hlth & Community Med, Kensington, NSW 2033, Australia; [Khatun, Fatema] Univ New S Wales, Australian Sch Business, Sch Informat Syst Technol & Management, Asia Pacific Ubiquitous Healthcare Res Ctr, Kensington, NSW 2033, Australia; [Rahman, M. Shafiqur] Univ Dhaka, Inst Stat Res & Training, Dhaka 1000, Bangladesh; [Peters, David H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of New South Wales Sydney; University of New South Wales Sydney; University of Dhaka; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Khatun, F (corresponding author), Bangladesh icddr b, Int Ctr Diarrhoeal Dis Res, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh.	kfatema@icddrb.org	rasheed, sabrina/A-4145-2010	Hanifi, Manzoor A./0000-0002-1483-5557; rasheed, sabrina/0000-0002-7444-200X; Peters, David/0000-0001-8377-3444; Mahmood, Shehrin Shaila/0000-0002-6546-9120	Department for International Development (DFID) [DFID/PO:5457]; ESRC [ES/J018651/1] Funding Source: UKRI	Department for International Development (DFID); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research study was funded by Department for International Development (DFID), grant number_DFID/PO:5457. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T., 2014, E HLTH M HLTH BANGLA; Akter S., 2010, USER PERCEIVED SERVI; Bangladesh Health Watch, 2008, STAT HLTH BANGL 2007, P1212; Bhuiya A., 2009, HLTH RURAL MASSES IN; Bhuiya A, 2013, USE MHEALTH IMPROVE; GSMA Development Fund Cherie Blair Foundation for Women& Vital Wave Consulting, 2010, WOM MOB GLOB OPP STU; Hanifi SMA, 2011, CHAKARIA HLTH DEMOGR; Huq NL, 2012, INT J SOCIOLOGY ANTH, V4; Ivatury G, 2009, MIT PRESS J, V4, P119, DOI DOI 10.1162/ITGG.2009.4.1.119]; Mahmood SS, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-18; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2011, BANGL DEM HLTH SURV; The Earth Institute at Columbia University Promise. M (UNDP). TUDP, 2010, MILL VILL PROJ IMP M; United Nations Foundation and Vodafone Foundation, 2009, MHEALTH DEV OPP MOB; Wahed T, 2012, DOCTORING VILLAGE DO; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; WHO, 2007, WHO BANGL COUNTR COO; Zurovac D, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-20	17	39	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111413	10.1371/journal.pone.0111413	http://dx.doi.org/10.1371/journal.pone.0111413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375255	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600038
J	Yao, X; Durr, UHN; Gattin, Z; Laukat, Y; Narayanan, RL; Bruckner, AK; Meisinger, C; Lange, A; Becker, S; Zweckstetter, M				Yao, Xuejun; Duerr, Ulrich H. N.; Gattin, Zrinka; Laukat, Yvonne; Narayanan, Rhagavendran L.; Brueckner, Ann-Kathrin; Meisinger, Chris; Lange, Adam; Becker, Stefan; Zweckstetter, Markus			NMR-Based Detection of Hydrogen/Deuterium Exchange in Liposome-Embedded Membrane Proteins	PLOS ONE			English	Article							SOLID-STATE NMR; DEPENDENT ANION CHANNEL; HYDROGEN-DEUTERIUM EXCHANGE; DYNAMIC CHARACTERIZATION; RESONANCE ASSIGNMENT; 2-DIMENSIONAL NMR; MASS-SPECTROMETRY; AMYLOID FIBRILS; APSY-NMR; SPECTROSCOPY	Membrane proteins play key roles in biology. Determination of their structure in a membrane environment, however, is highly challenging. To address this challenge, we developed an approach that couples hydrogen/deuterium exchange of membrane proteins to rapid unfolding and detection by solution-state NMR spectroscopy. We show that the method allows analysis of the solvent protection of single residues in liposome-embedded proteins such as the 349-residue Tom40, the major protein translocation pore in the outer mitochondrial membrane, which has resisted structural analysis for many years.	[Yao, Xuejun; Duerr, Ulrich H. N.; Gattin, Zrinka; Laukat, Yvonne; Narayanan, Rhagavendran L.; Brueckner, Ann-Kathrin; Lange, Adam; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Meisinger, Chris] Univ Freiburg, Inst Biochem & Molekularbiol, ZBMZ, D-79106 Freiburg, Germany; [Meisinger, Chris] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Goottingen, Germany; [Zweckstetter, Markus] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	Max Planck Society; University of Freiburg; University of Freiburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Zweckstetter, M (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	Markus.Zweckstetter@dzne.de	Meisinger, Chris/J-1110-2014	Meisinger, Chris/0000-0002-8326-3548; Zweckstetter, Markus/0000-0002-2536-6581; Lange, Adam/0000-0002-7534-5973	ERC [282008]; Marie Curie fellowship within the 7th EU Framework Programme; DFG collaborative research center [803]; Emmy Noether fellowship	ERC(European Research Council (ERC)European Commission); Marie Curie fellowship within the 7th EU Framework Programme; DFG collaborative research center(German Research Foundation (DFG)); Emmy Noether fellowship(German Research Foundation (DFG))	ERC (grant agreement number 282008) to M Zweckstetter; Marie Curie fellowship within the 7th EU Framework Programme to Z Gattin; DFG collaborative research center 803 and Emmy Noether fellowship to A Lange. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus M, 1996, J MAGN RESON SER A, V121, P65, DOI 10.1006/jmra.1996.0137; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Bockmann A, 2005, J BIOMOL NMR, V32, P195, DOI 10.1007/s10858-005-8073-y; Catoire LJ, 2010, EUR BIOPHYS J BIOPHY, V39, P623, DOI 10.1007/s00249-009-0513-2; Chill JH, 2007, BBA-BIOMEMBRANES, V1768, P3260, DOI 10.1016/j.bbamem.2007.08.006; Chill JH, 2011, CURR OPIN STRUC BIOL, V21, P627, DOI 10.1016/j.sbi.2011.07.003; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Cross TA, 2011, TRENDS BIOCHEM SCI, V36, P117, DOI 10.1016/j.tibs.2010.07.005; Csizmok V, 2008, J AM CHEM SOC, V130, P16873, DOI 10.1021/ja805510b; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMPSEY CE, 1994, J BIOMOL NMR, V4, P879, DOI 10.1007/BF00398417; Eddy MT, 2012, J AM CHEM SOC, V134, P6375, DOI 10.1021/ja300347v; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Fernandez C, 2004, J MOL BIOL, V336, P1211, DOI 10.1016/j.jmb.2003.09.014; Fiorito F, 2006, J BIOMOL NMR, V35, P27, DOI 10.1007/s10858-006-0030-x; Gopinath T, 2013, PROG NUCL MAG RES SP, V75, P50, DOI 10.1016/j.pnmrs.2013.07.004; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+; Hong M, 2012, ANNU REV PHYS CHEM, V63, P1, DOI 10.1146/annurev-physchem-032511-143731; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Knight MJ, 2012, P NATL ACAD SCI USA, V109, P11095, DOI 10.1073/pnas.1204515109; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Marassi FM, 2011, METHODS, V55, P363, DOI 10.1016/j.ymeth.2011.09.009; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Murray DT, 2013, ACCOUNTS CHEM RES, V46, P2172, DOI 10.1021/ar3003442; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nietlispach D, 2011, CURR OPIN STRUC BIOL, V21, P497, DOI 10.1016/j.sbi.2011.06.009; Novacek J, 2013, J BIOMOL NMR, V56, P291, DOI 10.1007/s10858-013-9761-7; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Qureshi T, 2012, TOP CURR CHEM, V326, P123, DOI 10.1007/128_2011_306; Radoicic J, 2014, Q REV BIOPHYS, V47, P249, DOI 10.1017/S0033583514000080; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Tong KI, 2008, J BIOMOL NMR, V42, P59, DOI 10.1007/s10858-008-9264-0; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Van Melckebeke H, 2011, J MOL BIOL, V405, P765, DOI 10.1016/j.jmb.2010.11.004; Vilar M, 2012, METHODS MOL BIOL, V849, P185, DOI 10.1007/978-1-61779-551-0_13; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	3	3	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112374	10.1371/journal.pone.0112374	http://dx.doi.org/10.1371/journal.pone.0112374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375235	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600137
J	Chen, X; Hirt, H; Li, YP; Gorr, SU; Aparicio, C				Chen, Xi; Hirt, Helmut; Li, Yuping; Gorr, Sven-Ulrik; Aparicio, Conrado			Antimicrobial GL13K Peptide Coatings Killed and Ruptured the Wall of Streptococcus gordonii and Prevented Formation and Growth of Biofilms	PLOS ONE			English	Article							IMPLANT-ASSOCIATED INFECTIONS; SALIVARY FLOW-RATE; PORPHYROMONAS-GINGIVALIS; PERIPROSTHETIC INFECTION; BACTERIAL-COLONIZATION; COATED TITANIUM; TEICHOIC-ACID; SURFACE; ANTIBACTERIAL; DEFICIENCY	Infection is one of the most prevalent causes for dental implant failure. We have developed a novel antimicrobial peptide coating on titanium by immobilizing the antimicrobial peptide GL13K. GL13K was developed from the human salivary protein BPIFA2. The peptide exhibited MIC of 8 mu g/ml against planktonic Pseudonomas aeruginosa and their biofilms were reduced by three orders of magnitude with 100 mu g/ml GL13K. This peptide concentration also killed 100% of Streptococcus gordonii. At 1 mg/ml, GL13K caused less than 10% lysis of human red blood cells, suggesting low toxicity to mammalian cells. Our GL13K coating has also previously showed bactericidal effect and inhibition of biofilm growth against peri-implantitis related pathogens, such as Porphyromonas gingivalis. The GL13K coating was cytocompatible with human fibroblasts and osteoblasts. However, the bioactivity of antimicrobial coatings has been commonly tested under (quasi) static culture conditions that are far from simulating conditions for biofilm formation and growth in the oral cavity. Oral salivary flow over a coating is persistent, applies continuous shear forces, and supplies sustained nutrition to bacteria. This accelerates bacteria metabolism and biofilm growth. In this work, the antimicrobial effect of the coating was tested against Streptococcus gordonii, a primary colonizer that provides attachment for the biofilm accretion by P. gingivalis, using a drip-flow biofilm bioreactor with media flow rates simulating salivary flow. The GL13K peptide coatings killed bacteria and prevented formation and growth of S. gordonii biofilms in the drip-flow bioreactor and under regular mild-agitation conditions. Surprisingly the interaction of the bacteria with the GL13K peptide coatings ruptured the cell wall at their septum or polar areas leaving empty shell-like structures or exposed protoplasts. The cell wall rupture was not detected under regular culture conditions, suggesting that cell wall rupture induced by GL13K peptides also requires media flow and possible attendant biological sequelae of the conditions in the bioreactor.	[Chen, Xi; Li, Yuping; Aparicio, Conrado] Univ Minnesota, Sch Dent, Minnesota Dent Res Ctr Biomat & Biomech, Dept Restorat Sci, Minneapolis, MN 55455 USA; [Hirt, Helmut; Gorr, Sven-Ulrik] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Aparicio, C (corresponding author), Univ Minnesota, Sch Dent, Minnesota Dent Res Ctr Biomat & Biomech, Dept Restorat Sci, Minneapolis, MN 55455 USA.	apari003@umn.edu	Li, Yuping/H-5259-2013; Aparicio, Conrado/J-9903-2012	Li, Yuping/0000-0002-2506-1155; Aparicio, Conrado/0000-0003-2969-6067	3M Foundation; 3M Non-tenured Faculty Award; Office of the Vice-president for Research at the University of Minnesota; Research, Artistry and Scholarship Program [55466]; U.S. Public Health Service - National Institute of Dental and Craniofacial Research [R01DE017989, R90DE023058]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017989, R90DE023058] Funding Source: NIH RePORTER	3M Foundation(3M); 3M Non-tenured Faculty Award(3M); Office of the Vice-president for Research at the University of Minnesota; Research, Artistry and Scholarship Program; U.S. Public Health Service - National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by 3M Foundation (http://solutions.3m.com/wps/portal/3M/en_US/Community-Giving/US-Home), 3M Non-tenured Faculty Award to CA; The Office of the Vice-president for Research at the University of Minnesota (http://www.research.umn.edu), Project #55466 of the Grant-in-Aid of Research, Artistry and Scholarship Program to CA; U.S. Public Health Service - National Institute of Dental and Craniofacial Research, (http://www.nidcr.nih.gov) R01DE017989, to S.U.G; U.S. Public Health Service - National Institute of Dental and Craniofacial Research, (http://www.nidcr.nih.gov; R90DE023058), to XC. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolhosseini M, 2012, PEPTIDES, V35, P231, DOI 10.1016/j.peptides.2012.03.017; Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50; Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2; Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348; Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016; Balhara V, 2013, BBA-BIOMEMBRANES, V1828, P2193, DOI 10.1016/j.bbamem.2013.05.027; Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Bizzini A, 2007, MICROBIOL-SGM, V153, P490, DOI 10.1099/mic.0.29256-0; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Chan KG, 2007, INFECT IMMUN, V75, P3033, DOI 10.1128/IAI.01549-06; Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003; Chen X., 2013, BIOL MED PHYS BIOMED, P105, DOI DOI 10.1007/978-94-007-2592-8_4; Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005; Cook GS, 1998, J PERIODONTAL RES, V33, P323, DOI 10.1111/j.1600-0765.1998.tb02206.x; DAWES C, 1972, J PHYSIOL-LONDON, V220, P529, DOI 10.1113/jphysiol.1972.sp009721; Domingues MM, 2014, NANOMED-NANOTECHNOL, V10, P543, DOI 10.1016/j.nano.2013.11.002; Fenoll-Palomares C, 2004, REV ESP ENFERM DIG, V96, P773; Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x; Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013; Hirt H, 2013, ANTIMICROB AGENTS CH, V57, P4903, DOI 10.1128/AAC.00311-13; Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017; Jahoda D, 2006, Acta Chir Orthop Traumatol Cech, V73, P108; Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036; Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035; Kim WH, 2008, SURF INTERFACE ANAL, V40, P202, DOI 10.1002/sia.2809; Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07; Koyanagi T, 2013, J CLIN PERIODONTOL, V40, P218, DOI 10.1111/jcpe.12047; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; MADIGAN MT, 2002, BROCK BIOL MICROORGA; Moy PK, 2005, INT J ORAL MAX IMPL, V20, P569; Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037; Sawant SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063311; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x	39	53	56	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111579	10.1371/journal.pone.0111579	http://dx.doi.org/10.1371/journal.pone.0111579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372402	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900055
J	Kacik, M; Olivan-Viguera, A; Kohler, R				Kacik, Michael; Olivan-Viguera, Aida; Koehler, Ralf			Modulation of K(Ca)3.1 Channels by Eicosanoids, Omega-3 Fatty Acids, and Molecular Determinants	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNELS; VASCULAR SMOOTH-MUSCLE; INTERMEDIATE-CONDUCTANCE; EPOXYEICOSATRIENOIC ACIDS; FATTY-ACIDS; DOCOSAHEXAENOIC ACID; K(V)1.3 CHANNELS; KCA3.1; PHARMACOLOGY	Background: Cytochrome P450- and omega-hydrolase products (epoxyeicosatrienoic acids (EETs), hydroxyeicosatetraeonic acid (20-HETE)), natural omega-3 fatty acids (omega 3), and pentacyclic triterpenes have been proposed to contribute to a wide range of vaso-protective and anti-fibrotic/anti-cancer signaling pathways including the modula-tion of membrane ion channels. Here we studied the modulation of intermediate-conductance Ca2+/calmodulin-regulated K+ channels (K(Ca)3.1) by EETs, 20-HETE, omega 3, and pentacyclic triterpenes and the structural requirements of these fatty acids to exert channel blockade. Methodology/Principal Findings: We studied modulation of cloned human hK(Ca)3.1 and the mutant hK(Ca)3.1(V275A) in HEK-293 cells, of rK(Ca)3.1 in aortic endothelial cells, and of mK(Ca)3.1 in 3T3-fibroblasts by inside-out and whole-cell patch-clamp experiments, respectively. In inside-out patches, Ca2+-activated hK(Ca)3.1 were inhibited by the omega 3, DHA and alpha-LA, and the omega 6, AA, in the lower mu molar range and with similar potencies. 5,6-EET, 8,9-EET, 5,6-DiHETE, and saturated arachidic acid, had no appreciable effects. In contrast, 14,15-EET, its stable derivative, 14,15-EEZE, and 20-HETE produced channel inhibition. 11,12-EET displayed less inhibitory activity. The K(Ca)3.1(V275A) mutant channel was insensitive to any of the blocking EETs. Non-blocking 5,6-EET antagonized the inhibition caused by AA and augmented cloned hK(Ca)3.1 and rK(Ca)3.1 whole-cell currents. Pentacyclic triterpenes did not modulate K(Ca)3.1 currents. Conclusions/Significance: Inhibition of K(Ca)3.1 by EETs (14,15-EET), 20-HETE, and omega 3 critically depended on the presence of electron double bonds and hydrophobicity within the 10 carbons preceding the carboxyl-head of the molecules. From the physiological perspective, metabolism of AA to non-blocking 5,6,- and 8,9-EET may cause AA-de-blockade and contribute to cellular signal transduction processes influenced by these fatty acids.	[Kacik, Michael] Univ Marburg, Fac Med, D-48153 Munster, Germany; [Kacik, Michael] Univ Munster, Univ Hosp, Clemenshosp, Med Ctr 1, D-48153 Munster, Germany; [Olivan-Viguera, Aida; Koehler, Ralf] Aragon Inst Hlth Sci I CS IIS, Zaragoza 50009, Spain; [Koehler, Ralf] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza 50018, Spain	Philipps University Marburg; University of Munster	Kohler, R (corresponding author), Aragon Inst Hlth Sci I CS IIS, Zaragoza 50009, Spain.	rkohler.iacs@aragon.es	Oliván-Viguera, Aida/I-4260-2015; Oliván-Viguera, Aida/ABG-4048-2020	Oliván-Viguera, Aida/0000-0001-5348-924X; Oliván-Viguera, Aida/0000-0001-5348-924X; Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft (DFG) [KO1899/10-1, 11-1]; European Community (FP7-PEOPLE Project) [321721]; Fondo de Investigacion Sanitaria (Red HERACLES) [RD12/0042/0014]; intramural funding of the University Hospital Marburg Giessen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Community (FP7-PEOPLE Project); Fondo de Investigacion Sanitaria (Red HERACLES)(Instituto de Salud Carlos III); intramural funding of the University Hospital Marburg Giessen	The study was supported by grants of the Deutsche Forschungsgemeinschaft (DFG): KO1899/10-1 and 11-1 to RK (www.dfg.de). European Community (FP7-PEOPLE Project 321721), and the Fondo de Investigacion Sanitaria (Red HERACLES RD12/0042/0014). MK and RK were supported by intramural funding of the University Hospital Marburg & Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Balut CM, 2012, CHEMMEDCHEM, V7, P1741, DOI 10.1002/cmdc.201200226; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bertuccio CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092013; Bi D, 2013, J BIOL CHEM, V288, P15843, DOI 10.1074/jbc.M112.427187; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Chen C, 2011, J PHARMACOL EXP THER, V336, P344, DOI 10.1124/jpet.110.174805; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081006; D'Alessandro G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.279; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Di L, 2010, P NATL ACAD SCI USA, V107, P1541, DOI 10.1073/pnas.0910133107; Ding Yindi, 2014, J Pharmacol Exp Ther, V350, P14, DOI 10.1124/jpet.114.214254; Earley S, 2011, J CARDIOVASC PHARM, V57, P148, DOI 10.1097/FJC.0b013e3181f580d9; Fan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082482; Feletou M, 2012, ANN MED, V44, P694, DOI 10.3109/07853890.2011.585658; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fleming I, 2011, CANCER METAST REV, V30, P541, DOI 10.1007/s10555-011-9302-3; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Hamilton KL, 2003, J BIOL CHEM, V278, P16690, DOI 10.1074/jbc.M212959200; Hua XQ, 2013, TRANSPLANTATION, V95, P285, DOI 10.1097/TP.0b013e318275a2f4; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Keserue B, 2008, FASEB J, V22, P4306, DOI 10.1096/fj.08-112821; KIRBER MT, 1992, FEBS LETT, V297, P24, DOI 10.1016/0014-5793(92)80319-C; Koch Hansen L, 2014, J CROHNS COLITIS; Kohler R, 2005, KIDNEY INT, V67, P2280, DOI 10.1111/j.1523-1755.2005.00331.x; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, PFLUG ARCH EUR J PHY, V459, P969, DOI 10.1007/s00424-010-0819-z; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; Lambertsen KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047744; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Lou-Bonafonte JM, 2012, MOL NUTR FOOD RES, V56, P1043, DOI 10.1002/mnfr.201100668; Lu T, 2005, J BIOL CHEM, V280, P19097, DOI 10.1074/jbc.M414065200; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Marquez-Martin A, 2006, CYTOKINE, V36, P211, DOI 10.1016/j.cyto.2006.12.007; Martin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041545; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Nielsen G, 2013, BASIC CLIN PHARMACOL, V113, P250, DOI 10.1111/bcpt.12092; Olivan-Viguera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058614; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; Pfister SL, 2010, ADV PHARMACOL, V60, P27, DOI [10.1016/B978-0-12-385061-4.00002-7, 10.1016/S1054-3589(10)60008-7]; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Rosa JC, 1998, J MED CHEM, V41, P2; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Siddesha JM, 2014, CELL SIGNAL, V26, P933, DOI 10.1016/j.cellsig.2014.01.005; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Szekely A, 2007, IMMUNOBIOLOGY, V212, P213, DOI 10.1016/j.imbio.2007.01.005; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Tunctan Bahar, 2013, Antiinflamm Antiallergy Agents Med Chem, V12, P1; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff H, 2013, J CARDIOVASC PHARM, V61, P102, DOI 10.1097/FJC.0b013e318279ba20; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Xiao YF, 2007, PROSTAG OTH LIPID M, V82, P11, DOI 10.1016/j.prostaglandins.2006.05.023; Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003; Zou AP, 1996, AM J PHYSIOL-RENAL, V270, pF822, DOI 10.1152/ajprenal.1996.270.5.F822	68	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112081	10.1371/journal.pone.0112081	http://dx.doi.org/10.1371/journal.pone.0112081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372486	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900110
J	Lin, LX; Bo, XY; Tan, YZ; Sun, FX; Song, M; Zhao, J; Ma, ZH; Li, M; Zheng, KJ; Xu, SM				Lin, Lai-xiang; Bo, Xiang-yu; Tan, Yuan-zhen; Sun, Feng-xian; Song, Ming; Zhao, Juan; Ma, Zhi-hong; Li, Mei; Zheng, Kai-jun; Xu, Shu-mei			Feasibility of beta-Sheet Breaker Peptide-H102 Treatment for Alzheimer's Disease Based on beta-Amyloid Hypothesis	PLOS ONE			English	Article							CHOLINE-ACETYLTRANSFERASE; PROTEIN CONFORMATION; IN-VITRO; A-BETA; TAU; AGGREGATION; INHIBITION; BRAIN; STRATEGIES; TOXICITY	beta-amyloid hypothesis is the predominant hypothesis in the study of pathogenesis of Alzheimer's disease. This hypothesis claims that aggregation and neurotoxic effects of amyloid beta (A beta) is the common pathway in a variety of etiological factors for Alzheimer's disease. A beta peptide derives from amyloid precursor protein (APP). beta-sheet breaker peptides can directly prevent and reverse protein misfolding and aggregation in conformational disorders. Based on the stereochemical structure of A beta 1-42 and aggregation character, we had designed a series of beta-sheet breaker peptides in our previous work and screened out a 10-residue peptide beta-sheet breaker peptide, H102. We evaluated the effects of H102 on expression of P-tau, several associated proteins, inflammatory factors and apoptosis factors, and examined the cognitive ability of APP transgenic mice by behavioral test. This study aims to validate the beta-amyloid hypothesis and provide an experimental evidence for the feasibility of H102 treatment for Alzheimer's disease.	[Bo, Xiang-yu; Tan, Yuan-zhen; Sun, Feng-xian; Song, Ming; Zhao, Juan; Ma, Zhi-hong; Li, Mei; Zheng, Kai-jun; Xu, Shu-mei] Tianjin Med Univ, Dept Physiol, Tianjin, Peoples R China; [Lin, Lai-xiang] Tianjin Med Univ, Metab Dis Hosp, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormone & Dev,Minist Hlth, Tianjin, Peoples R China; [Lin, Lai-xiang] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Xu, SM (corresponding author), Tianjin Med Univ, Dept Physiol, Tianjin, Peoples R China.	xushm_ty@126.com			National Major New Drug Creation of China [2009ZX09103-029]; Science and Technology Research Foundation of Tianjin, China [09ZCKFSH00100]	National Major New Drug Creation of China; Science and Technology Research Foundation of Tianjin, China	This work was supported by the National Major New Drug Creation of China (2009ZX09103-029) and the Science and Technology Research Foundation of Tianjin, China (09ZCKFSH00100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Akiyama Haruhiko, 2006, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V26, P23; Al-Obeidi E, 1998, MOL BIOTECHNOL, V9, P205, DOI 10.1007/BF02915794; Banks WA, 1996, LIFE SCI, V59, P1923, DOI 10.1016/S0024-3205(96)00380-3; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Casal C, 2004, NEUROSCI RES, V48, P315, DOI 10.1016/j.neures.2003.11.006; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; Estrada LD, 2006, CURR PHARM DESIGN, V12, P2557, DOI 10.2174/138161206777698792; ETIENNE P, 1986, NEUROSCIENCE, V19, P1279, DOI 10.1016/0306-4522(86)90142-9; Fu AL, 2004, NEUROSCI LETT, V368, P258, DOI 10.1016/j.neulet.2004.05.116; GEULA C, 1989, NEUROSCIENCE, V33, P469, DOI 10.1016/0306-4522(89)90399-0; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Inestrose Nibaldo C., 2004, Current Alzheimer Research, V1, P249, DOI 10.2174/1567205043332063; IVERSEN LL, 1995, BIOCHEM J, V311, P1; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Joseph J, 2001, NEUROBIOL AGING, V22, P131, DOI 10.1016/S0197-4580(00)00211-6; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Li Mei, 2009, Zhongguo Xinyao yu Linchuang Zazhi, V28, P106; Li YK, 2003, J NEUROSCI, V23, P1605; [马志红 MA Zhihong], 2008, [天津医药, Tianjin Medical Journal], V36, P198; Nadimpally KC, 2014, ACS CHEM NEUROSCI, V5, P400, DOI 10.1021/cn500064z; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Robinson SR, 2002, NEUROBIOL AGING, V23, P1051, DOI 10.1016/S0197-4580(01)00342-6; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Song M, 2010, J TIANJIN MED U, V16, P566; Soto C, 1999, J MOL MED-JMM, V77, P412, DOI 10.1007/s001090050371; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Vitiello G, 2012, BIOCHEM BIOPH RES CO, V417, P88, DOI 10.1016/j.bbrc.2011.11.061; Vitiello G, 2010, J PEPT SCI, V16, P115, DOI 10.1002/psc.1207; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang M, 2010, TIANJIN MED J, V38, P405; Wang ZQ, 2004, J MED CHEM, V47, P3329, DOI 10.1021/jm034224e; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yamada N, 2004, PHARMACOL BIOCHEM BE, V78, P787, DOI 10.1016/j.pbb.2004.05.017; Zhao Juan, 2008, Zhongguo Xinyao yu Linchuang Zazhi, V27, P675	49	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112052	10.1371/journal.pone.0112052	http://dx.doi.org/10.1371/journal.pone.0112052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372040	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900106
J	Shortt, K; Chaudhary, S; Grigoryev, D; Heruth, DP; Venkitachalam, L; Zhang, LQ; Ye, SQ				Shortt, Katherine; Chaudhary, Suman; Grigoryev, Dmitry; Heruth, Daniel P.; Venkitachalam, Lakshmi; Zhang, Li Q.; Ye, Shui Q.			Identification of Novel Single Nucleotide Polymorphisms Associated with Acute Respiratory Distress Syndrome by Exome-Seq	PLOS ONE			English	Article							ACUTE LUNG INJURY; GENOME-WIDE ASSOCIATION; COLONY-ENHANCING FACTOR; GENE POLYMORPHISMS; POPULATION; STRATIFICATION; EPIDEMIOLOGY; OUTCOMES; SEPSIS; XP22.3	Acute respiratory distress syndrome (ARDS) is a lung condition characterized by impaired gas exchange with systemic release of inflammatory mediators, causing pulmonary inflammation, vascular leak and hypoxemia. Existing biomarkers have limited effectiveness as diagnostic and therapeutic targets. To identify disease-associating variants in ARDS patients, whole-exome sequencing was performed on 96 ARDS patients, detecting 1,382,399 SNPs. By comparing these exome data to those of the 1000 Genomes Project, we identified a number of single nucleotide polymorphisms (SNP) which are potentially associated with ARDS. 50,190SNPs were found in all case subgroups and controls, of which89 SNPs were associated with susceptibility. We validated three SNPs (rs78142040, rs9605146 and rs3848719) in additional ARDS patients to substantiate their associations with susceptibility, severity and outcome of ARDS. rs78142040 (C>T) occurs within a histone mark (intron 6) of the Arylsulfatase D gene. rs9605146 (G>A) causes a deleterious coding change (proline to leucine) in the XK, Kell blood group complex subunit-related family, member 3 gene. rs3848719 (G>A) is a synonymous SNP in the Zinc-Finger/Leucine-Zipper Co-Transducer NIF1 gene. rs78142040, rs9605146, and rs3848719 are associated significantly with susceptibility to ARDS. rs3848719 is associated with APACHE II score quartile. rs78142040 is associated with 60-day mortality in the overall ARDS patient population. Exome-seq is a powerful tool to identify potential new biomarkers for ARDS. We selectively validated three SNPs which have not been previously associated with ARDS and represent potential new genetic biomarkers for ARDS. Additional validation in larger patient populations and further exploration of underlying molecular mechanisms are warranted.	[Shortt, Katherine; Chaudhary, Suman; Grigoryev, Dmitry; Heruth, Daniel P.; Zhang, Li Q.; Ye, Shui Q.] Univ Missouri, Sch Med, Childrens Mercy Hosp, Dept Pediat,Div Expt & Translat Genet, Kansas City, MO 64110 USA; [Shortt, Katherine; Grigoryev, Dmitry; Venkitachalam, Lakshmi; Ye, Shui Q.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Ye, SQ (corresponding author), Univ Missouri, Sch Med, Childrens Mercy Hosp, Dept Pediat,Div Expt & Translat Genet, Kansas City, MO 64110 USA.	sqye@cmh.edu	; Grigoryev, Dmitry/C-9422-2015	Shortt, Katherine/0000-0002-6207-1862; Venkitachalam, Lakshmi/0000-0003-0703-3932; Grigoryev, Dmitry/0000-0002-1849-1763	NHLBI/NIH Grant [HL080042, HL080042-S1]; endowments of Children's Mercy Hospitals and Clinics; UMKC; Sarah Morrison Student Research Award of UMKC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080042] Funding Source: NIH RePORTER	NHLBI/NIH Grant; endowments of Children's Mercy Hospitals and Clinics; UMKC; Sarah Morrison Student Research Award of UMKC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was in part provided by NHLBI/NIH Grant (HL080042 & HL080042-S1, Ye, SQ), start-up fund and endowments of Children's Mercy Hospitals and Clinics, UMKC (Ye, SQ), and a Sarah Morrison Student Research Award of UMKC (Shortt, K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anasiewicz A, 1997, Wiad Lek, V50 Suppl 1 Pt 2, P96; ASHBAUGH DG, 1967, LANCET, V2, P319; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Crader KM, 2012, J PULMONAR RESPIRAT, V2; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dooley TP, 2000, BIOCHEM BIOPH RES CO, V277, P236, DOI 10.1006/bbrc.2000.3643; Fang XC, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-9; Flores C, 2010, MINERVA ANESTESIOL, V76, P860; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; Garcia JG, 2005, T AM CLIN CLIMAT ASS, P116; Garcia Joe G N, 2005, Trans Am Clin Climatol Assoc, V116, P205; Goh Gerald, 2012, Genomics & Informatics, V10, P214, DOI 10.5808/GI.2012.10.4.214; Gong MN, 2006, CLIN CHEST MED, V27, P705, DOI 10.1016/j.ccm.2006.07.001; Gullapalli Rama R, 2012, J Pathol Inform, V3, P40, DOI 10.4103/2153-3539.103013; Hinrichs AL, 2009, GENET EPIDEMIOL, V33, pS88, DOI 10.1002/gepi.20478; Khrunin AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058552; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Le Goff GC, 2010, ANAL CHEM, V82, P6185, DOI 10.1021/ac101008d; Lee KA, 2011, CHEST, V140, P382, DOI 10.1378/chest.10-3100; Liu YX, 2012, CLIN CHEM LAB MED, V50, P1917, DOI 10.1515/cclm-2012-0238; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; McGlothlin JR, 2005, BIOCHEM GENET, V43, P127, DOI 10.1007/s10528-005-1505-2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Takata A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r92; Trojani A, 2012, CANCER BIOMARK, V11, P15, DOI 10.3233/CBM-2012-0259; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-62; Urbitsch P, 2000, DNA CELL BIOL, V19, P765, DOI 10.1089/104454900750058125; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111953	10.1371/journal.pone.0111953	http://dx.doi.org/10.1371/journal.pone.0111953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372662	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900094
J	Sugawara, SK; Tanaka, S; Tanaka, D; Seki, A; Uchiyama, HT; Okazaki, S; Koeda, T; Sadato, N				Sugawara, Sho K.; Tanaka, Satoshi; Tanaka, Daisuke; Seki, Ayumi; Uchiyama, Hitoshi T.; Okazaki, Shuntaro; Koeda, Tastuya; Sadato, Norihiro			Sleep Is Associated with Offline Improvement of Motor Sequence Skill in Children	PLOS ONE			English	Article							TIME-COURSE; CONSOLIDATION; MEMORY; PERFORMANCE; ADOLESCENCE; ADAPTATION; PARAMETERS; CHILDHOOD; SPINDLES; VALUES	In adults, sleep is necessary for the offline improvement of certain skills, such as sequential finger tapping, but whether children show a similar effect is still debatable. Here, we tested whether sleep is associated with offline performance improvement in children. Nine- and 11-year-old children trained on an explicit sequential finger tapping task. On the night following training, their parents observed and recorded the duration of each child's sleep. The following day, all children performed a surprise retest session on the previously trained sequence. In both 9- and 11-year-old children, skill performance was significantly improved during the first retest session relative to the end of training on the previous day, confirming the offline improvement in performance. There was a significant correlation between the degree of improvement and sleep duration the night after training, suggesting that in children, as in adults, sleep is associated with offline skill enhancement.	[Sugawara, Sho K.; Okazaki, Shuntaro; Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan; [Sugawara, Sho K.] Japan Soc Promot Sci, Tokyo, Japan; [Tanaka, Satoshi] Hamamatsu Univ, Sch Med, Psychol Lab, Hamamatsu, Shizuoka, Japan; [Tanaka, Daisuke; Seki, Ayumi; Koeda, Tastuya] Tottori Univ, Fac Reg Sci, Dept Educ, Tottori 680, Japan; [Seki, Ayumi; Koeda, Tastuya] Natl Hosp Org, Tottori Med Ctr, Dept Clin Res, Tottori, Japan; [Uchiyama, Hitoshi T.] Int Univ Hlth & Welf, Sch Hlth Sci, Ohtawara, Japan; [Sadato, Norihiro] Grad Univ Adv Studies, SOKENDAI, Dept Physiol Sci, Hayama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Society for the Promotion of Science; Hamamatsu University School of Medicine; Tottori University; International University of Health & Welfare; Graduate University for Advanced Studies - Japan	Sadato, N (corresponding author), Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan.	sadato@nips.ac.jp	OKAZAKI, SHUNTARO/U-6813-2019	Sadato, Norihiro/0000-0002-9786-3907	Japan Society for the Promotion of Science [S21220005]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research S21220005 to N.S. from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). Part of this study is the result of the project "Development of biomarker candidates for social behavior", carried out under the Strategic Research Program for Brain Science by the Minister of Education, Culture, Sports, Science and Technology of Japan (http://brainprogram.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G., 2012, J SLEEP RES, V22, P144; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Carskadon M.A., 2011, PRINC PRACT SLEEP ME, V4, P16, DOI [10.1016/b978-1-4160-6645-3.00002-5, DOI 10.1016/B978-1-4160-6645-3.00002-5]; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Dorfberger S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000240; Dorffierger S, 2009, BEHAV BRAIN RES, V198, P165, DOI 10.1016/j.bbr.2008.10.033; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fischer S, 2007, J COGNITIVE NEUROSCI, V19, P214, DOI 10.1162/jocn.2007.19.2.214; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Largo RH, 2001, DEV MED CHILD NEUROL, V43, P436, DOI 10.1017/S0012162201000810; MERICA H, 1985, SLEEP, V8, P261, DOI 10.1093/sleep/8.3.261; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Scholle S, 2011, SLEEP MED, V12, P542, DOI 10.1016/j.sleep.2010.11.011; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Sugawara SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048174; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111635	10.1371/journal.pone.0111635	http://dx.doi.org/10.1371/journal.pone.0111635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372609	gold, Green Published			2022-12-27	WOS:000344556900057
J	Angers, A; Drapeau, P				Angers, Annie; Drapeau, Pierre			Itch Is Required for Lateral Line Development in Zebrafish	PLOS ONE			English	Article							UBIQUITIN LIGASE ITCH; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL-GROWTH-FACTOR; INTERACTING PROTEIN 4; CELL-MIGRATION; WNT/BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TISSUE MIGRATION; DOWN-REGULATION	The zebrafish posterior lateral line is formed during early development by the deposition of neuromasts from a migrating primordium. The molecular mechanisms regulating the regional organization and migration of the primordium involve interactions between Fgf and Wnt/beta-catenin signaling and the establishment of specific cxcr4b and cxcr7b cytokine receptor expression domains. Itch has been identified as a regulator in several different signaling pathways, including Wnt and Cxcr4 signaling. We identified two homologous itch genes in zebrafish, itcha and itchb, with generalized expression patterns. By reducing itchb expression in particular upon morpholino knockdown, we demonstrated the importance of Itch in regulating lateral line development by perturbing the patterns of cxcr4b and cxcr7b expression. Itch knockdown results in a failure to down-regulate Wnt signaling and overexpression of cxcr4b in the primordium, slowing migration of the posterior lateral line primordium and resulting in abnormal development of the lateral line.	[Angers, Annie] Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Ctr Hosp, Dept Neurosci, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, GRSNC, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Angers, A (corresponding author), Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada.	annie.angers@umontreal.ca	Angers, Annie/P-1217-2018	Angers, Annie/0000-0003-0131-256X	Natural Sciences and Engineering Research Council of Canada [288238]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Neuroscience; Fonds de recherche en sante du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Neuroscience; Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	Funding provided by AA Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.ca) grant No. 288238, PD Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.ca) grant, PD Canada Research Chair in Neuroscience (http://www.chairs-chaires.gc.ca) and PD Fonds de recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/fr/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov V, 2011, MOL BIOSYST, V7, P3223, DOI 10.1039/c1mb05185g; Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Aman A, 2011, CELL ADHES MIGR, V5, P499, DOI 10.4161/cam.5.6.19113; Aman A, 2011, DEV BIOL, V349, P470, DOI 10.1016/j.ydbio.2010.10.022; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x; Azakir BA, 2009, CELL SIGNAL, V21, P1326, DOI 10.1016/j.cellsig.2009.03.020; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Breau MA, 2012, DEVELOPMENT, V139, P2246, DOI 10.1242/dev.080275; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Chitnis AB, 2012, DEV NEUROBIOL, V72, P234, DOI 10.1002/dneu.20962; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COLLAZO A, 1994, SCIENCE, V264, P426, DOI 10.1126/science.8153631; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gamba L, 2010, DEV DYNAM, V239, P3163, DOI 10.1002/dvdy.22469; Gamba L, 2010, P NATL ACAD SCI USA, V107, P6358, DOI 10.1073/pnas.0909998107; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hansen TM, 2007, BIOCHEM BIOPH RES CO, V361, P33, DOI 10.1016/j.bbrc.2007.06.104; Head JR, 2013, DEV DYNAM, V242, P832, DOI 10.1002/dvdy.23973; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Kabashi E, 2010, TRENDS GENET, V26, P373, DOI 10.1016/j.tig.2010.05.004; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lum WM, 2011, ZEBRAFISH, V8, P65, DOI 10.1089/zeb.2011.0691; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2009, METHOD ENZYMOL, V460, P413, DOI 10.1016/S0076-6879(09)05221-5; Matsuda M, 2013, DEVELOPMENT, V140, P2387, DOI 10.1242/dev.091348; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Mizoguchi T, 2011, J NEUROSCI, V31, P15522, DOI 10.1523/JNEUROSCI.3948-11.2011; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Parravicini V, 2008, BLOOD, V111, P4273, DOI 10.1182/blood-2007-10-115667; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; Rathinam C, 2011, NAT IMMUNOL, V12, P399, DOI 10.1038/ni.2021; Rossi M, 2006, CELL CYCLE, V5, P1816, DOI 10.4161/cc.5.16.2861; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; Schuler S, 2013, J CELL SCI, V126, P196, DOI 10.1242/jcs.111674; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; Valdivia LE, 2011, DEVELOPMENT, V138, P3931, DOI 10.1242/dev.062695; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	72	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111799	10.1371/journal.pone.0111799	http://dx.doi.org/10.1371/journal.pone.0111799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369329	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000104
J	Attarwala, AA; Molina-Duran, F; Busing, KA; Schonberg, SO; Bailey, DL; Willowson, K; Glatting, G				Attarwala, Ali Asgar; Molina-Duran, Flavia; Buesing, Karen-Anett; Schoenberg, Stefan O.; Bailey, Dale L.; Willowson, Kathy; Glatting, Gerhard			Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging	PLOS ONE			English	Article							INTERNAL PAIR PRODUCTION; HEPATOCELLULAR-CARCINOMA; RADIONUCLIDE THERAPY; COMPUTED-TOMOGRAPHY; DOSE-RESPONSE; MICROSPHERES; EMISSION; DOSIMETRY; TIME	Yttrium-90 is known to have a low positron emission decay of 32 ppm that may allow for personalized dosimetry of liver cancer therapy with Y-90 labeled microspheres. The aim of this work was to image and quantify Y-90 so that accurate predictions of the absorbed dose can be made. The measurements were performed within the QUEST study (University of Sydney, and Sirtex Medical, Australia). A NEMA IEC body phantom containing 6 fillable spheres (10-37 mm) was used to measure the Y-90 distribution with a Biograph mCT PET/CT (Siemens, Erlangen, Germany) with time-of-flight (TOF) acquisition. A sphere to background ratio of 8:1, with a total Y-90 activity of 3 GBq was used. Measurements were performed for one week (0, 3, 5 and 7 d). he acquisition protocol consisted of 30 min-2 bed positions and 120 min-single bed position. mages were reconstructed with 3D ordered subset expectation maximization (OSEM) and point spread function (PSF) for iteration numbers of 1-12 with 21 (TOF) and 24 (non-TOF) subsets and CT based attenuation and scatter correction. Convergence of algorithms and activity recovery was assessed based on regions-of-interest (ROI) analysis of the background (100 voxels), spheres (4 voxels) and the central low density insert (25 voxels). For the largest sphere, the recovery coefficient (RC) values for the 30 min-2-bed position, 30 min-single bed and 120 min-single bed were 1.12 +/- 0.20, 1.14 +/- 0.13, 0.97 +/- 0.07 respectively. For the smaller diameter spheres, the PSF algorithm with TOF and single bed acquisition provided a comparatively better activity recovery. Quantification of Y-90 using Biograph mCT PET/CT is possible with a reasonable accuracy, the limitations being the size of the lesion and the activity concentration present. At this stage, based on our study, it seems advantageous to use different protocols depending on the size of the lesion.	[Attarwala, Ali Asgar; Molina-Duran, Flavia; Glatting, Gerhard] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Mannheim, Germany; [Buesing, Karen-Anett; Schoenberg, Stefan O.] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Bailey, Dale L.] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia; [Willowson, Kathy] Univ Sydney, Sch Phys, Inst Med Phys, Sydney, NSW 2006, Australia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Royal North Shore Hospital; University of Sydney; University of Sydney	Glatting, G (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Mannheim, Germany.	gerhard.glatting@medma.uni-heidelberg.de	Bailey, Dale L/A-3359-2012; Glatting, Gerhard/ABF-2506-2020	Glatting, Gerhard/0000-0001-7916-1576	Sirtex (Sydney, Australia); "Stiftung fur Krebs und Scharlachforschung Mannheim" (Foundation for Cancer and Scarlatina Research); Australian Research Council [LP110201109]	Sirtex (Sydney, Australia); "Stiftung fur Krebs und Scharlachforschung Mannheim" (Foundation for Cancer and Scarlatina Research); Australian Research Council(Australian Research Council)	The studies reported in this publication were financially supported by Sirtex (Sydney, Australia), which is developing products related to research described in this publication. The authors (F.M. and G.G.) gratefully acknowledge a grant by the "Stiftung fur Krebs und Scharlachforschung Mannheim" (Foundation for Cancer and Scarlatina Research). KW is supported by an Australian Research Council Linkage Grant (LP110201109), of which Sirtex is a contributor as one of the linkage partners. The funder provided support in the form of salaries for authors (KW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Attarwala, 2014, QUAL QUANT ASS YTTR; Berger F, 2002, EUR J NUCL MED MOL I, V29, P1225, DOI 10.1007/s00259-002-0850-1; Buther F, 2013, EUR J NUCL MED MOL I, V40, P602, DOI 10.1007/s00259-012-2313-7; Campbell JM, 2009, INT J RADIAT ONCOL, V74, P313, DOI 10.1016/j.ijrobp.2008.12.058; Carlier T, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-11; Cherubal S., 2006, Proceedings. 14th Asian Test Symposium, DOI 10.1007/0-387-34946-4_1; Clifford Mark A, 2002, Comput Aided Surg, V7, P291, DOI 10.3109/10929080209146038; D'Arienzo M, 2013, ATOMS, V1, P2, DOI 10.3390/atoms1010002; Elschot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055742; Elschot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026174; FORD KW, 1955, PHYS REV, V98, P1516, DOI 10.1103/PhysRev.98.1516; Garin E, 2013, EUR J NUCL MED MOL I, V40, P1057, DOI 10.1007/s00259-013-2395-x; Glatting G, 2011, Z MED PHYS, V21, P246, DOI 10.1016/j.zemedi.2011.07.005; Gobel T, 2013, Dtsch Med Wochenschr, V138, P1425, DOI 10.1055/s-0033-1343232; Goedicke A, 2013, IEEE T MED IMAGING, V32, P485, DOI 10.1109/TMI.2012.2221135; GREENBERG JS, 1956, PHYS REV, V102, P415, DOI 10.1103/PhysRev.102.415; Healthcare S, 2008, BIOGRAPH MCT TECHNOL; Jelic S, 2010, ANN ONCOL, V21, P59, DOI DOI 10.1093/ANN0NC/MDQ166); Kao YH, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-57; Kao YH, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-56; Kennedy AS, 2010, CANCER J, V16, P163, DOI 10.1097/PPO.0b013e3181d7e8cf; Kim Greer CNMT, 2002, NEMA IEC BOD PHANT U; Kucuk ON, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-86; Lambert B, 2010, ACTA GASTRO-ENT BELG, V73, P484; Lau WY, 2011, INT J RADIAT ONCOL, V81, P460, DOI 10.1016/j.ijrobp.2010.06.010; Lhommel R, 2010, EUR J NUCL MED MOL I, V37, P1654, DOI 10.1007/s00259-010-1470-9; Mamawan MD, 2013, J NUCL MED TECHNOL, V41, P42, DOI 10.2967/jnmt.112.114413; Minarik D, 2009, PHYS MED BIOL, V54, P5873, DOI 10.1088/0031-9155/54/19/014; Minarik D, 2010, J NUCL MED, V51, P1974, DOI 10.2967/jnumed.110.079897; Molina-Duran F, 2014, Z MED PHYS, V24, P73, DOI [10.1016/j.zemedi.2013.03.002, 10.1016/j.zemedi.201.3.03.002]; Nickles RJ, 2004, ASSAYING PET IMAGING, V3416; Preylowski V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071729; Rietzel E, 2005, MED PHYS, V32, P874, DOI 10.1118/1.1869852; Selwyn RG, 2007, APPL RADIAT ISOTOPES, V65, P318, DOI 10.1016/j.apradiso.2006.08.009; Sirtex Technology Pty Ltd S A The University of Sydney and Royal North Shore Hospital, 2013, QUEST SIT ASS PROT S; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Stubbs R S, 2004, HPB (Oxford), V6, P133, DOI 10.1080/13651820410025084; Walrand S, 2011, EUR J NUCL MED MOL I, V38, P57, DOI 10.1007/s00259-011-1771-7; Willowson K, 2012, MED PHYS, V39, P7153, DOI 10.1118/1.4762403; Wink NM, 2006, J APPL CLIN MED PHYS, V7, P77, DOI 10.1120/jacmp.2027.25373; Zhu AX, 2006, ONCOLOGIST, V11, P790, DOI 10.1634/theoncologist.11-7-790	41	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110401	10.1371/journal.pone.0110401	http://dx.doi.org/10.1371/journal.pone.0110401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369020	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000019
J	Chow, CK; Corsi, DJ; Lock, K; Madhavan, M; Mackie, P; Li, W; Yi, S; Wang, Y; Swaminathan, S; Lopez-Jaramillo, P; Gomez-Arbelaez, D; Avezum, A; Lear, SA; Dagenais, G; Teo, K; Mckee, M; Yusuf, S				Chow, Clara K.; Corsi, Daniel J.; Lock, Karen; Madhavan, Manisha; Mackie, Pam; Li, Wei; Yi, Sun; Wang, Yang; Swaminathan, Sumathi; Lopez-Jaramillo, Patricio; Gomez-Arbelaez, Diego; Avezum, Alvaro; Lear, Scott A.; Dagenais, Gilles; Teo, Koon; McKee, Martin; Yusuf, Salim			A Novel Method to Evaluate the Community Built Environment Using Photographs - Environmental Profile of a Community Health (EPOCH) Photo Neighbourhood Evaluation Tool	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIETAL INFLUENCES; WALKABILITY SCALE; COUNTRIES; INSTRUMENT; VALIDITY; ADULTS; LEVEL	Background: Previous research has shown that environments with features that encourage walking are associated with increased physical activity. Existing methods to assess the built environment using geographical information systems (GIS) data, direct audit or large surveys of the residents face constraints, such as data availability and comparability, when used to study communities in countries in diverse parts of the world. The aim of this study was to develop a method to evaluate features of the built environment of communities using a standard set of photos. In this report we describe the method of photo collection, photo analysis instrument development and inter-rater reliability of the instrument. Methods/Principal Findings: A minimum of 5 photos were taken per community in 86 communities in 5 countries according to a standard set of instructions from a designated central point of each community by researchers at each site. A standard pro forma derived from reviewing existing instruments to assess the built environment was developed and used to score the characteristics of each community. Photo sets from each community were assessed independently by three observers in the central research office according to the pro forma and the inter-rater reliability was compared by intra-class correlation (ICC). Overall 87% (53 of 60) items had an ICC of >= 0.70, 7% (4 of 60) had an ICC between 0.60 and 0.70 and 5% (3 of 60) items had an ICC < 0.50. Conclusions/Significance: Analysis of photos using a standardized protocol as described in this study offers a means to obtain reliable and reproducible information on the built environment in communities in very diverse locations around the world. The collection of the photographic data required minimal training and the analysis demonstrated high reliability for the majority of items of interest.	[Chow, Clara K.; Corsi, Daniel J.; Madhavan, Manisha; Mackie, Pam; Teo, Koon; Yusuf, Salim] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Chow, Clara K.] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Chow, Clara K.] Univ Sydney, Sydney Med Sch, Westmead Hosp, Sydney, NSW 2006, Australia; [Lock, Karen; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Corsi, Daniel J.] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Li, Wei; Yi, Sun; Wang, Yang] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Li, Wei; Yi, Sun; Wang, Yang] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Swaminathan, Sumathi] St Johns Natl Acad Hlth Sci, St Johns Res Inst, Bangalore, Karnataka, India; [Lopez-Jaramillo, Patricio; Gomez-Arbelaez, Diego] Univ Santander, Fdn Oftalmol Santander Clin Carlos Arila Lulle, Res Direct, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio; Gomez-Arbelaez, Diego] Univ Santander, Sch Med, Bucaramanga, Colombia; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Lear, Scott A.] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	McMaster University; Population Health Research Institute; George Institute for Global Health; University of Sydney; University of Sydney; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; St. John's National Academy of Health Sciences; St. John's Research Institute; Universidad Industrial de Santander; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Simon Fraser University; Laval University	Chow, CK (corresponding author), McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.	cchow@georgeinstitute.org.au	Avezum, Alvaro/AAP-7687-2020; Gómez-Arbeláez, Diego/K-1883-2013; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Avezum, Alvaro AA/K-6137-2016; Swaminathan, Sumathi/AGI-7678-2022; Corsi, Daniel J/S-4689-2018	Gómez-Arbeláez, Diego/0000-0001-6150-0066; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Avezum, Alvaro AA/0000-0002-3073-6890; Corsi, Daniel J/0000-0001-7063-3354; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Teo, Koon/0000-0002-3731-0956; Yusuf, Salim/0000-0003-4776-5601	Australian National Health and Medical Research Council (NHMRC) - National Heart Foundation; Sydney Medical Foundation; Heart and Stroke Foundation of Ontario; National Institute for Health Research [PDF/01/2008/031] Funding Source: researchfish	Australian National Health and Medical Research Council (NHMRC) - National Heart Foundation; Sydney Medical Foundation; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Institute for Health Research(National Institute for Health Research (NIHR))	CK Chow is supported by an Australian National Health and Medical Research Council (NHMRC) Career development Fellowship co-funded by the National Heart Foundation and a Sydney Medical Foundation Chapman Fellowship. S Yusuf is supported by an endowed chair from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Cerin E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-309; Charreire H, 2014, HEALTH PLACE, V25, P1, DOI [10.1016/j.healthplace.2013.09.017, 10.1010/j.healthplace.2013.09.017]; Chow CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014294; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Corsi DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044410; Day K, 2006, AM J PREV MED, V30, P144, DOI 10.1016/j.amepre.2005.09.017; Foster C, 2009, J PHYS ACT HEALTH, V6, pS70, DOI 10.1123/jpah.6.s1.s70; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Gasevic D., 2011, J ENV PUBLIC HLTH, V2011; Lovasi GS, 2013, ANN BEHAV MED, V45, pS76, DOI 10.1007/s12160-012-9416-z; Parsons JA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-6; Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1; Pomerleau J, 2013, PUBLIC HEALTH, V127, P259, DOI 10.1016/j.puhe.2012.12.025; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Schaefer-McDaniel N, 2010, SOC SCI MED, V71, P651, DOI 10.1016/j.socscimed.2010.03.060; Schaefer-McDaniel N, 2010, SOC SCI MED, V70, P277, DOI 10.1016/j.socscimed.2009.10.018; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Watson K, 2013, EUR J PUBLIC HEALTH, V23, P291, DOI 10.1093/eurpub/cks054; Weich S, 2001, HEALTH PLACE, V7, P283, DOI 10.1016/S1353-8292(01)00019-3	22	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110042	10.1371/journal.pone.0110042	http://dx.doi.org/10.1371/journal.pone.0110042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369366	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000344402000016
J	Geiger, TR; Ha, NH; Faraji, F; Michael, HT; Rodriguez, L; Walker, RC; Green, JE; Simpson, RM; Hunter, KW				Geiger, Thomas R.; Ngoc-Han Ha; Faraji, Farhoud; Michael, Helen T.; Rodriguez, Loren; Walker, Renard C.; Green, Jeffery E.; Simpson, R. Mark; Hunter, Kent W.			Functional Analysis of Prognostic Gene Expression Network Genes in Metastatic Breast Cancer Models	PLOS ONE			English	Article							KINASE AURORA-A; TPX2 GENE; CARCINOMA; TUMORS; SUSCEPTIBILITY; COMPLEX; PROTEIN; SYSTEM; TARGET; CELLS	Identification of conserved co-expression networks is a useful tool for clustering groups of genes enriched for common molecular or cellular functions [1]. The relative importance of genes within networks can frequently be inferred by the degree of connectivity, with those displaying high connectivity being significantly more likely to be associated with specific molecular functions [2]. Previously we utilized cross-species network analysis to identify two network modules that were significantly associated with distant metastasis free survival in breast cancer. Here, we validate one of the highly connected genes as a metastasis associated gene. Tpx2, the most highly connected gene within a proliferation network specifically prognostic for estrogen receptor positive (ER+) breast cancers, enhances metastatic disease, but in a tumor autonomous, proliferation-independent manner. Histologic analysis suggests instead that variation of TPX2 levels within disseminated tumor cells may influence the transition between dormant to actively proliferating cells in the secondary site. These results support the co-expression network approach for identification of new metastasis-associated genes to provide new information regarding the etiology of breast cancer progression and metastatic disease.	[Geiger, Thomas R.; Ngoc-Han Ha; Faraji, Farhoud; Michael, Helen T.; Rodriguez, Loren; Walker, Renard C.; Green, Jeffery E.; Simpson, R. Mark; Hunter, Kent W.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	hunterk@mail.nih.gov	Faraji, Farhoud/AAG-2417-2019; Michael, Helen/GVS-8802-2022	Faraji, Farhoud/0000-0001-5078-813X; Michael, Helen/0000-0002-8326-0806	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC010953, ZIGBC010931] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; [Anonymous], 2003, NATURE, V426, P789; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Goldberger N, 2013, CANCER RES, V73, P2671, DOI 10.1158/0008-5472.CAN-12-3513; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu Y, 2012, P NATL ACAD SCI USA, V109, P3184, DOI 10.1073/pnas.1117872109; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Liu HC, 2013, BIOMED PHARMACOTHER, V67, P751, DOI 10.1016/j.biopha.2013.04.004; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Neumayer G, 2014, CELL MOL LIFE SCI; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Wei P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-313; Yan L, 2013, TUMOR BIOL, V34, P4089, DOI 10.1007/s13277-013-1000-z; Yang X, 2014, PATHOL ONCOL RES; Yao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045894	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111813	10.1371/journal.pone.0111813	http://dx.doi.org/10.1371/journal.pone.0111813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368990	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000106
J	Komala, MG; Gross, S; Mudaliar, H; Huang, CL; Pegg, K; Mather, A; Shen, S; Pollock, CA; Panchapakesan, U				Komala, Muralikrishna Gangadharan; Gross, Simon; Mudaliar, Harshini; Huang, Chunling; Pegg, Katherine; Mather, Amanda; Shen, Sylvie; Pollock, Carol A.; Panchapakesan, Usha			Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); PPAR-GAMMA AGONISTS; CELLS; DISEASE; INJURY; SGLT2; HYPERGLYCEMIA; TRANSPORTERS; INFLAMMATION; PROGRESSION	Background and Objective: Sodium glucose cotransporter 2 (SGLT2) is the main luminal glucose transporter in the kidney. SGLT2 inhibition results in glycosuria and improved glycaemic control. Drugs inhibiting this transporter have recently been approved for clinical use and have been suggested to have potential renoprotective benefits by limiting glycotoxicity in the proximal tubule. We aimed to determine the renoprotective benefits of empagliflozin, an SGLT2 inhibitor, independent of its glucose lowering effect. Research Design and Methods: We induced diabetes using a low dose streptozotocin protocol in 7-8 week old endothelial nitric oxide (eNOS) synthase knockout mice. We measured fasting blood glucose on a monthly basis, terminal urinary albumin/creatinine ratio. Renal histology was assessed for inflammatory and fibrotic changes. Renal cortical mRNA transcription of inflammatory and profibrotic cytokines, glucose transporters and protein expression of SGLT2 and GLUT1 were determined. Outcomes were compared to diabetic animals receiving the angiotensin receptor blocker telmisartan (current best practice). Results: Diabetic mice had high matched blood glucose levels. Empagliflozin did not attenuate diabetes-induced albuminuria, unlike telmisartan. Empagliflozin did not improve glomerulosclerosis, tubular atrophy, tubulointerstitial inflammation or fibrosis, while telmisartan attenuated these. Empagliflozin did not modify tubular toll-like receptor-2 expression in diabetic mice. Empagliflozin did not reduce the upregulation of macrophage chemoattractant protein-1 (MCP-1), transforming growth factor beta 1 and fibronectin mRNA observed in the diabetic animals, while telmisartan decreased transcription of MCP-1 and fibronectin. Empagliflozin increased GLUT1 mRNA expression and telmisartan increased SGLT2 mRNA expression in comparison to untreated diabetic mice. However no significant difference was found in protein expression of GLUT1 or SGLT2 among the different groups. Conclusion: Hence SGLT2 inhibition does not have renoprotective benefits independent of glucose lowering.	[Komala, Muralikrishna Gangadharan; Gross, Simon; Mudaliar, Harshini; Huang, Chunling; Pegg, Katherine; Mather, Amanda; Shen, Sylvie; Pollock, Carol A.; Panchapakesan, Usha] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Lab, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Panchapakesan, U (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Lab, St Leonards, NSW 2065, Australia.	usha.panchapakesan@sydney.edu.au	Gangadharan Komala, Muralikrishna/ABH-3183-2021; Gangadharan Komala, Muralikrishna/ABA-5078-2021	Gangadharan Komala, Muralikrishna/0000-0003-0534-0584	National Health and Medical Research Council, Australia [APP1004926]; Research Entry Scholarship from the Jacquot Foundation through the Royal Australasian College of Physicians; Boehringer Ingelheim, Germany	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Research Entry Scholarship from the Jacquot Foundation through the Royal Australasian College of Physicians; Boehringer Ingelheim, Germany(Boehringer Ingelheim)	The study was funded by a Research Grant from the National Health and Medical Research Council, Australia (APP1004926, https://www.nhmrc.gov.au). MGK received Research Entry Scholarship from the Jacquot Foundation through the Royal Australasian College of Physicians. The study drug empagliflozin and telmisartan was supplied by Boehringer Ingelheim, Germany, and they partially funded the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PW, 1996, KIDNEY INT, V50, P745, DOI 10.1038/ki.1996.372; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Evans M, 2012, NEPHROL DIAL TRANSPL, V27, P2255, DOI 10.1093/ndt/gfr696; Ghezzi C, 2012, AM J PHYSIOL-CELL PH, V303, pC348, DOI 10.1152/ajpcell.00115.2012; Ghosh RK, 2012, J CLIN PHARMACOL, V52, P457, DOI 10.1177/0091270011400604; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Johnson DW, 1998, KIDNEY INT, V53, P1601, DOI 10.1046/j.1523-1755.1998.00916.x; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; Mather A, 2011, KIDNEY INT S, DOI [10.1038/ki.2010.509:S1-6, DOI 10.1038/KI.2010.509:S1-6]; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Mudaliar H, 2013, AM J PHYSIOL-RENAL, V305, pF143, DOI 10.1152/ajprenal.00398.2012; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Panchapakesan U, 2004, AM J PHYSIOL-RENAL, V287, pF528, DOI 10.1152/ajprenal.00445.2003; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; POLLOCK CA, 1991, AM J PHYSIOL, V260, pF946, DOI 10.1152/ajprenal.1991.260.6.F946; POLLOCK CA, 1991, PFLUG ARCH EUR J PHY, V418, P14, DOI 10.1007/BF00370446; Powell DR, 2013, AM J PHYSIOL-ENDOC M, V304, pE117, DOI 10.1152/ajpendo.00439.2012; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2006, AM J PHYSIOL-RENAL, V291, pF1070, DOI 10.1152/ajprenal.00013.2006; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Sarafidis PA, 2006, AM J NEPHROL, V26, P232, DOI 10.1159/000093632; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Vallon V, 2010, CURR OPIN NEPHROL HY, V19, P425, DOI 10.1097/MNH.0b013e32833bec06; Yale JF, 2013, DIABETES OBES METAB, V15, P463, DOI 10.1111/dom.12090; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	33	40	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e108994	10.1371/journal.pone.0108994	http://dx.doi.org/10.1371/journal.pone.0108994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369239	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000006
J	Nguyen, M; Boutinaud, M; Petridou, B; Gabory, A; Pannetier, M; Chat, S; Bouet, S; Jouneau, L; Jaffrezic, F; Laloe, D; Klopp, C; Brun, N; Kress, C; Jammes, H; Charlier, M; Devinoy, E				Nguyen, Minh; Boutinaud, Marion; Petridou, Barbara; Gabory, Anne; Pannetier, Maelle; Chat, Sophie; Bouet, Stephan; Jouneau, Luc; Jaffrezic, Florence; Laloe, Denis; Klopp, Christophe; Brun, Nicolas; Kress, Clemence; Jammes, Helene; Charlier, Madia; Devinoy, Eve			DNA Methylation and Transcription in a Distal Region Upstream from the Bovine AlphaS1 Casein Gene after Once or Twice Daily Milking	PLOS ONE			English	Article							ONCE-DAILY MILKING; MAMMARY EPITHELIAL-CELLS; EXPRESSION ANALYSIS; STAT5; BINDING; LACTATION; PROTEIN; PROMOTER; SEQUENCE; GLAND	Once daily milking (ODM) induces a reduction in milk production when compared to twice daily milking (TDM). Unilateral ODM of one udder half and TDM of the other half, enables the study of underlying mechanisms independently of inter-individual variability (same genetic background) and of environmental factors. Our results show that in first-calf heifers three CpG, located 10 kb upstream from the CSN1S1 gene were methylated to 33, 34 and 28%, respectively, after TDM but these levels were higher after ODM, 38, 38 and 33%, respectively. These methylation levels were much lower than those observed in the mammary gland during pregnancy (57, 59 and 50%, respectively) or in the liver (74, 78 and 61%, respectively). The methylation level of a fourth CpG (CpG4), located close by (29% during TDM) was not altered after ODM. CpG4 methylation reached 39.7% and 59.5%, during pregnancy or in the liver, respectively. CpG4 is located within a weak STAT5 binding element, arranged in tandem with a second high affinity STAT5 element. STAT5 binding is only marginally modulated by CpG4 methylation, but it may be altered by the methylation levels of the three other CpG nearby. Our results therefore shed light on mechanisms that help to explain how milk production is almost, but not fully, restored when TDM is resumed (15.1 +/- 0.2 kg/day instead of 16.2 +/- 0.2 kg/day, p<0.01). The STAT5 elements are 100 bp away from a region transcribed in the antisense orientation, in the mammary gland during lactation, but not during pregnancy or in other reproductive organs (ovary or testes). We now need to clarify whether the transcription of this novel RNA is a consequence of STAT5 interacting with the CSN1S1 distal region, or whether it plays a role in the chromatin structure of this region.	[Nguyen, Minh; Petridou, Barbara; Chat, Sophie; Bouet, Stephan; Jaffrezic, Florence; Laloe, Denis; Brun, Nicolas; Charlier, Madia; Devinoy, Eve] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Boutinaud, Marion] INRA, Physiol Environm & Genet Anim & Syst Elevage UMR1, St Gilles, France; [Pannetier, Maelle; Jouneau, Luc; Jammes, Helene] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Klopp, Christophe] INRA, Sigenae, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Kress, Clemence] Univ Lyon 1, INRA, INSERM,U846,UMR S 846, AGROBIOSYSTEM,Stem Cell & Brain Res Inst,USC1361, Bron, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Devinoy, E (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	eve.devinoy@jouy.inra.fr	Jouneau, Luc/AAC-4711-2020; Klopp, Christophe/J-3164-2019; Laloe, Denis/O-7045-2019; Pannetier, Maëlle/AAQ-1626-2020	Klopp, Christophe/0000-0001-7126-5477; Laloe, Denis/0000-0001-8359-0760; Gabory, Anne/0000-0002-0059-7375; Chat, Sophie/0000-0003-0671-5229	INRA PHASE Division (CI "Epigenetique"); French ANR; APIS-GENE [PCS-09-GENM-022]	INRA PHASE Division (CI "Epigenetique"); French ANR(French National Research Agency (ANR)); APIS-GENE	This project and Minh Nguyen's position were funded by the INRA PHASE Division (CI "Epigenetique" 2011-2013) and the French ANR with the support of APIS-GENE (PCS-09-GENM-022, 2010-2014). The funders agreed with the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ben Chedly H, 2013, ANIMAL, V7, P124, DOI 10.1017/S1751731112001176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Boutinaud M, 2004, DOMEST ANIM ENDOCRIN, V27, P363, DOI 10.1016/j.domaniend.2004.04.002; Boutinaud M, 2013, PHYSIOL GENOMICS, V45, P973, DOI 10.1152/physiolgenomics.00059.2013; Buser AC, 2011, MOL ENDOCRINOL, V25, P955, DOI 10.1210/me.2011-0064; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Davis SR, 1999, LIVEST PROD SCI, V59, P77, DOI 10.1016/S0301-6226(98)00204-8; de Sousa-Pereira P, 2013, ARCH ORAL BIOL, V58, P451, DOI 10.1016/j.archoralbio.2012.12.011; Delamaire E, 2006, J DAIRY SCI, V89, P3439, DOI 10.3168/jds.S0022-0302(06)72381-5; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eleswarapu S, 2008, ENDOCRINOLOGY, V149, P2230, DOI 10.1210/en.2007-1344; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Farr VC, 2000, AM J PHYSIOL-HEART C, V279, pH1813, DOI 10.1152/ajpheart.2000.279.4.H1813; Farrar MA, 2011, NAT IMMUNOL, V12, P1139, DOI 10.1038/ni.2163; Foster JS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-227; Gerencser A, 2002, GENET SEL EVOL, V34, P117, DOI [10.1186/1297-9686-34-1-117, 10.1051/gse:2001007]; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Imamura Y, 2009, J BIOCHEM, V145, P279, DOI 10.1093/jb/mvn165; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kress C, 2011, CHROMOSOME RES, V19, P979, DOI 10.1007/s10577-011-9249-9; Laz EV, 2009, MOL ENDOCRINOL, V23, P1242, DOI 10.1210/me.2008-0449; Lemay DG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-872; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Littlejohn MD, 2010, PHYSIOL GENOMICS, V41, P21, DOI 10.1152/physiolgenomics.00108.2009; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mariette J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-462; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Meyer WKH, 1997, J BIOL CHEM, V272, P31821, DOI 10.1074/jbc.272.50.31821; Millot B, 2003, BIOCHEM J, V372, P41, DOI 10.1042/BJ20021894; Montazer-Torbati MB, 2008, EXP CELL RES, V314, P975, DOI 10.1016/j.yexcr.2008.01.001; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; PIERRE S, 1994, MOL ENDOCRINOL, V8, P1720, DOI 10.1210/me.8.12.1720; Platenburg GJ, 1996, TRANSGENIC RES, V5, P421, DOI 10.1007/BF01980207; Remond B, 2007, LIVEST SCI, V110, P192, DOI 10.1016/j.livsci.2006.12.009; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; SABATINI LM, 1989, J DENT RES, V68, P1138, DOI 10.1177/00220345890680070101; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Sakurada K, 2011, LEGAL MED-TOKYO, V13, P309, DOI 10.1016/j.legalmed.2011.07.002; Seyfert HM, 2000, J MOL EVOL, V50, P550, DOI 10.1007/s002390010058; Sigl T, 2014, J ANIM PHYSIOL AN N, V98, P84, DOI 10.1111/jpn.12039; Singh K, 2008, J DAIRY SCI, V91, P2236, DOI 10.3168/jds.2007-0900; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; STEWART AF, 1984, NUCLEIC ACIDS RES, V12, P3895, DOI 10.1093/nar/12.9.3895; Tost Jorg, 2007, V373, P89; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Wheeler TT, 1997, MOL CELL ENDOCRINOL, V133, P141, DOI 10.1016/S0303-7207(97)00161-5; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Yandell BS, 1997, PRACTICAL DATA ANAL; Yang J, 2000, J ANIM SCI, V78, P3126; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	63	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111556	10.1371/journal.pone.0111556	http://dx.doi.org/10.1371/journal.pone.0111556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369064	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000068
J	Trachana, K; Forslund, K; Larsson, T; Powell, S; Doerks, T; von Mering, C; Bork, P				Trachana, Kalliopi; Forslund, Kristoffer; Larsson, Tomas; Powell, Sean; Doerks, Tobias; von Mering, Christian; Bork, Peer			A Phylogeny-Based Benchmarking Test for Orthology Inference Reveals the Limitations of Function-Based Validation	PLOS ONE			English	Article							GENE; EVOLUTION; ARCHAEAL; GENOMES; TREE; RECONSTRUCTION; IDENTIFICATION; CONSERVATION; ARCHITECTURE; PERFORMANCE	Accurate orthology prediction is crucial for many applications in the post-genomic era. The lack of broadly accepted benchmark tests precludes a comprehensive analysis of orthology inference. So far, functional annotation between orthologs serves as a performance proxy. However, this violates the fundamental principle of orthology as an evolutionary definition, while it is often not applicable due to limited experimental evidence for most species. Therefore, we constructed high quality "gold standard" orthologous groups that can serve as a benchmark set for orthology inference in bacterial species. Herein, we used this dataset to demonstrate 1) why a manually curated, phylogeny-based dataset is more appropriate for benchmarking orthology than other popular practices and 2) how it guides database design and parameterization through careful error quantification. More specifically, we illustrate how function-based tests often fail to identify false assignments, misjudging the true performance of orthology inference methods. We also examined how our dataset can instruct the selection of a "core'' species repertoire to improve detection accuracy. We conclude that including more genomes at the proper evolutionary distances can influence the overall quality of orthology detection. The curated gene families, called Reference Orthologous Groups, are publicly available at http://eggnog.embl.de/orthobench2.	[Forslund, Kristoffer; Larsson, Tomas; Powell, Sean; Doerks, Tobias; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Larsson, Tomas] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Trachana, Kalliopi] Inst Syst Biol, Seattle, WA USA; [von Mering, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [von Mering, Christian] Swiss Inst Bioinformat, Zurich, Switzerland	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Institute for Systems Biology (ISB); University of Zurich; Swiss Institute of Bioinformatics	Bork, P (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	bork@embl.de	Bork, Peer/F-1813-2013; Powell, Sean/B-2374-2009; Forslund, Sofia K/Y-2393-2019; von Mering, Christian/B-3300-2008	Bork, Peer/0000-0002-2627-833X; Powell, Sean/0000-0002-0994-5911; von Mering, Christian/0000-0001-7734-9102; Forslund, Sofia K/0000-0003-4285-6993	EU-funded IHMS [FP7-HEALTH-2010-261376]; METACARDIS [FP7-HEALTH-2012-305312]; FP7-IDEAS-ERC project CancerBiome [268985]	EU-funded IHMS; METACARDIS; FP7-IDEAS-ERC project CancerBiome	The authors received funding for this work from EU-funded IHMS (FP7-HEALTH-2010-261376) and METACARDIS (FP7-HEALTH-2012-305312) grants, as well as FP7-IDEAS-ERC project CancerBiome (reference: 268985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dalquen DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056925; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Forslund K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-326; Gao B, 2009, INT J SYST EVOL MICR, V59, P234, DOI 10.1099/ijs.0.002741-0; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Milinkovitch MC, 1996, GENETICS, V144, P1817; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Poptsova Maria, 2009, V532, P227, DOI 10.1007/978-1-60327-853-9_13; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Skunca N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002533; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Susko E, 2005, J MOL EVOL, V61, P351, DOI 10.1007/s00239-004-0352-9; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wolf YI, 2012, GENOME BIOL EVOL, V4, P1286, DOI 10.1093/gbe/evs100; Zheng Y, 2002, GENOME RES, V12, P1221, DOI 10.1101/gr.200602	56	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111122	10.1371/journal.pone.0111122	http://dx.doi.org/10.1371/journal.pone.0111122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369365	Green Published, Green Accepted, gold			2022-12-27	WOS:000344402000040
J	Zhang, Q; Yu, H				Zhang, Qing; Yu, Hong			Computational Approaches for Predicting Biomedical Research Collaborations	PLOS ONE			English	Article							SMALL-WORLD; NETWORKS	Biomedical research is increasingly collaborative, and successful collaborations often produce high impact work. Computational approaches can be developed for automatically predicting biomedical research collaborations. Previous works of collaboration prediction mainly explored the topological structures of research collaboration networks, leaving out rich semantic information from the publications themselves. In this paper, we propose supervised machine learning approaches to predict research collaborations in the biomedical field. We explored both the semantic features extracted from author research interest profile and the author network topological features. We found that the most informative semantic features for author collaborations are related to research interest, including similarity of out-citing citations, similarity of abstracts. Of the four supervised machine learning models (naive Bayes, naive Bayes multinomial, SVMs, and logistic regression), the best performing model is logistic regression with an ROC ranging from 0.766 to 0.980 on different datasets. To our knowledge we are the first to study in depth how research interest and productivities can be used for collaboration prediction. Our approach is computationally efficient, scalable and yet simple to implement. The datasets of this study are available at https://github.com/qingzhanggithub/medline-collaboration-datasets.	[Zhang, Qing; Yu, Hong] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA; [Yu, Hong] VA Cent Massachusetts, Leeds, W Yorkshire, England	University of Massachusetts System; University of Massachusetts Worcester	Yu, H (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA.	hong.yu@umassmed.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095476] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; Ahmed NK, 2012, ARXIV12113412; Al Hasan M, 2006, SDM 06 WORKSH LIN AN; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Choi BCK, 2007, CLIN INVEST MED, V30, pE224, DOI 10.25011/cim.v30i6.2950; Ding Y, 2011, J INFORMETR, V5, P187, DOI 10.1016/j.joi.2010.10.008; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025101; Gray B, 2008, AM J PREV MED, V35, pS124, DOI 10.1016/j.amepre.2008.03.037; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Huang J, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P553; Huang J., 2008, P INT C WEB SEARCH D, P107, DOI [10.11451341531.1341548////, DOI 10.1145/1341531.1341548, 10.1145/1341531.1341548]; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Lee K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014279; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Luo JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017684; Manning C. D., 2008, INTRO INFORM RETRIEV, P319, DOI [10.1017/CBO9780511809071.016, DOI 10.1017/CBO9780511809071.016]; McCallum A., 1998, AAAI 98 WORKSH LEARN; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Okeke IN, 2008, NAT REV MICROBIOL, V6, P858, DOI 10.1038/nrmicro1989; Pan R. K., 2012, SCI REP, V2; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Sun YZ, 2011, 2011 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2011), P121, DOI 10.1109/ASONAM.2011.112; Vardell Emily, 2011, Medical Reference Services Quarterly, V30, P283, DOI 10.1080/02763869.2011.603592; Wang C, 2007, IEEE DATA MINING, P322, DOI 10.1109/ICDM.2007.108; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang Y., 1997, P 14 INT C MACH LEAR, P412, DOI DOI 10.1016/J.ESWA.2008.05.026; Zhang Q, 2013, STUD HEALTH TECHNOL, V192, P832, DOI 10.3233/978-1-61499-289-9-832	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111795	10.1371/journal.pone.0111795	http://dx.doi.org/10.1371/journal.pone.0111795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375164	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600063
J	Haslam, M; Cardoso, RM; Visalberghi, E; Fragaszy, D				Haslam, Michael; Cardoso, Raphael Moura; Visalberghi, Elisabetta; Fragaszy, Dorothy			Stone Anvil Damage by Wild Bearded Capuchins (Sapajus libidinosus) during Pounding Tool Use: A Field Experiment	PLOS ONE			English	Article							MONKEYS CEBUS-LIBIDINOSUS; LONG-TAILED MACAQUES; HAMMER TOOLS; NUT-CRACKING; USAGE	We recorded the damage that wild bearded capuchin monkeys (Sapajus libidinosus) caused to a sandstone anvil during pounding stone tool use, in an experimental setting. The anvil was undamaged when set up at the Fazenda Boa Vista (FBV) field laboratory in Piaui, Brazil, and subsequently the monkeys indirectly created a series of pits and destroyed the anvil surface by cracking palm nuts on it. We measured the size and rate of pit formation, and recorded when adult and immature monkeys removed loose material from the anvil surface. We found that new pits were formed with approximately every 10 nuts cracked, (corresponding to an average of 38 strikes with a stone tool), and that adult males were the primary initiators of new pit positions on the anvil. Whole nuts were preferentially placed within pits for cracking, and partially-broken nuts outside the established pits. Visible anvil damage was rapid, occurring within a day of the anvil's introduction to the field laboratory. Destruction of the anvil through use has continued for three years since the experiment, resulting in both a pitted surface and a surrounding archaeological debris field that replicate features seen at natural FBV anvils.	[Haslam, Michael] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Cardoso, Raphael Moura] Univ Sao Paulo, Inst Psychol, Sao Paulo, Brazil; [Visalberghi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy; [Fragaszy, Dorothy] Univ Georgia, Dept Psychol, Athens, GA 30602 USA	University of Oxford; Universidade de Sao Paulo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University System of Georgia; University of Georgia	Haslam, M (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England.	michael.haslam@rlaha.ox.ac.uk	, Doree/HCI-4354-2022	Visalberghi, Elisabetta/0000-0001-7407-5468; Haslam, Michael/0000-0001-8234-7806; Cardoso, Raphael/0000-0002-4377-4722	OUP John Fell Fund; UK Arts and Humanities Research Council; European Research Council (PRIMARCH) [283959]; CNPq [143014/2009-9]; Short-Term Mobility program - CNR; University of Georgia; National Geographic Society; L.S.B. Leakey Foundation	OUP John Fell Fund; UK Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); European Research Council (PRIMARCH); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Short-Term Mobility program - CNR; University of Georgia; National Geographic Society(National Geographic Society); L.S.B. Leakey Foundation	MH was supported by the OUP John Fell Fund, an UK Arts and Humanities Research Council Early Career Fellowship and European Research Council Starting Grant #283959 (PRIMARCH). RMC was supported by a CNPq scholarship (process: CNPq 143014/2009-9). EV was supported by the Short-Term Mobility program funded by the CNR. DF was funded by the University of Georgia, the National Geographic Society, and the L.S.B. Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; Canale GR, 2009, AM J PRIMATOL, V71, P366, DOI 10.1002/ajp.20648; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; Elisabetta V, 2013, J ARCHAEOL SCI, V40, P3222, DOI 10.1016/j.jas.2013.03.021; Emidio RA, 2012, AM J PRIMATOL, V74, P332, DOI 10.1002/ajp.22009; Ferreira RG, 2010, AM J PRIMATOL, V72, P270, DOI 10.1002/ajp.20771; Fragaszy D, 2010, ANIM BEHAV, V79, P321, DOI 10.1016/j.anbehav.2009.11.004; Fragaszy DM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0410; Fragaszy DM, 2010, ANIM BEHAV, V80, P205, DOI 10.1016/j.anbehav.2010.04.018; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Gumert MD, 2009, AM J PRIMATOL, V71, P594, DOI 10.1002/ajp.20694; Haslam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072872; Haslam M, 2012, ANTIQUITY, V86, P299, DOI 10.1017/S0003598X00062773; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Liu Q, 2009, AM J PHYS ANTHROPOL, V138, P210, DOI 10.1002/ajpa.20920; Liu Q, 2011, ANIM BEHAV, V81, P297, DOI 10.1016/j.anbehav.2010.10.021; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; Marchant LF., 2005, STONE KNAPPING NECES, P341; Massaro L, 2012, ANIM COGN, V15, P1065, DOI 10.1007/s10071-012-0530-x; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Spagnoletti N, 2012, ANIM BEHAV, V83, P1285, DOI 10.1016/j.anbehav.2012.03.002; Spagnoletti N, 2011, J HUM EVOL, V61, P97, DOI 10.1016/j.jhevol.2011.02.010; Visalberghi E, 2008, AM J PRIMATOL, V70, P884, DOI 10.1002/ajp.20578; Visalberghi E, 2007, AM J PHYS ANTHROPOL, V132, P426, DOI 10.1002/ajpa.20546; Visalberghi E, 2009, PRIMATES, V50, P95, DOI 10.1007/s10329-008-0127-9; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064	30	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111273	10.1371/journal.pone.0111273	http://dx.doi.org/10.1371/journal.pone.0111273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AS9IQ	25372879	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900042
J	Hodgson, I; Plummer, ML; Konopka, SN; Colvin, CJ; Jonas, E; Albertini, J; Amzel, A; Fogg, KP				Hodgson, Ian; Plummer, Mary L.; Konopka, Sarah N.; Colvin, Christopher J.; Jonas, Edna; Albertini, Jennifer; Amzel, Anouk; Fogg, Karen P.			A Systematic Review of Individual and Contextual Factors Affecting ART Initiation, Adherence, and Retention for HIV-Infected Pregnant and Postpartum Women	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; COMMUNITY-HEALTH WORKERS; DOSE NEVIRAPINE REGIMEN; IMPROVE ADHERENCE; POSITIVE WOMEN; FOLLOW-UP; CAPE-TOWN; PREVENTION	Background: Despite progress reducing maternal mortality, HIV-related maternal deaths remain high, accounting, for example, for up to 24 percent of all pregnancy-related deaths in sub-Saharan Africa. Antiretroviral therapy (ART) is effective in improving outcomes among HIV-infected pregnant and postpartum women, yet rates of initiation, adherence, and retention remain low. This systematic literature review synthesized evidence about individual and contextual factors affecting ART use among HIV-infected pregnant and postpartum women. Methods: Searches were conducted for studies addressing the population (HIV-infected pregnant and postpartum women), intervention (ART), and outcomes of interest (initiation, adherence, and retention). Quantitative and qualitative studies published in English since January 2008 were included. Individual and contextual enablers and barriers to ART use were extracted and organized thematically within a framework of individual, interpersonal, community, and structural categories. Results: Thirty-four studies were included in the review. Individual-level factors included both those within and outside a woman's awareness and control (e.g., commitment to child's health or age). Individual-level barriers included poor understanding of HIV, ART, and prevention of mother-to-child transmission, and difficulty managing practical demands of ART. At an interpersonal level, disclosure to a spouse and spousal involvement in treatment were associated with improved initiation, adherence, and retention. Fear of negative consequences was a barrier to disclosure. At a community level, stigma was a major barrier. Key structural barriers and enablers were related to health system use and engagement, including access to services and health worker attitudes. Conclusions: To be successful, programs seeking to expand access to and continued use of ART by integrating maternal health and HIV services must identify and address the relevant barriers and enablers in their own context that are described in this review. Further research on this population, including those who drop out of or never access health services, is needed to inform effective implementation.	[Konopka, Sarah N.; Jonas, Edna] Ctr Hlth Serv Management Sci Hlth, Arlington, VA 22203 USA; [Colvin, Christopher J.] Univ Cape Town, Sch Publ Hlth & Family Med, CIDER, Div Social & Behav Sci, ZA-7925 Cape Town, South Africa; [Albertini, Jennifer] USAID, Africa Bur, Washington, DC USA; [Amzel, Anouk] USAID, Bur Global Hlth, Off HIV AIDS, Washington, DC USA; [Fogg, Karen P.] USAID, BGH, Off Hlth Infect Dis & Nutr, Washington, DC USA	University of Cape Town; United States Agency for International Development (USAID); United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Konopka, SN (corresponding author), Ctr Hlth Serv Management Sci Hlth, Arlington, VA 22203 USA.	skonopka@msh.org	Harding, Richard/G-9729-2012; Colvin, Christopher/AAB-8276-2019; Colvin, Christopher/AAQ-1607-2021	Colvin, Christopher/0000-0002-8930-7863; Plummer, Mary Louisa/0000-0002-6816-8235	Africa Bureau of USAID	Africa Bureau of USAID(United States Agency for International Development (USAID))	This review was supported by funding from the Africa Bureau of USAID. Three coauthors on the paper are from USAID. They played a role in designing the review questions and methods, and contributed to revisions of the manuscript. They were not involved in data collection and analysis or drafting of the initial manuscript.	Abdool Karim Q, 2010, LANCET, V375, P1948, DOI 10.1016/S0140-6736(10)60747-7; Awiti-Ujiji O, 2011, AJAR-AFR J AIDS RES, V10, P157, DOI 10.2989/16085906.2011.593378; Ayuo P, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17994; Aziz SA, 2011, SEX TRANSM INFECT, V87, pA356, DOI 10.1136/sextrans-2011-050119.17; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bardeguez AD, 2008, JAIDS-J ACQ IMM DEF, V48, P408, DOI 10.1097/QAI.0b013e31817bbe80; Boateng D, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-2; Burton J, 2010, AIDS BEHAV, V14, P1, DOI 10.1007/s10461-008-9471-4; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Calvert C, 2013, AIDS; Chalker J, 2010, JAIDS-J ACQ IMM DEF, V53, P159, DOI 10.1097/QAI.0b013e3181befa12; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohn SE, 2008, AIDS PATIENT CARE ST, V22, P29, DOI 10.1089/apc.2007.0053; Colvin C, PLOS ONE IN PRESS; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Dean AL, 2012, J TELEMED TELECARE, V18, P399, DOI 10.1258/jtt.2012.120118; Delvaux T, 2009, JAIDS-J ACQ IMM DEF, V50, P223, DOI 10.1097/QAI.0b013e31819001a3; Dourado I, 2014, AIDS CARE; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ekama SO, 2012, JOURNAL, V2012; Ferguson L, 2012, JAIDS-J ACQ IMM DEF, V60, pE90, DOI 10.1097/QAI.0b013e318253258a; Finocchario-Kessler S, 2012, PATIENT EDUC COUNS, V89, P163, DOI 10.1016/j.pec.2012.03.020; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jasseron C, 2013, AIDS BEHAV, V17, P488, DOI 10.1007/s10461-011-0084-y; Jerome JS, 2012, AIDS CARE, V24, P491, DOI 10.1080/09540121.2011.613906; Kanjipite W, 2012, J INT AIDS SOC, V15, P132; Kasenga F, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.1882; Kenya S, 2011, HIV MED, V12, P525, DOI 10.1111/j.1468-1293.2011.00921.x; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Kohler P, 2012, J INT AIDS SOC, V15, P131; Kreitchmann R, 2012, AIDS PATIENT CARE ST, V26, P486, DOI 10.1089/apc.2012.0013; Kuonza LR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-218; Lewin S, 2013, 21 COCHR C QUEB CAN; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Liotta G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071653; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; McDonald K, 2011, AIDS CARE, V23, P578, DOI 10.1080/09540121.2010.482124; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Moodley J, 2011, BJOG-INT J OBSTET GY, V118, P219, DOI 10.1111/j.1471-0528.2010.02726.x; Muchedzi A, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-38; Myer L, 2012, AIDS CARE, V24, P986, DOI 10.1080/09540121.2012.668173; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; O'Gorman DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-354; Pellowski JA, 2012, CURR HIV-AIDS REP, V9, P326, DOI 10.1007/s11904-012-0133-9; Peltzer K, 2011, ACTA PAEDIATR, V100, P1253, DOI 10.1111/j.1651-2227.2011.02253.x; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P175; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Rosen S, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2010.02512.x; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schutz A., 1962, COLLECT PAPERS, V1; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Skevington SM, 2013, AIDS BEHAV, V17, P1025, DOI 10.1007/s10461-012-0327-6; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; SURE Collaboration, 2011, ID ADDR BARR IMPL PO; Sword W, 1999, J ADV NURS, V29, P1170, DOI 10.1046/j.1365-2648.1999.00986.x; Thetard R, 2014, SYSTEMATIC REV INTER; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNICEF, 2012, OPT B B KEY CONS COU; Varga C, 2008, QUAL HEALTH RES, V18, P786, DOI 10.1177/1049732308318449; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040091; WHO, 2007, EV BUS STRENGTH HLTH; WHO and UNICEF, 2014, TRENDS MAT MORT 1990; WHO UNICEF UNFPA & Bank T. W, 2010, TRENDS MAT MORT 1990; Wise J, 2008, AIDS PATIENT CARE ST, V22, P495, DOI 10.1089/apc.2007.0180; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X	77	190	192	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111421	10.1371/journal.pone.0111421	http://dx.doi.org/10.1371/journal.pone.0111421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372479	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900047
J	Ilheu, M; Matono, P; Bernardo, JM				Ilheu, Maria; Matono, Paula; Bernardo, Joao Manuel			Invasibility of Mediterranean-Climate Rivers by Non-Native Fish: The Importance of Environmental Drivers and Human Pressures	PLOS ONE			English	Article							FRESH-WATER FISH; PUMPKINSEED LEPOMIS-GIBBOSUS; LIFE-HISTORY TRAITS; BIOTIC INTEGRITY; SPATIAL AUTOCORRELATION; SANDER-LUCIOPERCA; ALQUEVA RESERVOIR; SPECIES RICHNESS; GAMBUSIA-AFFINIS; ALIEN FISH	Invasive species are regarded as a biological pressure to natural aquatic communities. Understanding the factors promoting successful invasions is of great conceptual and practical importance. From a practical point of view, it should help to prevent future invasions and to mitigate the effects of recent invaders through early detection and prioritization of management measures. This study aims to identify the environmental determinants of fish invasions in Mediterranean-climate rivers and evaluate the relative importance of natural and human drivers. Fish communities were sampled in 182 undisturbed and 198 disturbed sites by human activities, belonging to 12 river types defined for continental Portugal within the implementation of the European Union's Water Framework Directive. Pumpkinseed sunfish, Lepomis gibbosus (L.), and mosquitofish, Gambusia holbrooki (Girard), were the most abundant non-native species (NNS) in the southern river types whereas the Iberian gudgeon, Gobio lozanoi Doadrio and Madeira, was the dominant NNS in the north/centre. Small northern mountain streams showed null or low frequency of occurrence and abundance of NNS, while southern lowland river types with medium and large drainage areas presented the highest values. The occurrence of NNS was significantly lower in undisturbed sites and the highest density of NNS was associated with high human pressure. Results from variance partitioning showed that natural environmental factors determine the distribution of the most abundant NNS while the increase in their abundance and success is explained mainly by human-induced disturbance factors. This study stresses the high vulnerability of the warm water lowland river types to non-native fish invasions, which is amplified by human-induced degradation.	[Ilheu, Maria; Matono, Paula; Bernardo, Joao Manuel] Univ Evora, Escola Ciencias & Tecnol, Dept Paisagem Ambiente & Ordenamento, Evora, Portugal; [Ilheu, Maria; Matono, Paula] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Evora, Portugal	University of Evora; University of Evora	Ilheu, M (corresponding author), Univ Evora, Escola Ciencias & Tecnol, Dept Paisagem Ambiente & Ordenamento, Evora, Portugal.	milheu@uevora.pt	Ilhéu, Maria/B-5418-2014; Matono, Paula/AFL-5122-2022	Matono, Paula/0000-0002-1665-3298; /0000-0001-5833-0692	INAG (Instituto da Agua); Foundation for Science and Technology (FCT) [PTDC/AAC-AMB/102541/2008, SFRH/BD/23435/2005]; FEDER under the programme COMPETE; National Funds through FCT [PEst-OE/AGR/UI0115/2014]	INAG (Instituto da Agua); Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER under the programme COMPETE; National Funds through FCT(Portuguese Foundation for Science and Technology)	This study was partially funded by INAG (Instituto da Agua) as part of a larger programme on the implementation of the Water Framework Directive and by the Foundation for Science and Technology (FCT) through the research project (PTDC/AAC-AMB/102541/2008). Additional funding was provided by FEDER under the programme COMPETE and by National Funds through FCT under the Strategic Project PEst-OE/AGR/UI0115/2014. P. Matono was supported by a PhD grant from FCT (SFRH/BD/23435/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre CM, 2010, RIVER RES APPL, V26, P977, DOI 10.1002/rra.1308; Allen CR, 2013, GLOBAL ECOL BIOGEOGR, V22, P889, DOI 10.1111/geb.12054; Almeida D, 2009, ECOL FRESHW FISH, V18, P15, DOI 10.1111/j.1600-0633.2008.00317.x; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; ANDREASEN JK, 1985, ARCH ENVIRON CON TOX, V14, P573, DOI 10.1007/BF01055387; Angermeier PL, 2000, T AM FISH SOC, V129, P962, DOI 10.1577/1548-8659(2000)129<0962:RFACMF>2.3.CO;2; Arthington A. H., 1990, BUREAU RURAL RESOURC, V8, P61; Belote RT, 2008, ECOLOGY, V89, P183, DOI 10.1890/07-0270.1; Benejam Lluis, 2007, Limnetica, V26, P169; Benejam L, 2009, BIOL INVASIONS, V11, P2265, DOI 10.1007/s10530-008-9413-0; Bernardo JM, 2003, RIVER RES APPL, V19, P521, DOI 10.1002/rra.726; Blanchett S, 2009, P ROY SOC B-BIOL SCI, V276, P2385, DOI 10.1098/rspb.2009.0156; Bomford M, 2010, BIOL INVASIONS, V12, P2559, DOI 10.1007/s10530-009-9665-3; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BROWNPETERSON N, 1990, ENVIRON BIOL FISH, V27, P33, DOI 10.1007/BF00004902; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Caiola N, 2002, J FISH BIOL, V61, P1058, DOI 10.1006/jfbi.2002.2103; CEN, 2003, 140112003 CEN; CIS-WFD, 2003, GUID EST REF COND EC; Clavero M, 2006, ECOL APPL, V16, P2313, DOI 10.1890/1051-0761(2006)016[2313:HDAIRO]2.0.CO;2; Comesana Julian, 2009, Aquatic Invasions, V4, P425, DOI 10.3391/ai.2009.4.2.25; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Copp GH, 2004, FOLIA ZOOL, V53, P237; Daniel WW, 1987, BIOSTATISTICS FDN AN, V4; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Doadrio I., 2004, Graellsia, V60, P107; Drake JA, 1989, BIOL INVASIONS GLOBA; Duncan RP, 2001, J ANIM ECOL, V70, P621, DOI 10.1046/j.1365-2656.2001.00517.x; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Fausch KD, 2001, ECOL APPL, V11, P1438, DOI 10.1890/1051-0761(2001)011[1438:FDRIRT]2.0.CO;2; Filipe AF, 2010, DIVERS DISTRIB, V16, P773, DOI 10.1111/j.1472-4642.2010.00678.x; GALAT DL, 1992, ENVIRON BIOL FISH, V33, P249, DOI 10.1007/BF00005869; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; GILLER PS, 1998, BIOL STREAMS RIVERS; Godinho Francisco Nunes, 2000, Biological Invasions, V2, P231, DOI 10.1023/A:1010022123669; Gonzalez AL, 2010, OIKOS, V119, P779, DOI 10.1111/j.1600-0706.2009.18549.x; Gozlan RE, 2010, AQUAT INVASIONS, V5, P231, DOI 10.3391/ai.2010.5.3.02; Halliwell DB, 1998, ASSESSING THE SUSTAINABILITY AND BIOLOGICAL INTEGRITY OF WATER RESOURCES USING FISH COMMUNITIES, P301; Harris JH, 1999, FRESHWATER BIOL, V41, P235, DOI 10.1046/j.1365-2427.1999.00428.x; Hermoso V, 2011, ECOL APPL, V21, P175, DOI 10.1890/09-2011.1; HINCH SG, 1994, CAN J FISH AQUAT SCI, V51, P701, DOI 10.1139/f94-070; HUGHES RM, 1988, J WATER POLLUT CON F, V60, P486; Ilheu M, 2004, THESIS U EVORA; INAG IP, 2008, RIV TYP CONT PORT IM; INAG IP, 2008, MAN BIOL ASS WAT QUA; Joy MK, 2004, ENVIRON MANAGE, V34, P415, DOI 10.1007/s00267-004-0083-0; Kennard MJ, 2005, FRESHWATER BIOL, V50, P174, DOI 10.1111/j.1365-2427.2004.01293.x; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Leunda PM, 2010, AQUAT INVASIONS, V5, P239, DOI 10.3391/ai.2010.5.3.03; Lloyd LN, 1984, J AUSTR NEW GUINEA F, V1, P31; LOBONCERVIA J, 1991, J FISH BIOL, V39, P285, DOI 10.1111/j.1095-8649.1991.tb04363.x; Perez-Bote JL, 2009, LIMNETICA, V28, P225; Marr SM, 2013, HYDROBIOLOGIA, V719, P317, DOI 10.1007/s10750-013-1486-9; Meador Michael R., 2003, Ecological Indicators, V3, P81, DOI 10.1016/S1470-160X(03)00013-X; MEFFE GK, 1984, ECOLOGY, V65, P1525, DOI 10.2307/1939132; Minckley WL, 1987, COMMUNITY EVOLUTIONA, P96; Miranda R, 2005, ANN LIMNOL-INT J LIM, V41, P7, DOI 10.1051/limn/2005007; Miranda R, 2010, AQUAT INVASIONS, V5, P291, DOI 10.3391/ai.2010.5.3.06; NIEMELA J, 1991, OIKOS, V62, P351, DOI 10.2307/3545500; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2006, ECOL MONOGR, V76, P25, DOI 10.1890/05-0330; Power ME, 1996, ENVIRON MANAGE, V20, P887, DOI 10.1007/BF01205969; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Ribeiro F, 2009, FISHERIES MANAG ECOL, V16, P255, DOI 10.1111/j.1365-2400.2009.00659.x; Ribeiro F, 2009, CYBIUM, V33, P255; Ribeiro F, 2006, CYBIUM, V30, P283; Ross RM, 2001, BIOL INVASIONS, V3, P347, DOI 10.1023/A:1015847305717; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; Saiki MK, 2004, ARCH ENVIRON CON TOX, V47, P363, DOI [10.1007/s00244-2051-3, 10.1007/s00244-004-2051-3]; Schmutz S, 2007, FISHERIES MANAG ECOL, V14, P441, DOI 10.1111/j.1365-2400.2007.00582.x; Schmutz Stefan, 2004, DEV EV IMPL STAND FI; Schultz AA, 2003, N AM J FISH MANAGE, V23, P503, DOI 10.1577/1548-8675(2003)023<0503:EOFOAO>2.0.CO;2; Smith K. G., 2006, STATUS DISTRIBUTION; Sterud Erik, 2006, Aquatic Invasions, V1, P278; Townsend CR, 1996, BIOL CONSERV, V78, P13, DOI 10.1016/0006-3207(96)00014-6; Vila-Gispert A, 2005, BIOL INVASIONS, V7, P107, DOI 10.1007/s10530-004-9640-y; Villeneuve F, 2005, J APPL ICHTHYOL, V21, P275, DOI 10.1111/j.1439-0426.2005.00679.x; Williamson M., 1996, BIOL INVASIONS; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	87	18	18	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109694	10.1371/journal.pone.0109694	http://dx.doi.org/10.1371/journal.pone.0109694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372284	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900009
J	Kim, S; Lee, J; Hong, ME; Do, IG; Kang, SY; Ha, SY; Kim, ST; Park, SH; Kang, WK; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, DH; Kim, KM				Kim, Seokhwi; Lee, Jeeyun; Hong, Min Eui; Do, In-Gu; Kang, So Young; Ha, Sang Yun; Kim, Seung Tae; Park, Se Hoon; Kang, Won Ki; Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung; Kim, Duk-Hwan; Kim, Kyoung-Mee			High-Throughput Sequencing and Copy Number Variation Detection Using Formalin Fixed Embedded Tissue in Metastatic Gastric Cancer	PLOS ONE			English	Article							GENE AMPLIFICATION; MUTATIONS; EXPRESSION; SURVIVAL	In the era of targeted therapy, mutation profiling of cancer is a crucial aspect of making therapeutic decisions. To characterize cancer at a molecular level, the use of formalin-fixed paraffin-embedded tissue is important. We tested the Ion AmpliSeq Cancer Hotspot Panel v2 and nCounter Copy Number Variation Assay in 89 formalin-fixed paraffin-embedded gastric cancer samples to determine whether they are applicable in archival clinical samples for personalized targeted therapies. We validated the results with Sanger sequencing, real-time quantitative PCR, fluorescence in situ hybridization and immunohistochemistry. Frequently detected somatic mutations included TP53 (28.17%), APC (10.1%), PIK3CA (5.6%), KRAS (4.5%), SMO (3.4%), STK11 (3.4%), CDKN2A (3.4%) and SMAD4 (3.4%). Amplifications of HER2, CCNE1, MYC, KRAS and EGFR genes were observed in 8 (8.9%), 4 (4.5%), 2 (2.2%), 1 (1.1%) and 1 (1.1%) cases, respectively. In the cases with amplification, fluorescence in situ hybridization for HER2 verified gene amplification and immunohistochemistry for HER2, EGFR and CCNE1 verified the overexpression of proteins in tumor cells. In conclusion, we successfully performed semiconductor-based sequencing and nCounter copy number variation analyses in formalin-fixed paraffin-embedded gastric cancer samples. High-throughput screening in archival clinical samples enables faster, more accurate and costeffective detection of hotspot mutations or amplification in genes.	[Kim, Seokhwi; Hong, Min Eui; Do, In-Gu; Kang, So Young; Ha, Sang Yun; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Jeeyun; Kim, Seung Tae; Park, Se Hoon; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Hong, Min Eui; Kim, Kyoung-Mee] Samsung Med Ctr, Canc Compan Diagnost Ctr, Seoul, South Korea; [Kim, Duk-Hwan] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Kim, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	kkmkys@skku.edu	Park, Se Hoon/GMX-1199-2022; kim, st/O-5928-2014; Lee, Jeeyun/I-7171-2015; Kim, Sung/G-4114-2014	Park, Se Hoon/0000-0001-5084-9326; 	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [A101130]; Samsung Biomedical Research Institute grant [SBRI-SP1B20112]; Samsung Medical Center intramural grant [GFO1140111]	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea; Samsung Biomedical Research Institute grant(Samsung); Samsung Medical Center intramural grant(Samsung)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A101130) and a Samsung Biomedical Research Institute grant (#SBRI-SP1B20112). This study was also supported by a Samsung Medical Center intramural grant, 20 x 20 Project (#GFO1140111). Co-authors Seokhwi Kim, Jeeyun Lee, Min Eui Hong, In-Gu Do, So Young Kang, Sang Yun Ha, Seung Tae Kim, Se Hoon Park, Won Ki Kang, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Sung Kim and Kyoung-Mee Kim are employed by Samsung Medical Center. Co-author Duk-Hwan Kim is employed by Samsung Biomedical Research Institute. Samsung Biomedical Research Institute and Samsung Medical Center provided support in the form of salaries for authors Seokhwi Kim, JL, MEH, IGD, SYK, SYH, STK, SHP, WKK, MGC, JHL, TSS, JMB, Sung Kim, KMK and DHK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Cho EY, 2013, MODERN PATHOL, V26, P677, DOI 10.1038/modpathol.2012.205; Cho EY, 2012, PATHOLOGY, V44, P216, DOI 10.1097/PAT.0b013e3283513e8b; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Graziano F, 2011, J CLIN ONCOL; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082770; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lee SE, 2014, AM J SURG PATHOL, V38, P784, DOI 10.1097/PAS.0000000000000185; Ma Patrick C, 2012, Cleve Clin J Med, V79 Electronic Suppl 1, peS56, DOI 10.3949/ccjm.79.s2.12; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Nadauld LD, 2013, J CLIN ONCOL, V31, P838, DOI 10.1200/JCO.2012.47.1714; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Smyth EC, 2012, CURR TREAT OPTION ON, V13, P377, DOI 10.1007/s11864-012-0192-6; Tanney A, 2010, PERS MED, V7, P205, DOI 10.2217/PME.10.8; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wong H, 2013, THER ADV GASTROENTER, V6, P15, DOI 10.1177/1756283X12453636; Wu YH, 2013, GUT, V62, P1100, DOI 10.1136/gutjnl-2011-301373; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang LH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02992	32	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111693	10.1371/journal.pone.0111693	http://dx.doi.org/10.1371/journal.pone.0111693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372287	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900063
J	Ruggles, KV; Rajan, S				Ruggles, Kelly V.; Rajan, Sonali			Gun Possession among American Youth: A Discovery-Based Approach to Understand Gun Violence	PLOS ONE			English	Article							RISK BEHAVIOR SURVEILLANCE; PUBLIC-HEALTH; SCREEN TIME; WHOLE CHILD; ADOLESCENTS; OUTCOMES; SCIENCE; INJURY; CALL	Objective: To apply discovery-based computational methods to nationally representative data from the Centers for Disease Control and Preventions' Youth Risk Behavior Surveillance System to better understand and visualize the behavioral factors associated with gun possession among adolescent youth. Results: Our study uncovered the multidimensional nature of gun possession across nearly five million unique data points over a ten year period (2001-2011). Specifically, we automated odds ratio calculations for 55 risk behaviors to assemble a comprehensive table of associations for every behavior combination. Downstream analyses included the hierarchical clustering of risk behaviors based on their association "fingerprint" to 1) visualize and assess which behaviors frequently cooccur and 2) evaluate which risk behaviors are consistently found to be associated with gun possession. From these analyses, we identified more than 40 behavioral factors, including heroin use, using snuff on school property, having been injured in a fight, and having been a victim of sexual violence, that have and continue to be strongly associated with gun possession. Additionally, we identified six behavioral clusters based on association similarities: 1) physical activity and nutrition; 2) disordered eating, suicide and sexual violence; 3) weapon carrying and physical safety; 4) alcohol, marijuana and cigarette use; 5) drug use on school property and 6) overall drug use. Conclusions: Use of computational methodologies identified multiple risk behaviors, beyond more commonly discussed indicators of poor mental health, that are associated with gun possession among youth. Implications for prevention efforts and future interdisciplinary work applying computational methods to behavioral science data are described.	[Ruggles, Kelly V.] NYU, Ctr Bioinformat & Hlth Informat, Langone Med Ctr, New York, NY 10012 USA; [Rajan, Sonali] Columbia Univ, Teachers Coll, Dept Hlth & Behav Studies, New York, NY 10027 USA	New York University; NYU Langone Medical Center; Columbia University; Columbia University Teachers College	Ruggles, KV (corresponding author), NYU, Ctr Bioinformat & Hlth Informat, Langone Med Ctr, New York, NY 10012 USA.	kelly.ruggles@nyumc.org		Ruggles, Kelly/0000-0002-0152-0863				Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; Allensworth D, 2011, PREV CHRONIC DIS, V8; [Anonymous], 2013, PROT CHILD NOT GUNS; Baker R., 2009, J ED DATA MINING, V1, P1; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Basch CE, 2011, J SCHOOL HEALTH, V81, P650, DOI 10.1111/j.1746-1561.2011.00640.x; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Branas CC, 2009, AM J PUBLIC HEALTH, V99, P2034, DOI 10.2105/AJPH.2008.143099; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Brener Nancy D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Burgason KA, 2014, J INTERPERS VIOLENCE, V29, P371, DOI 10.1177/0886260513505212; Busch V, 2013, AM J HEALTH BEHAV, V37, P819, DOI 10.5993/AJHB.37.6.11; Carter PM, 2013, PEDIATRICS, V132, P213, DOI 10.1542/peds.2013-0163; Diamond A, 2010, EARLY EDUC DEV, V21, P780, DOI 10.1080/10409289.2010.514522; Domine F, 2012, ENDOCR DEV, V22, P271, DOI 10.1159/000326697; Downey LA, 2013, SOUTH MED J, V106, P161, DOI 10.1097/SMJ.0b013e3182804968; Duhig AM, 2005, ADDICT BEHAV, V30, P271, DOI 10.1016/j.addbeh.2004.05.016; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elson M, 2013, BRIT J PSYCHIAT, V203, P322, DOI 10.1192/bjp.bp.113.128652; Espelage DL, 2012, J ADOLESCENT HEALTH, V50, P60, DOI 10.1016/j.jadohealth.2011.07.015; Fisher CE, 2013, ANN INTERN MED, V159, P423, DOI 10.7326/0003-4819-159-5-201309030-00679; Fleegler EW, 2013, JAMA INTERN MED, V173, DOI [10.1001/jamainternmed.2013.9957, 10.1001/jamainternmed.2013.1286]; Furlong MJ, 2001, PSYCHOL SCHOOLS, V38, P127, DOI 10.1002/pits.1005; Hong Cao, 2013, Intelligent Science and Intelligent Data Engineering. Third Sino-foreign-interchange Workshop, IScIDE 2012. Revised Selected Papers, P655, DOI 10.1007/978-3-642-36669-7_80; Kates D, 2007, HARVARD J LAW PUBLIC, V30, P46; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Kepple KA, 2013, MASS SHOOTINGS TOLL; Law Center to Prevent Gun Violence, 2014, TRACK STAT GUN LAWS; Muehlenkamp JJ, 2012, SUICIDE LIFE-THREAT, V42, P416, DOI 10.1111/j.1943-278X.2012.00100.x; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; National Institute of Justice, 2013, GUN VIOL; Pandya A, 2013, J PSYCHIATR PRACT, V19, P410, DOI 10.1097/01.pra.0000435040.75802.90; Papachristos AV, 2014, AM J PUBLIC HEALTH, V104, P143, DOI 10.2105/AJPH.2013.301441; Ramo DE, 2014, ADDICT BEHAV, V39, P77, DOI 10.1016/j.addbeh.2013.08.035; Reich K, 2002, FUTURE CHILDREN; Rencher A.C., 2012, METHODS MULTIVARIATE, DOI DOI 10.1002/9781118391686; Romanowicz M, 2013, J AFFECT DISORDERS, V151, P467, DOI 10.1016/j.jad.2013.06.026; Stone AA, 2009, SCI SELF REPORT AMPL; Swahn MH, 2012, INT J ENV RES PUB HE, V9, P178, DOI 10.3390/ijerph9010178; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Underwood E, 2013, SCIENCE, V339, P381, DOI 10.1126/science.339.6118.381; Vaughn MG, 2012, J INTERPERS VIOLENCE, V27, P2003, DOI 10.1177/0886260511432150; Webster D, 2012, CASE GUN POLICY REFO; Wintemute Garen, 2013, JAMA, V310, P468, DOI 10.1001/jama.2013.75770; Ziebarth JD, 2013, BIOINFORMATICS; Zosel A, 2013, J AM ACAD CHILD PSY, V52, P196, DOI 10.1016/j.jaac.2012.11.014	50	24	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111893	10.1371/journal.pone.0111893	http://dx.doi.org/10.1371/journal.pone.0111893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372864	Green Published, gold			2022-12-27	WOS:000344556900087
J	Tanaka, K; Koike, Y; Shimura, T; Okigami, M; Ide, S; Toiyama, Y; Okugawa, Y; Inoue, Y; Araki, T; Uchida, K; Mohri, Y; Mizoguchi, A; Kusunoki, M				Tanaka, Koji; Koike, Yuhki; Shimura, Tadanobu; Okigami, Masato; Ide, Shozo; Toiyama, Yuji; Okugawa, Yoshinaga; Inoue, Yasuhiro; Araki, Toshimitsu; Uchida, Keiichi; Mohri, Yasuhiko; Mizoguchi, Akira; Kusunoki, Masato			In Vivo Characterization of Neutrophil Extracellular Traps in Various Organs of a Murine Sepsis Model	PLOS ONE			English	Article							DNA TRAPS; MICE; BACTERIA; NETOSIS	Neutrophil extracellular traps (NETs) represent extracellular microbial trapping and killing. Recently, it has been implicated in thrombogenesis, autoimmune disease, and cancer progression. The aim of this study was to characterize NETs in various organs of a murine sepsis model in vivo and to investigate their associations with platelets, leukocytes, or vascular endothelium. NETs were classified as two distinct forms; cell-free NETs that were released away from neutrophils and anchored NETs that were anchored to neutrophils. Circulating cell-free NETs were characterized as fragmented or cotton-like structures, while anchored NETs were characterized as linear, reticular, membranous, or spot-like structures. In septic mice, both anchored and cell-free NETs were significantly increased in postcapillary venules of the cecum and hepatic sinusoids with increased leukocyte-endothelial interactions. NETs were also observed in both alveolar space and pulmonary capillaries of the lung. The interactions of NETs with platelet aggregates, leukocyte-platelet aggregates or vascular endothelium of arterioles and venules were observed in the microcirculation of septic mice. Microvessel occlusions which may be caused by platelet aggregates or leukocyte-platelet aggregates and heterogeneously decreased blood flow were also observed in septic mice. NETs appeared to be associated with the formation of platelet aggregates or leukocyte-platelet aggregates. These observational findings may suggest the adverse effect of intravascular NETs on the host during a sepsis.	[Tanaka, Koji; Koike, Yuhki; Shimura, Tadanobu; Okigami, Masato; Ide, Shozo; Toiyama, Yuji; Okugawa, Yoshinaga; Inoue, Yasuhiro; Araki, Toshimitsu; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal, Tsu, Mie 514, Japan; [Tanaka, Koji; Koike, Yuhki; Shimura, Tadanobu; Okigami, Masato; Ide, Shozo; Toiyama, Yuji; Okugawa, Yoshinaga; Inoue, Yasuhiro; Araki, Toshimitsu; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Paediat Surg, Tsu, Mie 514, Japan; [Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat, Tsu, Mie 514, Japan; [Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Cell Commun, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, K (corresponding author), Mie Univ, Grad Sch Med, Dept Gastrointestinal, Tsu, Mie 514, Japan.	qouji@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 25462052, 25462771]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI 25462052 to KT and 25462771 to YK). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Carmona-Rivera C, 2014, NEUTROPHIL EXTRACELL; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Koike Y, 2011, J THROMB THROMBOLYS, V32, P138, DOI 10.1007/s11239-011-0600-y; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Megens RTA, 2012, THROMB HAEMOSTASIS, V107, P597, DOI 10.1160/TH11-09-0650; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Morimoto Y, 2011, J GASTROINTEST SURG, V15, P1842, DOI 10.1007/s11605-011-1632-5; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfeiler S, 2014, THROMB RES, V133, pS35, DOI 10.1016/j.thromres.2014.03.016; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Tanaka K, 2013, SURG TODAY, V43, P123, DOI 10.1007/s00595-012-0283-9; Tanaka K, 2012, ONCOL REP, V28, P1822, DOI 10.3892/or.2012.1983; Tanaka K, 2012, MICROSC RES TECHNIQ, V75, P307, DOI 10.1002/jemt.21059; Toiyama Y, 2010, J GASTROENTEROL, V45, P544, DOI 10.1007/s00535-009-0187-7; Ustione A, 2011, J MICROSC-OXFORD, V243, P221, DOI 10.1111/j.1365-2818.2011.03532.x; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	32	98	100	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111888	10.1371/journal.pone.0111888	http://dx.doi.org/10.1371/journal.pone.0111888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372699	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900085
J	Zheng, LH; Yi, Y; Liu, J; Lin, XK; Yang, KL; Lv, M; Zhou, XW; Hao, JH; Liu, JZ; Zheng, Y; Sun, M				Zheng, Lanhong; Yi, Yao; Liu, Jia; Lin, Xiukun; Yang, Kangli; Lv, Mei; Zhou, Xinwen; Hao, Jianhua; Liu, Junzhong; Zheng, Yuan; Sun, Mi			Isolation and Characterization of Marine Brevibacillus sp S-1 Collected from South China Sea and a Novel Antitumor Peptide Produced by the Strain	PLOS ONE			English	Article							DIDEMNIN-B; DISCOVERY; CANCER; METABOLITES; STRATEGIES; MICROBES; BACTERIA; PATHWAY	A Gram-positive, rod-shaped bacterium, designated as S-1, was isolated from a marine sediment sample collected from South China Sea. Phylogenetic analysis based on 16S rRNA gene sequence showed that S-1 belongs to the genus Brevibacillus. A novel cytotoxic peptide was isolated from the fermentation broth of the marine-derived bacterium Brevibacillus sp. S-1, using ion-exchange chromatography and reverse-phase HPLC chromatography. The molecular weight of this peptide was determined as 1570 Da by MALDI-TOF mass spectrometry, and its structure was proposed as a cyclic peptide elucidated by MALDI-TOF/TOF mass spectrometry and de novo sequencing. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay showed that this peptide exhibited cytotoxicity against BEL-7402 human hepatocellular carcinoma cells, RKO human colon carcinoma cells, A549 human lung carcinoma cells, U251 human glioma cells and MCF-7 human breast carcinoma cells. Additionally, SBP exhibited low cytotoxicity against HFL1 human normal fibroblast lung cells. The result suggested that the cytotoxic effect of the peptide is specific to tumor cells.	[Zheng, Lanhong; Yi, Yao; Yang, Kangli; Lv, Mei; Hao, Jianhua; Liu, Junzhong; Zheng, Yuan; Sun, Mi] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Liu, Jia] Qingdao Univ, Qingdao 266071, Peoples R China; [Lin, Xiukun] Capital Med Univ, Dept Pharmacol, Beijing, Peoples R China; [Yang, Kangli; Lv, Mei] Qingdao Univ Sci & Technol, Qingdao, Peoples R China; [Zhou, Xinwen] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao University; Capital Medical University; Qingdao University of Science & Technology; Fudan University	Sun, M (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.	sunmi@ysfri.ac.cn		Lin, Xiukun/0000-0002-0306-4953	Special Scientific Research Funds for Central Non-profit Institutes; Chinese Academy of Fishery Sciences [2013B01YQ01]; Science and Technology Development Plans of Shandong Province [2014GGF01060]; Special Scientific Research Funds for Central Non-profit Institutes, Yellow Sea Fisheries Research Institutes [20603022013017, 20603022012013]; 863 High Technology Project [2014AA093503]	Special Scientific Research Funds for Central Non-profit Institutes; Chinese Academy of Fishery Sciences; Science and Technology Development Plans of Shandong Province; Special Scientific Research Funds for Central Non-profit Institutes, Yellow Sea Fisheries Research Institutes; 863 High Technology Project(National High Technology Research and Development Program of China)	This work was supported by Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2013B01YQ01), Science and Technology Development Plans of Shandong Province (2014GGF01060), and Special Scientific Research Funds for Central Non-profit Institutes, Yellow Sea Fisheries Research Institutes (20603022013017 and 20603022012013). This work was also partly supported by 863 High Technology Project (2014AA093503). The authors are grateful to all members of the laboratory for their continuous technical advice and helpful discussion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Beaglehole R, 2011, PUBLIC HEALTH, V125, P821, DOI 10.1016/j.puhe.2011.09.029; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; CAIN JM, 1992, INVEST NEW DRUG, V10, P23, DOI 10.1007/BF01275473; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Depenbrock H, 1998, BRIT J CANCER, V78, P739, DOI 10.1038/bjc.1998.570; El-Sersy NA, 2012, J BASIC MICROB, V52, P513, DOI 10.1002/jobm.201100290; GRUBB DR, 1995, BIOCHEM BIOPH RES CO, V215, P1130, DOI 10.1006/bbrc.1995.2580; Guedes SD, 2003, BIOCHEM BIOPH RES CO, V312, P545, DOI 10.1016/j.bbrc.2003.10.156; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JENSEN PR, 1994, ANNU REV MICROBIOL, V48, P559, DOI 10.1146/annurev.mi.48.100194.003015; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; Li X, 2005, TRENDS BIOTECHNOL, V23, P539, DOI 10.1016/j.tibtech.2005.08.006; Liu XY, 2010, J ANTIBIOT, V63, P415, DOI 10.1038/ja.2010.56; MONTGOMERY DW, 1985, TRANSPLANTATION, V40, P49, DOI 10.1097/00007890-198507000-00011; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nalda-Molina R, 2009, CANCER CHEMOTH PHARM, V64, P97, DOI 10.1007/s00280-008-0841-4; Newman DJ, 2006, J IND MICROBIOL BIOT, V33, P539, DOI 10.1007/s10295-006-0115-2; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; Smibert Robert M., 1994, P607; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR SA, 1992, INVEST NEW DRUG, V10, P55, DOI 10.1007/BF01275484; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tindall BJ., 2007, METHODS GEN MOL MICR, V3, P330, DOI DOI 10.1128/9781555817497.CH15; Urdiales JL, 1996, CANCER LETT, V102, P31, DOI 10.1016/0304-3835(96)04151-1; Vater J, 2009, RAPID COMMUN MASS SP, V23, P1493, DOI 10.1002/rcm.4031; Waters AL, 2010, CURR OPIN BIOTECH, V21, P780, DOI 10.1016/j.copbio.2010.09.013; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xiong ZQ, 2013, MAR DRUGS, V11, P700, DOI 10.3390/md11030700; Yergey AL, 2002, J AM SOC MASS SPECTR, V13, P784, DOI 10.1016/S1044-0305(02)00393-8; Zheng LH, 2011, MAR DRUGS, V9, P1840, DOI 10.3390/md9101840; Zheng LH, 2013, BBA-REV CANCER, V1836, P42, DOI 10.1016/j.bbcan.2013.02.006	33	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111270	10.1371/journal.pone.0111270	http://dx.doi.org/10.1371/journal.pone.0111270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372839	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900041
J	Agrawal, YO; Sharma, PK; Shrivastava, B; Ojha, S; Upadhya, HM; Arya, DS; Goyal, SN				Agrawal, Yogeeta O.; Sharma, Pankaj Kumar; Shrivastava, Birendra; Ojha, Shreesh; Upadhya, Harshita M.; Arya, Dharamvir Singh; Goyal, Sameer N.			Hesperidin Produces Cardioprotective Activity via PPAR-gamma Pathway in Ischemic Heart Disease Model in Diabetic Rats	PLOS ONE			English	Article							REPERFUSION INJURY; HYPERTENSIVE-RATS; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ORANGE JUICE; ROSIGLITAZONE; BIOAVAILABILITY; PIOGLITAZONE; TELMISARTAN; AGONIST	The present study investigated the effect of hesperidin, a natural flavonoid, in cardiac ischemia and reperfusion (I/R) injury in diabetic rats. Male Wistar rats with diabetes were divided into five groups and were orally administered saline once daily (IR-sham and IR-control), Hesperidin (100 mg/kg/day; IR-Hesperidin), GW9962 (PPAR-gamma receptor antagonist), or combination of both for 14 days. On the 15th day, in the IR-control and IR-treatment groups, rats were subjected to left anterior descending (LAD) coronary artery occlusion for 45 minutes followed by a one-hour reperfusion. Haemodynamic parameters were recorded and rats were sacrificed; hearts were isolated for biochemical, histopathological, ultrastructural and immunohistochemistry. In the IR-control group, significant ventricular dysfunctions were observed along with enhanced expression of pro-apoptotic protein Bax. A decline in cardiac injury markers lactate dehydrogenase activity, CK-MB and increased content of thiobarbituric acid reactive substances, a marker of lipid peroxidation, and TNF-alpha were observed. Hesperidin pretreatment significantly improved mean arterial pressure, reduced left ventricular end-diastolic pressure, and improved both inotropic and lusitropic function of the heart (+LVdP/dt and -LVdP/dt) as compared to IR-control. Furthermore, hesperidin treatment significantly decreased the level of thiobarbituric acid reactive substances and reversed the activity of lactate dehydrogenase towards normal value. Hesperidin showed anti-apoptotic effects by upregulating Bcl-2 protein and decreasing Bax protein expression. Additionally, histopathological and ultrastructural studies reconfirmed the protective action of hesperidin. On the other hand, GW9662, selective PPAR-gamma receptor antagonist, produced opposite effects and attenuated the hesperidin induced improvements. The study for the first time evidence the involvement of PPAR-gamma pathway in the cardioprotective activity of hesperidin in I/R model in rats.	[Agrawal, Yogeeta O.; Sharma, Pankaj Kumar; Shrivastava, Birendra] Jaipur Natl Univ, Sch Pharmaceut Sci, Jaipur, Rajasthan, India; [Agrawal, Yogeeta O.; Arya, Dharamvir Singh] All India Inst Med Sci, Dept Pharmacol, New Delhi, India; [Agrawal, Yogeeta O.; Goyal, Sameer N.] RC Patel Inst Pharmaceut Educ & Res, Dept Pharmaceut & Pharmacol, Shirpur, Maharashtra, India; [Ojha, Shreesh] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Upadhya, Harshita M.] Sunils Daibet & Res Ctr, Nagpur, Maharashtra, India	Jaipur National University; All India Institute of Medical Sciences (AIIMS) New Delhi; United Arab Emirates University	Sharma, PK (corresponding author), Jaipur Natl Univ, Sch Pharmaceut Sci, Jaipur, Rajasthan, India.	jnupharmacyresearch@gmail.com; goyal.aiims@gmail.com	Shrivastava, Birendra/AAW-8735-2020; sharma, pankaj/HGE-4423-2022	Goyal, sameer/0000-0002-5241-7049; OJHA, SHREESH/0000-0001-7801-2966; Agrawal (Goyal), Yogeeta/0000-0002-3293-5607; Shrivastava, Birendra/0000-0001-5914-1762				Ameer B, 1996, CLIN PHARMACOL THER, V60, P34, DOI 10.1016/S0009-9236(96)90164-2; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bolten Charles W, 2007, Diab Vasc Dis Res, V4, P117; Cao ZL, 2007, PHARMACOLOGY, V79, P184, DOI 10.1159/000100870; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; De Biase L, 2003, THROMB HAEMOSTASIS, V90, P317, DOI 10.1160/TH03-02-0105; De Bono D.P., 1992, DAVIDSONS PRINCIPLE, P249; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Erlund I, 2001, J NUTR, V131, P235, DOI 10.1093/jn/131.2.235; Geng DF, 2006, INT J CARDIOL, V113, P86, DOI 10.1016/j.ijcard.2006.03.060; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Gumieniczek A, 2003, LIFE SCI, V74, P553, DOI 10.1016/j.lfs.2003.03.004; Hagar HH, 2002, PHARMACOL RES, V46, P213, DOI 10.1016/S1043-6618(02)00095-6; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Huang EJ, 2006, CLIN CHIM ACTA, V366, P293, DOI 10.1016/j.cca.2005.10.025; Ikejima H, 2008, J HYPERTENS, V26, P964, DOI 10.1097/HJH.0b013e3282f52c36; Ipseeta Mohanty, 2007, International Journal of Integrative Biology, V1, P178; Ito H, 2003, LAB INVEST, V83, P1715, DOI 10.1097/01.LAB.0000106724.29121.DA; Kakadiya J, 2010, INT J BIOL TECH, V1, P57; Kakadiya Jagdish, 2010, J Basic Clin Pharm, V1, P85; Kobayashi N, 2008, AM J HYPERTENS, V21, P576, DOI 10.1038/ajh.2008.27; Liu HR, 2004, CARDIOVASC RES, V62, P135, DOI 10.1016/j.cardiores.2003.12.027; Loh HK, 2007, BASIC CLIN PHARMACOL, V100, P233, DOI 10.1111/j.1742-7843.2007.00022.x; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Manach C, 2003, EUR J CLIN NUTR, V57, P235, DOI 10.1038/sj.ejcn.1601547; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Matsumoto H, 2004, J AGR FOOD CHEM, V52, P6653, DOI 10.1021/jf0491411; Mohanty IR, 2008, CLIN NUTR, V27, P635, DOI 10.1016/j.clnu.2008.05.006; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Nakamura T, 2000, CHEM PHARM BULL, V48, P235; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Rajadurai M, 2006, TOXICOLOGY, V228, P259, DOI 10.1016/j.tox.2006.09.005; Sahoo KC, 2009, J RENIN-ANGIO-ALDO S, V10, P201, DOI 10.1177/1470320308353059; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Silva GD, 2011, EXP TOXICOL PATHOL, V63, P1, DOI 10.1016/j.etp.2009.09.001; Singh AD, 2006, BASIC CLIN PHARMACOL, V98, P604, DOI 10.1111/j.1742-7843.2006.pto_405.x; Vanden Heuvel JP, 1999, TOXICOL SCI, V47, P1, DOI 10.1093/toxsci/47.1.1; Wayman NS, 2002, FASEB J, V16, P1027, DOI 10.1096/fj.01-0793com; Wilmsen PK, 2005, J AGR FOOD CHEM, V53, P4757, DOI 10.1021/jf0502000; Wu LY, 2004, AM J HYPERTENS, V17, P749, DOI 10.1016/j.amjhyper.2004.04.010; Yamamoto M, 2013, FOOD FUNCT, V4, P1346, DOI 10.1039/c3fo60030k	43	70	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111212	10.1371/journal.pone.0111212	http://dx.doi.org/10.1371/journal.pone.0111212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369053	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000044
J	Alymova, IV; York, IA; McCullers, JA				Alymova, Irina V.; York, Ian A.; McCullers, Jonathan A.			Non-Avian Animal Reservoirs Present a Source of Influenza A PB1-F2 Proteins with Novel Virulence-Enhancing Markers	PLOS ONE			English	Article							HUMAN INFECTION; VIRUS; GENE; H3N2; TRANSMISSION; EXPRESSION; ORIGIN; PATHOGENICITY; EVOLUTION; CANINE	PB1-F2 protein, expressed from an alternative reading frame of most influenza A virus (IAV) PB1 segments, may possess specific residues associated with enhanced inflammation (L62, R75, R79, and L82) and cytotoxicity (I68, L69, and V70). These residues were shown to increase the pathogenicity of primary viral and secondary bacterial infections in a mouse model. In contrast to human seasonal influenza strains, virulence-associated residues are present in PB1-F2 proteins from pandemic H1N1 1918, H2N2 1957, and H3N2 1968, and highly pathogenic H5N1 strains, suggesting their contribution to viruses' pathogenic phenotypes. Non-human influenza strains may act as donors of virulent PB1-F2 proteins. Previously, avian influenza strains were identified as a potential source of inflammatory, but not cytotoxic, PB1-F2 residues. Here, we analyze the frequency of virulence-associated residues in PB1-F2 sequences from IAVs circulating in mammalian species in close contact with humans: pigs, horses, and dogs. All four inflammatory residues were found in PB1-F2 proteins from these viruses. Among cytotoxic residues, I68 was the most common and was especially prevalent in equine and canine IAVs. Historically, PB1-F2 from equine (about 75%) and canine (about 20%) IAVs were most likely to have combinations of the highest numbers of residues associated with inflammation and cytotoxicity, compared to about 7% of swine IAVs. Our analyses show that, in addition to birds, pigs, horses, and dogs are potentially important sources of pathogenic PB1-F2 variants. There is a need for surveillance of IAVs with genetic markers of virulence that may be emerging from these reservoirs in order to improve pandemic preparedness and response.	[Alymova, Irina V.; York, Ian A.] Centers Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA; [Alymova, Irina V.; McCullers, Jonathan A.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [McCullers, Jonathan A.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA	Centers for Disease Control & Prevention - USA; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	McCullers, JA (corresponding author), Centers Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA.	jon.mccullers@stjude.org	York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Anhlan D, 2011, RNA, V17, P64, DOI 10.1261/rna.2395211; Brockmeier S. L, 2002, POLYMICROBIAL DIS; Buehler J, 2013, J VIROL, V87, P10687, DOI 10.1128/JVI.01520-13; Chambers TM, 2009, EQUINE VET J, V41, P87, DOI 10.2746/042516408X371937; Chen GW, 2004, EMERG INFECT DIS, V10, P630, DOI 10.3201/eid1004.030412; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Harder TC, 2010, VET IMMUNOL IMMUNOP, V134, P54, DOI 10.1016/j.vetimm.2009.10.009; Huber VC, 2012, VIRULENCE, V3, P523, DOI 10.4161/viru.21811; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Kang YM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-92; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Lu G, 2013, VIRUS GENES, V47, P250, DOI 10.1007/s11262-013-0935-x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pena L, 2012, J GEN VIROL, V93, P2204, DOI 10.1099/vir.0.045005-0; Pena L, 2012, J VIROL, V86, P5523, DOI 10.1128/JVI.00134-12; Quinlivan M, 2007, VACCINE, V25, P7056, DOI 10.1016/j.vaccine.2007.07.059; Rivailler P, 2010, VIROLOGY, V408, P71, DOI 10.1016/j.virol.2010.08.022; SARASOLA P, 1992, VET REC, V131, P441, DOI 10.1136/vr.131.19.441; Smith AM, 2013, VIRUS RES MAR, V14; Smith AM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001081; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song D, 2008, EMERG INFECT DIS, V14, P741, DOI 10.3201/eid1405.071471; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vincent A, 2013, ZOONOSES PUBLIC HLTH, DOI [10.1111/zph.12049, DOI 10.1111/ZPH.12049.[]; WADDELL GH, 1963, J AM VET MED ASSOC, V143, P587; Wattrang E, 2003, VIRAL IMMUNOL, V16, P57, DOI 10.1089/088282403763635456; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weeks-Gorospe JN, 2012, J VIROL, V86, P9035, DOI 10.1128/JVI.00369-12; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	40	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111603	10.1371/journal.pone.0111603	http://dx.doi.org/10.1371/journal.pone.0111603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368997	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000074
J	Bouchut, A; Geiger, JA; DeRocher, AE; Parsons, M				Bouchut, Anne; Geiger, Jennifer A.; DeRocher, Amy E.; Parsons, Marilyn			Vesicles Bearing Toxoplasma Apicoplast Membrane Proteins Persist Following Loss of the Relict Plastid or Golgi Body Disruption	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PLASMODIUM-FALCIPARUM; MOLECULAR CHARACTERIZATION; BINDING PROTEIN; LIPID DROPLETS; GONDII; TRAFFICKING; TRANSPORT; PATHWAY; CHLOROPLAST	Toxoplasma gondii and malaria parasites contain a unique and essential relict plastid called the apicoplast. Most apicoplast proteins are encoded in the nucleus and are transported to the organelle via the endoplasmic reticulum (ER). Three trafficking routes have been proposed for apicoplast membrane proteins: (i) vesicular trafficking from the ER to the Golgi and then to the apicoplast, (ii) contiguity between the ER membrane and the apicoplast allowing direct flow of proteins, and (iii) vesicular transport directly from the ER to the apicoplast. Previously, we identified a set of membrane proteins of the T. gondii apicoplast which were also detected in large vesicles near the organelle. Data presented here show that the large vesicles bearing apicoplast membrane proteins are not the major carriers of luminal proteins. The vesicles continue to appear in parasites which have lost their plastid due to mis-segregation, indicating that the vesicles are not derived from the apicoplast. To test for a role of the Golgi body in vesicle formation, parasites were treated with brefeldin A or transiently transfected with a dominant-negative mutant of Sar1, a GTPase required for ER to Golgi trafficking. The immunofluorescence patterns showed little change. These findings were confirmed using stable transfectants, which expressed the toxic dominant-negative sar1 following Cre-loxP mediated promoter juxtaposition. Our data support the hypothesis that the large vesicles do not mediate the trafficking of luminal proteins to the apicoplast. The results further show that the large vesicles bearing apicoplast membrane proteins continue to be observed in the absence of Golgi and plastid function. These data raise the possibility that the apicoplast proteome is generated by two novel ER to plastid trafficking pathways, plus the small set of proteins encoded by the apicoplast genome.	[Bouchut, Anne; Geiger, Jennifer A.; DeRocher, Amy E.; Parsons, Marilyn] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Geiger, Jennifer A.; Parsons, Marilyn] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Parsons, M (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	Marilyn.parsons@seattlebiomed.org		Parsons, Marilyn/0000-0003-3994-8096	National Institute of Allergy and Infectious Diseases [T32AI007509]; National Institutes of Health [R01AI50506]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050506, T32AI007509] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JAG was supported by a training grant from the National Institute of Allergy and Infectious Diseases (Grant T32AI007509). The work was supported by a grant from the National Institutes of Health R01AI50506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa A, 2007, INT J PARASITOL, V37, P1127, DOI 10.1016/j.ijpara.2007.02.009; Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; BANGS JD, 1993, J CELL SCI, V105, P1101; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; Budimulja AS, 1997, MOL BIOCHEM PARASIT, V84, P137, DOI 10.1016/S0166-6851(96)02781-8; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; Chaudhari R, 2012, FEBS J, V279, P3872, DOI 10.1111/j.1742-4658.2012.08746.x; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; DeRocher A, 2005, J CELL SCI, V118, P565, DOI 10.1242/jcs.01627; DeRocher A, 2000, J CELL SCI, V113, P3969; DeRocher AE, 2008, EUKARYOT CELL, V7, P1518, DOI 10.1128/EC.00081-08; DeRocher AE, 2012, TRAFFIC, V13, P694, DOI 10.1111/j.1600-0854.2012.01335.x; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Glaser S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405100; Gorelick FS, 2001, MOL CELL ENDOCRINOL, V177, P13, DOI 10.1016/S0303-7207(01)00438-5; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; He CY, 2001, J BIOL CHEM, V276, P28436, DOI 10.1074/jbc.M102000200; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Karnataki A, 2007, TRAFFIC, V8, P1543, DOI 10.1111/j.1600-0854.2007.00637.x; Karnataki A, 2007, MOL MICROBIOL, V63, P1653, DOI 10.1111/j.1365-2958.2007.05619.x; Karnataki A, 2009, MOL BIOCHEM PARASIT, V166, P126, DOI 10.1016/j.molbiopara.2009.03.004; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kohler S, 2005, PARASITOL RES, V96, P258, DOI 10.1007/s00436-005-1338-2; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; McConkey GA, 1997, J BIOL CHEM, V272, P2046, DOI 10.1074/jbc.272.4.2046; Meissner M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.22.e115; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NAKANO A, 1994, J BIOCHEM-TOKYO, V116, P243, DOI 10.1093/oxfordjournals.jbchem.a124513; Nassoury N, 2003, J CELL SCI, V116, P2867, DOI 10.1242/jcs.00517; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Sulli C, 1999, J BIOL CHEM, V274, P457, DOI 10.1074/jbc.274.1.457; SULLI C, 1995, J BIOL CHEM, V270, P13084, DOI 10.1074/jbc.270.22.13084; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Poppel NFJ, 2006, INT J PARASITOL, V36, P443, DOI 10.1016/j.ijpara.2006.01.005; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang Z, 2012, BIOCHEM SOC T, V40, P457, DOI 10.1042/BST20110752; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x	75	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112096	10.1371/journal.pone.0112096	http://dx.doi.org/10.1371/journal.pone.0112096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369183	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000141
J	Bouhaddioui, W; Provost, PR; Tremblay, Y				Bouhaddioui, Wafae; Provost, Pierre R.; Tremblay, Yves			Identification of Most Stable Endogenous Control Genes for MicroRNA Quantification in the Developing Mouse Lung	PLOS ONE			English	Article							PULMONARY SURFACTANT; EXPRESSION PROFILE; PCR DATA; RT-PCR; LET-7; RNAS; DIFFERENTIATION; NORMALIZATION; MURINE; PROLIFERATION	MicroRNAs (miRNAs) are endogenous small non coding RNAs acting as negative regulators. miRNA are involved in lung development and pulmonary diseases. Measurement of their levels by qPCR is directly influenced by the stability of normalization gene(s), which can be affected by the experimental conditions. The developing lung is a changing tissue and one normalization gene showing stability on one developmental day may be modulated over time. Moreover, some developmental events are affected by sex, which also has to be considered. In this study, we compared stability of five putative control genes in the lung between sexes from the pseudoglandular to the alveolar stages and in adult lungs. Expression of sno135, sno142, sno202, sno234, and sno251 was studied by qPCR in male and female lung samples collected at seven time points from GD 15.5 to PN 30. Cq values of sno251 showed the highest variation across the different developmental stages, while sno234 was the most stable gene. Gene expression stability was studied by geNorm, NormFinder and BestKeeper. Our data showed that ranking of genes based on expression stability changed according to developmental time and sex. sno135/sno234 and sno142/sno234 were proposed as best combinations of normalization genes when both sexes and all the studied developmental stages are considered. Normalization of let7-a RNA levels with different pairs of control genes proposed by geNorm and NormFinder gave similar data, while the use of less stable genes introduced a statistically significant difference on PN 0. In conclusion, variations in stability of normalization gene expression are observed over time and according to sex during lung development. Best pairs of normalization genes are presented for specific developmental stages, and for the period extending from the pseudoglandular to the alveolar stages. The use of normalization genes selected for their expression stability is essential in lung development studies.	[Bouhaddioui, Wafae; Provost, Pierre R.; Tremblay, Yves] Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Provost, Pierre R.; Tremblay, Yves] Univ Laval, Fac Med, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1K 7P4, Canada; [Bouhaddioui, Wafae; Provost, Pierre R.; Tremblay, Yves] Univ Laval, Fac Med, CRBR, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Tremblay, Y (corresponding author), Ctr Rech CHU Quebec, Quebec City, PQ, Canada.	yves.tremblay@crchudequebec.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [171140-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Number 171140-2010 to YT (http://www.nserc-crsng.gc.ca/index_eng.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Bhaskaran M, 2012, PHYSIOL GENOMICS, V44, P970, DOI 10.1152/physiolgenomics.00145.2011; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bresson E, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-2; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Finnegan EJ, 2003, J CELL SCI, V116, P4689, DOI 10.1242/jcs.00838; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grosshans H, 2002, J CELL BIOL, V156, P17, DOI 10.1083/jcb.200111033; HE L, 2004, NAT REV GENET, V5, P522; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Matouskova P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086033; Mujahid S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-13; NIELSEN HC, 1985, J CLIN INVEST, V76, P177, DOI 10.1172/JCI111943; NIELSEN HC, 1981, PEDIATR RES, V15, P1245, DOI 10.1203/00006450-198109000-00004; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Provost PR, 2004, AM J RESP CRIT CARE, V170, P296, DOI 10.1164/rccm.200312-1680OC; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shin JI, 2014, NAT REV CANCER, V14, P70, DOI DOI 10.1038/nrc3477-c1; Simard M, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-25; Simard M, 2007, ANAL BIOCHEM, V362, P142, DOI 10.1016/j.ab.2006.12.036; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varkonyi-Gasic E, 2010, METHODS MOL BIOL, V631, P109, DOI 10.1007/978-1-60761-646-7_10; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wong LLK, 2010, 2010 APPL BIOS; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3; Zhang XY, 2011, RESP CARE, V56, P1009, DOI 10.4187/respcare.01032; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	55	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111855	10.1371/journal.pone.0111855	http://dx.doi.org/10.1371/journal.pone.0111855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368994	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000114
J	Choi, JA; Han, K; Park, YM; Park, CK				Choi, Jin A.; Han, Kyungdo; Park, Yong-Moon; Park, Chan Kee			Age-Related Association of Refractive Error with Intraocular Pressure in the Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; SYSTEMIC FACTORS; RISK-FACTORS; SOUTH-KOREA; GLAUCOMA; MYOPIA; EYE; POPULATION; PREVALENCE; BIOMECHANICS	Background: To investigate the distribution of intraocular pressure (IOP) and refractive errors according to age group in a representative sample of non-glaucomatous Korean adults. Methods: A total of 7,277 adults (>= 19 years) who participated in the Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011 underwent ophthalmic examination were divided into three groups according to age: the young- (19-39 years), middle- (40-59 years), and old- (>= 60 years) age groups. Simple and multiple regression analyses between IOP and various parameters (including the refractive error) were conducted. Results: The mean IOP of the total population was 14.0 +/- 0.1 mmHg [young: 13.9 +/- 0.1 mmHg; middle: 14.1 +/- 0.1 mmHg; old: 13.8 +/- 0.2 mmHg (P for trend = 0.085)]. Myopia and high myopia were more prevalent in the young- (70.8% and 16.1%, respectively), compared to the middle- (44.6% and 10.9%) and old- (8.9% and 2.2%) age groups. Univariate analysis in the total population showed that higher IOP was associated with myopic refractive error, the female gender, higher body mass index (BMI), diabetes, hypertension, and hypercholesterolemia (all P<0.05). In the young- and middle-age groups, higher IOP was associated with myopic refractive error, the female gender, higher BMI, hypercholesterolemia and diabetes (all P<0.05). In the old-age group, the association between IOP and refractive error was not significant (P = 0.828). In multiple linear regression analysis, similar significant relationships between the refractive error and IOP were found in the young- and middle-age groups (beta = -0.08 and -0.12; P = 0.002 and <0.001 for young- and middle-age group, respectively), but not in the old-age group (beta = 0.03; P = 0.728), after adjusting for age, gender, BMI, region of habitation, diabetes, hypertension, and hypercholesterolemia. Conclusions: Myopic refractive error was an independent predictor of higher IOP in non-glaucomatous eyes, and the association between refractive error and IOP differed according to age.	[Choi, Jin A.] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol, Suwon, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Suwon, South Korea; [Park, Yong-Moon] Catholic Univ Korea, Coll Med, Dept Prevent Med, Suwon, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	ckpark@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879				Astrom S, 2014, ACTA OPHTHALMOL, V92, P417, DOI 10.1111/aos.12232; Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Cheng CY, 2013, OPTOMETRY VISION SCI, V90, P400, DOI 10.1097/OPX.0b013e3182873449; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Fazio MA, 2012, INVEST OPHTH VIS SCI, V53, P5326, DOI 10.1167/iovs.12-9668; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Hashemi H, 2005, BRIT J OPHTHALMOL, V89, P652, DOI 10.1136/bjo.2004.058057; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Kim EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080361; Kim MJ, 2014, ACTA OPHTHALMOL; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Lee JH, 2013, INVEST OPHTH VIS SCI, V54, P5466, DOI 10.1167/iovs.13-12478; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; McBrien NA, 1997, INVEST OPHTH VIS SCI, V38, P321; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Park BJ, 2013, MENOPAUSE, V20, P742, DOI [10.1097/gme.0b013e31827ce3c6, 10.1097/GME.0b013e31827ce3c6]; Suh W, 2012, AM J OPHTHALMOL, V154, P99, DOI 10.1016/j.ajo.2012.01.009; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Wang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077180; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	29	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111879	10.1371/journal.pone.0111879	http://dx.doi.org/10.1371/journal.pone.0111879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369147	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000117
J	Domingues-Hamdi, E; Vasseur, C; Fournier, JB; Marden, MC; Wajcman, H; Baudin-Creuza, V				Domingues-Hamdi, Elisa; Vasseur, Corinne; Fournier, Jean-Baptiste; Marden, Michael C.; Wajcman, Henri; Baudin-Creuza, Veronique			Role of alpha-Globin H Helix in the Building of Tetrameric Human Hemoglobin: Interaction with alpha-Hemoglobin Stabilizing Protein (AHSP) and Heme Molecule	PLOS ONE			English	Article							ESCHERICHIA-COLI; BETA-HEMOGLOBIN; BINDING; THALASSEMIA; CHAPERONE; VARIANTS; EXPRESSION; STATE; ERYTHROPOIESIS; MUTATIONS	Alpha-Hemoglobin Stabilizing Protein (AHSP) binds to alpha-hemoglobin (alpha-Hb) or alpha-globin and maintains it in a soluble state until its association with the beta-Hb chain partner to form Hb tetramers. AHSP specifically recognizes the G and H helices of alpha-Hb. To investigate the degree of interaction of the various regions of the alpha-globin H helix with AHSP, this interface was studied by stepwise elimination of regions of the alpha-globin H helix: five truncated alpha-Hbs alpha-Hb1-138, alpha-Hb1-134, alpha-Hb1-126, alpha-Hb1-123, alpha-Hb1-117 were co-expressed with AHSP as two glutathione-S-transferase (GST) fusion proteins. SDS-PAGE and Western Blot analysis revealed that the level of expression of each truncated alpha-Hb was similar to that of the wild type alpha-Hb except the shortest protein alpha-Hb1-117 which displayed a decreased expression. While truncated GST-alpha-Hb1-138 and GST-alpha-Hb1- 134 were normally soluble; the shorter globins GST-alpha-Hb1-126 and GST-alpha-Hb1-117 were obtained in very low quantities, and the truncated GST-alpha-Hb1-123 provided the least material. Absorbance and fluorescence studies of complexes showed that the truncated alpha-Hb1-134 and shorter forms led to modified absorption spectra together with an increased fluorescence emission. This attests that shortening the H helix leads to a lower affinity of the alpha-globin for the heme. Upon addition of beta-Hb, the increase in fluorescence indicates the replacement of AHSP by beta-Hb. The CO binding kinetics of different truncated AHSP(WT)/alpha-Hb complexes showed that these Hbs were not functionally normal in terms of the allosteric transition. The N-terminal part of the H helix is primordial for interaction with AHSP and C-terminal part for interaction with heme, both features being required for stability of alpha-globin chain.	[Domingues-Hamdi, Elisa; Vasseur, Corinne; Fournier, Jean-Baptiste; Marden, Michael C.; Baudin-Creuza, Veronique] Univ Paris 11, INSERM, U779, Paris, France; [Wajcman, Henri] UPEC, Hop Henri Mondor, INSERM, U955, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Baudin-Creuza, V (corresponding author), Univ Paris 11, INSERM, U779, Paris, France.	veronique.baudin-creuza@inserm.fr	Vasseur, Corinne/AAV-1384-2021; BAUDIN-CREUZA, Véronique/K-7309-2017; Marden, Michael/AAA-5923-2020; Marden, Michael C/G-3139-2012	Vasseur, Corinne/0000-0002-4422-7069; BAUDIN-CREUZA, Véronique/0000-0003-1032-3236; Marden, Michael C/0000-0002-5254-6385	Institut National de la Sante et de la Recherche Medicale; University Paris XI	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris XI	This work was supported by the Institut National de la Sante et de la Recherche Medicale and the University Paris XI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI E, 1971, DERIVATIVES FERROUS, P13; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; Bunn F. H., 1986, HEMOGLOBIN MOL GENET; Chiu F, 1998, BIOCHEM BIOPH RES CO, V242, P365, DOI 10.1006/bbrc.1997.7955; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Fermi G., 1981, HAEMOGLOBIN MYOGLOBI; Graves PE, 2008, BBA-PROTEINS PROTEOM, V1784, P1471, DOI 10.1016/j.bbapap.2008.04.012; Harteveld CL, 2001, HAEMATOLOGICA, V86, P36; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kiger L, 2014, BBA-GEN SUBJECTS, V1840, P277, DOI 10.1016/j.bbagen.2013.09.015; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Komar AA, 1997, J BIOL CHEM, V272, P10646; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Lacerra G, 2007, HAEMATOLOGICA, V93, P141, DOI 10.3324/haematol.11789; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARDEN MC, 1988, BIOCHEMISTRY-US, V27, P1659, DOI 10.1021/bi00405a041; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Rachmilewitz E A, 1976, Birth Defects Orig Artic Ser, V12, P123; SACK JS, 1978, HEMOGLOBIN, V2, P153, DOI 10.3109/03630267809074782; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Turbpaiboon C, 2006, BRIT J HAEMATOL, V132, P370, DOI 10.1111/j.1365-2141.2005.05865.x; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vasseur C, 2009, CLIN BIOCHEM, V42, P1818, DOI 10.1016/j.clinbiochem.2009.05.011; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vasseur-Godbillon C, 2006, BLOOD CELL MOL DIS, V37, P173, DOI 10.1016/j.bcmd.2006.09.002; Wajcman H, 2008, HEMOGLOBIN, V32, P327, DOI 10.1080/03630260802173833; Weatherall DJ, 2004, NAT REV GENET, V5, P625, DOI 10.1038/nrg1406; WEISS IM, 1994, MOL CELL BIOL, V14, P8123, DOI 10.1128/MCB.14.12.8123; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030	32	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111395	10.1371/journal.pone.0111395	http://dx.doi.org/10.1371/journal.pone.0111395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369055	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000052
J	Koleva, P; Ketabi, A; Valcheva, R; Ganzle, MG; Dieleman, LA				Koleva, Petya; Ketabi, Ali; Valcheva, Rosica; Ganzle, Michael G.; Dieleman, Levinus A.			Chemically Defined Diet Alters the Protective Properties of Fructo-Oligosaccharides and Isomalto-Oligosaccharides in HLA-B27 Transgenic Rats	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REAL-TIME PCR; BUTYRATE-PRODUCING BACTERIA; INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; FECAL SAMPLES; FATTY-ACIDS; LACTOBACILLUS; METABOLISM; PRIMERS	Non-digestible oligosaccharides (NDO) were shown to reduce inflammation in experimental colitis, but it remains unclear whether microbiota changes mediate their colitis-modulating effects. This study assessed intestinal microbiota and intestinal inflammation after feeding chemically defined AIN-76A or rat chow diets, with or without supplementation with 8 g/kg body weight of fructo-oligosaccharides (FOS) or isomalto-oligosaccharides (IMO). The study used HLA-B27 transgenic rats, a validated model of inflammatory bowel disease (IBD), in a factorial design with 6 treatment groups. Intestinal inflammation and intestinal microbiota were analysed after 12 weeks of treatment. FOS and IMO reduced colitis in animals fed rat chow, but exhibited no anti-inflammatory effect when added to AIN-76A diets. Both NDO induced specific but divergent microbiota changes. Bifidobacteria and Enterobacteriaceae were stimulated by FOS, whereas copy numbers of Clostridium cluster IV were decreased. In addition, higher concentrations of total short-chain fatty acids (SCFA) were observed in cecal contents of rats on rat chow compared to the chemically defined diet. AIN-76A increased the relative proportions of propionate, iso-butyrate, valerate and iso-valerate irrespective of the oligosaccharide treatment. The SCFA composition, particularly the relative concentration of iso-butyrate, valerate and iso-valerate, was associated (P <= 0.004 and r >= 0.4) with increased colitis and IL-1 beta concentration of the cecal mucosa. This study demonstrated that the protective effects of fibres on colitis development depend on the diet. Although diets modified specific cecal microbiota, our study indicates that these changes were not associated with colitis reduction. Intestinal inflammation was positively correlated to protein fermentation and negatively correlated with carbohydrate fermentation in the large intestine.	[Koleva, Petya; Ketabi, Ali; Ganzle, Michael G.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Koleva, Petya; Valcheva, Rosica; Dieleman, Levinus A.] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Ganzle, Michael G.] Hubei Univ Technol, Sch Food & Pharmaceut Engn, Wuhan, Peoples R China	University of Alberta; University of Alberta; Hubei University of Technology	Ganzle, MG (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	mgaenzle@ualberta.ca	Dieleman, Levinus/AAT-8198-2021; Gänzle, Michael/F-1432-2017	Gänzle, Michael/0000-0003-0972-928X; Dieleman, Levinus/0000-0001-7852-2122	National Science and Engineering Council of Canada (NSERC); Alberta Advanced Education and Technology; Faculty of ALES, University of Alberta; Canada Research Chair Program; Faculty of Medicine	National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Advanced Education and Technology; Faculty of ALES, University of Alberta; Canada Research Chair Program(Canada Research Chairs); Faculty of Medicine	This study was supported by the National Science and Engineering Council of Canada (NSERC) and Alberta Advanced Education and Technology. PK is supported by an Interfaculty Student Scholarship of the Faculty of Medicine and the Faculty of ALES, University of Alberta. MG acknowledges the Canada Research Chair Program for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Benjamin JL, 2011, GUT, V60, P923, DOI 10.1136/gut.2010.232025; Bornet FRJ, 2002, DIGEST LIVER DIS, V34, pS111, DOI 10.1016/S1590-8658(02)80177-3; Casellas F, 2007, ALIMENT PHARM THER, V25, P1061, DOI 10.1111/j.1365-2036.2007.03288.x; Castagnini C, 2009, BRIT J NUTR, V102, P1620, DOI 10.1017/S0007114509990936; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen X, 2013, DIGEST DIS SCI, V58, P1560, DOI 10.1007/s10620-013-2563-7; Cummings JH, 1997, CLIN NUTR, V16, P3, DOI 10.1016/S0261-5614(97)80252-X; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; Cummings JH, 1997, EUR J GASTROEN HEPAT, V9, P149, DOI 10.1097/00042737-199702000-00008; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Farrell RJ, 2002, GASTROENTEROL CLIN N, V31, P41, DOI 10.1016/S0889-8553(01)00004-8; Ferguson LR, 2007, GENES NUTR, V2, P71, DOI 10.1007/s12263-007-0046-1; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Geier MS, 2007, DIS COLON RECTUM, V50, P1061, DOI 10.1007/s10350-007-0213-x; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Goto H, 2010, J NUTR, V140, P2121, DOI 10.3945/jn.110.125948; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Han WQ, 2007, APPL ENVIRON MICROB, V73, P4082, DOI 10.1128/AEM.01820-06; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hoentjen F, 2005, INFLAMM BOWEL DIS, V11, P977, DOI 10.1097/01.MIB.0000183421.02316.d5; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Htoo JK, 2007, J ANIM SCI, V85, P3303, DOI 10.2527/jas.2007-0105; Hu Y, 2013, LETT APPL MICROBIOL, V57, P108, DOI 10.1111/lam.12076; Huda-Faujan N, 2010, Open Biochem J, V4, P53, DOI 10.2174/1874091X01004010053; Issa M, 2011, NUTR CLIN PRACT, V26, P151, DOI 10.1177/0884533611400233; Iwaya H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050658; Ketabi A, 2011, J APPL MICROBIOL, V110, P1297, DOI 10.1111/j.1365-2672.2011.04984.x; Kim J, 2008, NATURE, V452, P239, DOI 10.1038/nature06637; Kish L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062220; KOHMOTO T, 1992, BIOSCI BIOTECH BIOCH, V56, P937, DOI 10.1271/bbb.56.937; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Le Bourhis AG, 2005, APPL ENVIRON MICROB, V71, P29, DOI 10.1128/AEM.71.1.29-38.2005; Le Leu R, 2013, DIGEST DIS SCI, V58, P3475, DOI 10.1007/s10620-013-2844-1; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Marteau P, 2009, DIGEST DIS, V27, P99, DOI 10.1159/000268128; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Meister D, 2005, WORLD J GASTROENTERO, V11, P7466, DOI 10.3748/wjg.v11.i47.7466; Messelhausser U, 2007, J VERBRAUCH LEBENSM, V2, P194, DOI 10.1007/s00003-007-0173-z; Nilsson U, 2005, BRIT J NUTR, V94, P705, DOI 10.1079/BJN20051531; Ooi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086366; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Reif S, 1997, GUT, V40, P754, DOI 10.1136/gut.40.6.754; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Roberfroid MB, 1998, J NUTR, V128, P11, DOI 10.1093/jn/128.1.11; Ross AB, 2011, BRIT J NUTR, V105, P1492, DOI 10.1017/S0007114510005209; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thompson-Chagoyan OC, 2005, CLIN NUTR, V24, P339, DOI 10.1016/j.clnu.2005.02.009; Tieking M, 2005, J AGR FOOD CHEM, V53, P2456, DOI 10.1021/jf048307v; USA American Institute of Nutrition, 1977, Journal of Nutrition, V107, P1340; van den Berg RJ, 2006, CLIN MICROBIOL INFEC, V12, P184, DOI 10.1111/j.1469-0691.2005.01301.x; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	62	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111717	10.1371/journal.pone.0111717	http://dx.doi.org/10.1371/journal.pone.0111717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369019	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000091
J	Teremetz, M; Amado, I; Bendjemaa, N; Krebs, MO; Lindberg, PG; Maier, MA				Teremetz, Maxime; Amado, Isabelle; Bendjemaa, Narjes; Krebs, Marie-Odile; Lindberg, Pavel G.; Maier, Marc A.			Deficient Grip Force Control in Schizophrenia: Behavioral and Modeling Evidence for Altered Motor Inhibition and Motor Noise	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; CORTICAL INHIBITION; NEUROLOGICAL SIGNS; INTRACORTICAL INHIBITION; PRECISION; METAANALYSIS; DEXTERITY; CORTEX; STOP	Whether upper limb sensorimotor control is affected in schizophrenia and how underlying pathological mechanisms may potentially intervene in these deficits is still being debated. We tested voluntary force control in schizophrenia patients and used a computational model in order to elucidate potential cerebral mechanisms underlying sensorimotor deficits in schizophrenia. A visuomotor grip force-tracking task was performed by 17 medicated and 6 non-medicated patients with schizophrenia (DSM-IV) and by 15 healthy controls. Target forces in the ramp-hold-and-release paradigm were set to 5N and to 10% maximal voluntary grip force. Force trajectory was analyzed by performance measures and Principal Component Analysis (PCA). A computational model incorporating neural control signals was used to replicate the empirically observed motor behavior and to explore underlying neural mechanisms. Grip task performance was significantly lower in medicated and non-medicated schizophrenia patients compared to controls. Three behavioral variables were significantly higher in both patient groups: tracking error (by 50%), coefficient of variation of force (by 57%) and duration of force release (up by 37%). Behavioral performance did not differ between patient groups. Computational simulation successfully replicated these findings and predicted that decreased motor inhibition, together with an increased signal-dependent motor noise, are sufficient to explain the observed motor deficits in patients. PCA also suggested altered motor inhibition as a key factor differentiating patients from control subjects: the principal component representing inhibition correlated with clinical severity. These findings show that schizophrenia affects voluntary sensorimotor control of the hand independent of medication, and suggest that reduced motor inhibition and increased signal-dependent motor noise likely reflect key pathological mechanisms of the sensorimotor deficit.	[Teremetz, Maxime; Lindberg, Pavel G.; Maier, Marc A.] Univ Paris 05, Sorbonne Paris Cite, CNRS, FR3636, F-75006 Paris, France; [Amado, Isabelle; Bendjemaa, Narjes; Krebs, Marie-Odile] Univ Paris 05, Hop St Anne, SHU, F-75014 Paris, France; [Amado, Isabelle; Bendjemaa, Narjes; Krebs, Marie-Odile] Univ Paris 05, Sorbonne Paris Cite, INSERM, U894,GDR3557, F-75014 Paris, France; [Maier, Marc A.] Univ Paris Diderot, Sorbonne Paris Cite, F-75012 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Maier, MA (corresponding author), Univ Paris 05, Sorbonne Paris Cite, CNRS, FR3636, F-75006 Paris, France.	marc.maier@parisdescartes.fr	Lindberg, Pavel/P-9792-2019; Maier, Marc/HGU-9498-2022; Lindberg, Pavel G/E-5926-2017; Krebs, Marie-Odile/O-2104-2017	Lindberg, Pavel/0000-0001-6976-6387; Lindberg, Pavel G/0000-0001-6976-6387; Krebs, Marie-Odile/0000-0002-4715-9890; Lindberg, Pavel/0000-0002-7507-7817	French national agency for research and technology (ANRT) (CIFRE) [2013/0226]; Sensix (Poitiers, France); French national research agency [ANR-08-MNPS-004]; Fondation Pierre Deniker; European Research Area Net (ERA-NET Neuron); Fondation de France	French national agency for research and technology (ANRT) (CIFRE)(French National Research Agency (ANR)); Sensix (Poitiers, France); French national research agency(French National Research Agency (ANR)); Fondation Pierre Deniker; European Research Area Net (ERA-NET Neuron); Fondation de France(Fondation de France)	MMT was supported by a PhD fellowship (CIFRE #2013/0226) from the French national agency for research and technology (ANRT) and Sensix (Poitiers, France). This project was in part funded by the French national research agency (grant # ANR-08-MNPS-004), by Fondation Pierre Deniker, by the European Research Area Net (ERA-NET Neuron 2010) and by Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badcock JC, 2002, PSYCHOL MED, V32, P287, DOI 10.1017/S0033291701005128; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bleton JP, 2014, MOVEMENT DISORD, V29, P130, DOI 10.1002/mds.25690; Bleuler E., 1911, DEMENTIA PRAECOX GRO, P1950; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Chan RCK, 2010, SCHIZOPHRENIA BULL, V36, P1089, DOI 10.1093/schbul/sbp011; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Clark LK, 2010, SCHIZOPHR RES, V124, P169, DOI 10.1016/j.schres.2010.08.004; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Daskalakis ZJ, 2008, J PSYCHOPHARMACOL, V22, P203, DOI 10.1177/0269881107084002; Daskalakis ZJ, 2002, ARCH GEN PSYCHIAT, V59, P347, DOI 10.1001/archpsyc.59.4.347; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; Delevoye-Turrell Y, 2003, AM J PSYCHIAT, V160, P134, DOI 10.1176/appi.ajp.160.1.134; Delevoye-Turrell Y, 2002, NEUROREPORT, V13, P1537, DOI 10.1097/00001756-200208270-00010; Delevoye-Turrell Y, 2007, J ABNORM PSYCHOL, V116, P56, DOI 10.1037/0021-843X.116.1.56; Donohoe Gary, 2006, Cogn Neuropsychiatry, V11, P13, DOI 10.1080/13546800444000155; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Frantseva M, 2014, CEREB CORTEX, V24, P211, DOI 10.1093/cercor/bhs304; Giersch A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00620; Grootens KP, 2009, SCHIZOPHR RES, V107, P294, DOI 10.1016/j.schres.2008.09.032; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HEINRICHS DW, 1988, AM J PSYCHIAT, V145, P11; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kraepelin E, 1919, DEMENTIA PRAECOX PAR; Krebs MO, 2010, PSYCHIAT RES, V179, P279, DOI 10.1016/j.psychres.2009.07.008; Krebs MO, 2000, SCHIZOPHR RES, V45, P245, DOI 10.1016/S0920-9964(99)00206-6; Lafargue G, 2006, CORTEX, V42, P711, DOI 10.1016/S0010-9452(08)70409-X; Le Seac'h A, 2012, PSYCHIAT RES, V198, P230, DOI 10.1016/j.psychres.2011.12.039; Lehoux C, 2003, SCHIZOPHR RES, V62, P269, DOI 10.1016/S0920-9964(02)00327-4; Lindberg P, 2009, EXP BRAIN RES, V193, P213, DOI 10.1007/s00221-008-1613-4; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Liu SK, 2009, BIOL PSYCHIAT, V65, P503, DOI 10.1016/j.biopsych.2008.09.012; MAIER MA, 1993, J NEUROPHYSIOL, V69, P772, DOI 10.1152/jn.1993.69.3.772; MANSCHRECK TC, 1982, PSYCHOL MED, V12, P73, DOI 10.1017/S0033291700043300; Manschreck TC, 2004, SCHIZOPHRENIA BULL, V30, P351, DOI 10.1093/oxfordjournals.schbul.a007084; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Midorikawa A, 2008, PSYCHIAT RES, V159, P281, DOI 10.1016/j.psychres.2007.04.004; Motawar B, 2012, EXP BRAIN RES, V221, P299, DOI 10.1007/s00221-012-3173-x; Neely KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058403; Nowak DA, 2006, J NEUROL NEUROSUR PS, V77, P650, DOI 10.1136/jnnp.2005.084749; Prodoehl J, 2009, NEUROSCI BIOBEHAV R, V33, P900, DOI 10.1016/j.neubiorev.2009.03.004; Putzhammer Albert, 2006, Dialogues Clin Neurosci, V8, P123; Radhu N, 2013, CLIN NEUROPHYSIOL, V124, P1309, DOI 10.1016/j.clinph.2013.01.014; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; Rantalainen T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00068; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rolls ET, 2011, NEUROSCI BIOBEHAV R, V35, P1644, DOI 10.1016/j.neubiorev.2010.09.001; ROSEN AJ, 1991, J ABNORM PSYCHOL, V100, P583, DOI 10.1037/0021-843X.100.4.583; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Spitzer M, 1997, SCHIZOPHRENIA BULL, V23, P29, DOI 10.1093/schbul/23.1.29; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Uhlhaas PJ, 2013, CURR OPIN NEUROBIOL, V23, P283, DOI 10.1016/j.conb.2012.11.004; WANNIER TMJ, 1991, J NEUROPHYSIOL, V65, P572, DOI 10.1152/jn.1991.65.3.572; Wolff AL, 1999, J PSYCHIATR NEUROSCI, V24, P304	61	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111853	10.1371/journal.pone.0111853	http://dx.doi.org/10.1371/journal.pone.0111853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369465	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402000113
J	Ting, WY; Huang, SF; Lee, MC; Lin, YY; Lee, YC; Feng, JY; Su, WJ				Ting, Wen-Ying; Huang, Shiang-Fen; Lee, Ming-Che; Lin, Yung-Yang; Lee, Yu-Chin; Feng, Jia-Yih; Su, Wei-Juin			Gender Disparities in Latent Tuberculosis Infection in High-Risk Individuals: A Cross-Sectional Study	PLOS ONE			English	Article							SKIN-TEST; PULMONARY TUBERCULOSIS; TAIWAN; SUSCEPTIBILITY; DIAGNOSIS; OUTCOMES; TOBACCO; COHORT; ASSAY; AREA	Male predominance in active tuberculosis (TB) is widely-reported globally. Gender inequalities in socio-cultural status are frequently regarded as contributing factors for disparities in sex in active TB. The disparities of sex in the prevalence of latent TB infection (LTBI) are less frequently investigated and deserve clarification. In this cross-sectional study conducted in a TB endemic area, we enrolled patients at high-risk for LTBI and progression from LTBI to active TB from 2011 to 2012. Diagnosis of LTBI was made by QuantiFERON-TB Gold In-Tube (QFT-GIT). Differences in sex in terms of prevalence of LTBI and clinical predictors for LTBI were investigated. Associations among age, smoking status, and sex disparities in LTBI were also analyzed. A total of 1018 high-risk individuals with definite QFT-GIT results were included for analysis, including 534 males and 484 females. The proportion of LTBI was significantly higher in males than in females (32.6% vs. 25.2%, p = 0.010). Differences in the proportion of LTBI between sexes were most prominent in older patients (age >= 55 years). In multivariate analysis, independent clinical factors associated with LTBI were age (p = 0.014), smoking (p = 0.048), and fibro-calcified lesions on chest radiogram (p = 0.009). Male sex was not an independent factor for LTBI (p = 0.88). When stratifying patients according to the smoking status, the proportion of LTBI remained comparable between sexes among smokers and nonsmokers. In conclusion, although the proportion of LTBI is higher in men, there is no significant disparity in terms of sex in LTBI among high-risk individuals after adjusting for age, smoking status, and other clinical factors.	[Ting, Wen-Ying; Lee, Ming-Che; Lee, Yu-Chin; Feng, Jia-Yih; Su, Wei-Juin] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Huang, Shiang-Fen] Taipei Vet Gen Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Huang, Shiang-Fen; Lee, Yu-Chin; Su, Wei-Juin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Neurophysiol Lab, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Feng, Jia-Yih] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Feng, JY (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	jyfeng@vghtpe.gov.tw; wjsu@vghtpe.gov.tw	Huang, Shiang-Fen/ABA-5375-2021	Huang, Shiang-Fen/0000-0003-0390-9108; Huang, Shiang-Fen/0000-0002-6685-8259	Institute for Biotechnology and Medicine Industry of Taiwan; Taipei Veterans General Hospital [V99C1-181, V99A-023, V100A-002, V101B-027, V102B-030]	Institute for Biotechnology and Medicine Industry of Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was funded by the Institute for Biotechnology and Medicine Industry of Taiwan and by Taipei Veterans General Hospital (V99C1-181, V99A-023, V100A-002, V101B-027, and V102B-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2013, WHO GLOB TUB REP; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Diel R, 2013, EUR RESPIR J, V42, P785, DOI 10.1183/09031936.00205512; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023715; Fortun J, 2007, J ANTIMICROB CHEMOTH, V59, P794, DOI 10.1093/jac/dkm025; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Kim HR, 2008, RESPIROLOGY, V13, P413, DOI 10.1111/j.1440-1843.2008.01282.x; Kim SY, 2013, INFECTION, V41, P103, DOI 10.1007/s15010-012-0291-0; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Soysal A, 2012, NEPHROL DIAL TRANSPL, V27, P1645, DOI 10.1093/ndt/gfr516; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; Vlassoff C, 2002, SOC SCI MED, V54, P1713, DOI 10.1016/S0277-9536(01)00339-2; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P829; YAMAMOTO Y, 1990, AM REV RESPIR DIS, V142, P430, DOI 10.1164/ajrccm/142.2.430; Yamasaki-Nakagawa M, 2001, INT J TUBERC LUNG D, V5, P24; Yen YF, 2013, SCAND J INFECT DIS, V45, P504, DOI 10.3109/00365548.2013.768354; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066412	30	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110104	10.1371/journal.pone.0110104	http://dx.doi.org/10.1371/journal.pone.0110104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369472	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000017
J	Vigelius, M; Meyer, B; Pascoe, G				Vigelius, Matthias; Meyer, Bernd; Pascoe, Geoffrey			Multiscale Modelling and Analysis of Collective Decision Making in Swarm Robotics	PLOS ONE			English	Article							SYSTEMS	We present a unified approach to describing certain types of collective decision making in swarm robotics that bridges from a microscopic individual-based description to aggregate properties. Our approach encompasses robot swarm experiments, microscopic and probabilistic macroscopic-discrete simulations as well as an analytic mathematical model. Following up on previous work, we identify the symmetry parameter, a measure of the progress of the swarm towards a decision, as a fundamental integrated swarm property and formulate its time evolution as a continuous-time Markov process. Contrary to previous work, which justified this approach only empirically and a posteriori, we justify it from first principles and derive hard limits on the parameter regime in which it is applicable.	[Vigelius, Matthias; Meyer, Bernd; Pascoe, Geoffrey] Monash Univ, FIT Ctr Res Intelligent Syst, Melbourne, Vic 3004, Australia	Monash University	Meyer, B (corresponding author), Monash Univ, FIT Ctr Res Intelligent Syst, Melbourne, Vic 3004, Australia.	bernd.meyer@monash.edu			Australian Research Council [ARC DP0879239]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council (http://www.arc.gov.au/) under ARC DP0879239, providing salary support for MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayindir L, 2007, TURKISH J ELECT ENG, V15; Berman S, 2007, LECT NOTES COMPUT SC, V4433, P56; Correll N, 2009, P 7 INT S DISTR AUT; Dantu K, 2012, INT C INT ROB SYST I; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; FRANKOWICZ M, 1993, J PHYS CHEM-US, V97, P1891, DOI 10.1021/j100111a029; Gardiner C, 2009, SPRINGER SERIES SYNE; Gazi V, 2007, LECT NOTES COMPUT SC, V4433, P71; Gillespie D, 1991, MARKOV PROCESSES; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3253798; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Haken H, 1978, SYNERGETICS INTRO NO, DOI [10.1007/978-3-642-96469-5, DOI 10.1007/978-3-642-96469-5]; Hamann H, 2007, PARALLEL PROCESS LET, V17, P287, DOI 10.1142/S0129626407003022; Hamann H, 2010, LECT NOTES ARTIF INT, V6226, P639, DOI 10.1007/978-3-642-15193-4_60; Illian J, 2008, STAT ANAL MODELLING; Isaacson SA, 2009, SIAM J APPL MATH, V70, P77, DOI 10.1137/070705039; Klavins E, 2007, CONTROL SYSTEMS MAGA, V24; Lerman K, 2006, INT J ROBOT RES, V25, P225, DOI 10.1177/0278364906063426; Lerman K, 2005, LECT NOTES COMPUT SC, V3342, P143; Lerman K, 2001, ARTIF LIFE, V7, P375, DOI 10.1162/106454601317297013; Martinoli A, 2004, INT J ROBOT RES, V23, P415, DOI 10.1177/0278364904042197; Matthey L, 2009, P 2009 IEEE INT C RO; Milutinovic D, 2006, IEEE T ROBOTICS, V22; Napp N, 2009, P AM CONTR C ACC09; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Pascoe G, 2012, THESIS MONASH U; Pavlic T. P., 2013, INT S ROB RES ISRR S; Prorok A, 2011, INT J ROBOTICS RES, V30; Rubenstein M, 2012, KILOBOT LOW COST SCA, DOI [10.1109/ICRA.2012.6224638, DOI 10.1109/ICRA.2012.6224638]; Tian JJP, 2006, STOCH ANAL APPL, V24, P685, DOI 10.1080/07362990600632045; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vigelius M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042508; Vigelius M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033384; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622	36	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111542	10.1371/journal.pone.0111542	http://dx.doi.org/10.1371/journal.pone.0111542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369026	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000067
J	Bressel, PJRD; McNally, GP				Bressel, Philip Jean-Richard Dit; McNally, Gavan P.			The Role of the Lateral Habenula in Punishment	PLOS ONE			English	Article							BASAL GANGLIA; DOPAMINE; NEURONS; REWARD; TRANSMISSION; ACTIVATION; SEEKING; INPUT	The lateral habenula (LHb) is a small epithalamic structure that projects via the fasciculus retroflexus to the midbrain. The LHb is known to modulate midbrain dopamine (DA) neurons, including inhibition of ventral tegmental area (VTA) neurons via glutamatergic excitation of the GABAergic rostromedial tegmental nucleus (RMTg). A variety of lines of evidence show activity in LHb and the LHb-RMTg pathway is correlated with, and is sufficient to support, punishment learning. However, it is not immediately clear whether LHb is necessary for punishment. Here we used a within-subjects punishment task to assess the role of LHb in the acquisition and expression of punishment as well as in aversive choice. Rats that pressed two individually presented levers for pellet rewards rapidly suppressed responding to one lever if it also caused footshock deliveries (punished lever) but continued pressing a second lever that did not cause footshock (unpunished lever). Infusions of an AMPA receptor antagonist (NBQX) into LHb had no effect on the acquisition or expression of this punishment, or on aversive choice, but did increase locomotion. Infusion of the sodium channel blocker bupivacaine likewise had no effect on expression of punishment. However, infusion of the calcium channel blocker mibefradil did affect expression of punishment by significantly decreasing the latency with which rats responded on the punished lever and significantly increasing unpunished lever-pressing. Taken together, these findings indicate that the LHb plays a limited role in punishment, influencing only latency to respond. This role is linked to calcium channel permeability and not AMPA receptor or sodium channel permeability.	[Bressel, Philip Jean-Richard Dit; McNally, Gavan P.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	McNally, GP (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	g.mcnally@unsw.edu.au	Jean-Richard-dit-Bressel, Philip/AAR-6185-2020; Jean-Richard, Philip/AAK-2006-2021	Jean-Richard-dit-Bressel, Philip/0000-0002-0898-8987; McNally, Gavan/0000-0001-9061-6463	Australian Research Council [FT120100250, DP130100310]	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council FT120100250, Australian Research Council DP130100310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Brown PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060678; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gifuni AJ, 2012, NEUROPHARMACOLOGY, V63, P945, DOI 10.1016/j.neuropharm.2012.07.032; Haack AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092701; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; HUGUENARD JR, 1993, J NEUROPHYSIOL, V70, P158, DOI 10.1152/jn.1993.70.1.158; Jhou TC, 2013, J NEUROSCI, V33, P7501, DOI 10.1523/JNEUROSCI.3634-12.2013; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026701; Meye FJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00860; Millan EZ, 2011, LEARN MEMORY, V18, P414, DOI 10.1101/lm.2144411; Mirrione MM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00029; Nair SG, 2013, BRAIN RES, V1511, P93, DOI 10.1016/j.brainres.2012.10.011; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stoetzer C, 2014, BR J ANAESTH; Stopper CM, 2014, NAT NEUROSCI, V17, P33, DOI 10.1038/nn.3587; Tomaiuolo M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00170; Yadid Gal, 2013, Front Hum Neurosci, V7, P806, DOI 10.3389/fnhum.2013.00806; Zuo WH, 2013, NEUROPHARMACOLOGY, V70, P180, DOI 10.1016/j.neuropharm.2013.01.008	34	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111699	10.1371/journal.pone.0111699	http://dx.doi.org/10.1371/journal.pone.0111699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365401	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100107
J	Campbell, IC; Suever, JD; Timmins, LH; Veneziani, A; Vito, RP; Virmani, R; Oshinski, JN; Taylor, WR				Campbell, Ian C.; Suever, Jonathan D.; Timmins, Lucas H.; Veneziani, Alessandro; Vito, Raymond P.; Virmani, Renu; Oshinski, John N.; Taylor, W. Robert			Biomechanics and Inflammation in Atherosclerotic Plaque Erosion and Plaque Rupture: Implications for Cardiovascular Events in Women	PLOS ONE			English	Article							SUDDEN CORONARY DEATH; CIRCUMFERENTIAL STRESS; CAP THICKNESS; LIPID CORE; THROMBOSIS; STABILITY; MORPHOLOGY; ARTERIES; LESIONS; PREVENTION	Objective: Although plaque erosion causes approximately 40% of all coronary thrombi and disproportionally affects women more than men, its mechanism is not well understood. The role of tissue mechanics in plaque rupture and regulation of mechanosensitive inflammatory proteins is well established, but their role in plaque erosion is unknown. Given obvious differences in morphology between plaque erosion and rupture, we hypothesized that inflammation in general as well as the association between local mechanical strain and inflammation known to exist in plaque rupture may not occur in plaque erosion. Therefore, our objective was to determine if similar mechanisms underlie plaque rupture and plaque erosion. Methods and Results: We studied a total of 74 human coronary plaque specimens obtained at autopsy. Using lesion-specific computer modeling of solid mechanics, we calculated the stress and strain distribution for each plaque and determined if there were any relationships with markers of inflammation. Consistent with previous studies, inflammatory markers were positively associated with increasing strain in specimens with rupture and thin-cap fibroatheromas. Conversely, overall staining for inflammatory markers and apoptosis were significantly lower in erosion, and there was no relationship with mechanical strain. Samples with plaque erosion most closely resembled those with the stable phenotype of thick-cap fibroatheromas. Conclusions: In contrast to classic plaque rupture, plaque erosion was not associated with markers of inflammation and mechanical strain. These data suggest that plaque erosion is a distinct pathophysiological process with a different etiology and therefore raises the possibility that a different therapeutic approach may be required to prevent plaque erosion.	[Campbell, Ian C.; Suever, Jonathan D.; Timmins, Lucas H.; Veneziani, Alessandro; Vito, Raymond P.; Oshinski, John N.; Taylor, W. Robert] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Timmins, Lucas H.; Taylor, W. Robert] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Veneziani, Alessandro] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Vito, Raymond P.] Georgia Inst Technol, George W Woodruff Dept Mech Engn, Atlanta, GA 30332 USA; [Virmani, Renu] CVPath Inst Inc, Gaithersburg, MD USA; [Oshinski, John N.] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Taylor, W. Robert] Atlanta Vet Affairs Med Ctr, Div Cardiol, Decatur, GA USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; CVPath Institute; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Taylor, WR (corresponding author), Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.	wtaylor@emory.edu	Campbell, Ian/J-4432-2012	Campbell, Ian/0000-0002-4640-2692	American Heart Association Postdoctoral Fellowship; National Science Foundation Graduate Research Fellowship [DGE-0644493]; National Institutes of Health Bioengineering Research Partnership [R01 HL70531]; NIH Program of Excellence in Nanotechnology Award [HHSN268201000043C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070531] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health Bioengineering Research Partnership(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Program of Excellence in Nanotechnology Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by an American Heart Association Predoctoral Fellowship (ICC), an American Heart Association Postdoctoral Fellowship (LHT), by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-0644493 (ICC and JDS), by the National Institutes of Health Bioengineering Research Partnership Grant No. R01 HL70531, and a NIH Program of Excellence in Nanotechnology Award (HHSN268201000043C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie D, 1998, J BIOMECH ENG-T ASME, V120, P602, DOI 10.1115/1.2834750; Campbell Ian C, 2013, Cardiovasc Eng Technol, V4, DOI 10.1007/s13239-013-0165-3; Campbell IC, 2013, AM J PHYSIOL-HEART C, V304, pH473, DOI 10.1152/ajpheart.00620.2012; Canfeld T, 1987, HDB BIOENGINEERING; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; Chodorowski A, 2005, PROC SPIE, V5747, P1589, DOI 10.1117/12.594944; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Everett BM, 2013, AM HEART J, V166, P199, DOI 10.1016/j.ahj.2013.03.018; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Finet G, 2004, CORONARY ARTERY DIS, V15, P13, DOI 10.1097/00019501-200402000-00003; Fung Y. C., 1997, BIOMECHANICS CIRCULA; FUNG YC, 1979, AM J PHYSIOL, V237, pH620, DOI 10.1152/ajpheart.1979.237.5.H620; Fuster V, 1996, MAYO CLIN PRACTICE C, P1056; Hallow KM, 2009, BIOMECH MODEL MECHAN, V8, P473, DOI 10.1007/s10237-009-0151-8; Holzapfel GA, 2005, AM J PHYSIOL-HEART C, V289, pH2048, DOI 10.1152/ajpheart.00934.2004; Holzapfel GA, 1998, COMPUT BIOL MED, V28, P377, DOI 10.1016/S0010-4825(98)00022-5; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Humphrey JD, 2002, MATH MOD METH APPL S, V12, P407, DOI 10.1142/S0218202502001714; Kilpatrick D, 2001, J BIOMECH ENG-T ASME, V123, P635, DOI 10.1115/1.1406037; Kolodgie FD, 2004, CURR OPIN LIPIDOL, V15, P575, DOI 10.1097/00041433-200410000-00012; Kramer MCA, 2010, J AM COLL CARDIOL, V55, P122, DOI 10.1016/j.jacc.2009.09.007; Lee RT, 2000, Z KARDIOL, V89, P80; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; Li ZY, 2006, STROKE, V37, P1195, DOI 10.1161/01.STR.0000217331.61083.3b; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P1350, DOI 10.1161/01.ATV.0000135322.78008.55; Maldonado N, 2012, AM J PHYSIOL-HEART C, V303, pH619, DOI 10.1152/ajpheart.00036.2012; Mayranpaa MI, 2007, ENDOTHELIUM-J ENDOTH, V14, P81, DOI 10.1080/10623320701346783; Ohayon J, 2008, AM J PHYSIOL-HEART C, V295, pH717, DOI 10.1152/ajpheart.00005.2008; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; Rosenson RS, 2010, J AM COLL CARDIOL, V56, P1079, DOI 10.1016/j.jacc.2010.06.015; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Sumi T, 2010, J THROMB HAEMOST, V8, P1394, DOI 10.1111/j.1538-7836.2010.03843.x; Timmins LH, 2013, IEEE T MED IMAGING; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Weber M, 2011, HEART, V97, P626, DOI 10.1136/hrt.2010.210419; Yezzi AJ, 2003, IEEE T MED IMAGING, V22, P1332, DOI 10.1109/TMI.2003.817775	40	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111785	10.1371/journal.pone.0111785	http://dx.doi.org/10.1371/journal.pone.0111785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365517	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100121
J	Klumper, W; Qaim, M				Kluemper, Wilhelm; Qaim, Matin			A Meta-Analysis of the Impacts of Genetically Modified Crops	PLOS ONE			English	Article							COMMERCIALIZED GM CROPS; FARM-LEVEL; BT COTTON; BENEFITS; CHINA; FOOD	Background: Despite the rapid adoption of genetically modified (GM) crops by farmers in many countries, controversies about this technology continue. Uncertainty about GM crop impacts is one reason for widespread public suspicion. Objective: We carry out a meta-analysis of the agronomic and economic impacts of GM crops to consolidate the evidence. Data Sources: Original studies for inclusion were identified through keyword searches in ISI Web of Knowledge, Google Scholar, EconLit, and AgEcon Search. Study Eligibility Criteria: Studies were included when they build on primary data from farm surveys or field trials anywhere in the world, and when they report impacts of GM soybean, maize, or cotton on crop yields, pesticide use, and/or farmer profits. In total, 147 original studies were included. Synthesis Methods: Analysis of mean impacts and meta-regressions to examine factors that influence outcomes. Results: On average, GM technology adoption has reduced chemical pesticide use by 37%, increased crop yields by 22%, and increased farmer profits by 68%. Yield gains and pesticide reductions are larger for insect-resistant crops than for herbicide-tolerant crops. Yield and profit gains are higher in developing countries than in developed countries. Limitations: Several of the original studies did not report sample sizes and measures of variance. Conclusion: The meta-analysis reveals robust evidence of GM crop benefits for farmers in developed and developing countries. Such evidence may help to gradually increase public trust in this technology.	[Kluemper, Wilhelm; Qaim, Matin] Univ Gottingen, Dept Agr Econ & Rural Dev, D-37073 Gottingen, Germany	University of Gottingen	Qaim, M (corresponding author), Univ Gottingen, Dept Agr Econ & Rural Dev, D-37073 Gottingen, Germany.	mqaim@uni-goettingen.de	Qaim, Matin/P-4489-2016	Qaim, Matin/0000-0003-4143-0763	German Federal Ministry of Economic Cooperation and Development (BMZ); European Union's Seventh Framework Programme (FP7) [290693 FOODSECURE]	German Federal Ministry of Economic Cooperation and Development (BMZ); European Union's Seventh Framework Programme (FP7)	This research was financially supported by the German Federal Ministry of Economic Cooperation and Development (BMZ) and the European Union's Seventh Framework Programme (FP7/2007-2011) under Grant Agreement 290693 FOODSECURE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neither BMZ nor FOODSECURE and any of its partner organizations, any organization of the European Union or the European Commission are accountable for the content of this article.	Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Andreasen M, 2014, NAT BIOTECHNOL, V32, P25, DOI 10.1038/nbt.2790; [Anonymous], 2013, NATURE BIOTECHNOLOGY, V31, P767; Areal FJ, 2013, J AGR SCI-CAMBRIDGE, V151, P7, DOI 10.1017/S0021859612000111; Borenstein M, 2009, INTRO META ANAL; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; DeFrancesco L, 2013, NAT BIOTECHNOL, V31, P794, DOI 10.1038/nbt.2686; European Academies Science Advisory Council, 2013, PLANT FUT OPP CHALL; European Commission, 2010, DECADE EU FUNDED GMO; Fernandez-Cornejo J, 2014, ERR162 USDA; Finger R, 2011, SUSTAINABILITY-BASEL, V3, P743, DOI 10.3390/su3050743; Gilbert N, 2013, NATURE, V497, P24, DOI 10.1038/497024a; Glover D, 2010, J AGRAR CHANGE, V10, P482, DOI 10.1111/j.1471-0366.2010.00283.x; Huang JK, 2008, ECON DEV CULT CHANGE, V56, P241, DOI 10.1086/522898; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Morse S, 2004, NAT BIOTECHNOL, V22, P379, DOI 10.1038/nbt0404-379b; Pray CE, 2002, PLANT J, V31, P423, DOI 10.1046/j.1365-313X.2002.01401.x; Qaim M, 2005, AGR ECON, V32, P73, DOI 10.1111/j.0169-5150.2005.00006.x; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Qaim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064879; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Rothstein H.R., 2009, HDB RES SYNTHESIS ME, P103; Sexton S., 2012, INTENDED UNINTENDED, P269, DOI DOI 10.7208/CHICAGO/9780226988061.003.0009; Shadish W. R., 2009, HDB RES SYNTHESIS ME, P257; Smale M., 2009, MEASURING EC IMPACTS; Stone G. D., 2012, Economic and Political Weekly, V47, P62	26	388	406	14	427	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111629	10.1371/journal.pone.0111629	http://dx.doi.org/10.1371/journal.pone.0111629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365303	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100091
J	Lee, DV; Li, DM; Yan, QY; Zhu, YM; Goodwin, B; Calle, R; Brenner, MB; Talukdar, S				Lee, Darwin V.; Li, Dongmei; Yan, Qingyun; Zhu, Yimin; Goodwin, Bryan; Calle, Roberto; Brenner, Martin B.; Talukdar, Saswata			Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes	PLOS ONE			English	Article							ENERGY-EXPENDITURE; FGF21; MICE; MOUSE; METABOLISM; PEPTIDES; TISSUE; BROWN	Fibroblast growth factor 21 (FGF21) has evolved as a major metabolic regulator, the pharmacological administration of which causes weight loss, insulin sensitivity and glucose control in rodents and humans. To understand the molecular mechanisms by which FGF21 exerts its metabolic effects, we developed a human in vitro model of adipocytes to examine crosstalk between FGF21 and insulin signaling. Human adipose stem cell-derived (hASC) adipocytes were acutely treated with FGF21 alone, insulin alone, or in combination. Insulin signaling under these conditions was assessed by measuring tyrosine phosphorylation of insulin receptor (InsR), insulin receptor substrate-1 (IRS-1), and serine 473 phosphorylation of Akt, followed by a functional assay using 14C-2-deoxyglucose [C-14]-2DG to measure glucose uptake in these cells. FGF21 alone caused a modest increase of glucose uptake, but treatment with FGF21 in combination with insulin had a synergistic effect on glucose uptake in these cells. The presence of FGF21 also effectively lowered the insulin concentration required to achieve the same level of glucose uptake compared to the absence of FGF21 by 10-fold. This acute effect of FGF21 on insulin signaling was not due to IR, IGF-1R, or IRS-1 activation. Moreover, we observed a substantial increase in basal S473-Akt phosphorylation by FGF21 alone, in contrast to the minimal shift in basal glucose uptake. Taken together, our data demonstrate that acute co-treatment of hASC-adipocytes with FGF21 and insulin can result in a synergistic improvement in glucose uptake. These effects were shown to occur at or downstream of Akt, or separate from the canonical insulin signaling pathway.	[Lee, Darwin V.; Li, Dongmei; Yan, Qingyun; Zhu, Yimin; Goodwin, Bryan; Calle, Roberto; Brenner, Martin B.; Talukdar, Saswata] Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, Cambridge, MA USA	Pfizer	Talukdar, S (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, Cambridge, MA USA.	Saswata.Talukdar@pfizer.com		Calle, Roberto/0000-0001-6577-5657	Pfizer, CVMED	Pfizer, CVMED	The study was paid for by Pfizer, CVMED. The funder provided support in the form of salaries for authors [D.V.L., D.L., Q.Y., Y.Z., B.G., R.C., M.B.B., S.T.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Huang J, 2013, J PHARMACOL EXP THER, V346, P270, DOI 10.1124/jpet.113.204420; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Koh HJ, 2007, BIOCHEM J, V403, P473, DOI 10.1042/BJ20061479; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Muise ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073011; Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652; Owen BM, 2014, CELL METAB; Reitman ML, 2013, CELL METAB, V18, P307, DOI 10.1016/j.cmet.2013.08.014; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yang C. F., 2012, BIOCH PHYSL OPEN ACC, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0033870; Yie JM, 2012, CHEM BIOL DRUG DES, V79, P398, DOI 10.1111/j.1747-0285.2012.01325.x; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	32	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111767	10.1371/journal.pone.0111767	http://dx.doi.org/10.1371/journal.pone.0111767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365322	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100117
J	Xu, L; Chen, YQ; Yang, K; Wang, YF; Tian, LC; Zhang, J; Wang, EW; Sun, DJ; Lu, WJ; Wang, J				Xu, Lei; Chen, Yuqin; Yang, Kai; Wang, Yingfeng; Tian, Lichun; Zhang, Jie; Wang, Elizabeth Wenqian; Sun, Dejun; Lu, Wenju; Wang, Jian			Chronic Hypoxia Increases TRPC6 Expression and Basal Intracellular Ca2+ Concentration in Rat Distal Pulmonary Venous Smooth Muscle	PLOS ONE			English	Article							RECEPTOR POTENTIAL EXPRESSION; CAPACITATIVE CALCIUM-ENTRY; UP-REGULATION; CELL PROLIFERATION; ARTERIAL; VEINS; SILDENAFIL; MIGRATION; PROTEINS; CHANNELS	Background: Hypoxia causes remodeling and contractile responses in both pulmonary artery (PA) and pulmonary vein (PV). Here we explore the effect of hypoxia on PV and pulmonary venous smooth muscle cells (PVSMCs). Methods: Chronic hypoxic pulmonary hypertension (CHPH) model was established by exposing rats to 10% O-2 for 21 days. Rat distal PVSMCs were isolated and cultured for in vitro experiments. The fura-2 based fluorescence calcium imaging was used to measure the basal intracellular Ca2+ concentration ([Ca2+](i)) and store-operated Ca2+ entry (SOCE). Quantitative RTPCR and western blotting were performed to measure the expression of mRNA and levels of canonical transient receptor potential (TRPC) protein respectively. Results: Hypoxia increased the basal [Ca2+](i) and SOCE in both freshly dissociated and serum cultured distal PVSMCs.Moreover, hypoxia increased TRPC6 expression at mRNA and protein levels in both cultured PVSMCs exposed to prolonged hypoxia (4% O-2, 60 h) and distal PV isolated from CHPH rats. Hypoxia also enhanced proliferation and migration of rat distal PVSMCs. Conclusions: Hypoxia induces elevation of SOCE in distal PVSMCs, leading to enhancement of basal [Ca2+](i) in PVSMCs. This enhancement is potentially correlated with the increased expression of TRPC6. Hypoxia triggered intracellular calcium contributes to promoted proliferation and migration of PVSMCs.	[Xu, Lei; Chen, Yuqin; Yang, Kai; Wang, Yingfeng; Tian, Lichun; Zhang, Jie; Lu, Wenju; Wang, Jian] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Xu, Lei; Yang, Kai; Lu, Wenju; Wang, Jian] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Sun, Dejun; Wang, Jian] Inner Mongolia Peoples Hosp, Div Pulm & Crit Care Med, Hohhot, Inner Mongolia, Peoples R China; [Wang, Elizabeth Wenqian] Geisinger Med Ctr, Danville, PA 17822 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Johns Hopkins University; Geisinger Medical Center	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com; jwang31@jhmi.edu	Yang, Kai/I-6524-2019	Yang, Kai/0000-0003-3044-2240; Chen, Yuqin/0000-0002-7011-7250	NIH Research Grants [R01HL093020]; National Natural Science Foundation of China [81070043, 81071917, 81173112, 81170052, 81220108001]; Chinese Central Government Key Research Projects of the 973 grants [2009CB522107]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong Department of Science and Technology of China [2009B050700041, 2010B03160030]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant [cxzd1025]; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	NIH Research Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Central Government Key Research Projects of the 973 grants(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Department of Science and Technology of China; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH Research Grants (R01HL093020), National Natural Science Foundation of China (81070043, 81071917, 81173112, 81170052, 81220108001), Chinese Central Government Key Research Projects of the 973 grants (2009CB522107), Changjiang Scholars and Innovative Research Team in University grant (IRT0961), Guangdong Department of Science and Technology of China (2009B050700041, 2010B03160030), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2008) China, Guangdong Department of Education research grant (cxzd1025), Guangdong Natural Science Foundation team grant (2010), Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). Lei Xu was supported by the Guangzhou Elite Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; CHAZOVA I, 1995, AM J PATHOL, V146, P389; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; DINGEMANS KP, 1978, AM J PATHOL, V93, P353; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; FINNEGAN P, 1977, IRISH J MED SCI, V146, P233, DOI 10.1007/BF03030965; Gao YS, 2005, AM J PHYSIOL-LUNG C, V288, pL213, DOI 10.1152/ajplung.00103.2004; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hillier SC, 1997, J APPL PHYSIOL, V82, P1084, DOI 10.1152/jappl.1997.82.4.1084; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Kunichika N, 2004, AM J RESP CRIT CARE, V170, P1101, DOI 10.1164/rccm.200312-1668OC; Leggett K, 2012, AM J PHYSIOL-LUNG C, V303, pL343, DOI 10.1152/ajplung.00130.2012; Lu WJ, 2008, AM J PHYSIOL-LUNG C, V295, pL104, DOI 10.1152/ajplung.00058.2008; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC114, DOI 10.1152/ajpcell.00629.2008; Michelakis ED, 2001, AM J PHYSIOL-LUNG C, V280, pL1138, DOI 10.1152/ajplung.2001.280.6.L1138; MIGALLY N, 1982, J SUBMICR CYTOL PATH, V14, P239; Ng LC, 2012, AM J PHYSIOL-CELL PH, V303, pC1156, DOI 10.1152/ajpcell.00065.2012; Peng GY, 2013, J THORAC DIS, V5, P605, DOI 10.3978/j.issn.2072-1439.2013.08.68; Peng GY, 2010, AM J PHYSIOL-LUNG C, V299, pL621, DOI 10.1152/ajplung.00176.2009; Peng GY, 2010, HYPERTENS RES, V33, P308, DOI 10.1038/hr.2009.234; RAJ JU, 1990, J APPL PHYSIOL, V69, P2183; Ramanathan G, 2012, J THROMB HAEMOST, V10, P419, DOI 10.1111/j.1538-7836.2011.04596.x; Remillard CV, 2006, MICROCIRCULATION, V13, P671, DOI 10.1080/10739680600930313; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Takahashi H, 2001, AM J PHYSIOL-LUNG C, V280, pL1104, DOI 10.1152/ajplung.2001.280.6.L1104; Wang C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-123; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Wang J, 2013, AM J RESP CELL MOL, V49, P231, DOI 10.1165/rcmb.2012-0185OC; Wang J, 2013, AM J RESP CELL MOL, V48, P125, DOI 10.1165/rcmb.2012-0071OC; Yang QW, 2012, AM J PHYSIOL-LUNG C, V303, pL1001, DOI 10.1152/ajplung.00092.2012; Yu LY, 2011, AM J RESP CELL MOL, V45, P923, DOI 10.1165/rcmb.2011-0032OC; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Zhang S, 2005, AM J PHYSIOL-CELL PH, V288, pC245, DOI 10.1152/ajpcell.00411.2004; Zhang Y, 2013, AM J PHYSIOL-CELL PH, V304, pC833, DOI 10.1152/ajpcell.00036.2012; ZHAO Y, 1993, AM J PHYSIOL, V265, pL87; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G	39	17	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e112007	10.1371/journal.pone.0112007	http://dx.doi.org/10.1371/journal.pone.0112007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365342	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100142
J	Kim, B; Lee, H; Kawata, K; Park, JY				Kim, Boa; Lee, Hojun; Kawata, Keisuke; Park, Joon-Young			Exercise-Mediated Wall Shear Stress Increases Mitochondrial Biogenesis in Vascular Endothelium	PLOS ONE			English	Article							LOWER-LIMB EXERCISE; BLOOD-FLOW; OXIDATIVE STRESS; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; HEMODYNAMIC CONDITIONS; NAD(P)H OXIDASE; CELLS; ARTERY; HUMANS	Objective: Enhancing structural and functional integrity of mitochondria is an emerging therapeutic option against endothelial dysfunction. In this study, we sought to investigate the effect of fluid shear stress on mitochondrial biogenesis and mitochondrial respiratory function in endothelial cells (ECs) using in vitro and in vivo complementary studies. Methods and Results: Human aortic- or umbilical vein-derived ECs were exposed to laminar shear stress (20 dyne/cm(2)) for various durations using a cone-and-plate shear apparatus. We observed significant increases in the expression of key genes related to mitochondrial biogenesis and mitochondrial quality control as well as mtDNA content and mitochondrial mass under the shear stress conditions. Mitochondrial respiratory function was enhanced when cells were intermittently exposed to laminar shear stress for 72 hrs. Also, shear-exposed cells showed diminished glycolysis and decreased mitochondrial membrane potential (Delta Psi m). Likewise, in in vivo experiments, mice that were subjected to a voluntary wheel running exercise for 5 weeks showed significantly higher mitochondrial content determined by en face staining in the conduit (greater and lesser curvature of the aortic arch and thoracic aorta) and muscle feed (femoral artery) arteries compared to the sedentary control mice. Interestingly, however, the mitochondrial biogenesis was not observed in the mesenteric artery. This region-specific adaptation is likely due to the differential blood flow redistribution during exercise in the different vessel beds. Conclusion: Taken together, our findings suggest that exercise enhances mitochondrial biogenesis in vascular endothelium through a shear stress-dependent mechanism. Our findings may suggest a novel mitochondrial pathway by which a chronic exercise may be beneficial for vascular function.	[Kim, Boa; Lee, Hojun; Kawata, Keisuke; Park, Joon-Young] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Kim, Boa; Park, Joon-Young] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Park, JY (corresponding author), Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA.	parkjy@temple.edu		Park, Joon-Young/0000-0002-7705-7086	American Heart Association [12SDG12070327, 12PRE11960049]; Temple University; College of Health Professions and Social Work Research Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126952] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Temple University; College of Health Professions and Social Work Research Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grants 12SDG12070327 (to J-Y. Park) and Predoctoral Fellowship 12PRE11960049 (to B. Kim), Temple University's University Felowships (to B. Kim and H. Lee), and College of Health Professions and Social Work Research Seed Grant (J-Y. Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Addabbo F, 2009, AM J PATHOL, V174, P34, DOI 10.2353/ajpath.2009.080650; Al-Mehdi Abu-Bakr, 2007, V2, P169, DOI 10.1007/978-0-387-69945-5_7; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Boushel R, 2000, J PHYSIOL-LONDON, V524, P305, DOI 10.1111/j.1469-7793.2000.t01-2-00305.x; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Cheng CP, 2004, AM J PHYSIOL-HEART C, V287, pH921, DOI 10.1152/ajpheart.00022.2004; Cheng CP, 2003, ATHEROSCLEROSIS, V168, P323, DOI 10.1016/S0021-9150(03)00099-6; Chistiakov DA, 2012, WORLD J CARDIOL, V4, P148, DOI 10.4330/wjc.v4.i5.148; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Denvir MA, 2009, J PHYSIOL-LONDON, V587, P4137, DOI 10.1113/jphysiol.2009.178624; DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Duerrschmidt N, 2006, J PHYSIOL-LONDON, V576, P557, DOI 10.1113/jphysiol.2006.111070; Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771; Eskurza I, 2004, J PHYSIOL-LONDON, V556, P315, DOI 10.1113/jphysiol.2003.057042; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; FLAMM SD, 1990, CIRCULATION, V81, P1550, DOI 10.1161/01.CIR.81.5.1550; Green DJ, 2012, EXP PHYSIOL, V97, P295, DOI 10.1113/expphysiol.2011.058826; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Groschner LN, 2012, PFLUG ARCH EUR J PHY, V464, P63, DOI 10.1007/s00424-012-1085-z; Harrison DG, 2006, J INTERN MED, V259, P351, DOI 10.1111/j.1365-2796.2006.01621.x; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Hjortdal VE, 2003, CIRCULATION, V108, P1227, DOI 10.1161/01.CIR.0000087406.27922.6B; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; Kasikcioglu E, 2005, TOHOKU J EXP MED, V205, P45, DOI 10.1620/tjem.205.45; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Knaub LA, 2013, DIABETES VASC DIS RE, V10, P222, DOI 10.1177/1479164112459664; Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95; Kudo S, 2000, BIOCHEM BIOPH RES CO, V270, P616, DOI 10.1006/bbrc.2000.2482; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laughlin MH, 1996, HDB PATHOPHYSIOLOGY; Li RS, 2009, BIOCHEM BIOPH RES CO, V388, P406, DOI 10.1016/j.bbrc.2009.08.022; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Miller MW, 2013, AM J PHYSIOL-HEART C, V304, pH1624, DOI 10.1152/ajpheart.00987.2012; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Ong SB, 2013, ANTIOXID REDOX SIGN, V19, P400, DOI 10.1089/ars.2012.4777; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Schlager O, 2011, EUR J VASC ENDOVASC, V41, P821, DOI 10.1016/j.ejvs.2011.01.006; Seals DR, 2008, J APPL PHYSIOL, V105, P1323, DOI 10.1152/japplphysiol.90553.2008; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Shimasaki Y, 2013, CIRC RES, V113, P891, DOI 10.1161/CIRCRESAHA.113.301319; Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006; Spence AL, 2013, J PHYSIOL-LONDON, V591, P1265, DOI 10.1113/jphysiol.2012.247387; Suh GY, 2011, ANN BIOMED ENG, V39, P2186, DOI 10.1007/s10439-011-0313-6; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274; Tang BT, 2006, AM J PHYSIOL-HEART C, V291, pH668, DOI 10.1152/ajpheart.01301.2005; Taylor CA, 1999, J VASC SURG, V29, P1077, DOI 10.1016/S0741-5214(99)70249-1; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; van Duijnhoven NTL, 2010, HYPERTENSION, V56, P240, DOI 10.1161/HYPERTENSIONAHA.110.152868; WADE OL, 1956, CLIN SCI, V15, P457; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	61	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111409	10.1371/journal.pone.0111409	http://dx.doi.org/10.1371/journal.pone.0111409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375175	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600037
J	Knutsvik, G; Stefansson, IM; Aziz, S; Arnes, J; Eide, J; Collett, K; Akslen, LA				Knutsvik, Goril; Stefansson, Ingunn M.; Aziz, Sura; Arnes, Jarle; Eide, Johan; Collett, Karin; Akslen, Lars A.			Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays	PLOS ONE			English	Article							PATHOLOGICAL PROGNOSTIC-FACTORS; INTERNATIONAL EXPERT CONSENSUS; ESTROGEN-RECEPTOR; FORMALIN FIXATION; INTRATUMORAL HETEROGENEITY; MOLECULAR CLASSIFICATION; ADJUVANT CHEMOTHERAPY; PROTEIN EXPRESSION; HISTOLOGICAL GRADE; PRIMARY THERAPY	Introduction: Tumor cell proliferation in breast cancer is strongly prognostic and may also predict response to chemotherapy. However, there is no consensus on counting areas or cut-off values for patient stratification. Our aim was to assess the matched level of proliferation by Ki67 when using different tissue categories (whole sections, WS; core needle biopsies, CNB; tissue microarrays, TMA), and the corresponding prognostic value. Methods: We examined a retrospective, population-based series of breast cancer (n = 534) from the Norwegian Breast Cancer Screening Program. The percentage of Ki67 positive nuclei was evaluated by visual counting on WS (n = 534), CNB (n = 154) and TMA (n = 459). Results: The median percentage of Ki67 expression was 18% on WS (hot-spot areas), 13% on CNB, and 7% on TMA, and this difference was statistically significant in paired cases. Increased Ki67 expression by all evaluation methods was associated with aggressive tumor features (large tumor diameter, high histologic grade, ER negativity) and reduced patient survival. Conclusion: There is a significant difference in tumor cell proliferation by Ki67 across different sample categories. Ki67 is prognostic over a wide range of cut-off points and for different sample types, although Ki67 results derived from TMA sections are lower compared with those obtained using specimens from a clinical setting. Our findings indicate that specimen specific cut-off values should be applied for practical use.	[Knutsvik, Goril; Stefansson, Ingunn M.; Aziz, Sura; Arnes, Jarle; Akslen, Lars A.] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway; [Knutsvik, Goril; Stefansson, Ingunn M.; Aziz, Sura; Arnes, Jarle; Eide, Johan; Collett, Karin; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway.	lars.akslen@k1.uib.no	Akslen, Lars A/C-1202-2017; Akslen, Lars A./AAG-6097-2021	Akslen, Lars A/0000-0003-2710-9543; Akslen, Lars A./0000-0003-2710-9543	Research Council of Norway through its Centres of Excellence [223250]; Helse Vest Research Fund [911637]; Norwegian Cancer Society; Research Council of Norway; Helse Vest Research Fund	Research Council of Norway through its Centres of Excellence(Research Council of Norway); Helse Vest Research Fund; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Helse Vest Research Fund	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223250. GK is supported by grant No 911637 from the Helse Vest Research Fund. LAA is supported by other grants from the Norwegian Cancer Society, the Research Council of Norway and Helse Vest Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badoual C, 2005, BREAST, V14, P22, DOI 10.1016/j.breast.2004.07.005; Batistatou A, 2013, ANTICANCER RES, V33, P2139; Burge CN, 2006, BREAST, V15, P167, DOI 10.1016/j.breast.2005.06.004; Callagy G, 2003, DIAGN MOL PATHOL, V12, P27, DOI 10.1097/00019606-200303000-00004; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen XS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-390; Chung GG, 2007, LAB INVEST, V87, P662, DOI 10.1038/labinvest.3700543; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Connor AJM, 1997, BREAST, V6, P171, DOI 10.1016/S0960-9776(97)90568-3; Connor CS, 2002, AM J SURG, V184, P322, DOI 10.1016/S0002-9610(02)00953-4; Cortesi L, 2012, TUMORI J, V98, P743, DOI 10.1700/1217.13498; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; DiLoreto C, 1996, EUR J CANCER, V32A, P1693, DOI 10.1016/0959-8049(96)00192-X; Dodd LG, 1997, J SURG ONCOL, V64, P280, DOI 10.1002/(SICI)1096-9098(199704)64:4<280::AID-JSO6>3.0.CO;2-5; Douglas-Jones AG, 2001, J CLIN PATHOL, V54, P951, DOI 10.1136/jcp.54.12.951; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Geyer FC, 2012, ADV ANAT PATHOL, V19, P39, DOI 10.1097/PAP.0b013e31823fafa0; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Greer LT, 2013, J AM COLL SURGEONS, V216, P239, DOI 10.1016/j.jamcollsurg.2012.09.007; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Harris GC, 2003, AM J SURG PATHOL, V27, P11, DOI 10.1097/00000478-200301000-00002; Hitchman E, 2011, HISTOPATHOLOGY, V59, P1261, DOI 10.1111/j.1365-2559.2011.03974.x; Honma N, 2013, BREAST CANC, P1; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Iqbal S, 2002, BREAST, V11, P252, DOI 10.1054/brst.2002.0408; Jacquemier J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3051; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; Kwok TC, 2010, HISTOPATHOLOGY, V57, P212, DOI 10.1111/j.1365-2559.2010.03620.x; Layfield LJ, 1998, AM J CLIN PATHOL, V110, P758; Lehr HA, 2013, MODERN PATHOL, V26, P336, DOI 10.1038/modpathol.2012.140; McIlhenny C, 2002, BRIT J SURG, V89, P84, DOI 10.1046/j.0007-1323.2001.01950.x; Nassar A, 2010, APPL IMMUNOHISTO M M, V18, P433, DOI 10.1097/PAI.0b013e3181dddb20; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; O'Leary R, 2004, J CLIN PATHOL, V57, P193, DOI 10.1136/jcp.2003.12914; Otali D, 2009, BIOTECH HISTOCHEM, V84, P223, DOI 10.1080/10520290903039094; Park SY, 2009, AM J SURG, V197, P266, DOI 10.1016/j.amjsurg.2007.11.024; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Rakha EA, 2013, HISTOPATHOLOGY, V62, P695, DOI 10.1111/his.12066; Ricci MD, 2012, REV ASSOC MED BRAS, V58, P532; Romero Q, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-341; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Sapino A, 2006, VIRCHOWS ARCH, V449, P288, DOI 10.1007/s00428-006-0233-2; Skarlos P, 2012, CANCER CHEMOTH PHARM, V69, P533, DOI 10.1007/s00280-011-1730-9; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; WEIDNER N, 1994, HUM PATHOL, V25, P337, DOI 10.1016/0046-8177(94)90140-6; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648	53	41	42	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112121	10.1371/journal.pone.0112121	http://dx.doi.org/10.1371/journal.pone.0112121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375149	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600107
J	Cancelliere, EC; DeAngelis, N; Nkurunungi, JB; Raubenheimer, D; Rothman, JM				Cancelliere, Emma C.; DeAngelis, Nicole; Nkurunungi, John Bosco; Raubenheimer, David; Rothman, Jessica M.			Minerals in the Foods Eaten by Mountain Gorillas (Gorilla beringel)	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; NUTRIENT COMPOSITION; DIETS IMPLICATIONS; ALOUATTA-PIGRA; MONKEYS; SELECTION; CALCIUM; CHIMPANZEES; COLOBUS; SODIUM	Minerals are critical to an individual's health and fitness, and yet little is known about mineral nutrition and requirements in free-ranging primates. We estimated the mineral content of foods consumed by mountain gorillas (Gorilla beringei beringei) in the Bwindi Impenetrable National Park, Uganda. Mountain gorillas acquire the majority of their minerals from herbaceous leaves, which constitute the bulk of their diet. However, less commonly eaten foods were sometimes found to be higher in specific minerals, suggesting their potential importance. A principal component analysis demonstrated little correlation among minerals in food items, which further suggests that mountain gorillas might increase dietary diversity to obtain a full complement of minerals in their diet. Future work is needed to examine the bioavailability of minerals to mountain gorillas in order to better understand their intake in relation to estimated needs and the consequences of suboptimal mineral balance in gorilla foods.	[Cancelliere, Emma C.; Rothman, Jessica M.] CUNY, Grad Ctr, Dept Anthropol, New York, NY 10031 USA; [Cancelliere, Emma C.; Rothman, Jessica M.] New York Consortium Evolutionary Primatol, New York, NY USA; [DeAngelis, Nicole] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Nkurunungi, John Bosco] Mbarara Univ Sci & Technol, Dept Biol, Mbarara, Uganda; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Fac Vet Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Rothman, Jessica M.] CUNY, Hunter Coll, Dept Anthropol, New York, NY 10021 USA	City University of New York (CUNY) System; Cornell University; Mbarara University of Science & Technology; University of Sydney; City University of New York (CUNY) System; Hunter College (CUNY)	Rothman, JM (corresponding author), CUNY, Grad Ctr, Dept Anthropol, New York, NY 10031 USA.	jessica.rothman@hunter.cuny.edu		Raubenheimer, David/0000-0001-9050-1447	Cornell University; Hunter College	Cornell University; Hunter College	Cornell University and Hunter College funded this research within larger research projects (no specific funding was received for this work). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman C. B., 1995, Bioavailability of nutrients for animals: amino acids, minerals, and vitamins., P83, DOI 10.1016/B978-012056250-3/50031-7; Barboza P.S., 2008, INTEGRATIVE WILDLIFE; Behie AM, 2012, AM J PRIMATOL, V74, P1054, DOI 10.1002/ajp.22059; Blake JG, 2010, INT J PRIMATOL, V31, P471, DOI 10.1007/s10764-010-9407-5; CALVERT JJ, 1985, OECOLOGIA, V65, P236, DOI 10.1007/BF00379223; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chaves OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025070; Cruz-Rivera E, 2000, OECOLOGIA, V123, P252, DOI 10.1007/s004420051012; Dierenfeld ES, 1999, ZOO BIOL, V18, P481, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;481::AID-ZOO3&gt;3.0.CO;2-9; Doran Diane M., 2001, Cambridge Studies in Biological and Evolutionary Anthropology, V27, P123; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Frossard E, 2000, J SCI FOOD AGR, V80, P861, DOI 10.1002/(SICI)1097-0010(20000515)80:7&lt;861::AID-JSFA601&gt;3.0.CO;2-P; Frye FF, 1997, P NUTR SOC, V56, P1105, DOI 10.1079/PNS19970114; Goff JP, 1997, J DAIRY SCI, V80, P176, DOI 10.3168/jds.S0022-0302(97)75925-3; Harris TR, 2007, PRIMATES, V48, P208, DOI 10.1007/s10329-006-0036-8; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; Heaney RP, 2002, J AM COLL NUTR, V21, P239, DOI 10.1080/07315724.2002.10719216; Hellwig JP, 2006, DIETARY REFERENCE IN; Hockett B, 2003, EVOL ANTHROPOL, V12, P211, DOI 10.1002/evan.10116; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Isbell LA, 2013, AM J PHYS ANTHROPOL, V150, P286, DOI 10.1002/ajpa.22205; Kay Robin N. B., 1994, P229; KLEPPEL GS, 1995, ICES J MAR SCI, V52, P297, DOI 10.1016/1054-3139(95)80045-X; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; MAHANEY WC, 1993, PRIMATES, V34, P85, DOI 10.1007/BF02381284; Mahaney WC, 1999, J TROP ECOL, V15, P565, DOI 10.1017/S0266467499001029; McGarigal K., 2000, MULTIVARIATE STAT WI; MILLS CF, 1985, ANNU REV NUTR, V5, P173, DOI 10.1146/annurev.nu.05.070185.001133; Milton K, 2003, COMP BIOCHEM PHYS A, V136, P47, DOI 10.1016/S1095-6433(03)00084-9; National Research Council, 2003, NUTR REQ NONH PRIM; O'Brien TG, 1998, NATURE, V392, P668, DOI 10.1038/33580; O'Malley RC, 2014, J HUM EVOL, V71, P46, DOI 10.1016/j.jhevol.2013.09.014; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Oftedal Olav T., 1996, P148; Power ML, 1999, AM J OBSTET GYNECOL, V181, P1560, DOI 10.1016/S0002-9378(99)70404-7; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; Reiner WB, 2014, AM J PRIMATOL, V76, P281, DOI 10.1002/ajp.22232; Reynolds V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006194; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rode KD, 2006, BIOTROPICA, V38, P625, DOI 10.1111/j.1744-7429.2006.00183.x; Rode KD, 2003, INT J PRIMATOL, V24, P541, DOI 10.1023/A:1023788330155; Rothman JM, 2007, J TROP ECOL, V23, P673, DOI 10.1017/S0266467407004555; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Rothman JM, 2006, AM J PRIMATOL, V68, P675, DOI 10.1002/ajp.20243; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; Rothman JM, 2014, J HUM EVOL, V71, P59, DOI 10.1016/j.jhevol.2014.02.016; Rothman JM, 2013, HIGH ALTITUDE PRIMAT; Sandberg AS, 2002, BRIT J NUTR, V88, pS281, DOI 10.1079/BJN/2002718; Schmidt DA, 2010, ZOO BIOL, V29, P375, DOI 10.1002/zoo.20267; Setz EZF, 1999, J ZOOL, V247, P91, DOI 10.1111/j.1469-7998.1999.tb00196.x; Silver SC, 2000, ZOO BIOL, V19, P95, DOI 10.1002/1098-2361(2000)19:2<95::AID-ZOO1>3.0.CO;2-D; SPELMAN LH, 1989, ZOO BIOL, V8, P239, DOI 10.1002/zoo.1430080305; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; Underwood EJ, 1999, MINERAL NUTR LIVESTO, P3; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; Weaver C.M., 1999, MODERN NUTR HLTH DIS, P141; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; WILLIG MR, 1991, J MAMMAL, V72, P314, DOI 10.2307/1382101; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106; Yeager CP, 1997, AM J PRIMATOL, V41, P117, DOI 10.1002/(SICI)1098-2345(1997)41:2<117::AID-AJP4>3.3.CO;2-J	61	6	7	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112117	10.1371/journal.pone.0112117	http://dx.doi.org/10.1371/journal.pone.0112117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372712	Green Published, gold			2022-12-27	WOS:000344556900112
J	Kim, DH; Yu, HS				Kim, Dong-Hee; Yu, Hak Sun			Effect of a One-Off Educational Session about Enterobiasis on Knowledge, Preventative Practices, and Infection Rates among Schoolchildren in South Korea	PLOS ONE			English	Article							RISK-FACTORS; PRESCHOOL-CHILDREN; HEALTH-EDUCATION; PREVALENCE; IMPACT; VERMICULARIS; PROGRAMS; TRIAL	Although health education has proven to be cost-effective in slowing the spread of enterobiasis, assessments of the effectiveness of health education to reduce infectious diseases specifically in children are rare. To evaluate the effect of health education on knowledge, preventative practices, and the prevalence of enterobiasis, 319 children from 16 classes were divided into experimental and control groups. Data were collected from May 2012 to March 2013. A 40-minute in-class talk was given once in the experimental group. There were significant differences over the time in the mean scores for children's knowledge of Enterobius vermicularis infection in the intervention group compared to the control group (p<0.001). After the educational session, the score for knowledge about E. vermicularis infection increased from 60.2 +/- 2.32 to 92.7 +/- 1.19 in the experimental group; this gain was partially lost 3 months later, decreasing to 83.6 +/- 1.77 (p<0.001). Children's enterobiasis infection prevention practice scores also increased, from 3.23 +/- 0.27 to 3.73 +/- 0.25, 1 week after the educational session, a gain that was partially lost at 3 months, decreasing to 3.46 +/- 0.36 (p<0.001). The overall E. vermicularis egg detection rate was 4.4%; the rates for each school ranged from 0% to 12.9% at screening. The infection rate at 3 months after the treatment sharply decreased from 12.3% to 0.8% in the experimental group, compared to a decrease from 8.5% to 3.7% in the control group during the same period. We recommend that health education on enterobiasis be provided to children to increase their knowledge about enterobiasis and improve prevention practices.	[Kim, Dong-Hee] Pusan Natl Univ, Coll Nursing, Dept Nursing, Yangsan, Gyeongsangnamdo, South Korea; [Yu, Hak Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, Gyeongsangnamdo, South Korea; [Yu, Hak Sun] Brain Busan 21 project, Immunoregulatory Therapeut Grp, Pusan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital	Yu, HS (corresponding author), Pusan Natl Univ, Sch Med, Dept Parasitol, Yangsan, Gyeongsangnamdo, South Korea.	hsyu@pusan.ac.kr			National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A1A1A05012615]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A1A05012615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2003, ACTA TROP, V86, P233, DOI 10.1016/S0001-706X(03)00043-3; Bager P, 2012, GASTROENTEROLOGY, V142, P55, DOI 10.1053/j.gastro.2011.09.046; Bieri FA, 2013, NEW ENGL J MED, V368, P1603, DOI 10.1056/NEJMoa1204885; COOK GC, 1994, GUT, V35, P1159, DOI 10.1136/gut.35.9.1159; Degerli Serpil, 2009, Turkiye Parazitoloji Dergisi, V33, P95; Dick W, 2005, SYSTEMATIC DESIGN IN, Vxx; Gai L, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P269; Kang IS, 2012, ACTA TROP, V122, P59, DOI 10.1016/j.actatropica.2011.11.017; Kang Seokha, 2006, Korean Journal of Parasitology, V44, P247, DOI 10.3347/kjp.2006.44.3.247; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Kim Bong Jin, 2003, Korean Journal of Parasitology, V41, P75, DOI 10.3347/kjp.2003.41.1.75; Kim C. H, 1971, Korean J Parasit, V9, P25, DOI 10.3347/kjp.1971.9.1.25; Kim DH, 2010, KOREAN J PARASITOL, V48, P121, DOI 10.3347/kjp.2010.48.2.121; Lee Kyu-Jae, 2001, Korean Journal of Parasitology, V39, P327, DOI 10.3347/kjp.2001.39.4.327; Myint-U A, 2010, HEALTH PROMOT PRACT, V11, P408, DOI 10.1177/1524839908318830; Naldi L, 2007, J INVEST DERMATOL, V127, P1871, DOI 10.1038/sj.jid.5700835; Nithikathkul C, 2005, J HELMINTHOL, V79, P61, DOI 10.1079/JOH2004272; Owais A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-239; Report of Ministry of Health and Welfare of Republic of Korea and the Korea Association of Health, 1971, 1 MIN HLTH WELF REP; Report of Ministry of Health and Welfare of Republic of Korea and the Korea Association of Health, 1997, 6 MIN HLTH WELF REP; Roberts LS, 2009, FDN PARASITOLOGY, Vxvii; Seo Byong Seol, 1969, Kisaengchunghak Chapchi, V7, P53, DOI 10.3347/kjp.1969.7.1.53; Song HJ, 2003, PARASITOL RES, V91, P46, DOI 10.1007/s00436-003-0836-3; St Georgiev V, 2001, Expert Opin Pharmacother, V2, P267, DOI 10.1517/14656566.2.2.267	24	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112149	10.1371/journal.pone.0112149	http://dx.doi.org/10.1371/journal.pone.0112149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372146	Green Submitted, gold, Green Published			2022-12-27	WOS:000344556900116
J	Kim, GA; Oh, HJ; Kim, MJ; Jo, YK; Choi, J; Park, JE; Park, EJ; Lim, SH; Yoon, BI; Kang, SK; Jang, G; Lee, BC				Kim, Geon A.; Oh, Hyun Ju; Kim, Min Jung; Jo, Young Kwang; Choi, Jin; Park, Jung Eun; Park, Eun Jung; Lim, Sang Hyun; Yoon, Byung Il; Kang, Sung Keun; Jang, Goo; Lee, Byeong Chun			Survival of Skin Graft between Transgenic Cloned Dogs and Non-Transgenic Cloned Dogs	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HISTOCOMPATIBILITY ANTIGEN; NUCLEAR TRANSPLANTATION; FLUORESCENT PROTEIN; GENE-THERAPY; CELL; REJECTION; MICE; PIGS; LYMPHOCYTES	Whereas it has been assumed that genetically modified tissues or cells derived from somatic cell nuclear transfer (SCNT) should be accepted by a host of the same species, their immune compatibility has not been extensively explored. To identify acceptance of SCNT-derived cells or tissues, skin grafts were performed between cloned dogs that were identical except for their mitochondrial DNA (mtDNA) haplotypes and foreign gene. We showed here that differences in mtDNA haplotypes and genetic modification did not elicit immune responses in these dogs: 1) skin tissues from genetically-modified cloned dogs were successfully transplanted into genetically-modified cloned dogs with different mtDNA haplotype under three successive grafts over 63 days; and 2) non-transgenic cloned tissues were accepted into transgenic cloned syngeneic recipients with different mtDNA haplotypes and vice versa under two successive grafts over 63 days. In addition, expression of the inserted gene was maintained, being functional without eliciting graft rejection. In conclusion, these results show that transplanting genetically-modified tissues into normal, syngeneic or genetically-modified recipient dogs with different mtDNA haplotypes do not elicit skin graft rejection or affect expression of the inserted gene. Therefore, therapeutically valuable tissue derived from SCNT with genetic modification might be used safely in clinical applications for patients with diseased tissues.	[Kim, Geon A.; Oh, Hyun Ju; Kim, Min Jung; Jo, Young Kwang; Choi, Jin; Park, Jung Eun; Park, Eun Jung; Jang, Goo; Lee, Byeong Chun] Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul, South Korea; [Lim, Sang Hyun] Cent Res Inst, K Stem Cell, Seoul, South Korea; [Yoon, Byung Il] Kangwon Natl Univ, Coll Vet Med, Lab Histol & Mol Pathogenesis, Chunchon, Gangwon Do, South Korea	Seoul National University (SNU); Kangwon National University	Lee, BC (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul, South Korea.	bclee@snu.ac.kr			Rural Development Administration [PJ008975022014]; Korea Institute of Planning and Evaluation for Technology [311062-04-3SB010]; NATURE CELL [2014-0082]; Research Institute for Veterinary Science; Nestle Purina PetCare; Natural Balance Korea; BK21 plus program	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korea Institute of Planning and Evaluation for Technology; NATURE CELL; Research Institute for Veterinary Science; Nestle Purina PetCare(Nestle SA); Natural Balance Korea; BK21 plus program	This study was supported by Rural Development Administration (# PJ008975022014), Korea Institute of Planning and Evaluation for Technology (# 311062-04-3SB010), NATURE CELL (# 2014-0082), Research Institute for Veterinary Science, Nestle Purina PetCare, Natural Balance Korea, and the BK21 plus program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2003, BLOOD, V101, P4305, DOI 10.1182/blood-2002-06-1649; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Burnett RC, 1997, TISSUE ANTIGENS, V49, P484, DOI 10.1111/j.1399-0039.1997.tb02783.x; CHAN T, 1985, TRANSPLANTATION, V39, P477, DOI 10.1097/00007890-198505000-00003; Chang RS, 2011, BIOMATERIALS, V32, P9785, DOI 10.1016/j.biomaterials.2011.09.017; Do M, 2012, BIOCHEM BIOPH RES CO, V424, P765, DOI 10.1016/j.bbrc.2012.07.031; GLUCKMAN JC, 1980, CR ACAD SCI D NAT, V290, P105; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hiendleder S, 2007, ADV EXP MED BIOL, V591, P103; Hong SG, 2009, ANIM REPROD SCI, V115, P334, DOI 10.1016/j.anireprosci.2008.12.005; Hong SG, 2009, GENESIS, V47, P314, DOI 10.1002/dvg.20504; Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P269, DOI 10.1111/j.1399-0039.2006.00778.x; Kinoshita Y, 2010, NEUROL RES, V32, P429, DOI 10.1179/174313209X455718; KOLB HJ, 1975, TRANSPLANT P, V7, P461; Kwak HH, 2013, TRANSPL P, V45, P1754, DOI 10.1016/j.transproceed.2013.02.103; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee CY, 2011, BIOMATERIALS, V32, P6264, DOI 10.1016/j.biomaterials.2011.05.012; LINDAHL KF, 1982, P NATL ACAD SCI-BIOL, V79, P5362, DOI 10.1073/pnas.79.17.5362; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Lu Feng, 2007, Zhonghua Zheng Xing Wai Ke Za Zhi, V23, P412; Martin MJ, 2003, CLONING STEM CELLS, V5, P117, DOI 10.1089/153623003322234713; Ogawa H, 2006, GLYCOCONJUGATE J, V23, P663, DOI 10.1007/s10719-006-9005-0; Oiso N, 2013, J DERMATOL, V40, P330, DOI 10.1111/j.1346-8138.2012.01583.x; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Theoret CL, 2006, THERIOGENOLOGY, V65, P1465, DOI 10.1016/j.theriogenology.2005.08.019; Webb KM, 2009, J FORENSIC SCI, V54, P275, DOI 10.1111/j.1556-4029.2008.00952.x; WIDMER MB, 1972, J EXP MED, V135, P1204, DOI 10.1084/jem.135.5.1204; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	32	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108330	10.1371/journal.pone.0108330	http://dx.doi.org/10.1371/journal.pone.0108330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372489	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900003
J	Kruger, F; Nyolt, M; Yordanova, K; Hein, A; Kirste, T				Krueger, Frank; Nyolt, Martin; Yordanova, Kristina; Hein, Albert; Kirste, Thomas			Computational State Space Models for Activity and Intention Recognition. A Feasibility Study	PLOS ONE			English	Article							COGNITIVE ASSISTANCE; PLAN RECOGNITION; SMART; DEMENTIA	Background: Computational state space models (CSSMs) enable the knowledge-based construction of Bayesian filters for recognizing intentions and reconstructing activities of human protagonists in application domains such as smart environments, assisted living, or security. Computational, i. e., algorithmic, representations allow the construction of increasingly complex human behaviour models. However, the symbolic models used in CSSMs potentially suffer from combinatorial explosion, rendering inference intractable outside of the limited experimental settings investigated in present research. The objective of this study was to obtain data on the feasibility of CSSM-based inference in domains of realistic complexity. Methods: A typical instrumental activity of daily living was used as a trial scenario. As primary sensor modality, wearable inertial measurement units were employed. The results achievable by CSSM methods were evaluated by comparison with those obtained from established training-based methods (hidden Markov models, HMMs) using Wilcoxon signed rank tests. The influence of modeling factors on CSSM performance was analyzed via repeated measures analysis of variance. Results: The symbolic domain model was found to have more than 10(8) states, exceeding the complexity of models considered in previous research by at least three orders of magnitude. Nevertheless, if factors and procedures governing the inference process were suitably chosen, CSSMs outperformed HMMs. Specifically, inference methods used in previous studies (particle filters) were found to perform substantially inferior in comparison to a marginal filtering procedure. Conclusions: Our results suggest that the combinatorial explosion caused by rich CSSM models does not inevitably lead to intractable inference or inferior performance. This means that the potential benefits of CSSM models (knowledge-based model construction, model reusability, reduced need for training data) are available without performance penalty. However, our results also show that research on CSSMs needs to consider sufficiently complex domains in order to understand the effects of design decisions such as choice of heuristics or inference procedure on performance.	[Krueger, Frank; Nyolt, Martin; Yordanova, Kristina; Hein, Albert; Kirste, Thomas] Univ Rostock, Inst Comp Sci, D-18055 Rostock, Germany	University of Rostock	Kruger, F (corresponding author), Univ Rostock, Inst Comp Sci, D-18055 Rostock, Germany.	Frank.Krueger2@uni-rostock.de	Yordanova, Kristina/AAJ-8269-2020; Krüger, Frank/S-2977-2019	Yordanova, Kristina/0000-0002-6428-1062; Krüger, Frank/0000-0002-7925-3363	Deutsche Forschungsgemeinschaft graduate research school	Deutsche Forschungsgemeinschaft graduate research school(German Research Foundation (DFG))	This work is partially funded by Deutsche Forschungsgemeinschaft (www.dfg.de) graduate research school 1424 MuSAMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Bouchard B, 2007, APPL ARTIF INTELL, V21, P623, DOI 10.1080/08839510701492579; Bui H. H., 2008, P NAT C ART INT AAAI, P1345; Bui HH, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P324; Chen LM, 2012, IEEE T SYST MAN CY C, V42, P790, DOI 10.1109/TSMCC.2012.2198883; Chen LM, 2012, IEEE T KNOWL DATA EN, V24, P961, DOI 10.1109/TKDE.2011.51; Clarke EM, 1999, MODEL CHECKING, P1; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook DJ, 2007, PERVASIVE MOB COMPUT, V3, P53, DOI 10.1016/j.pmcj.2006.12.001; Dai P, 2008, IEEE T SYST MAN CY B, V38, P275, DOI 10.1109/TSMCB.2007.909939; Dash D, 2013, P 23 INT JOINT C ART, P839; de la Torre Fernando, 2009, CHI 2009 WORKSHOP DE; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Doucet A, 2001, STAT ENG IN, P3; Doucet A., 2000, P 16 C UNC ART INT, V2, P176, DOI DOI 10.1049/IET-SPR:20070075.; Duong T, 2009, ARTIF INTELL, V173, P830, DOI 10.1016/j.artint.2008.12.005; Fox CW, 2012, ARTIF INTELL REV, V38, P85, DOI 10.1007/s10462-011-9236-8; Gal Y, 2012, ARTIF INTELL, V176, P2270, DOI 10.1016/j.artint.2011.09.002; Gong S, 2011, VISUAL ANAL HUMANS, P455, DOI DOI 10.1007/978-0-85729-997-0_23; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hiatt L, 2011, P 22 INT JOINT C ART, P2077; Hodgins F., 2009, CMU RI T 08 22; Hoey J, 2011, PERVASIVE MOB COMPUT, V7, P299, DOI 10.1016/j.pmcj.2010.11.007; Hoey J, 2010, COMPUT VIS IMAGE UND, V114, P503, DOI 10.1016/j.cviu.2009.06.008; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jones MLH, 2009, SAE INT J PASSEN CAR, V1, P1163, DOI 10.4271/2008-01-1875; Kalra L, 2013, J AMB INTEL SMART EN, V5, P273, DOI 10.3233/AIS-130208; KOLLER D., 2009, PROBABILISTIC GRAPHI; Krippendorff K., 2013, CONTENT ANAL INTRO I; Kruger F, 2012, J AMB INTEL SMART EN, V4, P209, DOI 10.3233/AIS-2012-0148; Kruger Frank, 2013, Proceedings of the 5th International Conference on Agents and Artificial Intelligence. ICAART 2013, P283; Lara OD, 2013, IEEE COMMUN SURV TUT, V15, P1192, DOI 10.1109/SURV.2012.110112.00192; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Mendling J, 2010, INFORM SYST, V35, P467, DOI 10.1016/j.is.2009.03.009; Nguyen N. T., 2006, P 17 BRIT MACH VIS C, P1239, DOI DOI 10.5244/C.20.126; Nguyen NT, 2003, PROC CVPR IEEE, P620; NIELSEN J, 1993, HUMAN FACTORS IN COMPUTING SYSTEMS, P206; Nielson F., 2004, PRINCIPLES PROGRAM A; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Patterson DJ, 2005, NINTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P44, DOI 10.1109/ISWC.2005.22; Patterson DJ, 2004, LECT NOTES COMPUT SC, V3205, P433; Pearl J., 2009, CAUSALITY MODELS REA; Perkowitz M., 2004, P 13 INT C WORLD WID, P573, DOI DOI 10.1145/988672.988750; Ramirez M., 2011, P 22 INT JOINT C ART, P2009, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-335; Ramirez M, 2010, AAAI CONF ARTIF INTE, P1121; Rohrbach M, 2012, P 25 IEEE C COMP VIS; Rossi F., 2013, P 23 INT JOINT C ART; Roy P, 2007, PROCEEDINGS OF THE IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON INTELLIGENT AGENT TECHNOLOGY (IAT 2007), P131, DOI 10.1109/IAT.2007.17; Roy PC, 2011, ATL AMB PERVAS INTEL, V4, P33; Russell SJ, 2010, ARTIF INTELL; Sadilek A, 2012, J ARTIF INTELL RES, V43, P87, DOI 10.1613/jair.3421; Serna A, 2007, USER MODEL USER-ADAP, V17, P415, DOI 10.1007/s11257-007-9032-y; Shi YF, 2004, PROC CVPR IEEE, P862; Stein K., 2008, BMI, P28; Szewcyzk S, 2009, Technol Health Care, V17, P161, DOI 10.3233/THC-2009-0546; Tanenbaum A.S., 2009, MODERN OPERATING SYS, Vthird; Han TA, 2013, AI COMMUN, V26, P237, DOI 10.3233/AIC-130559; van der Aalst WMP, 2007, INFORM SYST, V32, P713, DOI 10.1016/j.is.2006.05.003; van Kasteren T, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P1, DOI 10.1145/1409635.1409637; Walsh T, 2011, P 22 INT JOINT C ART; Ward JA, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1889681.1889687; Wu J, 2007, PROCEEDINGS OF THE 2007 IEEE INTERNATIONAL CONFERENCE ON SERVICE OPERATIONS AND LOGISTICS, AND INFORMATICS, P7, DOI 10.1109/SOLI.2007.4383891; Youngstrom MJ, 2002, AM J OCCUP THER, V56, P609; Yu ZW, 2010, ACM COMPUT SURV, V42, DOI 10.1145/1667062.1667065; Zhuo H.H., 2013, IJCAI 2013 P 23 INT, P2444, DOI DOI 10.5555/2540128.2540479	68	51	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109381	10.1371/journal.pone.0109381	http://dx.doi.org/10.1371/journal.pone.0109381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372138	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900008
J	Lycett, SJ				Lycett, Stephen J.			Dynamics of Cultural Transmission in Native Americans of the High Great Plains	PLOS ONE			English	Article							MANTEL TEST; REGRESSION; LANGUAGE	Culture is a phenomenon shared by all humans. Attempts to understand how dynamic factors affect the origin and distribution of cultural elements are, therefore, of interest to all humanity. As case studies go, understanding the distribution of cultural elements in Native American communities during the historical period of the Great Plains would seem a most challenging one. Famously, there is a mixture of powerful internal and external factors, creating-for a relatively brief period in time-a seemingly distinctive set of shared elements from a linguistically diverse set of peoples. This is known across the world as the "Great Plains culture.'' Here, quantitative analyses show how different processes operated on two sets of cultural traits among nine High Plains groups. Moccasin decorations exhibit a pattern consistent with geographically-mediated between-group interaction. However, group variations in the religious ceremony of the Sun Dance also reveal evidence of purifying cultural selection associated with historical biases, dividing down ancient linguistic lines. The latter shows that while the conglomeration of "Plains culture'' may have been a product of merging new ideas with old, combined with cultural interchange between groups, the details of what was accepted, rejected or elaborated in each case reflected preexisting ideological biases. Although culture may sometimes be a "melting pot,'' the analyses show that even in highly fluid situations, cultural mosaics may be indirectly shaped by historical factors that are not always obvious.	SUNY Buffalo, Dept Anthropol, Amherst, NY 14228 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lycett, SJ (corresponding author), SUNY Buffalo, Dept Anthropol, Amherst, NY 14228 USA.	sjlycett@buffalo.edu						Anderson JD, 2013, ARAPAHO WOMENS QUILL; Archambault J., 2001, HDB N AM INDIANS, V13, P983; Bebbington JM, 1982, QUILLWORK PLAINS; Bengtson VL, 2009, INT SOCIOL, V24, P325, DOI 10.1177/0268580909102911; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Boas F, 1896, Science, V4, P901, DOI 10.1126/science.4.103.901; Boyd R., 1985, CULTURE EVOLUTIONARY; Cambell L, 1997, AM INDIAN LANGUAGES; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Clements F, 1931, AM ANTHROPOL, V33, P216, DOI 10.1525/aa.1931.33.2.02a00060; Connelly M, 1999, CHRISTMAS HIST; DeMallie RJ, 2001, HDB N AM INDIANS PLA, V13, P1; DEMALLIE RJ, 2001, HDB N AM INDIANS PLA, V13; Driver H.E., 1932, U CALIFORNIA PUBLICA, P211; DURHAM WH, 1992, ANNU REV ANTHROPOL, V21, P331, DOI 10.1146/annurev.an.21.100192.001555; Durkheim Emile, 1915, ELEMENTARY FORMS REL; Eerkens JW, 2007, J ARCHAEOL RES, V15, P239, DOI 10.1007/s10814-007-9013-z; Ellen Roy., 2013, UNDERSTANDING CULTUR; Gilbert BM, 1980, ANTHR GREAT PLAINS, P8; Goddard I, 2001, HDB N AM INDIANS PLA, V13, P61; Goddard I, 1996, HDB N AM INDIANS LAN, V17; GUGLIELMINO CR, 1995, P NATL ACAD SCI USA, V92, P7585, DOI 10.1073/pnas.92.16.7585; Hammarstrom H., 2014, GLOTTOLOG 2 3; Harmon LJ, 2010, EVOLUTION, V64, P2173, DOI 10.1111/j.1558-5646.2010.00973.x; Holder P, 1970, HOE HORSE PLAINS; Hollow R., 1980, ANTHR GREAT PLAINS, P68; JANSSEN SG, 1981, DEMOGRAPHY, V18, P511, DOI 10.2307/2060945; Jordan P, 2003, J ANTHROPOL ARCHAEOL, V22, P42, DOI 10.1016/S0278-4165(03)00004-7; Jordan P, TECHNOLOGY HUMAN SOC; Kroeber AL, 1947, CULTURAL AREAS NATUR; Liberty Margot, 1980, ANTHR GREAT PLAINS, P164; Lipo CP, 2006, MAPPING OUR ANCESTOR; Lott D.F., 2002, AM BISON NATURAL HIS; Lowie RH, 1954, INDIANS PLAINS; Lyford CA, 1940, QUILL BEADWORK W SIO; MANTEL N, 1967, CANCER RES, V27, P209; Mesoudi A., 2011, CULTURAL EVOLUTION D; Nunn CL, 2006, CROSS-CULT RES, V40, P177, DOI 10.1177/1069397105283401; OBrien M, 2010, INNOVATION CULTURAL; OBrien MJ, 2008, CULTURAL TRANSMISSIO; Orchard WC., 1929, BEADS BEADWORK AM IN, DOI [10.5479/sil.910561.39088014419360, DOI 10.5479/SIL.910561.39088014419360]; RELETHFORD JH, 1985, AM J PHYS ANTHROPOL, V66, P317, DOI 10.1002/ajpa.1330660309; Restad Penne L, 1995, CHRISTMAS AM HIST; Richerson PJ., 2005, NOT GENES ALONE CULT; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Rogers DS, 2009, P ROY SOC B-BIOL SCI, V276, P3835, DOI 10.1098/rspb.2009.1088; Rogers DS, 2008, P NATL ACAD SCI USA, V105, pE28; Rogers E.M., 1995, DIFFUSION INNOVATION; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Ross RM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3065; Scaglion R, 1980, ANTHR GREAT PLAINS, P23; Shennan S., 1997, QUANTIFYING ARCHAEOL; Shennan S, 2011, PHILOS T R SOC B, V366, P1070, DOI 10.1098/rstb.2010.0380; Skoyles John R, 2008, Proc Natl Acad Sci U S A, V105, pE28, DOI 10.1073/pnas.0802586105; SMOUSE PE, 1992, YEARB PHYS ANTHROPOL, V35, P187; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spier L, 1921, ANTHROPOL PAP AM MUS, V16, P459; Tehrani J, 2011, EVOLUTION ED OUTREAC, V4, P390; Towner MC, 2012, HUM NATURE-INT BIOS, V23, P283, DOI 10.1007/s12110-012-9142-z; Wedel Waldo R., 2001, HDB N AM INDIANS, V13, P44; WELSCH RL, 1992, AM ANTHROPOL, V94, P568, DOI 10.1525/aa.1992.94.3.02a00030; Wissler C, 1921, ANTHROPOL PAP AM MUS, VXVI, pv; Wissler C, 1927, ANTHROPOL PAP AM MUS, V29, P5; Wissler Clark, 1938, AM INDIAN	64	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112244	10.1371/journal.pone.0112244	http://dx.doi.org/10.1371/journal.pone.0112244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372277	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900126
J	Rempe, T; Wolff, S; Riedel, C; Baron, R; Stroman, PW; Jansen, O; Gierthmuhlen, J				Rempe, Torge; Wolff, Stephan; Riedel, Christian; Baron, Ralf; Stroman, Patrick W.; Jansen, Olav; Gierthmuehlen, Janne			Spinal fMRI Reveals Decreased Descending Inhibition during Secondary Mechanical Hyperalgesia	PLOS ONE			English	Article							NEUROPATHIC PAIN; BRAIN-STEM; GABAERGIC INTERNEURONS; CENTRAL SENSITIZATION; DORSAL-HORN; CORD; NEURONS; MODULATION; RESPONSES; CONTRAST	Mechanical hyperalgesia is one distressing symptom of neuropathic pain which is explained by central sensitization of the nociceptive system. This sensitization can be induced experimentally with the heat/capsaicin sensitization model. The aim was to investigate and compare spinal and supraspinal activation patterns of identical mechanical stimulation before and after sensitization using functional spinal magnetic resonance imaging (spinal fMRI). Sixteen healthy subjects (6 female, 10 male, mean age 27.2 +/- 4.0 years) were investigated with mechanical stimulation of the C6 dermatome of the right forearm during spinal fMRI. Testing was always performed in the area outside of capsaicin application (i.e. area of secondary mechanical hyperalgesia). During slightly noxious mechanical stimulation before sensitization, activity was observed in ipsilateral dorsolateral pontine tegmentum (DLPT) which correlated with activity in ipsilateral spinal cord dorsal gray matter (dGM) suggesting activation of descending nociceptive inhibition. During secondary mechanical hyperalgesia, decreased activity was observed in bilateral DLPT, ipsilateral/midline rostral ventromedial medulla (RVM), and contralateral subnucleus reticularis dorsalis, which correlated with activity in ipsilateral dGM. Comparison of voxel-based activation patterns during mechanical stimulation before/after sensitization showed deactivations in RVM and activations in superficial ipsilateral dGM. This study revealed increased spinal activity and decreased activity in supraspinal centers involved in pain modulation (SRD, RVM, DLPT) during secondary mechanical hyperalgesia suggesting facilitation of nociception via decreased endogenous inhibition. Results should help prioritize approaches for further in vivo studies on pain processing and modulation in humans.	[Rempe, Torge; Wolff, Stephan; Riedel, Christian; Jansen, Olav; Gierthmuehlen, Janne] Univ Hosp Kiel, Dept Neuroradiol, D-24105 Kiel, Germany; [Rempe, Torge; Baron, Ralf] Univ Hosp Kiel, Dept Neurol, D-24105 Kiel, Germany; [Baron, Ralf; Gierthmuehlen, Janne] Univ Hosp Kiel, Div Neurol Pain Res & Therapy, D-24105 Kiel, Germany; [Stroman, Patrick W.] Queens Univ, Dept Phys, Ctr Neurosci Studies, Dept Diagnost Radiol, Kingston, ON K7L 3N6, Canada	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Queens University - Canada	Rempe, T (corresponding author), Univ Hosp Kiel, Dept Neuroradiol, Arnold Heller Str 3, D-24105 Kiel, Germany.	t.rempe@neurologie.uni-kiel.de	Jansen, Olav/CAF-4179-2022	Rempe, Torge/0000-0003-0538-1378	German Federal Ministry of Education and Research (BMBF) [01EM05/04]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by the German Federal Ministry of Education and Research (BMBF, 01EM05/04). However, the authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; Cahill CM, 2011, MAGN RESON IMAGING, V29, P342, DOI 10.1016/j.mri.2010.10.007; CLARK FM, 1991, BRAIN RES, V547, P279, DOI 10.1016/0006-8993(91)90972-X; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Fields HL., 1994, TXB PAIN, V3rd, P243; Figley CR, 2012, MAGN RESON IMAGING, V30, P471, DOI 10.1016/j.mri.2011.12.015; Gassner M, 2009, PAIN, V145, P204, DOI 10.1016/j.pain.2009.06.021; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Ghazni NF, 2010, AM J NEURORADIOL, V31, P661, DOI 10.3174/ajnr.A1909; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Kincaid W, 2006, J NEUROPHYSIOL, V95, P33, DOI 10.1152/jn.00449.2005; Lee MC, 2008, J NEUROSCI, V28, P11642, DOI 10.1523/JNEUROSCI.2638-08.2008; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Morgan MM, 1998, J NEUROPHYSIOL, V79, P174, DOI 10.1152/jn.1998.79.1.174; Naidich T.P., 2009, INTERNAL ARCHITECTUR, P53, DOI 10.1007/978-3-211-73971-6_4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ossipov MH, 2006, HAND CLINIC, V81, P193, DOI 10.1016/S0072-9752(06)80018-7; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Pertovaara A, 2006, HAND CLINIC, V81, P179, DOI 10.1016/S0072-9752(06)80017-5; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Rempe T, 2015, J MAGN RESON IMAGING, V41, P1046, DOI 10.1002/jmri.24627; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Stroman PW, 2008, MAGN RESON IMAGING, V26, P809, DOI 10.1016/j.mri.2008.01.038; Stroman PW, 2005, CLIN MED RES, V3, P146, DOI 10.3121/cmr.3.3.146; Stroman PW, 2009, MAGN RESON IMAGING, V27, P1333, DOI 10.1016/j.mri.2009.05.038; Stroman PW, 2005, MAGN RESON IMAGING, V23, P843, DOI 10.1016/j.mri.2005.07.009; Stroman PW, 2002, MAGN RESON MED, V48, P122, DOI 10.1002/mrm.10178; Stroman PW, 2012, 20 ANN M INT SOC MAG; Trepel M., 2021, NEUROANATOMIE STRUKT; Villanueva L, 1996, PAIN, V67, P231, DOI 10.1016/0304-3959(96)03121-1; Villanueva L, 2006, HAND CLINIC, V81, P93, DOI 10.1016/S0072-9752(06)80012-6; Westlund KN, 2006, HAND CLINIC, V81, P103, DOI 10.1016/S0072-9752(06)80013-8; Xu M, 1999, EUR J PHARMACOL, V366, P41, DOI 10.1016/S0014-2999(98)00910-8; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005	42	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112325	10.1371/journal.pone.0112325	http://dx.doi.org/10.1371/journal.pone.0112325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372292	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900135
J	Walsh, PM; Byrne, J; Kelly, M; McDevitt, J; Comber, H				Walsh, Paul M.; Byrne, Julianne; Kelly, Maria; McDevitt, Joe; Comber, Harry			Socioeconomic Disparity in Survival after Breast Cancer in Ireland: Observational Study	PLOS ONE			English	Article							PROGNOSTIC FACTORS; WOMEN; STAGE; INEQUALITIES; DEPRIVATION; HEALTH; POPULATION; DIAGNOSIS; MORTALITY; COMORBIDITY	We evaluated the relationship between breast cancer survival and deprivation using data from the Irish National Cancer Registry. Cause-specific survival was compared between five area-based socioeconomic deprivation strata using Cox regression. Patient and tumour characteristics and treatment were compared using modified Poisson regression with robust variance estimation. Based on 21356 patients diagnosed 1999-2008, age-standardized five-year survival averaged 80% in the least deprived and 75% in the most deprived stratum. Age-adjusted mortality risk was 33% higher in the most deprived group (hazard ratio 1.33, 95% CI 1.21-1.45, P<0.001). The most deprived groups were more likely to present with advanced stage, high grade or hormone receptor-negative cancer, symptomatically, or with significant comorbidity, and to be smokers or unmarried, and less likely to have breast-conserving surgery. Cox modelling suggested that the available data on patient, tumour and treatment factors could account for only about half of the survival disparity (adjusted hazard ratio 1.18, 95% CI 0.97-1.43, P = 0.093). Survival disparity did not diminish over time, compared with the period 1994-1998. Persistent survival disparities among Irish breast cancer patients suggest unequal use of or access to services and highlight the need for further research to understand and remove the behavioural or other barriers involved.	[Walsh, Paul M.; Kelly, Maria; McDevitt, Joe; Comber, Harry] Natl Canc Registry, Cork, Ireland; [Byrne, Julianne] Boyne Res Inst, Drogheda, Ireland		Walsh, PM (corresponding author), Natl Canc Registry, Cork, Ireland.	p.walsh@ncri.ie			Department of Health of the Government of Ireland	Department of Health of the Government of Ireland	The authors received no specific funding for this work, but the National Cancer Registry is funded by the Department of Health of the Government of Ireland.	Aarts MJ, 2012, BRIT J CANCER, V107, P12, DOI 10.1038/bjc.2012.205; Aarts MJ, 2011, BREAST CANCER RES TR, V128, P517, DOI 10.1007/s10549-011-1363-z; Agurs-Collins T, 2010, SEMIN ONCOL, V37, P384, DOI 10.1053/j.seminoncol.2010.05.002; [Anonymous], 1997, AJCC CANC STAGING MA; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Breslow RA, 2011, AM J EPIDEMIOL, V174, P1044, DOI 10.1093/aje/kwr210; BRUNNER E, 2006, SOCIAL DETERMINANTS; CARNON AG, 1994, BRIT MED J, V309, P1054, DOI 10.1136/bmj.309.6961.1054; Carsin Sharp L, 2009, ATLAS CANC IRELAND 1; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Downing A, 2007, BRIT J CANCER, V96, P836, DOI 10.1038/sj.bjc.6603622; Ellis L, 2012, EUR J CANCER, V48, P270, DOI 10.1016/j.ejca.2011.10.008; Gillis CR, 1996, BRIT MED J, V312, P145, DOI 10.1136/bmj.312.7024.145; Kaffashian F, 2003, BRIT J CANCER, V89, P1693, DOI 10.1038/sj.bjc.6601339; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; Kelly A, 2007, NATL DEPRIVATION IND; Kim J, 2012, BREAST CANCER RES TR, V131, P527, DOI 10.1007/s10549-011-1836-0; Kogevinas M, 1997, IARC SCI PUBLICATION, V138; Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949; Louwman WJ, 2005, EUR J CANCER, V41, P779, DOI 10.1016/j.ejca.2004.12.025; Lyratzopoulos G, 2011, ANN ONCOL, V22, P1661, DOI 10.1093/annonc/mdq647; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Macleod U, 2000, BRIT MED J, V320, P1442, DOI 10.1136/bmj.320.7247.1442; Macleod U, 2000, ANN ONCOL, V11, P105, DOI 10.1023/A:1008385321476; Morgan K., 2009, SLAN 2007 SURVEY LIF; National Cancer Registry, 2012, BREAST CANC INC MORT; O'Reilly D, 2002, AGE AGEING, V31, P197, DOI 10.1093/ageing/31.3.197; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; SCHRIJVERS CTM, 1995, BRIT J CANCER, V72, P738, DOI 10.1038/bjc.1995.403; SCHRIJVERS CTM, 1995, INT J CANCER, V63, P324, DOI 10.1002/ijc.2910630303; Schrijvers CTM, 1997, CANCER-AM CANCER SOC, V80, P1482; Scottish Cancer Intelligence Unit, 2000, TRENDS CANC SURV SCO; Sprague BL, 2011, CANCER-AM CANCER SOC, V117, P1542, DOI 10.1002/cncr.25589; Teljeur C, 2013, NATL DEPRIVATION IND; Thomson CS, 2001, J EPIDEMIOL COMMUN H, V55, P308, DOI 10.1136/jech.55.5.308; Twelves CJ, 2001, BRIT J CANCER, V85, P637, DOI 10.1054/bjoc.2001.1957; Ugnat AM, 2004, BRIT J CANCER, V90, P1138, DOI 10.1038/sj.bjc.6601662; van Lenthe FJ, 2004, EUR J PUBLIC HEALTH, V14, P63, DOI 10.1093/eurpub/14.1.63; Wiley MM, 2005, IRISH J MED SCI, V174, P52, DOI 10.1007/BF03169130; Woods LM, 2010, AUST NZ J PUBL HEAL, V34, P206, DOI 10.1111/j.1753-6405.2010.00508.x; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111729	10.1371/journal.pone.0111729	http://dx.doi.org/10.1371/journal.pone.0111729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372837	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900068
J	Wang, Y; Zhang, M; Liu, ZW; Ren, WG; Shi, YC; Sun, YL; Wang, HB; Jin, L; Wang, FS; Shi, M				Wang, Ying; Zhang, Min; Liu, Zhen-Wen; Ren, Wei-Guo; Shi, Yan-Chao; Sun, Yan-Ling; Wang, Hong-Bo; Jin, Lei; Wang, Fu-Sheng; Shi, Ming			The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation	PLOS ONE			English	Article							TH17 CELLS; OPERATIONAL TOLERANCE; PERIPHERAL-BLOOD; IL-17; INTERLEUKIN-17; LYMPHOCYTES; GENERATION; PROMOTES; PREVENT; IMPACT	CD4(+) CD25(+) FoxP3(+) regulatory T cells (Tregs) and Th17 cells are known to be involved in the alloreactive responses in organ transplantation, but little is known about the relationship between Tregs and Th17 cells in the context of liver alloresponse. Here, we investigated whether the circulating Tregs/Th17 ratio is associated with acute allograft rejection in liver transplantation. In present study, thirty-eight patients who received liver transplant were enrolled. The patients were divided into two groups: acute allograft rejection group (Gr-AR) (n = 16) and stable allograft liver function group (Gr-SF) (n = 22). The frequencies of circulating Tregs and circulating Th17 cells, as well as Tregs/Th17 ratio were determined using flow cytometry. The association between Tregs/Th17 ratio and acute allograft rejection was then analyzed. Our results showed that the frequency of circulating Tregs was significantly decreased, whereas the frequency of circulating Th17 cells was significantly increased in liver allograft recipients who developed acute rejection. Tregs/Th17 ratio had a negative correlation with liver damage indices and the score of rejection activity index (RAI) after liver transplantation. In addition, the percentages of CTLA-4(+), HLA-DR+, Ki67(+), and IL-10(+) Tregs were higher in Gr-SF group than in Gr-AR group. Our results suggested that the ratio of circulating Tregs/Th17 cells is associated with acute allograft rejection, thus the ratio may serve as an alternative marker for the diagnosis of acute rejection.	[Wang, Ying; Shi, Yan-Chao; Shi, Ming] Peking Univ, Beijing Hosp 302, Hlth Sci Ctr, Res Ctr Liver Transplantat, Beijing 100871, Peoples R China; [Wang, Ying; Zhang, Min; Liu, Zhen-Wen; Shi, Yan-Chao; Sun, Yan-Ling; Wang, Hong-Bo; Shi, Ming] Beijing 302 Hosp, Res Ctr Liver Transplantat, Beijing, Peoples R China; [Ren, Wei-Guo] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Jin, Lei; Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China	Beijing Hospital; Fifth Medical Center of Chinese PLA General Hospital; Peking University; Fifth Medical Center of Chinese PLA General Hospital; Central South University; Fifth Medical Center of Chinese PLA General Hospital	Shi, M (corresponding author), Peking Univ, Beijing Hosp 302, Hlth Sci Ctr, Res Ctr Liver Transplantat, Beijing 100871, Peoples R China.	shiming302@sina.com		ren, weiguo/0000-0002-4678-4360	Project of Research on The Application of Capital, Clinical Characteristics [Z111107058811069]; Key Project of Medical Science and Technology of PLA of China [BWS11J075]	Project of Research on The Application of Capital, Clinical Characteristics; Key Project of Medical Science and Technology of PLA of China	This work was supported by Project of Research on The Application of Capital, Clinical Characteristics (Z111107058811069); The Key Project of Medical Science and Technology of PLA (BWS11J075) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadja F, 2011, TRANSPLANTATION, V92, P396, DOI 10.1097/TP.0b013e3182247b5f; Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Afzali B, 2013, EUR J IMMUNOL, V43, P2043, DOI 10.1002/eji.201243296; Antonysamy MA, 1999, J IMMUNOL, V162, P577; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blocher S, 2007, CLIN IMMUNOL, V124, P98, DOI 10.1016/j.clim.2007.04.005; Burrell BE, 2010, TRANSPLANTATION, V90, P945, DOI 10.1097/TP.0b013e3181f5c3de; Chen HY, 2009, TRANSPL IMMUNOL, V21, P155, DOI 10.1016/j.trim.2009.03.006; Crispim JCO, 2009, TRANSPL P, V41, P1562, DOI 10.1016/j.transproceed.2009.01.092; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; Demetris AJ, 1997, HEPATOLOGY, V25, P658; Deteix C, 2010, J IMMUNOL, V184, P5344, DOI 10.4049/jimmunol.0902999; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Fan H, 2012, HEPATOB PANCREAT DIS, V11, P606, DOI 10.1016/S1499-3872(12)60231-8; Feng G, 2008, TRANSPLANTATION, V86, P578, DOI 10.1097/TP.0b013e3181806a60; Gorantla VS, 2010, TRANSPLANT REV-ORLAN, V24, P147, DOI 10.1016/j.trre.2010.04.002; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hanidziar D, 2010, CURR OPIN ORGAN TRAN, V15, P411, DOI 10.1097/MOT.0b013e32833b7929; He Q, 2011, TRANSPL P, V43, P1696, DOI 10.1016/j.transproceed.2011.03.084; Heidt S, 2010, CURR OPIN ORGAN TRAN, V15, P456, DOI 10.1097/MOT.0b013e32833b9bfb; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Keller MR, 2011, SEMIN IMMUNOPATHOL, V33, P105, DOI 10.1007/s00281-011-0252-1; Kim HY, 2013, IMMUNOLOGY, V138, P124, DOI 10.1111/imm.12021; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Koshiba T, 2007, TRANSPL IMMUNOL, V17, P94, DOI 10.1016/j.trim.2006.10.004; Li J, 2006, EUR J CARDIO-THORAC, V29, P779, DOI 10.1016/j.ejcts.2006.01.052; Li JZ, 2011, INT IMMUNOPHARMACOL, V11, P962, DOI 10.1016/j.intimp.2011.02.010; Li Y, 2004, AM J TRANSPLANT, V4, P2118, DOI 10.1111/j.1600-6143.2004.00611.x; Li Y, 2008, TRANSPLANTATION, V86, P1837, DOI 10.1097/TP.0b013e31818febc4; Long E, 2009, TRANSPLANTATION, V88, P1050, DOI 10.1097/TP.0b013e3181bb7913; Loong CC, 2002, J PATHOL, V197, P322, DOI 10.1002/path.1117; O'Leary JG, 2008, GASTROENTEROLOGY, V134, P1764, DOI 10.1053/j.gastro.2008.02.028; Pesenacker AM, 2013, BLOOD, V121, P2647, DOI 10.1182/blood-2012-08-443473; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Stenard F, 2009, PEDIATR TRANSPLANT, V13, P70, DOI 10.1111/j.1399-3046.2008.00917.x; Tang JL, 2001, TRANSPLANTATION, V72, P348, DOI 10.1097/00007890-200107270-00035; Vanaudenaerde BM, 2006, EUR RESPIR J, V27, P779, DOI 10.1183/09031936.06.00019405; Wood KJ, 2011, TRANSPL P, V43, P2135, DOI 10.1016/j.transproceed.2011.06.050; Yoshida S, 2006, AM J TRANSPLANT, V6, P724, DOI 10.1111/j.1600-6143.2006.01236.x; Yu X, 2013, TRANSPL IMMUNOL, V29, P118, DOI 10.1016/j.trim.2013.09.001; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937; Zhang XS, 2008, CLIN IMMUNOL, V127, P313, DOI 10.1016/j.clim.2008.01.013; Zuber J, 2009, NEPHROL DIAL TRANSPL, V24, P3847, DOI 10.1093/ndt/gfp435	44	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112135	10.1371/journal.pone.0112135	http://dx.doi.org/10.1371/journal.pone.0112135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372875	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900114
J	Wu, L; Xu, J; Yuan, WQ; Wu, BJ; Wang, H; Liu, GQ; Wang, XX; Du, J; Cai, SH				Wu, Long; Xu, Jun; Yuan, Weiqi; Wu, Baojian; Wang, Hao; Liu, Guangquan; Wang, Xiaoxiong; Du, Jun; Cai, Shaohui			The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance In Vitro and In Vivo Derived from Human Breast MCF-7/ADR Cells	PLOS ONE			English	Article							EXPRESSION; DOXORUBICIN; BCRP/ABCG2	Purpose: P-glycoprotein mediated efflux is one of the main mechanisms for multidrug resistance in cancers, and 3-Bromopyruvate acts as a promising multidrug resistance reversal compound in our study. To test the ability of 3-Bromopyruvate to overcome P-glycoprotein-mediated multidrug resistance and to explore its mechanisms of multidrug resistance reversal in MCF-7/ADR cells, we evaluate the in vitro and in vivo modulatory activity of this compound. Methods: The in vitro and in vivo activity was determined using the MTT assay and human breast cancer xenograft models. The gene and protein expression of P-glycoprotein were determined using real-time polymerase chain reaction and the Western blotting technique, respectively. ABCB-1 bioactivity was tested by fluorescence microscopy, multi-mode microplate reader, and flow cytometry. The intracellular levels of ATP, HK-II, and ATPase activity were based on an assay kit according to the manufacturer's instructions. Results: 3-Bromopyruvate treatment led to marked decreases in the IC50 values of selected chemotherapeutic drugs [e.g., doxorubicin (283 folds), paclitaxel (85 folds), daunorubicin (201 folds), and epirubicin (171 folds)] in MCF-7/ADR cells. 3-Bromopyruvate was found also to potentiate significantly the antitumor activity of epirubicin against MCF-7/ADR xenografts. The intracellular level of ATP decreased 44%, 46% in the presence of 12.5.25 mu M 3-Bromopyruvate, whereas the accumulation of rhodamine 123 and epirubicin (two typical P-glycoprotein substrates) in cells was significantly increased. Furthermore, we found that the mRNA and the total protein level of P-glycoprotein were slightly altered by 3-Bromopyruvate. Moreover, the ATPase activity was significantly inhibited when 3-Bromopyruvate was applied. Conclusion: We demonstrated that 3-Bromopyruvate can reverse P-glycoprotein-mediated efflux in MCF-7/ADR cells. Multidrug resistance reversal by 3-Bromopyruvate occurred through at least three approaches, namely, a decrease in the intracellular level of ATP and HK-II bioactivity, the inhibition of ATPase activity, and the slight decrease in P-glycoprotein expression in MCF-7/ADR cells.	[Wu, Long; Xu, Jun; Yuan, Weiqi; Liu, Guangquan; Wang, Xiaoxiong; Cai, Shaohui] Jinan Univ, Coll Pharm, Dept Clin Pharmacol, Guangzhou 510632, Guangdong, Peoples R China; [Wu, Baojian] Jinan Univ, Coll Pharm, Div Pharmaceut, Guangzhou 510632, Guangdong, Peoples R China; [Wang, Hao; Du, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	Jinan University; Jinan University; Sun Yat Sen University	Du, J (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	dujun2345@yahoo.cn; csh5689@sina.com			National Natural Science Foundation of China [30973565, 81273538, 81202461]; Fundamental Research Funds for the Central Universities [21612115]; China Postdoctoral Science Foundation [2013M531906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by the National Natural Science Foundation of China (No. 30973565, No. 81273538 and No. 81202461) and the Fundamental Research Funds for the Central Universities (No. 21612115) as well as China Postdoctoral Science Foundation (No. 2013M531906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albermann N, 2005, BIOCHEM PHARMACOL, V70, P949, DOI 10.1016/j.bcp.2005.06.018; Allam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051345; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Chen JJ, 2012, CANCER SCI, V103, P1531, DOI 10.1111/j.1349-7006.2012.02328.x; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; Fang R, 2013, CANCER LETT, V333, P66, DOI 10.1016/j.canlet.2013.01.014; Fernandes AF, 2014, BREAST CANCER RES, V3, P47, DOI DOI 10.4236/ABCR.2014.32007; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Jiang GM, 2010, INT J BIOCHEM CELL B, V42, P1840, DOI 10.1016/j.biocel.2010.07.020; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; LUK CK, 1989, JNCI-J NATL CANCER I, V81, P55, DOI 10.1093/jnci/81.1.55; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; Mathupala SP, 2009, HEXOKINASE 2 BOUND M, P5475; Nakano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027222; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Ni LN, 2011, MED ONCOL, V28, P265, DOI 10.1007/s12032-010-9456-9; Pedersen PL, 2012, J BIOENERG BIOMEMBR, V44, P1, DOI 10.1007/s10863-012-9425-4; Shoshan MC, 2012, J BIOENERG BIOMEMBR, V44, P7, DOI 10.1007/s10863-012-9419-2; SKOWRONEK P, 1992, BIOCHEM BIOPH RES CO, V187, P991, DOI 10.1016/0006-291X(92)91295-2; Thomas Hilary, 2003, Cancer Control, V10, P159; Touil Y, 2013, STEM CELLS, V31, P641, DOI 10.1002/stem.1333; Trivedi ER, 2012, TETRAHEDRON LETT, V53, P5475, DOI 10.1016/j.tetlet.2012.07.087; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zhang DM, 2012, MOL PHARMACEUT, V9, P3147, DOI 10.1021/mp300249s; Zhang JJ, 2011, CANCER-AM CANCER SOC, V117, P86, DOI 10.1002/cncr.25522	30	22	23	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112132	10.1371/journal.pone.0112132	http://dx.doi.org/10.1371/journal.pone.0112132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372840	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900113
J	Baillon, S; Hamel, JF; Mercier, A				Baillon, Sandrine; Hamel, Jean-Francois; Mercier, Annie			Diversity, Distribution and Nature of Faunal Associations with Deep-Sea Pennatulacean Corals in the Northwest Atlantic	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; STABLE-ISOTOPE ANALYSIS; COLD-WATER CORALS; BENTHIC INVERTEBRATES; GORGONIAN CORALS; PACIFIC-OCEAN; PEN; HABITAT; CANADA; OCTOCORALLIA	Anthoptilum grandiflorum and Halipteris finmarchica are two deep-sea corals (Octocorallia: Pennatulacea) common on soft bottoms in the North Atlantic where they are believed to act as biogenic habitat. The former also has a worldwide distribution. To assist conservation efforts, this study examines spatial and temporal patterns in the abundance, diversity, and nature of their faunal associates. A total of 14 species were found on A. grandiflorum and 6 species on H. finmarchica during a multi-year and multi-site sampling campaign in eastern Canada. Among those, 7 and 5 species, respectively, were attached to the sea pens and categorized as close associates or symbionts. Rarefaction analyses suggest that the most common associates of both sea pens have been sampled. Biodiversity associated with each sea pen is analyzed according to season, depth and region using either close associates or the broader collection of species. Associated biodiversity generally increases from northern to southern locations and does not vary with depth (similar to 100-1400 m). Seasonal patterns in A. grandiflorum show higher biodiversity during spring/summer due to the transient presence of early life stages of fishes and shrimps whereas it peaks in fall for H. finmarchica. Two distinct endoparasitic species of highly modified copepods (families Lamippidae and Corallovexiidae) commonly occur in the polyps of A. grandiflorum and H. finmarchica, and a commensal sea anemone frequently associates with H. finmarchica. Stable isotope analyses (delta C-13 and delta N-15) reveal potential trophic interactions between the parasites and their hosts. Overall, the diversity of obligate/permanent associates of sea pens is moderate; however the presence of mobile/transient associates highlights an ecological role that has yet to be fully elucidated and supports their key contribution to the enhancement of biodiversity in the Northwest Atlantic.	[Baillon, Sandrine; Mercier, Annie] Mem Univ, Dept Ocean Sci, St John, NF, Canada; [Hamel, Jean-Francois] SEVE, St Philips, NF, Canada	Memorial University Newfoundland	Baillon, S (corresponding author), Mem Univ, Dept Ocean Sci, St John, NF, Canada.	sbaillon@mun.ca	Baillon, Sandrine/F-4486-2015; Mercier, Annie/B-4254-2012	Baillon, Sandrine/0000-0002-0781-0706; Mercier, Annie/0000-0003-0807-2378	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Discovery grants from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammons AW, 2008, DEEP-SEA RES PT II, V55, P2657, DOI 10.1016/j.dsr2.2008.07.015; Baillon S, 2014, CHARACTERIZATION ROL, P300; Baillon S, 2014, MAR BIOL, V161, P29, DOI 10.1007/s00227-013-2311-8; Baillon S, 2012, FRONT ECOL ENVIRON, V10, P351, DOI 10.1890/120022; Baillon S, 2011, DEEP-SEA RES PT I, V58, P260, DOI 10.1016/j.dsr.2010.12.010; Baker KD, 2012, MAR ECOL PROG SER, V445, P235, DOI 10.3354/meps09448; BouIIgand Y., 1966, Symposia of the Zoological Society of London, VNo. 16, P267; Bouligand Y., 1965, Crustaceana, V8, P1, DOI 10.1163/156854065X00505; Brodeur RD, 2001, CONT SHELF RES, V21, P207, DOI 10.1016/S0278-4343(00)00083-2; Buhl-Mortensen L, 2005, ERLANGEN EARTH C SER, P849, DOI 10.1007/3-540-27673-4_44; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2004, J NAT HIST, V38, P1233, DOI 10.1080/0022293031000155205; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Buhl-Mortensen P, 2014, MAR BIOL RES, V10, P253, DOI 10.1080/17451000.2013.810759; Carlier A, 2009, MAR ECOL PROG SER, V397, P125, DOI 10.3354/meps08361; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COLL JC, 1992, CHEM REV, V92, P613, DOI 10.1021/cr00012a006; Dalyell JG, 1848, RARE REMARKABLE ANIM; de Moura Neves B, 2013, 6 ANN BIOL GRAD STUD; DeWaard Jeremy R., 2008, V410, P275; Donaldson A, 2010, IMPACTS FISHING GEAR, P90; DUBE MA, 1971, J PHYCOL, V7, P218; Edwards DCB, 2008, MAR BIOL, V155, P303, DOI 10.1007/s00227-008-1028-6; Etnoyer P, 2005, ERLANGEN EARTH C SER, P331, DOI 10.1007/3-540-27673-4_16; Fautin D.G., 2013, HEXACORALLIANS WORLD; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gale KSP, 2013, DEEP-SEA RES PT I, V80, P25, DOI 10.1016/j.dsr.2013.05.016; Gale KSP, 2013, ECOLOGY DEEP SEA AST, P135; Garcia-Matucheski S, 2012, J EXP MAR BIOL ECOL, V416, P208, DOI 10.1016/j.jembe.2011.12.014; Gilkinson K, 2009, CAN TECH REP FISH AQ, P142; Hoare R, 1977, BIOL BENTHIC ORGANIS, P329; HUMES AG, 1978, T AM MICROSC SOC, V97, P524, DOI 10.2307/3226168; HUMES AG, 1985, T AM MICROSC SOC, V104, P313, DOI 10.2307/3226484; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Iken K, 2005, POLAR BIOL, V28, P238, DOI 10.1007/s00300-004-0669-2; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnstone AK, 1969, PTILOSARCUS GUERNEYI, P84; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Krug PJ, 2006, MAR MOL BIOTECHNOL, V42, P1; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; LAUBIER L, 1972, Crustaceana (Leiden), V22, P285, DOI 10.1163/156854072X00570; Longo C, 2005, J MAR BIOL ASSOC UK, V85, P1341, DOI 10.1017/S0025315405012518; MACKIE AM, 1987, COMP BIOCHEM PHYS A, V86, P629, DOI 10.1016/0300-9629(87)90613-X; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Mercier A, DEEP SEA RES 1, V91, P27; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Muzuka ANN, 1999, MAR GEOL, V160, P251, DOI 10.1016/S0025-3227(99)00022-5; *NAFO, 2008, 0824 NAFO SCS; Nilsen M, 2008, CAN J FISH AQUAT SCI, V65, P2791, DOI 10.1139/F08-180; Nygren A, 2010, J MAR BIOL ASSOC UK, V90, P1441, DOI 10.1017/S0025315409991536; PIELOU EC, 1966, AM NAT, V100, P463, DOI 10.1086/282439; Pires DO, 2009, MAR ECOL PROG SER, V397, P103, DOI 10.3354/meps08322; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rex M.A., 2010, BIOSCIENCE; Rex MA, 1997, MARINE BIODIVERSITY-BOOK, P94, DOI 10.1017/CBO9780511752360.006; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SANKARANKUTTY C., 1961, JOUR MAR BIOL ASSOC INDIA, V3, P96; Sherwood GD, 2005, ESTUAR COAST SHELF S, V63, P537, DOI 10.1016/j.ecss.2004.12.010; Sherwood OA, 2008, DEEP-SEA RES PT I, V55, P1392, DOI 10.1016/j.dsr.2008.05.013; Soong K, 2005, MAR BIOL, V146, P1103, DOI 10.1007/s00227-004-1509-1; Tissot BN, 2006, FISH B-NOAA, V104, P167; Troffe PM, 2005, AQUAT CONSERV, V15, P523, DOI 10.1002/aqc.685; Wang Changyun, 2008, Acta Ecologica Sinica, V28, P2320; Wareham VE, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P289; Wating L, 2011, ADV MAR BIOL, V60, P41, DOI 10.1016/B978-0-12-385529-9.00002-0; Williams GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022747; WILLIAMS GC, 1995, ZOOL J LINN SOC-LOND, V113, P93, DOI 10.1006/zjls.1995.0004; Williams GC, 2013, HALIPTERIS FINMARCHI; Wilson MT, 2002, HYDROBIOLOGIA, V471, P133, DOI 10.1023/A:1016509506094; [No title captured]	75	32	33	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111519	10.1371/journal.pone.0111519	http://dx.doi.org/10.1371/journal.pone.0111519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369515	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000344402000065
J	Kuhn, E; Du, XY; McGrath, K; Coveney, S; O'Regan, N; Richardson, S; Teodorczuk, A; Allan, L; Wilson, D; Inouye, SK; MacLullich, AMJ; Meagher, D; Brayne, C; Timmons, S; Davis, D				Kuhn, Elvira; Du, Xinyi; McGrath, Keith; Coveney, Sarah; O'Regan, Niamh; Richardson, Sarah; Teodorczuk, Andrew; Allan, Louise; Wilson, Dan; Inouye, Sharon K.; MacLullich, Alasdair M. J.; Meagher, David; Brayne, Carol; Timmons, Suzanne; Davis, Daniel			Validation of a Consensus Method for Identifying Delirium from Hospital Records	PLOS ONE			English	Article							CONFUSION ASSESSMENT METHOD; COGNITIVE DECLINE; PREVENT DELIRIUM; DEMENTIA; MANAGEMENT; MORTALITY; COHORT; RISK	Background: Delirium is increasingly considered to be an important determinant of trajectories of cognitive decline. Therefore, analyses of existing cohort studies measuring cognitive outcomes could benefit from methods to ascertain a retrospective delirium diagnosis. This study aimed to develop and validate such a method for delirium detection using routine medical records in UK and Ireland. Methods: A point prevalence study of delirium provided the reference-standard ratings for delirium diagnosis. Blinded to study results, clinical vignettes were compiled from participants' medical records in a standardised manner, describing any relevant delirium symptoms recorded in the whole case record for the period leading up to case-ascertainment. An expert panel rated each vignette as unlikely, possible, or probable delirium and disagreements were resolved by consensus. Results: From 95 case records, 424 vignettes were abstracted by 5 trained clinicians. There were 29 delirium cases according to the reference standard. Median age of subjects was 76.6 years (interquartile range 54.6 to 82.5). Against the original study DSM-IV diagnosis, the chart abstraction method gave a positive likelihood ratio (LR) of 7.8 (95% CI 5.7-12.0) and the negative LR of 0.45 (95% CI 0.40-0.47) for probable delirium (sensitivity 0.58 (95% CI 0.53-0.62); specificity 0.93 (95% CI 0.90-0.95); AUC 0.86 (95% CI 0.82-0.89)). The method diagnosed possible delirium with positive LR 3.5 (95% CI 2.9-4.3) and negative LR 0.15 (95% CI 0.11-0.21) (sensitivity 0.89 (95% CI 0.85-0.91); specificity 0.75 (95% CI 0.71-0.79); AUC 0.86 (95% CI 0.80-0.89)). Conclusions: This chart abstraction method can retrospectively diagnose delirium in hospitalised patients with good accuracy. This has potential for retrospectively identifying delirium in cohort studies where routine medical records are available. This example of record linkage between hospitalisations and epidemiological data may lead to further insights into the inter-relationship between acute illness, as an exposure, for a range of chronic health outcomes.	[Kuhn, Elvira; McGrath, Keith; Coveney, Sarah; O'Regan, Niamh; Timmons, Suzanne] St Finbarrs Hosp, Ctr Gerontol & Rehabil, Sch Med, Cork, Ireland; [Du, Xinyi] Univ Cambridge, Sch Med, Cambridge, England; [Coveney, Sarah; O'Regan, Niamh; Richardson, Sarah] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wilson, Dan] Kings Coll Hosp London, NHS Fdn Trust, Dept Clin Gerontol, London, England; [Inouye, Sharon K.] Harvard Univ, Sch Med, Aging Brain Ctr, Inst Aging Res,Hebrew SeniorLife, Boston, MA 02215 USA; [Inouye, Sharon K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [MacLullich, Alasdair M. J.; Davis, Daniel] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [MacLullich, Alasdair M. J.] Univ Edinburgh, Edinburgh Delirium Res Grp, Edinburgh, Midlothian, Scotland; [Meagher, David] Univ Limerick, Dept Psychiat, Limerick, Ireland; [Brayne, Carol; Davis, Daniel] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Davis, Daniel] UCL, MRC Unit Lifelong Hlth & Ageing, London, England	University of Cambridge; Newcastle University - UK; King's College Hospital NHS Foundation Trust; King's College Hospital; Oxford University Hospitals NHS Foundation Trust; Harvard University; Harvard Medical School; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Edinburgh; University of Edinburgh; University of Limerick; University of Cambridge; University of London; University College London	Davis, D (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	daniel.davis@ucl.ac.uk	Davis, Daniel/F-9995-2012; Brayne, Carol/AAA-4285-2020; Inouye, Sharon/R-7216-2019; Allan, Louise M/A-2918-2009; O'Regan, Niamh/I-6798-2016; Teodorczuk, Andrew/R-3345-2016	Davis, Daniel/0000-0002-1560-1955; Brayne, Carol/0000-0001-5307-663X; Allan, Louise M/0000-0002-8912-4901; O'Regan, Niamh/0000-0003-2510-2495; MacLullich, Alasdair/0000-0003-3159-9370; Timmons, Suzanne/0000-0001-7790-9552; Du-Harpur, Xinyi/0000-0002-5738-8734; Richardson, Sarah/0000-0002-5771-1845; Teodorczuk, Andrew/0000-0003-0802-718X	Wellcome Trust [WT 090661]; MRC [MR/L023210/1, MC_UU_12019/1] Funding Source: UKRI; Medical Research Council [MR/L023210/1, MC_UU_12019/1, MR/K026992/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084, ACF-2012-01-001] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Daniel Davis is funded by the Wellcome Trust as a research training fellow (WT 090661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akunne A, 2012, AGE AGEING, V41, P285, DOI 10.1093/ageing/afr147; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davis DHJ, 2012, BRAIN, V135, P2809, DOI 10.1093/brain/aws190; Davis DH, 2013, AM J GERIATR PSYCHIA; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Gross AL, 2012, ARCH INTERN MED, V172, P1324, DOI 10.1001/archinternmed.2012.3203; Inouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.x; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 2013, LANCET; JOHNSON JC, 1992, J AM GERIATR SOC, V40, P316, DOI 10.1111/j.1532-5415.1992.tb02128.x; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Maclullich AMJ, 2013, AGE AGEING, V42, P667, DOI 10.1093/ageing/aft148; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Partridge JSL, 2013, INT J GERIATR PSYCH, V28, P804, DOI 10.1002/gps.3900; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Young J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3704	24	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111823	10.1371/journal.pone.0111823	http://dx.doi.org/10.1371/journal.pone.0111823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369057	gold, Green Published			2022-12-27	WOS:000344402000108
J	Kurko, J; Vida, A; Ocsko, T; Tryniszewska, B; Rauch, TA; Glant, TT; Szekanecz, Z; Mikecz, K				Kurko, Julia; Vida, Andras; Ocsko, Timea; Tryniszewska, Beata; Rauch, Tibor A.; Glant, Tibor T.; Szekanecz, Zoltan; Mikecz, Katalin			Suppression of Proteoglycan-Induced Autoimmune Arthritis by Myeloid-Derived Suppressor Cells Generated In Vitro from Murine Bone Marrow	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-BEARING MICE; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; SYNOVIAL-FLUID; CANCER; TRANSPLANTATION; ACTIVATION; MECHANISMS; DISEASE	Background: Myeloid-derived suppressor cells (MDSCs) are innate immune cells capable of suppressing T-cell responses. We previously reported the presence of MDSCs with a granulocytic phenotype in the synovial fluid (SF) of mice with proteoglycan (PG)-induced arthritis (PGIA), a T cell-dependent autoimmune model of rheumatoid arthritis (RA). However, the limited amount of SF-MDSCs precluded investigations into their therapeutic potential. The goals of this study were to develop an in vitro method for generating MDSCs similar to those found in SF and to reveal the therapeutic effect of such cells in PGIA. Methods: Murine bone marrow (BM) cells were cultured for 3 days in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), and granulocyte colony-stimulating factor (G-CSF). The phenotype of cultured cells was analyzed using flow cytometry, microscopy, and biochemical methods. The suppressor activity of BM-MDSCs was tested upon co-culture with activated T cells. To investigate the therapeutic potential of BM-MDSCs, the cells were injected into SCID mice at the early stage of adoptively transferred PGIA, and their effects on the clinical course of arthritis and PG-specific immune responses were determined. Results: BM cells cultured in the presence of GM-CSF, IL-6, and G-CSF became enriched in MDSC-like cells that showed greater phenotypic heterogeneity than MDSCs present in SF. BM-MDSCs profoundly inhibited both antigen-specific and polyclonal T-cell proliferation primarily via production of nitric oxide. Injection of BM-MDSCs into mice with PGIA ameliorated arthritis and reduced PG-specific T-cell responses and serum antibody levels. Conclusions: Our in vitro enrichment strategy provides a SF-like, but controlled microenvironment for converting BM myeloid precursors into MDSCs that potently suppress both T-cell responses and the progression of arthritis in a mouse model of RA. Our results also suggest that enrichment of BM in MDSCs could improve the therapeutic efficacy of BM transplantation in RA.	[Kurko, Julia; Vida, Andras; Ocsko, Timea; Tryniszewska, Beata; Rauch, Tibor A.; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Dept Orthoped Surg, Sect Mol Med, Chicago, IL 60612 USA; [Kurko, Julia; Szekanecz, Zoltan] Univ Debrecen, Fac Med, Dept Rheumatol, Debrecen, Hungary	Rush University; University of Debrecen	Mikecz, K (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Sect Mol Med, Chicago, IL 60612 USA.	Katalin_Mikecz@rush.edu	Szekanecz, Zoltán/GXN-0235-2022	Mikecz, Katalin/0000-0003-1506-4296	National Institute of Health [AR062332, AR064206, AR064948]; National Excellence Program - European Union [TAMOP 4.2.4.A/2-11-1-2012-0001]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064948, R01AR064206, R21AR062332] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Excellence Program - European Union; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants AR062332 and AR064206 (to KM) and AR064948 (to TAR) from the National Institute of Health http://www.nih.gov., and by the TAMOP 4.2.4.A/2-11-1-2012-0001 National Excellence Program co-financed by the European Union and Hungary (to ZS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Angyal A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2954; Bardos T, 2002, J IMMUNOL, V168, P6013, DOI 10.4049/jimmunol.168.12.6013; Berlo SE, 2006, ARTHRITIS RHEUM-US, V54, P2423, DOI 10.1002/art.22013; Bingisser RM, 1998, J IMMUNOL, V160, P5729; BJELLE A, 1982, SCAND J RHEUMATOL, V11, P124, DOI 10.3109/03009748209098176; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Brinkman DMC, 2007, ARTHRITIS RHEUM-US, V56, P2410, DOI 10.1002/art.22656; Charles JF, 2012, J CLIN INVEST, V122, P4592, DOI 10.1172/JCI60920; Cope AP, 2002, ARTHRITIS RES THER, V4, pS197, DOI 10.1186/ar557; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Egelston C, 2012, ARTHRITIS RHEUM-US, V64, P3179, DOI 10.1002/art.34494; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Faust N, 2000, BLOOD, V96, P719; Firestein GS, 2005, KELLEYS TXB RHEUMATO, P996; Forghani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064837; Fox DA, 2005, ARTHRITIS ALLIED CON, P1085; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Glant TT, 2011, ARTHRITIS RHEUM-US, V63, P1312, DOI 10.1002/art.30261; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; HOLMDAHL R, 1988, LAB INVEST, V58, P53; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Hutas G, 2008, BLOOD, V112, P4999, DOI 10.1182/blood-2008-04-150383; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Jiao Z, 2013, SCAND J RHEUMATOL, V42, P85, DOI 10.3109/03009742.2012.716450; Kerr EC, 2008, J AUTOIMMUN, V31, P354, DOI 10.1016/j.jaut.2008.08.006; Kurko J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-281; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Moore JJ, 2003, BONE MARROW TRANSPL, V32, pS53, DOI 10.1038/sj.bmt.1703944; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Pastula A, 2011, INT J EXP PATHOL, V92, P73, DOI 10.1111/j.1365-2613.2010.00754.x; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Ribechini E, 2009, EUR J IMMUNOL, V39, P3538, DOI 10.1002/eji.200939530; Roord STA, 2008, BLOOD, V111, P5233, DOI 10.1182/blood-2007-12-128488; Rossner S, 2005, EUR J IMMUNOL, V35, P3533, DOI 10.1002/eji.200526172; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; SUBIZA JL, 1989, INT J CANCER, V44, P307, DOI 10.1002/ijc.2910440220; Wright HL, 2012, RHEUMATOLOGY, V51, P451, DOI 10.1093/rheumatology/ker338; Yamamoto Tetsuro, 1996, Seminars in Thrombosis and Hemostasis, V22, P507, DOI 10.1055/s-2007-999052; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47	54	31	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111815	10.1371/journal.pone.0111815	http://dx.doi.org/10.1371/journal.pone.0111815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369029	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000107
J	Tsai, KJ; Chang, CH				Tsai, Kevin J.; Chang, Chuan-Hsiung			Diagnostics for Stochastic Genome-Scale Modeling via Model Slicing and Debugging	PLOS ONE			English	Article							SIMULATION; NETWORKS; TOOLBOX; BIOLOGY	Modeling of biological behavior has evolved from simple gene expression plots represented by mathematical equations to genome-scale systems biology networks. However, due to obstacles in complexity and scalability of creating genome-scale models, several biological modelers have turned to programming or scripting languages and away from modeling fundamentals. In doing so, they have traded the ability to have exchangeable, standardized model representation formats, while those that remain true to standardized model representation are faced with challenges in model complexity and analysis. We have developed a model diagnostic methodology inspired by program slicing and debugging and demonstrate the effectiveness of the methodology on a genome-scale metabolic network model published in the BioModels database. The computer-aided identification revealed specific points of interest such as reversibility of reactions, initialization of species amounts, and parameter estimation that improved a candidate cell's adenosine triphosphate production. We then compared the advantages of our methodology over other modeling techniques such as model checking and model reduction. A software application that implements the methodology is available at http://gel.ym.edu.tw/gcs/.	[Tsai, Kevin J.] Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei 115, Taiwan; [Tsai, Kevin J.; Chang, Chuan-Hsiung] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chang, Chuan-Hsiung] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chang, CH (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	chc@gel.ym.edu.tw	Tsai, Kevin/GQR-1990-2022		National Science Council (NSC) of Taiwan [NSC 101-2319-B-010-002, NSC 101-3113-P-110-002]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council (NSC) of Taiwan [NSC 101-2319-B-010-002, NSC 101-3113-P-110-002]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; CLARKE BL, 1992, J CHEM PHYS, V97, P4066, DOI 10.1063/1.463911; Dalchau N, 2012, J R SOC INTERFACE, V9, P2883, DOI 10.1098/rsif.2012.0280; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Gay S, 2010, BIOINFORMATICS, V26, pi575, DOI 10.1093/bioinformatics/btq388; GILL S, 1951, PROC R SOC LON SER-A, V206, P538, DOI 10.1098/rspa.1951.0087; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hunt CA, 2008, NAT BIOTECHNOL, V26, P737, DOI 10.1038/nbt0708-737; Iafolla MAJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-373; Jha SK, 2009, LECT N BIOINFORMAT, V5688, P218, DOI 10.1007/978-3-642-03845-7_15; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Keating SM, 2006, BIOINFORMATICS, V22, P1275, DOI 10.1093/bioinformatics/btl111; Kwiatkowska Marta, 2008, Performance Evaluation Review, V35, P14, DOI 10.1145/1364644.1364651; Li C, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-42; Lopez CF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.1; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; Miller JA, 1997, PROC ANNU SIMUL SYMP, P31, DOI 10.1109/SIMSYM.1997.586473; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Peters SA, 2008, CLIN PHARMACOKINET, V47, P261, DOI 10.2165/00003088-200847040-00004; Petzold L, 1999, AICHE J, V45, P869, DOI 10.1002/aic.690450418; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Roberts E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002010; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; TK Lu, 2010, BIOENG BUGS, V1; WEISER M, 1984, IEEE T SOFTWARE ENG, V10, P352, DOI 10.1109/TSE.1984.5010248; Wrzodek C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-15	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110380	10.1371/journal.pone.0110380	http://dx.doi.org/10.1371/journal.pone.0110380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368989	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000018
J	Uddin, N; Hasan, MR; Hasan, MM; Hossain, MM; Alam, MR; Hasan, MR; Islam, AFMM; Rahman, T; Rana, MS				Uddin, Nizam; Hasan, Md. Rakib; Hasan, Md. Mahadi; Hossain, Md. Monir; Alam, Md. Robiul; Hasan, Mohammad Raquibul; Islam, A. F. M. Mahmudul; Rahman, Tasmina; Rana, Md. Sohel			Assessment of Toxic Effects of the Methanol Extract of Citrus macroptera Montr. Fruit via Biochemical and Hematological Evaluation in Female Sprague-Dawley Rats	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-DISEASE; PLASMA; RISK; HYPERTENSION; CHOLESTEROL; METABOLISM; PARAMETERS; ANIMALS; INSULIN	Citrus macroptera Montr. (C. macroptera) is locally known as Satkara. The fruit of this plant is used as appetite stimulant and in the treatment of fever. This study therefore aimed to evaluate the toxic effects of the fruit extract using some biochemical and hematological parameters in rat model. The effects of methanol extract of Citrus macroptera Montr. fruit administered at 250, 500 and 1000 mg/kg body weight were investigated on hematological and biochemical parameters in Sprague-Dawley female rats. Moreover, histopathological study was performed to observe the presence of pathological lesions in primary body organs. The extract presented no significant effect on body weight, percent water content, relative organ weight and hematological parameters in rat. Significant decrease from control group was observed in the levels of triglyceride, total cholesterol, low density lipoprotein and very low density lipoprotein; thus leading to significant decrease of cardiac risk ratio, castelli's risk index-2, atherogenic coefficient and atherogenic index of plasma at all doses. 500 mg/kg dose significantly decreased alkaline phosphatase (P<0.05), 1000 mg/kg dose significantly increased high density lipoprotein cholesterol (P<0.05) and 250 mg/kg dose significantly decreased the level of glycated hemoglobin (P<0.05) from the control group. There were no significant alterations observed with other serum biochemical parameters. Histopathological study confirmed the absence of inflammatory and necrotic features in the primary body organs. Study results indicate that methanolic fruit extract is unlikely to have significant toxicity. Moreover, these findings justified the cardio-protective, moderate hepato-protective and glucose controlling activities of the fruit extract.	[Uddin, Nizam; Hasan, Md. Rakib; Hasan, Md. Mahadi; Hossain, Md. Monir; Alam, Md. Robiul; Hasan, Mohammad Raquibul; Islam, A. F. M. Mahmudul; Rahman, Tasmina; Rana, Md. Sohel] Jahangirnagar Univ, Dept Pharm, Dhaka 1342, Bangladesh	Jahangirnagar University	Uddin, N (corresponding author), Jahangirnagar Univ, Dept Pharm, Dhaka 1342, Bangladesh.	sami.pharm22@gmail.com			Jahangirnagar University Annual Research Grant [JU-ARG-2012-005]	Jahangirnagar University Annual Research Grant	This study was supported with funding from Jahangirnagar University Annual Research Grant (Grant no: JU-ARG-2012-005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa Oladipo, 2005, Lipids Health Dis, V4, P19, DOI 10.1186/1476-511X-4-19; Ashafa AOT, 2009, AFR J BIOTECHNOL, V8, P1425; Ayhan S, 2013, EXP CLIN CARDIOL, V18, pE12; Brehm A, 2004, CLIN CHEM, V50, P2316, DOI 10.1373/clinchem.2004.037556; CASTELLI WP, 1983, CIRCULATION, V67, P730, DOI 10.1161/01.CIR.67.4.730; Chowdhury SA, 2008, BANG J SCI IND RES, V43, P449; Das S, 1999, BIOTECHNOLOGY MED PL, P126; Dobiasova M, 2004, CLIN CHEM, V50, P1113, DOI 10.1373/clinchem.2004.033175; Drury R.A.B., 1980, CARLETON HISTOLOGICA; Dybing E, 2002, FOOD CHEM TOXICOL, V40, P237, DOI 10.1016/S0278-6915(01)00115-6; Elevitch CR, 2006, TRADITIONAL TREES PA, P243; Endler G, 2002, BRIT J HAEMATOL, V117, P399, DOI 10.1046/j.1365-2141.2002.03441.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaillard E., 1995, Annales Pharmaceutiques Francaises, V53, P75; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Grotto HZW, 2004, CLIN LAB HAEMATOL, V26, P347, DOI 10.1111/j.1365-2257.2004.00634.x; Gupta S. S., 1994, Indian Journal of Pharmacology, V26, P1; Guyton CA, 1986, TXB MED PHYSL, P2; Jaroszynska J, 2003, POL J ENVIRON STUD, V12, P481; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Martins AC, 2006, CLINICAL CHEMISTRY A, P7; Martirosyan DM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-1; McBride P, 2008, CURR ATHEROSCLER REP, V10, P386, DOI 10.1007/s11883-008-0060-9; Newman D. J., 1998, TIETZ TXB CLIN CHEM, P1204; ODUTOLA AAA, 1992, RAPID INTERPRETATION, P1; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Pari L, 2004, DIABETES OBES METAB, V6, P286, DOI 10.1111/j.1462-8902.2004.0349.x; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Rahmatullah M., 2010, ADV NAT APPL SCI, V4, P52; Rana VS, 2012, NAT PROD COMMUN, V7, P1371; Ringer D.H., 1979, LABORATORY RAT, V1, P105; Ruot B, 2000, AM J PHYSIOL-ENDOC M, V279, pE244, DOI 10.1152/ajpendo.2000.279.2.E244; Shen GX, 2007, CURR PHARM ANAL, V3, P17, DOI 10.2174/157341207779802386; Shepherd J, 1998, EUR HEART J, V19, P1776, DOI 10.1053/euhj.1998.1122; Tennant B. C., 1997, Clinical biochemistry of domestic animals., P337, DOI 10.1016/B978-012396305-5/50014-2; Uddin Nizam, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P473, DOI 10.12980/APJTB.4.2014C1173; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Waikedre J, 2010, CHEM BIODIVERS, V7, P871, DOI 10.1002/cbdv.200900196; WOLFORD ST, 1986, J TOXICOL ENV HEALTH, V18, P161, DOI 10.1080/15287398609530859; Zicha J, 1999, AM J HYPERTENS, V12, P315, DOI 10.1016/S0895-7061(98)00178-2	41	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111101	10.1371/journal.pone.0111101	http://dx.doi.org/10.1371/journal.pone.0111101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369061	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402000036
J	Fodor, A; Segura, V; Denis, M; Neuenschwander, S; Fournier-Level, A; Chatelet, P; Homa, FAA; Lacombe, T; This, P; Le Cunff, L				Fodor, Agota; Segura, Vincent; Denis, Marie; Neuenschwander, Samuel; Fournier-Level, Alexandre; Chatelet, Philippe; Homa, Felix Abdel Aziz; Lacombe, Thierry; This, Patrice; Le Cunff, Loic			Genome-Wide Prediction Methods in Highly Diverse and Heterozygous Species: Proof-of-Concept through Simulation in Grapevine	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC ARCHITECTURE; QUANTITATIVE TRAITS; SELECTION GAIN; UNIT TIME; ASSOCIATION; ACCURACY; WINE; CONSERVATION; INFORMATION	Nowadays, genome-wide association studies (GWAS) and genomic selection (GS) methods which use genome-wide marker data for phenotype prediction are of much potential interest in plant breeding. However, to our knowledge, no studies have been performed yet on the predictive ability of these methods for structured traits when using training populations with high levels of genetic diversity. Such an example of a highly heterozygous, perennial species is grapevine. The present study compares the accuracy of models based on GWAS or GS alone, or in combination, for predicting simple or complex traits, linked or not with population structure. In order to explore the relevance of these methods in this context, we performed simulations using approx 90,000 SNPs on a population of 3,000 individuals structured into three groups and corresponding to published diversity grapevine data. To estimate the parameters of the prediction models, we defined four training populations of 1,000 individuals, corresponding to these three groups and a core collection. Finally, to estimate the accuracy of the models, we also simulated four breeding populations of 200 individuals. Although prediction accuracy was low when breeding populations were too distant from the training populations, high accuracy levels were obtained using the sole core-collection as training population. The highest prediction accuracy was obtained (up to 0.9) using the combined GWAS-GS model. We thus recommend using the combined prediction model and a core-collection as training population for grapevine breeding or for other important economic crops with the same characteristics.	[Fodor, Agota; This, Patrice; Le Cunff, Loic] IFV INRA Montpellier Supagro, UMT Genovigne, Montpellier, France; [Fodor, Agota; Chatelet, Philippe; Lacombe, Thierry; This, Patrice; Le Cunff, Loic] INRA, UMR AGAP, F-34060 Montpellier, France; [Segura, Vincent] INRA, UR AGPF 588, Orleans, France; [Denis, Marie; Homa, Felix Abdel Aziz] CIRAD, UMR AGAP, Montpellier, France; [Neuenschwander, Samuel] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Neuenschwander, Samuel] Univ Lausanne, Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland; [Fournier-Level, Alexandre] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia	INRAE; Institut Agro; Montpellier SupAgro; INRAE; Universite de Montpellier; INRAE; CIRAD; Universite de Montpellier; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Melbourne	Le Cunff, L (corresponding author), IFV INRA Montpellier Supagro, UMT Genovigne, Montpellier, France.	loic.lecunff@supagro.inra.fr	Segura, Vincent/B-4656-2013	Segura, Vincent/0000-0003-1860-2256; Neuenschwander, Samuel/0000-0002-4080-5546; FOURNIER-LEVEL, ALEXANDRE/0000-0002-6047-7164	Swiss National Science Foundation [31003A_138180]; French Ministry of Research and Higher Education; French Ministry of Food, Agriculture and Fisheries (project CAS DAR) [10AAPIT, 1009]; French Grapevine and Wine Institute (IFV)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); French Ministry of Research and Higher Education; French Ministry of Food, Agriculture and Fisheries (project CAS DAR); French Grapevine and Wine Institute (IFV)	S.N. was supported by Swiss National Science Foundation grant 31003A_138180 to Dr. J. Goudet. This work was funded in part by the French Ministry of Research and Higher Education and the French Ministry of Food, Agriculture and Fisheries (project CAS DAR no 10AAPIT no 1009) and a PhD grant from the French Grapevine and Wine Institute (IFV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bacilieri R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-25; Beaumont MA, 2002, GENETICS, V162, P2025; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; Bowers J, 1999, SCIENCE, V285, P1562, DOI 10.1126/science.285.5433.1562; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carrier G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032973; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; de Roos APW, 2009, GENETICS, V183, P1545, DOI 10.1534/genetics.109.104935; Doligez A, 2006, THEOR APPL GENET, V113, P369, DOI 10.1007/s00122-006-0295-1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eding H, 2001, J ANIM BREED GENET, V118, P141, DOI 10.1046/j.1439-0388.2001.00290.x; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Emanuelli F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-241; Fournier-Level A, 2010, HEREDITY, V104, P351, DOI 10.1038/hdy.2009.148; Fournier-Level A, 2009, GENETICS, V183, P1127, DOI 10.1534/genetics.109.103929; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2008, IMPACT GENETIC RELAT; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hannah L, 2013, P NATL ACAD SCI USA, V110, P6907, DOI 10.1073/pnas.1210127110; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Houel C, 2011, CARACTERISATION VARI; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Lacombe T, 2012, CONTRIBUTION ETUDE H; Lacombe T, 2013, THEOR APPL GENET, V126, P401, DOI 10.1007/s00122-012-1988-2; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Le Paslier M-C, 2013, GRAPERESEQ 18K VITIS; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Meuwissen THE, 2001, GENETICS, V157, P1819; Moriondo M, 2013, CLIMATIC CHANGE, V119, P825, DOI 10.1007/s10584-013-0739-y; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; Neuenschwander S, 2008, BIOINFORMATICS, V24, P1552, DOI 10.1093/bioinformatics/btn219; Ollat N, 2011, MULTIDISCIPLINARY RE; Park SDE, 2001, TRYPANOTOLERANCE W A; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; SPITZE K, 1993, GENETICS, V135, P367; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wong CK, 2008, THEOR APPL GENET, V116, P815, DOI 10.1007/s00122-008-0715-5; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zohary D, 1996, ORIGINS ANCIENT HIST, P31	81	23	24	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110436	10.1371/journal.pone.0110436	http://dx.doi.org/10.1371/journal.pone.0110436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365338	Green Published, gold			2022-12-27	WOS:000345558100021
J	Hoang, LT; Tolfvenstam, T; Ooi, EE; Khor, CC; Naim, ANM; Ho, EXP; Ong, SH; Wertheim, HF; Fox, A; Nguyen, CVV; Nghiem, NM; Ha, TM; Tran, ATN; Tambayah, P; Lin, R; Sangsajja, C; Manosuthi, W; Chuchottaworn, C; Sansayunh, P; Chotpitayasunondh, T; Suntarattiwong, P; Chokephaibulkit, K; Puthavathana, P; de Jong, MD; Farrar, J; van Doorn, HR; Hibberd, ML				Long Truong Hoang; Tolfvenstam, Thomas; Ooi, Eng Eong; Khor, Chiea Chuen; Naim, Ahmand Nazri Mohamed; Ho, Eliza Xin Pei; Ong, Swee Hoe; Wertheim, Heiman F.; Fox, Annette; Chau Van Vinh Nguyen; Ngoc My Nghiem; Tuan Manh Ha; Anh Thi Ngoc Tran; Tambayah, Paul; Lin, Raymond; Sangsajja, Chariya; Manosuthi, Weerawat; Chuchottaworn, Chareon; Sansayunh, Piamlarp; Chotpitayasunondh, Tawee; Suntarattiwong, Piyarat; Chokephaibulkit, Kulkanya; Puthavathana, Pilaipan; de Jong, Menno D.; Farrar, Jeremy; van Doorn, H. Rogier; Hibberd, Martin Lloyd			Patient-Based Transcriptome-Wide Analysis Identify Interferon and Ubiquination Pathways as Potential Predictors of Influenza A Disease Severity	PLOS ONE			English	Article							RIG-I; RESPONSES; VIRUS; INFECTION; INDUCTION; PATHOLOGY; H1N1; H5N1	Background: The influenza A virus is an RNA virus that is responsible for seasonal epidemics worldwide with up to five million cases of severe illness and 500,000 deaths annually according to the World Health Organization estimates. The factors associated with severe diseases are not well defined, but more severe disease is more often seen among persons aged.65 years, infants, pregnant women, and individuals of any age with underlying health conditions. Methodology/Principal Findings: Using gene expression microarrays, the transcriptomic profiles of influenza-infected patients with severe (N = 11), moderate (N = 40) and mild (N = 83) symptoms were compared with the febrile patients of unknown etiology (N = 73). We found that influenza-infected patients, regardless of their clinical outcomes, had a stronger induction of antiviral and cytokine responses and a stronger attenuation of NK and T cell responses in comparison with those with unknown etiology. More importantly, we found that both interferon and ubiquitination signaling were strongly attenuated in patients with the most severe outcomes in comparison with those with moderate and mild outcomes, suggesting the protective roles of these pathways in disease pathogenesis. Conclusion/Significances: The attenuation of interferon and ubiquitination pathways may associate with the clinical outcomes of influenza patients.	[Long Truong Hoang; Khor, Chiea Chuen; Naim, Ahmand Nazri Mohamed; Ho, Eliza Xin Pei; Ong, Swee Hoe; Hibberd, Martin Lloyd] Genome Inst Singapore, Singapore, Singapore; [de Jong, Menno D.; Farrar, Jeremy; van Doorn, H. Rogier] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Wertheim, Heiman F.; Fox, Annette] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Natl Hosp Trop Dis, Hanoi, Vietnam; [Wertheim, Heiman F.; Fox, Annette] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Chau Van Vinh Nguyen; Ngoc My Nghiem] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tuan Manh Ha; Anh Thi Ngoc Tran] Children Hosp 2, Ho Chi Minh City, Vietnam; [Tambayah, Paul; Lin, Raymond] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Sangsajja, Chariya; Manosuthi, Weerawat] Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Chuchottaworn, Chareon; Sansayunh, Piamlarp] Chest Dis Inst, Nonthaburi, Thailand; [Chotpitayasunondh, Tawee; Suntarattiwong, Piyarat] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Chokephaibulkit, Kulkanya; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand; [Tolfvenstam, Thomas] Karolinska Inst, Solna, Sweden	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; National Hospital of Tropical Diseases; University of Oxford; University of Oxford; National University of Singapore; Chest Disease Research Institute - Thailand; Mahidol University; Karolinska Institutet	Hoang, LT (corresponding author), Genome Inst Singapore, Singapore, Singapore.	hoangtl@gis.a-star.edu.sg	Hoang, Long/ABC-7442-2020; Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman FL/F-3338-2016; van Doorn, H. Rogier/H-3080-2019	Hoang, Long/0000-0002-6808-6758; Wertheim, Heiman FL/0000-0002-5003-5565; van Doorn, H. Rogier/0000-0002-9807-1821; Tolfvenstam, Thomas/0000-0003-3549-8083; Khor, Chiea Chuen/0000-0002-1128-4729; Ong, Swee Hoe/0000-0002-3629-5387; Farrar, Jeremy/0000-0002-2700-623X; Fox, Annette/0000-0002-0565-7146; Hibberd, Martin/0000-0001-8587-1849; Ooi, Eng Eong/0000-0002-0520-1544; Ha Manh, Tuan/0000-0002-4998-2581	South East Asia Infectious Disease Clinical Research Network [N01-A0-50042]; Wellcome Trust of Great Britain [077078/Z/05/Z]; Singapore Agency for Science, Technology and Research (A-STAR)	South East Asia Infectious Disease Clinical Research Network; Wellcome Trust of Great Britain(Wellcome Trust); Singapore Agency for Science, Technology and Research (A-STAR)(Agency for Science Technology & Research (A*STAR))	This work was funded by the South East Asia Infectious Disease Clinical Research Network (N01-A0-50042, www.seaicrn.org), and the Wellcome Trust of Great Britain (Grant 077078/Z/05/Z) and the Singapore Agency for Science, Technology and Research (A-STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Baum A, 2011, VIRULENCE, V2, P166, DOI 10.4161/viru.2.2.15481; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Juno J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/797180; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Lee SMY, 2014, P NATL ACAD SCI USA, V111, P3793, DOI 10.1073/pnas.1324266111; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12; Mao HW, 2010, J VIROL, V84, P4148, DOI 10.1128/JVI.02340-09; Marquez ME, 2010, CELL IMMUNOL, V264, P86, DOI 10.1016/j.cellimm.2010.05.002; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Rajsbaum R, 2013, TRENDS MICROBIOL, V21, P421, DOI 10.1016/j.tim.2013.06.006; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; South East Asia Infectious Disease Clinical Research Network, 2013, BMJ, V346, pf3039, DOI 10.1136/bmj.f3039; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N	26	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111640	10.1371/journal.pone.0111640	http://dx.doi.org/10.1371/journal.pone.0111640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365328	Green Accepted, Green Published, gold			2022-12-27	WOS:000345558100093
J	Maghsoudi, A; Baneshi, MR; Neydavoodi, M; Haghdoost, A				Maghsoudi, Ahmad; Baneshi, Mohammad Reza; Neydavoodi, Mojtaba; Haghdoost, AliAkbar			Network Scale-Up Correction Factors for Population Size Estimation of People Who Inject Drugs and Female Sex Workers in Iran	PLOS ONE			English	Article							PERSONAL NETWORK; HIV/AIDS; STIGMA; RISK; HIV	Introduction: The results of the network scale-up (NSU) method in estimating the size of key populations for HIV might be biased if the recruited subjects are not fully informed of the risky behaviors of people in their networks (low visibility), or key populations have a smaller social network (low popularity). We aimed to measure such biases in the size estimation of people who inject drugs (PWIDs), and female sex workers (FSWs) in Iran. Methods: We interviewed 163 male PWIDs, 76 FSWs (known as egos) and 600 subjects from the general population. We selected twenty first-names (ten males and ten females) and asked the study subjects separately how many people they knew with one of these names (known as alters). Visibility Factor (VF) was defined as the percentage of FSW or PWID alters that were aware of their behavior. In addition, the popularity factor (PF) was calculated by dividing the number of alters reported by FSWs and PWIDs into that of the general population. The 95% uncertainty intervals (UI) were calculated using bootstrap technique. Results: The VF was estimated at 54% (95% UI: 52%-56%) for PWID and 45% (95% UI: 42%-48%) for FSW. The VF among the peer alters was significantly higher than non-peer ones. The PF for PWID and FSW was 69% (95% UI: 66%-73%) and 77% (95% UI: 72%-83%), respectively. The cross-validation and name splitting analysis showed that our estimates were not influenced by any single name. Conclusions: Both correction factors, particularly VF were far from one, and NSU results without correction, could lead to up to 4 times underestimation of the sizes. Therefore, applying these coefficients is necessary in NSU projects.	[Maghsoudi, Ahmad] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Maghsoudi, Ahmad] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Baneshi, Mohammad Reza; Haghdoost, AliAkbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Dept Biostat & Epidemiol, Res Ctr Modeling Hlth, Kerman, Iran; [Neydavoodi, Mojtaba] Shiraz Univ Med Sci, Fac Publ Hlth, Shiraz, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; Shiraz University of Medical Science	Haghdoost, A (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, Dept Biostat & Epidemiol, Res Ctr Modeling Hlth, Kerman, Iran.	ahaghdoost@kmu.ac.ir	Baneshi, Mohammad Reza/C-2586-2017; Haghdoost, Ali Akbar/C-2823-2009	Baneshi, Mohammad Reza/0000-0002-6405-8688; Haghdoost, Ali Akbar/0000-0003-4628-4849	Student Research Committee of Kerman University of Medical Sciences	Student Research Committee of Kerman University of Medical Sciences	Support was provided by the Student Research Committee of Kerman University of Medical Sciences. The funder had no role in study design, data collection and analysis, descison to publish, or preparation of the manuscript.	Abadia-Barrero CE, 2006, SOC SCI MED, V62, P1219, DOI 10.1016/j.socscimed.2005.07.006; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; BERNARD HR, 1991, SOC SCI RES, V20, P109; Dhsprogram Website, 2012, EST SIZ POP HOUS SUR; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Jackson D, 2005, CONNECTIONS, V26, P49; Killworth PD, 2003, ATTEMPTING QUANTIFY; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; McCormick TH, 2010, J AM STAT ASSOC, V105, P59, DOI 10.1198/jasa.2009.ap08518; Paniotto V, 2009, ESTIMATING SIZE POPU; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Sabin K, 2010, METHODOL INNOV ONLIN, V5, P38, DOI [10.4256/mio.2010.0017, DOI 10.4256/MIO.2010.0017]; Salganik MJ, 2011, AM J EPIDEMIOL, V174, P1190, DOI 10.1093/aje/kwr246; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; SHELLEY GA, 1995, SOC NETWORKS, V17, P189, DOI 10.1016/0378-8733(95)00262-M; Shokoohi M, 2011, ADDICTION HLTH, V2, P81; Shokoohi M, 2012, INT J PREVENTIVE MED, V3, P471; Stroup DF, 2010, SIZE ESTIMATIO UNPUB; UNAIDS the US Office of the Global AIDS Coordinator, 2012, CONS NETW SCAL UP OT; Zolala F., 2011, EXPLORING ROUTINE DA	20	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110917	10.1371/journal.pone.0110917	http://dx.doi.org/10.1371/journal.pone.0110917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365341	Green Published, gold			2022-12-27	WOS:000345558100034
J	Berline, L; Rammou, AM; Doglioli, A; Molcard, A; Petrenko, A				Berline, Leo; Rammou, Anna-Maria; Doglioli, Andrea; Molcard, Anne; Petrenko, Anne			A Connectivity-Based Eco-Regionalization Method of the Mediterranean Sea	PLOS ONE			English	Article							SURFACE CIRCULATION; GENETIC-STRUCTURE; MARINE; TRANSPORT; VARIABILITY; WATER; COMMUNITY; PATTERNS; PLANKTON	Ecoregionalization of the ocean is a necessary step for spatial management of marine resources. Previous ecoregionalization efforts were based either on the distribution of species or on the distribution of physical and biogeochemical properties. These approaches ignore the dispersal of species by oceanic circulation that can connect regions and isolates others. This dispersal effect can be quantified through connectivity that is the probability, or time of transport between distinct regions. Here a new regionalization method based on a connectivity approach is described and applied to the Mediterranean Sea. This method is based on an ensemble of Lagrangian particle numerical simulations using ocean model outputs at 1/12 degrees resolution. The domain is divided into square subregions of 50 km size. Then particle trajectories are used to quantify the oceanographic distance between each subregions, here defined as the mean connection time. Finally the oceanographic distance matrix is used as a basis for a hierarchical clustering. 22 regions are retained and discussed together with a quantification of the stability of boundaries between regions. Identified regions are generally consistent with the general circulation with boundaries located along current jets or surrounding gyres patterns. Regions are discussed in the light of existing ecoregionalizations and available knowledge on plankton distributions. This objective method complements static regionalization approaches based on the environmental niche concept and can be applied to any oceanic region at any scale.	[Berline, Leo; Molcard, Anne] Univ Aix Marseille, Univ Sud Toulon Var, CNRS INSU IRD, MIO, La Garde, France; [Rammou, Anna-Maria; Doglioli, Andrea; Petrenko, Anne] Univ Aix Marseille, CNRS INSU IRD, MIO, La Garde, France; [Berline, Leo] CNRS, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Berline, Leo] Univ Paris 06, Lab Oceanog Villefranche, Villefranche Sur Mer, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Berline, L (corresponding author), Univ Aix Marseille, Univ Sud Toulon Var, CNRS INSU IRD, MIO, La Garde, France.	leo.berline@univ-amu.fr	Berline, Leo/AAM-8802-2021; Berline, Leo/AAJ-5885-2021; PETRENKO, Anne/AAN-7210-2021	PETRENKO, Anne/0000-0002-2519-9285; Molcard, Anne/0000-0001-7376-0973; Berline, Leo/0000-0002-5831-7399; Doglioli, Andrea/0000-0003-1309-9954	European Community [287844]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 2013) under Grant Agreement No. 287844 for the project "Towards COast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential'' (COCONET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2011, MOL ECOL, V20, P2543, DOI 10.1111/j.1365-294X.2011.05117.x; Andrello M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068564; [Anonymous], 1953, ZOOGEOGRAPHY SEA; Bahurel P, 2006, Ocean Weather Forecasting: An Integrated View of Oceanography, P381, DOI 10.1007/1-4020-4028-8_14; Beaugrand G, 2005, ICES J MAR SCI, V62, P333, DOI 10.1016/j.icesjms.2005.01.002; Berline L, 2013, MAR POLLUT BULL, V70, P90, DOI 10.1016/j.marpolbul.2013.02.016; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; BLANKE B, 1993, J PHYS OCEANOGR, V23, P1363, DOI 10.1175/1520-0485(1993)023<1363:VOTTAO>2.0.CO;2; Blanke B, 1997, J PHYS OCEANOGR, V27, P1038, DOI 10.1175/1520-0485(1997)027<1038:KOTPEU>2.0.CO;2; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Burlando M, 2008, INT J CLIMATOL, V28, P629, DOI 10.1002/joc.1561; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Carlotti F, 2010, PROG OCEANOGR, V84, P20, DOI 10.1016/j.pocean.2009.09.003; Casale P, 2014, MAR ECOL PROG SER, V498, P263, DOI 10.3354/meps10640; Chiba S, 2013, GEOPHYS RES LETT, V40, P5182, DOI 10.1002/grl.50999; Coll M., 2010, PLOS ONE, V5; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; de Madron XD, 2011, PROG OCEANOGR, V91, P97, DOI 10.1016/j.pocean.2011.02.003; de Puelles MLF, 2003, OCEANOL ACTA, V26, P673, DOI 10.1016/j.oceact.2003.07.001; Forbes E, 1856, PHYS ATLAS NATURAL P, P99; Fuda JL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014072; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guizien K, 2012, LIMNOL OCEANOGR, V57, P1099, DOI 10.4319/lo.2012.57.4.1099; Hamad N, 2005, PROG OCEANOGR, V66, P287, DOI 10.1016/j.pocean.2005.04.002; Hjelmervik KT, 2013, OCEAN DYNAM, V63, P809, DOI 10.1007/s10236-013-0623-3; Jribi Imed, 2012, BioInvasions Records, V1, P49, DOI 10.3391/bir.2012.1.1.11; Koubbi P, 2011, DEEP-SEA RES PT II, V58, P170, DOI 10.1016/j.dsr2.2010.09.007; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; LEGENDRE P, 1972, Taxon, V21, P567, DOI 10.2307/1219157; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; de Puelles MLF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028354; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Madec G, 2008, NEMO OCEAN ENGINE; Malanotte-Rizzoli P, 2014, OCEAN SCI, V10, P281, DOI 10.5194/os-10-281-2014; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Mesinger F., 1976, NUMERICAL METHODS US, V1; Millot C, 2005, HANDB ENVIRON CHEM, V5, P29, DOI 10.1007/b107143; Nowaczyk A, 2011, BIOGEOSCIENCES, V8, P2159, DOI 10.5194/bg-8-2159-2011; O'Brien TD, 2010, 307152 ICES; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Olita A, 2012, OCEAN COAST MANAGE, V57, P44, DOI 10.1016/j.ocecoaman.2011.11.006; Oliver MJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034238; Oliver MJ, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002072; Olli K, 2007, PROG OCEANOGR, V72, P84, DOI 10.1016/j.pocean.2006.08.002; Pizzigalli C, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003870; Poulain PM, 2007, CONT SHELF RES, V27, P981, DOI 10.1016/j.csr.2007.01.005; Queiroga H, 2004, ADV MAR BIOL, V47, P198; Reygondeau G, 2013, EGU GEN ASS 2013 VIE; Rixen M, 2000, OCEAN MODEL, V2, P45, DOI 10.1016/S1463-5003(00)00009-3; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; UNESCO, 2009, IOC TECHN SER, V84; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wernberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080168; ZALESAK ST, 1979, J COMPUT PHYS, V31, P335, DOI 10.1016/0021-9991(79)90051-2	63	43	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111978	10.1371/journal.pone.0111978	http://dx.doi.org/10.1371/journal.pone.0111978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375212	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600082
J	Bowen, AC; Burns, K; Tong, SYC; Andrews, RM; Liddle, R; O'Meara, IM; Westphal, DW; Carapetis, JR				Bowen, Asha C.; Burns, Kara; Tong, Steven Y. C.; Andrews, Ross M.; Liddle, Robyn; O'Meara, Irene M.; Westphal, Darren W.; Carapetis, Jonathan R.			Standardising and Assessing Digital Images for Use in Clinical Trials: A Practical, Reproducible Method That Blinds the Assessor to Treatment Allocation	PLOS ONE			English	Article							RHEUMATIC-FEVER; GLOBAL BURDEN; PHOTOGRAPHY; GUIDELINES; PYODERMA; DISEASE	With the increasing availability of high quality digital cameras that are easily operated by the non-professional photographer, the utility of using digital images to assess endpoints in clinical research of skin lesions has growing acceptance. However, rigorous protocols and description of experiences for digital image collection and assessment are not readily available, particularly for research conducted in remote settings. We describe the development and evaluation of a protocol for digital image collection by the non-professional photographer in a remote setting research trial, together with a novel methodology for assessment of clinical outcomes by an expert panel blinded to treatment allocation.	[Bowen, Asha C.; Tong, Steven Y. C.; Andrews, Ross M.; Liddle, Robyn; O'Meara, Irene M.; Westphal, Darren W.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Bowen, Asha C.; Burns, Kara; Tong, Steven Y. C.] Royal Darwin Hosp, Darwin, NT, Australia; [Burns, Kara] Queensland Univ Technol, Sch Business, Brisbane, Qld 4001, Australia; [Bowen, Asha C.; Westphal, Darren W.; Carapetis, Jonathan R.] Univ Western Australia, Telethon Kids Inst Child Hlth Res, Perth, WA 6009, Australia; [Bowen, Asha C.; Carapetis, Jonathan R.] Princess Margaret Hosp Children, Perth, WA, Australia	Charles Darwin University; Menzies School of Health Research; Queensland University of Technology (QUT); Telethon Kids Institute; University of Western Australia; University of Western Australia	Bowen, AC (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	Asha.bowen@menzies.edu.au	Carapetis, Jonathan R/H-8933-2014; Bowen, Asha Clare/X-5221-2018; Burns, Kara/AAF-4050-2020; Tong, Steven/N-2353-2013	Carapetis, Jonathan R/0000-0002-1182-9792; Bowen, Asha Clare/0000-0002-3242-1155; Tong, Steven/0000-0002-1368-8356; Burns, Kara/0000-0002-6491-4405	National Health and Medical Research Council (NHMRC) of Australia [545234]; NHMRC scholarship [605845]; Australian Academy of Sciences Douglas and Lola Douglas scholarship; NHMRC Career Development Fellowship [1065736]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Sciences Douglas and Lola Douglas scholarship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council (NHMRC) of Australia project grant (545234) for which AB, ST, RA and JC are all investigators and IMO is funded as the trial project manager. AB is the recipient of an NHMRC scholarship for PhD research (605845) and an Australian Academy of Sciences Douglas and Lola Douglas scholarship. ST is the recipient of a NHMRC Career Development Fellowship (1065736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie Graeme M, 2003, J Audiov Media Med, V26, P15, DOI 10.1080/0140511031000091239; Bar-Zeev SJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-250; Baumgarten M, 2009, WOUND REPAIR REGEN, V17, P287, DOI 10.1111/j.1524-475X.2009.00462.x; Bowen A. C., 2014, LANCET; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Craig FF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-51; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Faye O, 2007, INT J DERMATOL, V46, P19, DOI 10.1111/j.1365-4632.2007.03364.x; Flanagan M, 2003, J Wound Care, V12, P189; Gulkesen KH, 2010, J EUR ACAD DERMATOL, V24, P893, DOI 10.1111/j.1468-3083.2009.03538.x; Hoy WE, 2012, KIDNEY INT, V81, P1026, DOI 10.1038/ki.2011.478; Humphrey Clinton D, 2010, Facial Plast Surg Clin North Am, V18, P329, DOI 10.1016/j.fsc.2010.01.008; Institute of Medical Illustrators, 2007, IMMI NAT GUID CLIN P; Jakowenko J, 2009, J TELEMED TELECARE, V15, P7, DOI 10.1258/jtt.2008.008006; Jesada EC, 2013, J WOUND OSTOMY CONT, V40, P150, DOI 10.1097/WON.0b013e31828093a4; Katugampola R, 2012, J VIS COMMUN MED, V35, P5, DOI 10.3109/17453054.2012.656584; Khavkin J, 2011, FACIAL PLAST SURG CL, V19, P241, DOI 10.1016/j.fsc.2011.04.001; Koning S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003261.pub3; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; Murdoch J, 2005, J VIS COMMUN MED, V28, P68, DOI 10.1080/01405110500096934; Nayler J, 2001, J Audiov Media Med, V24, P166; Nayler J R, 2003, J Postgrad Med, V49, P256; NHMRC, 2018, NAT STAT ETH COND HU; Nirmal B, 2013, INDIAN J DERMATOL VE, V79, P193, DOI [10.4103/0019-5154.110827, 10.4103/0378-6323.107635]; O'Malley T, 2004, AUSTR GUIDELINES DIG; Parnaby MG, 2010, J PAEDIATR CHILD H, V46, P527, DOI 10.1111/j.1440-1754.2010.01841.x; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Sandler Jonathan, 2012, Prog Orthod, V13, P296, DOI 10.1016/j.pio.2011.12.002; Sandler J, 2009, AM J ORTHOD DENTOFAC, V135, P657, DOI 10.1016/j.ajodo.2007.04.038; Shallcross LJ, 2013, EMERG INFECT DIS, V19, P1646, DOI 10.3201/eid1910.130433; Shapter Michael, 2004, J Audiov Media Med, V27, P54, DOI 10.1080/01405110410001710734; Sheridan P, 2013, ANZ J SURG, V83, P188, DOI 10.1111/ans.12066; Thomas Jayakar, 2013, Indian Dermatol Online J, V4, P82, DOI 10.4103/2229-5178.110579; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Witmer WK, 2012, SEMIN CUTAN MED SURG, V31, P191, DOI 10.1016/j.sder.2012.06.004; Young S, 2009, J VIS COMMUN MED, V32, P4, DOI 10.1080/17453050802687963; Young S, 2008, J VIS COMMUN MED, V31, P99, DOI 10.1080/17453050802351198	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110395	10.1371/journal.pone.0110395	http://dx.doi.org/10.1371/journal.pone.0110395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375169	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600010
J	Kan, MWK; Leung, LHT; Yu, PKN				Kan, Monica W. K.; Leung, Lucullus H. T.; Yu, Peter K. N.			The Use of Biologically Related Model (Eclipse) for the Intensity-Modulated Radiation Therapy Planning of Nasopharyngeal Carcinomas	PLOS ONE			English	Article							GLAND FUNCTION; NECK TUMORS; RADIOTHERAPY; OPTIMIZATION; HEAD; IRRADIATION; DELIVERY; VOLUME; PLANS	Purpose: Intensity-modulated radiation therapy (IMRT) is the most common treatment technique for nasopharyngeal carcinoma (NPC). Physical quantities such as dose/dose-volume parameters are used conventionally for IMRT optimization. The use of biological related models has been proposed and can be a new trend. This work was to assess the performance of the biologically based IMRT optimization model installed in a popular commercial treatment planning system (Eclipse) as compared to its dose/dosevolume optimization model when employed in the clinical environment for NPC cases. Methods: Ten patients of early stage NPC and ten of advanced stage NPC were selected for this study. IMRT plans optimized using biological related approach (BBTP) were compared to their corresponding plans optimized using the dose/dose volume based approach (DVTP). Plan evaluation was performed using both biological indices and physical dose indices such as tumor control probability (TCP), normal tissue complication probability (NTCP), target coverage, conformity, dose homogeneity and doses to organs at risk. The comparison results of the more complex advanced stage cases were reported separately from those of the simpler early stage cases. Results: The target coverage and conformity were comparable between the two approaches, with BBTP plans producing more hot spots. For the primary targets, BBTP plans produced comparable TCP for the early stage cases and higher TCP for the advanced stage cases. BBTP plans reduced the volume of parotid glands receiving doses of above 40 Gy compared to DVTP plans. The NTCP of parotid glands produced by BBTP were 8.0 +/- 65.8 and 7.9 +/- 68.7 for early and advanced stage cases, respectively, while those of DVTP were 21.3 +/- 68.3 and 24.4 +/- 12.8, respectively. There were no significant differences in the NTCP values between the two approaches for the serial organs. Conclusions: Our results showed that the BBTP approach could be a potential alternative approach to the DVTP approach for NPC.	[Kan, Monica W. K.; Leung, Lucullus H. T.] Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China; [Kan, Monica W. K.; Yu, Peter K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon Tong, Hong Kong, Peoples R China	City University of Hong Kong	Kan, MWK (corresponding author), Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China.	kanwkm@ha.org.hk	Yu, Peter K.N./C-7051-2013	Yu, Peter K.N./0000-0003-1669-5348				BEDWINEK JM, 1980, CANCER, V45, P2725, DOI 10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO;2-1; Cheung Ky, 2006, Biomed Imaging Interv J, V2, pe19, DOI 10.2349/biij.2.1.e19; CRONQVIST AKA, 1995, ACTA ONCOL, V34, P851, DOI 10.3109/02841869509127196; Das S, 2009, MED PHYS, V36, P4672, DOI 10.1118/1.3220211; FRANZEN L, 1992, EUR J CANCER, V28A, P457, DOI 10.1016/S0959-8049(05)80076-0; Gressette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091325; Hunt MA, 2001, INT J RADIAT ONCOL, V49, P623, DOI 10.1016/S0360-3016(00)01389-4; International Commission on Radiation Units and Measurement, 2010, 82 ICRU; International Commission on Radiation Units and Measurements, 1993, 50 ICRU; Ji XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056208; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Kong FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091362; KUTCHER GJ, 1991, INT J RADIAT ONCOL, V21, P137, DOI 10.1016/0360-3016(91)90173-2; Kutcher GJ, 1989, INT J RAD BIOL PHYS, V16, P1625; Levin-Plotnik D, 2002, RADIAT RES, V155, P593; Li XA, 2012, MED PHYS, V39, P1386, DOI 10.1118/1.3685447; Lind BK, 1999, ACTA ONCOL, V38, P787; Pow HN, 2006, INT J RADIAT ONCOL, V66, P981; Qi XS, 2009, MED PHYS, V36, P1790, DOI 10.1118/1.3116775; Semenenko VA, 2008, MED PHYS, V35, P5851, DOI 10.1118/1.3013556; Someya M, 2003, JPN J CLIN ONCOL, V33, P336, DOI 10.1093/jjco/hyg066; Stavrev P, 2003, MED PHYS, V30, P2948, DOI 10.1118/1.1617411; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075304; Thieke C, 2003, MED PHYS, V30, P2332, DOI 10.1118/1.1598852; vantRiet A, 1997, INT J RADIAT ONCOL, V37, P731, DOI 10.1016/S0360-3016(96)00601-3; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Wu QW, 2002, INT J RADIAT ONCOL, V52, P224, DOI 10.1016/S0360-3016(01)02585-8; Wu QW, 2003, PHYS MED BIOL, V48, P279, DOI 10.1088/0031-9155/48/3/301; Zhou GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067488	30	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112229	10.1371/journal.pone.0112229	http://dx.doi.org/10.1371/journal.pone.0112229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372041	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900124
J	Sang, YM; Bergkamp, J; Blecha, F				Sang, Yongming; Bergkamp, Joseph; Blecha, Frank			Molecular Evolution of the Porcine Type I Interferon Family: Subtype-Specific Expression and Antiviral Activity	PLOS ONE			English	Article							ENDOGENOUS RETROVIRUSES; INFECTION; MACROPHAGES; INDUCTION; BACTERIAL; GENOMES; KAPPA; TIME; PIGS; WEB	Type I interferons (IFNs), key antiviral cytokines, evolve to adapt with ever-changing viral threats during vertebrate speciation. Due to novel pathogenic pressure associated with Suidae speciation and domestication, porcine IFNs evolutionarily engender both molecular and functional diversification, which have not been well addressed in pigs, an important livestock species and animal model for biomedical sciences. Annotation of current swine genome assembly Sscrofa10.2 reveals 57 functional genes and 16 pseudogenes of type I IFNs. Subfamilies of multiple IFNA, IFNW and porcine-specific IFND genes are separated into four clusters with similar to 60 kb intervals within the IFNB/IFNE bordered region in SSC1, and each cluster contains mingled subtypes of IFNA, IFNW and IFND. Further curation of the 57 functional IFN genes indicates that they include 18 potential artifactual duplicates. We performed phylogenetic construction as well as analyses of gene duplication/conversion and natural selection and showed that porcine type I IFN genes have been undergoing active diversification through both gene duplication and conversion. Extensive analyses of the non-coding sequences proximal to all IFN coding regions identified several genomic repetitive elements significantly associated with different IFN subtypes. Family-wide studies further revealed their molecular diversity with respect to differential expression and restrictive activity on the resurgence of a porcine endogenous retrovirus. Based on predicted 3-D structures of representative animal IFNs and inferred activity, we categorized the general functional propensity underlying the structure-activity relationship. Evidence indicates gene expansion of porcine type I IFNs. Genomic repetitive elements that associated with IFN subtypes may serve as molecular signatures of respective IFN subtypes and genomic mechanisms to mediate IFN gene evolution and expression. In summary, the porcine type I IFN profile has been phylogenetically defined family-wide and linked to diverse expression and antiviral activity, which is important information for further biological studies across the porcine type I IFN family.	[Sang, Yongming; Bergkamp, Joseph; Blecha, Frank] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Sang, YM (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA.	ysang@vet.k-state.edu			USDA AFRI NIFA/DHS [2010-39559-21860]; USDA NIFA [2013-67015-21236]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER	USDA AFRI NIFA/DHS; USDA NIFA(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the USDA AFRI NIFA/DHS 2010-39559-21860 (YS) and USDA NIFA 2013-67015-21236 (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Carrero JA, 2013, INT IMMUNOL, V25, P663, DOI 10.1093/intimm/dxt050; Cencic A, 2003, PLACENTA, V24, P862, DOI 10.1016/S0143-4004(03)00135-8; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Detournay O, 2013, J INTERF CYTOK RES, V33, P746, DOI 10.1089/jir.2012.0130; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goossens KE, 2013, DEV COMP IMMUNOL, V41, P370, DOI 10.1016/j.dci.2013.05.020; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katholnig K, 2013, BIOCHEM SOC T, V41, P927, DOI 10.1042/BST20130032; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Langevin C, 2013, J MOL BIOL, V425, P4904, DOI 10.1016/j.jmb.2013.09.033; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Ma JG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-211; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Paltrinieri S, 2007, VET IMMUNOL IMMUNOP, V118, P68, DOI 10.1016/j.vetimm.2007.04.007; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Sang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087613; Sang YM, 2010, PHYSIOL GENOMICS, V42, P248, DOI 10.1152/physiolgenomics.00198.2009; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Walker AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-187; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu L, 2013, PROTEIN CELL, V4, P383, DOI 10.1007/s13238-013-3021-1; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599	44	29	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112378	10.1371/journal.pone.0112378	http://dx.doi.org/10.1371/journal.pone.0112378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372927	Green Submitted, gold, Green Published			2022-12-27	WOS:000344556900141
J	Wang, JB; Wang, X; Zhao, MJ; Choo, SP; Ong, SJ; Ong, SYK; Chong, SS; Teo, YY; Lee, CGL				Wang, Jingbo; Wang, Xu; Zhao, Mingjue; Choo, Su Pin; Ong, Sin Jen; Ong, Simon Y. K.; Chong, Samuel S.; Teo, Yik Ying; Lee, Caroline G. L.			Potentially Functional SNPs (pfSNPs) as Novel Genomic Predictors of 5-FU Response in Metastatic Colorectal Cancer Patients	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; REDUCTASE GENE POLYMORPHISMS; HORMONE REPLACEMENT THERAPY; THYMIDYLATE SYNTHASE; EXO1 GENE; LUNG-CANCER; CLINICAL-RESPONSE; COLON-CARCINOMA; DLG5 VARIANTS; RISK	5-Fluorouracil (5-FU) and its pro-drug Capecitabine have been widely used in treating colorectal cancer. However, not all patients will respond to the drug, hence there is a need to develop reliable early predictive biomarkers for 5-FU response. Here, we report a novel potentially functional Single Nucleotide Polymorphism (pfSNP) approach to identify SNPs that may serve as predictive biomarkers of response to 5-FU in Chinese metastatic colorectal cancer (CRC) patients. 1547 pfSNPs and one variable number tandem repeat (VNTR) in 139 genes in 5-FU drug (both PK and PD pathway) and colorectal cancer disease pathways were examined in 2 groups of CRC patients. Shrinkage of liver metastasis measured by RECIST criteria was used as the clinical end point. Four non-responder-specific pfSNPs were found to account for 37.5% of all non-responders (P<0.0003). Five additional pfSNPs were identified from a multivariate model (AUC under ROC = 0.875) that was applied for all other pfSNPs, excluding the non-responder-specific pfSNPs. These pfSNPs, which can differentiate the other nonresponders from responders, mainly reside in tumor suppressor genes or genes implicated in colorectal cancer risk. Hence, a total of 9 novel SNPs with potential functional significance may be able to distinguish non-responders from responders to 5-FU. These pfSNPs may be useful biomarkers for predicting response to 5-FU.	[Wang, Jingbo; Lee, Caroline G. L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Wang, Xu; Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Choo, Su Pin; Ong, Sin Jen; Ong, Simon Y. K.] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Zhao, Mingjue; Chong, Samuel S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117548, Singapore; [Lee, Caroline G. L.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore	Teo, YY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	yik_ying_teo@nuhs.edu.sg; bchleec@nus.edu.sg	CHOO, Su Pin/ABB-3892-2020; Lee, Caroline G/M-8918-2019; wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; Chong, Samuel S./D-8098-2015	Lee, Caroline G/0000-0002-4323-3635; Chong, Samuel S./0000-0002-1872-5937	Singapore BioMedical Research Council - Science and Engineering Research Council (BMRC-SERC) [SERC 112 148 0008]	Singapore BioMedical Research Council - Science and Engineering Research Council (BMRC-SERC)	This work was supported by a grant (SERC 112 148 0008) from Singapore BioMedical Research Council - Science and Engineering Research Council (BMRC-SERC) to A/Professors Caroline Lee, Simon Ong, Yik Ying Teo and Samuel Chong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], 2011, TRENDS CANC INC SING; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bau DT, 2009, CHINESE J PHYSIOL, V52, P411, DOI 10.4077/CJP.2009.AMH076; Brondello JM, 2008, ONCOGENE, V27, P6093, DOI 10.1038/onc.2008.212; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Cohen V, 2003, CLIN CANCER RES, V9, P1611; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Deng T, 2009, BIOMED PHARMACOTHER, V63, P492, DOI 10.1016/j.biopha.2008.08.013; Etienne MC, 2004, PHARMACOGENETICS, V14, P785, DOI 10.1097/00008571-200412000-00001; Farina-Sarasqueta A, 2010, CANCER CHEMOTH PHARM, V66, P1167, DOI 10.1007/s00280-010-1403-0; Festen EA, 2008, GUT, V57, P1027, DOI 10.1136/gut.2007.144857; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Graziano F, 2008, BRIT J CANCER, V99, P716, DOI 10.1038/sj.bjc.6604555; Gross E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004003; He T, 2013, COLORECTAL DIS, V15, P12, DOI 10.1111/j.1463-1318.2012.02919.x; Hirata K, 1999, PHARMACOL TOXICOL, V85, P33, DOI 10.1111/j.1600-0773.1999.tb01060.x; Hsu NY, 2009, ANTICANCER RES, V29, P725; Ichikawa W, 2006, CLIN CANCER RES, V12, P3928, DOI 10.1158/1078-0432.CCR-05-2665; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Jakobsen A, 2005, J CLIN ONCOL, V23, P1365, DOI 10.1200/JCO.2005.06.219; Jin GF, 2008, LUNG CANCER, V60, P340, DOI 10.1016/j.lungcan.2007.11.003; Kawakami K, 2003, CANCER RES, V63, P6004; Koopman M, 2009, EUR J CANCER, V45, P1935, DOI 10.1016/j.ejca.2009.04.023; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Luo XP, 2012, INT J GYNECOL CANCER, V22, P220, DOI 10.1097/IGC.0b013e318234fd8a; Marcuello E, 2006, CANCER CHEMOTH PHARM, V57, P835, DOI 10.1007/s00280-005-0089-1; Martinez ME, 2001, J NATL CANCER I, V93, P1764, DOI 10.1093/jnci/93.23.1764; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nanda K, 1999, OBSTET GYNECOL, V93, P880, DOI 10.1016/S0029-7844(98)00424-4; Newman WG, 2006, HUM MUTAT, V27, P353, DOI 10.1002/humu.20301; Pan QR, 2005, CANCER LETT, V217, P139, DOI 10.1016/j.canlet.2004.07.021; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Potocnik U, 2008, CANCER GENET CYTOGEN, V183, P28, DOI 10.1016/j.cancergencyto.2008.01.023; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Potti A, 2011, NAT MED, V17, P135, DOI 10.1038/nm0111-135; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rennert G, 2009, J CLIN ONCOL, V27, P4542, DOI 10.1200/JCO.2009.22.0764; Ruzzo A, 2007, J CLIN ONCOL, V25, P1247, DOI 10.1200/JCO.2006.08.1844; Salgado J, 2007, ONCOL REP, V17, P325; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Slattery ML, 2011, CANCER CAUSE CONTROL, V22, P955, DOI 10.1007/s10552-011-9768-x; Sobrero AF, 1997, J CLIN ONCOL, V15, P368, DOI 10.1200/JCO.1997.15.1.368; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Soong R, 2009, BRIT J CANCER, V100, P676, DOI 10.1038/sj.bjc.6604899; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Tsai MH, 2009, ORAL ONCOL, V45, pE90, DOI 10.1016/j.oraloncology.2009.03.011; Tsuji T, 2003, CLIN CANCER RES, V9, P3700; Van Cutsem E, 2004, BRIT J CANCER, V90, P1190, DOI 10.1038/sj.bjc.6601676; Vignoli M, 2011, PHARMACOL RES, V64, P242, DOI 10.1016/j.phrs.2011.04.006; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wang JB, 2011, HUM MUTAT, V32, P19, DOI 10.1002/humu.21331; Webb EL, 2006, HUM MOL GENET, V15, P3263, DOI 10.1093/hmg/ddl401; Zhang H, 2007, MED ONCOL, V24, P251, DOI 10.1007/BF02698048; Zhang S, 2013, ONCOGENE, V32, P242, DOI 10.1038/onc.2012.32; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	63	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111694	10.1371/journal.pone.0111694	http://dx.doi.org/10.1371/journal.pone.0111694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372392	Green Submitted, gold, Green Published			2022-12-27	WOS:000344556900064
J	Winardhi, RS; Castang, S; Dove, SL; Yan, J				Winardhi, Ricksen S.; Castang, Sandra; Dove, Simon L.; Yan, Jie			Single-Molecule Study on Histone-Like Nucleoid-Structuring Protein (H-NS) Paralogue in Pseudomonas aeruginosa: MvaU Bears DNA Organization Mode Similarities to MvaT	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; FAMILY-MEMBER MVAT; ORDER OLIGOMERIZATION; GENE; STPA; REGULATOR; EXPRESSION; MECHANISM; FILAMENT; BACTERIA	Pseudomonas aeruginosa contains two distinct members of H-NS family of nucleoid-structuring proteins: MvaT and MvaU. Together, these proteins bind to the same regions of the chromosome and function coordinately in the regulation of hundreds of genes. Due to their structural similarity, they can associate to form heteromeric complexes. These findings left us wondering whether they bear similar DNA binding properties that underlie their gene-silencing functions. Using singlemolecule stretching and imaging experiments, we found striking similarities in the DNA organization modes of MvaU compared to the previously studied MvaT. MvaU can form protective nucleoprotein filaments that are insensitive to environmental factors, consistent with its role as a repressor of gene expression. Similar to MvaT, MvaU filament can mediate DNA bridging while excessive MvaU can cause DNA aggregation. The almost identical DNA organization modes of MvaU and MvaT explain their functional redundancy, and raise an interesting question regarding the evolutionary benefits of having multiple H-NS paralogues in the Pseudomonas genus.	[Winardhi, Ricksen S.] NUS, Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore; [Castang, Sandra; Dove, Simon L.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02163 USA; [Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Harvard University; Boston Children's Hospital; Harvard Medical School; National University of Singapore	Dove, SL (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Infect Dis, Boston, MA 02163 USA.	simon.dove@childrens.harvard.edu; phyyj@nus.edu.sg	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291	Ministry of Education of Singapore [MOE2008-T2-1-096]; Mechanobiology Institute Singapore; National Institutes of Health [AI069007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069007] Funding Source: NIH RePORTER	Ministry of Education of Singapore(Ministry of Education, Singapore); Mechanobiology Institute Singapore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants MOE2008-T2-1-096 from the Ministry of Education of Singapore and internal funding from the Mechanobiology Institute Singapore (to JY), and by National Institutes of Health Grant AI069007 (to SLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bertin P, 1999, MOL MICROBIOL, V31, P319, DOI 10.1046/j.1365-2958.1999.01176.x; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Castang S, 2012, J BACTERIOL, V194, P5101, DOI 10.1128/JB.00932-12; Castang S, 2010, MOL MICROBIOL, V78, P916, DOI 10.1111/j.1365-2958.2010.07378.x; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Free A, 1997, J BACTERIOL, V179, P909, DOI 10.1128/jb.179.3.909-918.1997; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Li CR, 2009, J BACTERIOL, V191, P6211, DOI 10.1128/JB.00888-09; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049885; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; LYUBCHENKO YL, 1993, NUCLEIC ACIDS RES, V21, P1117, DOI 10.1093/nar/21.5.1117; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; Renzi F, 2010, ENVIRON MICROBIOL, V12, P254, DOI 10.1111/j.1462-2920.2009.02064.x; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Sonden B, 1996, EMBO J, V15, P4970, DOI 10.1002/j.1460-2075.1996.tb00877.x; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Tendeng C, 2003, MICROBIOL-SGM, V149, P3047, DOI 10.1099/mic.0.C0125-0; Ueguchi C, 1997, J MOL BIOL, V274, P145, DOI 10.1006/jmbi.1997.1381; Vallet I, 2004, J BACTERIOL, V186, P2880, DOI 10.1128/JB.186.9.2880-2890.2004; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; VanNoort SJT, 1997, ULTRAMICROSCOPY, V69, P117, DOI 10.1016/S0304-3991(97)00037-5; Westfall LW, 2004, MICROBIOL-SGM, V150, P3797, DOI 10.1099/mic.0.27270-0; Winardhi RS, 2014, J BIOL CHEM, V289, P13739, DOI 10.1074/jbc.M113.545954; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Wolf T, 2006, J BACTERIOL, V188, P6728, DOI 10.1128/JB.00586-06; ZHANG AX, 1992, NUCLEIC ACIDS RES, V20, P6735, DOI 10.1093/nar/20.24.6735; Zhang AX, 1996, EMBO J, V15, P1340, DOI 10.1002/j.1460-2075.1996.tb00476.x	48	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112246	10.1371/journal.pone.0112246	http://dx.doi.org/10.1371/journal.pone.0112246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372370	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900127
J	Chinapaw, MJM; de Niet, M; Verloigne, M; De Bourdeaudhuij, I; Brug, J; Altenburg, TM				Chinapaw, Mai J. M.; de Niet, Mark; Verloigne, Maite; De Bourdeaudhuij, Ilse; Brug, Johannes; Altenburg, Teatske M.			From Sedentary Time to Sedentary Patterns: Accelerometer Data Reduction Decisions in Youth	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CHILDREN; BEHAVIOR; HEALTH; ADOLESCENTS; RELIABILITY; OVERWEIGHT; BREAKING; VALIDITY; DESIGN	Aim: This study aims to establish evidence-based accelerometer data reduction criteria to accurately assess total sedentary time and sedentary patterns in children. Methods: Participants (n = 1057 European children; 9-13 yrs) were invited to wear an accelerometer for at least 6 consecutive days. We explored 1) non-wear time criteria; 2) minimum daily valid wear time; 3) differences between weekday and weekend day; and 4) minimum number of days of accelerometer wear by comparing the effects of commonly used data reduction decisions on total sedentary time, and duration and number of prolonged sedentary bouts. Results: More than 60 consecutive minutes of zero counts was the optimal criterion for non-wear time. Increasing the definition of a valid day from 8 to 10 hours wear time hardly influenced the sedentary outcomes, while the sample size of children with more than 4 valid days increased from 69 to 81%. On weekdays, children had on average 1 hour more wear time, 50 minutes more total sedentary time, 26 minutes more sedentary time accumulated in bouts, and 1 more sedentary bout. At least 6 days of accelerometer data were needed to accurately represent weekly sedentary time and patterns. Conclusions: Based on our results we recommend 1) a minimum of 60 minutes of consecutive zeros as the most realistic criterion for non-wear time; and 2) including at least six days with minimum eight valid hours to characterize children's usual total sedentary time and patterns, preferably including one weekend day.	[Chinapaw, Mai J. M.; Altenburg, Teatske M.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Chinapaw, Mai J. M.; Brug, Johannes; Altenburg, Teatske M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [de Niet, Mark] Sci Support, Utrecht, Netherlands; [Verloigne, Maite; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Ghent University; Vrije Universiteit Amsterdam	Chinapaw, MJM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	m.chinapaw@vumc.nl	De+Bourdeaudhuij, Ilse/AAC-5528-2019; Paw, Mai Chin A/N-1665-2019; Akkal, Maureen/P-6919-2014; Brug, Johannes/A-8242-2018; Altenburg, Teatske/S-2059-2016	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Paw, Mai Chin A/0000-0001-6259-2441; Brug, Johannes/0000-0002-1904-7349; Altenburg, Teatske/0000-0002-8764-5631	European Commission; Netherlands Organization for Health Research and Development (ZonMw) [91211057]; Swiss Federal Office for Sport (BASPO); Swiss Federal Office of Public Health (BAG)	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Swiss Federal Office for Sport (BASPO); Swiss Federal Office of Public Health (BAG)	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7, http://cordis.europa.eu/fp7/home_en.html) of the European Commission, HEALTH (FP7-HEALTH-2007-8). The contributions of MC and TA were funded by the Netherlands Organization for Health Research and Development (ZonMw projectnr 91211057). The Swiss part of the ENERGY-project was funded by the Swiss Federal Office for Sport (BASPO) and the Swiss Federal Office of Public Health (BAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg TM, 2013, J APPL PHYSIOL, V115, P1751, DOI 10.1152/japplphysiol.00662.2013; Brug J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-276; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Colley RC, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-200, 10.1186/1471-2458-13-554]; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Fischer C, 2012, PEDIATR EXERC SCI, V24, P220, DOI 10.1123/pes.24.2.220; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Lubans DR, 2011, OBES REV, V12, P781, DOI 10.1111/j.1467-789X.2011.00896.x; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Saunders TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079143; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Toftager M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-140; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Yildirim M, 2011, BMC PUBLIC HEALTH, V11, P182	27	66	67	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111205	10.1371/journal.pone.0111205	http://dx.doi.org/10.1371/journal.pone.0111205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369021	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000043
J	Ikemori, RY; Machado, CML; Furuzawa, KM; Nonogaki, S; Osinaga, E; Umezawa, K; de Carvalho, MA; Verinaud, L; Chammas, R				Ikemori, Rafael Yamashita; Longo Machado, Camila Maria; Furuzawa, Karina Mie; Nonogaki, Suely; Osinaga, Eduardo; Umezawa, Kazuo; de Carvalho, Marcelo Alex; Verinaud, Liana; Chammas, Roger			Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival	PLOS ONE			English	Article							NF-KAPPA-B; CYTOCHROME-C RELEASE; ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; PROSTATE-CANCER; BINDING-PROTEIN; INDUCIBLE FACTOR-1-ALPHA; PILOCYTIC ASTROCYTOMAS; LGALS3 GALECTIN-3; EPITHELIAL-CELLS	Galectin-3 (gal-3) is a beta-galactoside binding protein related to many tumoral aspects, e. g. angiogenesis, cell growth and motility and resistance to cell death. Evidence has shown its upregulation upon hypoxia, a common feature in solid tumors such as glioblastoma multiformes (GBM). This tumor presents a unique feature described as pseudopalisading cells, which accumulate large amounts of gal-3. Tumor cells far from hypoxic/nutrient deprived areas express little, if any gal-3. Here, we have shown that the hybrid glioma cell line, NG97ht, recapitulates GBM growth forming gal-3 positive pseudopalisades even when cells are grafted subcutaneously in nude mice. In vitro experiments were performed exposing these cells to conditions mimicking tumor areas that display oxygen and nutrient deprivation. Results indicated that gal-3 transcription under hypoxic conditions requires previous protein synthesis and is triggered in a HIF-1 alpha and NF-kappa B dependent manner. In addition, a significant proportion of cells die only when exposed simultaneously to hypoxia and nutrient deprivation and demonstrate ROS induction. Inhibition of gal-3 expression using siRNA led to protein knockdown followed by a 1.7-2.2 fold increase in cell death. Similar results were also found in a human GBM cell line, T98G. In vivo, U87MG gal-3 knockdown cells inoculated subcutaneously in nude mice demonstrated decreased tumor growth and increased time for tumor engraftment. These results indicate that gal-3 protected cells from cell death under hypoxia and nutrient deprivation in vitro and that gal-3 is a key factor in tumor growth and engraftment in hypoxic and nutrient-deprived microenvironments. Overexpression of gal-3, thus, is part of an adaptive program leading to tumor cell survival under these stressing conditions.	[Ikemori, Rafael Yamashita; Longo Machado, Camila Maria; Furuzawa, Karina Mie; Chammas, Roger] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Longo Machado, Camila Maria] Lab Invest Med Med Nucl LIM43, Sao Paulo, Brazil; [Nonogaki, Suely] Adolfo Lutz Inst, Dept Patol, Sao Paulo, Brazil; [Osinaga, Eduardo] La Univ La Republ, Fac Med, Montevideo, Uruguay; [Umezawa, Kazuo] Aichi Med Univ, Nagakute, Aichi 48011, Japan; [de Carvalho, Marcelo Alex] Inst Fed Rio de Janeiro, Inst Nacl Canc, Rio De Janeiro, RJ, Brazil; [Verinaud, Liana] Univ Estadual Campinas, Inst Biol, Dept Microbiol & Immunol, Campinas, SP, Brazil	Universidade de Sao Paulo; Instituto Adolfo Lutz; Universidad de la Republica, Uruguay; Aichi Medical University; Instituto Federal do Rio de Janeiro (IFRJ); National Cancer Institute (Inca); Universidade de Sao Paulo; Universidade Estadual de Campinas	Ikemori, RY (corresponding author), Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil.	rafaelikemori@lim24.fm.usp.br; rchammas@lim24.fm.usp.br	machado, camila/AAH-5488-2019; Carvalho, Marcelo A/J-7144-2012; Carvalho, Marcelo/T-2014-2019; Ikemori, Rafael/F-4075-2016; Chammas, Roger/A-8004-2011; Machado, Camila/C-4077-2012	Carvalho, Marcelo A/0000-0002-7053-0053; Ikemori, Rafael/0000-0002-8825-3947; Chammas, Roger/0000-0003-0342-8726; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes-UDELAR);  [CEPID 98/14247-6];  [FAPESP 2009/10857-0];  [INCT-Redoxoma]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes-UDELAR); ; ; 	Contract grant sponsor: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes-UDELAR). Contract grant number: CEPID 98/14247-6, FAPESP 2009/10857-0 and INCT-Redoxoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahani S, 1997, CANCER RES, V57, P5272; Araya R, 1998, FEBS LETT, V439, P168, DOI 10.1016/S0014-5793(98)01363-5; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brat DJ, 2004, LAB INVEST, V84, P397, DOI 10.1038/labinvest.3700070; Bresalier RS, 1997, CANCER, V80, P776; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Camby I, 2001, BRAIN PATHOL, V11, P12; Carvalho RS, 2014, CANCER BIOL THER, V15, P840, DOI 10.4161/cbt.28873; Celegato M, 2014, CANCER LETT, V349, P26, DOI 10.1016/j.canlet.2014.03.030; Chen HJ, 2012, NEUROSCI LETT, V518, P1, DOI 10.1016/j.neulet.2012.02.065; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; D'Haene N, 2014, GLYCOBIOLOGY, V24, P892, DOI 10.1093/glycob/cwu049; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; de Souza GA, 2006, PROTEOMICS, V6, P1460, DOI 10.1002/pmic.200500243; Debray C, 2004, BIOCHEM BIOPH RES CO, V325, P1393, DOI 10.1016/j.bbrc.2004.10.181; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Dumont P, 2008, LAB INVEST, V88, P896, DOI 10.1038/labinvest.2008.54; Ellerhorst JA, 2002, PROSTATE, V50, P64, DOI 10.1002/pros.10033; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Gordower L, 1999, NEUROPATH APPL NEURO, V25, P319; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Grippo MC, 2001, CELL MOL NEUROBIOL, V21, P421, DOI 10.1023/A:1012662423863; Hill M, 2010, J HISTOCHEM CYTOCHEM, V58, P553, DOI 10.1369/jhc.2010.955237; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Hu R, 2007, PLACENTA, V28, P399, DOI 10.1016/j.placenta.2006.07.005; HUFLEJT ME, 1993, J BIOL CHEM, V268, P26712; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kadrofske MM, 1998, ARCH BIOCHEM BIOPHYS, V349, P7, DOI 10.1006/abbi.1997.0447; Kanaya K, 2003, BIOCHEM BIOPH RES CO, V306, P750, DOI 10.1016/S0006-291X(03)01041-6; Kim DW, 2008, CANCER SCI, V99, P1884, DOI 10.1111/j.1349-7006.2008.00901.x; Kim SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025103; Kobayashi T, 2011, INT J CANCER, V129, P2775, DOI 10.1002/ijc.25946; Kuklinski S, 2000, J NEUROSCI RES, V60, P45, DOI 10.1002/(SICI)1097-4547(20000401)60:1<45::AID-JNR5>3.0.CO;2-Y; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Le Mercier M, 2010, BRAIN PATHOL, V20, P17, DOI 10.1111/j.1750-3639.2009.00270.x; Li X, 2010, CELL DEATH DIFFER, V17, P1277, DOI 10.1038/cdd.2010.8; Lin HM, 2002, ONCOGENE, V21, P8001, DOI 10.1038/sj.onc.1205820; Machado CML, 2014, CANCER MED-US, V3, P201, DOI 10.1002/cam4.173; Machado CML, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-291; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Matarrese P, 2000, FEBS LETT, V473, P311, DOI 10.1016/S0014-5793(00)01547-7; Mazurek N, 2000, J BIOL CHEM, V275, P36311, DOI 10.1074/jbc.M003831200; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; Melvin A, 2011, CELL CYCLE, V10, P879, DOI 10.4161/cc.10.6.14910; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Neder L, 2004, BRAIN PATHOL, V14, P399; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Paron I, 2003, BIOCHEM BIOPH RES CO, V302, P545, DOI 10.1016/S0006-291X(03)00151-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccolo E, 2013, J MOL MED, V91, P83, DOI 10.1007/s00109-012-0936-6; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Roskams J, 2002, LAB REF HDB RECIPES; Rovetta F, 2013, TOXICOL APPL PHARM, V271, P196, DOI 10.1016/j.taap.2013.05.005; Silva-Monteiro E, 2007, AM J PATHOL, V170, P546, DOI 10.2353/ajpath.2007.060389; Sondergaard KL, 2002, NEUROPATH APPL NEURO, V28, P210, DOI 10.1046/j.1365-2990.2002.00391.x; Song SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042699; Song YK, 2002, AM J PATHOL, V160, P1069, DOI 10.1016/S0002-9440(10)64927-9; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; Strik HM, 2001, J NEURO-ONCOL, V53, P13, DOI 10.1023/A:1011874800612; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Umezawa K, 2002, MOL CELLS, V14, P163; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M; Vladimirova V, 2008, J NEUROSCI RES, V86, P2450, DOI 10.1002/jnr.21686; Wagner M, 1997, PATHOBIOLOGY, V65, P241, DOI 10.1159/000164135; Yamazaki K, 2001, BIOCHEM BIOPH RES CO, V280, P1077, DOI 10.1006/bbrc.2000.4193; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Zeno S, 2009, BIOCHEMISTRY-US, V48, P4652, DOI 10.1021/bi900064t; Zhang HY, 2009, ENDOCRINE, V35, P101, DOI 10.1007/s12020-008-9129-z; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	82	47	48	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111592	10.1371/journal.pone.0111592	http://dx.doi.org/10.1371/journal.pone.0111592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369297	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000071
J	Krammer, R; Heinzerling, L				Krammer, Ramona; Heinzerling, Lucie			Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls	PLOS ONE			English	Article							CELL LUNG-CANCER; IPILIMUMAB; CARE; CHEMOTHERAPY; COST; MELANOGENESIS; DECISIONS; VIEWS; AGE	Background: New melanoma therapies, like e. g. ipilimumab, improve survival. However, only a small subset of patients benefits while 60% encounter side effects. Furthermore, these marginal benefits come at a very high price of (sic)110'000 per treatment. This study examines attitudes towards melanoma therapy options of physicians, healthy individuals and patients, their willingness to pay and preference of quality versus length of life. Methods: Based on findings from a focus group questionnaires were developed and pretested. After obtaining ethical approval and informed consent surveys were conducted in a total of 90 participants (n = 30 for each group). Statistical analyses were conducted using R. Findings: Attitudes vastly differed between healthy participants, physicians and melanoma patients. Whereas melanoma patients show a high willingness to endure side effects despite very small survival gains (down to 1 extra week) or even only hope with no survival benefit, healthy controls are more critical, while physicians are the most therapy adverse. Consequently, if given (sic)100'000 and the free decision what to spend the money on the willingness to pay for therapy was much higher in the patient group (68%) compared to 28% of healthy controls and only 43% of the physicians, respectively. When lowering the amount of cash that could be received instead of ipilimumab to (sic)50'000 or (sic)10'000 to test price sensitivity 69% (+1%) and 76% (+8%) of melanoma patients, respectively, preferred ipilimumab over cash. When judging on societal spending even melanoma patients opted for spending on ipilimumab in only 21%. Conclusion: The judgment about the benefits of new treatment options largely differs between groups, physicians being the most critical against therapy. Price elasticity was low.	[Krammer, Ramona] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Krammer, Ramona; Heinzerling, Lucie] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Heinzerling, L (corresponding author), Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany.	lheinzer@post.harvard.edu		, lucie/0000-0003-4587-007X	'Verein zur Forderung des Tumorzentrums', Germany	'Verein zur Forderung des Tumorzentrums', Germany	This work was supported by the 'Verein zur Forderung des Tumorzentrums', Germany. This is a small non-profit organization that sponsors research projects in cancer. None of the authors have a financial relationship with the organization that sponsored the research. RK has received grants for material used for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboni T, 2011, CANCER-AM CANCER SOC, V117, P5383, DOI 10.1002/cncr.26221; Bisht M, 2010, INDIAN J MED PAEDIAT, V31, P121, DOI 10.4103/0971-5851.76194; Bosanquet N, 2004, LANCET ONCOL, V5, P568, DOI 10.1016/S1470-2045(04)01569-4; Bridges JFP, 2012, LUNG CANCER, V77, P224, DOI 10.1016/j.lungcan.2012.01.016; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; Dranitsaris G, 2004, PHARMACOECONOMICS, V22, P375, DOI 10.2165/00019053-200422060-00004; Farolfi A, 2012, MELANOMA RES, V22, P263, DOI 10.1097/CMR.0b013e328353e65c; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Foster JA, 2010, ONCOLOGIST, V15, P584, DOI 10.1634/theoncologist.2009-0198; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurley KE, 2005, ONCOLOGIST, V10, P739, DOI 10.1634/theoncologist.10-9-739; Jenkins Valerie A, 2011, JRSM Short Rep, V2, P69, DOI 10.1258/shorts.2011.011050; Kuchuk I, 2013, BREAST CANCER RES TR, V142, P101, DOI 10.1007/s10549-013-2727-3; Lakdawalla DN, 2012, HEALTH AFFAIR, V31, P676, DOI 10.1377/hlthaff.2011.1300; Leonard RC, 2010, ONCOLOGIST, V15, P657, DOI 10.1634/theoncologist.2009-0284; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Maciejewski PK, 2012, PSYCHO-ONCOLOGY, V21, P714, DOI 10.1002/pon.1967; Mullins CD, 2010, ONCOLOGIST, V15, P58, DOI 10.1634/theoncologist.2010-S1-58; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Prieto PA, 2012, CLIN CANCER RES, V18, P2039, DOI 10.1158/1078-0432.CCR-11-1823; Ramers-Verhoeven CW, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.349; Ramsey S, 2010, ONCOLOGIST, V15, P1, DOI 10.1634/theoncologist.2010-S1-1; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schickedanz A, 2010, ONCOLOGIST, V15, P73, DOI 10.1634/theoncologist.2010-S1-73; Schildmann J, 2013, ONCOLOGIST, V18, P90, DOI 10.1634/theoncologist.2012-0206; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009; Stiggelbout AM, 1996, MED DECIS MAKING, V16, P184, DOI 10.1177/0272989X9601600211; Sun CC, 2002, GYNECOL ONCOL, V87, P118, DOI 10.1006/gyno.2002.6807; Tarhini A, 2010, CANCER BIOTHER RADIO, V25, P601, DOI 10.1089/cbr.2010.0865; Voskens CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053745	36	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111237	10.1371/journal.pone.0111237	http://dx.doi.org/10.1371/journal.pone.0111237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369124	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000045
J	Verdonck, P; Kalmar, AF; Suy, K; Geeraerts, T; Vercauteren, M; Mottrie, A; De Wolf, AM; Hendrickx, JFA				Verdonck, Philip; Kalmar, Alain F.; Suy, Koen; Geeraerts, Thomas; Vercauteren, Marcel; Mottrie, Alex; De Wolf, Andre M.; Hendrickx, Jan F. A.			Optic Nerve Sheath Diameter Remains Constant during Robot Assisted Laparoscopic Radical Prostatectomy	PLOS ONE			English	Article							INCREASED INTRACRANIAL-PRESSURE; STEEP TRENDELENBURG POSITION; HEAD-DOWN TILT; CEREBRAL OXYGENATION; CO2 PNEUMOPERITONEUM; OCULAR SONOGRAPHY; ANIMAL-MODEL; BRAIN-INJURY; ULTRASONOGRAPHY; HEMODYNAMICS	Background: During robot assisted laparoscopic radical prostatectomy (RALRP), a CO2 pneumoperitoneum (CO2PP) is applied and the patient is placed in a head-down position. Intracranial pressure (ICP) is expected to acutely increase under these conditions. A non-invasive method, the optic nerve sheath diameter (ONSD) measurement, may warn us that the mechanism of protective cerebrospinal fluid (CSF) shifts becomes exhausted. Methods: After obtaining IRB approval and written informed consent, ONSD was measured by ocular ultrasound in 20 ASA I-II patients at various stages of the RALRP procedure: baseline awake, after induction, after applying the CO2PP, during head-down position, after resuming the supine position, in the postoperative anaesthesia care unit, and on day one postoperatively. Cerebral perfusion pressure (CPP) was calculated as the mean arterial (MAP) minus central venous pressure (CVP). Results: The ONSD did not change during head-down position, although the CVP increased from 4.2(2.5) mm Hg to 27.6(3.8) mm Hg. The CPP was decreased 70 min after assuming the head-down position until 15 min after resuming the supine position, but remained above 60 mm Hg at all times. Conclusion: Even though ICP has been documented to increase during CO2PP and head-down positioning, we did not find any changes in ONSD during head-down position. These results indicate that intracranial blood volume does not increase up to a point that CSF migration as a compensation mechanism becomes exhausted, suggesting any increases in ICP are likely to be small.	[Verdonck, Philip; Vercauteren, Marcel] Univ Antwerp Hosp, Dept Anaesthesiol, Edegem, Belgium; [Kalmar, Alain F.] Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, Groningen, Netherlands; [Suy, Koen; Hendrickx, Jan F. A.] OLV Clin, Dept Anaesthesiol & Intens Care Med, Aalst, Belgium; [Geeraerts, Thomas] Univ Paul Sabatier, Univ Hosp Toulouse, Dept Anaesthesiol & Crit care, Toulouse, France; [Mottrie, Alex] OLV Clin, Dept Urol, Aalst, Belgium; [De Wolf, Andre M.] Northwestern Univ, Feinberg Sch Med, Dept Anaesthesiol, Chicago, IL 60611 USA; [Mottrie, Alex] OLV Vattikuti Robot Surg Inst, Melle, Belgium	University of Antwerp; University of Groningen; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Northwestern University; Feinberg School of Medicine	Kalmar, AF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, Groningen, Netherlands.	A.Kalmar@umcg.nl		mottrie, alexandre/0000-0002-1253-1592; Kalmar, Alain/0000-0003-2036-9019	Department of Anaesthesiology and Intensive care medicine, OLV Clinic, Aalst, Belgium	Department of Anaesthesiology and Intensive care medicine, OLV Clinic, Aalst, Belgium	The authors received no specific funding for this work. This study was solely supported by departmental and institutional funding: Department of Anaesthesiology and Intensive care medicine, OLV Clinic, Aalst, Belgium. Moorselbaan 164, 9300 Aalst, Belgium. No individuals other than the named authors played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current funding sources for this study were used other than institutional fundings.	Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Brosnan RJ, 2002, J APPL PHYSIOL, V92, P2542, DOI 10.1152/japplphysiol.00055.2002; Closhen D, 2014, EUR J ANAESTH, V31, P104, DOI 10.1097/EJA.0000000000000000; Danic MJ, 2007, J ROBOT SURG, V1, P119, DOI 10.1007/s11701-007-0024-z; Doi M, 1998, JPN J PHYSIOL, V48, P63, DOI 10.2170/jjphysiol.48.63; Eklund A, 2007, MED BIOL ENG COMPUT, V45, P719, DOI 10.1007/s11517-007-0199-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ficarra V, 2009, EUR UROL, V55, P1037, DOI 10.1016/j.eururo.2009.01.036; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI [10.1186/cc6893, 10.1186/cc7006]; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Haas S, 2011, INT J MED ROBOT COMP, V7, P408, DOI 10.1002/rcs.410; Halverson A, 1998, SURG ENDOSC, V12, P266, DOI 10.1007/s004649900648; Halverson AL, 1999, SURG ENDOSC-ULTRAS, V13, P797, DOI 10.1007/s004649901102; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Jeong H, 2012, ACTA ANAESTH SCAND, V56, P872, DOI 10.1111/j.1399-6576.2012.02716.x; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; Kalmar AF, 2012, BRIT J ANAESTH, V108, P478, DOI 10.1093/bja/aer448; Kalmar AF, 2010, BRIT J ANAESTH, V104, P433, DOI 10.1093/bja/aeq018; Kalmar AF, 2009, BRIT J ANAESTH, V102, P361, DOI 10.1093/bja/aen381; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kim MS, 2014, J ENDOUROL, V28, P801, DOI 10.1089/end.2014.0019; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kotani J, 1992, Anesth Prog, V39, P209; Mavrocordatos P, 2000, J NEUROSURG ANESTH, V12, P10, DOI 10.1097/00008506-200001000-00003; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Munis JR, 2000, J NEUROSURG ANESTH, V12, P290, DOI 10.1097/00008506-200007000-00029; MUNK PL, 1991, AM J ROENTGENOL, V157, P1079, DOI 10.2214/ajr.157.5.1927796; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Pandey R, 2010, Acta Anaesthesiol Belg, V61, P163; Rollins M, 2012, ANESTHESIOLOGY, V116, P983, DOI 10.1097/ALN.0b013e31824c16e4; Rosenthal RJ, 1997, SURG ENDOSC, V11, P376, DOI 10.1007/s004649900367; Shimoyama R, 2000, JPN J PHYSIOL, V50, P141, DOI 10.2170/jjphysiol.50.141; Shimoyama R, 2000, J GRAVIT PHYSL, V7, P83; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tatebayashi K, 2003, BRAIN RES, V977, P55, DOI 10.1016/S0006-8993(03)02723-9; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040	38	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111916	10.1371/journal.pone.0111916	http://dx.doi.org/10.1371/journal.pone.0111916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369152	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000125
J	Perez, R; Calleros, L; Marandino, A; Sarute, N; Iraola, G; Grecco, S; Blanc, H; Vignuzzi, M; Isakov, O; Shomron, N; Carrau, L; Hernandez, M; Francia, L; Sosa, K; Tomas, G; Panzera, Y				Perez, Ruben; Calleros, Lucia; Marandino, Ana; Sarute, Nicolas; Iraola, Gregorio; Grecco, Sofia; Blanc, Herve; Vignuzzi, Marco; Isakov, Ofer; Shomron, Noam; Carrau, Lucia; Hernandez, Martin; Francia, Lourdes; Sosa, Katia; Tomas, Gonzalo; Panzera, Yanina			Phylogenetic and Genome-Wide Deep-Sequencing Analyses of Canine Parvovirus Reveal Co-Infection with Field Variants and Emergence of a Recent Recombinant Strain	PLOS ONE			English	Article							GENETIC DIVERSITY; VP2 GENE; EVOLUTION; FELINE; VIRUS; TYPE-2; REPLICATION; REPLACEMENT; INFECTIONS; ALIGNMENT	Canine parvovirus (CPV), a fast-evolving single-stranded DNA virus, comprises three antigenic variants (2a, 2b, and 2c) with different frequencies and genetic variability among countries. The contribution of co-infection and recombination to the genetic variability of CPV is far from being fully elucidated. Here we took advantage of a natural CPV population, recently formed by the convergence of divergent CPV-2c and CPV-2a strains, to study co-infection and recombination. Complete sequences of the viral coding region of CPV-2a and CPV-2c strains from 40 samples were generated and analyzed using phylogenetic tools. Two samples showed co-infection and were further analyzed by deep sequencing. The sequence profile of one of the samples revealed the presence of CPV-2c and CPV-2a strains that differed at 29 nucleotides. The other sample included a minor CPV-2a strain (13.3% of the viral population) and a major recombinant strain (86.7%). The recombinant strain arose from inter-genotypic recombination between CPV-2c and CPV-2a strains within the VP1/VP2 gene boundary. Our findings highlight the importance of deep-sequencing analysis to provide a better understanding of CPV molecular diversity.	[Perez, Ruben; Calleros, Lucia; Marandino, Ana; Sarute, Nicolas; Iraola, Gregorio; Grecco, Sofia; Carrau, Lucia; Hernandez, Martin; Francia, Lourdes; Sosa, Katia; Tomas, Gonzalo; Panzera, Yanina] Univ Republica, Fac Ciencias, Inst Biol, Secc Genet Evolut, Montevideo, Uruguay; [Blanc, Herve; Vignuzzi, Marco] CNRS, Viral Populat & Pathogenesis Unit, Inst Pasteur, Paris, France; [Isakov, Ofer; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Universidad de la Republica, Uruguay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Tel Aviv University; Sackler Faculty of Medicine	Perez, R (corresponding author), Univ Republica, Fac Ciencias, Inst Biol, Secc Genet Evolut, Montevideo, Uruguay.	rperez@fcien.edu.uy	Perez, Ruben/AAU-1516-2020; Iraola, Gregorio/L-6539-2019; Sarute, Nicolas/AAK-4259-2020; Tomás, Gonzalo/ABA-1513-2020	Iraola, Gregorio/0000-0002-6516-3404; Vignuzzi, Marco/0000-0002-4400-771X; Perez, Ruben/0000-0003-4961-4743; Calleros, Lucia/0000-0003-1456-6112; Grecco, Sofia/0000-0002-4091-5526; Sarute, Nicolas/0000-0001-6432-1880; Carrau, Lucia/0000-0003-0260-2841	Comision Sectorial de Investigacion Cientifica (CSIC) [2206]; French Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]	Comision Sectorial de Investigacion Cientifica (CSIC); French Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases(French National Research Agency (ANR))	Grant number: 2206, Comision Sectorial de Investigacion Cientifica (CSIC) (http://www.csic.edu.uy/) to KS. Grant number ANR-10-LABX-62-IBEID, French Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (http://www.agence-nationale-recherche.fr/investissementsdavenir/) to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBANDJE M, 1995, SEMIN VIROL, V6, P299, DOI 10.1006/smvy.1995.0036; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Battilani M, 2007, VET RES COMMUN, V31, P209, DOI 10.1007/s11259-007-0007-6; Battilani M, 2006, VIROLOGY, V352, P22, DOI 10.1016/j.virol.2006.06.002; Battilani M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-43; Bay RA, 2011, J MOL EVOL, V73, P273, DOI 10.1007/s00239-011-9473-0; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Clegg SR, 2011, J VIROL, V85, P7892, DOI 10.1128/JVI.01576-10; Cotmore SF, 2006, PARVOVIRUSES, P171; Decaro N, 2005, J VET DIAGN INVEST, V17, P133, DOI 10.1177/104063870501700206; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Doki M, 2006, COMP IMMUNOL MICROB, V29, P199, DOI 10.1016/j.cimid.2006.05.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoelzer K, 2008, J VIROL, V82, P11096, DOI 10.1128/JVI.01003-08; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson MK, 1996, AM J VET RES, V57, P1753; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin Chao-Nan, 2014, Taiwan Veterinary Journal, V40, P1, DOI 10.1142/S1682648514500012; Lopez-Bueno A, 2006, CURR TOP MICROBIOL, V299, P349; Martin DP, 2011, VIRUSES-BASEL, V3, P1699, DOI 10.3390/v3091699; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Maya L, 2013, ARCH VIROL, V158, P1133, DOI 10.1007/s00705-012-1591-5; Mengeling WL, 2000, ANIM REPROD SCI, V60, P199, DOI 10.1016/S0378-4320(00)00135-4; Mochizuki M, 2008, J VET MED SCI, V70, P1305, DOI 10.1292/jvms.70.1305; Moon HS, 2008, VET MICROBIOL, V131, P47, DOI 10.1016/j.vetmic.2008.02.016; Nelson CDS, 2007, VIROLOGY, V361, P283, DOI 10.1016/j.virol.2006.11.032; Ohshima T, 2009, J VET MED SCI, V71, P403, DOI 10.1292/jvms.71.403; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1988, J GEN VIROL, V69, P1111, DOI 10.1099/0022-1317-69-5-1111; PARRISH CR, 1988, VIROLOGY, V166, P293, DOI 10.1016/0042-6822(88)90500-4; Perez R, 2012, VET MICROBIOL, V155, P214, DOI 10.1016/j.vetmic.2011.09.017; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, FIGTREE VER 1 3 1 TR; REED AP, 1988, J VIROL, V62, P266, DOI 10.1128/JVI.62.1.266-276.1988; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; TATTERSALL P, 1976, NATURE, V263, P106, DOI 10.1038/263106a0; Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; Wang D, 1998, VIROLOGY, V240, P273, DOI 10.1006/viro.1997.8946; Wang JK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-252	48	61	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111779	10.1371/journal.pone.0111779	http://dx.doi.org/10.1371/journal.pone.0111779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365348	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100119
J	Haraguchi, A; Hayashida, N; Kamasaki, T; Miyamoto, I; Usui, T; Ando, T; Abiru, N; Yamasaki, H; Chiba, K; Kudo, T; Kawakami, A; Takamura, N				Haraguchi, Ai; Hayashida, Naomi; Kamasaki, Toshihiko; Miyamoto, Izumi; Usui, Toshiya; Ando, Takao; Abiru, Norio; Yamasaki, Hironori; Chiba, Kenya; Kudo, Takashi; Kawakami, Atsushi; Takamura, Noboru			Uptake of Aortic F-18-FDG Is Correlated with Low-Density Lipoprotein Cholesterol and Leptin in a General Population	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ATHEROSCLEROTIC PLAQUE INFLAMMATION; INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; FDG UPTAKE; RISK; PET/CT; ADIPOKINES; DISEASE	Objective: This study investigated the relationship between aortic F-18-fluoro-2-deoxy-D-glucose (F-18-FDG) uptake and clinical and laboratory findings related to atherosclerosis in a general population. Methods: F-18-FDG uptake in the ascending aorta was measured on the positron emission tomography/computed tomography (PET/CT) scans of 211 Japanese adults. The maximum target-to-background ratio (TBR) was compared with clinical and laboratory atherosclerosis findings. Results: By multivariate regression analysis adjusted for age and sex, TBR-ascending aorta (TBR-A) was significantly correlated with various clinical and laboratory parameters, such as body mass index, log visceral fat area, low-density lipoprotein cholesterol (LDL-C), log fasting immunoreactive insulin, log homeostasis model assessment of insulin resistance, log total adiponectin and log-leptin, in all subjects. Furthermore, by multivariate linear regression analysis adjusted for confounding factors, TBR-A was significantly correlated with LDL-C (beta = 0.001, p = 0.03) and log-leptin (beta = 0.336, p < 0.01) in all subjects. Conclusion: TBR-A was significantly correlated with LDL-C and log-leptin independent from confounding factors. Our results suggest that aortic F-18-FDG uptake is a good marker of atherosclerosis, even in a general population.	[Haraguchi, Ai; Hayashida, Naomi; Kamasaki, Toshihiko; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Haraguchi, Ai; Ando, Takao; Abiru, Norio; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Endocrinol & Metab, Nagasaki 852, Japan; [Kudo, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Yamasaki, Hironori] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki 852, Japan; [Kamasaki, Toshihiko; Miyamoto, Izumi; Usui, Toshiya; Chiba, Kenya] Nishi Isahaya Hosp, PET CT Diagnost Imaging Ctr, Isahaya, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp		Takamura, Noboru/0000-0002-5552-3234	Grants-in-Aid for Scientific Research [26305025] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Ben-Haim S, 2004, J NUCL MED, V45, P1816; Bural GG, 2008, EUR J NUCL MED MOL I, V35, P562, DOI 10.1007/s00259-007-0528-9; Chiba K, 2010, INT SURG, V95, P197; Dubey L, 2008, INT J CARDIOL, V126, P183, DOI 10.1016/j.ijcard.2007.03.126; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ference BA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0312-1; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Kamasaki T, 2014, NUCL MED COMMUN, V35, P44, DOI 10.1097/MNM.0000000000000029; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindholm H, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-50; LINDHOLM P, 1993, J NUCL MED, V34, P1; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Minami Shigeki, 2007, Acta Medica Nagasakiensia, V52, P59; Montecchi FR, 2001, DIABETES NUTR METAB, V14, P58; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Nichols WW, 1999, NEW ENGL J MED, V340, P1762; Noh TS, 2013, J NUCL MED, V54, P2070, DOI 10.2967/jnumed.113.119602; Pasterkamp G, 1998, J AM COLL CARDIOL, V32, P655, DOI 10.1016/S0735-1097(98)00304-0; Roemmich JN, 1998, AM J PHYSIOL-ENDOC M, V275, pE543, DOI 10.1152/ajpendo.1998.275.3.E543; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothwell PM, 2000, CEREBROVASC DIS, V10, P21, DOI 10.1159/000047601; Rudd JHF, 2007, J AM COLL CARDIOL, V50, P892, DOI 10.1016/j.jacc.2007.05.024; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Schneiderman J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001727; Sierra-Johnson J, 2007, AM J CARDIOL, V100, P234, DOI 10.1016/j.amjcard.2007.02.088; Tahara N, 2007, J AM COLL CARDIOL, V49, P1533, DOI 10.1016/j.jacc.2006.11.046; Tahara N, 2006, J AM COLL CARDIOL, V48, P1825, DOI 10.1016/j.jacc.2006.03.069; Takamura N, 2010, BIOMARKERS, V15, P340, DOI 10.3109/13547501003735532; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; Yang SJ, 2013, INT J CARDIOL, V163, P277, DOI 10.1016/j.ijcard.2011.06.054; Yoo HJ, 2011, J NUCL MED, V52, P10, DOI 10.2967/jnumed.110.080838; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111990	10.1371/journal.pone.0111990	http://dx.doi.org/10.1371/journal.pone.0111990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375161	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600090
J	Biraro, IA; Egesa, M; Toulza, F; Levin, J; Cose, S; Joloba, M; Smith, S; Dockrell, HM; Katamba, A; Elliott, AM				Biraro, Irene A.; Egesa, Moses; Toulza, Frederic; Levin, Jonathan; Cose, Stephen; Joloba, Moses; Smith, Steven; Dockrell, Hazel M.; Katamba, Achilles; Elliott, Alison M.			Impact of Co-Infections and BCG Immunisation on Immune Responses among Household Contacts of Tuberculosis Patients in a Ugandan Cohort	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; HELMINTHIC INFECTIONS; LATENT TUBERCULOSIS; HIV-INFECTION; PULMONARY TUBERCULOSIS; SCHISTOSOMA-MANSONI; CALMETTE-GUERIN; ANTIGENS	Background: Tuberculosis incidence in resource poor countries remains high. We hypothesized that immune modulating co-infections such as helminths, malaria, and HIV increase susceptibility to latent tuberculosis infection (LTBI), thereby contributing to maintaining the tuberculosis epidemic. Methods: Adults with sputum-positive tuberculosis (index cases) and their eligible household contacts (HHCs) were recruited to a cohort study between May 2011 and January 2012. HHCs were investigated for helminths, malaria, and HIV at enrolment. HHCs were tested using the QuantiFERON-TB Gold In-Tube (QFN) assay at enrolment and six months later. Overnight whole blood culture supernatants from baseline QFN assays were analyzed for cytokine responses using an 11-plex Luminex assay. Associations between outcomes (LTBI or cytokine responses) and exposures (co-infections and other risk factors) were examined using multivariable logistic and linear regression models. Results: We enrolled 101 index cases and 291 HHCs. Among HHCs, baseline prevalence of helminths was 9% (25/291), malaria 16% (47/291), HIV 6% (16/291), and LTBI 65% (179/277). Adjusting for other risk factors and household clustering, there was no association between LTBI and any co-infection at baseline or at six months: adjusted odds ratio (95% confidence interval (CI); p-value) at baseline for any helminth, 1.01 (0.39-2.66; 0.96); hookworm, 2.81 (0.56-14.14; 0.20); malaria, 1.06 (0.48-2.35; 0.87); HIV, 0.74 (0.22-2.47; 0.63). HHCs with LTBI had elevated cytokine responses to tuberculosis antigens but co-infections had little effect on cytokine responses. Exploring other risk factors, Th1 cytokines among LTBI-positive HHCs with BCG scars were greatly reduced compared to those without scars: (adjusted geometric mean ratio) IFN gamma 0.20 (0.09-0.42), <0.0001; IL-2 0.34 (0.20-0.59), <0.0001; and TNF alpha 0.36 (0.16-0.79), 0.01. Conclusions: We found no evidence that co-infections increase the risk of LTBI, or influence the cytokine response profile among those with LTBI. Prior BCG exposure may reduce Th1 cytokine responses in LTBI.	[Biraro, Irene A.; Egesa, Moses; Joloba, Moses; Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Levin, Jonathan; Cose, Stephen; Elliott, Alison M.] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Toulza, Frederic; Smith, Steven; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Cose, Stephen; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	Makerere University; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Biraro, IA (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.	andiaodanga@yahoo.com	Cose, Stephen/H-4851-2019	Cose, Stephen/0000-0002-5156-037X; Toulza, Frederic/0000-0002-1104-5795; Dockrell, Hazel/0000-0003-1869-9107; Smith, Steven/0000-0001-5623-7806; Egesa, Moses/0000-0001-5136-868X; Joloba, Moses/0000-0002-0334-9983; Elliott, Alison/0000-0003-2818-9549	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award [084344]; European Community's Seventh Framework Programme (FP7) under EC-GA [241642]; Wellcome Trust Senior Fellowship in Clinical Research [095778]	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award; European Community's Seventh Framework Programme (FP7) under EC-GA; Wellcome Trust Senior Fellowship in Clinical Research(Wellcome Trust)	This work was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by Dr. Irene Biraro, funded by a Wellcome Trust Strategic Award, grant number 084344, and by the European Community's Seventh Framework Programme (FP7/2007-2013) under EC-GA no 241642 (the IDEA consortium) (http://www.idearesearch.eu/). Professor Elliott is supported by a Wellcome Trust Senior Fellowship in Clinical Research (grant number 095778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Borkow G, 2000, B WORLD HEALTH ORGAN, V78, P1368; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Cauthen GM, 1996, AM J EPIDEMIOL, V144, P69, DOI 10.1093/oxfordjournals.aje.a008856; Cellestis, 2011, WHOL BLOOD IFN GAMM, P4; Chene A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026266; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Elias D, 2005, CLIN EXP IMMUNOL, V139, P398, DOI 10.1111/j.1365-2249.2004.02719.x; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; ELLIOTT AM, 1990, BRIT MED J, V301, P412, DOI 10.1136/bmj.301.6749.412; ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012; Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239; Engwerda CR, 2005, CURR OPIN IMMUNOL, V17, P381, DOI 10.1016/j.coi.2005.05.010; Eriksen J, 2010, THORAX, V65, P1067, DOI 10.1136/thx.2010.140186; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Essa S, 2009, TRANSPL P, V41, P1643, DOI 10.1016/j.transproceed.2008.10.098; Fleiss J.L., 2013, STAT METHODS RATES P; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Flom Peter L, 2007, P NE SAS US GROUP NE; George PJ, 2013, J IMMUNOL, V190, P5161, DOI 10.4049/jimmunol.1203311; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Gray JM, 2013, SEM RESP CRIT CAR ME, V34; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; Kabatereine NB, 2005, TROP MED INT HEALTH, V10, P1187, DOI 10.1111/j.1365-3156.2005.01509.x; Kamal SM, 2006, PARASITE IMMUNOL, V28, P483, DOI 10.1111/j.1365-3024.2006.00909.x; Karo B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-148; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; Leung CC, 2010, ARCH INTERN MED, V170, P287, DOI 10.1001/archinternmed.2009.506; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; Lodi S, 2013, THORAX, V68, P207, DOI 10.1136/thoraxjnl-2012-201740; Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553; MARKOWITZ N, 1993, ANN INTERN MED, V119, P185, DOI 10.7326/0003-4819-119-3-199308010-00002; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McGuinness D, 1997, J IMMUNOL METHODS, V201, P99, DOI 10.1016/S0022-1759(96)00216-5; Melrose WD, 2000, T ROY SOC TROP MED H, V94, P176, DOI 10.1016/S0035-9203(00)90266-9; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Ministry of Health, 2010, MAN NAT TUB LEPR PRO; Ministry of Health, 2011, UG MAL PROGR PERF RE; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Nemeth J, 2010, EUR CYTOKINE NETW, V21, P34, DOI 10.1684/ecn.2009.0182; NUNN PP, 1994, THORAX, V49, P511, DOI 10.1136/thx.49.5.511; Oni T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047072; Oni T, 2012, CLIN VACCINE IMMUNOL, V19, P1243, DOI 10.1128/CVI.00166-12; PASS RF, 1985, J INFECT DIS, V152, P243, DOI 10.1093/infdis/152.2.243; Rafi W, 2012, CURR OPIN HIV AIDS, V7, P239, DOI 10.1097/COH.0b013e3283524dc5; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; RILEY EM, 1989, AM J TROP MED HYG, V40, P141, DOI 10.4269/ajtmh.1989.40.141; RILEY EM, 1988, CLIN EXP IMMUNOL, V73, P17; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Seshadri C, 2008, East Afr Med J, V85, P442; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Silveira H, 1997, CLIN EXP IMMUNOL, V110, P26, DOI 10.1046/j.1365-2249.1997.5091407.x; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; U.S. Department of Health and Human Services, 2013, LAT TUB INF GUID PRI; UNAIDS, 2016, GLOB REP GLOB AIDS E; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 1994, WHOCTDSIP961; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; Woodburn PW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000473; World Health Organization, 2002, PREV CONTR SCHIST SO	76	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111517	10.1371/journal.pone.0111517	http://dx.doi.org/10.1371/journal.pone.0111517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372043	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900052
J	DeGabriel, JL; Moore, BD; Foley, WJ; Johnson, CN				DeGabriel, Jane L.; Moore, Ben D.; Foley, William J.; Johnson, Christopher N.			Male-Biased Predation and Its Effect on Paternity Skew and Life History in a Population of Common Brushtail Possums (Trichosurus vulpecula)	PLOS ONE			English	Article							PYTHONS MORELIA-SPILOTA; MATING SYSTEM; REPRODUCTIVE SKEW; SEX; DISPERSAL; ECOLOGY; SIZE; DIMORPHISM; MORTALITY; RATES	Differences in predation risk may exert strong selective pressures on life history strategies of populations. We investigated the potential for predation to shape male mating strategies in an arboreal folivore, the common brushtail possum (Trichosurus vulpecula Kerr). We predicted that possums in a tropical population exposed to high natural levels of predation would grow faster and reproduce earlier compared to those in temperate populations with lower predation. We trapped a population of possums in eucalypt woodland in northern Australia each month to measure life history traits and used microsatellites to genotype all individuals and assign paternity to all offspring. We observed very high levels of male-biased predation, with almost 60% of marked male possums being eaten by pythons, presumably as a result of their greater mobility due to mate-searching. Male reproductive success was also highly skewed, with younger, larger males fathering significantly more offspring. This result contrasts with previous studies of temperate populations experiencing low levels of predation, where older males were larger and the most reproductively successful. Our results suggest that in populations exposed to high levels of predation, male possums invest in increased growth earlier in life, in order to maximise their mating potential. This strategy is feasible because predation limits competition from older males and means that delaying reproduction carries a risk of failing to reproduce at all. Our results show that life histories are variable traits that can match regional predation environments in mammal species with widespread distributions.	[DeGabriel, Jane L.; Foley, William J.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [DeGabriel, Jane L.; Moore, Ben D.; Johnson, Christopher N.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [DeGabriel, Jane L.; Moore, Ben D.] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW, Australia; [Johnson, Christopher N.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia	Australian National University; James Cook University; Western Sydney University; University of Tasmania	DeGabriel, JL (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	j.degabriel@uws.edu.au	Moore, Ben/AAE-7885-2020; Foley, William J/C-8069-2009; DeGabriel, Jane/B-3373-2012; Johnson, Christopher/J-7894-2014; Moore, Ben D/C-3447-2008	Moore, Ben/0000-0002-6995-4721; Foley, William J/0000-0001-8587-1814; DeGabriel, Jane/0000-0003-1245-5291; Johnson, Christopher/0000-0002-9719-3771; Moore, Ben D/0000-0002-6995-4721	Australian Research Council [DP0449621, DP0449544]; Australian National University Graduate School Scholarship	Australian Research Council(Australian Research Council); Australian National University Graduate School Scholarship(Australian National University)	This work was supported by the Australian Research Council http://www.arc.gov.au/ Grant number DP0449621 to CNJ, DP0449544 to WJF. JLD was supported by an Australian National University Graduate School Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaine D, 2000, BEHAV PROCESS, V51, P21, DOI 10.1016/S0376-6357(00)00116-9; Arthur AD, 2012, AUSTRAL ECOL, V37, P958, DOI 10.1111/j.1442-9993.2011.02355.x; Christe P, 2006, OIKOS, V114, P381, DOI 10.1111/j.2006.0030-1299.15130.x; Clinchy M, 2004, MOL ECOL, V13, P195, DOI 10.1046/j.1365-294X.2003.02029.x; CLINCHY M, 1999, THESIS U BRIT COLUMB; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; DALY M, 1990, ANIM BEHAV, V40, P380, DOI 10.1016/S0003-3472(05)80934-0; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Efford M, 1998, J ANIM ECOL, V67, P503, DOI 10.1046/j.1365-2656.1998.00222.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fearn S, 2005, WILDLIFE RES, V32, P193, DOI 10.1071/WR04084; Fearn S, 2001, WILDLIFE RES, V28, P573, DOI 10.1071/WR00106; GORDON G, 1995, MAMMALS AUSTR, P174; Handasyde KA, 1996, WILDLIFE RES, V23, P755, DOI 10.1071/WR9960755; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Isaac JL, 2006, AUST J ZOOL, V54, P45, DOI 10.1071/ZO05060; Ji W, 2001, MOL ECOL, V10, P1527, DOI 10.1046/j.1365-294X.2001.01287.x; Kerle J. A, 2001, POSSUMS BRUSHTAILS R; KERLE JA, 1992, AUST J ZOOL, V40, P653, DOI 10.1071/ZO9920653; Kerr SE, 2005, THESIS J COOK U; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin JK, 2007, OECOLOGIA, V154, P227, DOI 10.1007/s00442-007-0823-y; Norrdahl K, 1998, ECOLOGY, V79, P226; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; Pearson D, 2002, BIOL J LINN SOC, V77, P113, DOI 10.1046/j.1095-8312.1999.00075.x; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Development Team, 2008, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sarre SD, 2000, MOL ECOL, V9, P723, DOI 10.1046/j.1365-294x.2000.00916.x; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; SLIP DJ, 1988, J HERPETOL, V22, P323, DOI 10.2307/1564156; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Taylor AC, 1998, MOL ECOL, V7, P1780, DOI 10.1046/j.1365-294x.1998.00517.x; Taylor AC, 2000, MOL ECOL, V9, P869, DOI 10.1046/j.1365-294x.2000.00941.x; Tecot SR, 2013, BEHAV ECOL, V24, P987, DOI 10.1093/beheco/art008; Thirgood S, 1999, ADV STUD BEHAV, V28, P333, DOI 10.1016/S0065-3454(08)60220-X; Waser PM, 2006, BEHAV ECOL, V17, P971, DOI 10.1093/beheco/arl034; White AM, 2007, ANIM BEHAV, V74, P349, DOI 10.1016/j.anbehav.2006.12.011; WINTER JW, 1980, AUST WILDLIFE RES, V7, P359, DOI 10.1071/WR9800359; Winter JW, 1976, THESIS U QUEENSLAND	43	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111746	10.1371/journal.pone.0111746	http://dx.doi.org/10.1371/journal.pone.0111746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372294	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000344556900072
J	Ortlieb, S; Gorzelniak, L; Nowak, D; Strobl, R; Grill, E; Thorand, B; Peters, A; Kuhn, KA; Karrasch, S; Horsch, A; Schulz, H				Ortlieb, Sandra; Gorzelniak, Lukas; Nowak, Dennis; Strobl, Ralf; Grill, Eva; Thorand, Barbara; Peters, Annette; Kuhn, Klaus A.; Karrasch, Stefan; Horsch, Alexander; Schulz, Holger			Associations between Multiple Accelerometry-Assessed Physical Activity Parameters and Selected Health Outcomes in Elderly People - Results from the KORA-Age Study	PLOS ONE			English	Article							OLDER-ADULTS; ASSESSMENT QUESTIONNAIRE; AMERICAN-COLLEGE; SPORTS-MEDICINE; PUBLIC-HEALTH; UNITED-STATES; DISABILITY; MULTIMORBIDITY; INDEX; RECOMMENDATION	Introduction: Accelerometry is an important method for extending our knowledge about intensity, duration, frequency and patterns of physical activity needed to promote health. This study has used accelerometry to detect associations between intensity levels and related activity patterns with multimorbidity and disability. Moreover, the proportion of people meeting the physical activity recommendations for older people was assessed. Methods: Physical activity was measured in 168 subjects (78 males; 65-89 years of age), using triaxial GT3X accelerometers for ten consecutive days. The associations between physical activity parameters and multimorbidity or disability was examined using multiple logistic regression models, which were adjusted for gender, age, education, smoking, alcohol consumption, lung function, nutrition and multimorbidity or disability. Results: 35.7% of the participants met the physical activity recommendations of at least 150 minutes of moderate to vigorous activity per week. Only 11.9% reached these 150 minutes, when only bouts of at least 10 minutes were counted. Differences in moderate to vigorous activity between people with and without multimorbidity or disability were more obvious when shorter bouts instead of only longer bouts were included. Univariate analyses showed an inverse relationship between physical activity and multimorbidity or disability for light and moderate to vigorous physical activity. A higher proportion of long activity bouts spent sedentarily was associated with higher risk for multimorbidity, whereas a high proportion of long bouts in light activity seemed to prevent disability. After adjustment for covariates, there were no significant associations, anymore. Conclusions: The accumulated time in moderate to vigorous physical activity seems to have a stronger relationship with health and functioning when shorter activity bouts and not only longer bouts were counted. We could not detect an association of the intensity levels or activity patterns with multimorbidity or disability in elderly people after adjustment for covariates.	[Ortlieb, Sandra; Karrasch, Stefan; Schulz, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Ortlieb, Sandra; Gorzelniak, Lukas; Kuhn, Klaus A.; Horsch, Alexander] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Nowak, Dennis; Karrasch, Stefan] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Nowak, Dennis] CPC M, Munich, Germany; [Strobl, Ralf; Grill, Eva] Univ Munich, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany; [Strobl, Ralf; Grill, Eva] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Thorand, Barbara; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Karrasch, Stefan] Tech Univ Munich, Univ Hosp, Klinikum Rechts Isar, Inst Gen Practice, D-80290 Munich, Germany; [Horsch, Alexander] Univ Tromso, Dept Comp Sci, Tromso, Norway; [Horsch, Alexander] Univ Tromso, Dept Clin Med, Tromso, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Schulz, H (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany.	schulz@helmholtz-muenchen.de	Peters, Annette/A-6117-2011; Grill, Eva/D-1875-2010; Karrasch, Stefan/GQI-2691-2022; Schulz, Holger/J-5643-2015; Thorand, Barbara/B-5349-2014; Horsch, Alexander/W-8322-2018; Grill, Eva/AAF-8104-2020	Peters, Annette/0000-0001-6645-0985; Grill, Eva/0000-0002-0273-7984; Schulz, Holger/0000-0002-1157-200X; Thorand, Barbara/0000-0002-8416-6440; Horsch, Alexander/0000-0001-7745-0139; Grill, Eva/0000-0002-0273-7984	Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; German Federal Ministry of Education and Research (BMBF) [FKZ 01ET0713]; BMBF [FKZ 01GI0882]; Graduate School of Information Science in Health (GSISH); Technische Universitat Munchen Graduate School	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Graduate School of Information Science in Health (GSISH); Technische Universitat Munchen Graduate School	The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (formerly GSF, National Research Center for Environment and Health), which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. KORA Age was financed by the German Federal Ministry of Education and Research (BMBF FKZ 01ET0713). Further support was provided by the BMBF funded Competence Network ASCONET, subnetwork COSYCONET (FKZ 01GI0882). The research was supported by the Graduate School of Information Science in Health (GSISH) and the Technische Universitat Munchen Graduate School. Lukas Gorzelniak received university grant monies as a PhD scholarship from 3/1/2009 to 6/30/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autenrieth CS, 2013, PREV MED, V57, P17, DOI 10.1016/j.ypmed.2013.02.014; Babyak M, 2009, PSYCHOSOM MED, V24, P8; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Bento T, 2012, REV SAUDE PUBL, V46, P561, DOI 10.1590/S0034-89102012005000022; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chaudhry S, 2005, MED CARE, V43, P607, DOI 10.1097/01.mlr.0000163658.65008.ec; Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; FRIES JF, 1982, J RHEUMATOL, V9, P789; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Harris TJ, 2009, BRIT J SPORT MED, V43, P442, DOI 10.1136/bjsm.2008.048033; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; Hudon C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-304; Kaminsky LA, 2012, PHYSIOL MEAS, V33, P1869, DOI 10.1088/0967-3334/33/11/1869; Kaplan MS, 2001, AM J PREV MED, V21, P306, DOI 10.1016/S0749-3797(01)00364-6; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krishnan E, 2004, ARTHRITIS RHEUM-US, V50, P953, DOI 10.1002/art.20048; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ortlieb S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-28; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Peters A, 2011, Z Gerontol Geriatr, V44 Suppl 2, P41, DOI 10.1007/s00391-011-0245-7; Machado VDS, 2012, MENOPAUSE, V19, P569, DOI 10.1097/gme.0b013e3182455963; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Shah RC, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-63; Sidall C, 2007, EU HLTH POLICY CONTE; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Strath SJ, 2003, INT J SPORTS MED, V24, P298, DOI 10.1055/s-2003-39504; Strobl R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-137; Tak E, 2013, AGEING RES REV, V12, P329, DOI 10.1016/j.arr.2012.10.001; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2005, MED SCI SPORT EXER, V37, pS487, DOI 10.1249/01.mss.0000185473.32846.c3; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; van den Bussche H., 2012, Z ALLG MED, V88, P365, DOI [DOI 10.3238/ZFA.2012.365-371, 10.3238/zfa.2012.365-371]; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wilms HU, 2007, COMPR PSYCHIAT, V48, P95, DOI 10.1016/j.comppsych.2006.04.001; Withall J, 2014, INT J ENV RES PUB HE, V11, P643, DOI 10.3390/ijerph110100643	45	22	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111206	10.1371/journal.pone.0111206	http://dx.doi.org/10.1371/journal.pone.0111206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372399	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900037
J	Biedermann, A; Kriebel, K; Kreikemeyer, B; Lang, H				Biedermann, Anne; Kriebel, Katja; Kreikemeyer, Bernd; Lang, Hermann			Interactions of Anaerobic Bacteria with Dental Stem Cells: An In Vitro Study	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; HUMAN PERIODONTAL-LIGAMENT; PORPHYROMONAS-GINGIVALIS; IMMUNE-RESPONSE; PRECURSOR CELLS; STROMAL CELLS; WISDOM TEETH; MULTIPOTENT; INTERLEUKIN-10; RECOGNITION	Background: In patients with periodontitis, it is highly likely that local (progenitor) cells encounter pathogenic bacteria. The purpose of this in vitro study was to elucidate how human dental follicle stem cells (hDFSC) react towards a direct challenge with anaerobic periodontal pathogens under their natural oxygen-free atmosphere. HDFSC were compared to human bone marrow mesenchymal stem cells (hBMSC) and differentiated primary human gingival fibroblasts (hGiF), as well as permanent gingival carcinoma cells (Ca9-22). Methodology/Principal Findings: The different cell types were investigated in a co-culture system with Porphyromonas gingivalis (P. gingivalis) and Fusobacterium nucleatum (F. nucleatum). The viability of the cells and pathogens under anaerobic conditions, as well as interactions in terms of adherence and internalization, were examined. Additionally, the release of pro-inflammatory interleukin-8 (IL-8) and anti-inflammatory interleukin-10 (IL-10) was quantified via enzyme-linked immunosorbent assay. The bacteria adhered less efficiently to hDFSC compared to Ca9-22 (P. gingivalis: 0.18% adherence to hDFSC; 3.1% adherence to Ca9-22). Similar results were observed for host cell internalization (F. nucleatum: 0.002% internalization into hDFSC; 0.09% internalization into Ca9-22). Statistically significantly less IL-8 was secreted from hDFSC after stimulation with F. nucleatum and P. gingivalis in comparison with hGiF (F. nucleatum: 2080.0 pg/ml - hGiF; 19.7 pg/ml - hDFSC). The IL-10 response of the differentiated cells was found to be low in relation to their pro-inflammatory IL-8 response. Conclusions/Significance: The results indicate that dental stem cells are less prone to interactions with pathogenic bacteria than differentiated cells in an anaerobic environment. Moreover, during bacterial challenge, the stem cell immune response seems to be more towards an anti-inflammatory reaction. For a potential future therapeutic use of hDFSC, these findings support the idea of a save application.	[Biedermann, Anne; Kriebel, Katja; Lang, Hermann] Univ Rostock, Dept Operat Dent & Periodontol, D-18055 Rostock, Germany; [Kreikemeyer, Bernd] Univ Rostock, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Lang, H (corresponding author), Univ Rostock, Dept Operat Dent & Periodontol, D-18055 Rostock, Germany.	hermann.lang@uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Belton C, 2001, CELLULAR MICROBIOLOG, V1, P215; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; BICKEL M, 1993, J PERIODONTOL, V64, P456; Chung WO, 2004, INFECT IMMUN, V72, P352, DOI 10.1128/IAI.72.1.352-358.2004; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DZINK JL, 1985, J CLIN PERIODONTOL, V12, P648, DOI 10.1111/j.1600-051X.1985.tb00936.x; Gaebel R, 2011, BIOMATERIALS, V32, P9218, DOI 10.1016/j.biomaterials.2011.08.071; Haddouti EM, 2009, MATERIALWISS WERKST, V40, P732, DOI 10.1002/mawe.200900505; Hajishengallis G, 2004, IMMUNOL INVEST, V33, P157, DOI 10.1081/IMM-120030917; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Honda Masaki J, 2010, J Oral Sci, V52, P541, DOI 10.2334/josnusd.52.541; Huard-Delcourt A, 1998, EUR J ORAL SCI, V106, P938, DOI 10.1046/j.0909-8836.1998.eos106506.x; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Kriebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078226; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lourbakos A, 2001, INFECT IMMUN, V69, P5121, DOI 10.1128/IAI.69.8.5121-5130.2001; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Morsczeck C, 2008, CLIN ORAL INVEST, V12, P113, DOI 10.1007/s00784-007-0170-8; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reichert S, 2008, J PERIODONTAL RES, V43, P40, DOI 10.1111/j.1600-0765.2007.00992.x; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; TAKASHIBA S, 1992, INFECT IMMUN, V60, P5253, DOI 10.1128/IAI.60.12.5253-5258.1992; Tomic S, 2011, STEM CELLS DEV, V20, P695, DOI 10.1089/scd.2010.0145; Wada N, 2013, PERIODONTOL 2000, V63, P198, DOI 10.1111/prd.12024; Wada N, 2009, J CELL PHYSIOL, V219, P667, DOI 10.1002/jcp.21710; Zhang J, 1999, MICROB PATHOGENESIS, V26, P275, DOI 10.1006/mpat.1998.0277	36	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110616	10.1371/journal.pone.0110616	http://dx.doi.org/10.1371/journal.pone.0110616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369260	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000023
J	Kohler, E; Villiger, J; Posch, T; Derlon, N; Shabarova, T; Morgenroth, E; Pernthaler, J; Blom, JF				Kohler, Esther; Villiger, Joerg; Posch, Thomas; Derlon, Nicolas; Shabarova, Tanja; Morgenroth, Eberhard; Pernthaler, Jakob; Blom, Judith F.			Biodegradation of Microcystins during Gravity-Driven Membrane (GDM) Ultrafiltration	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; DEGRADATION; LAKE; CYANOBACTERIA; DIVERSITY; LR; HEPATOTOXIN; BIOFILMS; REMOVAL; TOXINS	Gravity-driven membrane (GDM) ultrafiltration systems require little maintenance: they operate without electricity at ultra-low pressure in dead-end mode and without control of the biofilm formation. These systems are already in use for water purification in some regions of the world where adequate treatment and distribution of drinking water is not readily available. However, many water bodies worldwide exhibit harmful blooms of cyanobacteria that severely lower the water quality due to the production of toxic microcystins (MCs). We studied the performance of a GDM system during an artificial Microcystis aeruginosa bloom in lake water and its simulated collapse (i.e., the massive release of microcystins) over a period of 21 days. Presence of live or destroyed cyanobacterial cells in the feed water decreased the permeate flux in the Microcystis treatments considerably. At the same time, the microbial biofilms on the filter membranes could successfully reduce the amount of microcystins in the filtrate below the critical threshold concentration of 1 mu g L (-1) MC for human consumption in three out of four replicates after 15 days. We found pronounced differences in the composition of bacterial communities of the biofilms on the filter membranes. Bacterial genera that could be related to microcystin degradation substantially enriched in the biofilms amended with microcystin-containing cyanobacteria. In addition to bacteria previously characterized as microcystin degraders, members of other bacterial clades potentially involved in MC degradation could be identified.	[Kohler, Esther; Villiger, Joerg; Posch, Thomas; Shabarova, Tanja; Pernthaler, Jakob; Blom, Judith F.] Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland; [Derlon, Nicolas; Morgenroth, Eberhard] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Morgenroth, Eberhard] ETH, Inst Environm Engn, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Blom, JF (corresponding author), Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland.	blom@limnol.uzh.ch	Morgenroth, Eberhard/G-1723-2010; , Tanja/B-5327-2015	Morgenroth, Eberhard/0000-0002-1217-269X; , Tanja/0000-0003-4526-3587; derlon, nicolas/0000-0003-4240-9827; Blom, Judith/0000-0001-5000-1528; Posch, Thomas/0000-0001-5145-3761	ProDoc program "Predictive Toxicology'' - Swiss National Science Foundation [PDFMP3_132466]; Swiss Federal Department of Foreign Affairs through Polish-Swiss Research Program, Diversity and Ecology of Mixotrophic Nanoflagellates in the Gulf of Gdansk (DEMONA) [PSPB-036/2010]	ProDoc program "Predictive Toxicology'' - Swiss National Science Foundation; Swiss Federal Department of Foreign Affairs through Polish-Swiss Research Program, Diversity and Ecology of Mixotrophic Nanoflagellates in the Gulf of Gdansk (DEMONA)	This research was supported by the ProDoc program "Predictive Toxicology'' (PDFMP3_132466), funded by the Swiss National Science Foundation. J. Villiger was supported by the Swiss Federal Department of Foreign Affairs through Polish-Swiss Research Program, project PSPB-036/2010: Diversity and Ecology of Mixotrophic Nanoflagellates in the Gulf of Gdansk (DEMONA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Blom JF, 2010, APPL ENVIRON MICROB, V76, P6156, DOI 10.1128/AEM.01455-10; Campinas M, 2010, SEP PURIF TECHNOL, V71, P114, DOI 10.1016/j.seppur.2009.11.010; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Christoffersen K, 2002, AQUAT MICROB ECOL, V27, P125, DOI 10.3354/ame027125; Derlon N, 2013, WATER RES, V47, P2085, DOI 10.1016/j.watres.2013.01.033; Dyble J, 2008, ENVIRON TOXICOL, V23, P507, DOI 10.1002/tox.20370; Dziga D, 2013, CHEM RES TOXICOL, V26, P841, DOI 10.1021/tx4000045; Grutzmacher G, 2010, ENVIRON SCI TECHNOL, V44, P657, DOI 10.1021/es9016816; Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009; Ho LN, 2007, TOXICON, V50, P438, DOI 10.1016/j.toxicon.2007.03.021; Hoeger SJ, 2002, ENVIRON HEALTH PERSP, V110, P1127, DOI 10.1289/ehp.021101127; Holst T, 2003, WATER RES, V37, P4748, DOI 10.1016/S0043-1354(03)00413-5; Jiang YG, 2011, FEMS MICROBIOL LETT, V322, P108, DOI 10.1111/j.1574-6968.2011.02337.x; JONES GJ, 1994, WATER RES, V28, P871, DOI 10.1016/0043-1354(94)90093-0; Leclerc H, 2002, FEMS MICROBIOL REV, V26, P207, DOI [10.1111/j.1574-6976.2002.tb00611.x, 10.1016/S0168-6445(02)00097-9]; Li JM, 2012, BIORESOURCE TECHNOL, V106, P27, DOI 10.1016/j.biortech.2011.11.099; Mou XZ, 2013, J GREAT LAKES RES, V39, P352, DOI 10.1016/j.jglr.2013.03.014; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Park HD, 2001, ENVIRON TOXICOL, V16, P337, DOI 10.1002/tox.1041; Peter-Varbanets M, 2009, WATER RES, V43, P245, DOI 10.1016/j.watres.2008.10.030; Peter-Varbanets M, 2010, WATER RES, V44, P3607, DOI 10.1016/j.watres.2010.04.020; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/nclimate1581, 10.1038/NCLIMATE1581]; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rapala J, 2005, INT J SYST EVOL MICR, V55, P1563, DOI 10.1099/ijs.0.63599-0; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Roberts L, 2001, B WORLD HEALTH ORGAN, V79, P280; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; Shabarova T, 2014, FEMS MICROBIOL ECOL, V89, P111, DOI 10.1111/1574-6941.12339; Shimizu K, 2013, MAEJO INT J SCI TECH, V7, P22; Shimizu K, 2012, J BIOSCI BIOENG, V114, P630, DOI 10.1016/j.jbiosc.2012.07.004; Sibille I, 1998, APPL ENVIRON MICROB, V64, P197; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; Van den Wyngaert S, 2011, LIMNOL OCEANOGR, V56, P97, DOI 10.4319/lo.2011.56.1.0097; WHO, 2011, GUID DRINK WAT QUAL; Yamaguchi N, 2011, APPL ENVIRON MICROB, V77, P1536, DOI 10.1128/AEM.01765-10	39	30	31	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111794	10.1371/journal.pone.0111794	http://dx.doi.org/10.1371/journal.pone.0111794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369266	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000344402000103
J	Kushwaha, KP; Sankar, J; Sankar, MJ; Gupta, A; Dadhich, JP; Gupta, YP; Bhatt, GC; Ansari, DA; Sharma, B				Kushwaha, Komal P.; Sankar, Jhuma; Sankar, M. Jeeva; Gupta, Arun; Dadhich, J. P.; Gupta, Y. P.; Bhatt, Girish C.; Ansari, Dilshad A.; Sharma, B.			Effect of Peer Counselling by Mother Support Groups on Infant and Young Child Feeding Practices: The Lalitpur Experience	PLOS ONE			English	Article							INTERVENTIONS; PROMOTION	Objective: Our primary objective was to evaluate the effect of peer counselling by mother support groups (MSG's) in improving the infant and young child feeding (IYCF) practices in the community. Methods: We conducted this repeated-measure before and after study in the Lalitpur district of Uttar Pradesh, India between 2006 and 2011. We assessed the IYCF practices before and after creating MSG's within the community. The feeding practices were reassessed at two time points-2 (T1) and 5 years (T2) after the intervention and compared with that of the pre-intervention phase (T0). Results: The total population covered by the project from the time of its initiation was 105000. A total of 425 (T0), 480 (T1) and 521 (T2) mother infant pairs were selected from this population. There was significant improvement in the following IYCF practices in the community (represented as %; adjOR (95% CI, p) such as initiation of breast feeding within 1 hour at both T1 (71% vs. 11%); 19.6 (13.6, 28.2, p = < 0.0001) and T2 (62% vs. 11%); 13.3 (9.4, 18.9, p = < 0.0001); use of prelacteal feeds at both T1 (67% vs. 15%); 12.6 (CI: 9.0, 17.6, p < 0.0001) and T2 (67% vs. 5%); 44.4 (28.8, 68.4, p = < 0.0001); rates of exclusive breast feeding for 6 months at both T1 (50% vs. 7%); 13.6 (7.6, 25.0, p = < 0.0001) and T2 (60% vs. 7%); 20.5 (11.3, 37.2, p = < 0.0001); initiation of complementary feeding at T1 (85% vs. 54%); 5.6 (3.6, 8.7, p = < 0.0001) and T2 (96% vs. 54%); 22.9 (11.8, 44.1, p = < 0.0001) and complementary feeding along with continued breast feeding at both T1 (36% vs. 4.5%); 6 (1.15, 31.4, p = 0.033) and T2 (42% vs. 4.5%); 8.06 (1.96, 49.1, p = 0.005) as compared to pre-intervention period (T0) after adjusting for important social and demographic variables. Conclusions: Peer counseling by MSG's improved the IYCF practices in the district and could be sustained.	[Kushwaha, Komal P.; Bhatt, Girish C.; Ansari, Dilshad A.; Sharma, B.] BRD Med Coll, Dept Pediat, Gorakhpur, Uttar Pradesh, India; [Sankar, Jhuma; Sankar, M. Jeeva] AIIMS, Dept Pediat, New Delhi, India; [Gupta, Arun] IBFAN Asia, Delhi, India; [Dadhich, J. P.] BPNI, Delhi, India; [Gupta, Y. P.] YG Consultants Pvt Ltd, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Kushwaha, KP (corresponding author), BRD Med Coll, Dept Pediat, Gorakhpur, Uttar Pradesh, India.	komalpkushwaha13@gmail.com	Bhatt, Girish Chandra/AAH-1026-2019; Sankar, Jeeva/Q-1007-2019; Sankar, Jhuma/AAE-7057-2019; DADHICH, JP/R-8705-2019	Sankar, Jeeva/0000-0003-1474-1451; Sankar, Jhuma/0000-0002-9807-6550; 	UNICEF	UNICEF	The project was funded by UNICEF. The funding received was 3000000 INR/year for 5 years for implementation of the project activities only. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrasada GV, 2005, ACTA PAEDIATR, V94, P1109, DOI 10.1080/08035250510025752; Aidam BA, 2005, J NUTR, V135, P1691, DOI 10.1093/jn/135.7.1691; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bland RM, 2008, AIDS, V22, P883, DOI 10.1097/QAD.0b013e3282f768de; BPNI/IBFAN, 2009, 3 1 TRAIN PROGR CAP; CEF, 2007, PROGR CHILDR REP A S; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Hannula L, 2008, J CLIN NURS, V17, P1132, DOI 10.1111/j.1365-2702.2007.02239.x; istrar General of India, 2011, SAMPL REG SYST SRS S; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kushwaha KP, 2010, REACHING 2S UNIVERSA; Malhotra N, 2013, PUBLIC HEALTH NUTR, V16, P1723, DOI 10.1017/S1368980012004065; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Nor B, 2009, J HUM LACT, V25, P427, DOI 10.1177/0890334409341050; Quinn VJ, 2005, J HUM LACT, V21, P345, DOI 10.1177/0890334405278383; Renfrew MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub4; Sudfeld CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045143; WHO, 2003, GLOB STRAT INF YOUNG; WHO/UNICEF, 1991, BAB FRIENDL HOSP IN; WHO UNICEF, 2009, BAB FRIENDL HOSP IN; World Health Organization, BREASTF COUNS TRAIN	24	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109181	10.1371/journal.pone.0109181	http://dx.doi.org/10.1371/journal.pone.0109181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369452	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000008
J	Lou, XD; Zhai, SQ; Kang, B; Hu, YL; Hu, LL				Lou, Xue-Dong; Zhai, Sheng-Qiang; Kang, Bing; Hu, Ya-Lin; Hu, Li-Le			Rapid Response of Hydrological Loss of DOC to Water Table Drawdown and Warming in Zoige Peatland: Results from a Mesocosm Experiment	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; CLIMATE-CHANGE; FRESH-WATER; TEMPORAL VARIABILITY; CHEMICAL-COMPOSITION; METHANE EMISSIONS; TIBETAN PLATEAU; EXPORT; TEMPERATURE; DIOXIDE	A large portion of the global carbon pool is stored in peatlands, which are sensitive to a changing environment conditions. The hydrological loss of dissolved organic carbon (DOC) is believed to play a key role in determining the carbon balance in peatlands. Zoige peatland, the largest peat store in China, is experiencing climatic warming and drying as well as experiencing severe artificial drainage. Using a fully crossed factorial design, we experimentally manipulated temperature and controlled the water tables in large mesocosms containing intact peat monoliths. Specifically, we determined the impact of warming and water table position on the hydrological loss of DOC, the exported amounts, concentrations and qualities of DOC, and the discharge volume in Zoige peatland. Our results revealed that of the water table position had a greater impact on DOC export than the warming treatment, which showed no interactive effects with the water table treatment. Both DOC concentration and discharge volume were significantly increased when water table drawdown, while only the DOC concentration was significantly promoted by warming treatment. Annual DOC export was increased by 69% and 102% when the water table, controlled at 0 cm, was experimentally lowered by -10 cm and -20 cm. Increases in colored and aromatic constituents of DOC (measured by Abs(254 nm), SUVA(254 nm), Abs(400 nm), and SUVA(400 nm)) were observed under the lower water tables and at the higher peat temperature. Our results provide an indication of the potential impacts of climatic change and anthropogenic drainage on the carbon cycle and/or water storage in a peatland and simultaneously imply the likelihood of potential damage to downstream ecosystems. Furthermore, our results highlight the need for local protection and sustainable development, as well as suggest that more research is required to better understand the impacts of climatic change and artificial disturbances on peatland degradation.	[Lou, Xue-Dong; Zhai, Sheng-Qiang; Hu, Li-Le] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Lou, Xue-Dong; Kang, Bing] Northwest Agr Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Hu, Ya-Lin] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China	Chinese Research Academy of Environmental Sciences; Northwest A&F University - China; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Hu, LL (corresponding author), Chinese Res Inst Environm Sci, Beijing, Peoples R China.	hulile@craes.org.cn			Nature Science Foundation of China [41103041, 41271318]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding from the Nature Science Foundation of China under Grant Nos. 41103041 and 41271318 to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1999, OIKOS, V84, P44, DOI 10.2307/3546865; [Anonymous], SICHUAN ENV; Arnosti C, 2003, ESTUAR COAST SHELF S, V58, P197, DOI 10.1016/S0272-7714(03)00077-5; ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; Billett MF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002058; Blodau C, 2012, BIOGEOCHEMISTRY, V107, P107, DOI 10.1007/s10533-010-9535-1; Bohrer G, 2013, PLOS ONE, V8; Bridgham SD, 2008, ECOLOGY, V89, P3041, DOI 10.1890/08-0279.1; Bridgham SD, 1999, ECOL APPL, V9, P1345, DOI 10.1890/1051-0761(1999)009[1345:ECOTAE]2.0.CO;2; Briggs J, 2007, EARTH PLANET SC LETT, V253, P445, DOI 10.1016/j.epsl.2006.11.010; Carpenter SR, 1997, OIKOS, V78, P3, DOI 10.2307/3545794; Chen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008072; Cheng HL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078838, 10.1371/journal.pone.0053878]; Chin W-C, 2013, PLOS ONE, V8; Chivers MR, 2009, ECOSYSTEMS, V12, P1329, DOI 10.1007/s10021-009-9292-y; Clair TA, 2002, ENVIRON POLLUT, V116, pS143, DOI 10.1016/S0269-7491(01)00267-6; CLYMO RS, 1984, PHILOS T R SOC B, V303, P605, DOI 10.1098/rstb.1984.0002; [戴洋 DAI Yang], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P35; DEBEVEC EM, 1993, ARCTIC ALPINE RES, V25, P56, DOI 10.2307/1551481; deMars H, 1996, VEGETATIO, V126, P59; Dinsmore KJ, 2013, GLOBAL CHANGE BIOL, V19, P2133, DOI 10.1111/gcb.12209; Ellis T, 2009, ECOL ENG, V35, P978, DOI 10.1016/j.ecoleng.2008.10.011; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Evans CD, 2006, GLOBAL CHANGE BIOL, V12, P2044, DOI 10.1111/j.1365-2486.2006.01241.x; Fraser CJD, 2001, HYDROL PROCESS, V15, P3151, DOI 10.1002/hyp.322; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; FREEMAN C, 1993, BIOGEOCHEMISTRY, V19, P51; Froberg M, 2006, BIOGEOCHEMISTRY, V77, P1, DOI 10.1007/s10533-004-0564-5; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Grayson R, 2012, HYDROL PROCESS, V26, P27, DOI 10.1002/hyp.8106; Guo XJ, 2013, SCI TOTAL ENVIRON, V445, P231, DOI 10.1016/j.scitotenv.2012.12.048; Guo YD, 2010, J ENVIRON SCI, V22, P84, DOI 10.1016/S1001-0742(09)60078-4; Hao YB, 2008, ACTA OECOL, V33, P133, DOI 10.1016/j.actao.2007.07.002; Harrison AF, 2008, GLOBAL CHANGE BIOL, V14, P687, DOI 10.1111/j.1365-2486.2007.01504.x; HOBBIE JE, 1992, HYDROBIOLOGIA, V229, P169, DOI 10.1007/BF00006999; HOGG EH, 1992, ECOL APPL, V2, P298, DOI 10.2307/1941863; Jager DF, 2009, SCI TOTAL ENVIRON, V407, P1373, DOI 10.1016/j.scitotenv.2008.10.005; Kim SY, 2012, APPL SOIL ECOL, V57, P23, DOI 10.1016/j.apsoil.2012.02.015; Li GY, 2011, J APPL ECOL, V48, P659, DOI 10.1111/j.1365-2664.2011.01965.x; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Luo CY, 2009, SOIL BIOL BIOCHEM, V41, P2493, DOI 10.1016/j.soilbio.2009.09.006; MITCHELL G, 1992, WATER RES, V26, P321, DOI 10.1016/0043-1354(92)90029-4; MITCHELL GN, 1990, PROG PHYS GEOG, V14, P317, DOI 10.1177/030913339001400302; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; MOORE TR, 1989, WATER RESOUR RES, V25, P1321, DOI 10.1029/WR025i006p01321; Moore TR, 1998, CLIMATIC CHANGE, V40, P229, DOI 10.1023/A:1005408719297; MOORE TR, 1993, J SOIL SCI, V44, P651, DOI 10.1111/j.1365-2389.1993.tb02330.x; Morris PJ, 2011, J ECOL, V99, P1190, DOI 10.1111/j.1365-2745.2011.01842.x; Pastor J, 2003, OIKOS, V100, P380, DOI 10.1034/j.1600-0706.2003.11774.x; Price JS, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001302; SAFS (Sichuan Academy of Forest Science), 2006, SCI INV REP ZOIG MAR; Sapek A, 2009, INT J ENVIRON POLLUT, V37, P398, DOI 10.1504/IJEP.2009.026057; Scanlon D, 2000, SOIL SCI, V165, P153, DOI 10.1097/00010694-200002000-00006; Shi C-c, 2009, SW CHINA J AGR SCI, V6; Sommer M, 2006, GEODERMA, V133, P107, DOI 10.1016/j.geoderma.2006.03.040; Steinberg, 2003, ECOLOGY HUMIC SUBSTA; Strack M, 2008, HYDROL PROCESS, V22, P3373, DOI 10.1002/hyp.6931; Strack M, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002209; Strakova P, 2012, GLOBAL CHANGE BIOL, V18, P322, DOI 10.1111/j.1365-2486.2011.02503.x; Tang R, 2013, ENVIRON POLLUT, V173, P270, DOI 10.1016/j.envpol.2012.09.022; Trettin CC, 2006, CAN J SOIL SCI, V86, P269, DOI 10.4141/S05-089; Turetsky M.R., 2008, J GEOPHYS RES-BIOGEO, V113; Turunen J, 2008, DEV FINNISH PEATLAND; URBAN NR, 1989, WATER RESOUR RES, V25, P1619, DOI 10.1029/WR025i007p01619; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wallage ZE, 2010, SCI TOTAL ENVIRON, V408, P6235, DOI 10.1016/j.scitotenv.2010.09.009; Wallage ZE, 2006, SCI TOTAL ENVIRON, V367, P811, DOI 10.1016/j.scitotenv.2006.02.010; Walling D. E., 1981, RELIABILITY SUSPENDE; [王铭 Wang Ming], 2012, [湿地科学, Wetland Science], V10, P156; Watts CD, 2001, SCI TOTAL ENVIRON, V278, P57, DOI 10.1016/S0048-9697(00)00888-3; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Weltzin JF, 2000, ECOLOGY, V81, P3464, DOI 10.1890/0012-9658(2000)081[3464:ROBAFP]2.0.CO;2; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; Whittington PN, 2006, HYDROL PROCESS, V20, P3589, DOI 10.1002/hyp.6376; Wilson L, 2011, SCI TOTAL ENVIRON, V409, P2010, DOI 10.1016/j.scitotenv.2011.02.036; Worrall F, 2007, J HYDROL, V339, P1, DOI 10.1016/j.jhydrol.2006.12.025; Worrall F, 2003, SCI TOTAL ENVIRON, V312, P133, DOI 10.1016/S0048-9697(03)00226-2; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Yu Z, 2013, SENSITIVITY NO PEATL, P55; Zhang GS, 2008, ENVIRON MICROBIOL, V10, P1850, DOI 10.1111/j.1462-2920.2008.01606.x; Zhang X, 2005, WETLAND SCI, V3, P292; Zhang XH, 2012, ECOL ENG, V38, P86, DOI 10.1016/j.ecoleng.2011.09.004	84	13	15	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109861	10.1371/journal.pone.0109861	http://dx.doi.org/10.1371/journal.pone.0109861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369065	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000012
J	Mandorfer, M; Bota, S; Schwabl, P; Bucsics, T; Pfisterer, N; Summereder, C; Hagmann, M; Blacky, A; Ferlitsch, A; Sieghart, W; Trauner, M; Peck-Radosavljevic, M; Reiberger, T				Mandorfer, Mattias; Bota, Simona; Schwabl, Philipp; Bucsics, Theresa; Pfisterer, Nikolaus; Summereder, Christian; Hagmann, Michael; Blacky, Alexander; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas			Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites	PLOS ONE			English	Article							PORTAL-HYPERTENSION; LIVER-DISEASE; OVERGROWTH; ASSOCIATION; THERAPY; RISK; DEFINITION; MANAGEMENT; PROGNOSIS; DIAGNOSIS	Background and Aim: The aim of this study was to assess the impact of proton pump inhibitor (PPI) intake on the development of spontaneous bacterial peritonitis (SBP) or other infections, as well as on mortality, in a thoroughly documented cohort of patients with cirrhosis and ascites. Patients and Methods: We performed a retrospective analysis of follow-up data from 607 consecutive patients with cirrhosis undergoing their first paracentesis at a tertiary center. A binary logistic regression model investigating the association between PPI intake and SBP at the first paracentesis was calculated. Competing risk analyses and Cox models were used to investigate the effect of PPIs on the cumulative incidence of SBP or other infections and transplant-free survival, respectively. Adjustments were made for age, hepatocellular carcinoma, history of variceal bleeding, varices and model of end-stage liver disease score. Results: Eighty-six percent of patients were receiving PPIs. After adjusting for potential confounding factors, PPI intake was neither associated with increased SBP prevalence at the first paracentesis (odds ratio (OR): 1.11,95% confidence interval (95% CI): 0.6-2.06; P = 0.731) nor cumulative incidence of SBP (subdistribution hazard ratio (SHR): 1.38; 95% CI: 0.63-3.01; P = 0.42) and SBP or other infections (SHR: 1.71; 95% CI: 0.85-3.44; P = 0.13) during follow-up. Moreover, PPI intake had no impact on transplant-free survival in both the overall cohort (hazard ratio (HR): 0.973,95% CI: 0.719-1.317; P = 0.859) as well as in the subgroups of patients without SBP (HR: 1.01,95% CI: 0.72-1.42; P = 0.971) and without SBP or other infections at the first paracentesis (HR: 0.944,95% CI: 0.668-1.334; P = 0.742). Conclusions: The proportion of cirrhotic patients with PPI intake was higher than in previous reports, suggesting that PPI indications were interpreted liberally. In our cohort with a particularly high prevalence of PPI intake, we observed no association between PPIs and SBP or other infections, as well as mortality. Thus, the severity of liver disease and other factors, rather than PPI treatment per se may predispose for infectious complications.	[Mandorfer, Mattias; Bota, Simona; Schwabl, Philipp; Bucsics, Theresa; Pfisterer, Nikolaus; Summereder, Christian; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Hagmann, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria; [Blacky, Alexander] Vienna Gen Hosp, Hosp Hyg, Inst Clin, Vienna, Austria; [Mandorfer, Mattias; Bota, Simona; Schwabl, Philipp; Bucsics, Theresa; Pfisterer, Nikolaus; Summereder, Christian; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Reiberger, T (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.	thomas.reiberger@meduniwien.ac.at	Mandorfer, Mattias/H-7603-2019; Reiberger, Thomas/H-7613-2019	Mandorfer, Mattias/0000-0003-2330-0017; Reiberger, Thomas/0000-0002-4590-3583; Schwabl, Philipp/0000-0002-7183-8076; Mullner-Bucsics, Theresa/0000-0003-3901-4111; Trauner, Michael/0000-0002-1275-6425				[Anonymous], 1992, CRITICAL CARE MED, V20, P864; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Bajaj JS, 2012, ALIMENT PHARM THER, V36, P866, DOI 10.1111/apt.12045; Bajaj JS, 2009, AM J GASTROENTEROL, V104, P1130, DOI 10.1038/ajg.2009.80; Bauer TM, 2001, AM J GASTROENTEROL, V96, P2962, DOI 10.1111/j.1572-0241.2001.04668.x; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Campbell MS, 2008, DIGEST DIS SCI, V53, P394, DOI 10.1007/s10620-007-9899-9; Chang CS, 1998, HEPATOLOGY, V28, P1187, DOI 10.1002/hep.510280504; Child C, 1964, SURG PORTAL HYPERTEN, P50; Choi EJ, 2011, SCAND J GASTROENTERO, V46, P616, DOI 10.3109/00365521.2011.551891; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; de Vos M, 2013, LIVER INT, V33, P1316, DOI 10.1111/liv.12210; Deshpande A, 2013, J GASTROEN HEPATOL, V28, P235, DOI 10.1111/jgh.12065; EAftSot Liver, 2010, J HEPATOL, V53, P397; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fernandez J, 2012, J HEPATOL, V56, pS1, DOI 10.1016/S0168-8278(12)60002-6; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goel GA, 2012, CLIN GASTROENTEROL H, V10, P422, DOI 10.1016/j.cgh.2011.11.019; Gunnarsdottir SA, 2003, AM J GASTROENTEROL, V98, P1362, DOI 10.1016/S0002-9270(03)00250-8; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Jun DW, 2010, DIGEST DIS SCI, V55, P1465, DOI 10.1007/s10620-009-0870-9; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kwon JH, 2014, J GASTROEN HEPATOL, V29, P775, DOI 10.1111/jgh.12426; Lodato F, 2008, WORLD J GASTROENTERO, V14, P2980, DOI 10.3748/wjg.14.2980; Mandorfer M, 2014, GASTROENTEROLOGY, V146, P1680, DOI 10.1053/j.gastro.2014.03.005; MORENCOS FC, 1995, DIGEST DIS SCI, V40, P1252; Peck-Radosavljevic M, 2005, ENDOSCOPY, V37, P667, DOI 10.1055/s-2005-861464; Peck-Radosavljevic M, 2013, WIEN KLIN WOCHENSCHR, V125, P200, DOI 10.1007/s00508-013-0337-z; Reiberger T, 2013, GUT, V62, P1634, DOI 10.1136/gutjnl-2012-304038; Reiberger T, 2013, J HEPATOL, V58, P911, DOI 10.1016/j.jhep.2012.12.011; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; SIRINGO S, 1995, J HEPATOL, V22, P633, DOI 10.1016/0168-8278(95)80219-3; van Vlerken LG, 2012, EUR J CLIN INVEST, V42, P760, DOI 10.1111/j.1365-2362.2011.02643.x	35	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110503	10.1371/journal.pone.0110503	http://dx.doi.org/10.1371/journal.pone.0110503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369194	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000022
J	Martinez, CS; Torres, JGD; Pecanha, FM; Anselmo-Franci, JA; Vassallo, DV; Salaices, M; Alonso, MJ; Wiggers, GA				Martinez, Caroline S.; Torres, Joao Guilherme D.; Pecanha, Franck M.; Anselmo-Franci, Janete A.; Vassallo, Dalton V.; Salaices, Mercedes; Alonso, Maria J.; Wiggers, Giulia A.			60-Day Chronic Exposure to Low Concentrations of HgCl2 Impairs Sperm Quality: Hormonal Imbalance and Oxidative Stress as Potential Routes for Reproductive Dysfunction in Rats	PLOS ONE			English	Article							INORGANIC MERCURY; TESTICULAR TOXICITY; LIPID-PEROXIDATION; METHYL MERCURY; CHLORIDE; METHYLMERCURY; CADMIUM; MECHANISM; SYSTEM; TISSUE	Mercury is a toxic and bio-accumulative heavy metal of global concern. While good deals of research have been conducted on the toxic effects of mercury, little is known about the mechanisms involved in the pathogenesis of male reproductive dysfunction induced by mercury. Therefore, the purpose of this study was to assess the effects and underlying mechanisms of chronic mercury exposure at low levels on male reproductive system of rats. Three-month-old male Wistar rats were divided into two groups and treated for 60 days with saline (i.m., Control) and HgCl2 (i.m. 1st dose: 4.6 mu g/kg, subsequent doses 0.07 mu g/kg/day). We analyzed sperm parameters, hormonal levels and biomarkers of oxidative stress in testis, epididymis, prostate and vas deferens. Mercury treatment decreased daily sperm production, count and motility and increased head and tail morphologic abnormalities. Moreover, mercury treatment decreased luteinizing hormone levels, increased lipid peroxidation on testis and decreased antioxidant enzymes activities (superoxide dismutase and catalase) on reproductive organs. Our data demonstrate that 60-day chronic exposure to low concentrations of HgCl2 impairs sperm quality and promotes hormonal imbalance. The raised oxidative stress seems to be a potential mechanism involved on male reproductive toxicity by mercury.	[Martinez, Caroline S.; Torres, Joao Guilherme D.; Pecanha, Franck M.; Wiggers, Giulia A.] Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil; [Anselmo-Franci, Janete A.] Univ Sao Paulo, Sch Dent, Dept Morphol Stomatol & Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Espirito Santo, Spain; [Salaices, Mercedes] Univ Autonoma Madrid, Sch Med, Dept Pharmacol, Madrid, Spain; [Alonso, Maria J.] Univ Rey Juan Carlos, Dept Biochem Physiol & Mol Genet, Alcorcon, Spain	Universidade Federal do Pampa; Universidade de Sao Paulo; Autonomous University of Madrid; Universidad Rey Juan Carlos	Wiggers, GA (corresponding author), Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil.	giuliawp@gmail.com	Alonso, María/AAB-4309-2019; Martinez, Caroline S/B-2184-2019; Anselmo-Franci, Janete/E-7124-2012; Wiggers, Giulia/AAG-2039-2019; Vassallo, Dalton/K-8289-2016	Alonso, María/0000-0003-4912-1121; Martinez, Caroline S/0000-0001-5742-3635; Anselmo-Franci, Janete/0000-0002-6480-1187; Wiggers, Giulia/0000-0001-5401-828X; Vassallo, Dalton/0000-0002-4463-4174; Salaices Sanchez, Mercedes/0000-0003-3323-1692	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Espirito Santo; Fundo Estadual de Ciencia e Tecnologia [39767531/07]; Ministerio de Ciencia e Innovacion [SAF 2012-36400, PHB2011-0001-PC]; Instituto de Salud Carlos III - ISCIII [RIC RD12/0042/0024]; Pro-reitoria de Pesquisa - Universidade Federal do Pampa [Nu 10.0010.13]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Espirito Santo; Fundo Estadual de Ciencia e Tecnologia; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III - ISCIII(Instituto de Salud Carlos IIIEuropean Commission); Pro-reitoria de Pesquisa - Universidade Federal do Pampa	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Espirito Santo; Fundo Estadual de Ciencia e Tecnologia [39767531/07]; Ministerio de Ciencia e Innovacion [SAF 2012-36400 and PHB2011-0001-PC]; Instituto de Salud Carlos III - ISCIII [RIC RD12/0042/0024]; Pro-reitoria de Pesquisa - Universidade Federal do Pampa [Nu 10.0010.13]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; Bando I, 2005, J BIOCHEM MOL TOXIC, V19, P154, DOI 10.1002/jbt.20067; Birch RJ, 2014, ENVIRON RES, V14; Boujbiha MA, 2009, REPROD TOXICOL, V28, P81, DOI 10.1016/j.reprotox.2009.03.011; Boujbiha MAM, 2011, BIOL TRACE ELEM RES, V142, P598, DOI 10.1007/s12011-010-8774-2; CARMIGNANI M, 1992, BRIT J IND MED, V49, P226; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; Choy CMY, 2002, BJOG-INT J OBSTET GY, V109, P1121, DOI 10.1111/j.1471-0528.2002.02084.x; Cornett CR, 1998, BIOL TRACE ELEM RES, V62, P107, DOI 10.1007/BF02820026; Corvelo TCD, 2014, B ENVIRON CONTAM TOX, V93, P42, DOI 10.1007/s00128-014-1279-5; El-Desoky GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059177; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ERFURTH EM, 1990, BRIT J IND MED, V47, P639; Farina M, 2003, TOXICOLOGY, V184, P179, DOI 10.1016/S0300-483X(02)00576-0; Filler R., 1993, MALE REPROD TOXICOLO, P334, DOI DOI 10.1016/B978-0-12-461207-5.50025-0; Ghaffari Mohammad Ali, 2011, Iranian Biomedical Journal, V15, P38; Goyer RA, 2004, BIOMETALS, V17, P555, DOI 10.1023/B:BIOM.0000045738.59708.20; Homma-Takeda S, 2001, TOXICOLOGY, V169, P25, DOI 10.1016/S0300-483X(01)00487-5; Kalender S, 2013, FOOD CHEM TOXICOL, V55, P456, DOI 10.1016/j.fct.2013.01.024; KECK C, 1993, REPROD TOXICOL, V7, P469, DOI 10.1016/0890-6238(93)90092-L; Khan AT, 2004, FOOD CHEM TOXICOL, V42, P571, DOI 10.1016/j.fct.2003.10.018; Kumar Banothu Anil, 2013, J Nat Sci Biol Med, V4, P414, DOI 10.4103/0976-9668.117021; Laks DR, 2009, BIOMETALS, V22, P1103, DOI 10.1007/s10534-009-9261-0; Louis GMB, 2014, REPRODUCTION, V147, pR97, DOI 10.1530/REP-13-0472; Martinez CS, 2014, J TOXICOL ENV HEAL A, V77, P143, DOI 10.1080/15287394.2014.867202; McKelvey W, 2007, ENVIRON HEALTH PERSP, V115, P1435, DOI 10.1289/ehp.10056; Mello-Carpes PB, 2013, INT J DEV NEUROSCI, V31, P468, DOI 10.1016/j.ijdevneu.2013.05.009; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mocevic E, 2013, ASIAN J ANDROL, V15, P97, DOI 10.1038/aja.2012.121; MOHAMED MK, 1987, PHARMACOL TOXICOL, V60, P29, DOI 10.1111/j.1600-0773.1987.tb01715.x; National Academy of Sciences, 2000, TOX EFF METH; Nyland JF, 2012, TOXICOL SCI, V125, P134, DOI 10.1093/toxsci/kfr264; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Omura M, 1996, FUND APPL TOXICOL, V32, P72, DOI 10.1006/faat.1996.0108; Perottoni J, 2004, FOOD CHEM TOXICOL, V42, P17, DOI 10.1016/j.fct.2003.08.002; Popescu HI, 1978, BMJ-BRIT MED J, V1, P23; Ramalingam V, 2003, J ENVIRON BIOL, V24, P401; Rana SVS, 2014, BIOL TRACE ELEM RES, V160, P1, DOI 10.1007/s12011-014-0023-7; Rao MV, 2008, TOXICOL IN VITRO, V22, P935, DOI 10.1016/j.tiv.2008.01.014; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; Santos FW, 2005, CHEM-BIOL INTERACT, V151, P159, DOI 10.1016/j.cbi.2005.01.001; Sharma AK, 1996, REPROD TOXICOL, V10, P153, DOI 10.1016/0890-6238(95)02058-6; VAHTER ME, 1995, TOXICOL APPL PHARM, V134, P273, DOI 10.1006/taap.1995.1193; Waye A, 2011, J TOXICOL ENV HEAL B, V14, P270, DOI 10.1080/10937404.2011.578273; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013; Zhang YB, 2011, TOXICOL SCI, V119, P270, DOI 10.1093/toxsci/kfq334	49	26	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111202	10.1371/journal.pone.0111202	http://dx.doi.org/10.1371/journal.pone.0111202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368988	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000042
J	Azevedo, H; Fujita, A; Bando, SY; Iamashita, P; Moreira, CA				Azevedo, Hatylas; Fujita, Andre; Bando, Silvia Yumi; Iamashita, Priscila; Moreira-Filho, Carlos Alberto			Transcriptional Network Analysis Reveals that AT1 and AT2 Angiotensin II Receptors Are Both Involved in the Regulation of Genes Essential for Glioma Progression	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME TUMORS; GROWTH-FACTOR RECEPTORS; SMOOTH-MUSCLE-CELLS; CROSS-TALK; MALIGNANT GLIOMA; BRAIN-TUMORS; EXPRESSION; ACTIVATION; PROTEIN; CANCER	Gliomas are aggressive primary brain tumors with high infiltrative potential. The expression of Angiotensin II (Ang II) receptors has been associated with poor prognosis in human astrocytomas, the most common type of glioma. In this study, we investigated the role of Angiotensin II in glioma malignancy through transcriptional profiling and network analysis of cultured C6 rat glioma cells exposed to Ang II and to inhibitors of its membrane receptor subtypes. C6 cells were treated with Ang II and specific antagonists of AT1 and AT2 receptors. Total RNA was isolated after three and six hours of Ang II treatment and analyzed by oligonucleotide microarray technology. Gene expression data was evaluated through transcriptional network modeling to identify how differentially expressed (DE) genes are connected to each other. Moreover, other genes co-expressing with the DE genes were considered in these analyses in order to support the identification of enriched functions and pathways. A hub-based network analysis showed that the most connected nodes in Ang II-related networks exert functions associated with cell proliferation, migration and invasion, key aspects for glioma progression. The subsequent functional enrichment analysis of these central genes highlighted their participation in signaling pathways that are frequently deregulated in gliomas such as ErbB, MAPK and p53. Noteworthy, either AT1 or AT2 inhibitions were able to down-regulate different sets of hub genes involved in protumoral functions, suggesting that both Ang II receptors could be therapeutic targets for intervention in glioma. Taken together, our results point out multiple actions of Ang II in glioma pathogenesis and reveal the participation of both Ang II receptors in the regulation of genes relevant for glioma progression. This study is the first one to provide systems-level molecular data for better understanding the protumoral effects of Ang II in the proliferative and infiltrative behavior of gliomas.	[Azevedo, Hatylas; Bando, Silvia Yumi; Iamashita, Priscila; Moreira-Filho, Carlos Alberto] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Fujita, Andre] Univ Sao Paulo, Dept Comp Sci, Inst Matemat & Estat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Moreira, CA (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil.	carlos.moreira@hc.fm.usp.br	moreira-filho, carlos alberto/J-2551-2014; Fujita, Andre/Q-1271-2019; Azevedo, Hatylas FZ/M-5332-2013	moreira-filho, carlos alberto/0000-0003-3433-4714; Fujita, Andre/0000-0002-7756-7051; Azevedo, Hatylas FZ/0000-0001-9233-0696; Bando, Silvia Yumi/0000-0003-3794-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2005/56446-0, 2009/53443-1, 2011/50761-2, 2011/07762-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [305635/2009-3]; NAP e-Science USP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NAP e-Science USP	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (Grants 2005/56446-0, 2009/53443-1, 2011/50761-2, 2011/07762-8), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (Grant 305635/2009-3) and NAP e-Science USP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; Ager EI, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-19; Alm E, 2003, CURR OPIN STRUC BIOL, V13, P193, DOI 10.1016/S0959-440X(03)00031-9; Arrieta O, 2008, BRIT J CANCER, V99, P160, DOI 10.1038/sj.bjc.6604431; Arrieta O, 2005, BRIT J CANCER, V92, P1247, DOI 10.1038/sj.bjc.6602483; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banakh I, 2002, EUR J IMMUNOGENET, V29, P307, DOI 10.1046/j.1365-2370.2002.00330.x; Bassett MH, 2004, MOL CELL ENDOCRINOL, V217, P67, DOI 10.1016/j.mce.2003.10.011; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Bredel M, 1998, NEUROSURGERY, V43, P124, DOI 10.1097/00006123-199807000-00081; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Campos AH, 2003, CIRC RES, V92, P111, DOI 10.1161/01.RES.0000049100.22673.F6; Carpentier AF, 2012, EUR J NEUROL, V19, P1337, DOI 10.1111/j.1468-1331.2012.03766.x; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen Hua, 2007, Zhonghua Zhongliu Zazhi, V29, P484; Chen WY, 2001, ONCOGENE, V20, P7686, DOI 10.1038/sj.onc.1204989; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Crea F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-265; De Godoy MAF, 2002, J PHARMACOL EXP THER, V303, P333, DOI 10.1124/jpet.102.036970; de Godoy MAF, 2006, J PHARMACOL EXP THER, V319, P1088, DOI 10.1124/jpet.106.108084; De Paolis P, 2002, J HYPERTENS, V20, P693, DOI 10.1097/00004872-200204000-00027; De S, 2009, CANCER RES, V69, P8035, DOI 10.1158/0008-5472.CAN-09-1224; de Tayrac M, 2011, CLIN CANCER RES, V17, P317, DOI 10.1158/1078-0432.CCR-10-1126; Deng XB, 2013, J NEURO-ONCOL, V114, P263, DOI 10.1007/s11060-013-1179-2; Droit A, 2005, J MOL ENDOCRINOL, V34, P263, DOI 10.1677/jme.1.01693; Du L, 2013, ONCOGENE; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ehtesham M, 2005, NEUROSURG FOCUS, V19, P5; Erten S, 2010, LECT NOTES COMPUT SC, V6023, P13, DOI 10.1007/978-3-642-12211-8_2; Facoetti A, 2006, ANTICANCER RES, V26, P3513; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Fogarty DJ, 2002, GLIA, V39, P304, DOI 10.1002/glia.10117; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Gallagher PE, 2011, CURR CANCER DRUG TAR, V11, P394; Glass TL, 2000, NEURO-ONCOLOGY, V2, P151, DOI 10.1093/neuonc/2.3.151; Godin CM, 2012, MINI-REV MED CHEM, V12, P812; Gunther W, 2003, ACTA NEUROCHIR, V145, P1029, DOI 10.1007/s00701-003-0099-x; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Honjho Y, 1996, NEUROL SURG TOKYO, V24, P143; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Huang ZX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-308; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Inagami T, 1999, J AM SOC NEPHROL, V10, pS57; Ino K, 2011, CURR CANCER DRUG TAR, V11, P405, DOI 10.2174/156800911795538057; Itabashi H, 2008, HEPATOL RES, V38, P601, DOI 10.1111/j.1872-034X.2007.00304.x; Johnson H, 2012, MOL CELL PROTEOMICS, V11, P1724, DOI 10.1074/mcp.M112.019984; Jones DTW, 2012, CELL MOL LIFE SCI, V69, P1799, DOI 10.1007/s00018-011-0898-9; Jones DTW, 2011, ACTA NEUROPATHOL, V121, P753, DOI 10.1007/s00401-011-0810-6; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Ke HL, 2013, J NEURO-ONCOL, V113, P327, DOI 10.1007/s11060-013-1121-7; KEISER JA, 1992, J PHARMACOL EXP THER, V262, P1154; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kim YC, 2012, AM J PHYSIOL-LUNG C, V303, pL228, DOI 10.1152/ajplung.00087.2012; Kosaka T, 2007, PROSTATE, V67, P41, DOI 10.1002/pros.20486; Kozlowski L, 2000, ARCH DERMATOL RES, V292, P68, DOI 10.1007/s004030050012; Kurella M, 2001, J AM SOC NEPHROL, V12, P1072, DOI 10.1681/ASN.V1251072; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Kusano S, 2010, BIOCHEM BIOPH RES CO, V396, P608, DOI 10.1016/j.bbrc.2010.04.111; Kwiatkowska A, 2013, ADV EXP MED BIOL, V986, P121, DOI 10.1007/978-94-007-4719-7_7; L'Esperance S, 2006, INT J ONCOL, V29, P5; Li JH, 2003, J BIOL CHEM, V278, P52355, DOI 10.1074/jbc.M305232200; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049915; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Lo HW, 2010, CURR CANCER DRUG TAR, V10, P840, DOI 10.2174/156800910793357970; Ma ZY, 2013, INT J CLIN EXP PATHO, V6, P862; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Merlo A, 2003, NEUROSURG REV, V26, P145, DOI 10.1007/s10143-003-0267-8; Messina S, 2011, ONCOGENE, V30, P3813, DOI 10.1038/onc.2011.99; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Miura S, 2013, CURR PHARM DESIGN, V19, P2981; Momota H, 2010, BRAIN TUMOR PATHOL, V27, P95, DOI 10.1007/s10014-010-0272-x; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Nakai Y, 2010, BRIT J CANCER, V103, P1644, DOI 10.1038/sj.bjc.6605955; Naville D, 2001, EUR J BIOCHEM, V268, P1802, DOI 10.1046/j.1432-1327.2001.02055.x; Nawashiro Hiroshi, 2005, Brain Tumor Pathol, V22, P89, DOI 10.1007/s10014-005-0188-z; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Nogueira EF, 2009, MOL CELL ENDOCRINOL, V302, P230, DOI 10.1016/j.mce.2008.08.024; Ohira K, 2006, BIOCHEM BIOPH RES CO, V342, P867, DOI 10.1016/j.bbrc.2006.02.033; Ono R, 2008, INT J MOL MED, V22, P199, DOI 10.3892/ijmm_00000009; Orr BA, 2011, J NEUROPATH EXP NEUR, V70, P568, DOI 10.1097/NEN.0b013e31821ff8d8; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Poirel CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S14; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Rekers NH, 2011, J CHEMOTHERAPY, V23, P187, DOI 10.1179/joc.2011.23.4.187; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Rivera E, 2001, BRIT J CANCER, V85, P1396, DOI 10.1054/bjoc.2001.2102; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Romero DG, 2007, PHYSIOL GENOMICS, V30, P26, DOI 10.1152/physiolgenomics.00187.2006; Romero DG, 2004, PHYSIOL GENOMICS, V19, P106, DOI 10.1152/physiolgenomics.00097.2004; Roos WP, 2009, MOL PHARMACOL, V76, P927, DOI 10.1124/mol.109.058131; Rostila A, 2012, LUNG CANCER, V77, P450, DOI 10.1016/j.lungcan.2012.03.024; Sanderson RJ, 1998, J BIOL CHEM, V273, P24822, DOI 10.1074/jbc.273.38.24822; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smith Gary Robert, 2004, J Inflamm (Lond), V1, P3, DOI 10.1186/1476-9255-1-3; Soni D, 2005, J CLIN NEUROSCI, V12, P1, DOI 10.1016/j.jocn.2004.04.001; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szekeres M, 2009, MOL CELL ENDOCRINOL, V302, P244, DOI 10.1016/j.mce.2008.12.015; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Thiel G, 2011, ENDOCRINOLOGY, V152, P4211, DOI 10.1210/en.2011-1243; Thomas CY, 2003, INT J CANCER, V104, P19, DOI 10.1002/ijc.10880; Trojan J, 2007, NEUROSCIENCE, V145, P795, DOI 10.1016/j.neuroscience.2007.01.021; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vinson GP, 2012, ENDOCR-RELAT CANCER, V19, pR1, DOI 10.1530/ERC-11-0335; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Yamaguchi K, 2005, CANCER CHEMOTH PHARM, V56, P585, DOI 10.1007/s00280-005-1030-3; Yamaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01160; Yamamura M, 2013, INT J ONCOL, V42, P873, DOI 10.3892/ijo.2013.1761; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yang W, 2013, CANCER SCI, V104, P70, DOI 10.1111/cas.12047; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; Yang XL, 2011, NEUROSURGERY, V68, P932, DOI 10.1227/NEU.0b013e3182098c30; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Zagzag D, 2000, PEDIATR NEUROSURG, V33, P49, DOI 10.1159/000028975; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhao ZY, 2011, BRAIN RES BULL, V86, P189, DOI 10.1016/j.brainresbull.2011.07.010; Zheng PP, 2004, AM J PATHOL, V164, P2217, DOI 10.1016/S0002-9440(10)63778-9; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	136	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110934	10.1371/journal.pone.0110934	http://dx.doi.org/10.1371/journal.pone.0110934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365520	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100037
J	Liang, YT; Li, L; Luo, TW; Zhang, Y; Zhang, R; Jiao, NZ				Liang, Yantao; Li, Li; Luo, Tingwei; Zhang, Yao; Zhang, Rui; Jiao, Nianzhi			Horizontal and Vertical Distribution of Marine Virioplankton: A Basin Scale Investigation Based on a Global Cruise	PLOS ONE			English	Article							BATHYPELAGIC WATERS; VIRAL ABUNDANCE; SPATIAL-DISTRIBUTION; MEDITERRANEAN SEA; COUNTING VIRUSES; ORGANIC-MATTER; FLOW-CYTOMETRY; ADRIATIC SEA; DEEP WATERS; OCEAN	Despite the fact that marine viruses have been increasingly studied in the last decade, there is little information on viral abundance and distribution on a global scale. In this study, we report on a global-scale survey covering the Pacific, Atlantic, and Indian Oceans on viral distribution using flow cytometry. Viruses were stained with the SYBR Green I, which targets only dsDNA viruses. The average viral abundance was 1.10 +/- 0.73x10(7) ml(-1) in global surface oceans and decreased from the areas with high chlorophyll concentration (on average, 1.47 +/- 0.78x10(7) ml(-1)) to the oligotrophic subtropical gyres (on average, 6.34 +/- 2.18x10(6) ml(-1)). On a large-spatial-scale, viruses displayed significant relationships with both heterotrophic and autotrophic picoplankton abundance, suggesting that viral distribution is dependent on their host cell abundance. Our study provided a basin scale pattern of marine viral distributions and their relationship with major host cells, indicating that viruses play a significant role in the global marine ecosystem.	[Liang, Yantao; Li, Li; Luo, Tingwei; Zhang, Yao; Zhang, Rui; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Liang, Yantao; Li, Li; Luo, Tingwei; Zhang, Yao; Zhang, Rui; Jiao, Nianzhi] Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen, Peoples R China; [Liang, Yantao] Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, Qingdao, Peoples R China	Xiamen University; Xiamen University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Zhang, R (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	ruizhang@xmu.edu.cn; jiao@xmu.edu.cn	Luo, Tingwei/B-7425-2012		National Key Basic Research Program of China [2013CB955700]; SOA project [GASI-03-01-02-05]; 863 Program [2012AA092003]; NSFC [41376132]; Fundamental Research Funds for the Central Universities [2012121052]	National Key Basic Research Program of China(National Basic Research Program of China); SOA project; 863 Program(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Basic Research Program of China (grant No. 2013CB955700), the SOA project (GASI-03-01-02-05), and the 863 Program (2012AA092003). R. Z. was supported by NSFC (41376132) and the Fundamental Research Funds for the Central Universities (2012121052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MC, 2001, MICROB ECOL, V42, P407, DOI 10.1007/s00248-001-0015-y; Anderson MJ, 2004, MAR ECOL PROG SER, V272, P33, DOI 10.3354/meps272033; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Brussaard CPD, 2008, DEEP-SEA RES PT II, V55, P752, DOI 10.1016/j.dsr2.2007.12.034; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; Corinaldesi C, 2003, APPL ENVIRON MICROB, V69, P2664, DOI 10.1128/AEM.69.5.2664-2673.2003; De Corte D, 2012, ISME J, V6, P1566, DOI 10.1038/ismej.2011.214; De Corte D, 2010, ISME J, V4, P1431, DOI [10.1038/ISMEJ.2010.65, 10.1038/ismej.2010.65]; FIEDLER PC, 1991, LIMNOL OCEANOGR, V36, P1834, DOI 10.4319/lo.1991.36.8.1834; FUHRMAN J, 1992, ENVIR SCI R, V43, P361; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Hara S, 1996, MAR ECOL PROG SER, V145, P269, DOI 10.3354/meps145269; Hwang CY, 2002, AQUAT MICROB ECOL, V30, P1, DOI 10.3354/ame030001; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jiao NZ, 2006, J MAR BIOL ASSOC UK, V86, P543, DOI 10.1017/S0025315406013452; Jiao NZ, 2002, AQUAT MICROB ECOL, V30, P37; Li Y, 2014, BIOGEOSCIENCES, V11, P2531, DOI 10.5194/bg-11-2531-2014; Magagnini M, 2007, DEEP-SEA RES PT I, V54, P1209, DOI 10.1016/j.dsr.2007.05.006; Magiopoulos I, 2012, DEEP-SEA RES PT I, V66, P1, DOI 10.1016/j.dsr.2012.03.009; MARANGER R, 1994, MAR ECOL PROG SER, V111, P121, DOI 10.3354/meps111121; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; Parada V, 2007, APPL ENVIRON MICROB, V73, P4429, DOI 10.1128/AEM.00029-07; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Weinbauer MG, 1997, AQUAT MICROB ECOL, V13, P225, DOI 10.3354/ame013225; WEINBAUER MG, 1993, APPL ENVIRON MICROB, V59, P4074, DOI 10.1128/AEM.59.12.4074-4082.1993; Wen K, 2004, APPL ENVIRON MICROB, V70, P3862, DOI 10.1128/AEM.70.7.3862-3867.2004; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winter C, 2009, DEEP-SEA RES PT I, V56, P1972, DOI 10.1016/j.dsr.2009.07.003; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yang YH, 2014, AQUAT MICROB ECOL, V71, P193, DOI 10.3354/ame01677; Yang YH, 2010, AQUAT MICROB ECOL, V60, P233, DOI 10.3354/ame01428	39	18	20	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111634	10.1371/journal.pone.0111634	http://dx.doi.org/10.1371/journal.pone.0111634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365318	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100092
J	Llana, MN; Sarnacki, SH; Castaneda, MDA; Pustovrh, MC; Gartner, AS; Buzzola, FR; Cerquetti, MC; Giacomodonato, MN				Noto Llana, Mariangeles; Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Carolina Pustovrh, Maria; Sonia Gartner, Alejandra; Roxana Buzzola, Fernanda; Cristina Cerquetti, Maria; Nancy Giacomodonato, Monica			Salmonella enterica Serovar Enteritidis Enterocolitis during Late Stages of Gestation Induces an Adverse Pregnancy Outcome in the Murine Model	PLOS ONE			English	Article							INFECTION; TYPHIMURIUM; EXPRESSION; MICE; INFLAMMATION; MECHANISMS; RESISTANCE; INDUCTION; APOPTOSIS; PATHOLOGY	Foodborne diseases caused by Salmonella enterica serovar Enteritidis (S. Enteritidis) are a significant health problem. Pregnancy, state of immunological tolerance, is a predisposing condition for the development of infections with intracellular pathogens. Salmonella species can cause pregnancy complications such as chorioamnionitis, transplacental fetal infection, pre term labor, abortions, neonatal and maternal septicemia. However, the specific mechanisms by which Salmonella infections trigger these alterations are not clear. In the present work, using a self-limiting enterocolitis murine model, we show that the ingestion of a low dose of S. Enteritidis at late stages of pregnancy (day 15 of gestation) is sufficient to induce massive maternal infection. We found that Salmonella infection leads to 40% of pre term delivery, 33% of abortion and fetal growth restriction. Placental dysfunction during S. Enteritidis enterocolitis was confirmed through cellular infiltration and hypoxia markers (MPO activity and COX-1 and COX-2 expression, respectively). Apoptosis in placental tissue due to Salmonella infection was also evident at day 18 of gestation when investigated by morphometric procedure, DNA fragmentation and Fas/FasL expression. Also, the expression of IFN-gamma, TNF-alpha, IL-17 and IL-10 was up regulated in response to Salmonella not only in placenta, but also in amniotic fluid and maternal serum. Altogether, our results demonstrate that S. Enteritidis enterocolitis during late stages of gestation causes detrimental effect on pregnancy outcome.	[Noto Llana, Mariangeles; Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Sonia Gartner, Alejandra; Roxana Buzzola, Fernanda; Cristina Cerquetti, Maria; Nancy Giacomodonato, Monica] Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med, Consejo Nacl Invest Cient & Tecn, IMPaM,UBA CONICET, Buenos Aires, DF, Argentina; [Carolina Pustovrh, Maria] Univ Valle, Dept Morfol, Cali, Colombia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad del Valle	Giacomodonato, MN (corresponding author), Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med, Consejo Nacl Invest Cient & Tecn, IMPaM,UBA CONICET, Buenos Aires, DF, Argentina.	monicagiaco@yahoo.com.ar	Buzzola, Fernanda/AAC-3352-2019	Buzzola, Fernanda/0000-0001-5900-4901; PUSTOVRH, MARIA CAROLINA/0000-0002-2909-1941	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP) [GI 11220110100911]; Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina (UBACyT) [20020120200021BA, 20020130200189BA]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP); Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina (UBACyT)	This work was supported in part by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP 2012-2014 GI 11220110100911) (http://www.conicet.gov.ar) (to MNG) and Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina (UBACyT 20020120200021BA and 20020130200189BA) (http://www.uba.ar) (to MNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo OM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-122; AWADALLA SG, 1985, OBSTET GYNECOL, V65, pS30; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bennett SD, 2012, SURVEILLANCE FOODBOR; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; CHAOUAT G, 1990, J REPROD FERTIL, V89, P447; Chattopadhyay A, 2010, INFECT IMMUN, V78, P2292, DOI 10.1128/IAI.01186-09; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Cerquetti MC, 2008, MICROBES INFECT, V10, P1431, DOI 10.1016/j.micinf.2008.08.008; Donnet-Hughes A, 2010, P NUTR SOC, V69, P407, DOI 10.1017/S0029665110001898; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Erel CT, 2001, INT J GYNECOL OBSTET, V73, P229, DOI 10.1016/S0020-7292(01)00373-3; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Font-Nieves M, 2012, J BIOL CHEM, V287, P6454, DOI 10.1074/jbc.M111.327874; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Guller S, 2008, ANN NY ACAD SCI, V1127, P129, DOI 10.1196/annals.1434.015; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; HEDRIANA HL, 1995, J REPROD MED, V40, P157; Hovsepian E, 2010, SHOCK, V34, P60, DOI 10.1097/SHK.0b013e3181cdc398; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Krishnan L, 1996, J IMMUNOL, V156, P644; Kusakabe K, 2005, J REPROD DEVELOP, V51, P333, DOI 10.1262/jrd.16086; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; Lin DM, 2003, INFECT IMMUN, V71, P5163, DOI 10.1128/IAI.71.9.5163-5168.2003; LUFT BJ, 1982, INFECT IMMUN, V38, P1164, DOI 10.1128/IAI.38.3.1164-1171.1982; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; Negi VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009139; Nguyen T, 2013, PLACENTA, V34, P765, DOI 10.1016/j.placenta.2013.06.003; Llana MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082588; Llana MN, 2012, INFECT IMMUN, V80, P2231, DOI 10.1128/IAI.00324-12; Pejcic-Karapetrovic B, 2007, J IMMUNOL, V179, P6088, DOI 10.4049/jimmunol.179.9.6088; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Saji F, 2000, J REPROD IMMUNOL, V47, P185, DOI 10.1016/S0165-0378(00)00064-4; Sarr D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-45; Schloesser RL, 2004, SCAND J INFECT DIS, V36, P773, DOI 10.1080/00365540410020802a; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.010; Whitehead CL, 2014, EXPERT REV MOL DIAGN, V14, P509, DOI 10.1586/14737159.2014.915749; Zhou HR, 2000, TOXICOL SCI, V53, P253, DOI 10.1093/toxsci/53.2.253	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111282	10.1371/journal.pone.0111282	http://dx.doi.org/10.1371/journal.pone.0111282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365504	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100059
J	Salehzadeh-Yazdi, A; Asgari, Y; Saboury, AA; Masoudi-Nejad, A				Salehzadeh-Yazdi, Ali; Asgari, Yazdan; Saboury, Ali Akbar; Masoudi-Nejad, Ali			Computational Analysis of Reciprocal Association of Metabolism and Epigenetics in the Budding Yeast: A Genome-Scale Metabolic Model (GSMM) Approach	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; EXPRESSION DATA; AMINO TERMINI; HISTONE H2A; NETWORK; RECONSTRUCTION; INTEGRATION; VALIDATION; OPTIMALITY	Metaboloepigenetics is a newly coined term in biological sciences that investigates the crosstalk between epigenetic modifications and metabolism. The reciprocal relation between biochemical transformations and gene expression regulation has been experimentally demonstrated in cancers and metabolic syndromes. In this study, we explored the metabolism-histone modifications crosstalk by topological analysis and constraint-based modeling approaches in the budding yeast. We constructed nine models through the integration of gene expression data of four mutated histone tails into a genome-scale metabolic model of yeast. Accordingly, we defined the centrality indices of the lowly expressed enzymes in the undirected enzyme-centric network of yeast by CytoHubba plug-in in Cytoscape. To determine the global effects of histone modifications on the yeast metabolism, the growth rate and the range of possible flux values of reactions, we used constraint-based modeling approach. Centrality analysis shows that the lowly expressed enzymes could affect and control the yeast metabolic network. Besides, constraint-based modeling results are in a good agreement with the experimental findings, confirming that the mutations in histone tails lead to non-lethal alterations in the yeast, but have diverse effects on the growth rate and reveal the functional redundancy.	[Salehzadeh-Yazdi, Ali; Asgari, Yazdan; Saboury, Ali Akbar; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran	University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Salehzadeh-Yazdi, Ali/J-9510-2019; Masoudi-Nejad, Ali/ABH-2078-2021; asgari, yazdan/AAL-9037-2020; Saboury, Ali Akbar/L-6136-2019	Salehzadeh-Yazdi, Ali/0000-0002-1678-0051; asgari, yazdan/0000-0001-6993-6956; 				Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Barrett Tanya, 2006, V338, P175; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Choi JK, 2010, IET SYST BIOL, V4, P289, DOI 10.1049/iet-syb.2010.0008; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Colyer Hilary A A, 2012, Methods Mol Biol, V863, P319, DOI 10.1007/978-1-61779-612-8_20; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Floratos A, 2010, BIOINFORMATICS, V26, P1779, DOI 10.1093/bioinformatics/btq282; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Gossett AJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002771; Gruning NM, 2010, TRENDS BIOCHEM SCI, V35, P220, DOI 10.1016/j.tibs.2009.12.001; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Herrgard MJ, 2006, GENOME RES, V16, P627, DOI 10.1101/gr.4083206; Horne AB, 2004, BIOINFORMATICS, V20, P2050, DOI 10.1093/bioinformatics/bth199; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Jensen PA, 2011, BIOINFORMATICS, V27, P541, DOI 10.1093/bioinformatics/btq702; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r78; Kim JA, 2012, P NATL ACAD SCI USA, V109, P5779, DOI 10.1073/pnas.1203453109; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2005, BIOPHYS J, V88, pL7, DOI 10.1529/biophysj.104.055723; Mazzio EA, 2012, EPIGENETICS-US, V7, P119, DOI 10.4161/epi.7.2.18764; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Nag R, 2010, NUCLEIC ACIDS RES, V38, P1450, DOI 10.1093/nar/gkp1074; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; Palsson B, 2009, FEBS LETT, V583, P3900, DOI 10.1016/j.febslet.2009.09.031; Parra MA, 2007, MOL CELL BIOL, V27, P7641, DOI 10.1128/MCB.00742-07; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Reed JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002662; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; SCHUSTER T, 1986, CELL, V45, P445, DOI 10.1016/0092-8674(86)90330-2; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sigurdsson MI, 2009, EPIGENETICS-US, V4, P43, DOI 10.4161/epi.4.1.7603; Tang HL, 2012, BIOCHEM BIOPH RES CO, V424, P7, DOI 10.1016/j.bbrc.2012.06.085; Wang YL, 2012, BMC SYST BIOL, V6, DOI [10.1186/1752-0509-6-153, 10.1186/1752-0509-6-S3-S21]; Yun J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00163; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	55	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111686	10.1371/journal.pone.0111686	http://dx.doi.org/10.1371/journal.pone.0111686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365344	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100106
J	Weymann, A; Patil, NP; Sabashnikov, A; Jungebluth, P; Korkmaz, S; Li, SL; Veres, G; Soos, P; Ishtok, R; Chaimow, N; Patzold, I; Czerny, N; Schies, C; Schmack, B; Popov, AF; Simon, AR; Karck, M; Szabo, G				Weymann, Alexander; Patil, Nikhil Prakash; Sabashnikov, Anton; Jungebluth, Philipp; Korkmaz, Sevil; Li, Shiliang; Veres, Gabor; Soos, Pal; Ishtok, Roland; Chaimow, Nicole; Patzold, Ines; Czerny, Natalie; Schies, Carsten; Schmack, Bastian; Popov, Aron-Frederik; Simon, Andre Ruediger; Karck, Matthias; Szabo, Gabor			Bioartificial Heart: A Human-Sized Porcine Model - The Way Ahead	PLOS ONE			English	Article							CARDIAC EXTRACELLULAR-MATRIX	Background: A bioartificial heart is a theoretical alternative to transplantation or mechanical left ventricular support. Native hearts decellularized with preserved architecture and vasculature may provide an acellular tissue platform for organ regeneration. We sought to develop a tissue-engineered whole-heart neoscaffold in human-sized porcine hearts. Methods: We decellularized porcine hearts (n = 10) by coronary perfusion with ionic detergents in a modified Langendorff circuit. We confirmed decellularization by histology, transmission electron microscopy and fluorescence microscopy, quantified residual DNA by spectrophotometry, and evaluated biomechanical stability with ex-vivo left-ventricular pressure/volume studies, all compared to controls. We then mounted the decellularized porcine hearts in a bioreactor and reseeded them with murine neonatal cardiac cells and human umbilical cord derived endothelial cells (HUVEC) under simulated physiological conditions. Results: Decellularized hearts lacked intracellular components but retained specific collagen fibers, proteoglycan, elastin and mechanical integrity; quantitative DNA analysis demonstrated a significant reduction of DNA compared to controls (82.6 +/- 3.2 ng DNA/mg tissue vs. 473.2 +/- 13.4 ng DNA/mg tissue, p < 0.05). Recellularized porcine whole-heart neoscaffolds demonstrated re-endothelialization of coronary vasculature and measurable intrinsic myocardial electrical activity at 10 days, with perfused organ culture maintained for up to 3 weeks. Conclusions: Human-sized decellularized porcine hearts provide a promising tissue-engineering platform that may lead to future clinical strategies in the treatment of heart failure.	[Weymann, Alexander; Korkmaz, Sevil; Li, Shiliang; Veres, Gabor; Chaimow, Nicole; Patzold, Ines; Czerny, Natalie; Schies, Carsten; Schmack, Bastian; Karck, Matthias; Szabo, Gabor] Heidelberg Univ, Dept Cardiac Surg, Heart & Marfan Ctr, Heidelberg, Germany; [Patil, Nikhil Prakash; Sabashnikov, Anton; Popov, Aron-Frederik; Simon, Andre Ruediger] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Dept Cardiothorac Transplantat & Mech Circulatory, London, England; [Jungebluth, Philipp] Karolinska Inst, Dept Clin Sci Intervent & Technol, Adv Ctr Translat Regenerat Med, Stockholm, Sweden; [Soos, Pal] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Ishtok, Roland] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary	Ruprecht Karls University Heidelberg; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Karolinska Institutet; Semmelweis University; Semmelweis University	Weymann, A (corresponding author), Heidelberg Univ, Dept Cardiac Surg, Heart & Marfan Ctr, Heidelberg, Germany.	weymann.alexander@googlemail.com	Popov, Aron-Frederik/AAA-9933-2020; Weymann, Alexander/AAQ-5115-2021; Sabashnikov, Anton/ABD-7044-2020	Popov, Aron-Frederik/0000-0003-4226-3004; Sabashnikov, Anton/0000-0002-6289-1035; Szabo, Gabor/0000-0001-6038-9968	Land Baden-Wurttemberg, Germany; Medical Faculty of the University of Heidelberg, Germany	Land Baden-Wurttemberg, Germany; Medical Faculty of the University of Heidelberg, Germany	This study was supported by the Land Baden-Wurttemberg, Germany, the Medical Faculty of the University of Heidelberg, Germany (to S.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85; Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d; Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506; Hara H, 2008, TRANSPL INT, V21, P1163, DOI 10.1111/j.1432-2277.2008.00736.x; Hulsmann J, 2013, J ARTIF ORGANS, V16, P294, DOI 10.1007/s10047-013-0705-5; Kobashigawa JA, 2006, NAT CLIN PRACT CARD, V3, P203, DOI 10.1038/ncpcardio0510; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Robertson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090406; Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436; Sekine H, 2006, J HEART LUNG TRANSPL, V25, P324, DOI 10.1016/j.healun.2005.09.017; Tonsho M, 2014, COLD SPRING HARB PER, V4; Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]; Weymann A, 2014, ARTIF ORGANS, V38, pE118, DOI 10.1111/aor.12321; Weymann A, 2014, MED SCI MONIT BASIC, V20, P55, DOI 10.12659/MSMBR.890444; Weymann A, 2013, CIRC J, V77, P207, DOI 10.1253/circj.CJ-12-0540; Weymann A, 2011, CIRC J, V75, P852, DOI 10.1253/circj.CJ-10-0717; Weymann A, 2010, J HEART VALVE DIS, V19, P279; Yao KJ, 1999, CIRCULATION, V100, P164; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644	22	43	45	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111591	10.1371/journal.pone.0111591	http://dx.doi.org/10.1371/journal.pone.0111591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365554	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100084
J	Sharaf, MR; Al Dhafer, HM; Aldawood, AS				Sharaf, Mostafa R.; Al Dhafer, Hathal M.; Aldawood, Abdulrahman S.			First Record of the Myrmicine Ant Genus Meranoplus Smith, 1853 (Hymenoptera: Formicidae) from the Arabian Peninsula with Description of a New Species and Notes on the Zoogeography of Southwestern Kingdom Saudi Arabia	PLOS ONE			English	Article							RED-SEA; EVOLUTION	The ant genus Meranoplus is reported for the first time from the Arabian Peninsula ( Kingdom of Saudi Arabia) by the new species M. pulcher sp. n., based on the worker caste. Specimens were collected from Al Sarawat and Asir Mountains of southwestern Kingdom of Saudi Arabia using pitfall traps. Meranoplus pulcher sp. n. is included in the Afrotropical M. magretii-group, with greatest similarity to M. magrettii Andre from Sudan. A key to the Afrotropical species of the M. magretii-group is presented. A brief review of the ant taxa with Afrotropical affinities in southwestern region of the Kingdom of Saudi Arabia is given.	[Sharaf, Mostafa R.; Al Dhafer, Hathal M.; Aldawood, Abdulrahman S.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia	King Saud University	Sharaf, MR (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia.	antsharaf@gmail.com	Aldawood, Abdulrahman Saad/M-3657-2019; Al Dhafer, Hathal/E-4535-2016	Al Dhafer, Hathal/0000-0002-4911-2332; Aldawood, Abdulrahman Saad/0000-0003-0721-6632	NSTIP Strategic technologies program, in the Kingdom of Saudi Arabia [12-ENV2484-02]	NSTIP Strategic technologies program, in the Kingdom of Saudi Arabia	This project was supported by the NSTIP Strategic technologies program, grant number (12-ENV2484-02), in the Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldawood AS, 2011, ZOOKEYS, P47, DOI 10.3897/zookeys.106.1390; Aldawood AS, 2011, ZOOKEYS, P61, DOI 10.3897/zookeys.92.770; Andersen Alan N., 2006, Myrmecologische Nachrichten, V8, P157; Andersen AN, 2000, J ANIM ECOL, V69, P975, DOI 10.1046/j.1365-2656.2000.00452.x; [Anonymous], 1973, GEOBOTANICAL FDN MID; Bolton B., 1981, Bulletin of the British Museum (Natural History) Entomology, V42, P43; Bolton B., 2003, MEMOIRS AM ENTOMOLOG; Bolton B., 1994, IDENTIFICATION GUIDE; Bosworth W, 2005, J AFR EARTH SCI, V43, P334, DOI 10.1016/j.jafrearsci.2005.07.020; Boudinot BE, 2013, ZOOTAXA, V3635, P301, DOI 10.11646/zootaxa.3635.4.1; Brown WL, 2000, BIOL DIVERSITY HDB S; Collingwood C.A., 1985, Fauna of Saudi Arabia, V7, P230; DAVISON I, 1994, GEOL SOC AM BULL, V106, P1474, DOI 10.1130/0016-7606(1994)106<1474:GEOTSR>2.3.CO;2; Doha Said A., 2009, Egyptian Academic Journal of Biological Sciences E Medical Entomology and Parasitology, V1, P31; Dornhaus A, 2010, ANT ECOLOGY, P210; Eig A., 1938, PALESTINE JOUR BOT SER J, V1, P161; El-Hawagry MS, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.274.4529; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Fisher BL, 2010, ANT ECOLOGY, P18; HOLLDOBLER B, 1988, Psyche (Cambridge), V95, P139, DOI 10.1155/1988/74829; KUGLER C, 1978, Studia Entomologica, V20, P413; Lehrer Andy Z., 2008, Fragmenta Dipterologica, V14, P1; Mahnert V, 2014, ZOOTAXA, V 3764, P387, DOI 10.11646/zootaxa.3764.3.8; Passerin d'Entreves P, 2004, NOTA LEPIDOPTEROLOGI, V26, P153; Robertson Hamish G., 2000, Journal of Hymenoptera Research, V9, P71; Schoedl S., 1998, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V100, P361; Schoedl S., 2004, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V105B, P349; Schoedl Stefan, 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P370; Schoedl Stefan, 1999, Entomological Problems, V30, P61; Sharaf MR, 2014, SOCIOBIOLOGY, V61, P293; Sharaf MR, 2013, P ENTOMOL SOC WASH, V115, P75, DOI 10.4289/0013-8797.115.1.75; Sharaf MR, 2012, ZOOKEYS, P39, DOI 10.3897/zookeys.228.3559; Sharaf MR, 2012, ZOOKEYS, P35, DOI 10.3897/zookeys.212.3325; Sharaf MR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030811, 10.1371/journal.pone.0049485]; Smith F., 1853, T ENTOMOLOGICAL SOC, V2, P213, DOI DOI 10.1111/J.1365-2311.1854.TB02221.X; Taylor R.W., 1990, GEN APPL ENTOMOLOGY, V22, P31; Taylor Robert W., 2006, Myrmecologische Nachrichten, V8, P21; Wheeler WM, 1935, BERNICE P BISHOP MUS, V11, P2	38	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111298	10.1371/journal.pone.0111298	http://dx.doi.org/10.1371/journal.pone.0111298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375104	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402600034
J	de Vries, FM; Kolthof, J; Postma, MJ; Denig, P; Hak, E				de Vries, Folgerdiena M.; Kolthof, Johan; Postma, Maarten J.; Denig, Petra; Hak, Eelko			Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; LDL CHOLESTEROL; HEART-DISEASE; 80 MG; SIMVASTATIN; MELLITUS; PEOPLE; TRIALS; SAFETY	Aims: To estimate the efficacy of standard and intensive statin treatment in the secondary prevention of major cardiovascular and cerebrovascular events in diabetes patients. Methods: A systematic search was conducted in Medline over the years 1990 to September 2013. Randomized, double-blind, clinical trials comparing a standard-dose statin with placebo or a standard-dose statin with an intensive-dose statin for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients were selected. Trial and patient characteristics were extracted independently by two researchers. The combined effect on the composite primary endpoint was measured with a fixed-effect model. Potential publication bias was examined with a funnel plot. Results: Five trials were included in the analysis comparing standard-dose statins with placebo with a total of 4 351 participants. Four trials were included for comparing standard-dose with intensive-dose statins, including 4 805 participants. Compared with placebo, standard-dose statin treatment resulted in a significant relative risk (RR) reduction of 15% in the occurrence of any major cardiovascular or cerebrovascular event (RR 0.85, 95% CI 0.79-0.91). Compared with standard-dose statin treatment, intensive-dose statin treatment resulted in an additional 9% relative risk reduction (RR 0.91, 95% CI 0.84-0.98). Conclusion: Treatment with standard-dose statins to prevent cardiovascular or cerebrovascular events in diabetes patients with manifest cardiovascular disease results in an estimated 15% relative risk reduction and intensive-dose statin treatment adds 9%. If proven cost-effective, more intensive statin treatment should be recommended for diabetes patients at high cardiovascular risk.	[de Vries, Folgerdiena M.; Kolthof, Johan; Postma, Maarten J.; Hak, Eelko] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands	University of Groningen; University of Groningen	de Vries, FM (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands.	f.m.de.vries@rug.nl	Denig, Petra/L-9865-2014	Denig, Petra/0000-0002-7929-4739; Postma, Maarten/0000-0002-6306-3653				Ahmed S, 2006, EUR HEART J, V27, P2323, DOI 10.1093/eurheartj/ehl220; American Heart Association, 2013, VARD DIS DIAB; [Anonymous], 2000, Ital Heart J, V1, P810; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Banga J., 2012, HUISARTS WET, V55, P14; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Campeau L, 1997, NEW ENGL J MED, V336, P153; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Chang Yu-Hung, 2013, Rev Diabet Stud, V10, P157, DOI 10.1900/RDS.2013.10.157; Cochrane Collaboration, 2011, REV MAN REVMAN; Collins R, 2003, LANCET, V361, P2005; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Fintel D, 2007, VALUE HEALTH, V10, P161, DOI 10.1111/j.1524-4733.2006.00163.x; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heintjes EM, 2012, PHARMACOTHERAPY, V32, P631, DOI 10.1002/j.1875-9114.2011.01086.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keech A, 2003, DIABETES CARE, V26, P2713, DOI 10.2337/diacare.26.10.2713; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Ko DT, 2013, CIRC-CARDIOVASC QUAL, V6, P315, DOI 10.1161/CIRCOUTCOMES.111.000015; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Newman C, 2006, AM J CARDIOL, V97, P61, DOI 10.1016/j.amjcard.2005.07.108; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Scholten R J, 1999, Ned Tijdschr Geneeskd, V143, P786; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Sidorenkov G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024278; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Smith MEB., 2009, DRUG CLASS REV HMG C; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; World Health organisation, 2012, GLOB HLTH OBS 2012	40	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111247	10.1371/journal.pone.0111247	http://dx.doi.org/10.1371/journal.pone.0111247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372483	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900038
J	Doull, M; Welch, V; Puil, L; Runnels, V; Coen, SE; Shea, B; O'Neill, J; Borkhoff, C; Tudiver, S; Boscoe, M				Doull, Marion; Welch, Vivian; Puil, Lorri; Runnels, Vivien; Coen, Stephanie E.; Shea, Beverley; O'Neill, Jennifer; Borkhoff, Cornelia; Tudiver, Sari; Boscoe, Madeline			Development and Evaluation of 'Briefing Notes' as a Novel Knowledge Translation Tool to Aid the Implementation of Sex/Gender Analysis in Systematic Reviews: A Pilot Study	PLOS ONE			English	Article							CLINICAL-TRIALS; GENDER; SEX; HEALTH; PAIN	Background: There is increasing recognition of sex/gender differences in health and the importance of identifying differential effects of interventions for men and women. Yet, to whom the research evidence does or does not apply, with regard to sex/gender, is often insufficiently answered. This is also true for systematic reviews which synthesize results of primary studies. A lack of analysis and reporting of evidence on sex/gender raises concerns about the applicability of systematic reviews. To bridge this gap, this pilot study aimed to translate knowledge about sex/gender analysis (SGA) into a user-friendly 'briefing note' format and evaluate its potential in aiding the implementation of SGA in systematic reviews. Methods: Our Sex/Gender Methods Group used an interactive process to translate knowledge about sex/gender into briefing notes, a concise communication tool used by policy and decision makers. The briefing notes were developed in collaboration with three Cochrane Collaboration review groups (HIV/AIDS, Hypertension, and Musculoskeletal) who were also the target knowledge users of the briefing notes. Briefing note development was informed by existing systematic review checklists, literature on sex/gender, in-person and virtual meetings, and consultation with topic experts. Finally, we held a workshop for potential users to evaluate the notes. Results: Each briefing note provides tailored guidance on considering sex/gender to reviewers who are planning or conducting systematic reviews and includes the rationale for considering sex/gender, with examples specific to each review group's focus. Review authors found that the briefing notes provided welcome guidance on implementing SGA that was clear and concise, but also identified conceptual and implementation challenges. Conclusions: Sex/gender briefing notes are a promising knowledge translation tool. By encouraging sex/gender analysis and equity considerations in systematic reviews, the briefing notes can assist systematic reviewers in ensuring the applicability of research evidence, with the goal of improved health outcomes for diverse populations.	[Doull, Marion] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Welch, Vivian; Shea, Beverley] Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada; [Puil, Lorri] Univ British Columbia, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada; [Runnels, Vivien] Univ Ottawa, Inst Populat Hlth, Globalizat & Hlth Res Unit, Ottawa, ON, Canada; [Coen, Stephanie E.] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada; [O'Neill, Jennifer] Univ Ottawa, Ctr Global Hlth, Inst Populat Hlth, Ottawa, ON, Canada; [Borkhoff, Cornelia] Hosp Sick Children, Div Pediat Med Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Boscoe, Madeline] Reach Community Hlth Ctr, Vancouver, BC, Canada	University of British Columbia; University of Ottawa; University of British Columbia; University of Ottawa; Queens University - Canada; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Doull, M (corresponding author), Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	marion.doull@ubc.ca	Welch, Vivian Andrea/AAD-9338-2020; Coen, Stephanie/M-8560-2019	Welch, Vivian Andrea/0000-0002-5238-7097; Coen, Stephanie/0000-0003-3939-8792; Borkhoff, Cornelia/0000-0003-3420-1866	Knowledge Translation Supplement from the Canadian Institutes of Health Research [201106KTB]	Knowledge Translation Supplement from the Canadian Institutes of Health Research	This work is supported by a Knowledge Translation Supplement from the Canadian Institutes of Health Research (grant #201106KTB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GEND SEX HLTH RES GU; Aulakh AK, 2007, WOMEN HEALTH ISS, V17, P342, DOI 10.1016/j.whi.2007.04.002; Bennett G, 2011, KNOWLEDGE TRANSLATIO, P189; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Borkhoff CM, 2013, ARTHRIT CARE RES, V65, P1281, DOI 10.1002/acr.21970; Borkhoff CM, 2011, CLIN ORTHOP RELAT R, V469, P1829, DOI 10.1007/s11999-011-1879-x; Boscoe M, 2012, EQUITY UPDATE NEWSLE, V6, P1; Canadian Institutes of Health Research, 2014, KNOWL TRANSL COMM; Chandler J, 2013, Methodological expectations of Cochrane intervention reviews (MECIR) standards for the reporting of plain language summaries in new Cochrane intervention reviews; Coen S., 2012, WHAT DIFFERENCE SEX; Connell R, 2012, SOC SCI MED, V74, P1675, DOI 10.1016/j.socscimed.2011.06.006; Doull M, 2011, EQUITY UPDATE NEWSLE, V5, P1; Doull M, 2010, J WOMENS HEALTH, V19, P997, DOI 10.1089/jwh.2009.1626; Estabrooks CA, 2006, J CONTIN EDUC HEALTH, V26, P25, DOI 10.1002/chp.48; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Foulkes MA, 2011, J WOMENS HEALTH, V20, P829, DOI 10.1089/jwh.2010.2527; Glanz K., 2002, HLTH BEHAV HLTH ED T; GRILLI R, 1994, MED CARE, V32, P202, DOI 10.1097/00005650-199403000-00002; Hammarstrom A, 2014, J EPIDEMIOL COMMUN H, V68, P185, DOI 10.1136/jech-2013-202572; Hankivsky O, 2012, CAN POLITICAL SCI RE, V6, P171; Health Canada, 2009, FED HLTH PORTF SEX G; Health-evidence.ca, 2009, BRIEF NOT DEC RAT KE; Heidari S, 2011, J INT AIDS SOC, V14, DOI [10.1186/1758-2652-14-11, 10.1186/1758-2652-14-S2-S1]; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; IOM (Institute of Medicine), 2012, SEX SPEC REP SCI RES; Jackson Beth E., 2006, GENDER BASED ANAL WA; Johnson J., 2012, DESIGNING CONDUCTING, P17, DOI DOI 10.4135/9781452230610.N2; Johnson J. L., 2013, Canadian Journal of Public Health, V104, pe80; Johnson SM, 2003, J WOMEN HEALTH GEN-B, V12, P449, DOI 10.1089/154099903766651577; Kaiser A, 2009, BRAIN RES REV, V61, P49, DOI 10.1016/j.brainresrev.2009.03.005; Lavis John N, 2006, Healthc Policy, V1, P21; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11, 10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1]; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; National Research Council, 2001, EXPLORING BIOL CONTR; Novicoff WM, 2011, CLIN ORTHOP RELAT R, V469, P1824, DOI 10.1007/s11999-010-1765-y; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Petticrew M, 2004, J EPIDEMIOL COMMUN H, V58, P811, DOI 10.1136/jech.2003.015289; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1230, DOI 10.1016/j.jclinepi.2013.06.005; Prairie Women's Health Centre of Excellence Lissa Donner, 2005, INCL GEND HLTH PLANN; Public Health Agency of Canada, 2012, CHIEF PUBL HLTH OFF; Rabi DM, 2008, CAN J CARDIOL, V24, P491, DOI 10.1016/S0828-282X(08)70624-X; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Runnels V, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-33; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Spitzer Denise L., 2007, GENDER SEX BASED ANA; Springer KW, 2012, SOC SCI MED, V74, P1817, DOI 10.1016/j.socscimed.2011.05.033; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; The Canadian Task Force on Preventive Health Care, 1999, EFF DISS IMPL CAN TA; Therapeutics Initiative, 2012, THERAPEUTICS LET JUL, V87; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Thompson GN, 2006, J ADV NURS, V53, P691, DOI 10.1111/j.1365-2648.2006.03775.x; Tudiver S, 2012, WHAT DIFFERENCE SEX; Tugwell P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4739; Ueffing E, 2011, EQUITY CHECKLIST SYS; United States General Accounting Office, 2001, DRUG SAF MOST DRUGS; US Food Drug Administration, 2013, FDA 2013 ANN REP; Welch V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001333; Welch V, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000028.pub2; Yonkers KA, 2002, J CLIN PSYCHIAT, V63, P610, DOI 10.4088/JCP.v63n0714	61	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110786	10.1371/journal.pone.0110786	http://dx.doi.org/10.1371/journal.pone.0110786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372876	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900024
J	Li, YK; Liao, JJ; Guo, HD; Liu, ZW; Shen, GZ				Li, Yingkui; Liao, Jingjuan; Guo, Huadong; Liu, Zewen; Shen, Guozhuang			Patterns and Potential Drivers of Dramatic Changes in Tibetan Lakes, 1972-2010	PLOS ONE			English	Article							CLIMATE-CHANGE; NAM CO; GAUGE OBSERVATIONS; LEVEL CHANGES; INLAND LAKE; PLATEAU; GLACIER; QINGHAI; PRECIPITATION; PERMAFROST	Most glaciers in the Himalayas and the Tibetan Plateau are retreating, and glacier melt has been emphasized as the dominant driver for recent lake expansions on the Tibetan Plateau. By investigating detailed changes in lake extents and levels across the Tibetan Plateau from Landsat/ICESat data, we found a pattern of dramatic lake changes from 1970 to 2010 (especially after 2000) with a southwest-northeast transition from shrinking, to stable, to rapidly expanding. This pattern is in distinct contrast to the spatial characteristics of glacier retreat, suggesting limited influence of glacier melt on lake dynamics. The plateau-wide pattern of lake change is related to precipitation variation and consistent with the pattern of permafrost degradation induced by rising temperature. More than 79% of lakes we observed on the central-northern plateau (with continuous permafrost) are rapidly expanding, even without glacial contributions, while lakes fed by retreating glaciers in southern regions (with isolated permafrost) are relatively stable or shrinking. Our study shows the limited role of glacier melt and highlights the potentially important contribution of permafrost degradation in predicting future water availability in this region, where understanding these processes is of critical importance to drinking water, agriculture, and hydropower supply of densely populated areas in South and East Asia.	[Li, Yingkui; Liu, Zewen] Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA; [Li, Yingkui; Liao, Jingjuan; Guo, Huadong; Shen, Guozhuang] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Li, YK (corresponding author), Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA.	yli32@utk.edu	Guo, Huadong/G-9388-2017	Guo, Huadong/0000-0003-0337-1862; liao, jing juan/0000-0002-5915-2661	National Basic Research Program of China [2009CB723906]; National Natural Science Foundation of China [41328001]; Open Research Fund of Key Laboratory of Digital Earth, Chinese Academy of Sciences [2011LDE004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of Key Laboratory of Digital Earth, Chinese Academy of Sciences	This work was supported by the National Basic Research Program of China (no. 2009CB723906), the National Natural Science Foundation of China (no. 41328001), and the Open Research Fund of Key Laboratory of Digital Earth, Chinese Academy of Sciences (no. 2011LDE004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [边多 BIAN Duo], 2009, [冰川冻土, Journal of Glaciology and Geocryology], V31, P404; [边多 BIAN Duo], 2010, [地理学报, Acta Geographica Sinica], V65, P313; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Chen SB, 2006, CLIMATIC CHANGE, V76, P291, DOI 10.1007/s10584-006-9080-z; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Daly C, 2010, INT J CLIMATOL, V30, P1857, DOI 10.1002/joc.2007; Duong VH, 2008, INT J REMOTE SENS, V29, P1453, DOI 10.1080/01431160701736372; Frankl A, 2013, INT J DIGIT EARTH, V6, P196, DOI 10.1080/17538947.2012.744777; Frazier PS, 2000, PHOTOGRAMM ENG REM S, V66, P1461; Gao YC, 2013, HYDROL EARTH SYST SC, V17, P837, DOI 10.5194/hess-17-837-2013; GLIMS National Snow and Ice Data Center, 2005, GLIMS GLAC DAT; Huang L, 2011, CLIMATIC CHANGE, V109, P479, DOI 10.1007/s10584-011-0032-x; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Jarvis A, 2008, HOLE FILLED SEAMLESS; [贾珅玥 JIA Shen-yue], 2009, [国土资源遥感, Remote Sensing for Land & Resources], P78; Kropacek J, 2012, INT J APPL EARTH OBS, V17, P3, DOI 10.1016/j.jag.2011.10.001; [类延斌 LEI Yan-bin], 2009, [冰川冻土, Journal of Glaciology and Geocryology], V31, P48; Lei YB, 2013, J HYDROL, V483, P61, DOI 10.1016/j.jhydrol.2013.01.003; Lei YB, 2012, J GLACIOL, V58, P177, DOI 10.3189/2012JoG11J025; Li Junli, 2011, Hupo Kexue, V23, P311; Li R, 2012, CHINESE SCI BULL, V57, P4609, DOI 10.1007/s11434-012-5323-8; Li XY, 2007, WATER RESOUR MANAG, V21, P1505, DOI 10.1007/s11269-006-9096-1; Li ZX, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045404; Liao JJ, 2013, INT J DIGIT EARTH, V6, P534, DOI 10.1080/17538947.2012.656290; Liu J, 2010, HYDROL EARTH SYST SC, V14, P481, DOI 10.5194/hess-14-481-2010; Liu JS, 2009, GLOBAL PLANET CHANGE, V67, P209, DOI 10.1016/j.gloplacha.2009.03.010; [鲁安新 LU Anxin], 2006, [遥感技术与应用, Remote sensing Technology and Application], V21, P173; [鲁安新 LU Anxin], 2005, [冰川冻土, Journal of Glaciology and Geocryology], V27, P783; Nan ZT, 2005, SCI CHINA SER D, V48, P797, DOI 10.1360/03yd0258; Niu YiFang, 2008, Arid Land Geography, V31, P284; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Parry M. L., 2007, CLIMATE CHANGE 2007; Qin J, 2009, CLIMATIC CHANGE, V97, P321, DOI 10.1007/s10584-009-9733-9; Scherler D, 2011, NAT GEOSCI, V4, P156, DOI [10.1038/ngeo1068, 10.1038/NGEO1068]; Schutz BE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024009; Smith LC, 2005, SCIENCE, V308, P1429, DOI 10.1126/science.1108142; Solomon S., 2007, PHYS SCI BASIS WORKI; Tong K, 2014, INT J CLIMATOL, V34, P265, DOI 10.1002/joc.3682; Phan VH, 2012, INT J APPL EARTH OBS, V17, P12, DOI 10.1016/j.jag.2011.09.015; Walter IA, 2000, NATIONAL IRRIGATION SYMPOSIUM, PROCEEDINGS, P209; Wang LH, 2007, INT GEOSCI REMOTE SE, P4526; Wang S, 1998, RECORDS CHINA LAKES; Wang WC, 2011, ANN GLACIOL, V52, P9, DOI 10.3189/172756411797252347; [武慧智 WU Huizhi], 2007, [世界地质, World Geology], V26, P66; Wu QB, 2010, GLOBAL PLANET CHANGE, V72, P32, DOI 10.1016/j.gloplacha.2010.03.001; Wu QB, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012974; Wu YH, 2008, J GEOGR SCI, V18, P177, DOI 10.1007/s11442-008-0177-3; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yang K, 2011, CLIMATIC CHANGE, V109, P517, DOI 10.1007/s10584-011-0099-4; Yang L, 2008, J ARID ENVIRON, V72, P861, DOI 10.1016/j.jaridenv.2007.10.006; Yang YZ, 2013, QUATERN INT, V313, P85, DOI 10.1016/j.quaint.2013.07.037; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; Yao TD, 2012, ENVIRON DEV, V3, P52, DOI 10.1016/j.envdev.2012.04.002; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Ye QH, 2007, J GLACIOL, V53, P673, DOI 10.3189/002214307784409261; Ye QH, 2009, J MT SCI-ENGL, V6, P211, DOI 10.1007/s11629-009-1016-4; [叶庆华 YE Qinghua], 2008, [地理研究, Geographical Research], V27, P1178; Yin ZY, 2008, J HYDROMETEOROL, V9, P301, DOI 10.1175/2007JHM903.1; Yoshikawa K, 2003, PERMAFROST PERIGLAC, V14, P151, DOI 10.1002/ppp.451; Zhang B, 2011, J HYDROL, V405, P161, DOI 10.1016/j.jhydrol.2011.05.018; Zhang G, 2013, CHINESE SCI BULL, V58, P1; Zhang GQ, 2013, GEOPHYS RES LETT, V40, P2125, DOI 10.1002/grl.50462; Zhang GQ, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3601363; Zhang GQ, 2011, REMOTE SENS ENVIRON, V115, P1733, DOI 10.1016/j.rse.2011.03.005; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003; [赵林 ZHAO Lin], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P1; ZHAO YY, 2006, DIZHI XUEBAO, V80, P876; Zhu LP, 2010, CHINESE SCI BULL, V55, P1294, DOI 10.1007/s11434-010-0015-8	70	45	51	11	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111890	10.1371/journal.pone.0111890	http://dx.doi.org/10.1371/journal.pone.0111890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372787	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900086
J	Moon, H; Kim, C; Kwon, M; Chen, YT; Onushko, T; Lodha, N; Christou, EA				Moon, Hwasil; Kim, Changki; Kwon, Minhyuk; Chen, Yen Ting; Onushko, Tanya; Lodha, Neha; Christou, Evangelos A.			Force Control Is Related to Low-Frequency Oscillations in Force and Surface EMG	PLOS ONE			English	Article							MOTOR UNIT DISCHARGE; END-POINT ACCURACY; OLD ADULTS; VOLUNTARY CONTRACTIONS; ISOMETRIC CONTRACTIONS; MUSCLE FORCE; VARIABILITY; FLUCTUATIONS; DRIVE; PERFORMANCE	Force variability during constant force tasks is directly related to oscillations below 0.5 Hz in force. However, it is unknown whether such oscillations exist in muscle activity. The purpose of this paper, therefore, was to determine whether oscillations below 0.5 Hz in force are evident in the activation of muscle. Fourteen young adults (21.07 +/- 2.76 years, 7 women) performed constant isometric force tasks at 5% and 30% MVC by abducting the left index finger. We recorded the force output from the index finger and surface EMG from the first dorsal interosseous (FDI) muscle and quantified the following outcomes: 1) variability of force using the SD of force; 2) power spectrum of force below 2 Hz; 3) EMG bursts; 4) power spectrum of EMG bursts below 2 Hz; and 5) power spectrum of the interference EMG from 10-300 Hz. The SD of force increased significantly from 5 to 30% MVC and this increase was significantly related to the increase in force oscillations below 0.5 Hz (R-2 = 0.82). For both force levels, the power spectrum for force and EMG burst was similar and contained most of the power from 0-0.5 Hz. Force and EMG burst oscillations below 0.5 Hz were highly coherent (coherence = 0.68). The increase in force oscillations below 0.5 Hz from 5 to 30% MVC was related to an increase in EMG burst oscillations below 0.5 Hz (R-2 = 0.51). Finally, there was a strong association between the increase in EMG burst oscillations below 0.5 Hz and the interference EMG from 35-60 Hz (R-2 = 0.95). In conclusion, this finding demonstrates that bursting of the EMG signal contains low-frequency oscillations below 0.5 Hz, which are associated with oscillations in force below 0.5 Hz.	[Moon, Hwasil; Kim, Changki; Kwon, Minhyuk; Chen, Yen Ting; Onushko, Tanya; Lodha, Neha; Christou, Evangelos A.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Christou, Evangelos A.] Univ Florida, Dept Phys Therapy, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Christou, EA (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	eachristou@hhp.ufl.edu	Kwon, MinHyuk/HCH-5752-2022; Lodha, Neha/AAG-9581-2020		 [R01 AG031769]; NATIONAL INSTITUTE ON AGING [R01AG031769] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by R01 AG031769 to Evangelos A. Christou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baweja HS, 2012, EXP BRAIN RES, V222, P355, DOI 10.1007/s00221-012-3219-0; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Chao E.Y., 1989, BIOMECHANICS HAND BA; Chen YT, 2012, EXP GERONTOL, V47, P519, DOI 10.1016/j.exger.2012.04.007; Christou EA, 2005, MED SCI SPORT EXER, V37, P2126, DOI 10.1249/01.mss.0000178103.72988.cd; Christou EA, 2003, J APPL PHYSIOL, V95, P373, DOI 10.1152/japplphysiol.00060.2003; Christou EA, 2007, J NEUROPHYSIOL, V97, P3340, DOI 10.1152/jn.01138.2006; Christou EA, 2011, EXERC SPORT SCI REV, V39, P77, DOI 10.1097/JES.0b013e31820b85ab; Coombes SA, 2011, NEUROIMAGE, V54, P2226, DOI 10.1016/j.neuroimage.2010.10.003; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Deutsch KM, 2001, J EXP CHILD PSYCHOL, V80, P392, DOI 10.1006/jecp.2001.2642; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Fox EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055970; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOMMA T, 1991, ACTA ANAT, V141, P139; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Keogh J, 2006, EUR J APPL PHYSIOL, V97, P76, DOI 10.1007/s00421-006-0151-7; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Lodha N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083468; Negro F, 2011, J PHYSIOL-LONDON, V589, P629, DOI 10.1113/jphysiol.2010.202473; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; Neto OP, 2010, MUSCLE NERVE, V42, P348, DOI 10.1002/mus.21687; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Neto OP, 2010, J NEUROPHYSIOL, V103, P1093, DOI 10.1152/jn.00792.2009; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; Tracy BL, 2007, HUM MOVEMENT SCI, V26, P796, DOI 10.1016/j.humov.2007.07.001; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Yoshitake Y, 2013, EXP BRAIN RES, V231, P267, DOI 10.1007/s00221-013-3689-8; Yoshitake Y, 2013, MUSCLE NERVE, V47, P577, DOI 10.1002/mus.23628	31	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109202	10.1371/journal.pone.0109202	http://dx.doi.org/10.1371/journal.pone.0109202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372038	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900007
J	Akhvlediani, T; Bautista, CT; Shakarishvili, R; Tsertsvadze, T; Imnadze, P; Tatishvili, N; Davitashvili, T; Samkharadze, T; Chlikadze, R; Dvali, N; Dzigua, L; Karchava, M; Gatserelia, L; Macharashvili, N; Kvirkvelia, N; Habashy, EE; Farrell, M; Rowlinson, E; Sejvar, J; Hepburn, M; Pimentel, G; Dueger, E; House, B; Rivard, R				Akhvlediani, Tamar; Bautista, Christian T.; Shakarishvili, Roman; Tsertsvadze, Tengiz; Imnadze, Paata; Tatishvili, Nana; Davitashvili, Tamar; Samkharadze, Tamar; Chlikadze, Rusudan; Dvali, Natia; Dzigua, Lela; Karchava, Mariam; Gatserelia, Lana; Macharashvili, Nino; Kvirkvelia, Nana; Habashy, Engy Emil; Farrell, Margaret; Rowlinson, Emily; Sejvar, James; Hepburn, Matthew; Pimentel, Guillermo; Dueger, Erica; House, Brent; Rivard, Robert			Etiologic Agents of Central Nervous System Infections among Febrile Hospitalized Patients in the Country of Georgia	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; VIRAL-INFECTIONS; EPIDEMIOLOGY; DIAGNOSIS	Objectives: There is a large spectrum of viral, bacterial, fungal, and prion pathogens that cause central nervous system (CNS) infections. As such, identification of the etiological agent requires multiple laboratory tests and accurate diagnosis requires clinical and epidemiological information. This hospital-based study aimed to determine the main causes of acute meningitis and encephalitis and enhance laboratory capacity for CNS infection diagnosis. Methods: Children and adults patients clinically diagnosed with meningitis or encephalitis were enrolled at four reference health centers. Cerebrospinal fluid (CSF) was collected for bacterial culture, and in-house and multiplex RT-PCR testing was conducted for herpes simplex virus (HSV) types 1 and 2, mumps virus, enterovirus, varicella zoster virus (VZV), Streptococcus pneumoniae, HiB and Neisseria meningitidis. Results: Out of 140 enrolled patients, the mean age was 23.9 years, and 58% were children. Bacterial or viral etiologies were determined in 51% of patients. Five Streptococcus pneumoniae cultures were isolated from CSF. Based on in-house PCR analysis, 25 patients were positive for S. pneumoniae, 6 for N. meningitidis, and 1 for H. influenzae. Viral multiplex PCR identified infections with enterovirus (n = 26), VZV (n = 4), and HSV-1 (n = 2). No patient was positive for mumps or HSV-2. Conclusions: Study findings indicate that S. pneumoniae and enteroviruses are the main etiologies in this patient cohort. The utility of molecular diagnostics for pathogen identification combined with the knowledge provided by the investigation may improve health outcomes of CNS infection cases in Georgia.	[Akhvlediani, Tamar] Javakhishvili Tbilisi State Univ, Dept Neurol & Neurosurg, Tbilisi, Georgia; [Akhvlediani, Tamar] US Army, Med Res Unit Georgia, Tbilisi, Georgia; [Bautista, Christian T.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Shakarishvili, Roman] Sarajishvili Inst Clin Neurol & Neurosurg, Tbilisi, Georgia; [Tsertsvadze, Tengiz; Davitashvili, Tamar; Dvali, Natia; Dzigua, Lela; Karchava, Mariam; Gatserelia, Lana; Macharashvili, Nino] Sci Res Ctr Infect Pathol AIDS & Clin Immunol, Tbilisi, Georgia; [Imnadze, Paata; Chlikadze, Rusudan] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Tatishvili, Nana; Samkharadze, Tamar] Iashvili Childrens Hosp, Dept Neurol, Tbilisi, Georgia; [Habashy, Engy Emil; Farrell, Margaret; Rowlinson, Emily; Pimentel, Guillermo; Dueger, Erica; House, Brent] US Naval, Global Dis Detect & Response Program, Med Res Unit 3, Cairo, Egypt; [Sejvar, James] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Dueger, Erica] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Hepburn, Matthew; Rivard, Robert] US Army, Med Res Inst Infect Dis, Frederick, MD USA	Ivane Javakhishvili Tbilisi State University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Center for Disease Control & Public Health - Georgia; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Akhvlediani, T (corresponding author), Javakhishvili Tbilisi State Univ, Dept Neurol & Neurosurg, Tbilisi, Georgia.	t_akhvlediani@yahoo.com	Tsertsvadze, Tengiz/GXG-5822-2022	Tsertsvadze, Tengiz/0000-0002-4986-7874; Bautista, Christian/0000-0002-1228-0754; Tatishvili, Nana Nino/0000-0002-4292-264X	U.S. Department of Defense Global Emerging Infections Surveillance (GEIS) Program; U.S. Centers for Disease Control and Prevention	U.S. Department of Defense Global Emerging Infections Surveillance (GEIS) Program; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the U.S. Department of Defense Global Emerging Infections Surveillance (GEIS) Program and supported by the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuzawa N, 2013, J MED CASES, V4, P4; Big C, 2009, CLIN MED RES, V7, P142, DOI 10.3121/cmr.2009.864; Bottomley MJ, 2012, VACCINE, V30, pB78, DOI 10.1016/j.vaccine.2011.12.099; Butsashvili M, 2013, J COMMUN HEALTH, V38, P724, DOI 10.1007/s10900-013-9670-4; Demina AA, 1998, INT MED J, V2, P315; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Granerod J, 2007, NEUROPSYCHOL REHABIL, V17, P406, DOI 10.1080/09602010600989620; Griffiths UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021472; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Kasanmoentalib ES, 2013, CURR OPIN NEUROL, V26, P282, DOI 10.1097/WCO.0b013e328360415c; Ludwig E, 2012, CENT EUR J PUBL HEAL, V20, P121, DOI 10.21101/cejph.a3744; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Read SJ, 1999, J CLIN MICROBIOL, V37, P1352, DOI 10.1128/JCM.37.5.1352-1355.1999; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Seehusen DA, 2003, AM FAM PHYSICIAN, V68, P1103; Spiro CE, 2004, CLIN REV, V14, P53; Sundaram C, 2011, PATHOLOG RES INT, V2011, P8782; Taylor WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042099; TEASDALE G, 1974, LANCET, V2, P81; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845	21	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111393	10.1371/journal.pone.0111393	http://dx.doi.org/10.1371/journal.pone.0111393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369023	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000051
J	Aliferis, KA; Faubert, D; Jabaji, S				Aliferis, Konstantinos A.; Faubert, Denis; Jabaji, Suha			A Metabolic Profiling Strategy for the Dissection of Plant Defense against Fungal Pathogens	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; SIGNAL-TRANSDUCTION; MASS-SPECTROMETRY; SALICYLIC-ACID; BIOSYNTHESIS; ISOFLAVONES; HORMONE; PATHWAY; GROWTH; ROOTS	Here we present a metabolic profiling strategy employing direct infusion Orbitrap mass spectrometry (MS) and gas chromatography-mass spectrometry (GC/MS) for the monitoring of soybean's (Glycine max L.) global metabolism regulation in response to Rhizoctonia solani infection in a time-course. Key elements in the approach are the construction of a comprehensive metabolite library for soybean, which accelerates the steps of metabolite identification and biological interpretation of results, and bioinformatics tools for the visualization and analysis of its metabolome. The study of metabolic networks revealed that infection results in the mobilization of carbohydrates, disturbance of the amino acid pool, and activation of isoflavonoid, alpha-linolenate, and phenylpropanoid biosynthetic pathways of the plant. Components of these pathways include phytoalexins, coumarins, flavonoids, signaling molecules, and hormones, many of which exhibit antioxidant properties and bioactivity helping the plant to counterattack the pathogen's invasion. Unraveling the biochemical mechanism operating during soybean-Rhizoctonia interaction, in addition to its significance towards the understanding of the plant's metabolism regulation under biotic stress, provides valuable insights with potential for applications in biotechnology, crop breeding, and agrochemical and food industries.	[Aliferis, Konstantinos A.; Jabaji, Suha] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Faubert, Denis] Inst Rech Clin Montreal, Montreal, PQ, Canada	McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Jabaji, S (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	suha.jabaji@mcgill.ca	Jabaji, Suha/D-2479-2016	Jabaji, Suha/0000-0002-7232-9994	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was financially supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Aliferis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042576; Aliferis KA, 2011, METABOLOMICS, V7, P35, DOI 10.1007/s11306-010-0231-x; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Balmerl D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00082; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bourgaud F., 2006, Phytochemistry Reviews, V5, P293, DOI 10.1007/s11101-006-9040-2; Cheng JY, 2011, PHYTOCHEMISTRY, V72, P875, DOI 10.1016/j.phytochem.2011.03.010; de Pinto MC, 2003, PLANT CELL PHYSIOL, V44, P803, DOI 10.1093/pcp/pcg105; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dixon RA, 2010, PLANT PHYSIOL, V154, P453, DOI 10.1104/pp.110.161430; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Draper J, 2013, METABOLOMICS, V9, pS4, DOI 10.1007/s11306-012-0449-x; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Enkerli J, 1998, MOL PLANT MICROBE IN, V11, P317, DOI 10.1094/MPMI.1998.11.4.317; Fiehn O, 2007, METABOLOMICS, V3, P175, DOI 10.1007/s11306-007-0070-6; Fliegmann J, 2003, BIOL CHEM, V384, P437, DOI 10.1515/BC.2003.049; Gardner HW, 1998, LIPIDS, V33, P745, DOI 10.1007/s11745-998-0265-z; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hendrawati O, 2006, PLANT SCI, V170, P1118, DOI 10.1016/j.plantsci.2006.01.017; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeon HY, 2012, J AGR FOOD CHEM, V60, P2807, DOI 10.1021/jf204708n; Kim HJ, 2010, J AGR FOOD CHEM, V58, P11633, DOI 10.1021/jf102829z; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kirwan JA, 2013, ANAL BIOANAL CHEM, V405, P5147, DOI 10.1007/s00216-013-6856-7; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Kyle J, 2000, PASTURE PRODUCTION; Lee CH, 2005, FOOD CHEM, V90, P735, DOI 10.1016/j.foodchem.2004.04.034; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Lozovaya VV, 2004, PLANT PHYSIOL BIOCH, V42, P671, DOI 10.1016/j.plaphy.2004.06.007; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Lygin AV, 2010, PHYTOPATHOLOGY, V100, P897, DOI 10.1094/PHYTO-100-9-0897; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; McDonald KL, 1999, EUR J PLANT PATHOL, V105, P651, DOI 10.1023/A:1008705321113; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; Nakabayashi R, 2013, ANAL BIOANAL CHEM, P1; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Raman SB, 2004, PLANT SCI, V167, P961, DOI 10.1016/j.plantsci.2004.06.019; Ribeiro APB, 2009, FOOD RES INT, V42, P401, DOI 10.1016/j.foodres.2009.01.012; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Sato D, 2013, J CHROMATOGR B, V925, P95, DOI 10.1016/j.jchromb.2013.02.036; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shahidi F, 2009, TRENDS FOOD SCI TECH, V20, P376, DOI 10.1016/j.tifs.2008.08.004; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Takahashi H, 2008, PLANT SIGNAL BEHAV, V3, P945, DOI 10.4161/psb.6112; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Walters D, 2003, NEW PHYTOL, V159, P109, DOI 10.1046/j.1469-8137.2003.00802.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P115; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109	63	64	67	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111930	10.1371/journal.pone.0111930	http://dx.doi.org/10.1371/journal.pone.0111930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369450	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402000128
J	Boyer, S; Miarinjara, A; Elissa, N				Boyer, Sebastien; Miarinjara, Adelaide; Elissa, Nohal			Xenopsylla cheopis (Siphonaptera: Pulicidae) Susceptibility to Deltamethrin in Madagascar	PLOS ONE			English	Article							YERSINIA-PESTIS; PLAGUE; RESISTANCE; EMERGENCE; HISTORY; MAMMALS; RISK	The incidence of bubonic plague in Madagascar is high. This study reports the susceptibility of 32 different populations of a vector, the flea Xenopsylla cheopis (Siphonaptera: Pulicidae), to the insecticide Deltamethrin. Despite the use of Deltamethrin against fleas, plague epidemics have re-emerged in Madagascar. The majority of the study sites were located in the Malagasy highlands where most plague cases have occurred over the last 10 years. X. cheopis fleas were tested for susceptibility to Deltamethrin (0.05%): only two populations were susceptible to Deltamethrin, four populations were tolerant and 26 populations were resistant. KD50 (50% Knock-Down) and KD90 (90% Knock-Down) times were determined, and differed substantially from 9.4 to 592.4 minutes for KD50 and 10.4 min to 854.3 minutes for KD90. Susceptibility was correlated with latitude, but not with longitude, history of insecticide use nor date of sampling. Combined with the number of bubonic plague cases, our results suggest that an immediate switch to an insecticide other than Deltamethrin is required for plague vector control in Madagascar.	[Boyer, Sebastien; Miarinjara, Adelaide; Elissa, Nohal] Inst Pasteur Madagascar, Unite Entomol Med, Antananarivo, Madagascar; [Miarinjara, Adelaide] Univ Antananarivo, Ecole Doctorale Sci Vie & Environm, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University Antananarivo	Boyer, S (corresponding author), Inst Pasteur Madagascar, Unite Entomol Med, Antananarivo, Madagascar.	seboyer@pasteur.mg	Miarinjara, Adélaïde/AGF-1036-2022; Miarinjara, Adelaide/AGJ-9381-2022	Miarinjara, Adelaide/0000-0001-6251-8890; Boyer, Sebastien/0000-0002-2946-586X				Andrianaivoarimanana V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002382; [Anonymous], 1998, TEST PROC INS RES MO; BRYGOO E. R., 1966, Arch. Inst. Pasteur Madagascar, V35, P9; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; Carniel E, 2002, CR BIOL, V325, P851, DOI 10.1016/S1631-0691(02)01493-2; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; COULANGES P, 1984, Archives de l'Institut Pasteur de Madagascar, V51, P253; COULANGES P, 1984, B SOC PATHOL EXOT, V77, P705; Coulanges P, 1982, Arch Inst Pasteur Madagascar, V49, P171; Duchemin J-B, 2003, THESIS U PARIS 12 VA; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Fontenille D, 1987, ARCH I PASTEUR MADAG, V53, P249; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gratz NG, 1980, P INT C FLEAS ROTT, P217; GUEDES RNC, 1994, INT J PEST MANAGE, V40, P103, DOI 10.1080/09670879409371863; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Kasai S, 2007, J MED ENTOMOL, V44, P822, DOI 10.1603/0022-2585(2007)44[822:IRIPVM]2.0.CO;2; Migliani R, 2001, B SOC PATHOL EXOT, V94, P115; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Rahelinirina S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014111; Ratovonjato J., 1998, Archives de l'Institut Pasteur de Madagascar, V64, P25; Ratsitorahina M., 2002, Archives de l'Institut Pasteur de Madagascar, V68, P51; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Tollenaere C, 2010, J BIOGEOGR, V37, P398, DOI 10.1111/j.1365-2699.2009.02228.x; WHO, 2010, RELEVE PIDEMIOLOGIQU, P40; WHO, 1976, REP WHO EXP COMM RES; WHO, 1970, RES INS LUTT ANT DIX; WHO (World Health Organization), 2011, TECHN BAS COORD ACT; World Health Organization, 1981, WHOVBC81815; World health organization, 2013, WORLD HLTH STAT 2013	32	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111998	10.1371/journal.pone.0111998	http://dx.doi.org/10.1371/journal.pone.0111998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369291	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000135
J	Mares, J; Hajek, J; Urajova, P; Kopecky, J; Hrouzek, P				Mares, Jan; Hajek, Jan; Urajova, Petra; Kopecky, Jiri; Hrouzek, Pavel			A Hybrid Non-Ribosomal Peptide/Polyketide Synthetase Containing Fatty-Acyl Ligase (FAAL) Synthesizes the beta-Amino Fatty Acid Lipopeptides Puwainaphycins in the Cyanobacterium Cylindrospermum alatosporum	PLOS ONE			English	Article							PEPTIDE SYNTHETASE; GENE-CLUSTER; MOLECULAR CHARACTERIZATION; CYCLIC-PEPTIDES; ITURIN-A; SURFACTIN; BIOSYNTHESIS; MICROCYSTIN; POLYKETIDE; SEQUENCE	A putative operon encoding the biosynthetic pathway for the cytotoxic cyanobacterial lipopeptides puwainphycins was identified in Cylindrospermum alatosporum. Bioinformatics analysis enabled sequential prediction of puwainaphycin biosynthesis; this process is initiated by the activation of a fatty acid residue via fatty acyl-AMP ligase and continued by a multidomain non-ribosomal peptide synthetase/polyketide synthetase. High-resolution mass spectrometry and nuclear magnetic resonance spectroscopy measurements proved the production of puwainaphycin F/G congeners differing in FA chain length formed by either 3-amino-2-hydroxy-4-methyl dodecanoic acid (4-methyl-Ahdoa) or 3-amino-2-hydroxy-4-methyl tetradecanoic acid (4-methyl-Ahtea). Because only one puwainaphycin operon was recovered in the genome, we suggest that the fatty acyl-AMP ligase and one of the amino acid adenylation domains (Asn/Gln) show extended substrate specificity. Our results provide the first insight into the biosynthesis of frequently occurring beta-amino fatty acid lipopeptides in cyanobacteria, which may facilitate analytical assessment and development of monitoring tools for cytotoxic cyanobacterial lipopeptides.	[Mares, Jan; Hajek, Jan; Urajova, Petra; Kopecky, Jiri; Hrouzek, Pavel] Inst Microbiol AS CR, ALGATECH, Dept Phototroph Microorganisms, Vvi, Trebon, Czech Republic; [Mares, Jan; Hajek, Jan] Acad Sci Czech Republ, Inst Hydrobiol, Vvi, Biol Ctr AS CR, Ceske Budejovice, Czech Republic; [Mares, Jan] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Hajek, Jan] Univ South Bohemia, Fac Sci, Dept Mol Biol & Genet, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Hrouzek, P (corresponding author), Inst Microbiol AS CR, ALGATECH, Dept Phototroph Microorganisms, Vvi, Trebon, Czech Republic.	hrouzekp@gmail.com	Urajová, Petra/I-1663-2014; Mareš, Jan/B-2395-2009	Mareš, Jan/0000-0002-5745-7023; Hrouzek, Pavel/0000-0002-2061-0266	Grant Agency of the Czech Republic [14-18067S]; Center for Algal Biotechnology Trebon - ALGATECH [CZ. 1.05/21.00/03.0110]; European Union [EFRE RU2-EU-124/100-2010, M00146]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Center for Algal Biotechnology Trebon - ALGATECH; European Union(European Commission)	This study was supported by the Grant Agency of the Czech Republic, project "Toxic potential, Evolution of Toxin Synthesis and Factors Driving Anatoxin-a Production in Benthic and Soil Nostocacean Cyanobacteria'' (No. 14-18067S) and by the Center for Algal Biotechnology Trebon - ALGATECH (CZ. 1.05/21.00/03.0110). The NMR experiments were performed at the Upper Austrian - South Bohemian Research Infrastructure Center in Linz, co-financed by the European Union in the context of the project "RERI-uasb'', EFRE RU2-EU-124/100-2010 (ETC Austria-Czech Republic 2007-2013, project M00146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; An TY, 2007, J NAT PROD, V70, P730, DOI 10.1021/np060389p; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fewer DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073618; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FRANKMOLLE WP, 1992, J ANTIBIOT, V45, P1458, DOI 10.7164/antibiotics.45.1458; GERWICK WH, 1992, TETRAHEDRON, V48, P2313, DOI 10.1016/S0040-4020(01)88753-6; GREGSON JM, 1992, TETRAHEDRON, V48, P3727, DOI 10.1016/S0040-4020(01)92264-1; HELMS GL, 1988, J ORG CHEM, V53, P1298, DOI 10.1021/jo00241a033; Horgen FD, 2000, J NAT PROD, V63, P461, DOI 10.1021/np990449+; Hrouzek P, 2012, CHEM RES TOXICOL, V25, P1203, DOI 10.1021/tx300044t; Johansen JR, 2014, J PHYCOL, V50, P187, DOI 10.1111/jpy.12150; Jokela J, 2012, PLOS ONE, V7; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jungblut AD, 2006, ARCH MICROBIOL, V185, P107, DOI 10.1007/s00203-005-0073-5; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P1669, DOI 10.1080/00021369.1969.10859524; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P973, DOI 10.1080/00021369.1969.10859409; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P971, DOI 10.1080/00021369.1969.10859408; KAKINUMA A, 1969, AGR BIOL CHEM TOKYO, V33, P1523, DOI 10.1080/00021369.1969.10859499; Kang HS, 2012, BIOORGAN MED CHEM, V20, P6134, DOI 10.1016/j.bmc.2012.08.017; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kurmayer R, 2002, MICROB ECOL, V43, P107, DOI 10.1007/s00248-001-0039-3; MacMillan JB, 2002, J ORG CHEM, V67, P8210, DOI 10.1021/jo0261909; Maru N, 2010, TETRAHEDRON LETT, V51, P6384, DOI 10.1016/j.tetlet.2010.06.105; Mihali TK, 2008, APPL ENVIRON MICROB, V74, P716, DOI 10.1128/AEM.01988-07; Moffitt MC, 2004, APPL ENVIRON MICROB, V70, P6353, DOI 10.1128/AEM.70.11.6353-6362.2004; MOON SS, 1992, J ORG CHEM, V57, P1097, DOI 10.1021/jo00030a013; Moyne AL, 2004, FEMS MICROBIOL LETT, V234, P43, DOI [10.1016/j.femsle.2004.03.011, 10.1111/j.1574-6968.2004.tb09511.x]; NAKANO MM, 1991, J BACTERIOL, V173, P1770, DOI 10.1128/jb.173.5.1770-1778.1991; Neuhof T, 2005, J NAT PROD, V68, P695, DOI 10.1021/np049671r; Oftedal L, 2012, BBA-BIOMEMBRANES, V1818, P3000, DOI 10.1016/j.bbamem.2012.07.015; PERGAMENT I, 1994, TETRAHEDRON LETT, V35, P8473, DOI 10.1016/S0040-4039(00)74436-4; PEYPOUX F, 1986, J ANTIBIOT, V39, P636, DOI 10.7164/antibiotics.39.636; Plaza A, 2009, J ORG CHEM, V74, P486, DOI 10.1021/jo802553j; Rantala-Ylinen A, 2011, APPL ENVIRON MICROB, V77, P7271, DOI 10.1128/AEM.06022-11; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Rounge TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-396; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tsuge K, 2001, J BACTERIOL, V183, P6265, DOI 10.1128/JB.183.21.6265-6273.2001; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Vestola J, 2014, P NATL ACAD SCI USA, V111, pE1909, DOI 10.1073/pnas.1320913111; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Yao SY, 2003, CURR MICROBIOL, V47, P272, DOI 10.1007/s00284-002-4008-y; Zainuddin EN, 2009, J NAT PROD, V72, P1373, DOI 10.1021/np8007792; Zapomelova E, 2008, J PLANKTON RES, V30, P1257, DOI 10.1093/plankt/fbn081; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	54	43	43	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111904	10.1371/journal.pone.0111904	http://dx.doi.org/10.1371/journal.pone.0111904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369527	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000121
J	Takata, K; Kato, H; Shimosegawa, E; Okuno, T; Koda, T; Sugimoto, T; Mochizuki, H; Hatazawa, J; Nakatsuji, Y				Takata, Kazushiro; Kato, Hiroki; Shimosegawa, Eku; Okuno, Tatsusada; Koda, Toru; Sugimoto, Tomoyuki; Mochizuki, Hideki; Hatazawa, Jun; Nakatsuji, Yuji			C-11-Acetate PET Imaging in Patients with Multiple Sclerosis	PLOS ONE			English	Article							APPEARING WHITE-MATTER; COGNITIVE DYSFUNCTION; BRAIN; METABOLISM; ACETATE; LESIONS; ASTROCYTE; BINDING; MS; 1-C-11-ACETATE	Background: Activation of glial cells is a cardinal feature in multiple sclerosis (MS) pathology, and acetate has been reported to be selectively uptaken by astrocytes in the CNS. The aim of this study was to investigate the efficacy of PET with C-11-acetate for MS diagnosis. Materials and Methods: Six patients with relapsing-remitting MS and 6 healthy volunteers (HV) were enrolled. The C-11-acetate brain uptake on PET was measured in patients with MS and HV. Volume-of-interest analysis of cerebral gray and white matter based on the segmentation technique for co-registered MRI and voxel-based statistical parametric analysis were performed. Correlation between C-11-acetate uptake and the lesion number in T1-and T2-weighted MR images were also assessed. Results: The standardized uptake value (SUV) of C-11-acetate was increased in both white and gray matter in MS patients compared to HV. Voxel-based statistical analysis revealed a significantly increased SUV relative to that in the bilateral thalami (SUVt) in a broad area of white matter, particularly in the subcortical white matter of MS patients. The numbers of T2 lesions and T1 black holes were significantly correlated with SUV of C-11-acetate in white and gray matter. Conclusions: The C-11-acetate uptake significantly increased in MS patients and correlated to the number of MRI lesions. These preliminary data suggest that C-11-acetate PET can be a useful clinical examination for MS patients.	[Takata, Kazushiro; Okuno, Tatsusada; Koda, Toru; Mochizuki, Hideki; Nakatsuji, Yuji] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Kato, Hiroki; Shimosegawa, Eku; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Sugimoto, Tomoyuki] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori, Japan; [Hatazawa, Jun] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan	Osaka University; Osaka University; Hirosaki University; Osaka University	Hatazawa, J (corresponding author), Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan.	hatazawa@tracer.med.osaka-u.ac.jp; yuji@neurol.med.osaka-u.ac.jp	Sugimoto, Tomoyuki/J-9717-2019		Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science; Japan Society for the Promotion of Science KAKENHI [23592089]; Grants-in-Aid for Scientific Research [25860712] Funding Source: KAKEN	Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan, by a Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (YN and TO) and by the Japan Society for the Promotion of Science KAKENHI Grant Number 23592089 (HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Black JA, 2010, BRAIN, V133, P835, DOI 10.1093/brain/awq003; Blinkenberg M, 2000, NEUROLOGY, V54, P558, DOI 10.1212/WNL.54.3.558; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; BROWN M, 1987, CIRCULATION, V76, P687, DOI 10.1161/01.CIR.76.3.687; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Fernando KTM, 2004, BRAIN, V127, P1361, DOI 10.1093/brain/awh153; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Ho CL, 2003, J NUCL MED, V44, P213; Hosoi R, 2004, J CEREBR BLOOD F MET, V24, P188, DOI 10.1097/01.WCB.0000098606.42140.02; Hosoi R, 2009, BRAIN RES, V1253, P69, DOI 10.1016/j.brainres.2008.11.068; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; ISHIWATA K, 1995, APPL RADIAT ISOTOPES, V46, P1035, DOI 10.1016/0969-8043(95)00194-I; Kato H, 2012, AM J NEURORADIOL, V33, P1458, DOI 10.3174/ajnr.A3005; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lin C, 2014, EUR J NUCL MED MOL I, V41, P41, DOI 10.1007/s00259-013-2520-x; Liu RS, 2006, EUR J NUCL MED MOL I, V33, P420, DOI 10.1007/s00259-005-0023-0; Naismith RT, 2010, NEUROLOGY, V74, P1694, DOI 10.1212/WNL.0b013e3181e042c4; Nijland PG, 2014, GLIA, V62, P1125, DOI 10.1002/glia.22667; Odenthal A, 2014, AJNR AM J NEURORADIO; Oyama N, 2002, J NUCL MED, V43, P181; Oyama N, 2009, EUR J NUCL MED MOL I, V36, P422, DOI 10.1007/s00259-008-0981-0; Politis M, 2012, NEUROLOGY, V79, P523, DOI 10.1212/WNL.0b013e3182635645; Sahraian MA, 2010, ACTA NEUROL SCAND, V122, P1, DOI 10.1111/j.1600-0404.2009.01221.x; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; Sormani MP, 2013, LANCET NEUROL, V12, P669, DOI 10.1016/S1474-4422(13)70103-0; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; VANDENBERG CJ, 1966, BIOCHEM BIOPH RES CO, V23, P479, DOI 10.1016/0006-291X(66)90753-4; Vercellino M, 2007, J NEUROPATH EXP NEUR, V66, P732, DOI 10.1097/nen.0b013e31812571b0; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Wyss MT, 2011, J CEREBR BLOOD F MET, V31, P1668, DOI 10.1038/jcbfm.2011.84; Wyss MT, 2009, J CEREBR BLOOD F MET, V29, P44, DOI 10.1038/jcbfm.2008.86	40	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111598	10.1371/journal.pone.0111598	http://dx.doi.org/10.1371/journal.pone.0111598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369426	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000072
J	Kuhn, N; Abello, C; Godoy, F; Delrot, S; Arce-Johnson, P				Kuehn, Nathalie; Abello, Carlos; Godoy, Francisca; Delrot, Serge; Arce-Johnson, Patricio			Differential Behavior within a Grapevine Cluster: Decreased Ethylene-Related Gene Expression Dependent on Auxin Transport Is Correlated with Low Abscission of First Developed Berries	PLOS ONE			English	Article							VITIS-VINIFERA L.; APPLE FRUITLET ABSCISSION; SIGNALING PATHWAYS; SYNTHASE GENES; BIOSYNTHESIS; TOMATO; ACID; GROWTH; ARABIDOPSIS; SET	In grapevine, fruit abscission is known to occur within the first two to three weeks after flowering, but the reason why some berries in a cluster persist and others abscise is not yet understood. Ethylene sensitivity modulates abscission in several fruit species, based on a mechanism where continuous polar auxin transport across the pedicel results in a decrease in ethylene perception, which prevents abscission. In grapevine, flowering takes about four to seven days in a single cluster, thus while some flowers are developing into berries, others are just starting to open. So, in this work it was assessed whether uneven flowering accounted for differences in berry abscission dependent on polar auxin transport and ethylene-related gene expression. For this, flowers that opened in a cluster were tagged daily, which allowed to separately analyze berries, regarding their ability to persist. It was found that berries derived from flowers that opened the day that flowering started named as "first berries'' - had lower abscission rate than berries derived from flowers that opened during the following days - named as "late berries''. Use of radiolabeled auxin showed that "first berries'' had higher polar auxin transport, correlated with lower ethylene content and lower ethylene-related transcript abundance than "late berries''. When "first berries'' were treated with a polar auxin transport inhibitor they showed higher ethylene-related transcript abundance and were more prone to abscise than control berries. This study provides new insights on fruit abscission control. Our results indicate that polar auxin transport sustains the ability of "first berries'' to persist in the cluster during grapevine abscission and also suggest that this could be associated with changes in ethylene-related gene expression.	[Kuehn, Nathalie; Abello, Carlos; Godoy, Francisca; Arce-Johnson, Patricio] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Santiago, Chile; [Delrot, Serge] Univ Bordeaux, ISVV, INRA, EGFV,UMR 1287, Villenave Dornon, France	Pontificia Universidad Catolica de Chile; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Arce-Johnson, P (corresponding author), Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.	parce@bio.puc.cl	Kuhn, Nathalie/ABD-4529-2021	Kuhn, Nathalie/0000-0002-4980-6211; Delrot, Serge/0000-0001-9602-0441; Godoy Santin, Maria Francisca/0000-0002-3270-2299	ECOS-CONICYT [C11B01]; Millennium Nucleus Center for Plant Functional Genomics [P10-062]; FONDECYT [1100709]; CONICYT Fellowships	ECOS-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Nucleus Center for Plant Functional Genomics; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Fellowships	Funding provided by ECOS-CONICYT, project number C11B01, http://www.conicyt.cl/pci/category/lineas-del-programa/movilidad-lineas-del-programa/?anio=2011, Millennium Nucleus Center for Plant Functional Genomics P10-062, FONDECYT 1100709, http://w1.conicyt.cl/bases/fondecyt/proyectos/01/2010/1100709.html, CONICYT Fellowships, http://www.conicyt.cl/becas-conicyt/sobre-becas-conicyt/que-es-becas-conicyt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteca JM, 1999, PLANT MOL BIOL, V39, P209, DOI 10.1023/A:1006177902093; Bangerth F, 2000, PLANT GROWTH REGUL, V31, P43, DOI 10.1023/A:1006398513703; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Bennett M, 2005, PHYSIOL PLANTARUM, V123, P109, DOI 10.1111/j.1399-3054.2005.00483.x; BESSIS R, 1992, VITIS, V31, P9; Bessis R., 2000, Australian Journal of Grape and Wine Research, V6, P125, DOI 10.1111/j.1755-0238.2000.tb00170.x; Blanusa T, 2005, PLANT GROWTH REGUL, V45, P189, DOI 10.1007/s10725-005-3568-9; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Brown KM, 1997, PHYSIOL PLANTARUM, V100, P567, DOI 10.1034/j.1399-3054.1997.1000319.x; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Serrani JC, 2010, PLANT PHYSIOL, V153, P851, DOI 10.1104/pp.110.155424; Chervin C, 2010, VITIS, V49, P129; Ciardi J, 2001, ANN BOT-LONDON, V88, P813, DOI 10.1006/anbo.2001.1523; COOMBE BG, 1960, PLANT PHYSIOL, V35, P241, DOI 10.1104/pp.35.2.241; Costantini E, 2007, PLANT PHYSIOL, V143, P1689, DOI 10.1104/pp.106.095232; Dal Cin V, 2005, J EXP BOT, V56, P2995, DOI 10.1093/jxb/eri296; Dal Cin V, 2006, POSTHARVEST BIOL TEC, V42, P125, DOI 10.1016/j.postharvbio.2006.06.008; Dauelsberg P, 2011, J PLANT PHYSIOL, V168, P1667, DOI 10.1016/j.jplph.2011.03.006; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; Dokoozlian NK, 2001, HORTSCIENCE, V36, P706, DOI 10.21273/HORTSCI.36.4.706; Downey MO, 2003, AUST J GRAPE WINE R, V9, P110, DOI 10.1111/j.1755-0238.2003.tb00261.x; Else MA, 2004, J EXP BOT, V55, P2099, DOI 10.1093/jxb/erh208; Friend AP, 2003, AM J ENOL VITICULT, V54, P313; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; GRUBER J, 1990, PHYSIOL PLANTARUM, V79, P354; Hilt C, 2003, VITIS, V42, P1; Iannetta PPM, 2000, PHYSIOL PLANTARUM, V110, P535, DOI [10.1111/j.1399-3054.2000.1100417.x, 10.1034/j.1399-3054.2000.1100417.x]; Intrigliolo DS, 2009, VITIS, V48, P53; LEE JS, 1990, PLANT PHYSIOL, V94, P1770, DOI 10.1104/pp.94.4.1770; Lijavetzky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039547; Liu X, 2011, PLANT PHYSIOL, V157, P891, DOI 10.1104/pp.111.181388; Llop-Tous I, 2000, PLANT PHYSIOL, V123, P971, DOI 10.1104/pp.123.3.971; Mariotti L, 2011, J PLANT GROWTH REGUL, V30, P405, DOI 10.1007/s00344-011-9204-1; Meir S, 2006, PLANT PHYSIOL, V141, P1604, DOI 10.1104/pp.106.079277; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; MORGAN PW, 1966, PLANT PHYSIOL, V41, P45, DOI 10.1104/pp.41.1.45; Nick P, 2009, PLANT PHYSIOL, V151, P155, DOI 10.1104/pp.109.140111; Ojeda H, 1999, VITIS, V38, P145; ONeill SD, 1997, ANNU REV PLANT PHYS, V48, P547, DOI 10.1146/annurev.arplant.48.1.547; Perez FJ, 2000, AM J ENOL VITICULT, V51, P315; Petruzzelli L, 2000, PLANTA, V211, P144, DOI 10.1007/s004250000274; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; PRATT C, 1973, J AM SOC HORTIC SCI, V98, P489; PRATT C, 1971, AM J ENOL VITICULT, V22, P92; Ruperti B, 1998, PLANT CELL ENVIRON, V21, P731, DOI 10.1046/j.1365-3040.1998.00305.x; SEXTON R, 1982, ANNU REV PLANT PHYS, V33, P133, DOI 10.1146/annurev.pp.33.060182.001025; SUTTLE JC, 1988, PLANT PHYSIOL, V88, P795, DOI 10.1104/pp.88.3.795; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vega A, 2011, PLANT MOL BIOL, V77, P261, DOI 10.1007/s11103-011-9807-8; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang NN, 2005, J EXP BOT, V56, P909, DOI 10.1093/jxb/eri083; Yang XT, 2013, POSTHARVEST BIOL TEC, V78, P55, DOI 10.1016/j.postharvbio.2012.11.012	55	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111258	10.1371/journal.pone.0111258	http://dx.doi.org/10.1371/journal.pone.0111258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365421	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100058
J	Li, SY; Zhai, X; Rong, PJ; McCabe, MF; Wang, X; Zhao, JJ; Ben, H; Wang, SX				Li, Shaoyuan; Zhai, Xu; Rong, Peijing; McCabe, Michael F.; Wang, Xing; Zhao, Jingjun; Ben, Hui; Wang, Shuxing			Therapeutic Effect of Vagus Nerve Stimulation on Depressive-Like Behavior, Hyperglycemia and Insulin Receptor Expression in Zucker Fatty Rats	PLOS ONE			English	Article							ACUPUNCTURE; MELATONIN; DISORDER; OBESITY; MEMORY; TRIAL	Depression and type 2 diabetes (T2D) are common comorbid diseases and highly prevalent in the clinical setting with an unclarified mechanism. Zucker diabetic fatty (ZDF, fa/fa) rats natively develop T2D with hyperglycemia and hyperinsulinemia. Here we studied whether ZDF rats also innately develop depression, what a correlation is between depression and T2D, whether insulin receptor (IR) expression is involved in, and whether transcutaneous auricular vagus nerve stimulation (taVNS) would be beneficial in amelioration of the comorbidity. Six week old male ZDF and Zucker lean (ZL, fa/+) littermates were randomly divided into naive (ZDF, n = 6; ZL, n = 7) and taVNS (ZDF-taVNS, n = 8; ZL-taVNS, n = 6) groups. Once daily 30 min-taVNS sessions were administrated under anesthesia for 34 consecutive days in taVNS groups. Blood glucose levels were tested weekly, and plasma glycosylated hemoglobin (HbAlc) level and immobility time in forced swimming test were determined on day 35 in all groups. The expression of insulin receptor (IR) in various tissues was also detected by immunostaining and Western blot. We found that naive ZDF rats developed hyperglycemia steadily. These ZDF rats showed a strong positive correlation between longer immobility time and higher plasma HbAlC level. Long term taVNS treatment simultaneously prevented the development of depression-like behavior and progression of hyperglycemia in ZDF rats. The expression of IR in various tissues of naive ZDF rats is lower than in naive ZL and long-term taVNS treated ZDF rats. Collectively, our results indicate that in ZDF rats, i) depression and T2D develop simultaneously, ii) immobility time and HbAlc concentrations are highly and positively correlated, iii) a low expression of IR may be involved in the comorbidity of depression and T2D, and iv) taVNS is antidiabetic and antidepressive possibly through IR expression upregulation.	[Li, Shaoyuan; Zhai, Xu; Rong, Peijing; Zhao, Jingjun; Ben, Hui; Wang, Shuxing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China; [Li, Shaoyuan; Wang, Xing; Wang, Shuxing] Xinxiang Med Univ, Dept Anat, Xinxiang, Henan, Peoples R China; [McCabe, Michael F.; Wang, Shuxing] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Wang, Shuxing] Guangdong Entomol Inst, Primate Res Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Shuxing] Guangdong Landau Biotechnol Co Ltd, Guangzhou, Guangdong, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Xinxiang Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Rong, PJ (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China.	rongpj@hotmail.com; 13718103762@139.com	zhao, jing/B-3868-2019		National Natural Science Foundation of China [81271243]; National Basic Research Program of China (973 Program) [2012CB518503]; Project Supported National Science and Technology Ministry [2012BAF14B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Project Supported National Science and Technology Ministry	This work was supported by National Natural Science Foundation of China, 81271243; National Basic Research Program of China (973 Program), 2012CB518503; and Project Supported National Science and Technology Ministry, 2012BAF14B10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agil A, 2012, J PINEAL RES, V52, P203, DOI 10.1111/j.1600-079X.2011.00928.x; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Belivani M, 2013, ACUPUNCT MED, V31, P88, DOI 10.1136/acupmed-2012-010247; Buhl ES, 2010, AM J PHYSIOL-ENDOC M, V298, pE920, DOI 10.1152/ajpendo.00606.2009; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Cline BH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-110; Foran E, 2014, IR J MED SCI; Frese T, 2009, LIFE SCI, V85, P526, DOI 10.1016/j.lfs.2009.08.004; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Grillo CA, 2011, BEHAV BRAIN RES, V222, P230, DOI 10.1016/j.bbr.2011.03.052; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/615476; Huang F, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-203; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Liu RP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789674; Lyons Zaza, 2012, Complement Ther Clin Pract, V18, P216, DOI 10.1016/j.ctcp.2012.06.003; MAURIZI CP, 1984, SOUTH MED J, V77, P1516, DOI 10.1097/00007611-198412000-00010; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Mendenhall E, 2014, DIABETES RES CLIN PR, V103, P276, DOI 10.1016/j.diabres.2014.01.001; Mischoulon D, 2012, J AFFECT DISORDERS, V141, P469, DOI 10.1016/j.jad.2012.03.023; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peplow PV, 2012, J ACUPUNCT MERIDIAN, V5, P1, DOI 10.1016/j.jams.2011.11.018; Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052; Rong PJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-255; Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Wang Q, 2012, AM J CHINESE MED, V40, P1157, DOI 10.1142/S0192415X12500851; Wang SX, 2012, PAIN, V153, P2448, DOI 10.1016/j.pain.2012.08.016; Ward KR, 2011, HYPERTENSION, V57, P435, DOI 10.1161/HYPERTENSIONAHA.110.160671; Wilding JPH, 2014, INT J CLIN PRACT, V68, P682, DOI 10.1111/ijcp.12384; Yeung AS, 2011, J AFFECT DISORDERS, V130, P285, DOI 10.1016/j.jad.2010.07.025; Zeng Q, 2008, BRAIN RES, V1200, P27, DOI 10.1016/j.brainres.2008.01.038; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	35	19	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e112066	10.1371/journal.pone.0112066	http://dx.doi.org/10.1371/journal.pone.0112066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365428	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100144
J	Rawat, A; Engelthaler, DM; Driebe, EM; Keim, P; Foster, JT				Rawat, Arun; Engelthaler, David M.; Driebe, Elizabeth M.; Keim, Paul; Foster, Jeffrey T.			MetaGeniE: Characterizing Human Clinical Samples Using Deep Metagenomic Sequencing	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PATHOGEN IDENTIFICATION; READ ALIGNMENT; PLATFORMS; TOOL	With the decreasing cost of next-generation sequencing, deep sequencing of clinical samples provides unique opportunities to understand host-associated microbial communities. Among the primary challenges of clinical metagenomic sequencing is the rapid filtering of human reads to survey for pathogens with high specificity and sensitivity. Metagenomes are inherently variable due to different microbes in the samples and their relative abundance, the size and architecture of genomes, and factors such as target DNA amounts in tissue samples (i.e. human DNA versus pathogen DNA concentration). This variation in metagenomes typically manifests in sequencing datasets as low pathogen abundance, a high number of host reads, and the presence of close relatives and complex microbial communities. In addition to these challenges posed by the composition of metagenomes, high numbers of reads generated from high-throughput deep sequencing pose immense computational challenges. Accurate identification of pathogens is confounded by individual reads mapping to multiple different reference genomes due to gene similarity in different taxa present in the community or close relatives in the reference database. Available global and local sequence aligners also vary in sensitivity, specificity, and speed of detection. The efficiency of detection of pathogens in clinical samples is largely dependent on the desired taxonomic resolution of the organisms. We have developed an efficient strategy that identifies "all against all'' relationships between sequencing reads and reference genomes. Our approach allows for scaling to large reference databases and then genome reconstruction by aggregating global and local alignments, thus allowing genetic characterization of pathogens at higher taxonomic resolution. These results were consistent with strain level SNP genotyping and bacterial identification from laboratory culture.	[Rawat, Arun; Engelthaler, David M.; Driebe, Elizabeth M.; Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ 86001 USA; [Keim, Paul; Foster, Jeffrey T.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Foster, Jeffrey T.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	Translational Genomics Research Institute; Northern Arizona University; University System Of New Hampshire; University of New Hampshire	Rawat, A (corresponding author), Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ 86001 USA.	rawat.arun@gmail.com; jeff.foster@nau.edu	Rawat, Arun/ABD-6248-2021; Rawat, Arun/Q-2520-2019; Rawat, Arun/AAD-1534-2019	Rawat, Arun/0000-0003-0540-2044; Foster, Jeffrey/0000-0001-8235-8564	Department of Defense-United States Army Medical Research & Materiel Command, Telemedicine & Advanced Technology Research Center; United States Department of Homeland Security (DHS)	Department of Defense-United States Army Medical Research & Materiel Command, Telemedicine & Advanced Technology Research Center; United States Department of Homeland Security (DHS)(United States Department of Homeland Security (DHS))	Funding from the Department of Defense-United States Army Medical Research & Materiel Command, Telemedicine & Advanced Technology Research Center supported this work as well as funding from the United States Department of Homeland Security (DHS). Use of product or trade names does not constitute endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; Bhaduri A, 2012, BIOINFORMATICS, V28, P1174, DOI 10.1093/bioinformatics/bts100; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Coutinho Henrique Douglas M, 2008, Int Arch Med, V1, P24, DOI 10.1186/1755-7682-1-24; Darling A. E., 2010, PLOS ONE, V5; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Dimon MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064546; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Kuroda M, 2012, J CLIN MICROBIOL, V50, P1810, DOI 10.1128/JCM.06715-11; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Liu JS, 2013, OMEGA-INT J MANAGE S, V41, P3, DOI 10.1016/j.omega.2010.12.006; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rawat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030370; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Svraka S, 2010, J GEN VIROL, V91, P2846, DOI 10.1099/vir.0.024612-0; Takeuchi F, 2014, JPN J INFECT DIS, V67, P62, DOI 10.7883/yoken.67.62; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110915	10.1371/journal.pone.0110915	http://dx.doi.org/10.1371/journal.pone.0110915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365329	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100033
J	Abed, RMM; Polerecky, L; Al-Habsi, A; Oetjen, J; Strous, M; de Beer, D				Abed, Raeid M. M.; Polerecky, Lubos; Al-Habsi, Amal; Oetjen, Janina; Strous, Marc; de Beer, Dirk			Rapid Recovery of Cyanobacterial Pigments in Desiccated Biological Soil Crusts following Addition of Water	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; TOLERANT CYANOBACTERIUM; BACTERIAL DIVERSITY; MICROBIOTIC CRUSTS; NITROGEN-FIXATION; UV; MECHANISMS; MATS; REHYDRATION; SCYTONEMIN	We examined soil surface colour change to green and hydrotaxis following addition of water to biological soil crusts using pigment extraction, hyperspectral imaging, microsensors and C-13 labeling experiments coupled to matrix-assisted laser desorption and ionization time of flight-mass spectrometry (MALD-TOF MS). The topsoil colour turned green in less than 5 minutes following water addition. The concentrations of chlorophyll a (Chl a), scytonemin and echinenon rapidly increased in the top,1 mm layer while in the deeper layer, their concentrations remained low. Hyperspectral imaging showed that, in both wet and dehydrated crusts, cyanobacteria formed a layer at a depth of 0.2-0.4 mm and this layer did not move upward after wetting. C-13 labeling experiments and MALDI TOF analysis showed that Chl a was already present in the desiccated crusts and de novo synthesis of this molecule started only after 2 days of wetting due to growth of cyanobacteria. Microsensor measurements showed that photosynthetic activity increased concomitantly with the increase of Chl a, and reached a maximum net rate of 92 mu mol m(-2) h(-1) approximately 2 hours after wetting. We conclude that the colour change of soil crusts to green upon water addition was not due to hydrotaxis but rather to the quick recovery and reassembly of pigments. Cyanobacteria in crusts can maintain their photosynthetic apparatus intact even under prolonged periods of desiccation with the ability to resume their photosynthetic activities within minutes after wetting.	[Abed, Raeid M. M.; Al-Habsi, Amal] Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khoud, Oman; [Polerecky, Lubos; Strous, Marc; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Oetjen, Janina] Univ Bremen, MALDI Imaging Lab, D-28359 Bremen, Germany; [Strous, Marc] Univ Calgary, Dept Geosci, Calgary, AB, Canada	Sultan Qaboos University; Max Planck Society; University of Bremen; University of Calgary	Abed, RMM (corresponding author), Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khoud, Oman.	rabed@mpi-bremen.de	Strous, Marc/B-4064-2017; de Beer, Dirk/L-4840-2013; Polerecky, Lubos/E-1134-2014	Strous, Marc/0000-0001-9600-3828; de Beer, Dirk/0000-0001-5274-1781; Oetjen, Janina/0000-0002-4088-5742; Polerecky, Lubos/0000-0003-4425-585X	Research Council (TRC) of Oman [RC/SCI/BIOL/11/01]; Max-Planck Society; ERC (MASEM) [242635]	Research Council (TRC) of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Max-Planck Society(Max Planck SocietyFoundation CELLEX); ERC (MASEM)	This research was funded by The Research Council (TRC) of Oman (grant RC/SCI/BIOL/11/01), the Max-Planck Society and the ERC (MASEM, 242635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2008, FEMS MICROBIOL ECOL, V65, P449, DOI 10.1111/j.1574-6941.2008.00537.x; Abed RMM, 2012, FEMS MICROBIOL ECOL, V80, P294, DOI 10.1111/j.1574-6941.2011.01289.x; Abed RMM, 2010, FEMS MICROBIOL ECOL, V72, P418, DOI 10.1111/j.1574-6941.2010.00854.x; BEALE SI, 1993, MOL BIOL CYANOBACTER, P519; BEBOUT BM, 1995, APPL ENVIRON MICROB, V61, P4215, DOI 10.1128/AEM.61.12.4215-4222.1995; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; CAMERON ROY E., 1962, TRANS AMER MICROSCOP SOC, V81, P379, DOI 10.2307/3223790; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; CAMPBELL SE, 1979, ORIGINS LIFE EVOL B, V9, P335, DOI 10.1007/BF00926826; Dillon JG, 2002, ARCH MICROBIOL, V177, P322, DOI 10.1007/s00203-001-0395-x; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Fleming ED, 2007, ENVIRON MICROBIOL, V9, P1448, DOI 10.1111/j.1462-2920.2007.01261.x; Fukuda S, 2008, PLANT CELL PHYSIOL, V49, P488, DOI 10.1093/pcp/pcn018; Garcia-Pichel F, 2001, NATURE, V413, P380, DOI 10.1038/35096640; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; GIESKES W W C, 1991, Hydrobiological Bulletin, V25, P65, DOI 10.1007/BF02259591; GOLUBIC S, 1976, J PALEONTOL, V50, P1074; Gossauer A, 1996, J PHOTOCH PHOTOBIO B, V32, P141, DOI 10.1016/1011-1344(95)07257-8; Hader DP., 1987, FAY P, P325; Heber U, 2005, PHOTOSYNTH RES, V84, P85, DOI 10.1007/s11120-005-0413-y; Helm RF, 2000, J BACTERIOL, V182, P974, DOI 10.1128/JB.182.4.974-982.2000; Hortensteiner S, 1999, CELL MOL LIFE SCI, V56, P330, DOI 10.1007/s000180050434; Isichei A. O., 1980, Nitrogen cycling in West African ecosystems., P191; Kohls K, 2010, ENVIRON MICROBIOL, V12, P567, DOI 10.1111/j.1462-2920.2009.02095.x; Kruschel C, 1998, FEMS MICROBIOL ECOL, V27, P53, DOI 10.1016/S0168-6496(98)00056-7; Luttge U, 2008, J PLANT PHYSIOL, V165, P172, DOI 10.1016/j.jplph.2007.03.004; Malam Issa O, 2001, SOIL BIOL BIOCHEM, V33, P1425, DOI 10.1016/S0038-0717(01)00046-3; MARTIN CE, 1984, NEW PHYTOL, V96, P545, DOI 10.1111/j.1469-8137.1984.tb03588.x; Maya Y, 2002, GEOMICROBIOL J, V19, P505, DOI 10.1080/01490450290098469; McKew BA, 2011, ISME J, V5, P30, DOI 10.1038/ismej.2010.91; OLIE JJ, 1986, APPL ENVIRON MICROB, V52, P706, DOI 10.1128/AEM.52.4.706-710.1986; PAERL HW, 1985, SCIENCE, V227, P647, DOI 10.1126/science.227.4687.647; PEAT A, 1988, PROTOPLASMA, V146, P72, DOI 10.1007/BF01405915; Polerecky L, 2009, APPL ENVIRON MICROB, V75, P758, DOI 10.1128/AEM.00819-08; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; POTTS M, 1986, ARCH MICROBIOL, V146, P87, DOI 10.1007/BF00690164; Pringault O, 2004, MICROBIAL ECOL, V47, P366, DOI 10.1007/s00248-002-0107-3; Proctor MCF, 2000, J EXP BOT, V51, P1695, DOI 10.1093/jexbot/51.351.1695; Proctor MCF, 2000, PLANT ECOL, V151, P41, DOI 10.1023/A:1026517920852; Rajeev L, 2013, ISME J, V7, P2178, DOI 10.1038/ismej.2013.83; Revsbech N. P., 1989, LIMNOL OCEANOGR, V55, P1907; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Satoh K, 2002, PLANT CELL PHYSIOL, V43, P170, DOI 10.1093/pcp/pcf020; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Wada N, 2013, METABOLITES, V3, P463, DOI 10.3390/metabo3020463; Zeng XQ, 2013, NOVA HEDWIGIA, V96, P511, DOI 10.1127/0029-5035/2013/0097	49	19	20	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112372	10.1371/journal.pone.0112372	http://dx.doi.org/10.1371/journal.pone.0112372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375172	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600136
J	Liu, Z; Fei, Q; Wang, BQ; Lv, PF; Chi, C; Yang, Y; Zhao, F; Lin, JS; Ma, Z				Liu, Zheng; Fei, Qi; Wang, Bingqiang; Lv, Pengfei; Chi, Cheng; Yang, Yong; Zhao, Fan; Lin, Jisheng; Ma, Zhao			A Meta-Analysis of Unilateral versus Bilateral Pedicle Screw Fixation in Minimally Invasive Lumbar Interbody Fusion	PLOS ONE			English	Article							INSTRUMENTATION; POSTERIOR; RIGIDITY	Study Design: Meta-analysis. Background: Bilateral pedicle screw fixation (PS) after lumbar interbody fusion is a widely accepted method of managing various spinal diseases. Recently, unilateral PS fixation has been reported as effective as bilateral PS fixation. This meta-analysis aimed to comparatively assess the efficacy and safety of unilateral PS fixation and bilateral PS fixation in the minimally invasive (MIS) lumbar interbody fusion for one-level degenerative lumbar spine disease. Methods: MEDLINE/PubMed, EMBASE, BIOSIS Previews, and Cochrane Library were searched through March 30, 2014. Randomized controlled trials (RCTs) and controlled clinical trials (CCTs) on unilateral versus bilateral PS fixation in MIS lumbar interbody fusion that met the inclusion criteria and the methodological quality standard were retrieved and reviewed. Data on participant characteristics, interventions, follow-up period, and outcomes were extracted from the included studies and analyzed by Review Manager 5.2. Results: Six studies (5 RCTs and 1 CCT) involving 298 patients were selected. There were no significant differences between unilateral and bilateral PS fixation procedures in fusion rate, complications, visual analogue score (VAS) for leg pain, VAS for back pain, Oswestry disability index (ODI). Both fixation procedures had similar length of hospital stay (MD = 0.38, 95% CI = 20.83 to 1.58; P = 0.54). In contrast, bilateral PS fixation was associated with significantly more intra-operative blood loss (P = 0.002) and significantly longer operation time (P = 0.02) as compared with unilateral PS fixation. Conclusions: Unilateral PS fixation appears as effective and safe as bilateral PS fixation in MIS lumbar interbody fusion but requires less operative time and causes less blood loss, thus offering a simple alternative approach for one-level lumbar degenerative disease.	[Liu, Zheng; Lv, Pengfei; Chi, Cheng] Peking Univ, Shougang Hosp, Dept Orthopaed, Beijing 100871, Peoples R China; [Fei, Qi; Wang, Bingqiang; Yang, Yong; Zhao, Fan; Lin, Jisheng; Ma, Zhao] Capital Med Univ, Beijing Friendship Hosp, Dept Orthopaed, Beijing, Peoples R China	Peking University; Capital Medical University	Fei, Q (corresponding author), Peking Univ, Shougang Hosp, Dept Orthopaed, Beijing 100871, Peoples R China.	spinefei@126.com			Capital Medical University [13JL37]; Beijing Outstanding Talent Training Project [2013D003034000005]	Capital Medical University; Beijing Outstanding Talent Training Project	The study was funded by Basic-Clinical Cooperation Project in Capital Medical University (NO. 13JL37) and Beijing Outstanding Talent Training Project (NO. 2013D003034000005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2010, J NEUROSURG-SPINE, V13, P381, DOI 10.3171/2010.3.SPINE09590; Awad BI, 2013, GLOB SPINE J, V3, P225, DOI 10.1055/s-0033-1349399; Beringer WF, 2006, NEUROSURG FOCUS, V20, P1; Chen HH, 2005, SPINE, V30, pE92, DOI 10.1097/01.brs.0000153703.80747.16; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Chen ZM, 2009, INT ORTHOP, V33, P197, DOI 10.1007/s00264-008-0531-1; Choi UY, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.2.FOCUS12398; Dahdaleh NS, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.5.FOCUS13171; Deutsch H, 2006, NEUROSURG FOCUS, V20, P1, DOI DOI 10.3171/F0C.2006.20.3.11; Ding WB, 2014, EUR SPINE J, V23, P395, DOI 10.1007/s00586-013-3100-2; Dong JW, 2014, J NEUROSURG-SPINE, V20, P53, DOI 10.3171/2013.9.SPINE1392; Foley KT, 2003, SPINE, V28, pS26, DOI 10.1097/00007632-200308011-00006; GOEL VK, 1991, SPINE, V16, pS155, DOI 10.1097/00007632-199103001-00023; HA KY, 1993, J SPINAL DISORD, V6, P99; Holly Langston T, 2006, Neurosurg Focus, V20, pE6; Kasai Y, 2010, J CLIN NEUROSCI, V17, P364, DOI 10.1016/j.jocn.2009.06.017; Korovessis P, 2004, SPINE, V29, P735, DOI 10.1097/01.BRS.0000112072.83196.0F; Lin B, 2013, ORTHOPEDICS, V36, pE1071, DOI 10.3928/01477447-20130724-26; MCAFEE PC, 1991, SPINE, V16, pS190, DOI 10.1097/00007632-199106001-00003; Sim HB, 2010, J NEUROSURG-SPINE, V12, P700, DOI 10.3171/2009.12.SPINE09123; Slucky Andrew V, 2006, Spine J, V6, P78, DOI 10.1016/j.spinee.2005.08.003; Sonmez E, 2013, TURK NEUROSURG, V23, P372, DOI 10.5137/1019-5149.JTN.7122-12.1; Toyone T, 2010, ADJACENT SEGMENT DEG, V27; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Xiaolong S, 2013, J SPINAL DISORDERS T; Xue HM, 2012, SPINE J, V12, P209, DOI 10.1016/j.spinee.2012.01.010	26	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111979	10.1371/journal.pone.0111979	http://dx.doi.org/10.1371/journal.pone.0111979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375315	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600083
J	Lorenzo-Betancor, O; Ogaki, K; Soto-Ortolaza, A; Labbe, C; Vilarino-Guell, C; Rajput, A; Rajput, AH; Pastor, P; Ortega, S; Lorenzo, E; Strongosky, AJ; van Gerpen, JA; Uitti, RJ; Wszolek, ZK; Ross, OA				Lorenzo-Betancor, Oswaldo; Ogaki, Kotaro; Soto-Ortolaza, Alexandra; Labbe, Catherine; Vilarino-Gueell, Carles; Rajput, Alex; Rajput, Ali H.; Pastor, Pau; Ortega, Sara; Lorenzo, Elena; Strongosky, Audrey J.; van Gerpen, Jay A.; Uitti, Ryan J.; Wszolek, Zbigniew K.; Ross, Owen A.			Analysis of Nuclear Export Sequence Regions of FUS-Related RNA-Binding Proteins in Essential Tremor	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; PRION-LIKE DOMAINS; MUTATIONS; TDP-43; FUS/TLS; TOOL	Background and Objective: Genes encoding RNA-binding proteins, including FUS and TDP43, play a central role in different neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Recently, a mutation located in the nuclear export signal (NES) of the FUS gene has been reported to cause an autosomal dominant form of familial Essential tremor. Material and Methods: We sequenced the exons coding the NES domains of five RNA-binding proteins (TARDBP, hnRNPA2B1, hnRNPA1, TAF15 and EWSR1) that have been previously implicated in neurodegeneration in a series of 257 essential tremor (ET) cases and 376 healthy controls. We genotyped 404 additional ET subjects and 510 healthy controls to assess the frequency of the EWSR1 p.R471C substitution. Results: We identified a rare EWSR1 p.R471C substitution, which is highly conserved, in a single subject with familial ET. The pathogenicity of this substitution remains equivocal, as DNA samples from relatives were not available and the genotyping of 404 additional ET subjects did not reveal any further carriers. No other variants were observed with significant allele frequency differences compared to controls in the NES coding regions. Conclusions: The present study demonstrates that the NES domains of RNA-binding proteins are highly conserved. The role of the EWSR1 p.R471C substitution needs to be further evaluated in future studies.	[Lorenzo-Betancor, Oswaldo; Ogaki, Kotaro; Soto-Ortolaza, Alexandra; Labbe, Catherine; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Vilarino-Gueell, Carles] Univ British Columbia, Djavad Mowafaghian Ctr Brain Heath, Dept Med Genet, Vancouver, BC, Canada; [Rajput, Alex; Rajput, Ali H.] Univ Saskatchewan, Div Neurol, Saskatoon, SK, Canada; [Rajput, Alex; Rajput, Ali H.] Saskatoon Hlth Reg, Saskatoon, SK, Canada; [Pastor, Pau; Ortega, Sara; Lorenzo, Elena] Univ Navarra, Ctr Appl Med Res, Sch Med, Neurogenet Lab,Div Neurosci, E-31080 Pamplona, Spain; [Pastor, Pau; Ortega, Sara; Lorenzo, Elena] CIBERNED, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Pastor, Pau] Hosp Univ Mutua Terrassa, Dept Neurol, Barcelona, Spain; [Strongosky, Audrey J.; van Gerpen, Jay A.; Uitti, Ryan J.; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Ross, Owen A.] Mayo Clin, Mayo Grad Sch, Jacksonville, FL 32224 USA	Mayo Clinic; University of British Columbia; University of Saskatchewan; University of Saskatchewan; University of Navarra; CIBERNED; Instituto de Salud Carlos III; Hospital Universitario Mutua Terrassa; Mayo Clinic; Mayo Clinic	Ross, OA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu	Wszolek, Zbigniew K./AAB-1431-2019; Lorenzo-Betancor, Oswaldo/J-2753-2019; Vilarino-Guell, Carles/D-8628-2011; Pastor, Pau/C-9834-2009	Lorenzo-Betancor, Oswaldo/0000-0002-5607-8363; Vilarino-Guell, Carles/0000-0002-5612-5940; Pastor, Pau/0000-0002-7493-8777; Ross, Owen/0000-0003-4813-756X	Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50) [NS072187]; NINDS [R01 NS078086]; Spanish Ministry of Economy and Competitivity grants [SAF2006-10126, SAF2010-22329-C02-01]; UTE project FIMA; Canada Research Chair program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, R01NS078086] Funding Source: NIH RePORTER	Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Spanish Ministry of Economy and Competitivity grants; UTE project FIMA; Canada Research Chair program(Canada Research Chairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50 #NS072187) and NINDS R01 NS078086, by the Spanish Ministry of Economy and Competitivity grants SAF2006-10126 (2006-2009) and SAF2010-22329-C02-01 (2011-2013) to PP and by the UTE project FIMA to PP and SOC and by the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Labbe C, 2013, PARKINSONISM RELAT D, V19, P755, DOI 10.1016/j.parkreldis.2013.03.005; Merner ND, 2012, AM J HUM GENET, V91, P313, DOI 10.1016/j.ajhg.2012.07.002; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Ortega-Cubero S, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.024; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puschmann A, 2011, SEMIN NEUROL, V31, P65, DOI 10.1055/s-0031-1271312; Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942	20	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111989	10.1371/journal.pone.0111989	http://dx.doi.org/10.1371/journal.pone.0111989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375143	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600089
J	Skorek, M; Song, AV; Dunham, Y				Skorek, Malgorzata; Song, Anna V.; Dunham, Yarrow			Self-Esteem as a Mediator between Personality Traits and Body Esteem: Path Analyses across Gender and Race/Ethnicity	PLOS ONE			English	Article							EATING-DISORDER SYMPTOMATOLOGY; WORLD-WIDE-WEB; PRIMARY PREVENTION; ADOLESCENT GIRLS; SEX-DIFFERENCES; DISSATISFACTION; IMAGE; WEIGHT; HEALTH; BIG-5	Prior literature examines the direct relationship between personality traits and body esteem. This article explores the possibility that self-esteem mediates this relationship. 165 undergraduate women and 133 men (age 18-21; 42.6% Hispanic, 28.9% Asian, 28.5% Caucasian) completed items measuring personality traits (Big Five), self-esteem, and body esteem. Path analyses were used to test for mediation. The analyses confirmed that in both men and women self-esteem mediated the relationship between three personality traits and body esteem: higher levels of conscientiousness, emotional stability, and extraversion were associated with higher self-esteem and consequently higher body esteem. Once self-esteem was included in the model the relationships between personality traits and body esteem were not significant, suggesting full mediation. In addition, the analyses revealed several racial/ethnic differences. In Asian American participants, self-esteem mediated the relationship between conscientiousness and body esteem and between emotional stability and body esteem. In Hispanic Americans, self-esteem mediated the relationship between conscientiousness and body esteem and between extraversion and body esteem. And in Caucasian Americans, self-esteem mediated the relationship between emotional stability and body esteem and between extraversion and body esteem. The most important contribution of this study is evidence for an indirect relationship between personality traits and body esteem, with this relationship being mediated by self-esteem. This has important implications for the study of personality and eating disorders in young adults, most particularly implying a need for more emphasis on self-esteem as a predictor of body image problems.	[Skorek, Malgorzata; Song, Anna V.] Univ Calif Merced, Merced, CA 95343 USA; [Dunham, Yarrow] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of California System; University of California Merced; Yale University	Skorek, M (corresponding author), Univ Calif Merced, Merced, CA 95343 USA.	mskorek@ucmerced.edu						Bandura A., 1986, SOCIAL FOUNDATIONS O; BOWMAN RL, 1992, BEHAV THER, V23, P637, DOI 10.1016/S0005-7894(05)80226-6; Brannan ME, 2008, J COUNS PSYCHOL, V55, P263, DOI 10.1037/0022-0167.55.2.263; Carter JC, 1997, INT J EAT DISORDER, V22, P167; Cassin SE, 2005, CLIN PSYCHOL REV, V25, P895, DOI 10.1016/j.cpr.2005.04.012; Choma BL, 2010, SEX ROLES, V63, P645, DOI 10.1007/s11199-010-9829-8; Costa P. T., 1989, THE NEO PI NEO FFI M; Crago Marjorie, 2003, Eat Disord, V11, P289, DOI 10.1080/10640260390242515; Dalley SE, 2009, PERS INDIV DIFFER, V47, P47, DOI 10.1016/j.paid.2009.01.044; DAVIS C, 1991, PERS INDIV DIFFER, V12, P689, DOI 10.1016/0191-8869(91)90224-Y; Dionne Michelle M, 2004, Body Image, V1, P335, DOI 10.1016/j.bodyim.2004.10.003; Dwight SA, 2000, EDUC PSYCHOL MEAS, V60, P340, DOI 10.1177/00131640021970583; Ehrhart MG, 2009, PERS INDIV DIFFER, V47, P900, DOI 10.1016/j.paid.2009.07.012; Fairburn C., 1997, OX MED PUBL, P209; Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8; Feingold A, 1998, PSYCHOL SCI, V9, P190, DOI 10.1111/1467-9280.00036; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Foldes HJ, 2008, PERS PSYCHOL, V61, P579, DOI 10.1111/j.1744-6570.2008.00123.x; Fox S, 2002, COMPUT HUM BEHAV, V18, P389, DOI 10.1016/S0747-5632(01)00057-7; FRANZOI SL, 1984, J PERS ASSESS, V48, P173, DOI 10.1207/s15327752jpa4802_12; Franzoi SL, 2002, PSYCHOL WOMEN QUART, V26, P89, DOI 10.1111/1471-6402.00046; FRANZOI SL, 1994, J CLIN PSYCHOL, V50, P237, DOI 10.1002/1097-4679(199403)50:2<237::AID-JCLP2270500214>3.0.CO;2-P; Furnham A, 2008, PSYCHOL REP, V102, P312, DOI 10.2466/PR0.102.1.312-316; GARNER DM, 1985, INT J EAT DISORDER, V4, P701; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Grabe S, 2006, PSYCHOL BULL, V132, P622, DOI 10.1037/0033-2909.132.4.622; Grogan S., 2008, BODY IMAGE UNDERSTAN, V2nd; Grogan S, 2010, SEX ROLES, V63, P757, DOI 10.1007/s11199-010-9894-z; Harrison K, 1997, J COMMUN, V47, P40, DOI 10.1111/j.1460-2466.1997.tb02692.x; Harter S., 1999, THE CONSTRUCTION OF; Harter S, 1985, PSYCHOLOGICAL PERSPE; Henriques GR, 1999, J PSYCHOL, V133, P357, DOI 10.1080/00223989909599748; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Johnson F, 2005, J ABNORM PSYCHOL, V114, P119, DOI 10.1037/0021-843X.114.1.119; Kendler KS, 1998, PSYCHOL MED, V28, P1403, DOI 10.1017/S0033291798007508; KILLEN JD, 1993, INT J EAT DISORDER, V13, P369, DOI 10.1002/1098-108X(199305)13:4&lt;369::AID-EAT2260130405&gt;3.0.CO;2-0; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Kvalem Ingela Lundin, 2006, Body Image, V3, P263; Levine MP, 1996, DEV PSYCHOPATHOL, P235; Mann T, 1997, HEALTH PSYCHOL, V16, P215, DOI 10.1037/0278-6133.16.3.215; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MCCARTHY JD, 1982, DEV PSYCHOL, V18, P372, DOI 10.1037/0012-1649.18.3.372; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; MCCRAE RR, 1988, J GERONTOL, V43, pS177, DOI 10.1093/geronj/43.6.S177; McKinley NM, 1998, SEX ROLES, V39, P113, DOI 10.1023/A:1018834001203; Miller KJ, 2000, INT J EAT DISORDER, V27, P310, DOI 10.1002/(SICI)1098-108X(200004)27:3&lt;310::AID-EAT8&gt;3.0.CO;2-Q; Mond J, 2011, J ADOLESCENT HEALTH, V48, P373, DOI 10.1016/j.jadohealth.2010.07.022; Murray K, 2013, BODY IMAGE, V10, P544, DOI 10.1016/j.bodyim.2013.07.011; NEUMARKSZTAINER D, 1995, J NUTR EDUC, V27, P24, DOI 10.1016/S0022-3182(12)80262-7; O'Dea JA, 2000, INT J EAT DISORDER, V28, P43, DOI 10.1002/(SICI)1098-108X(200007)28:1<43::AID-EAT6>3.0.CO;2-D; Olivardia R., 2004, PSYCHOL MEN MASCULIN, V5, P112, DOI [10.1037/1524-9220.5.2.112, DOI 10.1037/1524-9220.5.2.112]; PAXTON SJ, 1993, HEALTH EDUC RES, V8, P43, DOI 10.1093/her/8.1.43; Pearl RL, 2014, OBESITY, V22, pE142, DOI 10.1002/oby.20617; Pettit FA, 2002, BEHAV RES METH INS C, V34, P50, DOI 10.3758/BF03195423; Roberts A, 2010, EAT BEHAV, V11, P211, DOI 10.1016/j.eatbeh.2010.04.002; Robins RW, 2001, J RES PERS, V35, P463, DOI 10.1006/jrpe.2001.2324; Rosenberg M., 1965, SOCIETY AND ADOLESCE; RUTTER M, 1976, J CHILD PSYCHOL PSYC, V17, P35, DOI 10.1111/j.1469-7610.1976.tb00372.x; Schmidt WC, 1997, BEHAV RES METH INS C, V29, P274, DOI 10.3758/BF03204826; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Siegel JM, 2002, J ADOLESCENT RES, V17, P27, DOI 10.1177/0743558402171002; SILBERSTEIN LR, 1988, SEX ROLES, V19, P219, DOI 10.1007/BF00290156; Skorek M, 2012, SEX ROLES, V66, P655, DOI 10.1007/s11199-012-0124-8; Strauss RS, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e15; Swami V, 2008, BODY IMAGE, V5, P322, DOI 10.1016/j.bodyim.2008.03.007; Thompson J. K., 1999, EXACTING BEAUTY THEO; Thompson JK, 2001, BODY IMAGE EASTING D; Tiggemann Marika, 2005, Body Image, V2, P129, DOI 10.1016/j.bodyim.2005.03.006; Tsai J L, 2001, Cultur Divers Ethnic Minor Psychol, V7, P284, DOI 10.1037/1099-9809.7.3.284; Twenge JM, 2002, PSYCHOL BULL, V128, P371, DOI 10.1037//0033-2909.128.3.371; Twenge JM, 2001, PERS SOC PSYCHOL REV, V5, P321, DOI 10.1207/S15327957PSPR0504_3; Tylka TL, 2004, J COUNS PSYCHOL, V51, P178, DOI 10.1037/0022-0167.51.2.178; Watson D, 2002, J PERS SOC PSYCHOL, V83, P185, DOI 10.1037//0022-3514.83.1.185; Watson PD, 2001, AUST NZ J PUBL HEAL, V25, P520, DOI 10.1111/j.1467-842X.2001.tb00316.x; Woods SA, 2005, EUR J PERSONALITY, V19, P373, DOI 10.1002/per.542; Yager Z, 2008, HEALTH PROMOT INT, V23, P173, DOI 10.1093/heapro/dan004; Yager Z, 2010, HEALTH EDUC RES, V25, P841, DOI 10.1093/her/cyq036	78	17	18	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112086	10.1371/journal.pone.0112086	http://dx.doi.org/10.1371/journal.pone.0112086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375238	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600100
J	Alcazar-Fuoli, L; Cairns, T; Lopez, JF; Zonja, B; Perez, S; Barcelo, D; Igarashi, Y; Bowyer, P; Bignell, E				Alcazar-Fuoli, Laura; Cairns, Timothy; Lopez, Jordi F.; Zonja, Bozo; Perez, Sandra; Barcelo, Damia; Igarashi, Yasuhiro; Bowyer, Paul; Bignell, Elaine			A Modified Recombineering Protocol for the Genetic Manipulation of Gene Clusters in Aspergillus fumigatus	PLOS ONE			English	Article							MELANIN BIOSYNTHESIS; ZINC-FINGER; PSEUROTIN-A; NIDULANS; VIRULENCE; SYSTEM; PATHOGENICITY; TRANSCRIPTION; SYNTHETASE; EXPRESSION	Genomic analyses of fungal genome structure have revealed the presence of physically-linked groups of genes, termed gene clusters, where collective functionality of encoded gene products serves a common biosynthetic purpose. In multiple fungal pathogens of humans and plants gene clusters have been shown to encode pathways for biosynthesis of secondary metabolites including metabolites required for pathogenicity. In the major mould pathogen of humans Aspergillus fumigatus, multiple clusters of co-ordinately upregulated genes were identified as having heightened transcript abundances, relative to laboratory cultured equivalents, during the early stages of murine infection. The aim of this study was to develop and optimise a methodology for manipulation of gene cluster architecture, thereby providing the means to assess their relevance to fungal pathogenicity. To this end we adapted a recombineering methodology which exploits lambda phage-mediated recombination of DNA in bacteria, for the generation of gene cluster deletion cassettes. By exploiting a pre-existing bacterial artificial chromosome (BAC) library of A. fumigatus genomic clones we were able to implement single or multiple intra-cluster gene replacement events at both subtelomeric and telomere distal chromosomal locations, in both wild type and highly recombinogenic A. fumigatus isolates. We then applied the methodology to address the boundaries of a gene cluster producing a nematocidal secondary metabolite, pseurotin A, and to address the role of this secondary metabolite in insect and mammalian responses to A. fumigatus challenge.	[Alcazar-Fuoli, Laura; Cairns, Timothy; Bowyer, Paul; Bignell, Elaine] Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Manchester, Lancs, England; [Lopez, Jordi F.] CSIC, Inst Environm Assessment & Water Res IDAEA, Dept Environm Chem, Barcelona, Spain; [Zonja, Bozo; Perez, Sandra; Barcelo, Damia] CSIC, Inst Environm Assessment & Water Res IDAEA, Water & Soil Qual Res Grp, Barcelona, Spain; [Barcelo, Damia] Univ Girona, ICRA, Catalan Inst Water Res, Girona, Spain; [Igarashi, Yasuhiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan	University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Institut Catala de Recerca de l'Aigua (ICRA); Universitat de Girona; Toyama Prefectural University	Bignell, E (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Manchester, Lancs, England.	elaine.bignell@manchester.ac.uk	Solsona, Sandra/AAL-7967-2021; BARCELO, DAMIA/O-4558-2016; Lopez Fernandez, Jordi/H-6252-2015	BARCELO, DAMIA/0000-0002-8873-0491; Lopez Fernandez, Jordi/0000-0001-8255-483X; Perez, Sandra/0000-0002-3179-3969; Zonja, Bozo/0000-0002-8671-4308; Zonja, Bozo/0000-0002-6995-8124; Cairns, Timothy/0000-0001-7106-224X; bowyer, paul/0000-0002-1083-9286	Medical Research Council [G0501164, MR/L00822/1]; BBSRC [BB/G009619/1, BB/D526396/1]; Fondo de Investigacion Sanitaria [FIS:CP11/00026]; Marie Curie Actions ITN CSI: Environment [PITNGA-2010-264329]; Ramon y Cajal Program of the Spanish Ministry of Economy and Competitiveness; Biotechnology and Biological Sciences Research Council [BB/G009619/1] Funding Source: researchfish; MRC [G0501164] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Marie Curie Actions ITN CSI: Environment; Ramon y Cajal Program of the Spanish Ministry of Economy and Competitiveness(Spanish Government); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants to EB from the Medical Research Council (G0501164 and MR/L00822/1; http://www.mrc.ac.uk); and BBSRC (BB/G009619/1; http://www.bbsrc.ac.uk). LAF is funded by Fondo de Investigacion Sanitaria with a Miguel Servet fellowship (FIS:CP11/00026; http://www.isciii.es). TC was funded by a BBSRC PhD Studentship (BB/D526396/1; http://www.bbsrc.ac.uk). BZ acknowledges the Marie Curie Actions ITN CSI: Environment PITNGA-2010-264329 for the Early Stage Researcher contract and funding. SP acknowledges the contract from the Ramon y Cajal Program of the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amich J, 2009, INT MICROBIOL, V12, P39, DOI 10.2436/20.1501.01.80; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Brock M, 2008, APPL ENVIRON MICROB, V74, P7023, DOI 10.1128/AEM.01288-08; Brown JS, 2000, MOL MICROBIOL, V36, P1371, DOI 10.1046/j.1365-2958.2000.01953.x; Bumpus SB, 2009, NAT BIOTECHNOL, V27, P951, DOI 10.1038/nbt.1565; Mesa-Arango AC, 2013, MED MYCOL, V51, P461, DOI 10.3109/13693786.2012.737031; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chiang YM, 2013, J AM CHEM SOC, V135, P7720, DOI 10.1021/ja401945a; Chiou CH, 2002, APPL ENVIRON MICROB, V68, P306, DOI 10.1128/AEM.68.1.306-315.2002; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Dean RA, 2007, NAT BIOTECHNOL, V25, P67, DOI 10.1038/nbt0107-67; Eliahu N, 2007, EUKARYOT CELL, V6, P421, DOI 10.1128/EC.00264-06; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Gacek A, 2012, APPL MICROBIOL BIOT, V95, P1389, DOI 10.1007/s00253-012-4208-8; Gomez-Lopez A, 2014, MED MYCOL, V52, P311, DOI 10.1093/mmy/myt022; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Hartmann T, 2010, APPL ENVIRON MICROB, V76, P6313, DOI 10.1128/AEM.00882-10; Hayashi A, 2007, BIOSCI BIOTECH BIOCH, V71, P1697, DOI 10.1271/bbb.70110; Hervas-Aguilar A, 2007, J BIOL CHEM, V282, P34735, DOI 10.1074/jbc.M706723200; Igarashi Y, 2004, J ANTIBIOT, V57, P748, DOI 10.7164/antibiotics.57.748; Ishikawa M, 2009, BIOORG MED CHEM LETT, V19, P1457, DOI 10.1016/j.bmcl.2009.01.029; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Komagata D, 1996, J ANTIBIOT, V49, P958, DOI 10.7164/antibiotics.49.958; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Krappmann S, 2006, TRENDS MICROBIOL, V14, P356, DOI 10.1016/j.tim.2006.06.005; Kubodera T, 2000, BIOSCI BIOTECH BIOCH, V64, P1416, DOI 10.1271/bbb.64.1416; Langfelder K, 2002, CURR GENET, V41, P268, DOI 10.1007/s00294-002-0313-z; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Liang SH, 1997, APPL ENVIRON MICROB, V63, P1058, DOI 10.1128/AEM.63.3.1058-1065.1997; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MACCABE AP, 1991, J BIOL CHEM, V266, P12646; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; O'Hanlon KA, 2011, INFECT IMMUN, V79, P3978, DOI 10.1128/IAI.00192-11; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Palmer JM, 2010, MICROBIOL-SGM, V156, P3522, DOI 10.1099/mic.0.039255-0; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rizzetto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056651; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Szewczyk E, 2010, EUKARYOT CELL, V9, P774, DOI 10.1128/EC.00375-09; TANG CM, 1993, INFECT IMMUN, V61, P1650, DOI 10.1128/IAI.61.5.1650-1656.1993; Tsuji G, 2000, MOL MICROBIOL, V38, P940, DOI 10.1046/j.1365-2958.2000.02181.x; Tsunematsu Y, 2014, ANGEW CHEM INT EDIT, V53, P1; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; YU JH, 1995, J BACTERIOL, V177, P4792, DOI 10.1128/jb.177.16.4792-4800.1995	60	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111875	10.1371/journal.pone.0111875	http://dx.doi.org/10.1371/journal.pone.0111875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372385	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900082
J	Padhi, AK; Banerjee, K; Gomes, J; Banerjee, M				Padhi, Aditya K.; Banerjee, Kamalika; Gomes, James; Banerjee, Manidipa			Computational and Functional Characterization of Angiogenin Mutations, and Correlation with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; HEXANUCLEOTIDE REPEAT; I-TASSER; ALS; PREDICTION; VARIANTS; IDENTIFICATION; PLATFORM; NEURONS; C9ORF72	The Angiogenin (ANG) gene is frequently mutated in patients suffering from the neurodegenerative disease -amyotrophic lateral sclerosis (ALS). Most of the ALS-causing mutations in Angiogenin affect either its ribonucleolytic or nuclear translocation activity. Here we report the functional characterization of two previously uncharacterized missense mutations in Angiogenin -D22G and L35P. We predict the nature of loss-of-function(s) in these mutants through our previously established Molecular Dynamics (MD) simulation extended to 100 ns, and show that the predictions are entirely validated through biochemical studies with wild-type and mutated proteins. Based on our studies, we provide a biological explanation for the loss-of-function of D22G-Angiogenin leading to ALS, and suggest that the L35P-Angiogenin mutation would probably cause ALS symptoms in individuals harboring this mutation. Our study thus highlights the strength of MD simulation-based predictions, and suggests that this method can be used for correlating mutations in Angiogenin or other effector proteins with ALS symptoms.	[Padhi, Aditya K.; Banerjee, Kamalika; Gomes, James; Banerjee, Manidipa] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Banerjee, M (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India.	mbanerjee@bioschool.iitd.ac.in	Padhi, Aditya Kumar/AAU-7373-2021	Padhi, Aditya Kumar/0000-0001-6732-2547	Department of Science and Technology, Government of India [SERB/F/6185/2013-14]; Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Science and Technology (SERB/F/6185/2013-14), Government of India. A.K.P. was supported by a Senior Research Fellowship from the Council of Scientific and Industrial Research (CSIR), while M.B. was supported by the Ramalingaswami Fellowship from the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brown JA, 2012, AMYOTROPH LATERAL SC, V13, P217, DOI 10.3109/17482968.2011.643899; Case DA, 2008, AMBER 11; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dhingra P, 2013, J COMPUT CHEM, V34, P1925, DOI 10.1002/jcc.23339; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jayaram B, 2006, NUCLEIC ACIDS RES, V34, P6195, DOI 10.1093/nar/gkl789; Jenkins JL, 2003, BIOCHEMISTRY-US, V42, P6674, DOI 10.1021/bi034164e; Kishikawa H, 2008, EXPERT OPIN THER TAR, V12, P1229, DOI 10.1517/14728222.12.10.1229 ; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Mishra A, 2014, BBA-PROTEINS PROTEOM, V1844, P1798, DOI 10.1016/j.bbapap.2014.07.010; Mishra A, 2013, BBA-PROTEINS PROTEOM, V1834, P1520, DOI 10.1016/j.bbapap.2013.04.023; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; MOROIANU J, 1994, BIOCHEM BIOPH RES CO, V203, P1765, DOI 10.1006/bbrc.1994.2391; Padhi AK, 2013, FEBS LETT, V587, P1762, DOI 10.1016/j.febslet.2013.04.022; Padhi AK, 2013, SCI REP-UK, V3, DOI 10.1038/srep01225; Padhi AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032479; Padhi Aditya K, 2014, F1000RES, V2, P227, DOI [DOI 10.12688/F1000RESEARCH.2-227.V3, 10.12688/f1000research.2-227.v3]; Redler RL, 2012, PROG MOL BIOL TRANSL, V107, P215, DOI 10.1016/B978-0-12-385883-2.00002-3; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; Ueki M, 2008, CELL BIOCHEM FUNCT, V26, P718, DOI 10.1002/cbf.1498; Vasaikar SV, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-3; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	34	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111963	10.1371/journal.pone.0111963	http://dx.doi.org/10.1371/journal.pone.0111963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372031	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900097
J	Alt, KW; Knipper, C; Peters, D; Muller, W; Maurer, AF; Kollig, I; Nicklisch, N; Muller, C; Karimnia, S; Brandt, G; Roth, C; Rosner, M; Mende, B; Schone, BR; Vida, T; von Freeden, U				Alt, Kurt W.; Knipper, Corina; Peters, Daniel; Mueller, Wolfgang; Maurer, Anne-France; Kollig, Isabelle; Nicklisch, Nicole; Mueller, Christiane; Karimnia, Sarah; Brandt, Guido; Roth, Christina; Rosner, Martin; Mende, Balasz; Schoene, Bernd R.; Vida, Tivadar; von Freeden, Uta			Lombards on the Move - An Integrative Study of the Migration Period Cemetery at Szolad, Hungary	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; BREAST-FEEDING PRACTICES; WATER FISH CONSUMPTION; MTDNA HAPLOGROUP-H; BONE-COLLAGEN; FRESH-WATER; CALCIUM SOURCES; TROPHIC LEVEL; STRONTIUM; NITROGEN	In 2005 to 2007 45 skeletons of adults and subadults were excavated at the Lombard period cemetery at Szolad (6th century A. D.), Hungary. Embedded into the well-recorded historical context, the article presents the results obtained by an integrative investigation including anthropological, molecular genetic and isotopic (delta N-15, delta C-13, Sr-87/Sr-86) analyses. Skeletal stress markers as well as traces of interpersonal violence were found to occur frequently. The mitochondrial DNA profiles revealed a heterogeneous spectrum of lineages that belong to the haplogroups H, U, J, HV, T2, I, and K, which are common in present-day Europe and in the Near East, while N1a and N1b are today quite rare. Evidence of possible direct maternal kinship was identified in only three pairs of individuals. According to enamel strontium isotope ratios, at least 31% of the individuals died at a location other than their birthplace and/or had moved during childhood. Based on the peculiar Sr-87/Sr-86 ratio distribution between females, males, and subadults in comparison to local vegetation and soil samples, we propose a three-phase model of group movement. An initial patrilocal group with narrower male but wider female Sr isotope distribution settled at Szolad, whilst the majority of subadults represented in the cemetery yielded a distinct Sr isotope signature. Owing to the virtual absence of Szolad-born adults in the cemetery, we may conclude that the settlement was abandoned after approx. one generation. Population heterogeneity is furthermore supported by the carbon and nitrogen isotope data. They indicate that a group of high-ranking men had access to larger shares of animal-derived food whilst a few individuals consumed remarkable amounts of millet. The inferred dynamics of the burial community are in agreement with hypotheses of a highly mobile lifestyle during the Migration Period and a short-term occupation of Pannonia by Lombard settlers as conveyed by written sources.	[Alt, Kurt W.; Nicklisch, Nicole] Danube Private Univ, Ctr Nat & Cultural Hist Teeth, Krems, Austria; [Alt, Kurt W.; Kollig, Isabelle; Nicklisch, Nicole] State Off Heritage Management & Archaeol Saxony A, Halle, Germany; [Alt, Kurt W.; Kollig, Isabelle] State Museum Prehist, Halle, Germany; [Alt, Kurt W.; Nicklisch, Nicole] Univ Basel, Inst Prehist & Archaeol Sci, Basel, Switzerland; [Knipper, Corina] Curt Engelhorn Ctr Archaeometry gGmbH, Mannheim, Germany; [Peters, Daniel] Free Univ Berlin, Inst Parhist Archaol, Berlin, Germany; [Mueller, Wolfgang] Royal Holloway Univ London, Dept Earth Sci, London, England; [Maurer, Anne-France] Univ Evora, Lab Hercules, Evora, Portugal; [Mueller, Christiane; Karimnia, Sarah; Brandt, Guido; Roth, Christina] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany; [Rosner, Martin] IsoAnal UG, Berlin, Germany; [Mende, Balasz] Hungarian Acad Sci, Res Ctr Humanities, Archaeol Inst, Budapest, Hungary; [Schoene, Bernd R.] Johannes Gutenberg Univ Mainz, Inst Geosci, D-55122 Mainz, Germany; [Vida, Tivadar] Eotvos Lorand Univ, Dept Prehist & Protohist, Budapest, Hungary; [von Freeden, Uta] German Archaeol Inst, Roman German Commiss, Frankfurt, Germany	University of Basel; Free University of Berlin; University of London; Royal Holloway University London; University of Evora; Johannes Gutenberg University of Mainz; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Johannes Gutenberg University of Mainz; Eotvos Lorand University	Alt, KW (corresponding author), Danube Private Univ, Ctr Nat & Cultural Hist Teeth, Krems, Austria.	kurt.alt@unibas.ch	Schöne, Bernd R/B-6294-2011; Rosner, Martin/B-9264-2009	Maurer, Anne-France/0000-0002-4997-5357; Nicklisch, Nicole/0000-0001-7423-8343; Muller, Wolfgang/0000-0001-5368-8011	German Archaeological Institute Berlin	German Archaeological Institute Berlin	The excavations between 2005 and 2007 were funded by the German Archaeological Institute Berlin (no grant number exists). The funders had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Alt K. W., 1997, ODONTOLOGISCHE VERWA; Alt K.W., 2001, PEIN PLAGEN ASPEKTE, P156; Alt KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065649; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; Aufderheide C., 1998, CAMBRIDGE ENCY HUMAN; Bemmann J, 2008, KULTURWANDEL MITTELE, P43; Bentley R. A., 2007, GOING MESOLITHIC NEO, P117; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2012, P NATL ACAD SCI USA, V109, P9326, DOI 10.1073/pnas.1113710109; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Bickle P, 2011, ANTIQUITY, V85, P1243, DOI 10.1017/S0003598X00062037; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Bona I, 2009, LANGBOARDISCHE GRABE; Brandt G, 2010, ANTHR ISOTOPIE DNA B, V3, P17; Budd P, 2000, APPL GEOCHEM, V15, P687, DOI 10.1016/S0883-2927(99)00069-4; Drouet T, 2005, GEODERMA, V126, P203, DOI 10.1016/j.geoderma.2004.09.010; Drouet T, 2005, GLOBAL CHANGE BIOL, V11, P1926, DOI 10.1111/j.1365-2486.2005.01034.x; Drucker DG, 2005, J HUM EVOL, V49, P19, DOI 10.1016/j.jhevol.2005.02.007; Dufour E, 1999, J ARCHAEOL SCI, V26, P617, DOI 10.1006/jasc.1998.0379; Evans J.A., 2004, GEOL SOC SPEC PUBL, V232, P237, DOI [10.1144/GSL.SP.2004.232.01.21, DOI 10.1144/GSL.SP.2004.232.01.21]; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Fraser RA, 2011, J ARCHAEOL SCI, V38, P2790, DOI 10.1016/j.jas.2011.06.024; Freeden U. von, 2008, AKTEN INT TAGUNG BON, P399; Fuller BT, 2012, J ANAL ATOM SPECTROM, V27, P807, DOI 10.1039/c2ja10366d; Geary Patrick J., 2002, MYTH NATIONS MEDIEVA; Giblin JI, 2013, J ARCHAEOL SCI, V40, P227, DOI 10.1016/j.jas.2012.08.024; Hakenbeck S, 2010, AM J PHYS ANTHROPOL, V143, P235, DOI 10.1002/ajpa.21309; Hansen J, 2013, THESIS MAINZ; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Heinrich-Tamaska Orsolya, 2011, KESZTHELY FENEKPUSZT, P457; Helmuth H, 1996, GERMANISCHE DENKMALE, V18; HENGEN OP, 1971, HOMO, V22, P57; Herrmann B, 1990, PRAHISTORISCHE ANTHR; Hollund HI, 2010, J ARCHAEOL SCI, V37, P2971, DOI 10.1016/j.jas.2010.08.009; Hoppe KA, 2003, INT J OSTEOARCHAEOL, V13, P20, DOI 10.1002/oa.663; Horn P, 1999, APPL GEOCHEM, V14, P263; Jakob T, 2009, PREVALENCE PATTERNS; Jarnut Jorg, 1982, GESCH LANGOBARDEN; Jay M, 2008, AM J PHYS ANTHROPOL, V136, P327, DOI 10.1002/ajpa.20815; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100755; Jorkov MLS, 2007, J ARCHAEOL SCI, V34, P1824, DOI 10.1016/j.jas.2006.12.020; Kanstrup M, 2011, RAPID COMMUN MASS SP, V25, P2879, DOI 10.1002/rcm.5176; Katzenberg M. A., 2008, BIOL ANTHR HUMAN SKE, V2, P413; Klanica Z, 1986, PREHELED VYZKUMU, V1986, P49; Knipper C, 2013, ARCHAEOL ANTHROP SCI, V5, P17, DOI 10.1007/s12520-012-0106-3; Kohl K-H, 1993, ETHNOLOGIE WISSENSCH; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Lohrke B, 2005, BERGVOLK MED NATUR K, P9; Lohrke B., 2004, FREIBURGER BEITRAGE, V9; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Martin R., 1914, LEHRBUCH ANTHR; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; Menghin, 1985, LANGOBARDEN ARCHAOLO; Montgomery J, 2005, AM J PHYS ANTHROPOL, V126, P123, DOI 10.1002/ajpa.20111; Muller W, 2003, SCIENCE, V302, P862, DOI 10.1126/science.1089837; Navitainuck D, 2013, HOMO, V64, P179, DOI 10.1016/j.jchb.2013.03.007; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nehlich O, 2010, J ARCHAEOL SCI, V37, P1131, DOI 10.1016/j.jas.2009.12.013; Nitsch EK, 2011, AM J PHYS ANTHROPOL, V146, P619, DOI 10.1002/ajpa.21623; Obertova Z, 2008, EARLY MEDIEVAL ALAMA; Palanichamy MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-304; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Peters D, 2014, SIEDLUNG LANDSCHAFT, P337; Pilloud MA, 2011, AM J PHYS ANTHROPOL, V145, P519, DOI 10.1002/ajpa.21520; Pohl W., 2008, KULTURWANDEL MITTELE, P1; Pohl W, 2008, LANGOBARDEN ENDE VOL, P23; Reitsema LJ, 2013, AM J HUM BIOL, V25, P445, DOI 10.1002/ajhb.22398; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rosing FW, 1975, THESIS U HAMBURG; Schmidtova J, 2008, KULTURWANDEL MITTELE, P337; Schutkowski H, 1999, J ARCHAEOL SCI, V26, P675, DOI 10.1006/jasc.1998.0384; Scorrano G, 2014, AM J PHYS ANTHROPOL, V154, P349, DOI 10.1002/ajpa.22517; Shishlina NI, 2009, RADIOCARBON, V51, P481, DOI 10.1017/S0033822200055879; Siegmund F., 2010, KORPERGROSSE MENSCHE; Stirling J, 1993, TERMESZETI VISZONYOK, P7; Strott N, 2006, THESIS U MUNCHEN; Strott N, 2008, DOC ARCHAEOBIOL, V5, P68; Sudhoff I, 1999, THESIS BONN; Tatrai I, 1999, ARCH HYDROBIOL, V146, P117; Tejral J, 1988, LANGOBARDEN NORDLICH, P39; Tejral Jaroslav, 2011, LANGOBARDISCHE GRABE; Tomory G, 2007, AM J PHYS ANTHROPOL, V134, P354, DOI 10.1002/ajpa.20677; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Vida Tivadar, 2008, LANGBORDEN ENDE VOLK, P73; Vitoria L, 2004, ENVIRON SCI TECHNOL, V38, P3254, DOI 10.1021/es0348187; VoB H. -U., 2008, KULTURWANDEL MITTELE, V11, P51; von Freeden U., 2007, GERMANIA, V85, P359; Webster CJ, 2004, ARCHAEOL J, V161, P54; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; Whittle A, 2013, 1 FARMERS CENTRAL EU, P49	94	50	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110793	10.1371/journal.pone.0110793	http://dx.doi.org/10.1371/journal.pone.0110793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369022	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000344402000027
J	Kelesidis, T; Roberts, CK; Huynh, D; Martinez-Maza, O; Currier, JS; Reddy, ST; Yang, OO				Kelesidis, Theodoros; Roberts, Christian K.; Huynh, Diana; Martinez-Maza, Otoniel; Currier, Judith S.; Reddy, Srinivasa T.; Yang, Otto O.			A High Throughput Biochemical Fluorometric Method for Measuring Lipid Peroxidation in HDL	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX CAPACITY; APOLIPOPROTEIN-A-I; SUBCLINICAL ATHEROSCLEROSIS; ANTIINFLAMMATORY PROPERTIES; INFLAMMATORY PROPERTIES; OXIDIZED PHOSPHOLIPIDS; ANTIOXIDANT PROPERTIES; METHIONINE SULFOXIDE; REACTIVE OXYGEN	Current cell-based assays for determining the functional properties of high-density lipoproteins (HDL) have limitations. We report here the development of a new, robust fluorometric cell-free biochemical assay that measures HDL lipid peroxidation (HDLox) based on the oxidation of the fluorochrome Amplex Red. HDLox correlated with previously validated cell-based (r = 0.47, p<0.001) and cell-free assays (r = 0.46, p<0.001). HDLox distinguished dysfunctional HDL in established animal models of atherosclerosis and Human Immunodeficiency Virus (HIV) patients. Using an immunoaffinity method for capturing HDL, we demonstrate the utility of this novel assay for measuring HDLox in a high throughput format. Furthermore, HDLox correlated significantly with measures of cardiovascular diseases including carotid intima media thickness (r = 0.35, p<0.01) and subendocardial viability ratio (r = -0.21, p = 0.05) and physiological parameters such as metabolic and anthropometric parameters (p<0.05). In conclusion, we report the development of a new fluorometric method that offers a reproducible and rapid means for determining HDL function/quality that is suitable for high throughput implementation.	[Kelesidis, Theodoros; Huynh, Diana; Currier, Judith S.; Reddy, Srinivasa T.; Yang, Otto O.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Roberts, Christian K.] Univ Calif Los Angeles, Sch Nursing, Exercise & Metab Dis Res Lab, Translat Sci Sect, Los Angeles, CA 90024 USA; [Martinez-Maza, Otoniel; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA; [Reddy, Srinivasa T.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Martinez-Maza, Otoniel; Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kelesidis, T (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	tkelesidis@mednet.ucla.edu	Kelesidis, Theodoros/AAE-1961-2020; Martinez-Maza, Otoniel/B-2667-2009	Martinez-Maza, Otoniel/0000-0003-1364-0675; Kelesidis, Theodoros/0000-0002-8463-3811	RO1 grants [HL095132, HL082823, HL71776]; K08 grant [K08AI08272]; UCLA AIDS Institute; UCLA Center for AIDS Research [AI28697]; University of Washington's CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center [5R01HL095126]; American Heart Association [BGIA 0765139Y]; National Heart, Lung and Blood Institute [P50 HL105188]; National Institute of Diabetes and Digestive and Kidney Diseases [DK090406]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082823, R01HL095126, R01HL095132, P50HL105188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI108272, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090406] Funding Source: NIH RePORTER	RO1 grants; K08 grant; UCLA AIDS Institute; UCLA Center for AIDS Research; University of Washington's CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center; American Heart Association(American Heart Association); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by RO1 grants HL095132 (JSC) and HL082823 and HL71776 (STR), K08 grant K08AI08272 (TK) and UCLA AIDS Institute and the UCLA Center for AIDS Research (AI28697). Partial funding for laboratory work was provided by the University of Washington's CVD and Metabolic Complications of HIV/AIDS Data Coordinating Center (5R01HL095126). The exercise work was supported by the American Heart Association (BGIA 0765139Y to CKR), the National Heart, Lung and Blood Institute (P50 HL105188 to CKR), and the National Institute of Diabetes and Digestive and Kidney Diseases (DK090406 to CKR). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or other granting agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; ANANTHARAMAIAH GM, 1988, J LIPID RES, V29, P309; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Borja MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071541; Boulton F, 2008, TRANSFUSION MED, V18, P13, DOI 10.1111/j.1365-3148.2007.00818.x; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; Charles-Schoeman C, 2009, ARTHRITIS RHEUM-US, V60, P2870, DOI 10.1002/art.24802; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DeMaio L, 2006, AM J PHYSIOL-HEART C, V290, pH674, DOI 10.1152/ajpheart.00554.2005; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Gutheil WG, 2000, ANAL BIOCHEM, V287, P196, DOI 10.1006/abio.2000.4835; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V205, P1072, DOI 10.1006/bbrc.1994.2775; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004; Imaizumi Satoshi, 2010, Drug Metab Lett, V4, P139; Ischiropoulos H, 1999, METHOD ENZYMOL, V301, P367; Jayaraman S, 2007, BIOCHEMISTRY-US, V46, P5790, DOI 10.1021/bi700225a; Ji X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091089, 10.1371/journal.pone.0107460]; Kagramanov V, 2001, JAMA-J AM MED ASSOC, V285, P881, DOI 10.1001/jama.285.7.881; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kelesidis T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-23; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Kelesidis T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-87; Kelesidis T, 2011, J LIPID RES, V52, P2341, DOI 10.1194/jlr.D018937; Khera AV, 2013, J AM COLL CARDIOL, V62, P1909, DOI 10.1016/j.jacc.2013.07.025; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; Mishin V, 2010, FREE RADICAL BIO MED, V48, P1485, DOI 10.1016/j.freeradbiomed.2010.02.030; Morgantini C, 2014, NUTR METAB CARDIOVAS, V24, P594, DOI 10.1016/j.numecd.2013.12.011; Morgantini C, 2011, DIABETES, V60, P2617, DOI 10.2337/db11-0378; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2000, J LIPID RES, V41, P1495; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1426, DOI 10.1161/01.ATV.0000167412.98221.1a; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Navab M, 2001, J LIPID RES, V42, P1308; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Patel PJ, 2013, EUR J HEART FAIL, V15, P1215, DOI 10.1093/eurjhf/hft084; Patel PJ, 2011, J AM COLL CARDIOL, V58, P2068, DOI 10.1016/j.jacc.2011.08.030; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Price TH, 2008, STANDARDS BLOOD BANK; Richer SC, 2001, MOL HUM REPROD, V7, P237, DOI 10.1093/molehr/7.3.237; Roberts CK, 2006, J APPL PHYSIOL, V101, P1727, DOI 10.1152/japplphysiol.00345.2006; Roberts CK, 2013, J APPL PHYSIOL, V115, P1043, DOI 10.1152/japplphysiol.00359.2013; Roberts CK, 2013, METABOLISM, V62, P725, DOI 10.1016/j.metabol.2012.12.004; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; SATTLER W, 1995, FREE RADICAL BIO MED, V18, P421, DOI 10.1016/0891-5849(94)00170-O; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Van Lenten BJ, 2007, J LIPID RES, V48, P2344, DOI 10.1194/jlr.M700138-JLR200; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Volkmann ER, 2010, ARTHRIT CARE RES, V62, P258, DOI 10.1002/acr.20076; Wang XS, 2009, J LIPID RES, V50, P586, DOI 10.1194/jlr.D800042-JLR200; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Watanabe J, 2007, J BIOL CHEM, V282, P23698, DOI 10.1074/jbc.M702163200; Watanabe J, 2012, ARTHRITIS RHEUM-US, V64, P1828, DOI 10.1002/art.34363; Watanabe J, 2009, J BIOL CHEM, V284, P18292, DOI 10.1074/jbc.M109.017202; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; WIDHALM K, 1991, CLIN CHEM, V37, P238; Zanni MV, 2014, ANTIVIR THER, V19, P805, DOI 10.3851/IMP2756	77	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111716	10.1371/journal.pone.0111716	http://dx.doi.org/10.1371/journal.pone.0111716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368900	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000090
J	Hernandez-Hernandez, AM; Huerta-Quintanilla, R				Maria Hernandez-Hernandez, Ana; Huerta-Quintanilla, Rodrigo			Modeling Body Mass Variation: Incorporating Social Influence into Calculations of Caloric Intake and Energy Expenditure	PLOS ONE			English	Article							WEIGHT-LOSS; COMPUTATIONAL MODEL; OBESITY; INTERRELATIONSHIPS; PREVENTION; BALANCE; HUMANS; HEALTH; FAT	Variations in individual body mass and composition have long been a key focus in the health sciences, particularly now that overweight and obesity are considered as public health problems. We study a mathematical model that describes body mass variations which are determined by the energy balance between caloric intake and total energy expenditure. To calculate the change in caloric intake and energy expenditure over time, we proposed a relationship for each of these quantities, and we used measured values that are reported in the literature for the initial conditions. To account for small variations in the daily energy balance of an individual, we include social interactions as the multiplication of two terms: social proximity and social influence. We observe that social interactions have a considerable effect when the body mass of an individual is quite constant and social interactions take random values. However, when an individual's mass value changes (either increases or decreases), social interactions do not have a notable effect. In our simulation, we tested two different models that describe the body mass composition, and it resulted that one fits better the data.	[Maria Hernandez-Hernandez, Ana; Huerta-Quintanilla, Rodrigo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis Aplicada, Merida, Yucatan, Mexico	Instituto Politecnico Nacional - Mexico	Huerta-Quintanilla, R (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis Aplicada, Merida, Yucatan, Mexico.	rhuerta@mda.cinvestav.mx						ALPERT SS, 1979, AM J CLIN NUTR, V32, P1710, DOI 10.1093/ajcn/32.8.1710; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Caballero B., 2005, ENCY HUMAN NUTR; Chan RSM, 2010, INT J ENV RES PUB HE, V7, P765, DOI 10.3390/ijerph7030765; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Deriaz O, 1993, Obes Res, V1, P179; FAO/WHO/UNU Expert Consultation, 2001, HUM EN REQ, P41; FORBES GB, 1987, NUTR REV, V45, P225; Gonzalez A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-755; Hall KD, 2007, INT J OBESITY, V0307-0565, P1; Hall KD, 2007, BRIT J NUTR, V97, P1059, DOI 10.1017/S0007114507691946; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hall KD, 2011, AM J CLIN NUTR, V94, P66, DOI 10.3945/ajcn.111.014399; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Heshka S, 2001, INT J OBESITY, V25, P1401, DOI 10.1038/sj.ijo.0801790; Heymsfield SB, 2010, AM J HUM BIOL, V22, P301, DOI 10.1002/ajhb.20985; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hush-Ashmore R, 1996, AJBH, V8, P159; Jordan PN, 2008, AM J CLIN NUTR, V87, P692, DOI 10.1093/ajcn/87.3.692; Latane B, 1996, J COMMUN, V46; Leahey TM, 2011, OBESITY, V19, P1157, DOI 10.1038/oby.2010.301; Lucassen EA, 2012, ANN NY ACAD SCI, V1264, P110, DOI 10.1111/j.1749-6632.2012.06655.x; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Thomas DM, 2010, AM J CLIN NUTR, V92, P1326, DOI 10.3945/ajcn.2010.29687; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; [No title captured]	27	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111709	10.1371/journal.pone.0111709	http://dx.doi.org/10.1371/journal.pone.0111709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369520	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000089
J	Leitao, MDG; Coimbra, EC; de Lima, RDP; Guimaraes, MD; Heraclio, SD; Neto, JDS; de Freitas, AC				Gomes Leitao, Maria da Conceicao; Coimbra, Eliane Campos; Pereira de Lima, Rita de Cassia; Guimaraes, Marilea de Lima; Heraclio, Sandra de Andrade; Silva Neto, Jacinto da Costa; de Freitas, Antonio Carlos			Quantifying mRNA and MicroRNA with qPCR in Cervical Carcinogenesis: A Validation of Reference Genes to Ensure Accurate Data	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; HUMAN-PAPILLOMAVIRUS; RELATIVE QUANTIFICATION; HOUSEKEEPING GENES; PCR DATA; CANCER; IDENTIFICATION; EXPRESSION; NORMALIZATION; BIOMARKERS	A number of recent studies have catalogued global gene expression patterns in a panel of normal, tumoral cervical tissues so that potential biomarkers can be identified. The qPCR has been one of the most widely used technologies for detecting these potential biomarkers. However, few studies have investigated a correct strategy for the normalization of data in qPCR assays for cervical tissues. The aim of this study was to validate reference genes in cervical tissues to ensure accurate quantification of mRNA and miRNA levels in cervical carcinogenesis. For this purpose, some issues for obtaining reliable qPCR data were evaluated such as the following: geNorm analysis with a set of samples which meet all of the cervical tissue conditions (Normal + CIN1 + CIN2 + CIN3 + Cancer); the use of individual Ct values versus pooled Ct values; and the use of a single (or multiple) reference genes to quantify mRNA and miRNA expression levels. Two different data sets were put on the geNorm to assess the expression stability of the candidate reference genes: the first dataset comprised the quantities of the individual Ct values; and the second dataset comprised the quantities of the pooled Ct values. Moreover, in this study, all the candidate reference genes were analyzed as a single "normalizer''. The normalization strategies were assessed by measuring p16(INK4a) and miR-203 transcripts in qPCR assays. We found that the use of pooled Ct values, can lead to a misinterpretation of the results, which suggests that the maintenance of inter-individual variability is a key factor in ensuring the reliability of the qPCR data. In addition, it should be stressed that a proper validation of the suitability of the reference genes is required for each experimental setting, since the indiscriminate use of a reference gene can also lead to discrepant results.	[Gomes Leitao, Maria da Conceicao; Coimbra, Eliane Campos; Pereira de Lima, Rita de Cassia; de Freitas, Antonio Carlos] Univ Fed Pernambuco, Lab Mol Studies & Expt Therapy LEMTE, Dept Genet, Ctr Biol Sci, Recife, PE, Brazil; [Guimaraes, Marilea de Lima] Univ Fed Pernambuco, Clin Hosp, Recife, PE, Brazil; [Heraclio, Sandra de Andrade] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil; [Silva Neto, Jacinto da Costa] Univ Fed Pernambuco, Dept Histol, Mol & Cytol Res Lab, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade Federal de Pernambuco	de Freitas, AC (corresponding author), Univ Fed Pernambuco, Lab Mol Studies & Expt Therapy LEMTE, Dept Genet, Ctr Biol Sci, Recife, PE, Brazil.	acf_ufpe@yahoo.com.br	Freitas, Antonio/G-1843-2012; Silva Neto, Jacinto da Costa/R-5602-2017	Freitas, Antonio/0000-0002-4957-9549; Silva Neto, Jacinto da Costa/0000-0003-4418-801X	CNPq-Universal [474837/2013-0]; FACEPE/PPSUS [APQ-0247-2.02/13]	CNPq-Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE/PPSUS(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work is funded by CNPq-Universal/2013:no 474837/2013-0 and FACEPE/PPSUS:APQ-0247-2.02/13 (CNPq: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, FACEPE: Fundacao de Apoio a Ciencia do Estado de Pernambuco, PPSUS: Programa Pesquisa para o Sistema Unico de Saude). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Cheah PL, 2012, ASIAN PAC J CANCER P, V13, P469, DOI 10.7314/APJCP.2012.13.2.469; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; de Freitas AC, 2014, BBA-REV CANCER, V1845, P91, DOI 10.1016/j.bbcan.2013.12.004; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dijkstra JR, 2014, MOL ONCOL, V8, P813, DOI 10.1016/j.molonc.2013.12.016; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Hagemann T, 2007, BRIT J CANCER, V96, P321, DOI 10.1038/sj.bjc.6603543; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Hu Y, 2011, J INT MED RES, V39, P712, DOI 10.1177/147323001103900303; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Lyng MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036170; Ma MZ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-71; Martin Cara M., 2009, V511, P333, DOI 10.1007/978-1-59745-447-6_15; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nishio S, 2013, J GYNECOL ONCOL, V24, P215, DOI 10.3802/jgo.2013.24.3.215; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pettengill Emily A, 2012, BMC Res Notes, V5, P366, DOI 10.1186/1756-0500-5-366; Pinto Alvaro P, 2010, Diagn Histopathol (Oxf), V16, P445; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Saviozzi S, 2006, BMC CANCER, V26, P1; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Schiffman M, 2010, OBSTET GYNECOL, V116, P177, DOI 10.1097/AOG.0b013e3181e4629f; Shen Y, 2013, BRIT J CANCER, V109, P92, DOI 10.1038/bjc.2013.308; Shen YM, 2011, EXP MOL MED, V43, P358, DOI 10.3858/emm.2011.43.6.039; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Sheng J, 2010, CHINESE MED J-PEKING, V123, P1000, DOI 10.3760/cma.j.issn.0366-6999.2010.08.005; Soto-Reyes E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-40; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Xia SS, 2014, ONCOL LETT, V7, P1889, DOI 10.3892/ol.2014.2023; Yao TT, 2012, BBA-MOL BASIS DIS, V1822, P248, DOI 10.1016/j.bbadis.2011.09.018; Yu JJ, 2012, J CANCER RES CLIN, V138, P671, DOI 10.1007/s00432-012-1147-9; Zhang SD, 2005, BIOINFORMATICS, V21, P4378, DOI 10.1093/bioinformatics/bti717; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	52	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111021	10.1371/journal.pone.0111021	http://dx.doi.org/10.1371/journal.pone.0111021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365304	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100043
J	Kollenberg, M; Winter, S; Gotz, M				Kollenberg, Mario; Winter, Stephan; Goetz, Monika			Quantification and Localization of Watermelon Chlorotic Stunt Virus and Tomato Yellow Leaf Curl Virus (Geminiviridae) in Populations of Bemisia tabaci (Hemiptera, Aleyrodidae) with Differential Virus Transmission Characteristics	PLOS ONE			English	Article							CIRCULATIVE TRANSMISSION; WHITEFLY-TRANSMISSION; ENDOSYMBIOTIC BACTERIA; SARDINIA-VIRUS; SWEET-POTATO; RAPID SPREAD; HOST-RANGE; B-BIOTYPE; VECTOR; PLANT	Bemisia tabaci (Gennadius) is one of the economically most damaging insects to crops in tropical and subtropical regions. Severe damage is caused by feeding and more seriously by transmitting viruses. Those of the genus begomovirus (Geminiviridae) cause the most significant crop diseases and are transmitted by B. tabaci in a persistent circulative mode, a process which is largely unknown. To analyze the translocation and to identify critical determinants for transmission, two populations of B. tabaci MEAM1 were compared for transmitting Watermelon chlorotic stunt virus (WmCSV) and Tomato yellow leaf curl virus (TYLCV). Insect populations were chosen because of their high and respectively low virus transmission efficiency to compare uptake and translocation of virus through insects. Both populations harbored Rickettsia, Hamiltonella and Wolbachia in comparable ratios indicating that endosymbionts might not contribute to the different transmission rates. Quantification by qPCR revealed that WmCSV uptake and virus concentrations in midguts and primary salivary glands were generally higher than TYLCV due to higher virus contents of the source plants. Both viruses accumulated higher in insects from the efficiently compared to the poorly transmitting population. In the latter, virus translocation into the hemolymph was delayed and virus passage was impeded with limited numbers of viruses translocated. FISH analysis confirmed these results with similar virus distribution found in excised organs of both populations. No virus accumulation was found in the midgut lumen of the poor transmitter because of a restrained virus translocation. Results suggest that the poorly transmitting population comprised insects that lacked transmission competence. Those were selected to develop a population that lacks virus transmission. Investigations with insects lacking transmission showed that virus concentrations in midguts were reduced and only negligible virus amounts were found at the primary salivary glands indicating for a missing or modified receptor responsible for virus attachment or translocation.	[Kollenberg, Mario; Winter, Stephan; Goetz, Monika] Leibniz Inst DSMZ German Collect Microorganisms &, Plant Virus Dept, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Gotz, M (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Plant Virus Dept, Braunschweig, Germany.	monika.goetz@jki.bund.de	Kollenberg, Mario/GLR-0218-2022	Kollenberg, Mario/0000-0003-1607-1527; Gotz, Monika/0000-0001-6089-1851	German-Israeli Foundation (GIF) [908-42.12/2006]	German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	This research was supported by Research Grants No. 908-42.12/2006 from the German-Israeli Foundation (GIF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi I, 2004, J APPL ENTOMOL, V128, P81, DOI 10.1046/j.1439-0418.2003.00793.x; Al-Musa A, 2011, VIRUS GENES, V43, P79, DOI 10.1007/s11262-011-0594-8; Bananej K, 2002, J PHYTOPATHOL, V150, P423, DOI 10.1046/j.1439-0434.2002.00769.x; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BEDFORD ID, 1994, EUR J PLANT PATHOL, V100, P243, DOI 10.1007/BF01876239; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bing XL, 2013, APPL ENVIRON MICROB, V79, P569, DOI 10.1128/AEM.03030-12; Bouvaine S, 2011, J GEN VIROL, V92, P1467, DOI 10.1099/vir.0.029355-0; Brault V, 2007, MICRON, V38, P302, DOI 10.1016/j.micron.2006.04.005; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Caciagli P, 2009, J VIROL, V83, P5784, DOI 10.1128/JVI.02267-08; Caspi-Fluger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021096; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P467, DOI 10.1017/S0007485311000022; Cicero JM, 2011, ANN ENTOMOL SOC AM, V104, P261, DOI 10.1603/AN10075; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; COSTA HS, 1991, ENTOMOL EXP APPL, V61, P211, DOI 10.1007/BF00187724; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; Czosnek H, 2001, ADV VIRUS RES, V57, P291, DOI 10.1016/S0065-3527(01)57006-2; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Ghanim M, 2001, PHYTOPATHOLOGY, V91, P188, DOI 10.1094/PHYTO.2001.91.2.188; Ghanim M, 2009, J VIROL METHODS, V159, P311, DOI 10.1016/j.jviromet.2009.04.017; Gil-Salas FM, 2007, J VIROL METHODS, V146, P45, DOI 10.1016/j.jviromet.2007.05.032; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; GOODMAN RM, 1977, VIROLOGY, V83, P171, DOI 10.1016/0042-6822(77)90220-3; Goodman RM, 1979, ASS APPL BIOL; Gorsane F, 2011, ENVIRON ENTOMOL, V40, P809, DOI 10.1603/EN10162; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; GRIMSLEY N, 1986, P NATL ACAD SCI USA, V83, P3282, DOI 10.1073/pnas.83.10.3282; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Harris KF, 1996, ZOOMORPHOLOGY, V116, P143; Hemayet SM, 2012, CURR RES AGR LIFE SC, V30, P124; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hunter WB, 1998, PLANT DIS, V82, P1147, DOI 10.1094/PDIS.1998.82.10.1147; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jiggins FM, 2011, SCIENCE, V332, P185, DOI 10.1126/science.1205386; Kheyr-Pour A, 2000, PHYTOPATHOLOGY, V90, P629, DOI 10.1094/PHYTO.2000.90.6.629; Kliot A, 2014, J VIROL, V88, P5652, DOI 10.1128/JVI.00071-14; Kliot A, 2013, VIRUSES-BASEL, V5, P1516, DOI 10.3390/v5061516; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Lapidot M, 2001, PHYTOPATHOLOGY, V91, P1209, DOI 10.1094/PHYTO.2001.91.12.1209; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Maruthi MN, 2004, SYST ENTOMOL, V29, P560, DOI 10.1111/j.0307-6970.2004.00272.x; Maruthi MN, 2002, VIRUS RES, V86, P71, DOI 10.1016/S0168-1702(02)00051-5; Medina V, 2006, J PLANT PATHOL, V88, P299; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; NAVOT N, 1991, VIROLOGY, V185, P151, DOI 10.1016/0042-6822(91)90763-2; Ohnishi J, 2009, J GEN PLANT PATHOL, V75, P131, DOI 10.1007/s10327-009-0147-3; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Papayiannis LC, 2010, J VIROL METHODS, V165, P238, DOI 10.1016/j.jviromet.2010.02.003; POLSTON JE, 1990, PHYTOPATHOLOGY, V80, P850, DOI 10.1094/Phyto-80-850; PUCHTLER H, 1968, HISTOCHEMISTRY, V16, P361, DOI 10.1007/BF00306359; Reinbold C, 2003, J GEN VIROL, V84, P3473, DOI 10.1099/vir.0.19415-0; Rekha AR, 2005, ENTOMOL EXP APPL, V117, P221, DOI 10.1111/j.1570-7458.2005.00352.x; Rosa JCCL, 2007, ENTOMOL EXP APPL, V124, P161, DOI 10.1111/j.1570-7458.2007.00564.x; Rosell RC, 1999, PHYTOPATHOLOGY, V89, P239, DOI 10.1094/PHYTO.1999.89.3.239; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; SHAHJAHAN RM, 1995, BIOTECHNIQUES, V19, P332; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Skaljac M, 2010, ISR J PLANT SCI, V58, P103, DOI 10.1560/IJPS.58.2.103; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Su Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089002; Sufrin-Ringwald T, 2011, PHYTOPATHOLOGY, V101, P281, DOI 10.1094/PHYTO-06-10-0159; Thao ML, 2003, CURR MICROBIOL, V47, P46, DOI 10.1007/s00284-002-3953-9; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Xue X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048148; Yang XL, 2008, J VIROL, V82, P291, DOI 10.1128/JVI.01736-07; ZEIDAN M, 1991, J GEN VIROL, V72, P2607, DOI 10.1099/0022-1317-72-11-2607	84	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111968	10.1371/journal.pone.0111968	http://dx.doi.org/10.1371/journal.pone.0111968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365330	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100141
J	Li, L; Ye, WH; Wei, SG; Lian, JY; Huang, ZL				Li, Lin; Ye, Wan Hui; Wei, Shi Guang; Lian, Ju Yu; Huang, Zhong Liang			Spatial Patterns and Associations between Species Belonging to Four Genera of the Lauraceae Family	PLOS ONE			English	Article							SUBTROPICAL FOREST; DIVERSITY; AGGREGATION; COMPETITION; FACILITATION; DEMOGRAPHY; RICHNESS; PLANTS; TREES	Spatial distribution pattern of biological related species present unique opportunities and challenges to explain species coexistence. In this study, we explored the spatial distributions and associations among congeneric species at both the species and genus levels to explain their coexistence through examining the similarities and differences at these two levels. We first used DNA and cluster analysis to confirmed the relative relationship of eight species within a 20 ha subtropical forest in southern China. We compared Diameter at breast height ( DBH) classes, aggregation intensities and spatial patterns, associations, and distributions of four closely related species pairs to reveal similarities and differences at the species and genus levels. These comparisons provided insight into the mechanisms of coexistence of these congeners. O- ring statistics were used to measure spatial patterns of species. Omega(0-10), the mean conspecific density within 10 m of a tree, was used as a measure of the intensity of aggregation of a species, and g- function was used to analyze spatial associations. Our results suggested that spatial aggregations were common, but the differences between spatial patterns were reduced at the genus level. Aggregation intensity clearly reduced at the genus level. Negative association frequencies decreased at the genus level, such that independent association was commonplace among all four genera. Relationships between more closely related species appeared to be more competitive at both the species and genus levels. The importance of competition on interactions is most likely influenced by similarity in lifestyle, and the habitat diversity within the species' distribution areas. Relatives with different lifestyles likely produce different distribution patterns through different interaction process. In order to fully understand the mechanisms generating spatial distributions of coexisting siblings, further research is required to determine the spatial patterns and associations at other classification levels.	[Li, Lin; Wei, Shi Guang] Guilin Univ Elect Technol, Guilin, Peoples R China; [Ye, Wan Hui; Lian, Ju Yu; Huang, Zhong Liang] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China	Guilin University of Electronic Technology; Chinese Academy of Sciences; South China Botanical Garden, CAS	Ye, WH (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	why@scbg.ac.cn; weishig@mails.ucas.ac.cn		Wei, ShiGuang/0000-0002-0273-4978	National Nature Science Foundation of China [31200326, 31200412, 31460155]; Scientific Research and Technological Development of GuangXi [gkg1140002-2-4]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-Z]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research and Technological Development of GuangXi; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was funded by the National Nature Science Foundation of China (31200326, 31200412, 31460155), The Project of Scientific Research and Technological Development of GuangXi (No.gkg1140002-2-4), and the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran E, 2012, ANN BOT-LONDON, V110, P1369, DOI 10.1093/aob/mcs089; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; CONNELL J H, 1971, P298; Davies SJ, 1998, J ECOL, V86, P662, DOI 10.1046/j.1365-2745.1998.00299.x; Debussche M, 2003, ACTA OECOL, V24, P35, DOI 10.1016/S1146-609X(02)00006-1; Du XG, 2011, J THEOR BIOL, V278, P127, DOI 10.1016/j.jtbi.2011.03.003; Garcia-Serrana H, 2007, ACTA OECOL, V31, P69, DOI 10.1016/j.actao.2006.09.005; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Li L, 2008, J INTEGR PLANT BIOL, V50, P1140, DOI 10.1111/j.1744-7909.2008.00690.x; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; Lloyd KM, 2002, CONSERV BIOL, V16, P975, DOI 10.1046/j.1523-1739.2002.01033.x; Manabe T, 2000, PLANT ECOL, V151, P181, DOI 10.1023/A:1026512404110; Medail F, 1997, BIOL CONSERV, V80, P269, DOI 10.1016/S0006-3207(96)00055-9; Mitsui H, 2000, ECOL RES, V15, P93, DOI 10.1046/j.1440-1703.2000.00328.x; Mooney KA, 2008, OIKOS, V117, P450, DOI 10.1111/j.2007.0030-1299.16284.x; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pei NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021273; Pellissier L, 2010, ECOGRAPHY, V33, P1004, DOI 10.1111/j.1600-0587.2010.06386.x; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Queenborough SA, 2007, PLANT ECOL, V192, P193, DOI 10.1007/s11258-007-9328-3; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; RABINOWITZ D, 1984, ECOLOGY, V65, P1144, DOI 10.2307/1938322; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Raven P.H., 1978, ORIGIN RELATIONSHIPS; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Sfenthourakis S, 2006, GLOBAL ECOL BIOGEOGR, V15, P39, DOI 10.1111/j.1466-822x.2005.00192.x; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Stoyan D., 1994, FRACTALS RANDOM SHAP; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Tanaka H, 2008, J VEG SCI, V19, P127, DOI 10.3170/2007-8-18342; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; Wang ZF, 2012, OIKOS, V121, P2044, DOI 10.1111/j.1600-0706.2012.20483.x; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhang J, 2010, ACTA OECOL, V36, P29, DOI 10.1016/j.actao.2009.09.005	47	7	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111500	10.1371/journal.pone.0111500	http://dx.doi.org/10.1371/journal.pone.0111500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365507	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100072
J	Dudekula, A; Rachakonda, V; Shaik, B; Behari, J				Dudekula, Anwar; Rachakonda, Vikrant; Shaik, Beebijan; Behari, Jaideep			Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting Is Largely Unsuccessful but Correlates with Frequency of Clinic Visits	PLOS ONE			English	Article							LIFE-STYLE MODIFICATION; CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; CONTROLLED-TRIAL; ADULTS; STEATOHEPATITIS; EPIDEMIOLOGY; ASSOCIATION; MAINTENANCE	Background and Aims: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. Weight loss improves clinical features of NAFLD; however, maintenance of weight loss outside of investigational protocols is poor. The goals of this study were to characterize patterns and clinical predictors of long-term weight loss in ambulatory patients with NAFLD. Methods: We retrospectively reviewed 924 non-cirrhotic patients with NAFLD presenting to a liver clinic from May 1st 2007 to April 30th 2013. Overweight and obese patients were counseled on lifestyle modifications for weight loss as per USPSTF guidelines. The primary outcome was percent weight change between the first and last recorded visits: % weight change = (weight(initial) - weight(final))/(weight(initial)). Baseline BMI and percent BMI change were secondary measures. Predictors of weight loss were determined using logistic regression. Results: The mean baseline BMI was 33.3 +/- 6.6 kg/m(2), and the mean follow-up duration was 17.3 +/- 17.6 months. Most patients with NAFLD were in either overweight (26.1%) or class I obesity (30.5%) categories at baseline, while the prevalence of underweight and class III obesity was lower (0.2% and 15.4%, respectively). Overall, there was no change in mean weight or BMI during the follow-up period, and only 183 patients (19.8%) lost at least 5% body weight during the follow up period. Independent predictors of weight loss included number of clinic visits and baseline BMI, and patients with higher baseline BMI required more clinic visits to lose weight. Conclusions: Weight loss is largely unsuccessful in NAFLD patients in the ambulatory care setting. Frequent clinical encounters are associated with weight reduction, especially among individuals with high baseline BMI. Future studies are required to define effective weight loss strategies in NAFLD patients.	[Dudekula, Anwar] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Rachakonda, Vikrant; Shaik, Beebijan; Behari, Jaideep] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Behari, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA.	beharij@upmc.edu			National Institutes of Health [UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the University of Pittsburgh Clinical and Translational Science Institute (CTSI) for assistance with statistical analysis. The CTSI is supported by the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005.	Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Bellentani S, 2004, EUR J GASTROEN HEPAT, V16, P1087, DOI 10.1097/00042737-200411000-00002; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Church TS, 2006, GASTROENTEROLOGY, V130, P2023, DOI 10.1053/j.gastro.2006.03.019; Cruz RJ, 2013, TRANSPLANTATION, V95, P617, DOI 10.1097/TP.0b013e31827a0f27; Harrison SA, 2009, HEPATOLOGY, V49, P80, DOI 10.1002/hep.22575; Haufe S, 2013, DIABETES CARE, V36, P3786, DOI 10.2337/dc13-0102; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Lazo M, 2010, DIABETES CARE, V33, P2156, DOI 10.2337/dc10-0856; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Long J.Scott., 2005, REGRESSION MODELS CA; McHugh PP, 2010, HEPATO-GASTROENTEROL, V57, P591; Moyer VA, 2012, ANN INTERN MED, V157, P367, DOI 10.7326/0003-4819-157-5-201209040-00486; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Nehra MS, 2013, J CLIN GASTROENTEROL, V47, pE50, DOI 10.1097/MCG.0b013e3182688d2f; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; Perseghin G, 2007, DIABETES CARE, V30, P683, DOI 10.2337/dc06-2032; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tsai AG, 2005, PSYCHIAT CLIN N AM, V28, P171, DOI 10.1016/j.psc.2004.10.003; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Zelber-Sagi S, 2006, CLIN GASTROENTEROL H, V4, P639, DOI 10.1016/j.cgh.2006.02.004	31	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111808	10.1371/journal.pone.0111808	http://dx.doi.org/10.1371/journal.pone.0111808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375228	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000344402600064
J	Martins, MCB; Silva, MC; Silva, LRS; Lima, VLM; Pereira, EC; Falcao, EPS; Melo, AMMA; da Silva, NH				Martins, Monica C. B.; Silva, Monique C.; Silva, Luanna R. S.; Lima, Vera L. M.; Pereira, Eugenia C.; Falcao, Emerson P. S.; Melo, Ana M. M. A.; da Silva, Nicacio Henrique			Usnic Acid Potassium Salt: An Alternative for the Control of Biomphalaria glabrata (Say, 1818)	PLOS ONE			English	Article							LICHEN SECONDARY METABOLITES; SCHISTOSOMA-MANSONI; MOLLUSCICIDAL ACTIVITY; ARTEMIA-SALINA; DEPSIDONES; TOXICITY; DEFENSE; VECTOR; LARVAE; BRAZIL	In Brazil, the snail Biomphalaria glabrata is the most important vector of schistosomiasis due to its wide geographical distribution, high infection rate and efficient disease transmission. Among the methods of schistosomiasis control, the World Health Organization recommends the use of synthetic molluscicides, such as niclosamide. However, different substances of natural origin have been tested as alternatives for the control or eradication of mollusks. The literature describes the antitumor, antimicrobial and antiviral properties of usnic acid as well as other important activities of common interest between medicine and the environment. However, usnic acid has a low degree of water solubility, which can be a limiting factor for its use, especially in aquatic environments, since the organic solvents commonly used to solubilize this substance can have toxic effects on aquatic biota. Thus, the aim of the present study was to test the potassium salt of usnic acid (potassium usnate) with regard to molluscicidal activity and toxicity to brine shrimp (Artemia salina). To obtain potassium usnate, usnic acid was extracted with diethyl ether isolated and purified from the lichen Cladonia substellata. Biological assays were performed with embryos and adult snails of B. glabrata exposed for 24 h to the usnate solution solubilized in dechlorinated water at 2.5; 5 and 10 mu g/ml for embryos, 0.5; 0.9; 1; 5 and 10 mu g/ml for mollusks and 0.5; 1; 5; 10 mu g/ml for A. salina. The lowest lethal concentration for the embryos and adult snails was 10 and 1 mu g/ml, respectively. No toxicity to A. salina was found. The results show that modified usnic acid has increased solubility (100%) without losing its biological activity and may be a viable alternative for the control of B. glabrata.	[Martins, Monica C. B.; Silva, Monique C.; Lima, Vera L. M.; da Silva, Nicacio Henrique] Univ Fed Pernambuco, Dept Bioquim, Recife, Brazil; [Silva, Luanna R. S.; Melo, Ana M. M. A.] Univ Fed Pernambuco, Dept Radiobiol, Recife, Brazil; [Pereira, Eugenia C.] Univ Pernambuco, Dept Ciencias Geog, Pernambuco, Brazil; [Falcao, Emerson P. S.] Univ Fed Pernambuco, Ctr Acad Vitoria De Santo Antao, Recife, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco	Martins, MCB (corresponding author), Univ Fed Pernambuco, Dept Bioquim, Recife, Brazil.	monicabarmartins@hotmail.com; verticillaris@gmail.com	PEREIRA, EUGÊNIA/AAP-9515-2021	PEREIRA, EUGÊNIA/0000-0002-5821-0938; Lima, Vera/0000-0003-2581-9218	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MCBM received a doctoral grant by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br). ECP has a grant in research productivity by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asahina Y., 1954, CHEM LICHEN SUBSTANC; Asplund J, 2009, BASIC APPL ECOL, V10, P273, DOI 10.1016/j.baae.2008.04.003; Martins MCB, 2010, BRAZ ARCH BIOL TECHN, V53, P115, DOI 10.1590/S1516-89132010000100015; Benesperi R, 2004, BIOCHEM SYST ECOL, V32, P127, DOI 10.1016/S0305-1978(03)00141-8; Brasil. Ministerio da Saude, 2010, CAD, V10, P19; Brasil. Programa de Vigilancia e Controle da Esquistossomose, 2011, COORD GER DOENC NEGL; BUSTINZA F, 1951, ENDEAVOUR, V10, P95; Campanella L, 2002, BIOCHIMIE, V84, P329, DOI 10.1016/S0300-9084(02)01386-X; Cantanhede SPD, 2010, REV BRAS FARMACOGN, V20, P282, DOI 10.1590/S0102-695X2010000200024; dos Reis DC, 2010, MEM I OSWALDO CRUZ, V105, P587, DOI 10.1590/S0074-02762010000400039; dos Santos AF, 2007, BIORESOURCE TECHNOL, V98, P135, DOI 10.1016/j.biortech.2005.11.020; Edwards HGM, 2003, J MOL STRUCT, V651, P27, DOI 10.1016/S0022-2860(02)00626-9; Einarsdottir E, 2010, PLANTA MED, V76, P969, DOI 10.1055/s-0029-1240851; Elo H, 2007, NATURWISSENSCHAFTEN, V94, P465, DOI 10.1007/s00114-006-0208-9; Gauslaa Y, 2005, OECOLOGIA, V143, P94, DOI 10.1007/s00442-004-1768-z; Giovanelli A, 2002, MEM I OSWALDO CRUZ, V90, P261; Huneck S, 1996, IDENTIFICATION LICHE; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Lawrey J. D., 1980, BRYOLOGIST, V23, P128; LAWREY JD, 1989, BRYOLOGIST, V92, P326, DOI 10.2307/3243401; LEGAZ ME, 1983, PLANT PHYSIOL, V71, P300, DOI 10.1104/pp.71.2.300; Lemma A, 1974, Ethiop Med J, V12, P109; Lima NMF, 2002, ACTA TROP, V83, P43, DOI 10.1016/S0001-706X(02)00055-4; Luna JD, 2005, J ETHNOPHARMACOL, V97, P199, DOI 10.1016/j.jep.2004.10.004; Nimis PL, 2006, ENVIRON EXP BOT, V55, P175, DOI 10.1016/j.envexpbot.2004.10.011; Odabasoglu F, 2006, J ETHNOPHARMACOL, V103, P59, DOI 10.1016/j.jep.2005.06.043; Oliveira EC, 2010, CHEMOSPHERE, V81, P218, DOI 10.1016/j.chemosphere.2010.06.038; Poykko H, 2005, ECOLOGY, V86, P2623, DOI 10.1890/04-1632; Poykko H, 2010, OECOLOGIA, V164, P423, DOI 10.1007/s00442-010-1682-5; Rawi S. M., 2011, International Journal of Zoological Research, V7, P169, DOI 10.3923/ijzr.2011.169.189; Ribeiro KAL, 2009, ACTA TROP, V111, P44, DOI 10.1016/j.actatropica.2009.02.008; Santos A. F., 2010, BIORESOURTECHNOL, V101, P794, DOI DOI 10.1016/J.BIORTECH.2009.07.062; Savic I, 2010, MACED J CHEM CHEM EN, V29, P157; Schall VT, 2001, ACTA TROP, V79, P165, DOI 10.1016/S0001-706X(01)00126-7; Solhaug KA, 2009, FLORA, V204, P40, DOI 10.1016/j.flora.2007.12.002; Treyvaud V, 2000, PHYTOCHEMISTRY, V55, P603, DOI 10.1016/S0031-9422(00)00233-8; Wei XL, 2008, PLANT PATHOLOGY J, V24, P202, DOI 10.5423/PPJ.2008.24.2.202; World Health Organization, 1965, WHO TECH REP SER, V299, P1; World Health Organization, 1993, WHO TECHN REP SER	39	29	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111102	10.1371/journal.pone.0111102	http://dx.doi.org/10.1371/journal.pone.0111102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375098	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600025
J	Muller, V; Lindenberger, U				Mueller, Viktor; Lindenberger, Ulman			Hyper-Brain Networks Support Romantic Kissing in Humans	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; CELL ASSEMBLIES; SMALL-WORLD; ALPHA OSCILLATIONS; SOCIAL-INTERACTION; CORTICAL NETWORKS; COMPLEX NETWORKS; FREQUENCY; INFORMATION; ORGANIZATION	Coordinated social interaction is associated with, and presumably dependent on, oscillatory couplings within and between brains, which, in turn, consist of an interplay across different frequencies. Here, we introduce a method of network construction based on the cross-frequency coupling (CFC) and examine whether coordinated social interaction is associated with CFC within and between brains. Specifically, we compare the electroencephalograms (EEG) of 15 heterosexual couples during romantic kissing to kissing one's own hand, and to kissing one another while performing silent arithmetic. Using graph-theory methods, we identify theta-alpha hyper-brain networks, with alpha serving a cleaving or pacemaker function. Network strengths were higher and characteristic path lengths shorter when individuals were kissing each other than when they were kissing their own hand. In both partner-oriented kissing conditions, greater strength and shorter path length for 5-Hz oscillation nodes correlated reliably with greater partner-oriented kissing satisfaction. This correlation was especially strong for inter-brain connections in both partner-oriented kissing conditions but not during kissing one's own hand. Kissing quality assessed after the kissing with silent arithmetic correlated reliably with intra-brain strength of 10-Hz oscillation nodes during both romantic kissing and kissing with silent arithmetic. We conclude that hyper-brain networks based on CFC may capture neural mechanisms that support interpersonally coordinated voluntary action and bonding behavior.	[Mueller, Viktor; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany	Max Planck Society	Muller, V (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	vmueller@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021	Muller, Viktor/0000-0002-3716-5445	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Baltes P.B., 1996, INTERACTIVE MINDS LI, P1, DOI DOI 10.5860/CHOICE.34-2459; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Boker S, 2003, MIRROR NEURONS EVOLU, P163; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Di Paolo E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00163; Dumas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036414; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Frith CD, 2003, PHILOS T R SOC B, V358, P431, DOI 10.1098/rstb.2002.1260; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hughes S. M., 2007, EVOLUTIONARY PSYCHOL, V5, DOI [10.1177/147470490700500310, DOI 10.1177/147470490700500310]; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jirsa V, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00078; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kim Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016103; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Muller V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073852; Muller V, 2012, DEVELOPMENTAL SCI, V15, P540, DOI 10.1111/j.1467-7687.2012.01153.x; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; Pulvermuller F, 2009, HUM BRAIN MAPP, V30, P3837, DOI 10.1002/hbm.20811; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanger J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00234; Sanger J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00312; Sakurai Y, 1999, NEUROSCI BIOBEHAV R, V23, P785, DOI 10.1016/S0149-7634(99)00017-2; Sakurai Y, 1998, BEHAV BRAIN RES, V91, P1, DOI 10.1016/S0166-4328(97)00106-X; Sanger Johanna, 2011, Commun Integr Biol, V4, P655; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vigario RN, 1997, ELECTROEN CLIN NEURO, V103, P395, DOI 10.1016/S0013-4694(97)00042-8; Vilar L., 2012, EUROPEAN J SPORT SCI, V14, P28, DOI DOI 10.1080/17461391.2012.725103; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	73	27	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112080	10.1371/journal.pone.0112080	http://dx.doi.org/10.1371/journal.pone.0112080			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375132	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600098
J	Ensminger, AL; Fernandez-Juricic, E				Ensminger, Amanda L.; Fernandez-Juricic, Esteban			Individual Variation in Cone Photoreceptor Density in House Sparrows: Implications for Between-Individual Differences in Visual Resolution and Chromatic Contrast	PLOS ONE			English	Article							COLOR-VISION; SPECTRAL SENSITIVITY; RETINAL MORPHOLOGY; BLUEFIN KILLIFISH; OPSIN EXPRESSION; PRACTICAL GUIDE; ECOLOGY; VARIABILITY; PERFORMANCE; PLASTICITY	Between-individual variation has been documented in a wide variety of taxa, especially for behavioral characteristics; however, intra-population variation in sensory systems has not received similar attention in wild animals. We measured a key trait of the visual system, the density of retinal cone photoreceptors, in a wild population of house sparrows (Passer domesticus). We tested whether individuals differed from each other in cone densities given within-individual variation across the retina and across eyes. We further tested whether the existing variation could lead to individual differences in two aspects of perception: visual resolution and chromatic contrast. We found consistent between-individual variation in the densities of all five types of avian cones, involved in chromatic and achromatic vision. Using perceptual modeling, we found that this degree of variation translated into significant between-individual differences in visual resolution and the chromatic contrast of a plumage signal that has been associated with mate choice and agonistic interactions. However, there was no evidence for a relationship between individual visual resolution and chromatic contrast. The implication is that some birds may have the sensory potential to perform "better" in certain visual tasks, but not necessarily in both resolution and contrast simultaneously. Overall, our findings (a) highlight the need to consider multiple individuals when characterizing sensory traits of a species, and (b) provide some mechanistic basis for between-individual variation in different behaviors (i.e., animal personalities) and for testing the predictions of several widely accepted hypotheses (e.g., honest signaling).	[Ensminger, Amanda L.; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ensminger, AL (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	amanda.ensminger@gmail.com			National Science Foundation [1103725]; Div Of Biological Infrastructure [1103725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation under award No. 1103725 to A.L.E. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 2006, SAS MIXED MODELS; ARCHER SN, 1987, VISION RES, V27, P1243, DOI 10.1016/0042-6989(87)90200-8; Bailes HJ, 2006, J COMP NEUROL, V494, P381, DOI 10.1002/cne.20809; Baumhardt PE, 2014, BRAIN BEHAV EVOL; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; Bokony V, 2006, ETHOLOGY, V112, P947, DOI 10.1111/j.1439-0310.2006.01246.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Bueno JM, 2011, BIOMED OPT EXPRESS, V2, P1637, DOI 10.1364/BOE.2.001637; Carpentier S, 2009, CRIT REV FOOD SCI, V49, P313, DOI 10.1080/10408390802066979; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Coimbra JP, 2014, J COMP NEUROLOGY; Collin SP, 2004, VISUAL NEUROSCI, V21, P765, DOI 10.1017/S0952523804215103; Cropp S, 2002, J MOL EVOL, V54, P734, DOI 10.1007/s0023901-0073-2; Crozier WJ, 1940, J GEN PHYSIOL, V23, P667, DOI 10.1085/jgp.23.6.667; Cummings ME, 2004, VISION RES, V44, P1127, DOI 10.1016/j.visres.2003.12.013; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Darwin C, 1859, ORIGIN SPECIES MEANS; David M, 2011, ANIM BEHAV, V82, P61, DOI 10.1016/j.anbehav.2011.03.025; Dees EW, 2011, BIOMED OPT EXPRESS, V2, P1351, DOI 10.1364/BOE.2.001351; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Fernandez-Juricic E., 2010, ENCY ANIMAL BEHAV, P544; Fernandez-Juricic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058985; Fernandez-Juricic E, 2012, BEHAV PROCESS, V89, P143, DOI 10.1016/j.beproc.2011.10.006; Fitzgerald MEC, 2001, VISUAL NEUROSCI, V18, P299, DOI 10.1017/S0952523801182143; Fuller RC, 2003, J COMP PHYSIOL A, V189, P609, DOI 10.1007/s00359-003-0435-x; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Gal G, 1999, CAN J FISH AQUAT SCI, V56, P311, DOI 10.1139/cjfas-56-2-311; Gomez D., 2006, AVICOL PROGRAM ANAL; Gumm JM, 2012, VISION RES, V55, P19, DOI 10.1016/j.visres.2011.12.005; Hamilton DG, 2013, BEHAV ECOL, V24, P1138, DOI 10.1093/beheco/art041; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2006, J EXP BIOL, V209, P4776, DOI 10.1242/jeb.02568; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 2000, CURR BIOL, V10, P115, DOI 10.1016/S0960-9822(00)00297-9; HODOS W, 1991, VISION RES, V31, P669, DOI 10.1016/0042-6989(91)90008-S; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; IMAKI H, 1993, J NEUROSCI RES, V36, P290, DOI 10.1002/jnr.490360307; Ismar SMH, 2011, NEW ZEAL J ZOOL, V38, P29, DOI 10.1080/03014223.2010.524228; JACOBS GH, 1984, J COMP PSYCHOL, V98, P347, DOI 10.1037/0735-7036.98.4.347; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Litherland L, 2008, VISUAL NEUROSCI, V25, P549, DOI 10.1017/S0952523808080693; MARTIN GR, 1986, J COMP PHYSIOL A, V159, P545, DOI 10.1007/BF00604174; Martin Graham R., 1993, P5; McGraw Kevin J., 2006, P177; Mitkus M, 2014, J COMP PHYSIOL A, V200, P371, DOI 10.1007/s00359-014-0894-2; Moore BA, 2012, J VISION, V12, DOI 10.1167/12.12.13; Moreno-Rueda G, 2012, BEHAV ECOL, V23, P271, DOI 10.1093/beheco/arr182; Moreno-Rueda G, 2010, J AVIAN BIOL, V41, P229, DOI 10.1111/j.1600-048X.2009.04859.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Osorio D, 1999, J EXP BIOL, V202, P2951; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Rick IP, 2012, BIOL J LINN SOC, V105, P359, DOI 10.1111/j.1095-8312.2011.01796.x; Rodriguez-Prieto I, 2010, BEHAV ECOL SOCIOBIOL, V64, P1937, DOI 10.1007/s00265-010-1004-2; Ronald KL, 2012, ANIM BEHAV, V84, P1283, DOI 10.1016/j.anbehav.2012.09.015; Safi K, 2010, EVOL ECOL, V24, P703, DOI 10.1007/s10682-009-9326-0; Schaefer HM, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P3, DOI 10.1007/978-3-642-02624-9_1; SEARCY WA, 2005, MG BEH ECOL, P1; Smith AR, 2011, MOL ECOL, V20, P299, DOI 10.1111/j.1365-294X.2010.04935.x; SNYDER AW, 1977, J OPT SOC AM, V67, P696, DOI 10.1364/JOSA.67.000696; TAMURA TAMOTSU, 1963, BULL MAR SCI GULF AND CARIBBEAN, V13, P433; TAMURA TAMOTSU, 1957, BULL JAPANESE SOC SCI FISH, V22, P536; Toomey MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021653; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; West B. T., 2007, LINEAR MIXED MODELS; West Mark J, 2013, Cold Spring Harb Protoc, V2013, P815, DOI 10.1101/pdb.top071894; Westneat DF, 2011, AM NAT, V178, P652, DOI 10.1086/662173; White EM, 2004, J FISH BIOL, V65, P227, DOI 10.1111/j.0022-1112.2004.00446.x; Zhang CZ, 2008, CURR SCI INDIA, V95, P1544	81	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111854	10.1371/journal.pone.0111854	http://dx.doi.org/10.1371/journal.pone.0111854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372039	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900079
J	Francisco, TM; Couto, DR; Zanuncio, JC; Serrao, JE; Silva, ID; Boere, V				Francisco, Talitha Mayumi; Couto, Dayvid Rodrigues; Zanuncio, Jose Cola; Serrao, Jose Eduardo; Silva, Ita de Oliveira; Boere, Vanner			Vegetable Exudates as Food for Callithrix spp. (Callitrichidae): Exploratory Patterns	PLOS ONE			English	Article							COMMON MARMOSETS; SAGUINUS-FUSCICOLLIS; ATLANTIC FOREST; SCENT-MARKING; ECOLOGY; MORPHOLOGY; GUMMIVORY; FRAGMENT; BEHAVIOR; JACCHUS	Marmosets of the genus Callithrix are specialized in the consumption of tree exudates to obtain essential nutritional resource by boring holes into bark with teeth. However, marmoset preferences for particular tree species, location, type, and other suitable factors that aid in exudate acquisition need further research. In the current study, the intensity of exudate use from Anadenanthera peregrina var. peregrina trees by hybrid marmosets Callithrix spp. groups was studied in five forest fragments in Vic, osa, in the state of Minas, Brazil. Thirty-nine A. peregrina var. peregrina trees were examined and 8,765 active and non-active holes were analyzed. The trunk of A. peregrina var. peregrina had a lower number of holes than the canopy: 11% were found on the trunk and 89% were found on the canopy. The upper canopy was the preferred area by Callithrix spp. for obtaining exudates. The intensity of tree exploitation by marmosets showed a moderate-to-weak correlation with diameter at breast height (DBH) and total tree height. The overall results indicate that Anadenanthera peregrina var. peregrina provides food resources for hybrid marmosets (Callithrix spp.) and these animals prefer to explore this resource on the apical parts of the plant, where the thickness, location, and age of the branches are the main features involved in the acquisition of exudates.	[Francisco, Talitha Mayumi; Zanuncio, Jose Cola; Silva, Ita de Oliveira] Univ Fed Vicosa, Dept Biol Anim, BR-36570900 Vicosa, MG, Brazil; [Couto, Dayvid Rodrigues] Univ Fed Rio de Janeiro, Dept Bot, Museu Nacl, BR-20940040 Rio De Janeiro, RJ, Brazil; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil; [Boere, Vanner] Univ Fed Vicosa, Dept Bioquim & Biol Mol, BR-36570900 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal do Rio de Janeiro; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Zanuncio, JC (corresponding author), Univ Fed Vicosa, Dept Biol Anim, BR-36570900 Vicosa, MG, Brazil.	zanuncio@ufv.br	Francisco, Talitha Mayumi/AAJ-7969-2021		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding provided by "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)", "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)" and "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amora TD, 2013, AM J PRIMATOL, V75, P333, DOI 10.1002/ajp.22110; [Anonymous], METEOROLOGIA BASICA; Bearder S.K., 1980, International Journal of Primatology, V1, P103, DOI 10.1007/BF02735592; Bouchardet da Fonseca G.A., 1984, Primates, V25, P441, DOI 10.1007/BF02381667; Carvalho PER., 1994, ESPECIES FLORESTAIS; Caton JM, 1996, COMP BIOCHEM PHYS A, V114, P1, DOI 10.1016/0300-9629(95)02013-6; COIMBRA-FILHO A F, 1981, Revista Brasileira de Biologia, V41, P141; COIMBRA-FILHO A F, 1980, Revista Brasileira de Biologia, V40, P177; Coimbra-Filho A. F., 1973, BRASIL FLORESTAL, V4, P7; Coimbra-Filho AF, 1977, BIOL CONSERVATION CA, P105; COIMBRAFILHO AF, 1976, NATURE, V262, P630, DOI 10.1038/262630a0; dePaula RCM, 1997, POLYM INT, V44, P55; Eng CM, 2009, J EXP BIOL, V212, P4040, DOI 10.1242/jeb.029983; Ferrari SF, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P157; FERRARI SF, 1992, AM J PHYS ANTHROPOL, V88, P97, DOI 10.1002/ajpa.1330880108; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; GARBER PA, 1986, AM J PHYS ANTHROPOL, V71, P331, DOI 10.1002/ajpa.1330710308; Garber PA, 2010, DEV PRIMATOL-PROG PR, P89, DOI 10.1007/978-1-4419-6661-2_4; Giongo Claudia, 2004, Braz. J. Bot., V27, P563, DOI 10.1590/S0100-84042004000300015; GOLFARI L., 1975, ZONEAMENTO ECOLOGICO; Hanna JB, 2011, AM J PHYS ANTHROPOL, V145, P43, DOI 10.1002/ajpa.21465; HARRISON ML, 1994, AM J PHYS ANTHROPOL, V95, P399, DOI 10.1002/ajpa.1330950404; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; LACHER TE, 1981, ANIM BEHAV, V29, P306, DOI 10.1016/S0003-3472(81)80185-6; LACHER TE, 1984, BIOTROPICA, V16, P202, DOI 10.2307/2388053; Lazaro-Perea C, 1999, BEHAV ECOL SOCIOBIOL, V46, P313, DOI 10.1007/s002650050625; LORENZI H., 2016, ARVORES BRASILEIRAS, V1; LORENZI H., 2002, ARVORES BRASILEIRAS, V1; Martins MM, 2000, INT J PRIMATOL, V21, P467, DOI 10.1023/A:1005491903220; Millsap BA, 2000, J WILDLIFE MANAGE, V64, P33, DOI 10.2307/3802972; Miranda G.H.B. de, 2001, Brazilian Journal of Biology, V61, P397; Mori CLSO, 2003, BRASIL FLORESTAL BRA, V77, P29; NASH LT, 1986, YEARB PHYS ANTHROPOL, V29, P113; NATORI M, 1992, J MAMMAL, V73, P668, DOI 10.2307/1382041; Nogueira DM, 2011, IHERINGIA SER ZOOL, V101, P156, DOI 10.1590/S0073-47212011000200002; Carneiro ADO, 2012, REV ARVORE, V36, P767, DOI 10.1590/S0100-67622012000400018; Ottoni I, 2009, APPL ANIM BEHAV SCI, V117, P42, DOI 10.1016/j.applanim.2008.11.002; Paes JB, 2010, SCI FOR, V38, P441; Passamani M, 2000, PRIMATES, V41, P27, DOI 10.1007/BF02557459; Passamani Marcelo, 1996, Boletim do Museu de Biologia Mello Leitao, V4, P25; Patterson Michael E., 2003, Urban Forestry & Urban Greening, V1, P171, DOI 10.1078/1618-8667-00017; Pereira Z.V., 2012, REV BRASILEIRA AGROE, V7, P126; PERRY DR, 1978, BIOTROPICA, V10, P155, DOI 10.2307/2388019; Pontes ARM, 2007, BIODIVERS CONSERV, V16, P1175, DOI 10.1007/s10531-006-9099-5; Power ML, 2010, DEV PRIMATOL-PROG PR, P25, DOI 10.1007/978-1-4419-6661-2_2; Power ML, 1996, AM J PRIMATOL, V40, P131, DOI 10.1002/(SICI)1098-2345(1996)40:2<131::AID-AJP2>3.3.CO;2-8; R Core Team, 2012, R LANG ENV STAT COMP; Raboy BE, 2008, INT J PRIMATOL, V29, P449, DOI 10.1007/s10764-008-9249-6; RIZZINI C T, 1981, Revista Brasileira de Biologia, V41, P579; ROSENBERGER AL, 1978, J MAMMAL, V59, P207, DOI 10.2307/1379899; Rylands A. B., 1984, Tropical rain-forest. The Leeds symposium, P155; Rylands Anthony B., 1993, P262; Schulke O, 2003, BEHAV ECOL SOCIOBIOL, V55, P11, DOI 10.1007/s00265-003-0676-2; Smith AC, 2000, INT J PRIMATOL, V21, P69, DOI 10.1023/A:1005423629627; Smith AC, 2010, DEV PRIMATOL-PROG PR, P109, DOI 10.1007/978-1-4419-6661-2_5; Soini P., 1988, P79; Starr C, 2013, AM J PRIMATOL, V75, P1054, DOI 10.1002/ajp.22171; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Stevenson MF, 1988, ECOLOGY BEHAVIOUR NE, V2, P131; SUSSMAN RW, 1984, AM J PHYS ANTHROPOL, V64, P419, DOI 10.1002/ajpa.1330640407; Taiz L, 2017, FISIOLOGIA DESENVOLV, V6nd; Taylor AB, 2004, J MORPHOL, V261, P276, DOI 10.1002/jmor.10249; Thompson CL, 2013, INT J PRIMATOL, V34, P65, DOI 10.1007/s10764-012-9647-7; Ushida K, 2006, AM J PRIMATOL, V68, P143, DOI 10.1002/ajp.20212; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Vinyard CJ, 2003, AM J PHYS ANTHROPOL, V120, P153, DOI 10.1002/ajpa.10129; Warren RD, 1997, AM J PHYS ANTHROPOL, V104, P471, DOI 10.1002/(SICI)1096-8644(199712)104:4<471::AID-AJPA4>3.0.CO;2-V; Yepez P, 2005, AM J PRIMATOL, V66, P145, DOI 10.1002/ajp.20134	68	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112321	10.1371/journal.pone.0112321	http://dx.doi.org/10.1371/journal.pone.0112321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372137	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900134
J	Herman, CW; Conlon, ASC; Rubenfire, M; Burghardt, AR; McGregor, SJ				Herman, Christopher W.; Conlon, Anna S. C.; Rubenfire, Melvyn; Burghardt, Andrew R.; McGregor, Stephen J.			The Very High Premature Mortality Rate among Active Professional Wrestlers Is Primarily Due to Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; UNITED-STATES; PREVALENCE; POPULATION; OBESITY	Purpose: Recently, much media attention has been given to the premature deaths in professional wrestlers. Since no formal studies exist that have statistically examined the probability of premature mortality in professional wrestlers, we determined survival estimates for active wresters over the past quarter century to establish the factors contributing to the premature mortality of these individuals. Methods: Data including cause of death was obtained from public records and wrestling publications in wrestlers who were active between January 1, 1985 and December 31, 2011. 557 males were considered consistently active wrestlers during this time period. 2007 published mortality rates from the Center for Disease Control were used to compare the general population to the wrestlers by age, BMI, time period, and cause of death. Survival estimates and Cox hazard regression models were fit to determine incident premature deaths and factors associated with lower survival. Cumulative incidence function (CIF) estimates given years wrestled was obtained using a competing risks model for cause of death. Results: The mortality for all wrestlers over the 26-year study period was. 007 deaths/total person-years or 708 per 100,000 per year, and 16% of deaths occurred below age 50 years. Among wrestlers, the leading cause of deaths based on CIF was cardiovascular-related (38%). For cardiovascular-related deaths, drug overdose-related deaths and cancer deaths, wrestler mortality rates were respectively 15.1, 122.7 and 6.4 times greater than those of males in the general population. Survival estimates from hazard models indicated that BMI is significantly associated with the hazard of death from total time wrestling (p<0.0001). Conclusion: Professional wrestlers are more likely to die prematurely from cardiovascular disease compared to the general population and morbidly obese wrestlers are especially at risk. Results from this study may be useful for professional wrestlers, as well as wellness policy and medical care implementation.	[Herman, Christopher W.; Burghardt, Andrew R.; McGregor, Stephen J.] Eastern Michigan Univ, Ypsilanti, MI 48197 USA; [Conlon, Anna S. C.; Rubenfire, Melvyn] Univ Michigan, Ann Arbor, MI 48109 USA	Eastern Michigan University; University of Michigan System; University of Michigan	Herman, CW (corresponding author), Eastern Michigan Univ, Ypsilanti, MI 48197 USA.	cherman2@emich.edu						[Anonymous], 2011, WWE INCOME STATEMENT; [Anonymous], 2011, R LANG ENV STAT COMP; [Anonymous], 2009, WWE STEROIDS STILL T; [Anonymous], 2006, WWE TAL WELLN PROGR; Barson S, 1994, HLTH HAZARD EVALUATI; Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Carman WJ, 2011, PHARMACOEPIDEM DR S, V20, P754, DOI 10.1002/pds.2131; Cohen E, WRESTLINGS DIRTY SEC; Deitch C, 2010, HEAVYWEIGHT CHAMPION; Foley M, 2010, COUNTDOWN LOCKDOWN H; Hart B, 2008, HITMAN MY REAL LIFE; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Knauf H, 2006, EUR J CLIN PHARMACOL, V62, P885, DOI 10.1007/s00228-006-0190-3; Lapi F, 2013, BMJ, V346; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Manson JE, 2003, JAMA-J AM MED ASSOC, V289, P229, DOI 10.1001/jama.289.2.229; Marijon E, 2013, EUR HEART J, V34, P3145, DOI 10.1093/eurheartj/eht347; Michaels S, 2006, HEARTBREAK TRIUMPH S; Nascimento JHM, 2011, MINI-REV MED CHEM, V11, P425; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; SAS Institute Inc., 2011, SAS VERS 9 2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shields B, 2009, WWE ENCY DEFINITIVE; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Trelle S., 2011, BMJ, V342; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Wolin KY, 2010, ONCOLOGIST, V15, P556, DOI 10.1634/theoncologist.2009-0285; Xu J, 2010, NATL VITAL STAT REPO, V58, P22	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109945	10.1371/journal.pone.0109945	http://dx.doi.org/10.1371/journal.pone.0109945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372569	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900012
J	Levine, RS; Kilbourne, BA; Rust, GS; Langston, MA; Husaini, BA; Gittner, LS; Sanderson, M; Hennekens, CH				Levine, Robert S.; Kilbourne, Barbara A.; Rust, George S.; Langston, Michael A.; Husaini, Baqar A.; Gittner, Lisaann S.; Sanderson, Maureen; Hennekens, Charles H.			Social Determinants and the Classification of Disease: Descriptive Epidemiology of Selected Socially Mediated Disease Constellations	PLOS ONE			English	Article							INFANT-MORTALITY; SOCIOECONOMIC POSITION; HEALTH; INEQUALITIES; ASSOCIATIONS; EPIGENETICS; SMOKING	Background: Most major diseases have important social determinants. In this context, classification of disease based on etiologic or anatomic criteria may be neither mutually exclusive nor optimal. Methods and Findings: Units of analysis comprised large metropolitan central and fringe metropolitan counties with reliable mortality rates - (n = 416). Participants included infants and adults ages 25 to 64 years with selected causes of death (1999 to 2006). Exposures included that residential segregation and race-specific social deprivation variables. Main outcome measures were obtained via principal components analyses with an orthogonal rotation to identify a common factor. To discern whether the common factor was socially mediated, negative binomial multiple regression models were developed for which the dependent variable was the common factor. Results showed that infant deaths, mortality from assault, and malignant neoplasm of the trachea, bronchus and lung formed a common factor for race-gender groups (black/white and men/women). Regression analyses showed statistically significant, positive associations between low socio-economic status for all race-gender groups and this common factor. Conclusions: Between 1999 and 2006, deaths classified as "assault" and "lung cancer", as well as "infant mortality" formed a socially mediated factor detectable in population but not individual data. Despite limitations related to death certificate data, the results contribute important information to the formulation of several hypotheses: (a) disease classifications based on anatomic or etiologic criteria fail to account for social determinants; (b) social forces produce demographically and possibly geographically distinct population-based disease constellations; and (c) the individual components of population-based disease constellations (e. g., lung cancer) are phenotypically comparable from one population to another but genotypically different, in part, because of socially mediated epigenetic variations. Additional research may produce new taxonomies that unify social determinants with anatomic and/or etiologic determinants. This may lead to improved medical management of individuals and populations.	[Levine, Robert S.; Kilbourne, Barbara A.; Sanderson, Maureen; Hennekens, Charles H.] Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA; [Kilbourne, Barbara A.] Tennessee State Univ, Dept Sociol, Nashville, TN 37203 USA; [Rust, George S.] Morehouse Sch Med, Dept Community & Prevent Med, Atlanta, GA 30310 USA; [Langston, Michael A.] Univ Tennessee, Dept Elect Engn & Informat Technol, Knoxville, TN USA; [Husaini, Baqar A.] Tennessee State Univ, Ctr Prevent Res, Nashville, TN 37203 USA; [Gittner, Lisaann S.] Texas Tech Univ, Dept Polit Sci, Lubbock, TX 79409 USA; [Hennekens, Charles H.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Epidemiol, Boca Raton, FL 33431 USA	Meharry Medical College; Tennessee State University; Morehouse School of Medicine; University of Tennessee System; University of Tennessee Knoxville; Tennessee State University; Texas Tech University System; Texas Tech University; State University System of Florida; Florida Atlantic University	Levine, RS (corresponding author), Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA.	rlevine@mmc.edu		Gittner, Lisaann/0000-0001-7407-828X; Rust, George/0000-0002-9040-9744	National Institute for Minority Health and Health Disparities [2P20MD000516]; National Institute on Minority Health and Health Disparities [P20MD000516] Funding Source: NIH RePORTER	National Institute for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded in part by grant # 2P20MD000516 from the National Institute for Minority Health and Health Disparities. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Abdalla S, 2013, J PUBLIC HEALTH-UK, V35, P533, DOI 10.1093/pubmed/fds106; [Anonymous], 2010, COMPR MORT FIL 1999, V20; Balgkouranidou I, 2013, BIOMARK MED, V7, P49, DOI [10.2217/BMM.12.111, 10.2217/bmm.12.111]; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Brown HL, 2013, CLIN OBSTET GYNECOL, V56, P107, DOI 10.1097/GRF.0b013e318282377d; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P10, DOI 10.1177/1403494812457732; Doria-Rose VP, 2009, LUNG CANCER, V63, P295, DOI 10.1016/j.lungcan.2008.05.019; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Geolytics Inc, 2012, US CENS 2010; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hirai AH, 2013, AM J PUBLIC HEALTH, V103, pE88, DOI 10.2105/AJPH.2013.301294; Kitsantas P, 2013, SOUTH MED J, V106, P310, DOI 10.1097/SMJ.0b013e318290c6e8; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lawlor DA, 2006, AM J EPIDEMIOL, V164, P907, DOI 10.1093/aje/kwj319; Link BG, 1996, AM J PUBLIC HEALTH, V86, P471, DOI 10.2105/AJPH.86.4.471; Link BG, 1998, MILBANK Q, V76, P375, DOI 10.1111/1468-0009.00096; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; National Center for Health Statistics, CLASS DIS INJ; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Reidpath DD, 2003, J EPIDEMIOL COMMUN H, V57, P344, DOI 10.1136/jech.57.5.344; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, P5; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID, P1892; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID, P1534; Schmidt CW, 2013, ENVIRON HEALTH PERSP, V121, pA298, DOI 10.1289/ehp.121-A298; Singh PN, 2013, ASIA-PAC J PUBLIC HE, V25, p64S, DOI 10.1177/1010539513493458; Villerme L.-R., 1840, TABLEAU ETAT PHYS MO, V2; World Health Organization, HIST DEV INT CLASS D; World Health Organization, 2008, ICD 10 INT STAT CLAS; World Health Organization, 2010, INT CLASS DIS ICD	36	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110271	10.1371/journal.pone.0110271	http://dx.doi.org/10.1371/journal.pone.0110271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372286	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900018
J	Zong, SH; Zeng, GF; Du, L; Fang, Y; Gao, TH; Zhao, JM				Zong, Shaohui; Zeng, Gaofeng; Du, Li; Fang, Ye; Gao, Taihang; Zhao, Jingmin			Treatment Results in the Different Surgery of Intradural Extramedullary Tumor of 122 Cases	PLOS ONE			English	Article							TRANSPEDICULAR SCREW FIXATION; BIOMECHANICAL ANALYSIS	Study Design: A retrospective study of intradural extramedullary tumor. Objective: To compare the treatment results in the different surgeries of spinal intradural extramedullary tumor. Methods: The study retrospectively reviewed 122 patients. The minimally invasive surgery (MIS) group was divided into Group A (hemilaminectomy + tumor microscopic excision) and Group B (laminectomy + tumor microscopic excision + pedicle screw fixation). Meanwhile, the non-MIS group was divided into Group C (hemilaminectomy + tumor excision), Group D (laminectomy + tumor excision), and Group E (laminectomy + tumor excision + pedicle screw fixation). In order to study postoperative spinal stability, we simultaneously divided all of the subjects into three categories, namely Group HE: hemilaminectomy + tumor excision; Group LE: laminectomy + tumor excision; and Group LEPSF: laminectomy + tumor excision + pedicle screw fixation. Results: The MIS group exhibited fewer postoperative complications (p<0.05), better short-term clinical efficacy (p<0.05) and less non-surgical cost (p<0.05) than in non-MIS group. The rate of postoperative spinal instability in hemilaminectomy was lower than in laminectomy in a single spinal segment (p<0.05). The rate of postoperative spinal instability in laminectomy + pedicle screw fixation was lower than in hemilaminectomy and laminectomy in two or more spinal segments (p<0.05). Conclusion: In the case of appropriate surgical indications, minimally invasive surgery for intradural extramedullary tumor is a useful method that can successfully produce good clinical results and reduce non-surgical cost. In addition, pedicle screw fixation helps avoid spinal postoperative instability.	[Zong, Shaohui; Du, Li; Fang, Ye; Gao, Taihang] Guangxi Med Univ, Affiliated Hosp 1, Dept Spine Osteopathia, Nanning, Guangxi, Peoples R China; [Zeng, Gaofeng] Guangxi Med Univ, Coll Publ Hyg, Nanning, Guangxi, Peoples R China; [Zhao, Jingmin] Guangxi Med Univ, Affiliated Hosp 1, Dept Orthopaed Trauma & Hand Surg, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Zhao, JM (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Orthopaed Trauma & Hand Surg, Nanning, Guangxi, Peoples R China.	zhaojingmin3008@sina.com			Guangxi Science and Technology Plan Fund, Gui Ke Gong [1298003-5-1]	Guangxi Science and Technology Plan Fund, Gui Ke Gong	The authors acknowledge support from the Guangxi Science and Technology Plan Fund, Gui Ke Gong 1298003-5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2002, J Neurosurg Sci, V46, P18; Canbay S, 2012, ASIAN SPINE J, V6, P43, DOI 10.4184/asj.2012.6.1.43; Guidetti B., 1974, ADV TECHNICAL STANDA, P173; HELSETH A, 1989, J NEUROSURG, V71, P842, DOI 10.3171/jns.1989.71.6.0842; Iacoangeli M, 2012, CLIN INTERV AGING, V7, P557, DOI 10.2147/CIA.S38923; IIDA Y, 1990, SPINE, V15, P1186, DOI 10.1097/00007632-199011010-00018; Kirshblum SC, 2002, AM J PHYS MED REHAB, V81, P502, DOI 10.1097/00002060-200207000-00006; Kobayashi S, 2007, MINIM INVAS NEUROSUR, V50, P120, DOI 10.1055/s-2007-982506; KOTANI Y, 1994, SPINE, V19, P2529, DOI 10.1097/00007632-199411001-00007; Kothe R, 2004, SPINE, V29, P1869, DOI 10.1097/01.brs.0000137287.67388.0b; Mayfield F H, 1976, Clin Neurosurg, V23, P435; Mazel C, 2004, SPINE, V29, P1246, DOI 10.1097/00007632-200406010-00015; Ogden AT, 2009, CLIN BIOMECH, V24, P143, DOI 10.1016/j.clinbiomech.2008.11.005; PANJABI MM, 1980, NEUROSURGERY, V7, P76, DOI 10.1227/00006123-198007000-00014; Postalci L, 2011, TURK NEUROSURG, V21, P449, DOI [10.5137/1019-5149.JTN.3518-10.2, 10.5137/1019-5149.JTN .3518-10.2]; Sachdev S, 2011, NEUROSURGERY, V69, P533, DOI 10.1227/NEU.0b013e318218db23; Smith ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092611; Starodubtsev A I, 1984, Zh Vopr Neirokhir Im N N Burdenko, P22; Sun Z, 2011, J LARYNGOL OTOL, V125, P418, DOI 10.1017/S0022215110002707; YASUOKA S, 1982, J NEUROSURG, V57, P441, DOI 10.3171/jns.1982.57.4.0441; Yeo DK, 2011, J KOREAN NEUROSURG S, V50, P195, DOI 10.3340/jkns.2011.50.3.195; Zong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063867	22	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111495	10.1371/journal.pone.0111495	http://dx.doi.org/10.1371/journal.pone.0111495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372863	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900051
J	Kawano, T; Nishiyama, K; Hayashi, H				Kawano, Takahisa; Nishiyama, Kei; Hayashi, Hiroyuki			Adding More Junior Residents May Worsen Emergency Department Crowding	PLOS ONE			English	Article							LENGTH-OF-STAY; ACCESS BLOCK; THROUGHPUT; IMPACT; ASSOCIATION; PERFORMANCE; PREDICTORS; OUTCOMES; MODEL; CARE	Background: Although increasing staff numbers during shifts when emergency department (ED) crowding is severe can help meet patient demand, it remains unclear how different types of added staff, particularly junior residents, may affect crowding. Methods: To identify associations between types of staff and ED crowding, we conducted a cross-sectional, single-center study in the ED of a large, teaching hospital in Japan between January and December 2012. Patients who visited the ED during the study period were enrolled. We excluded (1) patients previously scheduled to visit the ED, and (2) neonates transferred from other hospitals. During the study period, 27,970 patients were enrolled. Types of staff analyzed were junior (first and second year) residents, senior (third to fifth year) residents, attending (board-certified) physicians, and nurses. A generalized linear model was applied to length of ED stay for all patients as well as admitted and discharged patients to quantify an association with the additional staff. Results: In the model, addition of one attending physician or senior resident was associated with decreased length of ED stay for total patients by 3.88 or 1.64 minutes, respectively (95% CI, 2.20-5.56 and 0.81-2.48 minutes); while additional nursing staff had no association. Surprisingly, however, one additional junior resident was associated with prolonged length of ED stay for total patients by 0.97 minutes (95% CI 0.37-1.57 minutes) and for discharged patients by 1.01 minutes (95% CI 0.45-1.59 minutes). Conclusion: Staffing adjustments aimed at alleviating ED crowding should focus on adding more senior staff during peak-volume shifts.	[Kawano, Takahisa] Univ Fukui Hosp, Dept Emergency Med, Fukui, Yoshida County, Japan; [Nishiyama, Kei] Kyoto Univ, Grad Sch Med, Dept Primary Care & Emergency Med, Kyoto, Japan; [Hayashi, Hiroyuki] Univ Fukui Hosp, Dept Gen Med, Fukui, Yoshida County, Japan	University of Fukui; Kyoto University; University of Fukui	Kawano, T (corresponding author), Univ Fukui Hosp, Dept Emergency Med, Fukui, Yoshida County, Japan.	maketenakunarakattenake@hotmail.com		Nishiyama, Kei/0000-0003-3676-0135	Emergency Promotion Foundation	Emergency Promotion Foundation	Financial incentives were provided to the authors by the Emergency Promotion Foundation (http://www.fasd.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck A, 2013, CAN J EMERG MED, V15, P359; Asaro PV, 2007, ACAD EMERG MED, V14, P235, DOI 10.1197/j.aem.2006.10.104; Asaro PV, 2007, ACAD EMERG MED, V14, P157, DOI 10.1197/j.aem.2006.08.011; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Chin L, 1998, PEDIATR EMERG CARE, V14, P4, DOI 10.1097/00006565-199802000-00002; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Gardner RL, 2007, AM J EMERG MED, V25, P643, DOI 10.1016/j.ajem.2006.11.037; Hagiwara Y, 2010, NIHON KYUKYU IGAKUKA, V21, P889; Halperin H, 2007, CIRCULATION, V116, P1855, DOI 10.1161/CIRCULATIONAHA.107.186661; Harris A, 2010, EMERG MED J, V27, P508, DOI 10.1136/emj.2009.072546; Hillier DF, 2009, ANN EMERG MED, V53, P767, DOI 10.1016/j.annemergmed.2008.11.024; Holroyd BR, 2007, ACAD EMERG MED, V14, P702, DOI 10.1197/j.aem.2007.04.018; Japanese Association for Acute Medicine, 2012, NUMB BOARD CERT ED P; Kawano T, 2014, EMERG MED J, V31, P19, DOI 10.1136/emermed-2012-202050; Kennebeck SS, 2011, ACAD EMERG MED, V18, P1380, DOI 10.1111/j.1553-2712.2011.01221.x; Kocher KE, 2012, ACAD EMERG MED, V19, P525, DOI 10.1111/j.1553-2712.2012.01353.x; McCarthy ML, 2009, ANN EMERG MED, V54, P492, DOI 10.1016/j.annemergmed.2009.03.006; Ministry of Health Labour and Welfare, 2011, PAT SURV; Ministry of Health Labour and Welfare, 2009, BAS STAT REG HLTH CA; Ministry of Internal Affairs and Communications, 2010, RES ACC AMB MED I 20; Nakayama T, 2005, J EPIDEMIOL, V15, P107, DOI 10.2188/jea.15.107; Pines JM, 2012, ANN EMERG MED, V60, P293, DOI 10.1016/j.annemergmed.2012.01.024; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Thornton V, 2008, EMERG MED AUSTRALAS, V20, P425, DOI 10.1111/j.1742-6723.2008.01117.x; Timm NL, 2008, ACAD EMERG MED, V15, P832, DOI 10.1111/j.1553-2712.2008.00224.x; Tsukasa OJ, 2010, JAPANESE IJI SHINPOU, V4471, P101; Wiler JL, 2012, AM J EMERG MED, V30, P1860, DOI 10.1016/j.ajem.2012.03.028	27	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110801	10.1371/journal.pone.0110801	http://dx.doi.org/10.1371/journal.pone.0110801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369063	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000028
J	Lin, M; Zhang, BL; Yu, CN; Li, JL; Zhang, L; Sun, H; Gao, F; Zhou, GH				Lin, Meng; Zhang, Bolin; Yu, Changning; Li, Jiaolong; Zhang, Lin; Sun, Hui; Gao, Feng; Zhou, Guanghong			L-Glutamate Supplementation Improves Small Intestinal Architecture and Enhances the Expressions of Jejunal Mucosa Amino Acid Receptors and Transporters in Weaning Piglets	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; MONOSODIUM GLUTAMATE; TASTE RECEPTORS; DIGESTIVE PHYSIOLOGY; NUTRIENT ABSORPTION; DIETARY GLUTAMATE; METABOLIC-FATE; ARGININE; OCCLUDIN; CALCIUM	L-Glutamate is a major oxidative fuel for the small intestine. However, few studies have demonstrated the effect of L-glutamate on the intestinal architecture and signaling of amino acids in the small intestine. The aim of this study was to investigate the effects of dietary L-glutamate supplementation on the intestinal architecture and expressions of jejunal mucosa amino acid receptors and transporters in weaning piglets. A total of 120 weaning piglets aged 35 +/- 1 days with an average body weight at 8.91 +/- 0.45 kg were randomly allocated to two treatments with six replicates of ten piglets each, fed with diets containing 1.21% alanine, or 2% L-glutamate. L-Glutamate supplementation increased the activity of glutamate oxaloacetate transaminase (GOT) in the jejunal mucosa. Also, the mRNA expression level of jejunal mucosa glutamine synthetase (GS) was increased by L-glutamate supplementation. The height of villi in duodenal and jejunal segments, and the relative mRNA expression of occludin and zonula occludens protein-1 (ZO-1) in jejunal mucosa were increased by dietary L-glutamate supplementation. L-Glutamate supplementation increased plasma concentrations of glutamate, arginine, histidine, isoleucine, leucine, methionine, phenylalanine and threonine. L-Glutamate supplementation also increased the relative mRNA expression of the jejunal mucosa Ca2+-sensing receptor (CaR), metabotropic glutamate receptor 1 (mGluR1) and metabotropic glutamate receptor 4 (mGluR4), and neutral amino acid transporter B-0-like (SLC1A5) in the jejunal mucosa. These findings suggest that dietary addition of 2% L-glutamate improves the intestinal integrity and influences the expression of amino acid receptors and transporters in the jejunum of weaning, which is beneficial for the improvement of jejunal nutrients for digestion and absorption.	[Lin, Meng; Zhang, Bolin; Yu, Changning; Li, Jiaolong; Zhang, Lin; Gao, Feng; Zhou, Guanghong] Nanjing Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Key Lab Anim Origin Food Prod & Safety Guarantee, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Sun, Hui] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China	Nanjing Agricultural University; Jilin Agricultural University	Gao, F (corresponding author), Nanjing Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Key Lab Anim Origin Food Prod & Safety Guarantee, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	gaofeng0629@sina.com	Zhang, Lin/AAL-3573-2020; Zhang, bolin/GZN-2017-2022	Zhang, Lin/0000-0003-1555-1086; 	National Key Basic Research Program of China [2013CB127306]	National Key Basic Research Program of China(National Basic Research Program of China)	The present study was supported by National Key Basic Research Program of China (no. 2013CB127306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; Akiba Y, 2009, AM J CLIN NUTR, V90, p826S, DOI 10.3945/ajcn.2009.27462U; Amagase K, 2012, J PHARMACOL SCI, V118, P131, DOI 10.1254/jphs.11R03FM; Beutheu S, 2014, CLIN NUTR, V33, P694, DOI 10.1016/j.clnu.2013.09.003; Beyreuther K, 2007, EUR J CLIN NUTR, V61, P304, DOI 10.1038/sj.ejcn.1602526; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Boutry C, 2011, AM J PHYSIOL-GASTR L, V300, pG137, DOI 10.1152/ajpgi.00299.2010; Broer A, 2000, BIOCHEM J, V349, P787, DOI 10.1042/bj3490787; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Brosnan JT, 2013, AMINO ACIDS, V45, P413, DOI 10.1007/s00726-012-1280-4; Burrin DG, 2009, AM J CLIN NUTR, V90, p850S, DOI 10.3945/ajcn.2009.27462Y; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; Gabriel AS, 2009, J MED INVESTIG, V56, P209, DOI 10.2152/jmi.56.209; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Haynes TE, 2009, AMINO ACIDS, V37, P131, DOI 10.1007/s00726-009-0243-x; He LQ, 2013, AMINO ACIDS, V45, P383, DOI 10.1007/s00726-013-1514-0; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kirchgessner Annette L., 2001, Current Opinion in Pharmacology, V1, P591, DOI 10.1016/S1471-4892(01)00101-1; Li N, 2009, J NUTR, V139, P710, DOI 10.3945/jn.108.101485; Li XL, 2011, AMINO ACIDS, V40, P1159, DOI 10.1007/s00726-010-0740-y; Liou AP, 2013, J ANIM SCI, V91, P1946, DOI 10.2527/jas.2012-5910; Liu Y, 2000, J CELL SCI, V113, P2363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mace OJ, 2013, J ANIM SCI, V91, P1932, DOI 10.2527/jas.2012-5906; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; McCarthy KM, 1996, J CELL SCI, V109, P2287; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; National Research Council, 2012, NUTR REQ SWIN, P373; Nguyen CA, 2012, CURR MED CHEM, V19, P28; Nose K, 2010, J INTERF CYTOK RES, V30, P67, DOI 10.1089/jir.2009.0046; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rezaei R, 2013, AMINO ACIDS, V44, P911, DOI 10.1007/s00726-012-1420-x; Riedijk MA, 2007, PEDIATR RES, V62, P468, DOI 10.1203/PDR.0b013e31813cbeba; Sternini C, 2007, AM J PHYSIOL-GASTR L, V292, pG457, DOI 10.1152/ajpgi.00411.2006; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Thomas S, 2005, SURGERY, V137, P48, DOI 10.1016/j.surg.2004.04.038; Vermeulen MAR, 2011, WORLD J GASTROENTERO, V17, P1569, DOI 10.3748/wjg.v17.i12.1569; WINDMUELLER HG, 1976, ARCH BIOCHEM BIOPHYS, V175, P670, DOI 10.1016/0003-9861(76)90558-0; Wu G, 2013, AMINO ACIDS: BIOCHEMISTRY AND NUTRITION, P1, DOI 10.1201/b14661; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; WU GY, 1995, AM J PHYSIOL-REG I, V269, pR621, DOI 10.1152/ajpregu.1995.269.3.R621; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zhang SH, 2013, AMINO ACIDS, V45, P1191, DOI 10.1007/s00726-013-1577-y	51	41	48	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111950	10.1371/journal.pone.0111950	http://dx.doi.org/10.1371/journal.pone.0111950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368996	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000130
J	Niedojadlo, J; Kubicka, E; Kalich, B; Smolinski, DJ				Niedojadlo, Janusz; Kubicka, Ewa; Kalich, Beata; Smolinski, Dariusz J.			Poly(A) RNAs Including Coding Proteins RNAs Occur in Plant Cajal Bodies	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; MESSENGER-RNA; INTERCHROMATIN GRANULES; NUCLEAR DOMAINS; COILED BODIES; SMN; IDENTIFICATION; ORGANIZATION; METHYLATION; EXPRESSION	The localisation of poly(A) RNA in plant cells containing either reticular (Allium cepa) or chromocentric (Lupinus luteus, Arabidopsis thaliana) nuclei was studied through in situ hybridisation. In both types of nuclei, the amount of poly(A) RNA was much greater in the nucleus than in the cytoplasm. In the nuclei, poly(A) RNA was present in structures resembling nuclear bodies. The molecular composition as well as the characteristic ultrastructure of the bodies containing poly(A) RNA demonstrated that they were Cajal bodies. We showed that some poly(A) RNAs in Cajal bodies code for proteins. However, examination of the localisation of active RNA polymerase II and in situ run-on transcription assays both demonstrated that CBs are not sites of transcription and that BrU-containing RNA accumulates in these structures long after synthesis. In addition, it was demonstrated that accumulation of poly(A) RNA occurs in the nuclei and CBs of hypoxia-treated cells. Our findings indicated that CBs may be involved in the later stages of poly(A) RNA metabolism, playing a role storage or retention.	[Niedojadlo, Janusz; Kubicka, Ewa; Kalich, Beata; Smolinski, Dariusz J.] Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland	Nicolaus Copernicus University	Niedojadlo, J (corresponding author), Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Dept Cell Biol, Torun, Poland.	janiaszn@umk.pl	Smolinski, Dariusz/M-3794-2014; Smolinski, Dariusz Jan/AAV-8969-2021; Niedojadło, Janusz/O-3211-2015	Smolinski, Dariusz/0000-0002-8272-0196; Smolinski, Dariusz Jan/0000-0002-8272-0196; Niedojadlo, Janusz/0000-0003-3550-9854; Kubicka, Ewa/0000-0002-6856-959X				Akef A, 2013, NUCLEUS-PHILA, V4, P326, DOI 10.4161/nucl.26052; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; BEVEN AF, 1995, J CELL SCI, V108, P509; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boothby TC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-45; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; Cevher MA, 2010, WIRES RNA, V1, P193, DOI 10.1002/wrna.20; CLEVENGER CV, 1984, EXP CELL RES, V151, P194, DOI 10.1016/0014-4827(84)90368-9; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Cui P, 2003, PLANTA, V217, P21, DOI 10.1007/s00425-002-0966-3; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Deckert J, 1997, ACTA BIOCHIM POL, V44, P37; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Dury AY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003890; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Gohring J, 2014, PLANT CELL, V26, P754, DOI 10.1105/tpc.113.118075; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2013, INT J BIOCHEM CELL B, V45, P1314, DOI 10.1016/j.biocel.2013.03.019; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Jackson MB, 2005, ANN BOT-LONDON, V96, P501, DOI 10.1093/aob/mci205; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kolowerzo A, 2009, PROTOPLASMA, V236, P13, DOI 10.1007/s00709-009-0042-y; Lorkovic ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003989; Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139; Makarov V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053571; Melcak I, 2001, MOL BIOL CELL, V12, P393, DOI 10.1091/mbc.12.2.393; Muthuswamy S, 2011, PLANTA, V233, P201, DOI 10.1007/s00425-010-1278-7; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Niedojadlo J, 2008, PROTOPLASMA, V234, P77, DOI 10.1007/s00709-008-0018-3; Niedojadlo J, 2012, PLANTA, V236, P715, DOI 10.1007/s00425-012-1640-z; Niedojadlo J, 2011, EXP CELL RES, V317, P433, DOI 10.1016/j.yexcr.2010.10.026; Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030; Novotny I, 2011, MOL BIOL CELL, V22, P513, DOI 10.1091/mbc.E10-07-0560; Palanca A, 2014, BBA-MOL BASIS DIS, V1842, P848, DOI 10.1016/j.bbadis.2013.11.016; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pontes O, 2008, CURR OPIN GENET DEV, V18, P197, DOI 10.1016/j.gde.2008.01.008; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Schul W, 1998, MOL BIOL CELL, V9, P1025, DOI 10.1091/mbc.9.5.1025; Smolinski DJ, 2012, CHROMOSOMA, V121, P37, DOI 10.1007/s00412-011-0339-4; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Suzuki T, 2010, J CELL BIOL, V190, P603, DOI 10.1083/jcb.201004109; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; TURNER BM, 1987, J CELL SCI, V87, P269; VISA N, 1993, EXP CELL RES, V208, P19, DOI 10.1006/excr.1993.1218; Vuletic M, 2005, ANN NY ACAD SCI, V1048, P244, DOI 10.1196/annals.1342.022; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111780	10.1371/journal.pone.0111780	http://dx.doi.org/10.1371/journal.pone.0111780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369024	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000099
J	Silla, T; Kepp, K; Tai, ES; Goh, L; Davila, S; Ivkovic, TC; Calin, GA; Voorhoeve, PM				Silla, Toomas; Kepp, Katrin; Tai, E. Shyong; Goh, Liang; Davila, Sonia; Ivkovic, Tina Catela; Calin, George A.; Voorhoeve, P. Mathijs			Allele Frequencies of Variants in Ultra Conserved Elements Identify Selective Pressure on Transcription Factor Binding	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; NONCODING RNAS; SUPER-ENHANCERS; CELL IDENTITY; VERTEBRATE; FRAMEWORK; PROTEIN	Ultra- conserved genes or elements (UCGs/UCEs) in the human genome are extreme examples of conservation. We characterized natural variations in 2884 UCEs and UCGs in two distinct populations; Singaporean Chinese (n = 280) and Italian (n = 501) by using a pooled sample, targeted capture, sequencing approach. We identify, with high confidence, in these regions the abundance of rare SNVs (MAF<0.5%) of which 75% is not present in dbSNP137. UCEs association studies for complex human traits can use this information to model expected background variation and thus necessary power for association studies. By combining our data with 1000 Genome Project data, we show in three independent datasets that prevalent UCE variants (MAF>5%) are more often found in relatively less-conserved nucleotides within UCEs, compared to rare variants. Moreover, prevalent variants are less likely to overlap transcription factor binding site. Using SNPfold we found no significant influence of RNA secondary structure on UCE conservation. All together, these results suggest UCEs are not under selective pressure as a stretch of DNA but are under differential evolutionary pressure on the single nucleotide level.	[Silla, Toomas; Goh, Liang; Voorhoeve, P. Mathijs] Duke NUS, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Kepp, Katrin; Davila, Sonia] Genome Inst Singapore, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke NUS, Grad Sch Med, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Ivkovic, Tina Catela; Calin, George A.] Texas State Univ, Expt Therapeut & Canc Genet MD Anderson Canc Ctr, Houston, TX USA; [Ivkovic, Tina Catela] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Texas State University System; Texas State University San Marcos; University of Texas System; UTMD Anderson Cancer Center; Rudjer Boskovic Institute	Silla, T (corresponding author), Duke NUS, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore.	toomas.silla@mbg.au.dk; mathijs.voorhoeve@gmail.com	Ivkovic, Tina Catela/AAL-1324-2020; Calin, George/E-9390-2011	Ivkovic, Tina Catela/0000-0003-3909-6858; Tai, E Shyong/0000-0003-2929-8966; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578	Duke-NUS Signature Research Program; Singapore Ministry of Health's National Medical Research Council [MOE2010-2-006]; Estonian Research Council [MJD147]	Duke-NUS Signature Research Program; Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Estonian Research Council	This work was supported by the Duke-NUS Signature Research Program and the Singapore Ministry of Health's National Medical Research Council (grant MOE2010-2-006 to PMV), and the Estonian Research Council postdoctoral research program "MOBILITAS'' (grant MJD147 to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Castle JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020660; Chen CTL, 2007, AM J HUM GENET, V80, P692, DOI 10.1086/513149; Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Dimitrieva S, 2012, BIOINFORMATICS, V28, pI395, DOI 10.1093/bioinformatics/bts400; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Harmston N, 2013, PHILOS T R SOC B, V368, DOI [10.1101/gr.113167.110, DOI 10.1101/GR.113167.110]; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hudson RS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-13; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Licastro D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-151; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nielsen MM, 2014, RNA, V20, P236, DOI 10.1261/rna.038927.113; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sabanayagam C, 2010, NEPHROL DIAL TRANSPL, V25, P1167, DOI 10.1093/ndt/gfp591; Sabarinathan R, 2013, NUCLEIC ACIDS RES, V41, pW475, DOI 10.1093/nar/gkt291; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Sanges R, 2013, NUCLEIC ACIDS RES, V41, P3600, DOI 10.1093/nar/gkt030; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Viturawong T, 2013, CELL REP, V5, P531, DOI 10.1016/j.celrep.2013.09.022; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zeeland AASV, 2014, MOL PSYCHIATR, V19, P724, DOI 10.1038/mp.2013.91	48	4	4	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110692	10.1371/journal.pone.0110692	http://dx.doi.org/10.1371/journal.pone.0110692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369454	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000025
J	Zhai, JF; Dong, YY; Sun, YP; Wang, Q; Wang, N; Wang, FW; Liu, WC; Li, XW; Chen, H; Yao, N; Guan, LL; Chen, K; Cui, XY; Yang, MY; Li, HY				Zhai, Junfeng; Dong, Yuanyuan; Sun, Yepeng; Wang, Qi; Wang, Nan; Wang, Fawei; Liu, Weican; Li, Xiaowei; Chen, Huan; Yao, Na; Guan, Lili; Chen, Kai; Cui, Xiyan; Yang, Meiying; Li, Haiyan			Discovery and Analysis of MicroRNAs in Leymus chinensis under Saline-Alkali and Drought Stress Using High-Throughput Sequencing	PLOS ONE			English	Article							SMALL RNAS; IDENTIFICATION; EXPRESSION; GENE; SALT; TARGETS; MIRNAS; NETWORKS; MIRBASE	Leymus chinensis (Trin.) Tzvel. is a perennial rhizome grass of the Poaceae (also called Gramineae) family, which adapts well to drought, saline and alkaline conditions. However, little is known about the stress tolerance of L. chinensis at the molecular level. microRNAs (miRNAs) are known to play critical roles in nutrient homeostasis, developmental processes, pathogen responses, and abiotic stress in plants. In this study, we used Solexa sequencing technology to generate high-quality small RNA data from three L. chinensis groups: a control group, a saline-alkaline stress group (100 mM NaCl and 200 mM NaHCO3), and a drought stress group (20% polyethylene glycol 2000). From these data we identified 132 known miRNAs and 16 novel miRNAs candidates. For these miRNAs we also identified target genes that encode a broad range of proteins that may be correlated with abiotic stress regulation. This is the first study to demonstrate differentially expressed miRNAs in L. chinensis under saline-alkali and drought stress. These findings may help explain the saline-alkaline and drought stress responses in L. chinensis.	[Zhai, Junfeng; Dong, Yuanyuan; Sun, Yepeng; Wang, Nan; Wang, Fawei; Liu, Weican; Li, Xiaowei; Chen, Huan; Yao, Na; Guan, Lili; Chen, Kai; Li, Haiyan] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China; [Zhai, Junfeng; Cui, Xiyan; Yang, Meiying; Li, Haiyan] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Wang, Qi] NE Normal Univ, High Sch, Changchun, Jilin, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Northeast Normal University - China	Li, HY (corresponding author), Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China.	hyli99@163.com	yao, na/HDL-8772-2022		Program for the Special Program for Research of Transgenic Plants [2011ZX08010-002]; National Natural Science Foundation of China [30971804, 31101091, 31271746, 31201144]; State Key Laboratory of Crop Biology at Shandong Agricultural University, China [2010KF02]; Program for Young Scientific and Technological Talents & Outstanding Innovation Team [20111815]; National High Technology Research and Development Program of China (863 Program) [2011AA100606]	Program for the Special Program for Research of Transgenic Plants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Crop Biology at Shandong Agricultural University, China; Program for Young Scientific and Technological Talents & Outstanding Innovation Team; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the Program for the Special Program for Research of Transgenic Plants (Grant No. 2011ZX08010-002), the National Natural Science Foundation of China (Grant Nos. 30971804, 31101091, 31271746, 31201144), the State Key Laboratory of Crop Biology at Shandong Agricultural University, China (Grant No. 2010KF02), the Program for Young Scientific and Technological Talents & Outstanding Innovation Team (Grant No. 20111815), and the National High Technology Research and Development Program of China (863 Program) (Grant No. 2011AA100606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Feng H, 2013, PLANT MOL BIOL, V83, P433, DOI 10.1007/s11103-013-0101-9; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta OP, 2014, MOL BIOL REP, V41, P4623, DOI 10.1007/s11033-014-3333-0; Huang ZH, 2004, ANN BOT-LONDON, V93, P295, DOI 10.1093/aob/mch044; Jeong DH, 2010, METHODS MOL BIOL, V592, P203, DOI 10.1007/978-1-60327-005-2_14; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Li CL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-277; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao GH, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26753; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; Mutum RD, 2013, FEBS J, V280, P1717, DOI 10.1111/febs.12186; Prashanth SR, 2008, TRANSGENIC RES, V17, P281, DOI 10.1007/s11248-007-9099-6; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Shu QY, 2005, PLANT CELL REP, V24, P36, DOI 10.1007/s00299-004-0908-6; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Spanudakis E, 2014, J EXP BOT, V65, P365, DOI 10.1093/jxb/ert453; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Wang ST, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091357, 10.1371/journal.pone.0104745, 10.1371/journal.pone.0089848]; Windels D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095972; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Zhang HY, 2013, PLANT J, V74, P98, DOI 10.1111/tpj.12107; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zheng BL, 2011, PLANT CELL, V23, P1033, DOI 10.1105/tpc.111.083980; Zhu JF, 2013, PLANT CELL REP, V32, P1339, DOI 10.1007/s00299-013-1446-x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	48	13	13	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e105417	10.1371/journal.pone.0105417	http://dx.doi.org/10.1371/journal.pone.0105417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369004	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000002
J	Kumar, A; Pate, KM; Moss, MA; Dean, DN; Rangachari, V				Kumar, Amit; Pate, Kayla M.; Moss, Melissa A.; Dean, Dexter N.; Rangachari, Vijayaraghavan			Self-Propagative Replication of A beta Oligomers Suggests Potential Transmissibility in Alzheimer Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASES; FIBRIL FORMATION; IN-VITRO; PROTEIN; PRIONS; AGGREGATION; ELONGATION; PEPTIDE; SCRAPIE	The aggregation of amyloid-beta (A beta) peptide and its deposition in parts of the brain form the central processes in the etiology of Alzheimer disease (AD). The low-molecular weight oligomers of A beta aggregates (2 to 30 mers) are known to be the primary neurotoxic agents whose mechanisms of cellular toxicity and synaptic dysfunction have received substantial attention in the recent years. However, how these toxic agents proliferate and induce widespread amyloid deposition throughout the brain, and what mechanism is involved in the amplification and propagation of toxic oligomer species, are far from clear. Emerging evidence based on transgenic mice models indicates a transmissible nature of A beta aggregates and implicates a prion-like mechanism of oligomer propagation, which manifests as the dissemination and proliferation of A beta toxicity. Despite accumulating evidence in support of a transmissible nature of A beta aggregates, a clear, molecular-level understanding of this intriguing mechanism is lacking. Recently, we reported the characterization of unique replicating oligomers of A beta 42 (12-24 mers) in vitro called Large Fatty Acid-derived Oligomers (LFAOs) (Kumar et al., 2012, J. Biol. Chem). In the current report, we establish that LFAOs possess physiological activity by activating NF-kappa B in human neuroblastoma cells, and determine the experimental parameters that control the efficiency of LFAO replication by self-propagation. These findings constitute the first detailed report on monomer - oligomer lateral propagation reactions that may constitute potential mechanism governing transmissibility among Ab oligomers. These data support the previous reports on transmissible mechanisms observed in transgenic animal models.	[Kumar, Amit; Dean, Dexter N.; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Pate, Kayla M.; Moss, Melissa A.] Univ So Calif, Dept Chem Engn, Columbia, SC USA	University of Southern Mississippi; University of Southern California	Rangachari, V (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	Vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Dean, Dexter N./0000-0002-2279-3393	National Center for Research Resources [5P20RR016476-11]; National Institute of General Medical Sciences from the National Institutes of Health through INBRE [8 P20 GM103476-11]; National Institutes of Health, National Institute of General Medical Sciences through COBRE [P20GM103641]; American Heart Association [10GRNT4190124]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641, P20GM103476] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health through INBRE; National Institutes of Health, National Institute of General Medical Sciences through COBRE; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly funded by National Center for Research Resources (5P20RR016476-11) and the National Institute of General Medical Sciences (8 P20 GM103476-11) from the National Institutes of Health for funding through INBRE (to VR), National Institutes of Health, National Institute of General Medical Sciences for funding through COBRE (P20GM103641) (to MAM), and American Heart Association (10GRNT4190124) (to VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gast K, 2003, EUR BIOPHYS J BIOPHY, V32, P710, DOI 10.1007/s00249-003-0336-5; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Ghosh P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S24; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Watts JC, 2011, P NATL ACAD SCI USA, V108, P2528, DOI 10.1073/pnas.1019034108; Wilde GJC, 2000, EUR J NEUROSCI, V12, P3863, DOI 10.1046/j.1460-9568.2000.00273.x; Wong HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057288; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287	45	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111492	10.1371/journal.pone.0111492	http://dx.doi.org/10.1371/journal.pone.0111492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365422	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100071
J	Wai, CYY; Leung, NYH; Ho, MHK; Gershwin, LJ; Shu, SA; Leung, PSC; Chu, KH				Wai, Christine Y. Y.; Leung, Nicki Y. H.; Ho, Marco H. K.; Gershwin, Laurel J.; Shu, Shang An; Leung, Patrick S. C.; Chu, Ka Hou			Immunization with Hypoallergens of Shrimp Allergen Tropomyosin Inhibits Shrimp Tropomyosin Specific IgE Reactivity	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; BIRCH POLLEN ALLERGEN; MOUSE MODEL; MOLECULAR CHARACTERIZATION; ORAL IMMUNOTHERAPY; FOOD ALLERGY; MURINE MODEL; IDENTIFICATION; EPITOPES; ANTIBODIES	Designer proteins deprived of its IgE-binding reactivity are being sought as a regimen for allergen-specific immunotherapy. Although shrimp tropomyosin (Met e 1) has long been identified as the major shellfish allergen, no immunotherapy is currently available. In this study, we aim at identifying the Met e 1 IgE epitopes for construction of hypoallergens and to determine the IgE inhibitory capacity of the hypoallergens. IgE-binding epitopes were defined by three online computational models, ELISA and dot-blot using sera from shrimp allergy patients. Based on the epitope data, two hypoallergenic derivatives were constructed by site-directed mutagenesis (MEM49) and epitope deletion (MED171). Nine regions on Met e 1 were defined as the major IgE-binding epitopes. Both hypoallergens MEM49 and MED171 showed marked reduction in their in vitro reactivity towards IgE from shrimp allergy patients and Met e 1-sensitized mice, as well as considerable decrease in induction of mast cell degranulation as demonstrated in passive cutaneous anaphylaxis assay. Both hypoallergens were able to induce Met e 1-recognizing IgG antibodies in mice, specifically IgG(2a) antibodies, that strongly inhibited IgE from shrimp allergy subjects and Met e 1-sensitized mice from binding to Met e 1. These results indicate that the two designer hypoallergenic molecules MEM49 and MED171 exhibit desirable preclinical characteristics, including marked reduction in IgE reactivity and allergenicity, as well as ability to induce blocking IgG antibodies. This approach therefore offers promises for development of immunotherapeutic regimen for shrimp tropomyosin allergy.	[Wai, Christine Y. Y.; Leung, Nicki Y. H.; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Ho, Marco H. K.] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Gershwin, Laurel J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Shu, Shang An; Leung, Patrick S. C.] Univ Calif Davis, Sch Med, Div Rheumatol Allergy, Davis, CA 95616 USA	Chinese University of Hong Kong; University of Hong Kong; University of California System; University of California Davis; University of California System; University of California Davis	Chu, KH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kahouchu@cuhk.edu.hk	Chu, Ka Hou/B-8010-2011	Chu, Ka Hou/0000-0001-8107-5415; Ho, Marco/0000-0003-1802-2120	Research Grants Council, Hong Kong Special Administrative Region, China [CUHK 463911]	Research Grants Council, Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was fully supported by a research grant from the Research Grants Council, Hong Kong Special Administrative Region, China (CUHK 463911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Ayuso R, 2002, INT ARCH ALLERGY IMM, V127, P27, DOI 10.1159/000048166; Ayuso R, 2008, J ALLERGY CLIN IMMUN, V122, P795, DOI 10.1016/j.jaci.2008.07.023; Ayuso R, 2010, J ALLERGY CLIN IMMUN, V125, P1286, DOI 10.1016/j.jaci.2010.03.010; Ayuso R, 2009, J ALLERGY CLIN IMMUN, V124, P114, DOI 10.1016/j.jaci.2009.04.016; Bauer R, 2006, J ALLERGY CLIN IMMUN, V118, P269, DOI 10.1016/j.jaci.2006.03.033; Bauermeister K, 2011, MOL IMMUNOL, V48, P1983, DOI 10.1016/j.molimm.2011.06.216; Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610; Chafen JJS, 2010, JAMA-J AM MED ASSOC, V303, P1848, DOI 10.1001/jama.2010.582; Chen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034627; Chu KH, 2000, MAR BIOTECHNOL, V2, P499; Clark S, 2011, J ALLERGY CLIN IMMUN, V127, P682, DOI 10.1016/j.jaci.2010.10.040; Cromwell O, 2011, J ALLERGY CLIN IMMUN, V127, P865, DOI 10.1016/j.jaci.2011.01.047; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Dall'Antonia F, 2011, J ALLERGY CLIN IMMUN, V128, P872, DOI 10.1016/j.jaci.2011.07.007; DAUL CB, 1994, INT ARCH ALLERGY IMM, V105, P49, DOI 10.1159/000236802; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Garcia-Orozco KD, 2007, INT ARCH ALLERGY IMM, V144, P23, DOI 10.1159/000102610; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Hajeb P, 2012, CLIN REV ALLERG IMMU, V42, P365, DOI 10.1007/s12016-011-8284-9; Harduar-Morano L, 2011, J ALLERGY CLIN IMMUN, V128, P594, DOI 10.1016/j.jaci.2011.04.049; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Ho MHK, 2012, ASIAN PAC J ALLERGY, V30, P275; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jutel M, 2013, ALLERGOL INT, V62, P425, DOI 10.2332/allergolint.13-RAI-0608; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Landsman-Blumberg PB, 2013, J ALLER CL IMM-PRACT, V1, P595, DOI 10.1016/j.jaip.2013.07.003; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Leung NYH, 2014, CLIN REV ALLERG IMMU, V46, P180, DOI 10.1007/s12016-012-8336-9; Leung PSC, 2008, INT ARCH ALLERGY IMM, V147, P305, DOI 10.1159/000144038; Leung PSC, 1998, J ALLERGY CLIN IMMUN, V102, P847, DOI 10.1016/S0091-6749(98)70027-2; Leung PSC, 1998, MOL MAR BIOL BIOTECH, V7, P12; Leung PSC, 1996, J ALLERGY CLIN IMMUN, V98, P954, DOI 10.1016/S0091-6749(96)80012-1; LEUNG PSC, 1994, J ALLERGY CLIN IMMUN, V94, P882, DOI 10.1016/0091-6749(94)90156-2; Leung PSC, 2001, CLIN EXP ALLERGY, V31, P1287, DOI 10.1046/j.1365-2222.2001.01165.x; LI KW, 1988, ANAL BIOCHEM, V174, P97, DOI 10.1016/0003-2697(88)90523-4; Li XM, 2003, J ALLERGY CLIN IMMUN, V112, P159, DOI 10.1067/mai.2003.1622; Linhart B, 2012, VACCINE, V30, P4328, DOI 10.1016/j.vaccine.2011.11.011; Liu R, 2013, CLIN EXP ALLERGY, V43, P365, DOI 10.1111/cea.12056; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Mine Y, 2003, PROTEIN ENG, V16, P747, DOI 10.1093/protein/gzg095; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Nowak RM, 2014, AM J MED, V127, pS34, DOI 10.1016/j.amjmed.2013.09.012; Purohit A, 2008, CLIN EXP ALLERGY, V38, P1514, DOI 10.1111/j.1365-2222.2008.03042.x; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Ravkov EV, 2013, HUM IMMUNOL, V74, P1542, DOI 10.1016/j.humimm.2013.08.276; Reese G, 2005, J IMMUNOL, V175, P8354, DOI 10.4049/jimmunol.175.12.8354; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Saarne T, 2011, ALLERGY, V66, P255, DOI 10.1111/j.1398-9995.2010.02468.x; Schmitz N, 2009, J EXP MED, V206, P1941, DOI 10.1084/jem.20090199; SHANTI KN, 1993, J IMMUNOL, V151, P5354; Shiomi K, 2008, INT ARCH ALLERGY IMM, V146, P91, DOI 10.1159/000113512; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Smarr CB, 2013, CRIT REV IMMUNOL, V33, P389, DOI 10.1615/CritRevImmunol.2013007046; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Subbarayal B, 2013, ALLERGY, V68, P1377, DOI 10.1111/all.12236; Sun XL, 2013, FOOD CHEM TOXICOL, V56, P254, DOI 10.1016/j.fct.2013.02.014; Swoboda I, 2007, J IMMUNOL, V178, P6290, DOI 10.4049/jimmunol.178.10.6290; Tsabouri S, 2012, PEDIAT ALLERG IMM-UK, V23, P608, DOI 10.1111/j.1399-3038.2012.01275.x; Uermosi C, 2014, ALLERGY, V69, P338, DOI 10.1111/all.12327; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; van Hage-Hamsten M, 2002, CLIN EXP ALLERGY, V32, P1448, DOI 10.1046/j.1365-2745.2002.01495.x; van Neerven RJJ, 1999, J IMMUNOL, V163, P2944; Vickery BP, 2013, J ALLERGY CLIN IMMUN, V131, P128, DOI 10.1016/j.jaci.2012.10.048; Wachholz PA, 2003, J ALLERGY CLIN IMMUN, V112, P915, DOI 10.1016/S0091-6749(03)02022-0; Wai CYY, 2012, J ALLER THER, V3; Walgraffe D, 2009, J ALLERGY CLIN IMMUN, V123, P1150, DOI 10.1016/j.jaci.2008.11.038; Wiedermann U, 2001, INT ARCH ALLERGY IMM, V124, P391, DOI 10.1159/000053767; Worm M, 2011, J ALLERGY CLIN IMMUN, V127, P89, DOI 10.1016/j.jaci.2010.11.029; Yu CJ, 2003, J IMMUNOL, V170, P445, DOI 10.4049/jimmunol.170.1.445; Yuan HC, 2012, INT ARCH ALLERGY IMM, V157, P125, DOI 10.1159/000327544; Zheng LN, 2011, FOOD CHEM TOXICOL, V49, P2954, DOI 10.1016/j.fct.2011.07.043	74	41	43	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111649	10.1371/journal.pone.0111649	http://dx.doi.org/10.1371/journal.pone.0111649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365343	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100094
J	Sukhotnik, I; Geyer, T; Pollak, Y; Mogilner, JG; Coran, AG; Berkowitz, D				Sukhotnik, Igor; Geyer, Tatiana; Pollak, Yulia; Mogilner, Jorge G.; Coran, Arnold G.; Berkowitz, Drora			The Role of Wnt/beta-Catenin Signaling in Enterocyte Turnover during Methotrexate-Induced Intestinal Mucositis in a Rat	PLOS ONE			English	Article							STEM-CELLS; C-MYC; WNT; PROLIFERATION; CHEMOTHERAPY; TARGET	Background/Aims: Intestinal mucositis is a common side-effect in patients who receive aggressive chemotherapy. The Wnt signaling pathway is critical for establishing and maintaining the proliferative compartment of the intestine. In the present study, we tested whether Wnt/beta-catenin signaling is involved in methotrexate (MTX)-induced intestinal damage in a rat model. Methods: Non-pretreated and pretreated with MTX Caco-2 cells were evaluated for cell proliferation and apoptosis using FACS analysis. Adult rats were divided into three experimental groups: Control rats; MTX-2 animals were treated with a single dose of MTX given IP and were sacrificed on day 2, and MTX-4 rats were treated with MTX similar to group B and were sacrificed on day 4. Intestinal mucosal damage, mucosal structural changes, enterocyte proliferation, and enterocyte apoptosis were measured at sacrifice. Real Time PCR and Western blot was used to determine the level of Wnt/beta-catenin related genes and protein expression. Results: In the vitro experiment, treatment with MTX resulted in marked decrease in early cell proliferation rates following by a 17-fold increase in late cell proliferation rates compared to early proliferation. Treatment with MTX resulted in a significant increase in early and late apoptosis compared to Caco-2 untreated cells. In the vivo experiment, MTX-2 and MTX-4 rats demonstrated intestinal mucosal hypoplasia. MTX-2 rats demonstrated a significant decrease in FRZ-2, Wnt 3A Wnt 5A, beta-catenin, c-myc mRNA expression and a significant decrease in b-catenin and Akt protein levels compared to control animals. Four days following MTX administration, rats demonstrated a trend toward a restoration of Wnt/beta-catenin signaling especially in ileum. Conclusions: Wnt/beta-catenin signaling is involved in enterocyte turnover during MTX-induced intestinal mucositis in a rat.	[Sukhotnik, Igor] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Surg,Lab Intestinal Adaptat & Recover, IL-31096 Haifa, Israel; [Geyer, Tatiana; Pollak, Yulia] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Lab Intestinal Adaptat & Recovery, IL-31096 Haifa, Israel; [Mogilner, Jorge G.] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Surg, IL-31096 Haifa, Israel; [Coran, Arnold G.] CS Mott Childrens Hosp, Pediat Surg Sect, Ann Arbor, MI USA; [Coran, Arnold G.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Berkowitz, Drora] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Gastroenterol, IL-31096 Haifa, Israel	Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Michigan System; University of Michigan; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Sukhotnik, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Bnai Zion Med Ctr, Dept Pediat Surg,Lab Intestinal Adaptat & Recover, POB 9649, IL-31096 Haifa, Israel.	igor-dr@internet-zahav.net						Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Gate L, 1999, BIOMED PHARMACOTHER, V53, P169, DOI 10.1016/S0753-3322(99)80086-9; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Horvay K, 2013, ADV EXP MED BIOL, V786, P175, DOI 10.1007/978-94-007-6621-1_10; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Keefe DMK, 2004, SUPPORT CARE CANCER, V12, P6, DOI 10.1007/s00520-003-0550-9; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Kesik V, 2009, CANCER BIOL THER, V8, P1630, DOI 10.4161/cbt.8.17.9203; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Pico, 1998, Oncologist, V3, P446; Rubenstein EB, 2004, CANCER-AM CANCER SOC, V100, P2026, DOI 10.1002/cncr.20163; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; TRIER JS, 1962, GASTROENTEROLOGY, V43, P407; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	23	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110675	10.1371/journal.pone.0110675	http://dx.doi.org/10.1371/journal.pone.0110675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375224	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600019
J	Crannell, ZA; Rohrman, B; Richards-Kortum, R				Crannell, Zachary Austin; Rohrman, Brittany; Richards-Kortum, Rebecca			Equipment-Free Incubation of Recombinase Polymerase Amplification Reactions Using Body Heat	PLOS ONE			English	Article							RAPID DETECTION; DIAGNOSIS; PCR	The development of isothermal amplification platforms for nucleic acid detection has the potential to increase access to molecular diagnostics in low resource settings; however, simple, low-cost methods for heating samples are required to perform reactions. In this study, we demonstrated that human body heat may be harnessed to incubate recombinase polymerase amplification (RPA) reactions for isothermal amplification of HIV-1 DNA. After measuring the temperature of mock reactions at 4 body locations, the axilla was chosen as the ideal site for comfortable, convenient incubation. Using commonly available materials, 3 methods for securing RPA reactions to the body were characterized. Finally, RPA reactions were incubated using body heat while control RPA reactions were incubated in a heat block. At room temperature, all reactions with 10 copies of HIV-1 DNA and 90% of reactions with 100 copies of HIV-1 DNA tested positive when incubated with body heat. In a cold room with an ambient temperature of 10 degrees Celsius, all reactions containing 10 copies or 100 copies of HIV-1 DNA tested positive when incubated with body heat. These results suggest that human body heat may provide an extremely low-cost solution for incubating RPA reactions in low resource settings.	[Crannell, Zachary Austin; Rohrman, Brittany; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University	Rohrman, B (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	br4@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467				Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Baldinger P, 2008, POWERING HLTH OPTION; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Crannell ZA, 2014, ANAL CHEM, V86, P2565, DOI 10.1021/ac403750z; Gitman MR, 2013, J CLIN MICROBIOL, V51, P3765, DOI 10.1128/JCM.01413-13; GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874; Kersting S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-99; Krolov K, 2014, J MOL DIAGN, V16, P127, DOI 10.1016/j.jmoldx.2013.08.003; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; Lillis L, 2013, AM SOC TROPICAL MED, V13; Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189; Maritz J, 2012, J CLIN VIROL, V53, P106, DOI 10.1016/j.jcv.2011.12.002; Myers FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070266; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Segall HI, 2003, MOL THER, V8, P118, DOI 10.1016/S1525-0016(03)00134-5; TwistDx, 2014, REC POL AMPL BREAKTH; VWR, 2014, VWR AN DRY BLOCK HEA; Wang B, 2014, J CLIN MICROBIOL, V52, P1838, DOI 10.1128/JCM.03615-13	21	152	169	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112146	10.1371/journal.pone.0112146	http://dx.doi.org/10.1371/journal.pone.0112146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372030	Green Published, gold			2022-12-27	WOS:000344556900115
J	Mathewson, AM; Dunn, WR				Mathewson, Alastair M.; Dunn, William R.			A Comparison of Responses to Raised Extracellular Potassium and Endothelium-Derived Hyperpolarizing Factor (EDHF) in Rat Pressurised Mesenteric Arteries	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; K+-INDUCED HYPERPOLARIZATION; GAP-JUNCTIONS; SMOOTH-MUSCLE; MYOGENIC TONE; RESISTANCE ARTERIES; HYDROGEN-PEROXIDE; PREGNANT-WOMEN; HEPATIC-ARTERY; SENSORY NERVES	The present study examined the hypothesis that potassium ions act as an endothelium-derived hyperpolarizing factor (EDHF) released in response to ACh in small mesenteric arteries displaying myogenic tone. Small mesenteric arteries isolated from rats were set up in a pressure myograph at either 60 or 90 mmHg. After developing myogenic tone, responses to raising extracellular potassium were compared to those obtained with ACh (in the presence of nitric oxide synthase and cyclo-oxygenase inhibitors). The effects of barium and oubain, or capsaicin, on responses to raised extracellular potassium or ACh were also determined. The effects of raised extracellular potassium levels and ACh on membrane potential, were measured using sharp microelectrodes in pressurised arteries. Rat small mesenteric arteries developed myogenic tone when pressurised. On the background of vascular tone set by a physiological stimulus (i.e pressure), ACh fully dilated the small arteries in a concentration-dependent manner. This response was relatively insensitive to the combination of barium and ouabain, and insensitive to capsaicin. Raising extracellular potassium produced a more inconsistent and modest vasodilator response in pressurised small mesenteric arteries. Responses to raising extracellular potassium were sensitive to capsaicin, and the combination of barium and ouabain. ACh caused a substantial hyperpolarisation in pressurized arteries, while raising extracellular potassium did not. These data indicate that K+ is not the EDHF released in response to ACh in myogenically active rat mesenteric small arteries. Since the hyperpolarization produced by ACh was sensitive to carbenoxolone, gap junctions are the likely mediator of EDH responses under physiological conditions.	[Mathewson, Alastair M.; Dunn, William R.] Univ Nottingham, Sch Life Sci, Pharmacol Res Grp, Nottingham NG7 2RD, England	University of Nottingham	Dunn, WR (corresponding author), Univ Nottingham, Sch Life Sci, Pharmacol Res Grp, Nottingham NG7 2RD, England.	William.dunn@nottingham.ac.uk		Dunn, William/0000-0002-8864-6441	Wellcome Trust [WT069264]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors acknowledge the support of the Wellcome Trust (project grant WT069264). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2000, BRIT J PHARMACOL, V129, P1490, DOI 10.1038/sj.bjp.0703226; Brochet DXP, 2006, PFLUG ARCH EUR J PHY, V453, P33, DOI 10.1007/s00424-006-0106-1; BROCK JA, 1995, PFLUG ARCH EUR J PHY, V430, P901, DOI 10.1007/BF01837403; Burke EP, 1996, AM J PHYSIOL-CELL PH, V270, pC1405, DOI 10.1152/ajpcell.1996.270.5.C1405; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; de Wit C, 2010, PFLUG ARCH EUR J PHY, V459, P897, DOI 10.1007/s00424-010-0830-4; Dora KA, 2005, AM J PHYSIOL-HEART C, V289, pH1323, DOI 10.1152/ajpheart.00513.2005; Dora KA, 2002, AM J PHYSIOL-HEART C, V283, pH606, DOI 10.1152/ajpheart.01016.2001; Dora KA, 2001, AM J PHYSIOL-HEART C, V280, pH2424, DOI 10.1152/ajpheart.2001.280.6.H2424; Doughty JM, 2000, BRIT J PHARMACOL, V130, P1174, DOI 10.1038/sj.bjp.0703412; Dunn WR, 1997, HYPERTENSION, V29, P1140, DOI 10.1161/01.HYP.29.5.1140; Earley S, 2004, AM J PHYSIOL-HEART C, V287, pH2677, DOI 10.1152/ajpheart.00016.2004; Edwards G, 2004, PHARMACOL RES, V49, P535, DOI 10.1016/j.phrs.2003.11.013; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; FENGERGRON J, 1995, J PHYSIOL-LONDON, V488, P753, DOI 10.1113/jphysiol.1995.sp021006; Goto K, 2002, CLIN EXP PHARMACOL P, V29, P595, DOI 10.1046/j.1440-1681.2002.03689.x; Hammond S, 2011, EUR J PHARMACOL, V668, P225, DOI 10.1016/j.ejphar.2011.06.050; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Harris D, 2000, EUR J PHARMACOL, V402, P119, DOI 10.1016/S0014-2999(00)00512-4; Hogestatt ED, 2000, BRIT J PHARMACOL, V130, P27, DOI 10.1038/sj.bjp.0703258; Izzard AS, 1996, AM J PHYSIOL-HEART C, V270, pH1, DOI 10.1152/ajpheart.1996.270.1.H1; Kenny LC, 2002, BRIT J PHARMACOL, V136, P1085, DOI 10.1038/sj.bjp.0704817; Lacy PS, 2000, BRIT J PHARMACOL, V129, P605, DOI 10.1038/sj.bjp.0703076; Lagaud G, 2002, AM J PHYSIOL-HEART C, V283, pH2177, DOI 10.1152/ajpheart.00605.2001; Martin PEM, 2003, BRIT J PHARMACOL, V140, P1261, DOI 10.1038/sj.bjp.0705556; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; PERTL C, 1993, PAIN, V52, P351, DOI 10.1016/0304-3959(93)90169-P; Richards GR, 2001, BRIT J PHARMACOL, V134, P1, DOI 10.1038/sj.bjp.0704256; Rummery NM, 2007, J PHYSIOL-LONDON, V582, P745, DOI 10.1113/jphysiol.2007.134825; SUN D, 1992, AM J PHYSIOL, V263, pH1486, DOI 10.1152/ajpheart.1992.263.5.H1486; Van de Voorde J, 2000, J CARDIOVASC PHARM, V35, P543, DOI 10.1097/00005344-200004000-00005; Wesselman JPM, 1997, AM J PHYSIOL-HEART C, V272, pH2241, DOI 10.1152/ajpheart.1997.272.5.H2241; Weston AH, 2002, BRIT J PHARMACOL, V136, P918, DOI 10.1038/sj.bjp.0704787; White BJO, 2013, BRIT J PHARMACOL, V168, P785, DOI 10.1111/j.1476-5381.2012.02187.x; Zygmunt PM, 2000, N-S ARCH PHARMACOL, V361, P535, DOI 10.1007/s002100000229	37	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111977	10.1371/journal.pone.0111977	http://dx.doi.org/10.1371/journal.pone.0111977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372386	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900100
J	Vallen, MJE; Schmidt, S; Oosterhof, A; Bulten, J; Massuger, LFAG; van Kuppevelt, TH				Vallen, Myrtille J. E.; Schmidt, Samuel; Oosterhof, Arie; Bulten, Johan; Massuger, Leon F. A. G.; van Kuppevelt, Toin H.			Primary Ovarian Carcinomas and Abdominal Metastasis Contain 4,6-Disulfated Chondroitin Sulfate Rich Regions, Which Provide Adhesive Properties to Tumour Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CANCER METASTASIS; GLYCOSAMINOGLYCANS; COLLAGEN; GROWTH; DIFFERENTIATION; PROTEOGLYCANS; EXPRESSION; MIGRATION; MELANOMA	High mortality in ovarian cancer patients is primarily caused through rapid metastasis of the tumour, but the underlying mechanisms are poorly understood. Glycosaminoglycans, are abundantly present in tumours and chondroitin sulfate-E (CSE), a highly 4,6-sulfated glycosaminoglycan, has been indicated to play a role in carcinogenesis. In this study we investigated the presence of CSE in ovarian cancer metastasis and studied its role in tumour cell adhesiveness and migration. CSE was studied immunohistochemically in primary ovarian carcinomas and abdominal metastases using the single chain antibody GD3G7. The role of CSE was studied in 2D (scratch assays) and 3D (collagen matrices, spheroids) systems using SKOV3 cells applying 1: overexpression of CSE by stable transfection with DNA encoding GalNAc4S-6 sulfotransferase, 2: enzymatic removal of CS, and 3: addition of CSE. In ovarian cancer tissue, CSE expression was predominantly seen in the stromal compartment of both primary ovarian carcinomas and metastases, with a comparable degree of intensity and extent. Overexpression of CSE disaccharide units by tumour cells increased their adhesive properties which was especially seen in tumour spheroid formation. Increased expression of CSE reduced cell migration. Addition of free CSE had similar effects. The data presented here indicate that CSE is associated with metastatic lesions and that it provides tumours with adhesive properties. CSE rich motifs are put forward as a potential target for ovarian cancer therapy.	[Vallen, Myrtille J. E.; Oosterhof, Arie; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Vallen, Myrtille J. E.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Schmidt, Samuel] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [Bulten, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Vallen, MJE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands.	m.vallen@obgyn.umcn.nl	Bulten, J./L-4237-2015; Schmidt, Samuel/G-5989-2011; van Kuppevelt, A.H.M.S.M./L-4463-2015; Massuger, Leon F.A.G./H-8072-2014	Bulten, J./0000-0002-8168-6045; Schmidt, Samuel/0000-0001-9001-7970; 	Dutch Cancer Society [2008-4058]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society (2008-4058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosius M, 2009, CELL BIOL INT, V33, P848, DOI 10.1016/j.cellbi.2009.04.018; [Anonymous], 2011, J Natl Cancer Inst, V103, P1287, DOI 10.1093/jnci/djr342; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Casey RC, 2003, CLIN EXP METASTAS, V20, P143, DOI 10.1023/A:1022670501667; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Freedman Ralph S, 2004, J Transl Med, V2, P23, DOI 10.1186/1479-5876-2-23; FRIEDL P, 1993, J IMMUNOL METHODS, V165, P157, DOI 10.1016/0022-1759(93)90341-4; Friedl P, 1997, CANCER RES, V57, P2061; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Gardner MJ, 1996, CLIN EXP METASTAS, V14, P325, DOI 10.1007/BF00123391; Ghosh S, 2010, GYNECOL ONCOL, V119, P114, DOI 10.1016/j.ygyno.2010.05.029; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalathas D, 2009, ONCOL REP, V22, P369, DOI 10.3892/or_00000447; Kobayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054278; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Labiche A, 2010, INT J GYNECOL CANCER, V20, P28, DOI 10.1111/IGC.0b013e3181bda1cb; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Lv HZ, 2007, ONCOLOGY-BASEL, V72, P347, DOI 10.1159/000113145; Mizumoto S, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/56319, 10.1155/2013/656319]; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; NEDERMAN T, 1984, CANCER RES, V44, P3090; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Papadas TA, 2002, ACTA OTO-LARYNGOL, V122, P330, DOI 10.1080/000164802753648268; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Ricciardelli C, 2006, SEMIN REPROD MED, V24, P270, DOI 10.1055/s-2006-948556; Rozen S, 2000, Methods Mol Biol, V132, P365; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; TAKEUCHI J, 1972, BRIT J CANCER, V26, P115, DOI 10.1038/bjc.1972.17; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Vallen MJ, 2014, GYNECOL ONCOL, V23, P01276; Vallen MJE, 2012, GYNECOL ONCOL, V127, P202, DOI 10.1016/j.ygyno.2012.06.022; Wegrowski Y, 2006, ADV PHARMACOL, V53, P297, DOI 10.1016/S1054-3589(05)53014-X; Weyers A, 2013, GLYCOCONJ J; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Wolanska M, 1999, ACTA BIOCHIM POL, V46, P941	53	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111806	10.1371/journal.pone.0111806	http://dx.doi.org/10.1371/journal.pone.0111806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372710	Green Submitted, gold, Green Published			2022-12-27	WOS:000344556900076
J	Chen, YQ; Su, PT; Chen, YH; Wei, MT; Huang, CH; Osterday, K; del Alamo, JC; Syu, WJ; Chiou, A				Chen, Yin-Quan; Su, Pin-Tzu; Chen, Yu-Hsuan; Wei, Ming-Tzo; Huang, Chien-Hsiu; Osterday, Kathryn; del Alamo, Juan C.; Syu, Wan-Jr; Chiou, Arthur			The Effect of Enterohemorrhagic E-coli Infection on the Cell Mechanics of Host Cells	PLOS ONE			English	Article							CYTOSKELETAL TENSION; EXTRACELLULAR-MATRIX; STRESS FIBERS; FLUID; SHEAR; RHO; DIFFERENTIATION; MICRORHEOLOGY; DEFORMABILITY; NANORHEOLOGY	Enterohaemorrhagic E. coli (EHEC) is a type of human pathogenic bacteria. The main virulence characteristics of EHEC include the formation of attaching and effacing lesions (A/E lesions) and the production of one or more Shiga-like toxins, which may induce human uremic complications. When EHEC infects host cells, it releases translocated intimin receptor (Tir) and effector proteins inside the host cells, inducing the rearrangement and accumulation of the F-actin cytoskeleton, a phenotype leading to the formation of pedestals in the apical cell surface, and the growth of stress fibers at the base of the cells. To examine the effect of EHEC infection on cell mechanics, we carried out a series of experiments to examine HeLa cells with and without EHEC infection to quantify the changes in (1) focal adhesion area, visualized by anti-vinculin staining; (2) the distribution and orientation of stress fibers; and (3) the intracellular viscoelasticity, via directional video particle tracking microrheology. Our results indicated that in EHEC-infected HeLa cells, the focal adhesion area increased and the actin stress fibers became thicker and more aligned. The cytoskeletal reorganization induced by EHEC infection mediated a dramatic increase in the cytoplasmic elastic shear modulus of the infected cells, and a transition in the viscoelastic behavior of the cells from viscous-like to elastic-like. These changes in mechanobiological characteristics might modulate the attachments between EHEC and the host cell to withstand exfoliation, and between the host cell and the extracellular matrix, and might also alter epithelial integrity.	[Chen, Yin-Quan; Huang, Chien-Hsiu; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Su, Pin-Tzu; Syu, Wan-Jr; Chiou, Arthur] Natl Yang Ming Univ, BMIRC, Taipei 112, Taiwan; [Wei, Ming-Tzo] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA; [del Alamo, Juan C.] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Lehigh University; University of California System; University of California San Diego	del Alamo, JC (corresponding author), Dept Mech & Aerosp Engn, San Diego, CA 92161 USA.	jalamo@ucsd.edu; wjsyu@ym.edu.tw; aechiou@ym.edu.tw	del Alamo, Juan C./ABB-7702-2021	del Alamo, Juan C./0000-0001-5683-0239; Chen, YinQuan/0000-0002-7278-3855	National Science Council, Taiwan, ROC [NSC101-2815-C-010-008-E, NSC101-2320-B-010-048-MY2]; National Science Council, Taiwan, ROC (I-RiCE Program Project) [NSC100-2911-I-009-101]; Ministry of Education (The Top University Project); Taiwan National Science Council I-RICE Program [NSC-100-2911-I-009-101]; NSF CAREER grant [CBET-1055697]; NIH grant [1R01GM084227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084227] Funding Source: NIH RePORTER	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan, ROC (I-RiCE Program Project); Ministry of Education (The Top University Project); Taiwan National Science Council I-RICE Program; NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is jointly supported by The National Science Council, Taiwan, ROC (NSC101-2815-C-010-008-E, NSC101-2320-B-010-048-MY2, I-RiCE Program Project No. NSC100-2911-I-009-101) and by the Ministry of Education (The Top University Project). JCA and KO were partially supported by the Taiwan National Science Council I-RICE Program (NSC-100-2911-I-009-101), NSF CAREER grant CBET-1055697 and NIH grant 1R01GM084227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Chen YQ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.011008; del Alamo JC, 2008, P NATL ACAD SCI USA, V105, P15411, DOI 10.1073/pnas.0804573105; DeRycke J, 1997, INFECT IMMUN, V65, P2555, DOI 10.1128/IAI.65.7.2555-2563.1997; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Golde T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.044601; Gomez-Gonzalez M, 2013, J FLUID MECH, V725, P299, DOI 10.1017/jfm.2013.156; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasnain IA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031901; Hatami-Marbini H, 2011, STUD MECHANOBIOL TIS, V4, P3, DOI 10.1007/8415_2010_35; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; Hur SS, 2012, P NATL ACAD SCI USA, V109, P11110, DOI 10.1073/pnas.1207326109; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Krishnan R, 2011, AM J PHYSIOL-CELL PH, V300, pC146, DOI 10.1152/ajpcell.00195.2010; Lee JSH, 2006, J CELL SCI, V119, P1760, DOI 10.1242/jcs.02899; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mathur AB, 2007, ANN BIOMED ENG, V35, P1120, DOI 10.1007/s10439-007-9288-8; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McGrail DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033248; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988; Pourati J, 1998, AM J PHYSIOL-CELL PH, V274, pC1283, DOI 10.1152/ajpcell.1998.274.5.C1283; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; Saxton MJ, 2014, NAT METHODS, V11, P247, DOI 10.1038/nmeth.2851; Shaw RK, 2005, INFECT IMMUN, V73, P4385, DOI 10.1128/IAI.73.7.4385-4390.2005; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Wu PH, 2012, NAT PROTOC, V7, P155, DOI 10.1038/nprot.2011.436; Yi CR, 2009, P NATL ACAD SCI USA, V106, P6431, DOI 10.1073/pnas.0902773106; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zar J.H., 2010, BIOSTAT ANAL; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	54	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112137	10.1371/journal.pone.0112137	http://dx.doi.org/10.1371/journal.pone.0112137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369259	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000142
J	Wang, H; Lei, T; Liu, J; Li, MZ; Nan, HZ; Liu, Q				Wang, Hui; Lei, Tao; Liu, Jing; Li, Muzi; Nan, Huizhu; Liu, Qun			A Nuclear Factor of High Mobility Group Box Protein in Toxoplasma gondii	PLOS ONE			English	Article							4-WAY JUNCTION DNA; CELL-CYCLE; PLASMODIUM-FALCIPARUM; GENETIC-ANALYSIS; LINKER HISTONES; HMGB PROTEINS; ACIDIC TAIL; BINDING; TRANSFORMATION; TACHYZOITE	High mobility group box 1 (HMGB1) is a nuclear factor that usually binds DNA and modulates gene expression in multicellular organisms. Three HMGB1 orthologs were predicted in the genome of Toxoplasma gondii, an obligate intracellular protozoan pathogen, termed TgHMGB1a, b and c. Phylogenetic and bioinformatic analyses indicated that these proteins all contain a single HMG box and which shared in three genotypes. We cloned TgHMGB1a, a 33.9 kDa protein that can stimulates macrophages to release TNF-alpha, and, we demonstrated that the TgHMGB1a binds distorted DNA structures such as cruciform DNA in electrophoretic mobility shift assays (EMSA). Immunofluorescence assay indicated TgHMGB1a concentrated in the nucleus of intracellular tachyzoites but translocated into the cytoplasm while the parasites release to extracellular. There were no significant phenotypic changes when the TgHMGB1a B box was deleted, while transgenic parasites that overexpressed TgHMGB1a showed slower intracellular growth and caused delayed death in mouse, further quantitative RT-PCR analyses showed that the expression levels of many important genes, including virulence factors, increased when TgHMGB1a was overexpressed, but no significant changes were observed in TgHMGB1a B box-deficient parasites. Our findings demonstrated that TgHMGB1a is indeed a nuclear protein that maintains HMG box architectural functions and is a potential proinflammatory factor during the T. gondii infection. Further studies that clarify the functions of TgHMGB1s will increase our knowledge of transcriptional regulation and parasite virulence, and might provide new insight into host-parasite interactions for T. gondii infection.	[Wang, Hui; Lei, Tao; Liu, Jing; Li, Muzi; Nan, Huizhu; Liu, Qun] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, Q (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100094, Peoples R China.	qunliu@cau.edu.cn			National Natural Science Foundation of China [31372424]; National Key Basic Research Program (973 program) of China [2015CB150300]; Research Fund for the Doctoral Program of Higher Education of China [20110008110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program (973 program) of China(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the National Natural Science Foundation of China (Grant No. 31372424), the National Key Basic Research Program (973 program) of China (Grant No. 2015CB150300) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110008110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar MM, 2008, EUKARYOT CELL, V7, P1565, DOI 10.1128/EC.00123-08; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Appleford PJ, 1997, ACTA TROP, V65, P97, DOI 10.1016/S0001-706X(97)00656-6; Assenberg R, 2008, BIOCHEM J, V411, P553, DOI 10.1042/BJ20071613; de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Briquet S, 2006, EUKARYOT CELL, V5, P672, DOI 10.1128/EC.5.4.672-682.2006; Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129; Cribb P, 2011, INT J PARASITOL, V41, P1149, DOI 10.1016/j.ijpara.2011.06.009; Cui X, 2012, PARASITOLOGY, V139, P998, DOI 10.1017/S0031182012000285; DALRYMPLE BP, 1992, BIOCHEM BIOPH RES CO, V184, P31, DOI 10.1016/0006-291X(92)91153-H; Dixon SE, 2010, MOL BIOCHEM PARASIT, V173, P1, DOI 10.1016/j.molbiopara.2010.05.001; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; El Hajj H, 2008, EUKARYOT CELL, V7, P1019, DOI 10.1128/EC.00413-07; FERRARI S, 1994, J BIOL CHEM, V269, P28803; Gaji RY, 2011, MOL MICROBIOL, V79, P192, DOI 10.1111/j.1365-2958.2010.07441.x; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gnanasekar M, 2006, MOL BIOCHEM PARASIT, V145, P137, DOI 10.1016/j.molbiopara.2005.09.013; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k; KOLLER BH, 1992, ANNU REV IMMUNOL, V10, P705, DOI 10.1146/annurev.iy.10.040192.003421; Kumar K, 2008, PARASITOL INT, V57, P150, DOI 10.1016/j.parint.2007.11.005; KUN JFJ, 1995, MOL BIOCHEM PARASIT, V71, P249, DOI 10.1016/0166-6851(94)00047-Q; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; MORALES M, 1992, J CELL BIOCHEM, V50, P279, DOI 10.1002/jcb.240500308; MORISAKI JH, 1995, J CELL SCI, V108, P2457; Nardelli SC, 2013, MBIO, V4, DOI 10.1128/mBio.00922-13; Osmanov T, 2013, BIOCHEM BIOPH RES CO, V432, P231, DOI 10.1016/j.bbrc.2013.02.008; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sessa L, 2007, GENE, V387, P133, DOI 10.1016/j.gene.2006.08.034; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Thirugnanam S, 2012, PARASITOL RES, V111, P619, DOI 10.1007/s00436-012-2878-x; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; VARGAWEISZ P, 1994, BIOCHEM BIOPH RES CO, V203, P1904, DOI 10.1006/bbrc.1994.2410; Wong B, 2002, BIOCHEMISTRY-US, V41, P5404, DOI 10.1021/bi012077l; Zhang QC, 2010, BBA-GENE REGUL MECH, V1799, P28, DOI 10.1016/j.bbagrm.2009.11.009; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421; Zlatanova J, 1998, BIOESSAYS, V20, P584, DOI 10.1002/(SICI)1521-1878(199807)20:7<584::AID-BIES10>3.0.CO;2-W	55	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111993	10.1371/journal.pone.0111993	http://dx.doi.org/10.1371/journal.pone.0111993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369210	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000134
J	Zhao, XL; Yu, H; Kong, LF; Liu, SK; Li, Q				Zhao, Xuelin; Yu, Hong; Kong, Lingfeng; Liu, Shikai; Li, Qi			Comparative Transcriptome Analysis of Two Oysters, Crassostrea gigas and Crassostrea hongkongensis Provides Insights into Adaptation to Hypo-Osmotic Conditions	PLOS ONE			English	Article							RNA-SEQ DATA; PARALLEL EVOLUTION; SUBSTITUTION RATES; HIGH-THROUGHPUT; GENE ONTOLOGY; SNP DISCOVERY; 1ST INSIGHTS; HEAT-STRESS; HONG-KONG; EXPRESSION	Environmental salinity creates a key barrier to limit the distribution of most aquatic organisms. Adaptation to osmotic fluctuation is believed to be a factor facilitating species diversification. Adaptive evolution often involves beneficial mutations at more than one locus. Bivalves hold great interest, with numerous species living in waters, as osmoconformers, who maintain the osmotic pressure balance mostly by free amino acids. In this study, 107,076,589 reads from two groups of Crassostrea hongkongensis were produced and the assembled into 130,629 contigs. Transcripts putatively involved in stress-response, innate immunity and cell processes were identified according to Gene ontology and KEGG pathway analyses. Comparing with the transcriptome of C. gigas to characterize the diversity of transcripts between species with osmotic divergence, we identified 182,806 high-quality single nucleotide polymorphisms (SNPs) for C. hongkongensis, and 196,779 SNPs for C. gigas. Comparison of 11,602 pairs of putative orthologs allowed for identification of 14 protein-coding genes that experienced strong positive selection (Ka/Ks>1). In addition, 45 genes that may show signs of moderate positive selection (1 >= Ka/Ks>0.5) were also identified. Based on Ks ratios and divergence time between the two species published previously, we estimated a neutral transcriptome-wide substitution mutation rate of 1.39x10(-9) per site per year. Several genes were differentially expressed across the control and treated groups of each species. This is the first time to sequence the transcriptome of C. hongkongensis and provide the most comprehensive transcriptomic resource available for it. The increasing amount of transcriptome data on Crassostrea provides an excellent resource for phylogenetic analysis. A large number of SNPs identified in this work are expected to provide valuable resources for future marker and genotyping assay development. The analysis of natural selection provides an innovative view on the adaptation within species and sets the basis for future genetic and evolutionary studies.	[Zhao, Xuelin; Yu, Hong; Kong, Lingfeng; Liu, Shikai; Li, Qi] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao 266003, Peoples R China	Ocean University of China	Li, Q (corresponding author), Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao 266003, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAG-2473-2019; Liu, Shikai/AAO-2247-2021; Kong, Lingfeng/AAJ-3402-2021	Kong, Lingfeng/0000-0001-5263-1697; Liu, Shikai/0000-0001-5777-489X; 	973 Program [2010CB126406]; National High Technology Research and Development Program [2012AA10A405-6]; National Natural Science Foundation of China [31372524]	973 Program(National Basic Research Program of China); National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from 973 Program (2010CB126406), National High Technology Research and Development Program (2012AA10A405-6), and National Natural Science Foundation of China (31372524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2008, ADAPTATION NATURAL S; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avarre JC, 2014, MOL ECOL RESOUR, V14, P139, DOI 10.1111/1755-0998.12148; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Chapman RW, 2011, MOL ECOL, V20, P1431, DOI 10.1111/j.1365-294X.2011.05018.x; Chen J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-589; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Guo Ximing, 2008, V2, P163, DOI 10.1007/978-3-540-73837-4_8; Gut IG, 2004, NAT GENET, V36, P789, DOI 10.1038/ng0804-789; Hanelt B, 2008, J INVERTEBR PATHOL, V99, P192, DOI 10.1016/j.jip.2008.06.002; Hendre PS, 2012, PLANT BIOTECHNOL J, V10, P646, DOI 10.1111/j.1467-7652.2012.00699.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kobayashi MJ, 2013, MOL ECOL, V22, P4767, DOI 10.1111/mec.12344; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lam K, 2004, RAFFLES B ZOOL, V52, P11; Lam K, 2003, AQUACULTURE, V228, P1, DOI 10.1016/S0044-8486(03)00215-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2013, ISJ-INVERT SURVIV J, V10, P84; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Liu FJ, 2013, AQUAT TOXICOL, V132, P26, DOI 10.1016/j.aquatox.2013.01.022; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; McInerney JO, 2006, TRENDS ECOL EVOL, V21, P230, DOI 10.1016/j.tree.2006.03.008; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Montes I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070051; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pauley G.B., 1988, FISH WILDLIFE SERVIC; Pinosio S, 2014, MOL ECOL RESOUR, V14, P846, DOI 10.1111/1755-0998.12232; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Ren JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-394; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Schlenke TA, 2003, GENETICS, V164, P1471; Schunter C, 2014, MOL ECOL RESOUR, V14, P157, DOI 10.1111/1755-0998.12155; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang HY, 2008, J SHELLFISH RES, V27, P481, DOI 10.2983/0730-8000(2008)27[481:IOCAAR]2.0.CO;2; Wang HY, 2004, AQUACULTURE, V242, P137, DOI 10.1016/j.aquaculture.2004.09.014; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063927; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V323, P9, DOI 10.1016/j.bbrc.2004.08.048; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warwick RM, 2002, J MAR BIOL ASSOC UK, V82, P847, DOI 10.1017/S0025315402006227; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147	75	37	37	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111915	10.1371/journal.pone.0111915	http://dx.doi.org/10.1371/journal.pone.0111915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369077	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000124
J	Driscoll, DL; Chakravarty, A; Bowman, D; Shinde, V; Lasky, K; Shi, J; Vos, T; Stringer, B; Amidon, B; D'Amore, N; Hyer, ML				Driscoll, Denise L.; Chakravarty, Arijit; Bowman, Doug; Shinde, Vaishali; Lasky, Kerri; Shi, Judy; Vos, Tricia; Stringer, Bradley; Amidon, Ben; D'Amore, Natalie; Hyer, Marc L.			Plk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines	PLOS ONE			English	Article							POLO-LIKE KINASE-1; TERMINAL PROLIFERATION ARREST; ONCOGENE-INDUCED SENESCENCE; SMALL-MOLECULE INHIBITOR; HUMAN CANCER-CELLS; GROWTH IN-VIVO; ANTITUMOR-ACTIVITY; MITOTIC BLOCK; CHROMOSOME SEGREGATION; SELECTIVE INHIBITOR	Plk1 is a checkpoint protein whose role spans all of mitosis and includes DNA repair, and is highly conserved in eukaryotes from yeast to man. Consistent with this wide array of functions for Plk1, the cellular consequences of Plk1 disruption are diverse, spanning delays in mitotic entry, mitotic spindle abnormalities, and transient mitotic arrest leading to mitotic slippage and failures in cytokinesis. In this work, we present the in vitro and in vivo consequences of Plk1 inhibition in cancer cells using potent, selective small-molecule Plk1 inhibitors and Plk1 genetic knock-down approaches. We demonstrate for the first time that cellular senescence is the predominant outcome of Plk1 inhibition in some cancer cell lines, whereas in other cancer cell lines the dominant outcome appears to be apoptosis, as has been reported in the literature. We also demonstrate strong induction of DNA double-strand breaks in all six lines examined (as assayed by gamma H2AX), which occurs either during mitotic arrest or mitotic-exit, and may be linked to the downstream induction of senescence. Taken together, our findings expand the view of Plk1 inhibition, demonstrating the occurrence of a non-apoptotic outcome in some settings. Our findings are also consistent with the possibility that mitotic arrest observed as a result of Plk1 inhibition is at least partially due to the presence of unrepaired double-strand breaks in mitosis. These novel findings may lead to alternative strategies for the development of novel therapeutic agents targeting Plk1, in the selection of biomarkers, patient populations, combination partners and dosing regimens.	[Driscoll, Denise L.; Chakravarty, Arijit; Bowman, Doug; Shinde, Vaishali; Lasky, Kerri; Shi, Judy; Vos, Tricia; Stringer, Bradley; Amidon, Ben; D'Amore, Natalie; Hyer, Marc L.] Takeda Pharmaceut Int Co, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Hyer, ML (corresponding author), Takeda Pharmaceut Int Co, Cambridge, MA 02139 USA.	marc.hyer@takeda.com			Takeda Pharmaceuticals International Co.	Takeda Pharmaceuticals International Co.	The author(s) received no specific funding for this work. All authors are employees of Takeda Pharmaceuticals International Co. Takeda Pharmaceuticals International Co. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Guerrero AA, 2010, P NATL ACAD SCI USA, V107, P4159, DOI 10.1073/pnas.0912143106; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Chang BD, 1999, CANCER RES, V59, P3761; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chen XH, 2006, WORLD J GASTROENTERO, V12, P29, DOI 10.3748/wjg.v12.i1.29; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duffey MO, 2012, J MED CHEM, V55, P197, DOI 10.1021/jm2011172; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hikichi Y, 2012, MOL CANCER THER, V11, P700, DOI 10.1158/1535-7163.MCT-11-0762; Hood EA, 2012, MOL BIOL CELL, V23, P2264, DOI 10.1091/mbc.E11-12-1013; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; JOHNSON IS, 1963, CANCER RES, V23, P1390; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 1996, CANCER RES, V56, P816; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kim HJ, 2013, J GERONTOL A-BIOL, V68, P1145, DOI 10.1093/gerona/glt017; Klein LE, 2005, CELL CYCLE, V4, P501, DOI 10.4161/cc.4.3.1550; Kubara PM, 2012, BIOCHEM J, V446, P373, DOI 10.1042/BJ20120385; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee HJ, 2010, CELL CYCLE, V9, P2389, DOI 10.4161/cc.9.12.11904; Lei M, 2008, ONCOGENE, V27, P3935, DOI 10.1038/onc.2008.36; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; Mahen R, 2011, P NATL ACAD SCI USA, V108, P9310, DOI 10.1073/pnas.1101112108; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Roninson IB, 2003, CANCER RES, V63, P2705; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Schmit TL, 2009, J INVEST DERMATOL, V129, P2843, DOI 10.1038/jid.2009.172; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shi JQ, 2012, MOL CANCER THER, V11, P2045, DOI 10.1158/1535-7163.MCT-11-1036; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; te Poele RH, 2002, CANCER RES, V62, P1876; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Ullrich E, 2007, CANCER RES, V67, P851, DOI 10.1158/0008-5472.CAN-06-3766; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Watanabe N, 2009, J BIOL CHEM, V284, P2344, DOI 10.1074/jbc.M805308200; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yim HS, 2009, MOL CELL BIOL, V29, P2609, DOI 10.1128/MCB.01277-08; Yuan JP, 2011, AM J PATHOL, V179, P2091, DOI 10.1016/j.ajpath.2011.06.031; Zhang W, 2005, J BIOL CHEM, V280, P42994, DOI 10.1074/jbc.M505450200	60	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111060	10.1371/journal.pone.0111060	http://dx.doi.org/10.1371/journal.pone.0111060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365521	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100048
J	Ou, HS; Li, YM; Kang, M				Ou, Hesheng; Li, Yumei; Kang, Min			Activation of miR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; LUNG-CANCER; MICRORNA-21 TARGETS; EXPRESSION; INVASION; PATHWAYS; GROWTH; OVEREXPRESSION; TRANSCRIPTION	The present study is to investigate the role of microRNA-21 (miR-21) in nasopharyngeal carcinoma (NPC) and the mechanisms of regulation of PTEN by miR-21. Fifty-four tissue samples were collected from 42 patients with NPC and 12 healthy controls. Human NPC cell lines CNE-1, CNE-2, TWO3 and C666-1 were used for cell assays. To investigate the expression of miR-21, RT-PCR was employed. RT-PCR, Western blotting, and immunohistochemistry were used to measure the expression of STAT3 mRNA and STAT3 protein. To test the effect of miR-21 on the cell growth and apoptosis of NPC cells in vitro, transfection of CNE1 and CNE2 cell lines and flow cytometry were performed. TUNEL assay was used to detect DNA fragmentation. To validate whether miR-21 directly recognizes the 39-UTRs of PTEN mRNA, luciferase reporter assay was employed. miR-21 expression was increased in NPC tissues compared with control and the same result was found in NPC cell lines. Notably, increased expression of miR-21 was directly related to advanced clinical stage and lymph node metastasis. STAT3, a transcription factor activated by IL-6, directly activated miR-21 in transformed NPC cell lines. Furthermore, miR-21 markedly inhibited PTEN tumor suppressor, leading to increased AKT activity. Both in vitro and in vivo assays revealed that miR-21 enhanced NPC cell proliferation and suppressed apoptosis. miR-21, activated by STAT3, induced proliferation and suppressed apoptosis in NPC by targeting PTEN-AKT pathway.	[Ou, Hesheng; Li, Yumei] Guangxi Med Univ, Coll Pharm, Nanning, Guangxi Provinc, Peoples R China; [Kang, Min] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi Provinc, Peoples R China	Guangxi Medical University; Guangxi Medical University	Kang, M (corresponding author), Guangxi Med Univ, Coll Pharm, Nanning, Guangxi Provinc, Peoples R China.	km10192013@126.com			National Natural Science Foundation of China [81373403]; Research Foundation of the Education Department of Guangxi Province, China [2013YB049]; Research Foundation from the Regional Health Department of Guangxi Province, China [Z2012066]; Youth Foundation of Guangxi Medical University, China [02604001020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Education Department of Guangxi Province, China; Research Foundation from the Regional Health Department of Guangxi Province, China; Youth Foundation of Guangxi Medical University, China	This study was supported by grants from the National Natural Science Foundation of China (No. 81373403, Hesheng Ou), Research Foundation of the Education Department of Guangxi Province, China (No. 2013YB049, Hesheng Ou), Research Foundation from the Regional Health Department of Guangxi Province, China (No. Z2012066, Min Kang), and Youth Foundation of Guangxi Medical University, China (No. 02604001020, Min Kang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2012, INT J BIOL MARKER, V27, pE132, DOI 10.5301/JBM.2012.9146; Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Azim H, 2010, TARGET ONCOL, V5, P269, DOI 10.1007/s11523-010-0141-x; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHERN CJ, 1976, AM J HUM GENET, V28, P9; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Dai BB, 2011, CANCER RES, V71, P3658, DOI 10.1158/0008-5472.CAN-10-3647; Demaria M, 2012, CELL DEATH DIFFER, V19, P1390, DOI 10.1038/cdd.2012.20; Demaria M, 2012, ONCOTARGET, V3, P359; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ettl T, 2012, HUM PATHOL, V43, P921, DOI 10.1016/j.humpath.2011.08.006; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jeannel D, 1999, CANCER SURV, V33, P125; Kanaan Z, 2012, ANN SURG, V256, P544, DOI 10.1097/SLA.0b013e318265bd6f; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Kurose K, 2001, AM J PATHOL, V158, P2097, DOI 10.1016/S0002-9440(10)64681-0; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2012, J UROLOGY, V187, P1466, DOI 10.1016/j.juro.2011.11.082; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Netto GJ, 2010, PATHOLOGY, V42, P384, DOI 10.3109/00313021003779145; Ou HS, 2005, ARTERIOSCL THROM VAS, V25, P2509, DOI 10.1161/01.ATV.0000189306.99112.4c; Panigrahi AR, 2004, J PATHOL, V204, P93, DOI 10.1002/path.1611; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Pensa S, 2009, JAK STAT PATHWAY DIS, V100; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shodeinde AL, 2012, ONCOTARGETS THER, V5, P119, DOI 10.2147/OTT.S32559; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stewart AL, 2002, MOL MED, V8, P451, DOI 10.1007/BF03402025; Teng Y, 2013, TOXICOL SCI, V131, P71, DOI 10.1093/toxsci/kfs290; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang LH, 2007, CLIN CANCER RES, V13, P102, DOI 10.1158/1078-0432.CCR-06-1467; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Wu L, 2008, MOL CANCER THER, V7, P222, DOI 10.1158/1535-7163.MCT-07-0382; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056114; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yan LM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070658, 10.1371/journal.pone.0072548]; Yan LM, 2011, MOL CELL BIOCHEM, V357, P9, DOI 10.1007/s11010-011-0870-x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang MM, 2013, EUR J CANCER, V49, P604, DOI 10.1016/j.ejca.2012.09.031; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	70	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109929	10.1371/journal.pone.0109929	http://dx.doi.org/10.1371/journal.pone.0109929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365510	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100012
J	Peng, L; Zhao, Q; Ye, XH; Zhou, Y; Hu, DN; Zheng, SS				Peng, Ling; Zhao, Qiong; Ye, Xianghua; Zhou, Yun; Hu, Danna; Zheng, Shusen			Incidence and Risk of Proteinuria with Aflibercept in Cancer Patients: A Meta-Analysis	PLOS ONE			English	Article							PHASE-II; VEGF-TRAP; DOUBLE-BLIND; INTRAVENOUS AFLIBERCEPT; OVARIAN-CANCER; RECURRENT; PLACEBO; TRIAL; MECHANISMS; DOCETAXEL	Background: Aflibercept is a human recombinant fusion protein with antiangiogenic effects that functions as a decoy receptor to bind vascular endothelial growth factor A. Proteinuria is one of its major adverse effects with a substantial variation in the incidence rate, and the overall risk of proteinuria has not been systematically studied. We performed a meta-analysis of published clinical trials to quantify the incidence and relative risk of proteinuria in cancer patients treated with aflibercept. Methods: The electronic databases were searched, including PubMed, Embase, Cochrane databases, and ASCO (American Society of Clinical Oncology) abstracts. Eligible studies were phase II and III prospective clinical trials of cancer patients treated with aflibercept with toxicity data on proteinuria. Overall incidence rates, relative risk (RR), and 95% confidence intervals (CI) were calculated using fixed or random effects models depending on the heterogeneity of the included studies. Results: A total of 4,596 patients with a variety of solid tumors from 16 prospective clinical trials were included for the meta-analysis. The overall incidences of all-grade and high-grade proteinuria in cancer patients were 33.9% (95% CI: 27.3-42.1%) and 7.9% (95% CI: 6.1-10.2%). The relative risks of proteinuria of aflibercept compared to control were increased for all-grade (RR = 1.41, 95% CI: 1.13-1.77) and high-grade (RR = 6.18, 95% CI: 3.78-10.12) proteinuria. The risk of developing all-grade and high-grade proteinuria with aflibercept was substantially higher than that of bevacizumab (all-grade: RR 1.85, 95% CI: 1.63-2.11; high-grade: RR 2.37, 95% CI: 1.84-3.05). Conclusions: Aflibercept is associated with an increased risk of developing proteinuria. Appropriate monitoring and treatment is strongly recommended to prevent potential renal damage. Future studies are still needed to investigate the risk reduction and possible use of aflibercept in cancer patients.	[Peng, Ling; Zhao, Qiong; Hu, Danna] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Ye, Xianghua] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Radiat Dept, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Yun] Zhejiang Food & Drug Adm, Hangzhou, Zhejiang, Peoples R China; [Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzhengzy@163.com			Natural Science Foundation of Zhejiang Province, China [LQ13H160010]; Zhejiang Medical Association [2012ZYC-A12]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Zhejiang Medical Association	This study was supported by a grant from the Natural Science Foundation of Zhejiang Province, China (Grant number: LQ13H160010) and a clinical research grant from Zhejiang Medical Association (Grant number: 2012ZYC-A12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ZALTRAP ZIV AFLIBERC; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Choueiri TK, 2010, J CLIN ONCOL, V28, P2280, DOI 10.1200/JCO.2009.27.2757; Coleman RL, 2012, GYNECOL ONCOL, V127, P538, DOI 10.1016/j.ygyno.2012.08.020; Colombo N, 2012, GYNECOL ONCOL, V125, P42, DOI 10.1016/j.ygyno.2011.11.021; de Groot JF, 2011, J CLIN ONCOL, V29, P2689, DOI 10.1200/JCO.2010.34.1636; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gotlieb WH, 2012, LANCET ONCOL, V13, P154, DOI 10.1016/S1470-2045(11)70338-2; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Izzedine H, 2010, EUR J CANCER, V46, P439, DOI 10.1016/j.ejca.2009.11.001; Kanellis John, 2004, Nephron Physiol, V96, pP26, DOI 10.1159/000075577; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Leighl NB, 2010, J THORAC ONCOL, V5, P1054, DOI 10.1097/JTO.0b013e3181e2f7fb; Mackay HJ, 2012, GYNECOL ONCOL, V125, P136, DOI 10.1016/j.ygyno.2011.11.042; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ramlau R, 2012, J CLIN ONCOL, V30, P3640, DOI 10.1200/JCO.2012.42.6932; Rougier P, 2013, EUR J CANCER, V49, P2633, DOI 10.1016/j.ejca.2013.04.002; Sherman EJ, 2010, J CLIN ONCOL S, V28; Sideras K, 2012, CLIN BREAST CANCER, V12, P387, DOI 10.1016/j.clbc.2012.09.007; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Tang PA, 2012, CLIN CANCER RES, V18, P6023, DOI 10.1158/1078-0432.CCR-11-3252; Tannock IF, 2013, LANCET ONCOL, V14, P760, DOI 10.1016/S1470-2045(13)70184-0; Tarhini AA, 2011, CLIN CANCER RES, V17, P6574, DOI 10.1158/1078-0432.CCR-11-1463; Tesarova P, 2013, FOLIA BIOL-PRAGUE, V59, P15; Tew WP, 2014, CANCER-AM CANCER SOC, V120, P335, DOI 10.1002/cncr.28406; Twardowski P, 2010, UROLOGY, V76, P923, DOI 10.1016/j.urology.2010.04.025; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Wu SH, 2010, J AM SOC NEPHROL, V21, P1381, DOI 10.1681/ASN.2010020167; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zhang ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090135; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	33	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111839	10.1371/journal.pone.0111839	http://dx.doi.org/10.1371/journal.pone.0111839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365378	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100128
J	Li, CX; Cai, SJ; Wang, XS; Jiang, Z				Li, Chunxiang; Cai, Sanjun; Wang, Xishan; Jiang, Zheng			Hypomethylation-Associated Up-Regulation of TCF3 Expression and Recurrence in Stage II and III Colorectal Cancer	PLOS ONE			English	Article							OVARIAN ENDOMETRIOID ADENOCARCINOMAS; EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN; GENE-EXPRESSION; BETA-CATENIN; DNA-BINDING; ADJUVANT THERAPY; TUMOR-SUPPRESSOR; COLON-CANCER; TRANSCRIPTION	Background and Objectives: Transcription factor 3 (TCF3) implicates Wnt signaling pathway and regulates E-cadherin expression, which is involved in aggressiveness of tumors. This study aims to investigate the role of TCF3 in predicting prognosis of patients with stage II and III colorectal cancer (CRC). Methods: Real-Time quantitative PCR was performed in 64 fresh CRC tissues and 6 cell lines to examine TCF3 mRNA expression. TCF3 protein expression dynamics were detected by immunohistochemistry of 118 paraffin-embedded specimens, and the clinical significance of TCF3 was assessed by clinical correlation and Kaplan-Meier analyses. Aberrant hypomethylation of TCF3 promoter was also investigated using bisulfite sequencing and methylation specific PCR. Results: The up-regulation of TCF3 mRNA was frequently detected both in CRC tissues with recurrence and metastasis-derived cell lines. The expression level of TCF3 protein was significantly correlated with histological type (P = 0.038) and disease-free survival time (P = 0.002). Higher TCF3 expression indicated poor prognostic outcomes (P<0.05, log-rank test). Multivariate analysis also showed strong TCF3 protein expression and perineural invasion were independent adverse prognosticators in CRC (P = 0.010, 0.000). Moreover, it was showed that promoter hypomethylation of TCF3 is associated with its up-expression. Conclusions: This study highlighted the prognostic value of TCF3 in stage II and III CRC. The up-regulation of TCF3, which is mainly caused by promoter hypomethylation, is one of the molecular mechanisms involved in the development and progression of CRC.	[Li, Chunxiang] Harbin Med Univ, Med Genet Lab, Harbin, Heilongjiang, Peoples R China; [Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Wang, Xishan; Jiang, Zheng] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Harbin, Peoples R China; [Wang, Xishan; Jiang, Zheng] Heilongjiang Acad Med Sci, Colorectal Canc Inst, Harbin, Peoples R China	Harbin Medical University; Fudan University; Harbin Medical University	Wang, XS (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Harbin, Peoples R China.	wxshan1208@126.com; dr.jiangzheng@gmail.com			Postdoctoral Science Foundation of Heilongjiang Province [LRB87859]; Medical Scientific Research Foundation of Heilongjiang Province [2011-144]; Key Laboratory of Medical Genetics of Heilongjiang Higher Education Institutions; Natural Science Foundation of Heilongjiang Province [H201332]	Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation); Medical Scientific Research Foundation of Heilongjiang Province; Key Laboratory of Medical Genetics of Heilongjiang Higher Education Institutions; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This study was supported by Postdoctoral Science Foundation of Heilongjiang Province (LRB87859), Medical Scientific Research Foundation of Heilongjiang Province (2011-144), The Opening Project of Key Laboratory of Medical Genetics of Heilongjiang Higher Education Institutions and Natural Science Foundation of Heilongjiang Province (H201332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Oliver JA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-511; Asirvatharn AJ, 2007, PROSTATE, V67, P1411, DOI 10.1002/pros.20633; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; CHAKRABORTY T, 1991, MOL CELL BIOL, V11, P3633, DOI 10.1128/MCB.11.7.3633; Chatla Chakrapani, 2005, Cancer Biomarkers, V1, P241; Cserni G, 2003, J CLIN PATHOL, V56, P327, DOI 10.1136/jcp.56.5.327; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hata F, 2004, J EXP CLIN CANC RES, V23, P513; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Jiang Z, 2011, HUM PATHOL, V42, P361, DOI 10.1016/j.humpath.2010.03.009; Kijanka G, 2010, GUT, V59, P69, DOI 10.1136/gut.2009.178574; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Laux H, 2004, LAB INVEST, V84, P1372, DOI 10.1038/labinvest.3700158; Macdonald JS, 1999, CA-CANCER J CLIN, V49, P202, DOI 10.3322/canjclin.49.4.202; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Mareel M, 1997, J CELL PHYSIOL, V173, P271, DOI 10.1002/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Patel D, 2012, BIOCHEM BIOPH RES CO, V422, P146, DOI 10.1016/j.bbrc.2012.04.126; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Sagara N, 2000, CANCER RES, V60, P5959; Schwartz DR, 2003, CANCER RES, V63, P2913; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zhao HC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-317	36	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112005	10.1371/journal.pone.0112005	http://dx.doi.org/10.1371/journal.pone.0112005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375219	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600091
J	Dey, N; Sinha, M; Gupta, S; Gonzalez, MN; Fang, R; Endsley, JJ; Luxon, BA; Garg, NJ				Dey, Nilay; Sinha, Mala; Gupta, Shivali; Gonzalez, Mariela Natacha; Fang, Rong; Endsley, Janice J.; Luxon, Bruce A.; Garg, Nisha Jain			Caspase-1/ASC Inflammasome-Mediated Activation of IL-1 beta-ROS-NF-kappa B Pathway for Control of Trypanosoma cruzi Replication and Survival Is Dispensable in NLRP3(-/-) Macrophages	PLOS ONE			English	Article							CUTTING EDGE; HOST-RESISTANCE; EXPRESSION; INFECTION; SECRETION; ACCOUNT; CELLS	In this study, we have utilized wild-type (WT), ASC(-/-), and NLRP3(-/-) macrophages and inhibition approaches to investigate the mechanisms of inflammasome activation and their role in Trypanosoma cruzi infection. We also probed human macrophages and analyzed published microarray datasets from human fibroblasts, and endothelial and smooth muscle cells for T. cruzi-induced changes in the expression genes included in the RT Profiler Human Inflammasome arrays. T. cruzi infection elicited a subdued and delayed activation of inflammasome-related gene expression and IL-1 beta production in m phi s in comparison to LPS-treated controls. When WT and ASC(-/-) macrophages were treated with inhibitors of caspase-1, IL-1 beta, or NADPH oxidase, we found that IL-1 beta production by caspase-1/ASC inflammasome required reactive oxygen species (ROS) as a secondary signal. Moreover, IL-1 beta regulated NF-kappa B signaling of inflammatory cytokine gene expression and, subsequently, intracellular parasite replication in macrophages. NLRP3(-/-) macrophages, despite an inability to elicit IL-1 beta activation and inflammatory cytokine gene expression, exhibited a 4-fold decline in intracellular parasites in comparison to that noted in matched WT controls. NLRP3(-/-) macrophages were not refractory to T. cruzi, and instead exhibited a very high basal level of ROS (>100-fold higher than WT controls) that was maintained after infection in an IL-1 beta-independent manner and contributed to efficient parasite killing. We conclude that caspase-1/ASC inflammasomes play a significant role in the activation of IL-1 beta/ROS and NF-kappa B signaling of cytokine gene expression for T. cruzi control in human and mouse macrophages. However, NLRP3-mediated IL-1 beta/NF kappa B activation is dispensable and compensated for by ROS-mediated control of T. cruzi replication and survival in macrophages.	[Dey, Nilay; Gupta, Shivali; Endsley, Janice J.; Garg, Nisha Jain] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Gonzalez, Mariela Natacha; Garg, Nisha Jain] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Fac Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA; [Gonzalez, Mariela Natacha] Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dey, N (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	nidey@utmb.edu; nigarg@utmb.edu	Stefanadis, Christodoulos/ABH-2232-2020; Fang, Rong/ABD-6123-2020; Luxon, Bruce A/C-9140-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; GONZALEZ, MARIELA NATACHA/0000-0002-7274-4282	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI054578]; National Heart Lung and Blood Institute of the National Institutes of Health (NIH) [R01HL094802]; NIAID/NIH [R03AI208810]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart Lung and Blood Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases (NIAID R01AI054578) and National Heart Lung and Blood Institute (R01HL094802) of the National Institutes of Health (NIH) to NJG. ND was a recipient of a grant (R03AI208810) from NIAID/ NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Coelho PS, 2002, J LEUKOCYTE BIOL, V71, P837; Costales JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-252; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Dhiman M, 2011, J PATHOL, V225, P583, DOI 10.1002/path.2975; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; Garg NJ, 2011, AM J CARDIOVASC DIS, V1, P244; Goncalves VM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002469; Hirao K, 2009, J DENT RES, V88, P762, DOI 10.1177/0022034509341779; Huang H, 1999, J MOL CELL CARDIOL, V31, P75, DOI 10.1006/jmcc.1998.0848; Hwang YS, 2004, ONCOGENE, V23, P6603, DOI 10.1038/sj.onc.1207867; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kayama H, 2010, MICROBES INFECT, V12, P511, DOI 10.1016/j.micinf.2010.03.005; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Lo YYC, 1998, J CELL BIOCHEM, V69, P19, DOI 10.1002/(SICI)1097-4644(19980401)69:1<19::AID-JCB3>3.0.CO;2-Y; Machado Fabiana S, 2012, Front Biosci (Elite Ed), V4, P1743; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Monteiro AC, 2007, PLOS PATHOG, V3, P1730, DOI 10.1371/journal.ppat.0030185; Oliveira AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000870; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Schmitz V, 2009, J LEUKOCYTE BIOL, V85, P1005, DOI 10.1189/jlb.1108693; Schultz K, 2007, AM J PHYSIOL-HEART C, V292, pH2927, DOI 10.1152/ajpheart.00700.2006; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; Silva GK, 2013, J IMMUNOL, V191, P3373, DOI 10.4049/jimmunol.1203293; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; Wen JJ, 2008, J BIOENERG BIOMEMBR, V40, P587, DOI 10.1007/s10863-008-9184-4; World Health Organization, 2010, CHAG DIS CONTR EL; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208	39	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111539	10.1371/journal.pone.0111539	http://dx.doi.org/10.1371/journal.pone.0111539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372293	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900054
J	El-Bassel, N; Gilbert, L; Goddard-Eckrich, D; Chang, M; Wu, E; Hunt, T; Epperson, M; Shaw, SA; Rowe, J; Almonte, M; Witte, S				El-Bassel, Nabila; Gilbert, Louisa; Goddard-Eckrich, Dawn; Chang, Mingway; Wu, Elwin; Hunt, Tim; Epperson, Matt; Shaw, Stacey A.; Rowe, Jessica; Almonte, Maria; Witte, Susan			Efficacy of a Group-Based Multimedia HIV Prevention Intervention for Drug-Involved Women under Community Supervision: Project WORTH	PLOS ONE			English	Article							US CORRECTIONAL FACILITIES; RISK BEHAVIORS; INFECTED PRISONERS; COMPUTER; REDUCTION; HIV/AIDS; CARE; TECHNOLOGY; PREDICTORS; RELEASEES	Importance: This study is designed to address the need for evidence-based HIV/STI prevention approaches for drug-involved women under criminal justice community supervision. Objective: We tested the efficacy of a group-based traditional and multimedia HIV/STI prevention intervention (Project WORTH: Women on the Road to Health) among drug-involved women under community supervision. Design, Setting, Participants, and Intervention: We randomized 306 women recruited from community supervision settings to receive either: (1) a four-session traditional group-based HIV/STI prevention intervention (traditional WORTH); (2) a four-session multimedia group-based HIV/STI prevention intervention that covered the same content as traditional WORTH but was delivered in a computerized format; or (3) a four-session group-based Wellness Promotion intervention that served as an attention control condition. The study examined whether the traditional or multimedia WORTH intervention was more efficacious in reducing risks when compared to Wellness Promotion; and whether multimedia WORTH was more efficacious in reducing risks when compared to traditional WORTH. Main Outcomes and Measures: Primary outcomes were assessed over the 12-month post-intervention period and included the number of unprotected sex acts, the proportion of protected sex acts, and consistent condom use. At baseline, 77% of participants reported unprotected vaginal or anal sex (n = 237) and 63% (n = 194) had multiple sex partners. Results: Women assigned to traditional or multimedia WORTH were significantly more likely than women assigned to the control condition to report an increase in the proportion of protected sex acts (beta = 0.10; 95% CI = 0.02-0.18) and a decrease in the number of unprotected sex acts (IRR = 0.72; 95% CI = 0.57-0.90). Conclusion and Relevance: The promising effects of traditional and multimedia WORTH on increasing condom use and high participation rates suggest that WORTH may be scaled up to redress the concentrated epidemics of HIV/STIs among drug-involved women in the criminal justice system.	[El-Bassel, Nabila; Gilbert, Louisa; Goddard-Eckrich, Dawn; Chang, Mingway; Wu, Elwin; Hunt, Tim; Shaw, Stacey A.; Witte, Susan] Columbia Univ, Social Intervent Grp, New York, NY 10027 USA; [Epperson, Matt] Univ Chicago, Sch Social Serv Adm, Chicago, IL 60637 USA; [Rowe, Jessica] Columbia Ctr New Media Teaching & Learning, New York, NY USA; [Almonte, Maria] Bronx Community Solut, Ctr Court Innovat, New York, NY USA	Columbia University; University of Chicago	El-Bassel, N (corresponding author), Columbia Univ, Social Intervent Grp, New York, NY 10027 USA.	ne5@columbia.edu	Goddard-eckrich, Dawn/GNM-6708-2022	Goddard-Eckrich, Dawn/0000-0002-3456-2322	National Institute of Drug Abuse (NIDA) [R01DA025878]	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The study was funded by the National Institute of Drug Abuse (NIDA) to NE (R01DA025878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EST HIV INC US 2007; [Anonymous], 2009, GENERATIONS ONLINE 2; Bandura A, 1986, CHANGES, P1; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Belenko S, 2004, AIDS EDUC PREV, V16, P367, DOI 10.1521/aeap.16.4.367.40394; Bonczar T.P., 2013, PROBATION PAROLE US; Booth RE, 2004, JAIDS-J ACQ IMM DEF, V35, P82, DOI 10.1097/00126334-200401010-00012; Braithwaite RL, 2003, AM J PUBLIC HEALTH, V93, P759, DOI 10.2105/AJPH.93.5.759; Browne-Marshall GJ, 2011, J GENDER LAW POLICY, V19, P407; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; Chiasson MA, 2009, AIDS CARE, V21, P1081, DOI 10.1080/09540120902730013; Draine J, 2011, AIDS CARE, V23, P366, DOI 10.1080/09540121.2010.507738; El-Bassel N, 2010, ARCH INTERN MED, V170, P1594, DOI 10.1001/archinternmed.2010.261; El-Basset N, 2010, AFRICAN AMERICANS AND HIV/AIDS: UNDERSTANDING AND ADDRESSING THE EPIDEMIC, P113, DOI 10.1007/978-0-387-78321-5_7; ELBASSEL N, 1995, SOC WORK RES, V19, P131; Epperson MW, 2011, AIDS BEHAV, V15, P347, DOI 10.1007/s10461-009-9660-9; Evans AE, 2000, J ADOLESCENT HEALTH, V26, P244, DOI 10.1016/S1054-139X(99)00093-2; Gordon MS, 2013, AIDS BEHAV, V17, P2022, DOI 10.1007/s10461-013-0456-6; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; Jaccard J, 2002, J APPL SOC PSYCHOL, V32, P1863, DOI 10.1111/j.1559-1816.2002.tb00263.x; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Khan MR, 2012, AIDS BEHAV, V16, P1949, DOI 10.1007/s10461-011-0106-9; Kiene SM, 2006, J ADOLESCENT HEALTH, V39, P404, DOI 10.1016/j.jadohealth.2005.12.029; Maruschak LM, 2012, HIV PRISONS 2001 201; Moreno R, 2001, COGNITION INSTRUCT, V19, P177, DOI 10.1207/S1532690XCI1902_02; Moretti F, 2007, EQUITY HLTH NEW GLOB; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; NEEDLE R, 1995, PSYCHOL ADDICT BEHAV, V9, P242, DOI 10.1037/0893-164X.9.4.242; Noar SA, 2009, AIDS, V23, P107, DOI 10.1097/QAD.0b013e32831c5500; NYCDoHaM Hygiene, 2012, NEW YORK CIT HIV AID; Peled E, 2000, SOC WORK, V45, P9, DOI 10.1093/sw/45.1.9; Policy TWHOoNA, 2010, NAT HIV AIDS STRAT U; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Read SJ, 2006, HUM COMMUN RES, V32, P1, DOI 10.1111/j.1468-2958.2006.00001.x; Remien RH, 2013, AIDS BEHAV, V17, P1979, DOI 10.1007/s10461-013-0438-8; Rubin DB, 2009, MULTIPLE IMPUTATION; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Silvia PJ, 2004, BEHAV RES METH INS C, V36, P325, DOI 10.3758/BF03195578; Spaulding A, 2002, CLIN INFECT DIS, V35, P305, DOI 10.1086/341418; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Tross S, 2008, JAIDS-J ACQ IMM DEF, V48, P581, DOI 10.1097/QAI.0b013e31817efb6e; Weir BW, 2009, AIDS BEHAV, V13, P509, DOI 10.1007/s10461-008-9422-0; WIE LJ, 1986, ANN STAT, V14, P265; Witte SS, IMPLEMENTAT IN PRESS; Witte SS, 2007, SEX TRANSM DIS, V34, P302, DOI 10.1097/01.olq.0000240288.90846.6a; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4; Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158	49	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111528	10.1371/journal.pone.0111528	http://dx.doi.org/10.1371/journal.pone.0111528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372149	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900053
J	Freese, NH; Lam, BA; Staton, M; Scott, A; Chapman, SC				Freese, Nowlan H.; Lam, Brianna A.; Staton, Meg; Scott, Allison; Chapman, Susan C.			A Novel Gain-Of-Function Mutation of the Proneural IRX1 and IRX2 Genes Disrupts Axis Elongation in the Araucana Rumpless Chicken	PLOS ONE			English	Article							RETINOIC ACID; PARAXIAL MESODERM; TAIL BUD; MOUSE EMBRYO; STEM-CELLS; TRANSCRIPTION FACTOR; NEURAL DEVELOPMENT; IROQUOIS COMPLEX; PRIMITIVE STREAK; XENOPUS HOMOLOG	Axis elongation of the vertebrate embryo involves the generation of cell lineages from posterior progenitor populations. We investigated the molecular mechanism governing axis elongation in vertebrates using the Araucana rumpless chicken. Araucana embryos exhibit a defect in axis elongation, failing to form the terminal somites and concomitant free caudal vertebrae, pygostyle, and associated tissues of the tail. Through whole genome sequencing of six Araucana we have identified a critical 130 kb region, containing two candidate causative SNPs. Both SNPs are proximal to the IRX1 and IRX2 genes, which are required for neural specification. We show that IRX1 and IRX2 are both misexpressed within the bipotential chordoneural hinge progenitor population of Araucana embryos. Expression analysis of BRA and TBX6, required for specification of mesoderm, shows that both are downregulated, whereas SOX2, required for neural patterning, is expressed in ectopic epithelial tissue. Finally, we show downregulation of genes required for the protection and maintenance of the tailbud progenitor population from the effects of retinoic acid. Our results support a model where the disruption in balance of mesoderm and neural fate results in early depletion of the progenitor population as excess neural tissue forms at the expense of mesoderm, leading to too few mesoderm cells to form the terminal somites. Together this cascade of events leads to axis truncation.	[Freese, Nowlan H.; Lam, Brianna A.; Scott, Allison; Chapman, Susan C.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Staton, Meg] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	Clemson University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Chapman, SC (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	schapm2@clemson.edu	Chapman, Susan C/J-2688-2013	Chapman, Susan C/0000-0002-4314-9193; Staton, Margaret/0000-0003-2971-9353	National Institute on Deafness; NIFA/USDA [SC-1700374]; National Institutes of Health [R01DC009236]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009236] Funding Source: NIH RePORTER	National Institute on Deafness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIFA/USDA(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by National Institute on Deafness (http://www.nidcd.nih.gov/) and other Communication Disorders of the National Institutes of Health under award number R01DC009236 to SCC. Technical Contribution No. 6247 of the Clemson University Experiment Station. This material is based upon work supported by the NIFA/USDA, under project number SC-1700374 to SCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Alvares LE, 2009, DEV DYNAM, V238, P1166, DOI 10.1002/dvdy.21950; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; Brott BK, 2005, DIFFERENTIATION, V73, P323, DOI 10.1111/j.1432-0436.2005.00032.x; Buchberger A, 2000, MECH DEVELOP, V97, P223, DOI 10.1016/S0925-4773(00)00424-X; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; CATALA M, 1995, MECH DEVELOP, V51, P51, DOI 10.1016/0925-4773(95)00350-A; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; DELCORRAL RD, 2003, NEURON, V40, P65, DOI DOI 10.1016/S0896-6273(03)00565-8; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dunn LC, 1925, J HERED, V16, P127, DOI 10.1093/oxfordjournals.jhered.a102573; Dunn LC, 1934, J GENET, V29, P217, DOI 10.1007/BF02982198; Dunn LC, 1936, J GENET, V33, P401, DOI 10.1007/BF02982895; Diaz-Hernandez ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058549; Gluecksohn-Schoenheimer S, 1944, P NATL ACAD SCI USA, V30, P134, DOI 10.1073/pnas.30.6.134; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Gomez-Skarmeta JL, 1998, EMBO J, V17, P181, DOI 10.1093/emboj/17.1.181; Gomez-Skarmeta JL, 2001, DEVELOPMENT, V128, P551; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Iulianella A, 1999, DEV BIOL, V205, P33, DOI 10.1006/dbio.1998.9110; Kondoh H, 2012, CURR OPIN GENET DEV, V22, P374, DOI 10.1016/j.gde.2012.03.006; LANDAUER W, 1945, GENETICS, V30, P403; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lopez-Sanchez C, 2010, CARDIOVASC RES, V88, P111, DOI 10.1093/cvr/cvq179; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; McDonald LA, 2010, J ANAT, V216, P683, DOI 10.1111/j.1469-7580.2010.01233.x; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Miller SA, 1996, DEV DYNAM, V206, P212, DOI 10.1002/(SICI)1097-0177(199606)206:2<212::AID-AJA10>3.0.CO;2-4; MILLS CL, 1989, ANAT EMBRYOL, V180, P301, DOI 10.1007/BF00315888; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Noorai RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040974; Nowotschin S, 2012, DEV BIOL, V367, P1, DOI 10.1016/j.ydbio.2012.04.012; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Quinlan R, 2002, DEV DYNAM, V225, P54, DOI 10.1002/dvdy.10137; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Richardson MK, 1998, DEVELOPMENT, V125, P151; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; SCHOENWOLF GC, 1981, ANAT EMBRYOL, V162, P183, DOI 10.1007/BF00306490; SCHOENWOLF GC, 1979, ANAT RECORD, V193, P131, DOI 10.1002/ar.1091930108; Shimokita E, 2011, DEV GROWTH DIFFER, V53, P401, DOI 10.1111/j.1440-169X.2011.01260.x; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Shum ASW, 1999, MECH DEVELOP, V84, P17, DOI 10.1016/S0925-4773(99)00059-3; SOMES RG, 1981, J HERED, V72, P121, DOI 10.1093/oxfordjournals.jhered.a109439; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Tenin G, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-24; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wood JL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-16; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamazaki Y, 2011, BIOTECH HISTOCHEM, V86, P351, DOI 10.3109/10520295.2010.506158; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhao XL, 2009, GENE EXPR PATTERNS, V9, P430, DOI 10.1016/j.gep.2009.06.003; Zwilling E, 1942, GENETICS, V27, P641	88	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112364	10.1371/journal.pone.0112364	http://dx.doi.org/10.1371/journal.pone.0112364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372603	Green Submitted, gold, Green Published			2022-12-27	WOS:000344556900138
J	Muscella, A; Vetrugno, C; Calabriso, N; Cossa, LG; De Pascali, SA; Fanizzi, FP; Marsigliante, S				Muscella, Antonella; Vetrugno, Carla; Calabriso, Nadia; Cossa, Luca Giulio; De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo; Marsigliante, Santo			[Pt(O,O '-acac)(gamma-acac)(DMS)] Alters SH-SY5Y Cell Migration and Invasion by the Inhibition of Na+/H+ Exchanger Isoform 1 Occurring through a PKC-epsilon/ERK/mTOR Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; S6 KINASE; PLATINUM(II) COMPLEXES; INDEPENDENT PATHWAY; INTRACELLULAR PH; CARCINOMA CELLS; TUMOR INVASION; ACTIVATION; NHE1; GROWTH	We previously showed that [Pt(O,O'-acac)(gamma-acac)(DMS)] ([Pt(acac)(2)(DMS)]) exerted substantial cytotoxic effects in SH-SY5Y neuroblastoma cells, and decreased metalloproteases (MMPs) production and cells migration in MCF-7 breast cancer cells. The ubiquitously distributed sodium-hydrogen antiporter 1 (NHE1) is involved in motility and invasion of many solid tumours. The present study focuses on the effects of [Pt(acac)(2)(DMS)] in SH-SY5Y cell migration and also on the possibility that NHE1 may be involved in such effect. After sublethal [Pt(acac)(2)(DMS)] treatment cell migration was examined by wounding assay and cell invasion by transwell assay. NHE1 activity was measured in BCECF-loaded SH-SY5Y as the rate of Na+-dependent intracellular pH recovery in response to an acute acid pulse. Gelatin zymography for MMP-2/9 activities, Western blottings of MMPs, MAPKs, mTOR, S6 and PKCs and small interfering RNAs to PKC-epsilon/-delta mRNA were performed. Sublethal concentrations of [Pt(acac)(2)(DMS)] decreases NHE1 activity, inhibites cell migration and invasion and decreases expression and activity of MMP-2 and -9. [Pt(acac)(2)(DMS)] administered to SH-SY5Y cells provokes the increment of ROS, generated by NADPH oxidase, responsible for the PKC-epsilon and PKC-delta activation. Whilst PKC-delta activates p38/MAPK, responsible for the inhibition of MMP-2 and -9 secretion, PKC-epsilon activates a pathway made of ERK1/2, mTOR and S6K responsible for the inhibition of NHE1 activity and cell migration. In conclusion, we have shown a drastic impairment in tumour cell metastatization in response to inhibition of NHE1 and MMPs activities by [Pt(acac)(2)(DMS)] occurring through a novel mechanism mediated by PKC-delta/-epsilon activation	[Muscella, Antonella] Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Cell Pathol Lab, Lecce, Italy; [Vetrugno, Carla] Ist Neurol Sperimentale, Neuropathol Unit, Milan, Italy; [Vetrugno, Carla] Ist Sci IRCCS San Raffaele, Div Neurosci, Sez Lecce, Milan, Italy; [Calabriso, Nadia; Cossa, Luca Giulio; Marsigliante, Santo] Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Cell Physiol Lab, Lecce, Italy; [De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo] Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Gen & Inorgan Chem Lab, Lecce, Italy	University of Salento; University of Salento; University of Salento	Marsigliante, S (corresponding author), Salento Univ, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Cell Physiol Lab, Lecce, Italy.	santo.marsigliante@unisalento.it	Fanizzi, Francesco Paolo/K-5766-2012; Muscella, Antonella/AAE-8075-2019	Fanizzi, Francesco Paolo/0000-0003-3073-5772; Muscella, Antonella/0000-0002-2822-9929; Calabriso, Nadia/0000-0003-0726-2081; MARSIGLIANTE, Santo/0000-0001-6535-3286	Italian Ministry of Research and University (PRIN: Sintesi, caratterizzazione e studio del pathway d'induzione apoptotica di composti antitumorali di Pt per target non gnomic)	Italian Ministry of Research and University (PRIN: Sintesi, caratterizzazione e studio del pathway d'induzione apoptotica di composti antitumorali di Pt per target non gnomic)	The work presented was supported by the Italian Ministry of Research and University (PRIN 2009: 'Sintesi, caratterizzazione e studio del pathway d'induzione apoptotica di composti antitumorali di Pt per target non gnomic.') The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Bianchini L, 1997, J BIOL CHEM, V272, P271; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Cheng Ya, 2005, Zhonghua Zhongliu Zazhi, V27, P164; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; De Pascali SA, 2005, EUR J INORG CHEM, P788, DOI 10.1002/ejic.200400665; De Pascali SA, 2014, INORG CHIM ACTA, V412, P88, DOI 10.1016/j.ica.2013.12.018; De Pascali SA, 2009, DALTON T, P7786, DOI 10.1039/b909209a; De Pascali Sandra Angelica, 2011, Metal-Based Drugs, P763436, DOI 10.1155/2011/763436; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Friday E, 2007, CELL PHYSIOL BIOCHEM, V20, P751, DOI 10.1159/000110435; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Good DW, 2008, J BIOL CHEM, V283, P26602, DOI 10.1074/jbc.M803019200; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Kassis J, 2001, SEMIN CANCER BIOL, V11, P105, DOI 10.1006/scbi.2000.0362; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lagana A, 2000, J CELL SCI, V113, P3649; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Liu TB, 2013, ENDOCRINOLOGY, V154, P865, DOI 10.1210/en.2012-1813; Marala RB, 2002, EUR J PHARMACOL, V451, P37, DOI 10.1016/S0014-2999(02)02193-3; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; McHardy LM, 2004, CANCER RES, V64, P1468, DOI 10.1158/0008-5472.CAN-03-2733; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; Moor AN, 1999, J BIOL CHEM, V274, P22985, DOI 10.1074/jbc.274.33.22985; Morozevich GE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P791, DOI 10.1134/S0006297908070079; Muscella A, 2008, J CELL PHYSIOL, V217, P103, DOI 10.1002/jcp.21478; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.554; Muscella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.315; Muscella A, 2007, BIOCHEM PHARMACOL, V74, P28, DOI 10.1016/j.bcp.2007.03.027; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P1271, DOI 10.1016/j.bcp.2011.03.007; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P91, DOI 10.1016/j.bcp.2010.09.012; Muscella A, 2010, BRIT J PHARMACOL, V160, P1362, DOI 10.1111/j.1476-5381.2010.00782.x; Oliver R, 2005, AM J PHYSIOL-RENAL, V288, pF1257, DOI 10.1152/ajprenal.00205.2004; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Petkovic F, 2013, J NEUROIMMUNOL, V259, P55, DOI 10.1016/j.jneuroim.2013.03.010; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Putney LK, 2004, BMC GENOMICS, V16, P5; Reid AC, 2004, AM J PHYSIOL-HEART C, V286, pH1448, DOI 10.1152/ajpheart.01062.2003; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Ribatti D, 2004, ANN NY ACAD SCI, V1028, P133, DOI 10.1196/annals.1322.014; Ritter M, 1998, CONTRIB NEPHROL, V123, P135; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; SIMCHOWITZ L, 1986, J BIOL CHEM, V261, P6492; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Stock C, 2005, MIGRATION HUMAN MELA; Sugiura Y, 1998, CANCER RES, V58, P2209; Vetrugno C, 2014, BRIT J PHARMACOL, V171, P5139, DOI 10.1111/bph.12831; Watts BA, 2002, AM J PHYSIOL-RENAL, V282, pF1056, DOI 10.1152/ajprenal.00133.2001; Watts BA, 2006, AM J PHYSIOL-RENAL, V291, pF1005, DOI 10.1152/ajprenal.00507.2005; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Yamada T, 2011, NEUROCHEM INT, V58, P354, DOI 10.1016/j.neuint.2010.12.011; Yamagata M, 1996, BRIT J CANCER, V73, P1328, DOI 10.1038/bjc.1996.254; Yang XK, 2010, CANCER LETT, V295, P198, DOI 10.1016/j.canlet.2010.03.001	66	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112186	10.1371/journal.pone.0112186	http://dx.doi.org/10.1371/journal.pone.0112186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372487	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900119
J	Stenslokken, KO; Ellefsen, S; Vasieva, O; Fang, YX; Farrell, AP; Olohan, L; Vaage, J; Nilsson, GE; Cossins, AR				Stenslokken, Kare-Olav; Ellefsen, Stian; Vasieva, Olga; Fang, Yongxiang; Farrell, Anthony P.; Olohan, Lisa; Vaage, Jarle; Nilsson, Goeran E.; Cossins, Andrew R.			Life without Oxygen: Gene Regulatory Responses of the Crucian Carp (Carassius carassius) Heart Subjected to Chronic Anoxia	PLOS ONE			English	Article							HETEROLOGOUS HYBRIDIZATION; CARDIAC PROTECTION; REPERFUSION INJURY; PYRUVATE-KINASE; COMMON CARP; KAPPA-B; BRAIN; EXPRESSION; MECHANISMS; GLYCOLYSIS	Crucian carp are unusual among vertebrates in surviving extended periods in the complete absence of molecular oxygen. During this time cardiac output is maintained though these mechanisms are not well understood. Using a high-density cDNA microarray, we have defined the genome-wide gene expression responses of cardiac tissue after exposing the fish at two temperatures (8 and 13 degrees C) to one and seven days of anoxia, followed by seven days after restoration to normoxia. At 8 degrees C, using a false discovery rate of 5%, neither anoxia nor re-oxygenation elicited appreciable changes in gene expression. By contrast, at 13 degrees C, 777 unique genes responded strongly. Up-regulated genes included those involved in protein turnover, the pentose phosphate pathway and cell morphogenesis while down-regulated gene categories included RNA splicing and transcription. Most genes were affected between one and seven days of anoxia, indicating gene regulation over the medium term but with few early response genes. Re-oxygenation for 7 days was sufficient to completely reverse these responses. Glycolysis displayed more complex responses with anoxia up-regulated transcripts for the key regulatory enzymes, hexokinase and phosphofructokinase, but with down-regulation of most of the non-regulatory genes. This complex pattern of responses in genomic transcription patterns indicates divergent cardiac responses to anoxia, with the transcriptionally driven reprogramming of cardiac function seen at 13 degrees C being largely completed at 8 degrees C.	[Stenslokken, Kare-Olav; Nilsson, Goeran E.] Univ Oslo, Dept Biosci, Sect Physiol & Cell Biol, Oslo, Norway; [Stenslokken, Kare-Olav] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Ellefsen, Stian] Lillehammer Univ Coll, Dept Social Sci, Sect Sports Sci, Lillehammer, Norway; [Vasieva, Olga; Fang, Yongxiang; Olohan, Lisa; Cossins, Andrew R.] Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England; [Fang, Yongxiang; Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Vaage, Jarle] Univ Oslo, Hosp Ulleval, Inst Clin Med, Dept Emergency Med & Intens Care, Oslo, Norway	University of Oslo; University of Oslo; Inland Norway University of Applied Sciences; University of Liverpool; University of British Columbia; University of Oslo	Stenslokken, KO (corresponding author), Univ Oslo, Dept Biosci, Sect Physiol & Cell Biol, Oslo, Norway.	k.o.stenslokken@medisin.uio.no	Nilsson, Goran E/K-7668-2012; Vaage, Jarle/H-9079-2016; Nilsson, Göran Erik/Q-6129-2019	Nilsson, Goran E/0000-0002-3195-3053; Vaage, Jarle/0000-0002-8747-5193; Cossins, Andrew/0000-0002-0813-5212; Olohan, Lisa/0000-0001-7837-0157; Stenslokken, Kare-Olav/0000-0003-2962-4143	Natural Environment Research Council (UK); Research Council of Norway; UNIFOR; Natural Environment Research Council [NE/F001320/1] Funding Source: researchfish; NERC [NE/F001320/1] Funding Source: UKRI	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Research Council of Norway(Research Council of Norway); UNIFOR; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the following: Natural Environment Research Council (UK) (ARC); The Research Council of Norway (GEN); and UNIFOR (KOS). APF holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Buckley BA, 2007, J EXP BIOL, V210, P1602, DOI 10.1242/jeb.002402; Chen SZ, 2013, PROTEIN CELL, V4, P251, DOI 10.1007/s13238-013-2128-8; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Depre C, 1998, EUR J BIOCHEM, V258, P277, DOI 10.1046/j.1432-1327.1998.2580277.x; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Ellefsen S, 2008, ANAL BIOCHEM, V376, P83, DOI 10.1016/j.ab.2008.01.028; Ellefsen S, 2009, PHYSIOL GENOMICS, V36, P61, DOI 10.1152/physiolgenomics.90301.2008; Ellefsen S, 2008, PHYSIOL GENOMICS, V35, P5, DOI 10.1152/physiolgenomics.90221.2008; Ertracht O, 2013, PHARM THER; Evans H, 2008, PHYSIOL GENOMICS, V35, P18, DOI 10.1152/physiolgenomics.90266.2008; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Farrell AP, 2007, COMP BIOCHEM PHYS A, V147, P300, DOI 10.1016/j.cbpa.2007.01.021; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; Hipkiss AR, 2006, ANN NY ACAD SCI, V1067, P361, DOI 10.1196/annals.1354.051; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Inagi R, 2010, ADV EXP MED BIOL, V662, P49, DOI 10.1007/978-1-4419-1241-1_6; Johansson D, 1997, NEUROSCI LETT, V237, P73, DOI 10.1016/S0304-3940(97)00814-8; JOHANSSON D, 1995, J EXP BIOL, V198, P853; Kolar F, 2004, PHYSIOL RES, V53, pS3; Krivoruchko A, 2010, GENE, V450, P63, DOI 10.1016/j.gene.2009.10.005; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Lutz PL, 2004, RESP PHYSIOL NEUROBI, V141, P285, DOI 10.1016/j.resp.2004.03.013; Lutz PL, 1997, J EXP BIOL, V200, P411; Lutz PL, 2003, BRAIN OXYGEN CAUSES, Vviii; Mallet RT, 2003, MOL CELL BIOCHEM, V253, P103, DOI 10.1023/A:1026009519783; Marques IJ, 2008, J COMP PHYSIOL B, V178, P77, DOI 10.1007/s00360-007-0201-4; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; NILSSON GE, 1990, J EXP BIOL, V150, P295; Peltier S, 2005, MOL CELL BIOCHEM, V277, P55, DOI 10.1007/s11010-005-4882-2; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; SHOUBRIDGE EA, 1980, SCIENCE, V209, P308, DOI 10.1126/science.7384807; SKORKOWSKI EF, 1988, COMP BIOCHEM PHYS B, V90, P19, DOI 10.1016/0305-0491(88)90031-4; Smith RW, 2009, PROTEOMICS, V9, P2217, DOI 10.1002/pmic.200800662; Southworth R, 2009, J BIOENERG BIOMEMBR, V41, P187, DOI 10.1007/s10863-009-9207-9; Stecyk JAW, 2004, SCIENCE, V306, P77, DOI 10.1126/science.1100763; Stenslokken KO, 2010, AM J PHYSIOL-REG I, V298, pR1499, DOI 10.1152/ajpregu.00675.2009; Stenslokken KO, 2008, AM J PHYSIOL-REG I, V295, pR1803, DOI 10.1152/ajpregu.90590.2008; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; VANDERBOON J, 1992, COMP BIOCHEM PHYS B, V101, P583, DOI 10.1016/0305-0491(92)90342-O; VANWAVERSVELD J, 1989, J EXP BIOL, V142, P325; VORNANEN M, 1994, CAN J ZOOL, V72, P433, DOI 10.1139/z94-061; VORNANEN M, 1994, AM J PHYSIOL-REG I, V267, pR1567, DOI 10.1152/ajpregu.1994.267.6.R1567; Vornanen M, 2006, AM J PHYSL REGULATOR, V291, pR1482; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang XL, 2010, AM J PHYSIOL-ENDOC M, V299, pE207, DOI 10.1152/ajpendo.00215.2010; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wit E, 2005, J R STAT SOC C-APPL, V54, P817, DOI 10.1111/j.1467-9876.2005.00519.x; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yuan JA, 2010, J EXP ZOOL PART B, V314B, P445, DOI 10.1002/jez.b.21350	63	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109978	10.1371/journal.pone.0109978	http://dx.doi.org/10.1371/journal.pone.0109978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372666	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900013
J	Yang, P; Han, JF; Huang, JL				Yang, Peng; Han, Jinfeng; Huang, Jinling			Transcriptome Sequencing and De Novo Analysis of Cytoplasmic Male Sterility and Maintenance in JA-CMS Cotton	PLOS ONE			English	Article							PROGRAMMED-CELL-DEATH; DIFFERENTIALLY EXPRESSED GENES; COMPLETE NUCLEOTIDE-SEQUENCE; RNA-SEQ DATA; MITOCHONDRIAL GENOME; OXIDATIVE STRESS; ATP SYNTHASE; ARABIDOPSIS; FERTILE; ACID	Cytoplasmic male sterility (CMS) is the failure to produce functional pollen, which is inherited maternally. And it is known that anther development is modulated through complicated interactions between nuclear and mitochondrial genes in sporophytic and gametophytic tissues. However, an unbiased transcriptome sequencing analysis of CMS in cotton is currently lacking in the literature. This study compared differentially expressed (DE) genes of floral buds at the sporogenous cells stage (SS) and microsporocyte stage (MS) (the two most important stages for pollen abortion in JA-CMS) between JA-CMS and its fertile maintainer line JB cotton plants, using the Illumina HiSeq 2000 sequencing platform. A total of 709 (1.8%) DE genes including 293 up-regulated and 416 down-regulated genes were identified in JA-CMS line comparing with its maintainer line at the SS stage, and 644 (1.6%) DE genes with 263 up-regulated and 381 down-regulated genes were detected at the MS stage. By comparing the two stages in the same material, there were 8 up-regulated and 9 down-regulated DE genes in JA-CMS line and 29 up-regulated and 9 down-regulated DE genes in JB maintainer line at the MS stage. Quantitative RT-PCR was used to validate 7 randomly selected DE genes. Bioinformatics analysis revealed that genes involved in reduction-oxidation reactions and alpha-linolenic acid metabolism were down-regulated, while genes pertaining to photosynthesis and flavonoid biosynthesis were up-regulated in JA-CMS floral buds compared with their JB counterparts at the SS and/or MS stages. All these four biological processes play important roles in reactive oxygen species (ROS) homeostasis, which may be an important factor contributing to the sterile trait of JA-CMS. Further experiments are warranted to elucidate molecular mechanisms of these genes that lead to CMS.	[Yang, Peng; Han, Jinfeng] Henan Agr Univ, Dept Agron, Zhengzhou, Henan, Peoples R China; [Yang, Peng] Shanxi Agr Univ, Dept Rural Dev, Taigu, Shanxi, Peoples R China; [Huang, Jinling] Shanxi Agr Univ, Dept Agron, Taigu, Shanxi, Peoples R China	Henan Agricultural University; Shanxi Agricultural University; Shanxi Agricultural University	Huang, JL (corresponding author), Shanxi Agr Univ, Dept Agron, Taigu, Shanxi, Peoples R China.	huangjl@sxau.edu.cn	Huang, Jinling/ABI-6699-2020		Shanxi Scientific and Technological Project [20130311004-3]; Shanxi Agricultural University Ph.D. fund	Shanxi Scientific and Technological Project; Shanxi Agricultural University Ph.D. fund	This project was supported by Shanxi Scientific and Technological Project Grant 20130311004-3 to JH and Shanxi Agricultural University Ph.D. fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; de la Canal L, 2001, THEOR APPL GENET, V102, P1185, DOI 10.1007/s001220100558; de Leon IP, 2002, PLANT J, V29, P61, DOI 10.1046/j.1365-313x.2002.01195.x; Diamond M, 2011, ADVAN PL BIO, V1, P439; Dong X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072178; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Doyle SM, 2010, J EXP BOT, V61, P473, DOI 10.1093/jxb/erp320; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Heazlewood JL, 2003, FEBS LETT, V540, P201, DOI 10.1016/S0014-5793(03)00264-3; Hou L, 2001, DETECTION ISOLATION; Huang J, 2003, GENETIC STUDY JINA C; Jia ZC, 1990, CHINA COTTONS, V17, P11; Jiang PD, 2007, PLANT CELL REP, V26, P1627, DOI 10.1007/s00299-007-0351-6; Kempken F, 1998, FEBS LETT, V441, P159, DOI 10.1016/S0014-5793(98)01538-5; Kim DH, 2007, PLANT MOL BIOL, V63, P519, DOI 10.1007/s11103-006-9106-y; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kurek I, 1997, THEOR APPL GENET, V95, P1305, DOI 10.1007/s001220050697; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JJ, 2013, PLANTA, V237, P1097, DOI 10.1007/s00425-012-1824-6; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Liu G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382549; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma W, 2012, COTTON SCI, V34, P10; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Papini A, 1999, PROTOPLASMA, V207, P213, DOI 10.1007/BF01283002; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Stewart JM, 1992, PROD BELTW IDE COTTO; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Sun DZ., 2001, COTTON SCI, V13, P259; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Suzuki H, 2013, THEOR APPL GENET, V126, P1521, DOI 10.1007/s00122-013-2070-4; Szklarczyk M, 2000, THEOR APPL GENET, V100, P263, DOI 10.1007/s001220050035; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wan CX, 2007, PLANT CELL REP, V26, P373, DOI 10.1007/s00299-006-0234-2; Wang F, 2010, EUPHYTICA, V172, P93, DOI 10.1007/s10681-009-0055-9; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-97; Wei Z, 1987, COTTON BREEDING BASI, P103; Wu JY, 2011, EUPHYTICA, V181, P17, DOI 10.1007/s10681-011-0357-6; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yamamoto MP, 2005, MOL GENET GENOMICS, V273, P342, DOI 10.1007/s00438-005-1140-y; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Yang S, 2008, ANN BOT-LONDON, V102, P483, DOI 10.1093/aob/mcn116; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; YUAN J, 1996, CHINA COTTON, V23, P6; Zhang H, 2007, PLANT CELL REP, V26, P1065, DOI 10.1007/s00299-006-0293-4; [赵海燕 Zhao Haiyan], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P4130; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758	63	21	26	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112320	10.1371/journal.pone.0112320	http://dx.doi.org/10.1371/journal.pone.0112320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372034	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900133
J	Dhanasekaran, S; Biswas, M; Vignesh, AR; Ramya, R; Raj, GD; Tirumurugaan, KG; Raja, A; Kataria, RS; Parida, S; Subbiah, E				Dhanasekaran, Sakthivel; Biswas, Moanaro; Vignesh, Ambothi R.; Ramya, R.; Raj, Gopal Dhinakar; Tirumurugaan, Krishnaswamy G.; Raja, Angamuthu; Kataria, Ranjit S.; Parida, Satya; Subbiah, Elankumaran			Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo	PLOS ONE			English	Article							LYMPHOCYTE-ACTIVATION MOLECULE; BLOOD MONONUCLEAR-CELLS; IMMUNE-RESPONSES; BOVINE; SHEEP; OUTBREAK; TLR7; REPLICATION; INFECTION; CATTLE	Ovine rinderpest or goat plague is an economically important and contagious viral disease of sheep and goats, caused by the Peste des petits ruminants virus (PPRV). Differences in susceptibility to goat plague among different breeds and water buffalo exist. The host innate immune system discriminates between pathogen associated molecular patterns and self antigens through surveillance receptors known as Toll like receptors (TLR). We investigated the role of TLR and cytokines in differential susceptibility of goat breeds and water buffalo to PPRV. We examined the replication of PPRV in peripheral blood mononuclear cells (PBMC) of Indian domestic goats and water buffalo and demonstrated that the levels of TLR3 and TLR7 and downstream signalling molecules correlation with susceptibility vs resistance. Naturally susceptible goat breeds, Barbari and Tellichery, had dampened innate immune responses to PPRV and increased viral loads with lower basal expression levels of TLR 3/7. Upon stimulation of PBMC with synthetic TLR3 and TLR7 agonists or PPRV, the levels of proinflammatory cytokines were found to be significantly higher while immunosuppressive interleukin (IL) 10 levels were lower in PPRV resistant Kanni and Salem Black breeds and water buffalo at transcriptional level, correlating with reduced viralloads in infected PBMC. Water buffalo produced higher levels of interferon (IFN) alpha in comparison with goats at transcriptional and translational levels. Pre-treatment of Vero cells with human IFN alpha resulted in reduction of PPRV replication, confirming the role of IFN alpha in limiting PPRV replication. Treatment with IRS66, a TLR7 antagonist, resulted in the reduction of IFN alpha levels, with increased PPRV replication confirming the role of TLR7. Single nucleotide polymorphism analysis of TLR7 of these goat breeds did not show any marked nucleotide differences that might account for susceptibility vs resistance to PPRV. Analyzing other host genetic factors might provide further insights on susceptibility to PPRV and genetic polymorphisms in the host.	[Dhanasekaran, Sakthivel; Vignesh, Ambothi R.; Ramya, R.; Raj, Gopal Dhinakar; Tirumurugaan, Krishnaswamy G.; Raja, Angamuthu] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Anim Biotechnol, Madras, Tamil Nadu, India; [Biswas, Moanaro; Subbiah, Elankumaran] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Ctr Mol Med & Infect Dis, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Kataria, Ranjit S.] Natl Bur Anim Genet Resources, Div Anim Genet, Karnal, Haryana, India; [Parida, Satya] Pirbright Inst, FMD Vaccine Differentiat Grp, Surrey, England	Tamil Nadu Veterinary & Animal Sciences University; Virginia Polytechnic Institute & State University; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Parida, S (corresponding author), Pirbright Inst, FMD Vaccine Differentiat Grp, Surrey, England.	satya.parida@pirbright.ac.uk; kumarans@vt.edu	Rathinasamy, Vignesh/K-1267-2019; Parida, Satya/E-5463-2015; Kataria, RS/P-2105-2017; Hegde, Nagendra/J-5920-2014	Rathinasamy, Vignesh/0000-0002-4032-3424; Parida, Satya/0000-0001-8253-9461; Kataria, RS/0000-0003-2845-7486; Hegde, Nagendra/0000-0001-5260-2159; Sakthivel, Dhanasekaran/0000-0003-2894-2545; Biswas, Moanaro/0000-0002-2889-5905; Angamuthu, Raja/0000-0002-5477-2730; Gopal, Dhinakar Raj/0000-0003-0254-926X	TLR.NAIP; BBSRC [BB/L004801/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L004801/1] Funding Source: researchfish	TLR.NAIP; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support was provided by TLR.NAIP (http://www.naiptlr.com/NAIP-TLR.pdf). The sponsors have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSON E C, 1975, Journal of Wildlife Diseases, V11, P248; Banerjee P, 2012, DHR IJBLS, V3, P137; Bannerman DD, 2008, J DAIRY SCI, V91, P2225, DOI 10.3168/jds.2008-1013; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Booth JS, 2010, DEV COMP IMMUNOL, V34, P572, DOI 10.1016/j.dci.2009.12.018; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buza J, 2008, VET IMMUNOL IMMUNOP, V126, P273, DOI 10.1016/j.vetimm.2008.08.001; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; Diop M, 2005, EPIDEMIOL INFECT, V133, P711, DOI 10.1017/S0950268805003729; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Gopinath VP, 2011, J VIROL METHODS, V171, P98, DOI 10.1016/j.jviromet.2010.10.007; Govindarajan R, 1997, VET REC, V141, P573, DOI 10.1136/vr.141.22.573; Goyal S, 2012, ANIM BIOTECHNOL, V23, P194, DOI 10.1080/10495398.2012.684417; Harrison SM, 2007, AVIAN PATHOL, V36, P109, DOI 10.1080/03079450601156083; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jagtap SP, 2012, MICROB PATHOGENESIS, V52, P217, DOI 10.1016/j.micpath.2012.01.003; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kedmi M, 2011, VET MICROBIOL, V148, P408, DOI 10.1016/j.vetmic.2010.09.015; Khan HA, 2008, TROP ANIM HEALTH PRO, V40, P521, DOI 10.1007/s11250-008-9129-2; Kuchipudi SV, 2012, IMMUNOL CELL BIOL, V90, P116, DOI 10.1038/icb.2011.17; Lefevre P C, 1990, Rev Sci Tech, V9, P935; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; Mikula I, 2010, VET IMMUNOL IMMUNOP, V138, P51, DOI 10.1016/j.vetimm.2010.06.015; MORNET P., 1956, Revue de l'Elevage. Productions animales - Productions fourrageres, V9, P313; Nanda YP, 1996, VET MICROBIOL, V51, P207, DOI 10.1016/0378-1135(96)00025-9; Narayanan R, 2008, VET WORLD, V1, P81; PANIGRAHI P, 1988, ARCH VIROL, V98, P107, DOI 10.1007/BF01321011; Pawar RM, 2008, ACTA VIROL, V52, P231; Pawar RM, 2008, VIRUS RES, V136, P118, DOI 10.1016/j.virusres.2008.04.026; Raj GD, 2000, J VIROL METHODS, V89, P89, DOI 10.1016/S0166-0934(00)00206-8; ROEDER PL, 1994, TROP ANIM HEALTH PRO, V26, P69, DOI 10.1007/BF02239901; Roy P, 2010, INT J APPL RES VET M, V8, P155; Saeed IK, 2010, TROP ANIM HEALTH PRO, V42, P89, DOI 10.1007/s11250-009-9389-5; Saravanan P, 2010, BIOLOGICALS, V38, P479, DOI 10.1016/j.biologicals.2010.02.003; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Sentsui H, 1998, J VET MED SCI, V60, P1329, DOI 10.1292/jvms.60.1329; SHAILA MS, 1989, VET REC, V125, P602; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; TAYLOR WP, 1979, RES VET SCI, V26, P94; Taylor WP, 2002, PREV VET MED, V52, P305, DOI 10.1016/S0167-5877(01)00254-9; Tirumurugaan KG, 2010, VET IMMUNOL IMMUNOP, V133, P296, DOI 10.1016/j.vetimm.2009.08.015; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Vignesh AR, 2012, VET IMMUNOL IMMUNOP, V147, P51, DOI 10.1016/j.vetimm.2012.02.009; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yesilbag K, 2005, VET REC, V157, P260, DOI 10.1136/vr.157.9.260	55	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111609	10.1371/journal.pone.0111609	http://dx.doi.org/10.1371/journal.pone.0111609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369126	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000077
J	Matsushita, H; Yahata, T; Sheng, Y; Nakamura, Y; Muguruma, Y; Matsuzawa, H; Tanaka, M; Hayashi, H; Sato, T; Damdinsuren, A; Onizuka, M; Ito, M; Miyachi, H; Pandolfi, PP; Ando, K				Matsushita, Hiromichi; Yahata, Takashi; Sheng, Yin; Nakamura, Yoshihiko; Muguruma, Yukari; Matsuzawa, Hideyuki; Tanaka, Masayuki; Hayashi, Hideki; Sato, Tadayuki; Damdinsuren, Anar; Onizuka, Makoto; Ito, Mamoru; Miyachi, Hayato; Pandolfi, Pier Paolo; Ando, Kiyoshi			Establishment of a Humanized APL Model via the Transplantation of PML-RARA-Transduced Human Common Myeloid Progenitors into Immunodeficient Mice	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ALPHA FUSION PROTEIN; HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL CAPACITY; EX-VIVO EXPANSION; PML/RAR-ALPHA; TRANSGENIC MICE; MOUSE MODEL; NULL MICE; EXPRESSION	Recent advances in cancer biology have revealed that many malignancies possess a hierarchal system, and leukemic stem cells (LSC) or leukemia-initiating cells (LIC) appear to be obligatory for disease progression. Acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia characterized by the formation of a PML-RAR alpha fusion protein, leads to the accumulation of abnormal promyelocytes. In order to understand the precise mechanisms involved in human APL leukemogenesis, we established a humanized in vivo APL model involving retroviral transduction of PML-RARA into CD34(+) hematopoietic cells from human cord blood and transplantation of these cells into immunodeficient mice. The leukemia well recapitulated human APL, consisting of leukemic cells with abundant azurophilic abnormal granules in the cytoplasm, which expressed CD13, CD33 and CD117, but not HLA-DR and CD34, were clustered in the same category as human APL samples in the gene expression analysis, and demonstrated sensitivity to ATRA. As seen in human APL, the induced APL cells showed a low transplantation efficiency in the secondary recipients, which was also exhibited in the transplantations that were carried out using the sorted CD34(-) fraction. In order to analyze the mechanisms underlying APL initiation and development, fractionated human cord blood was transduced with PML-RARA. Common myeloid progenitors (CMP) from CD34(+)/CD38(+) cells developed APL. These findings demonstrate that CMP are a target fraction for PML-RARA in APL, whereas the resultant CD34(-) APL cells may share the ability to maintain the tumor.	[Matsushita, Hiromichi; Yahata, Takashi; Sheng, Yin; Nakamura, Yoshihiko; Muguruma, Yukari; Matsuzawa, Hideyuki; Ando, Kiyoshi] Tokai Univ, Sch Med, Res Ctr Canc Stem Cell, Isehara, Kanagawa 25911, Japan; [Matsushita, Hiromichi; Yahata, Takashi; Ando, Kiyoshi] Tokai Univ, Med Res Inst, Isehara, Kanagawa 25911, Japan; [Matsushita, Hiromichi; Damdinsuren, Anar; Miyachi, Hayato] Tokai Univ, Sch Med, Dept Lab Med, Isehara, Kanagawa 25911, Japan; [Yahata, Takashi] Tokai Univ, Sch Med, Dept Cell Transplantat, Isehara, Kanagawa 25911, Japan; [Matsuzawa, Hideyuki; Tanaka, Masayuki; Hayashi, Hideki; Sato, Tadayuki] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa 25911, Japan; [Onizuka, Makoto; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Ito, Mamoru] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Res Inst,Dept Med, Boston, MA 02215 USA; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Res Inst,Dept Pathol, Boston, MA 02215 USA	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Matsushita, H (corresponding author), Tokai Univ, Sch Med, Res Ctr Canc Stem Cell, Isehara, Kanagawa 25911, Japan.	hmatsu@is.ic.cc.u-tokai.ac.jp; andok@keyaki.cc.u-tokai.ac.jp	松下, 弘道/AEX-6164-2022	松下, 弘道/0000-0002-1629-6630; ONIZUKA, MAKOTO/0000-0003-3864-0823; Tanaka, Masayuki/0000-0002-8682-8719; Pandolfi, Pier Paolo/0000-0002-5352-5295	Ministry of Education, Culture, Sports, Science and Technology of Japan [24591411, 24390248]; Tokai University School of Medicine; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26430094, 24591411] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokai University School of Medicine; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Hiromichi Matsushita received funding from a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan (#24591411, URL http://www.jsps.go.jp/english/e-grants/), Tokai University School of Medicine Project Research (http://www.med.u-tokai.ac.jp/web/international/about_us/message_from_the_dean.html), and the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html). Kiyoshi Ando received support from a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan (#24390248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2006, BLOOD, V107, P3371, DOI 10.1182/blood-2005-08-3108; Becker MW, 2011, BLOOD REV, V25, P75, DOI 10.1016/j.blre.2010.11.001; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ferrucci PF, 1997, P NATL ACAD SCI USA, V94, P10901, DOI 10.1073/pnas.94.20.10901; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; Grimwade D, 2004, LEUKEMIA, V18, P375, DOI 10.1038/sj.leu.2403234; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kawada H, 1999, EXP HEMATOL, V27, P904, DOI 10.1016/S0301-472X(99)00012-0; Kerbauy DMB, 2004, BLOOD, V104, P2202, DOI 10.1182/blood-2004-04-1518; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lowenberg Bob, 2008, Hematology Am Soc Hematol Educ Program, P1, DOI 10.1182/asheducation-2008.1.1; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Matsushita H, 2006, J EXP MED, V203, P821, DOI 10.1084/jem.20050616; Muguruma Y, 2011, HAEMATOL-HEMATOL J, V96, P543, DOI 10.3324/haematol.2010.027557; Paietta E, 2003, BEST PRACT RES CL HA, V16, P369, DOI 10.1016/S1521-6926(03)00042-2; Paietta E, 2004, CYTOM PART B-CLIN CY, V59B, P1, DOI 10.1002/cyto.b.20001; Patel S, 2012, LEUKEMIA, V26, P2432, DOI 10.1038/leu.2012.154; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Puccetti E, 2004, LEUKEMIA, V18, P1169, DOI 10.1038/sj.leu.2403367; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Wartman LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046529; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Welch JS, 2011, J CLIN INVEST, V121, P1636, DOI 10.1172/JCI42953; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wojiski S, 2009, LEUKEMIA, V23, P1462, DOI 10.1038/leu.2009.63; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111082	10.1371/journal.pone.0111082	http://dx.doi.org/10.1371/journal.pone.0111082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369030	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000035
J	Petukh, M; Wu, BH; Stefl, S; Smith, N; Hyde-Volpe, D; Wang, L; Alexov, E				Petukh, Marharyta; Wu, Bohua; Stefl, Shannon; Smith, Nick; Hyde-Volpe, David; Wang, Li; Alexov, Emil			Chronic Beryllium Disease: Revealing the Role of Beryllium Ion and Small Peptides Binding to HLA-DP2	PLOS ONE			English	Article							CD4(+) T-CELLS; HLA-DP; CONFORMATIONAL FLEXIBILITY; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; PROTEIN; SUSCEPTIBILITY; IDENTIFICATION; SENSITIZATION; RECOGNITION	Chronic Beryllium (Be) Disease (CBD) is a granulomatous disorder that predominantly affects the lung. The CBD is caused by Be exposure of individuals carrying the HLA-DP2 protein of the major histocompatibility complex class II (MHCII). While the involvement of Be in the development of CBD is obvious and the binding site and the sequence of Be and peptide binding were recently experimentally revealed [1], the interplay between induced conformational changes and the changes of the peptide binding affinity in presence of Be were not investigated. Here we carry out in silico modeling and predict the Be binding to be within the acidic pocket (Glu26, Glu68 and Glu69) present on the HLA-DP2 protein in accordance with the experimental work [1]. In addition, the modeling indicates that the Be ion binds to the HLA-DP2 before the corresponding peptide is able to bind to it. Further analysis of the MD generated trajectories reveals that in the presence of the Be ion in the binding pocket of HLA-DP2, all the different types of peptides induce very similar conformational changes, but their binding affinities are quite different. Since these conformational changes are distinctly different from the changes caused by peptides normally found in the cell in the absence of Be, it can be speculated that CBD can be caused by any peptide in presence of Be ion. However, the affinities of peptides for Be loaded HLA-DP2 were found to depend of their amino acid composition and the peptides carrying acidic group at positions 4 and 7 are among the strongest binders. Thus, it is proposed that CBD is caused by the exposure of Be of an individual carrying the HLA-DP2*0201 allele and that the binding of Be to HLA-DP2 protein alters the conformational and ionization properties of HLA-DP2 such that the binding of a peptide triggers a wrong signaling cascade.	[Petukh, Marharyta; Stefl, Shannon; Smith, Nick; Wang, Li; Alexov, Emil] Clemson Univ, Computat Biophys & Bioinformat Phys Dept, Clemson, SC 29634 USA; [Wu, Bohua] Clemson Univ, Sch Nursing, Clemson, SC USA; [Hyde-Volpe, David] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University; Clemson University	Petukh, M (corresponding author), Clemson Univ, Computat Biophys & Bioinformat Phys Dept, Clemson, SC 29634 USA.	mpetukh@g.clemson.edu			NIH, NIGMS [R01GM093937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER	NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work of MP, SS, NS, LW and EA was supported by a grant from NIH, NIGMS grant number R01GM093937. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Amicosante M, 2001, HUM IMMUNOL, V62, P686, DOI 10.1016/S0198-8859(01)00261-0; Bill JR, 2005, J IMMUNOL, V175, P7029, DOI 10.4049/jimmunol.175.10.7029; Bowerman N, 2013, J IMMUNOLOGY, V190; Bowerman NA, 2014, J IMMUNOL; Bowerman N, 2011, J IMMUNOL, V186; Bowerman NA, 2011, J IMMUNOL, V187, P3694, DOI 10.4049/jimmunol.1101872; Chain JL, 2013, J IMMUNOL, V191, P1648, DOI 10.4049/jimmunol.1300282; Clayton GM, 2014, CELL, V158, P132, DOI 10.1016/j.cell.2014.04.048; Dai SD, 2013, CURR OPIN IMMUNOL, V25, P775, DOI 10.1016/j.coi.2013.07.012; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Diaz G, 2005, IMMUNOGENETICS, V56, P754, DOI 10.1007/s00251-004-0735-5; Doytchinova I, 2011, PROTEIN SCI, V20, P1918, DOI 10.1002/pro.732; Falta MT, 2013, J EXP MED, V210, P1403, DOI 10.1084/jem.20122426; Fontenot AP, 2006, J IMMUNOL, V177, P3874, DOI 10.4049/jimmunol.177.6.3874; Fontenot AP, 1999, J IMMUNOL, V163, P1019; Fontenot AP, 2000, P NATL ACAD SCI USA, V97, P12717, DOI 10.1073/pnas.220430797; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Li C, 2013, J COMPUTATIONAL CHEM; Li M, 2014, J CHEM THEORY COMPUT; Maier LA, 2012, RESP MED, V106, P1810, DOI 10.1016/j.rmed.2012.08.014; Martin AK, 2011, J ALLERGY CLIN IMMUN, V128, P1100, DOI 10.1016/j.jaci.2011.08.022; Mayer AS, 2013, J OCCUP ENVIRON MED, V55, P746, DOI 10.1097/JOM.0b013e3182972f1b; Morris D, 2014, GENES IMMUNITY; Nishi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066273; Onufriev AV, 2013, Q REV BIOPHYS, V46, P181, DOI 10.1017/S0033583513000024; Patronov A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-32; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petukh M, 2013, CURR PHARM DESIGN, V19, P4182, DOI 10.2174/1381612811319230004; Petukh M, 2013, BIOINFORMATICS, V29, P805, DOI 10.1093/bioinformatics/btt032; Petukh M, 2012, BIOPHYS J, V102, P2885, DOI 10.1016/j.bpj.2012.05.013; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pimentel-Santos FM, 2013, TISSUE ANTIGENS, V82, P374, DOI 10.1111/tan.12238; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Salvator H, 2013, EUR RESPIR J, V41, P234, DOI 10.1183/09031936.00095712; Scott BL, 2003, J INORG BIOCHEM, V94, P5, DOI 10.1016/S0162-0134(02)00628-1; Seidler A, 2012, OCCUP MED-OXFORD, V62, P506, DOI 10.1093/occmed/kqs069; Silveira LJ, 2012, J IMMUNOL, V189, P4014, DOI 10.4049/jimmunol.1200798; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Thomas CA, 2013, AM J IND MED, V56, P733, DOI 10.1002/ajim.22175; Van Dyke MV, 2011, OCCUP ENVIRON MED, V68, P842, DOI 10.1136/oem.2010.064220; Van Dyke MV, 2011, AM J RESP CRIT CARE, V183, P1680, DOI 10.1164/rccm.201002-0254OC; Wang Y, 2013, IMMUNOL RES, V55, P83, DOI 10.1007/s12026-012-8351-1; Welch LS, 2013, AM J IND MED, V56, P1125, DOI 10.1002/ajim.22202; Yucesoy B, 2014, J OCCUP ENVIRON MED, V56, P382, DOI 10.1097/JOM.0000000000000138; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zhang Z, 2012, BIOINFORMATICS, V28, P664, DOI 10.1093/bioinformatics/bts005; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111604	10.1371/journal.pone.0111604	http://dx.doi.org/10.1371/journal.pone.0111604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369028	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000075
J	Ye, LM; Hildebrand, F; Dingemans, J; Ballet, S; Laus, G; Matthijs, S; Berendsen, R; Cornelis, P				Ye, Lumeng; Hildebrand, Falk; Dingemans, Jozef; Ballet, Steven; Laus, George; Matthijs, Sandra; Berendsen, Roeland; Cornelis, Pierre			Draft Genome Sequence Analysis of a Pseudomonas putida W15Oct28 Strain with Antagonistic Activity to Gram-Positive and Pseudomonas sp Pathogens	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; PUTISOLVIN-II; GENE-CLUSTER; MOLECULAR CHARACTERIZATION; PYOVERDINE BIOSYNTHESIS; BIOFILM FORMATION; EFFLUX PUMPS; FLUORESCENS; IDENTIFICATION; AERUGINOSA	Pseudomonas putida is a member of the fluorescent pseudomonads known to produce the yellow-green fluorescent pyoverdine siderophore. P. putida W15Oct28, isolated from a stream in Brussels, was found to produce compound(s) with antimicrobial activity against the opportunistic pathogens Staphylococcus aureus, Pseudomonas aeruginosa, and the plant pathogen Pseudomonas syringae, an unusual characteristic for P. putida. The active compound production only occurred in media with low iron content and without organic nitrogen sources. Transposon mutants which lost their antimicrobial activity had the majority of insertions in genes involved in the biosynthesis of pyoverdine, although purified pyoverdine was not responsible for the antagonism. Separation of compounds present in culture supernatants revealed the presence of two fractions containing highly hydrophobic molecules active against P. aeruginosa. Analysis of the draft genome confirmed the presence of putisolvin biosynthesis genes and the corresponding lipopeptides were found to contribute to the antimicrobial activity. One cluster of ten genes was detected, comprising a NAD-dependent epimerase, an acetylornithine aminotransferase, an acyl CoA dehydrogenase, a short chain dehydrogenase, a fatty acid desaturase and three genes for a RND efflux pump. P. putida W15Oct28 genome also contains 56 genes encoding TonB-dependent receptors, conferring a high capacity to utilize pyoverdines from other pseudomonads. One unique feature of W15Oct28 is also the presence of different secretion systems including a full set of genes for type IV secretion, and several genes for type VI secretion and their VgrG effectors.	[Ye, Lumeng; Hildebrand, Falk; Dingemans, Jozef; Cornelis, Pierre] Vrije Univ Brussel, Dept Bioengn Sci, Microbiol Res Grp, Brussels, Belgium; [Ye, Lumeng; Hildebrand, Falk; Dingemans, Jozef; Cornelis, Pierre] VIB Struct Biol Brussels, Brussels, Belgium; [Ballet, Steven; Laus, George] Vrije Univ Brussel, Dept Chem, B-1050 Brussels, Belgium; [Matthijs, Sandra] Inst Rech Microbiol Wiame, Brussels, Belgium; [Berendsen, Roeland] Univ Utrecht, Utrecht, Netherlands	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Utrecht University	Cornelis, P (corresponding author), Vrije Univ Brussel, Dept Bioengn Sci, Microbiol Res Grp, Brussels, Belgium.	pcornel@vub.ac.be	Cornelis, Pierre/H-3058-2019; Berendsen, Roeland L/I-1594-2016; Hildebrand, Falk/K-1914-2014	Berendsen, Roeland L/0000-0003-2707-8919; Ye, Lumeng/0000-0001-8337-7118; Dingemans, Jozef/0000-0001-8079-3087; Hildebrand, Falk/0000-0002-0078-8948	European Research Council (ERC) [269072]	European Research Council (ERC)(European Research Council (ERC))	This work was supported by the European Research Council (ERC) [ERC Advanced Grant agreement number 269072 - PLANTIMMUSYS]. LY received a CSC-VUB fellowship for her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chen WQ, 2010, PROTEIN CELL, V1, P1093, DOI 10.1007/s13238-010-0127-6; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Dubern JF, 2008, MICROBIOL-SGM, V154, P2070, DOI 10.1099/mic.0.2008/016444-0; Dubern JF, 2006, FEMS MICROBIOL LETT, V263, P169, DOI 10.1111/j.1574-6968.2006.00406.x; Dubern JF, 2006, J BACTERIOL, V188, P2898, DOI 10.1128/JB.188.8.2898-2906.2006; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Espinosa-Urgel M, 2004, APPL ENVIRON MICROB, V70, P5190, DOI 10.1128/AEM.70.9.5190-5198.2004; Espinosa-Urgel Manuel, 2002, Microbiology (Reading), V148, P341, DOI 10.1099/00221287-148-2-341; Gao JW, 2012, J BACTERIOL, V194, P4121, DOI 10.1128/JB.00688-12; Garg RP, 2002, MOL MICROBIOL, V46, P505, DOI 10.1046/j.1365-2958.2002.03169.x; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Guillon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079111; Guillon L, 2012, ENVIRON MICROBIOL, V14, P1982, DOI 10.1111/j.1462-2920.2012.02741.x; Hartney SL, 2013, J BACTERIOL, V195, P765, DOI 10.1128/JB.01639-12; Iqbal A, 2011, ORG BIOMOL CHEM, V9, P6219, DOI 10.1039/c1ob05554b; Jin W, 2003, ORG LETT, V5, P2095, DOI 10.1021/ol034575n; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Kyrpides NC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001920; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062946; Loper JE, 2008, APPL ENVIRON MICROB, V74, P3085, DOI 10.1128/AEM.02848-07; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Matilla MA, 2010, ENV MICROBIOL REP, V2, P381, DOI 10.1111/j.1758-2229.2009.00091.x; Matthijs S, 2009, BIOMETALS, V22, P951, DOI 10.1007/s10534-009-9247-y; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Molina L, 2013, GENOME A, VA1; Mossialos D, 2002, MOL MICROBIOL, V45, P1673, DOI 10.1046/j.1365-2958.2002.03120.x; Mulet M, 2013, RES MICROBIOL, V164, P351, DOI 10.1016/j.resmic.2013.01.009; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Ohji S, 2014, GENOME A, V2; Palleroni NJ, 2010, ENVIRON MICROBIOL, V12, P1377, DOI 10.1111/j.1462-2920.2009.02041.x; Parret AHA, 2002, TRENDS MICROBIOL, V10, P107, DOI 10.1016/S0966-842X(02)02307-7; Penfold CN, 2012, BIOCHEM SOC T, V40, P1433, DOI 10.1042/BST20120253; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; Ravel J, 2003, TRENDS MICROBIOL, V11, P195, DOI 10.1016/S0966-842X(03)00076-3; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roca A, 2013, ENVIRON MICROBIOL, V15, P780, DOI 10.1111/1462-2920.12037; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Rokni-Zadeh H, 2013, ENV MICROBIOL REP, V5, P160, DOI 10.1111/1758-2229.12015; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Velasco A, 2005, MOL MICROBIOL, V56, P144, DOI 10.1111/j.1365-2958.2004.04433.x; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Ye LM, 2014, BIOMETALS, V27, P633, DOI 10.1007/s10534-014-9734-7; Ye LM, 2013, BIOMETALS, V26, P561, DOI 10.1007/s10534-013-9653-z; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002	60	17	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110038	10.1371/journal.pone.0110038	http://dx.doi.org/10.1371/journal.pone.0110038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369289	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000015
J	Chitrala, KN; Yeguvapalli, S				Chitrala, Kumaraswamy Naidu; Yeguvapalli, Suneetha			Computational Prediction and Analysis of Breast Cancer Targets for 6-Methyl-1, 3, 8-Trichlorodibenzofuran	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ESTROGEN; ALPHA; CELLS	Breast cancer is one of the most known cancer types caused to the women around the world. Dioxins on the other hand are a wide range of chemical compounds known to cause the effects on human health. Among them, 6-Methyl-1,3,8-trichlorodibenzofuran ( MCDF) is a relatively non toxic prototypical alkyl polychlorinated dibenzofuran known to act as a highly effective agent for inhibiting hormone-responsive breast cancer growth in animal models. In this study, we have developed a multi-level computational approach to identify possible new breast cancer targets for MCDF. We used PharmMapper Server to predict breast cancer target proteins for MCDF. Search results showed crystal Structure of the Antagonist Form of Glucocorticoid Receptor with highest fit score and AutoLigand analysis showed two potential binding sites, site-A and site-B for MCDF. A molecular docking was performed on these two sites and based on binding energy site-B was selected. MD simulation studies on Glucocorticoid receptor-MCDF complex revealed that MCDF conformation was stable at site-B and the intermolecular interactions were maintained during the course of simulation. In conclusion, our approach couples reverse pharmacophore analysis, molecular docking and molecular dynamics simulations to identify possible new breast cancer targets for MCDF.	[Chitrala, Kumaraswamy Naidu; Yeguvapalli, Suneetha] Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India	Sri Venkateswara University	Yeguvapalli, S (corresponding author), Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India.	ysuneethareddy4@gmail.com	Chitrala, Kumara Swamy Naidu/U-1617-2019; Yeguvapalli, Suneetha/ADT-5493-2022	Chitrala, Kumaraswamy naidu/0000-0003-0663-9529; YEGUVAPALLI, SUNEETHA/0000-0002-3035-7196				BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Castro-Rivera E, 1999, MOL CELL ENDOCRINOL, V150, P11, DOI 10.1016/S0303-7207(99)00041-6; Chen CC, 2011, J BIOL CHEM, V286, P43091, DOI 10.1074/jbc.M111.295865; Conde I, 2008, HISTOL HISTOPATHOL, V23, P77, DOI 10.14670/HH-23.77; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Crowe DL, 2004, BREAST CANCER RES, V6, pR546, DOI 10.1186/bcr913; Dallakyan S., 2008, PYRX PYTHON PRESCRIP; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; Mora-Santos M, 2011, J BIOL CHEM, V286, P30047, DOI 10.1074/jbc.M111.232330; Olivero-Verbel J, 2010, CHEMOSPHERE, V80, P1160, DOI 10.1016/j.chemosphere.2010.06.020; Pearce ST, 2004, CANCER RES, V64, P2889, DOI 10.1158/0008-5472.CAN-03-1770; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tsutsumi T, 2001, CHEMOSPHERE, V45, P1129, DOI 10.1016/S0045-6535(01)00151-5; Valensin S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-196; Walker MK, 2000, COMP BIOCHEM PHYS C, V126, P305, DOI 10.1016/S0742-8413(00)00119-5; Zhang S, 2009, ENDOCR-RELAT CANCER, V16, P835, DOI 10.1677/ERC-09-0054	24	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109185	10.1371/journal.pone.0109185	http://dx.doi.org/10.1371/journal.pone.0109185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365309	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100008
J	Tokue, H; Hirasawa, S; Morita, H; Koyma, Y; Miyazaki, M; Shibuya, K; Tokue, A; Nakano, S; Tsushima, Y				Tokue, Hiroyuki; Hirasawa, Satoshi; Morita, Hideo; Koyma, Yoshinori; Miyazaki, Masaya; Shibuya, Kei; Tokue, Azusa; Nakano, Sachiko; Tsushima, Yoshito			Percutaneous Image-Guided Biopsy for Non-Mass-Forming Isolated Splenomegaly and Suspected Malignant Lymphoma	PLOS ONE			English	Article							TISSUE CORE BIOPSY; FINE-NEEDLE BIOPSY; SPLENIC BIOPSY; SPLEEN	Background: The aim of this study was to evaluate the accuracy, safety, and role of splenic biopsy in the management of patients with non-mass-forming isolated splenomegaly and suspected malignant lymphoma. Methods: Between 2001 and 2013, 137 biopsies were performed under computed tomography (CT) fluoroscopic guidance in 39 patients. All patients had splenomegaly based on the CT findings and a suspected diagnosis of malignant lymphoma based on their clinical symptoms. The spleen was the only accessible site to perform a biopsy, and no mass lesions could be identified in the spleen. Results: The overall sensitivity, specificity, and diagnostic accuracy of image-guided biopsy for malignant lymphoma were 88%, 100% and 92%, respectively. Major complications occurred in 3 patients. In 1 patient, transcatheter arterial embolization was performed due to hemorrhage, and two patients needed blood transfusion because of hematoma development, without the need for further treatment. Conclusions: Image-guided splenic core-needle biopsy is a safe and accurate technique with a high diagnostic accuracy in most patients who with non-mass-forming isolated splenomegaly and suspected underlying malignant lymphoma.	[Tokue, Hiroyuki; Hirasawa, Satoshi; Koyma, Yoshinori; Miyazaki, Masaya; Shibuya, Kei; Tokue, Azusa; Nakano, Sachiko; Tsushima, Yoshito] Gunma Univ Hosp, Dept Diagnost & Intervent Radiol, Gunma, Japan; [Tokue, Hiroyuki; Morita, Hideo] Maebashi Red Cross Hosp, Dept Radiol, Gunma, Japan	Gunma University; Maebashi Red Cross Hospital	Tokue, H (corresponding author), Gunma Univ Hosp, Dept Diagnost & Intervent Radiol, Gunma, Japan.	tokue@s2.dion.ne.jp						CAVANNA L, 1992, CANCER, V69, P2932, DOI 10.1002/1097-0142(19920615)69:12<2932::AID-CNCR2820691211>3.0.CO;2-7; Cavill I, 1996, BRIT MED J, V312, P430; Civardi G, 2001, AM J HEMATOL, V67, P93, DOI 10.1002/ajh.1085; DISTASI M, 1996, J INTERVENT RADIOL, V11, P43; Gomez-Rubio M, 2009, J CLIN ULTRASOUND, V37, P445, DOI 10.1002/jcu.20608; Kang M, 2007, EUR J RADIOL, V64, P140, DOI 10.1016/j.ejrad.2007.02.011; Keogan MT, 1977, AJR, V172, P933; Liang P, 2007, J CLIN ULTRASOUND, V35, P477, DOI 10.1002/jcu.20390; Lieberman S, 2003, AM J ROENTGENOL, V181, P1025, DOI 10.2214/ajr.181.4.1811025; LINDGREN PG, 1985, BRIT J RADIOL, V58, P853, DOI 10.1259/0007-1285-58-693-853; Lopez JI, 2006, APMIS, V114, P492, DOI 10.1111/j.1600-0463.2006.apm_378.x; Lucey BC, 2006, AM J ROENTGENOL, V186, P562, DOI 10.2214/AJR.04.1051; McInnes MDF, 2011, RADIOLOGY, V260, P699, DOI 10.1148/radiol.11110333; Muraca S, 2001, RADIOLOGY, V218, P200, DOI 10.1148/radiology.218.1.r01ja16200; Pozo AL, 2009, BLOOD REV, V23, P105, DOI 10.1016/j.blre.2008.10.001; Singh AK, 2012, RADIOGRAPHICS, V32, P523, DOI 10.1148/rg.322115135; SUZUKI T, 1987, CANCER, V60, P879, DOI 10.1002/1097-0142(19870815)60:4<879::AID-CNCR2820600427>3.0.CO;2-4; Tam A, 2008, J VASC INTERV RADIOL, V19, P80, DOI 10.1016/j.jvir.2007.08.025; Venkataramu NK, 1999, BRIT J RADIOL, V72, P953, DOI 10.1259/bjr.72.862.10673946	19	5	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111657	10.1371/journal.pone.0111657	http://dx.doi.org/10.1371/journal.pone.0111657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365519	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100097
J	Xu, XB; Jiang, QH; Ma, XY; Ying, QC; Shen, B; Qian, YS; Song, HM; Wang, HZ				Xu, Xiangbin; Jiang, Qinghua; Ma, Xiuyan; Ying, Qicai; Shen, Bo; Qian, Yongsheng; Song, Hongmiao; Wang, Huizhong			Deep Sequencing Identifies Tissue-Specific MicroRNAs and Their Target Genes Involving in the Biosynthesis of Tanshinones in Salvia miltiorrhiza	PLOS ONE			English	Article							ACID B PROTECTS; ISOPRENOID BIOSYNTHESIS; SMALL RNAS; MEVALONATE PATHWAY; ACETOACETYL-COA; HAIRY ROOTS; ARABIDOPSIS; PLANTS; MIRNAS; BIOGENESIS	Salvia miltiorrhiza is one of the most popular traditional medicinal herbs in Asian nations. Its dried root contains a number of tanshinones, protocatechuic aldehyde, salvianolic acid B and rosmarinic, and is used for the treatment of various diseases. The finding of microRNAs (miRNAs) and their target genes will help understand their biological role on the biosynthesis of tanshinones in S. miltiorrhiza. In the present study, a total of 452 known miRNAs corresponding to 589 precursor miRNAs (pre-miRNAs), and 40 novel miRNAs corresponding to 24 pre-miRNAs were identified in different tissues of S. miltiorrhiza by high-throughput sequencing, respectively. Among them, 62 miRNAs express only in root, 95 miRNAs express only in stem, 19 miRNAs express only in leaf, and 71 miRNAs express only in flower, respectively. By the degradome analysis, 69 targets potentially cleaved by 25 miRNAs were identified. Among them, acetyl-CoA C-acetyltransferase was cleaved by miR5072, and involved in the biosynthesis of tanshinones. This study provided valuable information for understanding the tissue-specific expression patterns of miRNAs in S. miltiorrhiza, and offered a foundation for future studies of the miRNA-mediated biosynthesis of tanshinones.	[Xu, Xiangbin; Jiang, Qinghua; Ma, Xiuyan; Ying, Qicai; Shen, Bo; Qian, Yongsheng; Song, Hongmiao; Wang, Huizhong] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Song, HM (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	hmsongibcas@126.com; whz62@163.com	SHEN, BO/GOK-2179-2022	SHEN, BO/0000-0003-0490-2071	Key Laboratory of Zhejiang Province Medicinal Plants Germplasm Improvement and Quality Control Technology [ZK-14]	Key Laboratory of Zhejiang Province Medicinal Plants Germplasm Improvement and Quality Control Technology	This study was supported by the open foundation (ZK-14) of the Key Laboratory of Zhejiang Province Medicinal Plants Germplasm Improvement and Quality Control Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Cao EH, 1996, FREE RADICAL BIO MED, V20, P801, DOI 10.1016/0891-5849(95)02211-2; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CHAPPELL J, 1995, PLANT PHYSIOL, V107, P1, DOI 10.1145/224057.224059; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HISER L, 1994, J BIOL CHEM, V269, P31383; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kang DG, 2004, LIFE SCI, V75, P1801, DOI 10.1016/j.lfs.2004.02.034; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Ng DWK, 2011, PLANT CELL, V23, P1729, DOI 10.1105/tpc.111.083915; Pereto J, 2005, J MOL EVOL, V61, P65, DOI 10.1007/s00239-004-0280-8; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; THOMPSON SL, 1990, J BIOL CHEM, V265, P5731; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Wu SJ, 2009, BIOTECHNOL APPL BIOC, V52, P89, DOI 10.1042/BA20080004; Xu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070959; Yan XM, 2009, ACTA PHYSIOL PLANT, V31, P1015, DOI 10.1007/s11738-009-0320-5; Yang WZ, 2010, MOL BIOL REP, V37, P3081, DOI 10.1007/s11033-009-9881-z; Yuan Y, 2009, Z NATURFORSCH C, V64, P557; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhong GX, 2009, J AGR FOOD CHEM, V57, P6879, DOI 10.1021/jf901462s; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	44	21	30	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111679	10.1371/journal.pone.0111679	http://dx.doi.org/10.1371/journal.pone.0111679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365305	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100103
J	Guo, L; Shen, SM; Harris, E; Wang, Z; Jiang, W; Guo, Y; Feng, YM				Guo, Lu; Shen, Shuming; Harris, Eleanor; Wang, Zheng; Jiang, Wei; Guo, Yu; Feng, Yuanming			A Tri-Modality Image Fusion Method for Target Delineation of Brain Tumors in Radiotherapy	PLOS ONE			English	Article							CLINICAL-EXPERIENCE; VOLUME DELINEATION; OBSERVER VARIATION; PET; CT; THERAPY; SYSTEM	Purpose: To develop a tri-modality image fusion method for better target delineation in image-guided radiotherapy for patients with brain tumors. Methods: A new method of tri-modality image fusion was developed, which can fuse and display all image sets in one panel and one operation. And a feasibility study in gross tumor volume (GTV) delineation using data from three patients with brain tumors was conducted, which included images of simulation CT, MRI, and F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) examinations before radiotherapy. Tri-modality image fusion was implemented after image registrations of CT+PET and CT+MRI, and the transparency weight of each modality could be adjusted and set by users. Three radiation oncologists delineated GTVs for all patients using dual-modality (MRI/CT) and tri-modality (MRI/CT/PET) image fusion respectively. Inter-observer variation was assessed by the coefficient of variation (COV), the average distance between surface and centroid (ADSC), and the local standard deviation (SDlocal). Analysis of COV was also performed to evaluate intra-observer volume variation. Results: The inter-observer variation analysis showed that, the mean COV was 0.14(+/- 0.09) and 0.07(+/- 0.01) for dual-modality and tri-modality respectively; the standard deviation of ADSC was significantly reduced (p<0.05) with tri-modality; SDlocal averaged over median GTV surface was reduced in patient 2 (from 0.57 cm to 0.39 cm) and patient 3 (from 0.42 cm to 0.36 cm) with the new method. The intra-observer volume variation was also significantly reduced (p = 0.00) with the tri-modality method as compared with using the dual-modality method. Conclusion: With the new tri-modality image fusion method smaller inter-and intra-observer variation in GTV definition for the brain tumors can be achieved, which improves the consistency and accuracy for target delineation in individualized radiotherapy.	[Guo, Lu; Shen, Shuming; Guo, Yu; Feng, Yuanming] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Harris, Eleanor; Feng, Yuanming] E Carolina Univ, Dept Radiat Oncol, Greenville, NC USA; [Wang, Zheng; Jiang, Wei] Tianjin Huanhu Hosp, Dept Radiat Oncol, Tianjin, Peoples R China	Tianjin University; University of North Carolina; East Carolina University	Feng, YM (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China.	fengyu@ecu.edu		Harris, Eleanor/0000-0002-7529-7473				Caldwell CB, 2001, INT J RADIAT ONCOL, V51, P923, DOI 10.1016/S0360-3016(01)01722-9; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Deurloo KEI, 2005, INT J RADIAT ONCOL, V61, P228, DOI 10.1016/j.ijrobp.2004.09.023; Dirix P, 2009, J NUCL MED, V50, P1020, DOI 10.2967/jnumed.109.062638; Goldman S, 2011, MED NUCL, V35, P347, DOI 10.1016/j.mednuc.2011.02.003; Graf R, 2013, INT J RADIAT ONCOL, V85, P68, DOI 10.1016/j.ijrobp.2012.03.021; Grosu AL, 2005, INT J RADIAT ONCOL, V63, P64, DOI 10.1016/j.ijrobp.2005.01.045; Grosu AL, 2003, INT J RADIAT ONCOL, V56, P1450, DOI 10.1016/S0360-3016(03)00279-7; Grosu AL, 2010, RADIOTHER ONCOL, V96, P325, DOI 10.1016/j.radonc.2010.08.001; Grosu AL, 2006, INT J RADIAT ONCOL, V66, P339, DOI 10.1016/j.ijrobp.2006.02.047; Levivier M, 2004, J NUCL MED, V45, P1146; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Newell ME, 1972, P ACM ANN C, V1, P443; Rogers DF, 1998, PROCEDURAL ELEMENTS, P498; Steenbakkers RJHM, 2006, INT J RADIAT ONCOL, V64, P435, DOI 10.1016/j.ijrobp.2005.06.034; Veit-Haibach P, 2013, MAGN RESON MATER PHY, V26, P25, DOI 10.1007/s10334-012-0344-5; Verellen D, 2008, RADIOTHER ONCOL, V86, P4, DOI 10.1016/j.radonc.2007.11.023	17	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112187	10.1371/journal.pone.0112187	http://dx.doi.org/10.1371/journal.pone.0112187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375123	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600115
J	Hess, KL; Fisher, DG; Reynolds, GL				Hess, Kristen L.; Fisher, Dennis G.; Reynolds, Grace L.			Sensitivity and Specificity of Point-of-Care Rapid Combination Syphilis-HIV-HCV Tests	PLOS ONE			English	Article							LOS-ANGELES-COUNTY; TREPONEMAL ANTIBODIES; INFECTION	Background: New rapid point-of-care (POC) tests are being developed that would offer the opportunity to increase screening and treatment of several infections, including syphilis. This study evaluated three of these new rapid POC tests at a site in Southern California. Methods: Participants were recruited from a testing center in Long Beach, California. A whole blood specimen was used to evaluate the performance of the Dual Path Platform (DPP) Syphilis Screen & Confirm, DPP HIV-Syphilis, and DPP HIV-HCV-Syphilis rapid tests. The gold-standard comparisons were Treponema pallidum passive particle agglutination (TPPA), rapid plasma reagin (RPR), HCV enzyme immunoassay (EIA), and HIV-1/2 EIA. Results: A total of 948 whole blood specimens were analyzed in this study. The sensitivity of the HIV tests ranged from 95.7-100% and the specificity was 99.7-100%. The sensitivity and specificity of the HCV test were 91.8% and 99.3%, respectively. The treponemal-test sensitivity when compared to TPPA ranged from 44.0-52.7% and specificity was 98.7-99.6%. The nontreponemal test sensitivity and specificity when compared to RPR was 47.8% and 98.9%, respectively. The sensitivity of the Screen & Confirm test improved to 90.0% when cases who were both treponemal and nontreponemal positive were compared to TPPA+/RPR >= 1:8. Conclusions: The HIV and HCV on the multi-infection tests showed good performance, but the treponemal and nontreponemal tests had low sensitivity. These results could be due to a low prevalence of active syphilis in the sample population because the sensitivity improved when the gold standard was limited to those more likely to be active cases. Further evaluation of the new syphilis POC tests is required before implementation into testing programs.	[Hess, Kristen L.; Fisher, Dennis G.; Reynolds, Grace L.] Calif State Univ Long Beach, Ctr Behav Res & Serv, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Hess, KL (corresponding author), Calif State Univ Long Beach, Ctr Behav Res & Serv, Long Beach, CA 90840 USA.	kristenhess@gmail.com; dennis.fisher@csulb.edu	Fisher, Dennis/N-1049-2019; Reynolds, Grace/AAR-7815-2021	Fisher, Dennis/0000-0002-3813-2207; Reynolds, Grace/0000-0003-3324-0337	National Institute on Drug Abuse [R01DA030234]; National Institute of Minority Health and Health Disparities [P20MD003942]; California HIV Research Program [ID10-CSULB-008]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030234] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD003942] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); California HIV Research Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support was provided by grant R01DA030234 from the National Institute on Drug Abuse awarded to DGF; grant P20MD003942 from the National Institute of Minority Health and Health Disparities funded part of DGF and GLR time; grant ID10-CSULB-008 from the California HIV Research Program awarded to GLR ChemBio staff provided training on the use of their test materials but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PREVALENCE INCIDENCE; Binnicker MJ, 2012, CURR OPIN INFECT DIS, V25, P79, DOI 10.1097/QCO.0b013e32834e9a3c; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; Cagle H., 2002, DHHS PUB, V(SMA) 02; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Castro RR, 2001, AM J CLIN PATHOL, V116, P581; Causer LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091504; Esfandiari J, 2012, HIV DIAGN C ATL GA; Fenton KA, 2008, LANCET INFECT DIS, V8, P244, DOI 10.1016/S1473-3099(08)70065-3; Herring AJ, 2006, SEX TRANSM INFECT, V82, pV7, DOI 10.1136/sti.2006.022707; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Lopez-Zetina J, 2000, SEX TRANSM INFECT, V76, P462, DOI 10.1136/sti.76.6.462; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Marsh KA, 2010, EVAL HEALTH PROF, V33, P177, DOI 10.1177/0163278710361929; Mattei PL, 2012, AM FAM PHYSICIAN, V86, P433; Mishra S, 2010, SEX TRANSM INFECT, V86, P193, DOI 10.1136/sti.2009.038778; Reynolds GL, 2008, PUBLIC HEALTH REP, V123, P63, DOI 10.1177/00333549081230S308; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; Yin YP, 2013, CLIN INFECT DIS, V56, P659, DOI 10.1093/cid/cis928	20	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112190	10.1371/journal.pone.0112190	http://dx.doi.org/10.1371/journal.pone.0112190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375138	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600116
J	Junger, J; Habel, U; Brohr, S; Neulen, J; Neuschaefer-Rube, C; Birkholz, P; Kohler, C; Schneider, F; Derntl, B; Pauly, K				Junger, Jessica; Habel, Ute; Broehr, Sabine; Neulen, Josef; Neuschaefer-Rube, Christiane; Birkholz, Peter; Kohler, Christian; Schneider, Frank; Derntl, Birgit; Pauly, Katharina			More than Just Two Sexes: The Neural Correlates of Voice Gender Perception in Gender Dysphoria	PLOS ONE			English	Article							TO-FEMALE TRANSSEXUALS; EVENT-RELATED FMRI; RESTING-STATE FMRI; IDENTITY DISORDER; HUMAN BRAIN; PSYCHIATRIC COMORBIDITY; CEREBRAL LATERALIZATION; SEXUAL-DIFFERENTIATION; PREFRONTAL CORTEX; HORMONE-TREATMENT	Gender dysphoria (also known as "transsexualism'') is characterized as a discrepancy between anatomical sex and gender identity. Research points towards neurobiological influences. Due to the sexually dimorphic characteristics of the human voice, voice gender perception provides a biologically relevant function, e. g. in the context of mating selection. There is evidence for a better recognition of voices of the opposite sex and a differentiation of the sexes in its underlying functional cerebral correlates, namely the prefrontal and middle temporal areas. This fMRI study investigated the neural correlates of voice gender perception in 32 male-to-female gender dysphoric individuals (MtFs) compared to 20 non-gender dysphoric men and 19 non-gender dysphoric women. Participants indicated the sex of 240 voice stimuli modified in semitone steps in the direction to the other gender. Compared to men and women, MtFs showed differences in a neural network including the medial prefrontal gyrus, the insula, and the precuneus when responding to male vs. female voices. With increased voice morphing men recruited more prefrontal areas compared to women and MtFs, while MtFs revealed a pattern more similar to women. On a behavioral and neuronal level, our results support the feeling of MtFs reporting they cannot identify with their assigned sex.	[Junger, Jessica; Habel, Ute; Broehr, Sabine; Schneider, Frank; Derntl, Birgit; Pauly, Katharina] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Junger, Jessica; Habel, Ute; Schneider, Frank; Derntl, Birgit; Pauly, Katharina] Julich Aachen Res Alliance Translat Brain Med, Julich, Germany; [Neulen, Josef] Rhein Westfal TH Aachen, Sch Med, Dept Gynaecol Endocrinol & Reprod Med, Aachen, Germany; [Neuschaefer-Rube, Christiane; Birkholz, Peter] Rhein Westfal TH Aachen, Sch Med, Dept Phoniatr Pedaudiol & Commun Disorders, Aachen, Germany; [Kohler, Christian] Univ Penn, Sch Med, Dept Psychiat, Div Neuropsychiat, Philadelphia, PA 19104 USA	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Pennsylvania	Junger, J (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	jjunger@ukaachen.de		Neuschaefer-Rube, Christiane/0000-0002-2207-0670; Habel, Ute/0000-0003-0703-7722; Schneider, Frank/0000-0003-1557-7956; Derntl, Birgit/0000-0003-0133-4486	German Research Foundation [DFG: HA 3202/7-1, IRTG 1328]; Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research of the Faculty of Medicine at RWTH Aachen University, Germany	German Research Foundation(German Research Foundation (DFG)); Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research of the Faculty of Medicine at RWTH Aachen University, Germany	This study was supported by the German Research Foundation (DFG: HA 3202/7-1 and IRTG 1328) and the Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research of the Faculty of Medicine at RWTH Aachen University, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorfer JB, 2012, CORTEX, V48, P1218, DOI 10.1016/j.cortex.2011.05.014; American Psychiatric Association (APA), 2013, GEND DYSPH; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bentz EK, 2008, FERTIL STERIL, V90, P56, DOI 10.1016/j.fertnstert.2007.05.056; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Bestelmeyer PEG, 2012, CEREB CORTEX, V22, P1263, DOI 10.1093/cercor/bhr204; Boersma P., 2010, PRAAT DOING PHONETIC; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Bullough Vern L., 1994, HUMAN SEXUALITY ENCY; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carrillo B, 2010, PSYCHONEUROENDOCRINO, V35, P1213, DOI 10.1016/j.psyneuen.2010.02.010; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; COHEN H, 1995, CORTEX, V31, P565, DOI 10.1016/S0010-9452(13)80067-6; Cohen-Kettenis PT, 1998, PSYCHONEUROENDOCRINO, V23, P631; Cohen-Kettenis PT, 2009, ARCH SEX BEHAV; Corsello SM, 2011, MINERVA ENDOCRINOL, V36, P325; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; D'Ausilio A, 2011, BRAIN LANG, V118, P9, DOI 10.1016/j.bandl.2011.02.007; Duncan LA, 2007, EVOL HUM BEHAV, V28, P359, DOI 10.1016/j.evolhumbehav.2007.05.001; Ellison P., 2001, FERTILE GROUND NATUR; Engelien A, 2000, ANN NY ACAD SCI, V911, P477; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Garcia-Falgueras A, 2010, ENDOCR DEV, V17, P22, DOI 10.1159/000262525; Garcia-Falgueras A, 2008, BRAIN, V131, P3132, DOI 10.1093/brain/awn276; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Gelfer MP, 2000, J VOICE, V14, P22, DOI 10.1016/S0892-1997(00)80092-2; Gires, 2008, GEND VAR DYSPH; Gizewski ER, 2009, J SEX MED, V6, P440, DOI 10.1111/j.1743-6109.2008.00981.x; Gomez-Gil E, 2010, ARCH SEX BEHAV, V39, P546, DOI 10.1007/s10508-009-9524-4; Gooren L, 2006, HORM BEHAV, V50, P589, DOI 10.1016/j.yhbeh.2006.06.011; Gur RC, 2007, HUM BRAIN MAPP, V28, P263, DOI 10.1002/hbm.20319; Haraldsen IR, 2005, PSYCHIAT RES, V137, P161, DOI 10.1016/j.psychres.2005.05.014; Hare L, 2009, BIOL PSYCHIAT, V65, P93, DOI 10.1016/j.biopsych.2008.08.033; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hepp U, 2005, J PSYCHOSOM RES, V58, P259, DOI 10.1016/j.jpsychores.2004.08.010; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Heylens G, 2012, J SEX MED, V9, P751, DOI 10.1111/j.1743-6109.2011.02567.x; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Hofmann SG, 2006, PERS INDIV DIFFER, V40, P1683, DOI 10.1016/j.paid.2005.12.014; Hoshiai M, 2010, PSYCHIAT CLIN NEUROS, V64, P514, DOI 10.1111/j.1440-1819.2010.02118.x; Hutchison ER, 2008, NEUROIMAGE, V40, P342, DOI 10.1016/j.neuroimage.2007.10.064; Hwang JH, 2006, ACTA OTO-LARYNGOL, V126, P916, DOI 10.1080/00016480500546375; Joassin F, 2011, NEUROIMAGE, V54, P1654, DOI 10.1016/j.neuroimage.2010.08.073; Joel D, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-27; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Junger J, 2013, NEUROIMAGE, V79, P275, DOI 10.1016/j.neuroimage.2013.04.105; Koelsch S, 2005, ANN NY ACAD SCI, V1060, P412, DOI 10.1196/annals.1360.034; Kruijver FPM, 2000, J CLIN ENDOCR METAB, V85, P2034, DOI 10.1210/jc.85.5.2034; Lattner S, 2003, NEUROSCI LETT, V339, P191, DOI 10.1016/S0304-3940(03)00027-2; Lawrence AA, 2005, ARCH SEX BEHAV, V34, P135, DOI 10.1007/s10508-005-1792-z; Lehrl S., 1999, MEHRFACHWAHL WORTSCH; Lombardo F, 2013, J ENDOCRINOL INVEST; Luders E, 2011, J BEHAV BRAIN SCI; Luders E, 2009, NEUROIMAGE, V46, P904, DOI 10.1016/j.neuroimage.2009.03.048; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Miles C, 1998, HORM BEHAV, V34, P199, DOI 10.1006/hbeh.1998.1478; Miles C, 2006, HORM BEHAV, V50, P708, DOI 10.1016/j.yhbeh.2006.06.008; NARINS PM, 1976, SCIENCE, V192, P378, DOI 10.1126/science.1257772; Nawata H, 2010, PSYCHIAT CLIN NEUROS, V64, P157, DOI 10.1111/j.1440-1819.2009.02059.x; Oates J, 1997, VENEREOLOGY, V10, P178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Poon S., 2011, P 17 INT C PHON SCI; Proverbio AM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00169; Rametti G, 2010, J PSYCHIAT RES; Rametti G, 2012, PSYCHONEUROENDOCRINO, V37, P1261, DOI 10.1016/j.psyneuen.2011.12.019; Rametti G, 2011, J PSYCHIATR RES, V45, P949, DOI 10.1016/j.jpsychires.2010.11.007; Remedios R, 2009, J NEUROSCI, V29, P1034, DOI 10.1523/JNEUROSCI.4089-08.2009; RYAN MJ, 1992, AM NAT, V139, P1370, DOI 10.1086/285391; Santarnecchi E, 2012, NEUROENDOCRINOLOGY, V96, P188, DOI 10.1159/000342001; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Schneider F, 2010, TRANSSEXUELLENGESETZ, P247; Schoning S, 2010, J SEX MED, V7, P1858, DOI 10.1111/j.1743-6109.2009.01484.x; Semrud-Clikeman M, 2012, INT J NEUROSCI, V122, P590, DOI 10.3109/00207454.2012.693999; Shechner Tomer, 2010, Isr J Psychiatry Relat Sci, V47, P132; Simon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083947; Slabbekoorn D, 1999, PSYCHONEUROENDOCRINO, V24, P423, DOI 10.1016/S0306-4530(98)00091-2; Sokhi DS, 2005, NEUROIMAGE, V27, P572, DOI 10.1016/j.neuroimage.2005.04.023; Sommer IEC, 2008, EUR NEUROPSYCHOPHARM, V18, P215, DOI 10.1016/j.euroneuro.2007.10.002; Spreckelmeyer KN, 2013, NEUROIMAGE, V66, P223, DOI 10.1016/j.neuroimage.2012.10.068; Swaab DF, 2007, BEST PRACT RES CL EN, V21, P431, DOI 10.1016/j.beem.2007.04.003; Swaab DF, 2009, FUNCT NEUROL, V24, P17; Tesink CMJY, 2009, J COGNITIVE NEUROSCI, V21, P2085, DOI 10.1162/jocn.2008.21161; Thomsen T, 2000, Med Sci Monit, V6, P1186; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Ujike H, 2009, PROG NEURO-PSYCHOPH, V33, P1241, DOI 10.1016/j.pnpbp.2009.07.008; van Goozen SHM, 2002, BEHAV NEUROSCI, V116, P982, DOI 10.1037//0735-7044.116.6.982; VANDOMMELEN WA, 1990, LANG SPEECH, V33, P259, DOI 10.1177/002383099003300302; VANGOOZEN SHM, 1995, PSYCHONEUROENDOCRINO, V20, P343, DOI 10.1016/0306-4530(94)00076-X; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; von Kriegstein K, 2010, J NEUROSCI, V30, P629, DOI 10.1523/JNEUROSCI.2742-09.2010; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wisniewski AB, 2005, ARCH SEX BEHAV, V34, P167, DOI 10.1007/s10508-005-1794-x; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105; Ye Z, 2011, Z NEUROPSYCHOL, V22, P263, DOI 10.1024/1016-264X/a000056; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Zubiaurre-Elorza L, 2014, J SEX MED	114	28	28	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111672	10.1371/journal.pone.0111672	http://dx.doi.org/10.1371/journal.pone.0111672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375171	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600056
J	Reisinger, RR; Oosthuizen, WC; Peron, G; Toussaint, DC; Andrews, RD; de Bruyn, PJN				Reisinger, Ryan R.; Oosthuizen, W. Chris; Peron, Guillaume; Toussaint, Dawn Cory; Andrews, Russel D.; de Bruyn, P. J. Nico			Satellite Tagging and Biopsy Sampling of Killer Whales at Subantarctic Marion Island: Effectiveness, Immediate Reactions and Long-Term Responses	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; SOUTHERN RIGHT WHALES; MEGAPTERA-NOVAEANGLIAE; BEHAVIORAL-RESPONSES; HUMPBACK WHALES; ORCINUS-ORCA; HUMAN DISTURBANCE; MOVEMENTS; CONSERVATION; PENGUINS	Remote tissue biopsy sampling and satellite tagging are becoming widely used in large marine vertebrate studies because they allow the collection of a diverse suite of otherwise difficult-to-obtain data which are critical in understanding the ecology of these species and to their conservation and management. Researchers must carefully consider their methods not only from an animal welfare perspective, but also to ensure the scientific rigour and validity of their results. We report methods for shore-based, remote biopsy sampling and satellite tagging of killer whales Orcinus orca at Subantarctic Marion Island. The performance of these methods is critically assessed using 1) the attachment duration of low-impact minimally percutaneous satellite tags; 2) the immediate behavioural reactions of animals to biopsy sampling and satellite tagging; 3) the effect of researcher experience on biopsy sampling and satellite tagging; and 4) the mid- (1 month) and long- (24 month) term behavioural consequences. To study mid- and long-term behavioural changes we used multievent capture-recapture models that accommodate imperfect detection and individual heterogeneity. We made 72 biopsy sampling attempts (resulting in 32 tissue samples) and 37 satellite tagging attempts (deploying 19 tags). Biopsy sampling success rates were low (43%), but tagging rates were high with improved tag designs (86%). The improved tags remained attached for 26 +/- 14 days (mean +/- SD). Individuals most often showed no reaction when attempts missed (66%) and a slight reaction-defined as a slight flinch, slight shake, short acceleration, or immediate dive-when hit (54%). Severe immediate reactions were never observed. Hit or miss and age-sex class were important predictors of the reaction, but the method (tag or biopsy) was unimportant. Multievent trap-dependence modelling revealed considerable variation in individual sighting patterns; however, there were no significant mid-or long-term changes following biopsy sampling or tagging.	[Reisinger, Ryan R.; Oosthuizen, W. Chris; Toussaint, Dawn Cory; de Bruyn, P. J. Nico] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Peron, Guillaume] Univ Cape Town, Dept Stat Sci, Ctr Stat Ecol Environm & Conservat, ZA-7925 Cape Town, South Africa; [Andrews, Russel D.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK USA	University of Pretoria; University of Cape Town; University of Alaska System; University of Alaska Fairbanks	Reisinger, RR (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	rrreisinger@zoology.up.ac.za	PERON, Guillaume/C-5379-2013; De Bruyn, P.J.N./E-4176-2010; Reisinger, Ryan R/D-6151-2014; Oosthuizen, W. Chris/I-2947-2016	PERON, Guillaume/0000-0002-6311-4377; De Bruyn, P.J.N./0000-0002-9114-9569; Reisinger, Ryan R/0000-0002-8933-6875; Oosthuizen, W. Chris/0000-0003-2905-6297; Andrews, Russel/0000-0002-4545-137X	National Research Foundation's (NRF); South African Department of Science and Technology through the NRF; Mohamed bin Zayed Species Conservation Fund [10251290]; International Whaling Commission's Southern Ocean Research Partnership	National Research Foundation's (NRF); South African Department of Science and Technology through the NRF; Mohamed bin Zayed Species Conservation Fund; International Whaling Commission's Southern Ocean Research Partnership	Funding was provided by the National Research Foundation's (NRF) Thuthuka and South African National Antarctic programmes, the South African Department of Science and Technology through the NRF, the Mohamed bin Zayed Species Conservation Fund (Project number: 10251290) and the International Whaling Commission's Southern Ocean Research Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Baird RW, 2011, MAR MAMMAL SCI, V27, pE332, DOI 10.1111/j.1748-7692.2010.00458.x; Baird Robin W., 2010, Endangered Species Research, V10, P107, DOI 10.3354/esr00258; Ban SD, 2014, ANIM COGN, V17, P1353, DOI 10.1007/s10071-014-0771-y; Barbraud C, 2012, J ORNITHOL, V153, P375, DOI 10.1007/s10336-011-0752-8; BarrettLennard LG, 1996, MAR MAMMAL SCI, V12, P14, DOI 10.1111/j.1748-7692.1996.tb00302.x; Bates D., 2013, LME4 LINEAR MIXED EF; BATESON P, 1986, NEW SCI, V109, P30; Baumgartner MF, 2005, CAN J FISH AQUAT SCI, V62, P527, DOI 10.1139/F04-238; Beale CM, 2004, ANIM BEHAV, V68, P1065, DOI 10.1016/j.anbehav.2004.07.002; Best PB, 2005, J WILDLIFE MANAGE, V69, P1171, DOI 10.2193/0022-541X(2005)069[1171:BSRWTR]2.0.CO;2; Best Peter B., 2007, Journal of Cetacean Research and Management, V9, P111; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; BROWN MR, 1994, MAR MAMMAL SCI, V10, P391, DOI 10.1111/j.1748-7692.1994.tb00496.x; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Collecte Localisation Satellites, 2011, ARG US MAN; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Culik B., 1990, P177; Durban JW, 2012, BIOL LETTERS, V8, P274, DOI 10.1098/rsbl.2011.0875; Elwen S, 2006, J MAMMAL, V87, P866, DOI 10.1644/05-MAMM-A-307R2.1; Field IC, 2012, MAR MAMMAL SCI, V28, pE325, DOI 10.1111/j.1748-7692.2011.00519.x; Frid A, 2002, CONSERV ECOL, V6; Gales NJ, 2009, MAR MAMMAL SCI, V25, P725, DOI 10.1111/j.1748-7692.2008.00279.x; Gauthier J, 1999, MAR MAMMAL SCI, V15, P85, DOI 10.1111/j.1748-7692.1999.tb00783.x; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Giraudoux P., 2011, PGIRMESS DATA ANAL E; GOODYEAR JD, 1993, J WILDLIFE MANAGE, V57, P503, DOI 10.2307/3809274; Guinet, 2014, KILLER WHALES CROZET, DOI [10.6084/m9.figshare.1060247, DOI 10.6084/M9.FIGSHARE.1060247]; Hauser N, 2010, MAR MAMMAL SCI, V26, P679, DOI 10.1111/j.1748-7692.2009.00363.x; Hazekamp AAH, 2010, EUR J WILDLIFE RES, V56, P131, DOI 10.1007/s10344-009-0293-0; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Hunt KE, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot006; Keith M, 2001, AFR ZOOL, V36, P163; Kellar NM, 2013, MAR MAMMAL SCI, V29, pE366, DOI 10.1111/mms.12014; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Marino L, 2007, PLOS BIOL, V5, P966, DOI 10.1371/journal.pbio.0050139; Mate B, 2007, DEEP-SEA RES PT II, V54, P224, DOI 10.1016/j.dsr2.2006.11.021; Maxwell SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3688; McMahon CR, 2012, BIOL CONSERV, V153, P254, DOI 10.1016/j.biocon.2012.05.004; Mcmahon CR, 2012, WILDLIFE RES, V39, P375, DOI 10.1071/WR12014; Mizroch SA, 2011, MAR MAMMAL SCI, V27, P217, DOI 10.1111/j.1748-7692.2010.00391.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Noren DP, 2012, MAR MAMMAL SCI, V28, P154, DOI 10.1111/j.1748-7692.2011.00469.x; PATENAUDE NJ, 1995, MAR MAMMAL SCI, V11, P163, DOI 10.1111/j.1748-7692.1995.tb00515.x; Peron G, 2010, OIKOS, V119, P524, DOI 10.1111/j.1600-1706.2009.17882.x; Pistorius PA, 2002, S AFR J WILDL RES, V32, P86; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R., 1993, P29; Pradel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032666; Pradel R, 2010, J AGR BIOL ENVIR ST, V15, P248, DOI 10.1007/s13253-009-0008-8; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reeb D, 2006, MAR MAMMAL SCI, V22, P206, DOI 10.1111/j.1748-7692.2006.00015.x; Regel J, 1997, POLAR BIOL, V18, P246, DOI 10.1007/s003000050185; Reisinger RR, 2011, J ZOOL, V285, P1, DOI 10.1111/j.1469-7998.2011.00815.x; Reisinger RR, 2011, AFR J MAR SCI, V33, P99, DOI 10.2989/1814232X.2011.572356; Reisinger RR, 2014, MARION ISLAND KILLER, DOI [10.6084/m9.fig-share.971317, DOI 10.6084/M9.FIG-SHARE.971317]; Reisinger RR, 2011, AQUAT BIOL, V12, P177, DOI 10.3354/ab00340; Robbins J., 2013, REPORT SC65ASH05 PRE; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Tezanos-Pinto G, 2012, NEW ZEAL J MAR FRESH, V46, P13, DOI 10.1080/00288330.2011.583256; WATKINS WA, 1981, DEEP-SEA RES, V28, P589, DOI 10.1016/0198-0149(81)90119-9; WATKINS WA, 1991, MAR MAMMAL SCI, V7, P409, DOI 10.1111/j.1748-7692.1991.tb00116.x; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Williams AJ, 2009, AFR J MAR SCI, V31, P81, DOI 10.2989/AJMS.2009.31.1.7.778; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1991, POLAR BIOL, V11, P363; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416; Wolf M, 2009, ECOGRAPHY, V32, P401, DOI 10.1111/j.1600-0587.2008.05626.x; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; [No title captured]	82	15	16	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111835	10.1371/journal.pone.0111835	http://dx.doi.org/10.1371/journal.pone.0111835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375329	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600065
J	Alten, F; Motte, J; Ewering, C; Osada, N; Clemens, CR; Kadas, EM; Eter, N; Paul, F; Marziniak, M				Alten, Florian; Motte, Jeremias; Ewering, Carina; Osada, Nani; Clemens, Christoph R.; Kadas, Ella M.; Eter, Nicole; Paul, Friedemann; Marziniak, Martin			Multimodal Retinal Vessel Analysis in CADASIL Patients	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; NOTCH3 MUTATIONS; BLOOD-VESSELS; SKIN BIOPSY; STROKE; LEUKOENCEPHALOPATHY; ABNORMALITIES; DIAMETERS; THICKNESS	Purpose: To further elucidate retinal findings and retinal vessel changes in Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) patients by means of high resolution retinal imaging. Methods: 28 eyes of fourteen CADASIL patients and an equal number of control subjects underwent confocal scanning laser ophthalmoscopy (cSLO), spectral-domain optical coherence tomography (SD-OCT), retinal nerve fibre layer (RNFL) measurements, fluorescein and indocyanine angiography. Three vessel measurement techniques were applied: RNFL thickness, a semiautomatic software tool based on cSLO images and manual vessel outlining based on SD-OCT. Results: Mean age of patients was 56.2 +/- 11.6 years. Arteriovenous nicking was present in 22 (78.6%) eyes and venous dilation in 24 (85.7%) eyes. Retinal volume and choroidal volume were 8.77 +/- 0.46 mm(3) and 8.83 +/- 2.24 mm(3). RNFL measurements showed a global increase of 105.2 mu m (Control group: 98.4 mu m; p = 0.015). Based on semi-automatic cSLO measurements, maximum diameters of arteries and veins were 102.5 mu m (106.0 mu m; p = 0.21) and 128.6 mu m (124.4 mu m; p = 0.27) respectively. Manual SD-OCT measurements revealed significantly increased mean arterial 138.7 mu m (125.4 mu m; p<0.001) and venous 160.0 mu m (146.9; p = 0.003) outer diameters as well as mean arterial 27.4 mu m (19.2 mu m; p<0.001) and venous 18.3 mu m (15.7 mu m; p<0.001) wall thicknesses in CADASIL patients. Conclusions: The findings reflect current knowledge on pathophysiologic changes in vessel morphology in CADASIL patients. SD-OCT may serve as a complementary tool to diagnose and follow-up patients suffering from cerebral small-vessel diseases.	[Alten, Florian; Clemens, Christoph R.; Eter, Nicole] Univ Munster, Med Ctr, Dept Ophthalmol, D-48149 Munster, Germany; [Motte, Jeremias; Ewering, Carina; Marziniak, Martin] Univ Munster, Med Ctr, Dept Neurol, D-48149 Munster, Germany; [Osada, Nani] Univ Munster, Dept Med Informat & Biomath, D-48149 Munster, Germany; [Kadas, Ella M.; Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany; [Paul, Friedemann] NeuroCure Clin Res Ctr, Berlin, Germany	University of Munster; University of Munster; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Alten, F (corresponding author), Univ Munster, Med Ctr, Dept Ophthalmol, D-48149 Munster, Germany.	florian.alten@ukmuenster.de	Paul, Friedemann/ABF-9415-2020	Motte, Jeremias/0000-0002-6624-8565; paul, friedemann/0000-0002-6378-0070	German Research Foundation (DFG [Exc 257]; German Ministry for Education and Research (BMBF Competence Network Multiple Sclerosis)	German Research Foundation (DFG(German Research Foundation (DFG)); German Ministry for Education and Research (BMBF Competence Network Multiple Sclerosis)	Alten F, Heidelberg Engineering, Novartis, Bayer, Allergan; Motte J, none; Ewering C, none; Osada N, none; Clemens CR, Heidelberg Engineering, Novartis, Bayer, Allergan; Kadas EM, none; Eter N, Heidelberg Engineering, Bayer, Novartis, Allergan, Pfizer, Bausch and Lomb; Paul F, BiogenIdec, Teva, SanofiGenzyme, Merck, Novartis, Heidelberg Engineering; supported by German Research Foundation (DFG Exc 257), German Ministry for Education and Research (BMBF Competence Network Multiple Sclerosis); Marziniak M, none. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; BRINCHMANNHANSEN O, 1986, ACTA OPHTHALMOL, V64, P433; Chhablani J, 2012, INVEST OPHTH VIS SCI, V53, P2274, DOI 10.1167/iovs.12-9435; Chui TYP, 2013, INVEST OPHTH VIS SCI, V54, P7115, DOI 10.1167/iovs.13-13027; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Dong HR, 2013, STROKE, V44, P1456, DOI 10.1161/STROKEAHA.111.000721; Fischer MD, 2010, INVEST OPHTH VIS SCI, V51, P5254, DOI 10.1167/iovs.09-5139; GIUFFRE G, 1989, DOC OPHTHALMOL, V72, P175, DOI 10.1007/BF00156707; Goldenberg D, 2013, RETINA-J RET VIT DIS, V33, P1888, DOI 10.1097/IAE.0b013e31829477f2; Haritoglou C, 2004, AM J OPHTHALMOL, V138, P302, DOI 10.1016/j.ajo.2004.02.073; Haritoglou C, 2004, NEUROLOGY, V62, P1202, DOI 10.1212/01.WNL.0000118296.16326.E1; Hogan MJ, 1971, HISTOLOGY HUMAN EYE, P393; Ikram MK, 2006, NEUROLOGY, V66, P1339, DOI 10.1212/01.wnl.0000210533.24338.ea; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; Joutel A, 2001, LANCET, V358, P2049, DOI 10.1016/S0140-6736(01)07142-2; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; Liu Y, 2008, CLIN EXP OPHTHALMOL, V36, P532, DOI 10.1111/j.1442-9071.2008.01825.x; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; Malandrini A, 2007, NEUROLOGY, V68, P1430, DOI 10.1212/01.wnl.0000264018.46335.c8; Motte J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102034; Muraoka Y, 2013, AM J OPHTHALMOL, V156, P706, DOI 10.1016/j.ajo.2013.05.021; Muraoka Y, 2013, OPHTHALMOLOGY, V120, P91, DOI 10.1016/j.ophtha.2012.06.054; Oberstein SAJL, 2003, ACTA NEUROPATHOL, V106, P107, DOI 10.1007/s00401-003-0701-6; Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757; Ouyang Y, 2014, GRAEFES ARCH CLIN EX; Parisi V, 2007, EUR J NEUROL, V14, P627, DOI 10.1111/j.1468-1331.2007.01795.x; Pretegiani E, 2013, J STROKE CEREBROVASC, V22, P1377, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.032; Robinson W, 2001, SURV OPHTHALMOL, V45, P445, DOI 10.1016/S0039-6257(00)00206-X; Roine S, 2006, OPHTHALMOLOGY, V113, P1411, DOI 10.1016/j.ophtha.2006.03.030; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Rufa A, 2011, CEREBROVASC DIS, V31, P77, DOI 10.1159/000321339; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tanabe H, 2012, RETINA-J RET VIT DIS, V32, P134, DOI 10.1097/IAE.0b013e318217ff87; Tikka S, 2009, BRAIN, V132, P933, DOI 10.1093/brain/awn364; VERIN M, 1995, J NEUROL NEUROSUR PS, V59, P579, DOI 10.1136/jnnp.59.6.579; Viswanathan A, 2006, STROKE, V37, P2690, DOI 10.1161/01.STR.0000245091.28429.6a; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; YANNUZZI LA, 1992, RETINA-J RET VIT DIS, V12, P191, DOI 10.1097/00006982-199212030-00003	40	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112311	10.1371/journal.pone.0112311	http://dx.doi.org/10.1371/journal.pone.0112311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372785	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900131
J	De Filippis, F; Vannini, L; La Storia, A; Laghi, L; Piombino, P; Stellato, G; Serrazanetti, DI; Gozzi, G; Turroni, S; Ferrocino, I; Lazzi, C; Di Cagno, R; Gobbetti, M; Ercolini, D				De Filippis, Francesca; Vannini, Lucia; La Storia, Antonietta; Laghi, Luca; Piombino, Paola; Stellato, Giuseppina; Serrazanetti, Diana I.; Gozzi, Giorgia; Turroni, Silvia; Ferrocino, Ilario; Lazzi, Camilla; Di Cagno, Raffaella; Gobbetti, Marco; Ercolini, Danilo			The Same Microbiota and a Potentially Discriminant Metabolome in the Saliva of Omnivore, Ovo-Lacto-Vegetarian and Vegan Individuals	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; AGGRESSIVE PERIODONTITIS; ORAL MICROBIOME; HEALTH; DIVERSITY; CHILDREN; DISEASES; BACTERIA; ADOLESCENCE; POPULATIONS	The salivary microbiota has been linked to both oral and non-oral diseases. Scant knowledge is available on the effect of environmental factors such as long-term dietary choices on the salivary microbiota and metabolome. This study analyzed the microbial diversity and metabolomic profiles of the saliva of 161 healthy individuals who followed an omnivore or ovo-lacto-vegetarian or vegan diet. A large core microbiota was identified, including 12 bacterial genera, found in >98% of the individuals. The subjects could be stratified into three "salivary types'' that differed on the basis of the relative abundance of the core genera Prevotella, Streptococcus/Gemella and Fusobacterium/Neisseria. Statistical analysis indicated no effect of dietary habit on the salivary microbiota. Phylogenetic beta-diversity analysis consistently showed no differences between omnivore, ovo-lacto-vegetarian and vegan individuals. Metabolomic profiling of saliva using H-1-NMR and GC-MS/SPME identified diet-related biomarkers that enabled a significant discrimination between the 3 groups of individuals on the basis of their diet. Formate, urea, uridine and 5-methyl-3-hexanone could discriminate samples from omnivores, whereas 1-propanol, hexanoic acid and proline were characteristic of non-omnivore diets. Although the salivary metabolome can be discriminating for diet, the microbiota has a remarkable inter-individual stability and did not vary with dietary habits. Microbial homeostasis might be perturbed with sub-standard oral hygiene or other environmental factors, but there is no current indication that a choice of an omnivore, ovo-lacto-vegetarian or vegan diet can lead to a specific composition of the oral microbiota with consequences on the oral homeostasis.	[De Filippis, Francesca; La Storia, Antonietta; Piombino, Paola; Stellato, Giuseppina; Ercolini, Danilo] Univ Naples Federico II, Dept Agr Sci, Div Microbiol, Portici, Italy; [Vannini, Lucia; Laghi, Luca; Gozzi, Giorgia] Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci, Bologna, Italy; [Vannini, Lucia; Laghi, Luca; Serrazanetti, Diana I.] Alma Mater Studiorum Univ Bologna, Inter Dept Ctr Ind Agrifood Res, Cesena, Italy; [Turroni, Silvia] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Ferrocino, Ilario] Univ Turin, Dept Agr Forest & Food Sci, Grugliasco, Italy; [Lazzi, Camilla] Univ Parma, Dept Food Sci, I-43100 Parma, Italy; [Di Cagno, Raffaella; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy	University of Naples Federico II; University of Bologna; University of Bologna; University of Bologna; University of Turin; University of Parma; Universita degli Studi di Bari Aldo Moro	Ercolini, D (corresponding author), Univ Naples Federico II, Dept Agr Sci, Div Microbiol, Portici, Italy.	danilo.ercolini@unina.it	Laghi, Luca/R-5278-2016; Serrazanetti, Diana Isabella/K-2606-2016; Turroni, Silvia/J-7195-2016; Ferrocino, Ilario/K-7234-2016; De Filippis, Francesca/K-3816-2016; La Storia, Antonietta/K-8570-2016; Ercolini, Danilo/B-2431-2009; Gobbetti, Marco/K-4138-2014	Laghi, Luca/0000-0003-1593-7376; Serrazanetti, Diana Isabella/0000-0002-6796-4053; Turroni, Silvia/0000-0003-2345-9482; De Filippis, Francesca/0000-0002-3474-2884; FERROCINO, ILARIO/0000-0002-1657-0054; Piombino, Paola/0000-0001-8705-9846; GOZZI, Giorgia/0000-0001-6015-6144; La Storia, Antonietta/0000-0002-8318-9376; Lazzi, Camilla/0000-0001-5759-5154; Di Cagno, Raffaella/0000-0002-9431-4427; Vannini, Lucia/0000-0002-9417-8410; Ercolini, Danilo/0000-0003-3061-9560; Gobbetti, Marco/0000-0003-0869-2737	Italian Ministry of University and Research [MIUR] program	Italian Ministry of University and Research [MIUR] program(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Italian Ministry of University and Research [MIUR] program PRIN 2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2; AL-Kateb H, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036004; Alum MF, 2008, METABOLOMICS, V4, P122, DOI 10.1007/s11306-008-0103-9; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Arumugam M, 2014, NATURE, V506, DOI 10.1038/nature13075; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Cruciata M, 2014, APPL ENVIRON MICROB, V80, P2050, DOI 10.1128/AEM.03837-13; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; De Filippis F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070222; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Eren AM, 2014, P NATL ACAD SCI USA, V111, pE2875, DOI 10.1073/pnas.1409644111; Fabian TK, 2008, CURR GENOMICS, V9, P11, DOI 10.2174/138920208783884900; Fagnocchi L, 2012, J BACTERIOL, V194, P460, DOI 10.1128/JB.06161-11; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Hedrick VE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-109; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Janssen PH, 2004, ARCH MICROBIOL, V182, P482, DOI 10.1007/s00203-004-0732-y; Kim SJ, 2014, ENVIRON MICROBIOL, V16, P189, DOI 10.1111/1462-2920.12277; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Laffranchi L, 2010, Minerva Stomatol, V59, P583; Laine MA, 2014, ARCH ORAL BIOL, V59, P217, DOI 10.1016/j.archoralbio.2013.11.013; Lamsen EN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00196; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Liu YL, 2012, INT J ORAL SCI, V4, P135, DOI 10.1038/ijos.2012.54; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mason MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077287; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McEvoy CT, 2012, PUBLIC HEALTH NUTR, V15, P2287, DOI 10.1017/S1368980012000936; Meurman JH, 2011, ORAL DIS, V17, P779, DOI 10.1111/j.1601-0825.2011.01837.x; Mikkonen JJW., 2013, METABOLOMICS, V3, P128, DOI [10.4172/2153-0769.1000128, DOI 10.4172/2153-0769.1000128]; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; O'Gorman A, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301004; Parisi VA, 2009, MICROB BIOTECHNOL, V2, P202, DOI 10.1111/j.1751-7915.2009.00077.x; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Piombino P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085611; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Sakamoto M, 2004, J MED MICROBIOL, V53, P563, DOI 10.1099/jmm.0.45576-0; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Silva-Boghossian C, 2008, INT J PAEDIATR DENT, V18, P205, DOI 10.1111/j.1365-263X.2007.00864.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Soini HA, 2010, J CHEM ECOL, V36, P1035, DOI 10.1007/s10886-010-9846-7; Stahringer SS, 2012, GENOME RES, V22, P2146, DOI 10.1101/gr.140608.112; Takeda I, 2009, NMR BIOMED, V22, P577, DOI 10.1002/nbm.1369; Takeshita T, 2009, ISME J, V3, P65, DOI 10.1038/ismej.2008.91; Takeuchi Y, 2001, J PERIODONTOL, V72, P1354, DOI 10.1902/jop.2001.72.10.1354; Tikhonov M, 2015, ISME J, V9, P68, DOI 10.1038/ismej.2014.117; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Yang HW, 2004, J PERIODONTOL, V75, P592, DOI 10.1902/jop.2004.75.4.592; Yen CE, 2008, NUTR RES, V28, P430, DOI 10.1016/j.nutres.2008.03.012; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x; Zeigler CC, 2012, OBESITY, V20, P157, DOI 10.1038/oby.2011.305	66	82	83	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112373	10.1371/journal.pone.0112373	http://dx.doi.org/10.1371/journal.pone.0112373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372853	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900140
J	Pluchino, LA; Wang, HCR				Pluchino, Lenora Ann; Wang, Hwa-Chain Robert			Chronic Exposure to Combined Carcinogens Enhances Breast Cell Carcinogenesis with Mesenchymal and Stem-Like Cell Properties	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TOBACCO-SMOKE CARCINOGENS; DONE MEAT INTAKE; EPITHELIAL-CELLS; HETEROCYCLIC AMINES; MAMMARY CARCINOMAS; CANCER; MECHANISMS; INTERVENTION; LUNG	Breast cancer is the most common type of cancer affecting women in North America and Europe. More than 85% of breast cancers are sporadic and attributable to long-term exposure to small quantities of multiple carcinogens. To understand how multiple carcinogens act together to induce cellular carcinogenesis, we studied the activity of environmental carcinogens 4( methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a] pyrene (B[a] P), and dietary carcinogen 2-amino-1-methyl6- phenylimidazo[4,5-b] pyridine (PhIP) using our breast cell carcinogenesis model. Our study revealed, for the first time, that combined NNK and B[a] P enhanced breast cell carcinogenesis chronically induced by PhIP in both non-cancerous and cancerous breast cells. Co-exposure was more potent than sequential exposure to combined NNK and B[a] P followed by PhIP in inducing carcinogenesis. Initiation of carcinogenesis was measured by transient endpoints induced in a single exposure, while progression of carcinogenesis was measured by acquisition of constitutive endpoints in cumulative exposures. Transient endpoints included DNA damage, Ras-Erk-Nox pathway activation, reactive oxygen species elevation, and increased cellular proliferation. Constitutive endpoints included various cancer-associated properties and signaling modulators, as well as enrichment of cancer stem-like cell population and activation of the epithelial-to-mesenchymal transition program. Using transient and constitutive endpoints as targets, we detected that a combination of the green tea catechins ECG and EGCG, at non-cytotoxic levels, was more effective than individual agents in intervention of cellular carcinogenesis induced by combined NNK, B[a] P, and PhIP. Thus, use of combined ECG and EGCG should be seriously considered for early intervention of breast cell carcinogenesis associated with long-term exposure to environmental and dietary carcinogens.	[Pluchino, Lenora Ann; Wang, Hwa-Chain Robert] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Pluchino, Lenora Ann; Wang, Hwa-Chain Robert] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville	Wang, HCR (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	hcrwang@utk.edu	; Wang, Hwa-Chain/L-5646-2015	Pluchino, Lenora/0000-0002-1154-8931; Wang, Hwa-Chain/0000-0001-5836-4120	University of Tennessee, College of Veterinary Medicine, Center of Excellence in Livestock Diseases and Human Health	University of Tennessee, College of Veterinary Medicine, Center of Excellence in Livestock Diseases and Human Health	This work was supported by a grant from the University of Tennessee, College of Veterinary Medicine, Center of Excellence in Livestock Diseases and Human Health (to HCRW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Chhabra SK, 2000, TOXICOL APPL PHARM, V169, P191, DOI 10.1006/taap.2000.9068; Choudhary S, 2012, CARCINOGENESIS, V33, P876, DOI 10.1093/carcin/bgs097; Cohen SM, 2007, TOXICOL PATHOL, V35, P337, DOI 10.1080/01926230701197115; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; DeBruin LS, 2002, ENVIRON HEALTH PERSP, V110, P119, DOI 10.1289/ehp.02110s1119; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gammon MD, 2004, ARCH ENVIRON HEALTH, V59, P640, DOI 10.1080/00039890409602948; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P677; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gooderham NJ, 2007, TOXICOL LETT, V168, P269, DOI 10.1016/j.toxlet.2006.10.022; Gray J, 2009, INT J OCCUP ENV HEAL, V15, P43; Guengerich FP, 2000, CARCINOGENESIS, V21, P345, DOI 10.1093/carcin/21.3.345; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartz AJ, 2013, EPIDEMIOL HEALTH, V35, DOI 10.4178/epih/e2013003; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; Hecht SS, 1996, CRIT REV TOXICOL, V26, P163, DOI 10.3109/10408449609017929; Imaida K, 1996, JPN J CANCER RES, V87, P1116, DOI 10.1111/j.1349-7006.1996.tb03120.x; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Kelloff GJ, 2005, CANC CHEMOPREVENTION, V2; Kurbitz C, 2011, CANCER SCI, V102, P728, DOI 10.1111/j.1349-7006.2011.01870.x; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Mehta RG, 2000, EUR J CANCER, V36, P1275, DOI 10.1016/S0959-8049(00)00100-3; Mei JX, 2003, BREAST CANCER RES TR, V79, P95, DOI 10.1023/A:1023326121951; MORRIS JJ, 1992, MED HYPOTHESES, V38, P177, DOI 10.1016/0306-9877(92)90090-Y; NAGAO M, 1994, CANCER, V74, P1063, DOI 10.1002/1097-0142(19940801)74:3+<1063::AID-CNCR2820741514>3.0.CO;2-2; OBANA H, 1981, B ENVIRON CONTAM TOX, V27, P23, DOI 10.1007/BF01610981; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pan MH, 2011, FOOD FUNCT, V2, P101, DOI 10.1039/c0fo00174k; Rathore K, 2013, CANCER LETT, V333, P113, DOI 10.1016/j.canlet.2013.01.030; Rathore K, 2012, MOL CARCINOGEN, V51, P280, DOI 10.1002/mc.20844; Rathore K, 2012, CARCINOGENESIS, V33, P174, DOI 10.1093/carcin/bgr244; Rubin H, 2001, CARCINOGENESIS, V22, P1903, DOI 10.1093/carcin/22.12.1903; Rundle A, 2000, CARCINOGENESIS, V21, P1281, DOI 10.1093/carcin/21.7.1281; Sinha R, 2000, J NATL CANCER I, V92, P1352, DOI 10.1093/jnci/92.16.1352; Siriwardhana N, 2008, BREAST CANCER RES TR, V109, P427, DOI 10.1007/s10549-007-9666-9; Siriwardhana N, 2008, MOL CARCINOGEN, V47, P338, DOI 10.1002/mc.20392; Song XY, 2010, MOL CARCINOGEN, V49, P450, DOI 10.1002/mc.20616; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Zheng W, 1998, JNCI-J NATL CANCER I, V90, P1724, DOI 10.1093/jnci/90.22.1724; Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741	47	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e108698	10.1371/journal.pone.0108698	http://dx.doi.org/10.1371/journal.pone.0108698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372613	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900004
J	Soler, M; Ruiz-Raya, F; Carra, LG; Medina-Molina, E; Ibanez-Alamo, JD; Martin-Galvez, D				Soler, Manuel; Ruiz-Raya, Francisco; Carra, Laura G.; Medina-Molina, Eloy; Diego Ibanez-Alamo, Juan; Martin-Galvez, David			A Long-Term Experimental Study Demonstrates the Costs of Begging That Were Not Found over the Short Term	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; NESTLING TREE SWALLOWS; IMMUNE-RESPONSE; ENERGETIC COST; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; LOCAL RECRUITMENT; FOOD RESTRICTION; PIED FLYCATCHER; LIFE-HISTORY	Parent-offspring conflict theory predicts that begging behaviour could escalate continuously over evolutionary time if it is not prevented by costliness of begging displays. Three main potential physiological costs have been proposed: growth, immunological and metabolic costs. However, empirical evidence on this subject remains elusive because published results are often contradictory. In this study, we test for the existence of these three potential physiological costs of begging in house sparrow (Passer domesticus) nestlings by stimulating a group of nestlings to beg for longer and another group for shorter periods than in natural conditions. All nestlings were fed with the same quantity of food. Our study involves a long-term experimental treatment for begging studies (five consecutive days). Long-term studies frequently provide clearer results than short-term studies and, sometimes, relevant information not reported by the latter ones. Our long-term experiment shows (i) a clear effect on the immune response even since the first measurement (6 hours), but it was higher during the second (long-term) than during the first (short-term) test; (ii) evidence of a growth cost of begging in house sparrow nestlings not previously found by other studies; (iii) body condition was affected by our experimental manipulation only after 48 hour; (iv) a metabolic cost of begging never previously shown in any species, and (v) for the first time, it has shown a simultaneous effect of the three potential physiological costs of begging: immunocompetence, growth, and metabolism. This implies first, that a multilevel trade-off can occur between begging and all physiological costs and, second, that a lack of support in a short-term experiment for the existence of a tested cost of begging does not mean absence of that cost, because it can be found in a long-term experiment.	[Soler, Manuel; Ruiz-Raya, Francisco; Carra, Laura G.; Medina-Molina, Eloy; Diego Ibanez-Alamo, Juan] Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain; [Soler, Manuel] Univ Granada, CSIC, Unidad Asociada, Grp Coevolucio, Granada, Spain; [Martin-Galvez, David] Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain.	msoler@ugr.es	Ibáñez-Álamo, Juan Diego/H-7624-2019; Ruiz-Raya, Francisco/L-8639-2019; Martín-Gálvez, David/H-3707-2011	Ruiz-Raya, Francisco/0000-0002-4646-1975; Martín-Gálvez, David/0000-0002-1501-9578; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Junta de Andalucia [RNM 339]; Spanish Ministerio de Educacion y Ciencia/FEDER [CGL2011-25634]	Junta de Andalucia(Junta de Andalucia); Spanish Ministerio de Educacion y Ciencia/FEDER(Spanish Government)	Support was provided by the Junta de Andalucia (to the RNM 339 research group) Spanish Ministerio de Educacion y Ciencia/FEDER (research project CGL2011-25634). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 1998, PRINCIPLES ANIMAL CO; Apanius V., 1998, AVIAN GROWTH DEV EVO; Bachman GC, 1998, ANIM BEHAV, V55, P1607, DOI 10.1006/anbe.1997.0719; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Bergstrom CT, 1997, PHILOS T ROY SOC B, V352, P609, DOI 10.1098/rstb.1997.0041; Boncoraglio G, 2012, BEHAV ECOL SOCIOBIOL, V66, P539, DOI 10.1007/s00265-011-1302-3; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; BRISKIE JV, 1994, P ROY SOC B-BIOL SCI, V258, P73, DOI 10.1098/rspb.1994.0144; Brommer JE, 2004, P ROY SOC B-BIOL SCI, V271, pS110, DOI 10.1098/rsbl.2003.0103; Buchanan KL, 2007, HORM BEHAV, V52, P664, DOI 10.1016/j.yhbeh.2007.08.009; Budden AE, 2008, IBIS, V150, P234, DOI 10.1111/j.1474-919X.2007.00769.x; Chappell MA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P143, DOI 10.1007/0-306-47660-6_8; Chappell MA, 1998, AUK, V115, P863, DOI 10.2307/4089505; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; De Neve L, 2010, CAN J ZOOL, V88, P1021, DOI 10.1139/Z10-067; de Neve L, 2007, IBIS, V149, P763, DOI 10.1111/j.1474-919X.2007.00708.x; Dearborn DC, 1999, AUK, V116, P448, DOI 10.2307/4089378; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Ibanez-Alamo JD, 2012, J ORNITHOL, V153, P801, DOI 10.1007/s10336-011-0797-8; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dor R, 2007, BEHAV ECOL, V18, P97, DOI 10.1093/beheco/arl056; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Fisher R.A., 1974, DESIGN EXPT; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Goodship NM, 2007, HORM BEHAV, V52, P454, DOI 10.1016/j.yhbeh.2007.06.008; Grodzinski U, 2009, FUNCT ECOL, V19, P116; Grodzinski U, 2007, P R SOC B, V274, P2449, DOI 10.1098/rspb.2007.0658; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Hairston N. G., 1989, ECOLOGICAL EXPT PURP; HASKELL D, 1994, P ROY SOC B-BIOL SCI, V257, P161, DOI 10.1098/rspb.1994.0110; Haskell DG, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P163, DOI 10.1007/0-306-47660-6_9; Haskell DG, 1999, ANIM BEHAV, V57, P893, DOI 10.1006/anbe.1998.1053; Heil M, 2001, OECOLOGIA, V126, P395, DOI 10.1007/s004420000532; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Johnstone RA, 1998, AM NAT, V152, P45, DOI 10.1086/286148; Johnstone RA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P1, DOI 10.1007/0-306-47660-6_1; Kedar H, 2000, P ROY SOC B-BIOL SCI, V267, P1723, DOI 10.1098/rspb.2000.1201; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Knapp AK, 2012, BIOSCIENCE, V62, P377, DOI 10.1525/bio.2012.62.4.9; Kolliker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008606; Konarzewski M, 1996, FUNCT ECOL, V10, P97, DOI 10.2307/2390267; Korschens M., 2006, Plant, Soil and Environment, V52, P1; KREBS CJ, 1991, IBIS, V133, P3, DOI 10.1111/j.1474-919X.1991.tb07663.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Leech SM, 1997, BEHAV ECOL, V8, P644, DOI 10.1093/beheco/8.6.644; Leech SM, 1996, P ROY SOC B-BIOL SCI, V263, P983, DOI 10.1098/rspb.1996.0145; Leonard ML, 2003, BEHAV ECOL SOCIOBIOL, V54, P573, DOI 10.1007/s00265-003-0668-2; Lepczyk CA, 1998, PHYSIOL ZOOL, V71, P561, DOI 10.1086/515965; Lepczyk CA, 2000, AUK, V117, P164, DOI 10.1642/0004-8038(2000)117[0164:EOEFRO]2.0.CO;2; Letourneau DK, 1998, ECOLOGY, V79, P593, DOI 10.1890/0012-9658(1998)079[0593:ASBAFP]2.0.CO;2; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loiseau C, 2008, GEN COMP ENDOCR, V155, P101, DOI 10.1016/j.ygcen.2007.03.004; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin-Galvez D, 2011, J EXP BIOL, V214, P1463, DOI 10.1242/jeb.050153; Mauck RA, 2005, FUNCT ECOL, V19, P1001, DOI 10.1111/j.1365-2435.2005.01060.x; McCarty JP, 1996, AUK, V113, P178, DOI 10.2307/4088944; McDonald PG, 2009, BEHAV ECOL, V20, P821, DOI 10.1093/beheco/arp066; Merbach W, 2008, PLANT SOIL ENVIRON, V54, P219, DOI 10.17221/395-PSE; Merino S, 2000, OIKOS, V90, P327, DOI 10.1034/j.1600-0706.2000.900213.x; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Moreno J, 2005, J AVIAN BIOL, V36, P251, DOI 10.1111/j.0908-8857.2005.03413.x; Moreno-Rueda G, 2011, J EVOLUTION BIOL, V24, P1091, DOI 10.1111/j.1420-9101.2011.02242.x; Moreno-Rueda G, 2007, J ETHOL, V25, P215, DOI 10.1007/s10164-006-0020-1; Moreno-Rueda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040367; Moreno-Rueda G, 2010, P ROY SOC B-BIOL SCI, V277, P2083, DOI 10.1098/rspb.2010.0109; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navarro C, 2003, OIKOS, V101, P291, DOI 10.1034/j.1600-0706.2003.11663.x; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; O'Connor R.J., 1984, GROWTH DEV BIRDS; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; PINHEIRO J PINHEIRO J PINHEIRO J PINHEIRO J, 2014, NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA NLME LINEAR NONLINEA; Quillfeldt P, 2006, ANIM BEHAV, V71, P1359, DOI 10.1016/j.anbehav.2005.09.015; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Reeve HK, 1997, P ROY SOC B-BIOL SCI, V264, P1037, DOI 10.1098/rspb.1997.0143; Remes V, 2002, EVOLUTION, V56, P2505; RICKLEFS RE, 1984, ECOLOGY, V65, P1602, DOI 10.2307/1939139; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; Rodriguez-Girones MA, 2001, BEHAV ECOL, V12, P269, DOI 10.1093/beheco/12.3.269; Rodriguez-Girones MA, 1999, P ROY SOC B-BIOL SCI, V266, P2399, DOI 10.1098/rspb.1999.0937; RodriguezGirones MA, 1996, P NATL ACAD SCI USA, V93, P14637, DOI 10.1073/pnas.93.25.14637; Ros AFH, 2008, HORM BEHAV, V54, P234, DOI 10.1016/j.yhbeh.2008.02.022; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Salaberria C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084108; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smiseth PT, 2011, ANIM BEHAV, V81, P507, DOI 10.1016/j.anbehav.2010.11.029; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Soler JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010509; Soler M, 1999, CAN J ZOOL, V77, P1794, DOI 10.1139/cjz-77-11-1794; Soler M, 2011, ADAPTIVE BEHAV UNDER; Soler M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2518; Soler M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1997, DOI 10.1007/s00265-011-1209-z; Trivers RL, 1974, READINGS SOCIOBIOLOG, P233; Verhulst S, 1997, AUK, V114, P134, DOI 10.2307/4089078; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Wells JCK, 2003, Q REV BIOL, V78, P169, DOI 10.1086/374952; Wright J, 2010, ANIM BEHAV, V80, P517, DOI 10.1016/j.anbehav.2010.06.015; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuur Alain F., 2009, P1	112	18	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111929	10.1371/journal.pone.0111929	http://dx.doi.org/10.1371/journal.pone.0111929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372280	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900090
J	Liu, JB; Chen, RZ; Wang, ZM; An, JC; Hyyppa, J				Liu, Jingbin; Chen, Ruizhi; Wang, Zemin; An, Jiachun; Hyyppa, Juha			Long-Term Prediction of the Arctic Ionospheric TEC Based on Time-Varying Periodograms	PLOS ONE			English	Article							TOTAL ELECTRON-CONTENT; CAP HARMONIC-ANALYSIS; SOLAR-ACTIVITY; CYCLE; SYSTEM; MODEL; MAPS	Knowledge of the polar ionospheric total electron content (TEC) and its future variations is of scientific and engineering relevance. In this study, a new method is developed to predict Arctic mean TEC on the scale of a solar cycle using previous data covering 14 years. The Arctic TEC is derived from global positioning system measurements using the spherical cap harmonic analysis mapping method. The study indicates that the variability of the Arctic TEC results in highly time-varying periodograms, which are utilized for prediction in the proposed method. The TEC time series is divided into two components of periodic oscillations and the average TEC. The newly developed method of TEC prediction is based on an extrapolation method that requires no input of physical observations of the time interval of prediction, and it is performed in both temporally backward and forward directions by summing the extrapolation of the two components. The backward prediction indicates that the Arctic TEC variability includes a 9 years period for the study duration, in addition to the well-established periods. The long-term prediction has an uncertainty of 4.8-5.6 TECU for different period sets.	[Liu, Jingbin; Hyyppa, Juha] Finnish Geodet Inst, Dept Remote Sensing & Photogrammetry, Masala, Finland; [Chen, Ruizhi] Texas A&M Univ, Conrad Blucher Inst Surveying & Sci, Corpus Christi, TX USA; [Wang, Zemin; An, Jiachun] Wuhan Univ, Chinese Antarctic Ctr Surveying & Mapping, Wuhan 430072, Peoples R China	The National Land Survey of Finland; Finnish Geospatial Research Institute (FGI); Texas A&M University System; Wuhan University	Liu, JB (corresponding author), Finnish Geodet Inst, Dept Remote Sensing & Photogrammetry, Masala, Finland.	jingbin.liu@fgi.fi	Liu, Jingbin/AAE-8803-2020; An, Jiachun/ABG-4275-2020; ZeMin, Wang/AAU-3422-2020; Hyyppä, Juha M./ABH-1852-2021	Hyyppa, Juha/0000-0001-5360-4017	Finnish Centre of Excellence in Laser Scanning Research - Academy of Finland [272195]; National Natural Science Foundation of China [41174029, 41204028, 41231064]	Finnish Centre of Excellence in Laser Scanning Research - Academy of Finland; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Finnish Centre of Excellence in Laser Scanning Research, which is funded under project 272195 (JH) by the Academy of Finland (http://www.aka.fi). This work was also supported in part by the National Natural Science Foundation of China (grants 41174029(ZW), 41204028(JA), and 41231064(ZW))(http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraimovich EL, 2008, ANN GEOPHYS-GERMANY, V26, P335, DOI 10.5194/angeo-26-335-2008; Bilitza D, 2011, J GEODESY, V85, P909, DOI 10.1007/s00190-010-0427-x; Dikpati M, 2008, ANN GEOPHYS-GERMANY, V26, P259, DOI 10.5194/angeo-26-259-2008; FRIISCHRISTENSEN E, 1991, SCIENCE, V254, P698, DOI 10.1126/science.254.5032.698; Garcia-Rigo A, 2011, RADIO SCI, V46, DOI 10.1029/2010RS004643; Garner TW, 2008, ADV SPACE RES, V42, P720, DOI 10.1016/j.asr.2008.02.025; Ghoddousi-Fard R, 2011, SPACE WEATHER, V9, DOI 10.1029/2010SW000621; Gulyaeva TL, 2013, ADV SPACE RES, V52, P1837, DOI 10.1016/j.asr.2012.09.038; Gulyaeva TL, 2013, J ATMOS SOL-TERR PHY, V102, P329, DOI 10.1016/j.jastp.2013.06.011; HAINES GV, 1985, J GEOPHYS RES, V90, P2583, DOI 10.1029/JB090iB03p02583; Hemandez-Pajares M, 2014, J GEOPHYS RES SOLID, V119, P3823, DOI [10.1002/2013JB010568, DOI 10.1002/2013JB010568]; Hernandez-Pajares M, 2012, RADIO SCI, V47, DOI 10.1029/2011RS004951; Hernandez-Pajares M, 2009, J GEODESY, V83, P263, DOI 10.1007/s00190-008-0266-1; Ivanov-Kholodny G. S., 1986, PREDICTION IONOSPHER; Jakowski N, 2011, J GEODESY, V85, P965, DOI 10.1007/s00190-011-0455-1; Komjathy A., 1997, THESIS U NEW BRUNSWI; Lean JL, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016567; Lean JL, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016378; Liu J, 2010, J GLOBAL POSITIONING, V9, P22, DOI DOI 10.5081/JGPS.9.1.22; Liu JB, 2014, J GEOPHYS RES-SPACE, V119, P601, DOI 10.1002/2013JA019501; Liu JB, 2011, GPS SOLUT, V15, P109, DOI 10.1007/s10291-010-0174-8; [柳景斌 LIU Jingbin], 2008, [武汉大学学报. 信息科学版, Geomatics and Information Science of Wuhan University], V33, P792; Liu Jingbin, 2008, Geomatics and Information Science of Wuhan University, V33, P479; Liu LB, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014244; Mannucci AJ, 1998, RADIO SCI, V33, P565, DOI 10.1029/97RS02707; National Research Council, 2003, SUN EARTH AND DEC RE; National Space Weather Strategic Plan, 1995, NAT SPAC WEATH STRAT; Omlin M, 1999, ECOL MODEL, V115, P45, DOI 10.1016/S0304-3800(98)00174-4; Pesnell WD, 2012, SOL PHYS, V281, P507, DOI 10.1007/s11207-012-9997-5; Pietrella M, 2009, ADV SPACE RES, V43, P1611, DOI 10.1016/j.asr.2008.01.022; Rishbeth H, 1969, INT GEOPHYS SERIES, V14; SARDON E, 1994, RADIO SCI, V29, P577, DOI 10.1029/94RS00449; Schaer S, 1999, THESIS U BERN; Schaer S, 1998, IONEX IONOSPHERE MAP; Scharroo R, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014719; Strangeways HJ, 2009, ANN GEOPHYS-ITALY, V52, P255; WILSON BD, 1995, RADIO SCI, V30, P639, DOI 10.1029/94RS03186; Wu Y, 2010, ADV SPACE RES, V46, P144, DOI 10.1016/j.asr.2009.11.007; Zahra B., 2010, 38 COSPAR SCI ASS BR; Zolesi B, 2014, SPRINGER GEOPHYS SER, VXII	40	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111497	10.1371/journal.pone.0111497	http://dx.doi.org/10.1371/journal.pone.0111497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369066	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000060
J	Soto-Montenegro, ML; Pena-Zalbidea, S; Mateos-Perez, JM; Oteo, M; Romero, E; Morcillo, MA; Desco, M				Luisa Soto-Montenegro, Maria; Pena-Zalbidea, Santiago; Maria Mateos-Perez, Jose; Oteo, Marta; Romero, Eduardo; Angel Morcillo, Miguel; Desco, Manuel			Meningiomas: A Comparative Study of Ga-68-DOTATOC, Ga-68-DOTANOC and Ga-68-DOTATATE for Molecular Imaging in Mice	PLOS ONE			English	Article							SOMATOSTATIN RECEPTOR SUBTYPE-2; TARGET VOLUME DEFINITION; NEUROENDOCRINE TUMORS; HIGH-AFFINITY; DOTA-NOC; PET/CT; EXPRESSION; MRI; BIODISTRIBUTION; RADIOMETALS	Purpose: The goal of this study was to compare the tumor uptake kinetics and diagnostic value of three Ga-68-DOTA-labeled somatostatin analogues (Ga-68-DOTATOC, Ga-68-DOTANOC, and Ga-68-DOTATATE) using PET/CT in a murine model with subcutaneous meningioma xenografts. Methods: The experiment was performed with 16 male NUDE NU/NU mice bearing xenografts of a human meningioma cell line (CH-157MN). Ga-68-DOTATOC, Ga-68-DOTANOC, and Ga-68-DOTATATE were produced in a FASTLab automated platform. Imaging was performed on an Argus small-animal PET/CT scanner. The SUVmax of the liver and muscle, and the tumor-to-liver (T/L) and tumor-to-muscle (T/M) SUV ratios were computed. Kinetic analysis was performed using Logan graphical analysis for a two-tissue reversible compartmental model, and the volume of distribution (V-t) was determined. Results: Hepatic SUVmax and V-t were significantly higher with Ga-68-DOTANOC than with Ga-68-DOTATOC and Ga-68-DOTATATE. No significant differences between tracers were found for SUVmax in tumor or muscle. No differences were found in the T/L SUV ratio between Ga-68-DOTATATE and Ga-68-DOTATOC, both of which had a higher fraction than Ga-68-DOTANOC. The T/M SUV ratio was significantly higher with Ga-68-DOTATATE than with Ga-68-DOTATOC and Ga-68-DOTANOC. The V-t for tumor was higher with Ga-68-DOTATATE than with Ga-68-DOTANOC and relatively similar to that of Ga-68-DOTATOC. Conclusions: This study demonstrates, for the first time, the ability of the three radiolabeled somatostatin analogues tested to image a human meningioma cell line. Although V-t was relatively similar with Ga-68-DOTATATE and Ga-68-DOTATOC, uptake was higher with Ga-68-DOTATATE in the tumor than with Ga-68-DOTANOC and Ga-68-DOTATOC, suggesting a higher diagnostic value of Ga-68-DOTATATE for detecting meningiomas.	[Luisa Soto-Montenegro, Maria; Pena-Zalbidea, Santiago; Maria Mateos-Perez, Jose; Desco, Manuel] Inst Invest Sanitaria Gregorio Maranon, Unidad Med & Cirugi Expt, Madrid, Spain; [Luisa Soto-Montenegro, Maria] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain; [Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aerosp, Madrid, Spain; [Oteo, Marta; Romero, Eduardo; Angel Morcillo, Miguel] Ctr Invest Energet Medioambientales & Tecnol CIEM, Unidad Aplicac Biomed & Farmacocinet, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidad Carlos III de Madrid; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Soto-Montenegro, ML (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Unidad Med & Cirugi Expt, Madrid, Spain.	marisa@mce.hggm.es	Desco, Manuel/AAD-7137-2019; Morcillo, Miguel Angel/E-9046-2012; Romero, Eduardo/G-3083-2016; Soto-Montenegro, María Luisa/AFS-1781-2022; Aguiar, Isabel/AAC-1095-2020; Oteo, Marta/G-2587-2016	Desco, Manuel/0000-0003-0989-3231; Morcillo, Miguel Angel/0000-0002-1984-5834; Romero, Eduardo/0000-0003-1347-1947; Oteo, Marta/0000-0002-2855-3403; Soto Montenegro, Maria Luisa/0000-0003-4350-4789	Ministerio de Ciencia e Innovacion [PI11/00616, PI10/02986, CEN-20101014]; Comunidad de Madrid [ARTEMIS S2009/DPI-1802]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid)	This research was supported by Ministerio de Ciencia e Innovacion (PI11/00616, PI10/02986, CEN-20101014) and Comunidad de Madrid (ARTEMIS S2009/DPI-1802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2012, COMPUT METH PROG BIO, V107, P218, DOI 10.1016/j.cmpb.2011.06.008; Afshar-Oromieh A, 2012, EUR J NUCL MED MOL I, V39, P1409, DOI 10.1007/s00259-012-2155-3; Antunes P, 2007, EUR J NUCL MED MOL I, V34, P982, DOI 10.1007/s00259-006-0317-x; Arena S, 2004, J NEURO-ONCOL, V66, P155, DOI 10.1023/B:NEON.0000013498.19981.55; Combs SE, 2013, ACTA ONCOL, V52, P514, DOI 10.3109/0284186X.2013.762996; Dimitrakopoulou-Strauss A, 2006, EUR J NUCL MED MOL I, V33, P823, DOI 10.1007/s00259-005-0063-5; Dutour A, 1998, INT J CANCER, V76, P620, DOI 10.1002/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.3.CO;2-X; Graf R, 2013, INT J RADIAT ONCOL, V85, P68, DOI 10.1016/j.ijrobp.2012.03.021; Guermazi A, 2005, CLIN RADIOL, V60, P171, DOI 10.1016/j.crad.2004.01.019; Henze M, 2005, J NUCL MED, V46, P763; Kabasakal L, 2012, EUR J NUCL MED MOL I, V39, P1271, DOI 10.1007/s00259-012-2123-y; Kuyumcu S, 2013, ANN NUCL MED, V27, P538, DOI 10.1007/s12149-013-0718-4; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lubberink M, 2013, J NUCL MED, pP200; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Mateos-Perez JM, 2014, TRACER KINETIC MODEL, P301, DOI [10.1007/978-3-319-00846-2_75, DOI 10.1007/978-3-319-00846-2_75]; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Milker-Zabel S, 2006, INT J RADIAT ONCOL, V65, P222, DOI 10.1016/j.ijrobp.2005.12.006; Motulsky H, 2002, CURR PROTOC NEUROSCI; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Poeppel Thorsten D, 2013, Recent Results Cancer Res, V194, P353, DOI 10.1007/978-3-642-27994-2_18; Poeppel TD, 2011, J NUCL MED, V52, P1864, DOI 10.2967/jnumed.111.091165; Prasad V, 2010, Q J NUCL MED MOL IM, V54, P61; Ragel BT, 2008, SURG NEUROL, V70, P295, DOI 10.1016/j.surneu.2007.06.031; Ragel BT, 2008, J NEUROSURG, V108, P304, DOI 10.3171/JNS/2008/108/2/0304; Sandstrom M, 2013, J NUCL MED, V54, P1755, DOI 10.2967/jnumed.113.120600; Schulz S, 2000, CLIN CANCER RES, V6, P1865; Velikyan I, 2014, J NUCL MED, V55, P204, DOI 10.2967/jnumed.113.126177; Wild D, 2003, EUR J NUCL MED MOL I, V30, P1338, DOI 10.1007/s00259-003-1255-5; Wild D, 2005, EUR J NUCL MED MOL I, V32, P724, DOI 10.1007/s00259-004-1697-4; Wild D, 2013, J NUCL MED, V54, P364, DOI 10.2967/jnumed.112.111724; Yang J, 2013, ACTA RADIOL; Yilmaz S, 2013, REV ESP MED NUCL IMA, V32, P60, DOI 10.1016/j.remn.2012.02.001	33	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111624	10.1371/journal.pone.0111624	http://dx.doi.org/10.1371/journal.pone.0111624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369268	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000079
J	Madsen, DE; Hansen, S; Gram, J; Bygum, A; Drouet, C; Sidelmann, JJ				Madsen, Daniel Elenius; Hansen, Soren; Gram, Jorgen; Bygum, Anette; Drouet, Christian; Sidelmann, Johannes Jakobsen			Presence of C1-Inhibitor Polymers in a Subset of Patients Suffering from Hereditary Angioedema	PLOS ONE			English	Article							C1 INHIBITOR; Z ALPHA(1)-ANTITRYPSIN; ANGIONEUROTIC EDEMA; SERPIN DOMAIN; POLYMERIZATION; DEFICIENCY; PROTEINS	Hereditary angioedema (HAE) is a potentially life-threatening disease caused by mutations in the gene encoding the serine protease inhibitor (serpin) C1 inhibitor (C1-inh). The mutations cause decreased functional plasma levels of C1-inh, which triggers unpredictable recurrent edema attacks. Subjects suffering from HAE have been classified in type I patients with decreased functional and antigenic levels of C1-inh, and type II patients with decreased functional but normal antigenic C1-inh levels. However, a few reports have demonstrated that some mutations cause C1-inh polymerization in vitro, and it is speculated that C1-inh polymers may exist in patient plasma, challenging the current classification of HAE patients. To investigate the presence of C1-inh polymers in patient plasma samples, we developed an immunological method, where monoclonal antibodies produced against polymerized C1-inh were applied in native PAGE western blotting. Using this approach we analyzed genuine plasma samples from 31 Danish HAE families, and found that plasma samples from three genotypically distinct HAE type I families (classified upon C1-inh plasma concentrations) contained C1-inh polymers. Identical C1-inh polymerization phenotypes were observed in four affected family members from one of these families. Genotyping of the families revealed that the polymerogenic mutations of two families were located in proximity to the reactive center loop insertion site in C1-inh (p.Ile271Thr and p.Ser258_Pro260del), and one mutation affected helix C (p. Thr167Asn). In conclusion, we demonstrate that C1-inh polymers are present in the plasma of a subgroup of HAE type I patients.	[Madsen, Daniel Elenius; Gram, Jorgen; Sidelmann, Johannes Jakobsen] Univ Southern Denmark, Inst Publ Hlth, Unit Thrombosis Res, Esbjerg, Denmark; [Hansen, Soren] Univ Southern Denmark, Inst Mol Med Canc & Inflammat Res, Odense C, Denmark; [Bygum, Anette] Odense Univ Hosp, Dept Dermatol, Hereditary Angioedema Ctr Denmark, DK-5000 Odense C, Denmark; [Bygum, Anette] Odense Univ Hosp, Allergy Ctr, DK-5000 Odense C, Denmark; [Drouet, Christian] Univ Grenoble 1, Natl Reference Ctr Angioedema, Grenoble, France	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Madsen, DE (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Unit Thrombosis Res, Esbjerg, Denmark.	daniel@elenius.eu	DROUET, Christian/AAE-5682-2020; DROUET, Christian/J-8775-2019	DROUET, Christian/0000-0003-1318-4278; DROUET, Christian/0000-0003-1318-4278; Hansen, Soren/0000-0002-8186-4630; Bygum, Anette/0000-0002-3004-0180; Sidelmann, Johannes Jakobsen/0000-0001-6376-1796; Gram, Jorgen Brodersen/0000-0002-0203-1965	Karola Jorgensens Forskningsfond; Edith og Vagn Hedegaard Jensens Fond; Region, Syddanmarks Forskningsfond, Kgl; Hofbuntmager Aage Bangs Fond; Asthma-Allergi, Forbundet; Forskningsfond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Hans og Nora Buchards Fond; Messerschmidt og Hustrus Fond; PREHAEAT EU concerted action 2001 Programme; Lundbeck Foundation [R100-2011-9316] Funding Source: researchfish	Karola Jorgensens Forskningsfond; Edith og Vagn Hedegaard Jensens Fond; Region, Syddanmarks Forskningsfond, Kgl; Hofbuntmager Aage Bangs Fond; Asthma-Allergi, Forbundet; Forskningsfond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Hans og Nora Buchards Fond; Messerschmidt og Hustrus Fond; PREHAEAT EU concerted action 2001 Programme; Lundbeck Foundation(Lundbeckfonden)	Karola Jorgensens Forskningsfond, Edith og Vagn Hedegaard Jensens Fond, Region, Syddanmarks Forskningsfond, Kgl. Hofbuntmager Aage Bangs Fond, Asthma-Allergi, Forbundet, Augustinus Fonden, Dansk Dermatologisk Selskabs Forskningsfond, Direktor Jacob Madsen og Hustru Olga Madsens Fond, Hans og Nora Buchards Fond, P. A. Messerschmidt og Hustrus Fond and the PREHAEAT EU concerted action 2001 Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULAK KS, 1993, J BIOL CHEM, V268, P18088; Beinrohr L, 2007, J BIOL CHEM, V282, P21100, DOI 10.1074/jbc.M700841200; Bork K, 2012, J ALLERGY CLIN IMMUN, V130, P692, DOI 10.1016/j.jaci.2012.05.055; Bos IGA, 2003, J BIOL CHEM, V278, P29463, DOI 10.1074/jbc.M302977200; Bos IGA, 2002, IMMUNOBIOLOGY, V205, P518, DOI 10.1078/0171-2985-00151; Bossi F, 2009, J ALLERGY CLIN IMMUN, V124, P1303, DOI 10.1016/j.jaci.2009.08.007; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Cabrita LD, 2004, BIOCHEMISTRY-US, V43, P9834, DOI 10.1021/bi0491346; Cicardi M, 2014, ALLERGY, V69, P602, DOI 10.1111/all.12380; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; Elliott PR, 1998, AM J RESP CELL MOL, V18, P670, DOI 10.1165/ajrcmb.18.5.3065; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Galfre G, 1981, Methods Enzymol, V73, P3; Gompels MM, 2005, CLIN EXP IMMUNOL, V139, P379, DOI 10.1111/j.1365-2249.2005.02726.x; Kaplan AP, 2010, J ALLERGY CLIN IMMUN, V126, P918, DOI 10.1016/j.jaci.2010.08.012; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Longhurst H, 2012, LANCET, V379, P474, DOI 10.1016/S0140-6736(11)60935-5; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Mahadeva R, 1999, J CLIN INVEST, V103, P999, DOI 10.1172/JCI4874; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Osler W, 1888, AM J MED SCI, V95, P362; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; Zahedi R, 1996, J BIOL CHEM, V271, P24307, DOI 10.1074/jbc.271.39.24307	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112051	10.1371/journal.pone.0112051	http://dx.doi.org/10.1371/journal.pone.0112051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369003	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000138
J	Mandl, M; Schmitz, S; Weber, C; Hristov, M				Mandl, Manuela; Schmitz, Susanne; Weber, Christian; Hristov, Michael			Characterization of the CD14(++)CD16(+) Monocyte Population in Human Bone Marrow	PLOS ONE			English	Article							PREDICT CARDIOVASCULAR EVENTS; TIE2-EXPRESSING MONOCYTES; SUBSETS; ATHEROSCLEROSIS; RECRUITMENT; BLOOD	Numerous studies have divided blood monocytes according to their expression of the surface markers CD14 and CD16 into following subsets: classical CD14(++)CD16(-), intermediate CD14(++)CD16(+) and nonclassical CD14(+)CD16(++) monocytes. These subsets differ in phenotype and function and are further correlated to cardiovascular disease, inflammation and cancer. However, the CD14/CD16 nature of resident monocytes in human bone marrow remains largely unknown. In the present study, we identified a major population of CD14(++)CD16(+) monocytes by using cryopreserved bone marrow mononuclear cells from healthy donors. These cells express essential monocyte-related antigens and chemokine receptors such as CD11a, CD18, CD44, HLA-DR, Ccr2, Ccr5, Cx3cr1, Cxcr2 and Cxcr4. Notably, the expression of Ccr2 was inducible during culture. Furthermore, sorted CD14(++)CD16(+) bone marrow cells show typical macrophage morphology, phagocytic activity, angiogenic features and generation of intracellular oxygen species. Side-by-side comparison of the chemokine receptor profile with unpaired blood samples also demonstrated that these rather premature medullar monocytes mainly match the phenotype of intermediate and partially of (non) classical monocytes. Together, human monocytes obviously acquire their definitive CD14/CD16 signature in the bloodstream and the medullar monocytes probably transform into CD14(++)CD16(-) and CD14(+)CD16(++) subsets which appear enriched in the periphery.	[Mandl, Manuela; Schmitz, Susanne; Weber, Christian; Hristov, Michael] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Weber, Christian] Munich Heart Alliance, Munich, Germany	University of Munich; Munich Heart Alliance	Hristov, M (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Munich, Germany.	michael.hristov@med.uni-muenchen.de	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714	Deutsche Forschungsgemeinschaft; August-Lenz-Stiftung [FOR809, HR18/1-1, SFB 1123 A1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); August-Lenz-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft, (FOR809, HR18/1-1, SFB 1123 A1) August-Lenz-Stiftung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken Anne Margrethe, 2006, Curr Stem Cell Res Ther, V1, P47, DOI 10.2174/157488806775269179; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Hiebl B, 2008, CLIN HEMORHEOL MICRO, V39, P221, DOI 10.3233/CH-2008-1086; Hristov M, 2011, THROMB HAEMOSTASIS, V106, P757, DOI 10.1160/TH11-07-0500; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soehnlein O, 2013, EMBO MOL MED, V5, P471, DOI 10.1002/emmm.201201717; Sofrenovic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048067; Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x; Van Hemelen D, 2010, J IMMUNOL METHODS, V353, P138, DOI 10.1016/j.jim.2009.11.012; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	19	38	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112140	10.1371/journal.pone.0112140	http://dx.doi.org/10.1371/journal.pone.0112140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369328	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402000143
J	Puig-Vilanova, E; Aguilo, R; Rodriguez-Fuster, A; Martinez-Llorens, J; Gea, J; Barreiro, E				Puig-Vilanova, Ester; Aguilo, Rafael; Rodriguez-Fuster, Alberto; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther			Epigenetic Mechanisms in Respiratory Muscle Dysfunction of Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SEVERE COPD PATIENTS; SKELETAL-MUSCLE; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; HUMAN DIAPHRAGM; ACETYLATION; IDENTIFICATION; EXACERBATIONS; MICRORNA-1	Epigenetic events are differentially expressed in the lungs and airways of patients with chronic obstructive pulmonary disease (COPD). Moreover, epigenetic mechanisms are involved in the skeletal (peripheral) muscle dysfunction of COPD patients. Whether epigenetic events may also regulate respiratory muscle dysfunction in COPD remains unknown. We hypothesized that epigenetic mechanisms would be differentially expressed in the main inspiratory muscle (diaphragm) of patients with COPD of a wide range of disease severity compared to healthy controls. In diaphragm muscle specimens (thoracotomy due to lung localized neoplasms) of sedentary patients with mild-to-moderate and severe COPD, with preserved body composition, and sedentary healthy controls, expression of muscle-enriched microRNAs, histone acetyltransferases (HATs) and deacetylases (HDACs), total DNA methylation and protein acetylation, small ubiquitin-related modifier (SUMO) ligases, muscle-specific transcription factors, and muscle structure were explored. All subjects were also clinically evaluated: lung and muscle functions and exercise capacity. Compared to healthy controls, patients exhibited moderate airflow limitation and diffusion capacity, and reduced exercise tolerance and transdiaphragmatic strength. Moreover, in the diaphragm of the COPD patients, muscle-specific microRNA expression was downregulated, while HDAC4 and myocyte enhancer factor (MEF) 2C protein levels were higher, and DNA methylation levels, muscle fiber types and sizes did not differ between patients and controls. In the main respiratory muscle of COPD patients with a wide range of disease severity and normal body composition, muscle-specific microRNAs were downregulated, while HDAC4 and MEF2C levels were upregulated. It is likely that these epigenetic events act as biological adaptive mechanisms to better overcome the continuous inspiratory loads of the respiratory system in COPD. These findings may offer novel therapeutic strategies to specifically target respiratory muscle dysfunction in patients with COPD.	[Puig-Vilanova, Ester; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] UPF, IMIM Hosp Mar Parc Salut Mar, Hlth & Expt Sci Dept CEXS, Dept Pulmonol,Muscle & Resp Syst Res Unit URMAR, Barcelona, Spain; [Puig-Vilanova, Ester; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] Inst Salud Carlos III, Ctr Invest Red Enfermedades Resp CIBERES, Madrid, Spain; [Aguilo, Rafael; Rodriguez-Fuster, Alberto] Hosp Mar, Dept Thorac Surg, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Barreiro, E (corresponding author), UPF, IMIM Hosp Mar Parc Salut Mar, Hlth & Expt Sci Dept CEXS, Dept Pulmonol,Muscle & Resp Syst Res Unit URMAR, Barcelona Biomed Res Pk PRBB, Barcelona, Spain.	ebarreiro@imim.es	Rodríguez-Fuster, Albert/AAY-3233-2021	Rodriguez-Fuster, Alberto/0000-0002-4900-6126	CIBERES; FIS [11/02029, 12/02534]; SEPAR; FUCAP; Marato TV3 (Spain) [MTV3-07-1010]; ERS;  [SAF-2011-26908];  [2009-SGR-393]	CIBERES; FIS(Instituto de Salud Carlos III); SEPAR; FUCAP; Marato TV3 (Spain); ERS; ; 	This study has been supported by CIBERES; FIS 11/02029; FIS 12/02534; SAF-2011-26908; 2009-SGR-393; SEPAR 2009; FUCAP 2011; FUCAP 2012; and Marato TV3 (MTV3-07-1010) (Spain). Dr. Esther Barreiro was a recipient of the ERS COPD Research Award 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Barreiro E, 2005, AM J RESP CRIT CARE, V171, P1116, DOI 10.1164/rccm.200407-887OC; Barreiro E, 2013, J APPL PHYSIOL, V114, P1263, DOI 10.1152/japplphysiol.01027.2012; Bischof O, 2007, CELL CYCLE, V6, P677, DOI 10.4161/cc.6.6.4021; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; den Kamp CMO, 2012, LUNG CANCER, V76, P112, DOI 10.1016/j.lungcan.2011.09.012; Donaldson A, 2013, THORAX, V68, P1140, DOI 10.1136/thoraxjnl-2012-203129; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Gayan-Ramirez G, 2013, J APPL PHYSIOL, V114, P1291, DOI 10.1152/japplphysiol.00847.2012; Gea J, 2013, J APPL PHYSIOL, V114, P1222, DOI 10.1152/japplphysiol.00981.2012; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Hadoux J, 2014, INT J CANCER, V135, P2711, DOI 10.1002/ijc.28913; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Levine S, 1997, NEW ENGL J MED, V337, P1799, DOI 10.1056/NEJM199712183372503; Levine S, 2013, J APPL PHYSIOL, V114, P1235, DOI 10.1152/japplphysiol.01121.2012; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantilla CB, 2013, J APPL PHYSIOL, V114, P1246, DOI 10.1152/japplphysiol.01212.2012; Marin-Corral J, 2009, EUR RESPIR J, V33, P1309, DOI 10.1183/09031936.00072008; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P86, DOI 10.1016/j.arbres.2011.10.007; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Ortega F, 2002, AM J RESP CRIT CARE, V166, P669, DOI 10.1164/rccm.2107081; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Polkey MI, 1996, AM J RESP CRIT CARE, V154, P1310, DOI 10.1164/ajrccm.154.5.8912741; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puig-Vilanova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102296; Remels AHV, 2013, J APPL PHYSIOL, V114, P1253, DOI 10.1152/japplphysiol.00790.2012; Saccone V, 2014, GENE DEV, V28, P841, DOI 10.1101/gad.234468.113; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; SIMILOWSKI T, 1991, NEW ENGL J MED, V325, P917, DOI 10.1056/NEJM199109263251304; Toth MJ, 2013, J APPL PHYSIOL, V114, P858, DOI 10.1152/japplphysiol.01474.2012; Vilaro J, 2010, RESP MED, V104, P1896, DOI 10.1016/j.rmed.2010.05.001	46	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111514	10.1371/journal.pone.0111514	http://dx.doi.org/10.1371/journal.pone.0111514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369292	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000063
J	Shefer, G; Henderson, C; Howard, LM; Murray, J; Thornicroft, G				Shefer, Guy; Henderson, Claire; Howard, Louise M.; Murray, Joanna; Thornicroft, Graham			Diagnostic Overshadowing and Other Challenges Involved in the Diagnostic Process of Patients with Mental Illness Who Present in Emergency Departments with Physical Symptoms - A Qualitative Study	PLOS ONE			English	Article							EXCESS CANCER-MORTALITY; HEALTH-CARE; INTELLECTUAL DISABILITIES; PSYCHIATRIC-PATIENTS; DISORDERS; PEOPLE; SCHIZOPHRENIA; DISPARITIES	We conducted a qualitative study in the Emergency Departments (EDs) of four hospitals in order to investigate the perceived scope and causes of 'diagnostic overshadowing' - the misattribution of physical symptoms to mental illness and other challenges involved in the diagnostic process of people with mental illness who present in EDs with physical symptoms. Eighteen doctors and twenty-one nurses working in EDs and psychiatric liaisons teams in four general hospitals in the UK were interviewed. Interviewees were asked about cases in which mental illness interfered with diagnosis of physical problems and about other aspects of the diagnostic process. Interviews were transcribed and analysed thematically. Interviewees reported various scenarios in which mental illness or factors related to it led to misdiagnosis or delayed treatment with various degrees of seriousness. Direct factors which may lead to misattribution in this regard are complex presentations or aspects related to poor communication or challenging behaviour of the patient. Background factors are the crowded nature of the ED environment, time pressures and targets and stigmatising attitudes held by a minority of staff. The existence of psychiatric liaison team covering the ED twenty-four hours a day, seven days a week, can help reduce the risk of misdiagnosis of people with mental illness who present with physical symptoms. However, procedures used by emergency and psychiatric liaison staff require fuller operationalization to reduce disagreement over where responsibilities lie.	[Shefer, Guy; Henderson, Claire; Howard, Louise M.; Murray, Joanna; Thornicroft, Graham] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England	University of London; King's College London	Shefer, G (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England.	guy.shefer@cantab.net	Thornicroft, Graham/B-4027-2010; Howard, Louise/E-3495-2010; Henderson, Claire/E-4664-2010	Thornicroft, Graham/0000-0003-0662-0879; Howard, Louise/0000-0001-9942-744X; Henderson, Claire/0000-0002-6998-5659	Maudsley Charity; NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London; South London and Maudsley NHS Foundation Trust; National Institute for Health Research [NF-SI-0611-10053, RP-PG-0606-1053] Funding Source: researchfish	Maudsley Charity; NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London; South London and Maudsley NHS Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a grant from the Maudsley Charity. GT is funded through a NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London and the South London and Maudsley NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afia A, 2013, PLOS ONE, V8; Clarke DE, 2007, INT J MENT HEALTH NU, V16, P126, DOI 10.1111/j.1447-0349.2007.00455.x; Disability Rights Commission, 2006, EQ TREATM CLOS GAP F; Donner B, 2010, J APPL RES INTELLECT, V23, P214, DOI 10.1111/j.1468-3148.2009.00527.x; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Frayne SM, 2005, ARCH INTERN MED, V165, P2631, DOI 10.1001/archinte.165.22.2631; Gissler M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-834; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Howard LM, LANCET ONCOL, V11, P797; Joint Commissioning Panel for Mental Health, 2012, GUID COMM LIAIS MENT; Jones S, 2008, ACTA PSYCHIAT SCAND, V118, P169, DOI 10.1111/j.1600-0447.2008.01211.x; Kisely S, 2008, CAN J PSYCHIAT, V53, P753, DOI 10.1177/070674370805301107; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; Laursen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024597; Laursen TM, 2013, ANNU REV CLIN PSYCHO, V10; Lawrence D, ACTA PSYCHIAT SCAND, V101, P382; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; Mai Q, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-118; Mason J, 2004, J APPL RES INTELLECT, V17, P85, DOI 10.1111/j.1360-2322.2004.00184.x; Parks J., 2006, MORBIDITY MORTALITY; Ritchie J, 2014, QUALITATIVE RES PRAC; Roberts L, 2007, FAM PRACT, V24, P34, DOI 10.1093/fampra/cml054; Sullivan G, 2006, PSYCHIAT SERV, V57, P1126, DOI 10.1176/appi.ps.57.8.1126; Thornicroft G, 2007, BRIT J PSYCHIAT, V190, P192, DOI 10.1192/bjp.bp.106.025791; van Nieuwenhuizen A, 2013, J EPIDEM PSYCH SCI, V22, P255; Wood R, 2014, J PSYCHOSOM RES, V76, P175, DOI 10.1016/j.jpsychores.2014.01.002	26	101	101	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111682	10.1371/journal.pone.0111682	http://dx.doi.org/10.1371/journal.pone.0111682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369130	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000085
J	Sznajd-Weron, K; Szwabinski, J; Weron, R				Sznajd-Weron, Katarzyna; Szwabinski, Janusz; Weron, Rafal			Is the Person-Situation Debate Important for Agent-Based Modeling and Vice-Versa?	PLOS ONE			English	Article							DYNAMICS; BEHAVIOR; HISTORY; VALUES	Background: Agent-based models (ABM) are believed to be a very powerful tool in the social sciences, sometimes even treated as a substitute for social experiments. When building an ABM we have to define the agents and the rules governing the artificial society. Given the complexity and our limited understanding of the human nature, we face the problem of assuming that either personal traits, the situation or both have impact on the social behavior of agents. However, as the long-standing person-situation debate in psychology shows, there is no consensus as to the underlying psychological mechanism and the important question that arises is whether the modeling assumptions we make will have a substantial influence on the simulated behavior of the system as a whole or not. Methodology/Principal Findings: Studying two variants of the same agent-based model of opinion formation, we show that the decision to choose either personal traits or the situation as the primary factor driving social interactions is of critical importance. Using Monte Carlo simulations (for Barabasi-Albert networks) and analytic calculations (for a complete graph) we provide evidence that assuming a person-specific response to social influence at the microscopic level generally leads to a completely different and less realistic aggregate or macroscopic behavior than an assumption of a situation-specific response; a result that has been reported by social psychologists for a range of experimental setups, but has been downplayed or ignored in the opinion dynamics literature. Significance: This sensitivity to modeling assumptions has far reaching consequences also beyond opinion dynamics, since agent-based models are becoming a popular tool among economists and policy makers and are often used as substitutes of real social experiments.	[Sznajd-Weron, Katarzyna] Wroclaw Univ Technol, Inst Phys, PL-50370 Wroclaw, Poland; [Szwabinski, Janusz] Univ Wroclaw, Inst Theoret Phys, PL-50138 Wroclaw, Poland; [Weron, Rafal] Wroclaw Univ Technol, Inst Org & Management, PL-50370 Wroclaw, Poland	Wroclaw University of Science & Technology; University of Wroclaw; Wroclaw University of Science & Technology	Sznajd-Weron, K (corresponding author), Wroclaw Univ Technol, Inst Phys, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	katarzyna.weron@pwr.edu.pl	Weron, Rafał/ABG-6143-2021	Weron, Rafał/0000-0003-1619-5239; Szwabinski, Janusz/0000-0002-6992-3634; Sznajd-Weron, Katarzyna/0000-0002-1851-8508	National Science Centre (NCN) [2011/01/B/ST3/00727, 2013/11/B/HS4/01061]; PL-Grid Infrastructure	National Science Centre (NCN); PL-Grid Infrastructure	This work was partially supported by funds from the National Science Centre (NCN) through grants no. 2011/01/B/ST3/00727 and 2013/11/B/HS4/01061, and by the PL-Grid Infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bergmann JHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088080; Buchanan M, 2009, NATURE, V460, P680, DOI 10.1038/460680a; Castellano C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041129; de la Lama MS, 2005, EUROPHYS LETT, V72, P851, DOI 10.1209/epl/i2005-10299-3; Donnellan MB, 2009, J RES PERS, V43, P117, DOI 10.1016/j.jrp.2009.02.010; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Galam S, 2005, EUROPHYS LETT, V70, P705, DOI 10.1209/epl/i2004-10526-5; GALAM S, 1986, J MATH PSYCHOL, V30, P426, DOI 10.1016/0022-2496(86)90019-2; Galam S, 2007, PHYSICA A, V381, P366, DOI 10.1016/j.physa.2007.03.034; Garcia R, 2011, J PROD INNOVAT MANAG, V28, P148, DOI 10.1111/j.1540-5885.2011.00788.x; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Kiesling E, 2012, CENT EUR J OPER RES, V20, P183, DOI 10.1007/s10100-011-0210-y; Kowalska-Pyzalska A, 2014, ENERG POLICY, V72, P164, DOI 10.1016/j.enpol.2014.04.021; Krapivsky P., 2010, KINETIC VIEW STAT PH; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Liggett T.M., 1985, INTERACTING PARTICLE, DOI DOI 10.1007/978-1-4613-8542-4; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; Mobilia M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028701; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084592; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Myers D. G., 2013, SOCIAL PSYCHOL; Niss M, 2011, ARCH HIST EXACT SCI, V65, P625, DOI 10.1007/s00407-011-0086-1; Niss M, 2009, ARCH HIST EXACT SCI, V63, P243, DOI 10.1007/s00407-008-0039-5; Niu BL, 2013, APPL MECH MAT, V347-350, P3827; Nyczka P, 2013, J STAT PHYS, V151, P174, DOI 10.1007/s10955-013-0701-4; Nyczka P, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011105; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Schwartz SH, 2001, J CROSS CULT PSYCHOL, V32, P519, DOI 10.1177/0022022101032005001; Schwartz SH, 2012, J PERS SOC PSYCHOL, V103, P663, DOI 10.1037/a0029393; Sobkowicz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080524; Sobkowicz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044489; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Sznajd-Weron K, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/03/P03007; van Dolder D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092276; Weinberger S, 2011, NATURE, V471, P566, DOI 10.1038/471566a	39	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112203	10.1371/journal.pone.0112203	http://dx.doi.org/10.1371/journal.pone.0112203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369531	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000145
J	Thompson, ACS; Bruss, MD; Nag, N; Kharitonenkov, A; Adams, AC; Hellerstein, MK				Thompson, Airlia C. S.; Bruss, Matthew D.; Nag, Nitish; Kharitonenkov, Alexei; Adams, Andrew C.; Hellerstein, Marc K.			Fibroblast Growth Factor 21 Is Not Required for the Reductions in Circulating Insulin-Like Growth Factor-1 or Global Cell Proliferation Rates in Response to Moderate Calorie Restriction in Adult Mice	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; FATAL NEOPLASTIC DISEASES; IGF-BINDING-PROTEINS; LIFE-SPAN EXTENSION; DIETARY RESTRICTION; PPAR-ALPHA; DELAYED OCCURRENCE; FACTOR SYSTEM; DWARF MICE; HORMONE	Calorie restriction (CR) delays aging and extends lifespan in numerous organisms, including mice. Down-regulation of the somatotropic axis, including a reduction in insulin-like growth factor-1 (IGF-1), likely plays an important role in CR-induced lifespan extension, possibly by reducing cell proliferation rates, thereby delaying replicative senescence and inhibiting tumor promotion. Accordingly, elucidating the mechanism(s) by which IGF-1 is reduced in response to CR holds therapeutic potential in the fight against age-related diseases. Up-regulation of fibroblast growth factor 21 (FGF21) is one possible mechanism given that FGF21 expression is induced in response to nutritional deprivation and has been implicated as a negative regulator of IGF-1 expression. Here we investigated alterations in hepatic growth hormone (GH)-mediated IGF-1 production and signaling as well as the role of FGF21 in the regulation of IGF-1 levels and cell proliferation rates in response to moderate CR in adult mice. We found that in response to moderate CR, circulating GH and hepatic janus kinase 2 (JAK2) phosphorylation levels are unchanged but that hepatic signal transducer and activator of transcription 5 (STAT5) phosphorylation levels are reduced, identifying STAT5 phosphorylation as a potential key site of CR action within the somatotropic axis. Circadian measurements revealed that the relative level of FGF21 expression is both higher and lower in CR vs. ad libitum (AL)-fed mice, depending on the time of measurement. Employing FGF21-knockout mice, we determined that FGF21 is not required for the reduction in IGF-1 levels or cell proliferation rates in response to moderate CR. However, compared to AL-fed WT mice, AL-fed FGF21-knockout mice exhibited higher basal rates of cell proliferation, suggesting antimitotic effects of FGF21. This work provides insights into both GH-mediated IGF-1 production in the context of CR and the complex network that regulates FGF21 and IGF-1 expression and cell proliferation rates in response to nutritional status.	[Thompson, Airlia C. S.; Bruss, Matthew D.; Nag, Nitish; Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kharitonenkov, Alexei; Adams, Andrew C.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA; [Hellerstein, Marc K.] KineMed Inc, Emeryville, CA USA	University of California System; University of California Berkeley; Eli Lilly	Thompson, ACS (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	airlia.thompson@gmail.com; march@berkeley.edu	Nag, Nitish/H-8033-2016	Nag, Nitish/0000-0002-8409-1223	College of Natural Resources at the University of California at Berkeley; KineMed, Inc.; Lilly Research Laboratories (Lilly Corporate Center, Indianapolis, Indiana); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061918, P30DK026743] Funding Source: NIH RePORTER	College of Natural Resources at the University of California at Berkeley; KineMed, Inc.; Lilly Research Laboratories (Lilly Corporate Center, Indianapolis, Indiana); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from the College of Natural Resources at the University of California at Berkeley. MKH is an employee of KineMed, Inc., and received salary from them. ACA is currently and AK was previously employed at Lilly Research Laboratories (Lilly Corporate Center, Indianapolis, Indiana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, MOL METAB, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Alderman JM, 2010, GERONTOLOGY, V56, P404, DOI 10.1159/000235720; Alderman JM, 2009, EXP GERONTOL, V44, P26, DOI 10.1016/j.exger.2008.05.014; ARMARIO A, 1987, ANN NUTR METAB, V31, P81, DOI 10.1159/000177254; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BIELSCHOWSKY F, 1961, BRIT J CANCER, V15, P257, DOI 10.1038/bjc.1961.32; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Bruss MD, 2011, AM J PHYSIOL-ENDOC M, V300, pE735, DOI 10.1152/ajpendo.00661.2010; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Busch R, 2007, NAT PROTOC, V2, P3045, DOI 10.1038/nprot.2007.420; Chacon F, 2005, CHRONOBIOL INT, V22, P253, DOI 10.1081/CBI-200053522; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; de Magalhaes JP, 2008, BIOESSAYS, V30, P567, DOI 10.1002/bies.20760; Dunn SE, 1997, CANCER RES, V57, P4667; Ferry RJ, 1999, HORM RES, V51, P53; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fontana L, 2008, AGING CELL, V7, P681, DOI 10.1111/j.1474-9726.2008.00417.x; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Herington AC, 2012, OPEN ENDOCRINOLOGY J, V6, P13, DOI DOI 10.2174/1874216501206010013; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hsieh EA, 2005, AM J PHYSIOL-ENDOC M, V288, pE965, DOI 10.1152/ajpendo.00368.2004; Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241; HURSTING SD, 1993, CANCER RES, V53, P2750; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Katewa SD, 2010, AGING CELL, V9, P105, DOI 10.1111/j.1474-9726.2010.00552.x; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kubicky RA, 2012, ENDOCRINOLOGY, V153, P2287, DOI 10.1210/en.2011-1909; Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160; Lelbach A., 2005, ACTA PHYSIOLOGICA HUNGARICA, V92, P97, DOI 10.1556/APhysiol.92.2005.2.1; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lips MA, 2014, CLIN ENDOCRINOL, V81, P862, DOI 10.1111/cen.12496; LOK E, 1990, CANCER LETT, V51, P67, DOI 10.1016/0304-3835(90)90232-M; LOK E, 1988, CANCER LETT, V38, P249, DOI 10.1016/0304-3835(88)90016-X; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McCarty MF, 1997, MED HYPOTHESES, V48, P297, DOI 10.1016/S0306-9877(97)90098-0; Mendenhall CL, 1997, ALCOHOL CLIN EXP RES, V21, P1; Rosenfeld RG, 2009, HORM RES, V71, P36, DOI 10.1159/000192434; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; SONNTAG WE, 1995, NEUROENDOCRINOLOGY, V61, P601, DOI 10.1159/000126885; Sonntag WE, 1999, J GERONTOL A-BIOL, V54, pB521, DOI 10.1093/gerona/54.12.B521; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Touvier T, 2009, J CLIN INVEST, V119, P3830, DOI 10.1172/JCI34997; WOLF NS, 1995, EXP CELL RES, V217, P317, DOI 10.1006/excr.1995.1092; Wu SF, 2013, J BIOL CHEM, V288, P27375, DOI 10.1074/jbc.M113.462218; Xu J, 2009, AM J PHYSL ENDOCRINO; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	62	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111418	10.1371/journal.pone.0111418	http://dx.doi.org/10.1371/journal.pone.0111418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369265	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000055
J	van Bracht, E; Versteegden, LRM; Stolle, S; Verdurmen, WPR; Woestenenk, R; Raave, R; Hafmans, T; Oosterwijk, E; Brock, R; van Kuppevelt, TH; Daamen, WF				van Bracht, Etienne; Versteegden, Luuk R. M.; Stolle, Sarah; Verdurmen, Wouter P. R.; Woestenenk, Rob; Raave, Rene; Hafmans, Theo; Oosterwijk, Egbert; Brock, Roland; van Kuppevelt, Toin H.; Daamen, Willeke F.			Enhanced Cellular Uptake of Albumin-Based Lyophilisomes when Functionalized with Cell-Penetrating Peptide TAT in HeLa Cells	PLOS ONE			English	Article							DRUG-DELIVERY; CANCER THERAPEUTICS; CONTRAST AGENT; IN-VIVO; NANOPARTICLES; EFFICACY; PACLITAXEL; PROTEIN; INTERNALIZATION; CYTOTOXICITY	Lyophilisomes are a novel class of biodegradable proteinaceous nano/micrometer capsules with potential use as drug delivery carrier. Cell-penetrating peptides (CPPs) including the TAT peptide have been successfully implemented for intracellular delivery of a broad variety of cargos including various nanoparticulate pharmaceutical carriers. In the present study, lyophilisomes were modified using CPPs in order to achieve enhanced cellular uptake. Lyophilisomes were prepared by a freezing, annealing, and lyophilization method and a cystein-elongated TAT peptide was conjugated to the lyophilisomes using a heterobifunctional linker. Fluorescent-activated cell sorting (FACS) was utilized to acquire a lyophilisome population with a particle diameter smaller than 1000 nm. Cultured HeLa, OVCAR-3, Caco-2 and SKOV-3 cells were exposed to unmodified lyophilisomes and TAT-conjugated lyophilisomes and examined with FACS. HeLa cells were investigated in more detail using a trypan blue quenching assay, confocal microscopy, and transmission electron microscopy. TAT-conjugation strongly increased binding and cellular uptake of lyophilisomes in a time-dependent manner in vitro, as assessed by FACS. These results were confirmed by confocal microscopy. Transmission electron microscopy indicated rapid cellular uptake of TAT-conjugated lyophilisomes via phagocytosis and/or macropinocytosis. In conclusion, TAT-peptides conjugated to albumin-based lyophilisomes are able to enhance cellular uptake of lyophilisomes in HeLa cells.	[van Bracht, Etienne; Versteegden, Luuk R. M.; Stolle, Sarah; Verdurmen, Wouter P. R.; Raave, Rene; Hafmans, Theo; Brock, Roland; van Kuppevelt, Toin H.; Daamen, Willeke F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [Woestenenk, Rob] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 GA Nijmegen, Netherlands; [Oosterwijk, Egbert] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Urol, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Daamen, WF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	Willeke.Daamen@radboudumc.nl	Raave, Rene/R-3193-2019; Brock, Roland/O-9411-2019; Oosterwijk, Egbert/P-5466-2014; Woestenenk, Rob/C-6119-2016; Brock, Roland/K-2590-2012; Verdurmen, Wouter/H-7457-2016; Daamen, Willeke F./D-5854-2015; Raavé, René/E-2860-2016; van Kuppevelt, A.H.M.S.M./L-4463-2015	Raave, Rene/0000-0002-5234-0707; Brock, Roland/0000-0003-1395-6127; Verdurmen, Wouter/0000-0002-2463-277X; Daamen, Willeke F./0000-0003-3155-3030; Raavé, René/0000-0001-6066-4448; 	Radboud university medical centre	Radboud university medical centre	The research project was funded by the Radboud university medical centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329; Brandhonneur N, 2009, EUR J PHARM SCI, V36, P474, DOI 10.1016/j.ejps.2008.11.013; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Daamen WF, 2007, ADV MATER, V19, P673, DOI 10.1002/adma.200601947; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Elzoghby A.O., 2012, J CONTROL RELEASE; Elzoghby A.O., 2011, J CONTROL RELEASE; FEINSTEIN SB, 1990, J AM COLL CARDIOL, V16, P316, DOI 10.1016/0735-1097(90)90580-I; Frankel AD, 1992, CURR OPIN GENET DEV, V2, P293, DOI 10.1016/S0959-437X(05)80287-4; Fretz MM, 2004, BBA-BIOMEMBRANES, V1665, P48, DOI 10.1016/j.bbamem.2004.06.022; Garza-Licudine E, 2010, IEEE ENG MED BIO, P5736, DOI 10.1109/IEMBS.2010.5627861; GEISOW MJ, 1984, EXP CELL RES, V150, P29, DOI 10.1016/0014-4827(84)90698-0; GENY B, 1993, J AM COLL CARDIOL, V22, P1193, DOI 10.1016/0735-1097(93)90437-6; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Haley B, 2008, UROL ONCOL-SEMIN ORI, V26, P57, DOI 10.1016/j.urolonc.2007.03.015; Ibrahim NK, 2005, J CLIN ONCOL, V23, P6019, DOI 10.1200/JCO.2005.11.013; Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Lei TJ, 2011, NANOMED-NANOTECHNOL, V7, P324, DOI 10.1016/j.nano.2010.11.004; Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P6534, DOI 10.1166/jnn.2010.2637; MacEwan SR, 2013, WIRES NANOMED NANOBI, V5, P31, DOI 10.1002/wnan.1197; Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jconrel.2005.08.007; Nuutila J, 2005, CYTOM PART A, V65A, P93, DOI 10.1002/cyto.a.20139; Oh E, 2011, ACS NANO, V5, P6434, DOI 10.1021/nn201624c; Orr G, 2009, TOXICOL APPL PHARM, V236, P210, DOI 10.1016/j.taap.2009.01.022; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Qin Y, 2011, INT J PHARMACEUT, V420, P304, DOI 10.1016/j.ijpharm.2011.09.008; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Sawant RR, 2009, INT J PHARMACEUT, V374, P114, DOI 10.1016/j.ijpharm.2009.02.022; Tario Joseph D Jr, 2007, Immunol Invest, V36, P861, DOI 10.1080/08820130701712933; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; Tseng YL, 2002, MOL PHARMACOL, V62, P864, DOI 10.1124/mol.62.4.864; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; van Bracht E, 2014, EUR J PHARM BIOPHARM; van Bracht E, 2012, INT J PHARMACEUT, V439, P127, DOI 10.1016/j.ijpharm.2012.10.008; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wallace PK, 2008, CYTOM PART A, V73A, P1019, DOI 10.1002/cyto.a.20619; Wang J, 2011, SMALL, V7, P1919, DOI 10.1002/smll.201100442; Xia H, 2012, INT J PHARM	49	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110813	10.1371/journal.pone.0110813	http://dx.doi.org/10.1371/journal.pone.0110813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369131	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000029
J	Lee, HN; Lee, NO; Han, SJ; Ko, IJ; Oh, JI				Lee, Ha-Na; Lee, Na-On; Han, Seung J.; Ko, In-Jeong; Oh, Jeong-Il			Regulation of the ahpC Gene Encoding Alkyl Hydroperoxide Reductase in Mycobacterium smegmatis	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; CAMP RECEPTOR PROTEIN; ANTIOXIDANT DEFENSE SYSTEM; CYCLIC-AMP; ESCHERICHIA-COLI; CATALASE-PEROXIDASE; NITRIC-OXIDE; TRANSCRIPTION ACTIVATION; CRYSTAL-STRUCTURE; FUR PROTEIN	The ahpC (MSMEG_4891) gene encodes alkyl hydroperoxide reductase C in Mycobacterium smegmatis mc(2)155 and its expression is induced under oxidative stress conditions. Two well-defined inverted repeat sequences (IR1 and IR2) were identified in the upstream region of ahpC. Using a crp (cAMP receptor protein: MSMEG_6189) mutant and in vitro DNA-binding assay, it was demonstrated that the IR1 sequence serves as a Crp-binding site and that Crp functions as an activator in the regulation of ahpC expression. The expression level of ahpC was shown to be proportional to intracellular cAMP levels. Intracellular levels of cAMP were increased in M. smegmatis, when it was treated with oxidative stress inducers. The IR2 sequence is very similar to the known consensus sequence of FurA-binding sites and involved in the negative regulation of ahpC expression. Taken together, these results suggest that the induction of ahpC expression under oxidative stress conditions probably results from a combinatory effect of both inactivation of FurA by oxidative stress and activation of Crp in response to increased levels of cAMP.	[Lee, Ha-Na; Lee, Na-On; Oh, Jeong-Il] Pusan Natl Univ, Dept Microbiol, Pusan, South Korea; [Han, Seung J.] Yonsei Univ, Dept Microbiol, Seoul 120749, South Korea; [Han, Seung J.] Yonsei Univ, Inst Immunol & Immunol Dis, Seoul 120749, South Korea; [Ko, In-Jeong] Korea Adv Inst Sci & Technol, Korea Sci Acad, Pusan, South Korea	Pusan National University; Yonsei University; Yonsei University; Korea Advanced Institute of Science & Technology (KAIST)	Oh, JI (corresponding author), Pusan Natl Univ, Dept Microbiol, Pusan, South Korea.	joh@pusan.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A2004243]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program to JIO through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A2004243). The authors hereby declare that the funder, which is supporting the research related to this manuscript, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung HL, 2014, J BACTERIOL, V196, P3091, DOI 10.1128/JB.01771-14; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chauhan R, 2002, BIOCHEM J, V367, P255, DOI 10.1042/BJ20020545; Chawla M, 2012, MOL MICROBIOL, V85, P1148, DOI 10.1111/j.1365-2958.2012.08165.x; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Choudhary E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089759; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugherty A, 2011, J BACTERIOL, V193, P6824, DOI 10.1128/JB.05492-11; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Humpel A, 2010, J BACTERIOL, V192, P2491, DOI 10.1128/JB.00035-10; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Jeong Ji-A, 2013, [Journal of Life Science, 생명과학회지], V23, P290, DOI 10.5352/JLS.2013.23.2.290; Jessee J., 1986, FOCUS, V8, P9; Kahramanoglou C, 2014, NUCLEIC ACIDS RES, V42, P8320, DOI 10.1093/nar/gku548; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kim MJ, 2010, J BACTERIOL, V192, P4868, DOI 10.1128/JB.00550-10; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Kriakov J, 2003, J BACTERIOL, V185, P4983, DOI 10.1128/JB.185.16.4983-4991.2003; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Mouncey NJ, 1998, J BACTERIOL, V180, P5612, DOI 10.1128/JB.180.21.5612-5618.1998; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Oh JI, 2010, J BACTERIOL, V192, P3925, DOI 10.1128/JB.00286-10; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sambrook J., 2001, MOL CLONING LAB MANU; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x	66	15	16	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111680	10.1371/journal.pone.0111680	http://dx.doi.org/10.1371/journal.pone.0111680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365321	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100104
J	Azab, B; Camacho-Rivera, M; Taioli, E				Azab, Basem; Camacho-Rivera, Marlene; Taioli, Emanuela			Average Values and Racial Differences of Neutrophil Lymphocyte Ratio among a Nationally Representative Sample of United States Subjects	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; LONG-TERM MORTALITY; HEPATOCELLULAR-CARCINOMA; LIVER-TRANSPLANTATION; CANCER; INFLAMMATION; ASSOCIATION; RECURRENCE; SURVIVAL; RISK	Introduction: Several studies reported the negative impact of elevated neutrophil/lymphocyte ratio (NLR) on outcomes in many surgical and medical conditions. Previous studies used arbitrary NLR cut-off points according to the average of the populations under study. There is no data on the average NLR in the general population. The aim of this study is to explore the average values of NLR and according to race in adult non-institutional United States individuals by using national data. Methods: The National Health and Nutrition Examination Survey (NHANES) of aggregated cross-sectional data collected from 2007 to 2010 was analyzed; data extracted included markers of systemic inflammation (neutrophil count, lymphocyte count, and NLR), demographic variables and other comorbidities. Subjects who were prescribed steroids, chemotherapy, immunomodulators and antibiotics were excluded. Adjusted linear regression models were used to examine the association between demographic and clinical characteristics and neutrophil counts, lymphocyte counts, and NLR. Results: Overall 9427 subjects are included in this study. The average value of neutrophils is 4.3k cells/mL, of lymphocytes 2.1k cells/mL; the average NLR is 2.15. Non-Hispanic Black and Hispanic participants have significantly lower mean NLR values (1.76, 95% CI 1.71-1.81 and 2.08, 95% CI 2.04-2.12 respectively) when compared to non-Hispanic Whites (2.24, 95% CI 2.19-2.28-p<0.0001). Subjects who reported diabetes, cardiovascular disease, and smoking had significantly higher NLR than subjects who did not. Racial differences regarding the association of smoking and BMI with NLR were observed. Conclusions: This study is providing preliminary data on racial disparities in a marker of inflammation, NLR, that has been associated with several chronic diseases outcome, suggesting that different cut-off points should be set according to race. It also suggests that racial differences exist in the inflammatory response to environmental and behavioral risk factors.	[Azab, Basem] Staten Isl Univ Hosp, Dept Surg, Staten Isl, NY USA; [Camacho-Rivera, Marlene; Taioli, Emanuela] North Shore LIJ Hofstra Sch Med, Dept Populat Hlth, Great Neck, NY 11021 USA	Northwell Health; Hofstra University	Taioli, E (corresponding author), North Shore LIJ Hofstra Sch Med, Dept Populat Hlth, Great Neck, NY 11021 USA.	etaioli@nshs.edu		Camacho-Rivera, Marlene/0000-0003-2343-2941				Aliustaoglu M, 2010, HEPATO-GASTROENTEROL, V57, P640; Azab B, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-193; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Kantola T, 2012, BRIT J CANCER, V107, P1729, DOI 10.1038/bjc.2012.456; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Libby P, 2001, AM J CARDIOL, V88, p3J, DOI [DOI 10.1016/S0002-9149(01)02145-2, 10.1016/S0002-9149(01)02145-2]; LICHTMAN MA, 1970, NEW ENGL J MED, V283, P943, DOI 10.1056/NEJM197010292831801; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Ohno Y, 2010, J UROLOGY, V184, P873, DOI 10.1016/j.juro.2010.05.028; Rueda-Clausen CF, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/469169; Seals DR, 2014, PHYSIOLOGY, V29, P250, DOI 10.1152/physiol.00059.2013; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.039; Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412	26	183	186	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112361	10.1371/journal.pone.0112361	http://dx.doi.org/10.1371/journal.pone.0112361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375150	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600135
J	Correale, S; de Paola, I; Morgillo, CM; Federico, A; Zaccaro, L; Pallante, P; Galeone, A; Fusco, A; Pedone, E; Luque, FJ; Catalanotti, B				Correale, Stefania; de Paola, Ivan; Morgillo, Carmine Marco; Federico, Antonella; Zaccaro, Laura; Pallante, Pierlorenzo; Galeone, Aldo; Fusco, Alfredo; Pedone, Emilia; Luque, F. Javier; Catalanotti, Bruno			Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin	PLOS ONE			English	Article							SOLVATED INTERACTION ENERGY; UBCH10 EXPRESSION; MOLECULAR-DYNAMICS; CONJUGATING ENZYME; ACTIVATING ENZYME; DOMAINS; IDENTIFICATION; ALIGNMENT; FRAGMENT; INSIGHTS	UbcH10 is a component of the Ubiquitin Conjugation Enzymes (Ubc; E2) involved in the ubiquitination cascade controlling the cell cycle progression, whereby ubiquitin, activated by E1, is transferred through E2 to the target protein with the involvement of E3 enzymes. In this work we propose the first three dimensional model of the tetrameric complex formed by the human UbA1 (E1), two ubiquitin molecules and UbcH10 (E2), leading to the transthiolation reaction. The 3D model was built up by using an experimentally guided incremental docking strategy that combined homology modeling, proteinprotein docking and refinement by means of molecular dynamics simulations. The structural features of the in silico model allowed us to identify the regions that mediate the recognition between the interacting proteins, revealing the active role of the ubiquitin crosslinked to E1 in the complex formation. Finally, the role of these regions involved in the E1-E2 binding was validated by designing short peptides that specifically interfere with the binding of UbcH10, thus supporting the reliability of the proposed model and representing valuable scaffolds for the design of peptidomimetic compounds that can bind selectively to Ubcs and inhibit the ubiquitylation process in pathological disorders.	[Correale, Stefania] Kedr SpA, St Antimo, Na, Italy; [de Paola, Ivan; Zaccaro, Laura; Pedone, Emilia] CNR, Ist Biostrut & Bioimmagini, I-80125 Naples, Italy; [Federico, Antonella; Pallante, Pierlorenzo; Fusco, Alfredo] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Morgillo, Carmine Marco; Galeone, Aldo; Catalanotti, Bruno] Univ Naples Federico II, Dipartimento Farm, Naples, Italy; [Luque, F. Javier] Univ Barcelona, Fac Farm, Dept Fisicoquim & Inst Biomed IBUB, Santa Coloma De Gramenet, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Barcelona	Catalanotti, B (corresponding author), Univ Naples Federico II, Dipartimento Farm, Naples, Italy.	brucatal@unina.it	Pedone, Emilia/HDN-2342-2022; Pallante, Pierlorenzo/AAX-8758-2020; Catalanotti, Bruno/D-4025-2016; Galeone, Aldo/H-7248-2019; Pedone, Emilia Maria/K-2229-2015; Luque, F. Javier/L-9652-2014; de Paola, Ivan/B-6867-2017	Pedone, Emilia/0000-0003-0203-8611; Catalanotti, Bruno/0000-0002-7532-6959; Galeone, Aldo/0000-0001-8805-6348; Pedone, Emilia Maria/0000-0003-0203-8611; Luque, F. Javier/0000-0002-8049-3567; de Paola, Ivan/0000-0003-1508-6591; Fusco, Alfredo/0000-0003-3332-5197; Morgillo, Carmine Marco/0000-0002-6164-7647	HPC-EUROPA2 project [932, 1200]; European Community; Barcelona Supercomputer Center; CINECA (ISCRA project) [HP10B81QWA, HP10CNS2K3]; Icrea Academia; Spanish MCINN [SAF2011-27642]; Generalitat de Catalunya [2009SGR00249]; Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Italian MIUR [FIRB RBAP114AMK_006]	HPC-EUROPA2 project; European Community(European Commission); Barcelona Supercomputer Center; CINECA (ISCRA project)(CINECA, Italy); Icrea Academia(ICREA); Spanish MCINN(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC); Italian MIUR(Ministry of Education, Universities and Research (MIUR))	BC acknowledges the HPC-EUROPA2 project (projects 932 and 1200), with the support of the European Community-Research Infrastructure Action of the FP7, the Barcelona Supercomputer Center and the CINECA (ISCRA project ID HP10B81QWA and HP10CNS2K3) for the access to high performance computing resources. FJL acknowledges funding from Icrea Academia, the Spanish MCINN (SAF2011-27642), the Generalitat de Catalunya (2009SGR00249), the Xarxa de Recerca en Quimica Teorica i Computacional (XQRTC). EP and LZ acknowledge the Italian MIUR for financial support (FIRB RBAP114AMK_006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bezsonova I, 2008, BIOCHEMISTRY-US, V47, P8937, DOI 10.1021/bi800439t; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; de Gramont A, 2006, CELL CYCLE, V5, P2168, DOI 10.4161/cc.5.18.3219; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Donato G, 2008, CLIN NEUROPATHOL, V27, P219; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fujita T, 2008, CLIN CANCER RES, V14, P1966, DOI 10.1158/1078-0432.CCR-07-1585; HAAS AL, 1982, J BIOL CHEM, V257, P2543; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Jaremko L, 2006, J BIOMOL NMR, V36, P43, DOI 10.1007/s10858-006-9015-z; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kortemme T, 2004, SCI STKE, V219, ppl2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Schafer A, 2014, ACTA CRYSTALLOGR D, V70, P1311, DOI 10.1107/S1399004714002910; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Troncone G, 2009, HISTOPATHOLOGY, V54, P731, DOI 10.1111/j.1365-2559.2009.03296.x; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921	44	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112082	10.1371/journal.pone.0112082	http://dx.doi.org/10.1371/journal.pone.0112082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375166	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600099
J	McCann, SK; Dusting, GJ; Roulston, CL				McCann, Sarah K.; Dusting, Gregory J.; Roulston, Carli L.			Nox2 Knockout Delays Infarct Progression and Increases Vascular Recovery through Angiogenesis in Mice following Ischaemic Stroke with Reperfusion	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; NADPH OXIDASE; FOCAL ISCHEMIA; INJURY; INHIBITION; SUPEROXIDE; ACTIVATION; DAMAGE; ROLES; MICROGLIA	Evidence suggests the NADPH oxidases contribute to ischaemic stroke injury and Nox2 is the most widely studied subtype in the context of stroke. There is still conjecture however regarding the benefits of inhibiting Nox2 to improve stroke outcome. The current study aimed to examine the temporal effects of genetic Nox2 deletion on neuronal loss after ischaemic stroke using knockout (KO) mice with 6, 24 and 72 hour recovery. Transient cerebral ischaemia was induced via intraluminal filament occlusion and resulted in reduced infarct volumes in Nox2 KO mice at 24 h post-stroke compared to wild-type controls. No protection was evident at either 6 h or 72 h post-stroke, with both genotypes exhibiting similar volumes of damage. Reactive oxygen species were detected using dihydroethidium and were co-localised with neurons and microglia in both genotypes using immunofluorescent double-labelling. The effect of Nox2 deletion on vascular damage and recovery was also examined 24 h and 72 h post-stroke using an antibody against laminin. Blood vessel density was decreased in the ischaemic core of both genotypes 24 h post-stroke and returned to pre-stroke levels only in Nox2 KO mice by 72 h. Overall, these results are the first to show that genetic Nox2 deletion merely delays the progression of neuronal loss after stroke but does not prevent it. Additionally, we show for the first time that Nox2 deletion increases re-vascularisation of the damaged brain by 72 h, which may be important in promoting endogenous brain repair mechanisms that rely on re-vascularisation.	[McCann, Sarah K.; Roulston, Carli L.] St Vincents Hosp, OBrien Inst, Stroke Injury & Repair Team, Melbourne, Vic, Australia; [McCann, Sarah K.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Surg, Melbourne, Vic, Australia; [Dusting, Gregory J.] Royal Eye & Ear Hosp, Ctr Eye Res, Cytoprot Pharmacol Program, Melbourne, Vic, Australia; [Dusting, Gregory J.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Ophthalmol, Melbourne, Vic, Australia; [Roulston, Carli L.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Med, Melbourne, Vic, Australia	St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Roulston, CL (corresponding author), St Vincents Hosp, OBrien Inst, Stroke Injury & Repair Team, Melbourne, Vic, Australia.	carlir@unimelb.edu.au		McCann, Sarah/0000-0003-4737-2349	National Heart Foundation Australia [G07M3237]; National Health and Medical Research Council Australia [628767]; Bethlehem Griffiths Research Foundaiton	National Heart Foundation Australia(National Heart Foundation of Australia); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Bethlehem Griffiths Research Foundaiton	This work was supported by the National Heart Foundation Australia Research Grant-in-aid G07M3237 to GJD CLR, National Health and Medical Research Council Australia project grant #628767 to GJD CLR and Bethlehem Griffiths Research Foundaiton project grant to CLR GJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Callaway JK, 2000, J NEUROSCI METH, V102, P53, DOI 10.1016/S0165-0270(00)00278-8; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Clark WM, 1997, NEUROL RES, V19, P641; Coimbra C, 1996, STROKE, V27, P1578, DOI 10.1161/01.STR.27.9.1578; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Doverhag C, 2008, NEUROBIOL DIS, V31, P133, DOI 10.1016/j.nbd.2008.04.003; Feuerstein GZ, 2009, STROKE, V40, pS121, DOI 10.1161/STROKEAHA.108.535104; Feuerstein GZ, 2007, J CEREB BLOOD FLOW M; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Frantz S, 2006, BASIC RES CARDIOL, V101, P127, DOI 10.1007/s00395-005-0568-x; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; GARCIA JH, 1995, STROKE, V26, P643; Genovese T, 2011, BRAIN RES, V1372, P92, DOI 10.1016/j.brainres.2010.11.088; Harrigan TJ, 2008, J NEUROCHEM, V106, P2449, DOI 10.1111/j.1471-4159.2008.05553.x; Hong H, 2006, AM J PHYSIOL-HEART C, V291, pH2210, DOI 10.1152/ajpheart.01270.2005; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kahles T, 2010, NEUROBIOL DIS, V40, P185, DOI 10.1016/j.nbd.2010.05.023; Kelly KA, 2009, BRAIN RES, V1292, P165, DOI 10.1016/j.brainres.2009.07.052; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kunz A, 2007, J CEREBR BLOOD F MET, V27, P545, DOI 10.1038/sj.jcbfm.9600369; Li B, 2009, J INNATE IMMUN, V1, P570, DOI 10.1159/000235563; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SM, 2007, CAN J NEUROL SCI, V34, P356, DOI 10.1017/S031716710000682X; Lu Q, 2011, NITRIC OXIDE-BIOL CH, V24, P132, DOI 10.1016/j.niox.2011.01.007; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; McCann SK, 2013, BRAIN SCI, V3, P561, DOI 10.3390/brainsci3020561; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; Miller AA, 2009, AM J PHYSIOL-HEART C, V296, pH220, DOI 10.1152/ajpheart.00987.2008; Murotomi K, 2011, MOL CELL NEUROSCI, V46, P681, DOI 10.1016/j.mcn.2011.01.009; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Tang LL, 2007, J INT MED RES, V35, P517, DOI 10.1177/147323000703500411; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Taylor CJ, 2013, BRAIN SCI, V3, P294, DOI 10.3390/brainsci3010294; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; VALTYSSON J, 1994, ACTA NEUROCHIR, V129, P58, DOI 10.1007/BF01400874; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Weston RM, 2013, STROKE RES IN PRESS; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhao WY, 2009, CARDIOVASC PATHOL, V18, P156, DOI 10.1016/j.carpath.2007.12.013	57	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110602	10.1371/journal.pone.0110602	http://dx.doi.org/10.1371/journal.pone.0110602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375101	Green Published, gold			2022-12-27	WOS:000344402600016
J	Raphemot, R; Rouhier, MF; Swale, DR; Days, E; Weaver, CD; Lovell, KM; Konkel, LC; Engers, DW; Bollinger, SF; Hopkins, C; Piermarini, PM; Denton, JS				Raphemot, Rene; Rouhier, Matthew F.; Swale, Daniel R.; Days, Emily; Weaver, C. David; Lovell, Kimberly M.; Konkel, Leah C.; Engers, Darren W.; Bollinger, Sean F.; Hopkins, Corey; Piermarini, Peter M.; Denton, Jerod S.			Discovery and Characterization of a Potent and Selective Inhibitor of Aedes aegypti Inward Rectifier Potassium Channels	PLOS ONE			English	Article							K+ KIR CHANNELS; FUNCTIONAL-CHARACTERIZATION; RESISTANCE; DROSOPHILA; VECTOR	Vector-borne diseases such as dengue fever and malaria, which are transmitted by infected female mosquitoes, affect nearly half of the world's population. The emergence of insecticide-resistant mosquito populations is reducing the effectiveness of conventional insecticides and threatening current vector control strategies, which has created an urgent need to identify new molecular targets against which novel classes of insecticides can be developed. We previously demonstrated that small molecule inhibitors of mammalian Kir channels represent promising chemicals for new mosquitocide development. In this study, high-throughput screening of approximately 30,000 chemically diverse small-molecules was employed to discover potent and selective inhibitors of Aedes aegypti Kir1 (AeKir1) channels heterologously expressed in HEK293 cells. Of 283 confirmed screening 'hits', the small-molecule inhibitor VU625 was selected for lead optimization and in vivo studies based on its potency and selectivity toward AeKir1, and tractability for medicinal chemistry. In patch clamp electrophysiology experiments of HEK293 cells, VU625 inhibits AeKir1 with an IC50 value of 96.8 nM, making VU625 the most potent inhibitor of AeKir1 described to date. Furthermore, electrophysiology experiments in Xenopus oocytes revealed that VU625 is a weak inhibitor of AeKir2B. Surprisingly, injection of VU625 failed to elicit significant effects on mosquito behavior, urine excretion, or survival. However, when co-injected with probenecid, VU625 inhibited the excretory capacity of mosquitoes and was toxic, suggesting that the compound is a substrate of organic anion and/or ATP-binding cassette (ABC) transporters. The dose-toxicity relationship of VU625 (when co-injected with probenecid) is biphasic, which is consistent with the molecule inhibiting both AeKir1 and AeKir2B with different potencies. This study demonstrates proof-of-concept that potent and highly selective inhibitors of mosquito Kir channels can be developed using conventional drug discovery approaches. Furthermore, it reinforces the notion that the physical and chemical properties that determine a compound's bioavailability in vivo will be critical in determining the efficacy of Kir channel inhibitors as insecticides.	[Raphemot, Rene; Swale, Daniel R.; Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Raphemot, Rene; Weaver, C. David; Lovell, Kimberly M.; Konkel, Leah C.; Engers, Darren W.; Bollinger, Sean F.; Hopkins, Corey; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Rouhier, Matthew F.; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Days, Emily; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Inst Chem Biol, Nashville, TN 37212 USA; [Denton, Jerod S.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Lovell, Kimberly M.; Konkel, Leah C.; Engers, Darren W.; Bollinger, Sean F.; Hopkins, Corey] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; University System of Ohio; Ohio State University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Piermarini, PM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	piermarini.1@osu.edu; jerod.s.denton@vanderbilt.edu	Piermarini, Peter/AAO-5666-2021	Piermarini, Peter/0000-0003-1020-5774	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK082884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082884] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative. This work was also supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK082884; JSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 2011, J AGR FOOD CHEM, V59, P2909, DOI 10.1021/jf102525e; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Bhave G, 2011, MOL PHARMACOL, V79, P42, DOI 10.1124/mol.110.066928; Dahal GR, 2012, DEVELOPMENT, V139, P3653, DOI 10.1242/dev.078592; Denton JS, 2013, AM J PHYSIOL-RENAL, V305, pF931, DOI 10.1152/ajprenal.00230.2013; Denton JS, 2012, TRENDS ENDOCRIN MET, V23, P41, DOI 10.1016/j.tem.2011.09.004; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; Eleftherianos I, 2011, P NATL ACAD SCI USA, V108, P12024, DOI 10.1073/pnas.1108926108; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; FELLER N, 1995, FEBS LETT, V368, P385, DOI 10.1016/0014-5793(95)00677-2; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hill G, 2002, DRUG METAB DISPOS, V30, P13, DOI 10.1124/dmd.30.1.13; JAEHDE U, 1995, CLIN PHARMACOL THER, V58, P532, DOI 10.1016/0009-9236(95)90173-6; Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Meyer JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001478; Niswender CM, 2008, MOL PHARMACOL, V73, P1213, DOI 10.1124/mol.107.041053; O'Donnell MJ, 2009, J EXP BIOL, V212, P363, DOI 10.1242/jeb.023739; O'Donnell M, 2008, ADV INSECT PHYSIOL, V35, P1, DOI 10.1016/S0065-2806(08)00001-5; Pattnaik BR, 2012, MOL GENET METAB, V105, P64, DOI 10.1016/j.ymgme.2011.10.004; Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Raphemot R, 2013, JOVE-J VIS EXP, V71, P4209; Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002; Raphemot R, 2014, MOL PHARMACOL, V85, P858, DOI 10.1124/mol.114.091884; Raphemot R, 2013, ASSAY DRUG DEV TECHN, V11, P532, DOI 10.1089/adt.2013.544; Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; Rouhier MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100700; Rouhier MF, 2014, INSECT BIOCHEM MOLEC, V48, P91, DOI 10.1016/j.ibmb.2014.03.003; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; WHO, 2013, WORLD MAL REP WHO	35	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110772	10.1371/journal.pone.0110772	http://dx.doi.org/10.1371/journal.pone.0110772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375326	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600020
J	Straker, LM; Howie, EK; Smith, KL; Fenner, AA; Kerr, DA; Olds, TS; Abbott, RA; Smith, AJ				Straker, Leon M.; Howie, Erin K.; Smith, Kyla L.; Fenner, Ashley A.; Kerr, Deborah A.; Olds, Tim S.; Abbott, Rebecca A.; Smith, Anne J.			The Impact of Curtin University's Activity, Food and Attitudes Program on Physical Activity, Sedentary Time and Fruit, Vegetable and Junk Food Consumption among Overweight and Obese Adolescents: A Waitlist Controlled Trial	PLOS ONE			English	Article							ENERGY-EXPENDITURE; WEIGHT MANAGEMENT; HEALTHY-WEIGHT; INTERVENTION; CHILDREN; OUTCOMES; MAINTENANCE; ADIPOSITY; METAANALYSIS; PATTERNS	Background: To determine the effects of participation in Curtin University's Activity, Food and Attitudes Program (CAFAP), a community-based, family-centered behavioural intervention, on the physical activity, sedentary time, and healthy eating behaviours of overweight and obese adolescents. Methods: In this waitlist controlled clinical trial in Western Australia, adolescents (n = 69, 71% female, mean age 14.1 (SD 1.6) years) and parents completed an 8-week intervention followed by 12 months of telephone and text message support. Assessments were completed at baseline, before beginning the intervention, immediately following the intervention, and at 3-, 6-, and 12-months follow-up. The primary outcomes were physical activity and sedentary time assessed by accelerometers and servings of fruit, vegetables and junk food assessed by 3-day food records. Results: During the intensive 8-week intervention sedentary time decreased by -5.1 min/day/month (95% CI: -11.0, 0.8) which was significantly greater than the rate of change during the waitlist period (p = .014). Moderate physical activity increased by 1.8 min/day/month (95% CI: -0.04, 3.6) during the intervention period, which was significantly greater than the rate of change during the waitlist period (p = .041). Fruit consumption increased during the intervention period (monthly incidence rate ratio (IRR) 1.3, 95% CI: 1.10, 1.56) and junk food consumption decreased (monthly IRR 0.8, 95% CI: 0.74, 0.94) and these changes were different to those seen during the waitlist period (p = .004 and p = .020 respectively). Conclusions: Participating in CAFAP appeared to have a positive influence on the physical activity, sedentary and healthy eating behaviours of overweight and obese adolescents and many of these changes were maintained for one year following the intensive intervention.	[Straker, Leon M.; Howie, Erin K.; Smith, Kyla L.; Abbott, Rebecca A.; Smith, Anne J.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia; [Fenner, Ashley A.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Kerr, Deborah A.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Olds, Tim S.] Univ S Australia, HUT Grp, Adelaide, SA 5001, Australia	Curtin University; Curtin University; Curtin University; University of South Australia	Straker, LM (corresponding author), Curtin Univ, Sch Physiotherapy & Exercise Sci, GPO Box U1987, Perth, WA 6845, Australia.	L.Straker@curtin.edu.au	Olds, Tim/A-1223-2008; Straker, Leon M/B-2407-2013; Kerr, Deborah A/F-3356-2012; Kerr, Deborah A/N-8599-2019	Olds, Tim/0000-0001-6894-5519; Straker, Leon M/0000-0002-7786-4128; Kerr, Deborah A/0000-0002-1094-1299; Kerr, Deborah A/0000-0002-1094-1299; Abbott, Rebecca/0000-0003-4165-4484; Smith, Anne/0000-0002-4667-7389	Healthway Health Promotion Research Project Grant [19938]; National Health and Medical Research Council senior research fellowship [APP1019980]; APA/CRS scholarship; Healthway [19938] Funding Source: researchfish	Healthway Health Promotion Research Project Grant; National Health and Medical Research Council senior research fellowship(National Health and Medical Research Council (NHMRC) of Australia); APA/CRS scholarship; Healthway	This trial was funded by a Healthway Health Promotion Research Project Grant #19938. LS was supported by a National Health and Medical Research Council senior research fellowship #APP1019980. KS was supported by an APA/CRS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9; Bean MK, 2011, CLIN PEDIATR, V50, P408, DOI 10.1177/0009922810393497; Nguyen B, 2012, ARCH PEDIAT ADOL MED, V166, P170, DOI 10.1001/archpediatrics.2011.841; Brown WJ, 2012, DEV EVIDENCE BASED P; Colley RC, 2011, J SPORT SCI, V29, P783, DOI 10.1080/02640414.2011.557744; Collins CE, 2006, ARCH PEDIAT ADOL MED, V160, P906, DOI 10.1001/archpedi.160.9.906; Davis JN, 2012, PEDIATR OBES, V7, P16, DOI 10.1111/j.2047-6310.2011.00002.x; Davis JN, 2009, MED SCI SPORT EXER, V41, P1494, DOI 10.1249/MSS.0b013e31819b6aea; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Department of Health and Aging, 2014, NAT PHYS ACT GUID AU; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Evans RK, 2009, INT J PEDIATR OBES, V4, P130, DOI 10.1080/17477160802314997; Fenner AA, 2013, PSYCHOL SPORT EXERC, V14, P819, DOI 10.1016/j.psychsport.2013.06.005; Henes ST, 2013, NUTR CLIN PRACT, V28, P617, DOI 10.1177/0884533613497237; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Hoelscher DM, 2013, J ACAD NUTR DIET, V113, P1375, DOI 10.1016/j.jand.2013.08.004; Iannotti RJ, 2013, J ADOLESCENT HEALTH, V53, P280, DOI 10.1016/j.jadohealth.2013.03.007; Jennings A, 2012, OBESITY, V20, P1462, DOI 10.1038/oby.2012.72; Kirkpatrick SI, 2014, AM J PREV MED, V46, P94, DOI 10.1016/j.amepre.2013.08.015; Kong AS, 2013, J OBES, V2013, DOI 10.1155/2013/575016; Kuczmarski RJ, 2000, CDC GROWTH CHARTS US, P1; Luttikhuis HO, 2009, COCHRANE DB SYST REV, V187; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; National Health and Medical Research Council, 2013, ED GUID; Nguyen B, 2013, INT J OBESITY, V37, P468, DOI 10.1038/ijo.2012.74; Olds T, 2009, J ADOLESCENT HEALTH, V44, P64, DOI 10.1016/j.jadohealth.2008.05.003; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Rangan AM, 2008, EUR J CLIN NUTR, V62, P356, DOI 10.1038/sj.ejcn.1602720; Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086; Rich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067206; Robbins LB, 2012, J SCH NURS, V28, P302, DOI 10.1177/1059840512438777; Shrewsbury VA, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-13; Singh R, 2009, AM J CLIN NUTR, V89, P1744, DOI 10.3945/ajcn.2008.26752; Smith KL, 2014, J HUM NUTR DIET; Smith KL, 2014, J MED INTERNET RES, V16, P22, DOI 10.2196/jmir.3113; Smith KL, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-53; Soric M, 2013, ANN HUM BIOL; Straker L., 2010, Journal of Science and Medicine in Sport, V13, pe11, DOI 10.1016/j.jsams.2010.10.485; Straker LM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-471; USDA/ARS Children's Nutrition Center, 2003, CHILDR BMI PERC FOR; Warren JM, 2007, INT J PEDIATR OBES, V2, P73, DOI 10.1080/17477160601133671; Wengle JG, 2011, PAED CHILD HEALT-CAN, V16, P473, DOI 10.1093/pch/16.8.473; Zook KR, 2014, J ADOLESCENT HEALTH, V54, P74, DOI 10.1016/j.jadohealth.2013.07.015	45	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111954	10.1371/journal.pone.0111954	http://dx.doi.org/10.1371/journal.pone.0111954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375109	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000344402600079
J	Deng, WK; Wang, YB; Liu, ZX; Cheng, H; Xue, Y				Deng, Wankun; Wang, Yongbo; Liu, Zexian; Cheng, Han; Xue, Yu			HemI: A Toolkit for Illustrating Heatmaps	PLOS ONE			English	Article							MICROARRAY DATA; GENERATION	Recent high-throughput techniques have generated a flood of biological data in all aspects. The transformation and visualization of multi-dimensional and numerical gene or protein expression data in a single heatmap can provide a concise but comprehensive presentation of molecular dynamics under different conditions. In this work, we developed an easy-touse tool named Hemi (Heat map Illustrator), which can visualize either gene or protein expression data in heatmaps. Additionally, the heatmaps can be recolored, rescaled or rotated in a customized manner. In addition, Hemi provides multiple clustering strategies for analyzing the data. Publication-quality figures can be exported directly. We propose that Hemi can be a useful toolkit for conveniently visualizing and manipulating heatmaps. The stand-alone packages of Hemi were implemented in Java and can be accessed at http://hemi.biocuckoo.org/down.php.	[Deng, Wankun; Wang, Yongbo; Liu, Zexian; Cheng, Han; Xue, Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Xue, Y (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China.	xueyu@hust.edu.cn	Deng, Wankun/C-3824-2015; Liu, Zexian/D-1153-2011; Xue, Yu/G-5929-2011	Deng, Wankun/0000-0002-5052-9151; Liu, Zexian/0000-0001-9698-0610; Xue, Yu/0000-0002-9403-6869	National Basic Research Program (973 project) [2012CB910101, 2013CB9339002]; Natural Science Foundation of China [31171263, 81272578, J1103514]; International Science & Technology Cooperation Program of China [2014DFB30020]; China Postdoctoral Science Foundation [2014M550392]; Fundamental Research Funds for the Central Universities (HUST) [2013TS080, 2014YQ003]	National Basic Research Program (973 project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities (HUST)(Fundamental Research Funds for the Central Universities)	The work was supported, in whole or in part, by the National Basic Research Program (973 project) (2012CB910101, and 2013CB9339002), Natural Science Foundation of China (31171263, 81272578 and J1103514), International Science & Technology Cooperation Program of China (2014DFB30020), China Postdoctoral Science Foundation (2014M550392), and Fundamental Research Funds for the Central Universities (HUST: 2013TS080, 2014YQ003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Chen TJ, 2014, CURR TOP MICROBIOL, V377, P127, DOI 10.1007/82_2014_364; Collison M, 2012, BRIEF BIOINFORM, V13, P751, DOI 10.1093/bib/bbs002; Deu-Pons Jordi, 2014, Bioinformatics, V30, P1757, DOI 10.1093/bioinformatics/btu094; Koschmieder A, 2012, BRIEF BIOINFORM, V13, P46, DOI 10.1093/bib/bbr010; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111	10	773	837	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111988	10.1371/journal.pone.0111988	http://dx.doi.org/10.1371/journal.pone.0111988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372567	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900102
J	Humphries, DL; Behrman, JR; Crookston, BT; Dearden, KA; Schott, W; Penny, ME				Humphries, Debbie L.; Behrman, Jere R.; Crookston, Benjamin T.; Dearden, Kirk A.; Schott, Whitney; Penny, Mary E.		Young Lives Determinants & Consequ	Households across All Income Quintiles, Especially the Poorest, Increased Animal Source Food Expenditures Substantially during Recent Peruvian Economic Growth	PLOS ONE			English	Article							REDUCING CHILD MALNUTRITION; INTRAHOUSEHOLD ALLOCATION; HEALTH; NUTRITION; DEMAND; CONSUMPTION; NUTRIENTS; OUTCOMES; SUPPLEMENTATION; INEQUALITY	Background: Relative to plant-based foods, animal source foods (ASFs) are richer in accessible protein, iron, zinc, calcium, vitamin B-12 and other nutrients. Because of their nutritional value, particularly for childhood growth and nutrition, it is important to identify factors influencing ASF consumption, especially for poorer households that generally consume less ASFs. Objective: To estimate differential responsiveness of ASF consumption to changes in total household expenditures for households with different expenditures in a middle-income country with substantial recent income increases. Methods: The Peruvian Young Lives household panel (n = 1750) from 2002, 2006 and 2009 was used to characterize patterns of ASF expenditures. Multivariate models with controls for unobserved household fixed effects and common secular trends were used to examine nonlinear relationships between changes in household expenditures and in ASF expenditures. Results: Households with lower total expenditures dedicated greater percentages of expenditures to food (58.4% vs. 17.9% in 2002 and 24.2% vs. 21.5% in 2009 for lowest and highest quintiles respectively) and lower percentages of food expenditures to ASF (22.8% vs. 33.9% in 2002 and 30.3% vs. 37.6% in 2009 for lowest and highest quintiles respectively). Average percentages of overall expenditures spent on food dropped from 47% to 23.2% between 2002 and 2009. Households in the lowest quintiles of expenditures showed greater increases in ASF expenditures relative to total consumption than households in the highest quintiles. Among ASF components, meat and poultry expenditures increased more than proportionately for households in the lowest quintiles, and eggs and fish expenditures increased less than proportionately for all households. Conclusions: Increases in household expenditures were associated with substantial increases in consumption of ASFs for households, particularly households with lower total expenditures. Increases in ASF expenditures for all but the top quintile of households were proportionately greater than increases in total food expenditures, and proportionately less than overall expenditures.	[Humphries, Debbie L.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Behrman, Jere R.; Schott, Whitney] Univ Penn, Dept Econ, Philadelphia, PA 19104 USA; [Crookston, Benjamin T.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Dearden, Kirk A.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Penny, Mary E.] Inst Invest Nutr, Lima, Peru	Yale University; University of Pennsylvania; Brigham Young University; Boston University	Humphries, DL (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	debbie.humphries@yale.edu	Penny, Mary/J-2286-2017; Behrman, Jere R/A-9734-2009	Penny, Mary/0000-0001-5501-9399; Humphries, Debbie/0000-0002-5979-3717; Schott, Whitney/0000-0001-9303-8718	Bill & Melinda Gates Foundation (Global Health Grant) [OPP1032713]; Eunice Shriver Kennedy National Institute of Child Health and Development [R01 HD070993]; Grand Challenges Canada [0072-03]; Trustees of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070993] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation (Global Health Grant); Eunice Shriver Kennedy National Institute of Child Health and Development; Grand Challenges Canada(CGIAR); Trustees of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was conducted in compliance with the Principles of Ethical Practice of Public Health. The analysis in this manuscript was based on research funded by the Bill & Melinda Gates Foundation (Global Health Grant OPP1032713), Eunice Shriver Kennedy National Institute of Child Health and Development (Grant R01 HD070993) and Grand Challenges Canada (Grant 0072-03 to the Grantee, The Trustees of the University of Pennsylvania). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Abdulai A, 2004, AGR ECON-BLACKWELL, V31, P67, DOI [10.1111/j.1574-0862.2004.tb00222.x, 10.1016/j.agecon.2003.03.001]; Acosta AM, 2014, FOOD POLICY, V44, P26, DOI 10.1016/j.foodpol.2013.10.009; Agee MD, 2010, SOC SCI MED, V71, P1973, DOI 10.1016/j.socscimed.2010.09.020; Alderman H, 2006, ECON HUM BIOL, V4, P1, DOI 10.1016/j.ehb.2005.07.001; Allen LH, 2006, J PEDIATR GASTR NUTR, V43, pS8, DOI 10.1097/01.mpg.0000255845.99905.20; ANAND S, 1993, J ECON PERSPECT, V7, P133, DOI 10.1257/jep.7.1.133; Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015; Barnett I, 2012, INT J EPIDEMIOL; BEHRMAN JR, 1988, OXFORD ECON PAP, V40, P32, DOI 10.1093/oxfordjournals.oep.a041845; BEHRMAN JR, 1990, J HUM RESOUR, V25, P665, DOI 10.2307/145671; BEHRMAN JR, 1989, REV ECON STAT, V71, P666, DOI 10.2307/1928109; BEHRMAN JR, 1987, J POLIT ECON, V95, P492, DOI 10.1086/261469; Behrman JR, 1999, WORLD BANK ECON REV, V13, P211, DOI 10.1093/wber/13.2.211; BEHRMAN JR, 1988, J DEV ECON, V28, P43, DOI 10.1016/0304-3878(88)90013-2; BEHRMAN JR, 1987, J ECONOMETRICS, V36, P185, DOI 10.1016/0304-4076(87)90049-2; BENNETT M. K., 1941, Wheat Studies of the Food Res. Inst., Stanford Univ., California, V18, P37; Bhaumik SK, 1999, REV DEV ECON, V3, P242; Black RE, 2013, LANCET, V382, P396; Block SA, 2007, OXFORD ECON PAP, V59, P330, DOI 10.1093/oep/gpm001; Block SA, 2004, ECON HUM BIOL, V2, P21, DOI 10.1016/j.ehb.2003.12.007; Bouis HE, 1996, J DEV ECON, V51, P239, DOI 10.1016/S0304-3878(96)00414-2; BOUIS HE, 1992, J DEV ECON, V39, P333, DOI 10.1016/0304-3878(92)90043-9; Bouis HE, 2011, FOOD NUTR BULL, V32, pS14, DOI 10.1177/15648265110321S103; Chai A, 2010, J ECON PERSPECT, V24, P225, DOI 10.1257/jep.24.1.225; Chen DH, 2014, AGRIBUSINESS, V30, P85, DOI 10.1002/agr.21368; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Deaton A., 1980, EC CONSUMER BEHAV, DOI DOI 10.1017/CBO9780511805653; DeLoach SB, 2011, WORLD DEV, V39, P1808, DOI 10.1016/j.worlddev.2011.04.009; Dror DK, 2011, FOOD NUTR BULL, V32, P227, DOI 10.1177/156482651103200307; Dury S, 2014, WHAT RISKS DO AGR IN; Ecker O, 2011, WORLD DEV, V39, P412, DOI 10.1016/j.worlddev.2010.08.002; Gittelsohn J, 2003, J NUTR, V133, p4036S, DOI 10.1093/jn/133.11.4036S; Glewwe P, 1991, DISTRIBUTION WELFARE; Gorman WilliamM., 1981, ESSAYS THEORY MEASUR; Iannotti LL, 2008, AM J CLIN NUTR, V88, P154, DOI 10.1093/ajcn/88.1.154; Krebs NF, 2011, FOOD NUTR BULL, V32, P185, DOI 10.1177/156482651103200301; Lewbel A, 2007, NEW PALGRAVE DICT EC; de Mola CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092550; Marquis GS, 1997, AM J CLIN NUTR, V66, P1102, DOI 10.1093/ajcn/66.5.1102; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Neumann CG, 2007, J NUTR, V137, P1119, DOI 10.1093/jn/137.4.1119; PITT MM, 1990, AM ECON REV, V80, P1139; PITT MM, 1985, REV ECON STAT, V67, P212, DOI 10.2307/1924720; Rodrik D., 2014, CHALLENGE, V57, P5, DOI [10.2753/0577-5132570301, DOI 10.2753/0577-5132570301]; ROSENZWEIG MR, 1984, AM ECON REV, V74, P521; Wilson I., 2006, INT J SOC RES METHOD, V9, P351, DOI DOI 10.1080/13645570600658716; WOLFE BL, 1983, ECON DEV CULT CHANGE, V31, P525, DOI 10.1086/451340; World Bank, INT COMP PROGR DAT	48	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110961	10.1371/journal.pone.0110961	http://dx.doi.org/10.1371/journal.pone.0110961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372596	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900030
J	Wang, HD; Liu, SK; Cui, J; Li, CZ; Qiu, XM; Chang, YQ; Liu, ZJ; Wang, XL				Wang, Hongdi; Liu, Shikai; Cui, Jun; Li, Chengze; Qiu, Xuemei; Chang, Yaqing; Liu, Zhanjiang; Wang, Xiuli			Characterization and Expression Analysis of MicroRNAs in the Tube Foot of Sea Cucumber Apostichopus japonicus	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN HEALTH; SMALL RNAS; IDENTIFICATION; PATTERNS; HUNDREDS; TARGETS; MIRNAS; PCR	MicroRNAs (miRNAs) are a class of endogenous non-coding small RNA with average length of 22 nucleotides, participating in the post-transcriptional regulation of gene expression. In this study, we report the identification and characterization of miRNAs in the tube foot of sea cucumber (Apostichopus japonicus) by next generation sequencing with Illumina HiSeq 2000 platform. Through the bioinformatic analysis, we identified 260 conserved miRNAs and six novel miRNAs from the tube foot small RNA transcriptome. Quantitative realtime PCR (qRT-PCR) was performed to characterize the specific expression in the tube foot. The results indicated that four miRNAs, including miR-29a, miR-29b, miR-2005 and miR-278-3p, were significantly up-regulated in the tube foot. The target genes of the four specifically expressed miRNAs were predicted in silico and validated by performing qRT-PCR. Gene ontology (GO) and KEGG pathway analyses with the target genes of these four miRNAs were conducted to further understand the regulatory function in the tube foot. This is the first study to profile the miRNA transcriptome of the tube foot in sea cucumber. This work will provide valuable genomic resources to understand the mechanisms of gene regulation in the tube foot, and will be useful to assist the molecular breeding in sea cucumber.	[Wang, Hongdi; Cui, Jun; Li, Chengze; Qiu, Xuemei; Chang, Yaqing; Wang, Xiuli] Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Aquat Genom Unit, Auburn, AL 36849 USA	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Auburn University System; Auburn University; Auburn University System; Auburn University	Wang, XL (corresponding author), Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China.	xiuliwang417@sina.com	Cui, Jun/P-9378-2015; Li, Chengze/AAU-7168-2021; Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019	Li, Chengze/0000-0002-1519-750X; Liu, Shikai/0000-0001-5777-489X; 	State 863 High-Technology R & D Project of China [2012AA10A412]; Dalian Ocean University [2012HYDX02]	State 863 High-Technology R & D Project of China(National High Technology Research and Development Program of China); Dalian Ocean University	This project was supported by the State 863 High-Technology R & D Project of China (2012AA10A412) and the grant of Dalian Ocean University (2012HYDX02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Bizuayehu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061378; Chang YQ, 2011, AFR J BIOTECHNOL, V10, P13780; Chang YQ, 2009, MAR ECOL-EVOL PERSP, V30, P455, DOI 10.1111/j.1439-0485.2009.00292.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Enright AJ, 2004, GENOME BIOL, V5; Feng Z, 2009, STUDY EMBRYONIC DEV; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hong F, 2008, FOOD NUTR CHINA, V2, P54; Huang CW, 2012, J ANIM SCI, V90, P4266, DOI 10.2527/jas.2012-5142; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041158; Jeffrey SS, 2008, NAT BIOTECHNOL, V26, P400, DOI 10.1038/nbt0408-400; Kadri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029217; Katzman RL, 1970, COLLOQUE INT PHOTOGR; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; [李丹彤 LI Dantong], 2006, [大连水产学院学报, Journal of Dalian Fisheries College], V21, P278; Li DT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055107, 10.1371/journal.pone.0059360]; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Poething RS, 2002, CURR BIOL, V12, pR699; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Song JL, 2012, DEV BIOL, V362, P104, DOI 10.1016/j.ydbio.2011.11.015; Sun HJ, 2013, FISH SHELLFISH IMMUN, V34, P147, DOI 10.1016/j.fsi.2012.10.014; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Wang Y, 2009, SPECTROSC SPECT ANAL, V29, P511, DOI 10.3964/j.issn.1000-0593(2009)02-0511-04; Wang ZhePing, 2012, South China Fisheries Science, V8, P64; Watkins S. M., 2002, Food lipids: chemistry, nutrition, and biotechnology, P559; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Xiang Yi-hui, 2006, Fisheries Science (Liaoning), V25, P280; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Xu ZB, 2013, MOL BIOL REP, V40, P4075, DOI 10.1007/s11033-012-2485-z; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	49	4	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111820	10.1371/journal.pone.0111820	http://dx.doi.org/10.1371/journal.pone.0111820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372871	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900078
J	Fan, K; Wang, M; Miao, Y; Ni, M; Bibi, N; Yuan, SN; Li, F; Wang, XD				Fan, Kai; Wang, Ming; Miao, Ying; Ni, Mi; Bibi, Noreen; Yuan, Shuna; Li, Feng; Wang, Xuede			Molecular Evolution and Expansion Analysis of the NAC Transcription Factor in Zea mays	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; FACTOR GENE FAMILY; STRESS-RESPONSIVE GENES; NO-APICAL-MERISTEM; COMPREHENSIVE ANALYSIS; EXPRESSION ANALYSIS; MAIZE NAC; ARABIDOPSIS; PROTEIN; DOMAIN	NAC (NAM, ATAF1, 2 and CUC2) family is a plant-specific transcription factor and it controls various plant developmental processes. In the current study, 124 NAC members were identified in Zea mays and were phylogenetically clustered into 13 distinct subfamilies. The whole genome duplication (WGD), especially an additional WGD event, may lead to expanding ZmNAC members. Different subfamily has different expansion rate, and NAC subfamily preference was found during the expansion in maize. Moreover, the duplication events might occur after the divergence of the lineages of Z. mays and S. italica, and segmental duplication seemed to be the dominant pattern for the gene duplication in maize. Furthermore, the expansion of ZmNAC members may be also related to gain and loss of introns. Besides, the restriction of functional divergence was discovered after most of the gene duplication events. These results could provide novel insights into molecular evolution and expansion analysis of NAC family in maize, and advance the NAC researches in other plants, especially polyploid plants.	[Fan, Kai; Wang, Ming; Ni, Mi; Bibi, Noreen; Yuan, Shuna; Li, Feng; Wang, Xuede] Zhejiang Univ, Coll Agr & Biotechnol, Inst Crop Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Miao, Ying] Fujian Agr & Forestry Univ, Coll Life Sci, Ctr Mol Cell & Syst Biol, Fuzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Fujian Agriculture & Forestry University	Wang, XD (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Crop Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xdwang@zju.edu.cn		Ni, Mi/0000-0002-8930-6887	Ministry of Agriculture [2009ZX08009-061B]; National Natural Science Foundation of China [31171616]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Agriculture (2009ZX08009-061B) and the National Natural Science Foundation of China (no. 31171616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cenci A, 2014, PLANT MOL BIOL, P1; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; de Oliveira TM, 2011, TREE GENET GENOMES, V7, P1123, DOI 10.1007/s11295-011-0400-8; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Faria JAQA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-129; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang GQ, 2013, PLANT GROWTH REGUL, V71, P101, DOI 10.1007/s10725-013-9811-x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Li J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-220; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lu M, 2012, PLANT CELL REP, V31, P1701, DOI 10.1007/s00299-012-1284-2; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Ma J, 2014, SCI HORTIC-AMSTERDAM, V165, P82, DOI 10.1016/j.scienta.2013.11.005; Meng QC, 2007, J PLANT PHYSIOL, V164, P1002, DOI 10.1016/j.jplph.2006.05.019; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park KC, 2010, GENES GENOM, V32, P570, DOI 10.1007/s13258-010-0076-8; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ricachenevsky FK, 2010, MOL BIOL REP, V37, P3735, DOI 10.1007/s11033-010-0027-0; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Shang HH, 2013, J INTEGR PLANT BIOL, V55, P663, DOI 10.1111/jipb.12085; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Su HY, 2013, PLANT PHYSIOL BIOCH, V71, P11, DOI 10.1016/j.plaphy.2013.06.022; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Van Camp W, 2005, CURR OPIN BIOTECH, V16, P147, DOI 10.1016/j.copbio.2005.03.002; Voitsik AM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-85; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang ZY, 2013, ACTA PHYSIOL PLANT, V35, P1397, DOI 10.1007/s11738-012-1195-4; Welner DH, 2012, BIOCHEM J, V444, P395, DOI 10.1042/BJ20111742; Yoon HK, 2008, MOL CELLS, V25, P438; Zahn LM, 2005, GENETICS, V169, P2209, DOI 10.1534/genetics.104.037770; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003	71	43	50	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111837	10.1371/journal.pone.0111837	http://dx.doi.org/10.1371/journal.pone.0111837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369196	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000110
J	Gadaleta, F; Van Steen, K				Gadaleta, Francesco; Van Steen, Kristel			Discovering Main Genetic Interactions with LABNet LAsso-Based Network Inference	PLOS ONE			English	Article							MULTICOLLINEARITY; SELECTION	Genome-wide association studies can potentially unravel the mechanisms behind complex traits and common genetic diseases. Despite the valuable results produced thus far, many questions remain unanswered. For instance, which specific genetic compounds are linked to the risk of the disease under investigation; what biological mechanism do they act through; or how do they interact with environmental and other external factors? The driving force of computational biology is the constantly growing amount of big data generated by high-throughput technologies. A practical framework that can deal with this abundance of information and that consent to discovering genetic associations and interactions is provided by means of networks. Unfortunately, high dimensionality, the presence of noise and the geometry of data can make the aforementioned problem extremely challenging. We propose a penalised linear regression approach that can deal with the aforementioned issues that affect genetic data. We analyse the gene expression profiles of individuals with a common trait to infer the network structure of interactions among genes. The permutation-based approach leads to more stable and reliable networks inferred from synthetic microarray data. We show that a higher number of permutations determines the number of predicted edges, improves the overall sensitivity and controls the number of false positives.	[Gadaleta, Francesco; Van Steen, Kristel] Univ Liege, Inst Montefiore, B-4000 Liege, Belgium	University of Liege	Gadaleta, F (corresponding author), Univ Liege, Inst Montefiore, B-4000 Liege, Belgium.	francesco.gadaleta@ulg.ac.be			European Cooperation in Science and Technology (COST Action EU Pancreas) [BM1204]	European Cooperation in Science and Technology (COST Action EU Pancreas)	The authors acknowledge research opportunities offered by the FNRS (Projet de recherche "Foresting in Integromics Inference'' n T.0180.13). This work has been partially funded by the European Cooperation in Science and Technology (COST Action # BM1204: EU Pancreas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2006, GENETICS, V173, P1735, DOI 10.1534/genetics.106.055921; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Buhl S, 1993, EXISTENCE MAXIMUM LI; Buzkova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056976; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Farrar D, 1964, WORKING PAPER; Finegold M, 2011, ANN APPL STAT, V5, P1057, DOI 10.1214/10-AOAS410; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garg A, 2013, INT J MODELLING IDEN, V18; Geistlinger L, 2011, BIOINFORMATICS, V27, pI366, DOI 10.1093/bioinformatics/btr228; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hallinan JS, 2005, PROCEEDINGS OF THE 2005 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P90; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hirose K, 2013, COMPUT STAT DATA AN, V59, P28, DOI 10.1016/j.csda.2012.10.005; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5_1; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Meinshausen N, TECHNICAL REPORT; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Roso VM, 2005, J ANIM SCI, V83, P1788; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Sifakis EG, 2012, COMPUT BIOL MED, V42, P19, DOI 10.1016/j.compbiomed.2011.10.003; Silverman EK, 2012, DISCOV MED, V14, P143; Van Steen K, 2002, STAT MED, V21, P3865, DOI 10.1002/sim.1358; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Yakovlev LK, 2007, HIGH IS LEVEL TECHNI; Yi G, 2007, BIOINFORMATICS, V23, P1053, DOI 10.1093/bioinformatics/btl673; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	33	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110451	10.1371/journal.pone.0110451	http://dx.doi.org/10.1371/journal.pone.0110451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369052	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000020
J	Napoli, PE; Coronella, F; Satta, GM; Fossarello, M				Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Fossarello, Maurizio			A Novel Technique of Contrast-Enhanced Optical Coherence Tomography Imaging in Evaluation of Clearance of Lipids in Human Tears	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; DRY EYE DISEASE; ARTIFICIAL TEARS; CORNEAL SURFACE; OCULAR SURFACE; FILM; EVAPORATION; TURNOVER; LAYER; FLUOROPHOTOMETRY	Purpose: The aim of this work was to gather preliminary data in different conditions of healthy eyes, aqueous tear deficient dry eyes, obstructive meibomian gland disease (MGD) and non-obvious obstructive MGD (NOMGD) individuals, using a new, contrast-enhanced optical coherence tomography (OCT) imaging method to evaluate the clearance of lipids in human tears. Methods: Eighty-two adult patients presenting with complaints of ocular irritation were studied for abnormalities of the ocular surface and classified as healthy (n = 21), aqueous tear deficient dry eyes (n = 20), obstructive MGD (n = 15) and NOMGD (n = 26) individuals. A lipid-based tracer, containing an oil-in-water emulsion, was used to obtain an enhanced OCT imaging of the lower tear meniscus. After instillation, a dramatic initial increase of reflectivity of the lower tear meniscus was detected by OCT, followed by a decay back to baseline values over time. Based on this finding, the clearance of lipids was measured in real-time by Fourier-domain anterior segment OCT. Results: The differences in the clearance of lipids among the four groups as well as the correlations between symptom questionnaire score, standardized visual scale test, fluorescein break-up time, ocular surface fluorescein staining score, Schirmer I test scores were found to be statistically significant. The individual areas under the curve of the clearance of lipids calculated by the receiver operating characteristic curve technique ranged from 0.66 to 0.98, suggesting reliable sensitivity and specificity of lipid-enhanced OCT imaging. Conclusions: This new technique of contrast-enhanced OCT imaging of the tear film following lipid-based tracer instillation provides a measure of the clearance of lipids. The quantitative values found are in agreement with other methods of evaluation of the lacrimal system. An improvement of the clinician's ability in the diagnosis and understanding of abnormalities of the ocular surface may be achieved by this simple approach.	[Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Fossarello, Maurizio] Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy	University of Cagliari	Napoli, PE (corresponding author), Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy.	pietronapoli@ymail.com	Fossarello, Maurizio/AAD-8235-2021; Napoli, Pietro/AAP-8423-2020; Fossarello, Maurizio/G-2032-2015	Napoli, Pietro Emanuele/0000-0001-7020-0823; Fossarello, Maurizio/0000-0003-1520-7760				Amano S, 2010, J EYE ATARASHII GANK, V27, P627; [Anonymous], 2007, OCUL SURF, V5, P108; Blackie CA, 2010, CORNEA, V29, P1333, DOI 10.1097/ICO.0b013e3181d4f366; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Butovich IA, 2008, CURR EYE RES, V33, P405, DOI 10.1080/02713680802018419; Craig JP, 1997, OPTOMETRY VISION SCI, V74, P8, DOI 10.1097/00006324-199701000-00014; De La Lagrima TS, 2006, ARCH SOC ESP OFTALMO, V81, P365; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Gasymov OK, 2005, INVEST OPHTH VIS SCI, V46, P3589, DOI 10.1167/iovs.05-0569; Glasgow BJ, 1999, INVEST OPHTH VIS SCI, V40, P3100; Gobbels M, 1992, Ger J Ophthalmol, V1, P350; KUPPENS EVMJ, 1992, INVEST OPHTH VIS SCI, V33, P3442; Lemp M. A, 1992, DRY EYE COMPREHENSIV, P101; Macri A, 2000, OPHTHALMOLOGY, V107, P1338, DOI 10.1016/S0161-6420(00)00101-9; Mathers W, 2004, EXP EYE RES, V78, P389, DOI 10.1016/S0014-4835(03)00199-4; Mathers WD, 1996, OPHTHALMOLOGY, V103, P664, DOI 10.1016/S0161-6420(96)30637-4; Mathers WD, 1996, CORNEA, V15, P229, DOI 10.1097/00003226-199605000-00001; McNamara NA, 1998, OPTOMETRY VISION SCI, V75, P316, DOI 10.1097/00006324-199805000-00020; MISHIMA S., 1966, INVEST OPHTHALMOL, V5, P264; MISHIMA S, 1965, ARCH OPHTHALMOL-CHIC, V73, P233; Mochizuki H, 2008, BRIT J OPHTHALMOL, V92, P108, DOI 10.1136/bjo.2007.121533; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P4533, DOI 10.1167/iovs.14-14666; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P3179, DOI 10.1167/iovs.13-13613; Napoli PE, 2014, CAN J OPHTHALMOL, V49, P210, DOI 10.1016/j.jcjo.2013.10.003; Nichols JJ, 2002, OPTOMETRY VISION SCI, V79, P363, DOI 10.1097/00006324-200206000-00009; Pearce EI, 2001, OPTOMETRY VISION SCI, V78, P30, DOI 10.1097/00006324-200101010-00011; Redl B, 2000, BBA-PROTEIN STRUCT M, V1482, P241, DOI 10.1016/S0167-4838(00)00142-4; TIFFANY JM, 1987, ADV LIPID RES, V22, P1; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; VANBEST JA, 1995, GRAEF ARCH CLIN EXP, V233, P1; Walt JRM., 1997, DRUG INF J, V31, P1436; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P4349, DOI 10.1167/iovs.05-1654; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P3325, DOI 10.1167/iovs.06-0055	35	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109843	10.1371/journal.pone.0109843	http://dx.doi.org/10.1371/journal.pone.0109843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369027	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000011
J	Sicras-Mainar, A; Guijarro, P; Armada, B; Blanca-Tamayo, M; Navarro-Artieda, R				Sicras-Mainar, Antoni; Guijarro, Pablo; Armada, Beatriz; Blanca-Tamayo, Milagrosa; Navarro-Artieda, Ruth			Influence of the CYP2D6 Isoenzyme in Patients Treated with Venlafaxine for Major Depressive Disorder: Clinical and Economic Consequences	PLOS ONE			English	Article							CYTOCHROME-P450 2D6; PHARMACOKINETICS; TAMOXIFEN; DISEASE; CARE	Background: Antidepressant drugs are the mainstay of drug therapy for sustained remission of symptoms. However, the clinical results are not encouraging. This lack of response could be due, among other causes, to factors that alter the metabolism of the antidepressant drug. Objective: to evaluate the impact of concomitant administration of CYP2D6 inhibitors or substrates on the efficacy, tolerability and costs of patients treated with venlafaxine for major depressive disorder in clinical practice. Methods: We designed an observational study using the medical records of outpatients. Subjects aged >= 18 years who started taking venlafaxine during 2008-2010 were included. Three study groups were considered: no combinations (reference), venlafaxine-substrate, and venlafaxine-inhibitor. The follow-up period was 12 months. The main variables were: demographic data, comorbidity, remission (Hamilton <7), response to treatment, adverse events and costs. The statistical analysis included logistic regression models and ANCOVA, with p values <0.05 considered significant. Results: A total of 1,115 subjects were recruited. The mean age was 61.7 years and 75.1% were female. Approximately 33.3% (95% CI: 30.5 to 36.1) were receiving some kind of drug combination (venlafaxine-substrate: 23.0%, and venlafaxine-inhibitor: 10.3%). Compared with the venlafaxine-substrate and venlafaxine-inhibitor groups, patients not taking concomitant drugs had a better response to therapy (49.1% vs. 39.9% and 34.3%, p < 0.01), greater remission of symptoms (59.9% vs. 50.2% and 43.8%, p < 0.001), fewer adverse events (1.9% vs. 7.0% and 6.1%, p < 0.05) and a lower mean adjusted cost ((sic)2,881.7 vs. (sic)4,963.3 and (sic)7,389.1, p < 0.001), respectively. All cost components showed these differences. Conclusions: The patients treated with venlafaxine alone showed a better response to anti-depressant treatment, greater remission of symptoms, a lower incidence of adverse events and lower healthcare costs.	[Sicras-Mainar, Antoni] Badalona Serv Assistencials SA, Directorate Planning, Badalona, Barcelona, Spain; [Guijarro, Pablo; Armada, Beatriz] Pfizer, Madrid, Spain; [Blanca-Tamayo, Milagrosa] Badalona Serv Assistencials SA, Dept Psychiat, Badalona, Barcelona, Spain; [Navarro-Artieda, Ruth] Hosp Badalona Germans Trias & Pujol, Badalona, Barcelona, Spain	Pfizer; Hospital Germans Trias i Pujol	Sicras-Mainar, A (corresponding author), Badalona Serv Assistencials SA, Directorate Planning, Badalona, Barcelona, Spain.	asicras@bsa.cat			Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was funded by Pfizer Inc. All authors had a role in study design, decision to publish and manuscript preparation. A. Sicras was a paid as consultant from Pfizer responsible for data collection and analysis and statistical analysis.	American Psychiatric Association, 2008, DIAGN STAT MAN MENT; Bellon JA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-256; [Anonymous], 1991, GUID ATC CLASS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark Karen, 2012, W V Med J, V108, P64; Conde V., 1984, ESCALAS EVALUACION C; Haro JM, 2006, MED CLIN-BARCELONA, V126, P445, DOI 10.1157/13086324; Instituto Nacional de Estadistica, 2010, ENC COST LAB ANO 201; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; LAMBERTS H, 1993, INT CLASSIFICATION P; Lobello KW, 2010, J CLIN PSYCHIAT, V71, P1482, DOI 10.4088/JCP.08m04773blu; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nichols AI, 2009, J CLIN PSYCHOPHARM, V29, P383, DOI 10.1097/JCP.0b013e3181acc4dd; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Otton SV, 1996, BRIT J CLIN PHARMACO, V41, P149, DOI 10.1111/j.1365-2125.1996.tb00173.x; Poulsen L, 1996, EUR J CLIN PHARMACOL, V51, P289, DOI 10.1007/s002280050200; Preskorn SH, 2013, J CLIN PSYCHIAT, V74, P614, DOI 10.4088/JCP.12m07807; Preskorn SH, 2010, J PSYCHIATR PRACT, V16, P46, DOI 10.1097/01.pra.0000367777.96012.83; Preskorn SH, 2008, J PSYCHIATR PRACT, V14, P368, DOI 10.1097/01.pra.0000341891.43501.6b; Sachse C, 1997, AM J HUM GENET, V60, P284; Samer CF, 2010, BRIT J PHARMACOL, V160, P907, DOI 10.1111/j.1476-5381.2010.00673.x; Shelton RC., 2006, PRIM PSYCHIAT, V13, P73; Sicras-Mainar A, 2010, GAC SANIT, V24, P13, DOI 10.1016/j.gaceta.2009.05.012; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wade AG, 2007, 23 INT C PHARM THER; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e90453	10.1371/journal.pone.0090453	http://dx.doi.org/10.1371/journal.pone.0090453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369508	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000001
J	Zou, J; Baghdayan, AS; Payne, SJ; Shankar, N				Zou, Jun; Baghdayan, Arto S.; Payne, Sarah J.; Shankar, Nathan			A TIR Domain Protein from E-faecalis Attenuates MyD88-Mediated Signaling and NF-kappa B Activation	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; MALTOSE-BINDING PROTEIN; ENTEROCOCCUS-FAECALIS; ESCHERICHIA-COLI; BACTERIAL VIRULENCE; INNATE IMMUNITY; MACROPHAGES; SURVIVAL; FAMILY; SUBVERSION	Toll-like receptor signaling, mediated by functional Toll/interleukin-1 receptor (TIR) domains, plays a critical role in activating the innate immune response responsible for controlling and clearing infection. Bacterial protein mimics of components of this signaling pathway have been identified and function through inhibition of interactions between Toll-like receptors (TLRs) and their adaptor proteins, mediated by TIR domains. A previously uncharacterized gene, which we have named tcpF (for TIR domain-containing protein in E. faecalis) was identified in the genome of Enterococcus faecalis V583, and predicted to encode a protein resembling mammalian and bacterial TIR proteins. We overexpressed and purified TcpF from E. coli and found that the recombinant protein could bind to phosphatidylinositol phosphates in vitro, suggesting a mechanism by which TcpF may be anchored to the plasma membrane in close proximity to TIR domains of TLRs and adaptor proteins. Purified TcpF was also found to interact specifically with the TIR adaptor protein MyD88, and this interaction was dependent on the BB loop domain in the Box 2 region of TcpF. Despite no evidence of TcpF being a secreted protein, recombinant TcpF was effectively able to enter RAW264.7 cells in vitro although the mechanism by which this occurs remains to be determined. Overexpression of TcpF in mammalian cells suppressed the NF-kappa B activation induced by bacterial lipoteichoic acid. A mutant lacking the tcpF gene was attenuated for survival in macrophages, with increased ability to activate NF-kappa B compared to the wild type strain. Complementation in trans restored growth, and inhibition of NF-kappa B, to that of wild type levels. No appreciable difference in bacterial persistence, dissemination or pathogenesis was observed between the wild type and mutant in a mouse peritonitis model however, which suggested either a subtle role for TcpF or functional overlap with other redundant factor(s) in this virulence model.	[Zou, Jun; Shankar, Nathan] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Shankar, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA.	nathan-shankar@ouhsc.edu			Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103640-01]; President's Associates Presidential Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; President's Associates Presidential Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103640-01, and by a President's Associates Presidential Professorship (N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bates PA, 2001, PROTEINS, P39; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; Daw K, 2012, FEMS IMMUNOL MED MIC, V65, P270, DOI 10.1111/j.1574-695X.2012.00944.x; Ding Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020008; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gentry-Weeks CR, 1999, INFECT IMMUN, V67, P2160, DOI 10.1128/IAI.67.5.2160-2165.1999; Goh LL, 2003, PROTEIN EXPRES PURIF, V32, P194, DOI 10.1016/S1046-5928(03)00225-0; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kajfasz JK, 2012, INFECT IMMUN, V80, P2265, DOI 10.1128/IAI.00026-12; Knodler LA, 2001, NAT REV MOL CELL BIO, V2, P578, DOI 10.1038/35085062; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PALMER KL, 2010, J BACTERIOL; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Spear AM, 2012, MICROBIOL-SGM, V158, P1593, DOI 10.1099/mic.0.055012-0; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013	51	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112010	10.1371/journal.pone.0112010	http://dx.doi.org/10.1371/journal.pone.0112010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369374	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000136
J	Mazzoni, E; Pietrobon, S; Masini, I; Rotondo, JC; Gentile, M; Fainardi, E; Casetta, I; Castellazzi, M; Granieri, E; Caniati, ML; Tola, MR; Guerra, G; Martini, F; Tognon, M				Mazzoni, Elisa; Pietrobon, Silvia; Masini, Irene; Rotondo, John Charles; Gentile, Mauro; Fainardi, Enrico; Casetta, Ilaria; Castellazzi, Massimiliano; Granieri, Enrico; Caniati, Maria Luisa; Tola, Maria Rosaria; Guerra, Giovanni; Martini, Fernanda; Tognon, Mauro			Significant Low Prevalence of Antibodies Reacting with Simian Virus 40 Mimotopes in Serum Samples from Patients Affected by Inflammatory Neurologic Diseases, Including Multiple Sclerosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN BRAIN-TUMORS; LARGE T-ANTIGEN; SV40 ANTIBODIES; JC VIRUS; BK VIRUS; INFECTION; ASSOCIATION; HUMANS; MESOTHELIOMA	Many investigations were carried out on the association between viruses and multiple sclerosis (MS). Indeed, early studies reported the detections of neurotropic virus footprints in the CNS of patients with MS. In this study, sera from patients affected by MS, other inflammatory (OIND) and non-inflammatory neurologic diseases (NIND) were analyzed for antibodies against the polyomavirus, Simian Virus 40 (SV40). An indirect enzyme-linked immunosorbent assay (ELISA), with two synthetic peptides, which mimic SV40 antigens, was employed to detect specific antibodies in sera from patients affected by MS, OIND, NIND and healthy subjects (HS). Immunologic data indicate that in sera from MS patients antibodies against SV40 mimotopes are detectable with a low prevalence, 6%, whereas in HS of the same mean age, 40 yrs, the prevalence was 22%. The difference is statistically significant (P = 0.001). Significant is also the difference between MS vs. NIND patients (6% vs. 17%; P = 0.0254), whereas no significant difference was detected between MS vs OIND (6% vs 10%; P > 0.05). The prevalence of SV40 antibodies in MS patients is 70% lower than that revealed in HS.	[Mazzoni, Elisa; Pietrobon, Silvia; Masini, Irene; Rotondo, John Charles; Martini, Fernanda; Tognon, Mauro] Univ Ferrara, Sect Pathol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Fainardi, Enrico] Univ Hosp Ferrara, Unit Neuroradiol, Ferrara, Italy; [Gentile, Mauro; Casetta, Ilaria; Castellazzi, Massimiliano; Granieri, Enrico] Univ Ferrara, Sch Med, Neurol Sect, I-44100 Ferrara, Italy; [Caniati, Maria Luisa; Tola, Maria Rosaria] Univ Hosp Ferrara, Neurol Unit, Ferrara, Italy; [Guerra, Giovanni] Univ Hosp Ferrara, Clin Lab Anal, Ferrara, Italy	University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna	Martini, F (corresponding author), Univ Ferrara, Sect Pathol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.	mrf@unife.it; tgm@unife.it	Castellazzi, Massimiliano/X-3499-2019; Casetta, Ilaria/K-5289-2016; Rotondo, John Charles/A-4540-2017; gentile, mauro/AAC-4595-2021; Castellazzi, Massimiliano/K-5083-2016; Mazzoni, Elisa/K-6313-2016	Castellazzi, Massimiliano/0000-0001-6555-6075; Casetta, Ilaria/0000-0003-4099-8875; Rotondo, John Charles/0000-0001-5179-1525; gentile, mauro/0000-0002-6912-8868; Castellazzi, Massimiliano/0000-0001-6555-6075; Mazzoni, Elisa/0000-0001-6829-8569; Granieri, Enrico/0000-0003-4038-3192	University of Ferrara; FAR Projects; University Hospital of Ferrara; Regione Emilia Romagna; ERMES; MS project; Fondazione Cassa di Risparmio di Ferrara; Fondazione Cassa di Risparmio di Cento	University of Ferrara; FAR Projects; University Hospital of Ferrara; Regione Emilia Romagna(Regione Emilia Romagna); ERMES; MS project; Fondazione Cassa di Risparmio di Ferrara(Fondazione Carife); Fondazione Cassa di Risparmio di Cento	This study was sponsored, in part, by grants from The University of Ferrara, FAR Projects, University Hospital of Ferrara, Regione Emilia Romagna, ERMES, MS project to E.G., F.M. and M.T., Fondazione Cassa di Risparmio di Ferrara to E.G., and Fondazione Cassa di Risparmio di Cento to F.M. and M.T. Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbanti-Brodano G, 2006, ADV EXP MED BIOL, V577, P319; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; Barbanti-Brodano G, 1998, ADV VIRUS RES, V50, P69, DOI 10.1016/S0065-3527(08)60806-4; Broccolo F, 2013, SCI WORLD J, DOI 10.1155/2013/867389; Comar M, 2007, CANCER RES, V67, P8456, DOI 10.1158/0008-5472.CAN-07-2232; Comar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104848; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Corallini A, 2012, HUM IMMUNOL, V73, P502, DOI 10.1016/j.humimm.2012.02.009; de la Hera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090182; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Giovannoni G, 2006, LANCET NEUROL, V5, P887, DOI 10.1016/S1474-4422(06)70577-4; Granieri E, 1997, NEUROLOGY, V49, pS2, DOI 10.1212/WNL.49.2_Suppl_2.S2; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Hoffmann Franziska, 2014, Eur J Immunol, V44, P1247, DOI 10.1002/eji.201470045; HORVATH CJ, 1992, AM J PATHOL, V140, P1431; Kaliyaperumal S, 2013, AM J PATHOL, V183, P1910, DOI 10.1016/j.ajpath.2013.08.007; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kjaerheim K, 2007, INT J CANCER, V120, P2459, DOI 10.1002/ijc.22592; Kvistad S, 2014, MULTIPLE SCLEROSIS; Libbey JE, 2013, INT REV IMMUNOLOGY; Lundstig A, 2005, J GEN VIROL, V86, P1703, DOI 10.1099/vir.0.80783-0; Mameli G, 2013, J NEUROIMMUNOL, V264, P120, DOI 10.1016/j.jneuroim.2013.07.017; Martini F, 1996, CANCER RES, V56, P4820; MARTINI F, 1995, J NATL CANCER I, V87, P1331, DOI 10.1093/jnci/87.17.1331; Martini F, 1998, INT J CANCER, V78, P669, DOI 10.1002/(SICI)1097-0215(19981209)78:6<669::AID-IJC1>3.0.CO;2-B; Martini Fernanda, 2007, Infect Agent Cancer, V2, P13, DOI 10.1186/1750-9378-2-13; Mazzoni E, 2013, J INFECTION, V67, P356, DOI 10.1016/j.jinf.2013.06.002; Mazzoni E, 2014, NEURO-ONCOLOGY, V16, P513, DOI 10.1093/neuonc/not217; Myhr KM, 1998, J NEUROL NEUROSUR PS, V64, P539, DOI 10.1136/jnnp.64.4.539; Pakpoor J, 2013, EXPERT REV NEUROTHER, V13, P287, DOI [10.1586/ERN.13.6, 10.1586/ern.13.6]; Ribeiro T, 2010, NEUROL SCI, V31, P517, DOI 10.1007/s10072-010-0353-y; Taronna A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061182; Tognon M, 1996, CANCER GENET CYTOGEN, V90, P17, DOI 10.1016/0165-4608(96)00067-2; Viscidi RP, 2003, CLIN DIAGN LAB IMMUN, V10, P278, DOI 10.1128/CDLI.10.2.278-285.2003	34	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110923	10.1371/journal.pone.0110923	http://dx.doi.org/10.1371/journal.pone.0110923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365364	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100035
J	Noda, K; Nakajima, S; Godo, S; Saito, H; Ikeda, S; Shimizu, T; Enkhjargal, B; Fukumoto, Y; Tsukita, S; Yamada, T; Katagiri, H; Shimokawa, H				Noda, Kazuki; Nakajima, Sota; Godo, Shigeo; Saito, Hiroki; Ikeda, Shohei; Shimizu, Toru; Enkhjargal, Budbazar; Fukumoto, Yoshihiro; Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki; Shimokawa, Hiroaki			Rho-Kinase Inhibition Ameliorates Metabolic Disorders through Activation of AMPK Pathway in Mice	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LONG-TERM INHIBITION; PROTEIN-KINASE; SKELETAL-MUSCLE; METFORMIN; PHOSPHORYLATION; ADAPTATION; MECHANISM; UPSTREAM; SURVIVAL	Background: Metabolic disorders, caused by excessive calorie intake and low physical activity, are important cardiovascular risk factors. Rho-kinase, an effector protein of the small GTP-binding protein RhoA, is an important cardiovascular therapeutic target and its activity is increased in patients with metabolic syndrome. We aimed to examine whether Rho-kinase inhibition improves high-fat diet (HFD)-induced metabolic disorders, and if so, to elucidate the involvement of AMP-activated kinase (AMPK), a key molecule of metabolic conditions. Methods and Results: Mice were fed a high-fat diet, which induced metabolic phenotypes, such as obesity, hypercholesterolemia and glucose intolerance. These phenotypes are suppressed by treatment with selective Rho-kinase inhibitor, associated with increased whole body O-2 consumption and AMPK activation in the skeletal muscle and liver. Moreover, Rho-kinase inhibition increased mRNA expression of the molecules linked to fatty acid oxidation, mitochondrial energy production and glucose metabolism, all of which are known as targets of AMPK in those tissues. In systemic overexpression of dominant-negative Rho-kinase mice, body weight, serum lipid levels and glucose metabolism were improved compared with littermate control mice. Furthermore, in AMPK alpha 2-deficient mice, the beneficial effects of fasudil, a Rho-kinase inhibitor, on body weight, hypercholesterolemia, mRNA expression of the AMPK targets and increase of whole body O-2 consumption were absent, whereas glucose metabolism was restored by fasudil to the level in wild-type mice. In cultured mouse myocytes, pharmacological and genetic inhibition of Rho-kinase increased AMPK activity through liver kinase b1 (LKB1), with up-regulation of its targets, which effects were abolished by an AMPK inhibitor, compound C. Conclusions: These results indicate that Rho-kinase inhibition ameliorates metabolic disorders through activation of the LKB1/AMPK pathway, suggesting that Rho-kinase is also a novel therapeutic target of metabolic disorders.	[Noda, Kazuki; Nakajima, Sota; Godo, Shigeo; Saito, Hiroki; Ikeda, Shohei; Shimizu, Toru; Enkhjargal, Budbazar; Fukumoto, Yoshihiro; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Dept Metab Dis, Ctr Metab Dis, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Shimokawa, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	shimo@cardio.med.tohoku.ac.jp		Shimokawa, Hiroaki/0000-0001-7534-4826; Godo, Shigeo/0000-0002-4985-7828	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Grant-in-Aid for Scientific Research on Innovative Areas (Signaling Functions of Reactive Oxygen Species), the Grant-in-Aid for Tohoku University Global COE for Conquest of Signal Transduction Diseases with Network Medicine, and the Grants-in-Aid for Scientific Research, all of which are from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Huang H, 2012, NAT NEUROSCI, V15, P1391, DOI 10.1038/nn.3207; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kikuchi Y, 2007, J ENDOCRINOL, V192, P595, DOI 10.1677/JOE-06-0045; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lee SH, 2014, AM J PHYSIOL-ENDOC M, V306, pE332, DOI 10.1152/ajpendo.00619.2013; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Liu PY, 2007, J AM COLL CARDIOL, V49, P1619, DOI 10.1016/j.jacc.2006.12.043; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Nakajima S, 2012, CIRC RES, V111, P87, DOI 10.1161/CIRCRESAHA.112.270215; Noda K, 2012, TOHOKU J EXP MED, V228, P305, DOI 10.1620/tjem.228.305; Oakhill JS, 2009, ACTA PHYSIOL, V196, P3, DOI 10.1111/j.1748-1716.2009.01977.x; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Shimokawa H, 2001, CARDIOVASC RES, V51, P169, DOI 10.1016/S0008-6363(01)00291-7; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang YY, 2012, LIVER TRANSPLANT, V18, P1371, DOI 10.1002/lt.23520; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110446	10.1371/journal.pone.0110446	http://dx.doi.org/10.1371/journal.pone.0110446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365359	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100022
J	Cornman, RS; Robertson, LS; Galbraith, H; Blakeslee, C				Cornman, Robert S.; Robertson, Laura S.; Galbraith, Heather; Blakeslee, Carrie			Transcriptomic Analysis of the Mussel Elliptio complanata Identifies Candidate Stress-Response Genes and an Abundance of Novel or Noncoding Transcripts	PLOS ONE			English	Article							PROTEIN	Mussels are useful indicator species of environmental stress and degradation, and the global decline in freshwater mussel diversity and abundance is of conservation concern. Elliptio complanata is a common freshwater mussel of eastern North America that can serve both as an indicator and as an experimental model for understanding mussel physiology and genetics. To support genetic components of these research goals, we assembled transcriptome contigs from Illumina paired-end reads. Despite efforts to collapse similar contigs, the final assembly was in excess of 136,000 contigs with an N50 of 982 bp. Even so, comparisons to the CEGMA database of conserved eukaryotic genes indicated that similar to 20% of genes remain unrepresented. However, numerous candidate stress-response genes were present, and we identified lineage-specific patterns of diversification among molluscs for cytochrome P450 detoxification genes and two saccharide-modifying enzymes: 1,3 beta-galactosyltransferase and fucosyltransferase. Less than a quarter of contigs had protein-level similarity based on modest BLAST and Hmmer3 statistical thresholds. These results add comparative genomic resources for molluscs and suggest a wealth of novel proteins and noncoding transcripts.	[Cornman, Robert S.; Robertson, Laura S.] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA; [Galbraith, Heather; Blakeslee, Carrie] US Geol Survey, Leetown Sci Ctr, Northern Appalachian Res Branch, Wellsboro, PA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Cornman, RS (corresponding author), US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA.	rcornman@usgs.gov			United States Geological Survey, Ecosystems Mission Area; Leetown Science Center; Northern Appalachian Research Branch	United States Geological Survey, Ecosystems Mission Area; Leetown Science Center; Northern Appalachian Research Branch	This project was funded and carried out by the United States Geological Survey, Ecosystems Mission Area, with internal discretionary funds of its Leetown Science Center and Northern Appalachian Research Branch. Websites describing the facilities, staff, and operations of these research centers are at http://www.lsc.usgs.gov/ and http://www.lsc.usgs.gov/?q=northern-appalachian-research-branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard-Triquet C., 2013, CRC PRESS, DOI [10.1080/03067319.2013.870269, DOI 10.1080/03067319.2013.870269]; Andrews S, FASTQC SOFTWARE; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg DJ, 1995, J N AM BENTHOL SOC, V14, P577, DOI 10.2307/1467542; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Matozzo V, 2008, ENVIRON INT, V34, P531, DOI 10.1016/j.envint.2007.09.008; Meng J, 2013, PLOS ONE; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pelis RM, 2001, AM J PHYSIOL-REG I, V280, pR1844, DOI 10.1152/ajpregu.2001.280.6.R1844; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161	26	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112420	10.1371/journal.pone.0112420	http://dx.doi.org/10.1371/journal.pone.0112420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375103	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600142
J	Fortini, BK; Tring, S; Plummer, SJ; Edlund, CK; Moreno, V; Bresalier, RS; Barry, EL; Church, TR; Figueiredo, JC; Casey, G				Fortini, Barbara K.; Tring, Stephanie; Plummer, Sarah J.; Edlund, Christopher K.; Moreno, Victor; Bresalier, Robert S.; Barry, Elizabeth L.; Church, Timothy R.; Figueiredo, Jane C.; Casey, Graham			Multiple Functional Risk Variants in a SMAD7 Enhancer Implicate a Colorectal Cancer Risk Haplotype	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; SUPER-ENHANCERS; CELL IDENTITY; COLON; IDENTIFICATION; METAANALYSIS; EXPRESSION; ELEMENTS; DISEASE	Genome-wide association studies (GWAS) of colorectal cancer (CRC) have led to the identification of a number of common variants associated with modest risk. Several risk variants map within the vicinity of TGF beta/BMP signaling pathway genes, including rs4939827 within an intron of SMAD7 at 18q21.1. A previous study implicated a novel SNP (novel 1 or rs58920878) as a functional variant within an enhancer element in SMAD7 intron 4. In this study, we show that four SNPs including novel 1 (rs6507874, rs6507875, rs8085824, and rs58920878) in linkage disequilibrium (LD) with the index SNP rs4939827 demonstrate allele-specific enhancer effects in a large, multi-component enhancer of SMAD7. All four SNPs demonstrate allele-specific protein binding to nuclear extracts of CRC cell lines. Furthermore, some of the risk-associated alleles correlate with increased expression of SMAD7 in normal colon tissues. Finally, we show that the enhancer is responsive to BMP4 stimulation. Taken together, we propose that the associated CRC risk at 18q21.1 is due to four functional variants that regulate SMAD7 expression and potentially perturb a BMP negative feedback loop in TGF beta/BMP signaling pathways.	[Fortini, Barbara K.; Tring, Stephanie; Plummer, Sarah J.; Edlund, Christopher K.; Figueiredo, Jane C.; Casey, Graham] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Moreno, Victor] CIBERESP, Catalan Inst Oncol, Canc Prevent & Control Program, Barcelona, Spain; [Moreno, Victor] Univ Barcelona, Hosp Llobregat, Barcelona, Spain; [Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Barry, Elizabeth L.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA; [Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA	University of Southern California; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities	Fortini, BK (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	Barbara.Fortini@med.usc.edu	Moreno, Victor/A-1697-2010; Barry, Elizabeth/AAB-7916-2019; Church, Timothy/AAH-7017-2020	Moreno, Victor/0000-0002-2818-5487; Church, Timothy/0000-0003-3292-5035; Bresalier, Robert/0000-0002-9740-281X; Fortini, Barbara/0000-0003-3230-2604	National Institutes of Health [R01 CA143237, U19 CA148107]; Genetic Associations and Mechanisms in Oncology (GAME-ON), an NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE [U19CA148107, R01CA143237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Associations and Mechanisms in Oncology (GAME-ON), an NCI Cancer Post-GWAS Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA143237, U19 CA148107 to GC). The scientific development and funding of this project was in part supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON), an NCI Cancer Post-GWAS Initiative. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health, who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, COLD SPRING HARB PRO, V2009; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Biancolella M, 2014, HUM MOL GENET, V23, P2198, DOI 10.1093/hmg/ddt584; Bitzer M, 2000, GENE DEV, V14, P187; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brodin G, 2000, J BIOL CHEM, V275, P29023, DOI 10.1074/jbc.M002815200; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Derynck R, 2007, TGF BETA FAMILY CELL; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Gulubova M, 2010, INT J COLORECTAL DIS, V25, P591, DOI 10.1007/s00384-010-0906-9; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; LaVange LM, 2006, CIRCULATION, V114, P2528, DOI 10.1161/CIRCULATIONAHA.106.613638; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rizzo A, 2014, CARCINOGENESIS; Rizzo A, 2011, CANCER RES, V71, P7423, DOI 10.1158/0008-5472.CAN-11-1895; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Stolfi C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.49; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Wallace K, 2010, CANCER PREV RES, V3, P1552, DOI 10.1158/1940-6207.CAPR-10-0047; Whiffin N, 2013, HUM MOL GENET, V22, P5075, DOI 10.1093/hmg/ddt357; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018	40	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111914	10.1371/journal.pone.0111914	http://dx.doi.org/10.1371/journal.pone.0111914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375357	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600074
J	Krens, LL; Simkens, LHJ; Baas, JM; Koomen, ER; Gelderblom, H; Punt, CJA; Guchelaar, HJ				Krens, Lisanne L.; Simkens, Lieke H. J.; Baas, Jara M.; Koomen, Els R.; Gelderblom, Hans; Punt, Cornelis J. A.; Guchelaar, Henk-Jan			Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study	PLOS ONE			English	Article							RECTAL-CANCER; NEOADJUVANT CHEMORADIATION; PATHOLOGICAL RESPONSE; THERAPY; BEVACIZUMAB; RECURRENCE	Statins may inhibit the expression of the mutant KRAS phenotype by preventing the prenylation and thus the activation of the KRAS protein. This study was aimed at retrospectively evaluating the effect of statin use on outcome in KRAS mutant metastatic colorectal cancer patients (mCRC) treated with cetuximab. Treatment data were obtained from patients who were treated with capecitabine, oxaliplatin bevacizumab +/- cetuximab in the phase III CAIRO2 study. A total of 529 patients were included in this study, of whom 78 patients were on statin therapy. In patients with a KRAS wild type tumor (n = 321) the median PFS was 10.3 vs. 11.4 months for non-users compared to statin users and in patients with a KRAS mutant tumor (n = 208) this was 7.6 vs. 6.2 months, respectively. The hazard ratio (HR) for PFS for statin users was 1.12 (95% confidence interval 0.78-1.61) and was not influenced by treatment arm, KRAS mutation status or the KRAS*statin interaction. Statin use adjusted for covariates was not associated with increased PFS (HR = 1.01, 95% confidence interval 0.71-1.54). In patients with a KRAS wild type tumor the median OS for non-users compared to statin users was 22.4 vs. 19.8 months and in the KRAS mutant tumor group the OS was 18.1 vs. 14.5 months. OS was significantly shorter in statin users versus non-users (HR = 1.54; 95% confidence interval 1.06-2.22). However, statin use, adjusted for covariates was not associated with increased OS (HR = 1.41, 95% confidence interval 0.95-2.10). In conclusion, the use of statins at time of diagnosis was not associated with an improved PFS in KRAS mutant mCRC patients treated with chemotherapy and bevacizumab plus cetuximab.	[Krens, Lisanne L.; Koomen, Els R.; Guchelaar, Henk-Jan] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands; [Simkens, Lieke H. J.; Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [Baas, Jara M.; Gelderblom, Hans] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Guchelaar, HJ (corresponding author), Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands.	H.J.Guchelaar@lumc.nl	guchelaar, henk-jan/AAP-1381-2021	Gelderblom, Hans/0000-0001-9270-8636; Guchelaar, Henk-Jan/0000-0002-7085-1383				Chan KKW, 2003, CLIN CANCER RES, V9, P10; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Eisenberg Daniel A., 1998, American Journal of Medicine, V104, p2S, DOI 10.1016/S0002-9343(98)00038-2; Gonyeau MJ, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0383-z; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Katz MS, 2005, INT J RADIAT ONCOL, V62, P1363, DOI 10.1016/j.ijrobp.2004.12.033; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Krens LL, 2010, DRUG DISCOV TODAY, V15, P502, DOI 10.1016/j.drudis.2010.05.012; Lee J, 2009, CANCER CHEMOTH PHARM, V64, P657, DOI 10.1007/s00280-008-0913-5; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Liu Y, 2013, CANC CAUSES CONTROL; Mace AG, 2013, DIS COLON RECTUM, V56, P1217, DOI 10.1097/DCR.0b013e3182a4b236; Maciejak A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-68; Ng K, 2011, JNCI-J NATL CANCER I, V103, P1540, DOI 10.1093/jnci/djr307; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Scartozzi M, 2009, ANN ONCOL, V20, P227, DOI 10.1093/annonc/mdn637; Siddiqui AA, 2009, DIGEST DIS SCI, V54, P1307, DOI 10.1007/s10620-009-0790-8; Theodoropoulos G, 2002, DIS COLON RECTUM, V45, P895, DOI 10.1007/s10350-004-6325-7; Tol J, 2010, CLIN THER, V32, P437, DOI 10.1016/j.clinthera.2010.03.012; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268	21	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112201	10.1371/journal.pone.0112201	http://dx.doi.org/10.1371/journal.pone.0112201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375154	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600117
J	Nakamasu, A; Nakayama, H; Nakayama, N; Suematsu, NJ; Kimura, S				Nakamasu, Akiko; Nakayama, Hokuto; Nakayama, Naomi; Suematsu, Nobuhiko J.; Kimura, Seisuke			A Developmental Model for Branching Morphogenesis of Lake Cress Compound Leaf	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; ESCHSCHOLZIA-CALIFORNICA; PATTERN-FORMATION; ARABIDOPSIS; PAPAVERACEAE; INITIATION; FRAMEWORK; GROWTH; GENE	Lake cress, Rorippa aquatica (Brassicaceae), is a semi-aquatic plant that exhibits a variety of leaf shapes, from simple leaves to highly branched compound leaves, depending on the environment. Leaf shape can vary within a single plant, suggesting that the variation can be explained by a simple model. In order to simulate the branched structure in the compound leaves of R. aquatica, we implemented reaction-diffusion (RD) patterning onto a theoretical framework that had been developed for serration distribution in the leaves of Arabidopsis thaliana, with the modification of the one-dimensional reaction-diffusion domain being deformed with the spatial periodicity of the RD pattern while expanding. This simple method using an iterative pattern could create regular and nested branching patterns. Subsequently, we verified the plausibility of our theoretical model by comparing it with the experimentally observed branching patterns. The results suggested that our model successfully predicted both the qualitative and quantitative aspects of the timing and positioning of branching in growing R. aquatica leaves.	[Nakamasu, Akiko; Nakayama, Hokuto; Kimura, Seisuke] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto 603, Japan; [Nakamasu, Akiko; Suematsu, Nobuhiko J.] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo 101, Japan; [Nakayama, Naomi] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Lothian, Scotland; [Suematsu, Nobuhiko J.] Meiji Univ, Grad Sch Adv Math Sci, Tokyo 101, Japan	Kyoto Sangyo University; Meiji University; University of Edinburgh	Suematsu, NJ (corresponding author), Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo 101, Japan.	suematsu@meiji.ac.jp; seisuke@cc.kyoto-su.ac.jp	Suematsu, Nobuhiko J/L-3409-2017	Suematsu, Nobuhiko/0000-0001-5860-4147; Kimura, Seisuke/0000-0002-6796-3675	Meiji University Global COE Program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis''; JSPS KAKENHI [22870031, 24770047]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan	Meiji University Global COE Program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis''; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This study was supported by Grant-in-Aid for JSPS Fellows (http://www.jsps.go.jp/english/e-grants/index.html) to A.N. and H.N. and by Meiji University Global COE Program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis'' (http://gcoe.mims.meiji.ac.jp/index-e.html) to A.N. and N.J.S. In addition, it was partially supported by JSPS KAKENHI Grant Numbers 22870031 and 24770047 and the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (http://www.shigaku.go.jp/g_about_pmac.htm) to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Fisher JB, 1997, BOT GAZ, V138, P377; Gleissberg S, 2004, AM J BOT, V91, P306, DOI 10.3732/ajb.91.3.306; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Ikeuchi M, 2014, PLANTA, V240, P125, DOI 10.1007/s00425-014-2071-9; Ikeuchi M, 2013, AM J BOT, V100, P1116, DOI 10.3732/ajb.1200560; Kimura S, 2008, CURR BIOL, V18, P672, DOI 10.1016/j.cub.2008.04.008; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Meinhardt H, 1995, ALGOLISMIC BEAUTY SE, P31; Meinhardt H., 1982, MODELS BIOL PATTERN; Miura T, 2008, CURR TOP DEV BIOL, V81, P291, DOI 10.1016/S0070-2153(07)81010-6; Nakayama H., 2012, PLANT MORPHOL, V24, P57; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Prsinkiewicz P, 1990, ALGORITHMIC BEAUTY P; Prusinkiewicz P., 2013, SPRINGER P MATH, V15, P137, DOI DOI 10.1007/978-3-642-20164-6_12; Prusinkiewicz P, 2012, NEW PHYTOL, V193, P549, DOI 10.1111/j.1469-8137.2011.04009.x; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van Berkel K, 2013, DEVELOPMENT, V140, P2253, DOI 10.1242/dev.079111; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384	26	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111615	10.1371/journal.pone.0111615	http://dx.doi.org/10.1371/journal.pone.0111615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375102	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600052
J	Hua, GKH; Bertier, L; Soltaninejad, S; Hofte, M				Hua, Gia Khuong Hoang; Bertier, Lien; Soltaninejad, Saman; Hofte, Monica			Cropping Systems and Cultural Practices Determine the Rhizoctonia Anastomosis Groups Associated with Brassica spp. in Vietnam	PLOS ONE			English	Article							BINUCLEATE RHIZOCTONIA; 1ST REPORT; BIOLOGICAL-CONTROL; SOLANI AG-4; WEB BLIGHT; PATHOGENICITY; 1ST-REPORT; RESISTANCE; CABBAGE; CANOLA	Ninety seven Rhizoctonia isolates were collected from different Brassica species with typical Rhizoctonia symptoms in different provinces of Vietnam. The isolates were identified using staining of nuclei and sequencing of the rDNA-ITS barcoding gene. The majority of the isolates were multinucleate R. solani and four isolates were binucleate Rhizoctonia belonging to anastomosis groups (AGs) AG-A and a new subgroup of A-F that we introduce here as AG-Fc on the basis of differences in rDNA-ITS sequence. The most prevalent multinucleate AG was AG 1-IA (45.4% of isolates), followed by AG 1-ID (17.5%), AG 1-IB (13.4%), AG 4-HGI (12.4%), AG 2-2 (5.2%), AG 7 (1.0%) and an unknown AG related to AG 1-IA and AG 1-IE that we introduce here as AG 1-IG (1.0%) on the basis of differences in rDNA-ITS sequence. AG 1-IA and AG 1-ID have not been reported before on Brassica spp. Pathogenicity tests revealed that isolates from all AGs, except AG-A, induced symptoms on detached leaves of several cabbage species. In in vitro tests on white cabbage and Chinese cabbage, both hosts were severely infected by AG 1-IB, AG 2-2, AG 4-HGI, AG 1-IG and AG-Fc isolates, while under greenhouse conditions, only AG 4-HGI, AG 2-2 and AG-Fc isolates could cause severe disease symptoms. The occurrence of the different AGs seems to be correlated with the cropping systems and cultural practices in different sampling areas suggesting that agricultural practices determine the AGs associated with Brassica plants in Vietnam.	[Hua, Gia Khuong Hoang; Bertier, Lien; Soltaninejad, Saman; Hofte, Monica] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Phytopathol, B-9000 Ghent, Belgium	Ghent University	Hofte, M (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Phytopathol, B-9000 Ghent, Belgium.	monica.hofte@ugent.be	Hofte, Monica MR/A-6154-2008	Hofte, Monica/0000-0002-0850-3249	Special Research Fund of Ghent University (BOF); Agency of Innovation by Science and Technology in Flanders (IWT)	Special Research Fund of Ghent University (BOF)(Ghent University); Agency of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by a scholarship from the Special Research Fund of Ghent University (BOF) given to Gia Khuong Hoang Hua. Lien Bertier was funded by a PhD grant of the Agency of Innovation by Science and Technology in Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker EM, 2013, EUR J PLANT PATHOL, V136, P763, DOI 10.1007/s10658-013-0205-8; Baird RE, 1996, PLANT DIS, V80, P104, DOI 10.1094/PD-80-0104C; Budge GE, 2009, PLANT PATHOL, V58, P1059, DOI 10.1111/j.1365-3059.2009.02138.x; Carling DE, 1999, PHYTOPATHOLOGY, V89, P942, DOI 10.1094/PHYTO.1999.89.10.942; Carling DE, 2002, PHYTOPATHOLOGY, V92, P893, DOI 10.1094/PHYTO.2002.92.8.893; Carling DE, 2002, PHYTOPATHOLOGY, V92, P43, DOI 10.1094/PHYTO.2002.92.1.43; Commerce, 2014, CAN THO PROV; Demirci E, 2002, PLANT PATHOL, V51, P391, DOI 10.1046/j.1365-3059.2002.00704.x; Department of Culture Sport and Tourism of Soc Trang, 2014, OV SOC TRANG PROV; Department of Planning and Investment of Vinh Long, 2014, OV VINH LONG PROV; Department of Propaganda and Training of Hau Giang, 2014, OV HAU GIANG PROV; Dubey SC, 2012, FOLIA MICROBIOL, V57, P513, DOI 10.1007/s12223-012-0165-y; FREEMAN TE, 1982, PLANT DIS, V66, P861, DOI 10.1094/PD-66-861; Godoy-Lutz G, 2008, J GEN PLANT PATHOL, V74, P32, DOI 10.1007/s10327-007-0060-6; Harikrishnan R, 2004, PLANT DIS, V88, P817, DOI 10.1094/PDIS.2004.88.8.817; HASHIBA T, 1972, Annals of the Phytopathological Society of Japan, V38, P414, DOI 10.3186/jjphytopath.38.414; HERR LJ, 1995, CROP PROT, V14, P179, DOI 10.1016/0261-2194(95)00017-G; HOMMA Y, 1983, Annals of the Phytopathological Society of Japan, V49, P184, DOI 10.3186/jjphytopath.49.184; Hyakumachi M, 2005, PHYTOPATHOLOGY, V95, P784, DOI 10.1094/PHYTO-95-0784; Integrated Water Resources Management, 2014, LAM DONG PROV; International Federation of Red Cross and Red Crescent Societies, 2013, EM APP FIN REP VIET; Keijer J, 1997, PLANT PATHOL, V46, P659, DOI 10.1046/j.1365-3059.1997.d01-61.x; Keijer J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P149; Keinath AP, 1997, PLANT DIS, V81, P946, DOI 10.1094/PDIS.1997.81.8.946; Khangura RK, 1999, PLANT DIS, V83, P714, DOI 10.1094/PDIS.1999.83.8.714; Kuramae EE, 2003, EUR J PLANT PATHOL, V109, P391, DOI 10.1023/A:1023591520981; LEE FN, 1983, PLANT DIS, V67, P829, DOI 10.1094/PD-67-829; MARTIN SB, 1988, PHYTOPATHOLOGY, V78, P379, DOI 10.1094/Phyto-78-379; Ministry of Natural Resources and Environment Sub-Institute of Hydrometeorology and Environment of South Vietnam, 2010, CLIM CHANG MEK DELT; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Ohkura M, 2009, PLANT DIS, V93, P615, DOI 10.1094/PDIS-93-6-0615; Pannecoucque J, 2008, PLANT PATHOL, V57, P737, DOI 10.1111/j.1365-3059.2007.01823.x; Paulitz TC, 2006, PLANT DIS, V90, P829, DOI 10.1094/PD-90-0829B; People's committee of Dong Nai province, 2011, PROGR DEV MAIN CROPS; Poromarto SH, 1998, PHYTOPATHOLOGY, V88, P1056, DOI 10.1094/PHYTO.1998.88.10.1056; Priyatmojo A, 2001, PHYTOPATHOLOGY, V91, P1054, DOI 10.1094/PHYTO.2001.91.11.1054; Rollins PA, 1999, CAN J PLANT PATHOL, V21, P119, DOI 10.1080/07060669909501201; Ross RE, 1998, CROP PROT, V17, P99, DOI 10.1016/S0261-2194(97)00109-9; Sayama A, 2000, ANN REP SOC PLANT PR, V51, P54; Scholten OE, 2001, EUR J PLANT PATHOL, V107, P161, DOI 10.1023/A:1011208903344; Schwartz HF, 2007, DRY BEAN RHIZOCTONIA; Sharon M, 2008, MYCOSCIENCE, V49, P93, DOI 10.1007/s10267-007-0394-0; Sharon Michal, 2006, Mycoscience, V47, P299, DOI 10.1007/s10267-006-0320-x; Sneh B., 1991, IDENTIFICATION RHIZO; Taheri P, 2007, PHYTOPATHOLOGY, V97, P373, DOI 10.1094/PHYTO-97-3-0373; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thuan TTM, 2008, PLANT DIS, V92, P648, DOI 10.1094/PDIS-92-4-0648B; Van Beneden S, 2009, EUR J PLANT PATHOL, V124, P9, DOI 10.1007/s10658-008-9385-z; Verma PR, 1996, PHYTOPROTECTION, V77, P99, DOI 10.7202/706106ar; Viet's life, 2014, HA NOI CAP; Vietnam trade promotion agency, 2008, REP VIETN VEG FRUIT; Wharton P, 2007, RHIZOCTONIA STEM CAN; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang G, 2012, PLANT PATHOL, P41, DOI DOI 10.5772/39026; Yang GH, 2007, PLANT PATHOL, V56, P351, DOI 10.1111/j.1365-3059.2007.01543.x; Yang GH, 2004, PLANT PATHOL, V53, P260, DOI 10.1111/j.0032-0862.2004.00987.x; Yang J, 1996, PLANT DIS, V80, P513, DOI 10.1094/PD-80-0513; YITBAREK SM, 1987, CAN J PLANT PATHOL, V9, P6, DOI 10.1080/07060668709501904; ZETTLER FW, 1972, ANNU REV PHYTOPATHOL, V10, P455, DOI 10.1146/annurev.py.10.090172.002323	59	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111750	10.1371/journal.pone.0111750	http://dx.doi.org/10.1371/journal.pone.0111750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372406	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900073
J	Li, WR; Shi, QS; Liang, Q; Xie, XB; Huang, XM; Chen, YB				Li, Wen-Ru; Shi, Qing-Shan; Liang, Qing; Xie, Xiao-Bao; Huang, Xiao-Mo; Chen, Yi-Ben			Antibacterial Activity and Kinetics of Litsea cubeba Oil on Escherichia coli	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; EXTRACTS; CONSTITUENTS	Litsea cubeba oil is extracted from the fresh fruits of Litsea cubeba by distillation. In this study, its chemical constituents, antibacterial activity, kinetics and effects against Escherichia coli were studied. Its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were both 0.125% (v/v) by toxic food method. Moreover, the antibacterial kinetic curves indicated 0.0625% (v/v) of litsea cubeba oil was able to prolong the growth lag phase of E. coli cells to approximate 12 hours while 0.125% (v/v) of litsea cubeba oil was able to kill the cells completely. Furthermore, transmission electron microscope (TEM) observation showed most E. coli cells treated with 0.125% (v/v) of litsea cubeba oil were killed or destroyed severely within 2 hours. The litsea cubeba oil might penetrate and destroy the outer and inner membrane of E. coli cells. Thus many holes and gaps were observed on the damaged cells, which led to their death eventually. The antibacterial effects of litsea cubeba oil mainly attributed to the presence of aldehydes, which accounted for approximately 70% in its whole components analyzed by GC/MS. Based on the antimicrobial properties, litsea cubeba oil would have a broad application in the antimicrobial industry.	[Li, Wen-Ru; Shi, Qing-Shan; Liang, Qing; Xie, Xiao-Bao; Huang, Xiao-Mo; Chen, Yi-Ben] Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Shi, QS (corresponding author), Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.	jigan@gdim.cn			Guangdong Provincial Science and Technology [2009B011000011, 2011B010400039]	Guangdong Provincial Science and Technology	This study was supported by Guangdong Provincial Science and Technology Project (2009B011000011, 2011B010400039). The grant recipient was Wen-Ru Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ja'fari AH, 2011, PHYTOCHEMISTRY, V72, P1406, DOI 10.1016/j.phytochem.2011.04.013; Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3; Arora DS, 1999, INT J ANTIMICROB AG, V12, P257, DOI 10.1016/S0924-8579(99)00074-6; Avato P, 2000, PHYTOMEDICINE, V7, P239, DOI 10.1016/S0944-7113(00)80010-0; Bajpai VK, 2009, FOOD CHEM TOXICOL, V47, P1876, DOI 10.1016/j.fct.2009.04.043; Bajpai VK, 2009, APPL MICROBIOL BIOT, V83, P1127, DOI 10.1007/s00253-009-2017-5; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Ceylan E, 2004, J RAPID METH AUT MIC, V12, P1, DOI 10.1111/j.1745-4581.2004.tb00046.x; Chen CJ, 2012, J WOOD SCI, V58, P538, DOI 10.1007/s10086-012-1277-3; Chuang PH, 2007, BIORESOURCE TECHNOL, V98, P232, DOI 10.1016/j.biortech.2005.11.003; Delespaul Q, 2000, J ESSENT OIL RES, V12, P256, DOI 10.1080/10412905.2000.9699510; Ebrahimi SN, 2008, FOOD CHEM, V110, P927, DOI 10.1016/j.foodchem.2008.02.083; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Kalemba D., 2012, DIETARY PHYTOCHEMICA, DOI DOI 10.1007/978-94-007-3926-0_5,; Li WR, 2013, APPL MICROBIOL BIOT, V97, P7483, DOI 10.1007/s00253-012-4460-y; Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6; Luo M, 2005, J FOOD PROTECT, V68, P581, DOI 10.4315/0362-028X-68.3.581; Luo M, 2004, ACTA BIOCH BIOPH SIN, V36, P277, DOI 10.1093/abbs/36.4.277; Nogueira JHC, 2010, INT J FOOD MICROBIOL, V137, P55, DOI 10.1016/j.ijfoodmicro.2009.10.017; Rasooli I, 2005, PHYTOCHEMISTRY, V66, P2851, DOI 10.1016/j.phytochem.2005.09.029; SHELEF LA, 1984, J FOOD SAFETY, V6, P29, DOI 10.1111/j.1745-4565.1984.tb00477.x; Sheng LN, 2014, FOOD CONTROL, V46, P374, DOI 10.1016/j.foodcont.2014.05.050; Tian J, 2011, INT J FOOD MICROBIOL, V145, P464, DOI 10.1016/j.ijfoodmicro.2011.01.023; Wang HW, 2010, CHEM BIODIVERS, V7, P229, DOI 10.1002/cbdv.200800349; Wang Y, 2009, EUR FOOD RES TECHNOL, V228, P865, DOI 10.1007/s00217-008-0999-3; Yahyazadeh M, 2008, WORLD J MICROB BIOT, V24, P1445, DOI 10.1007/s11274-007-9636-8; Yang Y, 2010, MOLECULES, V15, P7075, DOI 10.3390/molecules15107075	28	42	50	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110983	10.1371/journal.pone.0110983	http://dx.doi.org/10.1371/journal.pone.0110983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372706	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900031
J	Nair, AR; Elks, CM; Vila, J; Del Piero, F; Paulsen, DB; Francis, J				Nair, Anand R.; Elks, Carrie M.; Vila, Jorge; Del Piero, Fabio; Paulsen, Daniel B.; Francis, Joseph			A Blueberry-Enriched Diet Improves Renal Function and Reduces Oxidative Stress in Metabolic Syndrome Animals: Potential Mechanism of TLR4-MAPK Signaling Pathway	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; MESSENGER-RNA EXPRESSION; TUBULOINTERSTITIAL INJURY; INSULIN-RESISTANCE; HYPERTENSIVE-RATS; ANGIOTENSIN-II; IN-VIVO; PROTEIN; OBESITY	Background: Metabolic syndrome (MetS) is characterized by a cluster of health factors that indicate a higher risk for cardiorenal diseases. Recent evidence indicates that antioxidants from berries are alternative to attenuate oxidative stress and inflammation. We tested the hypothesis that inflammation-induced renal damage is triggered by the activation of TLR4, and subsequent modulation of redox-sensitive molecules and mitogen-activated protein kinase (MAPK) pathway. Methods: Five-week old lean and obese Zucker rats (LZR and OZR) were fed a blueberry-enriched diet or an isocaloric control diet for 15 weeks. A glucose tolerance test and acute renal clearance experiments were performed. Gene and protein expression levels for TLR4, cytokines and phosphorylation of ERK and p38MAPK were measured. Kidney redox status and urinary albumin levels were quantified. Renal pathology was evaluated histologically. Results: Control OZR exhibited lower glucose tolerance; exacerbated renal function parameters; increased oxidative stress. Gene and protein expression levels of TLR4 were higher and this was accompanied by increased renal pathology with extensive albuminuria and deterioration in antioxidant levels in OZR. In addition, OZR had increased phosphorylation of ERK and p38MAPK. Blueberry-fed OZR exhibited significant improvements in all these parameters compared to OZR. Conclusion: TLR4-MAPK signaling pathway is a key to the renal structural injury and dysfunction in MetS and blueberry (BB) protect against this damage by inhibiting TLR4. Significance: This is the first study to put forth a potential mechanism of TLR4-induced kidney damage in a model of MetS and to elucidate a downstream mechanism by which blueberry exert their reno-protective effects.	[Nair, Anand R.; Elks, Carrie M.; Vila, Jorge; Del Piero, Fabio; Paulsen, Daniel B.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA; [Elks, Carrie M.] Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	jfrancis@vetmed.lsu.edu	Elks, Carrie Marie/N-1961-2017		National Center for Complementary & Integrative Health [T32AT004094] Funding Source: NIH RePORTER	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adelman RD, 2001, J PEDIATR-US, V138, P481, DOI 10.1067/mpd.2001.113006; Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Bellezza Ilaria, 2010, Cancers (Basel), V2, P483, DOI 10.3390/cancers2020483; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Cui XL, 2006, FREE RADICAL BIO MED, V41, P213, DOI 10.1016/j.freeradbiomed.2006.02.004; Eguchi K, 2014, J ATHEROSCLER THROMB; El-Atat FA, 2004, J AM SOC NEPHROL, V15, P2816, DOI 10.1097/01.ASN.0000133698.80390.37; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Elks CM, 2013, BIOACTIVES FRUIT HLT, DOI [10.1002/9781118635551.ch11, DOI 10.1002/9781118635551.CH11]; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Freeman LR, 2013, FREE RADICAL BIO MED, V56, P226, DOI 10.1016/j.freeradbiomed.2012.08.577; Fukuyama N, 1997, FREE RADICAL BIO MED, V22, P771, DOI 10.1016/S0891-5849(96)00401-7; Good DW, 2009, AM J PHYSIOL-RENAL, V297, pF866, DOI 10.1152/ajprenal.00335.2009; Ha HJ, 1999, FREE RADICAL BIO MED, V26, P944, DOI 10.1016/S0891-5849(98)00276-7; Hall AM, 2014, QJM-INT J MED, V107, P261, DOI 10.1093/qjmed/hct258; Hardy OT, 2013, PEDIATR OBES, V8, pe19, DOI 10.1111/j.2047-6310.2012.00098.x; Hisada Y, 1999, J CLIN INVEST, V103, P627, DOI 10.1172/JCI2454; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Johns BR, 2012, NEPHROL DIAL TRANSPL, V27, P1410, DOI 10.1093/ndt/gfr498; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Khoo Michael C K, 2013, IEEE Rev Biomed Eng, V6, P143, DOI 10.1109/RBME.2012.2232651; Khoo NKH, 2012, FREE RADICAL BIO MED, V52, P2312, DOI 10.1016/j.freeradbiomed.2012.04.011; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Koc M, 2011, NEPHROL DIAL TRANSPL, V26, P955, DOI 10.1093/ndt/gfq500; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lepenies J, 2011, NEPHRON CLIN PRACT, V119, pC97, DOI 10.1159/000324765; Long HD, 2013, J ENDOCRINOL INVEST, V36, P923, DOI 10.3275/8946; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moss NG, 2013, AM J PHYSIOL-RENAL, V305, pF830, DOI 10.1152/ajprenal.00048.2013; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Neri M, 2007, J CELL MOL MED, V11, P156, DOI 10.1111/j.1582-4934.2007.00009.x; Pamidimukkala J, 2004, CLIN EXP HYPERTENS, V26, P55, DOI 10.1081/CEH-120027331; Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058339; Peroval MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051243; Polichnowski AJ, 2010, HYPERTENSION, V55, P1425, DOI 10.1161/HYPERTENSIONAHA.110.151332; Queisser N, 2012, FREE RADICAL BIO MED, V53, P314, DOI 10.1016/j.freeradbiomed.2012.05.011; Rodrigo R, 2002, FREE RADICAL BIO MED, V33, P409, DOI 10.1016/S0891-5849(02)00908-5; Slyvka Y, 2009, ENDOCRINE, V35, P89, DOI 10.1007/s12020-008-9121-7; Ta NN, 2010, ATHEROSCLEROSIS, V213, P429, DOI 10.1016/j.atherosclerosis.2010.08.064; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Thobe BM, 2007, J CELL PHYSIOL, V210, P667, DOI 10.1002/jcp.20860; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wang C, 2013, FREE RADICAL BIO MED, V65, P1417, DOI 10.1016/j.freeradbiomed.2013.10.005; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Wilson CB, 2014, BEHAV BRAIN RES; Xi LA, 2011, HEPATOLOGY, V53, P127, DOI 10.1002/hep.24011; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang SM, 2014, FREE RADIC BIOL MED; Youn JY, 2014, DIABETES	61	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111976	10.1371/journal.pone.0111976	http://dx.doi.org/10.1371/journal.pone.0111976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372283	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900099
J	Perera, FP; Chang, HW; Tang, DL; Roen, EL; Herbstman, J; Margolis, A; Huang, TJ; Miller, RL; Wang, S; Rauh, V				Perera, Frederica P.; Chang, Hsin-wen; Tang, Deliang; Roen, Emily L.; Herbstman, Julie; Margolis, Amy; Huang, Tzu-Jung; Miller, Rachel L.; Wang, Shuang; Rauh, Virginia			Early-Life Exposure to Polycyclic Aromatic Hydrocarbons and ADHD Behavior Problems	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SUBSTANCE USE DISORDERS; AIR-POLLUTION; DNA-ADDUCTS; ACADEMIC-PERFORMANCE; METABOLITE LEVELS; MATERNAL STRESS; RISK-FACTORS; CANCER-RISK	Importance: Polycyclic aromatic hydrocarbons are widespread urban air pollutants from combustion of fossil fuel and other organic material shown previously to be neurotoxic. Objective: In a prospective cohort study, we evaluated the relationship between Attention Deficit Hyperactivity Disorder behavior problems and prenatal polycyclic aromatic hydrocarbon exposure, adjusting for postnatal exposure. Materials and Methods: Children of nonsmoking African-American and Dominican women in New York City were followed from in utero to 9 years. Prenatal polycyclic aromatic hydrocarbon exposure was estimated by levels of polycyclic aromatic hydrocarbon-DNA adducts in maternal and cord blood collected at delivery. Postnatal exposure was estimated by the concentration of urinary polycyclic aromatic hydrocarbon metabolites at ages 3 or 5. Attention Deficit Hyperactivity Disorder behavior problems were assessed using the Child Behavior Checklist and the Conners Parent Rating Scale-Revised. Results: High prenatal adduct exposure, measured by elevated maternal adducts was significantly associated with all Conners Parent Rating Scale-Revised subscales when the raw scores were analyzed continuously (N = 233). After dichotomizing at the threshold for moderately to markedly atypical symptoms, high maternal adducts were significantly associated with the Conners Parent Rating Scale-Revised DSM-IV Inattentive (OR = 5.06, 95% CI [1.43, 17.93]) and DSM-IV Total (OR = 3.37, 95% CI [1.10, 10.34]) subscales. High maternal adducts were positivity associated with the DSM-oriented Attention Deficit/Hyperactivity Problems scale on the Child Behavior Checklist, albeit not significant. In the smaller sample with cord adducts, the associations between outcomes and high cord adduct exposure were not statistically significant (N = 162). Conclusion: The results suggest that exposure to polycyclic aromatic hydrocarbons encountered in New York City air may play a role in childhood Attention Deficit Hyperactivity Disorder behavior problems.	[Perera, Frederica P.; Tang, Deliang; Roen, Emily L.; Herbstman, Julie; Miller, Rachel L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Perera, Frederica P.; Chang, Hsin-wen; Tang, Deliang; Roen, Emily L.; Herbstman, Julie; Margolis, Amy; Huang, Tzu-Jung; Miller, Rachel L.; Wang, Shuang; Rauh, Virginia] Columbia Univ, Columbia Ctr Childrens Environm Hlth, New York, NY USA; [Chang, Hsin-wen; Huang, Tzu-Jung; Wang, Shuang] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Margolis, Amy] Columbia Univ, Coll Phys & Surg, Div Child & Adolescent Psychiat, New York, NY USA; [Margolis, Amy] Columbia Univ, Coll Phys & Surg, Ctr Dev Neuropsychiat, New York State Psychiat Inst,Dept Psychiat, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Pediat Allergy & Immunol, New York, NY USA; [Rauh, Virginia] Columbia Univ, Heilbrunn Dept Populat & Family Hlth, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University	Perera, FP (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	fpp1@columbia.edu	Margolis, Amy E/AAU-9225-2021; Chang, Hsin-wen/AAP-3939-2021	Chang, Hsin-wen/0000-0003-4566-7047; Perera, Frederica/0000-0002-1364-9250	National Institute for Environmental Health Sciences (NIEHS); U.S. Environmental Protection Agency (US EPA): NIEHS/EPA [P01ES09600/R82702701]; NIEHS/EPA [P01ES09600/RD832141, P01ES09600/ RD834509]; NIEHS [R01ES08977]; US EPA [RD832096]; John & Wendy Neu Family Foundation; New York Community Trust; Trustees of the Blanchette Hooker Rockefeller Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, R01ES008977, P01ES009600] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Environmental Protection Agency (US EPA): NIEHS/EPA; NIEHS/EPA; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US EPA(United States Environmental Protection Agency); John & Wendy Neu Family Foundation; New York Community Trust; Trustees of the Blanchette Hooker Rockefeller Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the National Institute for Environmental Health Sciences (NIEHS) and the U.S. Environmental Protection Agency (US EPA): NIEHS/EPA P01ES09600/R82702701, NIEHS/EPA P01ES09600/RD832141, NIEHS/EPA P01ES09600/ RD834509, NIEHS R01ES08977. This publication was also made possible in part by US EPA grants RD832096, the John & Wendy Neu Family Foundation, the New York Community Trust, Trustees of the Blanchette Hooker Rockefeller Fund, and an anonymous foundation. Funding from all the institutions listed was used towards the design and conduct of the study; collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript. Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the US EPA. Further, US EPA does not endorse the purchase of any commercial products or services mentioned in the publication. Findings expressed in this paper are the opinions of the authors and do not necessarily reflect the official opinion of the Centers for Disease Control and Prevention.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; ALEXANDROV K, 1992, CANCER RES, V52, P6248; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Anderson LM, 2000, ENVIRON HEALTH PERSP, V108, P573, DOI 10.2307/3454549; [Anonymous], 2001, CHILD BEHAV CHECKLIS; Archibong AE, 2002, REPROD TOXICOL, V16, P801, DOI 10.1016/S0890-6238(02)00058-8; Barry TD, 2005, J AM ACAD CHILD PSY, V44, P265, DOI 10.1097/00004583-200503000-00011; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Bostic JQ, 2008, MASSACHUSETTS GEN HO; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bouchard M, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9504; Brown L., 1990, TEST NONVERBAL INTEL; Brown LA, 2007, NEUROTOXICOLOGY, V28, P965, DOI 10.1016/j.neuro.2007.05.005; BUI QQ, 1986, TOXICOLOGY, V42, P195, DOI 10.1016/0300-483X(86)90009-0; Caldwell B.M., 1979, HOME OBSERVATION MEA; Castano-Vinyals G, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.008375; CDC, 2013, ADHD DAT STAT; Charach A, 2011, J AM ACAD CHILD PSY, V50, P9, DOI 10.1016/j.jaac.2010.09.019; Chiu YHM, 2013, ENVIRON HEALTH PERSP, V121, P859, DOI 10.1289/ehp.1205940; Conners C.K., 1997, CONNERS RATING SCALE; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Cornelius MD, 2011, NEUROTOXICOL TERATOL, V33, P137, DOI 10.1016/j.ntt.2010.08.006; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; de Graaf R, 2008, OCCUP ENVIRON MED, V65, P835, DOI 10.1136/oem.2007.038448; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Ek U, 2011, ACTA PAEDIATR, V100, P402, DOI 10.1111/j.1651-2227.2010.02048.x; Froehlich TE, 2011, CURR PSYCHIAT REP, V13, P333, DOI 10.1007/s11920-011-0221-3; Garzon DL, 2008, ARCH PSYCHIAT NURS, V22, P288, DOI 10.1016/j.apnu.2007.12.006; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Groenman AP, 2013, ADDICTION, V108, P1503, DOI 10.1111/add.12188; Grova N, 2007, NEUROTOXICOLOGY, V28, P630, DOI 10.1016/j.neuro.2007.01.010; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Jacobson LA, 2013, ARCH CLIN NEUROPSYCH; Jerrett M, 2009, EPIDEMIOLOGY, V20, P231, DOI 10.1097/EDE.0b013e31819776a1; JONGENEELEN FJ, 1990, BRIT J IND MED, V47, P454; Knapp M, 2011, J MENT HEALTH POLICY, V14, P137; Kotsopoulos N, 2013, J MENT HEALTH POLICY, V16, P27; Kupper T, 2012, INT ARCH OCC ENV HEA, V85, P837, DOI 10.1007/s00420-012-0794-0; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2006, ANAL CHEM, V78, P5744, DOI 10.1021/ac0606094; MANCHESTER DK, 1987, CANCER RES, V47, P4861; MEYN MS, 1995, CANCER RES, V55, P5991; Miller RL, 2010, PEDIATR ALLERGY IMMU, V21, P260, DOI 10.1111/j.1399-3038.2009.00980.x; MOONEY LA, 1995, CANCER EPIDEM BIOMAR, V4, P627; Morello-Frosch R, 2011, HEALTH AFFAIR, V30, P879, DOI 10.1377/hlthaff.2011.0153; National Research Council, 1993, TOX TEST STRAT DET N; Newman NC, 2013, ENVIRON HEALTH PERSP, V121, P731, DOI 10.1289/ehp.1205555; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; Pelham WE, 2007, J PEDIATR PSYCHOL, V32, P711, DOI 10.1093/jpepsy/jsm022; Perera F, 2005, CANCER EPIDEM BIOMAR, V14, P709, DOI 10.1158/1055-9965.EPI-04-0457; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Perera FP, 2002, ENVIRON HEALTH PERSP, V110, P197, DOI 10.1289/ehp.02110197; Perera FP, 2012, ENV HLTH PERSPECT; Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Rodriguez-Barranco M, 2013, SCI TOTAL ENVIRON, V454, P562, DOI 10.1016/j.scitotenv.2013.03.047; Saunders CR, 2006, J APPL TOXICOL, V26, P427, DOI 10.1002/jat.1157; Schellenberger MT, 2013, TOXICOL APPL PHARM, V271, P175, DOI 10.1016/j.taap.2013.05.007; Schuurmans C, 2013, CLIN GENET, V83, P108, DOI 10.1111/cge.12049; Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Siddique S, 2011, EUR J PEDIATR, V170, P923, DOI 10.1007/s00431-010-1379-0; Spencer T, 1999, PEDIATR CLIN N AM, V46, P915, DOI 10.1016/S0031-3955(05)70163-2; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Stein J, 2002, J DEV BEHAV PEDIATR, V23, pS13, DOI 10.1097/00004703-200202001-00004; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Strickland P, 1996, ENVIRON HEALTH PERSP, V104, P927, DOI 10.2307/3433012; Strine Tara W, 2006, Prev Chronic Dis, V3, pA52; Takeda Ken, 2004, Environ Sci, V11, P33; Todd RD, 2001, AM J PSYCHIAT, V158, P1891, DOI 10.1176/appi.ajp.158.11.1891; Veglia F, 2008, CARCINOGENESIS, V29, P932, DOI 10.1093/carcin/bgm286; Wasserman GA, 1998, AM J PUBLIC HEALTH, V88, P481, DOI 10.2105/AJPH.88.3.481; Wilens TE, 2002, J AM ACAD CHILD PSY, V41, P262, DOI 10.1097/00004583-200203000-00005; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7; Wood J, 2006, DEV PSYCHOL, V42, P345, DOI 10.1037/0012-1649.42.2.345; WOOD KA, 1995, J NEUROSCI, V15, P5851; Woodruff TJ, 2003, ENVIRON HEALTH PERSP, V111, P942, DOI 10.1289/ehp.5317; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; Wu SY, 2013, RES DEV DISABIL, V34, P505, DOI 10.1016/j.ridd.2012.09.004; ZHAO ZH, 1990, SCI TOTAL ENVIRON, V92, P145, DOI 10.1016/0048-9697(90)90326-P	87	91	96	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111670	10.1371/journal.pone.0111670	http://dx.doi.org/10.1371/journal.pone.0111670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372862	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900059
J	Fantazzini, D				Fantazzini, Dean			Nowcasting and Forecasting the Monthly Food Stamps Data in the US Using Online Search Data	PLOS ONE			English	Article							STRUCTURAL-CHANGE; VECTOR AUTOREGRESSIONS; TESTS; PARAMETER; COINTEGRATION; CASELOADS	We propose the use of Google online search data for nowcasting and forecasting the number of food stamps recipients. We perform a large out-of-sample forecasting exercise with almost 3000 competing models with forecast horizons up to 2 years ahead, and we show that models including Google search data statistically outperform the competing models at all considered horizons. These results hold also with several robustness checks, considering alternative keywords, a falsification test, different out-of-samples, directional accuracy and forecasts at the state-level.	Moscow MV Lomonosov State Univ, Moscow Sch Econ, Moscow, Russia	Lomonosov Moscow State University	Fantazzini, D (corresponding author), Moscow MV Lomonosov State Univ, Moscow Sch Econ, Moscow, Russia.	fantazzini@mse-msu.ru		Fantazzini, Dean/0000-0002-1481-3382				Albert VN, 1996, SOC SERV REV, V70, P58, DOI 10.1086/604165; ANDREWS DWK, 1994, ECONOMETRICA, V62, P1383, DOI 10.2307/2951753; ANDREWS DWK, 1993, ECONOMETRICA, V61, P821, DOI 10.2307/2951764; [Anonymous], 2011, ECONOMIST; Aparicio F, 2006, J TIME SER ANAL, V27, P545, DOI 10.1111/j.1467-9892.2006.00474.x; Askitas N., 2009, APPL EC Q, V55, P107, DOI [10.1016/1047-2797(94)90062-0, DOI 10.1016/1047-2797(94)90062-0, DOI 10.3790/AEQ.55.2.107]; Bartlett S, 2004, TECHNICAL REPORT; Boswijk H, 1996, J TIME SER ANAL, V17, P221, DOI DOI 10.1111/J.1467-9892.1996.TB00274.X; Broock W.A., 1996, ECONOMET REV, V15, P197, DOI [10.1080/07474939608800353, DOI 10.1080/07474939608800353]; BROWN RL, 1975, J ROY STAT SOC B MET, V37, P149; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; CHU CSJ, 1995, BIOMETRIKA, V82, P603, DOI 10.1093/biomet/82.3.603; Conte M, 1998, J POLICY MODEL, V20, P461, DOI 10.1016/S0161-8938(97)00048-3; D'Amuri F., 2013, EC WORKING PAPERS, V891; Da Z, 2011, J FINANC, V66, P1461, DOI 10.1111/j.1540-6261.2011.01679.x; DAmuri F, 2009, TECHNICAL REPORT; Doan TA, 1984, ECON REV, V3, P1, DOI DOI 10.1080/07474938408800053; Dynaski M, 1991, FORECASTING FOOD STA; Edelman B, 2012, J ECON PERSPECT, V26, P189, DOI 10.1257/jep.26.2.189; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Fantazzini D, 2014, INT J COMPU IN PRESS; Franses P.H., 2000, NONLINEAR TIME SERIE; Franses P.H., 2004, PERIODIC TIME SERIES; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Greenslade JV, 2002, J ECON DYN CONTROL, V26, P1517, DOI 10.1016/S0165-1889(01)00083-5; Gregory AW, 1996, J ECONOMETRICS, V70, P99, DOI 10.1016/0304-4076(69)41685-7; Grogger J, 2007, CHILD YOUTH SERV REV, V29, P900, DOI 10.1016/j.childyouth.2006.12.011; Gurmu S, 2008, GOVT BUDGET FORECAST, P188; Hansen PR, 2011, ECONOMETRICA, V79, P453, DOI 10.3982/ECTA5771; Hatemi-J A, 2008, EMPIR ECON, V35, P497, DOI 10.1007/s00181-007-0175-9; Hayashi M, 2012, TECHNICAL REPORT, V2011-E03; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Johansen S., 2006, PALGRAVE HDB ECONOME, P540; Johansen S., 1995, LIKELIHOOD BASED INF, DOI DOI 10.1093/0198774508.001.0001; Johansen S, 2000, ECONOMET J, V3, P216, DOI [DOI 10.1111/1368-423X.00047, 10.1111/1368- 423X.00047]; Kang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055205; Klerman JA, 2011, J POLICY ANAL MANAG, V30, P863, DOI 10.1002/pam.20601; Koop Gary, 2009, Foundations and Trends in Econometrics, V3, P267, DOI 10.1561/0800000013; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; Kristoufek L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02713; Lazariu V, 2011, CONTEMP ECON POLICY, V29, P46, DOI 10.1111/j.1465-7287.2010.00203.x; Lee J, 2003, REV ECON STAT, V85, P1082, DOI 10.1162/003465303772815961; LITTERMAN RB, 1986, J BUS ECON STAT, V4, P25, DOI 10.2307/1391384; Liu J, 1997, STAT SINICA, V7, P497; LJUNG GM, 1979, BIOMETRIKA, V66, P265, DOI 10.1093/biomet/66.2.265; Mabli James., 2011, DETERMINANTS SUPPLEM; NAIK G, 1986, AM J AGR ECON, V68, P721, DOI 10.2307/1241556; Opitz W, 1996, POPUL RES POLICY REV, V15, P549; Osterholm P, 2004, APPL ECON LETT, V11, P213, DOI 10.1080/13504850410001674821; Pesaran MH, 2007, J ECONOMETRICS, V137, P134, DOI 10.1016/j.jeconom.2006.03.010; PLOBERGER W, 1992, ECONOMETRICA, V60, P271, DOI 10.2307/2951597; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Proietti T, 2003, COMPUT STAT DATA AN, V42, P451, DOI 10.1016/S0167-9473(02)00230-X; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Rossi E., 2014, J FINANCIAL IN PRESS; Sa-ngasoongsong A, 2012, INT J PROD ECON, V140, P875, DOI 10.1016/j.ijpe.2012.07.009; Suhoy T., 2009, 6 BANK ISR; Taylor MP, 1998, J INT ECON, V46, P281, DOI 10.1016/S0022-1996(97)00054-8; TODA HY, 1995, J ECONOMETRICS, V66, P225, DOI 10.1016/0304-4076(94)01616-8; Tong H, 1990, NONLINEAR TIME SERIE; United States General Accounting Office, 1999, FOOD STAMP PROGR VAR; Venables W., 2003, MODERN APPL STAT S; Wilde PE, 2013, AM J AGR ECON, V95, P325, DOI 10.1093/ajae/aas043; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Zeileis A, 2005, ECONOMET REV, V24, P445, DOI 10.1080/07474930500406053; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zeileis A., 2002, J STAT SOFTW, V7, P1, DOI [DOI 10.18637/JSS.V007.I02, 10.18637/jss.v007.i02]; Zeileis A, 2010, COMPUT STAT DATA AN, V54, P1696, DOI 10.1016/j.csda.2009.12.005; Ziliak JP, 2003, SOUTH ECON J, V69, P903, DOI 10.2307/1061657	75	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111894	10.1371/journal.pone.0111894	http://dx.doi.org/10.1371/journal.pone.0111894			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369315	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402000119
J	Niu, LL; Zhang, YL; Meng, L; Xiao, Y; Wong, KKL; Abbott, D; Zheng, HR; Zheng, RQ; Qian, M				Niu, Lili; Zhang, Yanling; Meng, Long; Xiao, Yang; Wong, Kelvin K. L.; Abbott, Derek; Zheng, Hairong; Zheng, Rongqin; Qian, Ming			Detection of Subclinical Atherosclerosis in Asymptomatic Subjects Using Ultrasound Radiofrequency-Tracking Technology	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; COMMON CAROTID-ARTERY; CARDIOVASCULAR RISK-FACTORS; SMOOTH-MUSCLE-CELLS; DISEASE RISK; YOUNG-ADULTS; STIFFNESS; ASSOCIATION; PREDICTION; CHILDREN	Objective: Atherosclerosis is a chronic and systemic disease and its developmental process involves the synergism of multiple risk factors such as hypertension, dyslipidemia, diabetes, obesity and smoking. The diagnosis of subclinical atherosclerosis is essential for strategic guidance towards suitable treatments and efficient prevention against acute cardiovascular events. This study employed ultrasound radiofrequency (RF) tracking technology to characterize human carotid arteries in vivo in terms of intima-media thickness (IMT) and artery stiffness, and evaluated the statistical correlation between carotid IMT and stiffness, and the number of risk factors for atherosclerosis. Methods: A total of 160 asymptomatic subjects were enrolled. Ultrasound RF-tracking technology was employed to acquire carotid IMT and stiffness parameters: maximum IMT ((MAX) IMT), RF Quality IMT ((RF) QIMT), distensibility coefficient (DC), compliance coefficient (CC), alpha index, beta index and local pulse wave velocity (PWV beta). The subjects were categorized in four groups in terms of the number of risk factors: 'zero', 'single', 'double', and 'multiple', and statistical analyses of carotid IMT and stiffness parameters were performed between these different groups. Results: The subjects (n = 145) with (IMT)-I-MAX smaller than 1.0 mm matched the IMT criteria for non-atherosclerosis and were named as NA-subjects. Spearman's rho correlation analysis of the whole group and the NA-subjects both showed that (IMT)-I-MAX correlated positively with (RF)QIMT, alpha, beta, and PWV beta, and negatively with DC and CC (p<0.01). The analysis of covariance of NA-subjects showed significant differences between subjects with and without risk factors, and also showed significant differences between the 'zero', 'single', 'double', and 'multiple' groups. Conclusions: The carotid IMT and stiffness parameters obtained by the ultrasound RF-tracking technology were demonstrated to possess significant statistical correlation with the number of risk factors from 160 subjects, and these anatomical and mechanical parameters may potentially be used together with the IMT criteria to support subclinical atherosclerosis diagnosis.	[Niu, Lili; Meng, Long; Xiao, Yang; Zheng, Hairong; Qian, Ming] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Zhang, Yanling; Zheng, Rongqin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Sun Yat Sen University; University of Adelaide; University of Adelaide	Zheng, HR (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	hr.zheng@siat.ac.cn; zhengrongqin@hotmail.com; ming.qian@siat.ac.cn	Wong, Kelvin Kian Loong/ABA-3915-2021; Abbott, Derek/E-8352-2011; Wong, Kelvin/AAL-8636-2021; XIAO, YANG/GPW-5529-2022	Wong, Kelvin Kian Loong/0000-0002-8600-1105; Abbott, Derek/0000-0002-0945-2674; 	National Research Program (973) from Ministry of Science and Technology, China [2011CB707903, 2013CB733800]; National Science Foundation Grants (NSFC) [11325420, 11302239, 11304341, 61020106008, 11002152, 11272329, 61002001, S2013040014610]	National Research Program (973) from Ministry of Science and Technology, China; National Science Foundation Grants (NSFC)	The work was supported by National Research Program (973 Grant Nos. 2011CB707903 and 2013CB733800) from Ministry of Science and Technology, China, and National Science Foundation Grants (NSFC Grant Nos. 11325420, 11302239, 11304341, 61020106008, 11002152, 11272329, 61002001, and S2013040014610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Brands PJ, 1997, ULTRASOUND MED BIOL, V23, P911, DOI 10.1016/S0301-5629(97)00021-5; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Carson AP, 2011, HYPERTENSION, V57, P1101, DOI 10.1161/HYPERTENSIONAHA.110.168005; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dan HJ, 2012, EUR J RADIOL, V81, P3289, DOI 10.1016/j.ejrad.2012.05.014; Dan HJ, 2011, CLIN PHYSIOL FUNCT I, V31, P315, DOI 10.1111/j.1475-097X.2011.01019.x; Jin Y, 2013, J ULTRAS MED, V32, P105; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Meinders JM, 2004, ULTRASOUND MED BIOL, V30, P147, DOI 10.1016/j.ultrasmedbio.2003.10.014; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Napoli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041316; Naredo E, 2013, RHEUMATOLOGY, V52, P376, DOI 10.1093/rheumatology/kes260; Niu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067809; O'Leary DH, 2010, EUR HEART J, V31, P1682, DOI 10.1093/eurheartj/ehq185; Orlandi A, 2006, ATHEROSCLEROSIS, V188, P221, DOI 10.1016/j.atherosclerosis.2006.01.018; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Sundholm J, 2014, ATHEROSCLEROSIS, V234, P283, DOI 10.1016/j.atherosclerosis.2014.03.006; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Vinereanu D, 2003, HEART, V89, P449, DOI 10.1136/heart.89.4.449; Yuan LJ, 2013, ULTRASOUND OBST GYN, V42, P644, DOI 10.1002/uog.12409	26	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111926	10.1371/journal.pone.0111926	http://dx.doi.org/10.1371/journal.pone.0111926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369320	Green Published, gold			2022-12-27	WOS:000344402000127
J	Song, E; Sun, HP; Xu, Y; Ma, YN; Zhu, H; Pan, CW				Song, E.; Sun, Hongpeng; Xu, Yong; Ma, Yana; Zhu, Hong; Pan, Chen-Wei			Age-Related Cataract, Cataract Surgery and Subsequent Mortality: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							BEAVER DAM EYE; VISUAL IMPAIRMENT; LENS OPACITIES; VISION IMPAIRMENT; INDIAN POPULATION; BARBADOS EYE; OLDER-ADULTS; BLINDNESS; DISEASE; PREVALENCE	Purpose: Changes in lens may reflect the status of systemic health of human beings but the supporting evidences are not well summarized yet. We aimed to determine the relationship of age-related cataract, cataract surgery and long-term mortality by pooling the results of published population-based studies. Methods: We searched PubMed and Embase from their inception till March, 2014 for population-based studies reporting the associations of any subtypes of age-related cataract, cataract surgery with all-cause mortality. We pooled the effect estimates (hazards ratios [HRs]) under a random effects model. Results: Totally, we identified 10 unique population-based studies including 39,659 individuals at baseline reporting the associations of any subtypes of cataract with all-cause mortality from 6 countries. The presence of any cataract including cataract surgery was significantly associated with a higher risk of death (pooled HR: 1.43, 95% CI, 1.21, 2.02; P<0.001; I-2 = 64.2%). In the meta-analysis of 9 study findings, adults with nuclear cataract were at higher risks of mortality (pooled HR: 1.55, 95% CI, 1.17, 2.05; P = 0.002; I-2 = 89.2%). In the meta-analysis of 8 study findings, cortical cataract was associated with higher risks of mortality (pooled HR: 1.26, 95% CI, 1.12, 1.42; P<0.001, I-2 = 29.7%). In the meta-analysis of 6 study findings, PSC cataract was associated with higher risks of mortality (pooled HR: 1.37, 95% CI, 1.04, 1.80; P = 0.03; I-2 = 67.3%). The association between cataract surgery and mortality was marginally non-significant by pooling 8 study findings (pooled HR: 1.27, 95% CI, 0.97, 1.66; P = 0.08; I-2 = 76.6%). Conclusions: All subtypes of age-related cataract were associated with an increased mortality with nuclear cataract having the strongest association among the 3 cataract subtypes. However, cataract surgery was not significantly related to mortality. These findings indicated that changes in lens may serve as markers for ageing and systemic health in general population.	[Song, E.] Soochow Univ, Lixiang Eye Hosp, Suzhou, Peoples R China; [Sun, Hongpeng; Xu, Yong; Ma, Yana; Zhu, Hong; Pan, Chen-Wei] Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Pan, CW (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou, Peoples R China.	pcwonly@gmail.com	Pan, Chen-Wei/L-7174-2019; Pan, Chen-Wei/E-6205-2015					Belikova J, 2013, COLLEGIUM ANTROPOL, V37, P25; Borger PH, 2003, OPHTHALMOLOGY, V110, P1292, DOI 10.1016/S0161-6420(03)00450-0; Chew M, 2012, AM J OPHTHALMOL, V154, P29, DOI 10.1016/j.ajo.2012.01.033; CHYLACK LT, 1989, ARCH OPHTHALMOL-CHIC, V107, P991, DOI 10.1001/archopht.1989.01070020053028; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Clemons TE, 2004, ARCH OPHTHALMOL-CHIC, V122, P716; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Duerksen R, 2003, OPHTHAL EPIDEMIOL, V10, P349, DOI 10.1076/opep.10.5.349.17326; Dunzhu S, 2003, BRIT J OPHTHALMOL, V87, P1443, DOI 10.1136/bjo.87.12.1443; Foong AWP, 2008, OPHTHALMOLOGY, V115, P802, DOI 10.1016/j.ophtha.2007.04.066; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; GOOSEY JD, 1984, INVEST OPHTH VIS SCI, V25, P608; Grewal DS, 2012, SAUDI J OPHTHALMOL, V26, P25, DOI 10.1016/j.sjopt.2011.11.001; Hennis A, 2001, OPHTHALMOLOGY, V108, P498, DOI 10.1016/S0161-6420(00)00542-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hyman L, 2001, OPHTHALMOLOGY, V108, P1751, DOI 10.1016/S0161-6420(01)00590-5; Khanna RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078002; Klein BEK, 2006, OPHTHALMOLOGY, V113, P2209, DOI 10.1016/j.ophtha.2006.04.035; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; KLEIN R, 1995, ARCH OPHTHALMOL-CHIC, V113, P333, DOI 10.1001/archopht.1995.01100030089026; Knudtson MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P243, DOI 10.1001/archopht.124.2.243; Li L, 2009, EYE, V23, P1464, DOI 10.1038/eye.2008.281; Li ZJ, 2011, OPHTHAL EPIDEMIOL, V18, P54, DOI 10.3109/09286586.2010.545503; Machan CM, 2012, OPTOMETRY VISION SCI, V89, P1165, DOI 10.1097/OPX.0b013e3182644cd1; McCarty CA, 2001, BRIT J OPHTHALMOL, V85, P322, DOI 10.1136/bjo.85.3.322; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Nemet AY, 2010, EYE, V24, P1352, DOI 10.1038/eye.2010.34; Nucci C, 2004, GRAEF ARCH CLIN EXP, V242, P289, DOI 10.1007/s00417-003-0837-z; Pan CW, 2014, OPTOMETRY VISION SCI, V91, P478, DOI 10.1097/OPX.0000000000000243; Rowe N G, 2000, Ophthalmic Epidemiol, V7, P103; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sweeney MHJ, 2003, EXP EYE RES, V77, P245, DOI 10.1016/S0014-4835(03)00110-6; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Thulasiraj RD, 2003, OPHTHALMOLOGY, V110, P1491, DOI 10.1016/S0161-6420(03)00565-7; Varma R, 2004, OPHTHALMOLOGY, V111, P1132, DOI 10.1016/j.ophtha.2004.02.002; Wang JJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1186, DOI 10.1001/archopht.119.8.1186; West SK, 2000, ARCH OPHTHALMOL-CHIC, V118, P393, DOI 10.1001/archopht.118.3.393; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Xu L, 2009, OPHTHALMOLOGY, V116, P732, DOI 10.1016/j.ophtha.2008.11.003; Ye Lin, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P578; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	45	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112054	10.1371/journal.pone.0112054	http://dx.doi.org/10.1371/journal.pone.0112054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369040	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000139
J	Huang, QY; Briggs, BR; Dong, HL; Jiang, HC; Wu, G; Edwardson, C; De Vlaminck, I; Quake, S				Huang, Qiuyuan; Briggs, Brandon R.; Dong, Hailiang; Jiang, Hongchen; Wu, Geng; Edwardson, Christian; De Vlaminck, Iwijn; Quake, Stephen			Taxonomic and Functional Diversity Provides Insight into Microbial Pathways and Stress Responses in the Saline Qinghai Lake, China	PLOS ONE			English	Article							COMMUNITY STRUCTURE; TIBETAN PLATEAU; PHOTOSYSTEM-II; CLIMATE-CHANGE; DYNAMICS; BACTERIA; ARCHAEA; WATER; SYNECHOCOCCUS; ENVIRONMENT	Microbe-mediated biogeochemical cycles contribute to the global climate system and have sensitive responses and feedbacks to environmental stress caused by climate change. Yet, little is known about the effects of microbial biodiversity (i.e., taxonmic and functional diversity) on biogeochemical cycles in ecosytems that are highly sensitive to climate change. One such sensitive ecosystem is Qinghai Lake, a high-elevation (3196 m) saline (1.4%) lake located on the Tibetan Plateau, China. This study provides baseline information on the microbial taxonomic and functional diversity as well as the associated stress response genes. Illumina metagenomic and metatranscriptomic datasets were generated from lake water samples collected at two sites (B and E). Autotrophic Cyanobacteria dominated the DNA samples, while heterotrophic Proteobacteria dominated the RNA samples at both sites. Photoheterotrophic Loktanella was also present at both sites. Photosystem II was the most active pathway at site B; while, oxidative phosphorylation was most active at site E. Organisms that expressed photosystem II or oxidative phosphorylation also expressed genes involved in photoprotection and oxidative stress, respectively. Assimilatory pathways associated with the nitrogen cycle were dominant at both sites. Results also indicate a positive relationship between functional diversity and the number of stress response genes. This study provides insight into the stress resilience of microbial metabolic pathways supported by greater taxonomic diversity, which may affect the microbial community response to climate change.	[Huang, Qiuyuan; Briggs, Brandon R.; Dong, Hailiang] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Dong, Hailiang] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [Dong, Hailiang; Jiang, Hongchen; Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Huang, Qiuyuan; Edwardson, Christian] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [De Vlaminck, Iwijn; Quake, Stephen] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Quake, Stephen] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Quake, Stephen] Howard Hughes Med Inst, Stanford, CA USA	University System of Ohio; Miami University; China University of Geosciences; China University of Geosciences; University System of Georgia; University of Georgia; Stanford University; Stanford University; Howard Hughes Medical Institute	Dong, HL (corresponding author), Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA.	dongh@miamioh.edu	De Vlaminck, Iwijn/P-6479-2015; Jiang, Hongchen/I-5838-2016; WU, Geng/F-8840-2010; Wu, Geng/G-9740-2018; Jiang, Hongchen/Y-9471-2018; Edwardson, Christian F/U-8604-2017	De Vlaminck, Iwijn/0000-0001-6085-7311; WU, Geng/0000-0002-7259-1044; Jiang, Hongchen/0000-0003-1271-7028; Edwardson, Christian F/0000-0001-7524-7209; Briggs, Brandon/0000-0002-3808-8269; Edwardson, Charlotte/0000-0001-6485-9330; Dong, Hailiang/0000-0002-7468-1350	National Natural Science Foundation of China [41030211, 41002123]; Scientific Research Funds for the 1000 "Talents" Program Plan from China University of Geosciences (Beijing); State Key Laboratory of Biogeology and Environmental Geology; China University of Geosciences [GBL11201]; Fundamental Research Funds for National University, China University of Geosciences (Wuhan); NSF IOS [1238801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Funds for the 1000 "Talents" Program Plan from China University of Geosciences (Beijing); State Key Laboratory of Biogeology and Environmental Geology; China University of Geosciences; Fundamental Research Funds for National University, China University of Geosciences (Wuhan); NSF IOS(National Science Foundation (NSF))	This research was supported by the National Natural Science Foundation of China (Grant Nos. 41030211 and 41002123), the Scientific Research Funds for the 1000 "Talents" Program Plan from China University of Geosciences (Beijing), State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences (No. GBL11201), and the Fundamental Research Funds for National University, China University of Geosciences (Wuhan). This work was fostered by NSF IOS grant 1238801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMSTRONG GA, 1989, MOL GEN GENET, V216, P254, DOI 10.1007/BF00334364; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Chowdhury N, 2011, PLANT SOIL, V344, P241, DOI 10.1007/s11104-011-0743-9; Cravo-Laureau C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00039; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dong H., 2010, GSA TODAY GEOL SOC A, V20, P4, DOI [10.1130/GSATG75A.1, DOI 10.1130/GSATG75A.1]; Dong HL, 2006, MICROB ECOL, V51, P65, DOI 10.1007/s00248-005-0228-6; FAHNENSTIEL GL, 1991, LIMNOL OCEANOGR, V36, P219, DOI 10.4319/lo.1991.36.2.0219; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Guo DL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016545; Hallin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051962; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hollibaugh JT, 2011, ISME J, V5, P866, DOI 10.1038/ismej.2010.172; Huang QY, 2013, FEMS MICROBIOL ECOL, V85, P452, DOI 10.1111/1574-6941.12134; Jiang HC, 2008, ENVIRON MICROBIOL, V10, P2355, DOI 10.1111/j.1462-2920.2008.01661.x; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Jiang HC, 2009, GEOMICROBIOL J, V26, P289, DOI 10.1080/01490450902892662; Jiang HC, 2009, GEOMICROBIOL J, V26, P199, DOI 10.1080/01490450902744004; Jiang HC, 2009, FEMS MICROBIOL ECOL, V67, P268, DOI 10.1111/j.1574-6941.2008.00616.x; Jimenez DJ, 2012, PLOS ONE, V7; JOINT I R, 1986, Canadian Bulletin of Fisheries and Aquatic Sciences, P287; Kara EL, 2013, ISME J, V7, P680, DOI 10.1038/ismej.2012.118; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lei YB, 2012, J GLACIOL, V58, P177, DOI 10.3189/2012JoG11J025; Li X, 2008, GLOBAL PLANET CHANGE, V62, P210, DOI 10.1016/j.gloplacha.2008.02.001; Liu JS, 2009, GLOBAL PLANET CHANGE, V67, P209, DOI 10.1016/j.gloplacha.2009.03.010; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Mella-Flores Daniella, 2012, Front Microbiol, V3, P285; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller C.B., 2004, BIOL OCEANOGRAPHY; Moeller RE, 2005, LIMNOL OCEANOGR, V50, P427, DOI 10.4319/lo.2005.50.2.0427; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Oksanen J., 2016, R PACKAG; Pernthaler J, 1998, APPL ENVIRON MICROB, V64, P4299; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Qiu J, 2008, NATURE, V468, P141; R Development Core Team, 2012, R LANG ENV STAT COMP; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P1908, DOI 10.1016/j.soilbio.2011.05.013; Severin I, 2012, ARCH MICROBIOL, V194, P483, DOI 10.1007/s00203-011-0787-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang HY, 2013, ORG GEOCHEM, V54, P69, DOI 10.1016/j.orggeochem.2012.09.011; Xing P, 2009, APPL ENVIRON MICROB, V75, P7017, DOI 10.1128/AEM.01544-09; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183	65	39	43	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111681	10.1371/journal.pone.0111681	http://dx.doi.org/10.1371/journal.pone.0111681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365331	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100105
J	Ganasegeran, K; Rajendran, AK; Al-Dubai, SAR				Ganasegeran, Kurubaran; Rajendran, Anantha Kumar; Al-Dubai, Sami Abdo Radman			Psycho-Socioeconomic Factors Affecting Complementary and Alternative Medicine Use among Selected Rural Communities in Malaysia: A Cross-Sectional Study	PLOS ONE			English	Article							ATTITUDES; ADULTS	Introduction: The use of complementary and alternative medicine (CAM) as a source of cure has gained much spectrum worldwide, despite skeptics and advocates of evidence-based practice conceptualized such therapies as human nostrum. Objective: This study aimed to explore the factors affecting CAM use among rural communities in Malaysia. Methods: A cross-sectional study was carried out on 288 occupants across four rural villages within the District of Selama, Perak, Malaysia. A survey that consisted of socio-economic characteristics, history of CAM use and the validated Holistic Complementary and Alternative Medicine Questionnaire (HCAMQ) were used. Results: The prevalence of self-reported CAM use over the past one year was 53.1%. Multiple logistic regression analyses yielded three significant predictors of CAM use: monthly household income of less than MYR 2500, higher education level, and positive attitude towards CAM. Conclusion: Psycho-socioeconomic factors were significantly associated with CAM use among rural communities in Malaysia.	[Ganasegeran, Kurubaran] HTAR, Dept Med, Klang, Selangor, Malaysia; [Ganasegeran, Kurubaran; Rajendran, Anantha Kumar] MSU, Int Med Sch, Off Persiaran Olahraga, Sect 13, Shah Alam, Selangor, Malaysia; [Al-Dubai, Sami Abdo Radman] Int Med Univ, Dept Community Med, Kuala Lumpur 57000, Malaysia	Management Science University; International Medical University Malaysia	Ganasegeran, K (corresponding author), HTAR, Dept Med, Jalan Langat, Klang, Selangor, Malaysia.	medkuru@yahoo.com	AL-DUBAI, SAMI/M-4129-2019; AL-DUBAI, SAMI ABDO/AAA-1731-2022; AL-DUBAI, SAMI Abdo Radman/J-6120-2013; Ganasegeran, Kurubaran/E-4931-2013	AL-DUBAI, SAMI/0000-0002-1989-5452; AL-DUBAI, SAMI ABDO/0000-0002-1989-5452; AL-DUBAI, SAMI Abdo Radman/0000-0002-1989-5452; Ganasegeran, Kurubaran/0000-0002-9480-1815				Abuduli M., 2011, MALAYS J PUBLIC HLTH, V11, P1; Adams J, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-85; Akyol AD, 2011, J CLIN NURS, V20, P1035, DOI 10.1111/j.1365-2702.2010.03498.x; Alshagga MA, 2011, ANN THORAC MED, V6, P115, DOI 10.4103/1817-1737.82438; [Anonymous], 2013, MALAYSIAN NO DEV COR; Arcury TA, 2006, J GERONTOL B-PSYCHOL, V61, P62; Arcury TA, 2006, ETHNIC DIS, V16, P723; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Bishop FL, 2007, J HEALTH PSYCHOL, V12, P851, DOI 10.1177/1359105307082447; Bulck JV, 2009, EUR J PUBLIC HEALTH, V20, P227; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; Chiappelli F, 2005, EVID-BASED COMPL ALT, V2, P453, DOI 10.1093/ecam/neh106; Ernst E, 2000, B WORLD HEALTH ORGAN, V78, P252; Farooqui M, 2013, ALTERN INTEG MED, V1; Frass M, 2012, OCHSNER J, V12, P45; Hu H, 2013, ISRN PUBLIC HLTH, V2013, P7; Hyland ME, 2003, COMPLEMENT THER MED, V11, P33, DOI 10.1016/S0965-2299(02)00113-9; Kuunibe N., 2012, International Journal of Humanities and Social Science, V2, P288; Limsatchapanich S., 2013, HLTH SCI J, V7, P436; McFadden KL, 2010, EXPLORE-NY, V6, P380, DOI 10.1016/j.explore.2010.08.004; McLaughlin D, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-34; Mollaoglu M, 2013, ACTA CLIN CROAT, V52, P181; Nguyen D, 2014, RURAL REMOTE HEALTH, V14; Shreffler-Grant J, 2005, PUBLIC HEALTH NURS, V22, P323, DOI 10.1111/j.0737-1209.2005.220407.x; Testerman J, 2004, COMPLEMENT HLTH PRAC, V9, P81, DOI [10.1177/1076167503261254, DOI 10.1177/1076167503261254]; Thomas K, 2004, J PUBLIC HEALTH, V26, P152, DOI 10.1093/pubmed/fdh139; Yekta Z, 2007, J RES HEALTH SCI, V7, P24; Zollman C, 1999, BRIT MED J, V319, P693, DOI 10.1136/bmj.319.7211.693	28	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112124	10.1371/journal.pone.0112124	http://dx.doi.org/10.1371/journal.pone.0112124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375256	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600109
J	Yu, C; Qi, D; Lian, W; Li, QZ; Li, HJ; Fan, HY				Yu, Chen; Qi, Dong; Lian, Wei; Li, Qing-Zhong; Li, Hong-Juan; Fan, Hua-Ying			Effects of Danshensu on Platelet Aggregation and Thrombosis: In Vivo Arteriovenous Shunt and Venous Thrombosis Models in Rats	PLOS ONE			English	Article							INDUCED GASTRIC DAMAGE; CYCLOOXYGENASE; ACID; ANTIPLATELET; INHIBITION; ADHESION; ASPIRIN	Danshensu, a type of dihydroxyphenyl lactic acid, is one of the most abundant active phenolic acids in the dried root of Salvia miltiorrhizae (Lamiaceae)-widely used traditional Chinese medicine. The effects of danshensu on platelet aggregation and thrombus formation in rats were examined using various methods. It was found that danshensu significantly reduced thrombus weight in 2 experimental thrombosis models; dose-dependent inhibition of adenosine diphosphate (ADP) and arachidonic acid (AA)-induced platelet aggregation occurred in normal and blood stasis-induced rats; Danshensu also significantly mitigated blood viscosity, plasma viscosity and hematocrit levels. Moreover, danshensu significantly inhibited venous thrombosis-induced expression of cyclooxygenases-2 (COX-2) rather than cyclooxygenases-1( COX-1) in the venous walls, down regulated thromboxane B-2 (TXB2) and up regulated 6-keto prostaglandin F-1 alpha (6-keto-PGF(1 alpha)), normalizing the TXB2/6-keto-PGF(1 alpha) ratio. In addition, danshensu did not induce gastric lesions and even had protective effects on aspirin-induced ulcer formation at doses as high as 60 mg/kg. These findings suggest that the antithrombotic and antiplatelet aggregation effects of danshensu are attributed to its highly selective inhibition of COX-2 and ability to normalize the thromboxane A(2)(TXA(2))/prostacyclin(PGI(2)) balance. These findings suggest that danshensu have great prospects in antithrombotic and antiplatelet therapy.	[Yu, Chen; Li, Qing-Zhong; Li, Hong-Juan] Binzhou Med Univ, Sch Pharm, Yantai, Shandong, Peoples R China; [Qi, Dong] Yantai Yu Huang Ding Qingdao Univ Hosp, Dept Nephrol, Yantai, Shandong, Peoples R China; [Lian, Wei] Yantai Yan Tai Shan Hosp, Yantai, Shandong, Peoples R China; [Fan, Hua-Ying] Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China	Binzhou Medical University; Yantai University	Yu, C (corresponding author), Binzhou Med Univ, Sch Pharm, Yantai, Shandong, Peoples R China.	yuchen810624@163.com; katiefhydong@sina.com			National Natural Science Foundation of China [81303259]; Shandong Province Natural Science Foundation [ZR2010HL065]; Research Award Fund for Outstanding Young and Middle-aged Scientists of Shandong Province of China [BS2013YY046]; Programs for Science and Technology Development and Plan of Yanta [2013WS262]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Research Award Fund for Outstanding Young and Middle-aged Scientists of Shandong Province of China; Programs for Science and Technology Development and Plan of Yanta	This study was supported by the Project of National Natural Science Foundation of China (Grant No. 81303259), URL: http://www.nsfc.gov.cn/, Shandong Province Natural Science Foundation (No. ZR2010HL065), URL: http://www.sdnsf.gov.cn/portal/, Research Award Fund for Outstanding Young and Middle-aged Scientists of Shandong Province of China (project No. BS2013YY046), URL: http://www.sdstc.gov.cn/, and the Programs for Science and Technology Development and Plan of Yanta (No. 2013WS262), URL: http://www.ytstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Chan K, 2004, LIFE SCI, V75, P3157, DOI 10.1016/j.lfs.2004.06.010; Chen XP, 2007, CHIN J HEMORH, V17, P525; Damiano BP, 2001, THROMB RES, V104, P113, DOI 10.1016/S0049-3848(01)00353-X; Guth PH, 1989, GASTROENTEROLOGY, P76; Halter F, 2001, GUT, V49, P443, DOI 10.1136/gut.49.3.443; Henke PK, 2006, THROMB HAEMOSTASIS, V95, P272, DOI 10.1160/Th05-02-0099; Henke PK, 2004, ARTERIOSCL THROM VAS, V24, P1130, DOI 10.1161/01.ATV.0000129537.72553.73; Kang DG, 2004, LIFE SCI, V75, P1801, DOI 10.1016/j.lfs.2004.02.034; Lechi C, 1996, THROMB HAEMOSTASIS, V76, P791; MASFERRER JL, 1990, J CLIN INVEST, V86, P1375, DOI 10.1172/JCI114850; Mei XT, 2013, FOOD CHEM TOXICOL, V60, P448, DOI 10.1016/j.fct.2013.07.075; Nosal R, 2002, THROMB RES, V105, P339, DOI 10.1016/S0049-3848(02)00036-1; Patrono C, 1979, NEW ENGL J MED, V353, P2373; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Ryu KH, 2009, THROMB RES, V124, P328, DOI 10.1016/j.thromres.2009.02.010; Sakata C, 2013, THROMB RES, V132, P56, DOI 10.1016/j.thromres.2013.03.005; Takeuchi K, 2012, WORLD J GASTROENTERO, V18, P2147, DOI 10.3748/wjg.v18.i18.2147; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; Umar A, 2004, FUND CLIN PHARMACOL, V18, P559, DOI 10.1111/j.1472-8206.2004.00285.x; Umar A, 2003, THROMB RES, V110, P135, DOI 10.1016/S0049-3848(03)00343-8; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; WEISS HJ, 1979, BLOOD, V53, P244; Wooten JG, 2008, AM J VET RES, V69, P457, DOI 10.2460/ajvr.69.4.457; Zhao GR, 2008, FOOD CHEM TOXICOL, V46, P73, DOI 10.1016/j.fct.2007.06.034	26	35	37	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110124	10.1371/journal.pone.0110124	http://dx.doi.org/10.1371/journal.pone.0110124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375124	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600008
J	Ahonen, SJ; Kaukonen, M; Nussdorfer, FD; Harman, CD; Komaromy, AM; Lohi, H				Ahonen, Saija J.; Kaukonen, Maria; Nussdorfer, Forrest D.; Harman, Christine D.; Komaromy, Andras M.; Lohi, Hannes			A Novel Missense Mutation in ADAMTS10 in Norwegian Elkhound Primary Glaucoma	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; PECTINATE LIGAMENT DYSPLASIA; IRIDOCORNEAL ANGLE; MOLECULAR-GENETICS; INHERITED GLAUCOMA; IDENTIFICATION; ASSOCIATION; FIBRILLIN-1; DEFINITION; PREDICTION	Primary glaucoma is one of the most common causes of irreversible blindness both in humans and in dogs. Glaucoma is an optic neuropathy affecting the retinal ganglion cells and optic nerve, and elevated intraocular pressure is commonly associated with the disease. Glaucoma is broadly classified into primary open angle (POAG), primary closed angle (PCAG) and primary congenital glaucoma (PCG). Human glaucomas are genetically heterogeneous and multiple loci have been identified. Glaucoma affects several dog breeds but only three loci and one gene have been implicated so far. We have investigated the genetics of primary glaucoma in the Norwegian Elkhound (NE). We established a small pedigree around the affected NEs collected from Finland, US and UK and performed a genome-wide association study with 9 cases and 8 controls to map the glaucoma gene to 750 kb region on canine chromosome 20 (p(raw) = 4.93 x 10(-6), p(genome) = 0.025). The associated region contains a previously identified glaucoma gene, ADAMTS10, which was subjected to mutation screening in the coding regions. A fully segregating missense mutation (p.A387T) in exon 9 was found in 14 cases and 572 unaffected NEs (p(Fisher) = 3.5 x 10(-27)) with a high carrier frequency (25.3%). The mutation interrupts a highly conserved residue in the metalloprotease domain of ADAMTS10, likely affecting its functional capacity. Our study identifies the genetic cause of primary glaucoma in NEs and enables the development of a genetic test for breeding purposes. This study establishes also a new spontaneous canine model for glaucoma research to study the ADAMTS10 biology in optical neuropathy.	[Ahonen, Saija J.; Kaukonen, Maria; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija J.; Kaukonen, Maria; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija J.; Kaukonen, Maria; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Nussdorfer, Forrest D.; Harman, Christine D.; Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Komaromy, Andras M.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Helsinki; University of Helsinki; Michigan State University; University of Pennsylvania	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Kaukonen, Maria/0000-0002-2146-4694; Ahonen, Saija/0000-0003-3313-784X	Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; National Institutes of Health [K12-EY015398]; Michigan State University faculty startup funds; Jane and Aatos Erkko Foundation, Biocentrum Helsinki, Academy of Finland; NATIONAL EYE INSTITUTE [K12EY015398] Funding Source: NIH RePORTER	Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University faculty startup funds; Jane and Aatos Erkko Foundation, Biocentrum Helsinki, Academy of Finland; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was partly supported by the Jane and Aatos Erkko Foundation, Biocentrum Helsinki, Academy of Finland, the Sigrid Juselius Foundation, the National Institutes of Health (K12-EY015398) and Michigan State University faculty startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahonen SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070903; Ahram DF, 2014, MOL VIS, V20, P497; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Aulchenko Y, 2010, BIOINFORMATICS, V5, P1294; Bjerkas E, 2002, VET OPHTHALMOL, V5, P49, DOI 10.1046/j.1463-5224.2002.00213.x; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; EKESTEN B, 1991, AM J VET RES, V52, P1875; Ekesten B, 1997, VET COMP OPHTHALMOL, V7, P14; Faivre L, 2002, HUM GENET, V110, P366, DOI 10.1007/s00439-002-0689-3; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Fuse N, 2010, TOHOKU J EXP MED, V221, P1, DOI 10.1620/tjem.221.1; GELATT KN, 1977, INVEST OPHTH VIS SCI, V16, P1135; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Hann CR, 2011, INVEST OPHTH VIS SCI, V52, P45, DOI 10.1167/iovs.10-5620; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Kato K, 2006, VET OPHTHALMOL, V9, P71, DOI 10.1111/j.1463-5224.2006.00438.x; Kaurani L, 2014, INVEST OPHTH VIS SCI, V55, P3258, DOI 10.1167/iovs.14-14339; Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kuchtey J, 2013, AM J MED GENET A, V161A, P880, DOI 10.1002/ajmg.a.35838; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kulkarni M L, 1995, Indian Pediatr, V32, P923; Kutz WE, 2011, J BIOL CHEM, V286, P17156, DOI 10.1074/jbc.M111.231571; Lee BL, 1998, J GLAUCOMA, V7, P366; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; MORRISON JC, 1982, INVEST OPHTH VIS SCI, V23, P726; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Ojha P, 2013, SEMIN OPHTHALMOL, V28, P301, DOI 10.3109/08820538.2013.825291; Oshima Y, 2004, VET OPHTHALMOL, V7, P185, DOI 10.1111/j.1463-5224.2004.04021.x; Palko JR, 2013, INVEST OPHTH VIS SCI, V54, P2685, DOI 10.1167/iovs.12-10621; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; PEIFFER RL, 1980, AM J VET RES, V41, P1808; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Read R. A., 1998, Veterinary Ophthalmology, V1, P85, DOI 10.1046/j.1463-5224.1998.00019.x; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Strom AR, 2011, VET OPHTHALMOL, V14, P121, DOI 10.1111/j.1463-5224.2010.00855.x; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; VANDERLINDESIPMAN JS, 1987, VET PATHOL, V24, P201, DOI 10.1177/030098588702400301; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; WHEATLEY HM, 1995, ARCH OPHTHALMOL-CHIC, V113, P103, DOI 10.1001/archopht.1995.01100010105028; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	54	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111941	10.1371/journal.pone.0111941	http://dx.doi.org/10.1371/journal.pone.0111941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372548	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900093
J	Chang, T; Hansen, AJ; Piekielek, N				Chang, Tony; Hansen, Andrew J.; Piekielek, Nathan			Patterns and Variability of Projected Bioclimatic Habitat for Pinus albicaulis in the Greater Yellowstone Area	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOLOGICAL THEORY; FUTURE CLIMATE; RANGE SHIFTS; UNCERTAINTY; PREDICTION; FORESTS; REGION; US	Projected climate change at a regional level is expected to shift vegetation habitat distributions over the next century. For the sub-alpine species whitebark pine (Pinus albicaulis), warming temperatures may indirectly result in loss of suitable bioclimatic habitat, reducing its distribution within its historic range. This research focuses on understanding the patterns of spatiotemporal variability for future projected P. albicaulis suitable habitat in the Greater Yellowstone Area (GYA) through a bioclimatic envelope approach. Since intermodel variability from General Circulation Models (GCMs) lead to differing predictions regarding the magnitude and direction of modeled suitable habitat area, nine bias-corrected statistically down-scaled GCMs were utilized to understand the uncertainty associated with modeled projections. P. albicaulis was modeled using a Random Forests algorithm for the 1980-2010 climate period and showed strong presence/absence separations by summer maximum temperatures and springtime snowpack. Patterns of projected habitat change by the end of the century suggested a constant decrease in suitable climate area from the 2010 baseline for both Representative Concentration Pathways (RCPs) 8.5 and 4.5 climate forcing scenarios. Percent suitable climate area estimates ranged from 2-29% and 0.04-10% by 2099 for RCP 8.5 and 4.5 respectively. Habitat projections between GCMs displayed a decrease of variability over the 2010-2099 time period related to consistent warming above the 1910-2010 temperature normal after 2070 for all GCMs. A decreasing pattern of projected P. albicaulis suitable habitat area change was consistent across GCMs, despite strong differences in magnitude. Future ecological research in species distribution modeling should consider a full suite of GCM projections in the analysis to reduce extreme range contractions/expansions predictions. The results suggest that restoration strageties such as planting of seedlings and controlling competing vegetation may be necessary to maintain P. albicaulis in the GYA under the more extreme future climate scenarios.	[Chang, Tony; Hansen, Andrew J.; Piekielek, Nathan] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Chang, T (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	tony.chang@msu.montana.edu		Piekielek, Nathan/0000-0002-2740-0675	National Aeronautics and Space Administration Applied Sciences Program [10-BIOCLIM10-0034]; National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) (INSTEP 3) [Track-I EPS-1101342]; North Central Climate Science Center [G13AC00392-G-8829-1]; Office Of The Director [1443108] Funding Source: National Science Foundation	National Aeronautics and Space Administration Applied Sciences Program; National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) (INSTEP 3); North Central Climate Science Center; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Aeronautics and Space Administration Applied Sciences Program (Grant 10-BIOCLIM10-0034); Funder URL: http://www.nasa.gov (AJH TC). It also received support from the National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) Track-I EPS-1101342 (INSTEP 3); Funder URL: http://www.nsf.gov/div/index.jsp?div = EPSC (NBP TC); and the North Central Climate Science Center (G13AC00392-G-8829-1); Funder URL: http://www.doi.gov/csc/northcentral/index.cfm (AJH NBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Arno SF, 1989, GTRINT253 INT RES; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bartlein PJ, 1997, CONSERV BIOL, V11, P782, DOI 10.1046/j.1523-1739.1997.95383.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bell DM, 2014, GLOBAL ECOL BIOGEOGR, V23, P168, DOI 10.1111/geb.12109; BOOTH GD, 1994, USDA FOR SERV INT R, P1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Busby J, 1988, POTENTIAL IMPACTS CL; Callaway RM, 1998, OIKOS, V82, P561, DOI 10.2307/3546376; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; Dingman S., 2002, PHYS HYDROLOGY; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Edwards TC, 2006, ECOL MODEL, V199, P132, DOI 10.1016/j.ecolmodel.2006.05.016; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Franklin J, 2009, MAPPING SPECIES DIST; Freire J, 2012, COMPUT SCI ENG, V14, P18, DOI 10.1109/MCSE.2012.76; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gibson J, 2014, ECOSYSTEMS, V17, P43, DOI 10.1007/s10021-013-9703-y; Guisan A, 1998, J VEG SCI, V9, P65, DOI 10.2307/3237224; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hibbard KA, 2011, CLIVAR EXCHANGES, V16, P12; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Intergovernmental Panel on Climate Change, 2007, 4 ASS REP CLIM CHANG; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Jean C, 2010, P FUT HIGH EL 5 NEED, P28; Jewett JT, 2011, FOREST SCI, V57, P320; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Keane B, 2013, CLIMATE CHANGE WHITE; Keane RE, 2012, RANGE WIDE RESTORATI, P108; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; Lockman I.B., 2007, P C WHIT PIN PAC COA, P146; Logan JA, 1999, ENVIRON ENTOMOL, V28, P924, DOI 10.1093/ee/28.6.924; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; Macfarlane WW, 2012, ECOLOGICAL APPL; Mahalovich MF, 2011, P HIGH 5 S 28 30 JUN; Mathys A, 2014, FOREST ECOL MANAG, V313, P144, DOI 10.1016/j.foreco.2013.11.005; McLane SC, 2012, ECOL APPL, V22, P142, DOI 10.1890/11-0329.1; Monahan WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083163; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Morisette JT, 2013, ECOGRAPHY, V36, P129, DOI 10.1111/j.1600-0587.2012.07815.x; Moss Richard, 2008, NEW SCENARIOS ANAL E; Pearce J, 1998, RESTOR ECOL, V6, P238, DOI 10.1046/j.1526-100X.1998.00636.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12; Pederson GT, 2011, J CLIMATE, V24, P1666, DOI 10.1175/2010JCLI3729.1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Rupp DE, 2013, J GEOPHYS RES-ATMOS, V118, P10884, DOI 10.1002/jgrd.50843; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; Tabachnick B, 1989, J PSYCHOPHYSIOL, V3, P46; TAUSCH RJ, 1993, J RANGE MANAGE, V46, P439, DOI 10.2307/4002664; Taylor KE, 2012, B AM METEOROLOGICAL, V93; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornthwaite CW, 1955, PUBLICATION CLIMATOL, VVIII; Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tomback D.F., 2001, WHITEBARK PINE COMMU, P243; Turner MG, 2001, LANDSCAPE ECOLOGY TH, DOI DOI 10.1007/B97434; Waring RH, 2011, REMOTE SENS ENVIRON, V115, P3554, DOI 10.1016/j.rse.2011.08.017; WEAVER T, 1974, AM MIDL NAT, V92, P222, DOI 10.2307/2424218; Weaver T, 2001, WHITEBARK PINE COMMU; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Whitlock C, 2003, FOREST ECOL MANAG, V178, P5, DOI 10.1016/S0378-1127(03)00051-3; WHITLOCK C, 1993, ECOL MONOGR, V63, P173, DOI 10.2307/2937179; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335	75	34	34	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111669	10.1371/journal.pone.0111669	http://dx.doi.org/10.1371/journal.pone.0111669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372719	gold, Green Published, Green Submitted			2022-12-27	WOS:000344556900058
J	Chen, CR; Shu, WY; Chang, CW; Hsu, IC				Chen, Chaang-Ray; Shu, Wun-Yi; Chang, Cheng-Wei; Hsu, Ian C.			Identification of Under-Detected Periodicity in Time-Series Microarray Data by Using Empirical Mode Decomposition	PLOS ONE			English	Article							CYCLE-REGULATED GENES; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; EXPRESSION; TRANSCRIPTION; SOFTWARE; ONTOLOGY; BIOLOGY; TOOL; EMD	Detecting periodicity signals from time-series microarray data is commonly used to facilitate the understanding of the critical roles and underlying mechanisms of regulatory transcriptomes. However, time-series microarray data are noisy. How the temporal data structure affects the performance of periodicity detection has remained elusive. We present a novel method based on empirical mode decomposition (EMD) to examine this effect. We applied EMD to a yeast microarray dataset and extracted a series of intrinsic mode function (IMF) oscillations from the time-series data. Our analysis indicated that many periodically expressed genes might have been under-detected in the original analysis because of interference between decomposed IMF oscillations. By validating a protein complex coexpression analysis, we revealed that 56 genes were newly determined as periodic. We demonstrated that EMD can be used incorporating with existing periodicity detection methods to improve their performance. This approach can be applied to other time-series microarray studies.	[Chen, Chaang-Ray; Chang, Cheng-Wei; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Hsu, IC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw		Chen, Chaang-Ray/0000-0003-2106-8699	 [101B3004K6]		This work was funded by Taiwan (Grant number: 101B3004K6, http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P23, DOI 10.1093/bioinformatics/bth915; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cacace F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002772; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Csikasz-Nagy A, 2009, BRIEF BIOINFORM, V10, P424, DOI 10.1093/bib/bbp005; de Lichtenberg U, 2005, YEAST, V22, P1191, DOI 10.1002/yea.1302; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Deckard A, 2013, BIOINFORMATICS, V29, P3174, DOI 10.1093/bioinformatics/btt541; Dequeant ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002856; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fulcher BD, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0048; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hu K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002601; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang W, 2002, P NATL ACAD SCI USA, V99, P2603, DOI 10.1073/pnas.042684399; Kim D, 2009, R J, V1, P40; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Lin SL, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066705; Liu CT, 2009, NUCLEIC ACIDS RES, V37, P526, DOI 10.1093/nar/gkn972; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Park Y, 2012, BIOINFORMATICS, V28, pI40, DOI 10.1093/bioinformatics/bts211; Shaw AK, 2013, PROC TECH, V10, P172, DOI 10.1016/j.protcy.2013.12.350; Shedden K, 2002, NUCLEIC ACIDS RES, V30, P2920, DOI 10.1093/nar/gkf414; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Soranzo N, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-18; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stamoulis C, 2011, BIOINFORMATICS, V27, P2338, DOI 10.1093/bioinformatics/btr402; Sweeney-Reed CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048357; Teodoro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061180; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wang YF, 2013, INT J DATA MIN BIOIN, V7, P103, DOI 10.1504/IJDMB.2013.053192; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Yang AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014612; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	42	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111719	10.1371/journal.pone.0111719	http://dx.doi.org/10.1371/journal.pone.0111719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372711	Green Submitted, Green Published, gold			2022-12-27	WOS:000344556900067
J	Hwang, JJ; Kim, KD; Park, H; Park, CS; Jeong, HG				Hwang, Jae Joon; Kim, Kee-Deog; Park, Hyok; Park, Chang Seo; Jeong, Ho-Gul			Factors Influencing Superimposition Error of 3D Cephalometric Landmarks by Plane Orientation Method Using 4 Reference Points: 4 Point Superimposition Error Regression Model	PLOS ONE			English	Article							TOMOGRAPHY IMAGES; FACIAL ASYMMETRY; 3D-CT EVALUATION; CLEFT-LIP; IDENTIFICATION; REGISTRATION; PRECISION; SURGERY; SYSTEM; PALATE	Superimposition has been used as a method to evaluate the changes of orthodontic or orthopedic treatment in the dental field. With the introduction of cone beam CT (CBCT), evaluating 3 dimensional changes after treatment became possible by superimposition. 4 point plane orientation is one of the simplest ways to achieve superimposition of 3 dimensional images. To find factors influencing superimposition error of cephalometric landmarks by 4 point plane orientation method and to evaluate the reproducibility of cephalometric landmarks for analyzing superimposition error, 20 patients were analyzed who had normal skeletal and occlusal relationship and took CBCT for diagnosis of temporomandibular disorder. The nasion, sella turcica, basion and midpoint between the left and the right most posterior point of the lesser wing of sphenoidal bone were used to define a three-dimensional (3D) anatomical reference co-ordinate system. Another 15 reference cephalometric points were also determined three times in the same image. Reorientation error of each landmark could be explained substantially (23%) by linear regression model, which consists of 3 factors describing position of each landmark towards reference axes and locating error. 4 point plane orientation system may produce an amount of reorientation error that may vary according to the perpendicular distance between the landmark and the x-axis; the reorientation error also increases as the locating error and shift of reference axes viewed from each landmark increases. Therefore, in order to reduce the reorientation error, accuracy of all landmarks including the reference points is important. Construction of the regression model using reference points of greater precision is required for the clinical application of this model.	[Hwang, Jae Joon; Park, Hyok; Park, Chang Seo; Jeong, Ho-Gul] Yonsei Univ, Dent Hosp, Coll Dent, Dept Oral & Maxillofacial Radiol, Seoul 120749, South Korea; [Kim, Kee-Deog] Yonsei Univ, Dent Hosp, Coll Dent, Dept Gen Dent, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jeong, HG (corresponding author), Yonsei Univ, Dent Hosp, Coll Dent, Dept Oral & Maxillofacial Radiol, Seoul 120749, South Korea.	RAR198@yuhs.ac		, Kee-Deog/0000-0003-3055-5130				Arat ZM, 2003, ANGLE ORTHOD, V73, P374; Ashmore JL, 2002, AM J ORTHOD DENTOFAC, V121, P18, DOI 10.1067/mod.2002.120687; Berkowitz S, 1999, CLEFT PALATE-CRAN J, V36, P413, DOI 10.1597/1545-1569(1999)036<0413:AMRSOS>2.3.CO;2; Broadbent BH, 1931, ANGLE ORTHOD, V1, P45, DOI [10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1981)051<0093:ANXTAI>2.0.CO;2, DOI 10.1043/0003-3219(1931)001<0045:ANXTAI>2.0.CO;2]; Gu Y, 2008, ANGLE ORTHOD, V78, P967, DOI 10.2319/070107-301.1; Hassan B, 2013, EUR J ORTHODONT, V35, P38, DOI 10.1093/ejo/cjr050; Hoffmann J, 2005, J CRANIO MAXILL SURG, V33, P13, DOI 10.1016/j.jcms.2004.10.001; Hofrath H, 1931, J OROFAC ORTHOP, V1, P232; Kang SH, 2012, DENTOMAXILLOFAC RAD, V41, P679, DOI 10.1259/dmfr/21358271; Katsumata A, 2005, ORAL SURG ORAL MED O, V99, P212, DOI 10.1016/j.tripleo.2004.06.072; Kitaura H, 2000, CLEFT PALATE-CRAN J, V37, P349, DOI 10.1597/1545-1569(2000)037<0349:SODCMF>2.3.CO;2; Lagravere MO, 2010, DENTOMAXILLOFAC RAD, V39, P400, DOI 10.1259/dmfr/17319459; Lagravere MO, 2010, AM J ORTHOD DENTOFAC, V137, P598, DOI 10.1016/j.ajodo.2008.07.018; Maeda M, 2006, ORAL SURG ORAL MED O, V102, P382, DOI 10.1016/j.tripleo.2005.10.057; Sachdeva R C, 2001, J Clin Orthod, V35, P245; Schlicher W, 2012, EUR J ORTHODONT, V34, P263, DOI 10.1093/ejo/cjq144; SECKEL NG, 1995, CLEFT PALATE-CRAN J, V32, P434, DOI 10.1597/1545-1569(1995)032<0434:LPOMOC>2.3.CO;2; Swennen GRJ, 2006, J CRANIOFAC SURG, V17, P314, DOI 10.1097/00001665-200603000-00019; Zamora N, 2012, MED ORAL PATOL ORAL, V17, pE678, DOI 10.4317/medoral.17721	19	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110665	10.1371/journal.pone.0110665	http://dx.doi.org/10.1371/journal.pone.0110665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372707	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900022
J	Kendall, T				Kendall, Tamil			Consequences of Missed Opportunities for HIV Testing during Pregnancy and Delayed Diagnosis for Mexican Women, Children and Male Partners	PLOS ONE			English	Article							CARE; TRANSMISSION; PREVENTION; PROGRAM; MALAWI; OPT	Introduction: HIV testing during pregnancy permits prevention of vertical (mother-to-child) transmission and provides an opportunity for women living with HIV to access treatment for their own health. In 2001, Mexico's National HIV Action Plan committed to universal offer of HIV testing to pregnant women, but in 2011, only 45.6% of women who attended antenatal care (ANC) were tested for HIV. The study objective was to document the consequences of missed opportunities for HIV testing and counseling during pregnancy and late HIV diagnosis for Mexican women living with HIV and their families. Methods: Semi-structured-interviews with 55 women living with HIV who had had a pregnancy since 2001 were completed between 2009 and 2011. Interviews were analyzed thematically using a priori and inductive codes. Results: Consistent with national statistics, less than half of the women living with HIV (42%) were offered HIV testing and counseling during ANC. When not diagnosed during ANC, women had multiple contacts with the health-care system due to their own and other family members' AIDS-related complications before being diagnosed. Missed opportunities for HIV testing and counseling during antenatal care and health-care providers failure to recognize AIDS-related complications resulted in pediatric HIV infections, AIDS-related deaths of children and male partners, and HIV disease progression among women and other family members. In contrast, HIV diagnosis permitted timely access to interventions to prevent vertical HIV transmission and long-term care and treatment for women living with HIV. Conclusions: Omissions of the offer of HIV testing and counseling in ANC and health-care providers' failure to recognize AIDS-related complications had negative health, economic and emotional consequences. Scaling-up provider-initiated HIV testing and counseling within and beyond antenatal care and pre-service and in-service trainings on HIV and AIDS for health-care providers can hasten timely HIV diagnosis and contribute to improved individual and public health in Mexico.	[Kendall, Tamil] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Women & Hlth Initiat, Boston, MA 02115 USA; [Kendall, Tamil] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Takemi Program Int Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kendall, T (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Women & Hlth Initiat, 665 Huntington Ave, Boston, MA 02115 USA.	tkendall@hsph.harvard.edu			Canadian Institutes of Health Research; Elliott Trudeau Foundation; Social Sciences and Humanities Research Council Canada Vanier Canada; UNWOMEN; Dominican Republic	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Elliott Trudeau Foundation; Social Sciences and Humanities Research Council Canada Vanier Canada; UNWOMEN; Dominican Republic	This research was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship (http://www.cihr-irsc.gc.ca/e/193.html), a Pierre Elliott Trudeau Foundation Doctoral and Post-Doctoral Scholarship (http://www.trudeaufoundation.ca/en), a Social Sciences and Humanities Research Council Canada Vanier Canada Graduate Scholarship (http://www.vanier.gc.ca/eng/home-accueil.aspx), and a grant from UNIFEM (now UNWOMEN) sub-regional office for Mexico, Central America, Cuba and the Dominican Republic (http://www.unwomen.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 2014, WORLD AIDS DAY 2014; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; CENSIDA, 2009, GUIA MAN ANT PERS CO; Centro Nacional para la Prevencion el y Control del VIH/SIDA, 2012, VIH SIDA MEX 2012; Charmaz K., 2005, HDB QUALITATIVE RES, V3rd, P507; CONASIDA, 2013, B GRUP INF SECT VIH; CONEVAL, 2011, MEAS FREQ ASK QUEST; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ferguson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089764; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Godinez Leal L, 2007, TIENE CENSIDA PRUEBA; Guttierez J, 2013, ENCUESTA NACL SALUD; Kendall T, 2010, GLOBAL HLTH GOVERNAN, P4; Kendall T. R., 2012, PREVENTION VERTICAL; Maman S, 2008, J MIDWIFERY WOM HEAL, V53, P195, DOI 10.1016/j.jmwh.2007.11.001; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Romero-Gutierrez G, 2007, MIDWIFERY, V23, P23, DOI 10.1016/j.midw.2006.05.007; Saavedra-Lopez J, 2006, SIDA ASPECTOS SALUD, P3; *SECR SAL, 2002, PROGR ACC VIH SIDA I; Secretaria de Salud, 2010, NOM010SSA22010; Secretaria de Salud, 1993, NOM007SSA21993; Secretaria de Salud, 2008, PROGR ACC ESP 2007 2; Squires KE, 2007, GENDER MED, V4, P294, DOI 10.1016/S1550-8579(07)80060-X; *UN, 2001, UN GEN ASS SPEC SESS; UNAIDS, 2011, COUNTD ZER GLOB PLAN; [United Nations Statisctics Division United Nations Statisctics Division], 2011, MILL DEV GOALS IND O; Vera Gamboa L, 2005, GINECOL OBSTET MEX, V73, P355; Walmsley S, 2003, CAN MED ASSOC J, V168, P707; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040091; WHO UNICEF UNAIDS, 2013, WHOHIV20139 UNICEF U; World Health Organization, 2010, UN ACC SCAL PRIOR HI	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e109912	10.1371/journal.pone.0109912	http://dx.doi.org/10.1371/journal.pone.0109912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372464	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900011
J	Muller, EM; van Woesik, R				Muller, Erinn M.; van Woesik, Robert			Genetic Susceptibility, Colony Size, and Water Temperature Drive White-Pox Disease on the Coral Acropora palmata	PLOS ONE			English	Article							CARIBBEAN ELKHORN CORAL; BAND DISEASE; ST-JOHN; RESISTANCE; FRAGMENTATION; RECOVERY; ECOLOGY; STRESS	Outbreaks of coral diseases are one of the greatest threats to reef corals in the Caribbean, yet the mechanisms that lead to coral diseases are still largely unknown. Here we examined the spatial-temporal dynamics of white-pox disease on Acropora palmata coral colonies of known genotypes. We took a Bayesian approach, using Integrated Nested Laplace Approximation algorithms, to examine which covariates influenced the presence of white-pox disease over seven years. We showed that colony size, genetic susceptibility of the coral host, and high-water temperatures were the primary tested variables that were positively associated with the presence of white-pox disease on A. palmata colonies. Our study also showed that neither distance from previously diseased individuals, nor colony location, influenced the dynamics of white-pox disease. These results suggest that white-pox disease was most likely a consequence of anomalously high water temperatures that selectively compromised the oldest colonies and the most susceptible coral genotypes.	[Muller, Erinn M.] Mote Marine Lab, Sarasota, FL 34236 USA; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Mote Marine Laboratory & Aquarium; Florida Institute of Technology	Muller, EM (corresponding author), Mote Marine Lab, Sarasota, FL 34236 USA.	emuller@mote.org			U.S. Geological Survey Natural Resource Preservation Program; National Oceanic and Atmospheric Administration Coral Reef Ecosystem Studies Program; National Park Service (Virgin Islands National Park); Mote Marine Laboratory Postdoctoral Fellowship	U.S. Geological Survey Natural Resource Preservation Program; National Oceanic and Atmospheric Administration Coral Reef Ecosystem Studies Program; National Park Service (Virgin Islands National Park); Mote Marine Laboratory Postdoctoral Fellowship	Data collected for this project was supported by funds from the U.S. Geological Survey Natural Resource Preservation Program and the National Oceanic and Atmospheric Administration Coral Reef Ecosystem Studies Program, and by in-kind contributions from the National Park Service (Virgin Islands National Park). Support for E. Muller was provided by a Mote Marine Laboratory Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; Cervino JM, 2004, SYMBIOSIS, V37, P63; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Grimont PA, 1994, BERGEYS MANUAL DETER, V4, P477; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hogarth W.T., 2006, FED REGISTER, V71, P26852; Holden C, 1996, SCIENCE, V273, P177; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Irikawa A, 2011, MARINE POLL B, V62, P455; Jones R, 2004, BEE WORLD, V85, P63; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 2014, FEMS MICROBIOL ECOL, V88, P457, DOI 10.1111/1574-6941.12311; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Muller EM, 2014, MAR BIOL, V161, P359, DOI 10.1007/s00227-013-2341-2; Muller EM, 2011, J EXP MAR BIOL ECOL, V397, P52, DOI 10.1016/j.jembe.2010.11.002; Muller EM, 2009, CORAL REEFS, V28, P757, DOI 10.1007/s00338-009-0504-x; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Polson SW, 2009, P 11 INT COR REEF S, V1, P251; R Core Team, 2021, R LANGUAGE ENV STAT; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Reed KC, 2010, DIS AQUAT ORGAN, V90, P85, DOI 10.3354/dao02213; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rogers CS, 2012, CORAL REEFS, V31, P807, DOI 10.1007/s00338-012-0898-8; Roth L, 2013, ECOL MODEL, V263, P223, DOI 10.1016/j.ecolmodel.2013.05.002; RUE H., 2005, GAUSSIAN MARKOV RAND; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; Stedman T.L, 1976, STEDMANS MED DICT; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Sutherland KP, 2004, CORAL HEALTH AND DISEASE, P289; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Wagner D, 2008, B MAR SCI, V83, P553	49	22	24	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110759	10.1371/journal.pone.0110759	http://dx.doi.org/10.1371/journal.pone.0110759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372835	Green Published, gold			2022-12-27	WOS:000344556900023
J	Peng, L; Damschroder, MM; Wu, HR; Dall'Acqua, WF				Peng, Li; Damschroder, Melissa M.; Wu, Herren; Dall'Acqua, William F.			Bi-Epitope SPR Surfaces: A Solution to Develop Robust Immunoassays	PLOS ONE			English	Article							PLASMON RESONANCE; ANTIBODY-AFFINITY; SENSITIVE DETECTION; IMMUNOGLOBULIN-G; POOR-PROGNOSIS; IMMOBILIZATION; BIOSENSOR; PROTEIN; MATURATION; OVEREXPRESSION	Surface plasmon resonance (SPR)-based immunoassays have numerous applications and require high affinity reagents for sensitive and reliable measurements. We describe a quick approach to turn low affinity antibodies into appropriate capture reagents. We used antibodies recognizing human ephrin type A receptor 2 (EphA2) and a ProteOn XPR36 as a model system. We generated so-called 'bi-epitope' sensor surfaces by immobilizing various pairs of anti-EphA2 antibodies using standard amine coupling. The apparent binding affinities to EphA2 and EphA2 detection sensitivities of the bi-epitope and 'single-epitope' surfaces were then compared. For all antibody pairs tested, bi-epitope surfaces exhibited an similar to 10-100-fold improvement in apparent binding affinities when compared with single-epitope ones. When pairing 2 antibodies of low intrinsic binding affinities (similar to 10(-8) M) and fast dissociation rates (similar to 10(-2) s(-1)), the apparent binding affinity and dissociation rate of the bi-epitope surface was improved up to similar to 10(-10) M and 10(-4) s(-1), respectively. This led to an similar to 100-200-fold enhancement in EphA2 limit of detection in crude cell supernatants. Our results show that the use of antibody mixtures in SPR applications constitutes a powerful approach to develop sensitive immunoassays, as previously shown for non-SPR formats. As SPR-based assays have significantly expanded their reach in the last decade, such an approach promises to further accelerate their development.	[Peng, Li; Damschroder, Melissa M.; Wu, Herren; Dall'Acqua, William F.] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Dall'Acqua, WF (corresponding author), Medimmune Inc, Dept Antibody Discovery & Prot Engn, One MedImmune Way, Gaithersburg, MD 20878 USA.	dallacquaw@medimmune.com		Damschroder, Melissa/0000-0001-9453-6532	MedImmune	MedImmune(AstraZenecaMedimmune)	All work was funded by the authors' employer, MedImmune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA A, 1992, BIOSENS BIOELECTRON, V7, P207, DOI 10.1016/0956-5663(92)87017-J; Anderson GP, 1997, BIOSENS BIOELECTRON, V12, P329, DOI 10.1016/S0956-5663(96)00074-7; Bradley SP, 2010, CANCER RES, V70, DOI 10.1158/1538-7445.AM10-826; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Copley CG, 2002, IMMUNOASSAY PRACTICA; Danczyk R, 2003, BIOTECHNOL BIOENG, V84, P215, DOI 10.1002/bit.10760; EHRLICH PH, 1982, J IMMUNOL, V128, P2709; EHRLICH PH, 1983, SCIENCE, V221, P279, DOI 10.1126/science.6857284; EHRLICH PH, 1983, J IMMUNOL, V131, P1906; Gobi KV, 2007, ANAL BIOANAL CHEM, V387, P2727, DOI 10.1007/s00216-007-1159-5; Guidi A, 2001, BIOSENS BIOELECTRON, V16, P971, DOI 10.1016/S0956-5663(01)00245-7; Heutmekers THJ, 2007, ANAL CHIM ACTA, V586, P239, DOI 10.1016/j.aca.2006.11.047; Hyuga M, 2001, Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku, P57; Indyk HE, 2003, J AOAC INT, V86, P386; Klonisch T, 1996, IMMUNOLOGY, V89, P165, DOI 10.1046/j.1365-2567.1996.d01-722.x; Kobayashi N, 2010, ANAL CHEM, V82, P1027, DOI 10.1021/ac902283n; Liang M, 2007, ASSAY DRUG DEV TECHN, V5, P655, DOI 10.1089/adt.2007.089; LIEDBERG B, 1995, BIOSENS BIOELECTRON, V10, pR1, DOI 10.1016/0956-5663(95)96965-2; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r; Meade-Tollin L, 2007, CANCER BIOL THER, V6, P288, DOI 10.4161/cbt.6.2.4024; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Muller BH, 2011, J MOL BIOL, V414, P545, DOI 10.1016/j.jmb.2011.10.008; Mytych DT, 2009, J PHARMACEUT BIOMED, V49, P415, DOI 10.1016/j.jpba.2008.11.028; NIMMO GR, 1984, J IMMUNOL METHODS, V72, P177, DOI 10.1016/0022-1759(84)90446-0; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Sandin S, 2004, STRUCTURE, V12, P409, DOI 10.1016/j.str.2004.02.011; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schmid EL, 1997, ANAL CHEM, V69, P1979, DOI 10.1021/ac9700033; Shriver-Lake LC, 1997, BIOSENS BIOELECTRON, V12, P1101, DOI 10.1016/S0956-5663(97)00070-5; Siegel RW, 2008, CLIN CHEM, V54, P1008, DOI 10.1373/clinchem.2007.097352; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; STEWARD MW, 1985, J IMMUNOL METHODS, V78, P173, DOI 10.1016/0022-1759(85)90074-2; Sun Y, 2007, BIOSENS BIOELECTRON, V23, P473, DOI 10.1016/j.bios.2007.06.016; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Vashist SK, 2011, ANALYST, V136, P4431, DOI 10.1039/c1an15325k; Wang JL, 2009, BIOSENS BIOELECTRON, V25, P124, DOI 10.1016/j.bios.2009.06.016; Zeng C, 2013, ANAL BIOCHEM, V440, P18, DOI 10.1016/j.ab.2013.04.026	39	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112070	10.1371/journal.pone.0112070	http://dx.doi.org/10.1371/journal.pone.0112070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372291	Green Published, Green Submitted, gold			2022-12-27	WOS:000344556900108
J	te Velde, SJ; Singh, A; Chinapaw, M; De Bourdeaudhuij, I; Jan, N; Kovacs, E; Bere, E; Vik, FN; Bringolf-Isler, B; Manios, Y; Moreno, L; Brug, J				te Velde, Saskia J.; Singh, Amika; Chinapaw, Mai; De Bourdeaudhuij, Ilse; Jan, Natasa; Kovacs, Eva; Bere, Elling; Vik, Froydis N.; Bringolf-Isler, Bettina; Manios, Yannis; Moreno, Luis; Brug, Johannes			Energy Balance Related Behaviour: Personal, Home- and Friend-Related Factors among Schoolchildren in Europe Studied in the ENERGY-Project	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BODY-WEIGHT; BREAKFAST CONSUMPTION; ENVIRONMENTAL PREDICTORS; VEGETABLE CONSUMPTION; BEVERAGE CONSUMPTION; 7 COUNTRIES; CHILDREN; ADOLESCENTS; FRUIT	Objective: To design interventions that target energy balance-related behaviours, knowledge of primary schoolchildren's perceptions regarding soft drink intake, fruit juice intake, breakfast consumption, TV viewing and physical activity (PA) is essential. The current study describes personal beliefs and attitudes, home-and friend-related variables regarding these behaviours across Europe. Design: Cross-sectional study in which personal, family and friend-related variables were assessed by validated questionnaires, and dichotomized as favourable versus unfavourable answers. Logistic regression analyses were conducted to estimate proportions of children giving unfavourable answers and test between-country differences. Setting: A survey in eight European countries. Subjects: A total of 7903 10-12 year old primary schoolchildren. Results: A majority of the children reported unfavourable attitudes, preferences and subjective norms regarding soft drink, fruit juice intake and TV viewing accompanied with high availability and accessibility at home. Few children reported unfavourable attitudes and preferences regarding breakfast consumption and PA. Many children reported unfavourable health beliefs regarding breakfast consumption and TV viewing. Substantial differences between countries were observed, especially for variables regarding soft drink intake, breakfast consumption and TV viewing. Conclusion: The surveyed children demonstrated favourable attitudes to some healthy behaviours (PA, breakfast intake) as well as to some unhealthy behaviours (soft drink consumption, TV viewing). Additionally, many children across Europe have personal beliefs and are exposed to social environments that are not supportive to engagement in healthy behaviours. Moreover, the large differences in personal, family and friend-related variables across Europe argue for implementing different strategies in the different European countries.	[te Velde, Saskia J.; Singh, Amika; Chinapaw, Mai; Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [te Velde, Saskia J.; Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Singh, Amika; Chinapaw, Mai] Vrije Univ Amsterdam, Med Ctr, Dept Occupat & Publ Hlth, Amsterdam, Netherlands; [De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Jan, Natasa] Slovenian Heart Fdn, Ljubljana, Slovenia; [Kovacs, Eva] Univ Pecs, Dept Paediat, Pecs, Hungary; [Bere, Elling; Vik, Froydis N.] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Bringolf-Isler, Bettina] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Bringolf-Isler, Bettina] Univ Basel, Basel, Switzerland; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Moreno, Luis] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Ghent University; University of Pecs; University of Agder; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Harokopio University Athens; University of Zaragoza	te Velde, SJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	s.tevelde@vumc.nl	Brug, Johannes/A-8242-2018; Akkal, Maureen/P-6919-2014; Manios, Yannis/AAM-8953-2021; Paw, Mai Chin A/N-1665-2019; Moreno, Luis/S-1780-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Brug, Johannes/0000-0002-1904-7349; Manios, Yannis/0000-0001-6486-114X; Paw, Mai Chin A/0000-0001-6259-2441; Moreno, Luis/0000-0003-0454-653X; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; te Velde, Saskia/0000-0002-4674-8052	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-B) [223254]; Netherlands Organization for Health Research and Development [50-50150-98-002]	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-B); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. In the Netherlands, the ENERGY-project was additionally supported by a grant from the Netherlands Organization for Health Research and Development (Grant number 50-50150-98-002). The European Commission had no role in the design, analysis or writing of this article. The Netherlands Organization for Health Research and Development had no role in the design, analysis or writing of this article.	AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bartholomew LK, 2006, PLANNING HLTH PROMOT; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Bere E, 2008, PUBLIC HEALTH NUTR, V11, P49, DOI 10.1017/S1368980007000122; Berkey CS, 2003, INT J OBESITY, V27, P1258, DOI 10.1038/sj.ijo.0802402; Bes-Rastrollo M, 2006, NUTRITION, V22, P504, DOI 10.1016/j.nut.2005.12.006; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Bruening M, 2011, J NUTR EDUC BEHAV, V43, P390, DOI 10.1016/j.jneb.2011.02.016; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brug Johannes, 2010, BMC Public Health, V10, P276, DOI 10.1186/1471-2458-10-276; Brug J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-610; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Cameron AJ, 2013, PEDIATR OBES, V8, P130, DOI 10.1111/j.2047-6310.2012.00094.x; Cheng TSY, 2008, J SCHOOL HEALTH, V78, P203, DOI 10.1111/j.1746-1561.2008.00287.x; Cislak A, 2012, CHILD CARE HLTH DEV, V38, P321, DOI 10.1111/j.1365-2214.2011.01285.x; Debastiani SD, 2013, J PHYS ACT HEALTH; DeJong CS, 2009, PREV MED, V48, P372, DOI 10.1016/j.ypmed.2009.02.009; Ezendam NPM, 2010, BRIT J NUTR, V103, P768, DOI 10.1017/S0007114509992297; Fernandez-Alvira JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-80; Fernandez-Alvira JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-5; Fernandez-Alvira JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071848; Golan M, 2006, INT J PEDIATR OBES, V1, P66, DOI 10.1080/17477160600644272; Grimm GC, 2004, J AM DIET ASSOC, V104, P1244, DOI 10.1016/j.jada.2004.05.206; Haerens L, 2008, EUR J CLIN NUTR, V62, P51, DOI 10.1038/sj.ejcn.1602681; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Herzig M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-139; Institute of Medicine CoFMatDoCaY, 2006, FOOD MARK CHILDR YOU; International Obesity Task Force, 2012, GLOB EP; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kyriazis I, 2012, ARCH MED SCI, V8, P859, DOI 10.5114/aoms.2012.31296; Mahoney CR, 2005, PHYSIOL BEHAV, V85, P635, DOI 10.1016/j.physbeh.2005.06.023; Martens MK, 2005, PUBLIC HEALTH NUTR, V8, P1258, DOI 10.1079/PHN2005828; Ministry of Health and Care Services, 2007, NORW ACT PLAN NUTR 2; Monsivais P, 2012, ARCH PEDIAT ADOL MED, V166, P459, DOI 10.1001/archpediatrics.2011.1599; Pearson N, 2012, BRIT J NUTR, V108, P932, DOI 10.1017/S000711451100612X; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Reilly JJ, 2008, P NUTR SOC, V67, P317, DOI 10.1017/S0029665108008604; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Stea TH, 2012, PUBLIC HEALTH NUTR, V15, P379, DOI 10.1017/S1368980011001959; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Tak NI, 2011, APPETITE, V56, P503, DOI 10.1016/j.appet.2011.01.013; te Velde SJ, 2010, INT J PEDIATR OBES; The Norwegian Consumer Council, 2007, RETN MARK MAT DRIKK; Timperio AF, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-15; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van der Horst K, 2006, HLTH ED RES; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; van der Horst K, 2010, PUBLIC HEALTH NUTR, V13, P1746, DOI 10.1017/S1368980010002314; Van Lippevelde W, 2013, APPETITE, V61, P59, DOI 10.1016/j.appet.2012.10.019; van Stralen MM, 2011, INT J OBESITY, V35, P1251, DOI 10.1038/ijo.2011.68; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Verloigne M, 2013, PUBLIC HEALTH NUTR, V16, P202, DOI 10.1017/S1368980012004120; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Verplanken B, 2006, BRIT J SOC PSYCHOL, V45, P639, DOI 10.1348/014466605X49122; WHO, 2003, WHO TECHN REP SER, V916, P54; Wind M, 2006, J NUTR EDUC BEHAV, V38, P211, DOI 10.1016/j.jneb.2006.02.011	60	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111775	10.1371/journal.pone.0111775	http://dx.doi.org/10.1371/journal.pone.0111775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS9IQ	25372490	Green Published, Green Accepted, gold			2022-12-27	WOS:000344556900074
J	Tornari, C; Towers, ER; Gale, JE; Dawson, SJ				Tornari, Chrysostomos; Towers, Emily R.; Gale, Jonathan E.; Dawson, Sally J.			Regulation of the Orphan Nuclear Receptor Nr2f2 by the DFNA15 Deafness Gene Pou4f3	PLOS ONE			English	Article							PROMOTER-TRANSCRIPTION FACTORS; COUP-TFII; HAIR CELL; STRESS GRANULES; DOMAIN FACTORS; FACTOR-II; LOCALIZATION; EXPRESSION; DIFFERENTIATION; IDENTIFICATION	Hair cells are the mechanotransducing cells of the inner ear that are essential for hearing and balance. POU4F3 - a POU-domain transcription factor selectively expressed by these cells - has been shown to be essential for hair cell differentiation and survival in mice and its mutation in humans underlies late-onset progressive hearing loss (DFNA15). The downstream targets of POU4F3 are required for hair cell differentiation and survival. We aimed to identify such targets in order to elucidate the molecular pathways involved in hair cell production and maintenance. The orphan thyroid nuclear receptor Nr2f2 was identified as a POU4F3 target using a subtractive hybridization strategy and EMSA analysis showed that POU4F3 binds to two sites in the Nr2f2 5' flanking region. These sites were shown to be required for POU4F3 activation as their mutation leads to a reduction in the response of an Nr2f2 5' flanking region reporter construct to POU4F3. Immunocytochemistry was carried out in the developing and adult inner ear in order to investigate the relevance of this interaction in hearing. NR2F2 expression in the postnatal mouse organ of Corti was shown to be detectable in all sensory epithelia examined and characterised. These data demonstrate that Nr2f2 is a direct target of POU4F3 in vitro and that this regulatory relationship may be relevant to hair cell development and survival.	[Tornari, Chrysostomos; Towers, Emily R.; Gale, Jonathan E.; Dawson, Sally J.] UCL, Ear Inst, London, England	University of London; University College London	Dawson, SJ (corresponding author), UCL, Ear Inst, London, England.	sally.dawson@ucl.ac.uk	Tornari, Chrysostomos/AAU-4091-2020; Gale, Jonathan/AAG-6874-2019	Tornari, Chrysostomos/0000-0002-1212-0590; Dawson, Sally/0000-0002-4421-2043; Gale, Jonathan/0000-0003-4678-4878	Action on hearing loss [483]; Wellcome Trust [091092/Z/09/Z, 064599]; GlaxoSmithKline via the UCL MB PhD programme	Action on hearing loss; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline via the UCL MB PhD programme	This work was funded by grants from: Action on hearing loss, http://actiononhearingloss.org.uk/ (grant number 483 to JEG and SJD); the Wellcome Trust, http://www.wellcome.ac.uk/ (grant number 091092/Z/09/Z to JEG and SJD); and the original subtractive hybridisation screen was supported by a grant from the Wellcome Trust (grant number 064599 to SJD). CT's research was undertaken as part of a studentship that was funded by GlaxoSmithKline (http://www.gsk.com/uk) via the UCL MB PhD programme (http://www.ucl.ac.uk/mbphd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; AURORA R, 1992, MOL CELL BIOL, V12, P455, DOI 10.1128/MCB.12.2.455; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi CH, 2008, FREE RADICAL BIO MED, V44, P1772, DOI 10.1016/j.freeradbiomed.2008.02.005; Clough RL, 2004, BIOCHEM BIOPH RES CO, V324, P372, DOI 10.1016/j.bbrc.2004.09.074; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; DASILVA SL, 1995, MOL BRAIN RES, V30, P131, DOI 10.1016/0169-328X(94)00289-Q; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Elnitski L, 2001, J BIOL CHEM, V276, P6289, DOI 10.1074/jbc.M009624200; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Frech K, 1996, NUCLEIC ACIDS RES, V24, P1212; Gross J, 2011, CELL MOL NEUROBIOL, V31, P1089, DOI 10.1007/s10571-011-9708-z; Gruber CA, 1997, MOL CELL BIOL, V17, P2391, DOI 10.1128/MCB.17.5.2391; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hertzano R, 2007, EUR J NEUROSCI, V25, P999, DOI 10.1111/j.1460-9568.2007.05332.x; HYDE GE, 1995, OTOLARYNG HEAD NECK, V113, P530, DOI 10.1177/019459989511300503; Keithley EM, 1999, HEARING RES, V134, P71, DOI 10.1016/S0378-5955(99)00070-2; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079063; Kingston RE, 2001, CURR PROTOC IMMUNOL; Krishnan V, 1997, MOL ENDOCRINOL, V11, P1458, DOI 10.1210/me.11.10.1458; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Lee HK, 2010, BIOCHEM BIOPH RES CO, V396, P626, DOI 10.1016/j.bbrc.2010.04.132; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Ling MM, 1997, ANAL BIOCHEM, V254, P157, DOI 10.1006/abio.1997.2428; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; Qin J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003285; Qiu Y, 1996, J STEROID BIOCHEM, V56, P81, DOI 10.1016/0960-0760(95)00225-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raz Y, 1999, DEV BIOL, V213, P180, DOI 10.1006/dbio.1999.9364; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Romand R, 2006, J NEUROBIOL, V66, P687, DOI 10.1002/neu.20244; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Suzuki T, 2000, MOL CELL ENDOCRINOL, V164, P69, DOI 10.1016/S0303-7207(00)00242-2; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tang LS, 2005, GENE EXPR PATTERNS, V5, P587, DOI 10.1016/j.modgep.2005.03.012; Towers ER, 2011, J CELL SCI, V124, P1145, DOI 10.1242/jcs.076141; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	66	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e112247	10.1371/journal.pone.0112247	http://dx.doi.org/10.1371/journal.pone.0112247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372459	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900128
J	Halimi, H; Rigato, A; Byrne, D; Ferracci, G; Sebban-Kreuzer, C; ElAntak, L; Guerlesquin, F				Halimi, Hubert; Rigato, Annafrancesca; Byrne, Deborah; Ferracci, Geraldine; Sebban-Kreuzer, Corinne; ElAntak, Latifa; Guerlesquin, Francoise			Glycan Dependence of Galectin-3 Self-Association Properties	PLOS ONE			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; PROTEIN; PHOSPHORYLATION	Human Galectin-3 is found in the nucleus, the cytoplasm and at the cell surface. This lectin is constituted of two domains: an unfolded N-terminal domain and a C-terminal Carbohydrate Recognition Domain (CRD). There are still uncertainties about the relationship between the quaternary structure of Galectin-3 and its carbohydrate binding properties. Two types of self-association have been described for this lectin: a C-type self-association and a N-type self-association. Herein, we have analyzed Galectin-3 oligomerization by Dynamic Light Scattering using both the recombinant CRD and the full length lectin. Our results proved that LNnT induces N-type self-association of full length Galectin-3. Moreover, from Nuclear Magnetic Resonance (NMR) and Surface Plasmon Resonance experiments, we observed no significant specificity or affinity variations for carbohydrates related to the presence of the N-terminal domain of Galectin-3. NMR mapping clearly established that the N-terminal domain interacts with the CRD. We propose that LNnT induces a release of the N-terminal domain resulting in the glycan-dependent self-association of Galectin-3 through N-terminal domain interactions.	[Halimi, Hubert; Rigato, Annafrancesca; Sebban-Kreuzer, Corinne; ElAntak, Latifa; Guerlesquin, Francoise] Aix Marseille Univ, CNRS, Lab Ingn Syst Mol, UMR 7255, Marseille, France; [Rigato, Annafrancesca] Aix Marseille Univ, INSERM, U1006, Marseille, France; [Byrne, Deborah] Aix Marseille Univ, CNRS, FR 3479, Inst Microbiol Mediterranee, Marseille, France; [Ferracci, Geraldine] Aix Marseille Univ, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR 7286, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Guerlesquin, F (corresponding author), Aix Marseille Univ, CNRS, Lab Ingn Syst Mol, UMR 7255, Marseille, France.	guerlesquin@imm.cnrs.fr	ELANTAK, Latifa/S-7004-2019					Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Balan V, 2012, J BIOL CHEM, V287, P5192, DOI 10.1074/jbc.C111.331686; Barboni EAM, 2000, GLYCOBIOLOGY, V10, P1201, DOI 10.1093/glycob/10.11.1201; Berbis MA, 2014, BIOCHEM BIOPH RES CO, V443, P126, DOI 10.1016/j.bbrc.2013.11.063; Collins PM, 2013, J MOL BIOL, V2836, P743; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Gong HC, 1999, CANCER RES, V59, P6239; Ippel H, 2015, BIOMOL NMR ASSIGN, V9, P59, DOI 10.1007/s12104-014-9545-3; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mazurek N, 2000, J BIOL CHEM, V275, P36311, DOI 10.1074/jbc.M003831200; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Song L, 2014, CLIN CHIM ACTA, V431, P185, DOI 10.1016/j.cca.2014.01.019; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Umemoto K, 2001, J BIOMOL NMR, V20, P91, DOI 10.1023/A:1011269008175; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c	19	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111836	10.1371/journal.pone.0111836	http://dx.doi.org/10.1371/journal.pone.0111836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369125	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000109
J	Karlsson, I; Friberg, H; Steinberg, C; Persson, P				Karlsson, Ida; Friberg, Hanna; Steinberg, Christian; Persson, Paula			Fungicide Effects on Fungal Community Composition in the Wheat Phyllosphere	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; PHYLLOPLANE MICROFLORA; RIBOSOMAL-RNA; WINTER-WHEAT; GRAIN-YIELD; DIVERSITY; YEASTS; DIOSZEGIA; MICROORGANISMS; AZOXYSTROBIN	The fungicides used to control diseases in cereal production can have adverse effects on non-target fungi, with possible consequences for plant health and productivity. This study examined fungicide effects on fungal communities on winter wheat leaves in two areas of Sweden. High-throughput 454 sequencing of the fungal ITS2 region yielded 235 operational taxonomic units (OTUs) at the species level from the 18 fields studied. It was found that commonly used fungicides had moderate but significant effect on fungal community composition in the wheat phyllosphere. The relative abundance of several saprotrophs was altered by fungicide use, while the effect on common wheat pathogens was mixed. The fungal community on wheat leaves consisted mainly of basidiomycete yeasts, saprotrophic ascomycetes and plant pathogens. A core set of six fungal OTUs representing saprotrophic species was identified. These were present across all fields, although overall the difference in OTU richness was large between the two areas studied.	[Karlsson, Ida; Persson, Paula] Swedish Univ Agr Sci, SLU, Dept Crop Prod Ecol, Uppsala, Sweden; [Friberg, Hanna] SLU, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Steinberg, Christian] INRA, UMR Agroecol 1347, F-21034 Dijon, France	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Karlsson, I (corresponding author), Swedish Univ Agr Sci, SLU, Dept Crop Prod Ecol, Uppsala, Sweden.	ida.karlsson@slu.se	Steinberg, Christian/AAU-8872-2020; Karlsson, Ida/F-4192-2017	Steinberg, Christian/0000-0002-5447-5349; Karlsson, Ida/0000-0002-5598-1200	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2010-1945]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	The study was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (http://www.formas.se/en/), registration number 2010-1945. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Agrios G., 2004, PLANT PATHOLOGY; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Bates D, 2014, ARXIV14065823; Bertelsen JR, 2001, PLANT PATHOL, V50, P190, DOI 10.1046/j.1365-3059.2001.00545.x; Birzele B, 2002, EUR J PLANT PATHOL, V108, P667, DOI 10.1023/A:1020632816441; BLAKEMAN JP, 1982, ANNU REV PHYTOPATHOL, V20, P167, DOI 10.1146/annurev.py.20.090182.001123; Blixt E, 2010, EUR J PLANT PATHOL, V126, P373, DOI 10.1007/s10658-009-9542-z; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; Castoria R, 2001, POSTHARVEST BIOL TEC, V22, P7, DOI 10.1016/S0925-5214(00)00186-1; Cromey MG, 2004, CROP PROT, V23, P1019, DOI 10.1016/j.cropro.2004.03.002; Crous PW, 2006, STUD MYCOL, P53, DOI 10.3114/sim.55.1.53; De Curtis F, 2012, FIELD CROP RES, V134, P36, DOI 10.1016/j.fcr.2012.04.014; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DICKINSON CH, 1973, T BRIT MYCOL SOC, V60, P423, DOI 10.1016/S0007-1536(73)80027-0; DICKINSON CH, 1976, T BRIT MYCOL SOC, V67, P103, DOI 10.1016/S0007-1536(76)80014-9; Durling MB, 2011, SCATA EFFICIEN UNPUB; European Network for Durable Exploitation of crop protection strategies (ENDURE), 2008, DEL DR 1 2 BEST CONT; FOKKEMA N J, 1988, P91; Fokkema N. J., 1981, EPPO Bulletin, V11, P303, DOI 10.1111/j.1365-2338.1981.tb01937.x; Fonseca A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P263, DOI 10.1007/3-540-30985-3_13; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Goetz J, 2006, PAC NW FUNGI, V1; Halekoh U, 2014, J STAT SOFTW, V59, P1; Henriksen B, 2005, J PHYTOPATHOL, V153, P214, DOI 10.1111/j.1439-0434.2005.00955.x; Herdina, 2004, FEMS MICROBIOL ECOL, V47, P143, DOI 10.1016/S0168-6496(03)00255-1; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; IKAI K, 1991, J ANTIBIOT, V44, P925, DOI 10.7164/antibiotics.44.925; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kinkel LL, 1997, ANNU REV PHYTOPATHOL, V35, P327, DOI 10.1146/annurev.phyto.35.1.327; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; LAST F. T., 1955, TRANS BRIT MYCOL SOC, V38, P221; Levetin E, 2006, AEROBIOLOGIA, V22, P3, DOI 10.1007/s10453-005-9012-9; Lindner DL, 2013, ECOL EVOL, V3, P1751, DOI 10.1002/ece3.586; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MAGAN N, 1986, ANN APPL BIOL, V109, P117, DOI 10.1111/j.1744-7348.1986.tb03190.x; MALESZKA R, 1993, YEAST, V9, P53, DOI 10.1002/yea.320090107; Morton V., 2008, SHORT HIST FUNGICIDE, DOI DOI 10.1094/APSNETFEATURE-2008-0308; Moulas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/969750; Newton AC, 2010, ANN APPL BIOL, V157, P343, DOI 10.1111/j.1744-7348.2010.00437.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Petit AN, 2012, PHOTOSYNTH RES, V111, P315, DOI 10.1007/s11120-012-9719-8; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P3, DOI 10.1007/978-0-387-92207-2_2; Rastogi G, 2013, FEMS MICROBIOL LETT, V348, P1, DOI 10.1111/1574-6968.12225; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; RODLAND KD, 1982, BIOCHIM BIOPHYS ACTA, V697, P162, DOI 10.1016/0167-4781(82)90072-0; Sampaio Jose Paulo, 2003, Mycological Progress, V2, P53, DOI 10.1007/s11557-006-0044-5; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Southwell RJ, 1999, AUSTRALAS PLANT PATH, V28, P139, DOI 10.1071/AP99024; Statistiska centralbyran, 2011, VAXTSK JORD TRADG 20; Sverige Statens jordbruksverk Sverige Statistiska centralbyran, 2012, JORDBR ARSB 2012 MED; Sylla J, 2013, AGRONOMY-BASEL, V3, P704, DOI 10.3390/agronomy3040704; Takashima M, 2001, J GEN APPL MICROBIOL, V47, P75, DOI 10.2323/jgam.47.75; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Wang QM, 2008, ANTON LEEUW INT J G, V93, P391, DOI 10.1007/s10482-007-9216-9; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	67	85	91	7	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111786	10.1371/journal.pone.0111786	http://dx.doi.org/10.1371/journal.pone.0111786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369054	Green Published, gold, Green Accepted			2022-12-27	WOS:000344402000100
J	Neller, MA; Lai, MHL; Lanagan, CM; O'Connor, LE; Pritchard, AL; Martinez, NR; Schmidt, CW				Neller, Michelle A.; Lai, Michael H. -L.; Lanagan, Catherine M.; O'Connor, Linda E.; Pritchard, Antonia L.; Martinez, Nathan R.; Schmidt, Christopher W.			High Efficiency Ex Vivo Cloning of Antigen-Specific Human Effector T Cells	PLOS ONE			English	Article							HUMAN NAIVE; IN-VITRO; MELANOMA; MEMORY; AVIDITY; CTL; LYMPHOCYTES; EXPRESSION; CLONES; CYTOMEGALOVIRUS	While cloned T cells are valuable tools for the exploration of immune responses against viruses and tumours, current cloning methods do not allow inferences to be made about the function and phenotype of a clone's in vivo precursor, nor can precise cloning efficiencies be calculated. Additionally, there is currently no general method for cloning antigen-specific effector T cells directly from peripheral blood mononuclear cells, without the need for prior expansion in vitro. Here we describe an efficient method for cloning effector T cells ex vivo. Functional T cells are detected using optimised interferon gamma capture following stimulation with viral or tumour cell-derived antigen. In combination with multiple phenotypic markers, single effector T cells are sorted using a flow cytometer directly into multi-well plates, and cloned using standard, non antigen-specific expansion methods. We provide examples of this novel technology to generate antigen-reactive clones from healthy donors using Epstein-Barr virus and cytomegalovirus as representative viral antigen sources, and from two melanoma patients using autologous melanoma cells. Cloning efficiency, clonality, and retention/loss of function are described. Ex vivo effector cell cloning provides a rapid and effective method of deriving antigen-specific T cells clones with traceable in vivo precursor function and phenotype.	[Neller, Michelle A.; Lai, Michael H. -L.; Lanagan, Catherine M.; O'Connor, Linda E.; Martinez, Nathan R.; Schmidt, Christopher W.] QIMR Berghofer Med Res Inst, Canc Immunotherapy Lab, Brisbane, Qld, Australia; [Pritchard, Antonia L.] QIMR Berghofer Med Res Inst, Oncogenom Lab, Brisbane, Qld, Australia; [Neller, Michelle A.] Univ Queensland, Queensland Mayne Med Sch, Sch Med, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland	Schmidt, CW (corresponding author), QIMR Berghofer Med Res Inst, Canc Immunotherapy Lab, Brisbane, Qld, Australia.	Chris.Schmidt@qimrberghofer.edu.au	Pritchard, Antonia/F-4288-2010; Schmidt, Christopher/A-4353-2009	Pritchard, Antonia/0000-0001-5336-0454; Schmidt, Christopher/0000-0002-3955-5076; Neller, Michelle/0000-0002-2457-1508	National Health and Medical Research Council of Australia [290358]; Rio Tinto Ride to Conquer Cancer QIMR Berghofer Medical Research Institute Flagship grant; Cure Cancer Australia Foundation; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rio Tinto Ride to Conquer Cancer QIMR Berghofer Medical Research Institute Flagship grant; Cure Cancer Australia Foundation; Australian Postgraduate Award(Australian Government)	This work was supported by the National Health and Medical Research Council of Australia (www.nhmrc.gov.au) (Grant 290358 to CWS); Rio Tinto Ride to Conquer Cancer (www.conquercancer.org.au) QIMR Berghofer Medical Research Institute Flagship grant to ALP and CWS; Cure Cancer Australia Foundation (www.cure.org.au) fellowship to ALP; and Australian Postgraduate Award to MAN (www.uq.edu.au/grad-school/apa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; Bacher P, 2013, CYTOM PART A, V83A, P692, DOI [10.1002/cyto.22317, 10.1002/cyto.a.22317]; Campbell JDM, 2003, METHODS, V31, P150, DOI 10.1016/S1046-2023(03)00125-7; Doyle AG, 1999, J EXP MED, V190, P1081, DOI 10.1084/jem.190.8.1081; Dunbar PR, 1999, J IMMUNOL, V162, P6959; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Gervois N, 2000, CLIN CANCER RES, V6, P1459; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Haney D, 2011, J IMMUNOL METHODS, V369, P33, DOI 10.1016/j.jim.2011.04.003; Ho WY, 2006, J IMMUNOL METHODS, V310, P40, DOI 10.1016/j.jim.2005.11.023; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kim M, 2006, INT IMMUNOL, V18, P435, DOI 10.1093/intimm/dxh383; Leggatt GR, 2004, J LEUKOCYTE BIOL, V76, P787, DOI 10.1189/jlb.0104026; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Martinuzzi E, 2011, BLOOD, V118, P2128, DOI 10.1182/blood-2010-12-326231; MORRISSEY PJ, 1987, J IMMUNOL, V139, P1113; O'Rourke MGE, 2003, CANCER IMMUNOL IMMUN, V52, P387, DOI 10.1007/s00262-003-0375-x; Ogg GS, 1998, CURR OPIN IMMUNOL, V10, P393, DOI 10.1016/S0952-7915(98)80110-6; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Plunkett FJ, 2005, MECH AGEING DEV, V126, P855, DOI 10.1016/j.mad.2005.03.006; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; RIDDELL SR, 1992, SCIENCE, V257, P238; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Yee C, 1999, J IMMUNOL, V162, P2227; Zhou D, 2006, LAB INVEST, V86, P314, DOI 10.1038/labinvest.3700381	32	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e110741	10.1371/journal.pone.0110741	http://dx.doi.org/10.1371/journal.pone.0110741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25368986	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000026
J	Papiorek, S; Junker, RR; Lunau, K				Papiorek, Sarah; Junker, Robert R.; Lunau, Klaus			Gloss, Colour and Grip: Multifunctional Epidermal Cell Shapes in Bee- and Bird-Pollinated Flowers	PLOS ONE			English	Article							HUMMINGBIRD POLLINATION; IPOMOPSIS-AGGREGATA; PETAL; PREFERENCES; PIGMENT; BUMBLEBEES; RANUNCULUS; EVOLUTION; NICHE	Flowers bear the function of filters supporting the attraction of pollinators as well as the deterrence of floral antagonists. The effect of epidermal cell shape on the visual display and tactile properties of flowers has been evaluated only recently. In this study we quantitatively measured epidermal cell shape, gloss and spectral reflectance of flowers pollinated by either bees or birds testing three hypotheses: The first two hypotheses imply that bee-pollinated flowers might benefit from rough surfaces on visually-active parts produced by conical epidermal cells, as they may enhance the colour signal of flowers as well as the grip on flowers for bees. In contrast, bird-pollinated flowers might benefit from flat surfaces produced by flat epidermal cells, by avoiding frequent visitation from non-pollinating bees due to a reduced colour signal, as birds do not rely on specific colour parameters while foraging. Moreover, flat petal surfaces in bird-pollinated flowers may hamper grip for bees that do not touch anthers and stigmas while consuming nectar and thus, are considered as nectar thieves. Beside this, the third hypothesis implies that those flower parts which are vulnerable to nectar robbing of bee-as well as bird-pollinated flowers benefit from flat epidermal cells, hampering grip for nectar robbing bees. Our comparative data show in fact that conical epidermal cells are restricted to visually-active parts of bee-pollinated flowers, whereas robbing-sensitive parts of bee-pollinated as well as the entire floral surface of bird-pollinated flowers possess on average flat epidermal cells. However, direct correlations between epidermal cell shape and colour parameters have not been found. Our results together with published experimental studies show that epidermal cell shape as a largely neglected flower trait might act as an important feature in pollinator attraction and avoidance of antagonists, and thus may contribute to the partitioning of flower-visitors.	[Papiorek, Sarah; Lunau, Klaus] Univ Dusseldorf, Dept Biol, Inst Sensory Ecol, Dusseldorf, Germany; [Junker, Robert R.] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria	Heinrich Heine University Dusseldorf; Salzburg University	Papiorek, S (corresponding author), Univ Dusseldorf, Dept Biol, Inst Sensory Ecol, Dusseldorf, Germany.	Sarah.Papiorek@uni-duesseldorf.de	Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201	E-Norm graduate school of Heinrich-Heine University Dusseldorf	E-Norm graduate school of Heinrich-Heine University Dusseldorf	Funding provided by the E-Norm graduate school of Heinrich-Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn K, 2012, FUNCT ECOL, V26, P941, DOI 10.1111/j.1365-2435.2012.02009.x; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Botes C, 2009, INT J PLANT SCI, V170, P151, DOI 10.1086/595291; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; COLLIAS NE, 1968, CONDOR, V70, P273, DOI 10.2307/1366705; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; Dyer AG, 2007, ARTHROPOD-PLANT INTE, V1, P45, DOI 10.1007/s11829-007-9002-7; Faegri K., 1966, PRINCIPLES POLLINATI; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; Galsterer S, 1999, PLANT BIOLOGY, V1, P670, DOI 10.1055/s-2007-978571; Glover BJ, 1998, HEREDITY, V80, P778, DOI 10.1046/j.1365-2540.1998.00345.x; Gorton HL, 1996, PLANT PHYSIOL, V112, P879, DOI 10.1104/pp.112.3.879; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Herrera G, 2008, J COMP PHYSIOL A, V194, P785, DOI 10.1007/s00359-008-0349-8; Irwin RE, 1999, ECOLOGY, V80, P1703; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Junker RR, 2013, FUNCT ECOL, V27, P329, DOI 10.1111/1365-2435.12005; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Menzel Randolf, 1991, P262; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Nussinovitch A, 1996, FOOD SCI TECHNOL-LEB, V29, P184; Odeen A, 2010, J COMP PHYSIOL A, V196, P91, DOI 10.1007/s00359-009-0474-z; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Papiorek S, 2013, NATURWISSENSCHAFTEN, V100, P633, DOI 10.1007/s00114-013-1060-3; Parkin J, 1928, ANN BOT-LONDON, V42, P739, DOI 10.1093/oxfordjournals.aob.a090138; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rands SA, 2011, ARTHROPOD-PLANT INTE, V5, P279, DOI 10.1007/s11829-011-9146-3; Rohde K, 2013, J COMP PHYSIOL A, V199, P197, DOI 10.1007/s00359-012-0783-5; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; STILES FG, 1976, CONDOR, V78, P10, DOI 10.2307/1366912; Thomson JD, 2008, INT J PLANT SCI, V169, P23, DOI 10.1086/523361; Valido A, 2011, J EVOLUTION BIOL, V24, P751, DOI 10.1111/j.1420-9101.2010.02206.x; van der Kooi CJ, 2014, NEW PHYTOL, V203, P667, DOI 10.1111/nph.12808; Vignolini S, 2012, NEW PHYTOL, V196, P1038, DOI 10.1111/j.1469-8137.2012.04356.x; Vignolini S, 2012, J R SOC INTERFACE, V9, P1295, DOI 10.1098/rsif.2011.0759; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Whitney HM, 2012, PLOS ONE, V7, P66, DOI 10.1371/journal.pone.0029476; Whitney Heather M., 2011, Curtis's Botanical Magazine, V28, P349, DOI 10.1111/j.1467-8748.2011.01762.x; Whitney HM, 2011, ANN BOT-LONDON, V108, P609, DOI 10.1093/aob/mcr065; Whitney HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017576; Whitney Heather M., 2009, Communicative & Integrative Biology, V2, P505; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Wilson P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P47	49	27	28	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e112013	10.1371/journal.pone.0112013	http://dx.doi.org/10.1371/journal.pone.0112013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369510	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000137
J	Qi, SQ; Zeng, QH; Luo, YM; Duan, HJ; Ding, C; Hu, WP; Li, H				Qi, Senqing; Zeng, Qinghong; Luo, Yangmei; Duan, Haijun; Ding, Cody; Hu, Weiping; Li, Hong			Impact of Working Memory Load on Cognitive Control in Trait Anxiety: An ERP Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DORSOLATERAL PREFRONTAL CORTEX; SELECTIVE ATTENTION; STATE; PERFORMANCE; ADAPTATION; CAPACITY; DEFICITS; INDEXES; THREAT	Whether trait anxiety is associated with a general impairment of cognitive control is a matter of debate. This study investigated whether and how experimentally manipulated working memory (WM) load modulates the relation between trait anxiety and cognitive control. This question was investigated using a dual-task design in combination with event-related potentials. Participants were required to remember either one (low WM load) or six letters (high WM load) while performing a flanker task. Our results showed that a high WM load disrupted participants' ability to overcome distractor interference and this effect was exacerbated for the high trait-anxious (HTA) group. This exacerbation was reflected by larger interference effects (i.e., incongruent minus congruent) on reaction times (RTs) and N2 amplitudes for the HTA group than for the low trait-anxious group under high WM load. The two groups, however, did not differ in their ability to inhibit task-irrelevant distractors under low WM load, as indicated by both RTs and N2 amplitudes. These findings underscore the significance of WM-related cognitive demand in contributing to the presence (or absence) of a general cognitive control deficit in trait anxiety. Furthermore, our findings show that when limited WM resources are depleted by high WM load, HTA individuals exhibit less efficient recruitments of cognitive control required for the inhibition of distractors, therefore resulting in a greater degree of response conflict.	[Qi, Senqing; Duan, Haijun; Hu, Weiping] Shaanxi Normal Univ, MOE Key Lab Modern Teaching Technol, Xian, Peoples R China; [Zeng, Qinghong] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Luo, Yangmei] Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China; [Ding, Cody] Liaoning Univ Engn & Technol, Inst Safety Psychol, Fuxing, Peoples R China; [Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China	Shaanxi Normal University; Chinese University of Hong Kong; Shaanxi Normal University; Shenzhen University	Hu, WP (corresponding author), Shaanxi Normal Univ, MOE Key Lab Modern Teaching Technol, Xian, Peoples R China.	weipinghu@163.com; lihongwrm@vip.sina.com	Zeng, Ginger Qinghong/AAH-1066-2022; Zeng, Ginger Qinghong/AEX-3916-2022	Luo, Yangmei/0000-0002-4440-6980	National Natural Science Foundation of China [NSFC31271110, NSFC31470977, NSFC81171289, NSFC30770727]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (Grant Nos. NSFC31271110, NSFC31470977, NSFC81171289, and NSFC30770727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043101; Amir N, 2011, J ABNORM PSYCHOL, V120, P504, DOI 10.1037/a0022849; Ansari TL, 2011, NEUROPSYCHOLOGIA, V49, P1146, DOI 10.1016/j.neuropsychologia.2011.01.019; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Basten U, 2011, J COGNITIVE NEUROSCI, V23, P3132, DOI 10.1162/jocn_a_00003; Berggren N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00188; Berggren N, 2013, BIOL PSYCHOL, V92, P440, DOI 10.1016/j.biopsycho.2012.03.007; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Caparos S, 2012, EMOTION, V12, P8, DOI 10.1037/a0026310; Chun MM, 2011, NEURON, V72, P520, DOI 10.1016/j.neuron.2011.10.026; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, BIOL PSYCHOL, V87, P282, DOI 10.1016/j.biopsycho.2011.03.011; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Dennis TA, 2009, PSYCHOPHYSIOLOGY, V46, P122, DOI 10.1111/j.1469-8986.2008.00758.x; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Indovina I, 2011, NEURON, V69, P563, DOI 10.1016/j.neuron.2010.12.034; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Morgan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038116; Moriya J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034244, 10.1371/journal.pone.0047221]; Moser JS, 2012, EMOTION, V12, P213, DOI 10.1037/a0026156; Nieuwenhuis S, 2013, J EXP PSYCHOL HUMAN, V39, P1797, DOI 10.1037/a0033980; Osinsky R, 2012, BIOL PSYCHOL, V89, P252, DOI 10.1016/j.biopsycho.2011.10.016; Osinsky R, 2010, COGN AFFECT BEHAV NE, V10, P372, DOI 10.3758/CABN.10.3.372; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Qi SQ, 2014, COGN AFFECT BEHAV NE, V14, P253, DOI 10.3758/s13415-013-0203-5; Redick TS, 2006, APPL COGNITIVE PSYCH, V20, P713, DOI 10.1002/acp.1224; Sadeh N, 2011, COGNITION EMOTION, V25, P747, DOI 10.1080/02699931.2010.500566; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; SHEK DTL, 1993, J CLIN PSYCHOL, V49, P349, DOI 10.1002/1097-4679(199305)49:3<349::AID-JCLP2270490308>3.0.CO;2-J; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Spielberger C.D, 1979, UNDERSTANDING STRESS; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stout DM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00058; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x	47	17	20	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111791	10.1371/journal.pone.0111791	http://dx.doi.org/10.1371/journal.pone.0111791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XG	25369121	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000101
J	Zhang, H; Korenkova, V; Sjoback, R; Svec, D; Bjorkman, J; Kruhoffer, M; Verderio, P; Pizzamiglio, S; Ciniselli, CM; Wyrich, R; Oelmueller, U; Kubista, M; Lindahl, T; Lonneborg, A; Rian, E				Zhang, Hui; Korenkova, Vlasta; Sjoback, Robert; Svec, David; Bjorkman, Jens; Kruhoffer, Mogens; Verderio, Paolo; Pizzamiglio, Sara; Ciniselli, Chiara Maura; Wyrich, Ralf; Oelmueller, Uwe; Kubista, Mikael; Lindahl, Torbjorn; Lonneborg, Anders; Rian, Edith			Biomarkers for Monitoring Pre-Analytical Quality Variation of mRNA in Blood Samples	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MIQE GUIDELINES; QUANTIFICATION; DEGRADATION; STORAGE; IMPACT; STABILIZATION; PUBLICATION; PCR	There is an increasing need for proper quality control tools in the pre-analytical phase of the molecular diagnostic workflow. The aim of the present study was to identify biomarkers for monitoring pre-analytical mRNA quality variations in two different types of blood collection tubes, K(2)EDTA (EDTA) tubes and PAXgene Blood RNA Tubes (PAXgene tubes). These tubes are extensively used both in the diagnostic setting as well as for research biobank samples. Blood specimens collected in the two different blood collection tubes were stored for varying times at different temperatures, and microarray analysis was performed on resultant extracted RNA. A large set of potential mRNA quality biomarkers for monitoring post-phlebotomy gene expression changes and mRNA degradation in blood was identified. qPCR assays for the potential biomarkers and a set of relevant reference genes were generated and used to pre-validate a sub-set of the selected biomarkers. The assay precision of the potential qPCR based biomarkers was determined, and a final validation of the selected quality biomarkers using the developed qPCR assays and blood samples from 60 healthy additional subjects was performed. In total, four mRNA quality biomarkers (USP32, LMNA, FOSB, TNRFSF10C) were successfully validated. We suggest here the use of these blood mRNA quality biomarkers for validating an experimental pre-analytical workflow. These biomarkers were further evaluated in the 2nd ring trial of the SPIDIA-RNA Program which demonstrated that these biomarkers can be used as quality control tools for mRNA analyses from blood samples.	[Zhang, Hui; Lindahl, Torbjorn; Lonneborg, Anders; Rian, Edith] DiaGen ASA, Oslo, Norway; [Korenkova, Vlasta; Svec, David; Kubista, Mikael] Acad Sci Czech Republ, Inst Biotechnol, Gene Express Lab, Prague, Czech Republic; [Sjoback, Robert; Svec, David; Bjorkman, Jens; Kubista, Mikael] TATAA Bioctr, Gothenburg, Sweden; [Kruhoffer, Mogens] AROS Appl Biotechnol AS, Aarhus, Denmark; [Verderio, Paolo; Pizzamiglio, Sara; Ciniselli, Chiara Maura] Fdn IRCCS Ist Nazl Tumori Milano, Milan, Italy; [Wyrich, Ralf; Oelmueller, Uwe] Qiagen GmbH, Hilden, Germany	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Fondazione IRCCS Istituto Nazionale Tumori Milan; QIAGEN GmbH	Zhang, H (corresponding author), DiaGen ASA, Oslo, Norway.	hui_kjellgren@hotmail.com	Korenková, Vlasta/G-6401-2014; Kubista, Mikael/A-5689-2008; Ciniselli, Chiara M/C-4518-2017; Verderio, Paolo/B-5034-2017; Pizzamiglio, Sara/C-1061-2017	Kubista, Mikael/0000-0002-2940-352X; Ciniselli, Chiara M/0000-0003-4488-885X; Verderio, Paolo/0000-0002-9231-1281; Pizzamiglio, Sara/0000-0002-7759-0550; Korenkova, Vlasta/0000-0002-6289-5175	FP7 SPIDIA (Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic) - European Union; BIOCEV [CZ.1.05/1.1.00/02.0109]; ERDF [BTU-AVOZ50520701]	FP7 SPIDIA (Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic) - European Union; BIOCEV; ERDF(European Commission)	All authors were funded by the FP7 SPIDIA (Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic) supported by European Union (www.spidia.eu). VK, DS and M. Kubista were supported by BIOCEV CZ.1.05/1.1.00/02.0109 and ERDF BTU-AVOZ50520701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Bauer M, 2003, FORENSIC SCI INT, V138, P94, DOI 10.1016/j.forsciint.2003.09.008; Betsou F, 2013, J MOL DIAGN, V15, P3, DOI 10.1016/j.jmoldx.2012.06.008; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dooms M, 2013, METHODS, V59, P147, DOI 10.1016/j.ymeth.2012.07.024; Ferguson RE, 2007, PROTEOM CLIN APPL, V1, P739, DOI 10.1002/prca.200700380; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Funk DMA, 2012, SEMIN THROMB HEMOST, V38, P576, DOI 10.1055/s-0032-1319768; Gong X, 2006, ANAL BIOCHEM, V357, P58, DOI 10.1016/j.ab.2006.06.025; Green SF, 2013, CLIN BIOCHEM, V46, P1175, DOI 10.1016/j.clinbiochem.2013.06.001; Johnson Gemma, 2013, Methods Mol Biol, V943, P1, DOI 10.1007/978-1-60327-353-4_1; Kim SJ, 2007, CLIN CHEM, V53, P1038, DOI 10.1373/clinchem.2006.078436; Lippi G, 2013, BIOANALYSIS, V5, P1571, DOI [10.4155/bio.13.110, 10.4155/BIO.13.110]; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Menke Andreas, 2012, BMC Res Notes, V5, P1, DOI 10.1186/1756-0500-5-1; MULLER KE, 1989, J AM STAT ASSOC, V84, P549; Murphy B Jamie, 2007, Expert Opin Med Diagn, V1, P31, DOI 10.1517/17530059.1.1.31; Nikula T, 2013, TRANSL RES, V161, P181, DOI 10.1016/j.trsl.2012.10.003; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Pahl A, 2002, CLIN CHEM, V48, P2251; Patel N, 2009, WHY IS EDTA ANTICOAG; Pizzamiglio S, 2010, ONCOL REP, V23, P853, DOI 10.3892/or_0000707; Rainen L, 2002, CLIN CHEM, V48, P1883; Salinas M, 2009, SCAND J CLIN LAB INV, V69, P822, DOI 10.3109/00365510903288352; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tanner MA, 2002, CLIN LAB HAEMATOL, V24, P337, DOI 10.1046/j.1365-2257.2002.00474.x; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Wang FF, 2007, J MOL DIAGN, V9, P441, DOI 10.2353/jmoldx.2007.070004	31	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111644	10.1371/journal.pone.0111644	http://dx.doi.org/10.1371/journal.pone.0111644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369468	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402000081
J	Adams, IP; Skelton, A; Macarthur, R; Hodges, T; Hinds, H; Flint, L; Nath, PD; Boonham, N; Fox, A				Adams, Ian P.; Skelton, Anna; Macarthur, Roy; Hodges, Tobias; Hinds, Howard; Flint, Laura; Nath, Palash Deb; Boonham, Neil; Fox, Adrian			Carrot yellow leaf virus Is Associated with Carrot Internal Necrosis	PLOS ONE			English	Article							GENERIC METHOD; SEQUENCE; RNA; IDENTIFICATION	Internal necrosis of carrot has been observed in UK carrots for at least 10 years, and has been anecdotally linked to virus infection. In the 2009 growing season some growers had up to 10% of yield with these symptoms. Traditional diagnostic methods are targeted towards specific pathogens. By using a metagenomic approach with high throughput sequencing technology, other, as yet unidentified causes of root necrosis were investigated. Additionally a statistical analysis has shown which viruses are most closely associated with disease symptoms. Carrot samples were collected from a crop exhibiting root necrosis (102 Affected: 99 Unaffected) and tested for the presence of the established carrot viruses: Carrot red leaf virus (CtRLV), Carrot mottle virus (CMoV), Carrot red leaf associated viral RNA (CtRLVaRNA) and Parsnip yellow fleck virus (PYFV). The presence of these viruses was not associated with symptomatic carrot roots either as single viruses or in combinations. A sub-sample of carrots of mixed symptom status was subjected to MiSeq sequencing. The results from these tests suggested Carrot yellow leaf virus (CYLV) was associated with symptomatic roots. Additionally a novel Torradovirus, a novel Closterovirus and two novel Betaflexiviradae related plant viruses were detected. A specific diagnostic test was designed for CYLV. Of the 102 affected carrots, 98% were positive for CYLV compared to 22% of the unaffected carrots. From these data we conclude that although we have yet to practically demonstrate a causal link, CYLV appears to be strongly associated with the presence of necrosis of carrots.	[Adams, Ian P.; Skelton, Anna; Macarthur, Roy; Hodges, Tobias; Flint, Laura; Boonham, Neil; Fox, Adrian] Food & Environm Res Agcy, Ctr Crop Protect, York, N Yorkshire, England; [Hinds, Howard] RootCrop Ltd, Hoveringham, Notts, England; [Hodges, Tobias] Univ York, York YO10 5DD, N Yorkshire, England; [Nath, Palash Deb] Assam Agr Univ, Dept Plant Pathol, Jorhat, Assam, India	Food & Environment Research Agency; University of York - UK; Assam Agricultural University	Fox, A (corresponding author), Food & Environm Res Agcy, Ctr Crop Protect, York, N Yorkshire, England.	adrian.fox@fera.gsi.gov.uk		fox, Adrian/0000-0003-1280-1836; Adams, Ian/0000-0002-5589-6460; Boonham, Neil/0000-0002-8886-5708	Horticultural Development Company, a levy board of the Agricultural and Horticultural Development Board [FV382a]	Horticultural Development Company, a levy board of the Agricultural and Horticultural Development Board	This work was funded by the Horticultural Development Company, a levy board of the Agricultural and Horticultural Development Board, as project FV382a. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Permission was required to allow submission of the manuscript.	Adams IP, 2013, PLANT PATHOL, V62, P741, DOI 10.1111/j.1365-3059.2012.02690.x; Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; BEM F, 1979, ANN APPL BIOL, V92, P237, DOI 10.1111/j.1744-7348.1979.tb03869.x; BEM F, 1979, ANN APPL BIOL, V92, P243, DOI 10.1111/j.1744-7348.1979.tb03870.x; Boonham N, 2003, J VIROL METHODS, V108, P181, DOI 10.1016/S0166-0934(02)00284-7; Botermans M, 2013, J VIROL METHODS, V187, P43, DOI 10.1016/j.jviromet.2012.09.004; Brunt A.A., 1996, PLANT VIRUSES ONLINE; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carnegie SF, 2010, POTATO RES, V53, P17, DOI 10.1007/s11540-010-9147-0; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Fox A, 2011, SYMPTOMATIC SURVEY V; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harju V, 2011, WATERCRESS NEW DIS R; Hill S.A., 1984, METHODS PLANT PATHOL, VVolume 1, P86; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; King E., 2011, VIRUS TAXONOMY; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Menzel W, 2009, ARCH VIROL, V154, P1343, DOI 10.1007/s00705-009-0428-3; Morgan D, 2004, PARSNIP YELLOW FLECK; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Morton A, 2003, PLANT PATHOL, V52, P795, DOI 10.1111/j.1365-3059.2003.00904.x; Murant AF, 1982, HELPER DEPENDENT TRA, P191; Murant AF, 1983, 189 SCOTT CROP RES I; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VANDIJK P, 1989, NETH J PLANT PATHOL, V95, P1; VANDIJK P, 1985, NETH J PLANT PATHOL, V91, P169, DOI 10.1007/BF02009678; Verbeek M, 2008, ARCH VIROL, V153, P127, DOI 10.1007/s00705-007-1076-0; Verbeek M, 2010, ARCH VIROL, V155, P751, DOI 10.1007/s00705-010-0640-1; Vercruysse P, 2000, J VIROL METHODS, V88, P153, DOI 10.1016/S0166-0934(00)00196-8; Yamashita S, 1976, ANN PHYTOPATHOL SOC, V42, P382	33	48	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109125	10.1371/journal.pone.0109125	http://dx.doi.org/10.1371/journal.pone.0109125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365290	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100007
J	Fonseca, CG; Pires, W; Lima, MRM; Guimaraes, JB; Lima, NRV; Wanner, SP				Fonseca, Cletiana Goncalves; Pires, Washington; Malheiros Lima, Milene Rodrigues; Guimaraes, Juliana Bohnen; Viana Lima, Nilo Resende; Wanner, Samuel Penna			Hypothalamic Temperature of Rats Subjected to Treadmill Running in a Cold Environment	PLOS ONE			English	Article							BRAIN TEMPERATURE; PROLONGED EXERCISE; BLOOD-FLOW; CARDIOVASCULAR ADJUSTMENTS; MUSCARINIC CHOLINOCEPTORS; METABOLIC-RESPONSES; PERCEIVED EXERTION; DYNAMIC EXERCISE; FATIGUE; PERFORMANCE	Different strategies for cooling the body prior to or during physical exercise have been shown to improve prolonged performance. Because of ethical and methodological issues, no studies conducted in humans have evaluated the changes in brain temperature promoted by cooling strategies. Therefore, our first aim sought to measure the hypothalamic temperature (T-hyp) of rats subjected to treadmill running in a cold environment. Moreover, evidence suggests that T-hyp and abdominal temperature (T-abd) are regulated by different physiological mechanisms. Thus, this study also investigated the dynamics of exercise-induced changes in T-hyp and T-abd at two ambient temperatures: 25 degrees C (temperate environment) and 12 degrees C (cold). Adult male Wistar rats were used in these experiments. The rats were implanted with a guide cannula in the hypothalamus and a temperature sensor in the abdominal cavity. After recovery from this surgery, the rats were familiarized with running on a treadmill and were then subjected to the two experimental trials: constant-speed running (20 m/min) at 12 degrees C and 25 degrees C. Both T-hyp and T-abd increased during exercise at 25 degrees C. In contrast, T-hyp and T-abd remained unchanged during fatiguing exercise at 12 degrees C. The temperature differential (i.e., T-hyp - T-abd) increased during the initial min of running at 25 degrees C and thereafter decreased toward pre-exercise values. Interestingly, external cooling prevented this early increase in the temperature differential from the 2nd to the 8th min of running. In addition, the time until volitional fatigue was higher during the constant exercise at 12 degrees C compared with 25 degrees C. Together, our results indicate that T-hyp and T-abd are regulated by different mechanisms in running rats and that external cooling affected the relationship between both temperature indexes observed during exercise without environmental thermal stress. Our data also suggest that attenuated hypothalamic hyperthermia may contribute to improved performance in cold environments.	[Fonseca, Cletiana Goncalves; Pires, Washington; Malheiros Lima, Milene Rodrigues; Guimaraes, Juliana Bohnen; Viana Lima, Nilo Resende; Wanner, Samuel Penna] Univ Fed Minas Gerais, Exercise Physiol Lab, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Guimaraes, Juliana Bohnen] Univ Estadual Minas Gerais, Inst Super Educ Anisio Teixeira, Ibirite, MG, Brazil	Universidade Federal de Minas Gerais; Universidade do Estado de Minas Gerais	Wanner, SP (corresponding author), Univ Fed Minas Gerais, Exercise Physiol Lab, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil.	samuelwanner@eeffto.ufmg.br	Malheiros-Lima, Milene R/F-9323-2017; Wanner, Samuel P./F-9654-2012	Wanner, Samuel P./0000-0002-4659-1032; Malheiros-Lima, Milene Rodrigues/0000-0001-5163-8424	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais; Coordenadoria de Apoio ao Pessoal de Nivel Superior (CAPES/Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais; Coordenadoria de Apoio ao Pessoal de Nivel Superior (CAPES/Brazil)	The authors are indebted to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais for financial support. C.G.F. received a fellowship from the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and M.R.M.L. and W.P. received fellowships from the Coordenadoria de Apoio ao Pessoal de Nivel Superior (CAPES/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS R, 1964, AM J PHYSIOL, V206, P641, DOI 10.1152/ajplegacy.1964.206.3.641; Ansley L, 2008, PHYSIOL RES, V57, P863, DOI 10.33549/physiolres.931260; Baffi JS, 2000, NEUROENDOCRINOLOGY, V72, P102, DOI 10.1159/000054577; CAPUTA M, 1986, PFLUG ARCH EUR J PHY, V406, P184, DOI 10.1007/BF00586681; Cheung SS, 2004, EXERC SPORT SCI REV, V32, P100, DOI 10.1097/00003677-200407000-00005; Crewe H, 2008, EUR J APPL PHYSIOL, V103, P569, DOI 10.1007/s00421-008-0741-7; DONHOFFER S, 1959, NATURE, V184, P993, DOI 10.1038/184993a0; Fuller A, 1998, J APPL PHYSIOL, V84, P877, DOI 10.1152/jappl.1998.84.3.877; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Gisolf CV, 2000, HOT BRAIN SURVIVAL T; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Guimaraes JB, 2013, SCAND J MED SCI SPOR, V23, P46, DOI 10.1111/j.1600-0838.2011.01350.x; Hasegawa H, 2008, J PHYSIOL-LONDON, V586, P141, DOI 10.1113/jphysiol.2007.142190; Ho CW, 1997, J APPL PHYSIOL, V82, P1126, DOI 10.1152/jappl.1997.82.4.1126; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kiyatkin EA, 2002, J NEUROSCI, V22, P1072, DOI 10.1523/JNEUROSCI.22-03-01072.2002; Kiyatkin EA, 2007, EUR J APPL PHYSIOL, V101, P3, DOI 10.1007/s00421-007-0450-7; KIYOHARA T, 1995, BRAIN RES BULL, V38, P193, DOI 10.1016/0361-9230(95)00093-T; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Kunstetter AC, 2014, BRAZ J MED BIOL RES, V47, P679, DOI 10.1590/1414-431X20143561; Laughlin MH, 1999, ADV PHYSIOL EDUC, V22, pS244, DOI 10.1152/advances.1999.277.6.S244; Lima NRV, 1998, PHYSIOL BEHAV, V64, P69, DOI 10.1016/S0031-9384(98)00024-9; Makinen T, 1996, COMP BIOCHEM PHYS A, V114, P57, DOI 10.1016/0300-9629(95)02088-8; MERCER JB, 1978, PFLUG ARCH EUR J PHY, V374, P179, DOI 10.1007/BF00581299; Miki K, 2002, EXP PHYSIOL, V87, P33, DOI 10.1113/eph8702281; MORAINE JJ, 1993, EUR J APPL PHYSIOL O, V67, P35, DOI 10.1007/BF00377701; Nielsen B, 2001, PFLUG ARCH EUR J PHY, V442, P41, DOI 10.1007/s004240100515; Nybo L, 2002, J PHYSIOL-LONDON, V545, P697, DOI 10.1113/jphysiol.2002.030023; Nybo L, 2001, J APPL PHYSIOL, V91, P2017, DOI 10.1152/jappl.2001.91.5.2017; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PINKEL D, 1958, CANCER RES, V18, P853; Pires W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072005; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Ross M, 2013, SPORTS MED, V43, P207, DOI 10.1007/s40279-012-0014-9; ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; SCHEURINK AJW, 1988, AM J PHYSIOL, V255, pR547, DOI 10.1152/ajpregu.1988.255.4.R547; Shafton Anthony D, 2014, Temperature (Austin), V1, P37, DOI 10.4161/temp.29597; Tang JS, 2010, OXID MED CELL LONGEV, V3, P332, DOI 10.4161/oxim.3.5.13184; VISSING J, 1989, AM J PHYSIOL, V256, pR1019, DOI 10.1152/ajpregu.1989.256.5.R1019; Wanner SP, 2010, PHYSIOL RES, V59, P165, DOI 10.33549/physiolres.931649; Wanner SP, 2007, BRAIN RES BULL, V73, P28, DOI 10.1016/j.brainresbull.2007.03.004; Wanner SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075733; Wanner SP, 2011, NEUROSCI LETT, V488, P210, DOI 10.1016/j.neulet.2010.11.031	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111501	10.1371/journal.pone.0111501	http://dx.doi.org/10.1371/journal.pone.0111501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365556	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100073
J	Gao, JF; Tian, HJ; Yang, Y; Yu, XL; Li, CH; Rao, NN				Gao, Junfeng; Tian, Hongjun; Yang, Yong; Yu, Xiaolin; Li, Chenhong; Rao, Nini			A Novel Algorithm to Enhance P300 in Single Trials: Application to Lie Detection Using F-Score and SVM	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CONCEALED INFORMATION TEST; EVENT-RELATED POTENTIALS; SUPPORT VECTOR MACHINES; BCI COMPETITION 2003; DATA SET IIB; WAVELET TRANSFORM; ARTIFACT REMOVAL; SELECTION; ICA	The investigation of lie detection methods based on P300 potentials has drawn much interest in recent years. We presented a novel algorithm to enhance signal-to-noise ratio (SNR) of P300 and applied it in lie detection to increase the classification accuracy. Thirty-four subjects were divided randomly into guilty and innocent groups, and the EEG signals on 14 electrodes were recorded. A novel spatial denoising algorithm (SDA) was proposed to reconstruct the P300 with a high SNR based on independent component analysis. The differences between the proposed method and our/other early published methods mainly lie in the extraction and feature selection method of P300. Three groups of features were extracted from the denoised waves; then, the optimal features were selected by the F-score method. Selected feature samples were finally fed into three classical classifiers to make a performance comparison. The optimal parameter values in the SDA and the classifiers were tuned using a grid-searching training procedure with cross-validation. The support vector machine (SVM) approach was adopted to combine with an F-score because this approach had the best performance. The presented model F-score_SVM reaches a significantly higher classification accuracy for P300 (specificity of 96.05%) and non-P300 (sensitivity of 96.11%) compared with the results obtained without using SDA and compared with the results obtained by other classification models. Moreover, a higher individual diagnosis rate can be obtained compared with previous methods, and the presented method requires only a small number of stimuli in the real testing application.	[Gao, Junfeng; Li, Chenhong] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Tian, Hongjun] Nanjing Fullshare Superconducting Technol Co Ltd, Nanjing, Jiangsu, Peoples R China; [Yang, Yong] Jiangxi Univ Finance & Econ, Sch Informat Technol, Nanchang, Peoples R China; [Gao, Junfeng; Rao, Nini] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	South Central Minzu University; Jiangxi University of Finance & Economics; University of Electronic Science & Technology of China	Li, CH (corresponding author), South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China.	lichen@mail.scuec.edu.cn; raonini@uestc.edu.cn			National Nature Science Foundation of China [81271659, 61262034, 61302011, 81171411, 30972848]; Academic Team of South Central University for Nationalities: Biomedical Signals Processing [XTZ09002]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Team of South Central University for Nationalities: Biomedical Signals Processing	This work was supported by National Nature Science Foundation of China (No. 81271659, 61262034, 61302011, 81171411 and 30972848), and Academic Team of South Central University for Nationalities: Biomedical Signals Processing (No. XTZ09002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abootalebi V, 2006, INT J PSYCHOPHYSIOL, V62, P309, DOI 10.1016/j.ijpsycho.2006.05.009; Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Ademoglu A, 1997, IEEE T BIO-MED ENG, V44, P881, DOI 10.1109/10.623057; Ambach W, 2010, INT J PSYCHOPHYSIOL, V75, P258, DOI 10.1016/j.ijpsycho.2009.12.007; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chen FL, 2010, EXPERT SYST APPL, V37, P4902, DOI 10.1016/j.eswa.2009.12.025; Chiang LH, 2000, CHEMOMETR INTELL LAB, V50, P243, DOI 10.1016/S0169-7439(99)00061-1; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; Demiralp T, 1999, BRAIN LANG, V66, P108, DOI 10.1006/brln.1998.2027; FARWELL LA, 1991, PSYCHOPHYSIOLOGY, V28, P531, DOI 10.1111/j.1469-8986.1991.tb01990.x; Friedrichs F, 2005, NEUROCOMPUTING, V64, P107, DOI 10.1016/j.neucom.2004.11.022; Gamer M, 2010, PSYCHOPHYSIOLOGY, V47, P355, DOI 10.1111/j.1469-8986.2009.00933.x; Gao JF, 2010, BRAIN TOPOGR, V23, P105, DOI 10.1007/s10548-009-0131-4; Gao JF, 2012, CLIN EEG NEUROSCI, V43, P54, DOI 10.1177/1550059411428715; Gao JF, 2011, COMPUT METH PROG BIO, V104, P410, DOI 10.1016/j.cmpb.2010.10.002; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hsu WY, 2007, J NEUROSCI METH, V163, P145, DOI 10.1016/j.jneumeth.2007.02.004; Huang CJ, 2008, EXPERT SYST APPL, V34, P2870, DOI 10.1016/j.eswa.2007.05.035; Hung CI, 2005, ANN BIOMED ENG, V33, P1053, DOI 10.1007/s10439-005-5772-1; Ito A, 2011, NEUROSCI RES, V69, P121, DOI 10.1016/j.neures.2010.11.001; Jouve PE, 2005, LECT NOTES COMPUT SC, V3488, P583; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 1998, ADV NEUR IN, V10, P894; Kalatzis I, 2004, COMPUT METH PROG BIO, V75, P11, DOI 10.1016/j.cmpb.2003.09.003; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lin CT, 2007, IEEE T BIO-MED ENG, V54, P1349, DOI 10.1109/TBME.2007.891164; Makeig S, 1996, ADV NEUR IN, V8, P145; Matsuda I, 2013, PSYCHOPHYSIOLOGY, V50, P617, DOI 10.1111/psyp.12046; Matsuda I, 2011, PSYCHOPHYSIOLOGY, V48, P1701, DOI 10.1111/j.1469-8986.2011.01266.x; Matsuda I, 2009, INT J PSYCHOPHYSIOL, V74, P58, DOI 10.1016/j.ijpsycho.2009.07.004; Meijer EH, 2007, INT J PSYCHOPHYSIOL, V66, P231, DOI 10.1016/j.ijpsycho.2007.08.001; Mrzagora AC, 2006, P 28 IEEE EMBS ANN I; Parra L, 2004, J MACH LEARN RES, V4, P1261; Peterson DA, 1999, LECT NOTES COMPUT SC, V1607, P265; Phan KL, 2005, ACAD RADIOL, V12, P164, DOI 10.1016/j.acra.2004.11.023; Polat K, 2009, EXPERT SYST APPL, V36, P10367, DOI 10.1016/j.eswa.2009.01.041; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Quiroga RQ, 2001, BRAIN RES PROTOC, V8, P16, DOI 10.1016/S1385-299X(01)00077-0; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 2004, PSYCHOPHYSIOLOGY, V41, P205, DOI 10.1111/j.1469-8986.2004.00158.x; Rosenfeld JP, 2002, HDB POLYGRAPH TESTIN, P265; Shao SY, 2009, IEEE T BIO-MED ENG, V56, P336, DOI 10.1109/TBME.2008.2005969; Shoker L, 2005, IEEE SIGNAL PROC LET, V12, P721, DOI 10.1109/LSP.2005.855539; Soskins M, 2001, INT J PSYCHOPHYSIOL, V40, P173, DOI 10.1016/S0167-8760(00)00154-9; Tang AC, 2006, NEUROIMAGE, V29, P335, DOI 10.1016/j.neuroimage.2005.07.058; Tang AC, 2000, NEUROCOMPUTING, V32, P1115, DOI 10.1016/S0925-2312(00)00286-1; Tarassenko L, 1998, IEE P-SCI MEAS TECH, V145, P270, DOI 10.1049/ip-smt:19982328; UNSER M, 1992, IEEE T INFORM THEORY, V38, P864, DOI 10.1109/18.119742; WASSERMAN S, 1989, PSYCHOPHYSIOLOGY, V26, P208, DOI 10.1111/j.1469-8986.1989.tb03159.x; Wu CH, 2009, EXPERT SYST APPL, V36, P4725, DOI 10.1016/j.eswa.2008.06.046; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Yong YPA, 2005, EUR SIGNAL PROCESS	60	14	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109700	10.1371/journal.pone.0109700	http://dx.doi.org/10.1371/journal.pone.0109700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365325	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100009
J	Koog, YH; Lee, JS; Wi, H				Koog, Yun Hyung; Lee, Jin Su; Wi, Hyungsun			Nonspecific Adverse Events in Knee Osteoarthritis Clinical Trials: A Systematic Review	PLOS ONE			English	Article							PLACEBO GROUPS; DOUBLE-BLIND; NOCEBO; METAANALYSIS; PAIN; HIP; RECOMMENDATIONS; REDUCTION; NAPROXEN	Background: Adverse events (AEs) derived from nonspecific activity of treatments can impair the validity of trials, and even make it difficult to identify specific AEs associated with treatments. To better understand these nonspecific AEs, we investigated the AEs in placebo groups by using knee osteoarthritis clinical trials. Methods: Randomized, placebo-controlled, knee osteoarthritis trials were identified by searching electronic databases. We determined the rate of patients with AEs and the rate of dropouts caused by AEs in the active and placebo groups. Furthermore, we calculated the rate of patients for individual AEs in the placebo groups. Finally, we performed secondary analyses to identify the factors associated with these rates. Results: Overall, 272 papers reporting 281 trials were included in the analysis. The rates of patients with AEs were 31.8% in the active groups and 27.4% in the placebo groups. The rate of the placebo groups accounted for 86.2% of the rate of the active groups. The rates of dropouts caused by AEs were 5.2% in the active groups and 4.8% in the placebo groups. The rate of the placebo groups accounted for 92.3% of the rate of the active groups. AEs in the placebo groups included a number of clinical conditions, with elevated alanine aminotransferase (0.59%; 95% CI: 0.46 to 0.77) being the most common objective outcome and headache (4.48%; 95% CI: 4.20 to 4.79) being the most frequent subjective outcome. The rate of patients with AEs and the rate of dropouts caused by AEs were associated with the treatment type, delivery route, and study design. Conclusions: The nonspecific AEs substantially accounted for the development of AEs in the active groups and included conditions involving the entire body.	[Koog, Yun Hyung; Lee, Jin Su; Wi, Hyungsun] Medifarm Hosp, Honam Res Ctr, Sunchon, South Korea; [Koog, Yun Hyung] Medifarm Hosp, Dept Oriental Med, Sunchon, South Korea; [Lee, Jin Su] Medifarm Hosp, Dept Rehabil, Sunchon, South Korea		Koog, YH (corresponding author), Medifarm Hosp, Honam Res Ctr, Sunchon, South Korea.	samlungchim@hanmail.net						Amanzio M, 2009, PAIN, V146, P261, DOI 10.1016/j.pain.2009.07.010; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Benedetti F, 2003, J NEUROSCI, V23, P4315; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Cohen S, 2014, BIOETHICS, V28, P147, DOI 10.1111/j.1467-8519.2012.01983.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ergun H, 2007, JCR-J CLIN RHEUMATOL, V13, P251, DOI 10.1097/RHU.0b013e318156b85f; Hauser W, 2012, DTSCH ARZTEBL INT, V109, P459, DOI 10.3238/arztebl.2012.0459; Hauser W, 2012, CLIN J PAIN, V28, P437, DOI 10.1097/AJP.0b013e3182321ad8; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Koog YH, 2013, ISRN PAIN, V2013; Koog YH, 2014, ARCH REHUMA IN PRESS; Koog YH, 2014, J CLIN EPIDEMIOL, V67, P858, DOI 10.1016/j.jclinepi.2014.02.021; Koog YH, 2013, TURK J RHEUMATOL, V28, P282, DOI 10.5606/tjr.2013.3735; Koog YH, 2013, CLIN RHEUMATOL, V32, P1569, DOI 10.1007/s10067-013-2342-z; Koog YH, 2013, SEMIN ARTHRITIS RHEU, V42, P346, DOI 10.1016/j.semarthrit.2012.07.006; Koog YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020679; Martel-Pelletier J, 2010, EKLEM HAST CERRAHISI, V21, P2; Miller FG, 2011, THEOR MED BIOETH, V32, P229, DOI 10.1007/s11017-011-9179-8; Mitsikostas DD, 2012, EUR J NEUROL, V19, P672, DOI 10.1111/j.1468-1331.2011.03528.x; Mitsikostas DD, 2014, PSYCHIAT RES, V215, P82, DOI 10.1016/j.psychres.2013.10.019; Mitsikostas DD, 2011, CEPHALALGIA, V31, P550, DOI 10.1177/0333102410391485; Nebeker JR, 2004, ANN INTERN MED, V140, P795, DOI 10.7326/0003-4819-140-10-200405180-00009; Papadopoulos D, 2010, MULT SCLER J, V16, P816, DOI 10.1177/1352458510370793; Papadopoulos D, 2012, J NEUROL, V259, P436, DOI 10.1007/s00415-011-6197-4; Reuter U, 2003, CEPHALALGIA, V23, P496, DOI 10.1046/j.1468-2982.2003.00530.x; Rief W, 2006, ARCH INTERN MED, V166, P155, DOI 10.1001/archinte.166.2.155; Rief W, 2011, PHARMACOEPIDEM DR S, V20, P405, DOI 10.1002/pds.2067; Rief W, 2009, DRUG SAFETY, V32, P1041, DOI 10.2165/11316580-000000000-00000; Ruff KJ, 2009, CLIN RHEUMATOL, V28, P907, DOI 10.1007/s10067-009-1173-4; Schnitzer TJ, 1999, ARTHRITIS RHEUM-US, V42, P1370, DOI 10.1002/1529-0131(199907)42:7<1370::AID-ANR10>3.0.CO;2-T; Sheftell FD, 2004, HEADACHE, V44, P978, DOI 10.1111/j.1526-4610.2004.04191.x; Stathis P, 2013, EUR J NEUROL, V20, P527, DOI 10.1111/ene.12014; Svensson O, 2006, ANN RHEUM DIS, V65, P781, DOI 10.1136/ard.2005.040519; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; We SR, 2013, RHEUMATOLOGY, V52, P815, DOI 10.1093/rheumatology/kes063; We SR, 2012, COMPLEMENT THER MED, V20, P83, DOI 10.1016/j.ctim.2011.10.003; We SeoRyang, 2012, African Journal of Biotechnology, V11, P2814; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2006, BRIT J SPORT MED, V40, P664, DOI 10.1136/bjsm.2004.016840; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111776	10.1371/journal.pone.0111776	http://dx.doi.org/10.1371/journal.pone.0111776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365336	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100118
J	Merlin, JS; Walcott, M; Ritchie, C; Herbey, I; Kertesz, SG; Chamot, E; Saag, M; Turan, JM				Merlin, Jessica S.; Walcott, Melonie; Ritchie, Christine; Herbey, Ivan; Kertesz, Stefan G.; Chamot, Eric; Saag, Michael; Turan, Janet M.			'Two Pains Together': Patient Perspectives on Psychological Aspects of Chronic Pain while Living with HIV	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; CHRONIC BACK-PAIN; MUSCULOSKELETAL PAIN; NONCANCER PAIN; OPIOID USE; GENERAL-POPULATION; DEPRESSION; MANAGEMENT; COMORBIDITY; ADULTS	Objective: Chronic pain is common in HIV-infected individuals. Understanding HIV-infected patients' chronic pain experience not just from a biological, but also from a psychological perspective, is a critical first step toward improving care for this population. Our objective was to explore HIV-infected patients' perspectives on psychological aspects of chronic pain using in-depth qualitative interviews. Methods: Investigators engaged in an iterative process of independent and group coding until theme saturation was reached. Results: Of the 25 patients with chronic pain interviewed, 20 were male, 15 were younger than age 50, and 15 were African-American. Key themes that emerged included the close relationship between mood and pain; mood and pain in the context of living with HIV; use of alcohol/drugs to self-medicate for pain; and the challenge of receiving prescription pain medications while dealing with substance use disorders. Conclusions: The results suggest that psychological approaches to chronic pain treatment may be well received by HIV-infected patients.	[Merlin, Jessica S.; Walcott, Melonie; Herbey, Ivan; Saag, Michael] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Merlin, Jessica S.] Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Birmingham, AL USA; [Ritchie, Christine] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA; [Ritchie, Christine] Jewish Home San Francisco Ctr Res Aging, San Francisco, CA USA; [Kertesz, Stefan G.] Birmingham VA Med Ctr, Birmingham, AL USA; [Kertesz, Stefan G.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL USA; [Chamot, Eric; Turan, Janet M.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Merlin, JS (corresponding author), Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA.	jmerlin@uab.edu	Harding, Richard/G-9729-2012	Turan, Janet/0000-0002-7802-6206	University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR); National Institutes of Health funded program [P30 A1027767]; Agency for Healthcare Research and Quality [1K12HS02169401]; National Institute on Aging [7K07AG031779]; Mary Fisher CARE Fund at UAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG031779] Funding Source: NIH RePORTER	University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR); National Institutes of Health funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mary Fisher CARE Fund at UAB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the University of Alabama at Birmingham (UAB) Center for AIDS Research (CFAR), an National Institutes of Health funded program (P30 A1027767) that was made possible by the following institutes: National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, National Institute on Aging, and the NIH Office of AIDS Research. JSM is supported by 1K12HS02169401 (Agency for Healthcare Research and Quality). CSR is supported by 7K07AG031779 (National Institute on Aging). Funding was also provided by the Mary Fisher CARE Fund at UAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RH, 2009, J PSYCHOSOM RES, V67, P607, DOI 10.1016/j.jpsychores.2009.08.008; Alok R, 2011, CLIN EXP RHEUMATOL, V29, pS70; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bergman AA, 2013, PAIN MED; Dominick CH, 2012, PAIN, V153, P293, DOI 10.1016/j.pain.2011.09.018; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Eccleston C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub2; Edelman EJ, 2013, J GEN INTERN MED, V28, P82, DOI 10.1007/s11606-012-2189-z; Frantsve LME, 2007, PAIN MED, V8, P25, DOI 10.1111/j.1526-4637.2007.00250.x; Galvan FH, 2003, J PSYCHOACTIVE DRUGS, P153, DOI 10.1080/02791072.2003.10400510; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gaynes BN, 2013, 8 INT C HIV PREV TRE; Gaynes BN, 2008, PSYCHOSOM MED, V70, P505, DOI 10.1097/PSY.0b013e31816aa0cc; Gudin J, 2012, J PAIN SYMPTOM MANAG, V44, pS4, DOI 10.1016/j.jpainsymman.2012.08.013; Kenny DT, 2004, PATIENT EDUC COUNS, V52, P297, DOI 10.1016/S0738-3991(03)00105-8; Koeppe J, 2010, CLIN J PAIN, V26, P190, DOI 10.1097/AJP.0b013e3181b91624; Kroenke K, 2007, GEN HOSP PSYCHIAT, V29, P506, DOI 10.1016/j.genhosppsych.2007.08.005; Kroenke K, 2011, J PAIN, V12, P964, DOI 10.1016/j.jpain.2011.03.003; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P249, DOI 10.1001/jama.297.3.249; Li L, 2013, J INTERN MED, V273, P511, DOI 10.1111/joim.12035; Li L, 2013, AM J EPIDEMIOL, V178, P559, DOI 10.1093/aje/kwt013; Lum PJ, 2011, JAIDS-J ACQ IMM DEF, V56, pS91, DOI 10.1097/QAI.0b013e31820a9a82; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P215; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Matthias MS, 2013, PATIENT EDUC COUNS, V93, P197, DOI 10.1016/j.pec.2013.06.021; Merlin JS, 2012, JAIDS-J ACQ IMM DEF, V61, P164, DOI 10.1097/QAI.0b013e3182662215; Merlin JS, 2012, J PAIN SYMPTOM MANAG, V43, P638, DOI 10.1016/j.jpainsymman.2011.04.019; Merlin JS, 2013, PAIN MED; Merlin JS, 2014, AIDS PATIENT CARE ST; Merlin JS, 2013, PAIN PRACT; Miaskowski C, 2011, J PAIN, V12, P1004, DOI 10.1016/j.jpain.2011.04.002; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Morasco BJ, 2011, J PAIN, V12, P352, DOI 10.1016/j.jpain.2010.07.010; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Reddy RG, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4462; Rhodes LA, 1999, SOC SCI MED, V48, P1189, DOI 10.1016/S0277-9536(98)00418-3; Servan-Schreiber D, 2000, AM FAM PHYSICIAN, V61, P1423; Silverberg MJ, 2012, CLIN J PAIN, V28, P39, DOI 10.1097/AJP.0b013e3182201a0f; Stubbs D, 2010, PAIN MED, V11, P232, DOI 10.1111/j.1526-4637.2009.00760.x; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Verra ML, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-145; VERVEST ACM, 1988, PAIN, V34, P318, DOI 10.1016/0304-3959(88)90129-7; Vivian CT, 2007, BRIT MED J, V335, P900, DOI 10.1136/bmj.39381.514780.BE	44	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111765	10.1371/journal.pone.0111765	http://dx.doi.org/10.1371/journal.pone.0111765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365306	Green Published, gold			2022-12-27	WOS:000345558100116
J	Roark, AM; Bjorndal, KA				Roark, Alison M.; Bjorndal, Karen A.			Bridging Developmental Boundaries: Lifelong Dietary Patterns Modulate Life Histories in a Parthenogenetic Insect	PLOS ONE			English	Article							RESOURCE-ALLOCATION; FOOD LIMITATION; SPAN EXTENSION; PHENOTYPIC PLASTICITY; CALORIC RESTRICTION; TRADE-OFFS; BODY-SIZE; FRUIT-FLY; REPRODUCTION; FECUNDITY	Determining the effects of lifelong intake patterns on performance is challenging for many species, primarily because of methodological constraints. Here, we used a parthenogenetic insect (Carausius morosus) to determine the effects of limited and unlimited food availability across multiple life-history stages. Using a parthenogen allowed us to quantify intake by juvenile and adult females and to evaluate the morphological, physiological, and life-history responses to intake, all without the confounding influences of pair-housing, mating, and male behavior. In our study, growth rate prior to reproductive maturity was positively correlated with both adult and reproductive lifespans but negatively correlated with total lifespan. Food limitation had opposing effects on lifespan depending on when it was imposed, as it protracted development in juveniles but hastened death in adults. Food limitation also constrained reproduction regardless of when food was limited, although decreased fecundity was especially pronounced in individuals that were food-limited as late juveniles and adults. Additional carry-over effects of juvenile food limitation included smaller adult size and decreased body condition at the adult molt, but these effects were largely mitigated in insects that were switched to ad libitum feeding as late juveniles. Our data provide little support for the existence of a trade-off between longevity and fecundity, perhaps because these functions were fueled by different nutrient pools. However, insects that experienced a switch to the limited diet at reproductive maturity seem to have fueled egg production by drawing down body stores, thus providing some evidence for a life-history trade-off. Our results provide important insights into the effects of food limitation and indicate that performance is modulated by intake both within and across life-history stages.	[Roark, Alison M.] Furman Univ, Dept Biol, Greenville, SC 29613 USA; [Bjorndal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida	Roark, AM (corresponding author), Furman Univ, Dept Biol, Greenville, SC 29613 USA.	alison.roark@furman.edu		Bjorndal, Karen/0000-0002-6286-1901	National Science Foundation Doctoral Dissertation Improvement Grant [0508592]	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This project was funded by a National Science Foundation Doctoral Dissertation Improvement Grant (project number 0508592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala BK, 2008, APPL ENTOMOL ZOOL, V43, P183, DOI 10.1303/aez.2008.183; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; AUSTAD SN, 1989, EXP GERONTOL, V24, P83, DOI 10.1016/0531-5565(89)90037-5; Ban S, 2009, J EXP BIOL, V212, P3174, DOI 10.1242/jeb.031518; Barnes AI, 2006, P ROY SOC B-BIOL SCI, V273, P939, DOI 10.1098/rspb.2005.3388; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bauerfeind SS, 2008, BASIC APPL ECOL, V9, P443, DOI 10.1016/j.baae.2007.05.005; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Blanckenhorn WU, 2006, J ZOOL, V268, P17, DOI 10.1111/j.1469-7998.2005.00018.x; BOGGS CL, 1993, ECOLOGY, V74, P433, DOI 10.2307/1939305; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; BRADLEY JT, 1995, COMP BIOCHEM PHYS B, V110, P255, DOI 10.1016/0305-0491(94)00100-9; Carey JR, 2002, AGING CELL, V1, P140, DOI 10.1046/j.1474-9728.2002.00019.x; Carey JR, 1998, FUNCT ECOL, V12, P359, DOI 10.1046/j.1365-2435.1998.00197.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Cooper TM, 2004, FASEB J, V18, P1591, DOI 10.1096/fj.03-1464fje; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; DeClercq P, 1997, ANN ENTOMOL SOC AM, V90, P121, DOI 10.1093/aesa/90.2.121; Dixon AFG, 2002, ECOL ENTOMOL, V27, P433, DOI 10.1046/j.1365-2311.2002.00429.x; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Dudycha JL, 2005, EVOLUTION, V59, P565; Fanson BG, 2012, AGE, V34, P1361, DOI 10.1007/s11357-011-9308-3; Foster SP, 1999, ENTOMOL EXP APPL, V91, P287, DOI 10.1023/A:1003674529752; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Glazier DS, 2002, EVOLUTION, V56, P1696, DOI 10.1111/j.0014-3820.2002.tb01481.x; Gribble KE, 2013, J GERONTOL A-BIOL, V68, P349, DOI 10.1093/gerona/gls170; Hatle JD, 2006, J COMP PHYSIOL B, V176, P27, DOI 10.1007/s00360-005-0028-9; Hatle JD, 2003, INTEGR COMP BIOL, V43, P635, DOI 10.1093/icb/43.5.635; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Joshi A, 1998, EVOL ECOL, V12, P363, DOI 10.1023/A:1006508418493; Juliano SA, 2004, ECOLOGY, V85, P2986, DOI 10.1890/03-0814; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; LEVINS RICHARD, 1968; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Mair W, 2004, EXP GERONTOL, V39, P1011, DOI 10.1016/j.exger.2004.03.018; Masoro EJ, 1996, J GERONTOL A-BIOL, V51, pB387, DOI 10.1093/gerona/51A.6.B387; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Meats A, 2004, PHYSIOL ENTOMOL, V29, P176, DOI 10.1111/j.1365-3032.2004.00383.x; Medeiros MN, 2011, J INSECT PHYSIOL, V57, P945, DOI 10.1016/j.jinsphys.2011.04.010; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Moehrlin GS, 1998, OECOLOGIA, V115, P492, DOI 10.1007/s004420050546; Morgan IJ, 2001, P ROY SOC B-BIOL SCI, V268, P295, DOI 10.1098/rspb.2000.1365; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Olijnyk AM, 2013, FUNCT ECOL, V27, P165, DOI 10.1111/1365-2435.12015; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; PERRIN N, 1992, AM NAT, V139, P1344, DOI 10.1086/285390; PERRIN N, 1990, OIKOS, V59, P70, DOI 10.2307/3545124; PERRIN N, 1993, ANNU REV ECOL SYST, V24, P379, DOI 10.1146/annurev.es.24.110193.002115; PIJNACKER LP, 1966, CHROMOSOMA, V19, P99, DOI 10.1007/BF00332794; Price P.W., 2011, INSECT ECOLOGY BEHAV; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Roark AM, 2009, EXP GERONTOL, V44, P413, DOI 10.1016/j.exger.2009.03.004; Roff Derek A., 1992; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; SIBLY R, 1984, J THEOR BIOL, V111, P463, DOI 10.1016/S0022-5193(84)80234-9; Sibly R. M., 1986, PHYSL ECOLOGY ANIMAL; SMITH JNM, 1981, EVOLUTION, V35, P1142, DOI 10.1111/j.1558-5646.1981.tb04985.x; Speakman JR, 2005, J COMP PHYSIOL B, V175, P375, DOI 10.1007/s00360-005-0013-3; Stearns S.C., 1992, pi; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Walker PW, 2010, ENTOMOL EXP APPL, V136, P290, DOI 10.1111/j.1570-7458.2010.01028.x; Weindruch R., 1988, RETARDATION AGING DI; Welsch R, 1980, REGRESSION DIAGNOSTI; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	77	2	2	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111654	10.1371/journal.pone.0111654	http://dx.doi.org/10.1371/journal.pone.0111654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365446	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100096
J	Yang, Y; Dang, YY; Li, Q; Lu, JJ; Li, XW; Wang, YT				Yang Yang; Dang Yuanye; Li Qing; Lu Jinjian; Li Xiwen; Wang Yitao			Complete Chloroplast Genome Sequence of Poisonous and Medicinal Plant Datura stramonium: Organizations and Implications for Genetic Engineering	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GREEN FLUORESCENT PROTEIN; PLASTID GENOME; CODON USAGE; TRANSFORMATION; EXPRESSION; DNA; TOBACCO; OVEREXPRESSION; SCOPOLAMINE	Datura stramonium is a widely used poisonous plant with great medicinal and economic value. Its chloroplast (cp) genome is 155,871 bp in length with a typical quadripartite structure of the large (LSC, 86,302 bp) and small (SSC, 18,367 bp) single-copy regions, separated by a pair of inverted repeats (IRs, 25,601 bp). The genome contains 113 unique genes, including 80 protein-coding genes, 29 tRNAs and four rRNAs. A total of 11 forward, 9 palindromic and 13 tandem repeats were detected in the D. stramonium cp genome. Most simple sequence repeats (SSR) are AT-rich and are less abundant in coding regions than in non-coding regions. Both SSRs and GC content were unevenly distributed in the entire cp genome. All preferred synonymous codons were found to use A/T ending codons. The difference in GC contents of entire genomes and of the three-codon positions suggests that the D. stramonium cp genome might possess different genomic organization, in part due to different mutational pressures. The five most divergent coding regions and four non-coding regions (trnH-psbA, rps4-trnS, ndhD-ccsA, and ndhI-ndhG) were identified using whole plastome alignment, which can be used to develop molecular markers for phylogenetics and barcoding studies within the Solanaceae. Phylogenetic analysis based on 68 protein-coding genes supported Datura as a sister to Solanum. This study provides valuable information for phylogenetic and cp genetic engineering studies of this poisonous and medicinal plant.	[Yang Yang; Dang Yuanye; Lu Jinjian; Li Xiwen; Wang Yitao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Li Qing] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China; [Li Xiwen] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	University of Macau; Naval Medical University; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Li, XW (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	xiweijia2004@aliyun.com; ytwang@umac.mo	Lu, Jinjian/X-2083-2019; xiwen, li/W-1990-2019; Lu, Jinjian/R-6207-2019; Wang, Yitao/O-5184-2016	Lu, Jinjian/0000-0001-6703-3120; 	Macau Science and Technology Development Fund [077/2011/A3, 074/2012/A3]; Research committee of University of Macau [MYRG208A (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG013/WYT/2013/ICMS]; National Natural Science Foundation of China [81202860, 81303160]	Macau Science and Technology Development Fund; Research committee of University of Macau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Macau Science and Technology Development Fund (http://www.fdct.gov.mo/) (077/2011/A3, 074/2012/A3), Research committee of University of Macau (http://www.umac.mo/research/research_committee.html) (MYRG208A (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG013/WYT/2013/ICMS) and the National Natural Science Foundation of China (81202860, 81303160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgard M, 2001, J MOL EVOL, V53, P465, DOI 10.1007/s002390010236; BENDICH AJ, 1987, BIOESSAYS, V6, P279, DOI 10.1002/bies.950060608; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Christhudas IVSN, 2013, CURR MICROBIOL, V67, P69, DOI 10.1007/s00284-013-0329-2; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dufourmantel N, 2007, PLANT BIOTECHNOL J, V5, P118, DOI 10.1111/j.1467-7652.2006.00226.x; Eftekhar F, 2005, FITOTERAPIA, V76, P118, DOI 10.1016/j.fitote.2004.10.004; Fan Y, 2007, HOU HAN SHU HUA TUO; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gaire BP, 2013, J INTEGR MED-JIM, V11, P73, DOI 10.3736/jintegrmed2013016; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Gupta Sonika, 2010, Asian Journal of Experimental Biological Sciences, V1, P151; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Hagemann R, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P93, DOI 10.1007/978-1-4020-3166-3_4; Hanson MR, 2013, J EXP BOT, V64, P731, DOI 10.1093/jxb/ers325; Heifetz PB, 2001, CURR OPIN PLANT BIOL, V4, P157, DOI 10.1016/S1369-5266(00)00153-9; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Iannacone R, 1997, PLANT MOL BIOL, V34, P485, DOI 10.1023/A:1005876323398; Jakabova S, 2012, J CHROMATOGR A, V1232, P295, DOI 10.1016/j.chroma.2012.02.036; Kawata M, 1997, CURR GENET, V31, P179, DOI 10.1007/s002940050193; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Kota M, 1999, P NATL ACAD SCI USA, V96, P1840, DOI 10.1073/pnas.96.5.1840; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Kurtz S, 2004, GENOME BIOL, P5; Lacy BE, 2013, SCAND J GASTROENTERO, V48, P926, DOI 10.3109/00365521.2013.804117; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Li Xi-wen, 2012, Yaoxue Xuebao, V47, P124; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Li XW, 2013, SCI CHINA LIFE SCI, V56, P189, DOI 10.1007/s11427-012-4430-8; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu S, 2013, CNS DRUGS, V27, P1093, DOI 10.1007/s40263-013-0111-9; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lutz KA, 2001, PLANT PHYSIOL, V125, P1585, DOI 10.1104/pp.125.4.1585; Mariotti R, 2010, BMC PLANT BIOL, V10; Mdee LK, 2009, S AFR J BOT, V75, P375, DOI 10.1016/j.sajb.2009.02.003; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morton BR, 2003, J MOL EVOL, V56, P616, DOI 10.1007/s00239-002-2430-1; Moyano E, 2003, J EXP BOT, V54, P203, DOI 10.1093/jxb/erg014; Moyano E, 2007, J PLANT PHYSIOL, V164, P521, DOI 10.1016/j.jplph.2006.06.012; Nair RR, 2012, BIOINFORMATION, V8, P1096, DOI 10.6026/97320630081096; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Nie XJ, 2012, PLOS ONE, P7; Palazon J, 2008, MOLECULES, V13, P1722, DOI 10.3390/molecules13081722; Peredery O, 2004, PHYTOTHER RES, V18, P700, DOI 10.1002/ptr.1511; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Pramod KK, 2010, PLANT PHYSIOL BIOCH, V48, P966, DOI 10.1016/j.plaphy.2010.09.003; Pretorius E, 2006, ENVIRON TOXICOL PHAR, V21, P331, DOI 10.1016/j.etap.2005.10.006; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Rasila Devi M, 2011, ASSAM U J SCI TECHNO, V7, P139; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Rouwendal GJA, 1997, PLANT MOL BIOL, V33, P989, DOI 10.1023/A:1005740823703; Ruf S, 2001, NAT BIOTECHNOL, V19, P870, DOI 10.1038/nbt0901-870; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmitz-Linneweber C, 2001, PLANT MOL BIOL, V45, P307, DOI 10.1023/A:1006478403810; Sharma A, 2009, INDIAN J PHARMACOL, V41, P129, DOI 10.4103/0253-7613.55212; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Singh AK, 2010, TRANSGENIC RES, V19, P113, DOI 10.1007/s11248-009-9290-z; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Swofford D.L., 2003, PHYLOGENETIC HDB PRA, P160; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HH, 2009, J GENET GENOMICS, V36, P387, DOI 10.1016/S1673-8527(08)60128-9; Weissman B, 2011, TOXICOLOGY, V290, P149, DOI 10.1016/j.tox.2011.09.004; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu JW, 2003, SCI CHINA SER C, V46, P561, DOI 10.1360/02yc0120; Ye GN, 2003, PLANT PHYSIOL, V133, P402, DOI 10.1104/pp.103.021949; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Zhang L, 2004, P NATL ACAD SCI USA, V101, P6786, DOI 10.1073/pnas.0401391101; Zhang T., 2012, P 10 ASIA PACIFIC C, P7, DOI DOI 10.1145/2350046.2350150; Zubko MK, 2004, TRANSGENIC RES, V13, P523, DOI 10.1007/s11248-004-2374-x	92	34	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110656	10.1371/journal.pone.0110656	http://dx.doi.org/10.1371/journal.pone.0110656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365514	gold, Green Published			2022-12-27	WOS:000345558100024
J	Han, Y; Meng, JR; Chen, J; Cai, WL; Wang, Y; Zhao, J; He, YP; Feng, YN; Hua, HX				Han, Yu; Meng, Jiarong; Chen, Jie; Cai, Wanlun; Wang, Yu; Zhao, Jing; He, Yueping; Feng, Yanni; Hua, Hongxia			Bt Rice Expressing Cry2Aa Does Not Harm Cyrtorhinus lividipennis, a Main Predator of the Nontarget Herbivore Nilapavarta lugens	PLOS ONE			English	Article							TRANSGENIC INDICA RICE; NILAPARVATA-LUGENS; BROWN PLANTHOPPER; BIOLOGICAL-CONTROL; PEST-MANAGEMENT; CRY1AB RICE; PLANTS; PREY; DELPHACIDAE; HOMOPTERA	T2A-1 is a newly developed transgenic rice that expresses a synthesized cry2Aa gene driven by the maize ubiquitin promoter. T2A-1 exhibits high resistance against lepidopteran pests of rice. The brown planthopper, Nilapavarta lugens (Stal), is a main nontarget sap-sucking insect pest of rice, and Cyrtorhinus lividipennis (Reuter) is the major predator of the eggs and young nymphs of planthoppers. As C. lividipennis may expose to the Cry2Aa protein via N. lugens, it is therefore essential to assess the potential effects of transgenic cry2Aa rice on this predator. In the present study, three experiments were conducted to evaluate the ecological risk of transgenic cry2Aa rice to C. lividipennis: (1) a direct feeding experiment in which C. lividipennis was fed an artificial diet containing Cry2Aa at the dose of 10-time higher than that it may encounter in the realistic field condition; (2) a tritrophic experiment in which the Cry2Aa protein was delivered to C. lividipennis indirectly through prey eggs or nymphs; (3) a realistic field experiment in which the population dynamics of C. lividipennis were investigated using vacuum-suction. Both direct exposure to elevated doses of the Cry2Aa protein and prey-mediated exposure to realistic doses of the protein did not result in significant detrimental effects on the development, survival, female ratio and body weight of C. lividipennis. No significant differences in population density and population dynamics were observed between C. lividipennis in transgenic cry2Aa and nontransgenic rice fields. It may be concluded that transgenic cry2Aa rice had no detrimental effects on C. lividipennis. This study represents the first report of an assessment continuum for the effects of transgenic cry2Aa rice on C. lividipennis.	[Han, Yu; Meng, Jiarong; Chen, Jie; Cai, Wanlun; Wang, Yu; Zhao, Jing; He, Yueping; Hua, Hongxia] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Feng, Yanni] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Hua, HX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	huahongxia@mail.hzau.edu.cn			National Genetically Modified Organisms Breeding Major Project: Technology of Environmental Risk Assessment on Transgenic Rice [2014ZX08011-001]	National Genetically Modified Organisms Breeding Major Project: Technology of Environmental Risk Assessment on Transgenic Rice	This research was supported by the National Genetically Modified Organisms Breeding Major Project: Technology of Environmental Risk Assessment on Transgenic Rice (2014ZX08011-001). HH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; Carino F.O., 1979, International Rice Research Newsletter, V4, P21; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; Chen J. M., 1992, ENTOMOL KNOWLEDG, V25, P370; Chen Jian-Ming, 1994, Acta Entomologica Sinica, V37, P63; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Cheng J. A., 1996, RICE INSECT PESTS; Cheng XY, 1998, P NATL ACAD SCI USA, V95, P2767, DOI 10.1073/pnas.95.6.2767; CHUA TH, 1989, ENVIRON ENTOMOL, V18, P251, DOI 10.1093/ee/18.2.251; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Fu Q, 2001, APPL ENTOMOL ZOOL, V36, P111, DOI 10.1303/aez.2001.111; Heinrichs E.A., 1979, P529; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING CS, 1961, ANNU REV ENTOMOL, V6, P163, DOI 10.1146/annurev.en.06.010161.001115; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Jiang Yong-hou, 2004, Acta Entomologica Sinica, V47, P454; KIRITANI K, 1979, ANNU REV ENTOMOL, V24, P279, DOI 10.1146/annurev.en.24.010179.001431; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2013, ECOTOXICOLOGY, V22, P1413, DOI 10.1007/s10646-013-1127-0; Lou YG, 2013, BIOL CONTROL, V67, P8, DOI 10.1016/j.biocontrol.2013.06.011; Matteson PC, 2000, ANNU REV ENTOMOL, V45, P549, DOI 10.1146/annurev.ento.45.1.549; Oerke EC., 1994, CROP PRODUCTION CROP; Pathak M. D, 1994, INSECT PEST RICE; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sogawa K., 2003, CHINESE J RICE SCI, V17, P23; Specty O, 2003, ARCH INSECT BIOCHEM, V52, P81, DOI 10.1002/arch.10070; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Tian JC, 2010, ENVIRON ENTOMOL, V39, P1369, DOI 10.1603/EN10003; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; Xu XL, 2011, SCI CHINA LIFE SCI, V54, P1019, DOI 10.1007/s11427-011-4234-2; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zeigler RS, 2008, RICE, V1, P3, DOI 10.1007/s12284-008-9001-z; 盛承发, 2003, [植物保护, Plant Protection], V29, P37	38	16	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112315	10.1371/journal.pone.0112315	http://dx.doi.org/10.1371/journal.pone.0112315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375147	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600126
J	Levy, H; Glinert, I; Weiss, S; Bar-David, E; Sittner, A; Schlomovitz, J; Altboum, Z; Kobiler, D				Levy, Haim; Glinert, Itai; Weiss, Shay; Bar-David, Elad; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David			The Central Nervous System as Target of Bacillus anthracis Toxin Independent Virulence in Rabbits and Guinea Pigs	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; PROTECTION; PATHOLOGY; VACCINE; ADHESIN; SEARCH; SPORES; BSLA	Infection of the central nervous system is considered a complication of Anthrax and was reported in humans and non-human primates. Previously we have reported that Bacillus anthracis possesses a toxin-independent virulent trait that, like the toxins, is regulated by the major virulence regulator, AtxA, in the presence of pXO2. This toxin-independent lethal trait is exhibited in rabbits and Guinea pigs following significant bacteremia and organ dissemination. Various findings, including meningitis seen in humans and primates, suggested that the CNS is a possible target for this AtxA-mediated activity. In order to penetrate into the brain tissue, the bacteria have to overcome the barriers isolating the CNS from the blood stream. Taking a systematic genetic approach, we compared intracranial (IC) inoculation and IV/SC inoculation for the outcome of the infection in rabbits/GP, respectively. The outstanding difference between the two models is exhibited by the encapsulated strain Vollum Delta pXO1, which is lethal when injected IC, but asymptomatic when inoculated IV/SC. The findings demonstrate that there is an apparent bottleneck in the ability of mutants to penetrate into the brain. Any mutant carrying either pXO1 or pXO2 will kill the host upon IC injection, but only those carrying AtxA either on pXO1 or in the chromosome in the background of pXO2 can penetrate into the brain following peripheral inoculation. The findings were corroborated by histological examination by H&E staining and immunofluorescence of rabbits' brains following IV and IC inoculations. These findings may have major implications on future research both on B. anthracis pathogenicity and on vaccine development.	[Levy, Haim; Glinert, Itai; Weiss, Shay; Bar-David, Elad; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Levy, H (corresponding author), Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel.	haiml@iibr.gov.il		Sittner, Assa/0000-0002-1633-8191	IIBR	IIBR	This work was funded by IIBR internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Fouet A, 2010, RES MICROBIOL, V161, P735, DOI 10.1016/j.resmic.2010.09.006; Grinberg LM, 2001, MODERN PATHOL, V14, P14; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; Lanska DJ, 2002, NEUROLOGY, V59, P8; Levy H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084947; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Sambrook J, 1989, MOL CLOINING LAB MAN; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; Weiss S, 2006, INFECT IMMUN, V74, P394, DOI 10.1128/IAI.74.1.394-398.2006; Weiss S, 2011, ANTIMICROB AGENTS CH, V55, P1533, DOI 10.1128/AAC.01689-10; Yoong P, 2006, J BACTERIOL, V188, P2711, DOI 10.1128/JB.188.7.2711-2714.2006	22	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112319	10.1371/journal.pone.0112319	http://dx.doi.org/10.1371/journal.pone.0112319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375158	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600127
J	Palmer, CGS; Boudreault, P; Baldwin, EE; Sinsheimer, JS				Palmer, Christina G. S.; Boudreault, Patrick; Baldwin, Erin E.; Sinsheimer, Janet S.			Impact of Genetic Counseling and Connexin-26 and Connexin-30 Testing on Deaf Identity and Comprehension of Genetic Test Results in a Sample of Deaf Adults: A Prospective, Longitudinal Study	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; HEARING-LOSS; EDUCATIONAL-EXPERIENCES; PARENTAL ATTITUDES; SOCIAL IDENTITY; IDENTIFICATION; INDIVIDUALS; TRANSLATION; MUTATIONS; COMMUNITY	Using a prospective, longitudinal study design, this paper addresses the impact of genetic counseling and testing for deafness on deaf adults and the Deaf community. This study specifically evaluated the effect of genetic counseling and Connexin-26 and Connexin-30 genetic test results on participants' deaf identity and understanding of their genetic test results. Connexin-26 and Connexin-30 genetic testing was offered to participants in the context of linguistically and culturally appropriate genetic counseling. Questionnaire data collected from 209 deaf adults at four time points ( baseline, immediately following pre-test genetic counseling, 1-month following genetic test result disclosure, and 6-months after result disclosure) were analyzed. Four deaf identity orientations (hearing, marginal, immersion, bicultural) were evaluated using subscales of the Deaf Identity Development Scale-Revised. We found evidence that participants understood their specific genetic test results following genetic counseling, but found no evidence of change in deaf identity based on genetic counseling or their genetic test results. This study demonstrated that culturally and linguistically appropriate genetic counseling can improve deaf clients' understanding of genetic test results, and the formation of deaf identity was not directly related to genetic counseling or Connexin-26 and Connexin-30 genetic test results.	[Palmer, Christina G. S.; Baldwin, Erin E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Palmer, Christina G. S.; Sinsheimer, Janet S.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Palmer, Christina G. S.; Sinsheimer, Janet S.] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA USA; [Boudreault, Patrick] Calif State Univ Northridge, Dept Deaf Studies, Northridge, CA 91330 USA; [Sinsheimer, Janet S.] Univ Calif Los Angeles, Dept Biomath & Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California State University System; California State University Northridge; University of California System; University of California Los Angeles	Palmer, CGS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	cpalmer@mednet.ucla.edu			National Human Genome Research Institute (Ethical, Legal, and Social Issues Branch) [R01 HG003871]; Brocher Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003871] Funding Source: NIH RePORTER	National Human Genome Research Institute (Ethical, Legal, and Social Issues Branch); Brocher Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	CGSP received funding from the National Human Genome Research Institute (Ethical, Legal, and Social Issues Branch) (R01 HG003871, http://projectreporter.nih.gov); and from the Brocher Foundation (http://www.brocher.ch/en/brocher-fundation-in-brief/) in support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnos KS, 2008, AM J HUM GENET, V83, P200, DOI 10.1016/j.ajhg.2008.07.001; Baldwin EE, 2012, J GENET COUNS, V21, P256, DOI 10.1007/s10897-011-9398-1; Barnett S, 1999, AM ANN DEAF, V144, P44, DOI 10.1353/aad.2012.0120; Bat-Chava Y, 2000, AM ANN DEAF, V145, P420, DOI 10.1353/aad.2012.0176; BATCHAVA Y, 1994, PERS SOC PSYCHOL B, V20, P494, DOI 10.1177/0146167294205006; Blanton SH, 2010, ANN HUM GENET, V74, P27, DOI 10.1111/j.1469-1809.2009.00553.x; Boudreault P, 2010, J DEAF STUD DEAF EDU, V15, P209, DOI 10.1093/deafed/enq012; Box GE., 1978, STAT EXPT; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Brunger JW, 2000, AM J HUM GENET, V67, P1621, DOI 10.1086/316901; Burton SK, 2006, GENET MED, V8, P779, DOI 10.1097/01.gim.0000250501.59830.ff; DEAUX K, 1993, PERS SOC PSYCHOL B, V19, P4, DOI 10.1177/0146167293191001; ETHIER KA, 1994, J PERS SOC PSYCHOL, V67, P243, DOI 10.1037/0022-3514.67.2.243; Fischer LC, 2001, J COUNS PSYCHOL, V48, P355, DOI 10.1037/0022-0167.48.3.355; GLICKMAN NS, 1993, REHABIL PSYCHOL, V38, P275, DOI 10.1037/0090-5550.38.4.275; Gorlin RJ, 1995, HEREDITARY HEARING L; Hadjikakou K, 2007, AM ANN DEAF, V152, P398, DOI 10.1353/aad.2008.0002; Halbert CH, 2010, PUBLIC HEALTH GENOM, V13, P440, DOI 10.1159/000293990; Holcomb TK, 1997, AM ANN DEAF, V142, P89, DOI 10.1353/aad.2012.0728; Hole R, 2007, NARRAT INQ, V17, P259, DOI 10.1075/ni.17.2.06hol; Hormuth S. E., 1990, ECOLOGY SELF RELOCAT; Humphries T.L., 2005, INSIDE DEAF CULTURE; Kannapell B., 1993, LANGUAGE CHOICE IDEN; Klitzman R, 2009, GENET MED, V11, P880, DOI 10.1097/GIM.0b013e3181bfd212; Kobayashi Y, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-145; Leigh I, 1998, J Deaf Stud Deaf Educ, V3, P329; Leigh IW, 2009, J DEAF STUD DEAF EDU, V14, P244, DOI 10.1093/deafed/enn038; Leigh IW, 1999, J DEAF STUD DEAF EDU, V3, P330; Lewis S, 2006, J PAEDIATR CHILD H, V42, P533, DOI 10.1111/j.1440-1754.2006.00917.x; Malcolm K, 2005, TOPICS SIGNED LANGUA, P107; Martinez A, 2003, GENET MED, V5, P106, DOI 10.1097/01.GIM.0000055200.52906.75; Maxwell-McCaw D., 2001, ACCULTURATION PSYCHO; Maxwell-McCaw D, 2011, J DEAF STUD DEAF EDU, V16, P325, DOI 10.1093/deafed/enq061; Michie S, 2001, J MED GENET, V38, P519, DOI 10.1136/jmg.38.8.519; Middleton A, 1998, AM J HUM GENET, V63, P1175, DOI 10.1086/302060; Middleton A, 2001, J Genet Couns, V10, P121, DOI 10.1023/A:1009439630457; Nikolaraizi M, 2006, J DEAF STUD DEAF EDU, V11, P477, DOI 10.1093/deafed/enl003; Ohna S.E., 2004, DEAFNESS ED INT, V6, P20, DOI [https://doi.org/10.1179/146431504790560609, DOI 10.1179/146431504790560609]; Padden C, 1988, DEAF AM VOICES CULTU; Pal T, 2010, CLIN GENET, V78, P124, DOI 10.1111/j.1399-0004.2010.01466.x; Palmer CGS, 2013, J GENET COUNS, V22, P492, DOI 10.1007/s10897-013-9573-7; Palmer CGS, 2009, AM J MED GENET A, V149A, P1169, DOI 10.1002/ajmg.a.32853; Parker MJ, 2000, J MED GENET, V37, P37; Prasad S, 2000, HUM MUTAT, V16, P502; Samady W, 2008, PUBLIC HEALTH NURS, V25, P480, DOI 10.1111/j.1525-1446.2008.00732.x; Senghas RJ, 2002, ANNU REV ANTHROPOL, V31, P69, DOI 10.1146/annurev.anthro.31.020402.101302; Sheridan M, 2000, INNER LIVES DEAF CHI; Steinberg Annie, 2007, Am J Audiol, V16, P57; Stern SJ, 2002, J MED GENET, V39, P449, DOI 10.1136/jmg.39.6.449; Sussner KM, 2010, J GENET COUNS, V19, P255, DOI 10.1007/s10897-010-9282-4; Taneja PR, 2004, AM J MED GENET A, V130A, P17, DOI 10.1002/ajmg.a.30051; Wald RL, 2000, ANN OTO RHINOL LARYN, V109, P87, DOI 10.1177/0003489400109S1238; Withrow KA, 2009, AM J MED GENET A, V149A, P1159, DOI 10.1002/ajmg.a.32800; Withrow KA, 2009, J GENET COUNS, V18, P618, DOI 10.1007/s10897-009-9246-8	54	5	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111512	10.1371/journal.pone.0111512	http://dx.doi.org/10.1371/journal.pone.0111512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375116	gold, Green Published			2022-12-27	WOS:000344402600043
J	Shahin, I; Sohal, R; Ginther, J; Hayden, L; MacDonald, JA; Mossman, K; Parikh, H; McGahan, A; Mitchell, W; Bhattacharyya, O				Shahin, Ilan; Sohal, Raman; Ginther, John; Hayden, Leigh; MacDonald, John A.; Mossman, Kathryn; Parikh, Himanshu; McGahan, Anita; Mitchell, Will; Bhattacharyya, Onil			Trans-National Scale-Up of Services in Global Health	PLOS ONE			English	Article								Background: Scaling up innovative healthcare programs offers a means to improve access, quality, and health equity across multiple health areas. Despite large numbers of promising projects, little is known about successful efforts to scale up. This study examines trans-national scale, whereby a program operates in two or more countries. Trans-national scale is a distinct measure that reflects opportunities to replicate healthcare programs in multiple countries, thereby providing services to broader populations. Methods: Based on the Center for Health Market Innovations (CHMI) database of nearly 1200 health programs, the study contrasts 116 programs that have achieved trans-national scale with 1,068 single-country programs. Data was collected on the programs' health focus, service activity, legal status, and funding sources, as well as the programs' locations (rural v. urban emphasis), and founding year; differences are reported with statistical significance. Findings: This analysis examines 116 programs that have achieved trans-national scale (TNS) across multiple disease areas and activity types. Compared to 1,068 single-country programs, we find that trans-nationally scaled programs are more donor-reliant; more likely to focus on targeted health needs such as HIV/AIDS, TB, malaria, or family planning rather than provide more comprehensive general care; and more likely to engage in activities that support healthcare services rather than provide direct clinical care. Conclusion: This work, based on a large data set of health programs, reports on trans-national scale with comparison to single-country programs. The work is a step towards understanding when programs are able to replicate their services as they attempt to expand health services for the poor across countries and health areas. A subset of these programs should be the subject of case studies to understand factors that affect the scaling process, particularly seeking to identify mechanisms that lead to improved health outcomes.	[Shahin, Ilan; Sohal, Raman; Hayden, Leigh; Mossman, Kathryn; Bhattacharyya, Onil] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada; [Sohal, Raman; Parikh, Himanshu] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Ginther, John] Univ Toronto, T HOPE, Toronto, ON, Canada; [MacDonald, John A.] MIT Media Lab, Boston, MA USA; [MacDonald, John A.] Sloan Sch Management, Boston, MA USA; [McGahan, Anita; Mitchell, Will] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada; [Bhattacharyya, Onil] Univ Toronto, Dept Family Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Shahin, I (corresponding author), Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada.	ilan.shahin@wchospital.ca		Hayden, Leigh/0000-0002-3345-7686				Alliance for Health Policy and Systems Research, 2004, STRENGTH HLTH SYST R; Bhattacharyya O, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-24; Bloom Gerald, 2010, SCALING PATHWAYS UNI; Cooley L., 2006, SCALING VISION LARGE, V1; Credit Suisse, 2012, INV IMP; Enthoven A, 2009, AM J MANAG CARE, V15, P284; Government of Tanzania and Clinton Foundation, 2008, TANZ PIL ACT SUBS RE; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johns B, 2005, HEALTH POLICY PLANN, V20, P1, DOI 10.1093/heapol/czi001; Kamal-Yanni MM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-414; Karamchandani A., 2009, EMERGING MARKETS EME; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Lunk C, 2009, J CHILD PSYCHOL PSYC, V50, P1121, DOI [10.1111/j.1469-7610.2009.02078, DOI 10.1111/J.1469-7610.2009.02078]; Mangham LJ, 2010, HEALTH POLICY PLANN, V25, P85, DOI 10.1093/heapol/czp066; McIntyre D, 2008, B WORLD HEALTH ORGAN, V86, P817; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Saksena P, 2012, TROP MED INT HEALTH, V17, P23, DOI 10.1111/j.1365-3156.2011.02894.x; Simmons R., 2009, SCALING HLTH SERVICE; Subramanian S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-336; Tung E, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-52; United Nations, 2002, MILL DEV GOALS; Waddington C, 2012, SCALING HLTH SERVICE; WHO, 2008, PHARMAFORUM 0121; World Bank, 2003, SCAL IMP GOOD PRACT; Yamey G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001049; Yu DB, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-8	26	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110465	10.1371/journal.pone.0110465	http://dx.doi.org/10.1371/journal.pone.0110465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375328	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600012
J	Wu, LL; Gu, RL; Cai, HJ; Luo, YLL; Zhang, JX				Wu, Lili; Gu, Ruolei; Cai, Huajian; Luo, Yu L. L.; Zhang, Jianxin			The Neural Response to Maternal Stimuli: An ERP Study	PLOS ONE			English	Article							VISUAL MISMATCH NEGATIVITY; MOTHERS FACE RECOGNITION; EVENT-RELATED POTENTIALS; TASK-DIFFICULTY; BRAIN POTENTIALS; TEMPORAL FEATURES; ASSOCIATION TASK; ATTENTION; IMPLICIT; P300	Mothers are important to all humans. Research has established that maternal information affects individuals' cognition, emotion, and behavior. We measured event-related potentials (ERPs) to examine attentional and evaluative processing of maternal stimuli while participants completed a Go/No-go Association Task that paired mother or others words with good or bad evaluative words. Behavioral data showed that participants responded faster to mother words paired with good than the mother words paired with bad but showed no difference in response to these others across conditions, reflecting a positive evaluation of mother. ERPs showed larger P200 and N200 in response to mother than in response to others, suggesting that mother attracted more attention than others. In the subsequent time window, mother in the mother + bad condition elicited a later and larger late positive potential (LPP) than it did in the mother + good condition, but this was not true for others, also suggesting a positive evaluation of mother. These results suggest that people differentiate mother from others during initial attentional stage, and evaluative mother positively during later stage.	[Wu, Lili; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Gu, Ruolei; Cai, Huajian; Luo, Yu L. L.] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Cai, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	caihj@psych.ac.cn; zhangjx@psych.ac.cn	Gu, Ruolei/H-6946-2019	Gu, Ruolei/0000-0001-8722-2172	National Natural Science Foundation of China [31200789, 31070919]; Chinese Academy of Sciences [KSCX2-EW-J-8]; Hundred Talents Program [Y0C2024002]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y0CX363S01, Y2CQ013005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program(Chinese Academy of Sciences); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China [Grants No. 31200789 and 31070919], the Knowledge Innovation Program of the Chinese Academy of Sciences [Grants No. KSCX2-EW-J-8], Hundred Talents Program [Y0C2024002] as well as the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Grants No. Y0CX363S01 and Y2CQ013005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Antonucci TC, 2004, ATTACH HUM DEV, V6, P353, DOI 10.1080/1461673042000303136; Arsalidou M, 2010, BRAIN COGNITION, V74, P47, DOI 10.1016/j.bandc.2010.06.003; Banfield JF, 2006, NEUROIMAGE, V31, P1841, DOI 10.1016/j.neuroimage.2006.02.017; Barber HA, 2013, BRAIN LANG, V125, P47, DOI 10.1016/j.bandl.2013.01.005; Bartholow BD, 2006, J PERS SOC PSYCHOL, V90, P272, DOI 10.1037/0022-3514.90.2.272; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Bowlby J., 1969, ATTACHMENT LOSS ATTA, DOI [10.2307/588279, DOI 10.2307/588279]; Bretherton I, 2010, EARLY CHILD DEV CARE, V180, P9, DOI 10.1080/03004430903414661; Bushnell IWR, 2001, INFANT CHILD DEV, V10, P67, DOI 10.1002/icd.248; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; CACIOPPO JT, 1994, J PERS SOC PSYCHOL, V67, P115, DOI 10.1037/0022-3514.67.1.115; CACIOPPO JT, 1993, PSYCHOL SCI, V4, P108, DOI 10.1111/j.1467-9280.1993.tb00470.x; Chen AT, 2008, J COGNITIVE NEUROSCI, V20, P816, DOI 10.1162/jocn.2008.20505; Chen J, 2013, NEUROSCI LETT, V535, P30, DOI 10.1016/j.neulet.2012.11.061; Chen J, 2011, BIOL PSYCHOL, V87, P290, DOI 10.1016/j.biopsycho.2011.03.012; deHaan M, 1997, CHILD DEV, V68, P187, DOI 10.2307/1131845; Dehart T, 2011, SELF IDENTITY, V10, P127, DOI 10.1080/15298861003687880; Doherty NA, 2004, PERS RELATIONSHIP, V11, P469, DOI 10.1111/j.1475-6811.2004.00093.x; Eagly A. H., 1994, EUROPEAN REV SOCIAL, V5, P1, DOI [10.1080/14792779543000002, DOI 10.1080/14792779543000002]; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; FOURIEZOS G, 1990, BEHAV BRAIN RES, V37, P1, DOI 10.1016/0166-4328(90)90066-N; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Green N, 2013, CURR BIOL, V23, P1681, DOI 10.1016/j.cub.2013.07.001; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; HOFER MA, 1994, ACTA PAEDIATR, V83, P9, DOI 10.1111/j.1651-2227.1994.tb13260.x; Hu XQ, 2011, BRAIN RES, V1369, P149, DOI 10.1016/j.brainres.2010.10.106; Hughes ME, 2013, BEHAV BRAIN RES, V256, P205, DOI 10.1016/j.bbr.2013.08.026; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Ito TA, 2009, TRENDS COGN SCI, V13, P524, DOI 10.1016/j.tics.2009.10.002; Kaczkurkin AN, 2013, BIOL PSYCHOL, V93, P122, DOI 10.1016/j.biopsycho.2013.01.001; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Kimura M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00267; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kremlacek J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00411; Lingnau A, 2013, CEREB CORTEX, V23, P1342, DOI 10.1093/cercor/bhs112; Luck S. J., 2005, COGNITIVE NEUROSCIEN; Lust SA, 2009, PSYCHOPHYSIOLOGY, V46, P420, DOI 10.1111/j.1469-8986.2008.00775.x; Mallers MH, 2010, DEV PSYCHOL, V46, P1651, DOI 10.1037/a0021020; Meixner JB, 2010, PSYCHOPHYSIOLOGY, V47, P57, DOI 10.1111/j.1469-8986.2009.00883.x; MEROLA JL, 1990, INT J NEUROSCI, V51, P35, DOI 10.3109/00207459009000506; Miyakoshi M, 2007, BRAIN COGNITION, V63, P182, DOI 10.1016/j.bandc.2006.12.001; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; Ninomiya H, 1998, PSYCHIAT CLIN NEUROS, V52, P519, DOI 10.1046/j.1440-1819.1998.00445.x; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Osterhout L, 1997, MEM COGNITION, V25, P273, DOI 10.3758/BF03211283; OWEIS A, 2008, MCN AM J MATERN CHIL, V33, P393; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Pinter B, 2005, EXP PSYCHOL, V52, P74, DOI 10.1027/1618-3169.52.1.74; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rautava S, 2002, J ALLERGY CLIN IMMUN, V109, P119, DOI 10.1067/mai.2002.120273; Rudman LA, 2004, J PERS SOC PSYCHOL, V87, P494, DOI 10.1037/0022-3514.87.4.494; Schevernels H, 2014, NEUROIMAGE, V84, P639, DOI 10.1016/j.neuroimage.2013.09.039; SEDIKIDES C, 1993, J PERS SOC PSYCHOL, V64, P71, DOI 10.1037/0022-3514.64.1.71; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Steeger CM, 2013, DEV PSYCHOL, V49, P804, DOI 10.1037/a0028599; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Tottenham N, 2012, DEV PSYCHOBIOL, V54, P598, DOI 10.1002/dev.20531; Tottenham N, 2012, DEVELOPMENTAL SCI, V15, P307, DOI 10.1111/j.1467-7687.2011.01128.x; van der Lugt AH, 2012, BRAIN RES, V1429, P98, DOI 10.1016/j.brainres.2011.10.032; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Verner M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00217; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P89, DOI 10.1111/j.1469-8986.1989.tb03137.x; Yap MBH, 2011, DEV PSYCHOPATHOL, V23, P267, DOI 10.1017/S0954579410000787; Yeung LTF, 2001, HEPATOLOGY, V34, P223, DOI 10.1053/jhep.2001.25885; Zhao C., 2008, THESIS CAPITAL NORMA; Zhou A.B., 2010, PSYCHOL EXPLORATION, V3, P39	72	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111391	10.1371/journal.pone.0111391	http://dx.doi.org/10.1371/journal.pone.0111391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375157	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600036
J	Barcelar, JDM; Aliverti, A; Rattes, C; Ximenes, ME; Campos, SL; Brandao, DC; Fregonezi, G; de Andrade, AD				Barcelar, Jacqueline de Melo; Aliverti, Andrea; Rattes, Catarina; Ximenes, Maria Eduarda; Campos, Shirley Lima; Brandao, Daniella Cunha; Fregonezi, Guilherme; de Andrade, Armele Dornelas			The Expansion of the Pulmonary Rib Cage during Breath Stacking Is Influenced by Age in Obese Women	PLOS ONE			English	Article							INCENTIVE SPIROMETRY; RESPIRATORY SYSTEM; AIR STACKING; CHEST-WALL; COMPLICATIONS; SURGERY; MECHANICS; CAPACITY; INDEX	Objective: To analyze in obese women the acute effects of the breath stacking technique on thoraco-abdominal expansion. Design and Methods: Nineteen obese women (BMI >= 30 kg/m(2)) were evaluated by anthropometry, spirometry and maximal respiratory muscle pressures and successively analyzed by Opto-Electronic Plethysmography and a Wright respirometer during quiet breathing and breath stacking maneuvers and compared with a group of 15 normal-weighted healthy women. The acute effects of the maneuvers were assessed in terms of total and compartmental chest wall volumes at baseline, end of the breath stacking maneuver and after the maneuver. Obese subjects were successively classified into two groups, accordingly to the response during the maneuver, group 1 = prevalent rib cage or group 2 = abdominal expansion. Results: Age was significantly lower in group 1 than group 2. When considering the two obese groups, FEV1 was lower and minute ventilation was higher only in group 2 compared to controls group. During breath stacking, inspiratory capacity was significant differences in obese subjects with a smaller expansion of the pulmonary rib cage and a greater expansion of the abdomen compared to controls and also between groups 1 and 2. A significant inverse linear relationship was found between age and inspiratory capacity of the pulmonary rib cage but not of the abdomen. Conclusions: In obese women the maximal expansion of the rib cage and abdomen is influenced by age and breath stacking maneuver could be a possible therapy for preventing respiratory complications.	[Barcelar, Jacqueline de Melo; Rattes, Catarina; Ximenes, Maria Eduarda; Campos, Shirley Lima; Brandao, Daniella Cunha; de Andrade, Armele Dornelas] Univ Fed Pernambuco, Dept Fisioterapia, Recife, PE, Brazil; [Aliverti, Andrea] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Fregonezi, Guilherme] Univ Fed Rio Grande do Norte, Dept Fisioterapia, BR-59072970 Natal, RN, Brazil	Universidade Federal de Pernambuco; Polytechnic University of Milan; Universidade Federal do Rio Grande do Norte	de Andrade, AD (corresponding author), Univ Fed Pernambuco, Dept Fisioterapia, Recife, PE, Brazil.	armeledornelas@hotmail.com	Campos, Shirley/AAR-6026-2021; Andrea, Aliverti/A-3901-2015; Fregonezi, Guilherme/AAQ-1493-2020; Fregonezi, Guilherme AF/B-2186-2019; Dornelas de Andrade, Armele/AAO-7337-2021	Campos, Shirley/0000-0003-3079-8300; Andrea, Aliverti/0000-0002-2950-0231; Fregonezi, Guilherme/0000-0003-4938-7018; Fregonezi, Guilherme AF/0000-0003-4938-7018; Dornelas de Andrade, Armele/0000-0001-9430-4395	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do estado de Pernambuco); CAPES/PROCAD-NF [792/2009]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do estado de Pernambuco)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CAPES/PROCAD-NF(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by grants from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do estado de Pernambuco) and CAPES/PROCAD-NF (Grant no. 792/2009) as responsible Prof. Armele Dornelas de Andrade. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bader WR, 2008, MED PRIN PRACT, V17, P20, DOI 10.1159/000109585; Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Aliverti A, 2003, Monaldi Arch Chest Dis, V59, P12; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; Bach JR, 2007, AM J PHYS MED REHAB, V86, P295, DOI 10.1097/PHM.0b013e318038d1ce; BAKER WL, 1990, AM REV RESPIR DIS, V141, P343, DOI 10.1164/ajrccm/141.2.343; Barcela JD, 2013, RESP PHYSIOL NEUROBI, V189, P167, DOI 10.1016/j.resp.2013.07.016; Brito MF, 2009, J BRAS PNEUMOL, V35, P973, DOI 10.1590/S1806-37132009001000005; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Cattano D, 2010, TRANSL RES, V156, P265, DOI 10.1016/j.trsl.2010.08.004; Chlif M, 2005, INT J OBESITY, V29, P1478, DOI 10.1038/sj.ijo.0803030; Chlif M, 2009, RESP PHYSIOL NEUROBI, V168, P198, DOI 10.1016/j.resp.2009.06.012; Dias CM, 2008, BRAZ J PHYS THER, V12, P94, DOI 10.1590/S1413-35552008000200004; Diniz DM, 2004, EUR J RESP DIS S, V24, p407s; Eichenberger AS, 2002, ANESTH ANALG, V95, P1788, DOI 10.1097/00000539-200212000-00060; Janssens JP, 2005, CLIN CHEST MED, V26, P469, DOI 10.1016/j.ccm.2005.05.004; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Kang SW, 2000, CHEST, V118, P61, DOI 10.1378/chest.118.1.61; Kenyon CM, 1997, J APPL PHYSIOL, V83, P1242, DOI 10.1152/jappl.1997.83.4.1242; Kessler R, 2001, CHEST, V120, P369, DOI 10.1378/chest.120.2.369; Koenig SM, 2001, AM J MED SCI, V321, P249, DOI 10.1097/00000441-200104000-00006; Ladosky W, 2001, RESP MED, V95, P281, DOI 10.1053/rmed.2001.1035; Lawrence VA, 2006, ANN INTERN MED, V144, P596, DOI 10.7326/0003-4819-144-8-200604180-00011; MARINI JJ, 1986, AM REV RESPIR DIS, V134, P694; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ogunnaike BO, 2002, ANESTH ANALG, V95, P1793, DOI 10.1097/00000539-200212000-00061; Pasquina P, 2006, CHEST, V130, P1887, DOI 10.1378/chest.130.6.1887; Pelosi P, 2010, BEST PRACT RES-CLIN, V24, P211, DOI 10.1016/j.bpa.2010.02.001; Pereira, 2002, J PNEUMOL, V28; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; Sharma G, 2006, CLIN INTERV AGING, V1, P253, DOI 10.2147/ciia.2006.1.3.253; Veale D, 2008, BREATHE, V4, P211; Wigfield CH, 2006, EUR J CARDIO-THORAC, V29, P434, DOI 10.1016/j.ejcts.2006.01.016	34	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110959	10.1371/journal.pone.0110959	http://dx.doi.org/10.1371/journal.pone.0110959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372469	Green Published, gold, Green Submitted			2022-12-27	WOS:000344556900029
J	Starr, J; Schweik, CM; Bush, N; Fletcher, L; Finn, J; Fish, J; Bargeron, CT				Starr, Jared; Schweik, Charles M.; Bush, Nathan; Fletcher, Lena; Finn, Jack; Fish, Jennifer; Bargeron, Charles T.			Lights, Camera ... Citizen Science: Assessing the Effectiveness of Smartphone-Based Video Training in Invasive Plant Identification	PLOS ONE			English	Article								The rapid growth and increasing popularity of smartphone technology is putting sophisticated data-collection tools in the hands of more and more citizens. This has exciting implications for the expanding field of citizen science. With smartphone-based applications (apps), it is now increasingly practical to remotely acquire high quality citizen-submitted data at a fraction of the cost of a traditional study. Yet, one impediment to citizen science projects is the question of how to train participants. The traditional "in-person'' training model, while effective, can be cost prohibitive as the spatial scale of a project increases. To explore possible solutions, we analyze three training models: 1) in-person, 2) app-based video, and 3) app-based text/images in the context of invasive plant identification in Massachusetts. Encouragingly, we find that participants who received video training were as successful at invasive plant identification as those trained in-person, while those receiving just text/images were less successful. This finding has implications for a variety of citizen science projects that need alternative methods to effectively train participants when in-person training is impractical.	[Starr, Jared; Schweik, Charles M.; Bush, Nathan; Fletcher, Lena; Finn, Jack] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Fish, Jennifer] Massachusetts Dept Conservat & Recreat, Serv Forestry, Amherst, MA USA; [Bargeron, Charles T.] Univ Georgia, Ctr Invas Species & Ecosyst Hlth, Tifton, GA USA	University of Massachusetts System; University of Massachusetts Amherst; University System of Georgia; University of Georgia	Schweik, CM (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	cschweik@pubpol.umass.edu	Bargeron, Charles/R-2577-2019		Northeastern Area State and Private Forestry program, USDA Forest Service [11-DG-11420004-294]	Northeastern Area State and Private Forestry program, USDA Forest Service	The Outsmart Invasive Species project is funded through a grant (11-DG-11420004-294) from the Northeastern Area State and Private Forestry program, USDA Forest Service. CS, JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; de la Cretaz AL, 2010, ASSESSMENT FOREST RE; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Foster D. R., 2000, NEW ENGLAND FORESTS; Greenwood JJD, 2007, J ORNITHOL, V148, pS77, DOI 10.1007/s10336-007-0239-9; LEPCZYK CA, 2009, B ECOL SOC AM, P308; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Newman G., 2010, APPL ENV ED COMMUNIC, V9, P276, DOI DOI 10.1080/1533015X.2010.530896; Nov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090375; Teacher AGF, 2013, ECOL EVOL, V3, P5268, DOI 10.1002/ece3.888; Zuur Alain F., 2009, P1	14	31	33	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e111433	10.1371/journal.pone.0111433	http://dx.doi.org/10.1371/journal.pone.0111433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372597	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900048
J	Ulery, BT; Hicklin, RA; Roberts, MA; Buscaglia, J				Ulery, Bradford T.; Hicklin, R. Austin; Roberts, Maria Antonia; Buscaglia, JoAnn			Measuring What Latent Fingerprint Examiners Consider Sufficient Information for Individualization Determinations	PLOS ONE			English	Article							ERROR	Latent print examiners use their expertise to determine whether the information present in a comparison of two fingerprints (or palmprints) is sufficient to conclude that the prints were from the same source (individualization). When fingerprint evidence is presented in court, it is the examiner's determination-not an objective metric-that is presented. This study was designed to ascertain the factors that explain examiners' determinations of sufficiency for individualization. Volunteer latent print examiners (n = 170) were each assigned 22 pairs of latent and exemplar prints for examination, and annotated features, correspondence of features, and clarity. The 320 image pairs were selected specifically to control clarity and quantity of features. The predominant factor differentiating annotations associated with individualization and inconclusive determinations is the count of corresponding minutiae; other factors such as clarity provided minimal additional discriminative value. Examiners' counts of corresponding minutiae were strongly associated with their own determinations; however, due to substantial variation of both annotations and determinations among examiners, one examiner's annotation and determination on a given comparison is a relatively weak predictor of whether another examiner would individualize. The extensive variability in annotations also means that we must treat any individual examiner's minutia counts as interpretations of the (unknowable) information content of the prints: saying "the prints had N corresponding minutiae marked" is not the same as "the prints had N corresponding minutiae." More consistency in annotations, which could be achieved through standardization and training, should lead to process improvements and provide greater transparency in casework.	[Ulery, Bradford T.; Hicklin, R. Austin] Noblis, Falls Church, VA USA; [Roberts, Maria Antonia] Fed Bur Invest Lab Div, Latent Print Support Unit, Quantico, VA USA; [Buscaglia, JoAnn] Fed Bur Invest Lab Div, Counterterrorism & Forens Sci Res Unit, Quantico, VA 22135 USA		Buscaglia, J (corresponding author), Fed Bur Invest Lab Div, Counterterrorism & Forens Sci Res Unit, Quantico, VA 22135 USA.	joann.buscaglia@ic.fbi.gov		Hicklin, R. Austin/0000-0003-2155-3432	Noblis, Inc. (GSA MOBIS) from the Federal Bureau of Investigation (FBI) Biometric Center of Excellence [GS-10F-0189T]; FBI Laboratory	Noblis, Inc. (GSA MOBIS) from the Federal Bureau of Investigation (FBI) Biometric Center of Excellence; FBI Laboratory	This work was funded in part under a contract award to Noblis, Inc. (GSA MOBIS contract GS-10F-0189T, task order #12) from the Federal Bureau of Investigation (FBI) Biometric Center of Excellence and the FBI Laboratory. M.A. Roberts and J. Buscaglia are employees of the FBI Laboratory; B.T. Ulery and R.A. Hicklin are contractors for the FBI. The views expressed are those of the authors and do not necessarily reflect the official policy or position of the FBI or the U.S. Government. The specific roles of these authors are articulated in the "author contributions" section. The funders had a role in approving the manuscript for submission, but did not have a role in the study design, data collection and analysis, and preparation of the manuscript.	Abraham J, 2013, FORENSIC SCI INT, V232, P131, DOI 10.1016/j.forsciint.2013.07.005; [Anonymous], 1995, J FORENSIC IDENTIFIC, V45, P578; Anthonioz A., 2008, J FORENSIC IDENTIF, V58, P562; Ashbaugh D.R, 1999, CRC SER PR CRIM; Budowle B, 2006, FORENSIC SCI COMMUNI, V8; Campbell A, 2011, FINGERPRINT INQUIR 6; Chapman W, 2013, NIST SPECIAL PUBLICA; COLE S, 2006, LAW POLICY, V28, P109, DOI DOI 10.1111/J.1467-9930.2005.00219.X; Cole SA, 2005, J CRIM LAW CRIM, V95, P985; Dror IE, 2011, FORENSIC SCI INT, V208, P10, DOI 10.1016/j.forsciint.2010.10.013; Evett I.W., 1996, J FORENSIC IDENTIFIC, V46, P49; Farelo A, 2012, 7 INT S FING LYON FR; Federal Bureau of Investigation, 2012, UN LAT WORKST ULW SO; Haber Lyn, 2008, PROBAB RISK, V7, P87; Hicklin RA, 2013, FORENSIC SCI INT, V226, P106, DOI 10.1016/j.forsciint.2012.12.015; Huber RA., 1959, CRIM LAW Q, V2, P276; Indovina M, 2011, 7775 NIST US DEP COM; Indovina M, 2012, 7859 NIST US DEP COM; Kalka ND, 2014, FORENSIC SCI INT, V244, P78, DOI 10.1016/j.forsciint.2014.08.007; Koehler JJ, 2008, HASTINGS LAW J, V59, P1077; Komarinski P. D., 2004, AUTOMATED FINGERPRIN; Langenberg G., 2009, J FORENSIC IDENTIF, V59, P219; Langenburg G, 2012, THESIS SWITZERLAND U; Langenburg G, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2011.12.017; Langenburg G, 2009, J FORENSIC SCI, V54, P571, DOI 10.1111/j.1556-4029.2009.01025.x; Locard E., 1920, ENQUETECRIMINELLE ME, P129; Mnookin Jennifer, 2008, LAW PROBAB RISK, V7, P127, DOI DOI 10.1093/LPR/MGM022; National Academy of Sciences, 2009, STRENGTHENING FORENS; National Institute of Standards and Technology, 2011, FACIAL OTHER BIOMETR; Neumann C, 2012, J R STAT SOC A STAT, V175, P371, DOI 10.1111/j.1467-985X.2011.01027.x; Neumann C, 2013, ADV FINGERPRINT TECH, P419; Neumann C, 2013, IMPROVING UNDERSTAND; Neumann C, 2007, J FORENSIC SCI, V52, P54, DOI 10.1111/j.1556-4029.2006.00327.x; Office of the Inspector General, 2006, REV FBI HANDL BRAND; Pankanti S, 2002, IEEE T PATTERN ANAL, V24, P1010, DOI 10.1109/TPAMI.2002.1023799; Polski J, 2011, REP INT ASS ID STAND; Standardization Committee of the International Association for Identification, 1973, REP STAND COMM INT A, P13; Stoney DA, 2001, CRC FOR P S, P327; Stoney DA, 2010, MODERN SCI EVIDENCE, V4, P337; Su C., 2010, ADV NEURAL INFORM PR; Su C, 2009, LECT NOTES COMPUT SC, V5718, P55; SWGFAST, 2012, STAND DEF MEAS RAT E; SWGFAST, 2013, STAND EX FRICT RIDG; Thompson MB, 2013, J FORENSIC SCI, V58, P1519, DOI 10.1111/1556-4029.12203; Ulery BT, 2013, FORENSIC SCI INT, V230, P99, DOI 10.1016/j.forsciint.2013.01.012; Ulery BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032800; Ulery BT, 2011, P NATL ACAD SCI USA, V108, P7733, DOI 10.1073/pnas.1018707108; Wilson C, 2004, 7123 NIST US DEP COM	48	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2014	9	11							e110179	10.1371/journal.pone.0110179	http://dx.doi.org/10.1371/journal.pone.0110179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS9IQ	25372036	gold, Green Submitted, Green Published			2022-12-27	WOS:000344556900016
J	Huang, YD; Duerr, A; Frahm, N; Zhang, LL; Moodie, Z; De Rosa, S; McElrath, MJ; Gilbert, PB				Huang, Yunda; Duerr, Ann; Frahm, Nicole; Zhang, Lily; Moodie, Zoe; De Rosa, Steve; McElrath, M. Juliana; Gilbert, Peter B.			Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-gamma Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; GAG/POL/NEF VACCINE; DOUBLE-BLIND; STEP TRIAL; ACQUISITION; RESPONSES; PARTICIPANTS; EXPOSURE; DESIGNS; WOMEN	Background: Elevated risk of HIV-1 infection among recipients of an adenovirus serotype 5 (Ad5)-vectored HIV-1 vaccine was previously reported in the Step HIV-1 vaccine efficacy trial. We assessed pre-infection cellular immune responses measured at 4 weeks after the second vaccination to determine their roles in HIV-1 infection susceptibility among Step study male participants. Methods: We examined ex vivo interferon-gamma (IFN-gamma) secretion from peripheral blood mononuclear cells (PBMC) using an ELISpot assay in 112 HIV-infected and 962 uninfected participants. In addition, we performed flow cytometric assays to examine T-cell activation, and ex vivo IFN-gamma and interleukin-2 secretion from CD4(+) and CD8(+) T cells. We accounted for the sub-sampling design in Cox proportional hazards models to estimate hazard ratios (HRs) of HIV-1 infection per 1-log(e) increase of the immune responses. Findings: We found that HIV-specific immune responses were not associated with risk of HIV-1 infection. However, each 1-log(e) increase of mock responses measured by the ELISpot assay (i.e., IFN-gamma secretion in the absence of antigen-specific stimulation) was associated with a 62% increase of HIV-1 infection risk among vaccine recipients (HR = 1.62, 95% CI: (1.28, 2.04), p < 0.001). This association remains after accounting for CD4(+) or CD8(+) T-cell activation. We observed a moderate correlation between ELISpot mock responses and CD4(+) T-cells secreting IFN-gamma (rho = 0.33, p = 0.007). In addition, the effect of the Step vaccine on infection risk appeared to vary with ELISpot mock response levels, especially among participants who had pre-existing anti-Ad5 antibodies (interaction p = 0.04). Conclusions: The proportion of cells, likely CD4(+) T-cells, producing IFN-gamma without stimulation by exogenous antigen appears to carry information beyond T-cell activation and baseline characteristics that predict risk of HIV-1 infection. These results motivate additional investigation to understand the potential link between IFN-gamma secretion and underlying causes of elevated HIV-1 infection risk among vaccine recipients in the Step study.	[Huang, Yunda; Duerr, Ann; Frahm, Nicole; Zhang, Lily; Moodie, Zoe; De Rosa, Steve; McElrath, M. Juliana; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Huang, Yunda; Duerr, Ann; Moodie, Zoe; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Duerr, Ann; Frahm, Nicole; McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Duerr, Ann] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [De Rosa, Steve; McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Huang, YD (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	yunda@scharp.org		Huang, Yunda/0000-0003-1546-6172	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1AI068635, UM1AI068618]; Bill and Melinda Gates Foundation [OPP1032317]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068614, UM1AI068618, UM1AI068635] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers UM1AI068635 (YH, LZ, ZM, PG) and UM1AI068618 (AD, NF, SD, JM) and by Bill and Melinda Gates Foundation grant OPP1032317 (YH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (www.nih.org) or the Gates Foundation (www.gatesfoundation.org). The authors thank the James B. Pendleton Charitable Trust for their generous equipment donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgan O, 2000, LIFETIME DATA ANAL, V6, P39, DOI 10.1023/A:1009661900674; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fellay J, 2011, J INFECT DIS, V203, P773, DOI 10.1093/infdis/jiq125; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Huang YD, 2012, STAT MED, V31, P3748, DOI 10.1002/sim.5446; Jones NG, 2009, VACCINE, V27, P1136, DOI 10.1016/j.vaccine.2008.11.071; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Naranbhai V, 2013, JAIDS-J ACQ IMM DEF, V63, P294, DOI 10.1097/QAI.0b013e31828e604b; Naranbhai V, 2012, AIDS, V26, P1745, DOI 10.1097/QAD.0b013e328357724f; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Tenbusch M, 2012, J VIROL, V86, P10533, DOI 10.1128/JVI.00796-12; Therneau TM, 1999, LIFETIME DATA ANAL, V5, P99, DOI 10.1023/A:1009691327335	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e108631	10.1371/journal.pone.0108631	http://dx.doi.org/10.1371/journal.pone.0108631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369172	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000005
J	Jingi, AM; Noubiap, JJN; Onana, AE; Nansseu, JRN; Wang, BH; Kingue, S; Kengne, AP				Jingi, Ahmadou M.; Noubiap, Jean Jacques N.; Onana, Arnold Ewane; Nansseu, Jobert Richie N.; Wang, Binhuan; Kingue, Samuel; Kengne, Andre Pascal			Access to Diagnostic Tests and Essential Medicines for Cardiovascular Diseases and Diabetes Care: Cost, Availability and Affordability in the West Region of Cameroon	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; HEALTH-INSURANCE; ENSURING ACCESS; LOW-INCOME; BURDEN	Objective: To assess the availability and affordability of medicines and routine tests for cardiovascular disease (CVD) and diabetes in the West region of Cameroon, a low-income setting. Methods: A survey was conducted on the availability and cost of twelve routine tests and twenty medicines for CVD and diabetes in eight health districts (four urban and four rural) covering over 60% of the population of the region (1.8 million). We analyzed the percentage of tests and medicines available, the median price against the international reference price (median price ratio) for the medicines, and affordability in terms of the number of days' wages it would cost the lowest-paid unskilled government worker for initial investigation tests and procurement for one month of treatment. Results: The availability of tests varied between 10% for the ECG to 100% for the fasting blood sugar. The average cost for the initial investigation using the minimum tests cost 29.76 days' wages. The availability of medicines varied from 36.4% to 59.1% in urban and from 9.1% to 50% in rural settings. Only metformin and benzathine-benzylpenicilline had a median price ratio of <= 1.5, with statins being largely unaffordable (at least 30.51 days' wages). One month of combination treatment for coronary heart disease costs at least 40.87 days' wages. Conclusion: The investigation and management of patients with medium-to-high cardiovascular risk remains largely unavailable and unaffordable in this setting. An effective non-communicable disease program should lay emphasis on primary prevention, and improve affordable access to essential medicines in public outlets.	[Jingi, Ahmadou M.; Kingue, Samuel] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon; [Noubiap, Jean Jacques N.] Edea Reg Hosp, Internal Med Unit, Edea, Cameroon; [Onana, Arnold Ewane] Yaounde Cent Hosp, Natl Obes Ctr, Yaounde, Cameroon; [Nansseu, Jobert Richie N.] Chantal Biya Fdn, Mother & Child Ctr, Sickle Cell Unit, Yaounde, Cameroon; [Wang, Binhuan] New York Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA; [Kengne, Andre Pascal] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Yaounde I; South African Medical Research Council; University of Cape Town	Noubiap, JJN (corresponding author), Edea Reg Hosp, Internal Med Unit, Edea, Cameroon.	noubiapjj@yahoo.fr	Kengne, Andre Pascal/ABB-3696-2020	Wang, Binhuan/0000-0002-3435-3424; Kengne, Andre Pascal/0000-0002-5183-131X; Noubiap, Jean Jacques/0000-0002-7722-9757				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Conseil National pour lEnseignement de la Sante et de la Securite au Travail, 2006, PROJ SYN; Echouffo-Tcheugui JB, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-44; Frye J., 2012, INT DRUG PRIC IND GU; Gelders S., 2006, PRICE AVAILABILITY A; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Jiang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070836; Joncheere K, 2002, INT J RISK SAFETY ME, P101; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Kanavos P., 2008, ECON POLICY, V23, P499, DOI DOI 10.1111/%28ISSN%291468-0327/ISSUES; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Kishore SP, 2011, J AM COLL CARDIOL, V57, P1980, DOI 10.1016/j.jacc.2010.12.029; Kotwani A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-285; Mendis S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/584041; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Njamnshi AK, 2006, DIABETES VOICE, V55, P18; Noubiap JJN, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.17.2279; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Quick JD, 2003, CLIN PHARMACOL THER, V73, P279, DOI 10.1016/S0009-9236(03)00002-X; Twagirumukiza M, 2009, AM J TROP MED HYG, V81, P776, DOI 10.4269/ajtmh.2009.09-0109; Vialle-Valentin Catherine E, 2008, Health Res Policy Syst, V6, P11, DOI 10.1186/1478-4505-6-11; WHO, 2010, WOR HEALT REP, P1; WHO, 2010, GLOB STAT REP NONC D; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; World Health Organization, 2007, AFRO ESS MED PRIC IN; World Health Organization, 2004, WHO POL PERSP MED; World Health Organization, 2011, GLOB HLTH OBS DAT RE; World Health Organization, 2007, PREV CARD DIS POCK G; World Health Organization (WHO), 2013, PREV REC HEART ATT S	33	46	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111812	10.1371/journal.pone.0111812	http://dx.doi.org/10.1371/journal.pone.0111812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369455	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000105
J	Santarlasci, A; Martelloni, G; Frizzi, F; Santini, G; Bagnoli, F				Santarlasci, Alisa; Martelloni, Gianluca; Frizzi, Filippo; Santini, Giacomo; Bagnoli, Franco			Modeling Warfare in Social Animals: A "Chemical" Approach	PLOS ONE			English	Article							LANCHESTER MODELS	We present here a general method for modelling the dynamics of battles among social animals. The proposed method exploits the procedures widely used to model chemical reactions, but still uncommon in behavioural studies. We applied this methodology to the interpretation of experimental observations of battles between two species of ants (Lasius neglectus and Lasius paralienus), but this scheme may have a wider applicability and can be extended to other species as well. We performed two types of experiment labelled as interaction and mortality. The interaction experiments are designed to obtain information on the combat dynamics and lasted one hour. The mortality ones provide information on the casualty rates of the two species and lasted five hours. We modelled the interactions among ants using a chemical model which considers the single ant individuals and fighting groups analogously to atoms and molecules. The mean-field behaviour of the model is described by a set of non-linear differential equations. We also performed stochastic simulations of the corresponding agent-based model by means of the Gillespie event-driven integration scheme. By fitting the stochastic trajectories with the deterministic model, we obtained the probability distribution of the reaction parameters. The main result that we obtained is a dominance phase diagram, that gives the average trajectory of a generic battle, for an arbitrary number of opponents. This phase diagram was validated with some extra experiments. With respect to other war models (e. g., Lanchester's ones), our chemical model considers all phases of the battle and not only casualties. This allows a more detailed description of the battle (with a larger number of parameters), allowing the development of more sophisticated models (e. g., spatial ones), with the goal of distinguishing collective effects from the strategic ones.	[Santarlasci, Alisa] Univ Florence, Dept Informat Engn, Florence, Italy; [Martelloni, Gianluca; Bagnoli, Franco] Univ Florence, Dept Phys & Astron, Sesto Fiorentino, FI, Italy; [Santarlasci, Alisa; Martelloni, Gianluca; Bagnoli, Franco] Univ Florence, CSDC, Sesto Fiorentino, FI, Italy; [Frizzi, Filippo; Santini, Giacomo] Univ Florence, Dept Biol, Sesto Fiorentino, FI, Italy; [Bagnoli, Franco] Natl Inst Nucl Phys, Sez Firenze, Florence, Italy	University of Florence; University of Florence; University of Florence; University of Florence; Istituto Nazionale di Fisica Nucleare (INFN)	Bagnoli, F (corresponding author), Univ Florence, Dept Phys & Astron, Sesto Fiorentino, FI, Italy.	franco.bagnoli@unifi.it	Bagnoli, Franco/K-6904-2015; Frizzi, Filippo/GYE-2065-2022; Santini, Giacomo/H-7366-2013	Bagnoli, Franco/0000-0002-6293-0305; Frizzi, Filippo/0000-0002-1419-0445; 				Adams ES, 2003, BEHAV ECOL, V14, P719, DOI 10.1093/beheco/arg061; Batchelor TP, 2012, ANIM BEHAV, V83, P111, DOI 10.1016/j.anbehav.2011.10.014; Batchelor TP, 2010, ANIM BEHAV, V80, P443, DOI 10.1016/j.anbehav.2010.05.030; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Black AJ, 2012, TRENDS ECOL EVOL, V27, P337, DOI 10.1016/j.tree.2012.01.014; BRACKEN J, 1995, NAV RES LOG, V42, P559, DOI 10.1002/1520-6750(199506)42:4<559::AID-NAV3220420405>3.0.CO;2-R; Cheney D.L., 1987, P267; Connors K., 1991, CHEM KINETICS STUDY; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Johnson IR, 2011, NAV RES LOG, V58, P210, DOI 10.1002/nav.20328; Jr RDF, 1998, NAV RES LOG, V45, P1; Kress M, 2012, SCIENCE, V336, P865, DOI 10.1126/science.1217724; Lanchester FW, 1916, AIRCRAFT WARFARE; Lanchester FW., 1956, WORLD MATH, V4, P2138; MARSILILIBELLI S, 1992, ECOL MODEL, V62, P233, DOI 10.1016/0304-3800(92)90001-U; McGlynn TP, 2000, BEHAV ECOL, V11, P686, DOI 10.1093/beheco/11.6.686; Nelder JA, 1965, COMPUT J, V62, P233; Plowes NJR, 2005, P ROY SOC B-BIOL SCI, V272, P1809, DOI 10.1098/rspb.2005.3162; Seifert Bernhard, 1992, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V66, P1; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; Whitehouse MEA, 1996, ANIM BEHAV, V51, P1207, DOI 10.1006/anbe.1996.0126; Wilson ML, 2001, P ROY SOC LOND B BIO, V269, P1107; Zabel Cynthia J., 1992, P113	24	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111310	10.1371/journal.pone.0111310	http://dx.doi.org/10.1371/journal.pone.0111310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369269	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000047
J	Tang, SS; Zhang, R; Jiang, F; Wang, J; Chen, M; Peng, DF; Yan, J; Bao, YQ; Hu, C; Jia, WP				Tang, Shanshan; Zhang, Rong; Jiang, Feng; Wang, Jie; Chen, Miao; Peng, Danfeng; Yan, Jing; Bao, Yuqian; Hu, Cheng; Jia, Weiping			An Interaction between a FNDC5 Variant and Obesity Modulates Glucose Metabolism in a Chinese Han Population	PLOS ONE			English	Article							DIABETES-MELLITUS; SKELETAL-MUSCLE; IRISIN; EXERCISE; FAT; HOMEOSTASIS; PLASMA; SERUM; GENE; MEN	Background: To investigate the impact of common variants of FNDC5 on type 2 diabetes and clinical traits related to glucose metabolism in a large Chinese population sample. Methods: Three tagging single nucleotide polymorphisms within the region of the FNDC5 gene were selected and genotyped in 6822 participants. Detailed clinical investigations and biochemistry measurements were carried out in all of the participants. Subjects without diabetes were classified into normal weight and overweight/obese subgroups according to body mass index (BMI). Results: None of the SNPs were associated with either the risk of type 2 diabetes in all of the participants or with any of the clinical quantitative traits in the controls with normal glucose regulation. Subgroup analysis showed that in controls with normal weight (BMI <25 kg/m(2)), the rs16835198 major allele G was significantly associated with fasting insulin levels, and that each additional copy of the allele resulted in a 0.0178 mU/L increment of the values (p = 0.046). Moreover, after adjusting for confounding variables, there were trends towards correlation of rs16835198 with HOMA-insulin resistance (HOMA-IR) (p = 0.057) and low-density lipoprotein cholesterol (LDL-C) levels (p = 0.083). In overweight/obese subjects (BMI >= 25 Kg/m(2)), we noted rs16835198 showed trends towards association with fasting insulin (p = 0.057) and HOMA-IR levels (p = 0.091), both of which declined with additional copies of the major allele G. Moreover, rs16835198 was significantly associated with high-density lipoprotein cholesterol (HDL-C) levels (p = 0.013), and HOMA-beta cell function (p = 0.028) in the overweight/obese subjects. Finally, we observed a significant interaction between BMI-rs16835198 and fasting insulin levels in the control group (p = 0.003). Conclusions: Our data indicate that the effect of the common FNDC5 SNP rs16835198 on fasting insulin was significantly modified by BMI in the Chinese Han population.	[Tang, Shanshan; Zhang, Rong; Jiang, Feng; Wang, Jie; Chen, Miao; Peng, Danfeng; Yan, Jing; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab,Shan, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Dept Endocrinol & Metab,Shan, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008; Jia, Weiping/B-7483-2012; 严, 婧/HHN-4334-2022	Hu, Cheng/0000-0003-4314-2386; 	Shanghai Municipality [11JC1409600]; National 863 program [2012AA02A509]; National Science Foundation of China [81322010, 81170735, 81200582, 81300691]; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2011ZX09307-001-02]; Key Discipline of Public Health of Shanghai [12GWZX0104]; Shanghai Jiao Tong University School of Medicine [BXJ201340]; Shanghai Talent Development Grant [2012041]; National Young Top Talent Supporting Program; Excellent Young Medical Expert of Shanghai [XYQ2011041]	Shanghai Municipality; National 863 program(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for "Significant New Drugs Development''; Key Discipline of Public Health of Shanghai; Shanghai Jiao Tong University School of Medicine; Shanghai Talent Development Grant; National Young Top Talent Supporting Program; Excellent Young Medical Expert of Shanghai	This work was funded by grants from the Key Program of the Shanghai Municipality for Basic Research (11JC1409600), National 863 program (2012AA02A509), National Science Foundation of China (81322010, 81170735, 81200582 and 81300691), National Major Scientific and Technological Special Project for "Significant New Drugs Development'' (2011ZX09307-001-02) and Key Discipline of Public Health of Shanghai (12GWZX0104), the Innovation Fund for PhD Students (BXJ201340) from the Shanghai Jiao Tong University School of Medicine, Excellent Young Medical Expert of Shanghai (XYQ2011041), Shanghai Talent Development Grant (2012041), and National Young Top Talent Supporting Program. The authors appreciate all the participants of this research study. The authors gratefully acknowledge the skillful technical support of all nursing and medical staff at the Shanghai Clinical Center for Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Hu CX, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013318, 10.1371/journal.pone.0015542]; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Jiang S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-22; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Polyzos SA, 2014, METABOLISM, V63, P207, DOI 10.1016/j.metabol.2013.09.013; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roque FR, 2013, CURR HYPERTENS REP, V15, P204, DOI 10.1007/s11906-013-0336-5; Staiger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061903; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Tanisawa K, 2014, METABOLISM, V63, P574, DOI 10.1016/j.metabol.2014.01.005; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109957	10.1371/journal.pone.0109957	http://dx.doi.org/10.1371/journal.pone.0109957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369206	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402000014
J	Xia, Y; Zhang, YL; Yu, C; Chang, T; Fan, HY				Xia, Yan; Zhang, Yin-Li; Yu, Chao; Chang, Ting; Fan, Heng-Yu			YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells	PLOS ONE			English	Article							HIPPO PATHWAY; STEM-CELLS; SELF-RENEWAL; MYELOID-LEUKEMIA; PROLIFERATION; DIFFERENTIATION; CATENIN; GROWTH; GENE; AMPHIREGULIN	Recent evidence suggests that some solid tumors, including ovarian cancer, contain distinct populations of stem cells that are responsible for tumor initiation, growth, chemo-resistance, and recurrence. The Hippo pathway has attracted considerable attention and some investigators have focused on YAP functions for maintaining stemness and cell differentiation. In this study, we successfully isolated the ovarian cancer initiating cells (OCICs) and demonstrated YAP promoted self-renewal of ovarian cancer initiated cell (OCIC) through its downstream co-activator TEAD. YAP and TEAD families were required for maintaining the expression of specific genes that may be involved in OCICs' stemness and chemoresistance. Taken together, our data first indicate that YAP/TEAD co-activator regulated ovarian cancer initiated cell pluripotency and chemo-resistance. It proposed a new mechanism on the drug resistance in cancer stem cell that Hippo-YAP signal pathway might serve as therapeutic targets for ovarian cancer treatment in clinical.	[Xia, Yan] Shaanxi Maternal & Child Care Serv Hosp, Assisted Reprod Ctr, Xian, Peoples R China; [Xia, Yan; Zhang, Yin-Li; Yu, Chao; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Yan; Zhang, Yin-Li; Yu, Chao; Fan, Heng-Yu] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chang, Ting] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Peoples R China	Zhejiang University; Zhejiang University; Air Force Military Medical University	Fan, HY (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	hyfan@zju.edu.cn			National Natural Science Foundation of China [81172473, 31371449]; National Basic Research Program of China [2011CB944504, 2012CB944403]; Zhejiang University [2011QN81001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Zhejiang University	This study was supported by the National Natural Science Foundation of China (81172473, 31371449), the National Basic Research Program of China (2011CB944504, 2012CB944403), and Basic Scientific Research Funding of Zhejiang University (2011QN81001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airiau K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.309; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Beverdam A, 2013, J INVEST DERMATOL, V133, P1497, DOI 10.1038/jid.2012.430; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chefetz I, 2013, CELL CYCLE, V12, P511, DOI 10.4161/cc.23406; Chen JS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-7; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Demircan T, 2013, STEM CELLS DEV, V22, P2174, DOI 10.1089/scd.2013.0006; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Flores ER, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002311; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Judson RN, 2012, J CELL SCI, V125, P6009, DOI 10.1242/jcs.109546; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kulkarni-Datar K, 2013, CANCER LETT, V339, P237, DOI 10.1016/j.canlet.2013.06.014; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lu D, 2012, CANCER RES, V72, P3451, DOI 10.1158/0008-5472.CAN-11-2536; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Nejigane S, 2013, INT J DEV BIOL, V57, P407, DOI 10.1387/ijdb.130010st; Pan WW, 2013, GENE, V526, P287, DOI 10.1016/j.gene.2013.03.103; Pan WW, 2013, J BIOL CHEM, V288, P13620, DOI 10.1074/jbc.M112.446369; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Ricci F, 2012, CELL CYCLE, V11, P1966, DOI 10.4161/cc.20308; Schwede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057799; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	44	54	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e109575	10.1371/journal.pone.0109575	http://dx.doi.org/10.1371/journal.pone.0109575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369529	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402000009
J	Zabala, G; Vodkin, LO				Zabala, Gracia; Vodkin, Lila O.			Methylation Affects Transposition and Splicing of a Large CACTA Transposon from a MYB Transcription Factor Regulating Anthocyanin Synthase Genes in Soybean Seed Coats	PLOS ONE			English	Article							MOLECULAR ANALYSIS; FUNCTIONAL-CHARACTERIZATION; DOMAIN PROTEIN; MESSENGER-RNA; ZEA-MAYS; FAMILY; IDENTIFICATION; EXPRESSION; ELEMENTS; BIOSYNTHESIS	We determined the molecular basis of three soybean lines that vary in seed coat color at the R locus which is thought to encode a MYB transcription factor. RM55-r(m) is homozygous for a mutable allele (r(m)) that specifies black and brown striped seeds; RM30-R* is a stable black revertant isoline derived from the mutable line; and RM38-r has brown seed coats due to a recessive r allele shown to translate a truncated MYB protein. Using long range PCR, 454 sequencing of amplicons, and whole genome re-sequencing, we determined that the variegated RM55-r(m) line had a 13 kb CACTA subfamily transposon insertion (designated TgmR*) at a position 110 bp from the beginning of Intron2 of the R locus, Glyma09g36983. Although the MYB encoded by R was expressed at only very low levels in older seed coats of the black revertant RM30-R* line, it upregulated expression of anthocyanidin synthase genes (ANS2, ANS3) to promote the synthesis of anthocyanins. Surprisingly, the RM30-R* revertant also carried the 13 kb TgmR* insertion in Intron2. Using RNA-Seq, we showed that intron splicing was accurate, albeit at lower levels, despite the presence of the 13 kb TgmR* element. As determined by whole genome methylation sequencing, we demonstrate that the TgmR* sequence was relatively more methylated in RM30-R* than in the mutable RM55-r(m) progenitor line. The stabilized and more methylated RM30-R* revertant line apparently lacks effective binding of a transposae to its subterminal repeats, thus allowing intron splicing to proceed resulting in sufficient MYB protein to stimulate anthocyanin production and thus black seed coats. In this regard, the TgmR* element in soybean resembles McClintock's Spm-suppressible and change-of-state alleles of maize. This comparison explains the opposite effects of the TgmR* element on intron splicing of the MYB gene in which it resides depending on the methylation state of the element.	[Zabala, Gracia; Vodkin, Lila O.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, LO (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			United Soybean Board; Illinois Soybean Association; USDA	United Soybean Board; Illinois Soybean Association; USDA(United States Department of Agriculture (USDA))	The research was funded by grants from the United Soybean Board, the Illinois Soybean Association and the USDA. The funders had no role in the design of the study, the data collection and analysis, the decision to publish nor the manuscript preparation.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; AKADA S, 1993, PLANT PHYSIOL, V102, P321, DOI 10.1104/pp.102.1.321; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BANKS JA, 1988, GENE DEV, V2, P1364, DOI 10.1101/gad.2.11.1364; CHANDLEE JM, 1989, THEOR APPL GENET, V77, P587, DOI 10.1007/BF00274285; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dellaporta SL, 1993, MAIZE HDB, P522; FEDOROFF NV, 1989, CELL, V56, P181, DOI 10.1016/0092-8674(89)90891-X; FRANKEN P, 1994, PLANT J, V6, P21, DOI 10.1046/j.1365-313X.1994.6010021.x; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; GOFF SA, 1991, GENE DEV, V5, P298, DOI 10.1101/gad.5.2.298; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; JOFUKU KD, 1989, PLANT CELL, V1, P427, DOI 10.1105/tpc.1.4.427; Kovinich N, 2012, J AGR FOOD CHEM, V60, P574, DOI 10.1021/jf2033939; Kovinich N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-381; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; McCarty DR, 1986, MAIZE GEN COOP NEWSL, V60, P61; MENSSEN A, 1990, EMBO J, V9, P3051, DOI 10.1002/j.1460-2075.1990.tb07501.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; PAZARES J, 1990, EMBO J, V9, P315, DOI 10.1002/j.1460-2075.1990.tb08113.x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; RHODES PR, 1985, P NATL ACAD SCI USA, V82, P493, DOI 10.1073/pnas.82.2.493; RHODES PR, 1988, GENETICS, V120, P597; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; VODKIN LO, 1983, CELL, V34, P1023, DOI 10.1016/0092-8674(83)90560-3; Wang C. S., 1994, Plant Molecular Biology Reporter, V12, P132, DOI 10.1007/BF02668374; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Wang CS, 1993, THESIS U ILLINOIS; WESSLER SR, 1988, SCIENCE, V242, P399, DOI 10.1126/science.2845581; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zabala G, 2003, GENETICS, V163, P295; Zabala G, 2007, CROP SCI, V47, pS113, DOI 10.2135/cropsci2006.12.0838tpg; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	49	30	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111959	10.1371/journal.pone.0111959	http://dx.doi.org/10.1371/journal.pone.0111959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369033	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000131
J	Cao, LM; Han, G; Gu, B; Yin, HF				Cao, Limin; Han, Gang; Gu, Ben; Yin, HaiFang			Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							MORPHOLINO OLIGOMER TREATMENT; MDX MICE; MUSCLE PATHOLOGY; GENE-THERAPY; RESTORATION; EXPRESSION; RNA; INSIGHTS; PROVIDE; RESCUE	A readily available animal model is essential for rapidly identifying effective treatments for Duchenne muscular dystrophy (DMD), a devastating neuromuscular disorder caused by the lack of dystrophin protein, which results from frame-disrupting mutations in the DMD gene. Currently, the mdx mouse is the most commonly used model for antisense oligonucleotide (AO)-mediated exon skipping pre-clinical studies, with a mild phenotype. However, the accessibility of mdx mouse colonies particularly in developing countries can constrain research. Therefore in this study we explore the feasibility of using wildtype mice as models to establish exon-skipping efficiency of various DMD AO chemistries and their conjugates. Four different strains of wild-type mice and six different AO chemistries were investigated intramuscularly and the results indicated that the same exon-skipping efficiency was achieved for all tested AOs as that from mdx mice. Notably, levels of exon-skipping obtained in C57BL6 and C3H and mdx mice were most closely matched, followed by ICR and BALB/C mice. Systemic validation revealed that wild-type mice are less responsive to AO-mediated exon skipping than mdx mice. Our study provides evidence for the first time that wild-type mice can be appropriate models for assessing DMD AO exon-skipping efficiency with similar sensitivity to that of mdx mice and this finding can further accelerate the development of effective DMD AOs.	[Yin, HaiFang] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; Tianjin Med Univ, Dept Cell Biol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yin, HF (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China.	haifangyin@tmu.edu.cn			National Natural Science Foundation of China [81361128013, 81273420, 81101340]; Research Fund for the Doctoral Program of Higher Education of China [20111202110002]; Program for New Century Excellent Talents [NCET-10-0957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (Grant No. 81361128013, 81273420, and 81101340), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20111202110002) and Program for New Century Excellent Talents (NCET-10-0957). The funding sources had no involvement in study design, the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Ahmad A, 2000, HUM MOL GENET, V9, P2507, DOI 10.1093/hmg/9.17.2507; Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Angelini Corrado, 2012, Acta Myol, V31, P9; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Araki E, 1997, BIOCHEM BIOPH RES CO, V238, P492, DOI 10.1006/bbrc.1997.7328; Bhattacharya S, 2004, BIOTECHNOL BIOENG, V86, P37, DOI 10.1002/bit.20042; Bremmer-Bout M, 2004, MOL THER, V10, P232, DOI 10.1016/j.ymthe.2004.05.031; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Extance A, 2009, NAT REV DRUG DISCOV, V8, P917, DOI 10.1038/nrd3069; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Goyenvalle A, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-8; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Heemskerk H, 2010, MOL THER, V18, P1210, DOI 10.1038/mt.2010.72; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Islamian Jalil Pirayesh, 2014, Cancer Biology Medicine, V11, P78, DOI 10.7497/j.issn.2095-3941.2014.02.002; Kang JK, 2011, MOL THER, V19, P159, DOI 10.1038/mt.2010.212; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Moulton HM, 2010, BBA-BIOMEMBRANES, V1798, P2296, DOI 10.1016/j.bbamem.2010.02.012; Rafael JA, 2000, HUM MOL GENET, V9, P1357, DOI 10.1093/hmg/9.9.1357; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Tidball JG, 2004, PEDIATR RES, V56, P831, DOI 10.1203/01.PDR.0000145578.01985.D0; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang QS, 2010, J GENE MED, V12, P354, DOI 10.1002/jgm.1446; Wu B, 2012, AM J PATHOL, V181, P392, DOI 10.1016/j.ajpath.2012.04.006; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061584; Yin HF, 2008, MOL THER, V16, P38, DOI 10.1038/sj.mt.6300329; Yin HF, 2011, MOL THER, V19, P1295, DOI 10.1038/mt.2011.79; Yin HF, 2010, MOL THER, V18, P819, DOI 10.1038/mt.2009.310; Yin HF, 2009, HUM MOL GENET, V18, P4405, DOI 10.1093/hmg/ddp395; Zheng Hong, 2013, Cancer Biology Medicine, V10, P123, DOI 10.7497/j.issn.2095-3941.2013.03.001	42	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111079	10.1371/journal.pone.0111079	http://dx.doi.org/10.1371/journal.pone.0111079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365558	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100049
J	Cappelletti, C; Galbardi, B; Kapetis, D; Vattemi, G; Guglielmi, V; Tonin, P; Salerno, F; Morandi, L; Tomelleri, G; Mantegazza, R; Bernasconi, P				Cappelletti, Cristina; Galbardi, Barbara; Kapetis, Dimos; Vattemi, Gaetano; Guglielmi, Valeria; Tonin, Paola; Salerno, Franco; Morandi, Lucia; Tomelleri, Giuliano; Mantegazza, Renato; Bernasconi, Pia			Autophagy, Inflammation and Innate Immunity in Inflammatory Myopathies	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IN-VITRO; MUSCLE; EXPRESSION; CELLS; POLYMYOSITIS; ANTIGEN; HMGB1; HEAT-SHOCK-PROTEIN-60; TOLL-LIKE-RECEPTOR-4	Autophagy has a large range of physiological functions and its dysregulation contributes to several human disorders, including autoinflammatory/autoimmune diseases such as inflammatory myopathies (IIMs). In order to better understand the pathogenetic mechanisms of these muscular disorders, we sought to define the role of autophagic processes and their relation with the innate immune system in the three main subtypes of IIM, specifically sporadic inclusion body myositis (sIBM), polymyositis (PM), dermatomyositis (DM) and juvenile dermatomyositis (JDM). We found that although the mRNA transcript levels of the autophagy-related genes BECN1, ATG5 and FBXO32 were similar in IIM and controls, autophagy activation in all IIM subgroups was suggested by immunoblotting results and confirmed by immunofluorescence. TLR4 and TLR3, two potent inducers of autophagy, were highly increased in IIM, with TLR4 transcripts significantly more expressed in PM and DM than in JDM, sIBM and controls, and TLR3 transcripts highly up-regulated in all IIM subgroups compared to controls. Co-localization between autophagic marker, LC3, and TLR4 and TLR3 was observed not only in sIBM but also in PM, DM and JDM muscle tissues. Furthermore, a highly association with the autophagic processes was observed in all IIM subgroups also for some TLR4 ligands, endogenous and bacterial HSP60, other than the high-mobility group box 1 (HMGB1). These findings indicate that autophagic processes are active not only in sIBM but also in PM, DM and JDM, probably in response to an exogenous or endogenous 'danger signal'. However, autophagic activation and regulation, and also interaction with the innate immune system, differ in each type of IIM. Better understanding of these differences may lead to new therapies for the different IIM types.	[Cappelletti, Cristina; Galbardi, Barbara; Kapetis, Dimos; Salerno, Franco; Morandi, Lucia; Mantegazza, Renato; Bernasconi, Pia] Fdn Ist Neurol Carlo Besta, Neurol Neuroimmunol & Neuromuscular Dis Unit 4, Milan, Italy; [Vattemi, Gaetano; Guglielmi, Valeria; Tonin, Paola; Tomelleri, Giuliano] Univ Verona, Dept Neurol & Movement Sci, Sect Clin Neurol, I-37100 Verona, Italy	IRCCS Istituto Neurologico Besta; University of Verona	Bernasconi, P (corresponding author), Fdn Ist Neurol Carlo Besta, Neurol Neuroimmunol & Neuromuscular Dis Unit 4, Milan, Italy.	pbernasconi@istituto-besta.it	Bernasconi, Pia/AAB-7590-2019; Salerno, Franco/J-9198-2016; Vattemi, Gaetano/AAC-4668-2022; Tonin, Paola/AAC-5052-2022; Galbardi, Barbara/ABH-4699-2020; Mantegazza, Renato/AAB-7569-2019; Cappelletti, Cristina/AAH-5493-2021	Salerno, Franco/0000-0003-0811-4443; Mantegazza, Renato/0000-0002-9810-5737; Cappelletti, Cristina/0000-0002-4855-3136; GUGLIELMI, Valeria/0000-0003-0968-0498; Bernasconi, Pia/0000-0003-0869-2104; Vattemi, Gaetano/0000-0003-3412-8339	Italian Ministry of Health; Associazione Italiana Miastenia e Malattie Immunodegenerative-Amici del Besta Onlus	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana Miastenia e Malattie Immunodegenerative-Amici del Besta Onlus	This work was supported by the Italian Ministry of Health 2012-2013 (Annual Research Funding to PB and RM), and the Associazione Italiana Miastenia e Malattie Immunodegenerative-Amici del Besta Onlus (AIM) to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009; Askanas Valerie, 2011, Presse Med, V40, pe219, DOI 10.1016/j.lpm.2010.11.024; BENNETT MR, 1990, POSTGRAD MED J, V66, P47, DOI 10.1136/pgmj.66.771.47; Bernasconi P, 2005, AM J PATHOL, V167, P129, DOI 10.1016/S0002-9440(10)62960-4; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Brunn A, 2012, J NEUROPATH EXP NEUR, V71, P855, DOI 10.1097/NEN.0b013e31826bf7f3; Cappelletti C, 2011, NEUROLOGY, V76, P2079, DOI 10.1212/WNL.0b013e31821f440a; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Elst EF, 2008, ARTHRITIS RHEUM-US, V58, P547, DOI 10.1002/art.23202; Girolamo F, 2013, NEUROPATH APPL NEURO, V39, P736, DOI 10.1111/nan.12040; Grundtman C, 2010, FASEB J, V24, P570, DOI 10.1096/fj.09-144782; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kang R, 2011, AUTOPHAGY, V7, P904, DOI 10.4161/auto.7.8.15704; Keller CW, 2011, J BIOL CHEM, V286, P3970, DOI 10.1074/jbc.M110.159392; Kim GT, 2010, CLIN RHEUMATOL, V29, P273, DOI 10.1007/s10067-009-1316-7; Kim H, 2009, BIOCHEM BIOPH RES CO, V388, P339, DOI 10.1016/j.bbrc.2009.08.007; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Perez C, 1999, SCAND J RHEUMATOL, V28, P125; Sachdev U, 2012, J VASC SURG, V55, P180, DOI 10.1016/j.jvs.2011.07.072; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scarlatti F, 2008, AUTOPHAGY, V4, P1083, DOI 10.4161/auto.7068; Seay MD, 2007, CELL HOST MICROBE, V2, P69, DOI 10.1016/j.chom.2007.07.008; Strawbridge AB, 2007, CURR OPIN IMMUNOL, V19, P87, DOI 10.1016/j.coi.2006.11.009; Tian J, 2013, CARDIOVASC RES, V98, P391, DOI 10.1093/cvr/cvt047; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Wang HJ, 2013, AM J PHYSIOL-CELL PH, V304, pC617, DOI 10.1152/ajpcell.00296.2012; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zampieri S, 2006, AUTOIMMUNITY, V39, P191, DOI 10.1080/08916930600622348; Zong M, 2013, ANN RHEUM DIS, V72, P1390, DOI 10.1136/annrheumdis-2012-202207; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	49	34	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111490	10.1371/journal.pone.0111490	http://dx.doi.org/10.1371/journal.pone.0111490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365350	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100070
J	Deng, W; Xu, HG; Ding, W; Liang, HJ				Deng, Wei; Xu, Huaguo; Ding, Wei; Liang, Haojun			DNA Logic Gate Based on Metallo-Toehold Strand Displacement	PLOS ONE			English	Article							MULTIPLEXED ANALYSIS; IONS; DRIVEN; HG2+; AG+; COMPUTATION; MERCURY(II); DESIGN; SENSOR; PROBE	DNA is increasingly being used as an ideal material for the construction of nanoscale structures, circuits, and machines. Toehold-mediated DNA strand displacement reactions play a very important role in these enzyme-free constructions. In this study, the concept of metallo-toehold was utilized to further develop a mechanism for strand displacement driven by Ag+ ions, in which the intercalation of cytosine-cytosine mismatched base pairs on the toeholds provides additional control by varying of the concentration of Ag+ ions. The characteristics of displacement reaction in response to different concentration of Ag+ ions are investigated by fluorescence spectral and non-denaturing polyacrylamide gel electrophoresis. The reaction can successfully occur when the concentration of Ag+ ions is suitabe; excess Ag+ ions block the reaction. Furthermore, the displacement reaction can be tuned and controlled most efficiently under the condition of two C: C mismatched base pairs placed on the six-nt toehold. Based on our research, a mechanism was developed to construct Boolean logic gate AND and OR by employing strand displacement reaction as a tool, Ag+ and Hg2+ as input.	[Deng, Wei; Xu, Huaguo; Ding, Wei; Liang, Haojun] Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Liang, Haojun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liang, HJ (corresponding author), Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	hjliang@ustc.edu.cn	Liang, Haojun/F-5960-2010		National Natural Science Foundation of China [20934004, 91127046]; National Basic Research Program of China [2012CB821500, 2010CB934500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Funding provided by the National Natural Science Foundation of China (Grant Nos. 20934004 and 91127046) and the National Basic Research Program of China (Grant Nos. 2012CB821500 and 2010CB934500). The funding sources had no role in the design and conduct of the study or in the collection, management, analysis, and interpretation of the data.	Aich P, 1999, J MOL BIOL, V294, P477, DOI 10.1006/jmbi.1999.3234; Bath J, 2005, ANGEW CHEM INT EDIT, V44, P4358, DOI 10.1002/anie.200501262; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Clever GH, 2007, ANGEW CHEM INT EDIT, V46, P6226, DOI 10.1002/anie.200701185; Clever GH, 2010, COORDIN CHEM REV, V254, P2391, DOI 10.1016/j.ccr.2010.04.014; Ding W, 2013, CHEM COMMUN, V49, P9953, DOI 10.1039/c3cc45373a; Elbaz J, 2009, NANO LETT, V9, P4510, DOI 10.1021/nl902859m; Freeman R, 2009, ANGEW CHEM INT EDIT, V48, P7818, DOI 10.1002/anie.200902395; Genot AJ, 2011, J AM CHEM SOC, V133, P2177, DOI 10.1021/ja1073239; Graf N, 2006, ANGEW CHEM INT EDIT, V45, P4013, DOI 10.1002/anie.200504319; He XX, 2012, ANAL METHODS-UK, V4, P345, DOI 10.1039/c2ay05823e; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Kanayama N, 2013, CHEM-EUR J, V19, P10794, DOI 10.1002/chem.201301995; LEE JS, 1993, BIOCHEM CELL BIOL, V71, P162, DOI 10.1139/o93-026; Lin ZZ, 2011, ANAL CHEM, V83, P6896, DOI 10.1021/ac2014096; Lu N, 2009, ANALYST, V134, P1822, DOI 10.1039/b908018j; Nutiu R, 2005, ANGEW CHEM INT EDIT, V44, P5464, DOI 10.1002/anie.200501214; Ono A, 2004, ANGEW CHEM INT EDIT, V43, P4300, DOI 10.1002/anie.200454172; Ono A, 2008, CHEM COMMUN, P4825, DOI 10.1039/b808686a; Ono A, 2011, CHEM SOC REV, V40, P5855, DOI 10.1039/c1cs15149e; PANYUTIN IG, 1994, FASEB J, V8, pA1395; Park KS, 2010, ANGEW CHEM INT EDIT, V49, P9757, DOI 10.1002/anie.201004406; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Seeman NC, 2005, TRENDS BIOCHEM SCI, V30, P119, DOI 10.1016/j.tibs.2005.01.007; Song TJ, 2012, J AM CHEM SOC, V134, P10803, DOI 10.1021/ja304746k; Stojanovic MN, 2005, J AM CHEM SOC, V127, P6914, DOI 10.1021/ja043003a; Switzer C, 2005, ANGEW CHEM INT EDIT, V44, P1529, DOI 10.1002/anie.200462047; Tanaka K, 2003, SCIENCE, V299, P1212, DOI 10.1126/science.1080587; Tang W, 2013, J AM CHEM SOC, V135, P13628, DOI 10.1021/ja406053b; Tian Y, 2004, J AM CHEM SOC, V126, P11410, DOI 10.1021/ja046507h; Torigoe H, 2012, THERMOCHIM ACTA, V532, P28, DOI 10.1016/j.tca.2011.03.018; Urata H, 2011, CHEM COMMUN, V47, P941, DOI 10.1039/c0cc04091f; Wang Y, 2012, CHEM COMMUN, V48, P2873, DOI 10.1039/c2cc16279b; Wang ZG, 2011, NANO LETT, V11, P304, DOI 10.1021/nl104088s; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Xiao ZY, 2013, CHEM COMMUN, V49, P3573, DOI 10.1039/c3cc40333e; Xu XW, 2014, CHEM COMMUN, V50, P805, DOI 10.1039/c3cc47102k; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Zhang GY, 2012, ANALYST, V137, P2687, DOI 10.1039/c2an35180c	46	4	5	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111650	10.1371/journal.pone.0111650	http://dx.doi.org/10.1371/journal.pone.0111650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365381	Green Published, gold			2022-12-27	WOS:000345558100095
J	Heilskov-Hansen, T; Svendsen, SW; Thomsen, JF; Mikkelsen, S; Hansson, GA				Heilskov-Hansen, Thomas; Svendsen, Susanne Wulff; Thomsen, Jane Frolund; Mikkelsen, Sigurd; Hansson, Gert-Ake			Sex Differences in Task Distribution and Task Exposures among Danish House Painters: An Observational Study Combining Questionnaire Data with Biomechanical Measurements	PLOS ONE			English	Article							MUSCULOSKELETAL DISORDERS; PHYSICAL WORKLOAD; GENDER-DIFFERENCES; OCCUPATIONAL-HEALTH; CARPAL-TUNNEL; WRIST; POSTURE; EPIDEMIOLOGY; FOREARM; INCLINOMETRY	Objectives: Sex differences in occupational biomechanical exposures may be part of the explanation why musculoskeletal complaints and disorders tend to be more common among women than among men. We aimed to determine possible sex differences in task distribution and task-specific postures and movements of the upper extremities among Danish house painters, and to establish sex-specific task exposure matrices. Methods: To obtain task distributions, we sent out a questionnaire to all members of the Painters' Union in Denmark (N = 9364), of whom 53% responded. Respondents reported their task distributions in a typical week. To obtain task exposures, postures and movements were measured in 25 male and 25 female house painters for one whole working day per person. We used goniometers on the wrists, and inclinometers on the forehead and the upper arms. Participants filled in a logbook allowing task-specific exposures to be identified. Percentiles and % time with non-neutral postures were used to characterise postures. Velocity, range of motion, repetitiveness, and variation were used as measures of movement. Cochran-Mantel-Haenszel statistics and unpaired double-sided t-tests with post-hoc Bonferroni correction were used to evaluate sex differences. Results: Statistically significant (p < 0.05) sex differences were revealed in task proportions, but the proportions differed by less than 4%. For task exposures, no statistically significant sex differences were found. Conclusions: Only minor sex differences were found in task distribution and task exposures regarding postures and movements among Danish house painters. Sex-specific task exposure matrices were established.	[Heilskov-Hansen, Thomas; Thomsen, Jane Frolund; Mikkelsen, Sigurd] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Svendsen, Susanne Wulff] Univ Res Clin, Dept Occupat Med, Danish Ramazzini Ctr, Reg Hosp West Jutland, Herning, Denmark; [Hansson, Gert-Ake] Lund Univ, Lund, Sweden; [Hansson, Gert-Ake] Reg Labs Reg Scania, Lund, Sweden	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Lund University	Heilskov-Hansen, T (corresponding author), Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	Thomas.Heilskov-Hansen@regionh.dk			Danish Working Environment Research Fund [43-2010-03]	Danish Working Environment Research Fund	The study was funded by the Danish Working Environment Research Fund (grant no. 43-2010-03) (http://arbejdstilsynet.dk/da/om%20arbejdstilsynet/arbejdsmiljoforskningsfonden.aspx). JFT and SM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P39, DOI 10.1136/jech.2007.059774; Arvidsson I, 2006, ERGONOMICS, V49, P1052, DOI 10.1080/00140130600733816; Arvidsson I, 2006, INT J IND ERGONOM, V36, P613, DOI 10.1016/j.ergon.2006.03.002; Arvidsson I, 2012, APPL ERGON, V43, P1026, DOI 10.1016/j.apergo.2012.03.001; Balogh I, 2006, INT J IND ERGONOM, V36, P353, DOI 10.1016/j.ergon.2004.09.009; Balogh I, 2009, J ELECTROMYOGR KINES, V19, P1005, DOI 10.1016/j.jelekin.2008.07.003; Benke G, 2000, ANN OCCUP HYG, V44, P475, DOI 10.1093/annhyg/44.6.475; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Crisco JJ, 2011, J BONE JOINT SURG AM, V93A, P169, DOI 10.2106/JBJS.I.01222; d'Almeida KW, 2008, OCCUP MED-OXFORD, V58, P506, DOI 10.1093/occmed/kqn084; Dahlberg R, 2004, APPL ERGON, V35, P521, DOI 10.1016/j.apergo.2004.06.008; de Zwart BCH, 2001, INT ARCH OCC ENV HEA, V74, P21; Delisle A, 2006, ERGONOMICS, V49, P139, DOI 10.1080/10610270500450739; Eng A, 2011, OCCUP ENVIRON MED, V68, P888, DOI 10.1136/oem.2010.064097; Fethke NB, 2011, APPL ERGON, V42, P725, DOI 10.1016/j.apergo.2010.11.007; Garg R, 2014, J HAND SURG-AM, V39, P634, DOI 10.1016/j.jhsa.2013.12.031; Hansson GA, 2006, J ELECTROMYOGR KINES, V16, P125, DOI 10.1016/j.jelekin.2005.06.009; Hansson GA, 2003, ERGONOMICS, V46, P407, DOI 10.1080/0014013021000034920; Hansson GA, 2001, MED BIOL ENG COMPUT, V39, P405, DOI 10.1007/BF02345361; Hansson GA, 1996, J ELECTROMYOGR KINES, V6, P23, DOI 10.1016/1050-6411(95)00017-8; Hansson GA, 2004, J ELECTROMYOGR KINES, V14, P355, DOI 10.1016/j.jelekin.2003.10.001; Hansson GA, 2010, INT J IND ERGONOM, V40, P267, DOI 10.1016/j.ergon.2009.11.002; Hansson GA, 2009, INT J IND ERGONOM, V39, P221, DOI 10.1016/j.ergon.2008.04.003; Harris-Adamson C, 2014, HUM FACTORS, V56, P143, DOI 10.1177/0018720813502807; Hooftman WE, 2005, J OCCUP ENVIRON MED, V47, P244, DOI 10.1097/01.jom.0000150387.14885.6b; Hooftman WE, 2004, SCAND J WORK ENV HEA, V30, P261, DOI 10.5271/sjweh.794; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; Keir PJ, 2007, HUM FACTORS, V49, P88, DOI 10.1518/001872007779598127; Kennedy SM, 2003, AM J IND MED, V44, P576, DOI 10.1002/ajim.10297; Klum M, 2012, J HAND SURG-AM, V37A, P2050, DOI 10.1016/j.jhsa.2012.06.031; Ladwig KH, 2000, EUR J EPIDEMIOL, V16, P511, DOI 10.1023/A:1007629920752; Leijon O, 2005, AM J IND MED, V47, P381, DOI 10.1002/ajim.20166; Li ZM, 2005, CLIN BIOMECH, V20, P177, DOI 10.1016/j.clinbiomech.2004.10.002; Locke SJ, 2014, OCCUPATIONAL ENV MED; Lundberg U, 2002, AM J IND MED, V41, P383, DOI 10.1002/ajim.10038; Mathiassen SE, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-36; McGorry RW, 2014, J ORTHOP RES, V32, P524, DOI 10.1002/jor.22571; MESSING K, 1994, J OCCUP ENVIRON MED, V36, P913; Messing K, 2003, AM J IND MED, V43, P618, DOI 10.1002/ajim.10225; Messing K, 2006, ENVIRON RES, V101, P149, DOI 10.1016/j.envres.2005.03.015; Meyland JK, 2014, EUR J APPL PHYSL; Myers CD, 2003, CLIN J PAIN, V19, P225, DOI 10.1097/00002508-200307000-00005; Niedhammer I, 2000, OCCUP ENVIRON MED, V57, P521, DOI 10.1136/oem.57.8.521; Nordander C, 2008, INT ARCH OCC ENV HEA, V81, P939, DOI 10.1007/s00420-007-0286-9; Nordander C, 2013, APPL ERGON, V44, P241, DOI 10.1016/j.apergo.2012.07.009; Nordander C, 2009, ERGONOMICS, V52, P1226, DOI 10.1080/00140130903056071; Nordlund A, 2000, EUROPEAN J PUBLIC HL, V10, P127; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Shiri R, 2007, J RHEUMATOL, V34, P1076; Svendsen SW, 2005, OCCUP ENVIRON MED, V62, P18, DOI 10.1136/oem.2004.015966; Svendsen SW, 2004, OCCUP ENVIRON MED, V61, P844, DOI 10.1136/oem.2003.010637; Thiehoff R, 2002, ORTHOPADE, V31, P949, DOI 10.1007/s00132-002-0350-9; Trask C, 2014, SCAND J WORK ENV HEA, V40, P252, DOI 10.5271/sjweh.3416; Unge J, 2005, ERGONOMICS, V48, P12, DOI 10.1080/00140130412331293364; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Werner R, 1997, CLIN BIOMECH, V12, P44, DOI 10.1016/S0268-0033(96)00044-7; Wijnhoven HAH, 2006, PAIN, V124, P158, DOI 10.1016/j.pain.2006.04.012; WINKEL J, 1994, ERGONOMICS, V37, P979, DOI 10.1080/00140139408963711	59	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110899	10.1371/journal.pone.0110899	http://dx.doi.org/10.1371/journal.pone.0110899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365301	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100031
J	Wang, WG; Tang, XY; Zhu, QL; Pan, K; Hu, QC; He, MX; Li, JT				Wang, Wenguo; Tang, Xiaoyu; Zhu, Qili; Pan, Ke; Hu, Qichun; He, Mingxiong; Li, Jiatang			Predicting the Impacts of Climate Change on the Potential Distribution of Major Native Non-Food Bioenergy Plants in China	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; MARGINAL LAND; ENERGY PLANTS; MAXENT; BIOFUELS; CROPS; PERFORMANCE; BIODIESEL; GRASSES; YIELD	Planting non-food bioenergy crops on marginal lands is an alternative bioenergy development solution in China. Native non-food bioenergy plants are also considered to be a wise choice to reduce the threat of invasive plants. In this study, the impacts of climate change (a consensus of IPCC scenarios A2a for 2080) on the potential distribution of nine non-food bioenergy plants native to China (viz., Pistacia chinensis, Cornus wilsoniana, Xanthoceras sorbifolia, Vernicia fordii, Sapium sebiferum, Miscanthus sinensis, M. floridulus, M. sacchariflorus and Arundo donax) were analyzed using a MaxEnt species distribution model. The suitable habitats of the nine non-food plants were distributed in the regions east of the Mongolian Plateau and the Tibetan Plateau, where the arable land is primarily used for food production. Thus, the large-scale cultivation of those plants for energy production will have to rely on the marginal lands. The variables of "precipitation of the warmest quarter" and "annual mean temperature" were the most important bioclimatic variables for most of the nine plants according to the MaxEnt modeling results. Global warming in coming decades may result in a decrease in the extent of suitable habitat in the tropics but will have little effect on the total distribution area of each plant. The results indicated that it will be possible to grow these plants on marginal lands within these areas in the future. This work should be beneficial for the domestication and cultivation of those bioenergy plants and should facilitate land-use planning for bioenergy crops in China.	[Wang, Wenguo; Tang, Xiaoyu; Zhu, Qili; Pan, Ke; Hu, Qichun; He, Mingxiong] Minist Agr, Key Lab Dev & Applicat Rural Renewable Energy, Biogas Inst, Chengdu 610064, Peoples R China; [Li, Jiatang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610064, Peoples R China	Chinese Academy of Agricultural Sciences; Biogas Institute of Ministry of Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Wang, WG (corresponding author), Minist Agr, Key Lab Dev & Applicat Rural Renewable Energy, Biogas Inst, Chengdu 610064, Peoples R China.	wangwenguo@caas.cn; lijt@cib.ac.cn	Li, Jia-Tang/AAC-7626-2020; he, mingxiong/D-6683-2017	he, mingxiong/0000-0002-9780-6865	National Natural Science Foundation of China [51108239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 51108239). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou E, 2008, BIOMASS BIOENERG, V32, P926, DOI 10.1016/j.biombioe.2008.01.015; Axmacher JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064173; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brosse N, 2012, BIOFUEL BIOPROD BIOR, V6, P580, DOI 10.1002/bbb.1353; Buddenhagen CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005261; Caspeta L, 2013, ENERG ENVIRON SCI, V6, P1077, DOI 10.1039/c3ee24403b; Chen SL, 2006, FLORA CHINA, V22, P582; Dalgaard T, 2006, SCIENCE, V312, P1743; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Evans JM, 2010, GCB BIOENERGY, V2, P63, DOI 10.1111/j.1757-1707.2010.01040.x; Flory SL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045904; Garcia A, 2014, ENVIRON CONSERV, V41, P1, DOI 10.1017/S0376892913000349; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gordon DR, 2011, BIOMASS BIOENERG, V35, P74, DOI 10.1016/j.biombioe.2010.08.029; Hedhly A, 2009, TRENDS PLANT SCI, V14, P30, DOI 10.1016/j.tplants.2008.11.001; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Herrera AM, 2003, BIOL INVASIONS, V5, P167, DOI 10.1023/A:1026190115521; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang CL, 2011, BIOMASS BIOENERG, V35, P1873, DOI 10.1016/j.biombioe.2011.01.032; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Khanum R, 2013, ACTA OECOL, V49, P23, DOI 10.1016/j.actao.2013.02.007; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Li BT, 2008, FLORA CHINA, V22, P266; Li J, 2012, BIORESOURCE TECHNOL, V108, P112, DOI 10.1016/j.biortech.2011.12.129; Li XF, 2010, ENVIRON MANAGE, V46, P579, DOI 10.1007/s00267-010-9443-0; Liang XY, 2013, J CLEAN PROD, V39, P24, DOI 10.1016/j.jclepro.2012.08.003; Liu L, 2006, FLORA CHINA, V22, P448; Lu L, 2012, ENERGIES, V5, P2165, DOI 10.3390/en5072165; Mangan ME, 2011, AGRON J, V103, P509, DOI 10.2134/agronj2010.0360; Mendu V, 2012, P NATL ACAD SCI USA, V109, P4014, DOI 10.1073/pnas.1112757109; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Radic V, 2011, J CLIMATE, V24, P5257, DOI 10.1175/JCLI-D-11-00011.1; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sang T, 2011, GCB BIOENERGY, V3, P79, DOI 10.1111/j.1757-1707.2010.01064.x; Shao HB, 2008, BIOMASS BIOENERG, V32, P283, DOI 10.1016/j.biombioe.2007.10.001; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tang Y, 2010, J INTEGR PLANT BIOL, V52, P112, DOI 10.1111/j.1744-7909.2010.00903.x; Trabucco A, 2010, GCB BIOENERGY, V2, P139, DOI 10.1111/j.1757-1707.2010.01049.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Tuck G, 2006, BIOMASS BIOENERG, V30, P183, DOI 10.1016/j.biombioe.2005.11.019; Villamil MB, 2012, RENEW SUST ENERG REV, V16, P3604, DOI 10.1016/j.rser.2012.03.033; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Wu CZ, 2010, ENERGY, V35, P4445, DOI 10.1016/j.energy.2009.04.006; Wu Z.Y., 2008, FLORA CHINA, V11, P335; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia NH, 2007, FLORA CHINA, V22, P6; Xiang QY, 2005, FLORA CHINA, V22, P215; Xiong SJ, 2008, BIORESOURCE TECHNOL, V99, P479, DOI 10.1016/j.biortech.2007.01.034; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Zamora DS, 2013, BIOMASS BIOENERG, V49, P222, DOI 10.1016/j.biombioe.2012.12.031; Zank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094625; Zhou D, 2012, J AGR SCI-CAMBRIDGE, V150, P179, DOI 10.1017/S0021859611000396; Zhu TP, 2007, PLANT RESOURCES CHIN, p[90, 404, 409, 418, 437]; Zhuang DF, 2011, RENEW SUST ENERG REV, V15, P1050, DOI 10.1016/j.rser.2010.11.041	64	17	19	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111587	10.1371/journal.pone.0111587	http://dx.doi.org/10.1371/journal.pone.0111587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365425	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100082
J	Liu, HH; Rossi, S; Zhou, HX; Chen, BG				Liu, Huanhuan; Rossi, Sonja; Zhou, Huixia; Chen, Baoguo			Electrophysiological Evidence for Domain-General Inhibitory Control during Bilingual Language Switching	PLOS ONE			English	Article							HIGHLY PROFICIENT BILINGUALS; COGNITIVE CONTROL; BRAIN; PERFORMANCE; MECHANISMS; ATTENTION; ERP	This paper presents an experiment that explored the role of domain-general inhibitory control on language switching. Reaction times (RTs) and event-related brain potentials (ERPs) were recorded when low-proficient bilinguals with high and low inhibitory control (IC) switched between overt picture naming in both their L1 and L2. Results showed that the language switch costs of bilinguals with high-IC were symmetrical, while that of bilinguals with low-IC were not. The N2 component failed to show a significant interaction between group, language and task, indicating that inhibition may not comes into play during the language task schema competition phase. The late positive component (LPC), however, showed larger amplitudes for L2 repeat and switch trials than for L1 trials in the high-IC group, indicating that inhibition may play a key role during the lexical response selection phase. These findings suggest that domain-general inhibitory control plays an important role in modulating language switch costs and its influence can be specified in lexical selection phase.	[Liu, Huanhuan; Zhou, Huixia; Chen, Baoguo] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Rossi, Sonja] Med Univ Innsbruck, Dept Med Psychol, A-6020 Innsbruck, Austria; [Rossi, Sonja] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Beijing Normal University; Medical University of Innsbruck; Max Planck Society	Chen, BG (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	Chenbg@bnu.edu.cn	Rossi, Sonja/D-1453-2016	Rossi, Sonja/0000-0002-3278-8993	National Social Science Fund [11BYY039]; Program for New Century Excellent Talents of Ministry of Education in China [NECT-11-0028]; Beijing Key Laboratory of Applied Experimental Psychology	National Social Science Fund; Program for New Century Excellent Talents of Ministry of Education in China; Beijing Key Laboratory of Applied Experimental Psychology	This research was supported by the National Social Science Fund [11BYY039], the Program for New Century Excellent Talents of Ministry of Education in China [NECT-11-0028] and Beijing Key Laboratory of Applied Experimental Psychology to Baoguo Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Berkman ET, 2009, NEUROIMAGE, V47, P705, DOI 10.1016/j.neuroimage.2009.04.084; Bialystok E, 2006, CAN J EXP PSYCHOL, V60, P68, DOI 10.1037/cjep2006008; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Calabria M, 2012, FRONT PSYCHOL, V2, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.3389/FPSYG.2011; Christoffels IK, 2007, BRAIN RES, V1147, P192, DOI 10.1016/j.brainres.2007.01.137; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; de Bruin A, 2014, NEUROIMAGE, V90, P348, DOI 10.1016/j.neuroimage.2013.12.049; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Guo TM, 2013, ACTA PSYCHOL, V143, P277, DOI 10.1016/j.actpsy.2013.04.002; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hosoda C, 2012, J NEUROLINGUIST, V25, P44, DOI 10.1016/j.jneuroling.2011.08.007; Jackson GM, 2001, BILING-LANG COGN, V4, P169, DOI [10.1017/S1366728901000268, DOI 10.1017/S1366728901000268]; Linck JA, 2012, BILING-LANG COGN, V15, P651, DOI 10.1017/S136672891100054X; Luk G, 2012, LANG COGNITIVE PROC, V27, P1479, DOI 10.1080/01690965.2011.613209; Martin CD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00815; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Umebayashi K, 2010, BRAIN RES, V1346, P165, DOI 10.1016/j.brainres.2010.05.050; Verhoef K, 2009, COGNITION, V110, P84, DOI 10.1016/j.cognition.2008.10.013; Verhoef KMW, 2010, J COGNITIVE NEUROSCI, V22, P1832, DOI 10.1162/jocn.2009.21291; [张清芳 Zhang Qingfang], 2003, [心理学报, Acta Psychologica Sinica], V35, P447	28	86	93	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2014	9	10							e110887	10.1371/journal.pone.0110887	http://dx.doi.org/10.1371/journal.pone.0110887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BL	25369471	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943500062
J	Liu, HX; Su, YY; Zhu, L; Xing, JN; Wu, J; Wang, N				Liu, Huixin; Su, Yingying; Zhu, Lin; Xing, Jiannan; Wu, Jing; Wang, Ning			Effectiveness of ART and Condom Use for Prevention of Sexual HIV Transmission in Serodiscordant Couples: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL TREATMENT; INFECTION; THERAPY; DECLINE; COHORT; RISK; INITIATION; PROVINCE; IMPACT	Background: Consistent and correct condom use and suppressive antiretroviral therapy for the infected partner are two of the primary strategies recommended for prevention of heterosexual HIV transmission in serodiscordant couples today. The applied effectiveness of treatment as a prevention strategy in China is still under investigation, and much less is known about its effects in the presence of other prevention strategies such as consistent condom use. Methods: We conducted a systematic search in PubMed and three Chinese language databases to identify relevant articles for the estimation of relative effectiveness of a) consistent condom use and b) ART use by index partners for preventing HIV transmission in serodiscordant couples. We also estimated the prevention effectiveness of ART stratified by condom use level and the prevention effectiveness of consistent condom use stratified by ART use level. Results: Pooled results from the eleven eligible studies found a pooled HIV seroconversion incidence of 0.92 cases per 100 person years (PY) among HIV-negative spouses whose index partners were taking ART versus 2.45 cases per 100 PY in untreated couples. The IRR comparing seroconversion in couples where the index-partner was on ART versus not on ART was 0.47 (95% CI: 0.43, 0.52), while stratified by condom use, the IRR was 0.33(0.17, 0.64). The IRR comparing incidence in couples reporting "consistent condom use'' versus those reporting otherwise was 0.02(95% CI: 0.01, 0.04), after stratified by ART use level, the IRR was 0.01(95% CI: 0.00, 0.06). Conclusions: ART use by index partners could reduce HIV transmission in serodiscordant couples, and the effectiveness of this prevention strategy could be further increased with consistent condom use.	[Liu, Huixin; Su, Yingying; Zhu, Lin; Xing, Jiannan; Wu, Jing; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	Rossi, Sonja/D-1453-2016	Rossi, Sonja/0000-0002-3278-8993	mega-projects of national science research for the 12th Five-Year Plan of China [2012ZX10001-001]	mega-projects of national science research for the 12th Five-Year Plan of China	Supported by the mega-projects of national science research for the 12th Five-Year Plan (2012ZX10001-001) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Duan Song, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P997; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Gray R, 2011, AIDS, V25, P863, DOI 10.1097/QAD.0b013e3283448790; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Heymer KJ, 2011, SEX HEALTH, V8, P280, DOI 10.1071/SH10084; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Li Jing-yun, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P192; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; [毛宇嵘 Mao Yurong], 2004, [中华流行病学杂志, Chinese Journal of Epidemiology], V25, P322; Ministry of Health of the People's Republic of China Joint United Nations Program on HIV/AIDS WHO, 2011, 2011 EST HIV AIDS EP; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pan Xiao-hong, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1023; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Qiao XiaoChun, 2009, Chinese Preventive Medicine, V10, P976; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; R Core Team, 2021, R LANGUAGE ENV STAT; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wang L, 2013, CHINESE MED J-PEKING, V126, P3694, DOI 10.3760/cma.j.issn.0366-6999.20123311; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; Wells G., 2014, S SYST REV BAS; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang K, 2001, CHINA J AIDS STD, V7, P286; Zheng Xi-Wen, 1993, Biomedical and Environmental Sciences, V6, P348; Zheng XW, 1994, CHIN J EPID, V15, P3	39	86	93	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2014	9	11							e111175	10.1371/journal.pone.0111175	http://dx.doi.org/10.1371/journal.pone.0111175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XG	25369471	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402000041
